FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Sorensen, CJ
   Borbor-Cordova, MJ
   Calvello-Hynes, E
   Diaz, A
   Lemery, J
   Stewart-Ibarra, AM
AF Sorensen, Cecilia J.
   Borbor-Cordova, Mercy J.
   Calvello-Hynes, Emilie
   Diaz, Avriel
   Lemery, Jay
   Stewart-Ibarra, Anna M.
TI Climate Variability, Vulnerability, and Natural Disasters: A Case Study
   of Zika Virus in Manabi, Ecuador Following the 2016 Earthquake
SO GEOHEALTH
LA English
DT Editorial Material
DE climate change; natural disaster; Zika virus; vulnerable populations
AB Climate change presents complex and wide-reaching threats to human health. A variable and changing climate can amplify and unmask ecological and socio-political weaknesses and increase the risk of adverse health outcomes in socially vulnerable regions. When natural disasters occur in such areas, underlying climatic conditions may amplify the public health crisis. We describe an emerging epidemic of Zika virus (ZIKV) in Ecuador following the 2016 earthquake, which coincided with an exceptionally strong El Nino event. We hypothesize that the trigger of a natural disaster during anomalous climate conditions and underlying social vulnerabilities were force multipliers contributing to a dramatic increase in ZIKV cases postearthquake.
C1 [Sorensen, Cecilia J.; Calvello-Hynes, Emilie; Lemery, Jay] Univ Colorado, Sch Med, Dept Emergency Med, Aurora, CO 80045 USA.
   [Borbor-Cordova, Mercy J.] Escuela Super Politecn Litoral, Fac Naval Engn Ocean Sci & Nat Resources, Guayaquil, Ecuador.
   [Diaz, Avriel] Columbia Univ, Dept Evolut Ecol & Environm Biol, New York, NY USA.
   [Stewart-Ibarra, Anna M.] SUNY Upstate Med Univ, Dept Publ Hlth & Preventat Med, Dept Med, Syracuse, NY 13210 USA.
RP Sorensen, CJ (corresponding author), Univ Colorado, Sch Med, Dept Emergency Med, Aurora, CO 80045 USA.
EM cecilia.sorensen@ucdenver.edu
OI Stewart-Ibarra, Anna/0000-0002-3383-4672
FU University of Colorado Consortium on Climate Change and Health; National
   Science FoundationNational Science Foundation (NSF) [DEB EEID 1518681,
   DEB RAPID 1641145]; Centro Internacional del Pacifico para la Reduccion
   de Riesgos de Desastres at ESPOL
FX This paper represents a collaboration through the University of Colorado
   Consortium on Climate Change and Health. Stewart-Ibarra receives support
   from the National Science Foundation (DEB EEID 1518681 and DEB RAPID
   1641145). Borbor-Cordova receives support from Centro Internacional del
   Pacifico para la Reduccion de Riesgos de Desastres at ESPOL. No other
   authors have financial disclosures or conflicts of interest to declare.
CR [Anonymous], 2017, ZIK EP REP
   Ashby J, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9040328
   Beccari Benjamin, 2016, PLoS Curr, V8, DOI 10.1371/currents.dis.453df025e34b682e9737f95070f9b970
   Bermudez N., 2017, YEAR ECUADORIAN EART
   Bi P, 2005, VECTOR-BORNE ZOONOT, V5, P95, DOI 10.1089/vbz.2005.5.95
   Borbor-Cordova M, 2016, CLIMATE SERVICES HLT
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cai WJ, 2014, NAT CLIM CHANGE, V4, P111, DOI [10.1038/NCLIMATE2100, 10.1038/nclimate2100]
   Colon-Gonzalez FJ, 2011, AM J TROP MED HYG, V84, P757, DOI 10.4269/ajtmh.2011.10-0609
   Recalde-Coronel GC, 2014, J APPL METEOROL CLIM, V53, P1471, DOI 10.1175/JAMC-D-13-0133.1
   Cutter SL, 2003, SOC SCI QUART, V84, P242, DOI 10.1111/1540-6237.8402002
   Field CB, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P1
   Fisman D. N., 2016, P NATL ACAD SCI USA, V114, P119
   Fuller DO, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/1/014011
   Gage KL, 2008, AM J PREV MED, V35, P436, DOI 10.1016/j.amepre.2008.08.030
   Gagnon AS, 2001, CLIM RES, V19, P35, DOI 10.3354/cr019035
   Githeko AK, 2000, B WORLD HEALTH ORGAN, V78, P1136
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Hurtado-Diaz M, 2007, TROP MED INT HEALTH, V12, P1327, DOI 10.1111/j.1365-3156.2007.01930.x
   Ibarra AMS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078263
   Johansson MA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000382
   Kim E. J., 2016, IMPACTS CLIMATE CHAN, P312
   Luber G., 2015, GLOBAL CLIMATE CHANG
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Moreno-Madrinan MJ, 2017, J MED ENTOMOL, V54, P251, DOI 10.1093/jme/tjw212
   Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556
   Munoz A. G., 2016, 201601 IRI
   Munoz AG, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01291
   Munoz AG, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0146-1
   National Oceanic and Atmospheric Administration, 2016, 2016 MARKS 3 CONS RE
   National Oceanic and Atmospheric Administration, 2015, STRONG NIN SETS STAG
   Pan American Health Organization, 2017, REG ZIK EP UPD AM MA
   Pan American Health Organization, 2017, ZIK CUM CAS
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Poveda G, 2000, NINO SO OSCILLATION, P183, DOI DOI 10.1017/CBO9780511573125.007
   Rossel F, 2009, HYDROL PROCESS, V23, P3253, DOI 10.1002/hyp.7401
   Santoso A, 2013, NATURE, V504, P126, DOI 10.1038/nature12683
   Stanforth A, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8090770
   Stewart-Ibarra AM, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0610-4
   Stewart-Ibarra AM, 2013, AM J TROP MED HYG, V88, P971, DOI 10.4269/ajtmh.12-0478
   Timmermann A, 1999, NATURE, V398, P694
   United States Environmental Protection Agency, 2017, CLIM CHANG IND SEA S
   Wang H, 2015, LANCET, V386, P1798, DOI 10.1016/S0140-6736(15)60931-X
   Watts N, 2017, LANCET, V389, P1151, DOI 10.1016/S0140-6736(16)32124-9
   World Bank, 2017, OV WORLD BANK EC
   World Health Organization, 2016, WHO DIS OUTBR NEWS
   World Health Organization, 2016, WHO PAN AM HLTH ORG, V121, P1
NR 48
TC 6
Z9 6
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2471-1403
J9 GEOHEALTH
JI GeoHealth
PD OCT
PY 2017
VL 1
IS 8
BP 298
EP 304
DI 10.1002/2017GH000104
PG 7
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA VI0FW
UT WOS:000458210400001
PM 32158994
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Krause, KK
   Azouz, F
   Shin, OS
   Kumar, M
AF Krause, Keeton K.
   Azouz, Francine
   Shin, Ok Sarah
   Kumar, Mukesh
TI Understanding the Pathogenesis of Zika Virus Infection Using Animal
   Models
SO IMMUNE NETWORK
LA English
DT Review
DE Zika virus; Animal model; Etiology
ID SEXUAL TRANSMISSION; GUINEA-PIG; ANTIVIRAL DRUG; VIRAL DYNAMICS;
   UNITED-STATES; MOUSE MODEL; EFFICACY; BRAIN; SOFOSBUVIR; VACCINE
AB Zika virus (ZIKV) is a member of Flaviviridae family that has emerged as a pathogen of significant public health importance. The rapid expansion of ZIKV in the South and Central America has recently gained medical attention emphasizing the capacity of ZIKV to spread to non-endemic regions. ZIKV infection during pregnancy has been demonstrated to cause microcephaly and other fetal developmental abnormalities. An increased incidence of Guillain-Barre syndrome, an immune mediated neuropathy of the peripheral nervous system, has also been reported in ZIKV-infected patients in French Polynesia and Brazil. No effective therapies currently exist for treating patients infected with ZIKV. Despite the relatively short time interval, an intensive effort by the global scientific community has resulted in development of animal models to study multiple aspects of ZIKV biology. Several animal models have been established to investigate pathogenesis of ZIKV in adults, pregnant mothers, and developing fetuses. Here we review the remarkable progress of newly developed small and large animal models for understanding ZIKV pathogenesis.
C1 [Krause, Keeton K.; Azouz, Francine; Kumar, Mukesh] Univ Hawaii Manoa, John A Burns Sch Med, Pacific Ctr Emerging Infect Dis Res, Dept Trop Med Med Microbiol & Pharmacol, 651 Ilalo St,BSB 320F, Honolulu, HI 96813 USA.
   [Shin, Ok Sarah] Korea Univ, Coll Med, Dept Biomed Sci, Seoul 02841, South Korea.
RP Kumar, M (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Pacific Ctr Emerging Infect Dis Res, Dept Trop Med Med Microbiol & Pharmacol, 651 Ilalo St,BSB 320F, Honolulu, HI 96813 USA.
EM mukesh@hawaii.edu
RI Kumar, Mukesh/AAI-1046-2019; Kumar, Mukesh/N-8814-2015
OI Kumar, Mukesh/0000-0003-0970-4875; Kumar, Mukesh/0000-0003-0970-4875
FU Centers of Biomedical Research Excellence, National Institute of General
   Medical Sciences [P30GM114737]; National Institute of Neurological
   Disorders and StrokeUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Neurological Disorders & Stroke (NINDS) [R21NS099838]; Office of the
   Director, National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [R21OD024896]
FX This work was supported by a grant (P30GM114737) from the Centers of
   Biomedical Research Excellence, National Institute of General Medical
   Sciences, grant (R21NS099838) from National Institute of Neurological
   Disorders and Stroke, and grant (R21OD024896) from the Office of the
   Director, National Institutes of Health.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Baz M, 2017, ANTIVIR THER, V22, P613, DOI 10.3851/IMP3180
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Best K, 2017, P NATL ACAD SCI USA, V114, P8847, DOI 10.1073/pnas.1704011114
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Cai L, 2017, ARCH VIROL, V162, P2847, DOI 10.1007/s00705-017-3436-8
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Fernandes NCCA, 2017, EXP TOXICOL PATHOL, V69, P63, DOI 10.1016/j.etp.2016.11.004
   Furuta Y, 2002, ANTIMICROB AGENTS CH, V46, P977, DOI 10.1128/AAC.46.4.977-981.2002
   Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015
   Furuta Y, 2009, ANTIVIR RES, V82, P95, DOI 10.1016/j.antiviral.2009.02.198
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Herrera BB, 2017, J INFECT DIS, V215, P1546, DOI 10.1093/infdis/jix182
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Kumar M, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0750-4
   Kumar M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005262
   Lanko K, 2017, ANTIVIR RES, V145, P82, DOI 10.1016/j.antiviral.2017.07.010
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Lin HH, 2018, BIOTECHNOL ADV, V36, P47, DOI 10.1016/j.biotechadv.2017.09.004
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Mess A, 2007, PLACENTA, V28, P812, DOI 10.1016/j.placenta.2007.02.005
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Musso D, 2017, LANCET INFECT DIS, V17, P255, DOI 10.1016/S1473-3099(17)30070-1
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Padilla-Carlin DJ, 2008, COMPARATIVE MED, V58, P324
   Reznik SE, 2017, INT J INFECT DIS, V55, P29, DOI 10.1016/j.ijid.2016.12.011
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   SALUZZO JF, 1982, B SOC PATHOL EXOT, V75, P262
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Walker WL, 2016, MMWR-MORBID MORTAL W, V65, P983, DOI 10.15585/mmwr.mm6536e5
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   WHO, 2016, SAUDI MED J, V37, P470
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 78
TC 10
Z9 10
U1 0
U2 1
PU KOREA ASSOC IMMUNOLOGISTS
PI SEOUL
PA KOREA SCIENCE & TECHNOLOGY CENTER, RM 701, 7 GIL 22, TEHERAN-RO, (635-4
   YEOKSAM-DONG) GANGMAN-GU, SEOUL, 06130, SOUTH KOREA
SN 1598-2629
EI 2092-6685
J9 IMMUNE NETW
PD OCT
PY 2017
VL 17
IS 5
BP 287
EP 297
DI 10.4110/in.2017.17.5.287
PG 11
WC Immunology
SC Immunology
GA FQ3VA
UT WOS:000418284200003
PM 29093650
OA Green Published
DA 2020-07-08
ER

PT J
AU Sallam, MF
   Fizer, C
   Pilant, AN
   Whung, PY
AF Sallam, Mohamed F.
   Fizer, Chelsea
   Pilant, Andrew N.
   Whung, Pai-Yei
TI Systematic Review: Land Cover, Meteorological, and Socioeconomic
   Determinants of Aedes Mosquito Habitat for Risk Mapping
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Review
DE Aedes; dengue; ecological modeling; physical systems; Zika
ID WEST-NILE-VIRUS; RIO-DE-JANEIRO; ALBOPICTUS DIPTERA; SURVIVAL RATES;
   DENGUE-FEVER; PUERTO-RICO; URBAN AREA; CULICIDAE; AEGYPTI; ABUNDANCE
AB Asian tiger and yellow fever mosquitoes (Aedes albopictus and Ae. aegypti) are global nuisances and are competent vectors for viruses such as Chikungunya (CHIKV), Dengue (DV), and Zika (ZIKV). This review aims to analyze available spatiotemporal distribution models of Aedes mosquitoes and their influential factors. A combination of five sets of 3-5 keywords were used to retrieve all relevant published models. Five electronic search databases were used: PubMed, MEDLINE, EMBASE, Scopus, and Google Scholar through 17 May 2017. We generated a hierarchical decision tree for article selection. We identified 21 relevant published studies that highlight different combinations of methodologies, models and influential factors. Only a few studies adopted a comprehensive approach highlighting the interaction between environmental, socioeconomic, meteorological and topographic systems. The selected articles showed inconsistent findings in terms of number and type of influential factors affecting the distribution of Aedes vectors, which is most likely attributed to: (i) limited availability of high-resolution data for physical variables; (ii) variation in sampling methods, Aedes feeding and oviposition behavior; (iii) data collinearity and statistical distribution of observed data. This review highlights the need and sets the stage for a rigorous multi-system modeling approach to improve our knowledge about Aedes presence/abundance within their flight range in response to the interaction between environmental, socioeconomic, and meteorological systems.
C1 [Sallam, Mohamed F.] Oak Ridge Inst Sci & Educ, Resilient Environm & Hlth Agr & Water Solut, Natl Exposure Res Lab, Syst Exposure Div, 109 TW Alexander Dr, Res Triangle Pk, NC 27711 USA.
   [Fizer, Chelsea] Oak Ridge Associated Univ, US EPA, Off Res & Dev, Natl Exposure Res Lab,Environm Protect Agcy, 109 TW Alexander Dr, Res Triangle Pk, NC 27711 USA.
   [Pilant, Andrew N.; Whung, Pai-Yei] Oak Ridge Associated Univ, Off Res & Dev, Natl Exposure Res Lab, Environm Protect Agcy, 109 TW,Alexander Dr, Res Triangle Pk, NC 27711 USA.
RP Sallam, MF (corresponding author), Oak Ridge Inst Sci & Educ, Resilient Environm & Hlth Agr & Water Solut, Natl Exposure Res Lab, Syst Exposure Div, 109 TW Alexander Dr, Res Triangle Pk, NC 27711 USA.
EM sallam.mohamed@epa.gov; Fizer.Chelsea@epa.gov; Pilant.Drew@epa.gov;
   Whung.Pai-Yei@epa.gov
CR AIKEN SR, 1980, SOC SCI MED-MED GEOG, V14, P307, DOI 10.1016/0160-8002(80)90043-X
   [Anonymous], 2004, WHO REPORT
   [Anonymous], 2013, WHO REPORT
   Ashby J, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9040328
   Barker CM, 2003, J MED ENTOMOL, V40, P403, DOI 10.1603/0022-2585-40.4.403
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Brady OJ, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P30, DOI 10.1079/9781845939649.0030
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Buckner EA, 2011, J VECTOR ECOL, V36, P269, DOI 10.1111/j.1948-7134.2011.00167.x
   Caminade C, 2014, INT J ENV RES PUB HE, V11, P903, DOI 10.3390/ijerph110100903
   Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135
   CHADEE DD, 1990, J AM MOSQUITO CONTR, V6, P148
   Chao Day-Yu, 2000, Dengue Bulletin, V24, P46
   Clements A.N, 1999, BIOL MOSQUITOES SENS, V2
   CLEMENTS AN, 1981, J APPL ECOL, V18, P373, DOI 10.2307/2402401
   CLEMENTS AN, 1999, BIOL MOSQUITOES SENS
   David MR, 2009, MEM I OSWALDO CRUZ, V104, P927, DOI 10.1590/S0074-02762009000600019
   DeGroote J, 2007, J MED ENTOMOL, V44, P1139, DOI 10.1603/0022-2585(2007)44[1139:SIOAMD]2.0.CO;2
   Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026
   Dixon P., 2014, Q REV BIOL, V89, P168
   Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x
   Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x
   Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x
   Fischer D, 2014, EUROSURVEILLANCE, V19, P34, DOI 10.2807/1560-7917.ES2014.19.6.20696
   Fischer D, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-51
   Fischer S, 2011, J VECTOR ECOL, V36, P94, DOI 10.1111/j.1948-7134.2011.00145.x
   FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489
   GDCH. Georgia Department of Community Health, MOSQ BORN VIR DIS WE
   Geiser RM, 2010, B ENTOMOL RES, V100, P153, DOI 10.1017/S0007485309006919
   Godsey MS, 2005, VECTOR-BORNE ZOONOT, V5, P82, DOI 10.1089/vbz.2005.5.82
   Harrigan RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015437
   Hayden MH, 2010, ECOHEALTH, V7, P64, DOI 10.1007/s10393-010-0288-z
   HERRERABASTO E, 1992, AM J TROP MED HYG, V46, P649, DOI 10.4269/ajtmh.1992.46.649
   Honorio NA, 2003, MEM I OSWALDO CRUZ, V98, P191, DOI 10.1590/S0074-02762003000200005
   Horwitz P, 2005, INT J PARASITOL, V35, P725, DOI 10.1016/j.ijpara.2005.03.002
   HYLTON AR, 1967, J INSECT PHYSIOL, V13, P153, DOI 10.1016/0022-1910(67)90011-X
   Jemal Y., 2016, SAUDI J BIOL SCI
   Jetten TH, 1997, AM J TROP MED HYG, V57, P285, DOI 10.4269/ajtmh.1997.57.285
   Kobayashi M, 2002, J MED ENTOMOL, V39, P4, DOI 10.1603/0022-2585-39.1.4
   KOOPMAN JS, 1991, AM J EPIDEMIOL, V133, P1168, DOI 10.1093/oxfordjournals.aje.a115829
   Koyadun S., 2012, INT PERSPECT INFECT, V2012, P12
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lance-Parker Susan, 2002, J Med Assoc Ga, V91, P32
   Landau KI, 2012, J VECTOR ECOL, V37, P407, DOI 10.1111/j.1948-7134.2012.00245.x
   Lockaby G, 2016, J VECTOR ECOL, V41, P232, DOI 10.1111/jvec.12218
   Manrique PD, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.022304
   Marini F, 2010, MED VET ENTOMOL, V24, P361, DOI 10.1111/j.1365-2915.2010.00898.x
   Massad E., 2016, GLOB HLTH ACTION, V9
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Monaghan Ai., 2016, PLOS CURR, V8
   MOORE CG, 1978, AM J TROP MED HYG, V27, P1225, DOI 10.4269/ajtmh.1978.27.1225
   Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1
   Pickard BR, 2015, ECOSYST SERV, V14, P45, DOI 10.1016/j.ecoser.2015.04.005
   Reisen WK, 2008, EMERG INFECT DIS, V14, P1747, DOI 10.3201/eid1411.080719
   Reiter ME, 2007, J MED ENTOMOL, V44, P861, DOI 10.1603/0022-2585(2007)44[861:LFITSD]2.0.CO;2
   REITER P, 1995, AM J TROP MED HYG, V52, P177, DOI 10.4269/ajtmh.1995.52.177
   Rey JR, 2006, J MED ENTOMOL, V43, P1134, DOI 10.1603/0022-2585(2006)43[1134:HSOMAV]2.0.CO;2
   Richards SL, 2006, J MED ENTOMOL, V43, P976, DOI 10.1603/0022-2585(2006)43[976:SAOAAD]2.0.CO;2
   Robert MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161365
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Rochlin I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023280
   Rubio A, 2013, ACTA TROP, V128, P680, DOI 10.1016/j.actatropica.2013.09.015
   Ruiz M. O., 2004, INT J HEALTH GEOGR, V3, P8, DOI DOI 10.1186/1476-072X-3-8
   Sallam M. F., HABITAT SUITABILITY
   Sallam M. F., 2016, TECH B FLA MOSQ CONT, V10, P18
   SALLAM MF, 2017, INT J ENV RES PUBLIC, V14
   Sallam MF, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1646-7
   Sallam MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065786
   Scott TW, 2000, J MED ENTOMOL, V37, P77, DOI 10.1603/0022-2585-37.1.77
   Sivan A, 2015, PARASITOL RES, V114, P3539, DOI 10.1007/s00436-015-4634-5
   Swanson J, 2000, J MED ENTOMOL, V37, P454, DOI 10.1603/0022-2585(2000)037[0454:OAEOAA]2.0.CO;2
   Thammapalo S., 2012, J TROPICAL MED, V2012, P7
   Troyo A, 2008, J VECTOR ECOL, V33, P1, DOI 10.3376/1081-1710(2008)33[1:AGSMFS]2.0.CO;2
   Wijayanti SPM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004964
   Zhou G, 2007, AM J TROP MED HYG, V77, P29, DOI 10.4269/ajtmh.2007.77.29
NR 77
TC 12
Z9 12
U1 0
U2 16
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD OCT
PY 2017
VL 14
IS 10
AR 1230
DI 10.3390/ijerph14101230
PG 15
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA FM1TF
UT WOS:000414763200139
PM 29035317
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tyler, KL
   Roos, KL
AF Tyler, Kenneth L.
   Roos, Karen L.
TI The Expanding Spectrum of Zika Virus Infections of the Nervous System
SO JAMA NEUROLOGY
LA English
DT Editorial Material
ID GUILLAIN-BARRE-SYNDROME
C1 [Tyler, Kenneth L.] Univ Colorado, Dept Neurol, Sch Med, 12700 E 19th Ave,Campus Mailstop B-182, Aurora, CO 80045 USA.
   [Tyler, Kenneth L.] Univ Colorado, Dept Med, Sch Med, Aurora, CO 80045 USA.
   [Tyler, Kenneth L.] Univ Colorado, Dept Immunol Microbiol, Sch Med, Aurora, CO 80045 USA.
   [Roos, Karen L.] Indiana Univ Sch Med, Dept Neurol, Indianapolis, IN 46202 USA.
RP Tyler, KL (corresponding author), Univ Colorado, Dept Neurol, Sch Med, 12700 E 19th Ave,Campus Mailstop B-182, Aurora, CO 80045 USA.
EM ken.tyler@ucdenver.edu
RI Tyler, Kenneth L./J-2420-2019
OI Tyler, Kenneth L./0000-0003-3294-5888
CR Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cragan JD, 2017, MMWR-MORBID MORTAL W, V66, P19, DOI 10.15585/mmwr.mm6608a4
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Kam YW, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92428
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Siu R, 2016, NEUROLOGY, V87, P1623, DOI 10.1212/WNL.0000000000003038
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
NR 16
TC 5
Z9 7
U1 0
U2 1
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6149
EI 2168-6157
J9 JAMA NEUROL
JI JAMA Neurol.
PD OCT
PY 2017
VL 74
IS 10
BP 1169
EP 1171
DI 10.1001/jamaneurol.2017.1471
PG 3
WC Clinical Neurology
SC Neurosciences & Neurology
GA FJ3UN
UT WOS:000412657800004
PM 28806454
DA 2020-07-08
ER

PT J
AU da Silva, IRF
   Frontera, JA
   de Filippis, AMB
   do Nascimento, OJM
AF Ferreira da Silva, Ivan Rocha
   Frontera, Jennifer A.
   Bispo de Filippis, Ana Maria
   Moreira do Nascimento, Osvaldo Jose
CA RIO GBS ZIKV Res Grp
TI Neurologic Complications Associated With the Zika Virus in Brazilian
   Adults
SO JAMA NEUROLOGY
LA English
DT Article
ID GUILLAIN-BARRE-SYNDROME; CASE DEFINITIONS; INFECTION; CRITERIA;
   CLASSIFICATION; ENCEPHALITIS; GUIDELINES; MANAGEMENT; DIAGNOSIS;
   MYELITIS
AB IMPORTANCE There are no prospective cohort studies assessing the incidence and spectrum of neurologic manifestations secondary to Zika virus (ZIKV) infection in adults.
   OBJECTIVE To evaluate the rates of acute ZIKV infection among patients hospitalized with Guillain-Barr, syndrome (GBS), meningoencephalitis, or transversemyelitis.
   DESIGN, SETTING, AND PARTICIPANTS A prospective, observational cohort studywas conducted at a tertiary referral center for neurological diseases in Rio de Janeiro, Brazil, between December 5, 2015, and May 10, 2016, among consecutive hospitalized adults (> 18 years of age) with new-onset acute parainfectious or neuroinflammatory disease. All participants were tested for a series of arbovirosis. Three-month functional outcome was assessed.
   INTERVENTIONS Samples of serum and cerebrospinal fluid were tested for ZIKV using real-time reverse-transcriptase-polymerase chain reaction and an IgMantibody-capture enzyme-linked immunosorbent assay. Clinical, radiographic (magnetic resonance imaging), electrophysiological, and 3-month functional outcome data were collected.
   MAIN OUTCOMES AND MEASURES The detection of neurologic complications secondary to ZIKV infection.
   RESULTS Forty patients (15 women and 25 men; median age, 44 years [range, 22-72 years]) were enrolled, including 29 patients (73%) with GBS (90% Brighton level 1 certainty), 7 (18%) with encephalitis, 3 (8%) with transversemyelitis, and 1 (3%) with newly diagnosed chronic inflammatory demyelinating polyneuropathy. Of these, 35 patients (88%) had molecular and/or serologic evidence of recent ZIKV infection in the serum and/or cerebrospinal fluid. Of the patients positive for ZIKV infection, 27 had GBS (18 demyelinating, 8 axonal, and 1 Miller Fisher syndrome), 5 had encephalitis (3 with concomitant acute neuromuscular disease), 2 had transversemyelitis, and 1 had chronic inflammatory demyelinating polyneuropathy. Admission to the intensive care unit was required for 9 patients positive for ZIKV infection (26%), and 5 (14%) required mechanical ventilation. Compared with admission during the period from December 5, 2013, toMay 10, 2014 (before the Brazilian outbreak of ZIKV), admissions for GBS increased from a mean of 1.0 per month to 5.6 per month, admissions for encephalitis increased from 0.4 per month to 1.4 per month, and admissions for transverse myelitis remained constant at 0.6 per month. At 3 months, 2 patients positive for ZIKV infection (6%) died (1 with GBS and 1 with encephalitis), 18 (51%) had chronic pain, and the median modified Rankin score among survivors was 2 (range, 0-5).
   CONCLUSIONS AND RELEVANCE In this single-center Brazilian cohort, ZIKV infection was associated with an increase in the incidence of a diverse spectrum of serious neurologic syndromes. The data also suggest that serologic and molecular testing using blood and cerebrospinal fluid samples can serve as a less expensive, alternative diagnostic strategy in developing countries, where plaque reduction neutralization testing is impractical. (C) 2017 American Medical Association. All rights reserved.
C1 [Ferreira da Silva, Ivan Rocha; Moreira do Nascimento, Osvaldo Jose] Univ Fed Fluminense, Neurol Dept, Niteroi, RJ, Brazil.
   [Ferreira da Silva, Ivan Rocha] Amer Med City, Neurocrit Care Dept, Rio De Janeiro, Brazil.
   [Frontera, Jennifer A.] NYU, Dept Neurol, Brooklyn, NY USA.
   [Bispo de Filippis, Ana Maria] Fundacao Oswaldo Cruz, Flavivirus Lab, Rio De Janeiro, Brazil.
RP do Nascimento, OJM (corresponding author), Univ Fed Fluminense, Neurol Dept, Rua Siqueira Campos 53-1204, BR-22031071 Copacabana, RJ, Brazil.
EM osvaldo_nascimento@hotmail.com
FU Cleveland Clinic Foundation [RPC194-S2]
FX This study was funded by award RPC194-S2 from the Cleveland Clinic
   Foundation.
CR Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Brecher K, 1998, J NEUROL NEUROSUR PS, V65, P917, DOI 10.1136/jnnp.65.6.917
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Centers for Disease Control and Prevention, UPD INT ZIK VIR CLIN
   Centers for Disease Control and Prevention, FACT SHEET HEALTHC P
   Centers for Disease Control and Prevention, FLOR INV LINKS REC Z
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   da Silva IRF, 2016, NEUROLOGY, V87, pE180, DOI 10.1212/WNL.0000000000003024
   Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285
   Frontera JA, 2016, NEW ENGL J MED, V375, P1581, DOI 10.1056/NEJMe1611840
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Hadden RDM, 1998, ANN NEUROL, V44, P780, DOI 10.1002/ana.410440512
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Jeha LE, 2003, NEUROLOGY, V61, P55, DOI 10.1212/01.WNL.0000073617.08185.0A
   Kalita J, 2008, J NEUROL NEUROSUR PS, V79, P289, DOI 10.1136/jnnp.2007.118000
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mansfield KL, 2011, J GEN VIROL, V92, P2821, DOI 10.1099/vir.0.031641-0
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mulkey SB, 2010, PEDIATR NEUROL, V43, P263, DOI 10.1016/j.pediatrneurol.2010.05.011
   Pan American Health Organization, EP UPD NEUR SYNDR CO
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Roze B, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.16.30205
   Sander HW, 2003, NEUROLOGY, V60, pS8, DOI 10.1212/WNL.60.8_suppl_3.S8
   Scott TF, 2011, NEUROLOGY, V77, P2128, DOI 10.1212/WNL.0b013e31823dc535
   Secretaria de Vigilancia em Saude-Ministerio da Saude, B EPIDEMIOLOGICO
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Tunkel AR, 2008, CLIN INFECT DIS, V47, P303, DOI 10.1086/589747
   Van den Bergh PYK, 2010, EUR J NEUROL, V17, P356, DOI 10.1111/j.1468-1331.2009.02930.x
   Van der Meche FGA, 2001, EUR NEUROL, V45, P133, DOI 10.1159/000052111
   Venkatesan A, 2013, CLIN INFECT DIS, V57, P1114, DOI 10.1093/cid/cit458
   Wakerley BR, 2014, NAT REV NEUROL, V10, P537, DOI 10.1038/nrneurol.2014.138
   World Health Organization, LAB TEST ZIK VIR INF
   World Health Organization, GUILL BARR SYNDR BRA
   Xiang JY, 2014, VIRAL IMMUNOL, V27, P418, DOI 10.1089/vim.2014.0049
   Yuki N, 2012, J NEUROL, V259, P1181, DOI 10.1007/s00415-011-6330-4
   Zambrano H, 2016, AM J TROP MED HYG, V95, P894, DOI 10.4269/ajtmh.16-0323
NR 40
TC 59
Z9 61
U1 1
U2 7
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6149
EI 2168-6157
J9 JAMA NEUROL
JI JAMA Neurol.
PD OCT
PY 2017
VL 74
IS 10
BP 1190
EP 1198
DI 10.1001/jamaneurol.2017.1703
PG 9
WC Clinical Neurology
SC Neurosciences & Neurology
GA FJ3UN
UT WOS:000412657800009
PM 28806453
OA Green Published
DA 2020-07-08
ER

PT J
AU Wong, LP
   Alias, H
   Aghamohammadi, N
   Sam, IC
   AbuBakar, S
AF Wong, Li Ping
   Alias, Haridah
   Aghamohammadi, Nasrin
   Sam, I-ching
   AbuBakar, Sazaly
TI Differences in Perceived Severity of Zika Virus Infection and Dengue
   Fever and its Influence on Mosquito Control Practices in Malaysia
SO JOURNAL OF COMMUNITY HEALTH
LA English
DT Article
DE Zika; Dengue; Perceived severity; Mosquito prevention
ID HEALTH BELIEF MODEL
AB The aims of this study were to explore the differences in (1) the perception of severity towards ZIKV infection and dengue fever, and (2) mosquito control practices before and after the ZIKV outbreak were declared a Public Health Emergency of International Concern (PHEIC). Data were collected between Feb to May 2016 using a computer-assisted telephone interviewing system. The median scale score for perceived severity of ZIKV was 3 (interquartile range [IQR] 1-5) versus 4 (IQR 3-5) for dengue (P < 0.001). The scores for mosquito control practices before and after ZIKV was declared a PHEIC were similar, at 4 (IQR 3-5). Multivariate analysis revealed that participants with a higher score for perception of severity of ZIKV were more likely to report greater mosquito control practices after the declaration of the PHEIC (OR 1.822 [95% CI 1.107-2.998]). The emerging ZIKV pandemic requires concerted efforts to enhance mosquito control practices among the Malaysian public. Efforts to improve public mosquito control practices should focus on enhancing the perception of the severity of ZIKV.
C1 [Wong, Li Ping; Alias, Haridah; Aghamohammadi, Nasrin] Univ Malaya, Dept Social & Prevent Med, Fac Med, Kuala Lumpur 50603, Malaysia.
   [Sam, I-ching; AbuBakar, Sazaly] Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur 50603, Malaysia.
   [AbuBakar, Sazaly] Univ Malaya, TIDREC, Kuala Lumpur 50603, Malaysia.
RP Wong, LP (corresponding author), Univ Malaya, Dept Social & Prevent Med, Fac Med, Kuala Lumpur 50603, Malaysia.
EM wonglp@um.edu.my; haridahalias@gmail.com; nasrin@ummc.edu.my;
   jicsam@um.edu.my; sazaly@um.edu.my
RI Lahuddin, Haslinda/S-1588-2017; abubakar, sazaly/B-3957-2010; Wong, Li
   Ping/B-2782-2010; Aghamohammadi, Nasrin/G-9392-2013; ALIAS,
   HARIDAH/A-8075-2017; Aghamohammadi, Nasrin/L-5822-2013; Sam, Jamal
   I-Ching/B-8688-2010
OI abubakar, sazaly/0000-0002-9267-1420; Wong, Li Ping/0000-0002-0107-0532;
   Aghamohammadi, Nasrin/0000-0002-7063-1671; ALIAS,
   HARIDAH/0000-0002-1830-4761; Aghamohammadi, Nasrin/0000-0002-7063-1671;
   Sam, Jamal I-Ching/0000-0002-1296-7898
FU Grand Challenge-SUS (Sustainability Science) [GCSUS-15SUS]; Ministry of
   Education, Malaysia [UM.C/625/1/HIR/MOE/MED/02 (E000013-20001)]
FX This study received financial support from Grand Challenge-SUS
   (Sustainability Science) GCSUS-15SUS and the High Impact Research Grant
   [UM.C/625/1/HIR/MOE/MED/02 (E000013-20001)] from the Ministry of
   Education, Malaysia.
CR BECKER MH, 1974, HEALTH EDUC QUART, V2, P409, DOI 10.1177/109019817400200407
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101
   Katz A, 2006, HEALTH AFFAIR, V25, P946, DOI 10.1377/hlthaff.25.4.946
   Lemeshow S., 2004, APPL LOGISTIC REGRES
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Mudin RN, 2015, INT MED J MALAYS, V14, P5
   Nunes ML, 2016, J PEDIAT-BRAZIL, V92, P230, DOI 10.1016/j.jped.2016.02.009
   Petrie KJ, 2012, CURR DIR PSYCHOL SCI, V21, P60, DOI 10.1177/0963721411429456
   Rosenstock IM, 1994, PREVENTING AIDS THEO, P5, DOI DOI 10.1007/978-1-4899-1193-3_2
   Sam J. I. C., 2016, MED J MALAYSIA, V71
   Schuler-Faccini L., 2016, MMWR MORBIDITY MORTA, V65
   Wong LP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122890
   WONG LP, 2016, INT J ENV RES PUB HE, V13
NR 16
TC 5
Z9 5
U1 0
U2 24
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0094-5145
EI 1573-3610
J9 J COMMUN HEALTH
JI J. Community Health
PD OCT
PY 2017
VL 42
IS 5
BP 854
EP 864
DI 10.1007/s10900-017-0326-7
PG 11
WC Health Policy & Services; Public, Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA FG6HK
UT WOS:000410472900003
PM 28238029
DA 2020-07-08
ER

PT J
AU Zhu, Z
   Gorman, MJ
   McKenzie, LD
   Chai, JN
   Hubert, CG
   Prager, BC
   Fernandez, E
   Richner, JM
   Zhang, R
   Shan, C
   Tycksen, E
   Wang, XX
   Shi, PY
   Diamond, MS
   Rich, JN
   Chheda, MG
AF Zhu, Zhe
   Gorman, Matthew J.
   McKenzie, Lisa D.
   Chai, Jiani N.
   Hubert, Christopher G.
   Prager, Briana C.
   Fernandez, Estefania
   Richner, Justin M.
   Zhang, Rong
   Shan, Chao
   Tycksen, Eric
   Wang, Xiuxing
   Shi, Pei-Yong
   Diamond, Michael S.
   Rich, Jeremy N.
   Chheda, Milan G.
TI Zika virus has oncolytic activity against glioblastoma stem cells (vol
   214, pg 3145, 2017)
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Correction
C1 [Tycksen, Eric] Washington Univ, Dept Genet, Genome Technol Access Ctr, St Louis, MO 63110 USA.
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165
CR Zhu Z, 2017, J EXP MED, V214
NR 1
TC 1
Z9 1
U1 2
U2 2
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA
SN 0022-1007
EI 1540-9538
J9 J EXP MED
JI J. Exp. Med.
PD OCT
PY 2017
VL 214
IS 10
PG 1
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA FI5IJ
UT WOS:000412015600022
DA 2020-07-08
ER

PT J
AU Benelli, G
   Caselli, A
   Canale, A
AF Benelli, Giovanni
   Caselli, Alice
   Canale, Angelo
TI Nanoparticles for mosquito control: Challenges and constraints
SO JOURNAL OF KING SAUD UNIVERSITY SCIENCE
LA English
DT Article
DE Aedes; Anopheles; Dengue; Malaria; Green nanosynthesis; Zika virus
ID SYNTHESIZED SILVER NANOPARTICLES; VECTOR CULEX-QUINQUEFASCIATUS; STERILE
   INSECT TECHNIQUE; AEDES-AEGYPTI; ZIKA VIRUS; MESOCYCLOPS-LONGISETUS;
   PLASMODIUM-FALCIPARUM; PREDATION EFFICIENCY; ANOPHELES-STEPHENSI;
   MEDIATED SYNTHESIS
AB Mosquito control programs are facing important and timely challenges, including the recent outbreaks of novel arbovirus, the development of resistance in several Culicidae species, and the rapid spreading of highly invasive mosquitoes worldwide. Current control tools mainly rely on the employment of (i) synthetic or microbial pesticides, (ii) insecticide-treated bed nets, (iii) adult repellents, (iv) biological control agents against mosquito young instars (mainly fishes, amphibians and copepods) (v) Sterile Insect Technique (SIT), (vi) "boosted SIT", (vii) symbiont-based methods and (viii) transgenic mosquitoes. Currently, none of these single strategies is fully successful. Novel eco-friendly strategies to manage mosquito vectors are urgently needed. The plant-mediated fabrication of nanoparticles is advantageous over chemical and physical methods, since it is cheap, single-step, and does not require high pressure, energy, temperature, or the use of highly toxic chemicals. In the latest years, a growing number of plant-borne compounds have been proposed for efficient and rapid extracellular synthesis of metal nanoparticles effective against mosquitoes at very low doses (i.e. 1-30 ppm). In this review, we focused on the promising potential of green-fabricated nanoparticles as toxic agents against mosquito young instars, and as adult oviposition deterrents. Furthermore, we analyzed current evidences about non-target effects of these nanocomposites used for mosquito control, pointing out their moderate acute toxicity for non-target aquatic organisms, absence of genotoxicity at the doses tested against mosquitoes, and the possibility to boost the predation rates of biological control agents against mosquitoes treating the aquatic environment with ultra-low doses (e.g. 1-3 ppm) of green-synthesized nanoparticles, which reduce the motility of mosquito larvae. Challenges for future research should shed light on (i) the precise mechanism(s) of action of green-fabricated metal nanoparticles, (ii) their fate in the aquatic environment, and (iii) the possible toxicity of residual silver ions in the aquatic ecosystems, (iv) standardization of chemical composition of botanical products used as sources of reducing and capping metabolites, (v) the optimization of the green nanosynthetic routes, in order to develop large-scale production of eco-friendly nanomosquitocides. (C) 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University.
C1 [Benelli, Giovanni; Caselli, Alice; Canale, Angelo] Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
   [Benelli, Giovanni] St Anna Sch Adv Studies, BioRobot Inst, Viale Rinaldo Piaggio 34, I-56025 Pontedera, Italy.
RP Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
EM benelli.giovanni@gmail.com
RI Benelli, Giovanni/A-9100-2013
OI Benelli, Giovanni/0000-0001-8971-6010; Caselli,
   Alice/0000-0003-1057-4457
FU PROAPI (PRAF); University of Pisa, Department of Agriculture, Food and
   Environment [COFIN2015_22]
FX G. Benelli is sponsored by PROAPI (PRAF 2015) and University of Pisa,
   Department of Agriculture, Food and Environment (Grant ID:
   COFIN2015_22). Funders had no role in the study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Amer A, 2006, PARASITOL RES, V99, P466, DOI [10.1007/s00436-006-0182-3, 10.1007/s00436-006-0184-1]
   Amer A, 2006, PARASITOL RES, V99, P491, DOI 10.1007/s00436-006-0185-0
   Amer A, 2006, PARASITOL RES, V99, P473, DOI 10.1007/s00436-006-0183-2
   Amerasan D, 2016, J PEST SCI, V89, P249, DOI 10.1007/s10340-015-0675-x
   Anbu P, 2016, NAT PROD RES, V30, P2077, DOI 10.1080/14786419.2015.1114935
   Anogwih JA, 2015, BIOL CONTROL, V81, P31, DOI 10.1016/j.biocontrol.2014.11.001
   ARTHINGTON AH, 1983, AUST J ECOL, V8, P87, DOI 10.1111/j.1442-9993.1983.tb01597.x
   ARUNACHALAM N, 1985, J MED ENTOMOL, V22, P648, DOI 10.1093/jmedent/22.6.648
   Attar N., 2016, NAT REV MICROBIOL, V14, P62, DOI DOI 10.1038/NRMICR0.2015.28
   Barik TK, 2012, PARASITOL RES, V111, P1075, DOI 10.1007/s00436-012-2934-6
   Becker Norbert, 2012, P31
   Bellini R, 2013, J MED ENTOMOL, V50, P94, DOI 10.1603/ME11058
   Benelli G., 2016, Asian Pacific Journal of Tropical Disease, V6, P253, DOI 10.1016/S2222-1808(15)61025-8
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P353, DOI 10.1016/j.apjtb.2015.10.015
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   BLAUSTEIN L, 1994, J ANIM ECOL, V63, P841, DOI 10.2307/5261
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Bourtzis K, 2016, ACTA TROP, V157, P115, DOI 10.1016/j.actatropica.2016.01.009
   Bouyer J, 2014, TRENDS PARASITOL, V30, P271, DOI 10.1016/j.pt.2014.04.002
   Bowatte G, 2013, BIOL CONTROL, V67, P469, DOI 10.1016/j.biocontrol.2013.10.005
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Brelsfoard CL, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-38
   Calvitti M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121813
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Chandramohan B, 2016, PARASITOL RES, V115, P1015, DOI 10.1007/s00436-015-4829-9
   Chitra Thangadurai, 2013, Asian Pacific Journal of Tropical Disease, V3, P111, DOI 10.1016/S2222-1808(13)60054-7
   Dinesh D, 2015, PARASITOL RES, V114, P1519, DOI 10.1007/s00436-015-4336-z
   Ekaneyeka D. H., 2007, P PER U RES SESS 30, V12, P1
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Foldbjerg R, 2015, TOXICOL RES-UK, V4, P563, DOI 10.1039/c4tx00110a
   GOODSELL DS, 2004, BIONANOTECHNOLOGY LE
   Goodsell JA, 1999, CONSERV BIOL, V13, P921, DOI 10.1046/j.1523-1739.1999.98237.x
   Govindarajan M, 2016, RSC ADV, V6, P59021, DOI 10.1039/c6ra10228j
   Govindarajan M, 2016, J CLUST SCI, V27, P745, DOI 10.1007/s10876-016-0977-z
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Griffin L, 2014, J VECTOR ECOL, V39, P197, DOI 10.1111/j.1948-7134.2014.12087.x
   Haldar KM, 2013, PARASITOL RES, V112, P1451, DOI 10.1007/s00436-013-3288-4
   Han WW, 2015, TROP MED INT HEALTH, V20, P1239, DOI 10.1111/tmi.12538
   Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Heng MY, 2013, TRAC-TREND ANAL CHEM, V50, P1, DOI 10.1016/j.trac.2013.03.012
   HOFTE H, 1989, MICROBIOL REV, V53, P242
   HURLBUT HERBERT S., 1938, JOUR PARASITOL, V24, P281, DOI 10.2307/3272301
   Jaganathan A, 2016, PARASITOL INT, V65, P276, DOI 10.1016/j.parint.2016.02.003
   Jensen M, 2009, PARASITOL RES, V105, P609, DOI 10.1007/s00436-009-1524-8
   Keane JP, 2004, NEW ZEAL J MAR FRESH, V38, P857, DOI 10.1080/00288330.2004.9517285
   KNIPLING EF, 1959, SCIENCE, V130, P902, DOI 10.1126/science.130.3380.902
   Kumar PM, 2016, PARASITOL RES, V115, P751, DOI 10.1007/s00436-015-4799-y
   Kumar PM, 2012, PARASITOL RES, V111, P609, DOI 10.1007/s00436-012-2876-z
   Kumar R, 2006, ZOOL STUD, V45, P447
   Kumar S, 2015, NANOMEDICINE-UK, V10, P2451, DOI [10.2217/NNM.15.112, 10.2217/nnm.15.112]
   Lacey LA, 2007, J AM MOSQUITO CONTR, V23, P133, DOI 10.2987/8756-971X(2007)23[133:BTSIAB]2.0.CO;2
   Lees RS, 2015, CURR OPIN INSECT SCI, V10, P156, DOI 10.1016/j.cois.2015.05.011
   Lees RS, 2014, ACTA TROP, V132, pS2, DOI 10.1016/j.actatropica.2013.11.005
   Madhiyazhagan P, 2015, PARASITOL RES, V114, P4305, DOI 10.1007/s00436-015-4671-0
   Manrique-Saide P, 1998, MED VET ENTOMOL, V12, P386, DOI 10.1046/j.1365-2915.1998.00126.x
   MARIMUTHU S., 2011, PARASITOL RES, V10, P2212
   MARTEN GG, 1989, J MED ENTOMOL, V26, P624, DOI 10.1093/jmedent/26.6.624
   Mehlhorn H., 2016, PARASITOL RES MONOGR, V8
   Mehlhorn H., 2015, ENCY PARASITOLOGY, P893
   Mehlhorn H, 2012, PARASITOL RES, V110, P259, DOI 10.1007/s00436-011-2480-7
   Mischke CC, 2016, J WORLD AQUACULT SOC, V47, P212, DOI 10.1111/jwas.12243
   Mokany A, 2003, OECOLOGIA, V135, P615, DOI 10.1007/s00442-003-1215-6
   Murugan K, 2016, ENVIRON SCI POLLUT R, V23, P16671, DOI 10.1007/s11356-016-6832-9
   Murugan K, 2016, RES VET SCI, V106, P14, DOI 10.1016/j.rvsc.2016.03.001
   Murugan K, 2016, PARASITOL RES, V115, P1085, DOI 10.1007/s00436-015-4838-8
   Murugan K, 2016, PARASITOL RES, V115, P1071, DOI 10.1007/s00436-015-4837-9
   Murugan K, 2016, PARASITOL RES, V115, P651, DOI 10.1007/s00436-015-4783-6
   Murugan K, 2015, PARASITOL RES, V114, P4349, DOI 10.1007/s00436-015-4676-8
   Murugan K, 2015, PARASITOL RES, V114, P2243, DOI 10.1007/s00436-015-4417-z
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pastula DM, 2016, J NEUROVIROL, V22, P257, DOI 10.1007/s13365-016-0428-5
   Patil CD, 2012, PARASITOL RES, V111, P555, DOI 10.1007/s00436-012-2867-0
   Patil CD, 2012, PARASITOL RES, V110, P1815, DOI 10.1007/s00436-011-2704-x
   Pavela R, 2016, EXP PARASITOL, V167, P103, DOI 10.1016/j.exppara.2016.05.010
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Raghavendra K, 2008, INDIAN J MED RES, V128, P22
   Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002
   Rajan R, 2015, IND CROP PROD, V70, P356, DOI 10.1016/j.indcrop.2015.03.015
   Rajasekharreddy P, 2014, MAT SCI ENG C-MATER, V39, P203, DOI 10.1016/j.msec.2014.03.003
   Raman N, 2012, SPECTROCHIM ACTA A, V96, P1031, DOI 10.1016/j.saa.2012.08.011
   Ramanibai R, 2015, RES VET SCI, V98, P82, DOI 10.1016/j.rvsc.2014.11.009
   Rawani A, 2013, ACTA TROP, V128, P613, DOI 10.1016/j.actatropica.2013.09.007
   RAWLINS SC, 1991, J AM MOSQUITO CONTR, V7, P7
   Saxena Shailendra K., 2016, VirusDisease, V27, P111, DOI 10.1007/s13337-016-0307-y
   Schaper S, 1999, J AM MOSQUITO CONTR, V15, P510
   Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998
   Schreiber ET, 1993, J FLA MOSQ CONTROL A, V64, P7317
   Semmler M, 2009, PARASITOL RES, V105, P1483, DOI 10.1007/s00436-009-1634-3
   Soumare MKF, 2011, J AM MOSQUITO CONTR, V27, P376, DOI 10.2987/11-6129.1
   Subarani S, 2013, PARASITOL RES, V112, P487, DOI 10.1007/s00436-012-3158-5
   Subramaniam J, 2016, ENVIRON SCI POLLUT R, V23, P7543, DOI 10.1007/s11356-015-6007-0
   Subramaniam J, 2015, ENVIRON SCI POLLUT R, V22, P20067, DOI 10.1007/s11356-015-5253-5
   Sujitha V, 2015, PARASITOL RES, V114, P3315, DOI 10.1007/s00436-015-4556-2
   Suresh U, 2015, PARASITOL RES, V114, P1551, DOI 10.1007/s00436-015-4339-9
   TABASHNIK BE, 1994, ANNU REV ENTOMOL, V39, P47, DOI 10.1146/annurev.en.39.010194.000403
   Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474
   Walton WE, 2012, HANDBOOK OF GLOBAL FRESHWATER INVASIVE SPECIES, P261
   Weterings R, 2015, J VECTOR ECOL, V40, P230, DOI 10.1111/jvec.12158
   White NJ, 2015, NEW ENGL J MED, V373, P1670, DOI 10.1056/NEJMe1511278
   WHO, 2016, YELLOW FEVER
   WHO, 2015, WHO UPD ART RES
   WHO, 2014, LYMPHATIC FILARIASIS
   Williamson C.E., 1999, ECOLOGY CLASSIFICATI, P787
   Wilson F., 1960, REV BIOL CONTROL INS, V1, P80
   World Health Organization, 2015, FACT SHEET WORLD MAL
   World Health Organization, 2016, NEGLECTED TROPICAL D
   World Health Organization, 2012, HDB INT VECT MAN
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
NR 114
TC 17
Z9 17
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1018-3647
EI 2213-686X
J9 J KING SAUD UNIV SCI
JI J. King Saud Univ. Sci.
PD OCT
PY 2017
VL 29
IS 4
BP 424
EP 435
DI 10.1016/j.jksus.2016.08.006
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FO9LC
UT WOS:000417208000005
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tan, SK
   Sahoo, MK
   Milligan, SB
   Taylor, N
   Pinsky, BA
AF Tan, Susanna K.
   Sahoo, Malaya K.
   Milligan, Stephen B.
   Taylor, Nathaniel
   Pinsky, Benjamin A.
TI Stability of Zika virus in urine: Specimen processing considerations and
   implications for the detection of RNA targets in urine
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE Zika virus; Urine; RNA stability; Pre-analytical
ID HEPATITIS-C VIRUS; NUCLEIC-ACIDS; SAMPLES; SALIVA; PLASMA; PCR
AB Background: Detection of Zika virus (ZIKV) RNA in urine is of increasing interest for the diagnosis of ZIKV infection. Pre-analytical variables can significantly impact the stability of RNA in urine.
   Methods: To determine optimal specimen processing protocols that would maximize detection of ZIKV RNA in urine by real-time, reverse transcriptase PCR, we investigated the effect of temperature, initial ZIKV concentration, use of nucleic acid stabilizers, and time on ZIKV RNA levels. Urine samples from healthy donors were spiked with ZIKV using the Exact Diagnostics ZIKV Verification Panel, a commercially available panel composed of heat-inactivated ZIKV, at concentrations of 5.0 log(10) copies/mL (ZIKV-high) and 4.0 log(10) copies/mL (ZIKV-low). Samples were stored at room temperature, 4 degrees C, or -80 degrees C and frozen aliquots were exposed to no stabilizer (urine), Buffer ATL (Qiagen, Germantown, MD), or DNA/RNA Shield (Zymo Research, Irvine, CA).
   Results: ZIKV RNA levels in urine declined steadily at room temperature, though was not significant by 48 h (ZIKV-high, p = 0.09; ZIKV-low, p = 0.20). ZIKV RNA titers were consistently higher when stored at 4 degrees C, suggesting that storage at 4 degrees C can slow the progression of RNA degradation. Freezing urine samples at -80 degrees C resulted in a significant loss of detectable ZIKV RNA in the ZIKV-low group. ZIKV RNA was detected in 5/6 replicates at 3 days, 1/6 replicates at 10 days, and 1/3 replicates at 30 days, with findings reproducible on repeat testing. Presence of either nucleic acid stabilizer in urine corrected this effect, and resulted in recovery of ZIKV RNA in all replicates. Use of a nucleic acid stabilizer in the ZIKV-high group did not add incremental benefit for the detection or quantitation of ZIKV RNA.
   Conclusions: ZIKV RNA is prone to degradation in urine with loss of detectable virus even when specimens are frozen at -80 degrees C for 10 days. Detection of ZIKV-positive urine samples, particularly those containing low ZIKV titers may be aided with the addition of a nucleic acid stabilizer during urine specimen processing.
C1 [Tan, Susanna K.; Pinsky, Benjamin A.] Stanford Univ, Dept Med, Div Infect Dis & Geog Med, Sch Med, Stanford, CA USA.
   [Sahoo, Malaya K.; Pinsky, Benjamin A.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.
   [Milligan, Stephen B.; Taylor, Nathaniel; Pinsky, Benjamin A.] Stanford Hlth Care, Clin Virol Lab, Stanford, CA USA.
RP Pinsky, BA (corresponding author), 3375 Hillview Ave,Room 2913, Palo Alto, CA 94304 USA.
EM bpinsky@stanford.edu
OI Pinsky, Benjamin/0000-0001-8751-4810; Sahoo, Malaya/0000-0001-9837-4032
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA
   [5T32AI007502-20]; Stanford Translational Research and Applied Medicine
   (TRAM) Pilot Grant Program; TL1 Clinical Research Training Program of
   the Stanford Clinical and Translational Science Award [NIH TL1 TR
   001084]
FX This work was conducted with support from National Institutes of Health
   (NIH) training grant 5T32AI007502-20, Stanford Translational Research
   and Applied Medicine (TRAM) Pilot Grant Program, and a TL1 Clinical
   Research Training Program of the Stanford Clinical and Translational
   Science Award to Spectrum (NIH TL1 TR 001084) (to S.K.T).
CR Anwar A, 2009, J MOL DIAGN, V11, P537, DOI 10.2353/jmoldx.2009.080164
   Baleriola C, 2011, J CLIN MICROBIOL, V49, P3163, DOI 10.1128/JCM.02447-10
   BARZON L, 2016, EUROSURVEILLANCE, V21, P2
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Blow JA, 2008, J VIROL METHODS, V150, P41, DOI 10.1016/j.jviromet.2008.02.003
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Bryzgunova OE, 2015, ACTA NATURAE, V7, P48, DOI 10.32607/20758251-2015-7-3-48-54
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cherepanova A, 2007, J IMMUNOL METHODS, V325, P96, DOI 10.1016/j.jim.2007.06.004
   Fourcade C, 2016, J CLIN VIROL, V82, P1, DOI 10.1016/j.jcv.2016.06.011
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Halfon P, 1996, J HEPATOL, V25, P307, DOI 10.1016/S0168-8278(96)80116-4
   Lamb LE, 2016, INT UROL NEPHROL, V48, P1961, DOI 10.1007/s11255-016-1406-9
   Lo DJ, 2014, NAT REV NEPHROL, V10, P215, DOI 10.1038/nrneph.2013.281
   Medeiros M, 2003, J IMMUNOL METHODS, V279, P135, DOI 10.1016/S0022-1759(03)00237-0
   Pessoa R, 2016, EURO SURVEILL, V21
   Ralla B, 2014, CRIT REV CL LAB SCI, V51, pA2, DOI 10.3109/10408363.2014.914888
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Traitanon O, 2014, CURR OPIN NEPHROL HY, V23, P625, DOI 10.1097/MNH.0000000000000064
   Van den Bossche D, 2015, EUR J CLIN MICROBIOL, V34, P1361, DOI 10.1007/s10096-015-2359-0
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
NR 23
TC 12
Z9 12
U1 2
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD OCT
PY 2017
VL 248
BP 66
EP 70
DI 10.1016/j.jviromet.2017.04.018
PG 5
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA FJ3FW
UT WOS:000412616900010
PM 28472623
DA 2020-07-08
ER

PT J
AU Leguia, M
   Cruz, CD
   Felices, V
   Torre, A
   Troncos, G
   Espejo, V
   Guevara, C
   Mores, C
AF Leguia, Mariana
   Cruz, Cristhopher D.
   Felices, Vidal
   Torre, Armando
   Troncos, Gilda
   Espejo, Victoria
   Guevara, Carolina
   Mores, Christopher
TI Full-genome amplification and sequencing of Zika viruses using a
   targeted amplification approach
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE Zika virus; Full-genome sequencing; Next-generation sequencing; Amplicon
   sequencing
ID AMERICA; ISOLATIONS; MOSQUITOS; NIGERIA
AB We have developed methods for full-genome sequencing of Zika viruses (ZIKVs) based on a targeted amplification approach. We used alignments of publicly available complete genome data to design a primer set that selectively amplifies ZIKVs. The approach includes amplification strategies for templates present at both high and low-copy number, and PCR cycling conditions that have been normalized across genome fragments in order to streamline laboratory handling. Abundant templates can be amplified using a strategy that uses 6 overlapping amplicons to cover the complete viral genome, whereas scarce templates can be amplified using a strategy that uses 11 overlapping amplicons of smaller size. The workflow is sequencing platform agnostic, and thus, can be used in low resource settings where access to traditional Sanger sequencing is the only option available. Given the scarcity of tools for ZIKV, this approach should facilitate epidemiological surveillance and other studies that require the generation of complete viral genomic information quickly and cost-effectively.
C1 [Leguia, Mariana; Cruz, Cristhopher D.; Felices, Vidal; Torre, Armando; Troncos, Gilda; Espejo, Victoria; Guevara, Carolina; Mores, Christopher] US Naval Med Res Unit 6 NAMRU 6, Av Venezuela C36S-N, Bellavista 2, Callao, Peru.
RP Leguia, M (corresponding author), US Naval Med Res Unit 6 NAMRU 6, Virol & Emerging Infect Dept, Genom & Pathogen Discovery Unit, Av Venezuela C36S-N, Bellavista 2, Callao, Peru.
EM mariana.leguia.fn@mail.mil; cristopher.d.cruz.ln@mail.mil;
   vidal.felices.ln@mail.mil; armando.torre@med.navy.mil;
   gilda.troncos.fn@mail.mil; victoria.espejoin.fn@mail.mil;
   carolina.guevara.fn@mail.mil; christopher.n.mores.ctr@mail.mil
RI Felices, Vidal/AAL-1717-2020
OI Felices, Vidal/0000-0001-5336-7293; Leguia, Mariana/0000-0002-7297-0263;
   Cruz, Cristhopher/0000-0001-5800-8505; Torre,
   Armando/0000-0002-6401-3885
CR Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   BOORMAN JPT, 1968, T ROY SOC TROP MED H, V62, P269, DOI 10.1016/0035-9203(68)90168-5
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cruz CD, 2016, J VIROL METHODS, V235, P158, DOI 10.1016/j.jviromet.2016.06.001
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li PE, 2017, NUCLEIC ACIDS RES, V45, P67, DOI 10.1093/nar/gkw1027
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   PAHO, 2015, IMPL PUBL HLTH AM, V2016
   Rodriguez-Roche R, 2012, INFECT GENET EVOL, V12, P332, DOI 10.1016/j.meegid.2011.12.005
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Wikan N, 2017, LANCET INFECT DIS, V17, P15, DOI 10.1016/S1473-3099(16)30525-4
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
NR 20
TC 4
Z9 4
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD OCT
PY 2017
VL 248
BP 77
EP 82
DI 10.1016/j.jviromet.2017.06.005
PG 6
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA FJ3FW
UT WOS:000412616900012
PM 28633961
DA 2020-07-08
ER

PT J
AU Charlier, C
   Beaudoin, MC
   Couderc, T
   Lortholary, O
   Lecuit, M
AF Charlier, Caroline
   Beaudoin, Marie-Claude
   Couderc, Therese
   Lortholary, Olivier
   Lecuit, Marc
TI Arboviruses and pregnancy: maternal, fetal, and neonatal effects
SO LANCET CHILD & ADOLESCENT HEALTH
LA English
DT Review
ID WEST-NILE-VIRUS; RIFT-VALLEY FEVER; VENEZUELAN EQUINE ENCEPHALITIS;
   CONGO HEMORRHAGIC-FEVER; TRANS-PLACENTAL TRANSMISSION; ZIKA VIRUS;
   JAPANESE ENCEPHALITIS; CHIKUNGUNYA VIRUS; TRANSPLACENTAL TRANSMISSION;
   UNITED-STATES
AB Arboviruses are an expanding public health threat, with pregnant women facing unique complications from arbovirus infections. These infections, such as dengue and Crimean-Congo haemorrhagic fever, can be more severe in pregnant women than in the general population. Vertical transmission is reported for many arboviruses and can severely affect pregnancy outcome. Indeed, arboviruses-particularly flaviviruses and alphaviruses-are associated with increased risks of fetal loss and premature birth. Arboviruses can be teratogenic, as is the case for Zika virus and Venezuelan equine encephalitis virus. Finally, intrapartum transmission can result in severe neonatal infections, as is true for chikungunya virus. Although the global burden of arboviruses is well recognised, few studies have provided data on arbovirus infection specifically in the context of maternal and child health. Epidemiological and clinical studies are therefore needed to better assess the burden of arbovirus infections during pregnancy and to improve the prevention and clinical management of these viral infections. In this Review, we analyse the information available and identify gaps in knowledge that require further assessment.
C1 [Charlier, Caroline; Couderc, Therese; Lecuit, Marc] Inst Pasteur, Biol Infect Unit, F-75015 Paris, France.
   [Charlier, Caroline; Couderc, Therese; Lecuit, Marc] INSERM, U1117, Paris, France.
   [Charlier, Caroline; Beaudoin, Marie-Claude; Lortholary, Olivier] Paris Descartes Univ, Sorbonne Paris Cite, Necker Enfants Malades Univ Hosp, Ctr Infectiol Necker Pasteur,AP HP,Inst Imagine, Paris, France.
   [Beaudoin, Marie-Claude] Laval Univ, Div Med Microbiol & Infect Dis, Quebec City, PQ, Canada.
   [Beaudoin, Marie-Claude] Univ Laval, CHU Quebec, Quebec City, PQ, Canada.
RP Charlier, C; Lecuit, M (corresponding author), Inst Pasteur, Biol Infect Unit, F-75015 Paris, France.
EM caroline.charlier@pasteur.fr; marc.lecuit@pasteur.fr
RI Lecuit, Marc/J-4073-2013; Charlier, Caroline/AAH-8547-2020; amsalu,
   ribka/G-8780-2019; Lecuit, Marc/M-4126-2019
OI Lecuit, Marc/0000-0002-4491-1063; Charlier,
   Caroline/0000-0002-9375-3620; Lecuit, Marc/0000-0002-4491-1063
CR AASKOV JG, 1981, AM J TROP MED HYG, V30, P198, DOI 10.4269/ajtmh.1981.30.198
   AASKOV JG, 1981, MED J AUSTRALIA, V2, P20, DOI 10.5694/j.1326-5377.1981.tb132048.x
   (ACIP) ACoIP, 2014, GUID VACC PREGN WOM
   Adam I, 2008, J MED VIROL, V80, P929, DOI 10.1002/jmv.21132
   Adam I, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-153
   Agerholm JS, 2015, ACTA VET SCAND, V57, DOI 10.1186/s13028-015-0145-8
   Aguilar PV, 2011, FUTURE VIROL, V6, P721, DOI 10.2217/FVL.11.50
   Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   ANDERSEN AA, 1975, INFECT IMMUN, V12, P1173, DOI 10.1128/IAI.12.5.1173-1183.1975
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P349
   Argolo AFLT, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-254
   Arishi HM, 2006, ANN TROP PAEDIATR, V26, P251, DOI 10.1179/146532806X120363
   Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028
   Baudin M, 2016, LANCET GLOB HEALTH, V4, pE864, DOI [10.1016/S2214-109X(16)30176-0, 10.1016/s2214-109x(16)30176-0]
   Ben-Nathan D, 2003, J INFECT DIS, V188, P5, DOI 10.1086/376870
   Bentlin MR, 2011, EMERG INFECT DIS, V17, P1779, DOI 10.3201/eid1709.110242
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brummer-Korvenkontio M, 2002, EPIDEMIOL INFECT, V129, P335, DOI 10.1017/S0950268802007409
   CALISHER CH, 1995, EMERG INFECT DIS, V1, P147, DOI 10.3201/eid0104.950409
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233
   Carles G, 1999, CLIN INFECT DIS, V28, P637, DOI 10.1086/515144
   Carles G, 2016, LANCET INFECT DIS, V16, P765, DOI 10.1016/S1473-3099(16)00130-4
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, 2016, TRAV HLTH YELL BOOK
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1135
   Charlier C, 2015, J INFECTION, V71, P131, DOI 10.1016/j.jinf.2015.01.010
   CHATURVEDI UC, 1980, J INFECT DIS, V141, P712, DOI 10.1093/infdis/141.6.712
   Cleton N, 2012, J CLIN VIROL, V55, P191, DOI 10.1016/j.jcv.2012.07.004
   COPPS SC, 1959, PEDIATRICS, V24, P31
   Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029
   Couderc T, 2009, J INFECT DIS, V200, P516, DOI 10.1086/600381
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Danis K, 2011, EMERG INFECT DIS, V17, P1868, DOI 10.3201/eid1710.110525
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dizbay M, 2009, J INFECTION, V59, P281, DOI 10.1016/j.jinf.2009.08.004
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Eklund C. M., 1959, Proc sixth intern Congr trop Med, V5, P197
   Elliott RM, 2014, CURR OPIN VIROL, V5, P50, DOI 10.1016/j.coviro.2014.01.011
   Ergonul O, 2010, CLIN MICROBIOL INFEC, V16, P647, DOI 10.1111/j.1469-0691.2009.02905.x
   Eyer L, 2017, ANTIVIR RES, V142, P63, DOI 10.1016/j.antiviral.2017.03.012
   Feng Y, 2013, EMERG INFECT DIS, V19, P672, DOI 10.3201/eid1904.120137
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Fritel X, 2010, EMERG INFECT DIS, V16, P418, DOI 10.3201/eid1603.091403
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   GARCIATAMAYO J, 1981, INFECT IMMUN, V32, P813
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Gozel MG, 2014, GYNECOL OBSTET INVES, V77, P266, DOI 10.1159/000360699
   Haley M, 2003, CLIN INFECT DIS, V37, pE88, DOI 10.1086/377172
   Hanf M, 2014, TROP MED INT HEALTH, V19, P153, DOI 10.1111/tmi.12240
   Hayes JM, 2003, AM J TROP MED HYG, V69, P629
   Hinckley A., 2009, Morbidity and Mortality Weekly Report, V58, P4
   Hoffmann AR, 2012, J VIROL, V86, P4793, DOI 10.1128/JVI.06858-11
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Jansen J., 2016, CRIMEAN CONGO HAEMOR
   Jean CM, 2007, EMERG INFECT DIS, V13, P1918, DOI 10.3201/eid1312.061265
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Julander JG, 2006, VIROLOGY, V347, P175, DOI 10.1016/j.virol.2005.11.040
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   JUSTINES G, 1980, AM J TROP MED HYG, V29, P653, DOI 10.4269/ajtmh.1980.29.653
   Karlas A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11320
   Khan AS, 2016, LANCET GLOB HEALTH, V4, pE773, DOI 10.1016/S2214-109X(16)30240-6
   Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9
   Kim K, 2016, TRENDS MICROBIOL, V24, P622, DOI 10.1016/j.tim.2016.06.002
   Kiran SK, 2015, EMERG INFECT DIS, V21, P146, DOI 10.3201/eid2101.141227
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kubar A, 2011, JPN J INFECT DIS, V64, P439
   Lanciotti RS TTF, 2011, MANUAL CLIN MICROBIO
   Lindsey NP, 2012, AM J TROP MED HYG, V87, P179, DOI 10.4269/ajtmh.2012.12-0113
   LONDON WT, 1977, TERATOLOGY, V16, P285, DOI 10.1002/tera.1420160307
   Machado CR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002217
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Romano APM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002740
   Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147
   MATHUR A, 1985, INDIAN J MED RES, V81, P9
   MATHUR A, 1981, INFECT IMMUN, V34, P26, DOI 10.1128/IAI.34.1.26-29.1981
   McClure EM, 2010, CLIN OBSTET GYNECOL, V53, P635, DOI 10.1097/GRF.0b013e3181eb6620
   McGready R, 2001, AM J TROP MED HYG, V65, P285, DOI 10.4269/ajtmh.2001.65.285
   McGready R, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000888
   Menendez C, 2008, PLOS MED, V5, P220, DOI 10.1371/journal.pmed.0050044
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Nair PMC, 2008, INDIAN PEDIATR, V45, P605
   Ng JKW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004031
   NIKLASSON B, 1987, EPIDEMIOL INFECT, V99, P517, DOI 10.1017/S0950268800068011
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   PAHO, 2017, ZIK EP REP
   Paisley JE, 2006, PEDIATRICS, V117, P814, DOI 10.1542/peds.2005-1187
   Paixao ES, 2016, LANCET INFECT DIS, V16, P857, DOI 10.1016/S1473-3099(16)00088-8
   PARSONSON IM, 1981, AM J TROP MED HYG, V30, P660, DOI 10.4269/ajtmh.1981.30.660
   Passi GR, 2008, INDIAN PEDIATR, V45, P240
   PETERS CJ, 1986, ANTIVIR RES, V6, P285, DOI 10.1016/0166-3542(86)90024-0
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   Pridjian G, 2016, BIRTH DEFECTS RES A, V106, P716, DOI 10.1002/bdra.23523
   Pshenichnaya NY, 2017, INT J INFECT DIS, V58, P58, DOI 10.1016/j.ijid.2017.02.019
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Ribeiro CF, 2017, INT J INFECT DIS, V55, P109, DOI 10.1016/j.ijid.2017.01.002
   Rwaguma EB, 1997, EMERG INFECT DIS, V3, P77, DOI 10.3201/eid0301.970112
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Sexton DJ, 1997, NEW ENGL J MED, V336, P547, DOI 10.1056/NEJM199702203360804
   Shenoy S, 2012, INDIAN PEDIATR, V49, P238
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   SHINEFIELD HR, 1953, J PEDIATR-US, V43, P21, DOI 10.1016/S0022-3476(53)80082-X
   Sice A, 1940, B SOC PATHOL EXOT, V33, P79
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Simon-Loriere E, 2017, NEW ENGL J MED, V376, P1483, DOI 10.1056/NEJMc1701600
   Simoni MK, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12613
   Singh S, 2010, STUD FAMILY PLANN, V41, P241, DOI 10.1111/j.1728-4465.2010.00250.x
   Sirinavin S, 2004, PEDIATR INFECT DIS J, V23, P1042, DOI 10.1097/01.inf.0000143644.95692.0e
   Sirois PA, 2014, BIRTH DEFECTS RES A, V100, P792, DOI 10.1002/bdra.23297
   SPERTZEL RO, 1972, INFECT IMMUN, V6, P339, DOI 10.1128/IAI.6.3.339-343.1972
   Suzano CES, 2006, VACCINE, V24, P1421, DOI 10.1016/j.vaccine.2005.09.033
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tan PC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001637
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Taylor R, 2016, J INFECT PUBLIC HEAL, V9, P220, DOI 10.1016/j.jiph.2016.04.002
   Torres JR, 2016, INT J INFECT DIS, V51, P85, DOI 10.1016/j.ijid.2016.09.009
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Weaver SC, 1996, LANCET, V348, P436, DOI 10.1016/S0140-6736(96)02275-1
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   WENGER F, 1977, TERATOLOGY, V16, P359, DOI 10.1002/tera.1420160317
   Whitehorn J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003025
   WHO, 2012, GLOB JAP ENC RISK MA
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   World Health Organization, YELLOW FEVER
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zumla A, 2014, NEW ENGL J MED, V371, P1076, DOI 10.1056/NEJMc1408436
NR 138
TC 16
Z9 17
U1 2
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2352-4642
J9 LANCET CHILD ADOLESC
JI Lancet Child. Adolesc. Health
PD OCT
PY 2017
VL 1
IS 2
BP 134
EP 146
DI 10.1016/S2352-4642(17)30021-4
PG 13
WC Pediatrics
SC Pediatrics
GA HE2QN
UT WOS:000453157700017
PM 30169203
DA 2020-07-08
ER

PT J
AU Sanchez-Purra, M
   Roig-Solvas, B
   Versiani, A
   Rodriguez-Quijada, C
   de Puig, H
   Bosch, I
   Gehrke, L
   Hamad-Schifferli, K
AF Sanchez-Purra, Maria
   Roig-Solvas, Biel
   Versiani, Alice
   Rodriguez-Quijada, Cristina
   de Puig, Helena
   Bosch, Irene
   Gehrke, Lee
   Hamad-Schifferli, Kimberly
TI Design of SERS nanotags for multiplexed lateral flow immunoassays
SO MOLECULAR SYSTEMS DESIGN & ENGINEERING
LA English
DT Article
ID ENHANCED RAMAN-SCATTERING; GOLD NANOSTARS; ZIKA VIRUS; SPECTROSCOPY;
   NANOPARTICLES; OPTIMIZATION; SENSITIVITY; DIAGNOSTICS; AGENTS; DENGUE
AB Surface enhanced Raman spectroscopy (SERS) has been attractive for enhancing the sensitivity of lateral flow immunoassays (LFA). A format that has enabled specific detection of biomarkers is to use Raman reporter molecules linked to gold nanoparticles (NPs), which are conjugated to laboratory made antibodies specific for the target of interest. Many factors such as the NP and Ab properties and the method of signal readout impact the sensitivity of a SERS based immunoassay. To understand how to optimize assay sensitivity, we studied SERS readouts of multiplexed sandwich immunoassays for the zika and dengue nonstructural protein 1 (NS1) biomarkers as a test case. We investigated the effect of NP shape on the SERS enhancement of the reporter molecules 1,2-bis(4-pyridyl) ethylene (BPE) and 4-mercaptobenzoic acid (MBA). We also performed SERS imaging of test lines to map the spatial distribution of signal in test lines on the nitrocellulose. Finally, we used a modified least squares analysis to differentiate reporter contributions.
C1 [Sanchez-Purra, Maria; Rodriguez-Quijada, Cristina; Hamad-Schifferli, Kimberly] Univ Massachusetts, Dept Engn, Boston, MA 02125 USA.
   [Roig-Solvas, Biel] Northeastern Univ, Dept Elect & Comp Engn, Boston, MA 02115 USA.
   [Versiani, Alice] Univ Fed Minas Gerais, Dept Microbiol, Belo Horizonte, MG, Brazil.
   [Versiani, Alice; Bosch, Irene; Gehrke, Lee] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [de Puig, Helena; Hamad-Schifferli, Kimberly] MIT, Dept Mech Engn, Cambridge, MA 02139 USA.
   [Gehrke, Lee] Harvard Med Sch, Dept Microbiol & Immunol, Boston, MA USA.
   [Bosch, Irene] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA.
RP Hamad-Schifferli, K (corresponding author), Univ Massachusetts, Dept Engn, Boston, MA 02125 USA.; Hamad-Schifferli, K (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.
EM kim.hamad@umb.edu
RI Versiani, Alice/M-9782-2018
OI Versiani, Alice/0000-0003-1378-5380; Gehrke, Lee/0000-0002-9387-8212;
   /0000-0002-5368-6996; Sanchez-Purra, Maria/0000-0001-8602-959X
FU NIH NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI100190]; MIT/SUTD International Design
   Centre; Broshy Fellowship; MIT Tata Center for Technology and Design
   Fellowship; Rafael del Pino Fellowships; NIGMSUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [P41-GM103311]
FX We thank the UMB Engineering Department for use of the Raman microscope.
   Work was supported by funding from the NIH NIAID (AI100190). We would
   like to thank Dr. Tom Tague and Dr. Peng Wang from Bruker Optics for
   technical assistance, and Dr. Justina Tam from the US FDA.; HdP was
   supported by the MIT/SUTD International Design Centre, a Broshy
   Fellowship and a MIT Tata Center for Technology and Design Fellowship.
   Both HdP and CRQ were supported by Rafael del Pino Fellowships.; Some of
   the figure graphics were generated using the UCSF Chimera package.
   Chimera is developed by the Resource for Biocomputing, Visualization,
   and Informatics at the University of California, San Francisco
   (supported by NIGMS P41-GM103311).
CR Atta S, 2016, J PHYS CHEM C, V120, P20749, DOI 10.1021/acs.jpcc.6b01949
   Chirumamilla M, 2012, MICROELECTRON ENG, V97, P189, DOI 10.1016/j.mee.2012.05.004
   Chirumamilla M, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/23/235303
   Dam DHM, 2012, ACS NANO, V6, P3318, DOI 10.1021/nn300296p
   de Puig H, 2017, BIOCONJUGATE CHEM, V28, P230, DOI 10.1021/acs.bioconjchem.6b00523
   de Puig H, 2015, J PHYS CHEM C, V119, P17408, DOI 10.1021/acs.jpcc.5b03624
   Esenturk EN, 2009, J RAMAN SPECTROSC, V40, P86, DOI 10.1002/jrs.2084
   Fabris L, 2015, J OPTICS-UK, V17, DOI 10.1088/2040-8978/17/11/114002
   FRENS G, 1973, NATURE-PHYS SCI, V241, P20, DOI 10.1038/physci241020a0
   Fu X, 2016, BIOSENS BIOELECTRON, V78, P530, DOI 10.1016/j.bios.2015.11.099
   Garcia-Leis A, 2015, NANOSCALE, V7, P13629, DOI 10.1039/c5nr02819a
   GERSTEN JI, 1980, J CHEM PHYS, V72, P5779, DOI 10.1063/1.439002
   Goncalves MR, 2012, J NANOTECHNOL, V2012, DOI 10.1155/2012/173273
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   HAALAND DM, 1980, APPL SPECTROSC, V34, P539, DOI 10.1366/0003702804731258
   Hwang J, 2016, NANOSCALE, V8, P11418, DOI 10.1039/c5nr07243c
   Kearns H, 2015, PHYS CHEM CHEM PHYS, V17, P1980, DOI 10.1039/c4cp04281f
   Khoury CG, 2008, J PHYS CHEM C, V112, P18849, DOI 10.1021/jp8054747
   Kim NH, 2010, NANO LETT, V10, P4181, DOI 10.1021/nl102495j
   Kumar S, 2008, NAT PROTOC, V3, P314, DOI 10.1038/nprot.2008.1
   Lee S, 2016, ANAL CHEM, V88, P8359, DOI 10.1021/acs.analchem.6b01828
   Li J, 2016, BIOSENS BIOELECTRON, V83, P177, DOI 10.1016/j.bios.2016.04.021
   Li J, 2016, LAB CHIP, V16, P242, DOI 10.1039/c5lc01323b
   Mulvaney SP, 2003, LANGMUIR, V19, P4784, DOI 10.1021/la026706j
   Osinkina L, 2013, J PHYS CHEM C, V117, P22198, DOI 10.1021/jp312149d
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Quesada-Gonzalez D, 2015, BIOSENS BIOELECTRON, V73, P47, DOI 10.1016/j.bios.2015.05.050
   Rodriguez-Lorenzo L, 2011, INTEGR BIOL-UK, V3, P922, DOI 10.1039/c1ib00029b
   Rodriguez-Lorenzo L, 2010, J PHYS CHEM C, V114, P7336, DOI 10.1021/jp909253w
   Tam Justina O, 2017, J Immunoassay Immunochem, V38, P355, DOI 10.1080/15321819.2016.1269338
   Vendrell M, 2013, TRENDS BIOTECHNOL, V31, P249, DOI 10.1016/j.tibtech.2013.01.013
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Xia XH, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2012.0092
   Xie JP, 2007, CHEM MATER, V19, P2823, DOI 10.1021/cm0700100
   Xie JP, 2008, ACS NANO, V2, P2473, DOI 10.1021/nn800442q
   Yen CW, 2015, LAB CHIP, V15, P1638, DOI 10.1039/c5lc00055f
   Zavaleta CL, 2009, P NATL ACAD SCI USA, V106, P13511, DOI 10.1073/pnas.0813327106
NR 38
TC 9
Z9 9
U1 9
U2 42
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2058-9689
J9 MOL SYST DES ENG
JI Mol. Syst. Des. Eng.
PD OCT 1
PY 2017
VL 2
IS 4
BP 401
EP 409
DI 10.1039/c7me00052a
PG 9
WC Chemistry, Physical; Engineering, Chemical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Engineering; Science & Technology - Other Topics; Materials
   Science
GA FJ5EH
UT WOS:000412769000007
PM 31681479
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Hajj, KA
   Whitehead, KA
AF Hajj, Khalid A.
   Whitehead, Kathryn A.
TI Tools for translation: non-viral materials for therapeutic mRNA delivery
SO NATURE REVIEWS MATERIALS
LA English
DT Review
ID LIPID-LIKE NANOPARTICLES; IN-VIVO; GENE DELIVERY; DENDRITIC CELLS;
   SYSTEMIC DELIVERY; CATIONIC LIPIDS; T-CELLS; PROTEIN EXPRESSION; SIRNA
   DELIVERY; POLY(A) TAIL
AB In recent years, messenger RNA (mRNA) has come into the spotlight as a versatile therapeutic with the potential to prevent and treat a staggering range of diseases. Billions of dollars have been invested in the commercial development of mRNA drugs, with ongoing clinical trials focused on vaccines (for example, influenza and Zika viruses) and cancer immunotherapy (for example, myeloma, leukaemia and glioblastoma). Although significant progress has been made in the design of in vitro-transcribed mRNA that retains potency while minimizing unwanted immune responses, the widespread use of mRNA drugs requires the development of safe and effective drug delivery vehicles. In this Review, we provide an overview of the field of mRNA therapeutics and describe recent advances in the development of synthetic materials that encapsulate and deliver mRNA payloads.
C1 [Hajj, Khalid A.; Whitehead, Kathryn A.] Carnegie Mellon Univ, Dept Chem Engn, Pittsburgh, PA 15213 USA.
   [Whitehead, Kathryn A.] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA.
RP Whitehead, KA (corresponding author), Carnegie Mellon Univ, Dept Chem Engn, Pittsburgh, PA 15213 USA.
EM kawhite@cmu.edu
FU Defense Advanced Research Projects Agency (DARPA)United States
   Department of DefenseDefense Advanced Research Projects Agency (DARPA)
   [D16AP00143]
FX Funding was provided by the Defense Advanced Research Projects Agency
   (DARPA), grant number D16AP00143. The authors thank R. Weiss for his
   feedback on the manuscript.
CR Aini H, 2016, SCI REP-UK, V6, DOI 10.1038/srep18743
   Akinc A, 2005, J GENE MED, V7, P657, DOI 10.1002/jgm.696
   Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m
   Anderson BR, 2010, NUCLEIC ACIDS RES, V38, P5884, DOI 10.1093/nar/gkq347
   Anderson DM, 2003, HUM GENE THER, V14, P191, DOI 10.1089/10430340360535751
   Andries O, 2015, J CONTROL RELEASE, V217, P337, DOI 10.1016/j.jconrel.2015.08.051
   Baba M, 2015, J CONTROL RELEASE, V201, P41, DOI 10.1016/j.jconrel.2015.01.017
   Badieyan ZS, 2016, J CONTROL RELEASE, V239, P137, DOI 10.1016/j.jconrel.2016.08.037
   Bahl K, 2017, MOL THER, V25, P1316, DOI 10.1016/j.ymthe.2017.03.035
   Balmayor ER, 2017, STEM CELLS DEV, V26, P25, DOI 10.1089/scd.2016.0171
   Barrett DM, 2013, HUM GENE THER, V24, P717, DOI 10.1089/hum.2013.075
   Barrett DM, 2011, HUM GENE THER, V22, P1575, DOI 10.1089/hum.2011.070
   Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799
   BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   BRENNER S, 1961, NATURE, V190, P576, DOI 10.1038/190576a0
   Broos Katrijn, 2016, Mol Ther Nucleic Acids, V5, pe326, DOI 10.1038/mtna.2016.38
   Cannarrozzi G, 2010, CELL, V141, P355, DOI 10.1016/j.cell.2010.02.036
   Cavazzana M, 2016, HUM GENE THER, V27, P108, DOI 10.1089/hum.2015.137
   Chahal JS, 2016, P NATL ACAD SCI USA, V113, pE4133, DOI 10.1073/pnas.1600299113
   Chang H, 2014, MOL CELL, V53, P1044, DOI 10.1016/j.molcel.2014.02.007
   CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1
   Chen QX, 2017, MOL THER, V25, P92, DOI 10.1016/j.ymthe.2016.10.006
   Cheng XW, 2016, ADV DRUG DELIVER REV, V99, P129, DOI 10.1016/j.addr.2016.01.022
   Chiper M, 2017, J CONTROL RELEASE, V246, P60, DOI 10.1016/j.jconrel.2016.12.005
   Choi HY, 2016, J CONTROL RELEASE, V235, P222, DOI 10.1016/j.jconrel.2016.06.007
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   CONRY RM, 1995, CANCER RES, V55, P1397
   CRICK F H, 1958, Symp Soc Exp Biol, V12, P138
   Deering RP, 2014, EXPERT OPIN DRUG DEL, V11, P885, DOI 10.1517/17425247.2014.901308
   DeRosa F, 2016, GENE THER, V23, P699, DOI 10.1038/gt.2016.46
   Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616
   DIMITRIADIS GJ, 1978, NATURE, V274, P923, DOI 10.1038/274923a0
   Dong YZ, 2016, NANO LETT, V16, P842, DOI 10.1021/acs.nanolett.5b02428
   Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096
   Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409
   Eshhar Z, 2001, J IMMUNOL METHODS, V248, P67, DOI 10.1016/S0022-1759(00)00343-4
   Evdokimova V, 2001, EMBO J, V20, P5491, DOI 10.1093/emboj/20.19.5491
   Eyquem J, 2017, NATURE, V543, P113, DOI 10.1038/nature21405
   Fenton OS, 2016, ADV MATER, V28, P2939, DOI 10.1002/adma.201505822
   FRIEDMANN T, 1972, SCIENCE, V175, P949, DOI 10.1126/science.175.4025.949
   Giacca M, 2012, J CONTROL RELEASE, V161, P377, DOI 10.1016/j.jconrel.2012.04.008
   Gilleron J, 2013, NAT BIOTECHNOL, V31, P638, DOI 10.1038/nbt.2612
   Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X
   Hafez IM, 2001, GENE THER, V8, P1188, DOI 10.1038/sj.gt.3301506
   Haghighat A, 1997, J BIOL CHEM, V272, P21677, DOI 10.1074/jbc.272.35.21677
   Harvie P, 1998, BIOPHYS J, V75, P1040, DOI 10.1016/S0006-3495(98)77593-9
   Hashimoto M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11315
   Hattinger E, 2015, J IMMUNOL RES, DOI 10.1155/2015/797421
   Hegde M, 2013, MOL THER, V21, P2087, DOI 10.1038/mt.2013.185
   Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620
   Heiser A, 2002, J CLIN INVEST, V109, P409, DOI 10.1172/JCI200214364
   Holtkamp S, 2006, BLOOD, V108, P4009, DOI 10.1182/blood-2006-04-015024
   Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505
   Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019
   Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010
   Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286
   Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501
   Jarzebinska A, 2016, ANGEW CHEM INT EDIT, V55, P9591, DOI 10.1002/anie.201603648
   Jayaraman M, 2012, ANGEW CHEM INT EDIT, V51, P8529, DOI 10.1002/anie.201203263
   Jiang C, 2017, CELL RES, V27, P440, DOI 10.1038/cr.2017.16
   JIRIKOWSKI GF, 1992, SCIENCE, V255, P996, DOI 10.1126/science.1546298
   Jokerst JV, 2011, NANOMEDICINE-UK, V6, P715, DOI [10.2217/nnm.11.19, 10.2217/NNM.11.19]
   Josephson N, 2013, HEMATOL-AM SOC HEMAT, P261, DOI 10.1182/asheducation-2013.1.261
   Kaczmarek J. C., 2016, ANGEW CHEM, V128, P14012, DOI DOI 10.1002/ANGE.201608450
   Kalos M, 2013, IMMUNITY, V39, P49, DOI 10.1016/j.immuni.2013.07.002
   Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008
   Kariko K, 1999, GENE THER, V6, P1092, DOI 10.1038/sj.gt.3300930
   Kariko K, 2008, MOL THER, V16, P1833, DOI 10.1038/mt.2008.200
   Kariko K, 2007, CURR OPIN DRUG DISC, V10, P523
   Kariko K, 2012, MOL THER, V20, P948, DOI 10.1038/mt.2012.7
   Kariko K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr695
   Kauffman KJ, 2015, NANO LETT, V15, P7300, DOI 10.1021/acs.nanolett.5b02497
   Khoury GA, 2011, SCI REP-UK, V1, DOI 10.1038/srep00090
   Kim Y, 2016, NAT BIOTECHNOL, V34, P808, DOI 10.1038/nbt.3614
   Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308
   KLEIN TM, 1987, NATURE, V327, P70, DOI 10.1038/327070a0
   Kormann MSD, 2011, NAT BIOTECHNOL, V29, P154, DOI 10.1038/nbt.1733
   Kranz LM, 2016, NATURE, V534, P396, DOI 10.1038/nature18300
   Landesman-Milo D, 2014, DRUG DELIV TRANSL RE, V4, P96, DOI 10.1007/s13346-013-0158-7
   Langlet C, 2012, J IMMUNOL, V188, P1751, DOI 10.4049/jimmunol.1102744
   Lee BL, 2014, TRENDS CELL BIOL, V24, P360, DOI 10.1016/j.tcb.2013.12.002
   Leonhardt C, 2014, NANOMED-NANOTECHNOL, V10, P679, DOI 10.1016/j.nano.2013.11.008
   Li B, 2015, NANO LETT, V15, P8099, DOI 10.1021/acs.nanolett.5b03528
   Li JH, 2017, ACS NANO, V11, P2531, DOI 10.1021/acsnano.6b08447
   Li M, 2016, J CONTROL RELEASE, V228, P9, DOI 10.1016/j.jconrel.2016.02.043
   Li WJ, 2007, PHARM RES, V24, P438, DOI 10.1007/s11095-006-9180-5
   Lin CY, 2016, J CONTROL RELEASE, V235, P268, DOI 10.1016/j.jconrel.2016.06.001
   Liu XJ, 2017, CELL RES, V27, P154, DOI 10.1038/cr.2016.142
   LOCKARD RE, 1969, BIOCHEM BIOPH RES CO, V37, P204, DOI 10.1016/0006-291X(69)90720-7
   Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003
   Lorenz C, 2011, RNA BIOL, V8, P627, DOI 10.4161/rna.8.4.15394
   Lungwitz U, 2005, EUR J PHARM BIOPHARM, V60, P247, DOI 10.1016/j.ejpb.2004.11.011
   Luo X, 2017, NANOSCALE, V9, P1575, DOI 10.1039/c6nr08496f
   Lv HT, 2006, J CONTROL RELEASE, V114, P100, DOI 10.1016/j.jconrel.2006.04.014
   Ma Z, 2005, BIOCHEM BIOPH RES CO, V330, P755, DOI 10.1016/j.bbrc.2005.03.041
   Mahiny AJ, 2015, NAT BIOTECHNOL, V33, P584, DOI 10.1038/nbt.3241
   Malissen B, 2014, NAT REV IMMUNOL, V14, P417, DOI 10.1038/nri3683
   MALONE RW, 1989, P NATL ACAD SCI USA, V86, P6077, DOI 10.1073/pnas.86.16.6077
   Mandal PK, 2013, NAT PROTOC, V8, P568, DOI 10.1038/nprot.2013.019
   Mandl CW, 1998, NAT MED, V4, P1438, DOI 10.1038/4031
   MARTINON F, 1993, EUR J IMMUNOL, V23, P1719, DOI 10.1002/eji.1830230749
   Matsui A, 2015, SCI REP-UK, V5, DOI 10.1038/srep15810
   Maus MV, 2014, BLOOD, V123, P2625, DOI 10.1182/blood-2013-11-492231
   McKinlay CJ, 2017, P NATL ACAD SCI USA, V114, pE448, DOI 10.1073/pnas.1614193114
   Meijer HA, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm830
   Midoux P, 2015, EXPERT REV VACCINES, V14, P221, DOI 10.1586/14760584.2015.986104
   Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004
   Miller JB, 2017, ANGEW CHEM INT EDIT, V56, P1059, DOI 10.1002/anie.201610209
   Murata-Hori M., 2005, ELS
   Nair SK, 2000, NAT MED, V6, P1011, DOI 10.1038/79519
   Nayak S, 2010, GENE THER, V17, P295, DOI 10.1038/gt.2009.148
   NEUMANN E, 1982, EMBO J, V1, P841, DOI 10.1002/j.1460-2075.1982.tb01257.x
   Oberli MA, 2017, NANO LETT, V17, P1326, DOI 10.1021/acs.nanolett.6b03329
   Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pardi N, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14630
   Pardi N, 2015, J CONTROL RELEASE, V217, P345, DOI 10.1016/j.jconrel.2015.08.007
   Perche F, 2011, NANOMED-NANOTECHNOL, V7, P445, DOI 10.1016/j.nano.2010.12.010
   Petsch B, 2012, NAT BIOTECHNOL, V30, P1210, DOI 10.1038/nbt.2436
   Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604
   POKROVSKAYA ID, 1994, ANAL BIOCHEM, V220, P420, DOI 10.1006/abio.1994.1360
   Qiu P, 1996, GENE THER, V3, P262
   Ramanj K, 1998, P NATL ACAD SCI USA, V95, P11886, DOI 10.1073/pnas.95.20.11886
   Ramaswamy S, 2017, P NATL ACAD SCI USA, V114, pE1941, DOI 10.1073/pnas.1619653114
   Rejman J, 2010, J CONTROL RELEASE, V147, P385, DOI 10.1016/j.jconrel.2010.07.124
   Ren JT, 2017, CLIN CANCER RES, V23, P2255, DOI 10.1158/1078-0432.CCR-16-1300
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Roesler E, 2009, J ALLERGY CLIN IMMUN, V124, P1070, DOI 10.1016/j.jaci.2009.06.036
   Rupp LJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00462-8
   Sahin U, 2014, NAT REV DRUG DISCOV, V13, P759, DOI 10.1038/nrd4278
   Schlake T, 2012, RNA BIOL, V9, P1319, DOI 10.4161/rna.22269
   Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030
   SHATKIN AJ, 1976, CELL, V9, P645, DOI 10.1016/0092-8674(76)90128-8
   Smits E, 2004, LEUKEMIA, V18, P1898, DOI 10.1038/sj.leu.2403463
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Tatiparti K, 2017, NANOMATERIALS-BASEL, V7, DOI 10.3390/nano7040077
   Thess A, 2015, MOL THER, V23, P1456, DOI 10.1038/mt.2015.103
   Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632
   Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117
   Uchida S, 2016, BIOMATERIALS, V82, P221, DOI 10.1016/j.biomaterials.2015.12.031
   Van Tendeloo VFI, 2001, BLOOD, V98, P49, DOI 10.1182/blood.V98.1.49
   Vila A, 2002, J CONTROL RELEASE, V78, P15, DOI 10.1016/S0168-3659(01)00486-2
   Walsh CL, 2013, BIOCONJUGATE CHEM, V24, P36, DOI [10.1021/bc300346h, 10.3969/j.issn.1001-1978.2013.01.009]
   Wang T, 2012, INT J PHARMACEUT, V427, P3, DOI 10.1016/j.ijpharm.2011.07.013
   WARNER JR, 1963, P NATL ACAD SCI USA, V49, P122, DOI 10.1073/pnas.49.1.122
   Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012
   Whitehead KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5277
   Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742
   Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886
   Wittrup A, 2015, NAT BIOTECHNOL, V33, P870, DOI 10.1038/nbt.3298
   WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918
   Wong CH, 2005, J ORG CHEM, V70, P4219, DOI 10.1021/jo050278f
   Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773
   Yao B, 2016, NAT REV NEUROSCI, V17, P537, DOI 10.1038/nrn.2016.70
   Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471
   Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763
   Yoon SH, 2009, CANCER GENE THER, V16, P489, DOI 10.1038/cgt.2008.98
   Zamecnik J, 2004, NEUROPATH APPL NEURO, V30, P338, DOI 10.1046/j.1365-2990.2003.0541.x
   Zangi L, 2013, NAT BIOTECHNOL, V31, P898, DOI 10.1038/nbt.2682
   Zelphati O, 1996, P NATL ACAD SCI USA, V93, P11493, DOI 10.1073/pnas.93.21.11493
   Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038
   Zhao MN, 2016, DRUG DELIV, V23, P2596, DOI 10.3109/10717544.2015.1038856
   Zhou WZ, 1999, HUM GENE THER, V10, P2719, DOI 10.1089/10430349950016762
NR 163
TC 91
Z9 90
U1 32
U2 156
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-8437
J9 NAT REV MATER
JI Nat. Rev. Mater.
PD OCT
PY 2017
VL 2
IS 10
AR 17056
DI 10.1038/natrevmats.2017.56
PG 17
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA FM6SS
UT WOS:000415188900004
DA 2020-07-08
ER

PT J
AU Varjak, M
   Donald, CL
   Mottram, TJ
   Sreenu, VB
   Merits, A
   Maringer, K
   Schnettler, E
   Kohl, A
AF Varjak, Margus
   Donald, Claire L.
   Mottram, Timothy J.
   Sreenu, Vattipally B.
   Merits, Andres
   Maringer, Kevin
   Schnettler, Esther
   Kohl, Alain
TI Characterization of the Zika virus induced small RNA response in Aedes
   aegypti cells
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID FULL-LENGTH CDNA; ANTIVIRAL IMMUNITY; CAPSID PROTEIN; INTERFERENCE;
   REPLICATION; ALPHAVIRUS; DROSOPHILA; ARBOVIRUS; INFECTION; PATHOGENESIS
AB RNA interference (RNAi) controls arbovirus infections in mosquitoes. Two different RNAi pathways are involved in antiviral responses: the PIWI-interacting RNA (piRNA) and exogenous short interfering RNA (exo-siRNA) pathways, which are characterized by the production of virus-derived small RNAs of 25-29 and 21 nucleotides, respectively. The exo-siRNA pathway is considered to be the key mosquito antiviral response mechanism. In Aedes aegypti-derived cells, Zika virus (ZIKV)-specific siRNAs were produced and loaded into the exo-siRNA pathway effector protein Argonaute 2 (Ago2); although the knockdown of Ago2 did not enhance virus replication. Enhanced ZIKV replication was observed in a Dcr2-knock-out cell line suggesting that the exo-siRNA pathway is implicated in the antiviral response. Although ZIKV-specific piRNA-sized small RNAs were detected, these lacked the characteristic piRNA ping-pong signature motif and were bound to Ago3 but not Piwi5 or Piwi6. Silencing of PIWI proteins indicated that the knockdown of Ago3, Piwi5 or Piwi6 did not enhance ZIKV replication and only Piwi4 displayed antiviral activity. We also report that the expression of ZIKV capsid (C) protein amplified the replication of a reporter alphavirus; although, unlike yellow fever virus C protein, it does not inhibit the exo-siRNA pathway. Our findings elucidate ZIKV-mosquito RNAi interactions that are important for understanding its spread.
C1 [Varjak, Margus; Donald, Claire L.; Mottram, Timothy J.; Sreenu, Vattipally B.; Kohl, Alain] Unive Glasgow, MRC, Ctr Virus Res, Glasgow, Lanark, Scotland.
   [Merits, Andres] Univ Tartu, Inst Technol, Nooruse 1, Tartu, Estonia.
   [Maringer, Kevin] Univ Surrey, Fac Hlth & Med Sci, Dept Microbial Sci, Guildford, Surrey, England.
   [Schnettler, Esther] Bernhard Nocht Inst Trop Med, Bernhard Nocht Str, Hamburg, Germany.
RP Varjak, M; Kohl, A (corresponding author), Unive Glasgow, MRC, Ctr Virus Res, Glasgow, Lanark, Scotland.
EM margus.varjak@glasgow.ac.uk; alain.kohl@glasgow.ac.uk
RI Merits, Andres/H-3125-2015; Donald, Claire/AAC-7556-2019
OI Merits, Andres/0000-0001-8193-0071; Donald, Claire/0000-0002-4370-0707;
   Varjak, Margus/0000-0003-2608-5148; Mottram,
   Timothy/0000-0001-9013-3664; Maringer, Kevin/0000-0003-0977-8807;
   Vattipally, Bala Sreenu/0000-0001-6673-4697
FU European Union's Horizon research and innovation programme [734548,
   661232]; UK Medical Research CouncilMedical Research Council UK (MRC)
   [MC_UU_12014]; Wellcome TrustWellcome Trust [096062]
FX This work was supported by the European Union's Horizon 2020 research
   and innovation programme (https://ec.europa.eu/ programmes/horizon2020/)
   under ZIKAlliance grant agreement No 734548 (AK, ES), and under the
   Marie Sktodowska-Cu de grant
   (https://ec.europa.eu/programmes/honzon2020/) agreement No 661232 (MV).
   This work was also funded by UK Medical Research Council (https://
   www.mrc.ac.uk/) [MC_UU_12014] (ES, AK) and Wellcome Trust
   (https://wellcome.ac.uk/) [Sir Henry Wellcome Fellowship, 096062] (KM).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aliyari R, 2008, CELL HOST MICROBE, V4, P387, DOI 10.1016/j.chom.2008.09.001
   [Anonymous], 2016, CURR BIOL CB, V26, pR1258
   Attarzadeh-Yazdi G, 2009, J VIROL, V83, P5735, DOI 10.1128/JVI.02440-08
   Bavia L, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0541-3
   Blair CD, 2015, VIRUSES-BASEL, V7, P820, DOI 10.3390/v7020820
   Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856
   Brackney DE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000502
   Campbell CL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-47
   Campbell CL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-425
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Cumberworth SL, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12737
   Dietrich I, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00090-17
   Dietrich I, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005272
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Flynt A, 2009, P NATL ACAD SCI USA, V106, P5270, DOI 10.1073/pnas.0813412106
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Geiss BJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-53
   Girardi E, 2017, NUCLEIC ACIDS RES, V45, P4881, DOI 10.1093/nar/gkw1368
   Han YH, 2011, J VIROL, V85, P13153, DOI 10.1128/JVI.05518-11
   Hess AM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-45
   Hilton L, 2006, J VIROL, V80, P11723, DOI 10.1128/JVI.01145-06
   Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101
   Khromykh AA, 2001, J VIROL, V75, P4633, DOI 10.1128/JVI.75.10.4633-4640.2001
   Kim K, 2007, RNA, V13, P22, DOI 10.1261/rna.283207
   Leger P, 2013, J VIROL, V87, P1631, DOI 10.1128/JVI.02795-12
   Li WX, 2004, P NATL ACAD SCI USA, V101, P1350, DOI 10.1073/pnas.0308308100
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044
   McFarlane M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002994
   Miesen P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004452
   Miesen P, 2015, NUCLEIC ACIDS RES, V43, P6545, DOI 10.1093/nar/gkv590
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Morazzani EM, 2012, PLOS PATHOG, P8
   Mueller S, 2010, P NATL ACAD SCI USA, V107, P19390, DOI 10.1073/pnas.1014378107
   Myles KM, 2009, RNA BIOL, V6, P387, DOI 10.4161/rna.6.4.8946
   Myles KM, 2008, P NATL ACAD SCI USA, V105, P19938, DOI 10.1073/pnas.0803408105
   Nayak A, 2010, NAT STRUCT MOL BIOL, V17, P547, DOI 10.1038/nsmb.1810
   Olson KE, 2015, CURR OPIN VIROL, V15, P119, DOI 10.1016/j.coviro.2015.10.001
   Rand TA, 2004, P NATL ACAD SCI USA, V101, P14385, DOI 10.1073/pnas.0405913101
   Saldana MA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005760
   Samuel GH, 2016, P NATL ACAD SCI USA, V113, P13863, DOI 10.1073/pnas.1600544113
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Saul S, 2015, J VIROL, V89, P11030, DOI 10.1128/JVI.01186-15
   Schnettler E, 2013, J GEN VIROL, V94, P1680, DOI 10.1099/vir.0.053850-0
   Scott JC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000848
   Siu RWC, 2011, J VIROL, V85, P2907, DOI 10.1128/JVI.02052-10
   Ulper L, 2008, J VIROL METHODS, V148, P265, DOI 10.1016/j.jviromet.2007.10.007
   van Mierlo JT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002872
   van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006
   Varjak M, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00144-17, 10.1128/msphere.00144-17]
   Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007
   Vodovar N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030861
   Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694
   Weinheimer I, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004711
   Zhou K, 2017, J NEUROVIROL, V23, P341, DOI 10.1007/s13365-017-0514-3
NR 55
TC 33
Z9 33
U1 2
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD OCT
PY 2017
VL 11
IS 10
AR e0006010
DI 10.1371/journal.pntd.0006010
PG 18
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FL5JJ
UT WOS:000414271400064
PM 29040304
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Lerat, V
   Garcia, M
   Wehbe, M
   Beby-Defaux, A
   Bodet, C
   Leveque, N
AF Lerat, Vincent
   Garcia, Magali
   Wehbe, Michel
   Beby-Defaux, Agnes
   Bodet, Charles
   Leveque, Nicolas
TI Innate immunity against Zika virus
SO REVIEWS IN MEDICAL MICROBIOLOGY
LA English
DT Editorial Material
DE brain; genital tract; innate immunity; pathogen recognition receptors;
   placenta; Zika virus
ID WEST-NILE-VIRUS; TOLL-LIKE RECEPTORS; RIG-I; ANTIVIRAL RESPONSES; SEXUAL
   TRANSMISSION; NEURAL PROGENITORS; STRANDED-RNA; MDA5; INFECTION; LEADS
AB Zika virus (ZIKV) can be transmitted by the mosquito bite, through blood transfusion, organ transplantation and potentially urine or saliva. From its inoculation site, the virus will spread to various organs such as the central nervous system leading to neurological complications, particularly Guillain-Barre syndrome, or the fetus causing microcephaly. During the infection, ZIKV will have to cross multiple barriers according to the route of transmission and the infection site such as the skin, male and female genital mucosa or blood-brain and placental barriers. At these sites, ZIKV will establish an infection that the innate immune response will try to block before systemic spread occurs to the target organs. The aim of this review is to summarize the knowledge on the mechanisms of anti-ZIKV innate immunity, its characteristics at the different barriers encountered and tissues infected during the infection, and on the escape mechanisms developed by the virus to deal with it. Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.
C1 [Lerat, Vincent; Garcia, Magali; Wehbe, Michel; Beby-Defaux, Agnes; Bodet, Charles; Leveque, Nicolas] Univ Poitiers, Lab Inflammat Tissus Epitheliaux & Cytokines EA, Poitiers, France.
   [Lerat, Vincent; Garcia, Magali; Beby-Defaux, Agnes; Leveque, Nicolas] CHU Poitiers, Lab Virol & Mycobacteriogie, 2 Rue Mil, F-86021 Poitiers, France.
RP Leveque, N (corresponding author), CHU Poitiers, Lab Virol & Mycobacteriogie, 2 Rue Mil, F-86021 Poitiers, France.
EM nicolas.leveque@chu-poitiers.fr
RI Bodet, Charles/Z-4585-2019; Garcia, Magali/AAF-1828-2020
OI Bodet, Charles/0000-0002-8016-0324; Garcia, Magali/0000-0001-6611-8683
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Clarke BD, 2015, VIRUS RES, V206, P53, DOI 10.1016/j.virusres.2015.01.026
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Errett JS, 2013, J VIROL, V87, P11416, DOI 10.1128/JVI.01488-13
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fredericksen BL, 2008, J VIROL, V82, P609, DOI 10.1128/JVI.01305-07
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Garcia M, 2017, EUR CYTOKIN IN PRESS, V28
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hamel R, 2017, INFECT GENET EVOL, V49, P134, DOI 10.1016/j.meegid.2017.01.015
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725
   Hou WH, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2338-4
   Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734
   Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac6108
   Lennemann NJ, 2017, AUTOPHAGY, V13, P322, DOI 10.1080/15548627.2016.1265192
   Lester SN, 2014, J MOL BIOL, V426, P1246, DOI 10.1016/j.jmb.2013.11.024
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Proost P, 2003, EUR J IMMUNOL, V33, P3146, DOI 10.1002/eji.200324136
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008
   Schneider BS, 2006, VIRAL IMMUNOL, V19, P74, DOI 10.1089/vim.2006.19.74
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Shipley JG, 2012, VIROLOGY, V432, P232, DOI 10.1016/j.virol.2012.06.009
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Styer LM, 2006, AM J TROP MED HYG, V75, P337, DOI 10.4269/ajtmh.2006.75.337
   Sun JF, 2016, JAMA OPHTHALMOL, V134, P1330, DOI 10.1001/jamaophthalmol.2016.3417
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 62
TC 0
Z9 0
U1 0
U2 9
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0954-139X
EI 1473-5601
J9 REV MED MICROBIOL
JI Rev. Med. Microbiol.
PD OCT
PY 2017
VL 28
IS 4
BP 167
EP 174
DI 10.1097/MRM.0000000000000112
PG 8
WC Microbiology
SC Microbiology
GA FI2RZ
UT WOS:000411792000007
DA 2020-07-08
ER

PT J
AU Correa-Oliveira, GE
   do Amaral, JL
   da Fonseca, BAL
   Del-Ben, CM
AF Correa-Oliveira, Gabriel Elias
   do Amaral, Julia Lopes
   Lopes da Fonseca, Benedito Antonio
   Del-Ben, Cristina Marta
TI Zika virus infection followed by a first episode of psychosis: another
   flavivirus leading to pure psychiatric symptomatology
SO REVISTA BRASILEIRA DE PSIQUIATRIA
LA English
DT Letter
C1 [Correa-Oliveira, Gabriel Elias; do Amaral, Julia Lopes; Del-Ben, Cristina Marta] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Neurociencias & Ciencias Comportamento, Serv Emergencias Psiquiatr, Ribeirao Preto, SP, Brazil.
   [Lopes da Fonseca, Benedito Antonio] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Div Molestias Infecciosas & Trop, Ribeirao Preto, SP, Brazil.
RP Correa-Oliveira, GE (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Neurociencias & Ciencias Comportamento, Serv Emergencias Psiquiatr, Ribeirao Preto, SP, Brazil.
RI Del-Ben, Cristina M/F-1817-2012; Del-Ben, Cristina Marta/X-1533-2019;
   Fonseca, Benedito/F-3252-2012
OI Del-Ben, Cristina M/0000-0003-0145-9975; Del-Ben, Cristina
   Marta/0000-0003-0145-9975; Fonseca, Benedito/0000-0003-3159-5687
CR Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   John CC, 2015, NATURE, V527, pS178, DOI 10.1038/nature16033
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
NR 5
TC 4
Z9 4
U1 0
U2 13
PU ASSOC BRASILEIRA PSIQUIATRIA
PI SAO PAULO
PA SUBSCRIPTION DEPARTMENT, RUA PEDRO DE TOLEDO, 967 - CASA 01, SAO PAULO,
   SP 04039-032  A, BRAZIL
SN 1516-4446
EI 1809-452X
J9 REV BRAS PSIQUIATR
JI Rev. Bras. Psiquiatr.
PD OCT-DEC
PY 2017
VL 39
IS 4
BP 381
EP 382
DI 10.1590/1516-4446-2017-2308
PG 3
WC Psychiatry
SC Psychiatry
GA FM9BR
UT WOS:000415387500020
PM 29160530
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Misslin, R
   Daude, E
AF Misslin, Renaud
   Daude, Eric
TI An environmental suitability index based on the ecological constraints
   of Aedes aegypti, vector of dengue
SO REVUE INTERNATIONALE DE GEOMATIQUE
LA English
DT Article
DE vector-borne disease; resource-based habitat concept; biogeography;
   spatial simulation; GIS; remote sensing
AB Aedes aegypti is the main vector of dengue and Zika virus. Along with vaccine research, vector control is a major lever for fighting these diseases. Studying dynamical and nonlinear relationships between the environment and vectors provides guidance for monitoring and control strategies. MODE's objective is to identify environmental dynamics that contribute to the spatiotemporal distribution of Aedes aegypti in urban areas. This paper presents (1) the resource-based habitat concept and its application to Aedes aegypti, (2) the generic methods for estimating the environmental factor of this habitat and (3) the factors dynamics. These concepts and methods are illustrated in (4) with an application on Bangkok, Thailand and (5) with the mapping of an environmental suitability index.
C1 [Misslin, Renaud; Daude, Eric] Univ Rouen, CNRS, UMR 6266 IDEES, Rouen, France.
RP Misslin, R (corresponding author), Univ Rouen, CNRS, UMR 6266 IDEES, Rouen, France.
EM renaud.misslin1@univ-rouen.fr; eric.daude@univ-rouen.fr
RI Daude, Eric/P-4133-2014
OI Daude, Eric/0000-0001-8656-3346
CR Arunachalam N, 2010, B WORLD HEALTH ORGAN, V88, P173, DOI 10.2471/BLT.09.067892
   Attaway D. F., 2014, MOSQUITO HABITAT DEN
   Cebeillac A., 2017, WHERE OFTEN WHAT CAN
   Cianci D, 2015, J MED ENTOMOL, V52, P329, DOI 10.1093/jme/tjv026
   Dennis RLH, 2003, OIKOS, V102, P417, DOI 10.1034/j.1600-0706.2003.12387.x
   Descloux E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001470
   Eisen L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000411
   Getis A, 2003, AM J TROP MED HYG, V69, P494, DOI 10.4269/ajtmh.2003.69.494
   GILLIES MT, 1972, B ENTOMOL RES, V61, P389, DOI 10.1017/S0007485300047295
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Hartemink N., 2014, BIOL REV
   Hopp MJ, 2003, CLIM RES, V25, P85, DOI 10.3354/cr025085
   Jetten TH, 1997, AM J TROP MED HYG, V57, P285, DOI 10.4269/ajtmh.1997.57.285
   Karl S, 2014, BMC INFECT DIS, V14, P1, DOI DOI 10.1186/1471-2334-14-447
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Leandro-Reguillo P., FUZZIFICATION MULTIC
   Li GY, 2010, CAN J REMOTE SENS, V36, P155, DOI 10.5589/m10-035
   LINACRE ET, 1977, AGR METEOROL, V18, P409, DOI 10.1016/0002-1571(77)90007-3
   Machault V, 2014, ISPRS INT J GEO-INF, V3, P1352, DOI 10.3390/ijgi3041352
   Maneerat S, 2017, CYBERGEO, DOI 10.4000/cybergeo.28078
   Maneerat S, 2016, ECOL MODEL, V333, P66, DOI 10.1016/j.ecolmodel.2016.04.012
   de Lima TFM, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13090920
   Mennis J, 2015, CITYSCAPE, V17, P115
   Misslin R, 2016, ANN NY ACAD SCI, V1382, P56, DOI 10.1111/nyas.13084
   Moloney JM, 1998, AM J TROP MED HYG, V59, P261, DOI 10.4269/ajtmh.1998.59.261
   Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/10.3201/eid1206.051210
   Peterson AT, 2014, MAPPING DISEASE TRANSMISSION RISK: ENRICHING MODELS USING BIOGEOGRAPHY AND ECOLOGY, P1
   Reiner RC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0921
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Rogers DJ, 2014, ACTA TROP, V129, P1, DOI 10.1016/j.actatropica.2013.08.008
   Smith DL, 2014, T ROY SOC TROP MED H, V108, P185, DOI 10.1093/trstmh/tru026
   Smith DL, 2009, TRENDS PARASITOL, V25, P511, DOI 10.1016/j.pt.2009.08.002
   Sougoufara S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-125
   Tsuda Y, 2006, J AM MOSQUITO CONTR, V22, P222, DOI 10.2987/8756-971X(2006)22[222:DSDOAA]2.0.CO;2
   TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0
   Vancutsem C, 2010, REMOTE SENS ENVIRON, V114, P449, DOI 10.1016/j.rse.2009.10.002
   Vezzani D, 2005, ACTA TROP, V95, P123, DOI 10.1016/j.actatropica.2005.03.010
   Yew Yuan, 1997, Computers, Environment and Urban Systems, V21, P245
   Zhu WB, 2013, REMOTE SENS ENVIRON, V130, P62, DOI 10.1016/j.rse.2012.10.034
NR 39
TC 1
Z9 1
U1 0
U2 0
PU LAVOISIER
PI CACHAN
PA 14, RUE DE PROVIGNY, 94236 CACHAN, FRANCE
SN 1260-5875
EI 2116-7060
J9 REV INT GEOMAT
JI Rev. Int. Geomat.
PD OCT-DEC
PY 2017
VL 27
IS 4
BP 481
EP 501
DI 10.3166/rig.2017.00044
PG 21
WC Remote Sensing
SC Remote Sensing
GA VH8JA
UT WOS:000455739900003
DA 2020-07-08
ER

PT J
AU Vraga, EK
   Bode, L
AF Vraga, Emily K.
   Bode, Leticia
TI Using Expert Sources to Correct Health Misinformation in Social Media
SO SCIENCE COMMUNICATION
LA English
DT Article
DE misinformation; social media; health communication; credibility; CDC
ID SOURCE CREDIBILITY; ZIKA VIRUS; INFORMATION; TWITTER; NEWS;
   COMMUNICATION; SCIENTISTS; SCIENCE; EBOLA; ADVOCACY
AB This study tests whether the number (1 vs. 2) and the source (another user vs. the Centers for Disease Control and Prevention [CDC]) of corrective responses affect successful reduction of misperceptions. Using an experimental design, our results suggest that while a single correction from another user did not reduce misperceptions, the CDC on its own could correct misinformation. Corrections were more effective among those higher in initial misperceptions. Notably, organizational credibility was not reduced when correcting misinformation, making this a low-cost behavior for public health organizations. We recommend that expert organizations like the CDC immediately and personally rebut misinformation about health issues on social media.
C1 [Vraga, Emily K.] George Mason Univ, Dept Commun, 4400 Univ Dr,MS 3D6, Fairfax, VA 22030 USA.
   [Bode, Leticia] Georgetown Univ, Commun Culture & Technol Masters Program, Washington, DC USA.
RP Vraga, EK (corresponding author), George Mason Univ, Dept Commun, 4400 Univ Dr,MS 3D6, Fairfax, VA 22030 USA.
EM evraga@gmu.edu
RI Vraga, Emily/K-9325-2019
OI Vraga, Emily/0000-0002-3016-3869
CR Aikin KJ, 2017, RES SOC ADMIN PHARM, V13, P378, DOI 10.1016/j.sapharm.2016.04.004
   Aikin KJ, 2015, J COMMUN, V65, P596, DOI 10.1111/jcom.12167
   Al-Qahtani AA, 2016, J INFECT DEV COUNTR, V10, P201, DOI 10.3855/jidc.8350
   Allgaier J, 2013, BIOSCIENCE, V63, P284, DOI 10.1525/bio.2013.63.4.8
   Amazeen MA, 2018, J MASS COMMUN Q, V95, P28, DOI 10.1177/1077699016678186
   AUSTIN EW, 1994, JOURNALISM QUART, V71, P973, DOI 10.1177/107769909407100420
   Bessi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118093
   Bode L, 2016, MASS COMMUN SOC, V19, P24, DOI 10.1080/15205436.2015.1045149
   Bode L, 2015, J COMMUN, V65, P619, DOI 10.1111/jcom.12166
   Boyd DM, 2007, J COMPUT-MEDIAT COMM, V13, P210, DOI 10.1111/j.1083-6101.2007.00393.x
   Bravo CA, 2016, J CANCER EDUC, V31, P236, DOI 10.1007/s13187-015-0796-1
   Brossard D, 2013, P NATL ACAD SCI USA, V110, P14096, DOI 10.1073/pnas.1212744110
   Castillo C., 2011, P 20 INT C WORLD WID, P675, DOI DOI 10.1145/1963405.1963500
   Centers for Disease Control and Prevention, 2016, KEY MESS ZIK VIR DIS
   CHAIKEN S, 1980, J PERS SOC PSYCHOL, V39, P752, DOI 10.1037/0022-3514.39.5.752
   CHAIKEN S, 1994, J PERS SOC PSYCHOL, V66, P460, DOI 10.1037/0022-3514.66.3.460
   Chen XR, 2015, J ACAD LIBR, V41, P583, DOI 10.1016/j.acalib.2015.07.003
   Choi J, 2016, J MASS COMMUN Q, V93, P816, DOI 10.1177/1077699016628812
   Chung JE, 2016, J HEALTH COMMUN, V21, P517, DOI 10.1080/10810730.2015.1103332
   Dalrymple KE, 2016, SCI COMMUN, V38, P442, DOI 10.1177/1075547016655546
   Davies SR, 2008, SCI COMMUN, V29, P413, DOI 10.1177/1075547008316222
   Diehl T, 2016, NEW MEDIA SOC, V18, P1875, DOI 10.1177/1461444815616224
   Dredze M, 2016, VACCINE, V34, P3441, DOI 10.1016/j.vaccine.2016.05.008
   Duke JC, 2014, J MED INTERNET RES, V16, P73, DOI 10.2196/jmir.3430
   Eastin M. S., 2001, J COMPUTER MEDIATED, V6
   Fischhoff B., 2007, NONPERSUASIVE COMMUN
   Fung ICH, 2016, PUBLIC HEALTH REP, V131, P461, DOI 10.1177/003335491613100312
   Garrett RK, 2013, J COMMUN, V63, P617, DOI 10.1111/jcom.12038
   GIFFIN K, 1967, PSYCHOL BULL, V68, P104, DOI 10.1037/h0024833
   Giglietto F, 2016, FAKES NEWS ELECTION
   Griffiths E., 2016, THE MIRROR
   Harris JK, 2014, J MED INTERNET RES, V16, P162, DOI [10.2196/jmir.2972, 10.2196/jmir.3622]
   Hayes A. F., 2013, INTRO MEDIATION MODE
   Hermida A, 2012, JOURNALISM STUD, V13, P815, DOI 10.1080/1461670X.2012.664430
   Himelboim I, 2014, J HEALTH COMMUN, V19, P210, DOI 10.1080/10810730.2013.811321
   Hovland CI, 1951, PUBLIC OPIN QUART, V15, P635, DOI 10.1086/266350
   Jerit J, 2012, J POLIT, V74, P672, DOI 10.1017/S0022381612000187
   Jong W, 2016, COMPUT HUM BEHAV, V59, P334, DOI 10.1016/j.chb.2016.02.032
   Kata A, 2010, VACCINE, V28, P1709, DOI 10.1016/j.vaccine.2009.12.022
   Kotcher JE, 2017, ENVIRON COMMUN, V11, P415, DOI 10.1080/17524032.2016.1275736
   Lee CS, 2012, COMPUT HUM BEHAV, V28, P331, DOI 10.1016/j.chb.2011.10.002
   Lee NM, 2015, SCI COMMUN, V37, P533, DOI 10.1177/1075547015588600
   Leiserowitz A, 2012, GLOBAL WARMINGS 6 AM
   Lewandowsky S, 2012, PSYCHOL SCI PUBL INT, V13, P106, DOI 10.1177/1529100612451018
   Messing S, 2014, COMMUN RES, V41, P1042, DOI 10.1177/0093650212466406
   Metzger MJ, 2007, J AM SOC INF SCI TEC, V58, P2078, DOI 10.1002/asi.20672
   Metzger MJ, 2010, J COMMUN, V60, P413, DOI 10.1111/j.1460-2466.2010.01488.x
   Munger K, 2017, POLIT BEHAV, V39, P629, DOI 10.1007/s11109-016-9373-5
   National Science Board, 2016, SCI TECHN PUBL ATT U
   Neiger BL, 2013, HEALTH PROMOT PRACT, V14, P157, DOI 10.1177/1524839912469378
   Nelson MP, 2009, CONSERV BIOL, V23, P1090, DOI 10.1111/j.1523-1739.2009.01250.x
   Nisbet EC, 2015, ANN AM ACAD POLIT SS, V658, P36, DOI 10.1177/0002716214555474
   Nyhan B, 2010, POLIT BEHAV, V32, P303, DOI 10.1007/s11109-010-9112-2
   Oyeyemi SO, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6178
   Papacharissi Z., 2012, INT J COMMUNICATION, V6, P1989
   Park H, 2013, J HEALTH COMMUN, V18, P410, DOI 10.1080/10810730.2012.727956
   Peters HP, 2014, EMBO REP, V15, P749, DOI 10.15252/embr.201438979
   Peters RG, 1997, RISK ANAL, V17, P43, DOI 10.1111/j.1539-6924.1997.tb00842.x
   Pew Research Center, 2015, PUBLIC SCI VIEWS SCI
   Pew Research Center, 2013, ROL NEWS FAC FAC NEW
   Pew Research Center, 2015, MOST VIEW CDC FAV VA
   Pew Research Center, 2011, HLTH TOPICS
   Pew Research Center, 2016, MAN AM BEL FAK NEWS
   Pew Research Center, 2015, SCI ENGAGE PUBLIC
   Sharma M, 2017, AM J INFECT CONTROL, V45, P301, DOI 10.1016/j.ajic.2016.08.022
   Southwell BG, 2015, J COMMUN, V65, P589, DOI 10.1111/jcom.12168
   Starbird K., 2013, ICONFERENCE 2014, V2014, P654, DOI DOI 10.9776/14308
   Stefanidis Anthony, 2017, JMIR Public Health Surveill, V3, pe22, DOI 10.2196/publichealth.6925
   Thorson E, 2016, POLIT COMMUN, V33, P460, DOI 10.1080/10584609.2015.1102187
   Vraga EK, 2018, INFORM COMMUN SOC, V21, P1337, DOI 10.1080/1369118X.2017.1313883
   Vraga EK, 2015, COMPUT HUM BEHAV, V45, P281, DOI 10.1016/j.chb.2014.12.025
   Winter S, 2016, COMMUNICATIONS-GER, V41, P339, DOI 10.1515/commun-2016-0008
   Winter S, 2015, CYBERPSYCH BEH SOC N, V18, P431, DOI 10.1089/cyber.2015.0005
   Wood T., 2016, ELUSIVE BACKFIRE EFF
   World Health Organization, 2016, DISP RUM ZIK COMPL
   Worth Katie, 2016, FRONTLINE
   Yeo S. K., 2014, 13 INT PUBL COMM SCI
NR 77
TC 32
Z9 31
U1 7
U2 72
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1075-5470
EI 1552-8545
J9 SCI COMMUN
JI Sci. Commun.
PD OCT
PY 2017
VL 39
IS 5
SI SI
BP 621
EP 645
DI 10.1177/1075547017731776
PG 25
WC Communication
SC Communication
GA FJ7NX
UT WOS:000412947100004
DA 2020-07-08
ER

PT J
AU Germain, M
   Delage, G
   O'Brien, SF
   Gregoire, Y
   Fearon, M
   Devine, D
AF Germain, Marc
   Delage, Gilles
   O'Brien, Sheila F.
   Gregoire, Yves
   Fearon, Margaret
   Devine, Dana
TI Mitigation of the threat posed to transfusion by donors traveling to
   Zika-affected areas: a Canadian risk-based approach
SO TRANSFUSION
LA English
DT Article
ID VIRUS-INFECTION; BLOOD; PREGNANCY; TRANSMISSION; SAFETY; DENGUE; LOAD
AB BACKGROUNDThe recent spread of the Zika virus to the Americas and the recognition that it can cause severe disease in the developing fetus has prompted the adoption of measures to mitigate the risk that this virus might pose to transfusion safety. In nonendemic countries, the risk to transfusion results from donors traveling to an endemic region. Canada implemented a 21-day temporary deferral for prospective donors who traveled to such regions. We present the rationale for this policy, including a quantitative risk assessment supported by a Monte Carlo simulation.
   STUDY DESIGN AND METHODSThe model considered the following parameters, each with specified values and ranges: the probability that a donor recently returned from a Zika-endemic region, the duration of travel to this region, the daily risk of acquiring Zika while in an endemic region, and the incubation and viremic periods. We ran the simulation 20 times, each with 10 million iterations.
   RESULTSIn the absence of any travel deferral, 32 donors (range, 20-46 donors) would be able to donate while still being at risk of transmitting Zika, corresponding to a rate of 1:312,500 (range, 1:217,000 to 1:500,000). None of these donors would be viremic beyond 21 days after returning from their travel, with a risk estimated at less than 1:200,000,000.
   CONCLUSIONSA 21-day temporary travel deferral offers an extremely wide margin of safety for the possible transmission of Zika by a donation obtained from someone who recently returned from a country where the virus is circulating.
C1 [Germain, Marc; Delage, Gilles; Gregoire, Yves] Hema Quebec, Med Affairs, 1070 Sci de la Vie Ave, Montreal, PQ G1V 5C3, Canada.
   [O'Brien, Sheila F.; Fearon, Margaret; Devine, Dana] Canadian Blood Serv, Ottawa, ON, Canada.
RP Germain, M (corresponding author), Hema Quebec, Med Affairs, 1070 Sci de la Vie Ave, Montreal, PQ G1V 5C3, Canada.
EM marc.germain@hema-quebec.qc.ca
CR [Anonymous], 2016, ZIK CUM CAS
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Bierlaire D, 2017, TRANSFUSION, V57, P729, DOI 10.1111/trf.14028
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Burattini MN, 2008, EPIDEMIOL INFECT, V136, P309, DOI 10.1017/S0950268807008667
   Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Galel SA, 2017, TRANSFUSION, V57, P762, DOI 10.1111/trf.14029
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Kuehnert MJ, 2016, TRANSFUSION, V56, P1669, DOI 10.1111/trf.13673
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanteri MC, 2016, TRANSFUSION, V56, P1907, DOI 10.1111/trf.13677
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Massad E, 2009, J TRAVEL MED, V16, P191, DOI 10.1111/j.1708-8305.2009.00310.x
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Murphy MSQ, 2017, TRANSFUSION, V57, P811, DOI 10.1111/trf.14001
   Musso D, 2017, J MED VIROL, V89, P1505, DOI 10.1002/jmv.24735
   O'Brien SF, 2016, TRANSFUSION, V56, p12A
   Paz-Bailey G, N ENGL J MED
   SOUTHAM CM, 1954, AM J TROP MED HYG, V3, P19, DOI 10.4269/ajtmh.1954.3.19
   Statistics Canada, INT TRAV 2010
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   U.S. Food and Drug Administration, 2016, REV REC RED RISK ZIK
   US Food and Drug Administration, 2016, REC DON SCREEN DEF P
   US Food and Drug Administration (FDA), 2016, GUID IND REV REC RED
NR 31
TC 2
Z9 2
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD OCT
PY 2017
VL 57
IS 10
BP 2463
EP 2468
DI 10.1111/trf.14247
PG 6
WC Hematology
SC Hematology
GA FI2CD
UT WOS:000411743400025
PM 28758222
OA Bronze
DA 2020-07-08
ER

PT J
AU Marban-Castro, E
   Gonce, A
   Martinez, MJ
   Fumado, V
   Esteve, C
   Fortuny, C
   Lopez, M
   Garcia, L
   Salazar, L
   Salvia, D
   Oliveira, I
   Rodriguez-Valero, N
   Pinazo, MJ
   Requena-Mendez, A
   Llenas-Garcia, J
   Alejo-Cancho, I
   Saco, A
   Castillo, P
   Fuente-Moreno, M
   Casellas, A
   Gonzalez, R
   Munoz, J
   Gascon, J
   Ordi, J
   Menendez, C
   Bardaji, A
AF Marban-Castro, E.
   Gonce, A.
   Martinez, M. J.
   Fumado, V.
   Esteve, C.
   Fortuny, C.
   Lopez, M.
   Garcia, L.
   Salazar, L.
   Salvia, D.
   Oliveira, I.
   Rodriguez-Valero, N.
   Pinazo, M. J.
   Requena-Mendez, A.
   Llenas-Garcia, J.
   Alejo-Cancho, I.
   Saco, A.
   Castillo, P.
   Fuente-Moreno, M.
   Casellas, A.
   Gonzalez, R.
   Munoz, J.
   Gascon, J.
   Ordi, J.
   Menendez, C.
   Bardaji, A.
TI Surveillance of zika virus in pregnant women returning from affected
   areas: results from a cohort study in southern Europe
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 [Marban-Castro, E.; Martinez, M. J.; Fumado, V.; Oliveira, I.; Rodriguez-Valero, N.; Pinazo, M. J.; Requena-Mendez, A.; Llenas-Garcia, J.; Fuente-Moreno, M.; Casellas, A.; Gonzalez, R.; Munoz, J.; Gascon, J.; Ordi, J.; Menendez, C.; Bardaji, A.] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain.
   [Gonce, A.; Lopez, M.; Garcia, L.; Salazar, L.; Salvia, D.] Univ Barcelona, Hosp Clin, BCNatal Barcelona Ctr Maternal Fetal & Neonatal M, Dept Maternal Fetal Med, Barcelona, Spain.
   [Gonce, A.; Lopez, M.; Garcia, L.; Salazar, L.; Salvia, D.] Univ Barcelona, Hosp St Joan de Deu, Barcelona, Spain.
   [Martinez, M. J.; Alejo-Cancho, I.] Hosp Clin Barcelona, Dept Clin Microbiol, Barcelona, Spain.
   [Fumado, V.; Esteve, C.; Fortuny, C.] Hosp St Joan de Deu, Dept Trop Pathol & Imported Dis, Barcelona, Spain.
   [Saco, A.; Castillo, P.] Hosp Clin Barcelona, Dept Pathol, Barcelona, Spain.
RI Gascon, Joaquim/M-3598-2015; Casellas, Aina/Q-1247-2016; Bardaji,
   Azucena/AAE-9145-2019; Rodriguez-Valero, Natalia/AAD-7083-2020; Pinazo,
   Maria Jesus M/X-6093-2018
OI Gascon, Joaquim/0000-0002-5045-1585; Casellas, Aina/0000-0003-4939-8411;
   Bardaji, Azucena/0000-0002-5135-0540; Pinazo, Maria Jesus
   M/0000-0002-4237-1075
NR 0
TC 1
Z9 1
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD OCT
PY 2017
VL 22
SU 1
SI SI
MA 3S1.5
BP 28
EP 29
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6VU
UT WOS:000412896900064
DA 2020-07-08
ER

PT J
AU Kang, CB
   Keller, TH
   Luo, DH
AF Kang, CongBao
   Keller, Thomas H.
   Luo, Dahai
TI Zika Virus Protease: An Antiviral Drug Target
SO TRENDS IN MICROBIOLOGY
LA English
DT Review
ID SMALL-MOLECULE INHIBITORS; NS2B-NS3 PROTEASE; WEST-NILE; NS3 PROTEASE;
   CRYSTAL-STRUCTURE; PEPTIDE INHIBITORS; DENGUE PROTEASE; IDENTIFICATION;
   ACTIVATION; DISCOVERY
AB The recent outbreak of Zika virus (ZIKV) infection has caused global concern due to its link to severe damage to the brain development of foetuses and neuronal complications in adult patients. A worldwide research effort has been undertaken to identify effective and safe treatment and vaccination options. Among the proposed viral and host components, the viral NS2B-NS3 protease represents an attractive drug target due to its essential role in the virus life cycle. Here, we outline recent progress in studies on the Zika protease. Biochemical, biophysical, and structural studies on different protease constructs provide new insight into the structure and activity of the protease. The unlinked construct displays higher enzymatic activity and better mimics the native state of the enzyme and therefore is better suited for drug discovery. Furthermore, the structure of the free enzyme adopts a closed conformation and a preformed active site. The availability of a lead fragment hit and peptide inhibitors, as well as the attainability of soakable crystals, suggest that the unlinked construct is a promising tool for drug discovery.
C1 [Kang, CongBao; Keller, Thomas H.] ASTAR, Expt Therapeut Ctr, 31 Biopolis Way,Nanos 03-01, Singapore 138669, Singapore.
   [Luo, Dahai] Nanyang Technol Univ, Lee Kong Chian Sch Med, EMB 03-07,59 Nanyang Dr, Singapore 636921, Singapore.
   [Luo, Dahai] Nanyang Technol Univ, NTU Inst Struct Biol, EMB 06-01,59 Nanyang Dr, Singapore 636921, Singapore.
RP Kang, CB; Keller, TH (corresponding author), ASTAR, Expt Therapeut Ctr, 31 Biopolis Way,Nanos 03-01, Singapore 138669, Singapore.; Luo, DH (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, EMB 03-07,59 Nanyang Dr, Singapore 636921, Singapore.; Luo, DH (corresponding author), Nanyang Technol Univ, NTU Inst Struct Biol, EMB 06-01,59 Nanyang Dr, Singapore 636921, Singapore.
EM cbkang@etc.a-star.edu.sg; thkeller@etc.a-star.edu.sg;
   luodahai@ntu.edu.sg
RI Kang, Congbao/AAP-7572-2020; Luo, Dahai/J-6022-2012
OI Kang, Congbao/0000-0002-9886-9374; Luo, Dahai/0000-0001-7637-7275;
   Keller, Thomas/0000-0002-7553-6235
FU Lee Kong Chian School of Medicine, Nanyang Technological
   UniversityNanyang Technological University; National Medical Research
   CouncilMedical Research Council UK (MRC) [CBRG15May045]; National
   Research Foundation [NRF2016NRF-CRP001-063]; A*STAR JCO grantAgency for
   Science Technology & Research (ASTAR) [1431AFG102/1331A028]
FX This work was supported by (i) a start-up grant from Lee Kong Chian
   School of Medicine, Nanyang Technological University, (ii) National
   Medical Research Council grant CBRG15May045, (iii) National Research
   Foundation grant NRF2016NRF-CRP001-063 to D.L., (iv) A*STAR JCO grant
   (1431AFG102/1331A028) to C.K.
CR Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Behnam MAM, 2015, J MED CHEM, V58, P9354, DOI 10.1021/acs.jmedchem.5b01441
   Brecher M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006411
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   Choksupmanee O, 2012, BIOCHEMISTRY-US, V51, P2840, DOI 10.1021/bi2018267
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de la Cruz L, 2011, J AM CHEM SOC, V133, P19205, DOI 10.1021/ja208435s
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   Gruba N, 2016, FEBS LETT, V590, P3459, DOI 10.1002/1873-3468.12443
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Huang QW, 2013, PROTEIN EXPRES PURIF, V92, P156, DOI 10.1016/j.pep.2013.09.015
   Kang CB, 2013, ANTIVIR RES, V97, P137, DOI 10.1016/j.antiviral.2012.11.008
   Kim YM, 2013, J BIOL CHEM, V288, P12891, DOI 10.1074/jbc.M112.442723
   Kouretova J, 2017, J ENZYM INHIB MED CH, V32, P712, DOI 10.1080/14756366.2017.1306521
   Kuiper B. D., 2017, BIOCH BIOPHYS RES CO
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Leon-Juarez M, 2016, VIROL J, V13, DOI 10.1186/s12985-015-0456-4
   Li Y., 2017, STRUCTURE
   Li Y., 2017, FEBS LETT
   Li Y, 2015, BBA-BIOMEMBRANES, V1848, P2244, DOI 10.1016/j.bbamem.2015.06.010
   Liew LSY, 2016, PROTEIN EXPRES PURIF, V121, P141, DOI 10.1016/j.pep.2016.02.001
   Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Mahawaththa MC, 2017, ANTIVIR RES, V142, P141, DOI 10.1016/j.antiviral.2017.03.011
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Nitsche C, 2014, CHEM REV, V114, P11348, DOI 10.1021/cr500233q
   Njoroge FG, 2008, ACCOUNTS CHEM RES, V41, P50, DOI 10.1021/ar700109k
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Poulsen A, 2014, CURR PHARM DESIGN, V20, P3422, DOI 10.2174/13816128113199990633
   Robin G, 2009, J MOL BIOL, V385, P1568, DOI 10.1016/j.jmb.2008.11.026
   Russell PK, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004589
   Rut W, 2017, ANTIVIR RES, V139, P88, DOI 10.1016/j.antiviral.2016.12.018
   Steuer C, 2011, BIOORGAN MED CHEM, V19, P4067, DOI 10.1016/j.bmc.2011.05.015
   Su XC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000561
   Weigel LF, 2015, J MED CHEM, V58, P7719, DOI 10.1021/acs.jmedchem.5b00612
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P1109, DOI 10.1016/S1473-3099(17)30494-2
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yin Z, 2006, BIOORG MED CHEM LETT, V16, P36, DOI 10.1016/j.bmcl.2005.09.062
   Yin Z, 2006, BIOORG MED CHEM LETT, V16, P40, DOI 10.1016/j.bmcl.2005.09.049
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
NR 46
TC 26
Z9 28
U1 0
U2 38
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0966-842X
EI 1878-4380
J9 TRENDS MICROBIOL
JI Trends Microbiol.
PD OCT
PY 2017
VL 25
IS 10
BP 797
EP 808
DI 10.1016/j.tim.2017.07.001
PG 12
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA FH2OD
UT WOS:000410978700005
PM 28789826
DA 2020-07-08
ER

PT J
AU Luplertlop, N
   Suwanmanee, S
   Ampawong, S
   Vongpunsawad, S
   Poovorawan, Y
AF Luplertlop, Natthanej
   Suwanmanee, San
   Ampawong, Sumate
   Vongpunsawad, Sompong
   Poovorawan, Yong
TI In vitro study of Zika virus infection in boar semen
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID SEXUAL TRANSMISSION; EPIDEMIC; PIG
AB Zika virus (ZIKV) is an important arbovirus that is capable of directly infecting neuronal cells. Infection can cause microcephaly in fetuses and Guillain-Barr, syndrome in adults. Recent epidemiological studies have shown that ZIKV is sexually transmitted, especially from infected males to uninfected females. This study aimed to investigate the transmission pattern of ZIKV in semen using boar semen. Experiments were performed ex vivo using semen from healthy boar. The samples were infected with ZIKV, and viral RNA was detected and cell morphology was examined at different time points postinfection. ZIKV infection was confirmed by transmission electron microscopy. Viral RNA levels were found to markedly decrease as the time postinfection increased, without any evidence of virus replication. The sperm showed no significant changes in morphology. Transmission electron microscopy revealed the presence of virus-free sperm, suggesting that ZIKV cannot replicate in boar semen. We suggest three possible reasons underlying this phenomenon. First, the spermatozoa of boar might not be the target of ZIKV associated with sexual transmission. Second, the effect of the external environment on spermatozoa may affect ZIKV replication. Third, ZIKV may not be tropic for spermatozoa. This ex vivo study might be used as a platform to study the association of sexual transmission with ZIKV in other longer-lasting cells, such as Leydig or Sertoli cells.
C1 [Luplertlop, Natthanej; Suwanmanee, San] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand.
   [Ampawong, Sumate] Mahidol Univ, Fac Trop Med, Dept Trop Pathol, Bangkok, Thailand.
   [Vongpunsawad, Sompong; Poovorawan, Yong] Chulalongkorn Univ, Dept Pediat, Ctr Excellence Clin Virol, Fac Med, Bangkok, Thailand.
RP Luplertlop, N (corresponding author), Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand.
EM natthanej.lup@mahidol.ac.th
OI AMPAWONG, Sumate/0000-0002-5378-2996
FU Royal Golden Jubilee scholarship [PHD/0001/2557]; Mahidol University
   research grant; Thailand One Health University Network through the
   United States Agency for International DevelopmentUnited States Agency
   for International Development (USAID) [017/2016]
FX This study was funded by the Royal Golden Jubilee scholarship
   (PHD/0001/2557), Mahidol University research grant and Thailand One
   Health University Network through the United States Agency for
   International Development (017/2016).
CR Chomsrimek N, 2008, THAI OBS GYNAECOL, V16, P109
   Christopher-Hennings D Jane, 1996, SWINE HEALTH PROD, V4, P37
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Darbellay J, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.133
   Dogan AC, 2017, J MATERN-FETAL NEO M, V30, P386, DOI 10.3109/14767058.2016.1174210
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002
   Mills KHG, 2014, J INFECT DIS, V209, pS16, DOI 10.1093/infdis/jit488
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Revenig L, 2014, TRANSL ANDROL UROL, V3, P41, DOI 10.3978/j.issn.2223-4683.2014.02.02
   Rozeboom KJ., 2000, EVALUATING BOAR SEME, P1
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Suwanmanee S, 2017, J MICROBIOL, V55, P81, DOI 10.1007/s12275-017-6494-4
   Torres MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160988
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
NR 21
TC 0
Z9 0
U1 0
U2 15
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD OCT
PY 2017
VL 162
IS 10
BP 3209
EP 3213
DI 10.1007/s00705-017-3453-7
PG 5
WC Virology
SC Virology
GA FH1OL
UT WOS:000410909200034
PM 28669037
DA 2020-07-08
ER

PT J
AU Ronnberg, B
   Gustafsson, A
   Vapalahti, O
   Emmerich, P
   Lundkvist, A
   Schmidt-Chanasit, J
   Blomberg, J
AF Ronnberg, Bengt
   Gustafsson, Ake
   Vapalahti, Olli
   Emmerich, Petra
   Lundkvist, Ake
   Schmidt-Chanasit, Jonas
   Blomberg, Jonas
TI Compensating for cross-reactions using avidity and computation in a
   suspension multiplex immunoassay for serotyping of Zika versus other
   flavivirus infections
SO MEDICAL MICROBIOLOGY AND IMMUNOLOGY
LA English
DT Article
DE Zika virus; Dengue virus; Flavivirus; Suspension multiplex immunoassay;
   Serological crossreaction; Pathogen surveillance
ID WEST NILE VIRUS; IMMUNOGLOBULIN-G; DENGUE VIRUS; REACTIVITY; ANTIBODIES;
   CHALLENGE; THREAT
AB The recent spread of Zika virus (ZIKV) in the Americas and Asia necessitates an increased preparedness for improved maternal and perinatal health and blood safety. However, serological cross-reactions, especially to Dengue virus (DENV), complicate ZIKV antibody serodiagnosis. A novel "pan-Flavi" suspension multiplex immunoassay (PFSMIA) using 25 antigens, whole virus (WV), non-structural protein 1 (NS1), and envelope (E) proteins, from 7 zoonotic flaviviruses for specific detection of ZIKV and DENV IgM and IgG was developed. Patterns of antibody cross-reactivity, avidity, and kinetics were established in 104 sera from returning travelers with known ZIKV and DENV infections. PFSMIA gave IgM- and IgG-sensitivities for both viruses of 96-100%, compared to an immunofluorescence assay. Main IgM cross-reactions were to NS1, for IgG to the E and WV antigens. Infecting virus yielded reactivity to several antigens of the homologous virus, while cross-reactions tended to occur only to a single antigen from heterologous virus(es). A specificity-enhancing computer procedure took into account antibody isotype, number of antibody-reactive antigens per virus, avidity, average degree of cross-reactivity to heterologous flavivirus antigens, and reactivity changes in serial sera. It classified all 50 cases correctly. Applied to sera from 200 pregnant women and 173 blood donors from Sweden, one blood donor was found ZIKV NS1 IgM positive, and another as ZIKV NS1 IgG positive. These samples did not react with other ZIKV antigens and were thereby judged as false-positives. PFSMIA provided sensitive and specific ZIKV and DENV serology, warranting high-throughput serological surveillance and a minimized need for laborious and expensive virus neutralization assays.
C1 [Ronnberg, Bengt; Lundkvist, Ake; Blomberg, Jonas] Uppsala Univ, Uppsala Acad Hosp, Sect Clin Microbiol, Dept Med Sci, S-75185 Uppsala, Sweden.
   [Ronnberg, Bengt; Gustafsson, Ake; Lundkvist, Ake; Blomberg, Jonas] Uppsala Univ, Dept Med Biochem & Microbiol, Zoonosis Sci Ctr, Uppsala, Sweden.
   [Gustafsson, Ake; Lundkvist, Ake] Univ Uppsala Hosp, Lab Clin Microbiol, Uppsala, Sweden.
   [Vapalahti, Olli] Univ Helsinki, Dept Vet Biosci & Virol, Helsinki, Finland.
   [Vapalahti, Olli] Helsinki Univ Hosp, Helsinki, Finland.
   [Emmerich, Petra; Schmidt-Chanasit, Jonas] Bernhard Nocht Inst Trop Med, WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, D-20359 Hamburg, Germany.
   [Emmerich, Petra] Univ Rostock, Dept Trop Med & Infect Dis, Ctr Internal Med 2, D-18057 Rostock, Germany.
   [Schmidt-Chanasit, Jonas] German Ctr Infect Res DZIF, Partner Site Hamburg Luebeck Borstel, Hamburg, Germany.
RP Blomberg, J (corresponding author), Uppsala Univ, Uppsala Acad Hosp, Sect Clin Microbiol, Dept Med Sci, S-75185 Uppsala, Sweden.; Blomberg, J (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Zoonosis Sci Ctr, Uppsala, Sweden.
EM jonas.blomberg@medsci.uu.se
RI amsalu, ribka/G-8780-2019
OI Blomberg, Jonas/0000-0001-6492-2491; Ronnberg,
   Bengt/0000-0003-0229-093X; Vapalahti, Olli/0000-0003-2270-6824
FU Academic Hospital in Uppsala; Akademiska Sjukhuset [ALF_2017, Alf_2016]
FX JB, AL, and AG received Grants from the Academic Hospital in Uppsala.
   The funding agency did not influence the content of this report. Funding
   was provided by Akademiska Sjukhuset (Grant Nos. ALF_2017, Alf_2016).
CR BLOMBERG J, 1983, J CLIN MICROBIOL, V17, P1081, DOI 10.1128/JCM.17.6.1081-1091.1983
   Blomberg J, 2012, CLIN VACCINE IMMUNOL, V19, P1399, DOI 10.1128/CVI.00391-12
   Daep CA, 2014, J NEUROVIROL, V20, P539, DOI 10.1007/s13365-014-0285-z
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Elfaitouri A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081155
   Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789
   Houghton-Triviño Natalia, 2008, Rev. salud pública, V10, P299
   Korhonen MH, 1999, CLIN DIAGN LAB IMMUN, V6, P725, DOI 10.1128/CDLI.6.5.725-728.1999
   Kurosaki T, 2015, NAT REV IMMUNOL, V15, P149, DOI 10.1038/nri3802
   Lanteri MC, 2016, TRANSFUSION, V56, P1907, DOI 10.1111/trf.13677
   Lennette H, 1969, DIAGNOSTIC PROCEDURE, P52
   Liu IJ, 2011, J BIOL CHEM, V286, P9726, DOI 10.1074/jbc.M110.170993
   MAKINO Y, 1994, MICROBIOL IMMUNOL, V38, P951, DOI 10.1111/j.1348-0421.1994.tb02152.x
   Mann BR, 2013, INT J ENV RES PUB HE, V10, P5111, DOI 10.3390/ijerph10105111
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   Muller JA, 2017, MED MICROBIOL IMMUN, V206, P175, DOI 10.1007/s00430-017-0493-2
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2017, BLOOD TRANSFUS-ITALY, V15, P272, DOI 10.2450/2016.0003-16
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   POLANEC J, 1994, J CLIN LAB ANAL, V8, P16, DOI 10.1002/jcla.1860080105
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rizwan Muhammad, 2016, Microarrays (Basel), V5, DOI 10.3390/microarrays5030022
   Rizzoli A, 2015, EUROSURVEILLANCE, V20, P28, DOI 10.2807/1560-7917.ES2015.20.20.21135
   Schmitz H, 2011, MED MICROBIOL IMMUN, V200, P233, DOI 10.1007/s00430-011-0195-0
   Sheikholvaezin A, 2011, PROTEIN EXPRES PURIF, V80, P176, DOI 10.1016/j.pep.2011.08.007
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Wan SW, 2013, J FORMOS MED ASSOC, V112, P3, DOI 10.1016/j.jfma.2012.11.006
   Wang YL, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-015-1194-3
   WHO, 2016, ZIK VIR EXP SPREAD E
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   Zeller H, 2012, OJ20100108P2010001 E, DOI [10.2900/62311, DOI 10.2900/62311]
NR 35
TC 5
Z9 5
U1 0
U2 16
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0300-8584
EI 1432-1831
J9 MED MICROBIOL IMMUN
JI Med. Microbiol. Immunol.
PD OCT
PY 2017
VL 206
IS 5
BP 383
EP 401
DI 10.1007/s00430-017-0517-y
PG 19
WC Immunology; Microbiology
SC Immunology; Microbiology
GA FH0BZ
UT WOS:000410805500006
PM 28852878
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Sharma, S
   Tandel, K
   Dash, PK
   Parida, M
AF Sharma, Shashi
   Tandel, Kundan
   Dash, Paban K.
   Parida, Manmohan
TI Zika virus: A public health threat
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Review
DE emergence; microcephaly; phylogeny; vector; zika virus
ID SEXUAL TRANSMISSION; UNITED-STATES; INFECTION; ARBOVIRUSES; MOSQUITOS;
   OUTBREAK; CELLS
AB The resurgence of Zika virus as public health emergency of an international concern with increased incidence of microcephaly has drawn attention of scientific community for its detailed understanding with regard to virus evolution, epidemiology, geographical spread, pathogenesis, etc. The scope of the present review is to discuss the detailed updated information in respect of Zika virus evolution since its inception.
C1 [Sharma, Shashi; Tandel, Kundan; Dash, Paban K.; Parida, Manmohan] Def Res & Dev Estab, Virol Div, Jhansi Rd, Gwalior 474002, Madhya Pradesh, India.
RP Parida, M (corresponding author), Def Res & Dev Estab, Virol Div, Jhansi Rd, Gwalior 474002, Madhya Pradesh, India.
EM paridamm@rediffmail.com
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Melo Freire CC, 2015, BIORXIV, V8, P715
   Derraik JG, 2015, AUST NZ J PUBL HEAL, V39, P5, DOI 10.1111/1753-6405.12302
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duca LM, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0557-x
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   HENDERSON BE, 1970, B WORLD HEALTH ORGAN, V42, P797
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Naccache SN, 2016, EMERG INFECT DIS, V22, P1788, DOI 10.3201/eid2210.160663
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Paz-Bailey G, 2017, N ENGL J MED
   Santora M., 2016, TWIST ZIKA OUTBREAK
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   World Health Organization, 2009, EP PAND AL DENG GUID
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 68
TC 4
Z9 4
U1 0
U2 57
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD OCT
PY 2017
VL 89
IS 10
BP 1693
EP 1699
DI 10.1002/jmv.24822
PG 7
WC Virology
SC Virology
GA FF7YA
UT WOS:000409231100002
PM 28369961
OA Bronze
DA 2020-07-08
ER

PT J
AU Yudhaputri, FA
   Trimarsanto, H
   Perkasa, A
   Yohan, B
   Haryanto, S
   Wiyatno, A
   Soebandrio, A
   Myint, KS
   Ledermann, JP
   Rosenberg, R
   Powers, AM
   Sasmono, RT
AF Yudhaputri, Frilasita A.
   Trimarsanto, Hidayat
   Perkasa, Aditya
   Yohan, Benediktus
   Haryanto, Sotianingsih
   Wiyatno, Ageng
   Soebandrio, Amin
   Myint, Khin Saw
   Ledermann, Jeremy P.
   Rosenberg, Ronald
   Powers, Ann M.
   Sasmono, R. Tedjo
TI Genomic characterization of Zika virus isolated from Indonesia
SO VIROLOGY
LA English
DT Article
DE Zika virus; Genome; Amino acid substitution; Indonesia
ID MOLECULAR EVOLUTION; FLAVIVIRUS; INFECTION; PROTEINS; AMERICA
AB Zika virus (ZIKV) JMB-185 strain was isolated from a febrile patient in Jambi, Indonesia in 2014. To understand its genetic characteristics, we performed whole genome sequencing using the Ion Torrent PGM platform on the supernatant of the first passage. The phylogenetic analysis showed that the isolate was not closely related to the Brazilian ZIKV associated with microcephaly or isolates from the recent Singapore Zika outbreak. Molecular evolution analysis indicated that JMB-185 strain may have been circulating in the Southeast Asia region, including Indonesia since 2000. We observed high nucleotide sequence identity between Indonesia, Thailand, Singapore, and American strains although unique amino acid substitutions were also observed. This report provides information on the genomic characteristics of Indonesian ZIKV which may be used for further studies.
C1 [Yudhaputri, Frilasita A.; Trimarsanto, Hidayat; Perkasa, Aditya; Yohan, Benediktus; Wiyatno, Ageng; Soebandrio, Amin; Myint, Khin Saw; Sasmono, R. Tedjo] Eijkman Inst Mol Biol, Jl Diponegoro 69, Jakarta 10430, Indonesia.
   [Haryanto, Sotianingsih] Siloam Hosp, Jambi, Indonesia.
   [Trimarsanto, Hidayat] Agcy Assessment & Applicat Technol, Jakarta, Indonesia.
   [Ledermann, Jeremy P.; Rosenberg, Ronald; Powers, Ann M.] Ctr Dis Control & Prevent, Ft Collins, CO USA.
RP Sasmono, RT (corresponding author), Eijkman Inst Mol Biol, Jl Diponegoro 69, Jakarta 10430, Indonesia.
EM sasmono@eijkman.go.id
RI Sasmono, Tedjo/H-5680-2016; Yohan, Benediktus/J-9039-2019
OI Sasmono, Tedjo/0000-0003-0986-2590; Yohan,
   Benediktus/0000-0003-2378-2386; Trimarsanto, Hidayat/0000-0003-2436-8283
FU Ministry of Research, Technology, and Higher Education of the Republic
   of Indonesia; US Centers for Disease Control and PreventionUnited States
   Department of Health & Human ServicesCenters for Disease Control &
   Prevention - USA; USAIDUnited States Agency for International
   Development (USAID)
FX This work was supported by the Ministry of Research, Technology, and
   Higher Education of the Republic of Indonesia, US Centers for Disease
   Control and Prevention, and USAID.
CR Baronti C, 2014, GENOME ANNOUNC, V2
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Brinton MA, 2015, VIRUS RES, V206, P108, DOI 10.1016/j.virusres.2015.02.006
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Calvet G., 2016, LANCET INFECT DIS
   Diamond MS, 2003, IMMUNOL CELL BIOL, V81, P196, DOI 10.1046/j.1440-1711.2003.01157.x
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Holmes EC, 2009, J CLIN INVEST, V119, P2488, DOI 10.1172/JCI38050
   Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3
   Khromykh AA, 1997, J VIROL, V71, P1497, DOI 10.1128/JVI.71.2.1497-1505.1997
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Murray CL, 2008, NAT REV MICROBIOL, V6, P699, DOI 10.1038/nrmicro1928
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Singapore Zika Study Group, 2017, LANCET INFECT DIS
   Twiddy SS, 2003, MOL BIOL EVOL, V20, P122, DOI 10.1093/molbev/msg010
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
NR 27
TC 5
Z9 6
U1 0
U2 49
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD OCT
PY 2017
VL 510
BP 248
EP 251
DI 10.1016/j.virol.2017.07.026
PG 4
WC Virology
SC Virology
GA FE7PT
UT WOS:000408400100028
PM 28755588
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Ha, YR
   Kim, JH
   Ryu, J
   Lee, SJ
AF Ha, Young Ran
   Kim, Jun Ho
   Ryu, Jeongeun
   Lee, Sang Joon
TI Superb feeding behavior of Aedes albopictus transmitting Zika virus
SO PLOS ONE
LA English
DT Article
ID PLASMODIUM-FALCIPARUM; ANOPHELES-SINENSIS; MOSQUITOS; TRANSMISSION;
   INGESTION; ADHESION; SPREAD; SUSCEPTIBILITY; SPOROZOITES; INFECTION
AB Disease-mediated mosquitoes have been receiving much attention, as the World Health Organization recently declared the Zika virus a global public health emergency. Mosquitoes transmit pathogens that cause various tropical diseases including malaria, dengue fever and yellow fever as well as Zika virus. The vector efficiency of mosquitoes depends on their blood-feeding characteristics and the mechanics of their blood-sucking pump system, but only a few studies have attempted to investigate these key issues. In this study, we demonstrate the rapid and gluttonous liquid-feeding characteristics of Ae. albopictus which transmits Zika virus can be explained by similar proportion of two blood-sucking pumps and accelerated liquid intake driven by fast expanding of pumps. Our results provide insight into the vector efficiency of Ae. albopictus in terms of feeding velocity, pumping frequency, liquid-intake rate, and wall shear stress.
C1 [Ha, Young Ran; Lee, Sang Joon] Pohang Univ Sci & Technol, Ctr Biofluid & Biomim Res, Pohang, South Korea.
   [Kim, Jun Ho; Ryu, Jeongeun; Lee, Sang Joon] Pohang Univ Sci & Technol, Dept Mech Engn, Ctr Biofluid & Biomim Res, Pohang, South Korea.
RP Lee, SJ (corresponding author), Pohang Univ Sci & Technol, Ctr Biofluid & Biomim Res, Pohang, South Korea.; Lee, SJ (corresponding author), Pohang Univ Sci & Technol, Dept Mech Engn, Ctr Biofluid & Biomim Res, Pohang, South Korea.
EM sjlee@postech.ac.kr
RI Lee, Sang Joon/AAG-2448-2019
OI LEE, SANG JOON/0000-0003-3286-5941
FU National Research Foundation of Korea grant - Korean government (MSIP)
   [2008-0061991]
FX This work was supported by a National Research Foundation of Korea grant
   funded by the Korean government (MSIP) (No. 2008-0061991). URL:
   http://www.nrf.re.kr/eng/main. The funder had no role in study design,
   data collection and analysis, decsion to publish, or preparation of the
   manuscript.
CR Anderson RA, 1999, P ROY SOC B-BIOL SCI, V266, P1729, DOI 10.1098/rspb.1999.0839
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Cator LJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0711
   Cavalcante RR, 2006, MEM I OSWALDO CRUZ, V101, P85, DOI 10.1590/S0074-02762006000100016
   El-Kirat-Chatel S, 2016, NANOSCALE HORIZ, V1, P69, DOI 10.1039/c5nh00049a
   Fernando S, 2016, MOL BIOTECHNOL, V58, P801, DOI 10.1007/s12033-016-9979-1
   Finger EB, 1996, NATURE, V379, P266, DOI 10.1038/379266a0
   Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Harada F, 1975, JAP J SANIT ZOOL
   Hegge S, 2010, FASEB J, V24, P2222, DOI 10.1096/fj.09-148700
   Jinj Y, 2007, INFECT IMMUN, V75, P5532, DOI 10.1128/IAI.00600-07
   Junkum A, 2003, MEM I OSWALDO CRUZ, V98, P481, DOI 10.1590/S0074-02762003000400009
   KASHIN P, 1966, J INSECT PHYSIOL, V12, P281, DOI 10.1016/0022-1910(66)90143-0
   Kebaier C, 2006, AM J TROP MED HYG, V75, P1200, DOI 10.4269/ajtmh.2006.75.1200
   Kikuchi K, 2011, MEAS SCI TECHNOL, V22, DOI 10.1088/0957-0233/22/6/064002
   Kim BH, 2014, SENSOR ACTUAT A-PHYS, V209, P133, DOI 10.1016/j.sna.2014.01.016
   Kim BH, 2013, J EXP BIOL, V216, P952, DOI 10.1242/jeb.072710
   Kim BH, 2011, J EXP BIOL, V214, P1163, DOI 10.1242/jeb.048793
   Koella JC, 1998, P ROY SOC B-BIOL SCI, V265, P763, DOI 10.1098/rspb.1998.0358
   Lee SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep20464
   Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11
   MITCHELL CJ, 1995, J VECTOR ECOL, V20, P44
   Park JH, 2012, EMERG INFECT DIS, V18, P1525, DOI 10.3201/eid1809.111811
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Poole-Smith BK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003462
   ROSEN L, 1978, SCIENCE, V199, P909, DOI 10.1126/science.203035
   Saeung A, 2014, SE ASIAN J TROP MED, V45, P588
   Sant'Anna MRV, 2001, J INSECT PHYSIOL, V47, P1459, DOI 10.1016/S0022-1910(01)00136-6
   SCHMIDT JM, 1991, J INSECT PHYSIOL, V37, P817, DOI 10.1016/0022-1910(91)90078-E
   Schwarz US, 2015, SEMIN CELL DEV BIOL, V46, P82, DOI 10.1016/j.semcdb.2015.09.025
   Sota T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131230
   Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1
   WEKESA JW, 1992, AM J TROP MED HYG, V47, P484, DOI 10.4269/ajtmh.1992.47.484
   World Health Organization (WHO), 2016, ZIK STRAT RESP FRAM
NR 35
TC 0
Z9 1
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 28
PY 2017
VL 12
IS 9
AR e0184871
DI 10.1371/journal.pone.0184871
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FI4YC
UT WOS:000411985200020
PM 28957351
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bosch, I
   de Puig, H
   Hiley, M
   Carre-Camps, M
   Perdomo-Celis, F
   Narvaez, CF
   Salgado, DM
   Senthoor, D
   O'Grady, M
   Phillips, E
   Durbin, A
   Fandos, D
   Miyazaki, H
   Yen, CW
   Gelvez-Ramirez, M
   Warke, RV
   Ribeiro, LS
   Teixeira, MM
   Almeida, RP
   Munoz-Medina, JE
   Ludert, JE
   Nogueira, ML
   Colombo, TE
   Terzian, ACB
   Bozza, PT
   Calheiros, AS
   Vieira, YR
   Barbosa-Lima, G
   Vizzoni, A
   Cerbino-Neto, J
   Bozza, FA
   Souza, TML
   Trugilho, MRO
   de Filippis, AMB
   de Sequeira, PC
   Marques, ETA
   Magalhaes, T
   Diaz, FJ
   Restrepo, BN
   Marin, K
   Mattar, S
   Olson, D
   Asturias, EJ
   Lucera, M
   Singla, M
   Medigeshi, GR
   de Bosch, N
   Tam, J
   Gomez-Marquez, J
   Clavet, C
   Villar, L
   Hamad-Schifferli, K
   Gehrke, L
AF Bosch, Irene
   de Puig, Helena
   Hiley, Megan
   Carre-Camps, Marc
   Perdomo-Celis, Federico
   Narvaez, Carlos F.
   Salgado, Doris M.
   Senthoor, Dewahar
   O'Grady, Madeline
   Phillips, Elizabeth
   Durbin, Ann
   Fandos, Diana
   Miyazaki, Hikaru
   Yen, Chun-Wan
   Gelvez-Ramirez, Margarita
   Warke, Rajas V.
   Ribeiro, Lucas S.
   Teixeira, Mauro M.
   Almeida, Roque P.
   Munoz-Medina, Jose E.
   Ludert, Juan E.
   Nogueira, Mauricio L.
   Colombo, Tatiana E.
   Terzian, Ana C. B.
   Bozza, Patricia T.
   Calheiros, Andrea S.
   Vieira, Yasmine R.
   Barbosa-Lima, Giselle
   Vizzoni, Alexandre
   Cerbino-Neto, Jose
   Bozza, Fernando A.
   Souza, Thiago M. L.
   Trugilho, Monique R. O.
   de Filippis, Ana M. B.
   de Sequeira, Patricia C.
   Marques, Ernesto T. A.
   Magalhaes, Tereza
   Diaz, Francisco J.
   Restrepo, Berta N.
   Marin, Katerine
   Mattar, Salim
   Olson, Daniel
   Asturias, Edwin J.
   Lucera, Mark
   Singla, Mohit
   Medigeshi, Guruprasad R.
   de Bosch, Norma
   Tam, Justina
   Gomez-Marquez, Jose
   Clavet, Charles
   Villar, Luis
   Hamad-Schifferli, Kimberly
   Gehrke, Lee
TI Rapid antigen tests for dengue virus serotypes and Zika virus in patient
   serum
SO SCIENCE TRANSLATIONAL MEDICINE
LA English
DT Article
ID OF-CARE TESTS; NS1 ANTIGEN; DIAGNOSIS; URINE; INFECTIONS; SAMPLES;
   SALIVA; IGM
AB The recent Zika virus (ZIKV) outbreak demonstrates that cost-effective clinical diagnostics are urgently needed to detect and distinguish viral infections to improve patient care. Unlike dengue virus (DENV), ZIKV infections during pregnancy correlate with severe birth defects, including microcephaly and neurological disorders. Because ZIKV and DENV are related flaviviruses, their homologous proteins and nucleic acids can cause cross-reactions and false-positive results in molecular, antigenic, and serologic diagnostics. We report the characterization of monoclonal antibody pairs that have been translated into rapid immunochromatography tests to specifically detect the viral nonstructural 1 (NS1) protein antigen and distinguish the four DENV serotypes (DENV1-4) and ZIKV without cross-reaction. To complement visual test analysis and remove user subjectivity in reading test results, we used image processing and data analysis for data capture and test result quantification. Using a 30-ml serum sample, the sensitivity and specificity values of the DENV1-4 tests and the pan-DENV test, which detects all four dengue serotypes, ranged from 0.76 to 1.00. Sensitivity/specificity for the ZIKV rapid test was 0.81/0.86, respectively, using a 150-mu l serum input. Serum ZIKV NS1 protein concentrations were about 10-fold lower than corresponding DENV NS1 concentrations in infected patients; moreover, ZIKV NS1 protein was not detected in polymerase chain reactionpositive patient urine samples. Our rapid immunochromatography approach and reagents have immediate application in differential clinical diagnosis of acute ZIKV and DENV cases, and the platform can be applied toward developing rapid antigen diagnostics for emerging viruses.
C1 [Bosch, Irene; de Puig, Helena; Hiley, Megan; Carre-Camps, Marc; Senthoor, Dewahar; O'Grady, Madeline; Phillips, Elizabeth; Durbin, Ann; Fandos, Diana; Miyazaki, Hikaru; Yen, Chun-Wan; Tam, Justina; Gomez-Marquez, Jose; Gehrke, Lee] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA.
   [Bosch, Irene] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA.
   [de Puig, Helena; Hamad-Schifferli, Kimberly] MIT, Dept Mech Engn, Cambridge, MA 02139 USA.
   [Carre-Camps, Marc; Fandos, Diana] Univ Ramon Llull, Inst Quim Sarria, Barcelona, Spain.
   [Perdomo-Celis, Federico; Narvaez, Carlos F.; Salgado, Doris M.] Univ Surcolombiana, Fac Salud, Programa Med, Neiva, Colombia.
   [Durbin, Ann] Harvard Med Sch, Div Med Sci, Program Virol, Boston, MA 02115 USA.
   [Gelvez-Ramirez, Margarita; Villar, Luis] Univ Ind Santander, Santander, Colombia.
   [Gelvez-Ramirez, Margarita; Villar, Luis] AEDES Program, Santander, Colombia.
   [Warke, Rajas V.] HiMedia Labs Pvt Ltd, Bombay, Maharashtra, India.
   [Ribeiro, Lucas S.; Teixeira, Mauro M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Immunopharmacol Grp, Ave Antonio Carlos 6627, Belo Horizonte, MG, Brazil.
   [Almeida, Roque P.] Univ Fed Sergipe, Hosp Univ, Empresa Brasileira Serv Hosp EBSERH, Dept Med Interna & Patol, Aracaju, Brazil.
   [Munoz-Medina, Jose E.] Inst Mexicano Seguro Social, Lab Cent Epidemiol, Ave Jacarandas S-N, Mexico City 02990, DF, Mexico.
   [Ludert, Juan E.] Inst Politecn Nacl CINVESTAV IPN, Ctr Invest & Estudios Avanzados, Dept Infect & Patogenesis Mol, Mexico City, DF, Mexico.
   [Nogueira, Mauricio L.; Colombo, Tatiana E.; Terzian, Ana C. B.] Fac Med Sao Jose Rio Preto FAMERP, Sao Jose Do Rio Preto, Brazil.
   [Bozza, Patricia T.; Calheiros, Andrea S.; Souza, Thiago M. L.] Fiocruz MS, Oswaldo Cruz Fdn, Immunopharmacol Lab, Rio De Janeiro, Brazil.
   [Vieira, Yasmine R.; Barbosa-Lima, Giselle; Vizzoni, Alexandre; Cerbino-Neto, Jose; Bozza, Fernando A.] Fiocruz MS, Natl Inst Infect Dis Evandro Chagas, Rio De Janeiro, Brazil.
   [Bozza, Fernando A.] DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil.
   [Souza, Thiago M. L.] Fiocruz MS, Ctr Technol Dev Hlth CDTS, Natl Inst Sci & Technol Innovat Neglected Dis INC, Rio De Janeiro, Brazil.
   [Trugilho, Monique R. O.] Fiocruz MS, Toxinol Lab, Rio De Janeiro, Brazil.
   [Trugilho, Monique R. O.] Fiocruz MS, Ctr Technol Dev Hlth CDTS, Rio De Janeiro, Brazil.
   [de Filippis, Ana M. B.; de Sequeira, Patricia C.] Fiocruz MS, Flavivirus Lab, Rio De Janeiro, Brazil.
   [Marques, Ernesto T. A.; Magalhaes, Tereza] Fiocruz MS, Aggeu Magalhaes Res Ctr, Recife, PE, Brazil.
   [Marques, Ernesto T. A.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA 15213 USA.
   [Magalhaes, Tereza] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Diaz, Francisco J.] Univ Antioquia, Sch Med, Immunovirol Grp, Medellin, Colombia.
   [Restrepo, Berta N.; Marin, Katerine] Univ CES, ICMT, Sabaneta, Antioquia, Colombia.
   [Mattar, Salim] Univ Cordoba, Monteria, Cordoba, Colombia.
   [Olson, Daniel; Asturias, Edwin J.] Univ Colorado, Sch Med, Dept Pediat, Div Infect Dis, Aurora, CO 80045 USA.
   [Lucera, Mark] Univ Colorado, Sch Med, Dept Med, Div Infect Dis, Aurora, CO 80045 USA.
   [Singla, Mohit] All India Inst Med Sci, Dept Paediat, New Delhi, India.
   [Medigeshi, Guruprasad R.] Translat Hlth Sci & Technol Inst, Faridabad, India.
   [de Bosch, Norma] Univ Cent Venezuela, Caracas, Venezuela.
   [Tam, Justina; Clavet, Charles] WEAC, Winchester, MA 01890 USA.
   [Hamad-Schifferli, Kimberly] Univ Massachusetts, Dept Engn, Boston, MA 02125 USA.
   [Gehrke, Lee] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.
RP Gehrke, L (corresponding author), MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA.; Hamad-Schifferli, K (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.; Hamad-Schifferli, K (corresponding author), Univ Massachusetts, Dept Engn, Boston, MA 02125 USA.; Gehrke, L (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.
EM kim.hamad@umb.edu; lgehrke@mit.edu
RI Teixeira, Mauro M/A-4587-2008; Ludert, Juan E./H-5658-2019; Vizzoni,
   Alexandre/W-8718-2019; Neto, Jose Cerbino/P-3713-2018; Medigeshi,
   Guruprasad/V-1566-2019; Nogueira, Mauricio L/B-7599-2012; Bozza,
   Fernando A/A-2618-2013; Marques, Ernesto T. A/L-4967-2013; Magalhaes,
   Tereza/V-6632-2019; Esteban, Munoz Medina Jose/B-6186-2015; Asturias,
   Edwin/D-9842-2016
OI Teixeira, Mauro M/0000-0002-6944-3008; Vizzoni,
   Alexandre/0000-0003-0004-5084; Neto, Jose Cerbino/0000-0001-9254-917X;
   Nogueira, Mauricio L/0000-0003-1102-2419; Bozza, Fernando
   A/0000-0003-4878-0256; Marques, Ernesto T. A/0000-0003-3826-9358;
   Esteban, Munoz Medina Jose/0000-0002-1289-4457; Bozza,
   Patricia/0000-0001-8349-9529; Perdomo Celis,
   Federico/0000-0003-0119-8306; Medigeshi, Guruprasad/0000-0001-5333-9743;
   Narvaez, Carlos/0000-0003-0129-5210; Souza, Thiago/0000-0003-2212-3899;
   /0000-0002-5368-6996; Secchim Ribeiro, Lucas/0000-0001-8876-3827;
   Asturias, Edwin/0000-0002-1275-0787; MARIN VELASQUEZ,
   KATERINE/0000-0003-0028-0500
FU National Council for Scientific and Technological Development of
   BrazilNational Council for Scientific and Technological Development
   (CNPq); Foundation for Research Support of the State of Rio de Janeiro,
   Brazil (FAPERJ); European Union's Horizon program [734857, 734584];
   Programa Pesquisa para o SUS-Fundacao de Amparo a Ciencia e Tecnologia
   (PPSUS-FACEPE) project of the Cura Zika Alliance, University of
   Pittsburgh [APQ-0302-4.01/13]; Department of Biotechnology, Government
   of IndiaDepartment of Biotechnology (DBT) India
   [BT/PR5132/MED/15/84/2012]; Wellcome Trust/DBT India AllianceWellcome
   Trust [IA/S/14/1/501291]; U.S. Public Health ServiceUnited States Public
   Health Service [AI100190]; Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [13/21719-3, 16/15021-1]; Science, Technology and Innovation
   Fund; Colombia-Fondo de Ciencia, Tecnologia e Innovacion of Sistema
   General de Regalias [BPIN 2013000100011]; AEDES Network; La Caixa
   FellowshipLa Caixa Foundation; Rafael del Pino Foundation; Broshy
   Fellowship; MIT-Tata Center for Technology and Design fellowship;
   MIT-Singapore University of Technology and Design International Design
   Center grant
FX F.A.B., M.M.T., A.C.B.T., and P.C.d.-S. received funding from the
   National Council for Scientific and Technological Development of Brazil
   and from the Foundation for Research Support of the State of Rio de
   Janeiro, Brazil (FAPERJ). A.M.B.d.F. was supported by the European
   Union's Horizon 2020 program under grant agreement numbers 734857 and
   734584. E.T.A.M. was supported by Programa Pesquisa para o SUS-Fundacao
   de Amparo a Ciencia e Tecnologia (PPSUS-FACEPE) project APQ-0302-4.01/13
   of the Cura Zika Alliance, University of Pittsburgh. G.R.M. received
   research support from the Department of Biotechnology, Government of
   India (sanction no. BT/PR5132/MED/15/84/2012) and Wellcome Trust/DBT
   India Alliance (IA/S/14/1/501291). L.G. received support from the U.S.
   Public Health Service (grant AI100190). M.L.N. received support from
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (grants
   13/21719-3 and 16/15021-1). L.V. received support from the Science,
   Technology and Innovation Fund, Colombia-Fondo de Ciencia, Tecnologia e
   Innovacion of Sistema General de Regalias (BPIN 2013000100011) and the
   AEDES Network. H.d.P. received support from a La Caixa Fellowship, a
   Rafael del Pino Foundation, a Broshy Fellowship, an MIT-Tata Center for
   Technology and Design fellowship, and an MIT-Singapore University of
   Technology and Design International Design Center grant. M. Benioff and
   L. Benioffprovided support toward obtaining commercially available Zika
   samples.
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Andries AC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1551-x
   Andries AC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004100
   Andries AC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001993
   Becerra A, 2009, J MED VIROL, V81, P1403, DOI 10.1002/jmv.21538
   Becerra A, 2009, J GEN VIROL, V90, P810, DOI 10.1099/vir.0.004416-0
   Bhamla MS, 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-016-0009
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bingham AM, 2016, MMWR MORB MORTAL WKL, V65
   Blacksell SD, 2011, CLIN VACCINE IMMUNOL, V18, P2095, DOI 10.1128/CVI.05285-11
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Chuansumrit A, 2011, DIAGN MICR INFEC DIS, V71, P467, DOI 10.1016/j.diagmicrobio.2011.08.020
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Estofolete CF, 2016, J CLIN VIROL, V81, P25, DOI 10.1016/j.jcv.2016.05.012
   FALCONAR AKI, 1991, J GEN VIROL, V72, P961, DOI 10.1099/0022-1317-72-4-961
   Forshey BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004398
   Fry SR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001199
   Hang VT, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000360
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Kao Chuan-Liang, 2005, Journal of Microbiology Immunology and Infection, V38, P5
   Korhonen EM, 2014, J CLIN VIROL, V61, P353, DOI 10.1016/j.jcv.2014.08.021
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lee J, 2015, DIAGN MICR INFEC DIS, V82, P128, DOI 10.1016/j.diagmicrobio.2015.03.009
   Lukman N, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5253842
   Miller R. K., 1989, MACHINE VISION
   Muller DA, 2017, J INFECT DIS, V215, pS89, DOI 10.1093/infdis/jiw649
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Nisalak A, 2003, AM J TROP MED HYG, V68, P191, DOI 10.4269/ajtmh.2003.68.191
   Ong A, 2007, INT J INFECT DIS, V11, P263, DOI 10.1016/j.ijid.2006.02.012
   Osorio L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-361
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Peeling RW, 2010, CLIN MICROBIOL INFEC, V16, P1062, DOI 10.1111/j.1469-0691.2010.03279.x
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Saito Y, 2015, JPN J INFECT DIS, V68, P455, DOI 10.7883/yoken.JJID.2014.441
   Tricou V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001309
   Tricou V, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-142
   Tyrrell C. H., 2013, LATERAL FLOW SMART P
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Vivek R, 2017, DIAGN MICR INFEC DIS, V87, P229, DOI 10.1016/j.diagmicrobio.2016.09.020
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Wang SM, 2010, AM J TROP MED HYG, V83, P690, DOI 10.4269/ajtmh.2010.10-0117
   Wild D., 2013, IMMUNOASSAY HDB, P89
   Zhang B, 2017, NAT MED, V23, P548, DOI 10.1038/nm.4302
   ZIKV Detect IgM Capture ELISA by InBios International Inc, 2016, MEDWATCH FDA SAF INF
NR 47
TC 51
Z9 52
U1 4
U2 29
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1946-6234
EI 1946-6242
J9 SCI TRANSL MED
JI Sci. Transl. Med.
PD SEP 27
PY 2017
VL 9
IS 409
AR eaan1589
DI 10.1126/scitranslmed.aan1589
PG 13
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA FI3PX
UT WOS:000411879400005
PM 28954927
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Ellingson, MK
   Bonk, CM
   Chamberlain, AT
AF Ellingson, Mallory K.
   Bonk, Catherine M.
   Chamberlain, Allison T.
TI A survey-based study of Zika virus communication preferences among
   pregnant women in Georgia, United States
SO BMC PREGNANCY AND CHILDBIRTH
LA English
DT Article
DE Zika; Public health emergency; Communication; Obstetric care; Prenatal
   care; Social media
ID UPDATE INTERIM GUIDANCE; INFLUENZA VACCINE; REPRODUCTIVE AGE;
   DECISION-MAKING; INFORMATION; PROVIDERS; HEALTH; KNOWLEDGE; EXPOSURE;
   IMMUNIZATION
AB Background: Because of the particularly severe perinatal outcomes associated with antenatal Zika virus infection, it is important for prenatal care providers to communicate Zika virus risks and strategies for prevention to their patients. Although face-to-face communication is ideal, clinic visits may not allow for in-depth discussion of all concerns. While previous studies have shown prenatal providers to be pregnant women's most trusted sources of health information, there is little knowledge on what secondary communication modalities pregnant women prefer for receiving information from their providers about an evolving public health emergency.
   Methods: A cross-sectional, descriptive anonymous 27-item survey was distributed to pregnant women at four clinics around Atlanta, Georgia from May 5th to June 20th, 2016. The survey assessed women's interest in and communication preferences about prenatal topics, including Zika virus. Descriptive statistics were calculated and chi-square tests were used to evaluate associations between the primary outcomes and patient characteristics.
   Results: Four-hundred and eight women completed the survey. The most popular resource for obtaining Zika virus information was the Centers for Disease Control and Prevention (CDC) website (73.0%). While their prenatal provider's own website for Zika information ranked 5th among sources currently accessed for Zika information, it ranked third behind educational brochures and emails for ways in which women wanted to receive information. The characteristics of Zika virus information deemed most important were: evidence-based (87.5%), endorsed by the CDC (74.1%), and endorsed by their own provider (67.9%).
   Conclusion: In any public health emergency affecting pregnant women, women are going to seek advice from their obstetric providers. Because providers may lack sufficient time to discuss concerns with every patient, they may consider providing patient education in other ways. For the women included in this study, educational brochures, emails and providers' own practice websites were preferred. Providers should consider taking greater advantage of these modalities to supplement in-person exchanges, particularly during a public health emergency.
C1 [Ellingson, Mallory K.; Chamberlain, Allison T.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, 1518 Clifton Rd NE, Atlanta, GA 30322 USA.
   [Bonk, Catherine M.] Atlanta Gynecol & Obstet, Decatur, GA USA.
RP Ellingson, MK (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, 1518 Clifton Rd NE, Atlanta, GA 30322 USA.
EM Mallory.ellingson@emory.edu
RI Chamberlain, Allison T./AAA-3835-2019
OI Chamberlain, Allison T./0000-0001-6009-537X; Ellingson,
   Mallory/0000-0003-2729-0661
FU Centers for Disease Control and Prevention's (CDC'S) Collaboration;
   Academia to Strengthen Public Health Workforce Capacity - CDC, Office of
   Public Health and Preparedness and Response, through the Association of
   Schools and Programs of Public Health (ASPPH) [3 U36 OE000002-04S05]
FX This publication was supported under cooperative agreement, the Centers
   for Disease Control and Prevention's (CDC'S) Collaboration with Academia
   to Strengthen Public Health Workforce Capacity (grant no. 3 U36
   OE000002-04S05) funded by the CDC, Office of Public Health and
   Preparedness and Response, through the Association of Schools and
   Programs of Public Health (ASPPH). Its contents are solely the
   responsibility of the authors and do not necessarily represent the
   official views of CDC, the Department of Health and Human Services, or
   ASPPH.
CR Asiodu IV, 2015, JOGNN-J OBST GYN NEO, V44, P268, DOI 10.1111/1552-6909.12552
   Berenson AB, 2017, AM J TROP MED HYG, V97, P155, DOI 10.4269/ajtmh.17-0062
   Blanchard-Rohner G, 2012, J MATERN-FETAL NEO M, V25, P1800, DOI 10.3109/14767058.2012.663835
   Bodeker B, 2014, VACCINE, V32, P4131, DOI 10.1016/j.vaccine.2014.06.007
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chamberlain AT, 2016, OBSTET GYNECOL, V127, P119, DOI 10.1097/AOG.0000000000001183
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Grimes HA, 2014, MIDWIFERY, V30, pE26, DOI 10.1016/j.midw.2013.10.007
   Guo Fangjian, 2017, Prev Med Rep, V7, P26, DOI 10.1016/j.pmedr.2017.05.003
   Healy CM, 2015, VACCINE, V33, P5445, DOI 10.1016/j.vaccine.2015.08.028
   Hearn L, 2014, J OBES, V2014, DOI 10.1155/2014/573928
   Huberty J, 2013, MATERN CHILD HLTH J, V17, P1363, DOI 10.1007/s10995-012-1160-2
   Kirzinger A, 2016, KAISER HLTH TRACKING
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Kraschnewski JL, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3385
   Krizinger A, 2016, KAISER HLTH TRACKING
   Lagan BM, 2011, BIRTH-ISS PERINAT C, V38, P336, DOI 10.1111/j.1523-536X.2011.00488.x
   Lagan BM, 2010, BIRTH-ISS PERINAT C, V37, P106, DOI 10.1111/j.1523-536X.2010.00390.x
   Larsson M, 2009, MIDWIFERY, V25, P14, DOI 10.1016/j.midw.2007.01.010
   Lehnert JD, 2017, J PUBLIC HLTH MANAG
   Mak DB, 2015, AUST NZ J OBSTET GYN, V55, P131, DOI 10.1111/ajo.12292
   Manore CA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005255
   McArdle A, 2015, WOMEN BIRTH, V28, P54, DOI 10.1016/j.wombi.2014.10.002
   Monaghan Ai., 2016, PLOS CURR, V8
   O'Higgins A, 2015, IRAN MED J, V108, P313
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rodger D, 2013, AUST J PRIM HEALTH, V19, P308, DOI 10.1071/PY13029
   Sayakhot P, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0856-5
   SMFM, 2016, PRACT ADV INT GUID C
   Whittemore K, 2017, EMERG INFECT DIS, V23, P164, DOI 10.3201/eid2301.161614
   Wiley KE, 2013, MED J AUSTRALIA, V198, P373, DOI 10.5694/mja12.11849
NR 35
TC 8
Z9 8
U1 0
U2 9
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2393
J9 BMC PREGNANCY CHILDB
JI BMC Pregnancy Childbirth
PD SEP 26
PY 2017
VL 17
AR 325
DI 10.1186/s12884-017-1516-0
PG 8
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FI2HL
UT WOS:000411759600002
PM 28950830
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Calvert, AE
   Biggerstaff, BJ
   Tanner, NA
   Lauterbach, M
   Lanciotti, RS
AF Calvert, Amanda E.
   Biggerstaff, Brad J.
   Tanner, Nathan A.
   Lauterbach, Molly
   Lanciotti, Robert S.
TI Rapid colorimetric detection of Zika virus from serum and urine
   specimens by reverse transcription loop-mediated isothermal
   amplification (RT-LAMP)
SO PLOS ONE
LA English
DT Article
ID JAPANESE ENCEPHALITIS-VIRUS; REAL-TIME DETECTION; MOLECULAR-DETECTION;
   DENGUE VIRUS; FEVER VIRUS; ASSAY; TRANSMISSION; CHIKUNGUNYA; INFECTION;
   BRAZIL
AB Zika virus (ZIKV) has emerged as a major global public health concern in the last two years due to its link as a causative agent of human birth defects. Its rapid expansion into the Western Hemisphere as well as the ability to be transmitted from mother to fetus, through sexual transmission and possibly through blood transfusions has increased the need for a rapid and expansive public health response to this unprecedented epidemic. A non-invasive and rapid ZIKV diagnostic screening assay that can be performed in a clinical setting throughout pregnancy is vital for prenatal care of women living in areas of the world where exposure to the virus is possible. To meet this need we have developed a sensitive and specific reverse transcriptase loop-mediated isothermal amplification (RT-LAMP) assay to detect ZIKV RNA in urine and serum with a simple visual detection. RT-LAMP results were shown to have a limit of detection 10-fold higher than qRT-PCR. As little as 1.2 RNA copies/mu l was detected by RT-LAMP from a panel of 178 diagnostic specimens. The assay was shown to be highly specific for ZIKV RNA when tested with diagnostic specimens positive for dengue virus (DENV) and chikungunya virus (CHIKV). The assay described here illustrates the potential for a fast, reliable, sensitive and specific assay for the detection of ZIKV from urine or serum that can be performed in a clinical or field setting with minimal equipment and technological expertise.
C1 [Calvert, Amanda E.; Biggerstaff, Brad J.; Lauterbach, Molly; Lanciotti, Robert S.] US Ctr Dis Control & Prevent, Arboviral Dis Branch, Div Vector Borne Dis, Ft Collins, CO USA.
   [Tanner, Nathan A.] New England Biolabs Inc, Ipswich, MA USA.
RP Calvert, AE (corresponding author), US Ctr Dis Control & Prevent, Arboviral Dis Branch, Div Vector Borne Dis, Ft Collins, CO USA.
EM zpz0@cdc.gov
OI Calvert, Amanda/0000-0002-8237-2654
FU New England Biolabs
FX New England Biolabs provided support in the form of salary for author
   NT, but did not have any additional role in the study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chevalier MS, 2017, EMERG INFECT DIS, V23, P790, DOI 10.3201/eid2305.161873
   Chotiwan N, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0538
   Curtis KA, 2008, J VIROL METHODS, V151, P264, DOI 10.1016/j.jviromet.2008.04.011
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dauner AL, 2015, DIAGN MICR INFEC DIS, V83, P30, DOI 10.1016/j.diagmicrobio.2015.05.004
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Elvira-Gonzalez L, 2017, J VIROL METHODS, V241, P11, DOI 10.1016/j.jviromet.2016.12.004
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Francois P, 2011, FEMS IMMUNOL MED MIC, V62, P41, DOI 10.1111/j.1574-695X.2011.00785.x
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Heukelbach J, 2016, LANCET, V388, P846, DOI 10.1016/S0140-6736(16)30931-X
   Hu S, 2015, P 2015 ACM INT JOINT, V15, P1, DOI DOI 10.1186/S12866-015-0595-1
   Hu Y, 2017, ANAL CHEM, V89, P745, DOI 10.1021/acs.analchem.6b03328
   Jangam SR, 2013, BIOSENS BIOELECTRON, V42, P69, DOI 10.1016/j.bios.2012.10.024
   Kaneko H, 2007, J BIOCHEM BIOPH METH, V70, P499, DOI 10.1016/j.jbbm.2006.08.008
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kwallah AO, 2013, J VIROL METHODS, V193, P23, DOI 10.1016/j.jviromet.2013.05.004
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lau YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138694
   Lee D, 2016, ANAL CHEM, V88, P12272, DOI 10.1021/acs.analchem.6b03460
   Li SH, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-360
   Liu CC, 2011, LAB CHIP, V11, P2686, DOI 10.1039/c1lc20345b
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211
   Musso D., 2014, EURO SURVEILL, V19
   Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Parida M, 2005, J CLIN MICROBIOL, V43, P2895, DOI 10.1128/JCM.43.6.2895-2903.2005
   Parida MM, 2007, J CLIN MICROBIOL, V45, P351, DOI 10.1128/JCM.01734-06
   Parida MM, 2006, J CLIN MICROBIOL, V44, P4172, DOI 10.1128/JCM.01487-06
   Pepe MS, 2003, STAT EVALUATION MED, pxvi
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Peyrefitte CN, 2008, J CLIN MICROBIOL, V46, P3653, DOI 10.1128/JCM.01188-08
   Poole CB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169011
   Priye A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44778
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roze B, 2016, EURO SURVEILL, P21
   Sanabani SS, 2017, PLOS CURR, V9
   Song JZ, 2017, CLIN CHEM, V63, P714, DOI 10.1373/clinchem.2016.263665
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Stone M, 2017, TRANSFUSION, V57, P734, DOI 10.1111/trf.14031
   Tanner NA, 2015, BIOTECHNIQUES, V58, P59, DOI 10.2144/000114253
   Teoh BT, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-387
   Tian B, 2016, BIOSENS BIOELECTRON, V86, P420, DOI 10.1016/j.bios.2016.06.085
   Toriniwa H, 2006, MICROBIOL IMMUNOL, V50, P379, DOI 10.1111/j.1348-0421.2006.tb03804.x
   Venturi G, 2014, EURO SURVEILL, V21
   Wang X, 2016, J VIROL METHODS, V238, P86, DOI 10.1016/j.jviromet.2016.10.010
   Wheeler SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147962
   Yaren O, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2382-0
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 56
TC 27
Z9 27
U1 2
U2 17
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 25
PY 2017
VL 12
IS 9
AR e0185340
DI 10.1371/journal.pone.0185340
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FI0UK
UT WOS:000411645100049
PM 28945787
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Guzman, JAC
   Espinal, R
   Baez, J
   Melgen, RE
   Rosario, PAP
   Mendoza, ER
AF Canario Guzman, Julio Arturo
   Espinal, Roberto
   Baez, Jeannette
   Elias Melgen, Ricardo
   Perez Rosario, Patricia Antonia
   Rafael Mendoza, Eddys
TI Ethical challenges for international collaborative research partnerships
   in the context of the Zika outbreak in the Dominican Republic: a
   qualitative case study
SO HEALTH RESEARCH POLICY AND SYSTEMS
LA English
DT Article
DE Research ethics; Health equity; Health research systems;
   Capacity-building; Research networks; Zika virus; Disease outbreaks;
   Developing countries; Caribbean region; Dominican Republic
ID CLINICAL-RESEARCH; HEALTH RESEARCH; GOVERNANCE; STANDARDS; COUNTRIES
AB Background: The establishment of international collaborative research partnerships in times of infectious disease outbreaks of international importance has been considered an ethical imperative. Frail health research systems in low-and middle-income countries can be an obstacle to achieve the goal of knowledge generation and the search for health equity before, during and after infectious disease outbreaks.
   Methods: A qualitative case study was conducted to identify the challenges and opportunities facing the Dominican Republic with regards to developing international collaborative research partnerships in the context of the Zika outbreak and its ethical implications. Researchers conducted 34 interviews (n = 30 individual; n = 4 group) with 39 participants (n = 23 males; n = 16 females) representing the government, universities, international donor agencies, non-governmental organisations, community-based organisations and medical societies, in two metropolitan cities.
   Results: Five international collaborative research projects related to the Zika virus were identified. Major ethical challenges were linked to the governance of health research, training of human resources, the institutionalisation of scientific activity, access to research funds and cultural aspects. Capacity-building was not necessarily a component of some partnership agreements. With few exceptions, local researchers were merely participating in data collection and less on defining the problem. Opportunities for collaborative work included the possibility of participation in international research consortiums through calls for proposals.
   Conclusions: The Dominican government and research stakeholders can contribute to the international response to the Zika virus through active participation in international collaborative research partnerships; however, public recognition of the need to embrace health research as part of public policy efforts is warranted. A working group led by the government and formed by national and international research stakeholders will be key to identify ways in which the country could respond to the ethical demand of generating new knowledge in times of outbreaks.
C1 [Canario Guzman, Julio Arturo; Espinal, Roberto; Baez, Jeannette; Elias Melgen, Ricardo; Perez Rosario, Patricia Antonia; Rafael Mendoza, Eddys] Ctr Heroes, Ctr Nacl Invest Salud Materno Infantil Dr Hugo Me, Santo Domingo, Dominican Rep.
RP Guzman, JAC (corresponding author), Ctr Heroes, Ctr Nacl Invest Salud Materno Infantil Dr Hugo Me, Santo Domingo, Dominican Rep.
EM arturo.canario@gmail.com
FU Global Forum on Bioethics in Research (GFBR) [2015/2016, 202887/Z/16/Z]
FX This work was supported by the Global Forum on Bioethics in Research
   (GFBR) 2015/2016 Fellowship (202887/Z/16/Z). The funders had no role in
   study design, data collection and analysis, decision to publish or
   preparation of the manuscript.
CR Aarons D, 2018, DEV WORLD BIOETH, V18, P375, DOI 10.1111/dewb.12157
   Amarasekera N, 2012, CEYLON MED J, V57, P137, DOI 10.4038/cmj.v57i4.5076
   Anderson MS, 2011, CHALLENGES TENSIONS
   [Anonymous], 2016, INT ETH GUID HLTH RE
   Archer SL, 2007, EUR HEART J, V28, P510, DOI 10.1093/eurheartj/ehl452
   Canario JA, 2016, REV PANAM SALUD PUBL, V39, P179
   Bradley M, 2007, IDRC CANADIAN PARTNE
   Braun V., 2006, QUALITATIVE RES PSYC, V3, P2, DOI [DOI 10.1191/1478088706QP0630A, 10.1191/1478088706qp063oa, DOI 10.1191/1478088706qp063oa]
   Carter N, 2014, ONCOL NURS FORUM, V41, P545, DOI 10.1188/14.ONF.545-547
   Commission on Health Research for Development, 1990, HLTH RES ESS LINK EQ
   Emanuel EJ, 2004, J INFECT DIS, V189, P930, DOI 10.1086/381709
   Folayan Morenike Oluwatoyin, 2015, Pan Afr Med J, V22 Suppl 1, P10, DOI 10.11694/pamj.supp.2015.22.1.6216
   Global Forum on Bioethics in Research, 2016, GLOB FOR BIOETH RES
   Global Ministerial Forum on Research for Health, 2008, BAM CALL ACT RES HLT
   Gomez P., 2016, SEM INV CIENT INN TE
   Gotuzzo Eduardo, 2010, Rev. perú. med. exp. salud publica, V27, P419, DOI 10.1590/s1726-46342010000300015
   Hellmann F, 2016, ARCH MED RES, V47, P67, DOI 10.1016/j.arcmed.2016.01.006
   Heymann DL, 2016, NEW ENGL J MED, V374, P1504, DOI 10.1056/NEJMp1602278
   Horby PW, 2015, LANCET INFECT DIS, V15, P1258, DOI 10.1016/S1473-3099(15)00375-8
   Horton D., 2009, 20093 INT POT CTR
   Ippolito G, 2015, LANCET INFECT DIS, V15, P1254, DOI 10.1016/S1473-3099(15)00236-4
   Israel M, 2017, SAGE HDB QUALITATIVE
   Neupane S, 2016, AM J BIOETHICS, V16, P62, DOI 10.1080/15265161.2016.1214316
   O'Brien BC, 2014, ACAD MED, V89, P1245, DOI 10.1097/ACM.0000000000000388
   Orsega CW Susan, 2014, J AIDS CLIN RES, V5, P385
   Palinkas LA, 2015, ADM POLICY MENT HLTH, V42, P533, DOI 10.1007/s10488-013-0528-y
   Pan American Health Organization, 2016, ZIK ETH CONS ETH GUI
   Pan American Health Organization World Health Organization, ZIK RES
   Pang T, 2003, B WORLD HEALTH ORGAN, V81, P815
   Pang T, 2004, B WORLD HEALTH ORGAN, V82, P719
   Parker M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163579
   Pratt B, 2016, AM J BIOETHICS, V16, P29, DOI 10.1080/15265161.2016.1214304
   Ravinetto R, 2016, AM J BIOETHICS, V16, P59, DOI 10.1080/15265161.2016.1214317
   Sack DA, 2009, B WORLD HEALTH ORGAN, V87, P487, DOI 10.2471/BLT.08.058099
   Sauer S, EX COR EL INT RES CO
   Solimano G, 2012, REV MED CHILE, V140, P1363, DOI 10.4067/S0034-98872012001000021
   The Work Bank, DAT INF MORT RAT DOM
   Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042
   United Nations Development Programme, HUM DEV REP TABL 1 H
   Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048
   WHO UNICEF UNFPA and WORLD BANK, 2007, MAT MORT 2005 EST DE
   World Bank, 2015, DOM REP OV
   World Health Organization, ETH EP EM DIS RES SU
   World Health Organization, ZIK OUTBR WHOS GLOB
   World Health Organization, 2016, WH DIR GEN SUMM OUTC
   Yozwiak NL, 2016, CELL, V166, P5, DOI 10.1016/j.cell.2016.06.029
NR 46
TC 2
Z9 2
U1 0
U2 7
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1478-4505
J9 HEALTH RES POLICY SY
JI Health Res. Policy Syst.
PD SEP 25
PY 2017
VL 15
AR 82
DI 10.1186/s12961-017-0246-0
PG 13
WC Health Policy & Services
SC Health Care Sciences & Services
GA FI1MU
UT WOS:000411698800001
PM 28946911
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lu, JW
   Hsieh, PS
   Lin, CC
   Hu, MK
   Huang, SM
   Wang, YM
   Liang, CY
   Gong, ZY
   Ho, YJ
AF Lu, Jeng-Wei
   Hsieh, Po-Shiuan
   Lin, Chang-Chi
   Hu, Ming-Kuan
   Huang, Shih-Ming
   Wang, Yu-Ming
   Liang, Chun-Yu
   Gong, Zhiyuan
   Ho, Yi-Jung
TI Synergistic effects of combination treatment using EGCG and suramin
   against the chikungunya virus
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Antiviral; Chikungunya virus; EGCG; Suramin; Synergistic effects
ID GREEN TEA POLYPHENOL; HEPATITIS-B-VIRUS; HERPES-SIMPLEX-VIRUS;
   EPIGALLOCATECHIN GALLATE; IN-VITRO; VIRAL REPLICATION; INHIBITS ZIKA;
   HIV-1 THERAPY; HOST FACTOR; ENTRY
AB Chikungunya is a severe disease that results from infection with the chikungunya virus (CHIKV), an arbovirus. Thus, we (1) explored a new approach to combining previously researched drugs that have shown the potential to inhibit CHIKV infection; and (2) demonstrated the antiviral effects of (-)-Epigallocatechin-3-gallate (EGCG) and the underlying mechanisms. Specifically, we used U2OS cells infected with CHIVK to assess the synergistic antiviral activities of EGCG and suramin. EGCG presented the ability to inhibit the viral RNA, progeny yield, and cytopathic effect (CPE) of CHIKV and also demonstrated the ability to protect against virus entry, replication, and release. Moreover, the results confirmed that EGCG and suramin can have synergistic effects against CHIKV strain S27 infection and two other clinical isolates of CHIKV. Our findings suggest that treatment with a combination of EGCG and suramin could provide a basis for the development of novel stretages against CHIKV infection. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Lu, Jeng-Wei; Gong, Zhiyuan] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore.
   [Hsieh, Po-Shiuan; Lin, Chang-Chi; Wang, Yu-Ming; Ho, Yi-Jung] Natl Def Med Ctr, Inst Prevent Med, Taipei, Taiwan.
   [Hsieh, Po-Shiuan] Natl Def Med Ctr, Dept Med Res, Taipei, Taiwan.
   [Hsieh, Po-Shiuan] Natl Def Med Ctr, Dept Physiol & Biophys, Taipei, Taiwan.
   [Lin, Chang-Chi] Natl Def Med Ctr, Dept & Grad Inst Microbiol & Immunol, Taipei, Taiwan.
   [Hu, Ming-Kuan; Ho, Yi-Jung] Natl Def Med Ctr, Sch Pharm, Taipei 11490, Taiwan.
   [Huang, Shih-Ming] Natl Def Med Ctr, Dept Biochem, Taipei, Taiwan.
   [Liang, Chun-Yu] Natl Def Med Ctr, Sch Nursing, Taipei, Taiwan.
RP Ho, YJ (corresponding author), Natl Def Med Ctr, Sch Pharm, Taipei 11490, Taiwan.
EM ejung330@gmail.com
RI Hsieh, Po-Shiuan/AAF-4173-2020; Gong, Zhiyuan/H-8794-2012
OI Gong, Zhiyuan/0000-0002-9660-5260
FU Institute of Preventive Medicine, National Defense Medical Center
   [104-9-B19, 105-G6-1(3), 106-P7]
FX This study was supported by grants (104-9-B19, 105-G6-1(3), 106-P7) from
   the Institute of Preventive Medicine, National Defense Medical Center.
CR Bhat R, 2014, BIOORG MED CHEM LETT, V24, P4162, DOI 10.1016/j.bmcl.2014.07.051
   Calland N, 2015, J VIROL, V89, P10053, DOI 10.1128/JVI.01473-15
   Calland N, 2012, HEPATOLOGY, V55, P720, DOI 10.1002/hep.24803
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Chen C, 2012, ARCH VIROL, V157, P1301, DOI 10.1007/s00705-012-1304-0
   Chow HHS, 2003, CLIN CANCER RES, V9, P3312
   Ciesek S, 2011, HEPATOLOGY, V54, P1947, DOI 10.1002/hep.24610
   de Oliveira A, 2013, FOOD CHEM TOXICOL, V52, P207, DOI 10.1016/j.fct.2012.11.006
   He XR, 2017, J CARDIOVASC PHARM, V69, P41, DOI [10.1097/FJC.0000000000000439, 10.1097/fjc.0000000000000439]
   Ho HY, 2009, J AGR FOOD CHEM, V57, P6140, DOI 10.1021/jf901128u
   Ho YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133511
   Hsu S., 2009, GREEN TEA SKIN PROTE, P33
   Hsu Stephen, 2015, Inflammation & Allergy Drug Targets, V14, P13, DOI 10.2174/1871528114666151022150122
   Huang HC, 2014, ANTIVIR RES, V111, P100, DOI 10.1016/j.antiviral.2014.09.009
   Isaacs CE, 2008, ANTIMICROB AGENTS CH, V52, P962, DOI 10.1128/AAC.00825-07
   Jiang F, 2010, CLIN IMMUNOL, V137, P347, DOI 10.1016/j.clim.2010.08.007
   Kawai K, 2003, J ALLERGY CLIN IMMUN, V112, P951, DOI 10.1016/S0091-6749(03)02007-4
   Kuo SC, 2016, ANTIVIR RES, V134, P89, DOI 10.1016/j.antiviral.2016.07.025
   Lambert JD, 2013, AM J CLIN NUTR, V98, p1667S, DOI 10.3945/ajcn.113.059352
   Li JL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-161
   Mounce BC, 2017, ANTIVIR RES, V142, P148, DOI 10.1016/j.antiviral.2017.03.014
   Nance CL, 2009, J ALLERGY CLIN IMMUN, V123, P459, DOI 10.1016/j.jaci.2008.12.024
   Ng LFP, 2009, MICROBES INFECT, V11, P1163, DOI 10.1016/j.micinf.2009.09.001
   Pang JY, 2014, J ZHEJIANG UNIV-SC B, V15, P533, DOI 10.1631/jzus.B1300307
   Reid S, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.61
   Reid SP, 2014, ANTIVIR RES, V109, P171, DOI 10.1016/j.antiviral.2014.07.004
   Rezai-Zadeh K, 2008, BRAIN RES, V1214, P177, DOI 10.1016/j.brainres.2008.02.107
   Rothan HA, 2016, ANTIVIR RES, V127, P50, DOI 10.1016/j.antiviral.2016.01.006
   Rothan HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126360
   Schwameis M, 2016, HUM VACC IMMUNOTHER, V12, P716, DOI 10.1080/21645515.2015.1101197
   Selvarajah S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002423
   Song JM, 2005, ANTIVIR RES, V68, P66, DOI 10.1016/j.antiviral.2005.06.010
   Steinmann J, 2013, BRIT J PHARMACOL, V168, P1059, DOI 10.1111/bph.12009
   Wang YZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21595
   Wang YM, 2016, ANTIVIR RES, V135, P81, DOI 10.1016/j.antiviral.2016.10.003
   Warter L, 2011, J IMMUNOL, V186, P3258, DOI 10.4049/jimmunol.1003139
   Weber C, 2015, ANTIVIR RES, V113, P1, DOI 10.1016/j.antiviral.2014.11.001
   Williamson MP, 2006, J ALLERGY CLIN IMMUN, V118, P1369, DOI 10.1016/j.jaci.2006.08.016
   Wu CC, 2006, LIFE SCI, V78, P2889, DOI 10.1016/j.lfs.2005.11.013
   Xu J, 2008, ANTIVIR RES, V78, P242, DOI 10.1016/j.antiviral.2007.11.011
   Xu J, 2016, J NAT MED-TOKYO, V70, P584, DOI 10.1007/s11418-016-0980-6
   Zhong L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.136
NR 42
TC 11
Z9 11
U1 1
U2 11
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD SEP 23
PY 2017
VL 491
IS 3
BP 595
EP 602
DI 10.1016/j.bbrc.2017.07.157
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA FH1CI
UT WOS:000410876900005
PM 28760340
DA 2020-07-08
ER

PT J
AU Hall, NB
   Broussard, K
   Evert, N
   Canfield, M
AF Hall, Noemi Borsay
   Broussard, Kelly
   Evert, Nicole
   Canfield, Mark
TI Notes from the Field: Zika Virus-Associated Neonatal Birth Defects
   Surveillance - Texas, January 2016 - July 2017 (vol 66, pg 835, 2017)
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Correction
CR Hall NB, 2017, MMWR-MORBID MORTAL W, V66, P835, DOI 10.15585/mmwr.mm6631a5
NR 1
TC 0
Z9 0
U1 0
U2 1
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD SEP 22
PY 2017
VL 66
IS 37
BP 1003
EP 1003
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FH6WL
UT WOS:000411321000010
DA 2020-07-08
ER

PT J
AU Shan, C
   Muruato, AE
   Jagger, BW
   Richner, J
   Nunes, BTD
   Medeiros, DBA
   Xie, XP
   Nunes, JGC
   Morabito, KM
   Kong, WP
   Pierson, TC
   Barrett, AD
   Weaver, SC
   Rossi, SL
   Vasconcelos, PFC
   Graham, BS
   Diamond, MS
   Shi, PY
AF Shan, Chao
   Muruato, Antonio E.
   Jagger, Brett W.
   Richner, Justin
   Nunes, Bruno T. D.
   Medeiros, Daniele B. A.
   Xie, Xuping
   Nunes, Jannyce G. C.
   Morabito, Kaitlyn M.
   Kong, Wing-Pui
   Pierson, Theodore C.
   Barrett, Alan D.
   Weaver, Scott C.
   Rossi, Shannan L.
   Vasconcelos, Pedro F. C.
   Graham, Barney S.
   Diamond, Michael S.
   Shi, Pei-Yong
TI A single-dose live-attenuated vaccine prevents Zika virus pregnancy
   transmission and testis damage
SO NATURE COMMUNICATIONS
LA English
DT Article
ID SEXUAL TRANSMISSION; PROTECTION; INFECTION; MICE; ANTIBODIES; IMMUNITY;
   DISEASE; BRAZIL
AB Zika virus infection during pregnancy can cause congenital abnormities or fetal demise. The persistence of Zika virus in the male reproductive system poses a risk of sexual transmission. Here we demonstrate that live-attenuated Zika virus vaccine candidates containing deletions in the 3' untranslated region of the Zika virus genome (ZIKV-3'UTR-LAV) prevent viral transmission during pregnancy and testis damage in mice, as well as infection of nonhuman primates. After a single-dose vaccination, pregnant mice challenged with Zika virus at embryonic day 6 and evaluated at embryonic day 13 show markedly diminished levels of viral RNA in maternal, placental, and fetal tissues. Vaccinated male mice challenged with Zika virus were protected against testis infection, injury, and oligospermia. A single immunization of rhesus macaques elicited a rapid and robust antibody response, conferring complete protection upon challenge. Furthermore, the ZIKV-3'UTR-LAV vaccine candidates have a desirable safety profile. These results suggest that further development of ZIKV-3'UTR-LAV is warranted for humans.
C1 [Shan, Chao; Nunes, Bruno T. D.; Medeiros, Daniele B. A.; Xie, Xuping; Nunes, Jannyce G. C.; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Muruato, Antonio E.; Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Jagger, Brett W.; Richner, Justin; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Nunes, Bruno T. D.; Medeiros, Daniele B. A.; Nunes, Jannyce G. C.; Vasconcelos, Pedro F. C.] Minist Hlth, Evandro Chagas Inst, Dept Arbovirol & Hemorrhag Fevers, BR-67030000 Ananindeua, Brazil.
   [Morabito, Kaitlyn M.; Kong, Wing-Pui] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Pierson, Theodore C.; Graham, Barney S.] NIAID, Viral Pathogenesis Sect, Viral Dis Lab, NIH, Bethesda, MD 20892 USA.
   [Barrett, Alan D.; Rossi, Shannan L.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Barrett, Alan D.; Rossi, Shannan L.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Barrett, Alan D.; Rossi, Shannan L.] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA.
   [Barrett, Alan D.; Weaver, Scott C.; Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA.
   [Weaver, Scott C.; Shi, Pei-Yong] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA.
   [Weaver, Scott C.] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
   [Vasconcelos, Pedro F. C.; Shi, Pei-Yong] Para State Univ, Dept Pathol, BR-67087670 Belem, Para, Brazil.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Phamarcol & Toxicol, Galveston, TX 77555 USA.
RP Shi, PY (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Para State Univ, Dept Pathol, BR-67087670 Belem, Para, Brazil.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Dept Phamarcol & Toxicol, Galveston, TX 77555 USA.
EM diamond@wusm.wustl.edu; peshi@utmb.edu
RI Weaver, Scott C/D-6490-2011; Graham, Barney S./AAC-5898-2019;
   Vasconcelos, Pedro/AAH-3142-2019; Diamond, Michael/AAH-1733-2019; Xie,
   Xuping/AAD-7406-2019
OI Weaver, Scott C/0000-0001-8016-8556; Graham, Barney
   S./0000-0001-8112-0853; Diamond, Michael/0000-0002-8791-3165; Shan,
   Chao/0000-0002-3953-3782; Morabito, Kaitlyn/0000-0002-4849-4690
FU University of Texas Medical Branch (UTMB); University of Texas STARs
   Award; CDC grant for the Western Gulf Center of Excellence for
   Vector-Borne Diseases; Pan American Health Organization
   [SCON2016-01353]; Kleberg Foundation; UTMB CTSAUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Center for Advancing Translational Sciences (NCATS)
   [UL1TR-001439]; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI127744, AI120942,
   AI073755, AI104972, AI106695]; National Institute of Allergy and
   Infectious DiseasesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID); CAPES (Zika Fast-Track); CNPq
   from Ministry of Science and Technology of Brazil [440405/2016-5,
   303999/2016-0]; Ministry of HealthMinistry of Health - Turkey
FX We thank colleagues at University of Texas Medical Branch for helpful
   discussions and support during the course of this study. We also thank
   J.P. Todd and R. Bailer for help with the nonhuman primate studies and
   sample processing. P.-Y.S. lab was supported by University of Texas
   Medical Branch (UTMB) startup award, University of Texas STARs Award,
   CDC grant for the Western Gulf Center of Excellence for Vector-Borne
   Diseases, Pan American Health Organization grant SCON2016-01353, the
   Kleberg Foundation award, UTMB CTSA UL1TR-001439 and NIH grant AI127744.
   K.M.M., W.-P.K., B.S.G., and T.C.P. are funded through intramural
   funding from the National Institute of Allergy and Infectious Diseases.
   This research was also partially supported by NIH grant AI120942 to
   S.C.W. and grants AI073755, AI104972, and AI106695 from the NIH to
   M.S.D.P.F.C.V. was suported by projects of CAPES (Zika Fast-Track) and
   CNPq: grants 440405/2016-5, and 303999/2016-0 from the Ministry of
   Science and Technology of Brazil and by the Ministry of Health.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   [Anonymous], 1987, World Health Organ Tech Rep Ser, V747, P1
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Betancourt D, 2017, J IMMUNOL, V198, P3023, DOI 10.4049/jimmunol.1602180
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Hansen DA, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.108845
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   McArthur M. A., 2017, VIRUSES
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Ong EZ, 2017, ANTIVIR RES, V144, P44, DOI 10.1016/j.antiviral.2017.05.007
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shan C, 2017, EBIOMEDICINE, V17, P157, DOI 10.1016/j.ebiom.2017.03.006
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
NR 36
TC 63
Z9 65
U1 0
U2 13
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD SEP 22
PY 2017
VL 8
AR 676
DI 10.1038/s41467-017-00737-8
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FH9JL
UT WOS:000411526700021
PM 28939807
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Fukruksa, C
   Yimthin, T
   Suwannaroj, M
   Muangpat, P
   Tandhavanant, S
   Thanwisai, A
   Vitta, A
AF Fukruksa, Chamaiporn
   Yimthin, Thatcha
   Suwannaroj, Manawat
   Muangpat, Paramaporn
   Tandhavanant, Sarunporn
   Thanwisai, Aunchalee
   Vitta, Apichat
TI Isolation and identification of Xenorhabdus and Photorhabdus bacteria
   associated with entomopathogenic nematodes and their larvicidal activity
   against Aedes aegypti
SO PARASITES & VECTORS
LA English
DT Article
DE Xenorhabdus; Photorhabdus; Phylogeny; Larvicidal activity; Aedes aegypti
ID BACILLUS-THURINGIENSIS; METARHIZIUM-ANISOPLIAE; INSECTICIDAL PROTEIN;
   DIPTERA-CULICIDAE; ORAL TOXICITY; SP NOV.; ALBOPICTUS;
   ENTEROBACTERIACEAE; LUMINESCENS; MOSQUITOS
AB Background: Aedes aegypti is a potential vector of West Nile, Japanese encephalitis, chikungunya, dengue and Zika viruses. Alternative control measurements of the vector are needed to overcome the problems of environmental contamination and chemical resistance. Xenorhabdus and Photorhabdus are symbionts in the intestine of entomopathogenic nematodes (EPNs) Steinernema spp. and Heterorhabditis spp. These bacteria are able to produce a broad range of bioactive compounds including antimicrobial, antiparasitic, cytotoxic and insecticidal compounds. The objectives of this study were to identify Xenorhabdus and Photorhabdus isolated from EPNs in upper northern Thailand and to study their larvicidal activity against Ae. aegypti larvae.
   Results: A total of 60 isolates of symbiotic bacteria isolated from EPNs consisted of Xenorhabdus (32 isolates) and Photorhabdus (28 isolates). Based on recA gene sequencing, BLASTN and phylogenetic analysis, 27 isolates of Xenorhabdus were identical and closely related to X. stockiae, 4 isolates were identical to X. miraniensis, and one isolate was identical to X. ehlersii. Twenty-seven isolates of Photorhabdus were closely related to P. luminescens akhurstii and P. luminescens hainanensis, and only one isolate was identical and closely related to P. luminescens laumondii. Xenorhabdus and Photorhabdus were lethal to Ae aegypti larvae. Xenorhabdus ehlersii bMH9.2_ TH showed 100% efficiency for killing larvae of both fed and unfed conditions, the highest for control of Ae. aegypti larvae and X. stockiae (bLPA18.4_TH) was likely to be effective in killing Ae. aegypti larvae given the mortality rates above 60% at 72 h and 96 h.
   Conclusions: The common species in the study area are X. stockiae, P. luminescens akhurstii, and P. luminescens hainanensis. Three symbiotic associations identified included P. luminescens akhurstii-H. gerrardi, P. luminescens hainanensis-H. gerrardi and X. ehlersii-S. Scarabaei which are new observations of importance to our knowledge of the biodiversity of, and relationships between, EPNs and their symbiotic bacteria. Based on the biological assay, X. ehlersii bMH9.2_TH begins to kill Ae. aegypti larvae within 48 h and has the most potential as a pathogen to the larvae. These data indicate that X. ehlersii may be an alternative biological control agent for Ae. aegypti and other mosquitoes.
C1 [Fukruksa, Chamaiporn; Yimthin, Thatcha; Suwannaroj, Manawat; Muangpat, Paramaporn; Thanwisai, Aunchalee; Vitta, Apichat] Naresuan Univ, Fac Med Sci, Dept Microbiol & Parasitol, Phitsanulok 65000, Thailand.
   [Yimthin, Thatcha; Tandhavanant, Sarunporn] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok 10400, Thailand.
   [Thanwisai, Aunchalee; Vitta, Apichat] Naresuan Univ, Fac Med Sci, CEMB, Phitsanulok 65000, Thailand.
   [Thanwisai, Aunchalee; Vitta, Apichat] Naresuan Univ, Ctr Excellence Biodivers, Fac Sci, Phitsanulok 65000, Thailand.
RP Vitta, A (corresponding author), Naresuan Univ, Fac Med Sci, Dept Microbiol & Parasitol, Phitsanulok 65000, Thailand.; Vitta, A (corresponding author), Naresuan Univ, Fac Med Sci, CEMB, Phitsanulok 65000, Thailand.
EM apichatv@nu.ac.th
RI Tandhavanant, Sarunporn/R-7620-2019; Tandhavanant, Sarunporn/Q-7376-2019
OI Tandhavanant, Sarunporn/0000-0003-0261-3233; Vitta,
   Apichat/0000-0002-2483-0100
FU Naresuan University [R2556B060, R2560B055, R2559C190]
FX This study was supported by Naresuan University (Grant Number R2556B060,
   and Grant Number R2560B055 for AV and Grant Number R2559C190 for AT).
CR Ahantarig A, 2009, APPL ENVIRON MICROB, V75, P4627, DOI 10.1128/AEM.00221-09
   An RS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145739
   Baldacchino F, 2015, PEST MANAG SCI, V71, P1471, DOI 10.1002/ps.4044
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bellini R, 2013, J MED ENTOMOL, V50, P317, DOI 10.1603/ME12048
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bode HB, 2009, CURR OPIN CHEM BIOL, V13, P224, DOI 10.1016/j.cbpa.2009.02.037
   Bussaman P., 2016, Biosciences, Biotechnology Research Asia, V13, P1871, DOI 10.13005/bbra/2342
   Bussaman P, 2012, J ZHEJIANG UNIV-SC B, V13, P261, DOI 10.1631/jzus.B1100155
   Calvitti M, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-254
   da Silva OS, 2013, PARASITOL RES, V112, P2891, DOI 10.1007/s00436-013-3460-x
   Darbro JM, 2012, AM J TROP MED HYG, V86, P656, DOI 10.4269/ajtmh.2012.11-0455
   ffrench-Constant RH, 2007, TOXICON, V49, P436, DOI 10.1016/j.toxicon.2006.11.019
   Forst S, 1997, ANNU REV MICROBIOL, V51, P47, DOI 10.1146/annurev.micro.51.1.47
   Gomes SA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1280-9
   Grundmann F, 2014, J NAT PROD, V77, P779, DOI 10.1021/np4007525
   Hinchliffe SJ, 2010, OPEN TOXINOL J, V3, P83, DOI DOI 10.2174/1875414701003010101
   Jaber S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1763-3
   Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010
   Kovendan K, 2012, PARASITOL RES, V110, P195, DOI 10.1007/s00436-011-2469-2
   Kovendan K, 2011, PARASITOL RES, V109, P1251, DOI 10.1007/s00436-011-2368-6
   Kumar PM, 2013, PARASITOL RES, V112, P761, DOI 10.1007/s00436-012-3196-z
   Lahariya Chandrakant, 2006, Journal of Vector Borne Diseases, V43, P151
   Laughlin CA, 2012, J INFECT DIS, V206, P1121, DOI 10.1093/infdis/jis351
   Leles RN, 2012, PARASITOL RES, V110, P1579, DOI 10.1007/s00436-011-2666-z
   Lemine AMM, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-1978-y
   Lengyel K, 2005, SYST APPL MICROBIOL, V28, P115, DOI 10.1016/j.syapm.2004.10.004
   Marten GG, 2007, J AM MOSQUITO CONTR, V23, P65, DOI 10.2987/8756-971X(2007)23[65:CC]2.0.CO;2
   MARTEN GG, 1990, J AM MOSQUITO CONTR, V6, P681
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Otta DA, 2012, PARASITOL RES, V111, P2017, DOI 10.1007/s00436-012-3050-3
   Owuama CI, 2001, WORLD J MICROB BIOT, V17, P505, DOI 10.1023/A:1011916021378
   Park Y, 2016, J EC ENTOMOL
   Park Y, 2015, J ASIA-PAC ENTOMOL, V18, P459, DOI 10.1016/j.aspen.2015.05.002
   Plichta KL, 2009, J HELMINTHOL, V83, P309, DOI 10.1017/S0022149X09222942
   Ruiu L, 2013, B INSECTOL, V66, P181
   Scholte EJ, 2007, ACTA TROP, V102, P151, DOI 10.1016/j.actatropica.2007.04.011
   Setha T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004973
   Shi HX, 2013, WORLD J MICROB BIOT, V29, P1705, DOI 10.1007/s11274-013-1333-1
   Shi HX, 2012, CURR MICROBIOL, V64, P604, DOI 10.1007/s00284-012-0114-7
   Shrestha YK, 2012, J INVERTEBR PATHOL, V109, P91, DOI 10.1016/j.jip.2011.10.011
   Tailliez P, 2006, INT J SYST EVOL MICR, V56, P2805, DOI 10.1099/ijs.0.64287-0
   Tailliez P, 2010, INT J SYST EVOL MICR, V60, P1921, DOI 10.1099/ijs.0.014308-0
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Thanwisai A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043835
   Touzri DB, 2013, J BASIC MICROB, V53, P1
   Veronesi R, 2015, J AM MOSQUITO CONTR, V31, P32, DOI 10.2987/13-6381.1
   Vitta A, 2017, SE ASIAN J TROP MED, V48, P18
   Vythilingam I, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01452
   Winskill P, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-68
   World Health Organization, 2016, ZIK VIR
NR 52
TC 10
Z9 10
U1 0
U2 30
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD SEP 21
PY 2017
VL 10
AR 440
DI 10.1186/s13071-017-2383-2
PG 10
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FH8HT
UT WOS:000411435500002
PM 28934970
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wang, JQ
   Bardelli, M
   Espinosa, DA
   Pedotti, M
   Ng, TS
   Bianchi, S
   Simonelli, L
   Lim, EXY
   Foglierini, M
   Zatta, F
   Jaconi, S
   Beltramello, M
   Cameroni, E
   Fibriansah, G
   Shi, J
   Barca, T
   Pagani, I
   Rubio, A
   Broccoli, V
   Vicenzi, E
   Graham, V
   Pullan, S
   Dowall, S
   Hewson, R
   Jurt, S
   Zerbe, O
   Stettler, K
   Lanzavecchia, A
   Sallusto, F
   Cavalli, A
   Harris, E
   Lok, SM
   Varani, L
   Corti, D
AF Wang, Jiaqi
   Bardelli, Marco
   Espinosa, Diego A.
   Pedotti, Mattia
   Ng, Thiam-Seng
   Bianchi, Siro
   Simonelli, Luca
   Lim, Elisa X. Y.
   Foglierini, Mathilde
   Zatta, Fabrizia
   Jaconi, Stefano
   Beltramello, Martina
   Cameroni, Elisabetta
   Fibriansah, Guntur
   Shi, Jian
   Barca, Taylor
   Pagani, Isabel
   Rubio, Alicia
   Broccoli, Vania
   Vicenzi, Elisa
   Graham, Victoria
   Pullan, Steven
   Dowall, Stuart
   Hewson, Roger
   Jurt, Simon
   Zerbe, Oliver
   Stettler, Karin
   Lanzavecchia, Antonio
   Sallusto, Federica
   Cavalli, Andrea
   Harris, Eva
   Lok, Shee-Mei
   Varani, Luca
   Corti, Davide
TI A Human Bi-specific Antibody against Zika Virus with High Therapeutic
   Potential
SO CELL
LA English
DT Article
ID WEST-NILE-VIRUS; DENGUE VIRUS; ENVELOPE GLYCOPROTEIN; REAL-TIME;
   STRUCTURAL BASIS; INFECTION; PROTEIN; MODEL; MICE; NEUTRALIZATION
AB Zika virus (ZIKV), a mosquito-borne flavivirus, causes devastating congenital birth defects. We isolated a human monoclonal antibody (mAb), ZKA190, that potently cross-neutralizes multi-lineage ZIKV strains. ZKA190 is highly effective in vivo in preventing morbidity and mortality of ZIKV-infected mice. NMR and cryo-electron microscopy show its binding to an exposed epitope on DIII of the E protein. ZKA190 Fab binds all 180 E protein copies, altering the virus quaternary arrangement and surface curvature. However, ZIKV escape mutants emerged in vitro and in vivo in the presence of ZKA190, as well as of other neutralizing mAbs. To counter this problem, we developed a bispecific antibody (FIT-1) comprising ZKA190 and a second mAb specific for DII of E protein. In addition to retaining high in vitro and in vivo potencies, FIT-1 robustly prevented viral escape, warranting its development as a ZIKV immunotherapy.
C1 [Wang, Jiaqi; Ng, Thiam-Seng; Lim, Elisa X. Y.; Fibriansah, Guntur; Lok, Shee-Mei] Duke Natl Univ Singapore, Program Emerging Infect Dis, Med Sch, Singapore 169857, Singapore.
   [Wang, Jiaqi; Ng, Thiam-Seng; Lim, Elisa X. Y.; Fibriansah, Guntur; Shi, Jian; Lok, Shee-Mei] Natl Univ Singapore, Ctr BioImaging Sci, Singapore 117557, Singapore.
   [Bardelli, Marco; Pedotti, Mattia; Simonelli, Luca; Foglierini, Mathilde; Lanzavecchia, Antonio; Sallusto, Federica; Cavalli, Andrea; Varani, Luca] Univ Svizzera Italiana, Inst Res Biomed, Via Vincenzo Vela 6, CH-6500 Bellinzona, Switzerland.
   [Espinosa, Diego A.; Barca, Taylor; Harris, Eva] Univ Calif Berkeley, Div Infect Dis & Vaccinol, Sch Publ Hlth, Li Ka Shing Ctr 185, 1951 Oxford St, Berkeley, CA 94720 USA.
   [Bianchi, Siro; Zatta, Fabrizia; Jaconi, Stefano; Beltramello, Martina; Cameroni, Elisabetta; Stettler, Karin; Corti, Davide] Humabs BioMed SA, Via Mirasole 1, CH-6500 Bellinzona, Switzerland.
   [Shi, Jian] Natl Univ Singapore, CryoEM Unit, Dept Biol Sci, Singapore 117557, Singapore.
   [Pagani, Isabel; Rubio, Alicia; Broccoli, Vania; Vicenzi, Elisa] Ist Sci San Raffaele, Viral Pathogens & Biosafety Unit, Via Olgettina 58, I-20132 Milan, Italy.
   [Broccoli, Vania] CNR Inst Neurosci, Via Vanvitelli 32, I-20129 Milan, Italy.
   [Graham, Victoria; Pullan, Steven; Dowall, Stuart; Hewson, Roger] Publ Hlth England, Natl Infect Serv, Salisbury, Wilts, England.
   [Jurt, Simon; Zerbe, Oliver] Univ Zurich, Dept Chem, Zurich, Switzerland.
RP Lok, SM (corresponding author), Duke Natl Univ Singapore, Program Emerging Infect Dis, Med Sch, Singapore 169857, Singapore.; Lok, SM (corresponding author), Natl Univ Singapore, Ctr BioImaging Sci, Singapore 117557, Singapore.; Varani, L (corresponding author), Univ Svizzera Italiana, Inst Res Biomed, Via Vincenzo Vela 6, CH-6500 Bellinzona, Switzerland.; Corti, D (corresponding author), Humabs BioMed SA, Via Mirasole 1, CH-6500 Bellinzona, Switzerland.
EM sheemei.lok@duke-nus.edu.sg; luca.varani@irb.usi.ch;
   davide.corti@humabs.ch
RI Vicenzi, Elisa/AAL-3980-2020; Pagani, Isabel/AAB-3301-2019; Fibriansah,
   Guntur/P-1201-2015
OI Pagani, Isabel/0000-0001-5396-0740; Broccoli, Vania/0000-0003-4050-0926;
   Simonelli, Luca/0000-0001-6331-7716; Fibriansah,
   Guntur/0000-0002-9990-3335; varani, luca/0000-0002-0963-0987; Pullan,
   Steven/0000-0002-8983-599X; Espinosa, Diego A./0000-0002-4364-5031; Lok,
   Shee-Mei/0000-0003-4631-8041
FU Singapore Ministry of Education Tier 3 grant [MOE2012-T3-1-008];
   National Research Foundation Investigatorship award [NRF-NRFI2016-01];
   National Research Foundation Competitive Research Project grant
   [NRF2016NRF-CRP001-063]; Duke-NUS Signature Research Programme -
   Ministry of Health, Singapore; US National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [5U19AI109761]; SNF [310030_166445, 157699,
   KFS-3728-08-2015]; Lions Club Monteceneri
FX We thank Victor A. Kostyuchenko and P. Robert Beatty for scientific
   discussion and Kuiama Lewandowski at PHE for the technical support in
   viral sequencing and Rocco D'Antuono for microscope assistance. We thank
   Fabio Benigni at Humabs for critical reading of the manuscript and
   Antonio Piralla from San Matteo Hospital in Pavia for helping in the
   sequencing of MARMs. We thank the European Virus Archive for consenting
   to the use of the ZIKV H/PF/2013 strain. The work was supported by
   Singapore Ministry of Education Tier 3 grant (MOE2012-T3-1-008),
   National Research Foundation Investigatorship award (NRF-NRFI2016-01),
   National Research Foundation Competitive Research Project grant
   (NRF2016NRF-CRP001-063) and the Duke-NUS Signature Research Programme
   funded by the Ministry of Health, Singapore, awarded to S-M.L, and grant
   5U19AI109761 from the US National Institutes of Health to Ian Lipkin and
   E.H. L.V. is grateful for support by G. Noseda, SNF grant 310030_166445,
   157699, KFS-3728-08-2015 and Lions Club Monteceneri. A. L. is the
   scientific founder of Humabs BioMed SA. A.L. holds shares in Humabs
   BioMed. K.S., F.Z., S.J., E.C., M.B. and D.C. are employees of Humabs
   Biomed.
CR Allison SL, 2001, J VIROL, V75, P4268, DOI 10.1128/JVI.75.9.4268-4275.2001
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardelli M, 2015, J MOL RECOGNIT, V28, P393, DOI 10.1002/jmr.2454
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Baronti C., 2014, GENOME ANNOUNC, V2
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   Brister JR, 2014, NUCLEIC ACIDS RES, V42, pD660, DOI 10.1093/nar/gkt1268
   Carragher B, 2000, J STRUCT BIOL, V132, P33, DOI 10.1006/jsbi.2000.4314
   Case D., 2017, AMBER 2017
   Chung KM, 2006, J VIROL, V80, P1340, DOI 10.1128/JVI.80.3.1340-1351.2006
   Corti D, 2013, NATURE, V501, P439, DOI 10.1038/nature12442
   Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Edeling MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004072
   Faria NR, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0356-2
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Frontera J. A., 2016, N ENGL J MED
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gong S., 2017, MABS, V165
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3
   Guntert P, 2015, J BIOMOL NMR, V62, P453, DOI 10.1007/s10858-015-9924-9
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Kaufmann B, 2006, P NATL ACAD SCI USA, V103, P12400, DOI 10.1073/pnas.0603488103
   Keller R., 2004, COMPUTER AIDED RESON
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Lai CJ, 2007, J VIROL, V81, P12766, DOI 10.1128/JVI.01420-07
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lok SM, 2016, TRENDS MICROBIOL, V24, P284, DOI 10.1016/j.tim.2015.12.004
   Loman NJ, 2015, NAT METHODS, V12, P733, DOI [10.1038/nmeth.3444, 10.1038/NMETH.3444]
   Loman NJ, 2014, BIOINFORMATICS, V30, P3399, DOI 10.1093/bioinformatics/btu555
   Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016
   Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Orozco S, 2012, J GEN VIROL, V93, P2152, DOI 10.1099/vir.0.045088-0
   Pedotti M, 2011, INT J MOL SCI, V12, P226, DOI 10.3390/ijms12010226
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Rodenhuis-Zybert IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000718
   Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Simonelli L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055561
   Simonelli L, 2010, J MOL BIOL, V396, P1491, DOI 10.1016/j.jmb.2009.12.053
   Sircar A, 2009, NUCLEIC ACIDS RES, V37, pW474, DOI 10.1093/nar/gkp387
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stiasny K, 1996, J VIROL, V70, P8142, DOI 10.1128/JVI.70.11.8142-8147.1996
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   VANDENBROEK MF, 1995, J VIROL, V69, P4792, DOI 10.1128/JVI.69.8.4792-4796.1995
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zhang XZ, 2015, J VIROL, V89, P743, DOI 10.1128/JVI.02411-14
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zou G, 2012, ANTIVIR RES, V95, P216, DOI 10.1016/j.antiviral.2012.06.010
NR 70
TC 54
Z9 55
U1 4
U2 26
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD SEP 21
PY 2017
VL 171
IS 1
BP 229
EP +
DI 10.1016/j.cell.2017.09.002
PG 28
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA FH7AA
UT WOS:000411331800023
PM 28938115
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Bragazzi, NL
   Alicino, C
   Trucchi, C
   Paganino, C
   Barberis, I
   Martini, M
   Sticchi, L
   Trinka, E
   Brigo, F
   Ansaldi, F
   Icardi, G
   Orsi, A
AF Bragazzi, Nicola Luigi
   Alicino, Cristiano
   Trucchi, Cecilia
   Paganino, Chiara
   Barberis, Ilaria
   Martini, Mariano
   Sticchi, Laura
   Trinka, Eugen
   Brigo, Francesco
   Ansaldi, Filippo
   Icardi, Giancarlo
   Orsi, Andrea
TI Global reaction to the recent outbreaks of Zika virus: Insights from a
   Big Data analysis
SO PLOS ONE
LA English
DT Article
ID DIGITAL DISEASE DETECTION; EBOLA OUTBREAK; UNITED-STATES; WEB; BEHAVIOR;
   TWITTER; TRENDS
AB Objective
   The recent spreading of Zika virus represents an emerging global health threat. As such, it is attracting public interest worldwide, generating a great amount of related Internet searches and social media interactions. The aim of this research was to understand Zika-related digital behavior throughout the epidemic spreading and to assess its consistence with real-world epidemiological data, using a behavioral informatics and analytics approach.
   Methods
   In this study, the global web-interest and reaction to the recently occurred outbreaks of the Zika Virus were analyzed in terms of tweets and Google Trends (GT), Google News, You-Tube, and Wikipedia search queries. These data streams were mined from 1 st January 2004 to 31 st October 2016, with a focus on the period November 2015-October 2016. This analysis was complemented with the use of epidemiological data. Spearman's correlation was performed to correlate all Zika-related data. Moreover, a multivariate regression was performed using Zika-related search queries as a dependent variable, and epidemiological data, number of inhabitants in 2015 and Human Development Index as predictor variables.
   Results
   Overall 3,864,395 tweets, 284,903 accesses to Wikipedia pages dedicated to the Zika virus were analyzed during the study period. All web-data sources showed that the main spike of researches and interactions occurred in February 2016 with a second peak in August 2016. All novel data streams-related activities increased markedly during the epidemic period with respect to pre-epidemic period when no web activity was detected. Correlations between data from all these web platforms resulted very high and statistically significant. The countries in which web searches were particularly concentrated are mainly from Central and South Americas. The majority of queries concerned the symptoms of the Zika virus, its vector of transmission, and its possible effect to babies, including microcephaly. No statistically significant correlation was found between novel data streams and global real-world epidemiological data. At country level, a correlation between the digital interest towards the Zika virus and Zika incidence rate or microcephaly cases has been detected.
   Conclusions An increasing public interest and reaction to the current Zika virus outbreak was documented by all web-data sources and a similar pattern of web reactions has been detected. The public opinion seems to be particularly worried by the alert of teratogenicity of the Zika virus. Stakeholders and health authorities could usefully exploited these internet tools for collecting the concerns of public opinion and reply to them, disseminating key information.
C1 [Bragazzi, Nicola Luigi; Alicino, Cristiano; Trucchi, Cecilia; Paganino, Chiara; Barberis, Ilaria; Martini, Mariano; Sticchi, Laura; Ansaldi, Filippo; Icardi, Giancarlo; Orsi, Andrea] Univ Genoa, Dept Hlth Sci, Genoa, Italy.
   [Sticchi, Laura; Icardi, Giancarlo; Orsi, Andrea] IRCCS, Osped Policlin San Martino, Teaching Hosp, Hyg Unit, Genoa, Italy.
   [Trinka, Eugen] Paracelsus Med Univ, Ctr Cognit Neurosci, Dept Neurol, Christian Doppler Klin, Salzburg, Austria.
   [Trinka, Eugen] UMIT Univ Hlth Sci Med Informat & Technol, Dept Publ Hlth Technol Assessment, Hall iT, Innsbruck, Austria.
   [Brigo, Francesco] Franz Tappeiner Hosp, Dept Neurol, Merano, Italy.
   [Brigo, Francesco] Univ Verona, Dept Neurol Biomed & Movement Sci, Verona, Italy.
RP Alicino, C (corresponding author), Univ Genoa, Dept Hlth Sci, Genoa, Italy.
EM cristiano.alicino@unige.it
RI Bragazzi, Nicola Luigi/G-1672-2011; PAN, ZEQIANG/X-6341-2018; Brigo,
   Francesco/H-6513-2013
OI Bragazzi, Nicola Luigi/0000-0001-8409-868X; Brigo,
   Francesco/0000-0003-0928-1577
CR Alicino C, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0090-9
   Althouse BM, 2015, EPJ DATA SCI, V4, DOI 10.1140/epjds/s13688-015-0054-0
   [Anonymous], 2016, LANCET, V387, P96, DOI 10.1016/S0140-6736(16)00014-3
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Ayers John W, 2016, JMIR Public Health Surveill, V2, pe16, DOI 10.2196/publichealth.5304
   Ayers JW, 2014, JAMA-J AM MED ASSOC, V311, P1399, DOI 10.1001/jama.2014.1505
   Brown C, 2016, CAN MED ASSOC J, V188, pE34, DOI 10.1503/cmaj.109-5212
   Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Fu KW, 2016, AM J INFECT CONTROL, V44, P1700, DOI 10.1016/j.ajic.2016.04.253
   Hossain L, 2016, EPIDEMIOL INFECT, V144, P2136, DOI 10.1017/S095026881600039X
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Khattab A., 2016, 2016 IEEE Sensors Applications Symposium (SAS), P1, DOI 10.1109/SAS.2016.7479827
   Lazard AJ, 2015, AM J INFECT CONTROL, V43, P1109, DOI 10.1016/j.ajic.2015.05.025
   Majumder Maimuna S, 2016, JMIR Public Health Surveill, V2, pe30, DOI 10.2196/publichealth.5814
   Nuti SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109583
   Olson DR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003256
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Santillana M, 2014, AM J PREV MED, V47, P341, DOI 10.1016/j.amepre.2014.05.020
   Segev E, 2016, PUBLIC UNDERST SCI
   Sharma M, 2016, AM J INFECT CONTROL
   Smallwood C, 2015, COMPLETE GUIDE USING
   Southwell BG, 2016, EMERG INFECT DIS, V22, P1320, DOI 10.3201/eid2207.160415
   Towers S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129179
   Valero N, 2015, INVEST CLIN, V56, P241
   Waddell LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156376
   Wojda TR, 2015, J GLOB INFECT DIS, V7, P127, DOI 10.4103/0974-777X.170495
   Wong R, 2017, J PUBLIC HEALTH MAN, V23, pE16, DOI 10.1097/PHH.0000000000000342
NR 33
TC 14
Z9 14
U1 6
U2 32
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 21
PY 2017
VL 12
IS 9
AR e0185263
DI 10.1371/journal.pone.0185263
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FH7CN
UT WOS:000411339900134
PM 28934352
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Vazquez-Calvo, A
   Blazquez, AB
   Escribano-Romero, E
   Merino-Ramos, T
   Saiz, JC
   Martin-Acebesw, MA
   de Oya, NJ
AF Vazquez-Calvo, Angela
   Blazquez, Ana-Belen
   Escribano-Romero, Estela
   Merino-Ramos, Teresa
   Saiz, Juan-Carlos
   Martin-Acebesw, Miguel A.
   de Oya, Nereida Jimenez
TI Zika virus infection confers protection against West Nile virus
   challenge in mice
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE antibodies; flavivirus; humoral immune response; protection; West Nile
   virus; Zika virus
ID CROSS-REACTIVITY; DENGUE VIRUS; MURINE MODEL; VACCINE; FLAVIVIRUSES;
   PATHOGENESIS; ENHANCEMENT; SPECIFICITY; MOSQUITOS; RESPONSES
AB Flaviviruses are RNA viruses that constitute a worrisome threat to global human and animal health. Zika virus (ZIKV), which was initially reported to cause a mild disease, recently spread in the Americas, infecting millions of people. During this recent epidemic, ZIKV infection has been linked to serious neurological diseases and birth defects, specifically Guillain-Barre syndrome (GBS) and microcephaly. Because information about ZIKV immunity remains scarce, we assessed the humoral response of immunocompetent mice to infection with three viral strains of diverse geographical origin (Africa, Asia and America). No infected animals showed any sign of disease or died after infection. However, specific neutralizing antibodies were elicited in all infected mice. Considering the rapid expansion of ZIKV throughout the American continent and its co-circulation with other medically relevant flaviviruses, such as West Nile virus (WNV), the induction of protective immunity between ZIKV and WNV was analyzed. Remarkably, protection after challenge with WNV was observed in mice previously infected with ZIKV, as survival rates were significantly higher than in control mice. Moreover, previous ZIKV infection enhanced the humoral immune response against WNV. These findings may be relevant in geographical areas where both ZIKV and WNV co-circulate, as well as for the future development of broad-spectrum flavivirus vaccines.
C1 [Vazquez-Calvo, Angela; Blazquez, Ana-Belen; Escribano-Romero, Estela; Merino-Ramos, Teresa; Saiz, Juan-Carlos; Martin-Acebesw, Miguel A.; de Oya, Nereida Jimenez] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotechnol, Madrid 28040, Spain.
RP Martin-Acebesw, MA; de Oya, NJ (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotechnol, Madrid 28040, Spain.
EM martin.mangel@inia.es; jdeoya@inia.es
RI Escribano-Romero, Estela/H-1495-2015; Jimenez de Oya,
   Nereida/K-8470-2016; Martin-Acebes, Miguel A./L-2258-2014; Blazquez,
   Ana/G-9791-2015; de Oya, Nereida Jimenez/T-6449-2019; Vazquez-Calvo,
   Angela/G-8795-2015
OI Escribano-Romero, Estela/0000-0002-5036-7607; Jimenez de Oya,
   Nereida/0000-0003-3129-813X; Martin-Acebes, Miguel
   A./0000-0001-6015-3613; Blazquez, Ana/0000-0002-0847-0977; de Oya,
   Nereida Jimenez/0000-0003-3129-813X; Vazquez-Calvo,
   Angela/0000-0003-3172-2762; Saiz, Juan-Carlos/0000-0001-8269-5544
FU INIAInstituto de Investigacion Agropecuaria (INIA)
   [E_RTA2013-00013-C04-2014, ZIKA-BIO-2016-01]; PLATESA from the Comunidad
   Autonoma de Madrid [P2013/ABI-2906]; Spanish Ministry of Economy and
   Competitiveness (MINECO) [AGL2014-56518-JIN]; 'Contrato de formacion
   postodoctoral' from MINECO; 'Formacion de Personal Investigador (FPI)'
   pre-doctoral fellowship from INIA
FX We are grateful to A Vazquez (National Center for Microbiology, ISCIII)
   for the MR766 ZIKV isolate, to Dr RB Tesh (World Reference Center for
   Emerging Viruses and Arboviruses, WRCEVA) for the FSS13025, PA259459
   ZIKV isolates and ZIKV-specific monoclonal murine ascitic fluid, and to
   Dr R Blasco (Department of Biotechnology, INIA) for the VSV Indiana
   isolate. We also thank M Calvo (Department of Biotechnology, INIA) for
   technical assistance. This work was supported in part by grants
   E_RTA2013-00013-C04-2014 and ZIKA-BIO-2016-01 from INIA, PLATESA
   (P2013/ABI-2906) from the Comunidad Autonoma de Madrid, and
   AGL2014-56518-JIN from the Spanish Ministry of Economy and
   Competitiveness (MINECO). AV-C is a recipient of a 'Contrato de
   formacion postodoctoral' from MINECO. TM-R is a recipient of a
   'Formacion de Personal Investigador (FPI)' pre-doctoral fellowship from
   INIA.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Adams Waldorf K.M., 2016, NAT MED
   Alonso-Padilla J, 2009, EPIDEMIOL INFECT, V137, P1163, DOI 10.1017/S0950268809002325
   Alonso-Padilla J, 2011, VACCINE, V29, P1830, DOI 10.1016/j.vaccine.2010.12.081
   Barba-Spaeth G, 2016, NATURE
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Baronti C, 2013, GENOME ANNOUNC, V2
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Blazquez Ana-Belen, 2016, World J Virol, V5, P135
   Blazquez AB, 2010, VIRUS RES, V151, P240, DOI 10.1016/j.virusres.2010.04.009
   Cervantes DT, 2015, EMERG INFECT DIS, V21, P681, DOI 10.3201/eid2104.141178
   Charles A. S., 2016, PLOS CURR, V8
   Cordoba L, 2007, J GEN VIROL, V88, P476, DOI 10.1099/vir.0.82439-0
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Escribano-Romero E, 2013, VACCINE, V31, P4523, DOI 10.1016/j.vaccine.2013.07.071
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fink K, 2006, EUR J IMMUNOL, V36, P2094, DOI 10.1002/eji.200635993
   Gray TJ, 2014, INT J GEN MED, V7, P193, DOI 10.2147/IJGM.S59902
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hadjichristodoulou C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143803
   Honke N, 2012, NAT IMMUNOL, V13, P51, DOI 10.1038/ni.2169
   Kim E, 2016, EBIOMEDICINE
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Lobigs M, 2012, EXPERT REV VACCINES, V11, P177, DOI [10.1586/erv.11.180, 10.1586/ERV.11.180]
   Martin-Acebes Miguel A, 2012, World J Virol, V1, P51, DOI 10.5501/wjv.v1.i2.51
   Martin-Acebes MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024970
   McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787
   Merino-Ramos T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108056
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, N ENGL J MED
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petrovic T., 2013, EURO SURVEILL, V18
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rossi SL, 2016, CELL STEM CELL, V19, P4, DOI 10.1016/j.stem.2016.06.009
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   SAIZ JC, 2016, FRONT MICROBIOL, V7
   Sapparapu G, 2016, NATURE
   Shirato K, 2004, J GEN VIROL, V85, P3637, DOI 10.1099/vir.0.80247-0
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Vaughan AT, 2011, INT J BIOCHEM CELL B, V43, P280, DOI 10.1016/j.biocel.2010.12.005
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Younger DS, 2016, NEUROL CLIN, V34, P1049, DOI 10.1016/j.ncl.2016.06.008
NR 59
TC 9
Z9 9
U1 1
U2 11
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD SEP 20
PY 2017
VL 6
AR e81
DI 10.1038/emi.2017.68
PG 6
WC Immunology; Microbiology
SC Immunology; Microbiology
GA FI6FS
UT WOS:000412088700001
PM 28928416
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Suter, T
   Crespo, MM
   de Oliveira, MF
   de Oliveira, TSA
   de Melo-Santos, MAV
   de Oliveira, CMF
   Ayres, CFJ
   Barbosa, RMR
   Araujo, AP
   Regis, LN
   Flacio, E
   Engeler, L
   Muller, P
   Silva-Filha, MHNL
AF Suter, Tobias
   Crespo, Monica Maria
   de Oliveira, Mariana Francelino
   de Oliveira, Thaynan Sama Alves
   de Melo-Santos, Maria Alice Varjal
   de Oliveira, Cludia Maria Fontes
   Ayres, Constancia Flavia Junqueira
   Barbosa, Rosangela Maria Rodrigues
   Araujo, Ana Paula
   Regis, Leda Narcisa
   Flacio, Eleonora
   Engeler, Lukas
   Muller, Pie
   Silva-Filha, Maria Helena Neves Lobo
TI Insecticide susceptibility of Aedes albopictus and Ae. aegypti from
   Brazil and the Swiss-Italian border region
SO PARASITES & VECTORS
LA English
DT Article
DE Vector control; Insecticide resistance; Biolarvicides; Insect growth
   regulator
ID THURINGIENSIS SUBSP ISRAELENSIS; BACILLUS-THURINGIENSIS;
   DIPTERA-CULICIDAE; FIELD POPULATIONS; MOSQUITO LARVAE; CULEX-PIPIENS;
   CATCH BASINS; RESISTANCE; SPHAERICUS; TOXINS
AB Background: Aedes aegypti and Ae. albopictus are two highly invasive mosquito species, both vectors of several viruses, including dengue, chikungunya and Zika. While Ae. aegypti is the primary vector in the tropics and sub-tropics, Ae. albopictus is increasingly under the public health watch as it has been implicated in arbovirus-transmission in more temperate regions, including continental Europe. Vector control using insecticides is the pillar of most control programmes; hence development of insecticide resistance is of great concern. As part of a Brazilian-Swiss Joint Research Programme we set out to assess whether there are any signs of existing or incipient insecticide resistance primarily against the larvicide Bacillus thuringiensis svar. israelensis (Bti), but also against currently applied and potentially alternative insecticides in our areas, Recife (Brazil) and the Swiss-Italian border region.
   Methods: Following World Health Organization guidelines, dose-response curves for a range of insecticides were established for both colonized and field caught Ae. aegypti and Ae. albopictus. The larvicides included Bti, two of its toxins, Cry11Aa and Cry4Ba, Lysinibacillus sphaericus, Vectomax CG (R), a formulated combination of Bti and L. sphaericus, and diflubenzuron. In addition to the larvicides, the Swiss-Italian Ae. albopictus populations were also tested against five adulticides (bendiocarb, dichlorodiphenyltrichloroethane, malathion, permethrin and lambda-cyhalothrin).
   Results: Showing a similar dose-response, all mosquito populations were fully susceptible to the larvicides tested and, in particular, to Bti which is currently used both in Brazil and Switzerland. In addition, there were no signs of incipient resistance against Bti as larvae were equally susceptible to the individual toxins, Cry11Aa and Cry4Ba. The field-caught Swiss-Italian populations were susceptible to the adulticides tested but DDT mortality rates showed signs of reduced susceptibility.
   Conclusions: The insecticides currently used for mosquito control in Switzerland and Brazil are still effective against the target populations. The present study provides an important reference as relatively few insecticide susceptibility surveys have been carried out with Ae. albopictus.
C1 [Suter, Tobias; Muller, Pie] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Socinstr 57,POB 4002, CH-4002 Basel, Switzerland.
   [Suter, Tobias; Muller, Pie] Univ Basel, Peterspl 1, CH-4003 Basel, Switzerland.
   [Suter, Tobias] Avia GIS, Risschotlei 33, B-2980 Zoersel, Belgium.
   [Crespo, Monica Maria; de Oliveira, Mariana Francelino; de Oliveira, Thaynan Sama Alves; de Melo-Santos, Maria Alice Varjal; de Oliveira, Cludia Maria Fontes; Ayres, Constancia Flavia Junqueira; Barbosa, Rosangela Maria Rodrigues; Araujo, Ana Paula; Regis, Leda Narcisa; Silva-Filha, Maria Helena Neves Lobo] Fiocruz MS, Inst Aggeu Magalhaes, Dept Entomol, BR-50740465 Recife, PE, Brazil.
   [Flacio, Eleonora; Engeler, Lukas] Univ Appl Sci & Arts Southern Switzerland, Lab Appl Microbiol, Bellinzona, Switzerland.
RP Muller, P (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Socinstr 57,POB 4002, CH-4002 Basel, Switzerland.; Muller, P (corresponding author), Univ Basel, Peterspl 1, CH-4003 Basel, Switzerland.
EM pie.mueller@swisstph.ch
RI Barbosa, Rosangela/AAC-3339-2020; Ayres, Constancia/AAQ-3448-2020;
   Filha, Maria Helena Neves Lobo Silva/AAF-4881-2019; Muller,
   Pie/R-7275-2018
OI Barbosa, Rosangela/0000-0002-1171-598X; Muller, Pie/0000-0003-0181-5781
FU Brazilian-Swiss Joint Research Programme [BJRP 0112-08];
   Guggenheim-Schnurr Stiftung (Basel, Switzerland); Conselho Nacional de
   Pesquisa [CNPq 590,154/2011-7, CNPq 472,491/2012-1]
FX This study received funds from the Brazilian-Swiss Joint Research
   Programme (Grant no. BJRP 0112-08), the Guggenheim-Schnurr Stiftung
   (Basel, Switzerland) and the Conselho Nacional de Pesquisa (CNPq
   590,154/2011-7, CNPq 472,491/2012-1).
CR Anderson JF, 2011, J AM MOSQUITO CONTR, V27, P45, DOI 10.2987/10-6079.1
   Angelini P., 2008, Parassitologia (Rome), V50, P97
   Araujo AP, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-297
   Bartlett-Healy K, 2012, J MED ENTOMOL, V49, P813, DOI 10.1603/ME11031
   Becker N, 1997, PARASITOL TODAY, V13, P485, DOI 10.1016/S0169-4758(97)01154-X
   Becker Norbert, 1998, Israel Journal of Entomology, V32, P63
   Bellinato DF, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8603263
   Berry C, 2002, APPL ENVIRON MICROB, V68, P5082, DOI 10.1128/AEM.68.10.5082-5095.2002
   BERRY C, 1993, J BACTERIOL, V175, P510, DOI 10.1128/JB.175.2.510-518.1993
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boyer S, 2007, ENVIRON TOXICOL CHEM, V26, P157, DOI 10.1897/06-205R.1
   Boyer S, 2012, BIOL CONTROL, V62, P75, DOI 10.1016/j.biocontrol.2012.02.001
   Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P113
   Cadavid-Restrepo G, 2012, MEM I OSWALDO CRUZ, V107, P74, DOI 10.1590/S0074-02762012000100010
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Carvalho RG, 2014, MEM I OSWALDO CRUZ, V109, P787, DOI 10.1590/0074-0276140304
   CRICKMORE N, 1995, FEMS MICROBIOL LETT, V131, P249
   Macoris MDD, 2014, REV SOC BRAS MED TRO, V47, P573, DOI 10.1590/0037-8682-0141-2014
   de Albuquerque CMR, 2000, REV SAUDE PUBL, V34, P314, DOI 10.1590/S0034-89102000000300017
   de Maagd RA, 2001, TRENDS GENET, V17, P193, DOI 10.1016/S0168-9525(01)02237-5
   DELECLUSE A, 1993, APPL ENVIRON MICROB, V59, P3922
   Delisle E, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.17.21108
   Chalegre KDD, 2009, APPL ENVIRON MICROB, V75, P1044, DOI 10.1128/AEM.02032-08
   dos Santos RLC, 2003, REV SAUDE PUBL, V37, P5
   Dritz DA, 2011, J AM MOSQUITO CONTR, V27, P398, DOI 10.2987/11-6161.1
   ECDC, 2017, VBORNET MOSQ MAPS
   Eritja R, 2013, J AM MOSQUITO CONTR, V29, P280, DOI 10.2987/12-6308R.1
   Fares RCG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/321873
   Flacio E, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1577-3
   Flacio E, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0793-6
   Flacio Eleonora, 2004, B SOC TICINESE SCI N, V92, P141
   Fonseca DM, 2013, PEST MANAG SCI, V69, P1351, DOI 10.1002/ps.3511
   Georghiou GP, 1997, APPL ENVIRON MICROB, V63, P1095, DOI 10.1128/AEM.63.3.1095-1101.1997
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   Gomez I, 2007, PEPTIDES, V28, P169, DOI 10.1016/j.peptides.2006.06.013
   Guidi V, 2011, APPL ENVIRON MICROB, V77, P3663, DOI 10.1128/AEM.00132-11
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Ishak IH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0797-2
   Kamgang B, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-79
   Kawada H, 2010, JPN J INFECT DIS, V63, P19
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Lacey LA, 2007, J AM MOSQUITO CONTR, V23, P133, DOI 10.2987/8756-971X(2007)23[133:BTSIAB]2.0.CO;2
   Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5
   Liu H, 2004, J MED ENTOMOL, V41, P946, DOI 10.1603/0022-2585-41.5.946
   Loke SR, 2010, TROP BIOMED, V27, P493
   Macoris MD, 2003, MEM I OSWALDO CRUZ, V98, P703, DOI 10.1590/S0074-02762003000500020
   Marcombe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101992
   Marten GG, 2007, J AM MOSQUITO CONTR, V23, P65, DOI 10.2987/8756-971X(2007)23[65:CC]2.0.CO;2
   Martins AJ, 2008, PEST MANAG SCI, V64, P676, DOI 10.1002/ps.1547
   MAZZARRI MB, 1995, J AM MOSQUITO CONTR, V11, P315
   Moreira Beltrao HDB, 2007, FEMS MICROBIOL LETT, V266, P163, DOI 10.1111/j.1574-6968.2006.00527.x
   Ngoagouni C, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1887-5
   Paris M, 2011, PEST MANAG SCI, V67, P122, DOI 10.1002/ps.2046
   Paul A, 2005, J AM MOSQUITO CONTR, V21, P305, DOI 10.2987/8756-971X(2005)21[305:IRICPF]2.0.CO;2
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Pocquet N, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-299
   R Development Core Team, 2011, R LANG ENV STAT COMP
   Regis L, 2008, MEM I OSWALDO CRUZ, V103, P50, DOI 10.1590/S0074-02762008000100008
   REITER P, 1987, J AM MOSQUITO CONTR, V3, P494
   ROBERTSON JL, 1995, J ECON ENTOMOL, V88, P1, DOI 10.1093/jee/88.1.1
   Scholte Ernst-Jan, 2007, European Mosquito Bulletin, V22, P5
   Secretaria de Vigilancia em Saude, 2009, 0152009CGPNCDDIGESSV
   Secretaria de Vigilancia em Saude, 2014, 1232014GABSVSMS MIN
   Secretaria de Vigilancia em Saude, 2008, RED NAC MONT RES AED
   Secretaria de Vigilancia em Saude Ministerio da Saude, 2016, MON CAS DENG FEBR CH, V52
   Sivan A, 2015, PARASITOL RES, V114, P4693, DOI 10.1007/s00436-015-4717-3
   Somboon Pradya, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P87
   Suter TT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004315
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Tetreau G, 2013, MEM I OSWALDO CRUZ, V108, P894, DOI 10.1590/0074-0276130155
   THIERY I, 1989, APPL MICROBIOL BIOT, V31, P577, DOI 10.1007/BF00270798
   THOMAS WE, 1983, FEBS LETT, V154, P362, DOI 10.1016/0014-5793(83)80183-5
   van den Berg H, 2012, ENVIRON HEALTH PERSP, V120, P577, DOI 10.1289/ehp.1104340
   Vanlerberghe V, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1959
   de Melo-Santos MAV, 2009, BIOL CONTROL, V49, P186, DOI 10.1016/j.biocontrol.2009.01.011
   Vasquez MI, 2009, J MED ENTOMOL, V46, P881, DOI 10.1603/033.046.0421
   WHO, 2006, GUID TEST MOSQ AD IN
   WHO, 2013, TEST PROC INREMO
   WHO Pesticide Evaluation Scheme, 2016, DISCR CONC INS AD MO
   WHO-World Health Organization, 2005, GUID LAB FIELD TEST
   Wickham H., 2016, GGPLOT2 ELEGANT GRAP
   Wirth MC, 2012, J MED ENTOMOL, V49, P886, DOI 10.1603/ME11192
   Wirth MC, 2004, J MED ENTOMOL, V41, P935, DOI 10.1603/0022-2585-41.5.935
   Wirth MC, 2010, OPEN TOXICOL J, V3, P126, DOI DOI 10.2174/1875414701003010126
   WRAIGHT SP, 1987, J INVERTEBR PATHOL, V49, P291, DOI 10.1016/0022-2011(87)90061-9
   Zhang HY, 2004, BIOCONTROL SCI TECHN, V14, P321, DOI 10.1080/09583150310001639187
NR 87
TC 7
Z9 8
U1 0
U2 17
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD SEP 19
PY 2017
VL 10
AR 431
DI 10.1186/s13071-017-2364-5
PG 11
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FH8HM
UT WOS:000411434700005
PM 28927441
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Tien, WP
   Lim, G
   Yeo, G
   Chiang, SN
   Chong, CS
   Ng, LC
   Hapuarachchi, HC
AF Tien, Wei-Ping
   Lim, Gareth
   Yeo, Gladys
   Chiang, Suzanna Nicole
   Chong, Chee-Seng
   Ng, Lee-Ching
   Hapuarachchi, Hapuarachchige Chanditha
TI SYBR green-based one step quantitative real-time polymerase chain
   reaction assay for the detection of Zika virus in field-caught
   mosquitoes
SO PARASITES & VECTORS
LA English
DT Article
DE Zika virus; RT-PCR; Vector; Diagnostics; Surveillance
ID RT-PCR; MICRONESIA; INFECTION; SINGAPORE
AB Background: The monitoring of vectors is one of the key surveillance measures to assess the risk of arbovirus transmission and the success of control strategies in endemic regions. The recent re-emergence of Zika virus (ZIKV) in the tropics, including Singapore, emphasizes the need to develop cost-effective, rapid and accurate assays to monitor the virus spread by mosquitoes. As ZIKV infections largely remain asymptomatic, early detection of ZIKV in the field-caught mosquitoes enables timely implementation of appropriate mosquito control measures.
   Results: We developed a rapid, sensitive and specific real-time reverse transcription polymerase chain reaction (rRT-PCR) assay for the detection of ZIKV in field-caught mosquitoes. The primers and PCR cycling conditions were optimized to minimize non-specific amplification due to cross-reactivity with the genomic material of Aedes aegypti, Aedes albopictus, Culex quinquefasciatus, Culex tritaeniorhynchus, Culex sitiens and Anopheles sinensis, as well as accompanying microbiota. The performance of the assay was further evaluated with a panel of flaviviruses and alphaviruses as well as in field-caught Ae. aegypti mosquitoes confirmed to be positive for ZIKV. As compared to a probe-based assay, the newly developed assay demonstrated 100% specificity and comparable detection sensitivity for ZIKV in mosquitoes.
   Conclusions: Being a SYBR Green-based method, the newly-developed assay is cost-effective and easy to adapt, thus is applicable to large-scale vector surveillance activities in endemic countries, including those with limited resources and expertise. The amplicon size (119 bp) also allows sequencing to confirm the virus type. The primers flank relatively conserved regions of ZIKV genome, so that, the assay is able to detect genetically diverse ZIKV strains. Our findings, therefore, testify the potential use of the newly-developed assay in vector surveillance programmes for ZIKV in endemic regions.
C1 [Tien, Wei-Ping; Lim, Gareth; Yeo, Gladys; Chiang, Suzanna Nicole; Chong, Chee-Seng; Ng, Lee-Ching; Hapuarachchi, Hapuarachchige Chanditha] Natl Environm Agcy, Environm Hlth Inst, 11,Biopolis Way,06-05-08, Singapore 138667, Singapore.
   [Ng, Lee-Ching] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.
RP Hapuarachchi, HC (corresponding author), Natl Environm Agcy, Environm Hlth Inst, 11,Biopolis Way,06-05-08, Singapore 138667, Singapore.
EM chanditha_hapuarachchi@nea.gov.sg
OI Chong, Chee-Seng/0000-0003-2993-1741; Hapuarachchi, Hapuarachchige
   Chanditha/0000-0001-7079-8538
FU National Environmental Agency, Singapore
FX This study was supported by the National Environmental Agency,
   Singapore. The funding sources of this study had no role in the study
   design, data collection, data analysis, data interpretation, writing of
   the report, or in the decision to submit the paper for publication.
CR Cao HP, 2012, J AGR FOOD CHEM, V60, P12296, DOI 10.1021/jf304690e
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   de Castro MG, 2012, MEM I OSWALDO CRUZ, V107, P940, DOI 10.1590/S0074-02762012000700017
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Kek R, 2014, J MED ENTOMOL, V51, P880, DOI 10.1603/ME13213
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee C, 2013, AM J TROP MED HYG, V88, P888, DOI 10.4269/ajtmh.12-0329
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tajadini Mohamadhasan, 2014, Adv Biomed Res, V3, P85, DOI 10.4103/2277-9175.127998
   Tan LK, 2013, ADV INFECT DIS, V3, P1
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Wang X, 2016, J VIROL METHODS, V238, P86, DOI 10.1016/j.jviromet.2016.10.010
   Xu MY, 2016, J VIROL METHODS, V236, P93, DOI 10.1016/j.jviromet.2016.07.014
   Yang CF, 2010, J VIROL METHODS, V168, P147, DOI 10.1016/j.jviromet.2010.05.006
NR 22
TC 5
Z9 5
U1 0
U2 10
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD SEP 19
PY 2017
VL 10
AR 427
DI 10.1186/s13071-017-2373-4
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FH8HM
UT WOS:000411434700001
PM 28927458
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ling, L
   Kokoza, VA
   Zhang, CY
   Aksoy, E
   Raikhel, AS
AF Ling, Lin
   Kokoza, Vladimir A.
   Zhang, Changyu
   Aksoy, Emre
   Raikhel, Alexander S.
TI MicroRNA-277 targets insulin-like peptides 7 and 8 to control lipid
   metabolism and reproduction in Aedes aegypti mosquitoes
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE microRNA; insulin; metabolism; reproduction; mosquito
ID YELLOW-FEVER MOSQUITO; INSULIN-LIKE PEPTIDES; FAT-BODY; LIFE-SPAN; ZIKA
   VIRUS; DROSOPHILA; INSECTS; ELEGANS; ENERGY; VITELLOGENESIS
AB Hematophagous female mosquitoes transmit numerous devastating human diseases, including malaria, dengue fever, Zika virus, and others. Because of their obligatory requirement of a vertebrate blood meal for reproduction, these mosquitoes need a lot of energy; therefore, understanding the molecular mechanisms linking metabolism and reproduction is of particular importance. Lipids are the major energy store providing the fuel required for host seeking and reproduction. They are essential components of the fat body, a metabolic tissue that is the insect analog of vertebrate liver and adipose tissue. In this study, we found that microRNA-277 (miR-277) plays an important role in regulating mosquito lipid metabolism. The genetic disruption of miR-277 using the CRISPR-Cas9 system led to failures in both lipid storage and ovary development. miR-277 mimic injection partially rescued these phenotypic manifestations. Examination of subcellular localization of FOXO protein via CRISPR-assisted, single-stranded oligodeoxynucleotide-mediated homology-directed repair revealed that insulin signaling is upregulated in response to miR-277 depletion. In silico target prediction identified that insulin-like peptides 7 and 8 (ilp7 and ilp8) are putative targets of miR-277; RNA immunoprecipitation and a luciferase reporter assay confirmed that ilp7 and ilp8 are direct targets of this miRNA. CRISPR-Cas9 depletion of ilp7 and ilp8 led to metabolic and reproductive defects. These depletions identified differential actions of ILP7 and ILP8 in lipid homeostasis and ovarian development. Thus, miR-277 plays a critical role in mosquito lipid metabolism and reproduction by targeting ilp7 and ilp8, and serves as a monitor to control ILP7 and ILP8 mRNA levels.
C1 [Ling, Lin; Kokoza, Vladimir A.; Zhang, Changyu; Aksoy, Emre; Raikhel, Alexander S.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.
   [Ling, Lin; Raikhel, Alexander S.] Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA.
   [Aksoy, Emre] Univ Calif Riverside, Grad Program Genet Gen & Bioinformat, Riverside, CA 92521 USA.
RP Raikhel, AS (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.; Raikhel, AS (corresponding author), Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA.
EM alexander.raikhel@ucr.edu
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 AI113729, R01
   AI036959]
FX This work was supported by National Institutes of Health Grants R01
   AI113729 and R01 AI036959 (to A.S.R.).
CR Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356
   Attardo GM, 2005, INSECT BIOCHEM MOLEC, V35, P661, DOI 10.1016/j.ibmb.2005.02.013
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0
   Briegel H, 2002, J INSECT PHYSIOL, V48, P547, DOI 10.1016/S0022-1910(02)00072-0
   Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102
   Bryant B, 2010, P NATL ACAD SCI USA, V107, P22391, DOI 10.1073/pnas.1016230107
   Burks DJ, 2000, NATURE, V407, P377, DOI 10.1038/35030105
   Clifton ME, 2012, J INSECT PHYSIOL, V58, P1007, DOI 10.1016/j.jinsphys.2012.05.005
   DiAngelo JR, 2009, MOL CELL BIOL, V29, P6341, DOI 10.1128/MCB.00675-09
   Flatt T, 2011, EXP GERONTOL, V46, P369, DOI 10.1016/j.exger.2010.10.008
   Fontana R, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020087
   Goudeau J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000599
   Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857
   Gulia-Nuss M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020401
   Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838
   Hansen M, 2013, CELL METAB, V17, P10, DOI 10.1016/j.cmet.2012.12.003
   Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043
   Judd ET, 2011, AGING CELL, V10, P972, DOI 10.1111/j.1474-9726.2011.00737.x
   Kistler KE, 2015, CELL REP, V11, P51, DOI 10.1016/j.celrep.2015.03.009
   Kokoza V, 2010, P NATL ACAD SCI USA, V107, P8111, DOI 10.1073/pnas.1003056107
   LAW JH, 1989, J BIOL CHEM, V264, P16335
   Liu GJ, 2015, MOL BIOL EVOL, V32, P623, DOI 10.1093/molbev/msu323
   Liu SP, 2014, P NATL ACAD SCI USA, V111, P14460, DOI 10.1073/pnas.1416278111
   Lucas KJ, 2015, P NATL ACAD SCI USA, V112, P1440, DOI 10.1073/pnas.1424408112
   McCormick M, 2012, AGING CELL, V11, P192, DOI 10.1111/j.1474-9726.2011.00768.x
   McNeil CJ, 2017, J TROP PEDIATRICS, V63, P242, DOI 10.1093/tropej/fmw080
   Mikuni T, 2016, CELL, V165, P1803, DOI 10.1016/j.cell.2016.04.044
   Mirth CK, 2007, BIOESSAYS, V29, P344, DOI 10.1002/bies.20552
   Moretti F, 2010, RNA, V16, P2493, DOI 10.1261/rna.2384610
   Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194
   Olofsson SO, 2009, BBA-MOL CELL BIOL L, V1791, P448, DOI 10.1016/j.bbalip.2008.08.001
   Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703
   Raikhel AS, 2002, INSECT BIOCHEM MOLEC, V32, P1275, DOI 10.1016/S0965-1748(02)00090-5
   Riehle MA, 2006, PEPTIDES, V27, P2547, DOI 10.1016/j.peptides.2006.07.016
   Roy SG, 2007, INSECT BIOCHEM MOLEC, V37, P1317, DOI 10.1016/j.ibmb.2007.08.004
   Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a
   Shanley DP, 2000, EVOLUTION, V54, P740, DOI 10.1111/j.0014-3820.2000.tb00076.x
   Simmons FH, 1997, J INSECT PHYSIOL, V43, P779, DOI 10.1016/S0022-1910(97)00037-1
   SOCHA R, 1991, J INSECT PHYSIOL, V37, P805, DOI 10.1016/0022-1910(91)90077-D
   STRONG L, 1967, J INSECT PHYSIOL, V13, P495, DOI 10.1016/0022-1910(67)90061-3
   THOMSEN E, 1955, J EXP BIOL, V32, P692
   Tsetsarkin KA, 2016, CURR OPIN VIROL, V16, P143, DOI 10.1016/j.coviro.2016.02.007
   VANHANDEL E, 1993, J INSECT PHYSIOL, V39, P831, DOI 10.1016/0022-1910(93)90115-8
   Wang MC, 2008, SCIENCE, V322, P957, DOI 10.1126/science.1162011
   Wang XL, 2017, P NATL ACAD SCI USA, V114, pE2709, DOI 10.1073/pnas.1619326114
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wu Q, 2006, ANNU REV ENTOMOL, V51, P1, DOI 10.1146/annurev.ento.51.110104.151011
   Xu WL, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S7-S4
   Zhang XF, 2017, P NATL ACAD SCI USA, V114, pE1895, DOI 10.1073/pnas.1701474114
   Zhang Y, 2016, P NATL ACAD SCI USA, V113, pE4828, DOI 10.1073/pnas.1609792113
   Zhou GL, 2004, INSECT BIOCHEM MOLEC, V34, P919, DOI 10.1016/j.ibmb.2004.05.009
   Ziegler R, 2001, J INSECT PHYSIOL, V47, P623, DOI 10.1016/S0022-1910(00)00158-X
NR 53
TC 30
Z9 32
U1 6
U2 53
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD SEP 19
PY 2017
VL 114
IS 38
BP E8017
EP E8024
DI 10.1073/pnas.1710970114
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FH4UH
UT WOS:000411157100021
PM 28874536
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Aris-Brosou, S
   Ibeh, N
   Noel, J
AF Aris-Brosou, Stephane
   Ibeh, Neke
   Noel, Jessica
TI Viral outbreaks involve destabilized evolutionary networks: evidence
   from Ebola, Influenza and Zika
SO SCIENTIFIC REPORTS
LA English
DT Article
ID VIRUS; TRANSMISSION; ALIGNMENT; HYPOTHESIS; DYNAMICS; SPREAD; ORIGIN
AB Recent history has provided us with one pandemic (Influenza A/H1N1) and two severe viral outbreaks (Ebola and Zika). In all three cases, post-hoc analyses have given us deep insights into what triggered these outbreaks, their timing, evolutionary dynamics, and phylogeography, but the genomic characteristics of outbreak viruses are still unclear. To address this outstanding question, we searched for a common denominator between these recent outbreaks, positing that the genome of outbreak viruses is in an unstable evolutionary state, while that of non-outbreak viruses is stabilized by a network of correlated substitutions. Here, we show that during regular epidemics, viral genomes are indeed stabilized by a dense network of weakly correlated sites, and that these networks disappear during pandemics and outbreaks when rates of evolution increase transiently. Post-pandemic, these evolutionary networks are progressively re-established. We finally show that destabilization is not caused by substitutions targeting epitopes, but more likely by changes in the environment sensu lato. Our results prompt for a new interpretation of pandemics as being associated with evolutionary destabilized viruses.
C1 [Aris-Brosou, Stephane; Ibeh, Neke; Noel, Jessica] Univ Ottawa, Dept Biol, Ottawa, ON K1N 6N5, Canada.
   [Aris-Brosou, Stephane] Univ Ottawa, Dept Math & Stat, Ottawa, ON K1N 6N5, Canada.
RP Aris-Brosou, S (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON K1N 6N5, Canada.; Aris-Brosou, S (corresponding author), Univ Ottawa, Dept Math & Stat, Ottawa, ON K1N 6N5, Canada.
EM sarisbro@uottawa.ca
OI Aris-Brosou, Stephane/0000-0003-4987-0296
FU Natural Sciences Research Council of CanadaNatural Sciences and
   Engineering Research Council of Canada; Canada Foundation for
   InnovationCanada Foundation for Innovation; University of Ottawa
FX We thank Jonathan Dench and George S. Long for discussions and comments,
   as well as two anonymous reviewers for additional comments. We also
   thank Compute Ontario and the Center for Advanced Computing for
   providing us access to their servers. This work was supported by the
   Natural Sciences Research Council of Canada and by the Canada Foundation
   for Innovation (S.A.B.) and by the University of Ottawa (N.I., J.N.).
CR Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Aris-Brosou S, 2014, EVOL APPL, V7, P403, DOI 10.1111/eva.12138
   Aris-Brosou S, 2012, METHODS MOL BIOL, V855, P111, DOI 10.1007/978-1-61779-582-4_4
   Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07
   Csardi G., 2014, INT J COMPLEX SYST, DOI [10.3724/SP.J.1087.2009.02191., DOI 10.3724/SP.J.1087.2009.02191]
   Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gao JX, 2016, NATURE, V530, P307, DOI 10.1038/nature16948
   Gilbert D, 2003, CURR PROTOC BIOINFOR
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Gong LI, 2013, ELIFE, V2, DOI 10.7554/eLife.00631
   Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727
   Gu Z, 2014, BIOINFORMATICS
   Ibeh N, 2016, J VIROL, V90, P5475, DOI 10.1128/JVI.00322-16
   Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138
   Labonte K, 2016, GENOME, V59, P253, DOI 10.1139/gen-2015-0163
   Larsen MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-424
   Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531
   Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133
   Nshogozabahizi JC, 2017, GENETICS, V205, P409, DOI 10.1534/genetics.116.193979
   Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412
   Pearl J., 1988, PROBABILISTIC REASON
   Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Poon AFY, 2007, PLOS COMPUT BIOL, V3, P2279, DOI 10.1371/journal.pcbi.0030231
   Poon AFY, 2008, BIOINFORMATICS, V24, P1949, DOI 10.1093/bioinformatics/btn313
   Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490
   Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182
   Tyler AL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005805
   Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0
   Xia YC, 2004, AM NAT, V164, P267, DOI 10.1086/422341
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zipf GK, 1946, AM SOCIOL REV, V11, P677, DOI 10.2307/2087063
NR 38
TC 2
Z9 2
U1 1
U2 14
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD SEP 19
PY 2017
VL 7
AR 11881
DI 10.1038/s41598-017-12268-9
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FH4XG
UT WOS:000411165100058
PM 28928377
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Elsinga, J
   van der Veen, HT
   Gerstenbluth, I
   Burgerhof, JGM
   Dijkstra, A
   Grobusch, MP
   Tami, A
   Bailey, A
AF Elsinga, Jelte
   van der Veen, Henry T.
   Gerstenbluth, Izzy
   Burgerhof, Johannes G. M.
   Dijkstra, Arie
   Grobusch, Martin P.
   Tami, Adriana
   Bailey, Ajay
TI Community participation in mosquito breeding site control: an
   interdisciplinary mixed methods study in Curacao
SO PARASITES & VECTORS
LA English
DT Article
DE Mosquito breeding site control; Community mobilization; Curacao;
   Chikungunya; Dengue; Mixed methods; Theory of planned behaviour; Health
   belief model; Integrated vector control; Aedes aegypti
ID ZIKA VIRUS; AEDES-AEGYPTI; CHIKUNGUNYA VIRUS; DENGUE; INTERVENTIONS;
   IMPLEMENTATION; DETERMINANTS; TRANSMISSION; ARTHRALGIA; BURDEN
AB Background: As the arboviral diseases dengue, chikungunya and Zika emerge in the Americas, so does the need for sustainable vector control policies. To successfully achieve mosquito control, joint efforts of both communities and governments are essential. This study investigates this important, but by-and-large neglected topic.
   Methods: In June and July 2015, a cross-sectional mixed methods study applying a survey questionnaire (response rate of 82.5%; n = 339), in-depth interviews (n = 20) and focus group discussions (n = 7; 50 participants) was performed in Curacao. The study was designed based on an integrated theoretical framework of the Health Belief Model and the Theory of Planned Behaviour.
   Results: Participants showed a good knowledge of, and a high-level performance of mosquito breeding site control (MBSC) practices. Personal protection against mosquitoes (e.g. topical repellents) was perceived as relatively less effective thus practiced to lower extent compared to MBSC practices (i.e. larval source management). A lower intention to perform MBSC was independently associated with: (i) satisfaction on governmental MBSC (P = 0.012); (ii) barriers to perform MBSC practices, i.e. Government doesn't control other breeding sites' (P = 0.005), 'Don't know how to control breeding sites' (P = 0.041), and 'a mosquito does not transmit dengue' (P = 0.016), (iii) attitudes towards MBSC (P = 0.001) and self-efficacy (person's perceived ability to act) to perform MBSC (P = 0.002). Mixed-methods evidence highlights three possible ways of improving community participation in MBSC. First, it highlights the need for ongoing media coverage, targeting (i) communities' perceptions on transmission routes of dengue and chikungunya, and (ii) presence of car tires in yards. Secondly, it shows that promotion of governmental activities in MBSC can enhance MBSC of communities, if people develop a sense of responsibility to perform MBSC at their own properties. Thirdly, this study describes the presence of key persons in communities, who could be engaged in mosquito control policies to improve MBSC in neighbourhoods.
   Conclusion: This study reveals gaps between policy and communities' lived realities. These gaps might be overcome with the proposed interventions, resulting in a higher performance of MBSC in the community in Curacao. Furthermore, this study shows how interdisciplinary mixed methods research can provide important, comprehensive, and in-depth insights to inform mosquito control policies.
C1 [Elsinga, Jelte; Tami, Adriana] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands.
   [van der Veen, Henry T.] Univ Groningen, Fac Spatial Sci, Groningen, Netherlands.
   [Gerstenbluth, Izzy] Curacao Biomed & Hlth Res Inst, Willemstad, Netherlands.
   [Gerstenbluth, Izzy] Med & Publ Hlth Serv Curacao, Epidemiol & Res Unit, Willemstad, Netherlands.
   [Burgerhof, Johannes G. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.
   [Dijkstra, Arie] Univ Groningen, Dept Social Psychol, Groningen, Netherlands.
   [Grobusch, Martin P.] Univ Amsterdam, Acad Med Ctr, Ctr Trop Med & Travel Med, Dept Infect Dis, Amsterdam, Netherlands.
   [Bailey, Ajay] Univ Groningen, Fac Spatial Sci, Populat Res Ctr, Groningen, Netherlands.
   [Bailey, Ajay] Manipal Univ, Dr TMA Pai Endowed Chair Qualitat Methods, Manipal, Karnataka, India.
RP Elsinga, J (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands.
EM j.elsinga@rug.nl
OI Elsinga, Jelte/0000-0003-2733-4820; Tami, Adriana/0000-0002-1918-9144
FU Junior Scientific Masterclass, University Medical Center Groningen
FX This work was supported by an MD PhD Scholarship for J. Elsinga from the
   Junior Scientific Masterclass, University Medical Center Groningen.
CR Abimbola S, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2015-900001
   Abraham C., 2005, PREDICTING HLTH BEHA, P28
   Ajzen I., 2002, CONSTRUCTING TPB QUE
   Atkinson JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-225
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Borgherini G, 2008, CLIN INFECT DIS, V47, P469, DOI 10.1086/590003
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Brewer NT, 2008, HLTH BEHAV HLTH ED T, P149
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Centraal Bureau voor de Statistiek, CAR NED
   Central Bureau of Statistics Curacao, 2014, CLIMATE
   Centre of Disease Control, DENG AED ALB MOSQ
   CHAMPION VL, 2008, HLTH BEHAV HLTH ED T, V4, P45
   Elsinga J, 2017, J INFECT DIS, V216, P573, DOI 10.1093/infdis/jix312
   Garelli FM, 2013, ACTA TROP, V128, P461, DOI 10.1016/j.actatropica.2013.07.019
   Gerend MA, 2012, ANN BEHAV MED, V44, P171, DOI 10.1007/s12160-012-9366-5
   Glanz K, 2010, ANNU REV PUBL HEALTH, V31, P399, DOI 10.1146/annurev.publhealth.012809.103604
   Gubler DJ, 1996, ACTA TROP, V61, P169, DOI 10.1016/0001-706X(95)00103-L
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Hennink M., 2010, QUALITATIVE RES METH
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   LaCon G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003038
   Larrieu S, 2010, J CLIN VIROL, V47, P85, DOI 10.1016/j.jcv.2009.11.014
   Lima-Serrano M, 2014, GAC SANIT, V28, P411, DOI 10.1016/j.gaceta.2014.05.003
   Limper M, 2016, ZOONOSES PUBLIC HLTH, V63, P129, DOI 10.1111/zph.12213
   Limper M, 2012, W INDIAN MED J, V61, P76
   Marina CF, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-95
   Meteorological Department Curacao, SUMM CLIM DAT PER 19
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Montaiio D.E., 2008, HLTH BEHAV HLTH ED T, P67, DOI DOI 10.1016/S0033-3506(49)81524-1
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nam VS, 1998, AM J TROP MED HYG, V59, P657, DOI 10.4269/ajtmh.1998.59.657
   PAHO: Pan American Health Organization, 2016, CHIK
   Rasanathan K, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0493-7
   Ridde V, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000115
   Rodriguez MM, 2007, J AM MOSQUITO CONTR, V23, P420, DOI 10.2987/5588.1
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Sanchez L, 2009, TROP MED INT HEALTH, V14, P1356, DOI 10.1111/j.1365-3156.2009.02379.x
   Sangoro O, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-347
   Sharp TM, 2016, CLIN INFECT DIS, V63, P1198, DOI 10.1093/cid/ciw476
   Sissoko D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000389
   Ter Bals M., 2011, DEMOGRAPHY CURACAO
   WHO, 2016, RISK COMM CONT ZIK V
   Wilson AL, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-446
   World Health Organization, DENG CONTR
   World Health Organization, 2012, COMM BEH IMP COMBI T
   World Health Organization (WHO), 2016, DENG SEV DENG
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Yee DA, 2008, J MED ENTOMOL, V45, P581, DOI 10.1603/0022-2585(2008)45[581:TAHFMA]2.0.CO;2
NR 49
TC 7
Z9 7
U1 1
U2 15
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD SEP 19
PY 2017
VL 10
AR 434
DI 10.1186/s13071-017-2371-6
PG 14
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FH8HM
UT WOS:000411434700008
PM 28927437
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Polonio, CM
   de Freitas, CL
   Zanluqui, NG
   Peron, JPS
AF Polonio, Carolina Manganeli
   de Freitas, Carla Longo
   Zanluqui, Nagela Ghabdan
   Peron, Jean Pierre Schatzmann
TI Zika virus congenital syndrome: experimental models and clinical aspects
SO JOURNAL OF VENOMOUS ANIMALS AND TOXINS INCLUDING TROPICAL DISEASES
LA English
DT Review
DE Zika virus; Congenital infection; Arthrogryposis; Ocular abnormality;
   Experimental models
ID ARTHROGRYPOSIS MULTIPLEX-CONGENITA; AEDES-AEGYPTI MOSQUITOS; DISTAL
   ARTHROGRYPOSIS; DIAGNOSTIC-APPROACH; INFECTION; BRAZIL; INFANTS;
   ETIOLOGY; CLASSIFICATION; ASSOCIATION
AB Viral infections have long been the cause of severe diseases to humans, increasing morbidity and mortality rates worldwide, either in rich or poor countries. Yellow fever virus, H1N1 virus, HIV, dengue virus, hepatitis B and C are well known threats to human health, being responsible for many million deaths annually, associated to a huge economic and social cost. In this context, a recently introduced flavivirus in South America, called Zika virus (ZIKV), led the WHO to declare in February 1st 2016 a warning on Public Health Emergency of International Concern (PHEIC). ZIKV is an arbovirus of the Flaviviridae family firstly isolated from sentinels Rhesus sp. monkeys at the Ziika forest in Uganda, Africa, in 1947. Lately, the virus has well adapted to the worldwide spread Aedes aegypti mosquito, the vector for DENV, CHIKV, YFV and many others. At first, it was not considered a threat to human health, but everything changed when a skyrocketing number of babies born with microcephaly and adults with Guillain-Barre syndrome were reported, mainly in northeastern Brazil. It is now well established that the virus is responsible for the so called congenital Zika syndrome (CZS), whose most dramatic features are microcephaly, arthrogryposis and ocular damage. Thus, in this review, we provide a brief discussion of these main clinical aspects of the CZS, correlating them with the experimental animal models described so far.
C1 [Polonio, Carolina Manganeli; de Freitas, Carla Longo; Zanluqui, Nagela Ghabdan; Peron, Jean Pierre Schatzmann] Univ Sao Paulo, Neuroimmune Interact Lab, Dept Immunol, ICB 4, Ave Prof Lineu Prestes,1730,Cidade Univ, BR-05508900 Sao Paulo, SP, Brazil.
RP Peron, JPS (corresponding author), Univ Sao Paulo, Neuroimmune Interact Lab, Dept Immunol, ICB 4, Ave Prof Lineu Prestes,1730,Cidade Univ, BR-05508900 Sao Paulo, SP, Brazil.
EM jeanpierre@usp.br
RI Peron, Jean Pierre S/F-9248-2012
OI Peron, Jean Pierre/0000-0003-1638-8866
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2011/18703-2]
FX This work was supported by FAPESP process no. 2011/18703-2.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   Bamshad M, 2009, J BONE JOINT SURG AM, V91A, P40, DOI 10.2106/JBJS.I.00281
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Brasil. Ministerio da Saude, 15 COES MIN SAUD
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Oliveira Dias Joao Rafael, 2018, Retin Cases Brief Rep, V12, P382, DOI 10.1097/ICB.0000000000000518
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   de Paula FB, 2016, JAMA OPHTHALMOL, DOI [10.1001/jamaophthalmol.2016.0267, DOI 10.1001/JAMAOPHTHALMOL.2016.0267]
   de Souza AS, 2016, CLIN INFECT DIS, V63, P1622, DOI 10.1093/cid/ciw613
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Donadeu M, 2009, WKLY EPIDEMIOL REC, V3, P445, DOI DOI 10.1016/J.ACTATROPICA.2012.04.013
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Falcao MB, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0172-y
   FEDRIZZI E, 1993, PEDIATR NEUROL, V9, P343, DOI 10.1016/0887-8994(93)90102-I
   Fontes BM, 2016, ARQ BRAS OFTALMOL, V79, P63, DOI 10.5935/0004-2749.20160020
   FRASER SH, 1994, J PAEDIATR CHILD H, V30, P450, DOI 10.1111/j.1440-1754.1994.tb00701.x
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Gurnett CA, 2010, HUM MOL GENET, V19, P1165, DOI 10.1093/hmg/ddp587
   Hall JG, 1997, J PEDIATR ORTHOP B, V6, P159, DOI 10.1097/01202412-199707000-00002
   Hall JG, 2014, EUR J MED GENET, V57, P464, DOI 10.1016/j.ejmg.2014.03.008
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Kalampokas Emmanouil, 2012, ISRN Obstet Gynecol, V2012, P264918, DOI 10.5402/2012/264918
   Kaur Savleen, 2013, Oman J Ophthalmol, V6, P77, DOI 10.4103/0974-620X.116622
   Kimber E, 2006, NEUROLOGY, V67, P597, DOI 10.1212/01.wnl.0000230168.05328.f4
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P300, DOI 10.1016/0035-9203(77)90104-3
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P254, DOI 10.1016/0035-9203(77)90020-7
   Kowalczyk B, 2016, ARCH MED SCI, V12, P10, DOI 10.5114/aoms.2016.57578
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   McCarthy M, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3416
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Perez S, 2016, EUROSURVEILLANCE, V21, P1, DOI 10.2807/1560-7917.ES.2016.21.24.30261
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tajsharghi H, 2008, ARCH NEUROL-CHICAGO, V65, P1083, DOI 10.1001/archneur.65.8.1083
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Ventura CV, 2016, OSLI RETINA, V47, P952, DOI 10.3928/23258160-20161004-09
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vizjak A, ARCH PATHOL LAB MED
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   World Health Organization, 2016, WHOZIKVMOC161
NR 67
TC 7
Z9 7
U1 0
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1678-9199
J9 J VENOM ANIM TOXINS
JI J. Venom. Anim. Toxins Trop. Dis.
PD SEP 15
PY 2017
VL 23
AR 41
DI 10.1186/s40409-017-0131-x
PG 9
WC Toxicology; Tropical Medicine; Zoology
SC Toxicology; Tropical Medicine; Zoology
GA FI7RK
UT WOS:000412195200001
PM 28932235
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Moni, MA
   Lio, P
AF Moni, Mohammad Ali
   Lio, Pietro
TI Genetic Profiling and Comorbidities of Zika Infection
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika Infection; Diseasome; Comorbidities; Co-infections; Genetic
   profiling
ID VIRUS
AB Background. The difficulty in distinguishing infection by Zika virus (ZIKV) from other flaviviruses is a global health concern, particularly given the high risk of neurologic complications (including Guillain-Barre syndrome [GBS]) with ZIKV infection.
   Methods. We developed quantitative frameworks to compare and explore infectome, diseasome, and comorbidity of ZIKV infections. We analyzed gene expression microarray and RNA-Seq data from ZIKV, West Nile fever (WNF), chikungunya, dengue, yellow fever, Japanese encephalitis virus, GBS, and control datasets. Using neighborhood-based benchmarking and multilayer network topology, we constructed relationship networks based on the Online Mendelian Inheritance in Man database and our identified significant genes.
   Results. ZIKV infections showed dysregulation in expression of 929 genes. Forty-seven genes were highly expressed in both ZIKV and dengue infections. However, ZIKV shared <15 significant transcripts with other flavivirus infections. Notably, dysregulation of MAFB and SELENBP1 was common to ZIKV, dengue, and GBS infection; ATF5, TNFAIP3, and BAMB1 were common to ZIKV, dengue, and WNF; and NAMPT and PMAlP1 were common to ZIKV, GBS, and WNF. Phylogenetic, ontologic, and pathway analyses showed that ZIKV infection most resembles dengue fever.
   Conclusions. We have developed methodologies to investigate disease mechanisms and predictions for infectome, diseasome, and comorbidities quantitatively, and identified particular similarities between ZIKV and dengue infections.
C1 [Moni, Mohammad Ali] Univ New South Wales, Garvan Inst Med Res, Sydney, NSW 2010, Australia.
   [Lio, Pietro] Univ Cambridge, Comp Lab, Cambridge, England.
RP Moni, MA (corresponding author), Univ New South Wales, Garvan Inst Med Res, Sydney, NSW 2010, Australia.
EM m.moni@garvan.org.au
OI Lio, Pietro/0000-0002-0540-5053
FU European UnionEuropean Union (EU) [FP7-Health-F5-2012, 305280]
FX This work was supported by the European Union Mimomics grant
   FP7-Health-F5-2012 under grant agreement number 305280.
CR Amberger J, 2011, HUM MUTAT, V32, P564, DOI 10.1002/humu.21466
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chang KH, 2012, PLOS ONE, V7, P80, DOI 10.1371/journal.pone.0029506
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292
   Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092
   Karlas A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11320
   Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017
   Kwissa M, 2014, CELL HOST MICROBE, V16, P115, DOI 10.1016/j.chom.2014.06.001
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Moni M, 2016, INT J INFECT DIS, V53, P14, DOI 10.1016/j.ijid.2016.11.040
   Moni M. A., 2014, J CLIN BIOINFORMATIC, V4, P1
   Moni Mohammad Ali, 2015, Front Cell Dev Biol, V3, P28, DOI 10.3389/fcell.2015.00028
   Moni MA, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-333
   Narayanan R., 2016, MOJ PROTEOMICS BIOIN, V3
   Navratil V, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-13
   Qian F, 2015, CLIN VACCINE IMMUNOL, V22, P6, DOI 10.1128/CVI.00508-14
   Rolfe AJ, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0110-x
   Segura-Cabrera A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071526
   Smith SA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-37
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tilak Rina, 2016, Med J Armed Forces India, V72, P157, DOI 10.1016/j.mjafi.2016.02.017
   Yacoub S, 2014, NAT REV CARDIOL, V11, P335, DOI 10.1038/nrcardio.2014.40
NR 28
TC 10
Z9 10
U1 0
U2 8
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD SEP 15
PY 2017
VL 216
IS 6
BP 703
EP 712
DI 10.1093/infdis/jix327
PG 10
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FH0CB
UT WOS:000410805700011
PM 28934431
OA Bronze
DA 2020-07-08
ER

PT J
AU Halai, UA
   Nielsen-Saines, K
   Moreira, ML
   de Sequeira, PC
   Pereira, JP
   Zin, AA
   Cherry, J
   Gabaglia, CR
   Gaw, SL
   Adachi, K
   Tsui, I
   Pilotto, JH
   Nogueira, RR
   de Filippis, AMB
   Brasil, P
AF Halai, Umme-Aiman
   Nielsen-Saines, Karin
   Moreira, Maria Lopes
   de Sequeira, Patricia Carvalho
   Pereira, Jose Paulo Junior
   Zin, Andrea de Araujo
   Cherry, James
   Gabaglia, Claudia Raja
   Gaw, Stephanie L.
   Adachi, Kristina
   Tsui, Irena
   Pilotto, Jose Henrique
   Nogueira, Rita Ribeiro
   de Filippis, Ana Maria Bispo
   Brasil, Patricia
TI Maternal Zika Virus Disease Severity, Virus Load, Prior Dengue
   Antibodies, and Their Relationship to Birth Outcomes
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE Zika; dengue; ZIKV; pregnancy; congenital
ID JANUARY 2016; INFECTION; PREGNANCY; RNA; SALIVA; URINE; WOMEN;
   TRANSMISSION; MICRONESIA; EPIDEMIC
AB Background. Congenital Zika virus (ZIKV) syndrome is a newly identified condition resulting from infection during pregnancy. We analyzed outcome data from a mother-infant cohort in Rio de Janeiro in order to assess whether clinical severity of maternal ZIKV infection was associated with maternal virus load, prior dengue antibodies, or abnormal pregnancy/ infant outcomes.
   Methods. A clinical severity assessment tool was developed based on duration of fever, severity of rash, multisystem involvement, and duration of symptoms during ZIKV infection. ZIKV-RNA load was quantified by polymerase chain reaction (PCR) cycles in blood/ urine. Dengue immunoglobulin G (IgG) antibodies were measured at baseline. Adverse outcomes were defined as fetal loss or a live infant with grossly abnormal clinical or brain imaging findings. Regression models were used to study potential associations.
   Results. 131 ZIKV-PCR positive pregnant women were scored for clinical disease severity, 6 (4.6%) had mild disease, 98 (74.8%) had moderate disease, and 27 (20.6%) severe manifestations of ZIKV infection. There were 58 (46.4%) abnormal outcomes with 9 fetal losses (7.2%) in 125 pregnancies. No associations were found between: disease severity and abnormal outcomes (P =.961; odds ratio [OR]: 1.00; 95% confidence interval [CI]: 0.796-1.270); disease severity and viral load (P =.994); viral load and adverse outcomes (P =.667; OR: 1.02; 95% CI: 0.922-1.135); or existence of prior dengue antibodies (88% subjects) with severity score, ZIKVRNA load or adverse outcomes (P =.667; OR: 0.78; 95% CI: 0.255-2.397).
   Conclusions. Congenital ZIKV syndrome does not appear to be associated with maternal disease severity, ZIKV-RNA load at time of infection or existence of prior dengue antibodies.
C1 [Halai, Umme-Aiman; Nielsen-Saines, Karin; Cherry, James; Adachi, Kristina; Tsui, Irena; de Filippis, Ana Maria Bispo] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.
   [Moreira, Maria Lopes; de Sequeira, Patricia Carvalho; Pereira, Jose Paulo Junior; Zin, Andrea de Araujo; Pilotto, Jose Henrique; Nogueira, Rita Ribeiro; Brasil, Patricia] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Gabaglia, Claudia Raja] Biomed Res Inst Southern Calif, Oceanside, CA USA.
   [Gaw, Stephanie L.] Univ Calif San Francisco, Sch Med, San Francisco, CA USA.
RP Halai, UA (corresponding author), David Geffen UCLA Sch Med, Dept Med, CHS 37-121,LeConte Ave, Los Angeles, CA 90049 USA.
EM aiman.shabbir@gmail.com
RI amsalu, ribka/G-8780-2019; Pilotto, Jose Henrique/AAD-9773-2019; Gaw,
   Stephanie/K-4592-2019
OI Pilotto, Jose Henrique/0000-0003-0521-8597; Gaw,
   Stephanie/0000-0003-0891-6964
FU Departamento de Ciencia e Tecnologia (DECIT) do Ministerio da Saude do
   Brasil; Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES
   [CAPES/ 88887.116627/2016-01]; National Institute of Allergy and
   Infectious Diseases (NIAID) of the National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [AI28697, 1R21AI129534-01]; Thrasher Research Fund
   [20164370]
FX This work was supported by the Departamento de Ciencia e Tecnologia
   (DECIT) do Ministerio da Saude do Brasil and grants from Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES/
   88887.116627/2016-01); the National Institute of Allergy and Infectious
   Diseases (NIAID) of the National Institutes of Health (AI28697 and
   1R21AI129534-01) and the Thrasher Research Fund (20164370).
CR ANDERSON MJ, 1985, J INFECT DIS, V152, P257, DOI 10.1093/infdis/152.2.257
   BARZON L, 2016, EUROSURVEILLANCE, V21, P2
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   BURK RD, 1994, J INFECT DIS, V170, P1418, DOI 10.1093/infdis/170.6.1418
   Burns DN, 1999, J REPROD IMMUNOL, V42, P147, DOI 10.1016/S0165-0378(98)00085-0
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Challis JR, 2009, REPROD SCI, V16, P206, DOI 10.1177/1933719108329095
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   de Souza AS, 2016, CLIN INFECT DIS, V63, P1622, DOI 10.1093/cid/ciw613
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Denney JM, 2011, CYTOKINE, V53, P170, DOI 10.1016/j.cyto.2010.11.005
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Mofenson LM, 1999, NEW ENGL J MED, V341, P385, DOI 10.1056/NEJM199908053410601
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   OHTO H, 1994, NEW ENGL J MED, V330, P744, DOI 10.1056/NEJM199403173301103
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roberts DJ, 2016, LANCET, V388, P847, DOI 10.1016/S0140-6736(16)30930-8
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Stone M, 2017, TRANSFUSION, V57, P734, DOI 10.1111/trf.14031
   Ticconi C, 2016, PATHOG GLOB HEALTH, V110, P262, DOI 10.1080/20477724.2016.1234804
NR 29
TC 44
Z9 44
U1 0
U2 47
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD SEP 15
PY 2017
VL 65
IS 6
BP 877
EP 883
DI 10.1093/cid/cix472
PG 7
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FF2BY
UT WOS:000408704100001
PM 28535184
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Marini, G
   Guzzetta, G
   Rosa, R
   Merler, S
AF Marini, G.
   Guzzetta, G.
   Rosa, R.
   Merler, S.
TI First outbreak of Zika virus in the continental United States: a
   modelling analysis
SO EUROSURVEILLANCE
LA English
DT Article
ID AEDES-AEGYPTI DIPTERA; MOSQUITO; TRANSMISSION; DISPERSAL; EPIDEMIC;
   SPREAD; DENGUE
AB Since 2015, Zika virus (ZIKV) has spread throughout Latin and Central America. This emerging infectious disease has been causing considerable public health concern because of severe neurological complications, especially in newborns after congenital infections. In July 2016, the first outbreak in the continental United States was identified in the Wynwood neighbourhood of Miami-Dade County, Florida. In this work, we investigated transmission dynamics using a mathematical model calibrated to observed data on mosquito abundance and symptomatic human infections. We found that, although ZIKV transmission was detected in July 2016, the first importation may have occurred between March and mid-April. The estimated highest value for R-o was 2.73 (95% confidence interval (CI): 1.65-4.17); the attack rate was 14% (95% CI: 5.6-27.4%), with 15 (95% CI: 6-29) pregnant women involved and a 12% probability of infected blood donations. Vector control avoided 60% of potential infections. According to our results, it is likely that further ZIKV outbreaks identified in other areas of Miami-Dade County were seeded by commuters to Wynwood rather than by additional importation from international travellers. Our study can help prepare future outbreak-related interventions in European areas where competent mosquitoes for ZIKV transmission are already established.
C1 [Marini, G.; Rosa, R.] Fdn Edmund Mach, Res & Innovat Ctr, Dept Biodivers & Mol Ecol, San Michele All Adige, Trento, Italy.
   [Guzzetta, G.; Merler, S.] Fdn Bruno Kessler, Trento, Italy.
RP Merler, S (corresponding author), Fdn Bruno Kessler, Trento, Italy.
EM merler@fbk.eu
RI amsalu, ribka/G-8780-2019; Rosa, Roberto/B-8562-2011; merler,
   stefano/I-3557-2017; Marini, Giovanni/C-3808-2018
OI Rosa, Roberto/0000-0002-8655-2230; merler, stefano/0000-0002-5117-0611;
   Marini, Giovanni/0000-0001-9721-7211; Guzzetta,
   Giorgio/0000-0002-9296-9470
FU European Union's Horizon Research and Innovation Programme under
   ZIKAlliance Grant [734548]
FX This work was supported by the European Union's Horizon 2020 Research
   and Innovation Programme under ZIKAlliance Grant Agreement no. 734548.
CR [Anonymous], 2017, COUNT COUNT COMM US
   Baldacchino F, 2017, PEST MANAG SCI, V73, P87, DOI 10.1002/ps.4417
   Bergero PE, 2013, J VECTOR DIS, V50, P163
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   David MR, 2009, MEM I OSWALDO CRUZ, V104, P927, DOI 10.1590/S0074-02762009000600019
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   FOCKS DA, 1993, J MED ENTOMOL, V30, P1018, DOI 10.1093/jmedent/30.6.1018
   Goindin D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135489
   Guzzetta G, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.15.30199
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437
   Keeling M. J., 2008, MODELING INFECT DIS
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Maciel-de-Freitas R, 2006, MEM I OSWALDO CRUZ, V101, P321, DOI 10.1590/S0074-02762006000300017
   Manore CA, 2014, J THEOR BIOL, V356, P174, DOI 10.1016/j.jtbi.2014.04.033
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   National Weather Service Forecast Office, MIAM S FLOR
   Neher RA, 2015, BIOINFORMATICS, V31, P3546, DOI 10.1093/bioinformatics/btv381
   Nishiura H, 2016, TRAVEL MED INFECT DI, V14, P274, DOI 10.1016/j.tmaid.2016.03.016
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Robert MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161365
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Shaz BH, 2011, J NATL MED ASSOC, V103, P351, DOI 10.1016/S0027-9684(15)30316-3
   Spiegelhalter DJ, 2002, J ROY STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   World Health Organization (WHO), NEW DET MOSQ BORN ZI
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 36
TC 6
Z9 6
U1 0
U2 13
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD SEP 14
PY 2017
VL 22
IS 37
BP 7
EP 14
AR 30612
DI 10.2807/1560-7917.ES.2017.22.37.30612
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA FH6ZA
UT WOS:000411328700002
PM 28933344
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Shankar, A
   Patil, AA
   Skariyachan, S
AF Shankar, Apoorva
   Patil, Amulya A.
   Skariyachan, Sinosh
TI Recent Perspectives on Genome, Transmission, Clinical Manifestation,
   Diagnosis, Therapeutic Strategies, Vaccine Developments, and Challenges
   of Zika Virus Research
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Review
DE mosquito-borne flavivirus; Zika virus (ZIKV); current animal models;
   vaccine development; computational drug discovery; novel molecular
   targets; ZIKV research
ID MOUSE MODEL; WOLBACHIA; INFECTION; OUTBREAK; TARGETS; BIOLOGY
AB One of the potential threats to public health microbiology in 21st century is the increased mortality rate caused by Zika virus (ZIKV), a mosquito-borne flavivirus. The severity of ZIKV infection urged World Health Organization (WHO) to declare this virus as a global concern. The limited knowledge on the structure, virulent factors, and replication mechanism of the virus posed as hindrance for vaccine development. Several vector and non-vector-borne mode of transmission are observed for spreading the disease. The similarities of the virus with other flaviviruses such as dengue and West Nile virus are worrisome; hence, there is high scope to undertake ZIKV research that probably provide insight for novel therapeutic intervention. Thus, this review focuses on the recent aspect of ZIKV research which includes the outbreak, genome structure, multiplication and propagation of the virus, current animal models, clinical manifestations, available treatment options (probable vaccines and therapeutics), and the recent advancements in computational drug discovery pipelines, challenges and limitation to undertake ZIKV research. The review suggests that the infection due to ZIKV became one of the universal concerns and an interdisciplinary environment of in vitro cellular assays, genomics, proteomics, and computational biology approaches probably contribute insights for screening of novel molecular targets for drug design. The review tried to provide cutting edge knowledge in ZIKV research with future insights required for the development of novel therapeutic remedies to curtail ZIKV infection.
C1 [Shankar, Apoorva; Patil, Amulya A.; Skariyachan, Sinosh] Dayananda Sagar Inst, R&D Ctr, Dept Biotechnol Engn, Bengaluru, India.
   [Skariyachan, Sinosh] Visvesvaraya Technol Univ, Belagavi, India.
RP Skariyachan, S (corresponding author), Dayananda Sagar Inst, R&D Ctr, Dept Biotechnol Engn, Bengaluru, India.; Skariyachan, S (corresponding author), Visvesvaraya Technol Univ, Belagavi, India.
EM sinosh-bt@dayanandasagar.edu
RI Skariyachan, Sinosh/T-4685-2017
OI Skariyachan, Sinosh/0000-0003-0950-7513
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Avsic Zupanc Tatjana, 2016, Zdr Varst, V55, P228
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Basharat Z., 2016, PEER J PREPRINTS, V4, DOI [10.7287/peerj.preprints.2047v2, DOI 10.7287/PEERJ.PREPRINTS.2047V2]
   Baud D., 2017, LANCET, DOI [10.1016/S0140-6736(17)31450-2, DOI 10.1016/S0140-6736(17)31450-2[EPUBAHEADOFPRINT]]
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   da Silva LRC, 2016, REV SOC BRAS MED TRO, V49, P267, DOI 10.1590/0037-8682-0150-2016
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Ceron-Carrasco J. P., 2016, DRUG DES, V5, pe131, DOI [10.1016/j.jaut.2016.02.006, DOI 10.1016/J.JAUT.2016.02.006]
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Cox Bryan D., 2015, Antiviral Chemistry & Chemotherapy, V24, P118, DOI 10.1177/2040206616653873
   Dasti JI, 2016, ASIAN PAC J TROP MED, V9, P601, DOI 10.1016/j.apjtm.2016.05.010
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Ekins Sean, 2016, F1000Res, V5, P275
   Ekins Sean, 2016, F1000Res, V5, P150, DOI 10.12688/f1000research.8013.1
   Elfiky AA, 2016, J MED VIROL, V88, P2044, DOI 10.1002/jmv.24678
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fellner Chris, 2016, P T, V41, P242
   Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heaton NS, 2011, VIRUSES-BASEL, V3, P1332, DOI 10.3390/v3081332
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Klase ZA, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-15
   Koenig KL, 2016, WEST J EMERG MED, V17, P238, DOI 10.5811/westjem.2016.3.30188
   Kumar M, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0750-4
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Logan IS, 2016, ZOOL RES, V37, P110, DOI 10.13918/j.issn.2095-8137.2016.2.110
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Molloy JC, 2016, APPL ENVIRON MICROB, V82, P3109, DOI 10.1128/AEM.00275-16
   Mumtaz N, 2016, CURR TREAT OPTIONS I, V8, P208, DOI [10.1007/s40506-016-0083-7, DOI 10.1007/S40506-016-0083-7]
   Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469
   Musso D, 2016, LANCET INFECT DIS, V16, P1108, DOI 10.1016/S1473-3099(16)30337-1
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   O'Neill SL, 2017, NATURE, V543, P182, DOI 10.1038/nature21509
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Pylro VS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004817
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rajah MM, 2016, ACS INFECT DIS, V2, P763, DOI 10.1021/acsinfecdis.6b00161
   Ramharack P, 2016, RSC ADV, V6, P68719, DOI 10.1039/c6ra12142j
   Rather IA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01417
   Ribeiro LS, 2016, CURR OPIN VIROL, V18, P76, DOI 10.1016/j.coviro.2016.04.002
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Shastry Siri, 2016, Emerg Med Clin North Am, V34, pe25, DOI 10.1016/j.emc.2016.04.001
   Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   Wahid B, 2016, ASIAN PAC J TROP MED, V9, P723, DOI 10.1016/j.apjtm.2016.06.019
   WHO, 2017, ZIK VIR SIT REP
   World Health Organization [WHO], 2017, ZIK VIR INF IND
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 73
TC 14
Z9 14
U1 0
U2 30
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD SEP 14
PY 2017
VL 8
AR 1761
DI 10.3389/fmicb.2017.01761
PG 14
WC Microbiology
SC Microbiology
GA FG7ZI
UT WOS:000410643900001
PM 28959246
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Jagger, BW
   Miner, JJ
   Cao, B
   Arora, N
   Smith, AM
   Kovacs, A
   Mysorekar, IU
   Coyne, CB
   Diamond, MS
AF Jagger, Brett W.
   Miner, Jonathan J.
   Cao, Bin
   Arora, Nitin
   Smith, Amber M.
   Kovacs, Attila
   Mysorekar, Indira U.
   Coyne, Carolyn B.
   Diamond, Michael S.
TI Gestational Stage and IFN-lambda Signaling Regulate ZIKV Infection In
   Utero
SO CELL HOST & MICROBE
LA English
DT Article
ID VIRUS-INFECTION; MOUSE MODEL; PREGNANCY; TRANSMISSION; BRAIN; CELLS
AB Although Zika virus (ZIKV)-induced congenital disease occurs more frequently during early stages of pregnancy, its basis remains undefined. Using established type I interferon (IFN)-deficient mouse models of ZIKV transmission in utero, we found that the placenta and fetus were more susceptible to ZIKV infection at earlier gestational stages. Whereas ZIKV infection at embryonic day 6 (E6) resulted in placental insufficiency and fetal demise, infections at midstage (E9) resulted in reduced cranial dimensions, and infection later in pregnancy (E12) caused no apparent fetal disease. In addition, we found that fetuses lacking type III IFN-lambda signaling had increased ZIKV replication in the placenta and fetus when infected at E12, and reciprocally, treatment of pregnant mice with IFN-lambda 2 reduced ZIKV infection. IFN-l treatment analogously diminished ZIKV infection in human midgestation fetal-and maternal-derived tissue explants. Our data establish a model of gestational stage dependence of ZIKV pathogenesis and IFN-lambda-mediated immunity at the maternal-fetal interface.
C1 [Jagger, Brett W.; Miner, Jonathan J.; Smith, Amber M.; Kovacs, Attila; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Miner, Jonathan J.; Mysorekar, Indira U.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Cao, Bin; Mysorekar, Indira U.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA.
   [Kovacs, Attila] Washington Univ, Sch Med, Cardiovasc Res Ctr, St Louis, MO 63110 USA.
   [Miner, Jonathan J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.
   [Arora, Nitin; Coyne, Carolyn B.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15224 USA.
   [Arora, Nitin; Coyne, Carolyn B.] UPMC, Childrens Hosp Pittsburgh, Ctr Microbial Pathogenesis, Pittsburgh, PA 15224 USA.
RP Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.
EM diamond@wusm.wustl.edu
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165; Arora, Nitin/0000-0001-6840-4333
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI073755, R01 AI104972, U19
   AI083019, R01 HD091218, T32 AI007172, R01 HD075665]; Burroughs Wellcome
   Investigators in the Pathogenesis of Infectious Disease AwardBurroughs
   Wellcome Fund;  [P30CA047904]
FX This work was supported by grants from the NIH (R01 AI073755, R01
   AI104972, and U19 AI083019 to M.S.D.; R01 HD091218 to I.U.M. and M.S.D.;
   T32 AI007172 to B.W.J.; and R01 HD075665 to C.B.C.) and the Burroughs
   Wellcome Investigators in the Pathogenesis of Infectious Disease Award
   (to C.B.C.). M.S.D. is a consultant for Inbios, Visterra, Aviana, and
   Sanofi-Pasteur, and is on the Scientific Advisory Boards of Moderna and
   OvaGene. We thank Jacqueline Corry (University of Pittsburgh) for
   technical support, Stephanie Worrell (Magee Women's Hospital) for
   assistance with placental tissue pathology, and the UPCI Tissue and
   Research Pathology/Health Sciences Tissue Bank, which receives funding
   from P30CA047904, for fetal tissue.
CR Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474
   Arora N, 2017, CELL HOST MICROBE, V21, P561, DOI 10.1016/j.chom.2017.04.007
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Corry J, 2017, P NATL ACAD SCI USA, V114, P9433, DOI 10.1073/pnas.1707513114
   de Paula Freitas B., 2016, JAMA OPHTHALMOL, V134, P529
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Honein M. A., 2017, JAMA-J AM MED ASSOC, V317, P59
   HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Kleber de Oliveira W, 2016, MMWR-MORBID MORTAL W, V65, P242
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear H. M., 2015, SCI TRANSL MED, V7
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lazear HM, 2015, IMMUNITY, V43, P15, DOI 10.1016/j.immuni.2015.07.001
   Leviton A, 2002, EARLY HUM DEV, V69, P91, DOI 10.1016/S0378-3782(02)00065-8
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   McConkey CA, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501462
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mu J., 2006, AM J PHYSIOL-HEART C, V291, pH1421
   Mu JW, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-34
   Murray SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012418
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rausch K., 2017, CELL REP, V18, P804
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Sheehan K. C., 2006, J INTERFERON CYTOKIN, V26, P804
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Simoni M. K., 2017, AM J REPROD IMMUNOL, V77
   Sun T, 2014, NAT REV NEUROSCI, V15, P217, DOI 10.1038/nrn3707
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang W. W., 2016, CELL REP, V17, P3091
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 46
TC 58
Z9 61
U1 0
U2 12
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD SEP 13
PY 2017
VL 22
IS 3
BP 366
EP +
DI 10.1016/j.chom.2017.08.012
PG 14
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA FG7CH
UT WOS:000410565400016
PM 28910635
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Barreto-Vieira, DF
   Jacome, FC
   da Silva, MAN
   Caldas, GC
   de Filippis, AMB
   de Sequeira, PC
   de Souza, EM
   Andrade, AA
   Manso, PPD
   Trindade, GF
   Lima, SMB
   Barth, OM
AF Barreto-Vieira, Debora Ferreira
   Jacome, Fernanda Cunha
   Nunes da Silva, Marcos Alexandre
   Caldas, Gabriela Cardoso
   Bispo de Filippis, Ana Maria
   de Sequeira, Patricia Carvalho
   de Souza, Elen Mello
   Andrade, Audrien Alves
   de Abreu Manso, Pedro Paulo
   Trindade, Gisela Freitas
   Barbosa Lima, Sheila Maria
   Barth, Ortrud Monika
TI Structural investigation of C6/36 and Vero cell cultures infected with a
   Brazilian Zika virus
SO PLOS ONE
LA English
DT Article
ID DENGUE VIRUS; REPLICATION; VIROPLASM; FACTORIES
AB Zika virus (ZIKV) is a member of the flavivirus genus, and its genome is approximately 10.8 kilobases of positive-strand RNA enclosed in a capsid and surrounded by a membrane. Studies on the replication dynamics of ZIKV are scarce, which limits the development of antiviral agents and vaccines directed against ZIKV. In this study, Aedes albopictus mosquito lineage cells (C6/36 cells) and African green monkey kidney epithelial cells (Vero cells) were inoculated with a ZIKV sample isolated from a Brazilian patient, and the infection was characterized by immunofluorescence staining, phase contrast light microscopy, transmission electron microscopy and real-time RT-PCR. The infection was observed in both cell lineages, and ZIKV particles were observed inside lysosomes, the rough endoplasmic reticulum and viroplasm-like structures. The susceptibility of C6/36 and Vero cells to ZIKV infection was demonstrated. Moreover, this study showed that part of the replicative cycle may occur within viroplasm-like structures, which has not been previously demonstrated in other flaviviruses.
C1 [Barreto-Vieira, Debora Ferreira; Jacome, Fernanda Cunha; Nunes da Silva, Marcos Alexandre; Caldas, Gabriela Cardoso; de Souza, Elen Mello; Andrade, Audrien Alves; Barth, Ortrud Monika] Fiocruz MS, Inst Oswaldo Cruz, Lab Morphol & Viral Morphogenesis, Ave Brasil, Rio De Janeiro, RJ, Brazil.
   [Bispo de Filippis, Ana Maria; de Sequeira, Patricia Carvalho] Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Ave Brasil, Rio De Janeiro, RJ, Brazil.
   [de Abreu Manso, Pedro Paulo] Fiocruz MS, Inst Oswaldo Cruz, Lab Pathol, Ave Brasil, Rio De Janeiro, RJ, Brazil.
   [Trindade, Gisela Freitas; Barbosa Lima, Sheila Maria] Biomanguinhos, Lab Virol Technol, Ave Brasil, Rio De Janeiro, RJ, Brazil.
RP Barreto-Vieira, DF (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Morphol & Viral Morphogenesis, Ave Brasil, Rio De Janeiro, RJ, Brazil.
EM barreto@ioc.fiocruz.br
RI de Abreu Manso, Pedro Paulo/M-7326-2018
OI de Abreu Manso, Pedro Paulo/0000-0002-7255-0429; Trindade,
   Gisela/0000-0002-1630-4143
FU Institute Oswaldo Cruz, Fundacao Oswaldo Cruz, Faperj; European Union's
   Horizon program [734857]; Instituto Oswaldo Cruz, Fundacao Oswaldo Cruz,
   Faperj
FX This study was funded by Institute Oswaldo Cruz, Fundacao Oswaldo Cruz,
   Faperj, and Ana Maria Bispo de Filippis is supported by the European
   Union's Horizon 2020 program under grant agreement No. 734857. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.; We are grateful
   to Jose Farias Filho and Arthur da Costa Rasinhas for technical
   assistance, to the Electron Microscopy Platform of the Biology
   Institute, Universidade Federal Fluminense and to the Microscopy
   Platform of Rudolf Barth, Instituto Oswaldo Cruz, Fiocruz. Ana Maria
   Bispo de Filippis is supported by the European Union's Horizon 2020
   program under grant agreement No. 734857.; Financial Support: Instituto
   Oswaldo Cruz, Fundacao Oswaldo Cruz, Faperj.
CR Altman L. K., 2007, NY TIMES
   Armstrong Najealicka, 2017, World J Virol, V6, P1, DOI 10.5501/wjv.v6.i1.1
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Bak A, 2013, J VIROL, V87, P12207, DOI 10.1128/JVI.01883-13
   Barreto-Vieira DF, 2016, MEM I O CRUZ, V111, P1
   BARRETOVIEIRA DF, 2015, INDIAN J APPL RES, V5, P44
   Barth O. M., 1999, Journal of Submicroscopic Cytology and Pathology, V31, P407
   Barth OM, 1996, MEM I OSWALDO CRUZ, V91, P255, DOI 10.1590/S0074-02761996000200025
   Barth OM, 2000, ATLAS DENGUE VIRUSES
   Barth OM, 2016, MEM I OSWALDO CRUZ, V111, P411, DOI 10.1590/0074-02760150433
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Calvet G., 2016, LANCET INFECT DIS
   Chan JF, 2016, EMERG MICROBES INFEC, V5
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Deng CL, 2016, VIROL SIN, V31, P176, DOI 10.1007/s12250-016-3778-5
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Eichwald C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047947
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grief C, 1997, ARCH VIROL, V142, P2347, DOI 10.1007/s007050050247
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heaton NS, 2011, VIRUSES-BASEL, V3, P1332, DOI 10.3390/v3081332
   Hennessey MJ, 2016, AM J TROP MED HYG, V95, P212, DOI 10.4269/ajtmh.16-0049
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Krejbich-Trotot P, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-432
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016
   Lindenbach B.D., 2007, FLAVIVIRIDAE VIRUSES
   MAJEROWICZ S, 1994, MEM I OSWALDO CRUZ, V89, P395, DOI 10.1590/S0074-02761994000300018
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Netherton CL, 2011, CURR OPIN VIROL, V1, P381, DOI 10.1016/j.coviro.2011.09.008
   Nikolay A, 2017, VACCINE
   Novoa RR, 2005, BIOL CELL, V97, P147, DOI 10.1042/BC20040058
   Offerdahl DK, 2017, VIROLOGY, V501, P54, DOI 10.1016/j.virol.2016.11.002
   Ponpuak M, 2015, CURR OPIN CELL BIOL, V35, P106, DOI 10.1016/j.ceb.2015.04.016
   Rossignol ED, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12740
   Sesso A., 2007, MANUAL TECNICAS BASI, P13
   Sharma M, 2014, AUTOPHAGY, V10, P1637, DOI 10.4161/auto.29455
   SINGH KRP, 1967, CURR SCI INDIA, V36, P506
   Szajner P, 2001, J VIROL, V75, P5752, DOI 10.1128/JVI.75.13.5752-5761.2001
   Tang BL, 2016, ARCH MICROBIOL, V13
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Wei T, 2006, ARCH VIROL, V151, P1701, DOI 10.1007/s00705-006-0757-4
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   WHO, 2016, HIST ZIK VIR
   XIONG C, 1982, EMBO J, V1, P971, DOI 10.1002/j.1460-2075.1982.tb01280.x
   Zhang ZW, 2017, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00206
NR 53
TC 9
Z9 9
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 12
PY 2017
VL 12
IS 9
AR e0184397
DI 10.1371/journal.pone.0184397
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FG6AR
UT WOS:000410449500025
PM 28898286
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wu, YH
   Cui, XY
   Wu, N
   Song, R
   Yang, W
   Zhang, W
   Fan, DY
   Chen, ZH
   An, J
AF Wu, Yanhua
   Cui, Xiaoyun
   Wu, Na
   Song, Rui
   Yang, Wei
   Zhang, Wei
   Fan, Dongying
   Chen, Zhihai
   An, Jing
TI A unique case of human Zika virus infection in association with severe
   liver injury and coagulation disorders
SO SCIENTIFIC REPORTS
LA English
DT Article
ID DENGUE VIRUS; DNA VACCINE; THROMBOCYTOPENIA; EPIDEMIOLOGY
AB Zika virus (ZIKV) has caused major concern globally due to its rapid dissemination and close association with microcephaly in children and Gullian-Barr syndrome in adults. In this study, we identified a patient returned from Cambodia who experienced high fever, chill and myalgia. Lab tests discovered sign of severe liver injury including significantly elevated serum transaminases' level, decreased serum albumin level, and markedly increased levels of lactic dehydrogenase, alpha-hydroxybutyric dehydrogenase and creatine kinase in serum. Moreover, severe thrombocytopenia and altered blood levels of fibrinogen and fibrinogen degradation product were also observed, indicating the existence of clotting disorders. A ZIKV strain clustered into the Asian lineage was isolated from the patient's serum. When inoculated into suckling mice, this virus significantly retarded mouse body-weight gain and caused 70% mortality. Our results demonstrate a close association between ZIKV and severe liver injury and coagulation disorders and suggest that clinicians should be aware of compatible symptoms in patients and manage them accordingly.
C1 [Wu, Yanhua; Cui, Xiaoyun; Yang, Wei; Fan, Dongying; An, Jing] Capital Med Univ, Sch Basic Med Sci, Dept Microbiol & Parasitol, Beijing, Peoples R China.
   [Wu, Na] Capital Med Univ, Dept Expt Anim, Beijing, Peoples R China.
   [Song, Rui; Zhang, Wei; Chen, Zhihai] Capital Med Univ, Beijing Ditan Hosp, Dept Infect Dis, Beijing, Peoples R China.
   [An, Jing] Beijing Inst Brain Disorders, Ctr Epilepsy, Beijing, Peoples R China.
RP An, J (corresponding author), Capital Med Univ, Sch Basic Med Sci, Dept Microbiol & Parasitol, Beijing, Peoples R China.; Chen, ZH (corresponding author), Capital Med Univ, Beijing Ditan Hosp, Dept Infect Dis, Beijing, Peoples R China.; An, J (corresponding author), Beijing Inst Brain Disorders, Ctr Epilepsy, Beijing, Peoples R China.
EM chenzhihai0001@126.com; anjing@ccmu.edu.cn
FU Natural Science Foundation of ChinaNational Natural Science Foundation
   of China [81471957, 81401676, 81671971, 81271839]; Beijing Natural
   Science FoundationBeijing Natural Science Foundation [7144194]
FX This work was supported by The Natural Science Foundation of China (No.
   81471957, 81401676, 81671971 and 81271839) and Beijing Natural Science
   Foundation (No. 7144194).
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   Chammard TB, 2017, EMERG INFECT DIS, V23, P696, DOI 10.3201/eid2304.161967
   Chen H, 2016, CLIN IMMUNOL, V171, P41, DOI 10.1016/j.clim.2016.08.021
   Chraibi S, 2016, J CLIN VIROL, V83, P61, DOI 10.1016/j.jcv.2016.08.299
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Grossi-Soyster EN, 2017, CURR OPIN PEDIATR, V29, P102, DOI 10.1097/MOP.0000000000000449
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Krittanawong C, 2016, INT J CARDIOL, V221, P859, DOI 10.1016/j.ijcard.2016.06.293
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lord ST, 2007, CURR OPIN HEMATOL, V14, P236, DOI 10.1097/MOH.0b013e3280dce58c
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   OBEYESEKERE I, 1972, BRIT HEART J, V34, P821
   Oehler E, 2014, EURO SURVEILL, V19
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Pongsiri P, 2012, ASIAN PAC J TROP MED, V5, P342, DOI 10.1016/S1995-7645(12)60055-8
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sharp TM, 2016, CLIN INFECT DIS, V63, P1198, DOI 10.1093/cid/ciw476
   Sheng ZY, 2016, VACCINE, V34, P5751, DOI 10.1016/j.vaccine.2016.10.001
   Vinhaes ES, 2017, CLIN INFECT DIS, V64, P675, DOI 10.1093/cid/ciw770
   Williamson DR, 2013, CHEST, V144, P1207, DOI 10.1378/chest.13-0121
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 25
TC 14
Z9 14
U1 0
U2 11
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD SEP 12
PY 2017
VL 7
AR 11393
DI 10.1038/s41598-017-11568-4
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FG4ZR
UT WOS:000410297900107
PM 28900143
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bideshi, DK
   Park, HW
   Hice, RH
   Wirth, MC
   Federici, BA
AF Bideshi, Dennis K.
   Park, Hyun-Woo
   Hice, Robert H.
   Wirth, Margaret C.
   Federici, Brian A.
TI Highly Effective Broad Spectrum Chimeric Larvicide That Targets Vector
   Mosquitoes Using a Lipophilic Protein
SO SCIENTIFIC REPORTS
LA English
DT Article
ID SPHAERICUS BINARY TOXIN; THURINGIENSIS SUBSP ISRAELENSIS;
   BACILLUS-THURINGIENSIS; LYSINIBACILLUS-SPHAERICUS; CYT1A; COMPONENTS;
   EXPRESSION; CULICIDAE; MECHANISM; BACTERIA
AB Two mosquitocidal bacteria, Bacillus thuringiensis subsp. israelensis (Bti) and Lysinibacillus sphaericus (Ls) are the active ingredients of commercial larvicides used widely to control vector mosquitoes. Bti's efficacy is due to synergistic interactions among four proteins, Cry4Aa, Cry4Ba, Cry11Aa, and Cyt1Aa, whereas Ls's activity is caused by Bin, a heterodimer consisting of BinA, the toxin, and BinB, a midgut-binding protein. Cyt1Aa is lipophilic and synergizes Bti Cry proteins by increasing midgut binding. We fused Bti's Cyt1Aa to Ls's BinA yielding a broad-spectrum chimeric protein highly mosquitocidal to important vector species including Anopheles gambiae, Culex quinquefasciatus, and Aedes aegypti, the latter an important Zika and Dengue virus vector insensitive to Ls Bin. Aside from its vector control potential, our bioassay data, in contrast to numerous other reports, provide strong evidence that BinA does not require conformational interactions with BinB or microvillar membrane lipids to bind to its intracellular target and kill mosquitoes.
C1 [Bideshi, Dennis K.; Park, Hyun-Woo; Hice, Robert H.; Wirth, Margaret C.; Federici, Brian A.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.
   [Bideshi, Dennis K.; Park, Hyun-Woo] Calif Baptist Univ, Dept Biol Sci, Riverside, CA 92504 USA.
   [Federici, Brian A.] Univ Calif Riverside, Interdept Grad Program Microbiol, Riverside, CA 92521 USA.
   [Federici, Brian A.] Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA.
RP Federici, BA (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.; Federici, BA (corresponding author), Univ Calif Riverside, Interdept Grad Program Microbiol, Riverside, CA 92521 USA.; Federici, BA (corresponding author), Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA.
EM brian.federici@ucr.edu
FU Public Health Service GrantUnited States Public Health Service [RO1 AI
   45817]; Microgrant through the Faculty Development Fund, California
   Baptist University, Riverside, California
FX This research was supported in part by Public Health Service Grant RO1
   AI 45817 to B.A.F. from the National Institute of Allergy and Infectious
   Diseases. Additionally, a portion of this research was supported by a
   Microgrant to D.K.B. and H.-W.P. awarded through the Faculty Development
   Fund, California Baptist University, Riverside, California.
CR Ben-Dov E, 2014, TOXINS, V6, P1222, DOI 10.3390/toxins6041222
   Berry C, 2012, J INVERTEBR PATHOL, V109, P1, DOI 10.1016/j.jip.2011.11.008
   Boonserm P, 2006, BIOCHEM BIOPH RES CO, V342, P1273, DOI 10.1016/j.bbrc.2006.02.086
   BOURGOUIN C, 1990, APPL ENVIRON MICROB, V56, P340, DOI 10.1128/AEM.56.2.340-344.1990
   Butko P, 2003, APPL ENVIRON MICROB, V69, P2415, DOI 10.1128/AEM.69.5.2415-2422.2003
   CLARK MA, 1990, J BACTERIOL, V172, P6759, DOI 10.1128/jb.172.12.6759-6763.1990
   Colletier JP, 2016, NATURE, V539, P43, DOI 10.1038/nature19825
   Darboux I, 2001, INSECT BIOCHEM MOLEC, V31, P981, DOI 10.1016/S0965-1748(01)00046-7
   Canton PE, 2014, PEPTIDES, V53, P286, DOI 10.1016/j.peptides.2013.10.011
   Enayati A, 2010, ANNU REV ENTOMOL, V55, P569, DOI 10.1146/annurev-ento-112408-085423
   Federici BA, 2003, J EXP BIOL, V206, P3877, DOI 10.1242/jeb.00643
   Hire RS, 2014, J INVERTEBR PATHOL, V122, P44, DOI 10.1016/j.jip.2014.08.005
   Huang YJS, 2014, VIRUSES-BASEL, V6, P4703, DOI 10.3390/v6114703
   Kale A, 2013, INSECT BIOCHEM MOLEC, V43, P1045, DOI 10.1016/j.ibmb.2013.07.011
   Lekakarn H, 2015, J INVERTEBR PATHOL, V132, P125, DOI 10.1016/j.jip.2015.09.010
   Limpanawat S, 2009, CURR MICROBIOL, V59, P509, DOI 10.1007/s00284-009-9468-x
   Manceva SD, 2005, BIOCHEMISTRY-US, V44, P589, DOI 10.1021/bi048493y
   Mathai D, 2009, J GLOB INFECT DIS, V1, P4, DOI 10.4103/0974-777X.52975
   NICOLAS L, 1993, FEMS MICROBIOL LETT, V106, P275, DOI 10.1111/j.1574-6968.1993.tb05976.x
   Opota O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014682
   Park HW, 2005, AM J TROP MED HYG, V72, P732, DOI 10.4269/ajtmh.2005.72.732
   Park HW, 2003, APPL ENVIRON MICROB, V69, P1331, DOI 10.1128/AEM.69.2.1331-1334.2003
   Promdonkoy B, 2000, BIOCHEM J, V350, P275, DOI 10.1042/0264-6021:3500275
   Smith AW, 2005, J INVERTEBR PATHOL, V88, P27, DOI 10.1016/j.jip.2004.10.005
   Srisucharitpanit K, 2014, PROTEINS, V82, P2703, DOI 10.1002/prot.24636
   Surya W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158356
   Tangsongcharoen C, 2015, J INVERTEBR PATHOL, V128, P57, DOI 10.1016/j.jip.2015.04.008
   Wirth M.C., 2010, OPEN TOXINOL J, V3, P101
   Wirth MC, 2000, APPL ENVIRON MICROB, V66, P1093, DOI 10.1128/AEM.66.3.1093-1097.2000
   WU D, 1995, APPL MICROBIOL BIOT, V42, P697, DOI 10.1007/BF00171947
   WU D, 1993, J BACTERIOL, V175, P5276, DOI 10.1128/JB.175.16.5276-5280.1993
NR 31
TC 7
Z9 7
U1 0
U2 9
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD SEP 12
PY 2017
VL 7
AR 11282
DI 10.1038/s41598-017-11717-9
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FG4ZG
UT WOS:000410296500015
PM 28900215
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tan, JJL
   Balne, PK
   Leo, YS
   Tong, L
   Ng, LFP
   Agrawal, R
AF Tan, Jeslin J. L.
   Balne, Praveen K.
   Leo, Yee-Sin
   Tong, Louis
   Ng, Lisa F. P.
   Agrawal, Rupesh
TI Persistence of Zika virus in conjunctival fluid of convalescence
   patients
SO SCIENTIFIC REPORTS
LA English
DT Article
ID EXTRACTION; INFECTION; OUTBREAK; DISEASES
AB A widespread epidemic of Zika fever, caused by Zika virus (ZIKAV) has spread throughout the Pacific islands, the Americas and Southeast Asia. The increased incidences of ocular anomalies observed in ZIKAV-infected infants and adults may be associated with the rapid spread of ZIKAV. The objective of this study was to check if ZIKAV could be detected in human tears after the first week of infection. Twenty-nine patients with PCR confirmed ZIKAV infection during the Singapore August 2016 ZIKAV outbreak were enrolled for the study. Detection and quantification of ZIKAV RNA was performed on conjunctival swabs collected from both eyes of these patients at the late convalescent phase (30 days post-illness). Efficiency of viral isolation from swab samples was confirmed by the limit of detection (as low as 0.1 PFU/mu L, equivalent to copy number of 4.9) in spiked swabs with different concentrations of ZIKAV (PFU/mu L). Samples from three patients were found positive by qRT-PCR for ZIKAV and the viral RNA copy numbers detected in conjunctival swabs ranged from 5.2 to 9.3 copies respectively. ZIKAV could persist in the tears of infected patients for up to 30 days post-illness, and may therefore possess a potential public health risk of transmission.
C1 [Tan, Jeslin J. L.; Ng, Lisa F. P.] ASTAR, Singapore Immunol Network, Singapore, Singapore.
   [Balne, Praveen K.; Agrawal, Rupesh] Tan Tock Seng Hosp, Natl Healthcare Grp Eye Inst, Singapore, Singapore.
   [Balne, Praveen K.; Tong, Louis; Agrawal, Rupesh] Singapore Eye Res Inst, Singapore, Singapore.
   [Leo, Yee-Sin; Agrawal, Rupesh] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore.
   [Leo, Yee-Sin; Tong, Louis] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Singapore, Singapore.
   [Tong, Louis] Singapore Natl Eye Ctr, Singapore, Singapore.
   [Tong, Louis] Duke NUS Med Sch, Singapore, Singapore.
   [Ng, Lisa F. P.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.
RP Ng, LFP (corresponding author), ASTAR, Singapore Immunol Network, Singapore, Singapore.; Agrawal, R (corresponding author), Tan Tock Seng Hosp, Natl Healthcare Grp Eye Inst, Singapore, Singapore.; Agrawal, R (corresponding author), Singapore Eye Res Inst, Singapore, Singapore.; Agrawal, R (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore.; Ng, LFP (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.
EM lisa_ng@immunol.a-star.edu.sg; rupeshttsh@gmail.com
RI Balne, Praveen Kumar/X-7075-2019
OI Balne, Praveen Kumar/0000-0001-8365-9991; Ng, Lisa/0000-0003-4071-5222;
   Agrawal, Rupesh/0000-0002-6662-5850; Tong, Louis/0000-0002-3986-6552
FU National Medical Research Council (Singapore)National Medical Research
   Council, Singapore [NMRC/CSA/045/2012]; BMRC A*STARAgency for Science
   Technology & Research (ASTAR) [15/1/82/27/001]
FX We thank the study subjects for their participation, clinical team at
   the Communicable Disease Centre/Tan Tock Seng Hospital contribution in
   patient recruitment and sample collection. The work is supported by the
   National Medical Research Council (Singapore) grant NMRC/CSA/045/2012
   and BMRC A*STAR-led Zika Virus Consortium Fund (Singapore) project
   number 15/1/82/27/001. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brent C, 2016, MMWR-MORBID MORTAL W, V65, P981, DOI 10.15585/mmwr.mm6536e4
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chen LH, 2004, CLIN INFECT DIS, V39, pE56, DOI 10.1086/423807
   Chia P. Y., 2017, J INFECT
   Dash AP, 2013, J VECTOR DIS, V50, P77
   de Paula Freitas B, 2016, JAMA OPHTHALMOL
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2017, INT J INFECT DIS, V54, P121, DOI 10.1016/j.ijid.2016.11.420
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Ho Z. J. M., 2017, LANCET INFECT DIS
   Kam Y. W., 2017, J INFECT DIS
   Knepp JH, 2003, J CLIN MICROBIOL, V41, P3532, DOI 10.1128/JCM.41.8.3532-3536.2003
   Kodati S, 2017, LANCET, V389, P125, DOI 10.1016/S0140-6736(16)32518-1
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li JH, 2017, CLIN INFECT DIS, V64, P1445, DOI 10.1093/cid/cix137
   Lum F. M., 2017, CLIN INFECT DIS
   Mackenzie JS, 2001, EMERG INFECT DIS, V7, P497, DOI 10.3201/eid0707.017703
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   Maurer-Stroh S., 2016, EURO SURVEILL, V21
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moron AF, 2016, BJOG-INT J OBSTET GY, V123, P1265, DOI 10.1111/1471-0528.14072
   Oehler E., 2013, EURO SURVEILL, V19
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Shipley MA, 2012, J MICROBIOL METH, V91, P179, DOI 10.1016/j.mimet.2012.06.008
   Sun JF, 2016, JAMA OPHTHALMOL, V134, P1330, DOI 10.1001/jamaophthalmol.2016.3417
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Verheyen J, 2012, J CLIN VIROL, V54, P255, DOI 10.1016/j.jcv.2012.03.008
NR 37
TC 3
Z9 3
U1 2
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD SEP 11
PY 2017
VL 7
AR 11194
DI 10.1038/s41598-017-09479-5
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FG3MB
UT WOS:000410064000030
PM 28894118
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Jarvis, L
AF Jarvis, Lisa
TI Sanofi ends Zika vaccine research
SO CHEMICAL & ENGINEERING NEWS
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0009-2347
EI 1520-605X
J9 CHEM ENG NEWS
JI Chem. Eng. News
PD SEP 11
PY 2017
VL 95
IS 36
BP 10
EP 10
PG 1
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA FG4TC
UT WOS:000410257400014
DA 2020-07-08
ER

PT J
AU Hou, WH
   Cruz-Cosme, R
   Armstrong, N
   Obwolo, LA
   Wen, FY
   Hu, WH
   Luo, MH
   Tang, QY
AF Hou, Wangheng
   Cruz-cosme, Ruth
   Armstrong, Najealicka
   Obwolo, Lilian Akello
   Wen, Fayuan
   Hu, Wenhui
   Luo, Min-Hua
   Tang, Qiyi
TI Molecular cloning and characterization of the genes encoding the
   proteins of Zika virus
SO GENE
LA English
DT Article
DE Zika virus (ZIKV); Capsid; Envelope; Nonstructural (NS) proteins;
   Centrosome; Mitochondria; Endoplasmic reticulum (ER); Golgi apparatus;
   Endosome; Autophagy
ID 3 SPLICE-SITE; IN-VITRO; BRAIN ORGANOIDS; CELL-CYCLE; EVOLUTION;
   PERSPECTIVES; REPLICATION; ISOLATIONS; EMERGENCE; HISTORY
AB Zika virus (ZIKV) encodes a precursor protein (also called poiyprotein) of about 3424 amino acids that is processed by proteases to generate 10 mature proteins and a small peptide. In the present study, we characterized the chemical features, suborganelle distribution and potential function of each protein using Flag-tagged protein expression system. Western blot analysis revealed the molecular weight of the proteins and the polymerization of E, NS1, and NS3 proteins. In addition, we performed multi-labeled fluorescent immunocytochemistry and subcellular fractionation to determine the subcellular localization of these proteins in host cells. We found that 1) the capsid protein colocalizes with 3 different cellular organelles: nucleoli, Golgi apparatus, and lipid droplet; NS2b and NS4a are associated with the Golgi apparatus; 2) the capsid and NS1proteins distribute in both cytoplasm and nucleus, NS5 is a nuclear protein; 3) NS3 protein colocalizes with tubulin and affects Lamin A; 4) Envelope, PrM, and NS2a proteins co-localize with the endoplasmic reticulum; 5) NS1 is associated with autophagosomes and NS4b is related to early endosome; 6) NS5 forms punctate structures in the nucleus that associate with splicing compartments shown by SC35, leading to reduction of SC35 protein level and trafficking of SC35 from the nucleus to the cytoplasm. These data suggest that ZIKV generates 10 functional viral proteins that exhibit distinctive subcellular distribution in host cells.
C1 [Hou, Wangheng; Cruz-cosme, Ruth; Armstrong, Najealicka; Obwolo, Lilian Akello; Wen, Fayuan; Tang, Qiyi] Howard Univ, Coll Med, Dept Microbiol, Seeley Mudd Bldg,520 W St NW, Washington, DC 20059 USA.
   [Hu, Wenhui] Temple Univ, Lewis Katz Sch Med, Dept Pathol & Lab Med, Ctr Metab Dis Res, 3500 N Broad St, Philadelphia, PA 19140 USA.
   [Luo, Min-Hua] Chinese Acad Sci, Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China.
RP Tang, QY (corresponding author), Howard Univ, Coll Med, Dept Microbiol, Seeley Mudd Bldg,520 W St NW, Washington, DC 20059 USA.
EM qiyi.tang@howard.edu
FU NIH/NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [SC1AI112785]; National Institute on
   Minority Health and Health Disparities of the National Institutes of
   Health [G12MD007597]
FX We acknowledge the instrument support of the PSM Molecular Biology Core
   Laboratory. This study was supported by an NIH/NIAID SC1AI112785 (Q.T.)
   and National Institute on Minority Health and Health Disparities of the
   National Institutes of Health under Award Number G12MD007597. We thank
   Tommy Tang for the English editing, Drs. Roane and Thompson for the
   scientific reviewing.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Armstrong Najealicka, 2017, World J Virol, V6, P1, DOI 10.5501/wjv.v6.i1.1
   Bernard A, 2015, AUTOPHAGY, V11, P2114, DOI 10.1080/15548627.2015.1099796
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Cai H.L.M, 2016, J VIROL ANTIVIR RES, V5
   Costa F., 2016, ANN INTERN MED
   da Silva SR, 2016, J MED VIROL
   Dabauvalle MC, 1999, EUR J CELL BIOL, V78, P749, DOI 10.1016/S0171-9335(99)80043-0
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   FU XD, 1992, P NATL ACAD SCI USA, V89, P11224, DOI 10.1073/pnas.89.23.11224
   FU XD, 1992, P NATL ACAD SCI USA, V89, P1725, DOI 10.1073/pnas.89.5.1725
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Gruenbaum Y, 2000, J STRUCT BIOL, V129, P313, DOI 10.1006/jsbi.2000.4216
   HADDOW A. J., 1964, BULL WORLD HEALTH ORGAN, V31, P57
   HENCHAL EA, 1990, CLIN MICROBIOL REV, V3, P376, DOI 10.1128/CMR.3.4.376-396.1990
   Hou WH, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2338-4
   Jones CT, 2003, J VIROL, V77, P7143, DOI 10.1128/JVI.77.12.7143-7149.2003
   Kim MO, 2008, INT J CANCER, V122, P2674, DOI 10.1002/ijc.23442
   Kim YM, 2013, J BIOL CHEM, V288, P12891, DOI 10.1074/jbc.M112.442723
   KOPS AD, 1988, CELL, V55, P857, DOI 10.1016/0092-8674(88)90141-9
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, CELL HOST MICROBE
   LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Mlakar J, 2016, N ENGL J MED
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   MUNCH K, 1992, J GEN VIROL, V73, P499, DOI 10.1099/0022-1317-73-3-499
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Qin XF, 2016, SCI CHINA LIFE SCI, V59, P737, DOI 10.1007/s11427-016-5069-7
   REESE JH, 1991, MOL CELL BIOCHEM, V104, P109
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Shen S, 2016, VIROL SIN, V31, P118, DOI 10.1007/s12250-016-3774-9
   Singh RK, 2016, VET QUART, V36, P150, DOI 10.1080/01652176.2016.1188333
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stratton S.J., 2016, PREHOSP DISASTER MED
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   WEISENBERG RC, 1972, SCIENCE, V177, P1104, DOI 10.1126/science.177.4054.1104
   Werner H, 2016, ULTRASOUND OBSTET GY
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wolf B, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.160231
   Zou J, 2015, J VIROL, V89, P3455, DOI 10.1128/JVI.03453-14
NR 54
TC 17
Z9 18
U1 1
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-1119
EI 1879-0038
J9 GENE
JI Gene
PD SEP 10
PY 2017
VL 628
BP 117
EP 128
DI 10.1016/j.gene.2017.07.049
PG 12
WC Genetics & Heredity
SC Genetics & Heredity
GA FI8MN
UT WOS:000412256800016
PM 28720531
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Lourenco, J
   de Lima, MM
   Faria, NR
   Walker, A
   Kraemer, MUG
   Villabona-Arenas, CJ
   Lambert, B
   de Cerqueira, EM
   Pybus, OG
   Alcantara, LCJ
   Recker, M
AF Lourenco, Jose
   de Lima, Maricelia Maia
   Faria, Nuno Rodrigues
   Walker, Andrew
   Kraemer, Moritz U. G.
   Villabona-Arenas, Christian Julian
   Lambert, Ben
   de Cerqueira, Erenilde Marques
   Pybus, Oliver G.
   Alcantara, Luiz C. J.
   Recker, Mario
TI Epidemiological and ecological determinants of Zika virus transmission
   in an urban setting
SO ELIFE
LA English
DT Article
ID VECTOR-BORNE TRANSMISSION; AEDES-AEGYPTI; DENGUE; TEMPERATURE;
   INFECTION; MODEL; POPULATION; SURVEILLANCE; CULICIDAE; OUTBREAK
AB The Zika virus has emerged as a global public health concern. Its rapid geographic expansion is attributed to the success of Aedes mosquito vectors, but local epidemiological drivers are still poorly understood. Feira de Santana played a pivotal role in the Chikungunya epidemic in Brazil and was one of the first urban centres to report Zika infections. Using a climate-driven transmission model and notified Zika case data, we show that a low observation rate and high vectorial capacity translated into a significant attack rate during the 2015 outbreak, with a subsequent decline in 2016 and fade-out in 2017 due to herd-immunity. We find a potential Zika-related, low risk for microcephaly per pregnancy, but with significant public health impact given high attack rates. The balance between the loss of herd-immunity and viral re-importation will dictate future transmission potential of Zika in this urban setting.
C1 [Lourenco, Jose; Faria, Nuno Rodrigues; Walker, Andrew; Kraemer, Moritz U. G.; Lambert, Ben; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford, England.
   [de Lima, Maricelia Maia; Alcantara, Luiz C. J.] Fiocruz MS, Lab Haematol Genet & Computat Biol, SalvadorBahia, Brazil.
   [Villabona-Arenas, Christian Julian] Univ Montreal, INSERM, UMI 233, Inst Rech Dev,U1175, Montpellier, France.
   [Villabona-Arenas, Christian Julian] Univ Montreal, LIRMM, Inst Biol Computat, Montpellier, France.
   [de Cerqueira, Erenilde Marques] Univ Estadual Feira de Santana, Dept Hlth, Ctr PostGrad Collect Hlth, Feira De SantanaBahia, Brazil.
   [Recker, Mario] Univ Exeter, Ctr Math & Environm, Penryn, England.
RP Lourenco, J (corresponding author), Univ Oxford, Dept Zool, Oxford, England.
EM jose.lourenco@zoo.ox.ac.uk
RI Pybus, Oliver g/B-2640-2012; Faria, Nuno/I-2975-2012
OI Pybus, Oliver g/0000-0002-8797-2667; Faria, Nuno/0000-0001-8839-2798;
   Alcantara, Luiz/0000-0002-6769-9931; Lourenco, Jose/0000-0002-9318-2581;
   Villabona Arenas, Christian Julian/0000-0001-9928-3968; Recker,
   Mario/0000-0001-9489-1315
FU European Research CouncilEuropean Research Council (ERC) [268904 -
   DIVERSITY, 614725-PATHPHYLODYN]; Wellcome TrustWellcome Trust
   [204311/Z/16/Z]; Royal SocietyRoyal Society of London [204311/Z/16/Z];
   International Development Emerging Pandemic Threats Program-2
   [AID-OAA-A-14-00102]; Labex EpiGenMed [ANR-10-LABX-12-01]; Engineering
   and Physical Sciences Research CouncilEngineering & Physical Sciences
   Research Council (EPSRC); Royal SocietyRoyal Society of London
FX Funder Grant reference number Author; European Research Council 268904 -
   DIVERSITY Jose Lourenco Andrew Walker; Wellcome Trust and Royal Society
   204311/Z/16/Z Nuno Rodrigues Faria; International Development Emerging
   Pandemic Threats Program-2 AID-OAA-A-14-00102 Moritz UG Kraemer; Labex
   EpiGenMed ANR-10-LABX-12-01 Christian Julian Villabona-Arenas;
   Engineering and Physical Sciences Research Council Ben Lambert; European
   Research Council 614725-PATHPHYLODYN Oliver G Pybus; Royal Society Mario
   Recker; The funders had no role in study design, data collection and
   interpretation, or the decision to submit the work for publication.
CR Alto BW, 2001, J MED ENTOMOL, V38, P646, DOI 10.1603/0022-2585-38.5.646
   Aman MJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004702
   Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085
   Bewick S., 2016, ZIKA VIRUS ENDEMIC V
   Bicout DJ, 2004, VECTOR-BORNE ZOONOT, V4, P33, DOI 10.1089/153036604773082979
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brazil BDMEP, 1961, BANC DAD MET ENS PES
   Brazil SINAN, 2016, SIST INF AGR NOT
   Brazil ZG, 2016, NAT GUID ZIK VIR PAT
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carlson CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004968
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Champagne C, 2016, ELIFE, V5, DOI [10.7554/eLife.19874.001, 10.7554/eLife.19874]
   Chowell G., 2016, PLOS CURRENTS, V8
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   De Santis M, 2006, REPROD TOXICOL, V21, P390, DOI 10.1016/j.reprotox.2005.01.014
   Dickerson CZ., 2007, DOCTOR OF PHILOS
   Dorigatti I, 2013, P NATL ACAD SCI USA, V110, P13422, DOI 10.1073/pnas.1303117110
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   EUROCAT, 2003, EUR SURV CONG AN FIN
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria N. R., 2016, PLOS CURRENTS, V8
   Faria NR, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0356-2
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Feldstein LR, 2015, T ROY SOC TROP MED H, V109, P303, DOI 10.1093/trstmh/trv012
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Funk S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005173
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Golden Gate Weather Services, 2017, NIN NIN YEARS INT BA
   Hii YL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001908
   Cuong HQ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001322
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Hugo LE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002669
   Jaenisch T, 2016, B WORLD HEALTH ORGAN, P1
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Lampoudi S, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3074302
   Xuan LTT, 2014, GLOBAL HEALTH ACTION, V7, P52, DOI 10.3402/gha.v7.23119
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Lounibos LP, 2008, J AM MOSQUITO CONTR, V24, P11, DOI 10.2987/5656.1
   Lourenco J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003083
   Lourenco J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003308
   Madeira NG, 2002, MEM I OSWALDO CRUZ, V97, P415, DOI 10.1590/S0074-02762002000300025
   Maxian  O., 2017, EPIDEMICS
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Moghadas SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05013-9
   Mohammed A, 2011, ACTA TROP, V119, P38, DOI 10.1016/j.actatropica.2011.04.004
   Mordecai E, 2016, TEMPERATURE DETERMIN
   Mourya DT, 2004, AM J TROP MED HYG, V70, P346, DOI 10.4269/ajtmh.2004.70.346
   Naccache SN, 2016, EMERG INFECT DIS, V22, P1788, DOI 10.3201/eid2210.160663
   Naing ZW, 2016, AUST NZ J OBSTET GYN, V56, P9, DOI 10.1111/ajo.12408
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Otero M, 2006, B MATH BIOL, V68, P1945, DOI 10.1007/s11538-006-9067-y
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018860
   Rodrigues LC, 2016, LANCET INFECT DIS
   Rossi MM, 2015, ANN BIOMETRICS BIOST, V2, P1
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Salje H, 2016, J INFECT DIS, V213, P604, DOI 10.1093/infdis/jiv470
   SCHOOLFIELD RM, 1981, J THEOR BIOL, V88, P719, DOI 10.1016/0022-5193(81)90246-0
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   de Araujo JSS, 2016, B WORLD HEALTH ORGAN, V94, P835, DOI 10.2471/BLT.16.170639
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Tran A, 2013, INT J ENV RES PUB HE, V10, P1698, DOI 10.3390/ijerph10051698
   TRPIS M, 1986, AM J TROP MED HYG, V35, P1263, DOI 10.4269/ajtmh.1986.35.1263
   TRPIS M, 1995, J MED ENTOMOL, V32, P27, DOI 10.1093/jmedent/32.1.27
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   van Panhuis WG, 2015, P NATL ACAD SCI USA, V112, P13069, DOI 10.1073/pnas.1501375112
   Wearing HJ, 2006, P NATL ACAD SCI USA, V103, P11802, DOI 10.1073/pnas.0602960103
   WHO, 2016, WHO BRAZ STAT
   WHO [World Health Organization], 2016, MOSQ VECT CONTR EM R
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
   Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040
   YASUNO M, 1970, B WORLD HEALTH ORGAN, V43, P319
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang Q, 2016, PROJECTED SPREAD ZIK
   ZIBRA, 2016, ZIK BRAZ REAL TIM AN
NR 91
TC 20
Z9 20
U1 0
U2 19
PU ELIFE SCIENCES PUBLICATIONS LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
J9 ELIFE
JI eLife
PD SEP 9
PY 2017
VL 6
AR e29820
DI 10.7554/elife.29820
PG 25
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA FJ9HC
UT WOS:000413083000001
PM 28887877
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Mogling, R
   Zeller, H
   Revez, J
   Koopmans, M
   Reusken, C
AF Mogling, R.
   Zeller, H.
   Revez, J.
   Koopmans, M.
   Reusken, C.
CA ZIKV Reference Lab Grp
TI Status, quality and specific needs of Zika virus (ZIKV) diagnostic
   capacity and capability in National Reference Laboratories for
   arboviruses in 30 EU/EEA countries, May 2016
SO EUROSURVEILLANCE
LA English
DT Article
ID INFECTION; TRAVELERS
AB With international travel, Zika virus (ZIKV) is introduced to Europe regularly. A country's ability to robustly detect ZIKV introduction and local transmission is important to minimise the risk for a ZIKV outbreak. Therefore, sufficient expertise and diagnostic capacity and capability are required in European laboratories. To assess the capacity, quality, operational specifics (guidelines and algorithms), technical and interpretation issues and other possible difficulties that were related to ZIKV diagnostics in European countries, a questionnaire was conducted among national reference laboratories in 30 countries in the European Union/European Economic Area (EU/EEA) in May 2016. While the coverage and capacity of ZIKV diagnostics in the EU/EEA national reference laboratories were found to be adequate, the assessment of the quality and needs indicated several crucial points of improvement that will need support at national and EU/EEA level to improve ZIKV preparedness, response and EU/EEA ZIKV surveillance activities.
C1 [Mogling, R.; Koopmans, M.; Reusken, C.] Erasmus Univ, Med Ctr, Dept Virosci, Rotterdam, Netherlands.
   [Zeller, H.; Revez, J.] European Ctr Dis Prevent & Control, Stockholm, Sweden.
   [Koopmans, M.] Netherlands Ctr Infect Dis Control, Bilthoven, Netherlands.
RP Reusken, C (corresponding author), Erasmus Univ, Med Ctr, Dept Virosci, Rotterdam, Netherlands.
EM c.reusken@erasmusmc.nl
RI Koopmans, Marion/Y-9170-2019; VENTURI, GIULIETTA/O-8123-2015; Ramiere,
   Christophe/M-8083-2014; Dudman, Susanne Gjeruldsen/A-8411-2013
OI Koopmans, Marion/0000-0002-5204-2312; VENTURI,
   GIULIETTA/0000-0002-9078-8350; Ramiere, Christophe/0000-0002-1981-7155;
   SANCHEZ-SECO, MARIA PAZ/0000-0001-9033-7704; Alves, Maria
   Joao/0000-0003-0065-9000; Van Esbroeck, Marjan/0000-0002-7294-6319;
   Dudman, Susanne Gjeruldsen/0000-0001-5047-4982; Tolfvenstam,
   Thomas/0000-0003-3549-8083; Fomsgaard, Anders/0000-0003-4304-0603
FU ECDC [SRS-003-2016-RS]
FX This study was conducted with ECDC-funding SRS-003-2016-RS.
CR [Anonymous], 2012, 151892012EN ISO
   Baud D, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12614
   Charrel R, 2016, J CLIN MICR IN PRESS
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Cleton N, 2014, TRAVEL MED INFECT DI, V12, P159, DOI 10.1016/j.tmaid.2013.10.015
   Cleton N, 2012, J CLIN VIROL, V55, P191, DOI 10.1016/j.jcv.2012.07.004
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   de Sousa R, 2014, J CLIN VIROL, V59, P4, DOI 10.1016/j.jcv.2013.10.030
   ECDC, 2016, RAP RISK ASS ZIK VIR
   ECDC, 2017, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control (ECDC), 2016, ECDC TECHN DOC ZIK V
   European Centre for Disease Prevention and Control (ECDC), EM VIR DIS EXP LAB N
   European Centre for Disease Prevention and Control (ECDC), 2012, COORD COMP BOD STRUC
   European Centre for Disease Prevention and Control (ECDC), 2017, AED ALB CURR KNOWN D
   European Commission, 2016, EUR UN INV 45 MILL R
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   International Organization for Standardization (ISO), 2005, 170252005 ISOIEC
   International Organization for Standardization (ISO), 2015, ISO90012015EN
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Pan American Health Organization (PAHO), 2016, ZIK VIR ZIKV SURV AM
   Pan American Health Organization (PAHO), 2016, YEAR ZIK EV EM LONG
   Pathogens. ACoD, 2013, APPR LIST BIOL AG
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Vouga M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00383-4
   World Health Organization, 2016, LAB TEST ZIK VIR INF
   World Health Organization. Fifth meeting of the Emergency Committee under the International Health Regulations, 2005, 5 M EM COMM INT HLTH
   World Health Organization W, 2016, TECHNICAL REPORT
   World Health Organization (WHO), 2005, 1 M INT HLTH REG
   World Health organization (WHO), 2016, EM US ASS LIST EUAL
NR 35
TC 6
Z9 6
U1 0
U2 6
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD SEP 7
PY 2017
VL 22
IS 36
BP 18
EP 26
AR 30609
DI 10.2807/1560-7917.ES.2017.22.36.30609
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA FG7PM
UT WOS:000410610800003
PM 28920574
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Yoon, KJ
   Song, G
   Qian, XY
   Pan, JB
   Xu, D
   Rho, HS
   Kim, NS
   Habela, C
   Zheng, L
   Jacob, F
   Zhang, FR
   Lee, EM
   Huang, WK
   Ringeling, FR
   Vissers, C
   Li, C
   Yuan, L
   Kang, K
   Kim, S
   Yeo, J
   Cheng, YC
   Liu, S
   Wen, ZX
   Qin, CF
   Wu, QF
   Christian, KM
   Tang, HL
   Jin, P
   Xu, ZH
   Qian, J
   Zhu, H
   Song, HJ
   Ming, GL
AF Yoon, Ki-Jun
   Song, Guang
   Qian, Xuyu
   Pan, Jianbo
   Xu, Dan
   Rho, Hee-Sool
   Kim, Nam-Shik
   Habela, Christa
   Zheng, Lily
   Jacob, Fadi
   Zhang, Feiran
   Lee, Emily M.
   Huang, Wei-Kai
   Ringeling, Francisca Rojas
   Vissers, Caroline
   Li, Cui
   Yuan, Ling
   Kang, Koeun
   Kim, Sunghan
   Yeo, Junghoon
   Cheng, Yichen
   Liu, Sheng
   Wen, Zhexing
   Qin, Cheng-Feng
   Wu, Qingfeng
   Christian, Kimberly M.
   Tang, Hengli
   Jin, Peng
   Xu, Zhiheng
   Qian, Jiang
   Zhu, Heng
   Song, Hongjun
   Ming, Guo-li
TI Zika-Virus-Encoded NS2A Disrupts Mammalian Cortical Neurogenesis by
   Degrading Adherens Junction Proteins
SO CELL STEM CELL
LA English
DT Article
ID STEM-CELLS; IDENTIFICATION; SCHIZOPHRENIA; DEGRADATION; INFECTION;
   CADHERIN; GROWTH
AB Zika virus (ZIKV) directly infects neural progenitors and impairs their proliferation. How ZIKV interacts with the host molecular machinery to impact neurogenesis in vivo is not well understood. Here, by systematically introducing individual proteins encoded by ZIKV into the embryonic mouse cortex, we show that expression of ZIKV-NS2A, but not Dengue virus (DENV)-NS2A, leads to reduced proliferation and premature differentiation of radial glial cells and aberrant positioning of newborn neurons. Mechanistically, in vitro mapping of protein-interactomes and biochemical analysis suggest interactions between ZIKA-NS2A and multiple adherens junction complex (AJ) components. Functionally, ZIKV-NS2A, but not DENV-NS2A, destabilizes the AJ complex, resulting in impaired AJ formation and aberrant radial glial fiber scaffolding in the embryonic mouse cortex. Similarly, ZIKA-NS2A, but not DENV-NS2A, reduces radial glial cell proliferation and causes AJ deficits in human forebrain organoids. Together, our results reveal pathogenic mechanisms underlying ZIKV infection in the developing mammalian brain.
C1 [Yoon, Ki-Jun; Qian, Xuyu; Kim, Nam-Shik; Jacob, Fadi; Huang, Wei-Kai; Ringeling, Francisca Rojas; Vissers, Caroline; Kang, Koeun; Kim, Sunghan; Yeo, Junghoon; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.
   [Yoon, Ki-Jun; Kim, Nam-Shik; Habela, Christa; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.
   [Song, Guang; Rho, Hee-Sool; Zhu, Heng] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.
   [Qian, Xuyu; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Bioengn Grad Program, Baltimore, MD 21205 USA.
   [Pan, Jianbo; Liu, Sheng; Qian, Jiang] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA.
   [Zheng, Lily; Song, Hongjun] Johns Hopkins Univ, Sch Med, Human Genet Predoctoral Program, Baltimore, MD 21205 USA.
   [Jacob, Fadi; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.
   [Huang, Wei-Kai; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Grad Program Pathobiol, Baltimore, MD 21205 USA.
   [Vissers, Caroline; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Biochem Cellular & Mol Biol Grad Program, Baltimore, MD 21205 USA.
   [Ming, Guo-li] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.
   [Xu, Dan; Li, Cui; Wu, Qingfeng; Xu, Zhiheng] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing 100101, Peoples R China.
   [Xu, Dan] Fuzhou Univ, Inst Life Sci, Coll Biol Sci & Engn, Fuzhou 350116, Fujian, Peoples R China.
   [Zhang, Feiran; Jin, Peng] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.
   [Wen, Zhexing] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA.
   [Wen, Zhexing] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA.
   [Cheng, Yichen] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA.
   [Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept Virol, Beijing 100071, Peoples R China.
   [Song, Hongjun; Ming, Guo-li] Univ Penn, Perelman Sch Med, Mahoney Inst Neurosci, Dept Neurosci, Philadelphia, PA 19104 USA.
   [Song, Hongjun; Ming, Guo-li] Univ Penn, Perelman Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA.
   [Song, Hongjun] Univ Penn, Perelman Sch Med, Epigenet Inst, Philadelphia, PA 19104 USA.
RP Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.; Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.; Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Bioengn Grad Program, Baltimore, MD 21205 USA.; Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.; Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Grad Program Pathobiol, Baltimore, MD 21205 USA.; Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Biochem Cellular & Mol Biol Grad Program, Baltimore, MD 21205 USA.; Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.; Ming, GL (corresponding author), Univ Penn, Perelman Sch Med, Mahoney Inst Neurosci, Dept Neurosci, Philadelphia, PA 19104 USA.; Ming, GL (corresponding author), Univ Penn, Perelman Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA.
EM gming@mail.med.upenn.edu
RI Yoon, Ki-Jun/S-8170-2018; Qin, Cheng-Feng/I-6839-2019; Wen,
   Zhexing/L-1228-2018; Qian, Xuyu/C-1240-2017; Song, guang/I-6224-2019;
   Pan, Jianbo/M-6708-2018
OI Qin, Cheng-Feng/0000-0002-0632-2807; Wen, Zhexing/0000-0002-1518-3845;
   Qian, Xuyu/0000-0001-5944-3816; Song, guang/0000-0002-7630-716X; Pan,
   Jianbo/0000-0001-6014-8160; Jacob, Fadi/0000-0002-0094-8454; Zheng,
   Lily/0000-0003-2722-3522; Yoon, Ki-Jun/0000-0003-2985-2541; Rojas
   Ringeling, Francisca/0000-0001-8776-9768; Wu,
   Qing-Feng/0000-0003-3272-6247; Ming, Guo-li/0000-0002-2517-6075; Xu,
   Zhiheng/0000-0002-4809-2851; Zhang, Feiran/0000-0001-6222-6177
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R35NS097370, R01MH105128, U19AI131130,
   R37NS047344, U19MH106434, P01NS097206, R01GM111514, R25NS065729,
   K12NS098482, AI119530]; Simons Foundation (SFARI grant) [308988];
   Maryland Stem Cell Research Fund (MSCRF); start-up funding from Emory;
   start-up funding from IGDB of CAS; China NSFNational Natural Science
   Foundation of China [31430037]; MOST "973'' program [2014CB942801,
   2012YQ03026006]; Zika seed funding from Florida State University; MSCRF;
   Young Investigator Award from Brain & Behavior Research Foundation; NSF
   fellowshipNational Science Foundation (NSF);  [T32GM007445]
FX We thank members of Ming and Song laboratories for suggestions, L. Liu
   and Y. Cai for technical support, J. Schnoll for manuscript editing, and
   Dr. Park for help with statistical analysis. This work was supported by
   NIH grants R35NS097370 and R01MH105128 (G.M.), U19AI131130 (G.M., H.T.,
   P.J., and Z.W.), R37NS047344 (H.S.), U19MH106434 (G.M., J.Q., and H.S.),
   P01NS097206 (H.S., J.Q., and P.J.), R01GM111514 (H.Z. and J.Q.),
   R25NS065729 and K12NS098482 (C.H.), and AI119530 (H.T.); the Simons
   Foundation (SFARI grant 308988 to H.S.); the Maryland Stem Cell Research
   Fund (MSCRF) (G.M. and H.S.); start-up funding from Emory (Z.W.);
   start-up funding from IGDB of CAS (Q.W.); China NSF (31430037) and the
   MOST "973'' program (2014CB942801 and 2012YQ03026006 to D.X. and Z.X.);
   and Zika seed funding from Florida State University (H.T.). K.-J.Y. was
   supported by a postdoctoral fellowship from MSCRF and by a Young
   Investigator Award from Brain & Behavior Research Foundation. C.V. was
   partially supported by an NSF fellowship and T32GM007445.
CR Agrawal T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069465
   Besnard M., 2016, EURO SURVEILL, V21
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Buchman JJ, 2007, NAT REV NEUROSCI, V8, P89, DOI 10.1038/nrn2058
   Chen YT, 1999, J CELL BIOL, V144, P687, DOI 10.1083/jcb.144.4.687
   Chiang CH, 2011, MOL PSYCHIATR, V16, P358, DOI 10.1038/mp.2011.13
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Currle D Spencer, 2007, J Vis Exp, P152, DOI 10.3791/152
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Garcia-Blanco MA, 2016, ANTIVIR RES, V134, P244, DOI 10.1016/j.antiviral.2016.09.010
   Giry-Laterriere M, 2011, METHODS MOL BIOL, V737, P183, DOI 10.1007/978-1-61779-095-9_8
   Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hu SH, 2013, ELIFE, V2, DOI 10.7554/eLife.00726
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Jeong JS, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016253
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   Ma DK, 2008, STEM CELLS, V26, P2131, DOI 10.1634/stemcells.2008-0388
   Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100
   Medigeshi GR, 2009, J VIROL, V83, P6125, DOI 10.1128/JVI.02617-08
   Ming G. L., 2016, NEW ENGL J MED, V19, P690
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Pylro VS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004817
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasin MR, 2007, NAT NEUROSCI, V10, P819, DOI 10.1038/nn1924
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sarno M, 2016, ULTRASOUND OBSTET GY
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Stocker AM, 2015, CELL ADHES MIGR, V9, P167, DOI 10.1080/19336918.2015.1027478
   Su YJ, 2017, NAT NEUROSCI, V20, P476, DOI 10.1038/nn.4494
   Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wen ZX, 2017, GENE DEV, V31, P849, DOI 10.1101/gad.298216.117
   Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yoon KJ, 2014, CELL STEM CELL, V15, P79, DOI 10.1016/j.stem.2014.05.003
   YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707
   Zhu J, 2009, J VIROL, V83, P5219, DOI 10.1128/JVI.02378-08
NR 45
TC 49
Z9 54
U1 0
U2 21
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1934-5909
EI 1875-9777
J9 CELL STEM CELL
JI Cell Stem Cell
PD SEP 7
PY 2017
VL 21
IS 3
BP 349
EP +
DI 10.1016/j.stem.2017.07.014
PG 16
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA FG1BN
UT WOS:000409527700012
PM 28826723
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Yuan, S
   Zhang, ZW
   Li, ZL
AF Yuan, Shu
   Zhang, Zhong-Wei
   Li, Zi-Lin
TI Trehalose May Decrease the Transmission of Zika Virus to the Fetus by
   Activating Degradative Autophagy
SO FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
LA English
DT Editorial Material
DE autophagy; exosome; lysosomal fusion; trehalose; Zika virus
ID HEPATITIS-C VIRUS; WEST NILE VIRUS; MOUSE MODEL; INFECTION; REPLICATION;
   DENGUE; EXOSOMES; FLUX
C1 [Yuan, Shu; Zhang, Zhong-Wei] Sichuan Agr Univ, Coll Resources, Chengdu, Sichuan, Peoples R China.
   [Li, Zi-Lin] Med Univ Air Force, Xijing Hosp, Dept Cardiovasc Surg, Xian, Shaanxi, Peoples R China.
RP Yuan, S (corresponding author), Sichuan Agr Univ, Coll Resources, Chengdu, Sichuan, Peoples R China.
EM roundtree318@hotmail.com
FU Preeminent Youth Fund of Sichuan Province [2015JQO045]
FX This work was funded by the Preeminent Youth Fund of Sichuan Province
   (2015JQO045).
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   BEDARD A, 2017, EUR RESPIR J, V50
   Belzile JP, 2016, J VIROL, V90, P1259, DOI 10.1128/JVI.02651-15
   Carneiro LAM, 2016, MICROBES INFECT, V18, P169, DOI 10.1016/j.micinf.2015.12.006
   Chahar HS, 2015, VIRUSES-BASEL, V7, P3204, DOI 10.3390/v7062770
   Chu LW, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.1.011018
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   de Souza AS, 2016, CLIN INFECT DIS, V63, P1622, DOI 10.1093/cid/ciw613
   Dong XN, 2013, J INNATE IMMUN, V5, P480, DOI 10.1159/000346388
   Dreux M, 2009, P NATL ACAD SCI USA, V106, P14046, DOI 10.1073/pnas.0907344106
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Echigo R, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-80
   Ejlerskov P, 2013, J BIOL CHEM, V288, P17313, DOI 10.1074/jbc.M112.401174
   Eroglu A, 2003, CRYOBIOLOGY, V46, P121, DOI 10.1016/S0011-2240(03)00018-X
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hazlett LD, 2010, OCUL IMMUNOL INFLAMM, V18, P237, DOI 10.3109/09273948.2010.501946
   Jackson WT, 2015, VIROLOGY, V479, P450, DOI 10.1016/j.virol.2015.03.042
   Kobayashi S, 2014, VIRUS RES, V191, P83, DOI 10.1016/j.virusres.2014.07.016
   Lee YR, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-65
   Lennemann NJ, 2017, AUTOPHAGY, V13, P322, DOI 10.1080/15548627.2016.1265192
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li JK, 2012, MICROBES INFECT, V14, P159, DOI 10.1016/j.micinf.2011.09.001
   Longatti A, 2015, VIRUSES-BASEL, V7, P6707, DOI 10.3390/v7122967
   Martin-Acebes MA, 2015, AUTOPHAGY, V11, P861, DOI 10.1080/15548627.2015.1037062
   Metz P, 2015, J VIROL, V89, P8026, DOI 10.1128/JVI.00787-15
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nour AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003585
   Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015
   Panyasrivanit M, 2009, AUTOPHAGY, V5, P434, DOI 10.4161/auto.5.3.7925
   Ponpuak M, 2015, CURR OPIN CELL BIOL, V35, P106, DOI 10.1016/j.ceb.2015.04.016
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Ramakrishnaiah V, 2013, P NATL ACAD SCI USA, V110, P13109, DOI 10.1073/pnas.1221899110
   Richards AB, 2002, FOOD CHEM TOXICOL, V40, P871, DOI 10.1016/S0278-6915(02)00011-X
   Rolfe AJ, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0110-x
   Schaeffer V, 2012, BRAIN, V135, P2169, DOI 10.1093/brain/aws143
   Sergin I, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15750
   Sharma M, 2014, AUTOPHAGY, V10, P1637, DOI 10.4161/auto.29455
   Shrivastava S, 2016, J VIROL, V90, P1387, DOI 10.1128/JVI.02383-15
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   TORJESEN I, 2017, BMJ-BRIT MED J, V358, DOI DOI 10.1136/BMJ.J3293
   Vandergaast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045800
   Wurmser AE, 2000, J CELL BIOL, V151, P551, DOI 10.1083/jcb.151.3.551
   Yuan S, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00231
   Yuan S, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00062
   Zhang XJ, 2014, AUTOPHAGY, V10, P588, DOI 10.4161/auto.27710
   Zhang XJ, 2011, AUTOPHAGY, V7, P412, DOI 10.4161/auto.7.4.14541
   Zhang ZW, 2017, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00206
NR 49
TC 5
Z9 5
U1 0
U2 8
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2235-2988
J9 FRONT CELL INFECT MI
JI Front. Cell. Infect. Microbiol.
PD SEP 6
PY 2017
VL 7
AR 402
DI 10.3389/fcimb.2017.00402
PG 5
WC Immunology; Microbiology
SC Immunology; Microbiology
GA FG3IN
UT WOS:000410041700001
PM 28932709
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hallmaier-Wacker, LK
   Munster, VJ
   Knauf, S
AF Hallmaier-Wacker, Luisa K.
   Munster, Vincent J.
   Knauf, Sascha
TI Disease reservoirs: from conceptual frameworks to applicable criteria
SO EMERGING MICROBES & INFECTIONS
LA English
DT Review
DE disease eradication; infection; infectious diseases; interdisciplinary;
   one health; multidisciplinary
ID LYME-DISEASE; ECHINOCOCCUS-MULTILOCULARIS; BORRELIA-BURGDORFERI;
   EBOLA-VIRUS; ZIKA VIRUS; INFECTION; RABIES; SURVEILLANCE; TRANSMISSION;
   CHALLENGES
AB Central to the One Health approach and any disease eradication program is the question of whether a pathogen has a non-human reservoir. Despite well-established conceptual frameworks that define a reservoir of infection, empirical characterization of reservoirs often remains controversial, challenging and sometimes misleading. What is essentially missing are applicable requirements that standardize the use of the term 'reservoir of infection' across multiple disciplines. We propose an empirical framework, considering maintenance and feasible transmission of a pathogen, to standardize the acceptance of a disease reservoir across multiple disciplines. We demonstrate the intended use of these requirements by applying them to different diseases that are known to infect both humans and animals.
C1 [Hallmaier-Wacker, Luisa K.; Knauf, Sascha] Leibniz Inst Primate Res, German Primate Ctr, Pathol Unit, Work Grp Neglected Trop Dis, Kellnerweg 4, D-37077 Gottingen, Germany.
   [Hallmaier-Wacker, Luisa K.] Leibniz Inst Primate Res, German Primate Ctr, Primate Genet Lab, Kellnerweg 4, D-37077 Gottingen, Germany.
   [Munster, Vincent J.] NIAID, Virus Ecol Unit, Lab Virol, Div Intramural Res,Rocky Mt Labs,NIH, Hamilton, MT 59840 USA.
RP Knauf, S (corresponding author), Leibniz Inst Primate Res, German Primate Ctr, Pathol Unit, Work Grp Neglected Trop Dis, Kellnerweg 4, D-37077 Gottingen, Germany.
EM sknauf@dpz.eu
RI Munster, Vincent/I-7607-2018
OI Munster, Vincent/0000-0002-2288-3196
FU Intramural Research Program of the National Institute of Allergy and
   Infectious Diseases (NIAID), National Institutes of Health (NIH); German
   Research Foundation (DFG)German Research Foundation (DFG) [KN1097/3-1,
   KN1097/4-1]
FX VJM is supported by the Intramural Research Program of the National
   Institute of Allergy and Infectious Diseases (NIAID), National
   Institutes of Health (NIH). SK received funding from the German Research
   Foundation (DFG): KN1097/3-1 and KN1097/4-1. We would like to thank the
   reviewer for addressing important aspects that clearly improved the
   proposed framework.
CR Almeida MAB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002741
   Barbour AG, 1996, J INFECT DIS, V173, P403, DOI 10.1093/infdis/173.2.403
   Bi ZQ, 2008, J INFECT DEV COUNTR, V2, P3
   Chautan M, 2000, MAMMALIA, V64, P391, DOI 10.1515/mamm.2000.64.4.391
   Craig P, 2003, CURR OPIN INFECT DIS, V16, P437, DOI 10.1097/00001432-200310000-00010
   Dapp MJ, 2013, J MOL BIOL, V425, P41, DOI 10.1016/j.jmb.2012.10.009
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dietze R, 1997, CLIN INFECT DIS, V25, P1240, DOI 10.1086/516096
   Ezenwa VO, 2015, SCIENCE, V347, P175, DOI 10.1126/science.1261714
   Favoretto S, 2016, BIORXIV
   Fitzgerald SD, 2013, VET PATHOL, V50, P488, DOI 10.1177/0300985812467472
   Giardina AR, 2000, CAN J ZOOL, V78, P2184, DOI 10.1139/cjz-78-12-2184
   Harper K, 2013, PRIMATES PATHOGENS E, P189
   Hemachudha T, 2002, LANCET NEUROL, V1, P101, DOI 10.1016/S1474-4422(02)00041-8
   Hofmann W, 1999, J VIROL, V73, P10020, DOI 10.1128/JVI.73.12.10020-10028.1999
   Hoye BJ, 2011, OIKOS, V120, P748, DOI 10.1111/j.1600-0706.2010.18961.x
   Kao RR, 2014, TRENDS MICROBIOL, V22, P282, DOI 10.1016/j.tim.2014.02.011
   Knauf S, 2016, EBIOMEDICINE, V11, P85, DOI 10.1016/j.ebiom.2016.07.033
   Knauf S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003637
   Kuenzi AJ, 2005, J WILDLIFE DIS, V41, P473, DOI 10.7589/0090-3558-41.3.473
   Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a
   Lindenfors P, 2007, GLOBAL ECOL BIOGEOGR, V16, P496, DOI 10.1111/j.1466-8238.2006.00301.x
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   McCafferty J, 2013, ISME J, V7, P2116, DOI 10.1038/ismej.2013.106
   MENGE BA, 1976, AM NAT, V110, P351, DOI 10.1086/283073
   Michel AL, 2010, VET MICROBIOL, V140, P371, DOI 10.1016/j.vetmic.2009.08.029
   Miosge LA, 2015, P NATL ACAD SCI USA, V112, pE5189, DOI 10.1073/pnas.1511585112
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Moriarty TJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000090
   Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001
   Ogden NH, 2010, ENVIRON HEALTH PERSP, V118, P909, DOI 10.1289/ehp.0901766
   Okinaka R, 1999, J APPL MICROBIOL, V87, P261, DOI 10.1046/j.1365-2672.1999.00883.x
   Pourrut X, 2005, MICROBES INFECT, V7, P1005, DOI 10.1016/j.micinf.2005.04.006
   Prakash T, 2012, BRIEF BIOINFORM, V13, P711, DOI 10.1093/bib/bbs033
   Roche B, 2013, AM NAT, V181, P1, DOI 10.1086/668591
   Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Rupprecht CE, 2002, LANCET INFECT DIS, V2, P327, DOI 10.1016/S1473-3099(02)00287-6
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   Schweiger A, 2007, EMERG INFECT DIS, V13, P878, DOI 10.3201/eid1306.061074
   Sidwa TJ, 2005, JAVMA-J AM VET MED A, V227, P785, DOI 10.2460/javma.2005.227.785
   Smajs D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020415
   Tang JW, 2009, J R SOC INTERFACE, V6, pS737, DOI 10.1098/rsif.2009.0227.focus
   Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888
   Tilly K, 2008, INFECT DIS CLIN N AM, V22, P217, DOI 10.1016/j.idc.2007.12.013
   VEIT P, 1995, PARASITOLOGY, V110, P79, DOI 10.1017/S0031182000081075
   Walker TM, 2014, LANCET RESP MED, V2, P285, DOI 10.1016/S2213-2600(14)70027-X
   Weingartl HM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00811
   Zeppelini CG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004949
NR 49
TC 8
Z9 8
U1 1
U2 20
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD SEP 6
PY 2017
VL 6
AR e79
DI 10.1038/emi.2017.65
PG 5
WC Immunology; Microbiology
SC Immunology; Microbiology
GA FF9VM
UT WOS:000409366200001
PM 28874791
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Nejati, J
   Bueno-Mari, R
   Collantes, F
   Hanafi-Bojd, AA
   Vatandoost, H
   Charrahy, Z
   Tabatabaei, SM
   Yaghoobi-Ershadi, MR
   Hasanzehi, A
   Shirzadi, MR
   Moosa-Kazemi, SH
   Sedaghat, MM
AF Nejati, Jalil
   Bueno-Mari, Ruben
   Collantes, Francisco
   Hanafi-Bojd, Ahmad A.
   Vatandoost, Hassan
   Charrahy, Zabihollah
   Tabatabaei, Seyed M.
   Yaghoobi-Ershadi, Mohammad R.
   Hasanzehi, Abdolghafar
   Shirzadi, Mohammad R.
   Moosa-Kazemi, Seyed H.
   Sedaghat, Mohammad M.
TI Potential Risk Areas of Aedes albopictus in South-Eastern Iran: A Vector
   of Dengue Fever, Zika, and Chikungunya
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Aedes albopictus; dengue fever; zika virus; modeling; analytical
   hierarchy process; geographical information system; remote sensing
ID CONGO HEMORRHAGIC-FEVER; BALUCHESTAN PROVINCE; DIPTERA-CULICIDAE;
   SEASONAL ACTIVITY; VIRUS-INFECTION; 1ST RECORD; SISTAN; TRANSMISSION;
   MOSQUITOS; AEGYPTI
AB The possibility of the rapid and global spread of Zika, chikungunya, yellow fever, and dengue fever by Aedes albopictus is well documented and may be facilitated by changes in climate. To avert and manage health risks, climatic and topographic information can be used to model and forecast which areas may be most prone to the establishment of Ae. albopictus. We aimed to weigh and prioritize the predictive value of various meteorological and climatic variables on distributions of Ae. albopictus in south-eastern Iran using the Analytical Hierarchy Process. Out of eight factors used to predict the presence of Ae. albopictus, the highest weighted were land use, followed by temperature, altitude, and precipitation. The inconsistency of this analysis was 0.03 with no missing judgments. The areas predicted to be most at risk of Ae. albopictus-borne diseases were mapped using Geographic Information Systems and remote sensing data. Five-year (2011-2015) meteorological data was collected from 11 meteorological stations and other data was acquired from Landsat and Terra satellite images. Southernmost regions were at greatest risk of Ae. albopictus colonization as well as more urban sites connected by provincial roads. This is the first study in Iran to determine the regional probability of Ae. albopictus establishment. Monitoring and collection of Ae. albopictus from the environment confirmed our projections, though on-going field work is necessary to track the spread of this vector of life-threatening disease.
C1 [Nejati, Jalil; Hanafi-Bojd, Ahmad A.; Vatandoost, Hassan; Yaghoobi-Ershadi, Mohammad R.; Moosa-Kazemi, Seyed H.; Sedaghat, Mohammad M.] Univ Tehran Med Sci, Sch Publ Hlth, Dept Med Entomol & Vector Control, Tehran, Iran.
   [Bueno-Mari, Ruben] Lab Lokim, Dept Invest & Desarrollo I D, Valencia, Spain.
   [Collantes, Francisco] Univ Murcia, Dept Zool & Phys Anthropol, Murcia, Spain.
   [Hanafi-Bojd, Ahmad A.; Vatandoost, Hassan] Univ Tehran Med Sci, Inst Environm Res, Dept Environm Chem Pollutants & Pesticides, Tehran, Iran.
   [Charrahy, Zabihollah] Univ Tehran, Dept Nat Resources & Environm Sci, Tehran, Iran.
   [Tabatabaei, Seyed M.; Hasanzehi, Abdolghafar] Zahedan Univ Med Sci, Infect Dis & Trop Med Res Ctr, Zahedan, Iran.
   [Shirzadi, Mohammad R.] Minist Hlth & Med Educ, Zoonoses Control Dept, Tehran, Iran.
RP Hanafi-Bojd, AA; Vatandoost, H (corresponding author), Univ Tehran Med Sci, Sch Publ Hlth, Dept Med Entomol & Vector Control, Tehran, Iran.; Hanafi-Bojd, AA; Vatandoost, H (corresponding author), Univ Tehran Med Sci, Inst Environm Res, Dept Environm Chem Pollutants & Pesticides, Tehran, Iran.
EM aahanafibojd@tums.ac.ir; hvatandoost1@yahoo.com
RI Collantes, Francisco/L-5937-2019; Collantes, Francisco/M-4798-2017;
   Nejati, Jalil/Y-5323-2019
OI Collantes, Francisco/0000-0002-8085-6399; Collantes,
   Francisco/0000-0002-8085-6399; shirzadi, mohammad
   reza/0000-0002-7993-8362; , Mohammad Mehdi Sedaghat/0000-0002-1365-0796
FU Tehran University of Medical SciencesTehran University of Medical
   Sciences [9121260011]
FX This study was financially supported by Tehran University of Medical
   Sciences with the Grant Number 9121260011.
CR Abbaspour M., 2005, INT J ENVIRON STUD, V62, P709, DOI DOI 10.1080/00207230500288968
   Abdul Aziz A.-A., 2012, INT J SOFTWARE ENG, V2, P7, DOI DOI 10.5923/J.SE.20120201.02
   Aghaie A, 2014, TRANSFUS APHER SCI, V50, P59, DOI 10.1016/j.transci.2013.07.034
   Alizadeh-Choobari O, 2014, ATMOS RES, V143, P328, DOI 10.1016/j.atmosres.2014.02.001
   Almeida APG, 2005, J MED ENTOMOL, V42, P419, DOI 10.1603/0022-2585(2005)042[0419:BAVCOA]2.0.CO;2
   Alto BW, 2001, J MED ENTOMOL, V38, P646, DOI 10.1603/0022-2585-38.5.646
   Amiraslani F, 2011, J ENVIRON MANAGE, V92, P1, DOI 10.1016/j.jenvman.2010.08.012
   [Anonymous], 2016, EUR CTR DIS PREV CON
   Aranda C, 2006, MED VET ENTOMOL, V20, P150, DOI 10.1111/j.1365-2915.2006.00605.x
   Banu S, 2011, TROP MED INT HEALTH, V16, P598, DOI 10.1111/j.1365-3156.2011.02734.x
   Baneres AB, 2012, B MALARIOL SALUD AMB, V52, P257
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Bueno-Mari R, 2015, J VECTOR DIS, V52, P175
   Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138
   CDC, 2016, COUNTR TERR WHER CHI
   Chinikar S, 2013, TRAVEL MED INFECT DI, V11, P166, DOI 10.1016/j.tmaid.2012.10.001
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Collantes F, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1262-y
   Dale P. E. R., 2008, Wetlands Ecology and Management, V16, P255, DOI 10.1007/s11273-008-9098-2
   Devi N. Pemola, 2004, Journal of Vector Borne Diseases, V41, P17
   Dhimal M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003545
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Dinpashoh Y, 2004, J HYDROL, V297, P109, DOI 10.1016/j.jhydrol.2004.04.009
   Doosti S, 2016, IRAN J PUBLIC HEALTH, V45, P1064
   Ganushkina LA, 2016, VECTOR-BORNE ZOONOT, V16, P58, DOI 10.1089/vbz.2014.1761
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Hanafi-Bojd AA, 2012, ACTA TROP, V121, P85, DOI 10.1016/j.actatropica.2011.04.017
   Hanafi-Bojd AA, 2015, J MED ENTOMOL, V52, P557, DOI 10.1093/jme/tjv058
   Higa Y, 2010, J AM MOSQUITO CONTR, V26, P1, DOI 10.2987/09-5945.1
   Honorio NA, 2003, MEM I OSWALDO CRUZ, V98, P191, DOI 10.1590/S0074-02762003000200005
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Izadi S, 2004, INT J INFECT DIS, V8, P299, DOI 10.1016/j.ijid.2003.10.008
   Jupille H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004901
   Khan J, 2015, IMMUNITY DIS, V3, pa11, DOI DOI 10.5281/ZEN0D0.816342
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Labib A., 2009, OR INSIGHT, V22, P201, DOI [DOI 10.1057/ori.2009.10, DOI 10.1057/0RI.2009.10]
   Lashkaripour GR, 2005, DESALINATION, V177, P1, DOI 10.1016/j.desal.2004.12.002
   Medlock JM, 2006, J VECTOR ECOL, V31, P292, DOI 10.3376/1081-1710(2006)31[292:AOTPFS]2.0.CO;2
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Mostafavi E, 2013, AM J TROP MED HYG, V89, P1135, DOI 10.4269/ajtmh.12-0509
   Mukhtar M, 2011, DENGUE B, V35, P99
   Nejati Jalil, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P1003, DOI 10.1016/S2221-1691(13)60193-8
   Neteler M, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-49
   Nihei N, 2014, GEOSPATIAL HEALTH, V8, P417, DOI 10.4081/gh.2014.30
   Owen T, 2005, AMBIO, V34, P445, DOI 10.1639/0044-7447(2005)034[0445:TMRSHS]2.0.CO;2
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Rasheed SB, 2013, PUBLIC HEALTH, V127, P11, DOI 10.1016/j.puhe.2012.09.006
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Roiz D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014800
   SAATY TL, 1990, EUR J OPER RES, V48, P9, DOI 10.1016/0377-2217(90)90057-I
   Sarfraz MS, 2014, GEOSPATIAL HEALTH, V8, pS685, DOI 10.4081/gh.2014.297
   SOTA T, 1992, ENTOMOL EXP APPL, V63, P155, DOI 10.1007/BF00343575
   Srivastava A, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-30
   Suleman M, 2016, ASIAN PAC J TROP MED, V9, P371, DOI 10.1016/j.apjtm.2016.03.010
   Takken W, 2007, EMERGING PESTS VECTO, DOI [10.3920/978-90-8686-626-7, DOI 10.3920/978-90-8686-626-7]
   Takumi K, 2009, VECTOR-BORNE ZOONOT, V9, P191, DOI 10.1089/vbz.2008.0038
   Vanwambeke SO, 2011, TROP MED INT HEALTH, V16, P174, DOI 10.1111/j.1365-3156.2010.02671.x
   Vatandoost H., 2011, Eastern Mediterranean Health Journal, V17, P439
   Waldock J, 2013, PATHOG GLOB HEALTH, V107, P224, DOI 10.1179/2047773213Y.0000000100
   Werneck GL, 2008, CIENC SAUDE COLETIVA, V13, P1753, DOI 10.1590/S1413-81232008000600010
   WHO, 2014, BEGK TRIO DUS STAT U
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization (WHO), 2016, ZIK VIR VECT RISK SP
NR 65
TC 5
Z9 6
U1 1
U2 26
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD SEP 5
PY 2017
VL 8
AR 1660
DI 10.3389/fmicb.2017.01660
PG 12
WC Microbiology
SC Microbiology
GA FF9OK
UT WOS:000409345800001
PM 28928720
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kauffman, E
   Payne, A
   Franke, MA
   Schmid, MA
   Harris, E
   Kramer, LD
AF Kauffman, Elizabeth
   Payne, Anne
   Franke, Mary A.
   Schmid, Michael A.
   Harris, Eva
   Kramer, Laura D.
TI Rearing of Culex spp. and Aedes spp. Mosquitoes
SO BIO-PROTOCOL
LA English
DT Article
DE Mosquito; Egg; Larva; Pupa; Adult; Colony; Blood-feeding; Aedes; Culex
AB Mosquito-transmitted pathogens cause major public health problems and contribute substantially to the global burden of disease. Aedes mosquitoes transmit dengue, Zika, yellow fever, and Chikungunya viruses; Culex mosquitoes transmit West Nile, Japanese encephalitis, and Saint Louis encephalitis viruses, among others. Experiments utilizing laboratory-reared colonized mosquitoes can address many issues such as vector biology, vector competence, vector-pathogen interaction, and vector control. The establishment of healthy and standardized mosquito colonies requires generation and implementation of protocols, attention to detail, and an understanding of the factors that affect mosquito fitness, such as temperature and humidity, nutrient quality and availability, population density, blood feeding and mating behavior, and egg-laying requirements. Here, we present a standard protocol for the rearing of Culex spp. and Aedes spp. mosquitoes and maintenance of the mosquito colony.
C1 [Kauffman, Elizabeth; Payne, Anne; Franke, Mary A.; Kramer, Laura D.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12203 USA.
   [Schmid, Michael A.] Univ Leuven, Rega Inst Med Res Virol & Chemotherapy, Dept Immunol & Microbiol, Leuven, Belgium.
   [Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Kramer, Laura D.] SUNY Albany, Sch Publ Hlth, Albany, NY 12222 USA.
RP Kramer, LD (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12203 USA.; Kramer, LD (corresponding author), SUNY Albany, Sch Publ Hlth, Albany, NY 12222 USA.
EM laura.kramer@health.ny.gov
OI Schmid, Michael A./0000-0002-1137-9322
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [1 C06 RR 17715-01]; Wadsworth Center
FX Establishment of the high-containment insectary facilities at the
   Wadsworth Center, New York State Department of Health, was made possible
   through funding grant from NIH (1 C06 RR 17715-01) and matching funds
   from Wadsworth Center. We thank all the insectary staff who over the
   years have assisted in rearing mosquitoes to establish colonies and
   supply mosquitoes for use in laboratory studies, and for their help in
   developing protocols.
CR Benedict MQ, 2003, VECTOR-BORNE ZOONOT, V3, P63
   Gerberg E., 1994, MANUAL MOSQUITO REAR
   Higgs S, 2005, BIOL DIS VECTORS, P727
   Higgs Stephen, 1996, P595
   Imam Hashmat, 2014, Trop Parasitol, V4, P53, DOI 10.4103/2229-5070.129167
   Schmid MA, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2407
NR 6
TC 8
Z9 8
U1 0
U2 4
PU BIO-PROTOCOL
PI SUNNYVALE
PA PO BOX 2073, SUNNYVALE, CA 94087 USA
EI 2331-8325
J9 BIO-PROTOCOL
JI Bio-protocol
PD SEP 5
PY 2017
VL 7
IS 17
AR e2542
DI 10.21769/BioProtoc.2542
PG 15
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA VH9EN
UT WOS:000457840700019
PM 29075656
OA Green Accepted
DA 2020-07-08
ER

PT J
AU George, J
   Valiant, WG
   Mattapallil, MJ
   Walker, M
   Huang, YJS
   Vanlandingham, DL
   Misamore, J
   Greenhouse, J
   Weiss, DE
   Verthelyi, D
   Higgs, S
   Andersen, H
   Lewis, MG
   Mattapallil, JJ
AF George, Jeffy
   Valiant, William G.
   Mattapallil, Mary J.
   Walker, Michelle
   Huang, Yan-Jang S.
   Vanlandingham, Dana L.
   Misamore, John
   Greenhouse, Jack
   Weiss, Deborah E.
   Verthelyi, Daniela
   Higgs, Stephen
   Andersen, Hanne
   Lewis, Mark G.
   Mattapallil, Joseph J.
TI Prior Exposure to Zika Virus Significantly Enhances Peak Dengue-2
   Viremia in Rhesus Macaques
SO SCIENTIFIC REPORTS
LA English
DT Article
ID CLINICAL LABORATORY RESPONSES; PERIPHERAL-BLOOD; IMMUNE-RESPONSE;
   INFECTION; MONKEYS; ANTIBODY; PATHOGENESIS; FEVER; SPECIFICITY;
   HEMORRHAGE
AB Structural and functional homologies between the Zika and Dengue viruses' envelope proteins raise the possibility that cross-reactive antibodies induced following Zika virus infection might enhance subsequent Dengue infection. Using the rhesus macaque model we show that prior infection with Zika virus leads to a significant enhancement of Dengue-2 viremia that is accompanied by neutropenia, lympocytosis, hyperglycemia, and higher reticulocyte counts, along with the activation of pro-inflammatory monocyte subsets and release of inflammatory mediators. Zika virus infection induced detectable Dengue cross-reactive serum IgG responses that significantly amplified after Dengue-2 virus infection. Serum from Zika virus immune animals collected prior to Dengue-2 infection showed significant capacity for in vitro antibody dependent enhancement of Dengue-1, 2, 3 and 4 serotypes suggesting that pre-existing immunity to Zika virus could potentially enhance infection by heterologous Dengue serotypes. Our results provide first in vivo evidence that prior exposure to Zika virus infection can enhance Dengue infection, which has implications for understanding pathogenesis and the development of vaccines.
C1 [George, Jeffy; Valiant, William G.; Mattapallil, Joseph J.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.
   [Mattapallil, Mary J.] NEI, NIH, Bethesda, MD 20892 USA.
   [Walker, Michelle; Misamore, John; Greenhouse, Jack; Weiss, Deborah E.; Andersen, Hanne; Lewis, Mark G.] Bioqual Inc, Rockville, MD USA.
   [Huang, Yan-Jang S.; Vanlandingham, Dana L.; Higgs, Stephen] Kansas State Univ, Coll Vet Med, Biosecur Res Inst, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA.
   [Verthelyi, Daniela] US FDA, Silver Spring, MD USA.
RP Mattapallil, JJ (corresponding author), Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.
EM joseph.mattapallil@usuhs.edu
RI GEORGE, JEFFY/M-9900-2019; GEORGE, JEFFY/A-1606-2010
OI GEORGE, JEFFY/0000-0003-1144-9244; Mattapallil,
   Joseph/0000-0002-7412-9507
FU Uniformed Services University; Kansas State University; FDA Medical
   Countermeasures Initiative
FX The described project was supported by funds from Uniformed Services
   University to JJM, Kansas State University to DLV, and the FDA Medical
   Countermeasures Initiative to DV. The opinions or assertions contained
   herein are the private ones of the authors and are not to be construed
   as official or reflecting the views of the Department of Defense, the
   Uniformed Services University or any other agency of the U.S.
   Government.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Azeredo EL, 2010, IMMUNOLOGY, V130, P202, DOI 10.1111/j.1365-2567.2009.03224.x
   Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Carvalho DM, 2014, J TROP MED-US, V2014, DOI 10.1155/2014/901276
   Chadwick D, 2006, J CLIN VIROL, V35, P147, DOI 10.1016/j.jcv.2005.06.002
   CHIOFALO MS, 1988, CELL IMMUNOL, V114, P272, DOI 10.1016/0008-8749(88)90321-8
   Clark KB, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00305
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Costa VV, 2013, AM J PATHOL, V182, P1950, DOI 10.1016/j.ajpath.2013.02.027
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   HALSTEAD SB, 1973, J INFECT DIS, V128, P15, DOI 10.1093/infdis/128.1.15
   HALSTEAD SB, 1973, AM J TROP MED HYG, V22, P375, DOI 10.4269/ajtmh.1973.22.375
   HALSTEAD SB, 1989, REV INFECT DIS, V11, pS830
   HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201
   HALSTEAD SB, 1973, J INFECT DIS, V128, P7, DOI 10.1093/infdis/128.1.7
   Halstead SB, 1988, J CHALL MOL BIO, V239, P476, DOI DOI 10.1126/SCIENCE.3277268
   Hickey AC, 2013, AM J TROP MED HYG, V89, P1043, DOI 10.4269/ajtmh.13-0145
   Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   KLEIN E, 1976, INT J CANCER, V18, P421, DOI 10.1002/ijc.2910180405
   Kwissa M, 2014, CELL HOST MICROBE, V16, P115, DOI 10.1016/j.chom.2014.06.001
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mattia K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027252
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Onlamoon N, 2010, BLOOD, V115, P1823, DOI 10.1182/blood-2009-09-242990
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527
   Potts JA, 2008, TROP MED INT HEALTH, V13, P1328, DOI 10.1111/j.1365-3156.2008.02151.x
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Priyamvada L, 2016, J VIROL, V90, P5574, DOI 10.1128/JVI.03203-15
   RODHAIN F, 1991, COMP IMMUNOL MICROB, V14, P9, DOI 10.1016/0147-9571(91)90036-D
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smith KM, 2012, AM J TROP MED HYG, V87, P743, DOI 10.4269/ajtmh.2012.12-0004
   Srikiatkhachorn A, 2010, CURR TOP MICROBIOL, V338, P67, DOI 10.1007/978-3-642-02215-9_6
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
NR 40
TC 65
Z9 65
U1 1
U2 13
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD SEP 5
PY 2017
VL 7
AR 10498
DI 10.1038/s41598-017-10901-1
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FF9AN
UT WOS:000409309300086
PM 28874759
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rather, IA
   Lone, JB
   Bajpai, VK
   Paek, WK
   Lim, J
AF Rather, Irfan A.
   Lone, Jameel B.
   Bajpai, Vivek K.
   Paek, Woon K.
   Lim, Jeongheui
TI Zika Virus: An Emerging Worldwide Threat (vol 8, 1417, 2017)
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Correction
DE ZIKV; disease; infection; vaccines; diagnosis
C1 [Rather, Irfan A.; Bajpai, Vivek K.] Yeungnam Univ, Sch Biotechnol, Dept Appl Microbiol & Biotechnol, Gyongsan, South Korea.
   [Lone, Jameel B.] Daegu Univ, Dept Biotechnol, Gyongsan, South Korea.
   [Paek, Woon K.; Lim, Jeongheui] Minist Sci ICT & Future Planning, Natl Sci Museum, Daejeon, South Korea.
RP Rather, IA; Bajpai, VK (corresponding author), Yeungnam Univ, Sch Biotechnol, Dept Appl Microbiol & Biotechnol, Gyongsan, South Korea.; Paek, WK; Lim, J (corresponding author), Minist Sci ICT & Future Planning, Natl Sci Museum, Daejeon, South Korea.
EM rather@ynu.ac.kr; vkbajpai04@gmail.com; paekwk@naver.com;
   jeongheuilim@gmail.com
RI Rather, Irfan A./AAH-1425-2019
CR Rather IA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01417
NR 1
TC 1
Z9 1
U1 0
U2 17
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD SEP 4
PY 2017
VL 8
AR 1740
DI 10.3389/fmicb.2017.01740
PG 1
WC Microbiology
SC Microbiology
GA FF9OI
UT WOS:000409345600001
PM 28900425
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Block, ES
AF Block, Elizabeth Sweeny
TI A Call to Action: Global Moral Crises and the Inadequacy of Inherited
   Approaches to Conscience
SO JOURNAL OF THE SOCIETY OF CHRISTIAN ETHICS
LA English
DT Article
AB This essay considers whether the model of conscience operative in Christian ethics, what I call the "reflexive conscience," is adequate to meet the global moral challenges we face today, problems such as gun violence, climate change, and the Zika virus. Drawing primarily on the work of Willis Jenkins, I argue that conscience has not yet caught up to the scale and interconnectedness of our global moral challenges. A truly "engaged conscience" must be focused not primarily on the self but on the other, and must be active. I conclude by turning to Elisabeth Vasko's criticisms of the victim/perpetrator binary to suggest that conscience must call us to greater responsibility for the systemic injustices in which particular moral challenges are embedded.
C1 [Block, Elizabeth Sweeny] St Louis Univ, Christian Eth, 3800 Lindell Blvd, St Louis, MO 63108 USA.
RP Block, ES (corresponding author), St Louis Univ, Christian Eth, 3800 Lindell Blvd, St Louis, MO 63108 USA.
EM elizabeth.block@slu.edu
CR [Anonymous], 2013, CONSCIENCE CALLING E
   [Anonymous], 2016, YAHOO NEWS
   [Anonymous], 2017, NY TIMES
   Collins Jeffrey, 2016, ASS PRESS YAHOO 1227
   Cox Kathryn Lilla, 2015, WATER SHAPING STONE
   Francis, LAUDATO SI
   Goode Erica, 2016, NY TIMES
   Grisez Germain, 2004, CONSCOEMCE READOMGS, V14, P41
   Gula Richard, 2004, CONSCIENCE READINGS, P53
   Hogan Linda, 2015, CONSCIENCE CATHOLICI, p[53, 84]
   Hogan Linda, 2000, CONFRONTING TRUTH CO, P36
   JENKINS W, 2013, FUTURE ETHICS SUSTAI, P36
   Jenkins Willis, 2017, LIVED THEOLOGY NEW P, P64
   Jenkins Willis, 2013, J SOC CHRIST ETHICS, V34, P68
   Keenan James, 2015, THEOL STUD, V76, P138
   Massingale Bryan N., 2015, CONSCIENCE CATHOLICI, P53
   May William E., 2004, CONSCIENCE READINGS, P14
   May William E., 2004, CONSCIENCE READINGS, V14, P95
   McNeil Jr Donald G., 2016, NY TIMES
   Patrick Anne E., 1997, LIB CONSCIENCE FEMIN
   Paul II Pope John, 1993, THE HOLY SEE
   Paul VI Pope, 1965, THE HOLY SEC, P16
   REUTERS, 2017, REUTERS
   Richer Alanna Durkin, 2016, WASHINGTON TIMES
   Schweiker W, 2016, J SOC CHRIST ETHICS, V36, P3, DOI 10.1353/sce.2016.0028
   Schweiker William, 2016, STUDIES CHRISTIAN ET, V29, P4
   Shin JS, 2008, J SOC CHRIST ETHICS, V28, P3, DOI 10.5840/jsce200828124
   Smith Robert, 1998, CONSCIENCE CATHOLCIS, P83
   Steenhuysen Julie, 2016, REUTERS
   Vasko Elisabeth T., 2015, APATHY THEOLOGY BYST
   Vischer Robert K., 2010, CONSCIENCE COMMON GO, P20
   Willingham AJ, 2016, CNN
NR 32
TC 0
Z9 0
U1 0
U2 0
PU SOC CHRISTIAN ETHICS
PI COLLEGEVILLE
PA ST JOHN'S UNIV, SCHOOL THEOLOGY-SEMINARY, PO BOX 50370, COLLEGEVILLE, MN
   56321-5633 USA
SN 1540-7942
EI 2326-2176
J9 J SOC CHRIST ETHICS
JI J. Soc. Christ. Ethics
PD FAL-WIN
PY 2017
VL 37
IS 2
BP 79
EP 96
DI 10.1353/sce.2017.0034
PG 18
WC Religion
SC Religion
GA GK1RK
UT WOS:000435895900006
DA 2020-07-08
ER

PT J
AU Naiyer, MM
   Cassidy, SA
   Magri, A
   Cowton, V
   Chen, K
   Mansour, S
   Kranidioti, H
   Mbirbindi, B
   Rettman, P
   Harris, S
   Fanning, LJ
   Mulder, A
   Claas, FHJ
   Davidson, AD
   Patel, AH
   Purbhoo, MA
   Khakoo, SI
AF Naiyer, Mohammed M.
   Cassidy, Sorcha A.
   Magri, Andrea
   Cowton, Vanessa
   Chen, Kevin
   Mansour, Salah
   Kranidioti, Hariklia
   Mbirbindi, Berenice
   Rettman, Pauline
   Harris, Scott
   Fanning, Liam J.
   Mulder, Arend
   Claas, Franz H. J.
   Davidson, Andrew D.
   Patel, Arvind H.
   Purbhoo, Marco A.
   Khakoo, Salim I.
TI KIR2DS2 recognizes conserved peptides derived from viral helicases in
   the context of HLA-C
SO SCIENCE IMMUNOLOGY
LA English
DT Article
ID IMMUNOGLOBULIN-LIKE RECEPTORS; I BINDING PREDICTION; CRYSTAL-STRUCTURE;
   NS3 HELICASE; MHC; EXPRESSION; DOMAIN; GENES; CELLS
AB Killer cell immunoglobulin-like receptors (KIRs) are rapidly evolving species-specific natural killer (NK) cell receptors associated with protection against multiple different human viral infections. We report that the activating receptor KIR2DS2 directly recognizes viral peptides derived from conserved regions of flaviviral superfamily 2 RNA helicases in the context of major histocompatibility complex class I. We started by documenting that peptide LNPSVAATL from the hepatitis C virus (HCV) helicase binds HLA-C*0102, leading to NK cell activation through engagement of KIR2DS2. Although this region is highly conserved across HCV isolates, the sequence is not present in other flaviviral helicases. Embarking on a search for a conserved target of KIR2DS2, we show that HLA-C*0102 presents a different highly conserved peptide from the helicase motif lb region of related flaviviruses, including dengue, Zika, yellow fever, and Japanese encephalitis viruses, to KIR2DS2. In contrast to LNPSVAATL from HCV, these flaviviral peptides all contain an "MCHAT" motif, which is present in 61 of 63 flaviviruses. Despite the difference in the peptide sequences, we show that KIR2DS2 recognizes endogenously presented helicase peptides and that KIR2DS2 is sufficient to inhibit HCV and dengue virus replication in the context of HLA-C*0102. Targeting short, but highly conserved, viral peptides provide nonrearranging innate immune receptors with an efficient mechanism to recognize multiple, highly variable, pathogenic RNA viruses.
C1 [Naiyer, Mohammed M.; Cassidy, Sorcha A.; Chen, Kevin; Mansour, Salah; Kranidioti, Hariklia; Mbirbindi, Berenice; Rettman, Pauline; Khakoo, Salim I.] Univ Southampton, Southampton Gen Hosp, Clin & Expt Sci, Fac Med, Tremona Rd, Southampton SO16 6YD, Hants, England.
   [Cassidy, Sorcha A.; Purbhoo, Marco A.] Imperial Coll London, Div Med, Sect Hepatol, South Wharf Rd, London W2 1PG, England.
   [Magri, Andrea; Cowton, Vanessa; Patel, Arvind H.] Univ Glasgow, Ctr Virus Res, MRC, Garscube Campus,464 Bearsden Rd, Glasgow G61 1QH, Lanark, Scotland.
   [Magri, Andrea] Univ Piemonte Orientale, Dept Translat Med, Novara, Italy.
   [Harris, Scott] Univ Southampton, Southampton Gen Hosp, Fac Med, Dept Stat Populat & Primary Care Med, Tremona Rd, Southampton SO16 6YD, Hants, England.
   [Fanning, Liam J.] Univ Coll Cork, Dept Med, Cork, Ireland.
   [Mulder, Arend; Claas, Franz H. J.] Leiden Univ, Dept Immunohematol & Blood Transfus, POB 9600, NL-2300 RC Leiden, Netherlands.
   [Davidson, Andrew D.] Univ Bristol, Sch Cellular & Mol Med, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England.
RP Khakoo, SI (corresponding author), Univ Southampton, Southampton Gen Hosp, Clin & Expt Sci, Fac Med, Tremona Rd, Southampton SO16 6YD, Hants, England.
EM s.i.khakoo@southampton.ac.uk
RI FANNING, LIAM J/F-5281-2015
OI FANNING, LIAM J/0000-0001-6629-8418; Mansour, Salah/0000-0002-5982-734X
FU Wellcome TrustWellcome Trust [WT089883MA, WT093465MA, WT076991MA];
   Medical Research CouncilMedical Research Council UK (MRC) [G1001738,
   G0401586, MC_UU 12014/2]
FX This work was supported by grants from the Wellcome Trust (WT089883MA to
   S.A.C., WT093465MA to M.A.P., and WT076991MA to S.I.K.) and the Medical
   Research Council (G1001738 to S.I.K., G0401586 to A.D.D., and MC_UU
   12014/2 to A.H.P.).
CR Alter G, 2011, NATURE, V476, P96, DOI 10.1038/nature10237
   Angus AGN, 2012, J VIROL, V86, P679, DOI 10.1128/JVI.05452-11
   Angus AGN, 2010, J GEN VIROL, V91, P122, DOI 10.1099/vir.0.015909-0
   Ashraf S, 2013, HEPATOLOGY, V58, P881, DOI 10.1002/hep.26415
   Barber LD, 1996, J EXP MED, V184, P735, DOI 10.1084/jem.184.2.735
   Borhis G, 2013, J IMMUNOL, V190, P2924, DOI 10.4049/jimmunol.1201032
   Boyington JC, 2002, MOL IMMUNOL, V38, P1007, DOI 10.1016/S0161-5890(02)00030-5
   Boyington JC, 2001, IMMUNOL REV, V181, P66, DOI 10.1034/j.1600-065X.2001.1810105.x
   Cassidy S, 2015, EUR J IMMUNOL, V45, P492, DOI 10.1002/eji.201444613
   Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5
   Cooley S, 2007, BLOOD, V110, P578, DOI 10.1182/blood-2006-07-036228
   DEMARS R, 1985, P NATL ACAD SCI USA, V82, P8183, DOI 10.1073/pnas.82.23.8183
   Fadda L, 2010, P NATL ACAD SCI USA, V107, P10160, DOI 10.1073/pnas.0913745107
   Garcia-Beltran WF, 2016, NAT IMMUNOL, V17, P1067, DOI 10.1038/ni.3513
   Gendzekhadze K, 2009, P NATL ACAD SCI USA, V106, P18692, DOI 10.1073/pnas.0906051106
   Gonzalez-Galarza FF, 2015, NUCLEIC ACIDS RES, V43, pD784, DOI 10.1093/nar/gku1166
   Graef T, 2009, J EXP MED, V206, P2557, DOI 10.1084/jem.20091010
   Gu MG, 2010, P NATL ACAD SCI USA, V107, P521, DOI 10.1073/pnas.0913380107
   Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z
   Ivarsson MA, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00184
   Jacob L, 2008, BIOINFORMATICS, V24, P358, DOI 10.1093/bioinformatics/btm611
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   Jojic N, 2006, BIOINFORMATICS, V22, pE227, DOI 10.1093/bioinformatics/btl255
   Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670
   Kurokohchi K, 1996, HEPATOLOGY, V23, P1181
   Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642
   Liu JX, 2014, P NATL ACAD SCI USA, V111, P2662, DOI 10.1073/pnas.1322052111
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Martin MP, 2013, IMMUNOL REV, V254, P245, DOI 10.1111/imr.12071
   Masse N, 2010, ANTIVIR RES, V86, P296, DOI 10.1016/j.antiviral.2010.03.010
   Momot T, 2004, ARTHRITIS RHEUM-US, V50, P1561, DOI 10.1002/art.20216
   Petitdemange C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108798
   Petitdemange C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002268
   Robinson J, 2013, NUCLEIC ACIDS RES, V41, pD1234, DOI 10.1093/nar/gks1140
   Saulquin X, 2003, J EXP MED, V197, P933, DOI 10.1084/jem.20021624
   Sim MJW, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00193
   Stewart CA, 2005, P NATL ACAD SCI USA, V102, P13224, DOI 10.1073/pnas.0503594102
   Thio CL, 2002, J VIROL, V76, P4792, DOI 10.1128/JVI.76.10.4792-4797.2002
   Thiruchelvam-Kyle L, 2017, J IMMUNOL, V198, P2556, DOI 10.4049/jimmunol.1600930
   Townsley E, 2016, CLIN EXP IMMUNOL, V183, P419, DOI 10.1111/cei.12722
   Yamashita T, 2008, VIROLOGY, V373, P426, DOI 10.1016/j.virol.2007.12.018
   Yen JH, 2001, J EXP MED, V193, P1159, DOI 10.1084/jem.193.10.1159
NR 43
TC 36
Z9 36
U1 0
U2 4
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 2470-9468
J9 SCI IMMUNOL
JI Sci. Immunol.
PD SEP
PY 2017
VL 2
IS 15
AR eaal5296
DI 10.1126/sciimmunol.aal5296
PG 11
WC Immunology
SC Immunology
GA GI4FU
UT WOS:000434327200001
PM 28916719
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Deverell, M
   Phu, A
   Zurynski, Y
   Elliott, E
AF Deverell, Marie
   Phu, Amy
   Zurynski, Yvonne
   Elliott, Elizabeth
CA Chief Investigators APSU
TI AUSTRALIAN PAEDIATRIC SURVEILLANCE UNIT ANNUAL REPORT, 2016
SO COMMUNICABLE DISEASES INTELLIGENCE
LA English
DT Article
AB This report summarises the cases reported to the Australian Paediatric Surveillance Unit (APSU) of rare infectious diseases or rare complications of more common infectious diseases in children. During the calendar year 2016, there were approximately 1500 paediatricians reporting to the APSU and the monthly report card return rate was 90%. APSU continued to provide unique national data on the perinatal exposure to HIV, congenital rubella, congenital cytomegalovirus, neonatal and infant herpes simplex virus, and congenital and neonatal varicella. APSU contributed 10 unique cases of Acute Flaccid Paralysis (a surrogate for polio) - these data are combined with cases ascertained through other surveillance systems including the Paediatric Active Disease Surveillance (PAEDS) to meet the World Health Organisation surveillance target. There was a decline in the number of cases of juvenile onset Recurrent Respiratory Papillomatosis which is likely to be associated with the introduction of the National HPV Vaccination Program. The number of cases of severe complications of influenza was significantly less in 2016 (N=32) than in 2015 (N=84) and for the first time in the last nine years no deaths due to severe influenza were reported to the APSU. In June 2016 surveillance for microcephaly commenced to assist with the detection of potential cases of congenital Zika virus infection and during that time there were 21 confirmed cases - none had a relevant history to suspect congenital Zika virus infection, however, these cases are being followed up to determine the cause of microcephaly.
C1 [Deverell, Marie; Phu, Amy; Zurynski, Yvonne; Elliott, Elizabeth] Kids Res Inst, Australian Paediat Surveillance Unit, Westmead, NSW, Australia.
   [Deverell, Marie; Phu, Amy; Zurynski, Yvonne; Elliott, Elizabeth] Univ Sydney, Sydney Med Sch, Discipline Child & Adolescent Hlth, Sydney, NSW, Australia.
   [Elliott, Elizabeth] Sydney Childrens Hosp Network Westmead, Westmead, NSW, Australia.
RP Zurynski, Y (corresponding author), Childrens Hosp Westmead, Kids Res Inst, Australian Paediat Surveillance Unit, Res, Locked Bag 4001, Westmead, NSW 2145, Australia.
EM yvonne.zurynski@health.nsw.gov.au
FU Australian Government Department of HealthAustralian
   GovernmentDepartment of Health & Ageing; Discipline of Child and
   Adolescent Health, Sydney Medical School, The University of Sydney; Kids
   Research Institute, Sydney Children's Hospitals Network (Westmead);
   Royal Australasian College of Physicians; Sydney Medical School
   Foundation, University of Sydney
FX APSU activities are funded by the Australian Government Department of
   Health, and supported by the Discipline of Child and Adolescent Health,
   Sydney Medical School, The University of Sydney; Kids Research
   Institute, Sydney Children's Hospitals Network (Westmead), and The Royal
   Australasian College of Physicians.; Yvonne Zurynski is supported in
   part by a Fellowship from the Sydney Medical School Foundation, the
   University of Sydney.
CR Australian Bureau of Statistics, 2016, 3101 0 AUSTR DEM STA
   Department of Health, COMMUNICABLE DIS INT
   Desai S, 2015, J PAEDIATR CHILD H, V51, P209, DOI 10.1111/jpc.12691
   Donovan B, 2018, J INFECT DIS, V217, P177, DOI 10.1093/infdis/jix499
   He SW, 2009, J PAEDIATR CHILD H, V45, P498, DOI 10.1111/j.1440-1754.2009.01549.x
   Khandaker G, 2014, VACCINE, V32, P6746, DOI 10.1016/j.vaccine.2014.10.021
   Novakovic Daniel, 2018, J Infect Dis, V217, P208, DOI 10.1093/infdis/jix498
   Zurynski Y, 2013, J PAEDIATR CHILD H, V49, P588, DOI 10.1111/jpc.12282
NR 8
TC 2
Z9 2
U1 0
U2 0
PU AUSTRALIAN GOVERNMENT, DEPT HEALTH & AGEING
PI CANBERRA
PA OFFICE HEALTH PROTECTION SURVEILLANCE BRANCH, GPO BOX 9848, CANBERRA,
   ACT 2601, AUSTRALIA
SN 0725-3141
EI 1445-4866
J9 COMMUN DIS INTELL
JI Commun. Dis. Intell.
PD SEP
PY 2017
VL 41
IS 3
BP E284
EP E289
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA FU6UL
UT WOS:000423988300013
DA 2020-07-08
ER

PT J
AU Huang, GKL
   Tio, SY
   Caly, L
   Nicholson, S
   Thevarajan, I
   Papadakis, G
   Catton, M
   Tong, SYC
   Druce, J
AF Huang, G. Khai Lin
   Tio, Shio Yen
   Caly, Leon
   Nicholson, Suellen
   Thevarajan, Irani
   Papadakis, Georgina
   Catton, Mike
   Tong, Steven Y. C.
   Druce, Julian
TI Prolonged Detection of Japanese Encephalitis Virus in Urine and Whole
   Blood in a Returned Short-term Traveler
SO OPEN FORUM INFECTIOUS DISEASES
LA English
DT Article
DE flavivirus; Japanese encephalitis; PCR; urine; whole blood
ID DENGUE VIRUS; ZIKA VIRUS; SAMPLES; RNA
AB We describe a fatal case of Japanese encephalitis virus infection following short-term travel to Thailand. Viral RNA was detected in urine and whole blood out to 26 and 28 days, respectively, after the onset of symptoms. Live virus was isolated from a urine specimen from day 14.
C1 [Huang, G. Khai Lin; Caly, Leon; Nicholson, Suellen; Papadakis, Georgina; Catton, Mike; Druce, Julian] Royal Melbourne Hosp, Victorian Infect Dis Reference Lab, 792 Elizabeth St, Melbourne, Vic 3000, Australia.
   [Huang, G. Khai Lin; Tio, Shio Yen; Caly, Leon; Nicholson, Suellen; Thevarajan, Irani; Papadakis, Georgina; Catton, Mike; Tong, Steven Y. C.; Druce, Julian] Univ Melbourne, Peter Doherty Inst Infect & Immun, 792 Elizabeth St, Melbourne, Vic 3000, Australia.
   [Tio, Shio Yen; Thevarajan, Irani; Tong, Steven Y. C.] Royal Melbourne Hosp, Victorian Infect Dis Serv, Melbourne, Vic, Australia.
   [Tong, Steven Y. C.] Menzies Sch Hlth Res, Darwin, NT, Australia.
RP Druce, J (corresponding author), Royal Melbourne Hosp, Victorian Infect Dis Reference Lab, 792 Elizabeth St, Melbourne, Vic 3000, Australia.; Druce, J (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, 792 Elizabeth St, Melbourne, Vic 3000, Australia.
EM julian.druce@mh.org.au
RI Tong, Steven/N-2353-2013
OI Tong, Steven/0000-0002-1368-8356
CR Buhl MR, 2009, J TRAVEL MED, V16, P217, DOI 10.1111/j.1708-8305.2009.00333.x
   Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233
   Hills SL, 2017, CDC YELLOW BOOK
   Klungthong C, 2007, J CLIN MICROBIOL, V45, P2480, DOI 10.1128/JCM.00305-07
   Lanteri MC, 2014, TRANSFUSION, V54, P3232, DOI 10.1111/trf.12764
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Nagy A, 2016, ARCH VIROL, V161, P1797, DOI 10.1007/s00705-016-2844-5
   Mai NTH, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx046
   Rios M, 2007, CLIN INFECT DIS, V45, P181, DOI 10.1086/518850
   Van den Bossche D, 2015, EUR J CLIN MICROBIOL, V34, P1361, DOI 10.1007/s10096-015-2359-0
   Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997
   World Health Organization, MAN LAB DIAGN JAP EN
   Zhao H, 2013, CLIN INFECT DIS, V57, P157, DOI 10.1093/cid/cit169
NR 14
TC 10
Z9 10
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 2328-8957
J9 OPEN FORUM INFECT DI
JI Open Forum Infect. Dis.
PD FAL
PY 2017
VL 4
IS 4
DI 10.1093/ofid/ofx203
PG 3
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FS1TH
UT WOS:000419560500029
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Simhadri, RK
   Fast, EM
   Guo, R
   Schultz, MJ
   Vaisman, N
   Ortiz, L
   Bybee, J
   Slatko, BE
   Frydman, HM
AF Simhadri, Rama K.
   Fast, Eva M.
   Guo, Rong
   Schultz, Michaela J.
   Vaisman, Natalie
   Ortiz, Luis
   Bybee, Joanna
   Slatko, Barton E.
   Frydman, Horacio M.
TI The Gut Commensal Microbiome of Drosophila melanogaster Is Modified by
   the Endosymbiont Wolbachia
SO MSPHERE
LA English
DT Article
DE Drosophila microbiome; gut microbiome; symbiosis; Wolbachia
ID STEM-CELL PROLIFERATION; MOSQUITO AEDES-AEGYPTI; HOMEOSTASIS; INFECTION;
   BACTERIA; POPULATIONS; ACTIVATION; INSIGHTS; DISEASE; DENGUE
AB Endosymbiotic Wolbachia bacteria and the gut microbiome have independently been shown to affect several aspects of insect biology, including reproduction, development, life span, stem cell activity, and resistance to human pathogens, in insect vectors. This work shows that Wolbachia bacteria, which reside mainly in the fly germline, affect the microbial species present in the fly gut in a lab-reared strain. Drosophila melanogaster hosts two main genera of commensal bacteria- Acetobacter and Lactobacillus. Wolbachia-infected flies have significantly reduced titers of Acetobacter. Sampling of the microbiome of axenic flies fed with equal proportions of both bacteria shows that the presence of Wolbachia bacteria is a significant determinant of the composition of the microbiome throughout fly development. However, this effect is host genotype dependent. To investigate the mechanism of microbiome modulation, the effect of Wolbachia bacteria on Imd and reactive oxygen species pathways, the main regulators of immune response in the fly gut, was measured. The presence of Wolbachia bacteria does not induce significant changes in the expression of the genes for the effector molecules in either pathway. Furthermore, microbiome modulation is not due to direct interaction between Wolbachia bacteria and gut microbes. Confocal analysis shows that Wolbachia bacteria are absent from the gut lumen. These results indicate that the mechanistic basis of the modulation of composition of the microbiome by Wolbachia bacteria is more complex than a direct bacterial interaction or the effect of Wolbachia bacteria on fly immunity. The findings reported here highlight the importance of considering the composition of the gut microbiome and host genetic background during Wolbachia-induced phenotypic studies and when formulating microbe-based disease vector control strategies.
   IMPORTANCE Wolbachia bacteria are intracellular bacteria present in the microbiome of a large fraction of insects and parasitic nematodes. They can block mosquitos' ability to transmit several infectious disease-causing pathogens, including Zika, dengue, chikungunya, and West Nile viruses and malaria parasites. Certain extracellular bacteria present in the gut lumen of these insects can also block pathogen transmission. However, our understanding of interactions between Wolbachia and gut bacteria and how they influence each other is limited. Here we show that the presence of Wolbachia strain wMel changes the composition of gut commensal bacteria in the fruit fly. Our findings implicate interactions between bacterial species as a key factor in determining the overall composition of the microbiome and thus reveal new paradigms to consider in the development of disease control strategies.
C1 [Simhadri, Rama K.; Fast, Eva M.; Guo, Rong; Schultz, Michaela J.; Vaisman, Natalie; Ortiz, Luis; Frydman, Horacio M.] Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.
   [Frydman, Horacio M.] Boston Univ, NEIDL, Boston, MA 02215 USA.
   [Bybee, Joanna; Slatko, Barton E.] New England Biolabs Inc, Genome Biol Div, Ipswich, MA USA.
   [Fast, Eva M.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.
RP Frydman, HM (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.; Frydman, HM (corresponding author), Boston Univ, NEIDL, Boston, MA 02215 USA.
EM hfrydman@bu.edu
RI Schultz, Michaela/AAP-1140-2020
OI Simhadri, Rama Krishna/0000-0003-1480-6710; Frydman,
   Horacio/0000-0003-0191-7948
FU Boston University; National Institute of Allergy and Infectious
   DiseasesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [1R56AI97589-01A1]; NSFNational Science
   Foundation (NSF) [1225360]
FX Work in the Frydman lab is supported by Boston University funds,
   National Institute of Allergy and Infectious Diseases grant
   1R56AI97589-01A1, and NSF 1225360.
CR Andrews ES, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003075
   Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75
   Bae YS, 2010, TRENDS IMMUNOL, V31, P278, DOI 10.1016/j.it.2010.05.003
   Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Blum JE, 2013, MBIO, V4, DOI 10.1128/mBio.00860-13
   Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004
   Brennan LJ, 2012, INSECT MOL BIOL, V21, P510, DOI 10.1111/j.1365-2583.2012.01155.x
   Brennan LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002083
   Broderick NA, 2014, MBIO, V5, DOI 10.1128/mBio.01117-14
   Brummel T, 2004, P NATL ACAD SCI USA, V101, P12974, DOI 10.1073/pnas.0405207101
   Buchon N, 2013, NAT REV MICROBIOL, V11, P615, DOI 10.1038/nrmicro3074
   Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003
   Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272
   Chen SC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01485
   Chrostek E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003896
   Cirimotich CM, 2011, CELL HOST MICROBE, V10, P307, DOI 10.1016/j.chom.2011.09.006
   Coon KL, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1660-9
   Corby-Harris V, 2007, APPL ENVIRON MICROB, V73, P3470, DOI 10.1128/AEM.02120-06
   Cox CR, 2007, INFECT IMMUN, V75, P1565, DOI 10.1128/IAI.01496-06
   Dale C, 2006, CELL, V126, P453, DOI 10.1016/j.cell.2006.07.014
   Dittmer J, 2014, MOL ECOL, V23, P2619, DOI 10.1111/mec.12760
   Elgart M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11280
   Emmert EAB, 1999, FEMS MICROBIOL LETT, V171, P1, DOI 10.1111/j.1574-6968.1999.tb13405.x
   Fast EM, 2011, SCIENCE, V334, P990, DOI 10.1126/science.1209609
   Fink C, 2013, APPL ENVIRON MICROB, V79, P6984, DOI 10.1128/AEM.01903-13
   Glaser RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011977
   Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418
   Hughes GL, 2014, P NATL ACAD SCI USA, V111, P12498, DOI 10.1073/pnas.1408888111
   Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001296
   Ikeya T, 2009, P ROY SOC B-BIOL SCI, V276, P3799, DOI 10.1098/rspb.2009.0778
   Jones RM, 2013, EMBO J, V32, P3017, DOI 10.1038/emboj.2013.224
   Joseph RM, 2009, P NATL ACAD SCI USA, V106, P11352, DOI 10.1073/pnas.0901419106
   Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143
   Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531
   Lee WJ, 2013, ANNU REV CELL DEV BI, V29, P571, DOI 10.1146/annurev-cellbio-101512-122333
   Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008
   McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110
   Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Newell PD, 2014, APPL ENVIRON MICROB, V80, P788, DOI 10.1128/AEM.02742-13
   Osman D, 2012, J CELL SCI, V125, P5944, DOI 10.1242/jcs.113100
   Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226
   Overend G, 2016, SCI REP-UK, V6, DOI 10.1038/srep27242
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548
   Ren C, 2007, CELL METAB, V6, P144, DOI 10.1016/j.cmet.2007.06.006
   Ridley EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036765
   Riegler M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S12
   Rossi P, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0888-0
   Rottschaefer SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040500
   Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357
   Serbus LR, 2008, ANNU REV GENET, V42, P683, DOI 10.1146/annurev.genet.41.110306.130354
   Sharon G, 2010, P NATL ACAD SCI USA, V107, P20051, DOI 10.1073/pnas.1009906107
   Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782
   Staubach F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070749
   Storelli G, 2011, CELL METAB, V14, P403, DOI 10.1016/j.cmet.2011.07.012
   Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002
   Toomey ME, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004577
   Toomey ME, 2013, P NATL ACAD SCI USA, V110, P10788, DOI 10.1073/pnas.1301524110
   Tzou P, 2000, IMMUNITY, V13, P737, DOI 10.1016/S1074-7613(00)00072-8
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   Wong CNA, 2011, ENVIRON MICROBIOL, V13, P1889, DOI 10.1111/j.1462-2920.2011.02511.x
   Wong ZS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025430
   Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069
   Yang ZY, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni149
   Ye YH, 2017, J INVERTEBR PATHOL, V143, P18, DOI 10.1016/j.jip.2016.11.011
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 69
TC 17
Z9 18
U1 3
U2 16
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5042
J9 MSPHERE
JI mSphere
PD SEP-OCT
PY 2017
VL 2
IS 5
AR e00287-17
DI 10.1128/mSphere.00287-17
PG 16
WC Microbiology
SC Microbiology
GA FO6TH
UT WOS:000416998800009
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Muraduzzaman, AKM
   Sultana, S
   Shirin, T
   Khatun, S
   Islam, M
   Rahman, M
AF Muraduzzaman, A. K. M.
   Sultana, Sharmin
   Shirin, Tahmina
   Khatun, Selina
   Islam, MdTarikul
   Rahman, Mahmudur
TI Introduction of Zika virus in Bangladesh: An impending public health
   threat
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
DE Zika virus; Bangladesh; Public health impact
ID TRANSMISSION; ARBOVIRUSES; INDONESIA; PACIFIC; FEVER
AB Objective: To explore the presence of Zika virus (ZIKV) in Bangladesh and to understand the associated risk factors.
   Methods: A retrospective sero-surveillance was performed on stored serum samples of dengue surveillance conducted from 2013 to 2016. Real time RT-PCR was performed on randomly selected acute serum samples to detect the Zika virus nucleic acid.
   Results: Of 200 samples screened, one was found positive for ZIKV by real time RT-PCR and further confirmed by genome sequencing. The case was a 65 years old male from a metropolitan city of Bangladesh who had no history of travel outside Bangladesh. Phylogenetic analysis of partial E gene sequences from Bangladeshi isolates demonstrated a close relationship with ZIKV from Brazil and current South American strains clustering within a monophyletic clade distinct from African lineage.
   Conclusions: Presence of ZIKV raises serious public health concerns in Bangladesh owing to its association with congenital anomalies/neurological-manifestations. We, therefore, recommend every suspected viral fever patient, particularly pregnant women be screened for ZIKV infection to rule out yet another emerging infection in Bangladesh.
C1 [Muraduzzaman, A. K. M.; Sultana, Sharmin; Shirin, Tahmina] Inst Epidemiol Dis Control & Res, Dept Virol, Room 315, Dhaka 1212, Bangladesh.
   [Khatun, Selina] Inst Epidemiol Dis Control & Res, Dept Epidemiol, Dhaka, Bangladesh.
   [Islam, MdTarikul] Inst Developing Sci & Hlth Initiat, Lab Genet & Genom, Dhaka, Bangladesh.
   [Rahman, Mahmudur] Inst Epidemiol Dis Control & Res, Dhaka, Bangladesh.
RP Shirin, T (corresponding author), Inst Epidemiol Dis Control & Res, Dept Virol, Room 315, Dhaka 1212, Bangladesh.
EM tahmina.shirin14@gmail.com
RI amsalu, ribka/G-8780-2019
OI Islam, Md Tarikul/0000-0003-2822-245X
CR Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   ICDDR B, 2008, HLTH SCI B, V7, P1
   Karim MN, 2012, INDIAN J MED RES, V136, P32
   Khan R, MEN ARE AWAY WOMEN B
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Patz JA, 2003, CLIMATE CHANGE HUMAN, P103
   Rahman M, 2002, EMERG INFECT DIS, V8, P738, DOI 10.3201/eid0807.010398
   Turton P, 2009, ARCH WOMEN MENT HLTH, V12, P35, DOI 10.1007/s00737-008-0040-7
   WB, POP DENS PEOPL SQ KM
   WHO, ZIK RISK ASS W PAC R
NR 20
TC 5
Z9 5
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1995-7645
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD SEP
PY 2017
VL 10
IS 9
BP 925
EP 928
DI 10.1016/j.apjtm.2017.08.015
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FO9NT
UT WOS:000417215100014
PM 29080624
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Conis, E
AF Conis, Elena
TI Vaccines, Pesticides, and Narratives of Exposure and Evidence
SO CANADIAN BULLETIN OF MEDICAL HISTORY
LA English
DT Article
DE DDT; exposure; vaccines and antivaccination movements; Zika outbreaks;
   global health; public health and citizenship; health journalism; public
   health narratives and historiography
AB This essay considers the cultural work performed by two public health narratives - the DDT narrative and the vaccine narrative - as they appeared in popular and professional discourse concerning two recent media events: controversy over an antivaccination film, and the emergence of a Zika global public health emergency. Like all narratives in the history of medicine, the stories historians and others tell about DDT and about vaccines organize a shared past to explain the present. They also point to a hoped-for future. The DDT and vaccine narratives share several themes: public health, expertise, evidence, exposure, and power. Their inclusions and exclusions, however, convey distinct messages about these themes, particularly regarding the right conduct of health citizens in the pursuit of public health. These narratives are analyzed to compare their agendas, and to propose a case study of how historical work can shed light on contemporary public health norms, practice, and challenges.
C1 [Conis, Elena] Univ Calif Berkeley, Grad Sch Journalism, Berkeley, CA 94720 USA.
RP Conis, E (corresponding author), Univ Calif Berkeley, Grad Sch Journalism, Berkeley, CA 94720 USA.
FU Chemical Heritage Foundation
FX Thanks to the Center for Science, Technology, Medicine and Society MEDS
   group at the University of California, Berkeley, for invaluable feedback
   on this essay. An early version of this essay was presented as the
   AMS-Paterson Lecture at the 2016 CSHM-SCHM Conference, and I am grateful
   for attendees' insightful remarks and critical commentary. Research for
   this essay was supported in part by a 2015-2016 Cain Fellowship from the
   Chemical Heritage Foundation.
CR ALLEN A, 2007, VACCINE CONTROVERSIA
   Anderson J. L., 2009, IND CORN BELT AGR TE
   [Anonymous], 1945, VALLEY MORNING  1209, P19
   [Anonymous], 1944, SOAP SANITARY CHEM, V20, P127
   [Anonymous], 1944, SOAP SANITARY CHEM, V20, P147
   [Anonymous], 1947, PHIL ALL PEST COLL
   [Anonymous], 1945, NY TIMES, P46
   Barnett Errol, 2016, CNN NEWSROOM    0211
   Bell Susan, 2009, DES DAUGHTERS EMBODI
   Biehler Dawn, 2013, PESTS CITY FLIES BED, P91
   Bishai David, 2016, BALTIMORE SUN, p13A
   Bosso Christopher J., 1987, PESTICIDES POLITICS, P63
   Briggs Charles L., 2016, MAKING HLTH PUBLIC P
   CARR D, 1986, TIME NARRATIVE HIST
   Carson Rachel, 2002, SILENT SPRING 40 ANN, P2
   Colgrove James, 2006, STATE IMMUNITY POLIT
   Collins H., 2014, ARE WE ALL SCI EXPER
   Colton F. Barrows, 1945, NATL GEOGRAPHIC  OCT, P385
   Conis E, 2011, J MED HUMANIT, V32, P155, DOI 10.1007/s10912-010-9132-2
   Conis E, 2010, PUBLIC HEALTH REP, V125, P337, DOI 10.1177/003335491012500224
   Conis Elena, 2016, SO SPACES       1028
   Conis Elena, 2015, VACCINE NATION AM CH, P116
   Cote Jacqueline Burt, 2016, THE STIR        0324
   CRONON W, 1992, J AM HIST, V78, P1347, DOI 10.2307/2079346
   Davis Frederick Rowe, 2014, BANNED HIST PESTICID, P116
   Del Pup L, 2015, ONCOL REP, V34, P3, DOI 10.3892/or.2015.3997
   Dixon Robyn, 2016, LOS ANGELES TIMES, pA6
   Dunaway Finis, 2015, SEEING GREEN USE ABU, P24
   Dunlap Thomas R., 1981, DDT SCI CITIZENS PUB
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Eskenazi B, 2009, ENVIRON HEALTH PERSP, V117, P1359, DOI 10.1289/ehp.11748
   Finney Patrick, 2001, HIST NARRATIVE READE, P400
   Garvin Glenn, 2016, LOS ANGELES TIMES, pA3
   Gregg Mitman, 2004, LANDSCAPES EXPOSURE
   Haberman Clyde, 2015, NY TIMES
   Health Yahoo, 2015, YAHOO NEWS
   Henderson D. A., 2009, SMALLPOX DEATH DIS
   Hounshell David A., 1992, SCI CORPORATE STRATE, P453
   Humphreys Margaret, 2001, MALARIA POVERTY RACE, P151
   Jacobs A., 2016, NY TIMES
   JOHNSTON RD, 2004, POLITICS HEALING HIS, P259
   June Laura, 2016, NEW YORK MAGAZINE
   Kinkela David, 2011, DDT AM CENTURY GLOBA
   Konrad Walecia, 2009, NY TIMES, pB6
   Kreps Daniel, 2016, ROLLING STONE
   Kuukkanen JM, 2012, HIST THEORY, V51, P340, DOI 10.1111/j.1468-2303.2012.00632.x
   Langston Nancy, 2010, TOXIC BODIES HORMONE, P83
   Largent MA, 2012, VACCINE: THE DEBATE IN MODERN AMERICA, P94
   Latour Bruno, 1993, WE HAVE NEVER BEEN M, P10
   Lewis-Mikhael AM, 2015, CANCER CAUSE CONTROL, V26, P1375, DOI 10.1007/s10552-015-0643-z
   Lin II Rong-Gong, 2009, LOS ANGELES TIMES
   Mallon Maggie, 2016, GLAMOUR
   Markowitz G, 2002, DECEIT DENIAL DEADLY
   McKay B., 2016, WALL STREET J
   Miller Henry I., 2003, NY TIMES, pA23
   Mnookin S., 2012, PANIC VIRUS TRUE STO
   Murphy Michelle, 2006, SICK BUILDING SYNDRO, P18
   Nash L, 2006, INESCAPABLE ECOLOGIES: A HISTORY OF ENVIRONMENT, DISEASE, AND KNOWLEDGE, P1
   OFFIT PA, 2007, VACCINATED ONE MANS
   Offit Paul A., 2011, DEADLY CHOICES ANTIV, P152
   Opie John, 1998, NATURES NATION ENV H, p[413, 437]
   Oshinsky David, 2006, POLIO AM STORY, P3
   Parker Laura, 2015, NATL GEOGRAPHIC
   Petryna A., 2002, LIFE EXPOSED BIOL CI
   Pollack A, 2016, NY TIMES
   PORTER D, 1999, HLTH CIVILIZATION ST, P57
   Revkin A.C., 2016, NY TIMES
   Ross Benjamin, 2010, POLLUTERS MAKING OUR, P57
   Russell Edmund, 2001, WAR NATURE FIGHTING
   Salzberg S., 2015, FORBES
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Scholes Robert, 2006, NATURE NARRATIVE, P4
   Snowden Frank M., 2006, CONQUEST MALARIA ITA, P201
   Tavernise S, 2016, NY TIMES
   Tomes Nancy, 1999, GOSPEL GERMS MEN WOM, P246
   US Department of Agriculture and US Public Health Service, 1947, DDT CONTR HOUS PESTS
   Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0
   Westcott L., 2015, NEWSWEEK
   White H, 1987, CONTENT FORM NARRATI
   WHO, 2016, ZIK SIT REP NEUR SYN
   WHORTON J, 1974, SILENT SPRING PESTIC
   Williams Mary Elizabeth, 2016, SALON
   Willingham Emily, 2016, FORBES
   Worland J., 2016, TIME
   Zavis Alexandra, 2016, LOS ANGELES TIMES, pA1
   Zipprich J, 2015, MMWR-MORBID MORTAL W, V64, P153
NR 86
TC 1
Z9 1
U1 0
U2 5
PU WILFRID LAURIER UNIV PRESS
PI WATERLOO
PA 75 UNIVERSITY AVENUE WEST, WATERLOO, ON N2L 3C5, CANADA
SN 0823-2105
J9 CAN BULL MED HIST
JI Can. Bull. Med. Hist.
PD FAL
PY 2017
VL 34
IS 2
BP 297
EP 326
DI 10.3138/cbmh.190-21122016
PG 30
WC History & Philosophy Of Science
SC History & Philosophy of Science
GA FO2TV
UT WOS:000416644200002
PM 28708418
DA 2020-07-08
ER

PT J
AU O'Leary, ST
   Maldonado, YA
   Byington, CL
AF O'Leary, Sean T.
   Maldonado, Yvonne A.
   Byington, Carrie L.
TI Update From the Advisory Committee on Immunization Practices
SO JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY
LA English
DT Article
DE Advisory Committee on Immunization Practices; Centers for Disease
   Control and Prevention; immunization
AB The Advisory Committee on Immunization Practices (ACIP), a group of medical and public health experts, meets 3 times per year to develop recommendations for vaccine use in the United States. The group has 15 voting members, and each member's term is 4 years. ACIP members and Centers for Disease Control and Prevention (CDC) staff discuss the epidemiology of vaccine-preventable diseases and vaccine research, effectiveness, safety data, and clinical trial results. Representatives from the American Academy of Pediatrics (C. L. B. and Y. A. M.) and the Pediatric Infectious Diseases Society (S. T. O.) are present as liaisons to the ACIP. The ACIP met February 22 and 23, 2017, to discuss proposed recommendations regarding vaccination for unprotected infants born to hepatitis B surface antigen (HBsAg)-positive mothers; topics included cost analysis, influenza surveillance, influenza vaccine effectiveness, herpes zoster vaccine, and considerations for meningococcal serogroup B booster doses in groups at increased risk. Updates on mumps epidemiology, Dengue virus vaccines, Zika virus vaccines, adult immunization, and yellow fever vaccine were also provided.
C1 [O'Leary, Sean T.] Childrens Hosp Colorado, Aurora, CO USA.
   [Maldonado, Yvonne A.] Stanford Univ, Sch Med, Stanford, CA 94305 USA.
   [Byington, Carrie L.] Texas A&M Coll Med, Bryan, TX USA.
RP O'Leary, ST (corresponding author), 13199 E Montview Blvd,Suite 300, Aurora, CO 80045 USA.
EM sean.oleary@ucdenver.edu
NR 0
TC 0
Z9 0
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 2048-7193
EI 2048-7207
J9 J PEDIATR INFECT DIS
JI J. Pediatr. Infect. Dis. Soc.
PD SEP
PY 2017
VL 6
IS 3
BP 215
EP 218
PG 4
WC Infectious Diseases; Pediatrics
SC Infectious Diseases; Pediatrics
GA FO2PR
UT WOS:000416622700028
PM 28903515
OA Bronze
DA 2020-07-08
ER

PT J
AU Pardigon, N
AF Pardigon, N.
TI Pathophysiological mechanisms of Flavivirus infection of the central
   nervous system
SO TRANSFUSION CLINIQUE ET BIOLOGIQUE
LA English
DT Article; Proceedings Paper
CT 28th Congress of the Societe-Francaise-de-Transfusion-Sanguine (SFTS)
CY SEP 20-22, 2017
CL Bordeaux, FRANCE
SP Soc Francaise Transfus Sanguine
DE Flavivirus; Neuropathogenesis; Neuroinvasion; Neurovirulence
ID JAPANESE ENCEPHALITIS-VIRUS; BLOOD-BRAIN-BARRIER; ZIKA VIRUS; MICE;
   CELLS; MENINGOENCEPHALITIS; PATHOGENESIS; PATHOLOGY; TROPISM
AB Flaviviruses are important human pathogens. Transmitted by the bite of infected mosquitoes, Flaviviruses such as West Nile and Japanese encephalitis may reach the central nervous system where they can elicit severe diseases. Their ability to cross the blood-brain-bather is still poorly understood. The newly emerging Zika Flavivirus on the other hand very rarely reaches the brain of adults, but can infect neural progenitors in the developing central nervous system of fetuses, eliciting devastating congenital malformations including microcephaly. This short review focuses on selected aspects of West Nile, Japanese encephalitis and Zika virus pathophysiological features such as neuroinvasion and neurovirulence, and highlights what we know about some possible mechanisms involved in Flaviviral neuropathogenesis. (C) 2017 Elsevier Masson SAS. All rights reserved.
C1 [Pardigon, N.] Inst Pasteur, Arbovirus Grp, Environm & Infect Risks, 25 Rue Dr Roux, F-75015 Paris, France.
RP Pardigon, N (corresponding author), Inst Pasteur, Arbovirus Grp, Environm & Infect Risks, 25 Rue Dr Roux, F-75015 Paris, France.
EM nathalie.pardigon@pasteur.fr
CR Al-Obaidi MMJ, 2017, VIRUS RES, V233, P17, DOI 10.1016/j.virusres.2017.02.012
   Best SM, 2017, J VIROL, V91, DOI [10.1128/JVI.01970-16, 10.1128/jvi.01970-16]
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chambers TJ, 2003, ADV VIRUS RES, V60, P273, DOI 10.1016/S0065-3527(03)60008-4
   Chan-Tack KM, 2006, J RHEUMATOL, V33, P191
   CHATURVEDI UC, 1980, J INFECT DIS, V141, P712, DOI 10.1093/infdis/141.6.712
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Gromowski GD, 2015, J VIROL, V89, P6328, DOI 10.1128/JVI.00219-15
   Hayes EB, 2005, EMERG INFECT DIS, V11, P1174, DOI 10.3201/eid1108.050289b
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Liu TH, 2008, J NEUROVIROL, V14, P514, DOI 10.1080/13550280802339643
   Ludlow M, 2016, ACTA NEUROPATHOL, V131, P159, DOI 10.1007/s00401-015-1511-3
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Misra UK, 2010, PROG NEUROBIOL, V91, P108, DOI 10.1016/j.pneurobio.2010.01.008
   Myint KSA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002980
   Neal JW, 2014, J INFECTION, V69, P203, DOI 10.1016/j.jinf.2014.05.010
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pierson TC, 2013, FLAVIVIRUSES FLAVIVI
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwartz DA, 2017, ARCH GYNECOL OBSTET, V295, P1361, DOI 10.1007/s00404-017-4361-5
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712
   Solomon T, 2004, NEW ENGL J MED, V351, P370, DOI 10.1056/NEJMra030476
   Suen WW, 2014, VIRUSES-BASEL, V6, P2796, DOI 10.3390/v6072796
   Sun JF, 2016, JAMA OPHTHALMOL, V134, P1330, DOI 10.1001/jamaophthalmol.2016.3417
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Ye J, 2013, VACCINE, V31, P461, DOI 10.1016/j.vaccine.2012.11.015
NR 35
TC 2
Z9 2
U1 3
U2 6
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 1246-7820
J9 TRANSFUS CLIN BIOL
JI Transfu. Clin. Biol.
PD SEP
PY 2017
VL 24
IS 3
BP 96
EP 100
DI 10.1016/j.tracli.2017.05.005
PG 5
WC Hematology; Immunology
SC Hematology; Immunology
GA FN8TB
UT WOS:000416297300002
PM 28666583
DA 2020-07-08
ER

PT J
AU Avchen, RN
   LeBlanc, TT
   Kosmos, C
AF Avchen, Rachel Nonkin
   LeBlanc, Tanya Telfair
   Kosmos, Christine
TI From Anthrax to Zika: Fifteen Years of Public Health Emergency
   Preparedness
SO AMERICAN JOURNAL OF PUBLIC HEALTH
LA English
DT Editorial Material
C1 [Avchen, Rachel Nonkin; LeBlanc, Tanya Telfair; Kosmos, Christine] Ctr Dis Control & Prevent, Div State & Local Readiness, Off Publ Hlth Preparedness & Response, Atlanta, GA 30333 USA.
RP Avchen, RN (corresponding author), Ctr Dis Control & Prevent, Div State & Local Readiness, Off Publ Hlth Preparedness & Response, Atlanta, GA 30333 USA.
NR 0
TC 1
Z9 1
U1 3
U2 3
PU AMER PUBLIC HEALTH ASSOC INC
PI WASHINGTON
PA 800 I STREET, NW, WASHINGTON, DC 20001-3710 USA
SN 0090-0036
EI 1541-0048
J9 AM J PUBLIC HEALTH
JI Am. J. Public Health
PD SEP
PY 2017
VL 107
SU 2
BP S117
EP S117
DI 10.2105/AJPH.2017.304058
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FO0CZ
UT WOS:000416411700002
PM 28892442
OA Green Published
DA 2020-07-08
ER

PT J
AU Iskander, J
   Rose, DA
   Ghiya, ND
AF Iskander, John
   Rose, Dale A.
   Ghiya, Neelam D.
TI Science in Emergency Response at CDC: Structure and Functions
SO AMERICAN JOURNAL OF PUBLIC HEALTH
LA English
DT Editorial Material
ID ZIKA VIRUS-INFECTION; PREPAREDNESS
AB Recent high-profile activations of the US Centers for Disease Control and Prevention (CDC) Emergency Operations Center (EOC) include responses to the West African Ebola and Zika virus epidemics.
   Within the EOC, emergency responses are organized according to the Incident Management System, which provides a standardized structure and chain of command, regardless of whether the EOC activation occurs in response to an outbreak, natural disaster, or other type of public health emergency. By embedding key scientific roles, such as the associate director for science, and functions within a Scientific Response Section, the current CDC emergency response structure ensures that both urgent and important science issues receive needed attention. Key functions during emergency responses include internal coordination of scientific work, data management, information dissemination, and scientific publication.
   We describe a case example involving the ongoing Zika virus response that demonstrates how the scientific response structure can be used to rapidly produce high-quality science needed to answer urgent public health questions and guide policy. Within the context of emergency response, longer-term priorities at CDC include both streamlining administrative requirements and funding mechanisms for scientific research.
C1 [Iskander, John; Ghiya, Neelam D.] Ctr Dis Control & Prevent CDC, Off Associate Director Sci, Off Director, Atlanta, GA USA.
   [Rose, Dale A.] CDC, Div Emergency Operat, Off Publ Hlth Preparedness & Response, Atlanta, GA 30333 USA.
RP Iskander, J (corresponding author), 1600 Clifton Rd,MS D-50, Atlanta, GA 30329 USA.
EM jxi0@cdc.gov
RI Rose, Dale A/P-2721-2018
OI Rose, Dale A/0000-0002-0943-6121
FU Centers for Disease Control and Prevention (CDC)United States Department
   of Health & Human ServicesCenters for Disease Control & Prevention - USA
FX Funding was provided by the Centers for Disease Control and Prevention
   (CDC).
CR Bhavsar TR, 2010, J AM PHARM ASSOC, V50, P165, DOI 10.1331/JAPhA.2010.09220
   Chapman LE, 2015, Concepts and Methods in Infectious Disease Surveillance, P163
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Fischer LS, 2016, MMWR-MORBID MORTAL W, V65, P1374, DOI 10.15585/mmwr.mm6548a4
   Hinton CF, 2015, MMWR-MORBID MORTAL W, V64, P972, DOI 10.15585/mmwr.mm6435a3
   Hombach J, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5923
   Iskander J, 2016, J PUBLIC HEALTH MAN, V22, P409, DOI 10.1097/PHH.0000000000000277
   Lant T, 2013, J PUBLIC HEALTH MAN, V19, pS3, DOI 10.1097/PHH.0b013e318293f73e
   Leidel L, 2013, MMWR-MORBID MORTAL W, V62, P709
   Lurie N, 2013, NEW ENGL J MED, V368, P1251, DOI 10.1056/NEJMsb1209510
   Moskosky S. B., 2011, Morbidity and Mortality Weekly Report, V60, P1
   Papagiotas SS, 2012, PUBLIC HEALTH REP, V127, P267, DOI 10.1177/003335491212700306
   Purpura LJ, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30330-9
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
NR 15
TC 1
Z9 1
U1 11
U2 28
PU AMER PUBLIC HEALTH ASSOC INC
PI WASHINGTON
PA 800 I STREET, NW, WASHINGTON, DC 20001-3710 USA
SN 0090-0036
EI 1541-0048
J9 AM J PUBLIC HEALTH
JI Am. J. Public Health
PD SEP
PY 2017
VL 107
SU 2
BP S122
EP S125
DI 10.2105/AJPH.2017.303951
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FO0CZ
UT WOS:000416411700005
PM 28892452
OA Green Published
DA 2020-07-08
ER

PT J
AU Al-Tawfiq, JA
   Gautret, P
   Memish, ZA
AF Al-Tawfiq, Jaffar A.
   Gautret, Philippe
   Memish, Ziad A.
TI Expected immunizations and health protection for Hajj and Umrah 2018-An
   overview
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Review
DE Hajj; Pilgrimage; Mass gathering; Vaccine requirements; Saudi Arabia
ID VIRAL RESPIRATORY-INFECTIONS; INFLUENZA-LIKE ILLNESS; MENINGOCOCCAL
   DISEASE; MASS GATHERINGS; MEASLES OUTBREAK; NASAL CARRIAGE;
   UNITED-STATES; A H1N1; PILGRIMS; SURVEILLANCE
AB Background: The annual Hajj and Umrah are one of the largest recurring religious mass gatherings across the globe drawing pilgrims from more than 185 countries. The living circumstances and activities of the pilgrims may create an environment for the occurrence and spread of communicable diseases. Each year, the Health authority of the Kingdom of Saudi Arabia, in coordination with international health authorities, updates health requirements for pilgrims. The Hajj for 2017 took place from August 24 to September 5, 2017. Here, we review the expected obligations for immunizations for the 2018 Hajj and Umrah.
   Results: The Hajj and Umrah vaccine requirements include mandatory vaccinations against yellow fever, quadrivalent meningococcal polysaccharide (every 3 years) or conjugated (every 5 years) vaccines and poliomyelitis vaccine. Influenza vaccine utilizing the 2016 (Southern Hemisphere vaccine to all pilgrims) was recommended but was not obligatory for pilgrims. Ciprofloxacin is required for individuals > 12 years excluding pregnant women as chemoprophylaxis to be given at the port of entry for Pilgrims coming from the meningitis belt. With the ongoing outbreaks of measles in Europe, it is recommended that all pilgrims have an updated immunization against vaccine-preventable diseases (diphtheria, tetanus, pertussis, polio, measles and mumps).
   Conclusion: The mandatory vaccines remain the same with continued vigilance for the development of any new or emerging infectious diseases. Continuing surveillance for Zika virus, cholera and MERS-CoV are ongoing.
C1 [Al-Tawfiq, Jaffar A.] Johns Hopkins Aramco Healthcare, POB 76,Room A-428-2,Bldg 61, Dhahran 31311, Saudi Arabia.
   [Al-Tawfiq, Jaffar A.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA.
   [Gautret, Philippe] Aix Marseille Univ, URMITE, CNRS, IRD,UMR 6236,Mediterranee Infect,Fac Med & Pharm, Marseille, France.
   [Memish, Ziad A.] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia.
   [Memish, Ziad A.] Prince Mohamed Bin Abdulaziz Hosp PMAH, Minist Hlth, Dept Med, Infect Dis Div, Riyadh, Saudi Arabia.
   [Memish, Ziad A.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.
RP Al-Tawfiq, JA (corresponding author), Johns Hopkins Aramco Healthcare, POB 76,Room A-428-2,Bldg 61, Dhahran 31311, Saudi Arabia.
EM jaffar.tawfiq@jhah.com
RI amsalu, ribka/G-8780-2019
CR Aberle JH, 2014, EMERG INFECT DIS, V2015, P726
   Ahmed QA, 2006, LANCET, V367, P1008, DOI 10.1016/S0140-6736(06)68429-8
   Ahmed Q, 2016, FRONT MED-PRC, V10, P527, DOI 10.1007/s11684-016-0487-2
   al-Gahtani YM, 1992, EPIDEMIOL INFECT, V1995, P399
   Al-Tawfiq JA, 2015, CLIN MICROBIOL INFEC, V21, P109, DOI [10.1016/j.cmi.2015.02.008, 10.1016/j.cmi.2014.11.013, 10.1016/j.cmi.2014.07.005]
   Al-Tawfiq JA, 2013, E MEDITERR HEALTH J, V19, pS48
   Al-Tawfiq JA, 2012, EUROSURVEILLANCE, V17, P6
   Al-Tawfiq JA, 2017, VACCINE
   Al-Tawfiq JA, 2012, INFECT DIS CLIN N AM, P26
   Al-Tawfiq JA, 2016, HUM VACC IMMUNOTHER, V12, P326, DOI 10.1080/21645515.2015.1058456
   Al-Tawfiq JA, 2014, INT J INFECT DIS, V27, P26, DOI 10.1016/j.ijid.2014.07.001
   Al-Tawfiq JA, 2012, INFECT DIS CLIN N AM, V26, P725, DOI 10.1016/j.idc.2012.05.005
   Alborzi A, E MEDITERR HLTH J, V14, P277
   Alborzi A, 2009, J TRAVEL MED, V16, P239, DOI 10.1111/j.1708-8305.2009.00301.x
   Aleflali M, 2015, HUM VACCIN IMMUNOTHE
   Alfelali M, 2015, VACCINE, V33, P2562, DOI 10.1016/j.vaccine.2015.04.006
   Annan A, 2013, TROP MED INT HEALTH, V20, P807
   Ashshi A, 2014, J INFECT DEV COUNTR, V8, P1169, DOI 10.3855/jidc.4204
   Atabani SF, 2016, INT J INFECT DIS, V47, P10, DOI 10.1016/j.ijid.2016.04.016
   Baharoon S, 2009, TRAVEL MED INFECT DI, V7, P247, DOI 10.1016/j.tmaid.2008.09.002
   Barasheed Osamah, 2014, Virologica Sinica, V29, P364, DOI 10.1007/s12250-014-3507-x
   Barasheed Osamah, 2014, Infectious Disorders - Drug Targets, V14, P110
   Benkouiten S, 2014, EMERG INFECT DIS, V20, P1821, DOI 10.3201/eid2011.140600
   Borrow R, 2009, TRAVEL MED INFECT DI, V7, P219, DOI 10.1016/j.tmaid.2009.05.003
   Chen TH, 2010, PEDIATR INFECT DIS J, V29, P794, DOI 10.1097/INF.0b013e3181dbaacf
   ECDC, 2017, PUBL HLTH RISKS REL
   Edouard S, 2017, VACCINE
   Elachola H, 2016, J HLTH SPECIALTIES, V4, P87
   Folaranmi T, 2015, MMWR-MORBID MORTAL W, V64, P608
   Gautret P, 2013, CLIN MICROBIOL INFEC, V19, pE315, DOI 10.1111/1469-0691.12174
   Gautret P, 2016, INT J INFECT DIS, V47, P46, DOI 10.1016/j.ijid.2016.03.007
   Gautret P, 2015, TRAVEL MED INFECT DI, V13, P159, DOI 10.1016/j.tmaid.2015.02.005
   Gautret P, 2014, EMERG INFECT DIS, V20, P728, DOI 10.3201/eid2004.131708
   Gautret P, 2011, J TRAVEL MED, V18, P53, DOI 10.1111/j.1708-8305.2010.00480.x
   Griffiths K, 2016, TRAVEL MED INFECT DI, V14, P414, DOI 10.1016/j.tmaid.2016.05.002
   Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063
   Issack MI, 2002, EMERG INFECT DIS, V8, P332
   Jafri RZ, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-17
   Kandeel A, 2011, EMERG INFECT DIS, V17, P1266, DOI 10.3201/eid1707.101484
   Leangapichart T, 2017, TRAVEL MED INFECT DI, V18, P3, DOI 10.1016/j.tmaid.2017.06.008
   Leangapichart T, 2017, J ANTIMICROB CHEMOTH, V72, P2627, DOI 10.1093/jac/dkx155
   Mayer LW, 2002, J INFECT DIS, V185, P1596, DOI 10.1086/340414
   McNamara LA, 2015, PEDIATRICS, V135, P798, DOI 10.1542/peds.2014-4015
   Memish Z., 2013, Eurosurveillance, V18, P20581
   Memish ZA, 2003, INT J ANTIMICROB AG, V21, P96, DOI 10.1016/S0924-8579(02)00364-3
   Memish ZA, 2002, CLIN INFECT DIS, V34, P84, DOI 10.1086/323403
   Memish ZA, 2013, LANCET GLOB HEALTH, P1
   Memish ZA, 2017, VACCINE, V35, P2473, DOI 10.1016/j.vaccine.2017.03.027
   Memish ZA, 2014, INT J INFECT DIS, V28, P171, DOI 10.1016/j.ijid.2014.09.005
   Memish ZA, 2014, TRAVEL MED INFECT DI, V12, P415, DOI 10.1016/j.tmaid.2014.09.003
   Memish ZA, 2014, J INFECT DIS, V210, P1067, DOI 10.1093/infdis/jiu150
   Memish ZA, 2014, INT J INFECT DIS, V25, P186, DOI 10.1016/j.ijid.2014.06.003
   Memish ZA, 2014, LANCET, V383, P2073, DOI 10.1016/S0140-6736(14)60381-0
   Memish ZA, 2012, J TRAVEL MED, V19, P15, DOI 10.1111/j.1708-8305.2011.00575.x
   Moattari A, 2012, INFLUENZA OTHER RESP, V6, pe77, DOI 10.1111/j.1750-2659.2012.00380.x
   Mushtaq A, 2015, TRAVEL MED INFECT DI, V13, P360, DOI 10.1016/j.tmaid.2015.06.004
   Parker AA, 2006, NEW ENGL J MED, V355, P447, DOI 10.1056/NEJMoa060775
   Pfaff G, 2010, EUROSURVEILLANCE, V15, P5
   ProMed, 2013, NOV COR E MED 03 SAU
   Rashid H, 2008, Emerg Health Threats J, V1, pe2, DOI 10.3134/ehtj.08.002
   Rashid H, 2008, CLIN MICROBIOL INFEC, V14, P569, DOI 10.1111/j.1469-0691.2008.01987.x
   Rashid Harunor, 2007, Travel Med Infect Dis, V5, P310, DOI 10.1016/j.tmaid.2007.07.006
   Refaey S, 2016, INFLUENZA OTHER RESP
   Shahin W, 2009, DENGUE B, P33
   Shibl A, 2013, E MEDITERR HEALTH J, V19, P389
   Soeters HM, 2015, MMWR-MORBID MORTAL W, V64, P606
   Wilder-Smith A, 2003, EMERG INFECT DIS, V9, P734
   Wilder-Smith A, 2002, BMJ-BRIT MED J, V325, P365, DOI 10.1136/bmj.325.7360.365
   Wilder-Smith A, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0363-y
   World Health Organization, 2016, COUNTR RISK YELL FEV
   World Health Organization, 2016, NEW YELL FEV VACC RE
   Ziyaeyan M, 2012, INFLUENZA OTHER RESP, V6, pe80, DOI 10.1111/j.1750-2659.2012.00381.x
NR 72
TC 28
Z9 28
U1 2
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD SEP
PY 2017
VL 19
BP 2
EP 7
DI 10.1016/j.tmaid.2017.10.005
PG 6
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA FN3HY
UT WOS:000415890000002
PM 29037978
OA Green Published
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Animal bite and non-vector-borne transmission of Zika virus
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Letter
C1 [Joob, Beuy] Anitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Joob, B (corresponding author), Anitat 1 Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Joob B, 2017, ASIAN PAC J TROP MED, V10, P199, DOI 10.1016/j.apjtm.2017.01.011
   Ragan IK, 2017, VECTOR BORNE ZOONOTI
NR 3
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD SEP
PY 2017
VL 19
BP 71
EP 71
DI 10.1016/j.tmaid.2017.07.003
PG 1
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA FN3HY
UT WOS:000415890000016
PM 28698028
DA 2020-07-08
ER

PT J
AU Salick, MR
   Wells, MF
   Eggan, K
   Kaykas, A
AF Salick, Max R.
   Wells, Michael F.
   Eggan, Kevin
   Kaykas, Ajamete
TI Modelling Zika Virus Infection of the Developing Human Brain In Vitro
   Using Stem Cell Derived Cerebral Organoids
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Neuroscience; Issue 127; Zika virus; ZIKV; microcephaly; cerebral
   organoids; stem cells; neural progenitor cells; neurodevelopment; Axl;
   Flaviviridae
ID NEURAL PROGENITORS; RHESUS
AB The recent emergence of Zika virus (ZIKV) in susceptible populations has led to an abrupt increase in microcephaly and other neurodevelopmental conditions in newborn infants. While mosquitos are the main route of viral transmission, it has also been shown to spread via sexual contact and vertical mother-to-fetus transmission. In this latter case of transmission, due to the unique viral tropism of ZIKV, the virus is believed to predominantly target the neural progenitor cells (NPCs) of the developing brain.
   Here a method for modeling ZIKV infection, and the resulting microcephaly, that occur when human cerebral organoids are exposed to live ZIKV is described. The organoids display high levels of virus within their neural progenitor population, and exhibit severe cell death and microcephaly over time. This three-dimensional cerebral organoid model allows researchers to conduct species-matched experiments to observe and potentially intervene with ZIKV infection of the developing human brain. The model provides improved relevance over standard two-dimensional methods, and contains human-specific cellular architecture and protein expression that are not possible in animal models.
C1 [Salick, Max R.; Kaykas, Ajamete] Novartis Inst BioMed Res, Dept Neurosci, Cambridge, MA 02139 USA.
   [Wells, Michael F.; Eggan, Kevin] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA USA.
   [Wells, Michael F.; Eggan, Kevin] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.
   [Wells, Michael F.; Eggan, Kevin] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA.
RP Kaykas, A (corresponding author), Novartis Inst BioMed Res, Dept Neurosci, Cambridge, MA 02139 USA.
EM ajamete.kaykas@novartis.com
RI Eggan, Kevin/P-7119-2018
FU Stanley Center for Psychiatric Research; Harvard Stem Cell Institute
FX The authors thank Priscilla L. Yang and Dominique J. Burri of Harvard
   Medical School for help with initial propagation and quantification of
   ZIKV. We also would like to thank Nathaniel D. Kirkpatrick for imaging
   support. K.E. was supported by the Stanley Center for Psychiatric
   Research and the Harvard Stem Cell Institute.
CR Beers J, 2012, NAT PROTOC, V7, P2029, DOI 10.1038/nprot.2012.130
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/NMETH.1593, 10.1038/nmeth.1593]
   Contreras D., 2016, JOVE-J VIS EXP, P10
   Cugola F. R., 2016, NATURE
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Oliveira-Szejnfeld P. Soares, 2016, RADIOLOGY
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
NR 27
TC 4
Z9 4
U1 1
U2 7
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD SEP
PY 2017
IS 127
AR e56404
DI 10.3791/56404
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FM8VR
UT WOS:000415370200096
PM 28994790
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Wiwanitkit, S
   Wiwanitkit, V
AF Wiwanitkit, Somsri
   Wiwanitkit, Viroj
TI Thrombocytopenia and bleeding: Existed but little mentioned in Zika
   virus infection
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Wiwanitkit, Somsri] Wiwanitkit House, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Wiwanitkit, S (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM somsriwiwan@hotmail.com
CR Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2
   Duijster JW, 2016, INFECTION
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
NR 4
TC 0
Z9 0
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD SEP-OCT
PY 2017
VL 10
IS 5
BP 1355
EP +
DI 10.4103/1755-6783.196753
PG 2
WC Tropical Medicine
SC Tropical Medicine
GA FM1VA
UT WOS:000414768900051
DA 2020-07-08
ER

PT J
AU Minogue, PJ
   Gao, J
   Zoltoski, RK
AF Minogue, P. J.
   Gao, J.
   Zoltoski, R. K.
TI Viral retinopathy in experimental models of Zika infection (vol 58, pg
   4355, 2017)
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Correction
CR Zhao ZY, 2017, INVEST OPHTH VIS SCI, V58, P4355, DOI 10.1167/iovs.17-22016
NR 1
TC 0
Z9 0
U1 0
U2 1
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD SEP
PY 2017
VL 58
IS 11
BP 4799
EP 4799
PG 1
WC Ophthalmology
SC Ophthalmology
GA FL5II
UT WOS:000414267700011
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Valente, PK
AF Valente, Pablo K.
TI Zika and Reproductive Rights in Brazil: Challenge to the Right to Health
SO AMERICAN JOURNAL OF PUBLIC HEALTH
LA English
DT Editorial Material
ID LATIN-AMERICA; POPULATION; ABORTION; STIGMA
C1 [Valente, Pablo K.] Columbia Univ, Dept Sociomed Sci, Mailman Sch Publ Hlth, 722 W 168th St,9th Floor, New York, NY 10032 USA.
RP Valente, PK (corresponding author), Columbia Univ, Dept Sociomed Sci, Mailman Sch Publ Hlth, 722 W 168th St,9th Floor, New York, NY 10032 USA.
EM pablokvalente@gmail.com
OI Valente, Pablo/0000-0002-2058-3472
CR Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   Attorney General of the Republic, 2016, PAR AC DIR INC 5 581
   Brazil Federal Supreme Court, 2016, MIN LR BARR VOT VIST
   Brazil Federal SupremeCourt, MIN MARC AUR MELL VO, V54
   Brazilian Federal Government, 2017, B EPIDEMIOLOGICO, V48, P1
   BrazilMinistry ofHealth, 2017, PREV COMB DENG CHIK
   Brum E., 2016, ABORTO DEFICIENCIA L
   Camargo TMCR, 2016, CAD SAUDE PUBLICA, V32
   Centers for Disease Control and Pre-vention, 2017, WORLD MAP AR RISK ZI
   Chamber of Deputies, 2010, CONST FED REP BRAZ
   Costa ND, 2016, CIENC SAUDE COLETIVA, V21, P3036, DOI 10.1590/1413-812320152110.18292016
   Cotrim A, 2016, MICROCEFALIA ABORTO
   Datafolha Research Institute, 2016, 51 REJ AB FET COM MI
   Dias A, 2016, ABORTO FEMINISMO POR
   Diniz D, 2010, CIENC SAUDE COLETIVA, V15, P959, DOI 10.1590/S1413-81232010000700002
   Diniz SG, 2015, GLOB PUBLIC HEALTH, V10, P183, DOI 10.1080/17441692.2014.986167
   Doniec K, 2016, LANCET, V388, P867, DOI 10.1016/S0140-6736(16)31428-3
   Douglas B., BRAZIL WARNS WOMEN N
   Fernandez-Salas I, 2015, ANTIVIR RES, V124, P30, DOI 10.1016/j.antiviral.2015.10.015
   Hastings G, 2004, PSYCHOL MARKET, V21, P961, DOI 10.1002/mar.20043
   Hatzenbuehler ML, 2013, AM J PUBLIC HEALTH, V103, P813, DOI 10.2105/AJPH.2012.301069
   Jarman Michelle, 2015, FEMINIST FORMATIONS, V27, P46, DOI [10.1353/ff.2015.0008, DOI 10.1353/FF.2015.0008]
   Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363
   Löwy Ilana, 2016, Physis, V26, P11, DOI 10.1590/S0103-73312016000100002
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   National Association of Public De-fenders, 2016, AC DIR INC 5 581
   Roberts DE, 2009, SIGNS, V34, P783, DOI 10.1086/597132
   Shakespeare T, 1998, DISABIL SOC, V13, P665, DOI 10.1080/09687599826452
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   UN Committee on the Rights of the Persons with Disabilities, 2015, CONCL OBS IN REP BRA
   Undurraga V, 2009, CONSTITUTING EQUALITY: GENDER EQUALITY AND COMPARATIVE CONSTITUTIONAL LAW, P215, DOI 10.1017/CBO9780511596780.012
   United Nations, 2016, UPH WOM HUM RIGHTS E
   United Nations Division for Social Policy and Development, 2006, UN COMM RIGHTS PERS
   Victora CG, 2011, LANCET, V377, P1863, DOI 10.1016/S0140-6736(11)60138-4
   Viens AM, 2009, J BIOETHIC INQ, V6, P207, DOI 10.1007/s11673-009-9149-2
   World Health Organization, 2016, RISK COMM COMM ENG Z
   World Health Organization, 2016, ZIK VIR
   World Health Organization. Fifth meeting of the Emergency Committee under the International Health Regulations, 2005, 5 M EM COMM INT HLTH
NR 38
TC 7
Z9 7
U1 0
U2 4
PU AMER PUBLIC HEALTH ASSOC INC
PI WASHINGTON
PA 800 I STREET, NW, WASHINGTON, DC 20001-3710 USA
SN 0090-0036
EI 1541-0048
J9 AM J PUBLIC HEALTH
JI Am. J. Public Health
PD SEP
PY 2017
VL 107
IS 9
BP 1376
EP 1380
DI 10.2105/AJPH.2017.303924
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FJ1QE
UT WOS:000412491700028
PM 28727526
OA Green Published
DA 2020-07-08
ER

PT J
AU Diaz-Quijano, FA
   Chiavegatto, ADP
AF Diaz-Quijano, Fredi Alexander
   Porto Chiavegatto Filho, Alexandre Dias
TI Reduction of the birth rate in Sao Paulo: a probable effect of the panic
   caused by the Zika-associated microcephaly epidemic
SO ANNALS OF EPIDEMIOLOGY
LA English
DT Letter
C1 [Diaz-Quijano, Fredi Alexander; Porto Chiavegatto Filho, Alexandre Dias] Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, Sao Paulo, Brazil.
RP Diaz-Quijano, FA (corresponding author), Univ Sao Paulo, Fac Saude Publ, Av Dr Arnaldo 715, BR-01246904 Sao Paulo, SP, Brazil.
EM frediazq@msn.com
RI Diaz-Quijano, Fredi Alexander/I-3740-2012
OI Diaz-Quijano, Fredi Alexander/0000-0002-1134-1930
CR Ahrens KA, 2017, MATERN CHILD HLTH J, V21, P982, DOI 10.1007/s10995-017-2275-2
   Eboli E, 2015, J GLOBO
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Lenharo M., 2017, J GLOBO
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
NR 5
TC 5
Z9 5
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1047-2797
EI 1873-2585
J9 ANN EPIDEMIOL
JI Ann. Epidemiol.
PD SEP
PY 2017
VL 27
IS 9
BP 616
EP 617
DI 10.1016/j.annepidem.2017.08.009
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FK0MW
UT WOS:000413174900012
PM 28869076
DA 2020-07-08
ER

PT J
AU Suder, P
   Pyrc, K
   Ner-Kluza, J
   Drabik, A
   Bodzon-Kulakowska, A
AF Suder, P.
   Pyrc, K.
   Ner-Kluza, J.
   Drabik, A.
   Bodzon-Kulakowska, A.
TI ZIKA virus protease NS3 interaction with human fibroblasts proteome
SO FEBS JOURNAL
LA English
DT Meeting Abstract
CT 42nd Congress of the Federation-of-European-Biochemical-Societies (FEBS)
   on From Molecules to Cells and Back
CY SEP 10-14, 2017
CL Jerusalem, ISRAEL
SP Federat European Biochem Soc
C1 [Suder, P.; Ner-Kluza, J.; Drabik, A.; Bodzon-Kulakowska, A.] AGH Univ Sci & Technol, Fac Mat Sci & Ceram, Dept Biochem & Neurobiol, Mickiewicza 30 Ave, PL-30059 Krakow, Poland.
   [Pyrc, K.] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Krakow, Poland.
   [Pyrc, K.] Jagiellonian Univ, Malopolska Ctr Biotechnol, Gronostajowa 7A, PL-30387 Krakow, Poland.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1742-464X
EI 1742-4658
J9 FEBS J
JI FEBS J.
PD SEP
PY 2017
VL 284
SU 1
SI SI
MA P.1.5.042
BP 134
EP 134
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA FG2IK
UT WOS:000409918902097
DA 2020-07-08
ER

PT J
AU Hirsch, AJ
AF Hirsch, Alec J.
TI Modeling Zika virus infection in nonhuman primates
SO FUTURE VIROLOGY
LA English
DT Editorial Material
DE animal models of infection; flavivirus; macaque; vaccine; Zika
ID RHESUS-MONKEYS; VACCINE; PROTECTION
C1 [Hirsch, Alec J.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA.
RP Hirsch, AJ (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA.
EM hirschal@ohsu.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R21 HD091032, U19 AI109680,
   HHSN27201400055C]
FX AJ Hirsch is supported by NIH grants and contracts R21 HD091032, U19
   AI109680, and HHSN27201400055C. The authors have no other relevant
   affiliations or financial involvement with any organization or entity
   with a financial interest in or financial conflict with the subject
   matter or materials discussed in the manuscript apart from those
   disclosed.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Clinicaltrials, ZIK VIR PUR IN VACC
   Clinicaltrials. Gov, SAF IMM ZIK VIR DNA
   Clinicaltrials. Gov, SAF TOL IMM MRNA 132
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Engelmann F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003295
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   MONATH TP, 1981, AM J TROP MED HYG, V30, P431, DOI 10.4269/ajtmh.1981.30.431
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wertheimer AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015514
   Zompi S, 2012, VIRUSES-BASEL, V4, P62, DOI 10.3390/v4010062
NR 27
TC 0
Z9 0
U1 0
U2 2
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0794
EI 1746-0808
J9 FUTURE VIROL
JI Future Virol.
PD SEP
PY 2017
VL 12
IS 9
BP 479
EP 483
DI 10.2217/fvl-2017-0067
PG 5
WC Virology
SC Virology
GA FJ0XK
UT WOS:000412434200003
DA 2020-07-08
ER

PT J
AU Fontaine, A
   Filipovic, L
   Fansiri, T
   Hoffmann, AA
   Cheng, C
   Kirkpatrick, M
   Rasic, G
   Lambrechts, L
AF Fontaine, Albin
   Filipovic, lgor
   Fansiri, Thanyalak
   Hoffmann, Ary A.
   Cheng, Changde
   Kirkpatrick, Mark
   Rasic, Gordana
   Lambrechts, Louis
TI Extensive Genetic Differentiation between Homomorphic Sex Chromosomes in
   the Mosquito Vector, Aedes aegypti
SO GENOME BIOLOGY AND EVOLUTION
LA English
DT Article
DE Aedes aegypti; sex chromosome; sex-linked alleles; RAD markers; WGS
ID X-CHROMOSOME; Y-CHROMOSOME; DE-NOVO; EVOLUTION; DENGUE; RECOMBINATION;
   POPULATIONS; WOLBACHIA; SOFTWARE; INSECTS
AB Mechanisms and evolutionary dynamics of sex-determination systems are of particular interest in insect vectors of human pathogens like mosquitoes because novel control strategies aim to convert pathogen-transmitting females into nonbiting males, or rely on accurate sexing for the release of sterile males. In Aedes aegypti, the main vector of dengue and Zika viruses, sex determination is governed by a dominant male-determining locus, previously thought to reside within a small, nonrecombining, sex-determining region (SDR) of an otherwise homomorphic sex chromosome. Here, we provide evidence that sex chromosomes in Ae. aegypti are genetically differentiated between males and females over a region much larger than the SDR. Our link age mapping intercrosses failed to detect recombination between X and Y chromosomes over a 123-Mbp region (40% of their physical length) containing the SDR. This region of reduced male recombination overlapped with a smaller 63-Mbp region (20% of the physical length of the sex chromosomes) displaying high male-female genetic differentiation in unrelated wild populations from Brazil and Australia and in a reference laboratory strain originating from Africa. In addition, the sex-differentiated genomic region was associated with a significant excess of male-to-female heterozygosity and contained a small cluster of loci consistent with Y-specific null alleles. We demonstrate that genetic differentiation between sex chromosomes is sufficient to assign individuals to their correct sex with high accuracy. We also show how data on allele frequency differences between sexes can be used to estimate linkage disequilibrium between loci and the sex-determining locus. Our discovery of large-scale genetic differentiation between sex chromosomes in Ae. aegypti lays a new foundation for mapping and population genomic studies, as well as for mosquito control strategies targeting the sex-determination pathway.
C1 [Fontaine, Albin; Lambrechts, Louis] Inst Pasteur, Insect Virus Interact Grp, Dept Genomes & Genet, Paris, France.
   [Fontaine, Albin] Inst Rech Biomed Armees, Dept Malad Infect, Unite Parasitol & Entomol, Marseille, France.
   [Fontaine, Albin; Lambrechts, Louis] CNRS, URA 3012, Paris, France.
   [Fontaine, Albin] Aix Marseille Univ, INSERM 1095, CNRS 7278, UM63,IRD 198,AP HM,IHU Mediterranee Infect, Marseille, France.
   [Filipovic, lgor; Hoffmann, Ary A.; Rasic, Gordana] Univ Melbourne, Fac Sci, Sch Biosci, Pest & Environm Adaptat Res Grp, Melbourne, Vic, Australia.
   [Filipovic, lgor; Hoffmann, Ary A.; Rasic, Gordana] Univ Melbourne, Fac Sci, Bio Inst 21, Melbourne, Vic, Australia.
   [Fansiri, Thanyalak] Armed Forces Res Inst Med Sci, Dept Entomol, Bangkok, Thailand.
   [Cheng, Changde; Kirkpatrick, Mark] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.
RP Lambrechts, L (corresponding author), Inst Pasteur, Insect Virus Interact Grp, Dept Genomes & Genet, Paris, France.; Lambrechts, L (corresponding author), CNRS, URA 3012, Paris, France.; Rasic, G (corresponding author), Univ Melbourne, Fac Sci, Sch Biosci, Pest & Environm Adaptat Res Grp, Melbourne, Vic, Australia.; Rasic, G (corresponding author), Univ Melbourne, Fac Sci, Bio Inst 21, Melbourne, Vic, Australia.
EM rasic.gordana@gmail.com; louis.lambrechts@pasteur.fr
RI Hoffmann, Ary/R-2972-2019; Fontaine, Albin/K-4345-2019; Rasic,
   Gordana/AAO-4360-2020
OI Hoffmann, Ary/0000-0001-9497-7645; Fontaine, Albin/0000-0001-6869-6516;
   Rasic, Gordana/0000-0002-3057-0093; Cheng, Changde/0000-0002-2458-2522
FU Agence Nationale de la RechercheFrench National Research Agency (ANR)
   [ANR-09-RPDOC-007-01]; French Government's Investissement d'Avenir
   program Laboratoire d'Excellence Integrative Biology of Emerging
   Infectious Diseases grant [ANR-10-LABX-62-IBEID]; City of Paris
   Emergence(s) program in Biomedical ResearchRegion Ile-de-France;
   European UnionEuropean Union (EU) [734584]; Delegation Generale pour
   l'Armement grant [PDH-2-NRBC-4-B1-405]; National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01-GM116853]; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF) [CRSII3-147625];
   University of MelbourneUniversity of Melbourne [501152]; Centre National
   de la Recherche Scientifique Visiting Researcher grant [1451452];
   National Health and Medical Research CouncilNational Health and Medical
   Research Council of Australia
FX We thank Alongkot Ponlawat, Jason Richardson, three anonymous reviewers
   and the Lambrechts lab members for their insights. We are grateful to
   Eric Deveaud, Nicolas Joly, Olivia Doppelt-Azeroual and Veronique
   Legrand for assistance with computational analysis, and to the Nectar
   Research Cloud for computational resources. The opinions or assertions
   contained herein are the private views of the authors and are not to be
   construed as reflecting the official views of the United States Army,
   Royal Thai Army, or the United States Department of Defense. The funders
   had no role in study design, data collection and interpretation, or the
   decision to submit the work for publication. This work was supported by
   Agence Nationale de la Recherche grant ANR-09-RPDOC-007-01, the French
   Government's Investissement d'Avenir program Laboratoire d'Excellence
   Integrative Biology of Emerging Infectious Diseases grant
   ANR-10-LABX-62-IBEID, the City of Paris Emergence(s) program in
   Biomedical Research, the European Union's Horizon 2020 research and
   innovation programme under ZikaPLAN grant agreement No 734584,
   Delegation Generale pour l'Armement grant No PDH-2-NRBC-4-B1-405,
   National Institutes of Health grant R01-GM116853, Swiss National Science
   Foundation grant CRSII3-147625, The University of Melbourne Early Career
   Researcher grant 501152, Centre National de la Recherche Scientifique
   Visiting Researcher grant 1451452, and National Health and Medical
   Research Council program and fellowship grants.
CR Abbott JK, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2806
   APOSTOL BL, 1994, AM J TROP MED HYG, V51, P89, DOI 10.4269/ajtmh.1994.51.89
   Bachtrog D, 2013, NAT REV GENET, V14, P113, DOI 10.1038/nrg3366
   Becker N., 2003, MOSQUITOES THEIR CON
   Bonin A, 2015, INFECT GENET EVOL, V35, P204, DOI 10.1016/j.meegid.2015.07.034
   Bopp D, 2014, SEX DEV, V8, P20, DOI 10.1159/000356458
   Brelsford A, 2017, MOL ECOL RESOUR, V17, P752, DOI 10.1111/1755-0998.12624
   Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112
   Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354
   Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240
   Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717
   Charlesworth B, 1996, CURR BIOL, V6, P149, DOI 10.1016/S0960-9822(02)00448-7
   Charlesworth D, 2010, GENETICS, V186, P9, DOI 10.1534/genetics.110.117697
   Cheng CD, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006170
   Dissanayake Sumudu N, 2010, BMC Res Notes, V3, P248, DOI 10.1186/1756-0500-3-248
   Dudchenko O, 2017, SCIENCE, V356, P92, DOI 10.1126/science.aal3327
   Eckermann KN, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-S2-S17
   Fansiri T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003621
   Gao F, 2015, J HERED, V106, P666, DOI 10.1093/jhered/esv059
   Gilles JRL, 2014, ACTA TROP, V132, pS178, DOI 10.1016/j.actatropica.2013.08.015
   Guerrero RF, 2012, J EVOLUTION BIOL, V25, P1947, DOI 10.1111/j.1420-9101.2012.02591.x
   Hall AB, 2016, P NATL ACAD SCI USA, V113, pE2114, DOI 10.1073/pnas.1525164113
   Hall AB, 2015, SCIENCE, V348, P1268, DOI 10.1126/science.aaa2850
   Hall AB, 2014, GENOME BIOL EVOL, V6, P179, DOI 10.1093/gbe/evu002
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoffmann AA, 2015, EVOL APPL, V8, P751, DOI 10.1111/eva.12286
   John A, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00075
   Jombart T., 2015, TUTORIAL DISCRIMINAN
   Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521
   Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94
   Juneja P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002652
   Kaiser VB, 2010, ANNU REV GENET, V44, P91, DOI 10.1146/annurev-genet-102209-163600
   Kofler R, 2011, BIOINFORMATICS, V27, P3435, DOI 10.1093/bioinformatics/btr589
   Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x
   Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109
   Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Margarido GRA, 2007, HEREDITAS, V144, P78, DOI 10.1111/j.2007.0018-0661.02000.x
   MOTARA MA, 1978, CHROMOSOMA, V70, P51, DOI 10.1007/BF00292215
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135
   Rasic G, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005096
   Rasic G, 2015, EVOL APPL, V8, P901, DOI 10.1111/eva.12301
   Rasic G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-275
   RICE WR, 1987, EVOLUTION, V41, P911, DOI 10.1111/j.1558-5646.1987.tb05864.x
   Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x
   Salz HK, 2011, CURR OPIN GENET DEV, V21, P395, DOI 10.1016/j.gde.2011.03.001
   Timoshevskiy VA, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-27
   Timoshevskiy VA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002052
   Tomchaney M, 2014, BIOL SEX DIFFER, V5, DOI 10.1186/s13293-014-0010-x
   Toups MA, 2010, GENETICS, V186, P763, DOI 10.1534/genetics.110.118794
   Vicoso B, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002078
   Vicoso B, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001643
   Vicoso B, 2013, P NATL ACAD SCI USA, V110, P6453, DOI 10.1073/pnas.1217027110
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x
   Yazdi HP, 2014, MOL BIOL EVOL, V31, P1444, DOI 10.1093/molbev/msu101
NR 57
TC 12
Z9 12
U1 0
U2 15
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1759-6653
J9 GENOME BIOL EVOL
JI Genome Biol. Evol.
PD SEP
PY 2017
VL 9
IS 9
BP 2322
EP 2335
DI 10.1093/gbe/evx171
PG 14
WC Evolutionary Biology; Genetics & Heredity
SC Evolutionary Biology; Genetics & Heredity
GA FI7AG
UT WOS:000412147400013
PM 28945882
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Christian, KA
   Iuliano, AD
   Uyeki, TM
   Mintz, ED
   Nichol, ST
   Rollin, P
   Staples, JE
   Arthur, RR
AF Christian, Kira A.
   Iuliano, A. Danielle
   Uyeki, Timothy M.
   Mintz, Eric D.
   Nichol, Stuart T.
   Rollin, Pierre
   Staples, J. Erin
   Arthur, Ray R.
TI What We Are WatchingTop Global Infectious Disease Threats, 2013-2016: An
   Update from CDC's Global Disease Detection Operations Center
SO HEALTH SECURITY
LA English
DT Article
DE Surveillance; Infectious diseases; Epidemic management; response; Avian
   influenza; Viral hemorrhagic fevers
ID INFLUENZA-A H5N1; TO-PERSON TRANSMISSION; AVIAN-INFLUENZA;
   VIRUS-INFECTION; EBOLA-VIRUS; H7N9 VIRUS; RISK-FACTORS; SEXUAL
   TRANSMISSION; A(H7N9) VIRUS; CHINA
AB To better track public health events in areas where the public health system is unable or unwilling to report the event to appropriate public health authorities, agencies can conduct event-based surveillance, which is defined as the organized collection, monitoring, assessment, and interpretation of unstructured information regarding public health events that may represent an acute risk to public health. The US Centers for Disease Control and Prevention's (CDC's) Global Disease Detection Operations Center (GDDOC) was created in 2007 to serve as CDC's platform dedicated to conducting worldwide event-based surveillance, which is now highlighted as part of the detect element of the Global Health Security Agenda (GHSA). The GHSA works toward making the world more safe and secure from disease threats through building capacity to better Prevent, Detect, and Respond to those threats. The GDDOC monitors approximately 30 to 40 public health events each day. In this article, we describe the top threats to public health monitored during 2012 to 2016: avian influenza, cholera, Ebola virus disease, and the vector-borne diseases yellow fever, chikungunya virus, and Zika virus, with updates to the previously described threats from Middle East respiratory syndrome-coronavirus (MERS-CoV) and poliomyelitis.
C1 [Christian, Kira A.; Arthur, Ray R.] CDC, Global Dis Detect Operat Ctr, Emergency Response & Recovery Branch, Div Global Hlth Protect,Ctr Global Hlth,Ctr Dis C, Atlanta, GA 30333 USA.
   [Iuliano, A. Danielle; Uyeki, Timothy M.] CDC, Epidemiol & Prevent Branch, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.
   [Mintz, Eric D.] CDC, Waterborne Dis Prevent Branch, Div Foodborne Waterborne & Enter Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Nichol, Stuart T.; Rollin, Pierre] CDC, Viral Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Staples, J. Erin] CDC, Arboviral Dis Branch, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Ft Collins, CO USA.
RP Christian, KA (corresponding author), Ctr Dis Control & Prevent, Global Dis Detect Operat Ctr, Emergency Response & Recovery Branch, Div Global Hlth Protect,Ctr Global Hlth, 1600 Clifton Rd NE,MS D-68, Atlanta, GA 30329 USA.
EM dot9@cdc.gov
OI Rollin, Pierre/0000-0002-4608-2641
CR Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279
   Ali M, 2012, B WORLD HEALTH ORGAN, V90, P209, DOI 10.2471/BLT.11.093427
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P433
   [Anonymous], 1978, Bull World Health Organ, V56, P271
   [Anonymous], 2014, EARL DET ASS RESP AC
   Center for Disease Control and Prevention, 2017, MICR OTH BIRTH DEF
   Centers for Disease Control and Prevention, 2016, EST RANG AED ALB AED
   Chan PKS, 2002, CLIN INFECT DIS, V34, pS58, DOI 10.1086/338820
   Cho SY, 2016, LANCET, V388, P994, DOI 10.1016/S0140-6736(16)30623-7
   Christian Kira A, 2013, Emerg Health Threats J, V6, P20632, DOI 10.3402/ehtj.v6i0.20632
   Chursi S, 2014, AM J TROP MED HYG, V90, P410, DOI 10.4269/ajtmh.12-0681
   Department of Defense, 2017, GLOB EM INF SURV RES
   Diallo B, 2016, CLIN INFECT DIS, V63, P1353, DOI 10.1093/cid/ciw601
   Dinh PN, 2006, EMERG INFECT DIS, V12, P1841
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Executive Office of the President; National Science and Technology Council, 2013, NAT BIOS SCI TECHN R
   Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584
   Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459
   Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225
   Gerardin P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-99
   Global Disease Detection Operations Center, 2016, EV AN MAN SYST
   Global Polio Eradication Initiative, 2016, STAT HAS NEV STOPP I
   Grobbelaar AA, 2016, EMERG INFECT DIS, V22, P1854, DOI 10.3201/eid2210.160818
   Iuliano AD, 2017, MMWR-MORBID MORTAL W, V66, P254, DOI 10.15585/mmwr.mm6609e2
   Ivers LC, 2017, NEW ENGL J MED, V376, P101, DOI 10.1056/NEJMp1614104
   Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930
   Kumar CVMN, 2010, INDIAN J VIROL, V21, P8, DOI 10.1007/s13337-010-0012-1
   Lai SJ, 2016, LANCET INFECT DIS, V16, pE108, DOI 10.1016/S1473-3099(16)00153-5
   Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617
   Liu B, 2014, CLIN INFECT DIS, V59, P787, DOI 10.1093/cid/ciu423
   Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773
   Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Peiris JSM, 2016, LANCET INFECT DIS, V16, P252, DOI 10.1016/S1473-3099(15)00502-2
   Rajabali N, 2015, CAN J INFECT DIS MED, V26, P221, DOI 10.1155/2015/961080
   Rollin PE, 1999, J INFECT DIS, V179, pS108, DOI 10.1086/514303
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Soka MJ, 2016, LANCET GLOB HEALTH, V4, pE736, DOI 10.1016/S2214-109X(16)30175-9
   Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021
   Uyeki TM, 2016, CLIN INFECT DIS, V62, P1552, DOI 10.1093/cid/ciw202
   Uyeki TM, 2013, NEW ENGL J MED, V368, P1862, DOI 10.1056/NEJMp1304661
   Wang H, 2008, LANCET, V371, P1427, DOI 10.1016/S0140-6736(08)60493-6
   WHO, 2017, HUM INF AV INFL H7N9
   WHO, 2016, EB SIT REP
   WHO, 2016, YELL FEV ANG
   WHO, 2016, SIT REP YELL FEV
   WHO, 2016, MIDDL E RESP SYNDR C
   World Health Organization, 2016, GLOB HLTH OBS GHO DA
   World Health Organization, 2015, INT HLTH REG 2005 GL
   World Health Organization, 2016, CHOL VACC SUPPL SET
   World Health Organization, 2013, CUM NUMB CONF HUM CA
   World Health Organization, 2016, WHO PARTN PROT MOR 1
   World Health Organization, 2016, EB HEM FEV GUIN
   World Health Organization, 2016, M EM COMM INT HLTH R
   World Health Organization, 2016, SIT REP ZIK VIR
   Yu HJ, 2014, LANCET, V383, P541, DOI 10.1016/S0140-6736(13)61904-2
   Yuan J, 2015, EMERG INFECT DIS, V21, P1784, DOI 10.3201/eid2110.150623
   Zhou L, 2017, WEST PAC SURVEILL RE, V8, DOI [10.5365/wpsar.2017.8.1.001, 10.5365/WPSAR.2017.8.1.001]
   Zhou L, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw182
   Zhou L, 2009, J INFECT DIS, V199, P1726, DOI 10.1086/599206
NR 60
TC 9
Z9 10
U1 1
U2 13
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2326-5094
EI 2326-5108
J9 HEALTH SECUR
JI Health Secur.
PD SEP-OCT
PY 2017
VL 15
IS 5
BP 453
EP 462
DI 10.1089/hs.2017.0004
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FK6FV
UT WOS:000413599700001
PM 28805465
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Zamani, M
   Zamani, V
AF Zamani, Mohammad
   Zamani, Vahid
TI Sexual Transmission of Zika Virus: An Assessment of the Evidence
SO IRANIAN JOURNAL OF PUBLIC HEALTH
LA English
DT Letter
C1 [Zamani, Mohammad] Babol Univ Med Sci, Student Res Comm, Babol Sar, Iran.
   [Zamani, Mohammad] Babol Univ Med Sci, Canc Res Ctr, Babol Sar, Iran.
   [Zamani, Vahid] Babol Univ Med Sci, Vice Chancellery Hlth, Babol Sar, Iran.
RP Zamani, M (corresponding author), Babol Univ Med Sci, Student Res Comm, Babol Sar, Iran.; Zamani, M (corresponding author), Babol Univ Med Sci, Canc Res Ctr, Babol Sar, Iran.
EM mzamani20@gmail.com
RI ; Zamani, Mohammad/A-7733-2016
OI Zamani, Vahid/0000-0001-7485-1842; Zamani, Mohammad/0000-0003-1916-3873
CR Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Centers for Disease Control and Prevention, 2017, SEX TRANSM PREV
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
NR 10
TC 4
Z9 5
U1 0
U2 0
PU IRANIAN SCIENTIFIC SOCIETY MEDICAL ENTOMOLOGY
PI TEHRAN
PA SCHOOL PUBLIC HEALTH & INST HEALTH RESEARCH, TEHRAN UNIV MEDICAL
   SCIENCES, P O BOX  6446-14155, TEHRAN, 00000, IRAN
SN 2251-6085
EI 2251-6093
J9 IRAN J PUBLIC HEALTH
JI Iran J. Public Health
PD SEP
PY 2017
VL 46
IS 9
BP 1305
EP +
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FJ0FH
UT WOS:000412383400023
PM 29026802
DA 2020-07-08
ER

PT J
AU Taira, M
   Ogawa, T
   Nishijima, H
   Yamamoto, K
   Hotta, C
   Akita, M
   Tajima, S
   Saijo, M
AF Taira, Masakatsu
   Ogawa, Tomoko
   Nishijima, Haruna
   Yamamoto, Kojiro
   Hotta, Chiemi
   Akita, Mamiko
   Tajima, Shigeru
   Saijo, Masayuki
TI The First Case of Zika Virus Isolated from a Japanese Patient Who
   Returned to Japan from Fiji in 2016
SO JAPANESE JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
AB Outbreaks of Zika virus (ZIKV) infection in tropical and subtropical regions are a cause of worldwide concern and represent a public health emergency. ZIKV was isolated from a 17-year-old patient with fever and maculopapular rash. The patient returned to Japan from the Republic of Fiji in late April 2016. The complete genome sequence of the ZIKV isolate (ZIKV/Hu/S36/Chiba/2016), which might be the first strain to be isolated in Japan, was identified and reported.
C1 [Taira, Masakatsu; Ogawa, Tomoko; Nishijima, Haruna; Hotta, Chiemi; Akita, Mamiko] Chiba Prefectural Inst Publ Hlth, Div Virol, Nitona Govt Off Bldg,666-2 Nitonacho, Chiba 2608715, Japan.
   [Yamamoto, Kojiro] Chiba Shiroi Hosp, Chiba 2701422, Japan.
   [Tajima, Shigeru; Saijo, Masayuki] Natl Inst Infect Dis, Dept Virol 1, Tokyo 1628640, Japan.
RP Taira, M (corresponding author), Chiba Prefectural Inst Publ Hlth, Chuo Ku, 666-2 Nitona Cho, Chiba 2608715, Japan.
EM m.tir4@pref.chiba.lg.jp
RI Saijo, Masayuki/L-2697-2019
OI Saijo, Masayuki/0000-0001-5458-7298; Shigeru, Tajima/0000-0002-1981-9062
FU Japan Agency for Medical Research and Development, AMEDJapan Agency for
   Medical Research and Development (AMED)
FX This research was supported by the Research Program on Emerging and
   Re-emerging Infectious Diseases of the Japan Agency for Medical Research
   and Development, AMED.
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control (ECDC), 2016, ZIK VIR DIS EP POT A
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Infectious Disease Surveillance Center and Department of Virology I. National Institute of Infectious Diseases and Tuberculosis and Infectious Diseases Control Division Ministry of Health Labour and Welfare, 2015, INFECT AGENT SURVEIL, V36, P47
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nakayama E, 2016, VIRUS GENES, V52, P722, DOI 10.1007/s11262-016-1356-4
   Takasaki Tomohiko, 2011, Trop Med Health, V39, P13, DOI 10.2149/tmh.2011-S07
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   World Health Organization. WHO statement on the first meeting of the International Health Regulations, 2005, WHO 1 M INT HLTH REG
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 15
TC 2
Z9 3
U1 0
U2 0
PU NATL INST INFECTIOUS DISEASES
PI TOKYO
PA JPN J INFECT DIS ED OFF NATL INST INFECTIOUS DISEASES TOYAMA 1-23-1,
   SHINJUKU-KU, TOKYO, 162-8640, JAPAN
SN 1344-6304
EI 1884-2836
J9 JPN J INFECT DIS
JI Jpn. J. Infect. Dis.
PD SEP
PY 2017
VL 70
IS 5
BP 586
EP 589
DI 10.7883/yoken.JJID.2017.042
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA FJ4MX
UT WOS:000412715600021
PM 28367888
OA Bronze
DA 2020-07-08
ER

PT J
AU Gridley-Smith, CL
AF Gridley-Smith, Chelsea L.
TI Examining Mosquito Surveillance and Control Capacity in the Top 10 Areas
   at Risk for Zika Virus Exposure in the United States
SO JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE
LA English
DT News Item
C1 [Gridley-Smith, Chelsea L.] Natl Assoc Cty & City Hlth Officials, 1201 Eye St NW,Ste 400, Washington, DC 20005 USA.
RP Gridley-Smith, CL (corresponding author), Natl Assoc Cty & City Hlth Officials, 1201 Eye St NW,Ste 400, Washington, DC 20005 USA.
EM cgridley-smith@naccho.org
CR American Mosquito Control Association, BEST PRACT INT MOSQ
   Centers for Disease Control and Prevention, ZIK VIR MOSQ CONTR P
   Centers for Disease Control and Prevention, ZIK VIR 2017 CAS COU
   Centers for Disease Control and Prevention, ZIK VIR HLTH EFF RIS
   Centers for Disease Control and Prevention, ZIK VIR MOSQ CONTR
   National Association of County & City Health Officials, MOSQ SURV CONTR ASS
NR 6
TC 1
Z9 1
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1078-4659
EI 1550-5022
J9 J PUBLIC HEALTH MAN
JI J. Public Health Manag. Pract.
PD SEP-OCT
PY 2017
VL 23
IS 5
BP 515
EP 517
DI 10.1097/PHH.0000000000000646
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FI7KB
UT WOS:000412174500018
PM 28759553
DA 2020-07-08
ER

PT J
AU Ajelli, M
   Moise, IK
   Hutchings, TCSG
   Brown, SC
   Kumar, N
   Johnson, NF
   Beier, JC
AF Ajelli, Marco
   Moise, Imelda K.
   Hutchings, Tricia Caroline S. G.
   Brown, Scott C.
   Kumar, Naresh
   Johnson, Neil F.
   Beier, John C.
TI Host outdoor exposure variability affects the transmission and spread of
   Zika virus: Insights for epidemic control
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID AEDES-AEGYPTI DIPTERA; MIAMI-DADE; DISPERSAL; SURVIVAL; TEMPERATURE;
   CHIKUNGUNYA; POPULATION; CULICIDAE; VECTOR; IMPACT
AB Background
   Zika virus transmission dynamics in urban environments follow a complex spatiotemporal pattern that appears unpredictable and barely related to high mosquito density areas. In this context, human activity patterns likely have a major role in Zika transmission dynamics. This paper examines the effect of host variability in the amount of time spent outdoors on Zika epidemiology in an urban environment.
   Methodology/Principal findings
   First, we performed a survey on time spent outdoors by residents of Miami-Dade County, Florida. Second, we analyzed both the survey and previously published national data on outdoors time in the U.S. to provide estimates of the distribution of the time spent outdoors. Third, we performed a computational modeling evaluation of Zika transmission dynamics, based on the time spent outdoors by each person. Our analysis reveals a strong heterogeneity of the host population in terms of time spent outdoors-data are well captured by skewed gamma distributions. Our model-based evaluation shows that in a heterogeneous population, Zika would cause a lower number of infections than in a more homogenous host population (up to 4-fold differences), but, at the same time, the epidemic would spread much faster. We estimated that in highly heterogeneous host populations the timing of the implementation of vector control measures is the major factor for limiting the number of Zika infections.
   Conclusions/Significance
   Our findings highlight the need of considering host variability in exposure time for managing mosquito-borne infections and call for the revision of the triggers for vector control strategies, which should integrate mosquito density data and human outdoor activity patterns in specific areas.
C1 [Ajelli, Marco] Northeastern Univ, Network Sci Inst, Lab Modeling Biol & Sociotech Syst, Boston, MA 02115 USA.
   [Ajelli, Marco] Bruno Kessler Fdn, Ctr Informat & Commun Technol, Trento, Italy.
   [Moise, Imelda K.; Hutchings, Tricia Caroline S. G.] Univ Miami, Dept Geog & Reg Studies, Coll Arts & Sci, Coral Gables, FL 33124 USA.
   [Moise, Imelda K.; Brown, Scott C.; Kumar, Naresh; Beier, John C.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.
   [Brown, Scott C.] Univ Miami, Sch Architecture, Coral Gables, FL 33124 USA.
   [Johnson, Neil F.] Univ Miami, Dept Phys, Coll Arts & Sci, Coral Gables, FL 33124 USA.
RP Ajelli, M (corresponding author), Northeastern Univ, Network Sci Inst, Lab Modeling Biol & Sociotech Syst, Boston, MA 02115 USA.; Ajelli, M (corresponding author), Bruno Kessler Fdn, Ctr Informat & Commun Technol, Trento, Italy.
EM aielli@fbk.eu
RI Moise, Imelda K/AAL-7226-2020
OI Moise, Imelda K/0000-0003-0222-780X
FU CDCUnited States Department of Health & Human ServicesCenters for
   Disease Control & Prevention - USA [1U01CK000510-01]
FX This research was supported by CDC (https://www.cdc.gov/) grant
   1U01CK000510-01: Southeastern Regional Center of Excellence in
   Vector-Borne Diseases: the Gateway Program. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Ajelli M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001519
   ANDERSON R M, 1991
   Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459
   Barrera R, 2017, J MED ENTOMOL, V54, P387, DOI 10.1093/jme/tjw187
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Chadee DD, 2000, J VECTOR ECOL, V25, P158
   Chowell G, 2016, PLOS CURR OUTBREAKS
   Diffey BL, 2011, BRIT J DERMATOL, V164, P848, DOI 10.1111/j.1365-2133.2010.10165.x
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Florida Department of Health, MOSQ BORN DIS SURV
   FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003
   Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103
   Gilks WR, 1995, MARKOV CHAIN MONTE C
   Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Huff A, 2016, PLOS CURR OUTBREAKS
   Klepeis NE, 2001, J EXPO ANAL ENV EPID, V11, P231, DOI 10.1038/sj.jea.7500165
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Lloyd AL, 2007, J R SOC INTERFACE, V4, P851, DOI 10.1098/rsif.2007.1064
   Mabaso MLH, 2004, TROP MED INT HEALTH, V9, P846, DOI 10.1111/j.1365-3156.2004.01263.x
   Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205
   Merler S, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-252
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Min B, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036102
   Moore KJ, 2017, J OCCUP ENVIRON MED, V59, pE17, DOI 10.1097/JOM.0000000000000960
   Moreno-Madrinan MJ, 2017, J MED ENTOMOL
   Muir LE, 1998, AM J TROP MED HYG, V58, P277, DOI 10.4269/ajtmh.1998.58.277
   Nishiura H, 2016, TRAVEL MED INFECT DI, V14, P274, DOI 10.1016/j.tmaid.2016.03.016
   Poletti P, 2011, PLOS ONE, V6
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
   REITER P, 1995, AM J TROP MED HYG, V52, P177, DOI 10.4269/ajtmh.1995.52.177
   Reiter P, 2007, VECTOR-BORNE ZOONOT, V7, P261, DOI 10.1089/vbz.2006.0630
   Salje H, 2016, P NATL ACAD SCI USA, V113, P13420, DOI 10.1073/pnas.1611391113
   Salje H, 2016, J INFECT DIS, V213, P604, DOI 10.1093/infdis/jiv470
   Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89
   SHEPPARD PM, 1969, J ANIM ECOL, V38, P661, DOI 10.2307/3042
   Simard F, 2005, J MED ENTOMOL, V42, P726, DOI 10.1603/0022-2585(2005)042[0726:GDABSP]2.0.CO;2
   Vazquez A., 2013, TEMPORAL NETWORKS
   Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338
   World Health Organization, ZIK VIR DIS
   Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040
   Yoon IK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001730
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
   Zhu L, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0555-0
NR 49
TC 15
Z9 15
U1 0
U2 30
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD SEP
PY 2017
VL 11
IS 9
AR e0005851
DI 10.1371/journal.pntd.0005851
PG 15
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FI6YN
UT WOS:000412142800020
PM 28910292
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pianka, K
   Rothman, A
   Tripathi, A
AF Pianka, Kurt
   Rothman, Alan
   Tripathi, Anubhav
TI Status of diagnostics for three arbovirus infections in resource-limited
   settings
SO TECHNOLOGY
LA English
DT Review
DE Zika Virus; Dengue Virus; Chikungunya Virus; Resource-Limited Setting;
   Point of Care; Differential Diagnostics; Molecular Assay; Senological
   Assay; Isothermal Amplification
ID MEDIATED ISOTHERMAL AMPLIFICATION; GUILLAIN-BARRE-SYNDROME; REVERSE
   TRANSCRIPTION-PCR; SEQUENCE-BASED AMPLIFICATION; DENGUE VIRUS SEROTYPES;
   REAL-TIME DETECTION; RT-LAMP ASSAY; ZIKA-VIRUS; CHIKUNGUNYA-VIRUS; RAPID
   DETECTION
AB Climate change, travel, and urbanization contribute to increasing exposure to Zika, Dengue and Chikungunya. Lab-based diagnostics are required because of overlapping clinical presentations. Here we review the current diagnostic methods, and find them poorly adapted to point of care use in resource-limited settings: generally, serologic assays are hindered by cross-reactivity while molecular assays require laboratory conditions. We conclude that a differential diagnostic device is critically needed, requiring a simpler molecular assay kit that maintains high sensitivity and specificity.
C1 [Pianka, Kurt; Tripathi, Anubhav] Brown Univ, Sch Engn, Ctr Biomed Engn, Providence, RI 02912 USA.
   [Rothman, Alan] Univ Rhode Isl, Dept Cell & Mol Biol, Lab Viral Immun & Pathogenesis, Kingston, RI 02881 USA.
RP Pianka, K (corresponding author), Brown Univ, Sch Engn, Ctr Biomed Engn, Providence, RI 02912 USA.
EM kurt_pianka@brown.edu
CR Abbott Molecular Inc, 2016, ABB REAL TIM ZIKA IN
   Abd El Wahed A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129682
   Alagarasu K, 2016, EPIDEMIOL INFECT, V144, P876, DOI 10.1017/S0950268815001922
   Altona Diagnostics, 2016, REALST ZIK VIR RT PC
   Ang CW, 2001, INFECT IMMUN, V69, P2462, DOI 10.1128/IAI.69.4.2462-2469.2001
   [Anonymous], 2016, WHO 1 M INT HLTH REG
   Arup Laboratories, 2016, ZIK VIR DET RT PCR I
   Beltran-Silva SL, 2016, REV MED HOSP GEN MEX, P1
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blacksell SD, 2011, CLIN VACCINE IMMUNOL, V18, P1773, DOI 10.1128/CVI.05288-11
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CDC, 2016, REV DIAGN TEST ZIK C
   CDC, 2013, CDC DENV 1 4 REAL TI
   CDC, 2014, DENG CLIN GUID
   CDC, 2016, ZIK VIR DIAGN TEST
   CDC, 2016, ZIK MAC ELISA INSTR
   Cecilia D, 2015, ARCH VIROL, V160, P323, DOI 10.1007/s00705-014-2217-x
   Centers for Disease Control, 2016, CHIK VIR US
   Centers for Disease Control and Prevention, 2012, SYMPT WHAT DO YOU TH
   Centers for Disease Control and Prevention, 2016, TRIOPL REAL TIM RT P
   Centers for Disease Control and Prevention, 2017, ZIK VIR SYMPT
   Centers for Disease Control and Prevention, 2017, ZIK VIR MICR OTH BIR
   Centers for Disease Control and Prevention (CDC), 2016, CHIK VIR SYMPT DIAGN
   Centers for Disease Control and Prevention (CDC), 2014, DENG EP
   CHAMBERLAIN R, 1961, ANNU REV ENTOMOL, V6, P371, DOI 10.1146/annurev.en.06.010161.002103
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chan K, 2016, SCI REP-UK, V6, DOI 10.1038/srep38223
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Deiman B, 2002, MOL BIOTECHNOL, V20, P163, DOI 10.1385/MB:20:2:163
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167
   ELITechGroup Inc, 2016, ZIK ELITE MGB KIT US
   Elling R, 2013, PEDIATR INFECT DIS J, V32, P1020, DOI 10.1097/INF.0b013e31829fd0e9
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Focus Diagnostics, 2016, ZIK VIR RNA QUAL REA
   Gardner Timothy, 2016, REUTERS
   Gibney KB, 2011, CLIN INFECT DIS, V52, pE121, DOI 10.1093/cid/ciq214
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Ho PS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-13
   Hologic Inc, 2016, APT ZIK VIR ASS INST
   Houng HSH, 2001, J VIROL METHODS, V95, P19, DOI 10.1016/S0166-0934(01)00280-4
   Hu SF, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0595-1
   Hughes RAC, 1997, LANCET, V349, P225
   Hughes RAC, 2007, BRAIN, V130, P2245, DOI 10.1093/brain/awm004
   Hughes RAC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002063.pub5
   InBios International Inc, 2016, ZIKV DET IGM CAPT EL
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Ito M, 2004, J CLIN MICROBIOL, V42, P5935, DOI 10.1128/JCM.42.12.5935-5937.2004
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Johnson BW, 2016, AM J TROP MED HYG, V95, P182, DOI 10.4269/ajtmh.16-0013
   Kaneko H, 2007, J BIOCHEM BIOPH METH, V70, P499, DOI 10.1016/j.jbbm.2006.08.008
   Kong YY, 2006, J VIROL METHODS, V138, P123, DOI 10.1016/j.jviromet.2006.08.003
   Lai YL, 2007, J CLIN MICROBIOL, V45, P935, DOI 10.1128/JCM.01258-06
   Lu X, 2012, AM J TROP MED HYG, V87, P947, DOI 10.4269/ajtmh.2012.11-0721
   Luminex Corporation, 2016, MULTIFLEX ZIK RNA AS
   Mori Y, 2013, J INFECT CHEMOTHER, V19, P404, DOI 10.1007/s10156-013-0590-0
   Nakauchi M, 2011, J MED VIROL, V83, P10, DOI 10.1002/jmv.21934
   National Institute of Neurological Disorders and Stroke, 2011, GUILL BARR SYNDR FAC
   Neeraja M, 2015, J VIROL METHODS, V211, P22, DOI 10.1016/j.jviromet.2014.10.005
   Tuan NM, 2017, CLIN INFECT DIS, V64, P656, DOI 10.1093/cid/ciw863
   Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63
   Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001
   Pal S, 2015, J CLIN MICROBIOL, V53, P1092, DOI 10.1128/JCM.03042-14
   Panning M, 2009, J CLIN MICROBIOL, V47, P3014, DOI 10.1128/JCM.01024-09
   Parashar D, 2014, CURR SCI INDIA, V107, P2011
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Parida MM, 2007, J CLIN MICROBIOL, V45, P351, DOI 10.1128/JCM.01734-06
   Parida MM, 2008, J BIOSCIENCES, V33, P617, DOI 10.1007/s12038-008-0079-7
   Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002
   Patel P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004953
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Prat CM, 2014, EMERG INFECT DIS, V20, P2129, DOI 10.3201/eid2012.141269
   Ranjit Suchitra, 2005, Pediatr Crit Care Med, V6, P412, DOI 10.1097/01.PCC.0000163676.75693.BF
   Ranjit S, 2011, PEDIATR CRIT CARE ME, V12, P90, DOI 10.1097/PCC.0b013e3181e911a7
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reddy V, 2012, J MED VIROL, V84, P1771, DOI 10.1002/jmv.23406
   Roche Molecular Systems Inc, 2016, LIGHTMIX ZIK RRT PCR
   Sahni Ajay Kumar, 2013, Med J Armed Forces India, V69, P246, DOI 10.1016/j.mjafi.2012.07.017
   Sam IC, 2015, VECTOR-BORNE ZOONOT, V15, P223, DOI 10.1089/vbz.2014.1680
   Sanyaolu A., 2016, SM J PUBLIC HLTH EPI, V2, P1028
   Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024
   Siemens Healthcare Diagnostics Inc, 2016, VERSANT ZIK RNA 1 0
   Simmons M, 2016, J CLIN MICROBIOL, V54, P1766, DOI 10.1128/JCM.00299-16
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Speer SD, 2016, SCIENCE, V353, P750, DOI 10.1126/science.aah6187
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Subhamoy P., 2014, PLOS ONE, V9
   Telles JN, 2009, J MED MICROBIOL, V58, P1168, DOI 10.1099/jmm.0.010736-0
   Teoh BT, 2015, J CLIN MICROBIOL, V53, P830, DOI 10.1128/JCM.02648-14
   Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009
   TwistDX, REC POL AMPL BREAKTH
   Usawattanakul W., 2002, Dengue Bulletin, V26, P131
   van Doorn PA, 2008, LANCET NEUROL, V7, P939, DOI 10.1016/S1474-4422(08)70215-1
   Van Koningsveld R, 2002, NEUROLOGY, V58, P610, DOI 10.1212/WNL.58.4.610
   van Koningsveld R, 2007, LANCET NEUROL, V6, P589, DOI 10.1016/S1474-4422(07)70130-8
   Vela Diagnostics, 2016, SENT SA ZIKV RT PCR
   Verma R, 2014, J NEUROL SCI, V346, P26, DOI 10.1016/j.jns.2014.08.044
   Viracor-IBT Laboratories Inc, 2016, ZIK VIR REAL TIM RT
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Waggoner JJ, 2013, J CLIN MICROBIOL, V51, P3418, DOI 10.1128/JCM.01359-13
   Waggoner JJ, 2013, J CLIN MICROBIOL, V51, P2172, DOI 10.1128/JCM.00548-13
   Wang X, 2016, J VIROL METHODS, V238, P86, DOI 10.1016/j.jviromet.2016.10.010
   WHO, 2016, ZIK VIR FACT SHEET
   Winer JB, 2001, J CLIN PATHOL-MOL PA, V54, P381
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 2017, SIT REP ZIK VIR MICR
   World Health Organization, 2016, DENG SEV DENG FACT S, V2012
   World Health Organization, 2016, CHIK FACT SHEET
   World Health Organization (WHO), 2015, CLIM CHANG HLTH
   Wu SJL, 2001, J CLIN MICROBIOL, V39, P2794, DOI 10.1128/JCM.39.8.2794-2798.2001
   Zaytseva NV, 2005, ANAL CHEM, V77, P7520, DOI 10.1021/ac0509206
NR 119
TC 1
Z9 1
U1 0
U2 9
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 2339-5478
EI 2345-7740
J9 TECHNOLOGY
JI Technology
PD SEP
PY 2017
VL 5
IS 3
BP 115
EP 128
DI 10.1142/S2339547817300025
PG 14
WC Engineering, Multidisciplinary
SC Engineering
GA FJ3WQ
UT WOS:000412663600001
DA 2020-07-08
ER

PT J
AU Ahmadivand, A
   Gerislioglu, B
   Manickam, P
   Kaushik, A
   Bhansali, S
   Nair, M
   Pala, N
AF Ahmadivand, Arash
   Gerislioglu, Burak
   Manickam, Pandiaraj
   Kaushik, Ajeet
   Bhansali, Shekhar
   Nair, Madhavan
   Pala, Nezih
TI Rapid Detection of Infectious Envelope Proteins by Magnetoplasmonic
   Toroidal Metasensors
SO ACS SENSORS
LA English
DT Article
DE terahertz plasmonics; toroidal metasurface; immunosensing; Zika-virus
   envelope protein; detection
ID FANO RESONANCES; TERAHERTZ METAMATERIAL; CHARGE-TRANSFER; EXCITATION;
   MODES; PHASE
AB Unconventional characteristics of magnetic toroidal multipoles have triggered researchers to study these unique resonant phenomena by using both 3D and planar resonators under intense radiation. Here, going beyond conventional planar unit cells, we report on the observation of magnetic toroidal modes using artificially engineered multimetallic planar plasmonic resonators. The proposed microstructures consist of iron (Fe) and titanium (Ti) components acting as magnetic resonators and torus, respectively. Our numerical studies and following experimental verifications show that the proposed structures allow for excitation of toroidal dipoles in the terahertz (THz) domain with the experimental Q-factor of similar to 18. Taking the advantage of high-Q toroidal line shape and its dependence on the environmental perturbations, we demonstrate that room-temperature toroidal metasurface is a reliable platform for immunosensing applications. As a proof of concept, we utilized our plasmonic metasurface to detect Zika-virus (ZIKV) envelope protein (with diameter of 40 nm) using a specific ZIKV antibody. The sharp toroidal resonant modes of the surface functionalized structures shift as a function of the ZIKV envelope protein for small concentrations (similar to pM). The results of sensing experiments reveal rapid, accurate, and quantitative detection of envelope proteins with the limit of detection of similar to 24.2 pg/mL and sensitivity of 6.47 GHz/log(pg/mL). We envision that the proposed toroidal metasurface opens new avenues for developing low-cost, and efficient THz plasmonic sensors for infection and targeted bioagent detection.
C1 [Ahmadivand, Arash; Gerislioglu, Burak; Pala, Nezih] Florida Int Univ, Dept Elect & Comp Engn, 10555 West Flagler St, Miami, FL 33174 USA.
   [Manickam, Pandiaraj; Bhansali, Shekhar] Florida Int Univ, BioMEMS & Microsyst Lab, 10555 West Flagler St, Miami, FL 33174 USA.
   [Kaushik, Ajeet; Nair, Madhavan] Florida Int Univ, Herbert Wertheim Coll Med, Dept Immunol, Ctr Personalized NanoMed,Inst Neurolmmune Pharmac, Miami, FL 33199 USA.
RP Ahmadivand, A (corresponding author), Florida Int Univ, Dept Elect & Comp Engn, 10555 West Flagler St, Miami, FL 33174 USA.
EM aahmadiv@fiu.edu
RI Kaushik, Ajeet/K-1289-2018; Gerislioglu, Burak/K-7729-2019
OI Kaushik, Ajeet/0000-0003-4206-1541; Gerislioglu,
   Burak/0000-0001-8575-7990; Ahmadivand, Arash/0000-0003-0808-8775
FU Army Research Laboratory (ARL) Multiscale Multidisciplinary Modelling of
   Electronic Materials (MSME) Collaborative Research Alliance (CRA)
   [W911NF-12-2-0023]; National Institutes of Health (NIH)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [R01-DA027049, R01-DA034547, R01-DA037838, R01-DA040537,
   R01-DA042706]; University Graduate School (UGS) at Florida International
   University
FX This work is supported by Army Research Laboratory (ARL) Multiscale
   Multidisciplinary Modelling of Electronic Materials (MSME) Collaborative
   Research Alliance (CRA) (Grant No. W911NF-12-2-0023, Program Manager:
   Dr. Meredith L. Reed). The authors have acknowledge grants R01-DA027049,
   R01-DA034547, R01-DA037838, R01-DA040537, and R01-DA042706 awarded by
   National Institutes of Health (NIH). Arash Ahmadivand gratefully
   acknowledges the financial support provided through doctoral evidence
   acquisition (DEA) fellowship by the University Graduate School (UGS) at
   Florida International University.
CR AFANASIEV GN, 1992, J PHYS A-MATH GEN, V25, P4869, DOI 10.1088/0305-4470/25/18/020
   Ahmadivand A, 2017, J INFRARED MILLIM TE, V38, P992, DOI 10.1007/s10762-017-0400-3
   Ahmadivand A, 2016, OPT LETT, V41, P5333, DOI 10.1364/OL.41.005333
   Ahmadivand A, 2015, J OPT SOC AM A, V32, P204, DOI 10.1364/JOSAA.32.000204
   Anker JN, 2008, NAT MATER, V7, P442, DOI 10.1038/nmat2162
   ASHKIN A, 1987, SCIENCE, V235, P1517, DOI 10.1126/science.3547653
   Berrier A, 2012, BIOMED OPT EXPRESS, V3, P2937, DOI 10.1364/BOE.3.002937
   Cetin AE, 2012, ACS NANO, V6, P9989, DOI 10.1021/nn303643w
   Chang WS, 2012, NANO LETT, V12, P4977, DOI 10.1021/nl302610v
   Chen X, 2017, OPT LETT, V42, P2034, DOI 10.1364/OL.42.002034
   Chowdhury DR, 2014, OPT EXPRESS, V22, P19401, DOI 10.1364/OE.22.019401
   Currie LA, 1999, ANAL CHIM ACTA, V391, P127, DOI 10.1016/S0003-2670(99)00105-1
   Dondapati SK, 2010, ACS NANO, V4, P6318, DOI 10.1021/nn100760f
   Dong ZG, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3488020
   DUBOVIK VM, 1990, PHYS REP, V187, P145, DOI 10.1016/0370-1573(90)90042-Z
   Fan YC, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.115417
   Fedotov VA, 2013, SCI REP-UK, V3, DOI 10.1038/srep02967
   Ferguson B, 2002, NAT MATER, V1, P26, DOI 10.1038/nmat708
   Fischer BM, 2002, PHYS MED BIOL, V47, P3807, DOI 10.1088/0031-9155/47/21/319
   Gallinet B, 2011, ACS NANO, V5, P8999, DOI 10.1021/nn203173r
   Gupta M, 2016, ADV OPT MATER, V4, P2119, DOI 10.1002/adom.201600553
   Jackson J., 1999, CLASSICAL ELECTRODYN
   Kaelberer T, 2010, SCIENCE, V330, P1510, DOI 10.1126/science.1197172
   Kaushik A, 2017, TRENDS BIOTECHNOL, V35, P308, DOI 10.1016/j.tibtech.2016.10.001
   Kravets VG, 2013, NAT MATER, V12, P304, DOI [10.1038/NMAT3537, 10.1038/nmat3537]
   Kuznetsov AI, 2011, ACS NANO, V5, P4843, DOI 10.1021/nn2009112
   Lee HJ, 2012, SENSOR ACTUAT B-CHEM, V169, P26, DOI 10.1016/j.snb.2012.01.044
   Lindquist NC, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/3/036501
   Liu W, 2015, OPT EXPRESS, V23, P24738, DOI 10.1364/OE.23.024738
   Maier SA, 2001, ADV MATER, V13, P1501, DOI 10.1002/1521-4095(200110)13:19<1501::AID-ADMA1501>3.0.CO;2-Z
   Mario LY, 2006, OPT EXPRESS, V14, P12770, DOI 10.1364/OE.14.012770
   Meng FY, 2012, IEEE T MICROW THEORY, V60, P3013, DOI 10.1109/TMTT.2012.2209455
   Menikh A, 2002, CHEMPHYSCHEM, V3, P655, DOI 10.1002/1439-7641(20020816)3:8<655::AID-CPHC655>3.0.CO;2-W
   Mickan SP, 2002, PHYS MED BIOL, V47, P3789, DOI 10.1088/0031-9155/47/21/317
   Miyamaru F, 2014, SCI REP-UK, V4, DOI 10.1038/srep04346
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nagel M, 2006, J PHYS-CONDENS MAT, V18, pS601, DOI 10.1088/0953-8984/18/18/S07
   Newton R. G., 1982, SCATTERING THEORY WA
   ORDAL MA, 1988, APPL OPTICS, V27, P1203, DOI 10.1364/AO.27.001203
   Ott C, 2013, SCIENCE, V340, P716, DOI 10.1126/science.1234407
   Palik E.D., 1997, HDB OPTICAL CONSTANT
   Papasimakis N, 2016, NAT MATER, V15, P263, DOI [10.1038/NMAT4563, 10.1038/nmat4563]
   Park SJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04988
   Savinov V, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.205112
   Saxena Shailendra K., 2016, VirusDisease, V27, P111, DOI 10.1007/s13337-016-0307-y
   Smye SW, 2001, PHYS MED BIOL, V46, pR101, DOI 10.1088/0031-9155/46/9/201
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Tao H, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3533367
   Vorou R, 2016, EUROSURVEILLANCE, V21, P27, DOI 10.2807/1560-7917.ES.2016.21.10.30161
   Wang JQ, 2013, OPT EXPRESS, V21, P2236, DOI 10.1364/OE.21.002236
   Wang N, 2013, OPT EXPRESS, V21, P17221, DOI 10.1364/OE.21.017221
   Wiltshire MCK, 2001, SCIENCE, V291, P849, DOI 10.1126/science.291.5505.849
   Wu CH, 2012, NAT MATER, V11, P69, DOI [10.1038/NMAT3161, 10.1038/nmat3161]
   Wu W, 2008, NANOSCALE RES LETT, V3, P397, DOI 10.1007/s11671-008-9174-9
   Xu WD, 2016, ACS PHOTONICS, V3, P2308, DOI 10.1021/acsphotonics.6b00463
   Yanik AA, 2011, P NATL ACAD SCI USA, V108, P11784, DOI 10.1073/pnas.1101910108
   Ye QW, 2013, PHYS SCRIPTA, V88, DOI 10.1088/0031-8949/88/05/055002
   Yu XD, 2010, ADV FUNCT MATER, V20, P1910, DOI 10.1002/adfm.201000135
   Zayats AV, 2013, ACTIVE PLASMONICS AND TUNEABLE PLASMONIC METAMATERIALS, P1, DOI 10.1002/9781118634394
   Zhang S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.047401
   Zheludev NI, 2012, NAT MATER, V11, P917, DOI [10.1038/NMAT3431, 10.1038/nmat3431]
   Zhu WM, 2011, ADV MATER, V23, P1792, DOI 10.1002/adma.201004341
   Zijlstra P, 2012, NAT NANOTECHNOL, V7, P379, DOI [10.1038/NNANO.2012.51, 10.1038/nnano.2012.51]
NR 63
TC 49
Z9 50
U1 5
U2 55
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2379-3694
J9 ACS SENSORS
JI ACS Sens.
PD SEP
PY 2017
VL 2
IS 9
BP 1359
EP 1368
DI 10.1021/acssensors.7b00478
PG 10
WC Chemistry, Multidisciplinary; Chemistry, Analytical; Nanoscience &
   Nanotechnology
SC Chemistry; Science & Technology - Other Topics
GA FI3IR
UT WOS:000411853000016
PM 28792206
DA 2020-07-08
ER

PT J
AU Zhu, S
   Luo, HL
   Liu, H
   Ha, YJ
   Mays, ER
   Lawrence, RE
   Winkelmann, E
   Barrett, AD
   Smith, SB
   Wang, M
   Wang, T
   Zhang, WB
AF Zhu, Shuang
   Luo, Huanle
   Liu, Hua
   Ha, Yonju
   Mays, Elizabeth R.
   Lawrence, Ryan E.
   Winkelmann, Evandro
   Barrett, Alan D.
   Smith, Sylvia B.
   Wang, Min
   Wang, Tian
   Zhang, Wenbo
TI p38MAPK plays a critical role in induction of a pro-inflammatory
   phenotype of retinal Muller cells following Zika virus infection
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Zika virus; Ocular abnormalities; Muller cells; Inflammation; p38MAPK
ID ACTIVATION; INHIBITORS; IDENTIFICATION; CXCL10; STRESS; MICE
AB Zika virus (ZIKV) infection has been associated with ocular abnormalities such as chorioretinal atrophy, optic nerve abnormalities, posterior uveitis and idiopathic maculopathy. Yet our knowledge about ZIKV infection in retinal cells and its potential contribution to retinal pathology is still very limited. Here we found that primary Muller cells, the principal glial cells in the retina, expressed a high level of ZIKV entry cofactor AXL gene and were highly permissive to ZIKV infection. In addition, ZIKV-infected Muller cells exhibited a pro-inflammatory phenotype and produced many inflammatory and growth factors. While a number of inflammatory signaling pathways such as ERK, p38MAPK, NF-kappa B, JAK/STAT3 and endoplasmic reticulum stress were activated after ZIKV infection, inhibition of p38MAPK after ZIKV infection most effectively blocked ZIKV-induced inflammatory and growth molecules. In comparison to ZIKV, Dengue virus (DENY), another Flavivirus infected Muller cells more efficiently but induced much lower pro inflammatory responses. These data suggest that Muller cells play an important role in ZIKV-induced ocular pathology by induction of inflammatory and growth factors in which the p38MAPK pathway has a central role. Blocking p38MAPK may provide a novel approach to control ZIKV-induced ocular inflammation. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Zhu, Shuang; Liu, Hua; Ha, Yonju; Zhang, Wenbo] Univ Texas Med Branch, Dept Ophthalmol & Visual Sci, Galveston, TX 77555 USA.
   [Luo, Huanle; Mays, Elizabeth R.; Lawrence, Ryan E.; Winkelmann, Evandro; Barrett, Alan D.; Wang, Tian] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Liu, Hua] Univ Texas Med Branch, Ctr Biomed Engn, Galveston, TX 77555 USA.
   [Barrett, Alan D.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Smith, Sylvia B.] Augusta Univ, Cellular Biol & Anat, Augusta, GA 30912 USA.
   [Wang, Min] FutraTech Inc, San Diego, CA 92121 USA.
   [Wang, Tian; Zhang, Wenbo] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Zhang, Wenbo] Univ Texas Med Branch, Neurosci & Cell Biol, Galveston, TX 77555 USA.
RP Wang, T; Zhang, WB (corresponding author), Univ Texas Med Branch, 301 Univ Blvd, Galveston, TX 77555 USA.
EM ti1wang@utmb.edu; we2zhang@utmb.edu
OI Winkelmann, Evandro/0000-0003-0602-7426
FU Institute for Human Infections Immunity; National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [EY022694, EY026629, A1099123]; John
   Sealy Memorial Endowment Fund for Biomedical Research; NIAID T35
   training grant [AI078878]; Retina Research Foundation
FX The authors wish to thank Dr. Robert B. Tesh for providing ZIKV FSS13025
   isolate and ZIKV antibody. We also thank Dr. Linsey Yeager for assisting
   in manuscript preparation. This work is supported by the Institute for
   Human Infections & Immunity (W.Z. and T.W.), the National Institutes of
   Health grant EY022694 and EY026629 (W.Z.), the John Sealy Memorial
   Endowment Fund for Biomedical Research and Retina Research Foundation
   (W.Z.), and the National Institutes of Health grant A1099123 (T.W.).
   R.E.L was a recipient of a summer internship from NIAID T35 training
   grant (AI078878, PI: Lynn Soong).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Ameri H, 2014, INVEST OPHTH VIS SCI, V55, P801, DOI 10.1167/iovs.13-12812
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Cui LY, 2017, EBIOMEDICINE, V20, P193, DOI 10.1016/j.ebiom.2017.04.029
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Hoz R, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2954721
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Fu YL, 2014, ANTIVIR RES, V110, P151, DOI 10.1016/j.antiviral.2014.08.004
   Green CJ, 2011, BIOCHEM J, V435, P463, DOI 10.1042/BJ20101517
   Hollborn M, 2011, MOL VIS, V17, P2738
   Jampol L.M, 2016, JAMA OPHTHALMOL, V387, P521
   Jiang R, 2014, J IMMUNOL RES, DOI 10.1155/2014/787023
   Keshari RS, 2013, J CELL BIOCHEM, V114, P532, DOI 10.1002/jcb.24391
   Klein RS, 2005, J VIROL, V79, P11457, DOI 10.1128/JVI.79.17.11457-11466.2005
   Kodati S, 2017, LANCET, V389, P125, DOI 10.1016/S0140-6736(16)32518-1
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Newman E, 1996, TRENDS NEUROSCI, V19, P307, DOI 10.1016/0166-2236(96)10040-0
   Norman P, 2015, EXPERT OPIN INV DRUG, V24, P383, DOI 10.1517/13543784.2015.1006358
   Pagani I, 2017, SCI REP-UK, V7, DOI 10.1038/srep44286
   Parke DW, 2016, OPHTHALMOLOGY, V123, P2432, DOI 10.1016/j.ophtha.2016.06.039
   Puerta-Guardo H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005738
   Reichenbach A, 2013, GLIA, V61, P651, DOI 10.1002/glia.22477
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Roach T, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0824-7
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Sauter MM, 2016, EXP EYE RES, V148, P12, DOI 10.1016/j.exer.2016.05.003
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
   Sreekanth GP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149486
   Stockert JC, 2012, ACTA HISTOCHEM, V114, P785, DOI 10.1016/j.acthis.2012.01.006
   Suthar MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003541
   Valadao ALC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01233
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wang J, 2015, FREE RADICAL BIO MED, V86, P25, DOI 10.1016/j.freeradbiomed.2015.04.009
   Wang JJ, 2015, WORLD J DIABETES, V6, P726, DOI 10.4239/wjd.v6.i5.726
   Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wong CW, 2017, RETIN CASES BRIEF RE
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zhang WB, 2009, INVEST OPHTH VIS SCI, V50, P3033, DOI 10.1167/iovs.08-2676
   Zhong YM, 2012, DIABETES, V61, P492, DOI 10.2337/db11-0315
   Zhu S, 2017, EXP EYE RES, V155, P1, DOI 10.1016/j.exer.2017.01.002
NR 52
TC 5
Z9 7
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD SEP
PY 2017
VL 145
BP 70
EP 81
DI 10.1016/j.antiviral.2017.07.012
PG 12
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA FH9QV
UT WOS:000411547700010
PM 28739278
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Liu, XZ
   Stechlinski, P
AF Liu, Xinzhi
   Stechlinski, Peter
TI SWITCHING VACCINATION SCHEMES FOR VECTOR-BORNE DISEASES WITH SEASONAL
   FLUCTUATIONS
SO JOURNAL OF BIOLOGICAL SYSTEMS
LA English
DT Article
DE Epidemic Model; Infectious Disease; Finite Incubation Period;
   Distributed Delays; Switched System; Hybrid System
ID SIR EPIDEMIC MODEL; PULSE VACCINATION; CHIKUNGUNYA-DISEASE;
   INFECTIOUS-DISEASES; DYNAMICS; STABILITY; STRATEGY; TEMPERATURE;
   POPULATION; THRESHOLD
AB Theory is developed for an epidemic model of a seasonally-spreading vector-borne disease using a hybrid system framework. Applicable to diseases spread by mosquitoes (e.g., chikungunya and Zika virus via Aedes albopictus), seasonal variations in transmission are modeled using switching parameters to represent term-time forcing. The vector agent is assumed to exhibit a period of incubation upon infection, modeled using a distribution. Three hybrid control strategies are analyzed in detail: switching cohort immunization, pulse vaccination at pre-specified times, and state-dependent pulse vaccination. Methods from switched systems theory are used to derive threshold disease eradication conditions involving the model parameters; convergence of solutions to a disease-free set or periodic solution is shown. A comprehensive analysis is performed to compare and contrast the different control schemes.
C1 [Liu, Xinzhi; Stechlinski, Peter] Univ Waterloo, Dept Appl Math, Waterloo, ON N2L 3G1, Canada.
RP Liu, XZ (corresponding author), Univ Waterloo, Dept Appl Math, Waterloo, ON N2L 3G1, Canada.
EM xzliu@uwaterloo.ca; pstechli@uwaterloo.ca
FU Natural Sciences and Engineering Research Council of Canada
   (NSERC)Natural Sciences and Engineering Research Council of Canada
FX The authors wish to thank Natural Sciences and Engineering Research
   Council of Canada (NSERC) for providing funding, and the anonymous
   reviewers for their helpful comments.
CR AGUR Z, 1993, P NATL ACAD SCI USA, V90, P11698, DOI 10.1073/pnas.90.24.11698
   ANDERSON RM, 1982, SCIENCE, V215, P1053, DOI 10.1126/science.7063839
   Bacaer N, 2007, B MATH BIOL, V69, P1067, DOI 10.1007/s11538-006-9166-9
   Bacaer N, 2006, J MATH BIOL, V53, P421, DOI 10.1007/s00285-006-0015-0
   Ballinger G, 1999, DYN CONTIN DISCRET I, V5, P579
   Beretta E, 2001, NONLINEAR ANAL-THEOR, V47, P4107, DOI 10.1016/S0362-546X(01)00528-4
   BERETTA E, 1995, J MATH BIOL, V33, P250, DOI 10.1007/BF00169563
   Beretta E, 1997, NONLINEAR ANAL-THEOR, V28, P1909, DOI 10.1016/S0362-546X(96)00035-1
   Charrel RN, 2007, NEW ENGL J MED, V356, P769, DOI 10.1056/NEJMp078013
   Cooke K. L., 1979, ROCKY MOUNTAIN J MAT, V9, P31
   D'Onofrio A, 2002, MATH COMPUT MODEL, V36, P473, DOI 10.1016/S0895-7177(02)00177-2
   DIEKMANN O, 1990, J MATH BIOL, V28, P365
   Diekmann O., 2000, MATH EPIDEMIOLOGY IN
   Dowell SF, 2001, EMERG INFECT DIS, V7, P369
   Dufourd C, 2013, COMPUT MATH APPL, V66, P1695, DOI 10.1016/j.camwa.2013.03.024
   Dumont Y, 2008, MATH BIOSCI, V213, P80, DOI 10.1016/j.mbs.2008.02.008
   Dumont Y, 2012, J MATH BIOL, V65, P809, DOI 10.1007/s00285-011-0477-6
   Dumont Y, 2010, MATH BIOSCI ENG, V7, P313, DOI 10.3934/mbe.2010.7.313
   Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667
   Gao SJ, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/64870
   Gao SJ, 2008, NONLINEAR ANAL-REAL, V9, P599, DOI 10.1016/j.nonrwa.2006.12.004
   Gao SJ, 2006, VACCINE, V24, P6037, DOI 10.1016/j.vaccine.2006.05.018
   Grassly NC, 2006, P ROY SOC B-BIOL SCI, V273, P2541, DOI 10.1098/rspb.2006.3604
   Guan ZH, 2006, INT J BIFURCAT CHAOS, V16, P229, DOI 10.1142/S0218127406014769
   Guan ZH, 2005, IEEE T AUTOMAT CONTR, V50, P1058, DOI 10.1109/TAC.2005.851462
   Hale J. K., 1993, INTRO FUNCTIONAL DIF
   Hale JK, 1998, PARTIAL STABILITY CO
   He YY, 2013, APPL MATH MODEL, V37, P8131, DOI 10.1016/j.apm.2013.03.035
   Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907
   Keeling M. J., 2008, MODELING INFECT DIS
   Keeling MJ, 2001, PHYSICA D, V148, P317, DOI 10.1016/S0167-2789(00)00187-1
   Lakshmikantham V., 1989, THEORY IMPULSIVE DIF
   Liu SY, 2009, APPL MATH MODEL, V33, P1923, DOI 10.1016/j.apm.2008.05.001
   Liu XN, 2008, J THEOR BIOL, V253, P1, DOI 10.1016/j.jtbi.2007.10.014
   Liu XZ, 2015, APPL MATH MODEL, V39, P3194, DOI 10.1016/j.apm.2014.10.035
   Liu XZ, 2013, NONLINEAR ANAL-REAL, V14, P264, DOI 10.1016/j.nonrwa.2012.06.003
   Liu XZ, 2012, APPL MATH MODEL, V36, P1974, DOI 10.1016/j.apm.2011.08.019
   Liu XZ, 2011, NONLINEAR ANAL-REAL, V12, P931, DOI 10.1016/j.nonrwa.2010.08.017
   Lu ZH, 2002, MATH COMPUT MODEL, V36, P1039, DOI 10.1016/S0895-7177(02)00257-1
   Ma WB, 2002, TOHOKU MATH J, V54, P581, DOI 10.2748/tmj/1113247650
   McCluskey CC, 2010, NONLINEAR ANAL-REAL, V11, P55, DOI 10.1016/j.nonrwa.2008.10.014
   Meng XZ, 2008, APPL MATH COMPUT, V197, P582, DOI 10.1016/j.amc.2007.07.083
   Moulay D, 2011, MATH BIOSCI, V229, P50, DOI 10.1016/j.mbs.2010.10.008
   Moulay D, 2012, MATH BIOSCI ENG, V9, P369, DOI 10.3934/mbe.2012.9.369
   Nie LF, 2012, NONLINEAR ANAL-REAL, V13, P1621, DOI 10.1016/j.nonrwa.2011.11.019
   Pang GP, 2007, CHAOS SOLITON FRACT, V34, P1629, DOI 10.1016/j.chaos.2006.04.061
   Renault P, 2007, AM J TROP MED HYG, V77, P727
   Schenzle D, 1984, IMA J Math Appl Med Biol, V1, P169
   Shulgin B, 1998, B MATH BIOL, V60, P1123, DOI 10.1016/S0092-8240(98)90005-2
   Stechlinski P, 2016, MATH COMPUTATIONAL A, P737
   Stone L, 2000, MATH COMPUT MODEL, V31, P207, DOI 10.1016/S0895-7177(00)00040-6
   Takeuchi Y, 2000, NONLINEAR ANAL-THEOR, V42, P931, DOI 10.1016/S0362-546X(99)00138-8
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Wang WD, 2008, J DYN DIFFER EQU, V20, P699, DOI 10.1007/s10884-008-9111-8
   Wonham MJ, 2008, LECT NOTES MATH, V1945, P365
   Wonham MJ, 2006, ECOL LETT, V9, P706, DOI 10.1111/j.1461-0248.2006.00912.x
   Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040
   Yang HM, 2009, EPIDEMIOL INFECT, V137, P1179, DOI 10.1017/S0950268809002052
   Zhou YC, 2003, MATH COMPUT MODEL, V38, P299, DOI [10.1016/S0895-7177(03)90088-4, 10.1016/S0895-7177(03)00221-8]
   Zhu W, 2010, NONLINEAR ANAL-HYBRI, V4, P608, DOI 10.1016/j.nahs.2010.03.009
NR 60
TC 0
Z9 0
U1 0
U2 2
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0218-3390
EI 1793-6470
J9 J BIOL SYST
JI J. Biol. Syst.
PD SEP
PY 2017
VL 25
IS 3
BP 441
EP 477
DI 10.1142/S0218339017500218
PG 37
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA FI2ZN
UT WOS:000411823900004
DA 2020-07-08
ER

PT J
AU Banumathi, B
   Vaseeharan, B
   Chinnasamy, T
   Vijayakumar, S
   Govindarajan, M
   Alharbi, NS
   Kadaikunnan, S
   Khaled, JM
   Benelli, G
AF Banumathi, Balan
   Vaseeharan, Baskaralingam
   Chinnasamy, Thenmozhi
   Vijayakumar, Sekar
   Govindarajan, Marimuthu
   Alharbi, Naiyf S.
   Kadaikunnan, Shine
   Khaled, Jamal M.
   Benelli, Giovanni
TI Euphorbia rothiana-Fabricated Ag Nanoparticles Showed High Toxicity on
   Aedes aegypti Larvae and Growth Inhibition on Microbial Pathogens: A
   Focus on Morphological Changes in Mosquitoes and Antibiofilm Potential
   Against Bacteria
SO JOURNAL OF CLUSTER SCIENCE
LA English
DT Article
DE Dengue; Microbial pathogen; Drug resistance; Nanosynthesis; XRD and TEM
ID SYNTHESIZED SILVER NANOPARTICLES; ZINC-OXIDE NANOPARTICLES; LEAF
   EXTRACT; CULEX-QUINQUEFASCIATUS; ANOPHELES-STEPHENSI; GREEN SYNTHESIS;
   BACILLUS-THURINGIENSIS; ANTIMICROBIAL ACTIVITY; VETERINARY IMPORTANCE;
   ACARICIDAL ACTIVITY
AB The green synthesis of pesticides and antibiotics is gaining increasing importance nowadays. We fabricated Euphorbia rothiana-capped Ag nanoparticles (Er-AgNPs), testing their antibiofilm and growth inhibition potential on various microbial pathogens. We evaluated the toxicity of E. rothiana-capped Ag nanoparticles on larvae of the Zika virus vector Aedes aegypti, shedding light on histological changes post-exposure to the plant leaf extract and Er-AgNPs. Nanoparticles were characterized by UV-Vis, and FTIR spectroscopy, XRD and TEM. Light microscopy showed the greatest inhibition of biofilm formation in Gram positive and Gram-negative bacteria post-treatment with E. rothiana-capped Ag nanoparticles at 75 mu g/ml. Confocal microscopy confirmed the biofilm interruption and disintegration post-treatment with nanoparticles at 75 mu g/ml. E. rothiana extract and Er-AgNPs showed 100% larvicidal activity on A.aegypti at 50 and 8 mg/L, respectively. AgNO3 led to 100% mortality of A. aegypti larvae at 40 mg/L after 48 h. Stereomicroscopic and histopathological analysis reported tissue damages and loss of cuticular parts in mosquito larvae.
C1 [Banumathi, Balan; Vaseeharan, Baskaralingam; Chinnasamy, Thenmozhi; Vijayakumar, Sekar] Alagappa Univ, Nanobiosci & Nanopharmacol Div, Dept Anim Hlth & Management, Biomat & Biotechnol Anim Hlth Lab, Sci Block,6th Floor, Karaikkudi 630004, Tamil Nadu, India.
   [Govindarajan, Marimuthu] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [Alharbi, Naiyf S.; Kadaikunnan, Shine; Khaled, Jamal M.] King Saud Univ, Dept Bot & Microbiol, Coll Sci, Riyadh 11451, Saudi Arabia.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
   [Benelli, Giovanni] Scuola Super Sant Anna, BioRobot Inst, Viale Rinaldo Piaggio 34, I-56025 Pisa, Italy.
RP Vaseeharan, B (corresponding author), Alagappa Univ, Nanobiosci & Nanopharmacol Div, Dept Anim Hlth & Management, Biomat & Biotechnol Anim Hlth Lab, Sci Block,6th Floor, Karaikkudi 630004, Tamil Nadu, India.
EM vaseeharanb@gmail.com
RI Benelli, Giovanni/A-9100-2013; Khaled, Jamal/D-8188-2017; /L-2836-2013;
   Sekar/A-8600-2018; GOVINDARAJAN, MARIMUTHU/A-8070-2019; Alharbi, Naiyf
   S/B-9402-2019
OI Benelli, Giovanni/0000-0001-8971-6010; /0000-0001-7018-5379;
   Sekar/0000-0001-8211-069X; GOVINDARAJAN, MARIMUTHU/0000-0002-4662-8931; 
FU UGCUniversity Grants Commission, India
   [F1-17.1/RGNF-2012-13-SC-TAM-23853]; Department of Biotechnology (DBT),
   New Delhi, IndiaDepartment of Biotechnology (DBT) India
   [BT/PR7903/AAquote/3/638/2013]; Department of Science and Technology
   (DST), New Delhi, IndiaDepartment of Science & Technology (India)
   [IF140145]; Deanship of Scientific Research at King Saud
   UniversityDeanship of Scientific Research at King Saud University
   [RG-1438-091]
FX The author B.B. gratefully acknowledges the UGC for Grant of Rajiv
   Gandhi National Fellowship (Ref. No: F1-17.1/RGNF-2012-13-SC-TAM-23853).
   This study was partially supported by Department of Biotechnology (DBT),
   New Delhi, India under the Project Grants Code
   BT/PR7903/AAquote/3/638/2013. S.V. thank the Department of Science and
   Technology (DST) for Grant of INSPIRE fellowship (Ref. No: IF140145),
   New Delhi, India. The authors extend their appreciation to the Deanship
   of Scientific Research at King Saud University for funding this work
   through research group No. RG-1438-091.
CR Aarthi N., 2010, J BIOPESTICIDES, V3, P199
   Aoki K, 2003, LANGMUIR, V19, P9904, DOI 10.1021/la035144g
   Banumathi B, 2016, VET PARASITOL, V216, P93, DOI 10.1016/j.vetpar.2015.12.003
   Benelli G, 2017, ENTOMOL GEN, V36, P309, DOI 10.1127/entomologia/2017/0496
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Benelli G, 2017, J CLUST SCI, V28, P287, DOI 10.1007/s10876-016-1088-6
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Bindhu MR, 2015, SPECTROCHIM ACTA A, V135, P373, DOI 10.1016/j.saa.2014.07.045
   Daoubi M, 2005, J AGR FOOD CHEM, V53, P6035, DOI 10.1021/jf050600n
   Das M. K., 2003, J VECTOR DIS, V40, P101
   Das S, 2010, ASSAM U J SCI TECHNO, V5, P95
   Dibrov P, 2002, ANTIMICROB AGENTS CH, V46, P2668, DOI 10.1128/AAC.46.8.2668-2670.2002
   Dinesh D, 2015, PARASITOL RES, V114, P1519, DOI 10.1007/s00436-015-4336-z
   Finney D.T., 1971, PROBIT ANAL
   Gibbons Simon, 2005, Phytochemistry Reviews, V4, P63, DOI 10.1007/s11101-005-2494-9
   Goodsell D. S., 2004, FOREST GENETIC RESOU, P99
   Govindarajan M, 2016, ENZYME MICROB TECH, V95, P155, DOI 10.1016/j.enzmictec.2016.05.005
   Govindarajan M, 2016, J PHOTOCH PHOTOBIO B, V161, P482, DOI 10.1016/j.jphotobiol.2016.06.016
   Govindarajan M, 2016, RSC ADV, V6, P59021, DOI 10.1039/c6ra10228j
   Govindarajan M, 2016, J CLUST SCI, V27, P745, DOI 10.1007/s10876-016-0977-z
   Govindarajan M, 2016, J ASIA-PAC ENTOMOL, V19, P51, DOI 10.1016/j.aspen.2015.11.009
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Govindarajan M, 2016, EXP PARASITOL, V161, P40, DOI 10.1016/j.exppara.2015.12.011
   Hamouda T, 2001, MICROBIOL RES, V156, P1, DOI 10.1078/0944-5013-00069
   Kalishwaralal K, 2010, COLLOID SURFACE B, V79, P340, DOI 10.1016/j.colsurfb.2010.04.014
   Kawadikar S. R., 1977, B BOT SOC, V23-24, P77
   Kierek-Pearscon K, 2005, ADV APPL MICROBIOL, V57, P79, DOI 10.1016/S0065-2164(05)57003-5
   Kim HG, 2005, FOOD SCI BIOTECHNOL, V14, P685
   Kovendan K, 2012, PARASITOL RES, V110, P669, DOI 10.1007/s00436-011-2540-z
   Kumar PM, 2012, PARASITOL RES, V110, P2541, DOI 10.1007/s00436-011-2797-2
   LAHKIMTSROR L, 1983, J INVERTEBR PATHOL, V41, P104, DOI 10.1016/0022-2011(83)90241-0
   Lawton EM, 2007, MINI-REV MED CHEM, V7, P1236, DOI 10.2174/138955707782795638
   Maheshumar P., 2016, PARASITOL RES, DOI [10.1007/s00436-015-4799-y, DOI 10.1007/S00436-015-4799-Y]
   Maiti S, 2014, J ANAL SCI TECHNOL, V5, P40, DOI DOI 10.1186/S40543-014-0040-3
   Murugan K, 2011, HYDROBIOLOGIA, V666, P331, DOI 10.1007/s10750-011-0629-0
   Muthukumaran U, 2015, PARASITOL RES, V114, P1817, DOI 10.1007/s00436-015-4368-4
   Muthukumaran U, 2015, PARASITOL RES, V114, P989, DOI 10.1007/s00436-014-4265-2
   Pavela R, 2016, TRENDS PLANT SCI, V21, P1000, DOI 10.1016/j.tplants.2016.10.005
   Pavela R, 2016, EXP PARASITOL, V167, P103, DOI 10.1016/j.exppara.2016.05.010
   Pednekar P. A., 2013, ASIAN J PHARM RES CL, P6
   Prasad T. N. V. K. V., 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P439, DOI 10.1016/S2221-1691(11)60096-8
   Priyadarshini KA, 2012, PARASITOL RES, V111, P997, DOI 10.1007/s00436-012-2924-8
   Rajakumar G, 2012, RES VET SCI, V93, P303, DOI 10.1016/j.rvsc.2011.08.001
   Rajakumar G, 2011, ACTA TROP, V118, P196, DOI 10.1016/j.actatropica.2011.03.003
   Roni M, 2013, PARASITOL RES, V112, P981, DOI 10.1007/s00436-012-3220-3
   Sandasi M, 2010, LETT APPL MICROBIOL, V50, P30, DOI 10.1111/j.1472-765X.2009.02747.x
   Sathyavathi R, 2010, ADV SCI LETT, V3, P138, DOI 10.1166/asl.2010.1099
   Scutera S, 2014, EXPERT OPIN DRUG DIS, V9, P353, DOI 10.1517/17460441.2014.894974
   Senthilkumar A, 2008, PARASITOL RES, V103, P959, DOI 10.1007/s00436-008-1085-2
   Singh K, 2014, J NANOMED NANOTECHNO, V5, P192, DOI [10.4172/2157-7439.1000192, DOI 10.4172/2157-7439.1000192]
   Sinha S., 2009, J APPL BIOSCI, V19, P1113
   Sivalingam Manju, 2014, Journal of the Fisheries Society of Taiwan, V41, P123
   Vaseeharan B., 2012, NANOTECHNOL DEV, V2, pe3
   Vaseeharan B., 2012, AQUAC RES, P1
   Veerakumar K, 2014, PARASITOL RES, V113, P1775, DOI 10.1007/s00436-014-3823-y
   Veerakumar K, 2013, PARASITOL RES, V112, P4073, DOI 10.1007/s00436-013-3598-6
   Vijayakumar S, 2015, SPECTROCHIM ACTA A, V137, P886, DOI 10.1016/j.saa.2014.08.064
   WHO, 1996, CTDWHOPESIC96
NR 60
TC 7
Z9 7
U1 2
U2 8
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1040-7278
EI 1572-8862
J9 J CLUST SCI
JI J. Clust. Sci.
PD SEP
PY 2017
VL 28
IS 5
BP 2857
EP 2872
DI 10.1007/s10876-017-1263-4
PG 16
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA FH0NN
UT WOS:000410837600036
DA 2020-07-08
ER

PT J
AU Khaled, JM
   Alharbi, NS
   Kadaikunnan, S
   Alobaidi, AS
   Al-Anbr, MN
   Gopinath, K
   Aurmugam, A
   Govindarajan, M
   Benelli, G
AF Khaled, Jamal M.
   Alharbi, Naiyf S.
   Kadaikunnan, Shine
   Alobaidi, Ahmed S.
   Al-Anbr, Mohammed N.
   Gopinath, Kasi
   Aurmugam, Ayyakannu
   Govindarajan, Marimuthu
   Benelli, Giovanni
TI Green Synthesis of Ag Nanoparticles with Anti-bacterial Activity Using
   the Leaf Extract of an African Medicinal Plant, Ipomoea asarifolia
   (Convolvulaceae)
SO JOURNAL OF CLUSTER SCIENCE
LA English
DT Article
DE AFM; Surface plasmon resonance; SEM; TEM; XRD
ID FERONIA-ELEPHANTUM RUTACEAE; ONE-POT FABRICATION; SILVER NANOPARTICLES;
   AQUEOUS EXTRACT; AEDES-AEGYPTI; CULEX-QUINQUEFASCIATUS;
   ANOPHELES-STEPHENSI; FACILE BIOSYNTHESIS; BARK EXTRACT; ZIKA VIRUS
AB Herbal drugs prepared with the plant Ipomoea asarifolia has many medicinal uses throughout West Africa, including its employ as diuretic, emmenagogue and purgative. This species is a good source of acylated anthocyanins, and the methanol and ethyl acetate extracts of I. asarifolia are known for their strong acetylcholinesterase inhibitory effects. Here, green synthesis of Ag nanoparticles (Ag NPs) was performed at room temperature using the I. asarifolia leaf extract. The Ag NPs were characterized by UV-visible spectroscopy, FT-IR, XRD, AFM, SEM with EDX and TEM. AFM and SEM analyses showed that spherical morphology of I. asarifolia-synthesized Ag NPs with a size range of 20 to 60 nm. TEM revealed that I. asarifolia-synthesized Ag NPs had a mean particle size of 40 nm. The I. asarifolia-synthesized Ag NPs was tested against four bacterial pathogens using the disk diffusion method. The zone of inhibition varied significantly in a dose-dependent manner. Overall, our results underlined the potential of cheap aqueous extracts from this African medicinal plant species for the synthesis of silver nanocomplexes with wide efficacy against human pathogenic bacteria.
C1 [Khaled, Jamal M.; Alharbi, Naiyf S.; Kadaikunnan, Shine; Alobaidi, Ahmed S.; Al-Anbr, Mohammed N.] King Saud Univ, Dept Bot & Microbiol, Coll Sci, Riyadh 11451, Saudi Arabia.
   [Gopinath, Kasi; Aurmugam, Ayyakannu] Alagappa Univ, Dept Bot, Karaikkudi 630003, Tamil Nadu, India.
   [Govindarajan, Marimuthu] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
   [Benelli, Giovanni] Scuola Super Sant Anna, BioRobot Inst, Viale Rinaldo Piaggio 34, I-56025 Pisa, Italy.
RP Kadaikunnan, S (corresponding author), King Saud Univ, Dept Bot & Microbiol, Coll Sci, Riyadh 11451, Saudi Arabia.; Gopinath, K (corresponding author), Alagappa Univ, Dept Bot, Karaikkudi 630003, Tamil Nadu, India.
EM sshine@ksu.edu.sa; gloriousnanogopi@gmail.com
RI Benelli, Giovanni/A-9100-2013; Alharbi, Naiyf S/B-9402-2019;
   GOVINDARAJAN, MARIMUTHU/A-8070-2019; /L-2836-2013; Khaled,
   Jamal/D-8188-2017
OI Benelli, Giovanni/0000-0001-8971-6010; GOVINDARAJAN,
   MARIMUTHU/0000-0002-4662-8931; /0000-0001-7018-5379; 
FU Scientific Research at King Saud UniversityDeanship of Scientific
   Research at King Saud University [RG-1438-074]
FX The authors extend their appreciation to the Deanship of Scientific
   Research at King Saud University for funding this work through research
   Group No RG-1438-074.
CR Aarthi C, 2018, ENVIRON SCI POLLUT R, V25, P10317, DOI 10.1007/s11356-017-9203-2
   Ahmad A, 2016, J PHOTOCH PHOTOBIO B, V161, P17, DOI 10.1016/j.jphotobiol.2016.05.003
   Alagummuthu G, 2012, INT J NANOMATER BIOS, V2, P30
   Alharbi NS, 2017, J CLUST SCI, V28, P507, DOI 10.1007/s10876-016-1130-8
   Ali M, 2016, MAT SCI ENG C-MATER, V58, P359, DOI 10.1016/j.msec.2015.08.045
   AlQahtani FS, 2017, J ASIA-PAC ENTOMOL, V20, P157, DOI 10.1016/j.aspen.2016.12.004
   AlShebly MM, 2017, ECOTOX ENVIRON SAFE, V137, P149, DOI 10.1016/j.ecoenv.2016.11.028
   An JS, 2008, LWT-FOOD SCI TECHNOL, V41, P1100, DOI 10.1016/j.lwt.2007.06.019
   Anarkali J., 2012, Archives of Applied Science Research, V4, P1436
   Anupama N., 2017, J INORG NANOMETAL CH, V47, P116
   Ashokan AP, 2017, J CLUST SCI, V28, P205, DOI 10.1007/s10876-016-1075-y
   Azarudeen RMST, 2017, J ASIA-PAC ENTOMOL, V20, P359, DOI 10.1016/j.aspen.2017.02.007
   Balalakshmi C, 2017, J PHOTOCH PHOTOBIO B, V173, P598, DOI 10.1016/j.jphotobiol.2017.06.040
   Banumathi B, 2017, J CLUST SCI, V28, P2027, DOI 10.1007/s10876-017-1201-5
   Banumathi B, 2017, PARASITOL RES, V116, P1637, DOI 10.1007/s00436-017-5438-6
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P10228, DOI 10.1007/s11356-017-8482-y
   Benelli G, 2017, J CLUST SCI, V28, P637, DOI 10.1007/s10876-017-1159-3
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Devi GK, 2017, MICROB PATHOGENESIS, V102, P120, DOI 10.1016/j.micpath.2016.11.026
   Dhand V, 2016, MAT SCI ENG C-MATER, V58, P36, DOI 10.1016/j.msec.2015.08.018
   Dinesh D, 2015, PARASITOL RES, V114, P1519, DOI 10.1007/s00436-015-4336-z
   Espenti CS, 2016, MATER LETT, V174, P129, DOI 10.1016/j.matlet.2016.03.106
   Feitosa CM, 2011, BRAZ J BIOL, V71, P783, DOI 10.1590/S1519-69842011000400025
   Furtado AA, 2016, J ETHNOPHARMACOL, V192, P225, DOI 10.1016/j.jep.2016.07.048
   Gopinath K, 2014, APPL NANOSCI, V4, P657, DOI 10.1007/s13204-013-0247-4
   Gopinath K, 2017, J CLUST SCI, V28, P1541, DOI 10.1007/s10876-017-1164-6
   Gopinath K, 2016, MICROB PATHOGENESIS, V101, P1, DOI 10.1016/j.micpath.2016.10.011
   Gopinath K, 2013, J NANOSTRUCTURE CHEM, V3
   Govindarajan M, 2016, RES VET SCI, V107, P95, DOI 10.1016/j.rvsc.2016.05.017
   Govindarajan M, 2016, J PHOTOCH PHOTOBIO B, V161, P482, DOI 10.1016/j.jphotobiol.2016.06.016
   Govindarajan M, 2016, J ASIA-PAC ENTOMOL, V19, P377, DOI 10.1016/j.aspen.2016.04.003
   Govindarajan M, 2016, J CLUST SCI, V27, P745, DOI 10.1007/s10876-016-0977-z
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Govindarajan M, 2016, EXP PARASITOL, V161, P40, DOI 10.1016/j.exppara.2015.12.011
   Jayanthi S, 2017, J PHOTOCH PHOTOBIO B, V170, P208, DOI 10.1016/j.jphotobiol.2017.04.011
   Jegadeeswaran P, 2012, DIG J NANOMATER BIOS, V7, P991
   Karthika V, 2017, J PHOTOCH PHOTOBIO B, V167, P189, DOI 10.1016/j.jphotobiol.2017.01.008
   Kharat SN, 2016, MAT SCI ENG C-MATER, V62, P719, DOI 10.1016/j.msec.2016.02.024
   Kim SR, 2014, ARCH PHARM RES, V37, P539, DOI 10.1007/s12272-013-0211-6
   Krishnaraj C, 2010, COLLOID SURFACE B, V76, P50, DOI 10.1016/j.colsurfb.2009.10.008
   Kumar CG, 2015, COLLOID SURFACE B, V125, P110, DOI 10.1016/j.colsurfb.2014.11.025
   Latha M, 2016, MICROB PATHOGENESIS, V93, P88, DOI 10.1016/j.micpath.2016.01.013
   Logaranjan K, 2016, NANOSCALE RES LETT, V11, DOI 10.1186/s11671-016-1725-x
   Lopez-Miranda JL, 2016, MATER LETT, V176, P285, DOI 10.1016/j.matlet.2016.04.126
   Muthukumaran U, 2015, PARASITOL RES, V114, P1817, DOI 10.1007/s00436-015-4368-4
   Muthukumaran U, 2015, PARASITOL RES, V114, P989, DOI 10.1007/s00436-014-4265-2
   Nabikhan A, 2010, COLLOID SURFACE B, V79, P488, DOI 10.1016/j.colsurfb.2010.05.018
   Nayak D, 2016, MAT SCI ENG C-MATER, V58, P44, DOI 10.1016/j.msec.2015.08.022
   Phull AR, 2016, FUTUR J PHARM SCI, V2, P31, DOI 10.1016/j.fjps.2016.03.001
   Pugazhendhi S, 2016, J PHOTOCH PHOTOBIO B, V159, P155, DOI 10.1016/j.jphotobiol.2016.03.043
   Rajkuberan C, 2017, J SAUDI CHEM SOC, V21, P911, DOI 10.1016/j.jscs.2016.01.002
   Rao NH, 2016, MAT SCI ENG C-MATER, V62, P553, DOI 10.1016/j.msec.2016.01.072
   Saha S, 2012, INT J NANOMATERIALS, V2, P1
   Sathishkumar M, 2009, COLLOID SURFACE B, V73, P332, DOI 10.1016/j.colsurfb.2009.06.005
   Shivaji S, 2011, PROCESS BIOCHEM, V46, P1800, DOI 10.1016/j.procbio.2011.06.008
   Singhal G, 2011, J NANOPART RES, V13, P2981, DOI 10.1007/s11051-010-0193-y
   Suganya P, 2017, J PHOTOCH PHOTOBIO B, V173, P404, DOI 10.1016/j.jphotobiol.2017.06.004
   Vaseeharan B., 2012, NANOTECHNOL DEV, V2, P3
   Veerakumar K, 2014, PARASITOL RES, V113, P4085, DOI 10.1007/s00436-014-4077-4
   Veerakumar K, 2014, PARASITOL RES, V113, P1775, DOI 10.1007/s00436-014-3823-y
   Veerakumar K, 2013, PARASITOL RES, V112, P4073, DOI 10.1007/s00436-013-3598-6
   Vijayan SR, 2014, SCI WORLD J, DOI 10.1155/2014/938272
   Yeh CH, 2014, FREE RADICAL BIO MED, V69, P249, DOI 10.1016/j.freeradbiomed.2014.01.028
   Zargar M, 2011, MOLECULES, V16, P6667, DOI 10.3390/molecules16086667
NR 65
TC 8
Z9 8
U1 2
U2 16
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1040-7278
EI 1572-8862
J9 J CLUST SCI
JI J. Clust. Sci.
PD SEP
PY 2017
VL 28
IS 5
BP 3009
EP 3019
DI 10.1007/s10876-017-1271-4
PG 11
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA FH0NN
UT WOS:000410837600046
DA 2020-07-08
ER

PT J
AU Li, Y
   Kang, CB
AF Li, Yan
   Kang, Congbao
TI Solution NMR Spectroscopy in Target-Based Drug Discovery
SO MOLECULES
LA English
DT Review
DE NMR; drug discovery; hit identification; protein dynamics;
   protein-ligand interactions; fragment screening
ID IN-CELL NMR; PROTEIN-STRUCTURE DETERMINATION; IV E SUBUNIT; NS2B-NS3
   PROTEASE; MEMBRANE-PROTEINS; LIGAND-BINDING; F-19 NMR; MULTIDIMENSIONAL
   NMR; FLUORINE-NMR; ZIKA VIRUS
AB Solution NMR spectroscopy is a powerful tool to study protein structures and dynamics under physiological conditions. This technique is particularly useful in target-based drug discovery projects as it provides protein-ligand binding information in solution. Accumulated studies have shown that NMR will play more and more important roles in multiple steps of the drug discovery process. In a fragment-based drug discovery process, ligand-observed and protein-observed NMR spectroscopy can be applied to screen fragments with low binding affinities. The screened fragments can be further optimized into drug-like molecules. In combination with other biophysical techniques, NMR will guide structure-based drug discovery. In this review, we describe the possible roles of NMR spectroscopy in drug discovery. We also illustrate the challenges encountered in the drug discovery process. We include several examples demonstrating the roles of NMR in target-based drug discoveries such as hit identification, ranking ligand binding affinities, and mapping the ligand binding site. We also speculate the possible roles of NMR in target engagement based on recent processes in in-cell NMR spectroscopy.
C1 [Li, Yan; Kang, Congbao] ASTAR, Expt Therapeut Ctr, 31 Biopolis Way,Nanos,03-01, Singapore 138669, Singapore.
RP Kang, CB (corresponding author), ASTAR, Expt Therapeut Ctr, 31 Biopolis Way,Nanos,03-01, Singapore 138669, Singapore.
EM yli@etc.a-star.edu.sg; cbkang@etc.a-star.edu.sg
RI Kang, Congbao/AAP-7572-2020; Li, Yan/G-4642-2013
OI Kang, Congbao/0000-0002-9886-9374; Li, Yan/0000-0003-1963-839X
FU A*STARAgency for Science Technology & Research (ASTAR); A*STAR JCO
   grantAgency for Science Technology & Research (ASTAR)
   [1431AFG102/1331A028]
FX We appreciate the support from A*STAR and the A*STAR JCO grant
   (1431AFG102/1331A028). We apologize for the papers not cited in this
   manuscript due to the space or unintentional oversights.
CR Aguirre C., 2001, CURRENT PROTOCOLS PR
   Apponyi Margit A., 2008, V426, P257, DOI 10.1007/978-1-60327-058-8_16
   Arai M, 2012, J AM CHEM SOC, V134, P3792, DOI 10.1021/ja209936u
   Baker M, 2013, NAT REV DRUG DISCOV, V12, P5, DOI 10.1038/nrd3926
   BALARAM P, 1972, J AM CHEM SOC, V94, P4017, DOI 10.1021/ja00766a064
   BALARAM P, 1972, J AM CHEM SOC, V94, P4015, DOI 10.1021/ja00766a063
   Barbieri L, 2016, NAT PROTOC, V11, P1101, DOI 10.1038/nprot.2016.061
   Barbieri L, 2015, SCI REP-UK, V5, DOI 10.1038/srep14456
   Bax A, 2003, PROTEIN SCI, V12, P1, DOI 10.1110/ps.0233303
   BAX A, 1989, ANNU REV BIOCHEM, V58, P223
   Begley DW, 2010, CHEM BIOL DRUG DES, V76, P218, DOI 10.1111/j.1747-0285.2010.01010.x
   Billeter M, 2008, J BIOMOL NMR, V42, P155, DOI 10.1007/s10858-008-9277-8
   Bolon PJ, 1999, J MOL BIOL, V293, P107, DOI 10.1006/jmbi.1999.3133
   Breeze AL, 2000, PROG NUCL MAG RES SP, V36, P323, DOI 10.1016/S0079-6565(00)00020-0
   Burz DS, 2006, NAT METHODS, V3, P91, DOI 10.1038/NMETH851
   Cala O, 2014, ANAL BIOANAL CHEM, V406, P943, DOI 10.1007/s00216-013-6931-0
   Calzolai L, 2003, J BIOL CHEM, V278, P35592, DOI 10.1074/jbc.M303005200
   Campos-Olivas R, 2011, CURR TOP MED CHEM, V11, P43, DOI 10.2174/156802611793611887
   Chagot B, 2011, J MOL BIOL, V406, P106, DOI 10.1016/j.jmb.2010.11.046
   Chen GY, 2015, CHEMPLUSCHEM, V80, P1250, DOI 10.1002/cplu.201500197
   Chen WN, 2014, FEBS LETT, V588, P2206, DOI 10.1016/j.febslet.2014.05.018
   Chung F, 2007, ANGEW CHEM INT EDIT, V46, P4489, DOI 10.1002/anie.200605201
   CLORE GM, 1983, J MAGN RESON, V53, P423, DOI 10.1016/0022-2364(83)90215-9
   CLORE GM, 1982, J MAGN RESON, V48, P402, DOI 10.1016/0022-2364(82)90073-7
   Cobb SL, 2009, J FLUORINE CHEM, V130, P132, DOI 10.1016/j.jfluchem.2008.11.003
   Costa S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00063
   D'Silva L, 2005, J AM CHEM SOC, V127, P13220, DOI 10.1021/ja052143x
   Dallmann A., 2014, CURR PROTOC NUCL ACI, V59, P1
   Dalvit C, 2000, J BIOMOL NMR, V18, P65, DOI 10.1023/A:1008354229396
   Dalvit C, 2001, J BIOMOL NMR, V21, P349, DOI 10.1023/A:1013302231549
   Dalvit C, 2003, J AM CHEM SOC, V125, P7696, DOI 10.1021/ja034646d
   Dalvit C, 2002, COMB CHEM HIGH T SCR, V5, P605, DOI 10.2174/1386207023329923
   Dalvit C, 2002, J AM CHEM SOC, V124, P7702, DOI 10.1021/ja020174b
   Dalvit C, 2007, PROG NUCL MAG RES SP, V51, P243, DOI 10.1016/j.pnmrs.2007.07.002
   de la Cruz L, 2011, J AM CHEM SOC, V133, P19205, DOI 10.1021/ja208435s
   Dedmon MM, 2002, P NATL ACAD SCI USA, V99, P12681, DOI 10.1073/pnas.202331299
   Didenko T, 2013, CURR OPIN STRUC BIOL, V23, P740, DOI 10.1016/j.sbi.2013.07.011
   Ding KY, 2003, J MAGN RESON, V163, P208, DOI 10.1016/S1090-7807(03)00081-8
   Dubach JM, 2017, NAT CHEM BIOL, V13, P168, DOI [10.1038/nchembio.2248, 10.1038/NCHEMBIO.2248]
   Durham TB, 2015, BIOORG MED CHEM LETT, V25, P998, DOI 10.1016/j.bmcl.2014.12.076
   Dutta A, 2012, METHODS MOL BIOL, V831, P55, DOI 10.1007/978-1-61779-480-3_4
   Egorova-Zachernyuk TA, 2011, APPL MICROBIOL BIOT, V89, P397, DOI 10.1007/s00253-010-2896-5
   Ekonomiuk D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000356
   Erlanson DA, 2004, J MED CHEM, V47, P3463, DOI 10.1021/jm040031v
   Erlanson DA, 2016, NAT REV DRUG DISCOV, V15, P605, DOI 10.1038/nrd.2016.109
   Etzkorn M, 2013, STRUCTURE, V21, P394, DOI 10.1016/j.str.2013.01.005
   Fejzo J, 2003, CURR TOP MED CHEM, V3, P81, DOI 10.2174/1568026033392796
   Fernandez Cesar, 2004, Drug Discov Today Technol, V1, P277, DOI 10.1016/j.ddtec.2004.10.003
   Ferreon JC, 2003, PROTEIN SCI, V12, P982, DOI 10.1110/ps.0238003
   FESIK SW, 1990, BIOCHEM PHARMACOL, V40, P161, DOI 10.1016/0006-2952(90)90191-M
   Frank AO, 2014, J MED CHEM, V57, P2455, DOI 10.1021/jm401730y
   Gardner KH, 1998, ANNU REV BIOPH BIOM, V27, P357, DOI 10.1146/annurev.biophys.27.1.357
   Gayen S, 2012, CURR PROTEIN PEPT SC, V13, P585, DOI 10.2174/138920312803582979
   Gee CT, 2016, NAT PROTOC, V11, P1414, DOI 10.1038/nprot.2016.079
   GERIG JT, 1994, PROG NUCL MAG RES SP, V26, P293, DOI 10.1016/0079-6565(94)80009-X
   Goldflam M, 2012, METHODS MOL BIOL, V831, P233, DOI 10.1007/978-1-61779-480-3_14
   Hajduk PJ, 2002, COMB CHEM HIGH T SCR, V5, P613, DOI 10.2174/1386207023329996
   Hammill JT, 2007, NAT PROTOC, V2, P2601, DOI 10.1038/nprot.2007.379
   Hanzawa H, 2010, YAKUGAKU ZASSHI, V130, P325, DOI 10.1248/yakushi.130.325
   Harner MJ, 2013, J BIOMOL NMR, V56, P65, DOI 10.1007/s10858-013-9740-z
   Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302
   Hoang J, 2014, BIOCHEMISTRY-US, V53, P5727, DOI 10.1021/bi500679c
   Horst R, 2013, ANGEW CHEM INT EDIT, V52, P10762, DOI 10.1002/anie.201305286
   Huth JR, 2005, METHOD ENZYMOL, V394, P549, DOI 10.1016/S0076-6879(05)94023-8
   Huth JR, 2002, COMB CHEM HIGH T SCR, V5, P631, DOI 10.2174/1386207023329941
   Ikeya T, 2010, NAT PROTOC, V5, P1051, DOI 10.1038/nprot.2010.69
   IKURA M, 1992, J AM CHEM SOC, V114, P2433, DOI 10.1021/ja00033a019
   Inomata K, 2009, NATURE, V458, P106, DOI 10.1038/nature07839
   Jackson JC, 2007, J AM CHEM SOC, V129, P1160, DOI 10.1021/ja064661t
   Jafari R, 2014, NAT PROTOC, V9, P2100, DOI 10.1038/nprot.2014.138
   Jahnke W, 2002, ANGEW CHEM INT EDIT, V41, P3420, DOI 10.1002/1521-3773(20020916)41:18<3420::AID-ANIE3420>3.0.CO;2-E
   Jaremko L, 2014, SCIENCE, V343, P1363, DOI 10.1126/science.1248725
   Jhoti H, 2007, CURR OPIN CHEM BIOL, V11, P485, DOI 10.1016/j.cbpa.2007.07.010
   Kang CB, 2015, BIOPHYS J, V109, P1969, DOI 10.1016/j.bpj.2015.10.001
   Kang CB, 2013, ANTIVIR RES, V97, P137, DOI 10.1016/j.antiviral.2012.11.008
   Kang CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052047
   Kang CB, 2011, CURR OPIN CHEM BIOL, V15, P560, DOI 10.1016/j.cbpa.2011.05.025
   Kay LE, 2005, J MAGN RESON, V173, P193, DOI 10.1016/j.jmr.2004.11.021
   Kay Lewis E, 2011, J Magn Reson, V213, P423, DOI 10.1016/j.jmr.2011.09.004
   Kazimierczuk K, 2015, MAGN RESON CHEM, V53, P921, DOI 10.1002/mrc.4284
   Kim YM, 2013, J BIOL CHEM, V288, P12891, DOI 10.1074/jbc.M112.442723
   Kitevski-LeBlanc JL, 2012, PROG NUCL MAG RES SP, V62, P1, DOI 10.1016/j.pnmrs.2011.06.003
   Klages J, 2007, ANALYST, V132, P693, DOI 10.1039/b709658p
   Kleckner IR, 2011, BBA-PROTEINS PROTEOM, V1814, P942, DOI 10.1016/j.bbapap.2010.10.012
   Koenig BW, 2000, J BIOMOL NMR, V16, P121, DOI 10.1023/A:1008378523816
   Lee MD, 2015, CHEM SCI, V6, P2614, DOI 10.1039/c4sc03892d
   Leone M, 2003, CHEMBIOCHEM, V4, P649, DOI 10.1002/cbic.200300597
   Leung EWW, 2014, CHEM BIOL DRUG DES, V84, P616, DOI 10.1111/cbdd.12355
   Li QX, 2015, SCI REP-UK, V5, DOI 10.1038/srep13586
   Li QX, 2014, FEBS LETT, V588, P2782, DOI 10.1016/j.febslet.2014.05.056
   Li Y., 2017, BIOMOL NMR ASSIGN
   Li Y, 2017, STRUCTURE, V25, P1242, DOI 10.1016/j.str.2017.06.006
   Li Y, 2016, ANGEW CHEM INT EDIT, V55, P12068, DOI 10.1002/anie.201606609
   Li Y, 2016, J BIOL CHEM, V291, P17743, DOI 10.1074/jbc.M116.737429
   Li Y, 2015, BIOCHEM BIOPH RES CO, V467, P961, DOI 10.1016/j.bbrc.2015.10.036
   Li Y, 2015, FEBS LETT, V589, P2683, DOI 10.1016/j.febslet.2015.07.044
   Lipsitz RS, 2004, ANNU REV BIOPH BIOM, V33, P387, DOI 10.1146/annurev.biophys.33.110502.140306
   Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802
   Luchinat E, 2017, IUCRJ, V4, P108, DOI 10.1107/S2052252516020625
   Luchinat E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6502
   Ma RS, 2016, MOLECULES, V21, DOI 10.3390/molecules21070854
   Mahawaththa MC, 2017, ANTIVIR RES, V142, P141, DOI 10.1016/j.antiviral.2017.03.011
   Mashalidis EH, 2013, NAT PROTOC, V8, P2309, DOI 10.1038/nprot.2013.130
   Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q
   McNulty BC, 2006, J MOL BIOL, V355, P893, DOI 10.1016/j.jmb.2005.11.033
   Medek A, 2000, J AM CHEM SOC, V122, P1241, DOI 10.1021/ja993921m
   Mercatelli E, 2016, BBA-MOL CELL RES, V1863, P198, DOI 10.1016/j.bbamcr.2015.11.009
   Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233
   Mobli M, 2014, PROG NUCL MAG RES SP, V83, P21, DOI 10.1016/j.pnmrs.2014.09.002
   Mobli M, 2012, PHYS CHEM CHEM PHYS, V14, P10835, DOI 10.1039/c2cp40174f
   Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606
   Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0
   Mulder FAA, 2001, J AM CHEM SOC, V123, P967, DOI 10.1021/ja003447g
   Murray CW, 2009, NAT CHEM, V1, P187, DOI [10.1038/nchem.217, 10.1038/NCHEM.217]
   Nakanishi T, 2002, J MOL BIOL, V318, P245, DOI 10.1016/S0022-2836(02)00018-9
   NEUHAUS D, 2000, NUCL OVERHAUSER EFFE
   NI F, 1994, PROG NUCL MAG RES SP, V26, P517, DOI 10.1016/0079-6565(94)80015-4
   NIRMALA NR, 1992, J MAGN RESON, V100, P25, DOI 10.1016/0022-2364(92)90363-C
   Norton RS, 2016, MOLECULES, V21, DOI 10.3390/molecules21070860
   O'Connell MR, 2009, PROTEOMICS, V9, P5224, DOI 10.1002/pmic.200900303
   O'Hagan D, 2002, NATURE, V416, P279, DOI 10.1038/416279a
   OTTING G, 1990, Q REV BIOPHYS, V23, P39, DOI 10.1017/S0033583500005412
   Ozawa K, 2004, EUR J BIOCHEM, V271, P4084, DOI 10.1111/j.1432-1033.2004.04346.x
   Pastore A., 2017, ARCH BIOCH BIOPHYS
   PATERSON Y, 1990, SCIENCE, V249, P755, DOI 10.1126/science.1697101
   Pellecchia M, 2002, NAT REV DRUG DISCOV, V1, P211, DOI 10.1038/nrd748
   Pellecchia M, 2008, NAT REV DRUG DISCOV, V7, P738, DOI 10.1038/nrd2606
   Pelz NF, 2016, J MED CHEM, V59, P2054, DOI 10.1021/acs.jmedchem.5b01660
   Petros AM, 2006, J MED CHEM, V49, P656, DOI 10.1021/jm0507532
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Post CB, 2003, CURR OPIN STRUC BIOL, V13, P581, DOI 10.1016/j.sbi.2003.09.012
   Powers Robert, 2002, Journal of Structural and Functional Genomics, V2, P113, DOI 10.1023/A:1020445506369
   Price WS, 2002, MAGN RESON CHEM, V40, P391, DOI 10.1002/mrc.1029
   Rahman S, 2017, BBA-PROTEINS PROTEOM, V1865, P547, DOI 10.1016/j.bbapap.2017.02.018
   Reckel S, 2005, CHEMBIOCHEM, V6, P1601, DOI 10.1002/cbic.200500076
   Reckel S, 2008, P NATL ACAD SCI USA, V105, P8262, DOI 10.1073/pnas.0710843105
   Riek R, 2000, TRENDS BIOCHEM SCI, V25, P462, DOI 10.1016/S0968-0004(00)01665-0
   Rudiger S, 2002, P NATL ACAD SCI USA, V99, P11085, DOI 10.1073/pnas.132393699
   Sakai T, 2006, J BIOMOL NMR, V36, P179, DOI 10.1007/s10858-006-9079-9
   Sakakibara D, 2009, NATURE, V458, P102, DOI 10.1038/nature07814
   Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585
   Sanders CR, 2006, MAGN RESON CHEM, V44, pS24, DOI 10.1002/mrc.1816
   Schade M, 2006, IDRUGS, V9, P110
   SCHAUMBURG K, 1968, J AM CHEM SOC, V90, P2495, DOI 10.1021/ja01012a009
   Schwarz D, 2007, NAT PROTOC, V2, P2945, DOI 10.1038/nprot.2007.426
   Selenko P, 2008, NAT STRUCT MOL BIOL, V15, P321, DOI 10.1038/nsmb.1395
   Selenko P, 2007, J STRUCT BIOL, V158, P244, DOI 10.1016/j.jsb.2007.04.001
   Serber Z, 2005, METHOD ENZYMOL, V394, P17, DOI 10.1016/S0076-6879(05)94002-0
   Shin J, 2011, J BIOL CHEM, V286, P22131, DOI 10.1074/jbc.M110.200162
   Shortridge MD, 2008, J COMB CHEM, V10, P948, DOI 10.1021/cc800122m
   Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531
   Siriwardena AH, 2002, ANGEW CHEM INT EDIT, V41, P3454, DOI 10.1002/1521-3773(20020916)41:18<3454::AID-ANIE3454>3.0.CO;2-L
   Sledz P., 2012, NMR BIOMOLECULES MEC, P264
   Staunton D, 2006, MAGN RESON CHEM, V44, pS2, DOI 10.1002/mrc.1835
   Su XC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000561
   Sun ZYJ, 2005, J BIOMOL NMR, V33, P43, DOI 10.1007/s10858-005-1284-4
   Sun ZYJ, 2005, J BIOMOL NMR, V32, P55, DOI 10.1007/s10858-005-3339-y
   Takeda M, 2012, METHODS MOL BIOL, V831, P71, DOI 10.1007/978-1-61779-480-3_5
   Takeuchi K, 2006, CURR OPIN STRUC BIOL, V16, P109, DOI 10.1016/j.sbi.2006.01.006
   Thongwichian Rossukon, 2012, Methods Mol Biol, V895, P33, DOI 10.1007/978-1-61779-927-3_3
   Tugarinov V, 2005, CHEMBIOCHEM, V6, P1567, DOI 10.1002/cbic.200500110
   Tugarinov V, 2005, P NATL ACAD SCI USA, V102, P622, DOI 10.1073/pnas.0407792102
   Tugarinov V, 2004, ANNU REV BIOCHEM, V73, P107, DOI 10.1146/annurev.biochem.73.011303.074004
   Tugarinov V, 2003, J AM CHEM SOC, V125, P13868, DOI 10.1021/ja030345s
   Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101
   Ueda T, 2014, Q REV BIOPHYS, V47, P143, DOI 10.1017/S0033583514000043
   Vajpai N, 2008, J BIOL CHEM, V283, P18292, DOI 10.1074/jbc.M801337200
   Vakonakis L, 2004, P NATL ACAD SCI USA, V101, P1479, DOI 10.1073/pnas.0305516101
   Viegas A, 2011, J CHEM EDUC, V88, P990, DOI 10.1021/ed101169t
   Vogtherr M, 2003, EXS, V93, P183
   Waudby CA, 2016, SCI REP-UK, V6, DOI 10.1038/srep24826
   Weigelt J, 1998, J AM CHEM SOC, V120, P10778, DOI 10.1021/ja982649y
   Weigelt J, 2002, COMB CHEM HIGH T SCR, V5, P623, DOI 10.2174/1386207023329978
   Wildes D, 2005, PROTEIN SCI, V14, P81, DOI 10.1110/ps.04990205
   Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001
   Wood MJ, 1999, J BIOMOL NMR, V13, P149, DOI 10.1023/A:1008398313350
   Xie JJ, 2009, J MED CHEM, V52, P3516, DOI 10.1021/jm9000743
   Ye LB, 2016, NATURE, V533, P265, DOI 10.1038/nature17668
   Ying JF, 2017, J BIOMOL NMR, V68, P101, DOI 10.1007/s10858-016-0072-7
   Zartler ER, 2007, CURR TOP MED CHEM, V7, P1592, DOI 10.2174/156802607782341055
   Zega A, 2017, J MED CHEM
   Zhang OW, 1997, J BIOMOL NMR, V9, P181, DOI 10.1023/A:1018658305040
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
   Zhu L, 2015, BIOCHEM BIOPH RES CO, V461, P677, DOI 10.1016/j.bbrc.2015.04.090
   Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q
NR 185
TC 9
Z9 9
U1 2
U2 30
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1420-3049
J9 MOLECULES
JI Molecules
PD SEP
PY 2017
VL 22
IS 9
AR 1399
DI 10.3390/molecules22091399
PG 21
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA FH9AV
UT WOS:000411499400158
PM 28832542
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Block, L
   Teixeira, L
   Zeng, X
   Dudley, D
   Antony, K
   Simmons, H
   Wiepz, G
   Aliota, M
   Barry, G
   Mohns, M
   Breitbach, M
   Stewart, L
   Schotzko, M
   Permar, S
   Mohr, E
   Capuano, S
   Osorio, J
   Friedrich, T
   O'Connor, D
   Golos, T
AF Block, Lindsey
   Teixeira, Leandro
   Zeng, Xiankun
   Dudley, Dawn
   Antony, Kathleen
   Simmons, Heather
   Wiepz, Gregory
   Aliota, Matthew
   Barry, Gabrielle
   Mohns, Mariel
   Breitbach, Meghan
   Stewart, Laurel
   Schotzko, Michele
   Permar, Sallie
   Mohr, Emma
   Capuano, Saverio, III
   Osorio, Jorge
   Friedrich, Thomas
   O'Connor, David
   Golos, Thaddeus
TI VERTICAL TRANSMISSION OF ZIICA VIRUS (ZIKV) IN RHESUS MACAQUES
SO PLACENTA
LA English
DT Meeting Abstract
CT Meeting of the International-Federation-of-Placenta-Associations (IFPA)
CY AUG 30-SEP 02, 2017
CL Manchester, ENGLAND
SP Int Federat Placenta Assoc
C1 [Block, Lindsey; Teixeira, Leandro; Dudley, Dawn; Antony, Kathleen; Simmons, Heather; Wiepz, Gregory; Aliota, Matthew; Barry, Gabrielle; Mohns, Mariel; Breitbach, Meghan; Stewart, Laurel; Schotzko, Michele; Mohr, Emma; Capuano, Saverio, III; Osorio, Jorge; Friedrich, Thomas; O'Connor, David; Golos, Thaddeus] Univ Wisconsin, Madison, WI USA.
   [Block, Lindsey; Simmons, Heather; Wiepz, Gregory; Schotzko, Michele; Capuano, Saverio, III; Golos, Thaddeus] Wisconsin Natl Primate Res Ctr, Madison, WI USA.
   [Permar, Sallie] Duke Univ, Sch Med, Durham, NC USA.
   [Zeng, Xiankun] US Army, Med Res Inst Infect Dis, Washington, DC 20310 USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD SEP
PY 2017
VL 57
MA P2.64
BP 312
EP 312
DI 10.1016/j.placenta.2017.07.279
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA FH9OL
UT WOS:000411541500289
DA 2020-07-08
ER

PT J
AU Theys, K
   Libin, P
   Dallmeier, K
   Pineda-Pena, AC
   Vandamme, AM
   Cuypers, L
   Abecasis, AB
AF Theys, Kristof
   Libin, Pieter
   Dallmeier, Kai
   Pineda-Pena, Andrea-Clemencia
   Vandamme, Anne-Mieke
   Cuypers, Lize
   Abecasis, Ana B.
TI Zika genomics urgently need standardized and curated reference sequences
SO PLOS PATHOGENS
LA English
DT Editorial Material
C1 [Theys, Kristof; Libin, Pieter; Vandamme, Anne-Mieke; Cuypers, Lize; Abecasis, Ana B.] Univ Leuven, KU Leuven, Dept Microbiol & Immunol, Rega Inst Med Res Clin & Epidemiol Virol, Leuven, Belgium.
   [Libin, Pieter] Vrije Univ Brussel, Artificial Intelligence Lab, Dept Comp Sci, Brussels, Belgium.
   [Dallmeier, Kai] Univ Leuven, KU Leuven, Dept Microbiol & Immunol, Rega Inst Med Res,Lab Virol & Chemotherapy, Leuven, Belgium.
   [Pineda-Pena, Andrea-Clemencia] Univ Rosario, Mol Biol & Immunol Dept, Fdn Inst Immunol Colombia FIDIC, Basic Sci Dept, Bogota, Colombia.
   [Pineda-Pena, Andrea-Clemencia; Vandamme, Anne-Mieke; Abecasis, Ana B.] Univ Nova Lisboa, Global Hlth & Trop Med, Inst Hyg & Trop Med, IHMT, Lisbon, Portugal.
RP Theys, K (corresponding author), Univ Leuven, KU Leuven, Dept Microbiol & Immunol, Rega Inst Med Res Clin & Epidemiol Virol, Leuven, Belgium.
EM kristof.theys@kuleuven.be
RI Vandamme, Anne-Mieke/I-4127-2012; Pineda-Pena,
   Andrea-Clemencia/N-9809-2015; Cuypers, Lize/D-9460-2018; Abecasis, Ana
   B/B-6295-2009; Theys, Kristof/D-9541-2018
OI Vandamme, Anne-Mieke/0000-0002-6594-2766; Pineda-Pena,
   Andrea-Clemencia/0000-0003-1937-0506; Cuypers, Lize/0000-0002-9433-8752;
   Abecasis, Ana B/0000-0002-3903-5265; Theys, Kristof/0000-0003-0242-7000
FU Fonds Wetenschappelijk Onderzoek - Vlaanderen (FWO)FWO; Research
   Foundation - Flanders (FWO)FWO; FCTPortuguese Foundation for Science and
   Technology [GHTM-UID/Multi/04413/2013]; European Union's Horizon
   research and innovation program [634650]; European Union's Horizon
   research and innovation program ZikaPLAN [734584]; European Union's
   Horizon research and innovation program ZIKAlliance [734548]
FX KT is funded by a postdoctoral grant of the Fonds Wetenschappelijk
   Onderzoek - Vlaanderen (FWO). PL is funded by a doctoral grant of the
   Research Foundation - Flanders (FWO). This work has been funded by FCT
   through funds to GHTM-UID/Multi/04413/2013. The VIROGENESIS project
   receives funding from the European Union's Horizon 2020 research and
   innovation program under grant agreement No 634650. This research was
   supported in part by the European Union's Horizon 2020 research and
   innovation programs ZikaPLAN (Agreement No 734584) and ZIKAlliance
   (Agreement No 734548). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hatcher EL, 2017, NUCLEIC ACIDS RES, V45, pD482, DOI 10.1093/nar/gkw1065
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Naccache SN, 2016, EMERG INFECT DIS, V22, P1788, DOI 10.3201/eid2210.160663
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Trosemeier J-H, 2016, GENOME ANNOUNC, V4
   Yun SI, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00800-16
NR 10
TC 5
Z9 6
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD SEP
PY 2017
VL 13
IS 9
AR e1006528
DI 10.1371/journal.ppat.1006528
PG 4
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA FI4TG
UT WOS:000411968300011
PM 28880955
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU McCloskey, B
   Endericks, T
AF McCloskey, B.
   Endericks, T.
TI The rise of Zika infection and microcephaly: what can we learn from a
   public health emergency?
SO PUBLIC HEALTH
LA English
DT Review
DE Public Health Emergency of International Concern (PHEIC); Zika; WHO;
   Emergency response; Lessons identified; Global Health Security
ID MALE SEXUAL TRANSMISSION; ONGOING TRANSMISSION; VIRUS
AB Objectives: To consider why Zika was declared a Public Health Emergency of International Concern (PHEIC), why it stopped being one and what we can learn from this for the future.
   Study design: This paper reviews the sequence of events and evidence base for the decision to declare Zika a PHEIC, the global response to this, the challenges in maintaining an evidence-based approach to outbreak response and identifies learning outcomes.
   Methods: Evidence review, all published articles in reputable UK and international journals were identified.
   Results: The association between Zika virus infection and congenital malformations including microcephaly became a PHEIC on 1st February 2016 and was declared to be no longer an emergency in November 2016. This shaped the global response led by WHO in the first global emergency since Ebola in West Africa.
   Conclusion: The response to Zika highlights important issues and lessons for future outbreaks that might pose an international risk. Particular challenges arose in trying to maintain an evidence-based approach to public risk communication when the evidence is unclear or still evolving. The Zika incident also demonstrates the importance of public health practitioners and agencies understanding the political context in which outbreaks must be managed and understanding the competing factors that shape the political response. (C) 2017 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.
C1 [McCloskey, B.] Publ Hlth England, Global Publ Hlth, London, England.
   [Endericks, T.] Publ Hlth England, WHO Collaborating Ctr Mass Gatherings & Global Hl, Global Publ Hlth, London, England.
RP McCloskey, B (corresponding author), Publ Hlth England, Global Publ Hlth, London, England.
EM Brian.McCloskey@phe.gov.uk
CR Attaran A, 2016, PODIUM WHY PUBLIC HL
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, N ENGL J MED
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Grills A, 2016, MMWR-MORBID MORTAL W, V65, P711, DOI 10.15585/mmwr.mm6528e1
   Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   McCloskey B, 2014, LANCET, V383, P2083, DOI 10.1016/S0140-6736(13)62342-9
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Rodrigues Faria Nuno, 2016, SCIENCE, V15, P345
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
NR 20
TC 5
Z9 5
U1 8
U2 14
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0033-3506
EI 1476-5616
J9 PUBLIC HEALTH
JI Public Health
PD SEP
PY 2017
VL 150
BP 87
EP 92
DI 10.1016/j.puhe.2017.05.008
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FH6SB
UT WOS:000411305900013
PM 28651111
OA Green Published
DA 2020-07-08
ER

PT J
AU Seltzer, EK
   Horst-Martz, E
   Lu, M
   Merchant, RM
AF Seltzer, E. K.
   Horst-Martz, E.
   Lu, M.
   Merchant, R. M.
TI Public sentiment and discourse about Zika virus on Instagram
SO PUBLIC HEALTH
LA English
DT Article
DE Zika; Social media; Instagram; Public sentiment; Public health emergency
ID TRANSMITTED-DISEASE PREVENTION; SOCIAL MEDIA; HEALTH INFORMATION;
   EMERGENCY; COMMUNICATION
AB Objective: Social media have strongly influenced the awareness and perceptions of public health emergencies, and a considerable amount of social media content is now shared through images, rather than text alone. This content can impact preparedness and response due to the popularity and real-time nature of social media platforms. We sought to explore how the image-sharing platform Instagram is used for information dissemination and conversation during the current Zika outbreak.
   Study design: This was a retrospective review of publicly posted images about Zika on Instagram.
   Methods: Using the keyword '#zika' we identified 500 images posted on Instagram from May to August 2016. Images were coded by three reviewers and contextual information was collected for each image about sentiment, image type, content, audience, geography, reliability, and engagement.
   Results: Of 500 images tagged with #zika, 342 (68%) contained content actually related to Zika. Of the 342 Zika-specific images, 299 were coded as 'health' and 193 were coded 'public interest'. Some images had multiple 'health' and 'public interest' codes. Health images tagged with #zika were primarily related to transmission (43%, 129/299) and prevention (48%, 145/299). Transmission-related posts were more often mosquito-human transmission (73%, 94/129) than human human transmission (27%, 35/129). Mosquito bite prevention posts outnumbered safe sex prevention; (84%, 122/145) and (16%, 23/145) respectively. Images with a target audience were primarily aimed at women (95%, 36/38). Many posts (60%, 61/101) included misleading, incomplete, or unclear information about the virus. Additionally, many images expressed fear and negative sentiment, (79/156, 51%).
   Conclusion: Instagram can be used to characterize public sentiment and highlight areas of focus for public health, such as correcting misleading or incomplete information or expanding messages to reach diverse audiences. (C) 2017 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.
C1 [Seltzer, E. K.; Horst-Martz, E.; Lu, M.; Merchant, R. M.] Univ Penn, Penn Med Ctr Digital Hlth, Philadelphia, PA 19104 USA.
RP Seltzer, EK (corresponding author), 3400 Civ Ctr Blvd,Floor 14-154, Philadelphia, PA 19104 USA.
EM Emily.seltzer@uphs.upenn.edu
OI Seltzer, Emily/0000-0002-9879-4739
CR Allem JP, 2017, NICOTINE TOB RES J S
   [Anonymous], 2016, FEMINIST APPROACH RE
   [Anonymous], 2016, INSTAGRAM TODAY 500
   Ayers JW, 2014, JAMA-J AM MED ASSOC, V311, P1399, DOI 10.1001/jama.2014.1505
   Cavazos-Rehg PA, 2016, PREV SCI, V17, P710, DOI 10.1007/s11121-016-0669-9
   CDC, 2017, CAS COUNTS US
   CDC, 2016, STD AW MONTH RES STD
   CDC, 2016, BUILD YOUR OWN ZIK P
   Chu KH, 2017, TOB CONTROL, V26, P575, DOI 10.1136/tobaccocontrol-2016-053052
   Dredze M, 2016, VACCINE, V34, P3441, DOI 10.1016/j.vaccine.2016.05.008
   Eysenbach G, 2011, AM J PREV MED, V40, pS154, DOI 10.1016/j.amepre.2011.02.006
   Finch KC, 2016, NAT HAZARDS, V83, P729, DOI 10.1007/s11069-016-2327-8
   Frieden TR, 2016, JAMA-J AM MED ASSOC, V316, P1443, DOI 10.1001/jama.2016.11941
   Friedman AL, 2016, SEX TRANSM DIS, V43, pS83, DOI 10.1097/OLQ.0000000000000286
   Friedman AL, 2014, SEX TRANSM DIS, V41, P151, DOI 10.1097/OLQ.0000000000000100
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Jin Jill, 2016, JAMA, V315, P2482, DOI 10.1001/jama.2016.4741
   Kittler AF, 2004, J MED INTERNET RES, V6, DOI 10.2196/jmir.6.1.e8
   McNeil Jr Donald G., 2016, NY TIMES
   Merchant RM, 2011, NEW ENGL J MED, V365, P289, DOI 10.1056/NEJMp1103591
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sered SA, 2016, FEMINIST SOCIOLOGIST
   Sharma M, 2016, AM J INFECT CONTROL
   Southwell BG, 2016, EMERG INFECT DIS, V22, P1320, DOI 10.3201/eid2207.160415
   Towers S, 2015, PLOS ONE, P10
   WHO, 2016, PREV SEX TRANSM ZIK
NR 26
TC 21
Z9 21
U1 15
U2 56
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0033-3506
EI 1476-5616
J9 PUBLIC HEALTH
JI Public Health
PD SEP
PY 2017
VL 150
BP 170
EP 175
DI 10.1016/j.puhe.2017.07.015
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FH6SB
UT WOS:000411305900023
PM 28806618
DA 2020-07-08
ER

PT J
AU Wiwanitkit, S
   Wiwanitkit, V
AF Wiwanitkit, Somsri
   Wiwanitkit, Viroj
TI Renal Failure due to Important Arbovirus Infection: A Short Summary
SO SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION
LA English
DT Letter
ID DENGUE HEMORRHAGIC-FEVER; KIDNEY; ZIKA
C1 [Wiwanitkit, Somsri] Wiwanitkit House, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Surindra Rajabhat Univ, Publ Hlth Curriculum, Surin, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Dept Trop Med, Haikou, Hainan, Peoples R China.
   [Wiwanitkit, Viroj] Dr DY Patil Univ, Dept Community Med, Bombay, Maharashtra, India.
   [Wiwanitkit, Viroj] Univ Nis, Dept Med, Fac Med, Nish, Serbia.
   [Wiwanitkit, Viroj] Joseph Ayobabalola Univ, Dept Biol Sci, Ilara Mokin, Nigeria.
RP Wiwanitkit, S (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM somsriwiwan@hotmail.com
CR Alcendor DJ, 2017, J INFECT DIS, V216, P162, DOI 10.1093/infdis/jix171
   Deng Yichu, 2016, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V28, P106, DOI 10.3760/cma.j.issn.2095-4352.2016.02.005
   Maia SHF, 2015, REV SOC BRAS MED TRO, V48, P783, DOI 10.1590/0037-8682-0205-2015
   Goonasekera CDA, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/917947
   Mallhi TH, 2016, POSTGRAD MED J, V92, P78, DOI 10.1136/postgradmedj-2015-133582
   Nakamura Y, 1985, Nihon Jinzo Gakkai Shi, V27, P839
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Peralta-Aros C, 2017, PEDIATR NEPHROL, V32, P897, DOI 10.1007/s00467-017-3588-5
   Rajapakse S, 2010, T ROY SOC TROP MED H, V104, P89, DOI 10.1016/j.trstmh.2009.07.031
   Tangnararatchakit K, 2012, TRANSPL P, V44, P303, DOI 10.1016/j.transproceed.2011.11.025
   Vachvanichsanong P, 2016, ARCH VIROL, V161, P771, DOI 10.1007/s00705-015-2727-1
   Vakrani GP, 2017, J CLIN DIAGN RES, V11, pOC10, DOI 10.7860/JCDR/2017/22800.9289
   Vasconcelos PFC, 2001, LANCET, V358, P91, DOI 10.1016/S0140-6736(01)05326-0
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
   Wiwanitkit V, 2005, RENAL FAILURE, V27, P803, DOI 10.1080/08860220500244914
   Wiwanitkit V, 2005, RENAL FAILURE, V27, P647, DOI 10.1080/08860220500200916
NR 16
TC 2
Z9 2
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1319-2442
EI 2320-3838
J9 SAUDI J KIDNEY DIS T
JI Saudi J. Kidney Dis. Transplant.
PD SEP-OCT
PY 2017
VL 28
IS 5
BP 1206
EP 1208
DI 10.4103/1319-2442.215124
PG 3
WC Urology & Nephrology
SC Urology & Nephrology
GA FI2EU
UT WOS:000411751400038
PM 28937090
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Libow, LS
AF Libow, Leslie S.
TI Zika, Ebola, and Age: Global and Cellular Aging and Their Catalytic
   Effect on These Infections
SO JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
LA English
DT Letter
C1 [Libow, Leslie S.] Mt Sinai Sch Med, Geriatr & Palliat Med & Med, New York, NY 10029 USA.
RP Libow, LS (corresponding author), Mt Sinai Sch Med, Geriatr & Palliat Med & Med, New York, NY 10029 USA.
FU Leir Foundation
FX Funded by the Leir Foundation.
CR Hayflick L, 1985, Clin Geriatr Med, V1, P15
   Libow LS, 2015, J AM GERIATR SOC, V63, P2440, DOI 10.1111/jgs.13809
   WITKOWSKI JA, 1980, MED HIST, V24, P129, DOI 10.1017/S0025727300040126
NR 3
TC 0
Z9 0
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0002-8614
EI 1532-5415
J9 J AM GERIATR SOC
JI J. Am. Geriatr. Soc.
PD SEP
PY 2017
VL 65
IS 9
BP 2114
EP 2115
DI 10.1111/jgs.14962
PG 2
WC Geriatrics & Gerontology; Gerontology
SC Geriatrics & Gerontology
GA FH3PB
UT WOS:000411060500046
PM 28703853
OA Bronze
DA 2020-07-08
ER

PT J
AU Pinto, D
   Braga, A
   Barata, A
   Borralho, P
   Ferreira, M
   Monteiro, L
AF Pinto, D.
   Braga, A.
   Barata, A.
   Borralho, P.
   Ferreira, M.
   Monteiro, L.
TI Microcephaly beyond the Zika virus: A two-center study with discussion
   of etiopathogenesis
SO VIRCHOWS ARCHIV
LA English
DT Meeting Abstract
C1 [Pinto, D.; Braga, A.; Barata, A.; Borralho, P.; Ferreira, M.; Monteiro, L.] EPE, CHLO, Anat Patol, Lisbon, Portugal.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0945-6317
EI 1432-2307
J9 VIRCHOWS ARCH
JI Virchows Arch.
PD SEP
PY 2017
VL 471
SU 1
MA OFP-06-011
BP S19
EP S19
PG 1
WC Pathology
SC Pathology
GA FF2NZ
UT WOS:000408735400078
DA 2020-07-08
ER

PT J
AU Aly, JM
   Pollack, SE
   Vega, MG
AF Aly, J. M.
   Pollack, S. E.
   Vega, M. G.
TI ZIKA VIRUS AWARENESS AMONGST PATIENTS SEEKING CONCEPTION VERSUS
   REPRODUCTIVE ENDOCRINOLOGY PHYSICIANS.
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT 73rd Scientific Congress and Expo of the
   American-Society-for-Reproductive-Medicine (ASRM)
CY OCT 28-NOV 01, 2017
CL San Antonio, TX
SP Amer Soc Reprod Med
C1 [Aly, J. M.] Cooper Univ Hosp, OBGYN, Camden, NJ USA.
   [Pollack, S. E.] Albert Einstein Coll Med, OBGYN, Bronx, NY 10467 USA.
   [Vega, M. G.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10467 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2017
VL 108
IS 3
SU S
MA P-581
BP E328
EP E328
DI 10.1016/j.fertnstert.2017.07.966
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA FG0MW
UT WOS:000409446002174
OA Bronze
DA 2020-07-08
ER

PT J
AU Broughton, DE
   Scheaffer, S
   Skaznik-Wikiel, ME
   Halabi, J
   Govero, J
   Caine, E
   Diamond, M
   Moley, K
AF Broughton, D. E.
   Scheaffer, S.
   Skaznik-Wikiel, M. E.
   Halabi, J.
   Govero, J.
   Caine, E.
   Diamond, M.
   Moley, K.
TI ZIKA VIRUS EXHIBITS TROPISM TO THE OVARY AND INCREASES FOLLICULAR
   APOPTOSIS IN A MOUSE MODEL.
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT 73rd Scientific Congress and Expo of the
   American-Society-for-Reproductive-Medicine (ASRM)
CY OCT 28-NOV 01, 2017
CL San Antonio, TX
SP Amer Soc Reprod Med
C1 [Broughton, D. E.; Scheaffer, S.; Halabi, J.; Moley, K.] Washington Univ, Obstet & Gynecol, St Louis, MO USA.
   [Skaznik-Wikiel, M. E.] Univ Colorado Denver, OB GYN, Aurora, CO USA.
   [Govero, J.; Caine, E.; Diamond, M.] Washington Univ, Med, St Louis, MO USA.
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165
FU  [R01 HD065435];  [R01 HD083895];  [R01 AI073755];  [R01 AI1049729]
FX Supported by: R01 HD065435, R01 HD083895, R01 AI073755, R01 AI1049729
CR Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
NR 1
TC 2
Z9 2
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2017
VL 108
IS 3
SU S
MA O-84
BP E35
EP E35
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA FG0MW
UT WOS:000409446000085
DA 2020-07-08
ER

PT J
AU Cassara, MO
   Busso, CE
   Tso, LO
   Romano, RS
   Rubin, CG
   Busso, N
AF Cassara, M. O.
   Busso, C. E.
   Tso, L. O.
   Sabato Romano, R.
   Rubin, C. G.
   Busso, N.
TI SEROPREVALENCE OF ZIKA VIRUS IN AN IVF CLINIC IN SAO PAULO - BRAZIL.
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT 73rd Scientific Congress and Expo of the
   American-Society-for-Reproductive-Medicine (ASRM)
CY OCT 28-NOV 01, 2017
CL San Antonio, TX
SP Amer Soc Reprod Med
C1 [Cassara, M. O.; Tso, L. O.; Sabato Romano, R.] Projeto ALFA, Human Reprod, Sao Paulo, Brazil.
   [Busso, C. E.; Rubin, C. G.] Projeto ALFA, Sao Paulo, Brazil.
   [Busso, N.] ALFA Project Assisted Fertilizat, Sao Paulo, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2017
VL 108
IS 3
SU S
MA P-579
BP E327
EP E327
DI 10.1016/j.fertnstert.2017.07.964
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA FG0MW
UT WOS:000409446002172
OA Bronze
DA 2020-07-08
ER

PT J
AU Dickson, DA
   Mankee-Sookram, S
   Jess, N
   Minto-Bain, CL
   Ramsewak, S
AF Dickson, D. A.
   Mankee-Sookram, S.
   Jess, N.
   Minto-Bain, C. L.
   Ramsewak, S.
TI KNOWLEDGE, ATTITUDES AND PRACTICES OF PATIENTS OF A FERTILITY CLINIC
   INAZIKA-ENDEMIC CARIBBEAN COUNTRY.
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT 73rd Annual Scientific Congress and Expo of the
   American-Society-for-Reproductive-Medicine (ASRM)
CY OCT 28-NOV 02, 2017
CL San Antonio, TX
SP Amer Soc Reprod Med
ID ZIKA VIRUS
C1 [Dickson, D. A.; Mankee-Sookram, S.; Jess, N.; Ramsewak, S.] Trinidad & Tobago IVF & Fertil Ctr, Embryol, Maraval, Trinidad Tobago.
   [Minto-Bain, C. L.] Trinidad & Tobago IVF & Fertil Ctr, Maraval, Trinidad Tobago.
FU Trinidad IVF; Fertility Centre
FX This project was solely financed by Trinidad IVF and Fertility Centre.
CR [Anonymous], 2016, INFERTILITY TREATMEN
   Brasil P., 2016, NEW ENGLAND J MED
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Khan MU, 2016, VALUE HEALTH, V19, pA423, DOI 10.1016/j.jval.2016.09.445
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Rowland A, 2016, J ASSIST REPROD GEN, V33, P435, DOI 10.1007/s10815-016-0684-6
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Zika links to microcephaly in two more nations, 2016, ZIK LINKS MICR 2 MOR
NR 10
TC 1
Z9 1
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2017
VL 108
IS 3
SU S
MA P-580
BP E327
EP E328
DI 10.1016/j.fertnstert.2017.07.965
PG 2
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA FG0MW
UT WOS:000409446002173
OA Bronze
DA 2020-07-08
ER

PT J
AU Dubaut, JP
   Gurung, S
   Trammell, MR
   Myers, D
   Reuter, D
   Preno, A
   Zavy, MT
   Papin, JF
AF Dubaut, J. P.
   Gurung, S.
   Trammell, M. R.
   Myers, D.
   Reuter, D.
   Preno, A.
   Zavy, M. T.
   Papin, J. F.
TI SEMEN PARAMETERS DURING ZIKA VIRUS INFECTION IN THE OLIVE BABOON (PAPIO
   ANUBIS)
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT 73rd Scientific Congress and Expo of the
   American-Society-for-Reproductive-Medicine (ASRM)
CY OCT 28-NOV 01, 2017
CL San Antonio, TX
SP Amer Soc Reprod Med
C1 [Dubaut, J. P.; Trammell, M. R.; Zavy, M. T.] Univ Oklahoma, HSC, REI, Obstet & Gynecol, Oklahoma City, OK USA.
   [Gurung, S.; Myers, D.] Univ Oklahoma, HSC, MFM, Obstet & Gynecol, Oklahoma City, OK USA.
   [Reuter, D.; Preno, A.; Papin, J. F.] Univ Oklahoma, HSC, Comparat Med, Oklahoma City, OK USA.
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R21 AI129560]; American Board of
   Obstetrics and Gynecology; American College of Obstetricians and
   Gynecologists; American Society for Reproductive Medicine; Society for
   Reproductive Endocrinology and Infertility
FX Supported by: NIH R21 AI129560. Supported by a grant from the American
   Board of Obstetrics and Gynecology, the American College of
   Obstetricians and Gynecologists, the American Society for Reproductive
   Medicine, and the Society for Reproductive Endocrinology and
   Infertility.
CR Govero J, 2016, NATURE, V540, P438
   Huits R.M.H.G., 2016, B WHO
   Ma W, 2016, CELL, V167
   Moreira J, 2017, CLIN MICROBIOLOGY IN
NR 4
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2017
VL 108
IS 3
SU S
MA O-126
BP E52
EP E53
DI 10.1016/j.fertnstert.2017.07.168
PG 2
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA FG0MW
UT WOS:000409446000127
OA Bronze
DA 2020-07-08
ER

PT J
AU Tiegs, AW
   Willson, S
   Kramer, Y
   McCulloh, DH
   McCaffrey, C
   Goldman, KN
AF Tiegs, A. W.
   Willson, S.
   Kramer, Y.
   McCulloh, D. H.
   McCaffrey, C.
   Goldman, K. N.
TI THE IMPACT OF ZIKA VIRUS ON REPRODUCTIVE PLANNING IN AN INFERTILE
   POPULATION.
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT 73rd Scientific Congress and Expo of the
   American-Society-for-Reproductive-Medicine (ASRM)
CY OCT 28-NOV 01, 2017
CL San Antonio, TX
SP Amer Soc Reprod Med
C1 [Tiegs, A. W.; Willson, S.] NYU, Sch Med, New York, NY USA.
   [Kramer, Y.; McCulloh, D. H.; McCaffrey, C.; Goldman, K. N.] NYU, Fertil Ctr, New York, NY USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2017
VL 108
IS 3
SU S
MA P-582
BP E328
EP E328
DI 10.1016/j.fertnstert.2017.07.967
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA FG0MW
UT WOS:000409446002175
OA Bronze
DA 2020-07-08
ER

PT J
AU Vega, MG
   Aly, JM
   Pollack, SE
AF Vega, M. G.
   Aly, J. M.
   Pollack, S. E.
TI ZIKA VIRUS - HOW WELL DO PHYSICIANS ADHERE TO PUBLISHED GUIDELINES?
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT 73rd Scientific Congress and Expo of the
   American-Society-for-Reproductive-Medicine (ASRM)
CY OCT 28-NOV 01, 2017
CL San Antonio, TX
SP Amer Soc Reprod Med
C1 [Vega, M. G.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10467 USA.
   [Aly, J. M.] Cooper Univ Hosp, OBGYN, Camden, NJ USA.
   [Pollack, S. E.] Albert Einstein Coll Med, OBGYN, Bronx, NY 10467 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2017
VL 108
IS 3
SU S
MA P-584
BP E329
EP E329
DI 10.1016/j.fertnstert.2017.07.969
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA FG0MW
UT WOS:000409446002177
OA Bronze
DA 2020-07-08
ER

PT J
AU Katanami, Y
   Kutsuna, S
   Taniguchi, S
   Tajima, S
   Takaya, S
   Yamamoto, K
   Takeshita, N
   Hayakawa, K
   Kanagawa, S
   Kato, Y
   Ohmagari, N
AF Katanami, Yuichi
   Kutsuna, Satoshi
   Taniguchi, Satoshi
   Tajima, Shigeru
   Takaya, Saho
   Yamamoto, Kei
   Takeshita, Nozomi
   Hayakawa, Kayoko
   Kanagawa, Shuzo
   Kato, Yasuyuki
   Ohmagari, Norio
TI Detection of Zika virus in a traveller from Vietnam to Japan
SO JOURNAL OF TRAVEL MEDICINE
LA English
DT Article
DE Zika virus infection; viral diseases; Vietnam; Asia; Southeastern
ID OUTBREAK; DISEASE; ISRAEL
AB We report an imported case of Zika fever in a traveller from Vietnam. Zika virus (ZIKV) is currently widespread in Vietnam. Ongoing transmission of ZIKV has been reported in Southeast Asia, and with frequent travel between neighbouring regions, careful surveillance for imported cases is needed.
C1 [Katanami, Yuichi; Kutsuna, Satoshi; Takaya, Saho; Yamamoto, Kei; Takeshita, Nozomi; Hayakawa, Kayoko; Kanagawa, Shuzo; Kato, Yasuyuki; Ohmagari, Norio] Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Tokyo 1628655, Japan.
   [Taniguchi, Satoshi; Tajima, Shigeru] Natl Inst Infect Dis, Dept Virol 1, Tokyo, Japan.
RP Katanami, Y (corresponding author), Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Tokyo 1628655, Japan.
EM yuichi.katanami@gmail.com
OI Shigeru, Tajima/0000-0002-1981-9062
FU National Center for Global Health and MedicineNational Center for Global
   Health & Medicine - Japan [27-6001]
FX This work was supported by grants from the National Center for Global
   Health and Medicine (27-6001).
CR A ProMED- mail, 2017, INT MAP PROM REP
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2017, CURR ZIK TRANSM
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Meltzer E, 2016, EMERG INFECT DIS, V22, P1521, DOI 10.3201/eid2208.160480
   National Institute of Infectious Diseases Japan, ZIK VIR RISK ASS
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197
NR 15
TC 12
Z9 13
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1195-1982
EI 1708-8305
J9 J TRAVEL MED
JI J. Travel Med.
PD SEP-OCT
PY 2017
VL 24
IS 5
AR tax031
DI 10.1093/jtm/tax031
PG 3
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Medicine, General & Internal
SC Public, Environmental & Occupational Health; Infectious Diseases;
   General & Internal Medicine
GA FG5KD
UT WOS:000410353500020
PM 28498965
OA Bronze
DA 2020-07-08
ER

PT J
AU Ng, D
   Ho, H
   Chow, A
   Wong, J
   Kyaw, W
   Tan, A
   Chia, P
   Choy, C
   Tan, G
   Barkham, T
   Yeo, T
   Leo, Y
AF Ng, D.
   Ho, H.
   Chow, A.
   Wong, J.
   Kyaw, W.
   Tan, A.
   Chia, P.
   Choy, C.
   Tan, G.
   Barkham, T.
   Yeo, T.
   Leo, Y.
TI Correlation of clinical illness with viremia in Zika virus disease
SO INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
LA English
DT Meeting Abstract
CT 11th International Symposium on Antimicrobial Agents and Resistance
   (ISAAR) / 3rd International Interscience Conference on Infection and
   Chemotherapy (ICIC)
CY SEP 14-16, 2017
CL Korean Soc Infect Dis, Busan, SOUTH KOREA
HO Korean Soc Infect Dis
C1 [Ng, D.; Chia, P.; Choy, C.; Tan, G.; Yeo, T.; Leo, Y.] Inst Infect Dis & Epidemiol, Dept Infect Dis, Singapore, Singapore.
   [Ho, H.; Chow, A.; Wong, J.; Kyaw, W.; Tan, A.] Inst Infect Dis & Epidemiol, Dept Epidemiol, Singapore, Singapore.
   [Barkham, T.] Tan Tock Seng Hosp, Dept Lab Med, Singapore, Singapore.
RI Chia, Po Ying/AAN-9657-2020
OI Chia, Po Ying/0000-0002-8797-9527
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0924-8579
EI 1872-7913
J9 INT J ANTIMICROB AG
JI Int. J. Antimicrob. Agents
PD SEP
PY 2017
VL 50
SU 1
MA P1-VR05
BP S122
EP S122
PG 1
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA FG5ML
UT WOS:000410364400180
DA 2020-07-08
ER

PT J
AU Dourado, ME
   Fernandes, U
   Vital, AL
   Ramos, E
   Urbano, JC
   Sena, A
   Fraiman, PHA
   Luz, K
   Queiroz, JW
   Jeronimo, SMB
AF Dourado, M. E.
   Fernandes, U.
   Vital, A. L.
   Ramos, E.
   Urbano, J. C.
   Sena, A.
   Fraiman, P. H. A.
   Luz, K.
   Queiroz, J. W.
   Jeronimo, S. M. B.
TI HIGH INCIDENCE OF GUILLAIN-BARRE SYNDROME AFTER ZIKA VIRUS INFECTION IN
   THE STATE RIO GRANDE DO NORTE, IN NORTHEAST BRAZIL
SO JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
LA English
DT Meeting Abstract
CT Peripheral-Nerve-Society Meeting
CY JUL 08-12, 2017
CL Sitges, SPAIN
SP Peripheral Nerve Soc, Alnylam Pharmaceut Inc, CSL Behring, Grifols S A, Kedr S p A, Pfizer Inc Rare Dis, Terumo BCT Inc, Shire Plc, GBS CIDP Fdn Int, Octapharma AG, Acceleron Pharma Inc, Ionis Pharmaceut Inc, LFB Biomedicaments, Mayo Med Labs, Pharnext SA, Hereditary Neuropathy Fdn, Syntimmune Inc, UCB Biosciences Inc
C1 [Dourado, M. E.; Fernandes, U.; Vital, A. L.; Ramos, E.; Urbano, J. C.; Sena, A.; Fraiman, P. H. A.; Luz, K.; Queiroz, J. W.; Jeronimo, S. M. B.] Univ Fed Rio Grande do Norte, Natal, RN, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1085-9489
EI 1529-8027
J9 J PERIPHER NERV SYST
JI J. Peripher. Nerv. Syst.
PD SEP
PY 2017
VL 22
IS 3
BP 275
EP 276
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FF8CU
UT WOS:000409243500125
DA 2020-07-08
ER

PT J
AU Leonhard, SE
   Amorelli, M
   Barreira, AA
   Cornblath, DR
   Mohammed, MD
   Van Doorn, PA
   Islam, Z
   Marques, W
   Pardo, CA
   Shahrizaila, N
   Umapathi, T
   Willison, HJ
   Jacobs, BC
AF Leonhard, S. E.
   Amorelli, M.
   Barreira, A. A.
   Cornblath, D. R.
   Mohammed, Deen M.
   Van Doorn, P. A.
   Islam, Z.
   Marques, W., Jr.
   Pardo, C. A.
   Shahrizaila, N.
   Umapathi, T.
   Willison, H. J.
   Jacobs, B. C.
CA IGOS-Zika Consortium
TI INTERNATIONAL ZIKA VIRUS RELATED GUILLAIN-BARRE SYNDROME OUTCOME STUDY
   (IGOS-ZIKA): A CASE-CONTROLLED STUDY
SO JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
LA English
DT Meeting Abstract
CT Peripheral-Nerve-Society Meeting
CY JUL 08-12, 2017
CL Sitges, SPAIN
SP Peripheral Nerve Soc, Alnylam Pharmaceut Inc, CSL Behring, Grifols S A, Kedr S p A, Pfizer Inc Rare Dis, Terumo BCT Inc, Shire Plc, GBS CIDP Fdn Int, Octapharma AG, Acceleron Pharma Inc, Ionis Pharmaceut Inc, LFB Biomedicaments, Mayo Med Labs, Pharnext SA, Hereditary Neuropathy Fdn, Syntimmune Inc, UCB Biosciences Inc
C1 [Leonhard, S. E.; Van Doorn, P. A.; Jacobs, B. C.] Erasmus MC, Dept Neurol, Rotterdam, Netherlands.
   [Amorelli, M.] Secretary State Hlth Fed Dist, Dept Infect Dis, Brasilia, DF, Brazil.
   [Barreira, A. A.; Marques, W., Jr.] Univ Sao Paulo, Dept Neurosci, Med Sch Ribeirao Preto, Ribeirao Preto, SP, Brazil.
   [Cornblath, D. R.; Pardo, C. A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.
   [Mohammed, Deen M.] Natl Inst Neurosci & Hosp NINS, Dhaka, Bangladesh.
   [Islam, Z.] Icddr B, Lab Sci & Serv Div, Dhaka, Bangladesh.
   [Shahrizaila, N.] Univ Malaya, Dept Neurol, Kuala Lumpur, Malaysia.
   [Umapathi, T.] Natl Neurosci Inst, Singapore, Singapore.
   [Willison, H. J.] Univ Glasgow, Dept Neurol, Glasgow, Lanark, Scotland.
   [Jacobs, B. C.] Erasmus MC, Dept Immunol, Rotterdam, Netherlands.
RI Marques, Wilson/G-4240-2012; Pardo, Carlos A./A-5192-2008
OI Marques, Wilson/0000-0002-4589-2749; Pardo, Carlos
   A./0000-0002-4128-5335
NR 0
TC 0
Z9 0
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1085-9489
EI 1529-8027
J9 J PERIPHER NERV SYST
JI J. Peripher. Nerv. Syst.
PD SEP
PY 2017
VL 22
IS 3
BP 329
EP 330
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FF8CU
UT WOS:000409243500260
DA 2020-07-08
ER

PT J
AU Ohnmar, O
   Kam, YW
   Ng, LFP
   Umapathi, T
AF Ohnmar, O.
   Kam, Y. W.
   Ng, L. F. P.
   Umapathi, T.
TI THE CHALLENGES OF ACCURATE DIAGNOSIS OF ZIKA VIRUS ASSOCIATED
   GUILLAIN-BARRE SYNDROME (GBS) IN A DENGUE ENDEMIC AREA
SO JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
LA English
DT Meeting Abstract
CT Peripheral-Nerve-Society Meeting
CY JUL 08-12, 2017
CL Sitges, SPAIN
SP Peripheral Nerve Soc, Alnylam Pharmaceut Inc, CSL Behring, Grifols S A, Kedr S p A, Pfizer Inc Rare Dis, Terumo BCT Inc, Shire Plc, GBS CIDP Fdn Int, Octapharma AG, Acceleron Pharma Inc, Ionis Pharmaceut Inc, LFB Biomedicaments, Mayo Med Labs, Pharnext SA, Hereditary Neuropathy Fdn, Syntimmune Inc, UCB Biosciences Inc
C1 [Ohnmar, O.] Univ Med 1, Yangon, Myanmar.
   [Kam, Y. W.; Ng, L. F. P.] ASTAR, Singapore Immunol Network, Singapore, Singapore.
   [Umapathi, T.] Natl Neurosci Inst, Singapore, Singapore.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1085-9489
EI 1529-8027
J9 J PERIPHER NERV SYST
JI J. Peripher. Nerv. Syst.
PD SEP
PY 2017
VL 22
IS 3
BP 349
EP 349
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FF8CU
UT WOS:000409243500309
DA 2020-07-08
ER

PT J
AU Santos, PP
   Torezani, GS
   Maciero, L
   Pagliarini, LFD
   Romao, TT
   Abunahman, MS
   Ferreira, IS
   Bittar, C
   Pupe, C
   Nascimento, OJM
AF Santos, P. P.
   Torezani, G. S.
   Maciero, L.
   Pagliarini, L. F. D.
   Romao, T. T.
   Abunahman, M. S.
   Ferreira, I. S.
   Bittar, C.
   Pupe, C.
   Nascimento, O. J. M.
TI ACUTE TRANSIENT POLYNEURITIS ASSOCIATED WITH ZIKA VIRUS INFECTION
SO JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
LA English
DT Meeting Abstract
CT Peripheral-Nerve-Society Meeting
CY JUL 08-12, 2017
CL Sitges, SPAIN
SP Peripheral Nerve Soc, Alnylam Pharmaceut Inc, CSL Behring, Grifols S A, Kedr S p A, Pfizer Inc Rare Dis, Terumo BCT Inc, Shire Plc, GBS CIDP Fdn Int, Octapharma AG, Acceleron Pharma Inc, Ionis Pharmaceut Inc, LFB Biomedicaments, Mayo Med Labs, Pharnext SA, Hereditary Neuropathy Fdn, Syntimmune Inc, UCB Biosciences Inc
C1 [Santos, P. P.; Torezani, G. S.; Maciero, L.; Pagliarini, L. F. D.; Romao, T. T.; Abunahman, M. S.; Ferreira, I. S.; Bittar, C.; Pupe, C.; Nascimento, O. J. M.] UFF, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1085-9489
EI 1529-8027
J9 J PERIPHER NERV SYST
JI J. Peripher. Nerv. Syst.
PD SEP
PY 2017
VL 22
IS 3
BP 377
EP 377
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FF8CU
UT WOS:000409243500376
DA 2020-07-08
ER

PT J
AU Styczynski, J
   Hoek, J
   Knelange, N
   Mikulska, M
   Cesaro, S
   Aljurf, M
   Gil, L
AF Styczynski, J.
   Hoek, J.
   Knelange, N.
   Mikulska, M.
   Cesaro, S.
   Aljurf, M.
   Gil, L.
TI No report on Zika virus infection in EBMT registry: Infectious Diseases
   Working Party statement
SO BONE MARROW TRANSPLANTATION
LA English
DT Letter
ID BLOOD-DONORS; TRANSMISSION; TRANSFUSION
C1 [Styczynski, J.] Nicolaus Copernicus Univ Torun, Dept Pediat Hematol & Oncol, Collegium Medicum, Bydgoszcz, Poland.
   [Hoek, J.; Knelange, N.] EBMT Data Office, Leiden, Netherlands.
   [Mikulska, M.] Univ Genoa, Dept Hlth Sci, Div Infect Dis, Osped Policlinco San Martino, Genoa, Italy.
   [Cesaro, S.] Azienda Osped Univ Integrata, Dept Pediat Hematol Oncol, Policlin GB Rossi, Verona, Italy.
   [Aljurf, M.] King Faisal Specialist Hosp & Res Ctr, Dept Oncol, Riyadh, Saudi Arabia.
   [Gil, L.] Med Univ, Dept Hematol & Stem Cell Transplantat, Poznan, Poland.
RP Styczynski, J (corresponding author), Nicolaus Copernicus Univ Torun, Dept Pediat Hematol & Oncol, Collegium Medicum, Bydgoszcz, Poland.
EM jstyczynski@cm.umk.pl
RI Cesaro, Simone/F-8118-2019; STYCZYNSKI, JAN/D-3922-2014; Cesaro,
   Simone/I-3272-2019
OI Cesaro, Simone/0000-0002-8698-9547; STYCZYNSKI, JAN/0000-0002-3158-119X;
   Cesaro, Simone/0000-0002-8698-9547; MIKULSKA,
   MALGORZATA/0000-0002-5535-4602
CR [Anonymous], 2016, MMWR MORB MORTAL WKL, V65, P627
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Domanovic D, 2016, ZIKA VIRUS SAFETY SU
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Galel SA, 2017, TRANSFUSION, V57, P762, DOI 10.1111/trf.14029
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Jimenez A, 2017, MED REV, V31, P1, DOI DOI 10.1016/J.TMRV.2016.08.001
   Kuehnert MJ, 2016, SCREENING BLOOD DONA
   Machado CM, 2017, BLOOD ADV, V1, P624, DOI 10.1182/bloodadvances.2016003285
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Vasquez AM, 2016, AM J TRANSPLANT, V16, P2487, DOI 10.1111/ajt.13941
NR 15
TC 2
Z9 2
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0268-3369
EI 1476-5365
J9 BONE MARROW TRANSPL
JI Bone Marrow Transplant.
PD SEP
PY 2017
VL 52
IS 9
BP 1345
EP 1346
DI 10.1038/bmt.2017.145
PG 2
WC Biophysics; Oncology; Hematology; Immunology; Transplantation
SC Biophysics; Oncology; Hematology; Immunology; Transplantation
GA FF9BB
UT WOS:000409310700021
PM 28692024
DA 2020-07-08
ER

PT J
AU Stone, M
   Bakkour, S
   Lee, TH
   Lanteri, M
   Simmons, G
   Brambilla, D
   Alsina, JO
   Williamson, PC
   Reik, RA
   Galel, SA
   Linnen, J
   Kleinman, S
   Busch, MP
AF Stone, Mars
   Bakkour, Sonia
   Lee, Tzong-Hae
   Lanteri, Marion
   Simmons, Graham
   Brambilla, Don
   Alsina, Jose Orlando
   Williamson, Phillip C.
   Reik, Rita A.
   Galel, Susan A.
   Linnen, Jeff
   Kleinman, Steve
   Busch, Michael Paul
CA NHLBI Recipient Epidemiology Donor
TI Zika RNA Persistence in Blood and Body Fluids and Clinical Outcomes in
   Infected Blood Donors
SO TRANSFUSION
LA English
DT Meeting Abstract
CT AABB Annual Meeting
CY OCT 07-10, 2017
CL San Diego, CA
SP AABB
C1 [Stone, Mars; Bakkour, Sonia; Lee, Tzong-Hae; Lanteri, Marion; Simmons, Graham; Busch, Michael Paul] Blood Syst Res Inst, San Francisco, CA USA.
   [Brambilla, Don] RTI Int, Res Triangle Pk, NC USA.
   [Alsina, Jose Orlando] Banco Sangre Serv Mutuos, San Juan, PR USA.
   [Williamson, Phillip C.] Creat Testing Solut, Bedford, TX USA.
   [Reik, Rita A.] OneBlood Inc, Jacksonville, FL USA.
   [Galel, Susan A.] Roche Mol Syst Inc, Pleasanton, CA USA.
   [Linnen, Jeff] Hologic, Marlborough, MA USA.
   [Kleinman, Steve] Univ British Columbia, Vancouver, BC, Canada.
   [NHLBI Recipient Epidemiology Donor] NHLBI, Bldg 10, Bethesda, MD 20892 USA.
NR 0
TC 2
Z9 2
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD SEP
PY 2017
VL 57
SU 3
SI SI
MA P5-A03A
BP 4A
EP 4A
PG 1
WC Hematology
SC Hematology
GA FF5UQ
UT WOS:000409065000006
DA 2020-07-08
ER

PT J
AU Saa, PP
   Nguyen, ML
   Proctor, MC
   Krysztof, DE
   Foster, GA
   Sash, EK
   Dickson, SS
   Yang, J
   Linnen, JM
   Gao, K
   Brodsky, JP
   Stramer, SL
AF Saa, Paula P.
   Nguyen, Megan L.
   Proctor, Melanie C.
   Krysztof, David E.
   Foster, Gregory A.
   Sash, Erin K.
   Dickson, Sandy S.
   Yang, Joua
   Linnen, Jeffrey M.
   Gao, Kui
   Brodsky, Jaye P.
   Stramer, Susan L.
TI Investigational Detection of Zika Virus RNA in US Blood Donors
SO TRANSFUSION
LA English
DT Meeting Abstract
CT AABB Annual Meeting
CY OCT 07-10, 2017
CL San Diego, CA
SP AABB
C1 [Saa, Paula P.; Nguyen, Megan L.; Proctor, Melanie C.; Krysztof, David E.; Foster, Gregory A.; Sash, Erin K.; Dickson, Sandy S.; Yang, Joua; Stramer, Susan L.] Amer Red Cross, Washington, DC 20006 USA.
   [Linnen, Jeffrey M.; Gao, Kui] Grifols Diagnost Solut Inc, Emeryville, CA USA.
   [Brodsky, Jaye P.] Qual Analyt Inc, Emeryville, CA USA.
NR 0
TC 2
Z9 2
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD SEP
PY 2017
VL 57
SU 3
SI SI
MA C7-A01C
BP 25A
EP 25A
PG 1
WC Hematology
SC Hematology
GA FF5UQ
UT WOS:000409065000059
DA 2020-07-08
ER

PT J
AU Williamson, PC
   Pate, LL
   Simmons, G
   Stone, M
   Winkelman, V
   Latoni, G
   Alsina, J
   Bakkour, S
   Galel, SA
   Busch, MP
AF Williamson, Phillip C.
   Pate, Lisa Lee
   Simmons, Graham
   Stone, Mars
   Winkelman, Valerie
   Latoni, Gerardo
   Alsina, Jose
   Bakkour, Sonia
   Galel, Susan A.
   Busch, Michael Paul
TI Evolving Viral and Serological Stages of NAT Yield Donations from the
   2016 Puerto Rico Zika Epidemic
SO TRANSFUSION
LA English
DT Meeting Abstract
CT AABB Annual Meeting
CY OCT 07-10, 2017
CL San Diego, CA
SP AABB
C1 [Williamson, Phillip C.; Winkelman, Valerie] Creat Testing Solut, Bedford, TX USA.
   [Pate, Lisa Lee; Galel, Susan A.] Roche Mol Syst Inc, Pleasanton, CA USA.
   [Simmons, Graham; Stone, Mars; Bakkour, Sonia; Busch, Michael Paul] Blood Syst Res Inst, San Francisco, CA USA.
   [Latoni, Gerardo; Alsina, Jose] Banco Sangre Serv Mutuos, San Juan, PR USA.
FU Biomedical Advanced Research and Development Authority, Office of the
   Assistant Secretary for Preparedness and Response, Office of the
   Secretary, Department of Health and Human Services [HHSO100201600010C]
FX This project has been funded in whole or in part with Federal funds from
   the Biomedical Advanced Research and Development Authority, Office of
   the Assistant Secretary for Preparedness and Response, Office of the
   Secretary, Department of Health and Human Services, under Contract
   #HHSO100201600010C.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD SEP
PY 2017
VL 57
SU 3
SI SI
MA C8-A01C
BP 25A
EP 26A
PG 2
WC Hematology
SC Hematology
GA FF5UQ
UT WOS:000409065000060
DA 2020-07-08
ER

PT J
AU Amorim, L
   Germain, M
   Delage, G
   Lopes, ME
   Gregoire, Y
AF Amorim, Luiz
   Germain, Marc
   Delage, Gilles
   Lopes, Maria Esther
   Gregoire, Yves
TI Risk Assessment for Zika Virus Transfusion-Transmission in Brazil Using
   Monte Carlo Simulation
SO TRANSFUSION
LA English
DT Meeting Abstract
CT AABB Annual Meeting
CY OCT 07-10, 2017
CL San Diego, CA
SP AABB
C1 [Amorim, Luiz; Lopes, Maria Esther] HEMORIO, Rio De Janeiro, Brazil.
   [Germain, Marc; Delage, Gilles; Gregoire, Yves] HemaQuebec, Montreal, PQ, Canada.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD SEP
PY 2017
VL 57
SU 3
SI SI
MA C10-A01C
BP 26A
EP 26A
PG 1
WC Hematology
SC Hematology
GA FF5UQ
UT WOS:000409065000062
DA 2020-07-08
ER

PT J
AU Pate, LL
   Williamson, PC
   Busch, MP
   Rossmann, S
   Jones, S
   Butcher, A
   Duncan, J
   Stanley, J
   Galel, SA
AF Pate, Lisa Lee
   Williamson, Phillip C.
   Busch, Michael Paul
   Rossmann, Susan
   Jones, Scott
   Butcher, Ann
   Duncan, John
   Stanley, Jean
   Galel, Susan A.
TI Detection of Zika Virus RNA in United States Blood Donations Using cobas
   (R) Zika on the cobas (R) 6800/8800 Systems
SO TRANSFUSION
LA English
DT Meeting Abstract
CT AABB Annual Meeting
CY OCT 07-10, 2017
CL San Diego, CA
SP AABB
C1 [Pate, Lisa Lee; Butcher, Ann; Duncan, John; Stanley, Jean; Galel, Susan A.] Roche Mol Syst Inc, Pleasanton, CA USA.
   [Williamson, Phillip C.] Creat Testing Solut, Bedford, TX USA.
   [Busch, Michael Paul] Blood Syst Res Inst, San Francisco, CA USA.
   [Rossmann, Susan] Gulf Coast Reg Blood Ctr Sugar Land, Sugar Land, TX USA.
   [Jones, Scott] QualTex Labs, San Antonio, TX USA.
NR 0
TC 3
Z9 3
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD SEP
PY 2017
VL 57
SU 3
SI SI
MA C9-A01C
BP 26A
EP 26A
PG 1
WC Hematology
SC Hematology
GA FF5UQ
UT WOS:000409065000061
DA 2020-07-08
ER

PT J
AU Lam, S
   Chua, SS
   Stone, M
   Busch, MP
   Ang, AL
AF Lam, Sally
   Chua, Sze Sze
   Stone, Mars
   Busch, Michael Paul
   Ang, Ai Leen
TI Universal Zika Screening for Blood Donors in Singapore
SO TRANSFUSION
LA English
DT Meeting Abstract
CT AABB Annual Meeting
CY OCT 07-10, 2017
CL San Diego, CA
SP AABB
C1 [Lam, Sally; Chua, Sze Sze; Ang, Ai Leen] Hlth Sci Author, Blood Serv Grp, Singapore, Singapore.
   [Stone, Mars; Busch, Michael Paul] Blood Syst Res Inst, San Francisco, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD SEP
PY 2017
VL 57
SU 3
SI SI
MA C12-A01C
BP 27A
EP 27A
PG 1
WC Hematology
SC Hematology
GA FF5UQ
UT WOS:000409065000064
DA 2020-07-08
ER

PT J
AU Ciubotariu, RM
   Tarnawski, M
   Dobrila, NL
   Albano, MS
   Scaradavou, A
   Rubinstein, P
AF Ciubotariu, Rodica M.
   Tarnawski, Michal
   Dobrila, Nela-Ludy
   Albano, Maria Susana
   Scaradavou, Andromachi
   Rubinstein, Pablo
TI ZIKV Impact on Eligibility Determination of HCT/P Donors - Cord Blood
   (CB)
SO TRANSFUSION
LA English
DT Meeting Abstract
CT AABB Annual Meeting
CY OCT 07-10, 2017
CL San Diego, CA
SP AABB
C1 [Ciubotariu, Rodica M.; Tarnawski, Michal; Scaradavou, Andromachi; Rubinstein, Pablo] New York Blood Ctr, Natl Cord Blood Program, New York, NY 10021 USA.
   [Dobrila, Nela-Ludy; Albano, Maria Susana] New York Blood Ctr, New York, NY 10021 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD SEP
PY 2017
VL 57
SU 3
SI SI
MA CP32
BP 79A
EP 79A
PG 1
WC Hematology
SC Hematology
GA FF5UQ
UT WOS:000409065000184
DA 2020-07-08
ER

PT J
AU Phillips, M
   Leparc, G
   Williamson, PC
   Palmer, L
   Reynolds, B
   Noedel, M
   Houghton, L
AF Phillips, Michael
   Leparc, German
   Williamson, Phillip C.
   Palmer, Lani
   Reynolds, Ben
   Noedel, Maria
   Houghton, Lindsey
TI Implementation of the 1st Zika Virus Screening Testing in the United
   States
SO TRANSFUSION
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Association-of-Blood-Banks (AABB)
CY OCT 07-10, 2017
CL San Diego, CA
SP Amer Assoc Blood Banks
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD SEP
PY 2017
VL 57
SU 3
SI SI
MA CP334
BP 193A
EP 193A
PG 1
WC Hematology
SC Hematology
GA FF5UQ
UT WOS:000409065000486
DA 2020-07-08
ER

PT J
AU Zhang, B
   Mo, Q
   Huang, YW
AF Zhang, Bo
   Mo, Qin
   Huang, Yuwen
TI Photochemical Inactivation of Zika Virus in Plasma By Methylene Blue
   with Visible Light
SO TRANSFUSION
LA English
DT Meeting Abstract
CT AABB Annual Meeting
CY OCT 07-10, 2017
CL San Diego, CA
SP AABB
C1 [Zhang, Bo; Mo, Qin; Huang, Yuwen] Shanghai Blood Ctr, Shanghai, Peoples R China.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD SEP
PY 2017
VL 57
SU 3
SI SI
MA CP352
BP 199A
EP 199A
PG 1
WC Hematology
SC Hematology
GA FF5UQ
UT WOS:000409065000504
DA 2020-07-08
ER

PT J
AU Dionne, S
   Baker, B
   Glassman, U
   Henderson, S
   Kantilal, H
   O'Neale, B
   Wolfe, B
AF Dionne, Sara
   Baker, Bryce
   Glassman, Urlene
   Henderson, Scott
   Kantilal, Hema
   O'Neale, Brenden
   Wolfe, Brian
TI Required Zika Virus Nucleic Acid Testing for Blood Donors: One Western
   Laboratory's Experience
SO TRANSFUSION
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Association-of-Blood-Banks (AABB)
CY OCT 07-10, 2017
CL San Diego, CA
SP Amer Assoc Blood Banks
C1 [Dionne, Sara; Baker, Bryce; Glassman, Urlene; Henderson, Scott; Kantilal, Hema; O'Neale, Brenden; Wolfe, Brian] LABS Inc, Centennial, CO USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD SEP
PY 2017
VL 57
SU 3
SI SI
MA CP357
BP 201A
EP 201A
PG 1
WC Hematology
SC Hematology
GA FF5UQ
UT WOS:000409065000509
DA 2020-07-08
ER

PT J
AU Covin, R
   Nguyen, KAT
AF Covin, Randal
   Nguyen, Kim-Anh T.
TI Zika Virus Donor Screening-First Year Experience of a Community Blood
   Center
SO TRANSFUSION
LA English
DT Meeting Abstract
CT AABB Annual Meeting
CY OCT 07-10, 2017
CL San Diego, CA
SP AABB
C1 [Covin, Randal; Nguyen, Kim-Anh T.] Blood Bank Hawaii, Honolulu, HI USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD SEP
PY 2017
VL 57
SU 3
SI SI
MA CP370
BP 205A
EP 206A
PG 2
WC Hematology
SC Hematology
GA FF5UQ
UT WOS:000409065000522
DA 2020-07-08
ER

PT J
AU Williams, JD
   Haubert, N
   Morgan, L
   Hurlburt, O
   Houghton, L
   Spizman, R
   Ritter, JL
   Humphries, M
   Macke, A
   Caglioti, S
   Leparc, G
   Williamson, PC
AF Williams, Joan Dunn
   Haubert, Nancy
   Morgan, Larry
   Hurlburt, O'Dina
   Houghton, Lindsey
   Spizman, Randall
   Ritter, Jennifer L.
   Humphries, Michelle
   Macke, Ami
   Caglioti, Sally
   Leparc, German
   Williamson, Phillip C.
TI Effects of Rapid Implementation of Zika Virus (ZKV) NAT Blood Donor
   Screening in High-Throughput Testing Laboratories
SO TRANSFUSION
LA English
DT Meeting Abstract
CT AABB Annual Meeting
CY OCT 07-10, 2017
CL San Diego, CA
SP AABB
C1 [Williams, Joan Dunn; Haubert, Nancy; Morgan, Larry; Hurlburt, O'Dina; Houghton, Lindsey; Spizman, Randall; Ritter, Jennifer L.; Humphries, Michelle; Macke, Ami; Caglioti, Sally; Williamson, Phillip C.] Creat Testing Solut, Bedford, TX USA.
   [Leparc, German] OneBlood, St Petersburg, FL USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD SEP
PY 2017
VL 57
SU 3
SI SI
MA AP51
BP 231A
EP 231A
PG 1
WC Hematology
SC Hematology
GA FF5UQ
UT WOS:000409065000585
DA 2020-07-08
ER

PT J
AU Williams, JD
   Noedel, M
   Haubert, N
   Hudson, K
   Morgan, L
   Shaw, R
   Fickett, T
   Jue, J
   Winkelman, V
   Caglioti, S
   Leparc, G
   Williamson, PC
AF Williams, Joan Dunn
   Noedel, Maria
   Haubert, Nancy
   Hudson, Kenneth
   Morgan, Larry
   Shaw, Robert
   Fickett, Tracy
   Jue, Jamie
   Winkelman, Valerie
   Caglioti, Sally
   Leparc, German
   Williamson, Phillip C.
TI Rapid Implementation of Zika Virus (ZKV) NAT Blood Donor Screening
SO TRANSFUSION
LA English
DT Meeting Abstract
CT AABB Annual Meeting
CY OCT 07-10, 2017
CL San Diego, CA
SP AABB
C1 [Williams, Joan Dunn; Noedel, Maria; Haubert, Nancy; Hudson, Kenneth; Morgan, Larry; Shaw, Robert; Fickett, Tracy; Jue, Jamie; Winkelman, Valerie; Caglioti, Sally; Leparc, German; Williamson, Phillip C.] Creat Testing Solut, Dallas, TX USA.
   [Leparc, German] OneBlood, Orlando, FL USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD SEP
PY 2017
VL 57
SU 3
SI SI
MA AP70
BP 238A
EP 239A
PG 2
WC Hematology
SC Hematology
GA FF5UQ
UT WOS:000409065000604
DA 2020-07-08
ER

PT J
AU Atwell, F
   Roback, J
   Arkin, R
   Bartlett, M
   Geiger, R
   Reeves, J
AF Atwell, Falisha
   Roback, John
   Arkin, Ronald
   Bartlett, Michael
   Geiger, Robert
   Reeves, Jaxk
TI From West Nile Virus to the Emergence of Zika Virus: A Nationwide Survey
   of How Regulators Are Keeping the Blood Supply Safe and Available
SO TRANSFUSION
LA English
DT Meeting Abstract
CT AABB Annual Meeting
CY OCT 07-10, 2017
CL San Diego, CA
SP AABB
C1 [Atwell, Falisha; Arkin, Ronald; Bartlett, Michael; Geiger, Robert; Reeves, Jaxk] Univ Georgia, Athens, GA 30602 USA.
   [Roback, John] Emory Hosp, Atlanta, GA USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD SEP
PY 2017
VL 57
SU 3
SI SI
MA AP96
BP 251A
EP 251A
PG 1
WC Hematology
SC Hematology
GA FF5UQ
UT WOS:000409065000630
DA 2020-07-08
ER

PT J
AU Jimenez, A
   Shaz, BH
   Kessler, D
   Bloch, EM
AF Jimenez, Alexandra
   Shaz, Beth H.
   Kessler, Debra
   Bloch, Evan M.
TI How do we manage blood donors and recipients after a positive Zika
   screening result?
SO TRANSFUSION
LA English
DT Editorial Material
ID MALE SEXUAL TRANSMISSION; VIRUS-INFECTION; UNITED-STATES; TRANSFUSION;
   MICRONESIA; DONATIONS; BRAZIL; RNA
AB Zika virus (ZIKV) is a mosquito-borne flavivirus that is the focus of an ongoing pandemic. ZIKV is notable for its severe neurologic sequelae in babies born to infected mothers. High rates of subclinical infection, as evidenced by the finding of ZIKV RNA in asymptomatic donors, raise concerns of risk to the blood supply. To date, a total of four suspected cases of transfusion-transmitted ZIKV have been reported (all in Brazil), none of which were associated with clinical infection in the transfusion recipients. In 2016, the US Food and Drug Administration issued a guidance mandating national blood donor screening for ZIKV in the United States. Five days after implementation of donor screening at our facility, we encountered a ZIKV-positive donor. We provide a practical approach to donor, recipient, and blood product management in the setting of a positive donor ZIKV result. Such has been informed by the challenges we faced in the workup of a ZIKV-reactive donation and recipient lookback.
C1 [Jimenez, Alexandra; Shaz, Beth H.; Kessler, Debra] New York Blood Ctr, 310 67th St, New York, NY 10065 USA.
   [Shaz, Beth H.] Columbia Univ, Med Ctr, New York, NY USA.
   [Bloch, Evan M.] Johns Hopkins Univ, Baltimore, MD USA.
RP Jimenez, A (corresponding author), New York Blood Ctr, 310 67th St, New York, NY 10065 USA.
EM ajimenez2@nybc.org
RI Bloch, Evan/G-7676-2018
OI Bloch, Evan/0000-0001-8181-9517
CR AABB, 2016, ASS B
   [Anonymous], 2017, FLOR OFF ZIK FOUND M
   [Anonymous], 2016, BRIEF HOL GRIF SAY F
   [Anonymous], 2016, ZIK VIR BIOV NETW AA
   [Anonymous], 2016, ZIKA MAC ELISA
   [Anonymous], 2017, ZIKA VIRUS      0606
   [Anonymous], 2016, REC DON SCREEN DEF P
   [Anonymous], 2017, ZIKA IN TEXAS   0606
   [Anonymous], 2016, INF ZIK VIR TEST
   [Anonymous], 2016, REV REC RED RISK ZIK
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Belluck P, 2017, NY TIMES
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CDC, 2016, GUID US LAB TEST ZIK
   Cunha M. S., 2016, GENOME ANNOUNC, V4
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Galel S., 2016, BLOOD HCTP SAFETY
   Galel SA, 2017, TRANSFUSION, V57, P762, DOI 10.1111/trf.14029
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Herriman R, 2015, OUTBREAK NEWS T 1218
   Hot Topic, 2016, AABB ANN M
   Interim guidance for Zika virus testing of urineUnited States, 2016, MMWR-MORBID MORTAL W, V65, P474
   Jimenez A, 2017, TRANSFUS MED REV, V31, P1, DOI 10.1016/j.tmrv.2016.08.001
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Lanteri MC, 2014, TRANSFUSION, V54, P3232, DOI 10.1111/trf.12764
   Lustig Y, 2016, EURO SURVEILL, V21
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Phippen JW, 2017, ATLANTIC MONTHLY GRO
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Report S, 2017, ZIK VIR MICR GUILL B
   Santora M., 2016, NEW YORK HLTH DEP EX
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Stone M, 2017, TRANSFUSION, V57, P734, DOI 10.1111/trf.14031
   Table 1, 2017, TABL 1 COUNTR TERR T
   Williamson PC, 2017, TRANSFUSION, V57, P770, DOI 10.1111/trf.14041
   World Health Organization, DIR GEN SUMM OUTC EM
NR 48
TC 5
Z9 5
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD SEP
PY 2017
VL 57
IS 9
BP 2077
EP 2083
DI 10.1111/trf.14252
PG 7
WC Hematology
SC Hematology
GA FF5VH
UT WOS:000409067000005
PM 28734023
OA Bronze
DA 2020-07-08
ER

PT J
AU Bukrejewska, M
   Derewenda, U
   Radwanska, M
   Engel, DA
   Derewenda, ZS
AF Bukrejewska, Malgorzata
   Derewenda, Urszula
   Radwanska, Malwina
   Engel, Daniel A.
   Derewenda, Zygmunt S.
TI Crystal structures of the methyltransferase and helicase from the ZIKA
   1947 MR766 Uganda strain
SO ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY
LA English
DT Article
DE Zika virus; NS5 methyltransferase; NS3 helicase; SAM-binding
   stereochemistry
ID CENTER-DOT-O; VIRUS HELICASE; HYDROGEN-BONDS; NS3 HELICASE; INFECTION;
   INSIGHTS; REVEALS; TARGETS; PHENIX
AB Two nonstructural proteins encoded by Zika virus strain MR766 RNA, a methyltransferase and a helicase, were crystallized and their structures were solved and refined at 2.10 and 2.01 angstrom resolution, respectively. The NS5 methyltransferase contains a bound S-adenosyl-l-methionine (SAM) co-substrate. The NS3 helicase is in the apo form. Comparison with published crystal structures of the helicase in the apo, nucleotide-bound and single-stranded RNA (ssRNA)-bound states suggests that binding of ssRNA to the helicase may occur through conformational selection rather than induced fit.
C1 [Bukrejewska, Malgorzata; Derewenda, Urszula; Radwanska, Malwina; Derewenda, Zygmunt S.] Univ Virginia, Sch Med, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA.
   [Bukrejewska, Malgorzata; Radwanska, Malwina; Engel, Daniel A.] Univ Virginia, Sch Med, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA.
RP Derewenda, ZS (corresponding author), Univ Virginia, Sch Med, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA.
EM zsd4n@virginia.edu
FU US Department of Energy, Office of Biological and Environmental
   ResearchUnited States Department of Energy (DOE) [DE-AC02-06CH11357]; US
   Department of EnergyUnited States Department of Energy (DOE)
   [DE-AC02-06CH11357]
FX The X-ray data- collection experiments were carried out at Argonne
   National Laboratory (ANL) and specifically on beamlines operated by the
   Structural Biology Centre (SBC) and South-Eastern Region Collaborative
   Access Team (SER-CAT) of the Advanced Photon Source. ANL is operated by
   the University of Chicago Argonne LLC for the US Department of Energy,
   Office of Biological and Environmental Research under Contract
   DE-AC02-06CH11357. Supporting institutions of SER-CAT may be found at
   http://www.ser-cal.org/members.html. Use of the Advanced Photon Source,
   an Office of Science User Facility operated for the US Department of
   Energy Office of Science by Argonne National Laboratory, was supported
   by US Department of Energy Contract DE-AC02-06CH11357. We thank Mateusz
   Czub and Dr Wladek Minor for discussions, and Ms Natalya Olekhnovich for
   technical assistance.
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Armstrong Najealicka, 2017, World J Virol, V6, P1, DOI 10.5501/wjv.v6.i1.1
   Baskaran K, 2014, BMC STRUCT BIOL, V14, DOI 10.1186/s12900-014-0022-0
   Bunkoczi G, 2013, ACTA CRYSTALLOGR D, V69, P2276, DOI 10.1107/S0907444913022750
   Cao XC, 2016, NUCLEIC ACIDS RES, V44, P10505, DOI 10.1093/nar/gkw941
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Coutard B, 2014, ANTIVIR RES, V106, P61, DOI 10.1016/j.antiviral.2014.03.013
   De Carvalho NS, 2016, BRAZ J INFECT DIS, V20, P282, DOI 10.1016/j.bjid.2016.02.006
   DEREWENDA ZS, 1995, J MOL BIOL, V252, P248, DOI 10.1006/jmbi.1995.0492
   Duan WQ, 2017, EMBO J, V36, P919, DOI 10.15252/embj.201696241
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grabowski M, 2016, ACTA CRYSTALLOGR D, V72, P1181, DOI 10.1107/S2059798316014716
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hercik K, 2017, ARCH VIROL, V162, P2091, DOI 10.1007/s00705-017-3345-x
   Horowitz S, 2012, J BIOL CHEM, V287, P41576, DOI 10.1074/jbc.R112.418574
   Jain R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01756-7
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Merfeld E, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.273
   Miller E, 2017, J NEUROL SCI, V375, P367, DOI 10.1016/j.jns.2017.02.029
   Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pierce AC, 2005, J MED CHEM, V48, P1278, DOI 10.1021/jm0492249
   Possas C, 2017, MEM I OSWALDO CRUZ, V112, P319, DOI 10.1590/0074-02760160510
   Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744
   Schulze JO, 2016, CELL CHEM BIOL, V23, P1193, DOI 10.1016/j.chembiol.2016.06.017
   Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003
   Shi Y, 2017, TRENDS BIOCHEM SCI, V42, P443, DOI 10.1016/j.tibs.2017.02.009
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Sweeney NL, 2015, ACS INFECT DIS, V1, P140, DOI 10.1021/id5000458
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Upadhyay AK, 2017, ACTA CRYSTALLOGR F, V73, P116, DOI 10.1107/S2053230X17001601
   Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749
   Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005
   Zhang F, 2016, BIOCHEM BIOPH RES CO, V477, P786, DOI 10.1016/j.bbrc.2016.06.136
   Zhou H, 2017, ONCOTARGET, V8, P14830, DOI 10.18632/oncotarget.14780
   Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28
NR 48
TC 8
Z9 8
U1 0
U2 13
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
SN 2059-7983
J9 ACTA CRYSTALLOGR D
JI Acta Crystallogr. Sect. D-Struct. Biol.
PD SEP
PY 2017
VL 73
BP 767
EP 774
DI 10.1107/S2059798317010737
PN 9
PG 8
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA FF8WJ
UT WOS:000409298200006
PM 28876240
DA 2020-07-08
ER

PT J
AU Jakhete, SS
   Allan, SA
   Mankin, RW
AF Jakhete, S. S.
   Allan, S. A.
   Mankin, R. W.
TI Wingbeat Frequency-Sweep and Visual Stimuli for Trapping Male Aedes
   aegypti (Diptera: Culicidae)
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE attraction; ZIKV; dengue; chikungunya; yellow fever
ID FLIGHT SOUNDS; ZIKA VIRUS; MOSQUITOS; TRAPS; FIELD; RESPONSES;
   WOLBACHIA; THAILAND; EFFICACY; SWARMS
AB Combinations of female wingbeat acoustic cues and visual cues were evaluated to determine their potential for use in male Aedes aegypti (L.) traps in peridomestic environments. A modified Centers for Disease control (CDC) light trap using a 350-500Hz frequency-sweep broadcast from a speaker as an acoustic stimulus, combined with a black poster-board half-cylinder behind the trap as a visual stimulus, captured a significantly greater proportion of males in a laboratory arena during daylight than a CDC trap with the visual stimulus alone or a CDC trap alone without stimuli. Traps of each treatment type captured relatively more males when they were placed at darker positions in the arena. Potential applications are discussed for the incorporation of these findings into trapping programs to reduce transmission of human pathogens vectored by Ae. aegypti.
C1 [Jakhete, S. S.; Allan, S. A.; Mankin, R. W.] ARS, USDA, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA.
RP Mankin, RW (corresponding author), ARS, USDA, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA.
EM jakheteshantanu@gmail.com; sandy.allan@ars.usda.gov;
   Richard.Mankin@ars.usda.gov
RI Mankin, R. W./AAC-6588-2019
OI Mankin, R. W./0000-0003-3369-8110
CR ALLAN SA, 1987, ANNU REV ENTOMOL, V32, P297, DOI 10.1146/annurev.en.32.010187.001501
   Alphey L, 2013, PATHOG GLOB HEALTH, V107, P170, DOI 10.1179/2047773213Y.0000000095
   Arthur BJ, 2014, J ACOUST SOC AM, V135, P933, DOI 10.1121/1.4861233
   Balestrino F, 2016, ACTA TROP, V164, P448, DOI 10.1016/j.actatropica.2016.09.002
   BELTON P, 1994, J AM MOSQUITO CONTR, V10, P297
   BIDLINGMAYER WL, 1994, J AM MOSQUITO CONTR, V10, P272
   Cabrera M, 2007, J AM MOSQUITO CONTR, V23, P1, DOI 10.2987/8756-971X(2007)23[1:AAPMLB]2.0.CO;2
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Cator LJ, 2011, J MED ENTOMOL, V48, P941, DOI 10.1603/ME11019
   Charif R. A., 2008, RAVEN PRO 1 3 USERS
   Christophers S., 1960, AEDES AEGYPTI L YELL
   DUHRKOPF RE, 1992, J MED ENTOMOL, V29, P796, DOI 10.1093/jmedent/29.5.796
   FAY RW, 1970, MOSQ NEWS, V30, P20
   FAY RW, 1968, MOSQ NEWS, V28, P1
   Garza-Hernandez JA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004144
   Gerberg E., 1994, MANUAL MOSQUITO REAR
   Gibson G, 2006, CURR BIOL, V16, P1311, DOI 10.1016/j.cub.2006.05.053
   Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Ikeshoji T., 1990, Japanese Journal of Sanitary Zoology, V41, P213
   Ikeshoji T., 1985, Japanese Journal of Sanitary Zoology, V36, P197
   Ikeshoji T., 1988, Japanese Journal of Sanitary Zoology, V39, P119
   Johnson BJ, 2016, J MED ENTOMOL, V53, P245, DOI 10.1093/jme/tjv165
   KAHN MC, 1949, AM J TROP MED, V29, P811
   KERDPIBULE V, 1989, Southeast Asian Journal of Tropical Medicine and Public Health, V20, P639
   KLOTER KO, 1983, MOSQ NEWS, V43, P297
   Mains JW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003406
   Mankin RW, 2013, FLA ENTOMOL, V96, P1546, DOI 10.1653/024.096.0437
   Mankin R. W., 2012, CAB Reviews, V7, P1, DOI 10.1079/PAVSNNR20127001
   Mankin RW, 2004, J ECON ENTOMOL, V97, P1299, DOI 10.1603/0022-0493-97.4.1299
   MANKIN RW, 1994, J AM MOSQUITO CONTR, V10, P302
   Mankin RW, 2016, P M AC, V25
   OFFENHAUSER WH, 1949, J ACOUST SOC AM, V21, P259, DOI 10.1121/1.1906505
   Paz-Soldan VA, 2011, AM J TROP MED HYG, V84, P208, DOI 10.4269/ajtmh.2011.09-0615
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Powell JR, 2016, SCIENCE, V354, P971, DOI 10.1126/science.aal1717
   Raman DR, 2007, T ASABE, V50, P1481, DOI 10.13031/2013.23606
   Rodhain F., 2001, DENGUE DENGUE HEMORR, P45
   SAS Institute Inc, 2012, SAS STAT 9 1 US GUID
   Silver J. B, 2008, SAMPLING ADULTS VISU, P1027
   Stone CM, 2013, J MED ENTOMOL, V50, P723, DOI 10.1603/ME13023
   TAUTZ J, 1979, NATURWISSENSCHAFTEN, V66, P452, DOI 10.1007/BF00399002
   TOWNE WF, 1989, SCIENCE, V244, P686, DOI 10.1126/science.244.4905.686
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Williams CR, 2006, J AM MOSQUITO CONTR, V22, P296, DOI 10.2987/8756-971X(2006)22[296:FEOTBC]2.0.CO;2
   WISHART G., 1959, CANADIAN ENT, V91, P181
NR 46
TC 4
Z9 5
U1 0
U2 15
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD SEP
PY 2017
VL 54
IS 5
BP 1415
EP 1419
DI 10.1093/jme/tjx074
PG 5
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA FF6OS
UT WOS:000409133700044
PM 28399312
DA 2020-07-08
ER

PT J
AU Hahn, MB
   Eisen, L
   McAllister, J
   Savage, HM
   Mutebi, JP
   Eisen, RJ
AF Hahn, Micah B.
   Eisen, Lars
   McAllister, Janet
   Savage, Harry M.
   Mutebi, John-Paul
   Eisen, Rebecca J.
TI Updated Reported Distribution of Aedes (Stegomyia) aegypti and Aedes
   (Stegomyia) albopictus (Diptera: Culicidae) in the United States,
   1995-2016
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Aedes aegypti; Aedes albopictus; surveillance; United States; Zika virus
AB Aedes (Stegomyia) aegypti (L.) and Aedes (Stegomyia) albopictus (Skuse) are potential vectors of Zika, dengue, and chikungunya viruses in the United States. A Zika virus outbreak in Florida in the summer of 2016, driven by Ae. aegypti and resulting in >200 locally acquired cases of human illness, underscored the need for up-to-date information on the geographic distribution of Ae. aegypti and Ae. albopictus in the United States. In early 2016, we conducted a survey and literature review to compile county records for presence of Ae. aegypti and Ae. albopictus in the United States from 1995 to 2016. Surveillance for these vectors was intensified across the United States during the summer and fall of 2016. At the end of 2016, we therefore conducted a follow-up survey of mosquito control agencies, university researchers, and state and local health departments to document new collection records for Ae. aegypti and Ae. albopictus. The repeated survey at the end of the year added Ae. aegypti collection records from 38 new counties and Ae. albopictus collection records from 127 new counties, representing a 21 and 10 percent increase, respectively, in the number of counties with reported presence of these mosquitoes compared with the previous report. Moreover, through our updated survey, 40 and 183 counties, respectively, added additional years of collection records for Ae. aegypti and Ae. albopictus from 1995 to 2016. Our findings underscore the continued need for systematic surveillance of Ae. aegypti and Ae. albopictus.
C1 [Hahn, Micah B.; Eisen, Lars; McAllister, Janet; Savage, Harry M.; Mutebi, John-Paul; Eisen, Rebecca J.] Ctr Dis Control & Prevent, Div Vector Borne Dis, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
RP Eisen, RJ (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
EM xht1@cdc.gov; evp4@cdc.gov; jvm6@cdc.gov; hms1@cdc.gov; grv0@cdc.gov;
   dyn2@cdc.gov
CR Alto BW, 2001, J MED ENTOMOL, V38, P646, DOI 10.1603/0022-2585-38.5.646
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Eisen L, 2013, J MED ENTOMOL, V50, P467, DOI 10.1603/ME12245
   Florida State Health Department, 2016, FLOR ARB SURV WEEK
   Hahn MB, 2016, J MED ENTOMOL, V53, P1169, DOI 10.1093/jme/tjw072
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Otero M, 2006, B MATH BIOL, V68, P1945, DOI 10.1007/s11538-006-9067-y
NR 7
TC 25
Z9 25
U1 0
U2 24
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD SEP
PY 2017
VL 54
IS 5
BP 1420
EP 1424
DI 10.1093/jme/tjx088
PG 5
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA FF6OS
UT WOS:000409133700045
PM 28874014
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Wong, G
   Gao, GF
AF Wong, Gary
   Gao, George F.
TI An mRNA-based vaccine strategy against Zika
SO CELL RESEARCH
LA English
DT Editorial Material
ID DENGUE VIRUS; INFECTION
AB Infections with Zika virus are strongly associated with complications such as congenital microcephaly and can trigger Guillain-Barre syndrome in humans, highlighting the urgent need for a safe, efficacious vaccine as a preventative countermeasure. In a recent paper published in Cell, Richner et al. generated a lipid nanoparticle encapsulated modified mRNA vaccine encoding the prM and E genes from Zika virus, which showed protection and sterilizing immunity in immunocompetent mice.
C1 [Wong, Gary; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.
   [Wong, Gary; Gao, George F.] Shenzhen Third Peoples Hosp, State Key Discipline Infect Dis, Shenzhen Key Lab Pathogen & Immun, Shenzhen, Guangdong, Peoples R China.
RP Wong, G (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.; Wong, G (corresponding author), Shenzhen Third Peoples Hosp, State Key Discipline Infect Dis, Shenzhen Key Lab Pathogen & Immun, Shenzhen, Guangdong, Peoples R China.
EM garyckwong@hotmail.com
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Zhang YJ, 2016, PROTEIN CELL, V7, P461, DOI 10.1007/s13238-016-0274-5
NR 11
TC 2
Z9 2
U1 0
U2 15
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1001-0602
EI 1748-7838
J9 CELL RES
JI Cell Res.
PD SEP
PY 2017
VL 27
IS 9
BP 1077
EP 1078
DI 10.1038/cr.2017.53
PG 2
WC Cell Biology
SC Cell Biology
GA FF4KX
UT WOS:000408916300002
PM 28397799
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Blom, K
   Sandberg, JT
   Lore, K
   Ljunggren, HG
AF Blom, K.
   Sandberg, J. T.
   Lore, K.
   Ljunggren, H. -G.
TI Prospects for induction of CD8 T cell-mediated immunity to Zika virus
   infection by yellow fever virus vaccination
SO JOURNAL OF INTERNAL MEDICINE
LA English
DT Editorial Material
DE Zika virus vaccination; CD8 T cells; Yellow fever vaccine; Adaptive
   immune responses
C1 [Blom, K.; Sandberg, J. T.; Ljunggren, H. -G.] Karolinska Inst, Dept Med Huddinge, Ctr Infect Med, Stockholm, Sweden.
   [Lore, K.] Karolinska Univ Hosp, Karolinska Inst, Dept Med Solna, Immunol & Allergy Unit, Stockholm, Sweden.
   [Ljunggren, H. -G.] Nova Southeastern Univ, Cell Therapy Inst, Ft Lauderdale, FL 33314 USA.
RP Blom, K (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Med H7, Ctr Infect Med, S-14186 Stockholm, Sweden.
EM kim.blom@ki.se
OI Sandberg, John Tyler/0000-0001-6747-6933
FU Swedish Research CouncilSwedish Research Council; Swedish Foundation for
   Strategic ResearchSwedish Foundation for Strategic Research; Karolinska
   InstitutetKarolinska Institutet; Karolinska University
   HospitalKarolinska Institutet
FX These results, and their possible implications, were generated as part
   of a larger study examining human immune responses to flavivirus
   vaccines.The study was funded by the Swedish Research Council, the
   Swedish Foundation for Strategic Research, Karolinska Institutet, and
   the Karolinska University Hospital.
CR Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Blom K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004622
   Gostin LO, 2016, LANCET INFECT DIS, V16, P1099, DOI 10.1016/S1473-3099(16)30332-2
   Larsen MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-424
   Mansfield KL, 2011, J GEN VIROL, V92, P2821, DOI 10.1099/vir.0.031641-0
   Plotkin SA, 2012, VACCINES E BOOK, V6
   Turtle L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005263
   Vannice KS, 2016, VACCINE
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   WHO, YELL FEV VACC BOOST
NR 10
TC 4
Z9 4
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0954-6820
EI 1365-2796
J9 J INTERN MED
JI J. Intern. Med.
PD SEP
PY 2017
VL 282
IS 3
BP 206
EP 208
DI 10.1111/joim.12638
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA FD9IZ
UT WOS:000407837300001
PM 28574621
OA Bronze
DA 2020-07-08
ER

PT J
AU Eyal, N
   Lipsitch, M
AF Eyal, Nir
   Lipsitch, Marc
TI Vaccine testing for emerging infections: the case for individual
   randomisation
SO JOURNAL OF MEDICAL ETHICS
LA English
DT Article
ID SIERRA-LEONE; TRIAL DESIGN; EBOLA; ETHICS; EQUIPOISE; TIME; RISK
AB During the 2014-2015 Ebola outbreak in Guinea, Liberia and Sierra Leone, many opposed the use of individually randomised controlled trials to test candidate Ebola vaccines. For a raging fatal disease, they explained, it is unethical to relegate some study participants to control arms. In Zika and future emerging infections, similar opposition may hinder urgent vaccine research, so it is best to address these questions now. This article lays out the ethical case for individually randomised control in testing vaccines against many emerging infections, including lethal infections in low-income countries, even when at no point in the trial do the controls receive the countermeasures being tested. When individual randomisation is feasible-and it often will be-it tends to save more lives than alternative designs would. And for emerging infections, individual randomisation also tends as such to improve care, access to the experimental vaccine and prospects for all participants relative to their opportunities absent the trial, and no less than alternative designs would. That obtains even under placebo control and without equipoise-requiring which would undermine individual randomisation and the alternative designs that opponents proffered. Our arguments expound four often-neglected factors: benefits to non-participants, benefits to participants once a trial is over including post-trial access to the study intervention, participants' prospects before randomisation to arms and the near-inevitable disparity between arms in any randomised controlled trial.
C1 [Eyal, Nir] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, FXB Bldg,7th Floor,651 Huntington Ave, Boston, MA 02115 USA.
   [Lipsitch, Marc] Harvard TH Chan Sch Publ Hlth, Ctr Communicable Dis Dynam, Dept Immunol & Infect Dis, Dept Epidemiol, Boston, MA USA.
RP Eyal, N (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, FXB Bldg,7th Floor,651 Huntington Ave, Boston, MA 02115 USA.
EM neyal@hsph.harvard.edu
FU National Institute of General Medical SciencesUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [U54GM088558]
FX ML was supported by Award Number U54GM088558 from the National Institute
   of General Medical Sciences. The content is solely the responsibility of
   the authors and does not necessarily represent the official views of the
   National Institute of General Medical Sciences or the National
   Institutes of Health.
CR Adebamowo C, 2014, LANCET, V384, P1423, DOI 10.1016/S0140-6736(14)61734-7
   Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100
   Bellan SE, 2015, LANCET INFECT DIS, V15, P703, DOI 10.1016/S1473-3099(15)70139-8
   Boseley S., 2014, GUARDIAN
   Branswell H., 2015, HALTED STUDY CANADIA
   Caplan AL, 2015, AM J BIOETHICS, V15, P4, DOI 10.1080/15265161.2015.1010993
   Cohen IG, 2015, IDENTIFIED VS STAT P
   Cohen J, 2014, SCI MAG
   Coleman CH, 2014, ETHICS USING PLACEBO
   Cox E, 2014, NEW ENGL J MED, V371, P2350, DOI 10.1056/NEJMp1414145
   Doussau A, 2016, J MED ETHICS, V42, P797, DOI 10.1136/medethics-2015-103292
   Draguez B, EBOLA EXPT TREATMENT
   Duerr A, 2012, J INFECT DIS, V206, P258, DOI 10.1093/infdis/jis342
   Ewer K, 2016, NEW ENGL J MED, V374, P1635, DOI 10.1056/NEJMoa1411627
   Fleck F, 2015, B WORLD HEALTH ORGAN, V93, P7, DOI 10.2471/BLT.15.020115
   Folayan MO, 2016, BMC MED ETHICS, V17, DOI 10.1186/s12910-016-0094-4
   FREEDMAN B, 1987, NEW ENGL J MED, V317, P141, DOI 10.1056/NEJM198707163170304
   FRIED C, 1974, MED EXPT PERSONAL IN
   GSK staff, OUR CONTRIBUTION TO
   Halloran ME, 2010, DESIGN ANAL VACCINE
   Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5
   Henao-Restrepo AM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3740
   Kass N, 2014, NY TIMES
   Ledgerwood JE, 2017, NEW ENGL J MED, V376, P928, DOI [10.1056/NEJMoa1410863, 10.1056/nejmoa1410863]
   Lemmens Trudo, 2002, American Journal of Bioethics, V2, P14, DOI 10.1162/152651602317533550
   Lilford RJ, 1995, J ROY SOC MED, V88, P552
   Lipsitch M, 2015, SCIENCE, V348, P46, DOI 10.1126/science.aaa3178
   Macklin R., 2014, HUFFINGTON POST
   Meltzer MI, 2014, ESTIMATING FUTURE NU, P1
   Miller FG, 2012, ETHICAL CHALLENGES H
   Moses L, 2014, NY TIMES
   O'Connor Dan, 2014, GUARDIAN
   Pitzer VE, 2007, AM J EPIDEMIOL, V166, P355, DOI 10.1093/aje/kwm082
   Presidential commission for the study of bioethical issues, 2015, ETH EB PUBL HLTH PLA
   Qin EQ, 2015, CLIN INFECT DIS, V61, P491, DOI 10.1093/cid/civ319
   Rid A, 2016, AM J PUBLIC HEALTH, V106, P432, DOI 10.2105/AJPH.2015.302996
   Rid A, 2015, AM J BIOETHICS, V15, P47, DOI 10.1080/15265161.2015.1009573
   Ruble K., END EBOLA INSIDE RAC
   Selgelid M, 2014, ETHICS PERSPECTIVE P
   Sissoko D, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001967
   Takahashi S, 2015, SCIENCE, V347, P1240, DOI 10.1126/science.aaa3438
   Toure A, 2014, NY TIMES
   Wasunna M, 2014, NY TIMES
   WHO Ethics Working Group, 2014, 20 21 OCT M
NR 44
TC 4
Z9 4
U1 0
U2 5
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0306-6800
EI 1473-4257
J9 J MED ETHICS
JI J. Med. Ethics
PD SEP
PY 2017
VL 43
IS 9
BP 625
EP 631
DI 10.1136/medethics-2015-103220
PG 7
WC Ethics; Medical Ethics; Social Issues; Social Sciences, Biomedical
SC Social Sciences - Other Topics; Medical Ethics; Social Issues;
   Biomedical Social Sciences
GA FF0AU
UT WOS:000408565400011
PM 28396558
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Khan, TA
   Pasca, SP
AF Khan, Themasap A.
   Pasca, Sergiu P.
TI The Zika threat to the periphery
SO NATURE NEUROSCIENCE
LA English
DT Editorial Material
ID NEURAL PROGENITORS; STEM-CELLS; VIRUS; NEUROGENESIS; BRAIN
AB Zika virus infection is associated with birth defects, including microcephaly, but also with disorders of peripheral nerves. Oh et al. use rodent and human cell models to explore how the virus affects the peripheral nervous system.
C1 [Khan, Themasap A.; Pasca, Sergiu P.] Stanford Univ, Dept Psychiat & Behav Sci, Sch Med, Stanford, CA 94305 USA.
   [Khan, Themasap A.] Stanford Univ, Sch Med, Grad Program Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.
RP Pasca, SP (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Sch Med, Stanford, CA 94305 USA.
EM spasca@stanford.edu
OI Pasca, Sergiu/0000-0002-3216-3248
CR Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   General D, 2005, WHO STAT 1 M INT HLT
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
NR 15
TC 0
Z9 0
U1 0
U2 6
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1097-6256
EI 1546-1726
J9 NAT NEUROSCI
JI Nat. Neurosci.
PD SEP
PY 2017
VL 20
IS 9
BP 1191
EP 1192
DI 10.1038/nn.4633
PG 2
WC Neurosciences
SC Neurosciences & Neurology
GA FF0JJ
UT WOS:000408587700001
PM 28849792
DA 2020-07-08
ER

PT J
AU Hammond, S
   Borland, K
   Weigand, MM
AF Hammond, Stephanie
   Borland, Kelli
   Weigand, Michelle M.
TI Zika Virus: Protecting Workers
SO WORKPLACE HEALTH & SAFETY
LA English
DT Meeting Abstract
EM shammond@uab.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 2165-0799
EI 2165-0969
J9 WORKPLACE HEALTH SAF
JI Workplace Health Saf.
PD SEP
PY 2017
VL 65
IS 9
BP 399
EP 399
PG 1
WC Nursing
SC Nursing
GA FF1BT
UT WOS:000408635500012
DA 2020-07-08
ER

PT J
AU Iannetta, M
   Ippolito, G
   Nicastri, E
AF Iannetta, Marco
   Ippolito, Giuseppe
   Nicastri, Emanuele
TI Azithromycin Shows Anti-Zika Virus Activity in Human Glial Cells
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Letter
DE Zika virus; antiviral agents; azithromycin; central nervous system
   infections; pregnancy
C1 [Iannetta, Marco; Ippolito, Giuseppe; Nicastri, Emanuele] IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Rome, Italy.
RP Iannetta, M (corresponding author), IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Rome, Italy.
EM marco.iannetta@inmi.it
RI Iannetta, Marco/M-4619-2019; Iannetta, Marco/B-5596-2017; nicastri,
   emanuele/K-7780-2016
OI Iannetta, Marco/0000-0002-6938-8627; Iannetta,
   Marco/0000-0002-6938-8627; nicastri, emanuele/0000-0002-5606-8712
CR Jaruratanasirikul S, 1996, ANTIMICROB AGENTS CH, V40, P825, DOI 10.1128/AAC.40.3.825
   Lin KJ, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.12.023
   Ramsey PS, 2003, AM J OBSTET GYNECOL, V188, P714, DOI 10.1067/mob.2003.141
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00411-17, 10.1128/aac.00411-17]
NR 5
TC 7
Z9 7
U1 0
U2 6
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD SEP
PY 2017
VL 61
IS 9
AR e01152-17
DI 10.1128/AAC.01152-17
PG 2
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA FE6GW
UT WOS:000408309000077
PM 28839081
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Saiz, JC
   Martin-Acebes, MA
AF Saiz, Juan-Carlos
   Martin-Acebes, Miguel A.
TI Reply to Iannetta et al., "Azithromycin Shows Anti-Zika Virus Activity
   in Human Glial Cells"
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Letter
C1 [Saiz, Juan-Carlos; Martin-Acebes, Miguel A.] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotechnol, Madrid, Spain.
RP Saiz, JC (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotechnol, Madrid, Spain.
EM jcsaiz@inia.es
RI Martin-Acebes, Miguel A./L-2258-2014
OI Martin-Acebes, Miguel A./0000-0001-6015-3613; Saiz,
   Juan-Carlos/0000-0001-8269-5544
CR Iannetta M, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01152-17
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00411-17, 10.1128/aac.00411-17]
NR 3
TC 1
Z9 1
U1 0
U2 5
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD SEP
PY 2017
VL 61
IS 9
AR e01192-17
DI 10.1128/AAC.01192-17
PG 1
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA FE6GW
UT WOS:000408309000080
PM 28839084
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Flor-Weiler, LB
   Rooney, AP
   Behle, RW
   Muturi, EJ
AF Flor-Weiler, Lina B.
   Rooney, Alejandro P.
   Behle, Robert W.
   Muturi, Ephantus J.
TI CHARACTERIZATION OF TOLYPOCLADIUM CYLINDROSPORUM (HYPOCREALES:
   OPHIOCORDYCIPITACEAE) AND ITS IMPACT AGAINST AEDES AEGYPTI AND AEDES
   ALBOPICTUS EGGS AT LOW TEMPERATURE
SO JOURNAL OF THE AMERICAN MOSQUITO CONTROL ASSOCIATION
LA English
DT Article
DE Aedes aegypti; Aedes albopictus; microbial control; ovicide;
   Tolypocladium cylindrosporum
ID METARHIZIUM-ANISOPLIAE; ENTOMOPATHOGENIC FUNGUS; DIPTERA-CULICIDAE;
   COELOMOMYCES-STEGOMYIAE; DENGUE VECTORS; MOSQUITO EGGS; ZIKA VIRUS;
   INFECTION; INSECT; LARVAE
AB We examined the growth characteristics of Tolypocladium cylindrosporum IBT 41712 and its potential to infect eggs of Aedes aegypti and Ae. albopictus at a low temperature (15 degrees C). When grown on Sabouraud dextrose agar supplemented with yeast extract, the IBT 41712 formed white colonies turning to a slightly darker, off-white color when mature. The mycelia bore swollen conidiophores producing smooth-walled, oblong to cylindrical conidia with varying sizes, ranging from 1.5 to 3.5 mu m long. To determine the optimum temperature for the fungus, we cultured the fungus at eight temperatures (4 degrees C, 12 degrees C, 15 degrees C, 21 degrees C, 28 degrees C, 33 degrees C, 37 degrees C, and 40 degrees C) and measured the diametric growth. The optimum temperature for growth was 28 degrees C since it had the highest diametric growth rate (2.1 +/- 0.05 mm/day) and the fastest sporulation period (within 8-10 days of incubation). There was no fungal growth at the 3 highest temperatures (33 degrees C, 37 degrees C, and 40 degrees C) but plates incubated at 33 degrees C, when shifted to optimal temperature (28 degrees C), showed visible growth indicating that following incubation at 33 degrees C, the fungus remained viable. The IBT 41712 successfully infected mosquito eggs at 15 degrees C. Fungal treatment induced egg hatch on moist seed-germination paper and this effect was more pronounced in Ae. aegypti compared to Ae. albopictus. When treated eggs were immersed in dH(2)O 21 days posttreatment, larval hatch of both Ae. aegypti (control = 91%, 1 x 10(7) conidia/ml, fungal treatment - 0%) and Ae. albopictus (control - 85%, fungal treatment - 28%) was significantly lower in fungal treatment compared to the controls. The ability of the strain to grow in a wide temperature range, and effectively infect mosquito eggs and induce egg hatch at a low temperature warrants further investigation for its potential as a mosquito control agent targeting eggs that overwinter or undergo long diapause.
C1 [Flor-Weiler, Lina B.; Rooney, Alejandro P.; Behle, Robert W.; Muturi, Ephantus J.] USDA ARS, Crop Bioprotect Res Unit, Natl Ctr Agr Utilizat Res, Peoria, IL 61604 USA.
RP Flor-Weiler, LB (corresponding author), USDA ARS, Crop Bioprotect Res Unit, Natl Ctr Agr Utilizat Res, Peoria, IL 61604 USA.
RI Rooney, Alejandro P/S-1201-2018
OI Rooney, Alejandro P/0000-0001-5450-4122
CR ALLEN GR, 1986, J AM MOSQUITO CONTR, V2, P368
   Blanford S, 2005, SCIENCE, V308, P1638, DOI 10.1126/science.1108423
   Butt TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081686
   Carolino AT, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-198
   CDC, 2016, ZIK VIR AR ZIK
   CDC [Centers for Disease Control and Prevention], 2014, 2014 FIN DAT US
   Charrel RN, 2007, NEW ENGL J MED, V356, P769, DOI 10.1056/NEJMp078013
   de Lamballerie X, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-33
   de Paula AR, 2008, BIOCONTROL SCI TECHN, V18, P1017, DOI 10.1080/09583150802509199
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fargues J, 1997, MYCOLOGIA, V89, P383, DOI 10.2307/3761032
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Floore TG, 2006, J AM MOSQUITO CONTR, V22, P527, DOI 10.2987/8756-971X(2006)22[527:MLCPPA]2.0.CO;2
   GARDNER JM, 1987, MYCOPATHOLOGIA, V97, P77, DOI 10.1007/BF00436841
   Gillespie JP, 1998, J INVERTEBR PATHOL, V71, P128, DOI 10.1006/jipa.1997.4733
   Gjullin CM, 1941, J CELL COMPAR PHYSL, V17, P193, DOI 10.1002/jcp.1030170205
   Gjullin CM, 1939, SCIENCE, V89, P539, DOI 10.1126/science.89.2319.539-a
   GOETTEL MS, 1987, J AM MOSQUITO CONTR, V3, P239
   GOETTEL MS, 1988, J INVERTEBR PATHOL, V51, P259, DOI 10.1016/0022-2011(88)90033-X
   GOETTEL MS, 1987, J AM MOSQUITO CONTR, V3, P561
   Hahn MB, 2016, J MED ENTOMOL, V53, P1169, DOI 10.1093/jme/tjw072
   HAJEK AE, 1994, ANNU REV ENTOMOL, V39, P293, DOI 10.1146/annurev.en.39.010194.001453
   JUDSON CHARLES L., 1960, ANN ENT SOC AMER, V53, P688, DOI 10.1093/aesa/53.5.688
   Kikankie CK, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-71
   Klingen I, 2002, J APPL ENTOMOL, V126, P231, DOI 10.1046/j.1439-0418.2002.00636.x
   Klingen I, 2002, AGR ECOSYST ENVIRON, V91, P191, DOI 10.1016/S0167-8809(01)00227-4
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kuno G, 2010, J MED ENTOMOL, V47, P957, DOI 10.1603/ME10152
   LACEY L, 1990, J AM MOSQUITO CONTR, V6, P3
   Lacey LA, 2001, BIOL CONTROL, V21, P230, DOI 10.1006/bcon.2001.0938
   Leles RN, 2012, PARASITOL RES, V110, P1579, DOI 10.1007/s00436-011-2666-z
   Leles RN, 2010, PARASITOL RES, V107, P1271, DOI 10.1007/s00436-010-1991-y
   Lobo LS, 2016, BIOCONTROL SCI TECHN, V26, P386, DOI 10.1080/09583157.2015.1123220
   Lucarotti CJ, 2000, J INVERTEBR PATHOL, V75, P292, DOI 10.1006/jipa.2000.4937
   Luz C, 2007, J MED ENTOMOL, V44, P799, DOI 10.1603/0022-2585(2007)44[799:OAOEHO]2.0.CO;2
   Luz C, 2010, ACTA TROP, V116, P105, DOI 10.1016/j.actatropica.2010.05.001
   Marcombe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101992
   MARTEN GG, 1994, HYDROBIOLOGIA, V293, P491
   McAllister JC, 2012, J VECTOR ECOL, V37, P325, DOI 10.1111/j.1948-7134.2012.00234.x
   Montalva C, 2016, J INVERTEBR PATHOL, V136, P109, DOI 10.1016/j.jip.2016.03.012
   NADEAU MP, 1994, J AM MOSQUITO CONTR, V10, P487
   Nam VS, 1998, AM J TROP MED HYG, V59, P657, DOI 10.4269/ajtmh.1998.59.657
   Okumu FO, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-12
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005
   Pereira CR, 2009, BIOCONTROL SCI TECHN, V19, P881, DOI 10.1080/09583150903147659
   Pluskota B, 2016, PARASITOL RES, V115, P3245, DOI 10.1007/s00436-016-5078-2
   Ponnusamy L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024409
   RAVALLEC M, 1989, J INVERTEBR PATHOL, V53, P7, DOI 10.1016/0022-2011(89)90067-0
   Riba G, 1986, J AM MOSQUITO CONTR, V2, P459
   Rocha LFN, 2015, J APPL MICROBIOL, V119, P1412, DOI 10.1111/jam.12945
   Santos MP, 2011, J INVERTEBR PATHOL, V108, P209, DOI 10.1016/j.jip.2011.09.001
   Scholte EJ, 2005, SCIENCE, V308, P1641, DOI 10.1126/science.1108639
   Scholte EJ, 2007, ACTA TROP, V102, P151, DOI 10.1016/j.actatropica.2007.04.011
   Scorsetti AC, 2012, REV BIOL TROP, V60, P833
   Shoulkamy MA, 2001, MYCOPATHOLOGIA, V149, P99, DOI 10.1023/A:1007299217926
   SOARES GG, 1984, J INVERTEBR PATHOL, V43, P242, DOI 10.1016/0022-2011(84)90143-5
   SOARES GG, 1982, ENTOMOPHAGA, V27, P283, DOI 10.1007/BF02374812
   Sousa NA, 2013, LETT APPL MICROBIOL, V57, P193, DOI 10.1111/lam.12097
   SWEENEY AW, 1983, J INVERTEBR PATHOL, V42, P162, DOI 10.1016/0022-2011(83)90058-7
   Thomas MB, 2007, NAT REV MICROBIOL, V5, P377, DOI 10.1038/nrmicro1638
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
NR 62
TC 3
Z9 3
U1 0
U2 10
PU AMER MOSQUITO CONTROL ASSOC
PI MOUNT LAUREL
PA 15000 COMMERCE PARKWAY, SUITE C, MOUNT LAUREL, NJ 08054 USA
SN 8756-971X
EI 1943-6270
J9 J AM MOSQUITO CONTR
JI J. Am. Mosq. Control Assoc.
PD SEP
PY 2017
VL 33
IS 3
BP 184
EP 192
DI 10.2987/16-6596R.1
PG 9
WC Entomology
SC Entomology
GA FF1CD
UT WOS:000408636500002
PM 28854112
DA 2020-07-08
ER

PT J
AU Buckner, EA
   Williams, KF
   Marsicano, AL
   Latham, MD
   Lesser, CR
AF Buckner, Eva A.
   Williams, Katie F.
   Marsicano, Ambyr L.
   Latham, Mark D.
   Lesser, Christopher R.
TI EVALUATING THE VECTOR CONTROL POTENTIAL OF THE IN2CARE (R) MOSQUITO TRAP
   AGAINST AEDES AEGYPTI AND AEDES ALBOPICTUS UNDER SEMIFIELD CONDITIONS IN
   MANATEE COUNTY, FLORIDA
SO JOURNAL OF THE AMERICAN MOSQUITO CONTROL ASSOCIATION
LA English
DT Article
DE Aedes aegypti; Aedes albopictus; autodissemination; Beauveria bassiana;
   dengue virus; pyriproxyfen; Zika virus
ID BEAUVERIA-BASSIANA; LARVAL HABITATS; DENGUE; INSECTICIDES; PYRIPROXYFEN;
   GROWTH
AB Successful integrated vector management programs may need new strategies in addition to conventional larviciding and adulticiding strategies to target Aedes aegypti and Ae. albopictus, which can develop in small, often cryptic, artificial and natural containers. The In2Care (R) mosquito trap was recently developed to target and kill larval and adult stages of these invasive container-inhabiting Aedes mosquitoes by utilizing autodissemination. Gravid females that visit the trap pick up pyriproxyfen (PPF) that they later transfer to nearby larval habitats as well as Beauveria bassiana spores that slowly kill them. We assessed the efficacy of the In2Care (R) mosquito trap in a semifield setting against locally sourced strains of Ae. aegypti and Ae. albopictus. We found that the In2Care (R) mosquito trap is attractive to gravid Ae. aegypti and Ae. albopictus females and serves as an egg sink, preventing any adult emergence from the trap (P = 0.0053 for both species). Adult females successfully autodisseminated PPF to surrounding water-filled containers, leading to a statistically significant reduction in new mosquito emergence (P <= 0.0002 for both species). Additionally, we found effective contamination with Beauveria bassiana spores, which significantly reduced the survivorship of exposed Ae. aegypti and Ae. albopictus (P <= 0.008 for both species in all experimental setups). In summary, the In2Care (R) mosquito trap successfully killed multiple life stages of 2 main mosquito vector species found in Florida under semifield conditions.
C1 [Buckner, Eva A.; Williams, Katie F.; Marsicano, Ambyr L.; Latham, Mark D.; Lesser, Christopher R.] Manatee Cty Mosquito Control Dist, 2317 2nd Ave W, Palmetto, FL 34221 USA.
RP Buckner, EA (corresponding author), Manatee Cty Mosquito Control Dist, 2317 2nd Ave W, Palmetto, FL 34221 USA.
CR Abad-Franch F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003702
   Blanford S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023591
   Caputo B, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001793
   CDC, 2016, AR WITH ZIK
   Darbro JM, 2012, AM J TROP MED HYG, V86, P656, DOI 10.4269/ajtmh.2012.11-0455
   Darriet F, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-88
   Devine GJ, 2009, P NATL ACAD SCI USA, V106, P11530, DOI 10.1073/pnas.0901369106
   Dong YM, 2012, INSECT BIOCHEM MOLEC, V42, P126, DOI 10.1016/j.ibmb.2011.11.005
   Fargues J, 1997, MYCOLOGIA, V89, P383, DOI 10.2307/3761032
   ITOH T, 1994, J AM MOSQUITO CONTR, V10, P344
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   NWS [National Weather Service], 2016, CLIM REP
   Ohba S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067045
   PAHO, 2017, REG ZIK EP UPD
   Paul A, 2006, J MED ENTOMOL, V43, P55, DOI 10.1603/0022-2585(2006)043[0055:EONIFC]2.0.CO;2
   Snetselaar J, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-200
   Suman DS, 2014, ACTA TROP, V135, P96, DOI 10.1016/j.actatropica.2014.03.026
NR 18
TC 5
Z9 5
U1 5
U2 21
PU AMER MOSQUITO CONTROL ASSOC
PI MOUNT LAUREL
PA 15000 COMMERCE PARKWAY, SUITE C, MOUNT LAUREL, NJ 08054 USA
SN 8756-971X
EI 1943-6270
J9 J AM MOSQUITO CONTR
JI J. Am. Mosq. Control Assoc.
PD SEP
PY 2017
VL 33
IS 3
BP 193
EP 199
DI 10.2987/17-6642R.1
PG 7
WC Entomology
SC Entomology
GA FF1CD
UT WOS:000408636500003
PM 28854105
DA 2020-07-08
ER

PT J
AU Cohnstaedt, LW
   Alfonso-Parra, C
   Fernandez-Salas, I
AF Cohnstaedt, Lee W.
   Alfonso-Parra, Catalina
   Fernandez-Salas, Ildefonso
TI MOSQUITO VECTOR BIOLOGY AND CONTROL IN LATIN AMERICA-A 27TH SYMPOSIUM
SO JOURNAL OF THE AMERICAN MOSQUITO CONTROL ASSOCIATION
LA English
DT Article
DE Aedes; Anopheles; Culex; dengue; insecticide resistance; mosquito
   control; phlebotomine sand flies
ID ABSTRACTS
AB The 27th Annual Latin American Symposium presented by the American Mosquito Control Association (AMCA) was held as part of the 83rd Annual Meeting of the AMCA in San Diego, CA, in February 2017. The Latin American Symposia promote the participation of vector control specialists, public health workers, and academicians from Latin America and the sharing of data between continents. Generally, presentations are in Spanish and simultaneously translated in English, although the majority of PowerPoint slides are in English so all meeting attendees can understand the content. This publication includes summaries of 23 oral presentations by participants from Brazil, Colombia, Mexico, Puerto Rico, and the USA. Topics addressed in the symposium included surveillance, operations and response thresholds/ planning, mosquito ecology, insecticide resistance, and population control via chemicals, natural products, and biological control. Sterile insect technique protocols were explored regarding larval rearing diets and the use of microRNAs. Presentations were related to vectors including Aedes, Culex, and Anopheles mosquitoes, which can transmit malaria, dengue, chikungunya, and Zika, and Lutzomyia phlebotomine sand flies, the key vectors of leishmaniasis.
C1 [Cohnstaedt, Lee W.] USDA, Arthropod Borne Anim Dis Res Unit, Ctr Grain & Anim Hlth Res, 1515 Coll Ave, Manhattan, KS 66502 USA.
   [Alfonso-Parra, Catalina] Univ Antioquia, Max Planck Tandem Grp Mosquito Reprod Biol, Medellin, Colombia.
   [Fernandez-Salas, Ildefonso] Autonomous Univ Nuevo Leon, Fac Biol Sci, Monterrey, Nuevo Leon, Mexico.
RP Cohnstaedt, LW (corresponding author), USDA, Arthropod Borne Anim Dis Res Unit, Ctr Grain & Anim Hlth Res, 1515 Coll Ave, Manhattan, KS 66502 USA.
FU Clarke Mosquito Control; AMCA
FX Financial support for the 27th Annual Symposium was provided by the
   following sponsor: Clarke Mosquito Control. Funds from this sponsor
   provided support for the Annual Meeting for the Latin American Student
   Competition. The continuing support by the AMCA for this symposium is
   also acknowledged. Enthusiasm and interest for this symposium among
   Spanish- and non-Spanish-speaking participants continues to be high and
   it will continue to be a part of the future annual meetings.
CR Clark GG, 2007, J AM MOSQUITO CONTR, V23, P449, DOI 10.2987/5684.1
   Clark Gary G, 2004, J Am Mosq Control Assoc, V20, P376
   Clark GG, 2006, J AM MOSQUITO CONTR, V22, P732, DOI 10.2987/8756-971X(2006)22[732:MVCABI]2.0.CO;2
   Clark GG, 2014, J AM MOSQUITO CONTR, V30, P204, DOI 10.2987/14-6418.1
   Clark GG, 2013, J AM MOSQUITO CONTR, V29, P251, DOI 10.2987/13-6356.1
   Clark GG, 2012, J AM MOSQUITO CONTR, V28, P102, DOI 10.2987/12-6253.1
   Clark GG, 2011, J AM MOSQUITO CONTR, V27, P280, DOI 10.2987/11-6147.1
   Clark GG, 2010, J AM MOSQUITO CONTR, V26, P306, DOI 10.2987/10-6033.1
   Clark GG, 2009, J AM MOSQUITO CONTR, V25, P486, DOI 10.2987/09-5929.1
   Clark GG, 2008, J AM MOSQUITO CONTR, V24, P571, DOI 10.2987/08-5810.1
   Clark GG, 2005, J AM MOSQUITO CONTR, V21, P412, DOI 10.2987/8756-971X(2006)21[412:MVCABI]2.0.CO;2
   Clark GG, 2002, J AM MOSQUITO CONTR, V18, P138
   Clark GG, 2001, J AM MOSQUITO CONTR, V17, P166
   Clark GG, 1997, J AM MOSQUITO CONTR, V13, P113
   CLARK GG, 1993, J AM MOSQUITO CONTR, V9, P441
   CLARK GG, 1995, J AM MOSQUITO CONTR, V11, P343
   CLARK GG, 1991, J AM MOSQUITO CONTR, V7, P633
   Clark GG, 1999, J AM MOSQUITO CONTR, V15, P407
   Clark GG, 1998, J AM MOSQUITO CONTR, V14, P219
   Clark GG, 1996, J AM MOSQUITO CONTR, V12, P460
   CLARK GG, 1992, J AM MOSQUITO CONTR, V8, P305
   Clark GG, 2000, J AM MOSQUITO CONTR, V16, P295
   Cohnstaedt LW, 2016, J AM MOSQUITO CONTR, V32, P315, DOI 10.2987/16-6605.1
   Cohnstaedt LW, 2015, J AM MOSQUITO CONTR, V31, P286, DOI 10.2987/moco-31-03-286-296.1
   Williams GM, PLOS ONE, V9
NR 25
TC 1
Z9 1
U1 1
U2 14
PU AMER MOSQUITO CONTROL ASSOC
PI MOUNT LAUREL
PA 15000 COMMERCE PARKWAY, SUITE C, MOUNT LAUREL, NJ 08054 USA
SN 8756-971X
EI 1943-6270
J9 J AM MOSQUITO CONTR
JI J. Am. Mosq. Control Assoc.
PD SEP
PY 2017
VL 33
IS 3
BP 215
EP 224
DI 10.2987/17-6653.1
PG 10
WC Entomology
SC Entomology
GA FF1CD
UT WOS:000408636500006
PM 28854106
DA 2020-07-08
ER

PT J
AU Goddard, J
   Moraru, GM
   Mcinnis, SJ
   Portugal, JS
   Yee, DA
   Deerman, JH
   Varnado, WC
AF Goddard, Jerome
   Moraru, Gail M.
   Mcinnis, Sarah J.
   Portugal, J. Santos
   Yee, Donald A.
   Deerman, J. Hunter
   Varnado, Wendy C.
TI A STATEWIDE SURVEY FOR CONTAINER-BREEDING MOSQUITOES IN MISSISSIPPI
SO JOURNAL OF THE AMERICAN MOSQUITO CONTROL ASSOCIATION
LA English
DT Article
DE Aedes aegypti; Aedes albopictus; epidemiology; distribution; mosquito;
   vector
ID ZIKA VIRUS; COMMUNITIES; PARAMETERS; CULICIDAE; DIPTERA; RECORD; TIRES
AB Container-breeding mosquitoes are important in public health due to outbreaks of Zika, chikungunya, and dengue viruses. This paper documents the distribution of container-breeding mosquito species in Mississippi, with special emphasis on the genus Aedes. Five sites in each of the 82 Mississippi counties were sampled monthly between May 1 and August 31, 2016, and 50,109 mosquitoes in 14 species were collected. The most prevalent and widely distributed species found was Ae. albopictus, being found in all 82 counties, especially during July. A recent invasive, Ae. japonicus, seems to be spreading rapidly in Mississippi since first being discovered in the state in 2011. The most abundant Culex species collected were Cx. quinquefasciatus (found statewide), Cx. salinarius (almost exclusively in the southern portion of the state), and Cx. restuans (mostly central and southern Mississippi). Another relatively recent invasive species, Cx. coronator, was found in 20 counties, predominantly in the southern one-third of the state during late summer. Co-occurrence data of mosquito species found in the artificial containers were also documented and analyzed. Lastly, even though we sampled extensively in 410 sites across Mississippi, no larval Ae. aegypti were found. These data represent the first modern statewide survey of container species in Mississippi, and as such, allows for better public health readiness for emerging diseases and design of more effective vector control programs.
C1 [Goddard, Jerome; Moraru, Gail M.; Mcinnis, Sarah J.; Portugal, J. Santos] Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, 100 Twelve Lane, Mississippi State, MS 39762 USA.
   [Yee, Donald A.; Deerman, J. Hunter] Univ Southern Mississippi, Dept Biol Sci, 118 Coll Dr, Hattiesburg, MS 36409 USA.
   [Varnado, Wendy C.] Mississippi Dept Hlth, Bur Environm Hlth, POB 1700, Jackson, MS 39215 USA.
RP Goddard, J (corresponding author), Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, 100 Twelve Lane, Mississippi State, MS 39762 USA.
OI Goddard, Jerome/0000-0002-2617-7141
FU Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA
   [U50\CCU416826-03]
FX We thank J. Everly and R. Rogers with assistance with data and C. Dean,
   A. Miller, T. Price, J. Valentine, and D. Williams for assistance in the
   field and lab. This study was funded by a grant from the Centers for
   Disease Control and Prevention to the Mississippi State Department of
   Health, "Epidemiology and Laboratory Capacity for Infectious Diseases''
   grant number U50\CCU416826-03.
CR [Anonymous], 2016, LANCET, V387, P96, DOI 10.1016/S0140-6736(16)00014-3
   Darsie Jr R. F., 2005, IDENTIFICATION GEOGR
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Goddard J, 2010, J VECTOR ECOL, V35, P79, DOI 10.1111/j.1948-7134.2010.00032.x
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Harrison BA, 2016, MOSQUITO VECTOR BORN, P2016
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   TDH [Texas Department of Health], 2016, CAS LOC AC ZIK VIR T
   Thorn M, 2012, J AM MOSQUITO CONTR, V28, P43, DOI 10.2987/11-6204.1
   USAF [US Air Force], 1989, MOSQ ID CY 1989
   Varnado WC, 2005, P ENTOMOL SOC WASH, V107, P476
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yee DA, 2012, J MED ENTOMOL, V49, P482, DOI 10.1603/ME11227
   Yee DA, 2008, J MED ENTOMOL, V45, P581, DOI 10.1603/0022-2585(2008)45[581:TAHFMA]2.0.CO;2
   Yee DA, 2015, J MED ENTOMOL, V52, P394, DOI 10.1093/jme/tjv028
   Yee DA, 2010, J MED ENTOMOL, V47, P53, DOI 10.1603/033.047.0107
NR 16
TC 4
Z9 4
U1 4
U2 15
PU AMER MOSQUITO CONTROL ASSOC
PI MOUNT LAUREL
PA 15000 COMMERCE PARKWAY, SUITE C, MOUNT LAUREL, NJ 08054 USA
SN 8756-971X
EI 1943-6270
J9 J AM MOSQUITO CONTR
JI J. Am. Mosq. Control Assoc.
PD SEP
PY 2017
VL 33
IS 3
BP 229
EP 232
DI 10.2987/17-6652R.1
PG 4
WC Entomology
SC Entomology
GA FF1CD
UT WOS:000408636500008
PM 28854113
DA 2020-07-08
ER

PT J
AU Bengoa, M
   Eritja, R
   Delacour, S
   Miranda, MA
   Sureda, A
   Lucientes, J
AF Bengoa, Mikel
   Eritja, Roger
   Delacour, Sarah
   Angel Miranda, Miguel
   Sureda, Antonio
   Lucientes, Javier
TI FIRST DATA ON RESISTANCE TO PYRETHROIDS IN WILD POPULATIONS OF AEDES
   ALBOPICTUS FROM SPAIN
SO JOURNAL OF THE AMERICAN MOSQUITO CONTROL ASSOCIATION
LA English
DT Article
DE bioassay; biochemical assay; discriminating concentration; pyrethroids;
   resistance
ID INSECTICIDE RESISTANCE; DIPTERA-CULICIDAE; STEGOMYIA AEGYPTI;
   SUSCEPTIBILITY; THAILAND; VECTORS
AB The invasive mosquito, Aedes albopictus, found in Spain since 2004, is a competent vector of yellow fever, Zika, dengue, and chikungunya viruses among other diseases. Although controversial, the use of adulticiding is a relevant tool for vector control and could be crucial for the management of any possible outbreak of imported diseases. We present the 1st study in Spain on the susceptibility of field populations from Barcelona, Peniscola, Castellon, and Mallorca of Ae. albopictus to several pyrethroids using either bioassays under the World Health Organization methodology and biochemical tests. In the bioassays, the discriminating concentrations were calculated using a local, susceptible laboratory strain. Different susceptibility levels were found for some combinations of populations and products. The biochemical tests carried out by enzymatic analysis supported these results, showing an overexpression of glutathione S-transferase activity in 1 population.
C1 [Bengoa, Mikel; Delacour, Sarah; Lucientes, Javier] Univ Zaragoza, Fac Vet, Dept Parasitol, Miguel Servet 177, E-50013 Zaragoza, Spain.
   [Eritja, Roger] Consell Comarcal Baix Llobregat, Serv Control Mosquits, Parc Torreblanca, Sant Feliu de Llobregat 08980, Spain.
   [Angel Miranda, Miguel] Univ Balearic Isl, Zool Lab, Palma De Mallorca, Majorca, Spain.
   [Sureda, Antonio] Univ Balearic Isl, Area Biochem & Mol Biol, Palma De Mallorca, Majorca, Spain.
   [Bengoa, Mikel] Tiger Mosquito Consultancy, Palma De Mallorca, Majorca, Spain.
RP Bengoa, M (corresponding author), Univ Zaragoza, Fac Vet, Dept Parasitol, Miguel Servet 177, E-50013 Zaragoza, Spain.; Bengoa, M (corresponding author), Tiger Mosquito Consultancy, Palma De Mallorca, Majorca, Spain.
RI Sureda, Antoni/N-9588-2019; Gomila, Antonio Sureda/L-7191-2014; Miranda,
   Miguel/I-8718-2019; , Antoni/AAB-5250-2019
OI Sureda, Antoni/0000-0001-8656-6838; Gomila, Antonio
   Sureda/0000-0003-2101-616X; Miranda, Miguel/0000-0003-0770-2593; ,
   Antoni/0000-0001-8656-6838; Eritja, Roger/0000-0001-5749-8370
FU Instituto de Salud Carlos III, CIBEROBNInstituto de Salud Carlos III
   [CB12/03/30038]
FX We are grateful to David Borras, Pedro Alarcon-Elbal, Rodrigo Jerez, and
   Carlos Barcelo for their support with the maintenance of colonies and
   bioassays. Thanks to Xavier Capo for the technical ability to complete
   the GST assay in 5 min. We express our gratitude as well to William G.
   Brogdon for helping us with the detailed laboratory procedures for
   biochemical assays. A. Sureda was supported by Instituto de Salud Carlos
   III, CIBEROBN (CB12/03/30038).
CR Alarcon-Elbal P.M., 2010, Revista Ibero-Latinoamericana de Parasitologia, V69, P140
   Boubidi SC, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1881-y
   Brogdon WG., 2011, MR4 METHODS ANOPHELE, P200
   Chan HH, 2011, TROP BIOMED, V28, P464
   Chan HH, 2013, J MED ENTOMOL, V50, P362, DOI 10.1603/ME12182
   Collantes F, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1262-y
   Macoris MDD, 2014, REV SOC BRAS MED TRO, V47, P573, DOI 10.1590/0037-8682-0141-2014
   ECDC, 2016, AED ALB
   Jirakanjanakit N, 2007, J ECON ENTOMOL, V100, P545, DOI 10.1603/0022-0493(2007)100[545:IRSIAS]2.0.CO;2
   Lee RML, 2014, TROP BIOMED, V31, P670
   Manica M, 2017, PEST MANAG SCI, V73, P138, DOI 10.1002/ps.4315
   Nauen R, 2007, PEST MANAG SCI, V63, P628, DOI 10.1002/ps.1406
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Ranson H, 2005, METHOD ENZYMOL, V401, P226, DOI 10.1016/S0076-6879(05)01014-1
   Romi R, 2003, J AM MOSQUITO CONTR, V19, P419
   Soderlund DM, 1990, PESTICIDE RESISTANCE, P79
   Thanispong K, 2015, J AM MOSQUITO CONTR, V31, P346, DOI 10.2987/moco-31-04-346-352.1
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   WHO, 2013, TEST PROC INREMO
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   WORLD HEALTH ORGANIZATION, 2006, WHOCDSNTDWHOPESGCDPP
NR 21
TC 5
Z9 5
U1 1
U2 14
PU AMER MOSQUITO CONTROL ASSOC
PI MOUNT LAUREL
PA 15000 COMMERCE PARKWAY, SUITE C, MOUNT LAUREL, NJ 08054 USA
SN 8756-971X
EI 1943-6270
J9 J AM MOSQUITO CONTR
JI J. Am. Mosq. Control Assoc.
PD SEP
PY 2017
VL 33
IS 3
BP 246
EP 249
DI 10.2987/17-6636R.1
PG 4
WC Entomology
SC Entomology
GA FF1CD
UT WOS:000408636500012
PM 28854116
DA 2020-07-08
ER

PT J
AU Mirsky, D
AF Mirsky, D.
TI Infections as Causes of Human Microcephaly: Rubella to Zika.
SO ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
LA English
DT Meeting Abstract
CT 48th Annual Meeting of the
   Environmental-Mutagenesis-and-Genomics-Society (EMGS) on Environmental
   Health Sciences Bridging the Gap between Exposure, Mechanism and Public
   Health
CY SEP 09-13, 2017
CL Raleigh, NC
SP Environm Mutagenesis & Genom Soc, Genet & Environm Mutagenesis Soc N Carolina, Thermo Fisher Sci, Trevigen, Charles River, Elsevier, E I Dupont DE Nemours & Co, Environm & Mol Mutagenesis Editorial Off, Integrated Lab Syst Inc, Litron Labs, Gilead Sci
C1 [Mirsky, D.] Univ Colorado, Aurora, CO USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0893-6692
EI 1098-2280
J9 ENVIRON MOL MUTAGEN
JI Environ. Mol. Mutagen.
PD SEP
PY 2017
VL 58
SU 1
MA S58
BP S40
EP S40
PG 1
WC Environmental Sciences; Genetics & Heredity; Toxicology
SC Environmental Sciences & Ecology; Genetics & Heredity; Toxicology
GA FE6JB
UT WOS:000408314700066
DA 2020-07-08
ER

PT J
AU Mirzaa, G
AF Mirzaa, G.
TI Genetics and Neurobiology of Human Microcephaly: Beyond The Zika Virus.
SO ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
LA English
DT Meeting Abstract
CT 48th Annual Meeting of the
   Environmental-Mutagenesis-and-Genomics-Society (EMGS) on Environmental
   Health Sciences Bridging the Gap between Exposure, Mechanism and Public
   Health
CY SEP 09-13, 2017
CL Raleigh, NC
SP Environm Mutagenesis & Genom Soc, Genet & Environm Mutagenesis Soc N Carolina, Thermo Fisher Sci, Trevigen, Charles River, Elsevier, E I Dupont DE Nemours & Co, Environm & Mol Mutagenesis Editorial Off, Integrated Lab Syst Inc, Litron Labs, Gilead Sci
C1 [Mirzaa, G.] Seattle Childrens Res Inst, Seattle, WA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0893-6692
EI 1098-2280
J9 ENVIRON MOL MUTAGEN
JI Environ. Mol. Mutagen.
PD SEP
PY 2017
VL 58
SU 1
MA S56
BP S40
EP S40
PG 1
WC Environmental Sciences; Genetics & Heredity; Toxicology
SC Environmental Sciences & Ecology; Genetics & Heredity; Toxicology
GA FE6JB
UT WOS:000408314700064
DA 2020-07-08
ER

PT J
AU Castellanos, JE
AF Castellanos, J. E.
TI Could the Use of Saliva Improve the Zika Diagnosis Challenge?
   Contributions from a Proteomics Perspective
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Editorial Material
DE virology; salivary diagnostics; Zika virus; biological markers;
   microcephaly; virus surveillance
ID VIRUS
C1 [Castellanos, J. E.] Univ Nacl Colombia, Grp Invest Basicas & Aplicadas Odontol, Fac Odontol, Carrera 30 45-03,Edificio 210 Oficina 301, Bogota, Colombia.
   [Castellanos, J. E.] Univ El Bosque, Grp Virol, Bogota, Colombia.
RP Castellanos, JE (corresponding author), Univ Nacl Colombia, Grp Invest Basicas & Aplicadas Odontol, Fac Odontol, Carrera 30 45-03,Edificio 210 Oficina 301, Bogota, Colombia.
EM jecastellanosp@unal.edu.co
RI Castellanos, Jaime/W-2635-2019
OI Castellanos, Jaime/0000-0003-1596-8383
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Bonne NJ, 2012, GENOME MED, V4, DOI 10.1186/gm383
   Castellanos Jaime E., 2016, Biomédica, V36, P5
   Corstjens PLAM, 2012, J AM DENT ASSOC, V143, P12, DOI DOI 10.14219/JADA.ARCHIVE.2012.0338
   Hirtz C, 2016, BIOANALYSIS, V8, P43, DOI 10.4155/bio.15.228
   Ivy W, 2012, JAIDS-J ACQ IMM DEF, V59, P207, DOI 10.1097/QAI.0b013e31823b4554
   Kaczor-Urbanowicz KE, 2017, J CELL MOL MED, V21, P640, DOI 10.1111/jcmm.13007
   Malamud Daniel, 2011, Dent Clin North Am, V55, P159, DOI 10.1016/j.cden.2010.08.004
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Zuanazzi D, 2017, J DENT RES, V96, P1078, DOI 10.1177/0022034517723325
NR 13
TC 1
Z9 1
U1 0
U2 9
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
EI 1544-0591
J9 J DENT RES
JI J. Dent. Res.
PD SEP
PY 2017
VL 96
IS 10
BP 1076
EP 1077
DI 10.1177/0022034517723327
PG 2
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA FE2LO
UT WOS:000408048000002
PM 28825519
DA 2020-07-08
ER

PT J
AU Zuanazzi, D
   Arts, EJ
   Jorge, PK
   Mulyar, Y
   Gibson, R
   Xiao, Y
   dos Santos, MB
   Machado, MAAM
   Siqueira, WL
AF Zuanazzi, D.
   Arts, E. J.
   Jorge, P. K.
   Mulyar, Y.
   Gibson, R.
   Xiao, Y.
   Bringel dos Santos, M.
   Machado, Maria Aparecida A. M.
   Siqueira, W. L.
TI Postnatal Identification of Zika Virus Peptides from Saliva
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Article
DE proteins; microcephaly; proteomics; diagnosis; mass spectrometry; viral
   markers
ID DISEASE; RNA
AB We explored the potential to diagnose Zika virus (ZIKV) infection by analyzing peptides in saliva during a convalescent phase of infection, long after resolution of acute disease. A 25-y-old woman clinically diagnosed with Zika fever in the first trimester was enrolled with her dizygotic twins for a 3-mo postnatal sample of saliva (9-mo after maternal infection). The female baby (A) had microcephaly while the male baby (B) was born healthy. Peptidomic analysis was completed by mass spectrometry (MS/MS), and ZIKV peptides were identified using the National Institutes of Health Zika Virus Resource database, then aligned and mapped to the ZIKV polyprotein to determine proteome coverage and phylogenetic studies. A total of 423 (mother), 607 (baby A), and 183 (baby B) unique ZIKV peptides were identified in saliva by MS/MS, providing a coverage of 67%, 84%, and 45%, respectively, of the entire ZIKV polyprotein (>3,400 amino acids). All peptides were aligned to other flaviviruses that are circulating in Brazil (dengue and yellow fever) to discard false-positive matches. Nine peptides identified were highly conserved to dengue virus. Alignment of a contiguous peptide sequence for mother/babies with the 74 ZIKV sequences suggested that the virus may have entered the oral cavity through the salivary glands, leading to an infection that persists into the postnatal period (vertical transmission). Furthermore, we identified 9 sequence variations that were unique to the baby with microcephaly (not found in the mother or the twin). This sequence information could provide a template for future neuropathogenic studies. A much larger sample size is required to determine whether sequence variation in the envelope protein significantly associates with microcephaly. Finally, from a public health perspective, it will be important to determine whether viral replication is still taking place after birth and whether the virus can be transmitted through salivary contact.
C1 [Zuanazzi, D.; Jorge, P. K.; Mulyar, Y.; Xiao, Y.; Siqueira, W. L.] Univ Western Ontario, Schulich Dent, Schulich Sch Med & Dent, London, ON, Canada.
   [Zuanazzi, D.; Jorge, P. K.; Mulyar, Y.; Xiao, Y.; Siqueira, W. L.] Univ Western Ontario, Dept Biochem, Schulich Sch Med & Dent, London, ON, Canada.
   [Arts, E. J.; Gibson, R.] Univ Western Ontario, Dept Microbiol & Immunol, Schulich Sch Med & Dent, London, ON, Canada.
   [Jorge, P. K.; Bringel dos Santos, M.; Machado, Maria Aparecida A. M.] Univ Sao Paulo Bauru, Bauru Dent Sch, Dept Pediat Dent, Sao Paulo, Brazil.
RP Siqueira, WL (corresponding author), Univ Western Ontario London, Schulich Sch Med & Dent, Dent Sci Bldg DSB0071, London, ON N6A 5C1, Canada.
EM walter.siqueira@uwo.ca
RI Machado, Maria Aparecida Andrade Moreira/D-8224-2012
OI Bringel dos Santos, Mayara/0000-0003-2530-0387
FU Canadian Institutes of Health Research (CIHR)Canadian Institutes of
   Health Research (CIHR) [106657]; Canada Foundation for
   Innovation-Leaders Opportunity Fund (CFI-LOF)Canada Foundation for
   Innovation [25116]; CIHRCanadian Institutes of Health Research (CIHR)
   [113166]; Schulich Dentistry Summer Research Studentship; Brazilian
   National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq)
FX The study was funded by the Canadian Institutes of Health Research (CIHR
   grant 106657) and the Canada Foundation for Innovation-Leaders
   Opportunity Fund (CFI-LOF grant 25116). W.L.S. is recipient of a CIHR
   New Investigator Award (grant 113166). Y.M. is recipient of a Schulich
   Dentistry Summer Research Studentship. P.K.J. is recipient of The
   Brazilian National Council for Scientific and Technological Development
   (CNPq) graduate student scholarships. The authors declare no potential
   conflicts of interest with respect to the authorship and/or publication
   of this article.
CR Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   BARZON L, 2016, EUROSURVEILLANCE, V21, P2
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brasil P, 2016, LANCET INFECT DIS, V16, P866, DOI 10.1016/S1473-3099(16)30117-7
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Siqueira WL, 2012, J DENT RES, V91, P1110, DOI 10.1177/0022034512462578
   Siqueira WL, 2009, ARCH ORAL BIOL, V54, P437, DOI 10.1016/j.archoralbio.2009.01.011
   Siqueira WL, 2005, CLIN ORAL INVEST, V9, P26, DOI 10.1007/s00784-004-0282-3
   Siqueira WL, 2016, BRAZ ORAL RES, P30
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Thomadaki K, 2011, J DENT RES, V90, P1325, DOI 10.1177/0022034511420721
   Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033
   World Health Organization, 2016, 1 M INT HLTH REG 200
   Xu X, 2016, PLOS CURR, V8
NR 24
TC 13
Z9 13
U1 0
U2 9
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
EI 1544-0591
J9 J DENT RES
JI J. Dent. Res.
PD SEP
PY 2017
VL 96
IS 10
BP 1078
EP 1084
DI 10.1177/0022034517723325
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA FE2LO
UT WOS:000408048000003
PM 28825520
DA 2020-07-08
ER

PT J
AU Racicot, K
   VanOeveren, S
   Alberts, A
AF Racicot, Karen
   VanOeveren, Sarah
   Alberts, Art
TI Viral Hijacking of Formins in Neurodevelopmental Pathologies
SO TRENDS IN MOLECULAR MEDICINE
LA English
DT Review
ID CONGENITAL CYTOMEGALOVIRUS-INFECTION; LYMPHOCYTIC CHORIOMENINGITIS
   VIRUS; PROGENITOR CELLS; NEURAL STEM; NEURONAL DIFFERENTIATION; ADHERENS
   JUNCTIONS; HEARING-LOSS; ACTIN; BRAIN; DROSOPHILA
AB The 2015 Zika virus (ZIKV) outbreak caused global concern when it was determined to cause microcephaly, hearing loss, and other neurodevelopmental manifestations upon fetal exposure. Significant progress has been made in our understanding of the interactions between ZIKV and the pregnant host, but there is still a critical need to understand how ZIKV and other neurotropic viruses affect fetal neurodevelopment. Diaphanous-related formins (Diaphs) have recently been identified as microcephaly-associated proteins in humans and mice. Mutations in Diaphs affect the function of neural progenitor cells, much like prenatal viral infection. We present a novel hypothesis that viruses 'hijack' Diaphs in neural progenitor cells, causing autonomous differentiation and apoptosis of neural progenitor cells, which could potentially contribute to virus-associated neurological pathologies.
C1 [Racicot, Karen] Michigan State Univ, Dept Obstet Gynecol & Reprod Biol, Coll Human Med, E Lansing, MI 48824 USA.
   [VanOeveren, Sarah] Michigan State Univ, Dept Translat Sci & Mol Med, Coll Human Med, E Lansing, MI 48824 USA.
   [Alberts, Art] Van Andel Res Inst, Lab Cell Struct & Signal Integrat, Grand Rapids, MI 49503 USA.
RP Racicot, K (corresponding author), Michigan State Univ, Dept Obstet Gynecol & Reprod Biol, Coll Human Med, E Lansing, MI 48824 USA.
EM Karen.racicot@hc.msu.edu
FU Robert J. and Jean P. Schultz Biomedical Research Fund
FX I would like to extend my gratitude to the Schultz family for their
   philanthropy. KR receives support from the Robert J. and Jean P. Schultz
   Biomedical Research Fund.
CR AHLFORS K, 1986, PEDIATRICS, V78, P1058
   Alberts AS, 2002, CURR BIOL, V12, pR796, DOI 10.1016/S0960-9822(02)01309-X
   Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200
   Arakawa Y, 2007, CELL HOST MICROBE, V1, P227, DOI 10.1016/j.chom.2007.04.006
   Bonthius DJ, 2012, SEMIN PEDIATR NEUROL, V19, P89, DOI 10.1016/j.spen.2012.02.002
   Bonthius DJ, 2007, PLOS PATHOG, V3, P1541, DOI 10.1371/journal.ppat.0030149
   Boppana SB, 2005, J PEDIATR-US, V146, P817, DOI 10.1016/j.jpeds.2005.01.059
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cappello S, 2006, NAT NEUROSCI, V9, P1099, DOI 10.1038/nn1744
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cheeran MCJ, 2009, CLIN MICROBIOL REV, V22, P99, DOI 10.1128/CMR.00023-08
   Cheeran MCJ, 2005, J NEUROSCI RES, V82, P839, DOI 10.1002/jnr.20682
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Damiani D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13509
   El Ghouzzi V, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.266
   Ercan-Sencicek AG, 2015, EUR J HUM GENET, V23, P165, DOI 10.1038/ejhg.2014.82
   Farkas LM, 2008, CURR OPIN CELL BIOL, V20, P707, DOI 10.1016/j.ceb.2008.09.008
   Goulidaki N, 2015, CELL CYCLE, V14, P2748, DOI 10.1080/15384101.2015.1066535
   Katayama KI, 2011, P NATL ACAD SCI USA, V108, P7607, DOI 10.1073/pnas.1101347108
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lynch ED, 1997, SCIENCE, V278, P1315, DOI 10.1126/science.278.5341.1315
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Mellor H, 2010, BBA-MOL CELL RES, V1803, P191, DOI 10.1016/j.bbamcr.2008.12.018
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Odeberg J, 2006, J VIROL, V80, P8929, DOI 10.1128/JVI.00676-06
   Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Robert A, 2006, MOL BIOL CELL, V17, P3329, DOI 10.1091/mbc.E05-12-1146
   Schoen CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056520
   Schoen CJ, 2010, P NATL ACAD SCI USA, V107, P13396, DOI 10.1073/pnas.1003027107
   Sharma-Walia N, 2004, J VIROL, V78, P4207, DOI 10.1128/JVI.78.8.4207-4223.2004
   Stritt S, 2016, BLOOD, V127, P2903, DOI 10.1182/blood-2015-10-675629
   Sun T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096442
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Taylor MP, 2011, NAT REV MICROBIOL, V9, P427, DOI 10.1038/nrmicro2574
   Thumkeo D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025465
   Tsutsui Y, 2008, PATHOL INT, V58, P257, DOI 10.1111/j.1440-1827.2008.02221.x
   Wallar BJ, 2007, EXP CELL RES, V313, P560, DOI 10.1016/j.yexcr.2006.10.033
   Watanabe N, 1999, NAT CELL BIOL, V1, P136
NR 39
TC 2
Z9 2
U1 0
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4914
EI 1471-499X
J9 TRENDS MOL MED
JI Trends Mol. Med
PD SEP
PY 2017
VL 23
IS 9
BP 778
EP 785
DI 10.1016/j.molmed.2017.07.004
PG 8
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA FE7BH
UT WOS:000408362100005
PM 28803703
DA 2020-07-08
ER

PT J
AU Cai, L
   Sun, YJ
   Song, YB
   Xu, LK
   Bei, ZC
   Zhang, DN
   Dou, YY
   Wang, HQ
AF Cai, Lei
   Sun, Yajie
   Song, Yabin
   Xu, Likun
   Bei, Zhuchun
   Zhang, Dongna
   Dou, Yuanyuan
   Wang, Hongquan
TI Viral polymerase inhibitors T-705 and T-1105 are potential inhibitors of
   Zika virus replication
SO ARCHIVES OF VIROLOGY
LA English
DT Article
DE Zika virus (ZIKV); Broad-spectrum antiviral drugs; T-705; T-1105
ID ORALLY-ADMINISTERED T-705; RNA-POLYMERASE; INFECTION; EFFICACY;
   BRINCIDOFOVIR; FAVIPIRAVIR; COMPOUND; CMX001; MODEL; MICE
AB Since 2015, 69 countries and territories have reported evidence of vector-borne Zika virus (ZIKV) transmission. Currently, there are no effective licensed vaccines or drugs available for the treatment or prevention of ZIKV infection. We tested a series of compounds for their ability to inhibit ZIKV replication in cell culture. The compounds in T-705 (favipiravir) and T-1105 were found to have antiviral activity, suggesting that these compounds are promising candidates for further development as specific antiviral drugs against ZIKV.
C1 [Cai, Lei; Sun, Yajie; Song, Yabin; Xu, Likun; Bei, Zhuchun; Zhang, Dongna; Dou, Yuanyuan; Wang, Hongquan] Acad Mil Med Sci, Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
RP Wang, HQ (corresponding author), Acad Mil Med Sci, Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
EM bjwanghq@163.com
FU National Science and Technology Major Project, China [2015ZX09102022]
FX This work was supported by the National Science and Technology Major
   Project, China, Grant Number 2015ZX09102022.
CR Cann AJ, 1999, VIRUS CULTURE PRACTI, P83
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Cox Bryan D., 2015, Antiviral Chemistry & Chemotherapy, V24, P118, DOI 10.1177/2040206616653873
   Crotty S, 2000, NAT MED, V6, P1375
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Faizan MI, 2016, INTERVIROLOGY, V59, P152, DOI 10.1159/000452950
   Florescu DF, 2015, CLIN INFECT DIS, V61, P969, DOI 10.1093/cid/civ395
   Florescu DF, 2014, EXPERT REV ANTI-INFE, V12, P1171, DOI 10.1586/14787210.2014.948847
   Furuta Y, 2005, ANTIMICROB AGENTS CH, V49, P981, DOI 10.1128/AAC.49.3.981-986.2005
   Furuta Y, 2002, ANTIMICROB AGENTS CH, V46, P977, DOI 10.1128/AAC.46.4.977-981.2002
   Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015
   Hercik K, 2017, ARCH VIROL, V162, P2091, DOI 10.1007/s00705-017-3345-x
   Hercik K, 2017, ANTIVIR RES, V137, P131, DOI 10.1016/j.antiviral.2016.11.020
   Julander JG, 2009, ANTIMICROB AGENTS CH, V53, P202, DOI 10.1128/AAC.01074-08
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Morrey JD, 2008, ANTIVIR RES, V80, P377, DOI 10.1016/j.antiviral.2008.07.009
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Oestereich L, 2014, ANTIVIR RES, V105, P17, DOI 10.1016/j.antiviral.2014.02.014
   Quenelle DC, 2010, J INFECT DIS, V202, P1492, DOI 10.1086/656717
   Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sidwell RW, 2007, ANTIMICROB AGENTS CH, V51, P845, DOI 10.1128/AAC.01051-06
   Sleeman K, 2010, ANTIMICROB AGENTS CH, V54, P2517, DOI 10.1128/AAC.01739-09
   WHO, 2017, ZIK SIT REP
NR 29
TC 12
Z9 15
U1 0
U2 20
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD SEP
PY 2017
VL 162
IS 9
BP 2847
EP 2853
DI 10.1007/s00705-017-3436-8
PG 7
WC Virology
SC Virology
GA FE2PZ
UT WOS:000408059500034
PM 28597088
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Safronetz, D
   Sloan, A
   Stein, DR
   Mendoza, E
   Barairo, N
   Ranadheera, C
   Scharikow, L
   Holloway, K
   Robinson, A
   Traykova-Andonova, M
   Makowski, K
   Dimitrova, K
   Giles, E
   Hiebert, J
   Mogk, R
   Beddome, S
   Drebot, M
AF Safronetz, David
   Sloan, Angela
   Stein, Derek R.
   Mendoza, Emelissa
   Barairo, Nicole
   Ranadheera, Charlene
   Scharikow, Leanne
   Holloway, Kimberly
   Robinson, Alyssia
   Traykova-Andonova, Maya
   Makowski, Kai
   Dimitrova, Kristina
   Giles, Elizabeth
   Hiebert, Joanne
   Mogk, Rhonda
   Beddome, Sharla
   Drebot, Michael
TI Evaluation of 5 Commercially Available Zika Virus Immunoassays
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID MICRONESIA; OUTBREAK; HISTORY
AB Because of the global spread of Zika virus, accurate and high-throughput diagnostic immunoassays are needed. We compared the sensitivity and specificity of 5 commercially available Zika virus serologic assays to the recommended protocol of Zika virus IgM-capture ELISA and plaque-reduction neutralization tests. Most commercial immunoassays showed low sensitivity, which can be increased.
C1 [Safronetz, David; Sloan, Angela; Stein, Derek R.; Mendoza, Emelissa; Barairo, Nicole; Ranadheera, Charlene; Scharikow, Leanne; Holloway, Kimberly; Robinson, Alyssia; Traykova-Andonova, Maya; Makowski, Kai; Dimitrova, Kristina; Giles, Elizabeth; Hiebert, Joanne; Mogk, Rhonda; Beddome, Sharla; Drebot, Michael] Publ Hlth Agcy Canada, Winnipeg, MB, Canada.
RP Safronetz, D (corresponding author), Publ Hlth Agcy Canada, Zoonot Dis & Special Pathogens, Natl Microbiol Lab, Winnipeg, MB R3E 3R2, Canada.
EM david.safronetz@phac-aspc.gc.ca
OI Hiebert, Joanne/0000-0003-3238-1859
FU Public Health Agency of Canada
FX This study was supported by the Public Health Agency of Canada.
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Grossi-Soyster EN, 2017, CURR OPIN PEDIATR, V29, P102, DOI 10.1097/MOP.0000000000000449
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
NR 9
TC 36
Z9 36
U1 1
U2 58
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD SEP
PY 2017
VL 23
IS 9
BP 1577
EP 1580
DI 10.3201/eid2309.162043
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA FD8PG
UT WOS:000407786000025
PM 28665268
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Calder, JAM
AF Calder, Jennifer Ann Marie
TI Zika Virus in the Americas: Is It Time to Revisit Mosquito Elimination?
SO JOURNAL OF ENVIRONMENTAL HEALTH
LA English
DT Editorial Material
AB Recent outbreaks of mosquito-borne diseases in the Americas indicate the need for the reinstatement of mosquito elimination efforts in the region. These efforts need to have buy-in from all governmental agencies within the region using a multidisciplinary effort with appropriate financial support.
C1 [Calder, Jennifer Ann Marie] Columbia Univ, City Stamford Dept Hlth, New York, NY 10027 USA.
RP Calder, JAM (corresponding author), City Stamford Dept Hlth, 880 Washington Blvd,8th Floor, Stamford, CT 06902 USA.
EM jcalder@stamfordct.gov
CR [Anonymous], 1997, Rev Panam Salud Publica, V1, P68
   Khanal K., 2014, PLOS CURR OUTBREAKS, VI, P1
   Komar N, 2006, REV PANAM SALUD PUBL, V19, P112, DOI 10.1590/S1020-49892006000200006
   Oliver CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133733
   Salvato Mark H., 2001, Journal of the Lepidopterists' Society, V55, P8
   Walshe DP, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008090.pub2
   Webster-Kerr K, 2011, TROP MED INT HEALTH, V16, P298, DOI 10.1111/j.1365-3156.2010.02700.x
NR 7
TC 0
Z9 0
U1 0
U2 22
PU NATL ENVIRON HEALTH ASSOC
PI DENVER
PA 720 S COLORADO BLVD SUITE 970, SOUTH TOWER, DENVER, CO 80246 USA
SN 0022-0892
J9 J ENVIRON HEALTH
JI J. Environ. Health
PD SEP
PY 2017
VL 80
IS 2
BP 26
EP 27
PG 2
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA FE4MI
UT WOS:000408187600006
DA 2020-07-08
ER

PT J
AU Nascimento, LB
   Siqueira, CM
   Coelho, GE
   Siqueira, JB
AF Nascimento, Laura B.
   Siqueira, Claudio M.
   Coelho, Giovanini E.
   Siqueira, Joao B., Jr.
TI Symptomatic dengue infection during pregnancy and livebirth outcomes in
   Brazil, 2007-13: a retrospective observational cohort study
SO LANCET INFECTIOUS DISEASES
LA English
DT Article
ID ZIKA VIRUS
AB Background Dengue is a major public health challenge in Brazil. We assessed the relationship between symptomatic dengue infection during pregnancy and adverse birth outcomes in the country between 2007 and 2013.
   Methods We did a retrospective observational cohort study using information reported in the Brazilian national reportable disease information system (SINAN) and the livebirth information system (SINASC) databases. We probabilistically linked confirmed dengue-positive and dengue-negative pregnancies with live childbirths using Fine-Grained Record Integration and Linkage (FRIL) software. We also included an external reference population of randomly selected newborn babies. Pregnancy was adopted as the unit of analysis. We assessed the relationship between symptomatic dengue infection during pregnancy and adverse birth outcomes, using multivariable logistic regression adjusted for relevant covariates.
   Findings 3898 dengue-positive pregnant women, 3165 dengue-negative women, and 3898 newborn babies from the reference population were included in the analysis. Preterm birth occurred in 322 (8.4%) of 3821 cases in the dengue-positive group versus 324 (10.4%) of 3101 in the dengue-negative group (unadjusted analysis: relative risk [RR] 0.81, 95% CI 0.70-0.93; adjusted analysis: odds ratio [OR] 1.26, 95% CI 1.06-1.49, p=0.006) and 349 (9.1%) of 3818 in the reference population (RR 0.92, 0.80-1.07; OR 0.98, 0.83-1.16, p=0.84). The prevalence of low birthweight (<2500 g) was similar for dengue-positive women and dengue-negative women (8.3% [322 of 3897] vs 9.8% [310 of 3163]; OR 1.17, 95% CI 0.99-1.39, p=0.07), and in the reference population (8.3% vs 9.0% [350 of 3895]; OR 1.00, 0.85-1.17, p=0.97). The prevalence of malformations did not differ significantly for the dengue-positive group (27 [0.7%] of 3789) versus the dengue-negative group (27 [0.9%] of 3059, p=0.51) or versus the reference population (32 [0.9%] of 3738, p=0.56).
   Interpretation In the adjusted analysis, the risk of preterm birth seems to be increased in women with symptomatic dengue infection during pregnancy. However, symptomatic dengue infection during pregnancy does not appear to be associated with congenital malformations or low birthweight.
C1 [Nascimento, Laura B.; Siqueira, Claudio M.; Coelho, Giovanini E.; Siqueira, Joao B., Jr.] Fed Univ Gois, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil.
RP Nascimento, LB (corresponding author), Fed Univ Gois, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil.
EM lbranquinhon@gmail.com
RI amsalu, ribka/G-8780-2019
FU Sanofi Pasteur
FX Sanofi Pasteur.
CR Argolo AFLT, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-254
   Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   de Frias PG, 2014, CAD SAUDE PUBLICA, V30, P2068, DOI 10.1590/0102-311X00196113
   Fares RCG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/321873
   Friedman EE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003226
   Fritel X, 2010, EMERG INFECT DIS, V16, P418, DOI 10.3201/eid1603.091403
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Hanf M, 2014, TROP MED INT HEALTH, V19, P153, DOI 10.1111/tmi.12240
   Jurczyk Pawel, 2008, AMIA Annu Symp Proc, P440
   Jurczyk P, 2008, BIRTH DEFECTS RES A, V82, P822, DOI 10.1002/bdra.20521
   Leite RC, 2014, J CLIN VIROL, V60, P16, DOI [10.1016/j.jcv.2014.02.009, 10.1016/J.JCV.2014.02.009]
   Mardekian SK, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/834371
   Nunes ML, 2016, J PEDIAT-BRAZIL, V92, P230, DOI 10.1016/j.jped.2016.02.009
   PAHO, DESCR CURR EP TRENDS
   Paixao ES, 2016, LANCET INFECT DIS, V16, P857, DOI 10.1016/S1473-3099(16)00088-8
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Restrepo Berta N, 2003, Biomedica, V23, P416
   Ribeiro CF, 2016, REV INST MED TROP SP, V58, DOI 10.1590/S1678-9946201658008
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Secretaria de Vigilancia em Saude Departamento de Analise de Situacao de Saude, 2011, MAN INSTR PREENCH DE
   Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091
   Tan PC, 2008, OBSTET GYNECOL, V111, P1111, DOI 10.1097/AOG.0b013e31816a49fc
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Wyllie D, 2015, J HOSP INFECT, V89, P267, DOI 10.1016/j.jhin.2015.01.005
NR 26
TC 10
Z9 11
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD SEP
PY 2017
VL 17
IS 9
BP 949
EP 956
DI 10.1016/S1473-3099(17)30169-X
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA FE5ST
UT WOS:000408272100030
PM 28528802
DA 2020-07-08
ER

PT J
AU De Cauwer, H
   Somville, FJMP
   Joillet, M
AF De Cauwer, Harald
   Somville, Francis J. M. P.
   Joillet, Marieke
TI Neurological aspects of chemical and biological terrorism: guidelines
   for neurologists
SO ACTA NEUROLOGICA BELGICA
LA English
DT Review
DE Neurology; Biological warfare; Chemical warfare; Terrorism
ID INHALATIONAL ANTHRAX; EBOLA-VIRUS; BOTULINUM TOXIN; ZIKA VIRUS;
   BIOTERRORISM; WARFARE; OUTBREAK; MENINGOENCEPHALITIS; MANAGEMENT;
   HOSPITALS
AB This statement paper deals with the key role an neurologist plays in the management of victims of chemical warfare/terrorist attacks. Because terrorist factions have expanded the war zone creating a worldwide risk of terrorist attacks, not only limited to some conflict zones in the Middle East, neurologists in all countries/regions have to be prepared for disaster response. The scope of this paper is to provide guidelines for the neurological management of victims of chemical and biological terrorist attacks.
C1 [De Cauwer, Harald] Dimpna Reg Hosp, Dept Neurol, AZ St Dimpna,JB Stessenstr 2, B-2440 Geel, Belgium.
   [Somville, Francis J. M. P.; Joillet, Marieke] Dimpna Reg Hosp, Dept Emergency, Geel, Belgium.
   [Somville, Francis J. M. P.] Leiden Univ, Dept Hlth Psychol, Leiden, Netherlands.
   [Somville, Francis J. M. P.] Univ Leuven, Fac Med, Clerkships Off, Louvain, Belgium.
   [Joillet, Marieke] Univ Maastricht, Fac Med, Maastricht, Netherlands.
RP De Cauwer, H (corresponding author), Dimpna Reg Hosp, Dept Neurol, AZ St Dimpna,JB Stessenstr 2, B-2440 Geel, Belgium.
EM dr.harald.decauwer@azstdimpna.be
CR ABRAMOVA FA, 1993, P NATL ACAD SCI USA, V90, P2291, DOI 10.1073/pnas.90.6.2291
   Aracava Y, 2009, J PHARMACOL EXP THER, V331, P1014, DOI 10.1124/jpet.109.160028
   Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059
   Asai Yasufumi, 2003, Prehosp Disaster Med, V18, P106
   Balali-Mood M, 2008, ARCH IRAN MED, V11, P65
   Baldacchino F, 2015, PEST MANAG SCI, V71, P1471, DOI 10.1002/ps.4044
   Bane V, 2014, TOXINS, V6, P693, DOI 10.3390/toxins6020693
   Barras V, 2014, CLIN MICROBIOL INFEC, V20, P497, DOI 10.1111/1469-0691.12706
   Bower WA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr6404a1
   Bray M, 2003, ANTIVIR RES, V57, P53, DOI 10.1016/S0166-3542(02)00200-0
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Brown CM, 2014, MMWR-MORBID MORTAL W, V63, P1163
   Bush LM, 2001, NEW ENGL J MED, V345, P1607, DOI 10.1056/NEJMoa012948
   Busl KM, 2012, NEUROTHERAPEUTICS, V9, P139, DOI 10.1007/s13311-011-0097-2
   Cannard K, 2006, J NEUROL SCI, V249, P86, DOI 10.1016/j.jns.2006.06.008
   Casebeer L, 2006, J CONTIN EDUC HEALTH, V26, P137, DOI 10.1002/chp.62
   Caya JG, 2004, ARCH PATHOL LAB MED, V128, P653
   Cenciarelli O, 2015, VIRUS RES, V210, P318, DOI 10.1016/j.virusres.2015.09.002
   Cole JB, 2015, MMWR-MORBID MORTAL W, V63, P1222
   Cosgrove SE, 2005, ARCH INTERN MED, V165, P2002, DOI 10.1001/archinte.165.17.2002
   Das D, 2003, J URBAN HEALTH, V80, pI76
   De Cauwer H, 2017, PREHOSP DISASTER MED, V32, P94, DOI 10.1017/S1049023X16001217
   Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107
   Donaghy M, 2006, J NEUROL SCI, V249, P55, DOI 10.1016/j.jns.2006.06.004
   Dvorin T., 2014, ISRAELNATIONAL NEWS
   Erbguth FJ, 2004, MOVEMENT DISORD, V19, pS2, DOI 10.1002/mds.20003
   Fitzgerald GJ, 2008, AM J PUBLIC HEALTH, V98, P611, DOI 10.2105/AJPH.2007.11930
   Franz DR, 1997, JAMA-J AM MED ASSOC, V278, P399, DOI 10.1001/jama.278.5.399
   Gilat E, 2005, TOXICOL APPL PHARM, V209, P74, DOI 10.1016/j.taap.2005.03.007
   Hajra A, 2016, N AM J MED SCI, V8, DOI 10.4103/1947-2714.179112
   Heffernan Richard, 2004, MMWR Suppl, V53, P23
   Howlett P, 2016, EMERG INFECT DIS, V22, P150, DOI 10.3201/eid2201.151212
   Inglesby TV, 1999, JAMA-J AM MED ASSOC, V281, P1735, DOI 10.1001/jama.281.18.1735
   Jacob H, 1971, MARBURG VIRUS DIS, pP54
   Jacobs M, 2016, LANCET, V388, P498, DOI 10.1016/S0140-6736(16)30386-5
   Jernigan JA, 2001, EMERG INFECT DIS, V7, P933, DOI 10.3201/eid0706.010604
   Katharios-Lanwermeyer S, 2016, CLIN INFECT DIS, V62, P1537, DOI 10.1093/cid/ciw184
   Kim HJ, 2001, AM J NEURORADIOL, V22, P1303
   Lanska DJ, 2002, NEUROLOGY, V59, P327, DOI 10.1212/WNL.59.3.327
   Lavon O, 2015, NEUROTOXICOLOGY, V49, P36, DOI 10.1016/j.neuro.2015.05.003
   Marrs Timothy C, 2004, Toxicol Rev, V23, P145, DOI 10.2165/00139709-200423030-00002
   Martin CO, 2003, ARCH NEUROL-CHICAGO, V60, P21, DOI 10.1001/archneur.60.1.21
   Mercey G, 2012, ACCOUNTS CHEM RES, V45, P756, DOI 10.1021/ar2002864
   Mortelmans LJM, 2014, EUR J EMERG MED, V21, P296, DOI 10.1097/MEJ.0000000000000072
   Moshiri M, 2012, DARU, V20, DOI 10.1186/2008-2231-20-81
   Noguchi Tamao, 2011, ISRN Toxicol, V2011, P276939, DOI 10.5402/2011/276939
   Okudera H, 1997, AM J EMERG MED, V15, P527, DOI 10.1016/S0735-6757(97)90201-1
   [Anonymous], 2000, MMWR Recomm Rep, V49, P1
   Osterholm MT, 2015, MBIO, V6, DOI 10.1128/mBio.00137-15
   Panicker JN, 2003, NEUROL INDIA, V51, P455
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Raveh L, 2014, TOXICOLOGY, V325, P115, DOI 10.1016/j.tox.2014.09.005
   Revich BA, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.8482
   Rosello A, 2015, ELIFE, V4, DOI 10.7554/eLife.09015
   Scholte E, 2010, EURO SURVEILL, V15
   Sejvar JJ, 2005, LANCET INFECT DIS, V5, P287, DOI 10.1016/S1473-3099(05)70113-4
   Strauss S, 2014, CAN MED ASSOC J, V186, P1206, DOI 10.1503/cmaj.109-4910
   Turner AD, 2015, MAR DRUGS, V13, P7357, DOI 10.3390/md13127070
   Weissman B, 2011, TOXICOLOGY, V290, P149, DOI 10.1016/j.tox.2011.09.004
NR 59
TC 0
Z9 0
U1 0
U2 34
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0300-9009
EI 2240-2993
J9 ACTA NEUROL BELG
JI Acta Neurol. Belg.
PD SEP
PY 2017
VL 117
IS 3
BP 603
EP 611
DI 10.1007/s13760-017-0774-y
PG 9
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FE3AV
UT WOS:000408089700002
PM 28343251
DA 2020-07-08
ER

PT J
AU Jiang, QS
   Chandar, YJ
   Cao, SS
   Kharasch, ED
   Singamaneni, S
   Morrissey, JJ
AF Jiang, Qisheng
   Chandar, Yatin J.
   Cao, Sisi
   Kharasch, Evan D.
   Singamaneni, Srikanth
   Morrissey, Jeremiah J.
TI Rapid, Point-of-Care, Paper-Based Plasmonic Biosensor for Zika Virus
   Diagnosis
SO ADVANCED BIOSYSTEMS
LA English
DT Article
DE metal-organic framework; plasmonic sensor; point of care; resource
   limited settings; Zika virus detection
ID MEMBRANE ASSOCIATION; SURFACE; NANORODS
AB Zika virus (ZIKV) is an increasing global health challenge. There is an urgent need for rapid, low-cost, and accurate diagnostic tests that can be broadly distributed and applied in pandemic regions. Here, an innovative, adaptable, and rapidly deployable bioplasmonic paper-based device (BPD) is demonstrated for the detection of ZIKV infection, via quantification of serum antiZIKV-nonstructural protein 1 (NS1) IgG and IgM. BPD is based on ZIKV-NS1 protein as a capture element and gold nanorods as plasmonic nanotransducers. The BPD displays excellent sensitivity and selectivity to both anti-ZIKV-NS1 IgG and IgM in human serum. In addition, excellent stability of BPDs at room and even elevated temperature for one month is achieved by metal-organic framework (MOF)-based biopreservation. MOF-based preservation obviates the need for device refrigeration during transport and storage, thus enabling their use in point-of-care and resource-limited settings for ZIKV surveillance. Furthermore, the versatile design (interchangeable recognition element) of BPDs more generally enables their ready adaptation to diagnose other emerging infectious diseases.
C1 [Jiang, Qisheng; Cao, Sisi; Singamaneni, Srikanth] Washington Univ, Inst Mat Sci & Engn, Dept Mech Engn & Mat Sci, St Louis, MO 63130 USA.
   [Chandar, Yatin J.] Davidson Acad Nevada, Reno, NV 89507 USA.
   [Kharasch, Evan D.; Morrissey, Jeremiah J.] Washington Univ, Dept Anesthesiol, Siteman Canc Ctr, St Louis, MO 63110 USA.
   [Kharasch, Evan D.] Washington Univ, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.
RP Singamaneni, S (corresponding author), Washington Univ, Inst Mat Sci & Engn, Dept Mech Engn & Mat Sci, St Louis, MO 63130 USA.; Morrissey, JJ (corresponding author), Washington Univ, Dept Anesthesiol, Siteman Canc Ctr, St Louis, MO 63110 USA.
EM singamaneni@wustl.edu; morrisseyjj@wustl.edu
FU National Science FoundationNational Science Foundation (NSF)
   [CBET1254399, CBET 1512043]; Department of Anesthesiology, Washington
   University School of Medicine in St. Louis; Department of Mechanical
   Engineering and Materials Science, Washington University in St. Louis
FX The authors acknowledge support from National Science Foundation
   (CBET1254399 and CBET 1512043) and funding from the Department of
   Anesthesiology, Washington University School of Medicine in St. Louis
   and the Department of Mechanical Engineering and Materials Science,
   Washington University in St. Louis. The authors thank Nano Research
   Facility (NRF) at Washington University for providing access to electron
   microscopy facilities. The authors thank clinical coordinator Marilee
   Fisher for consenting and obtaining sera from control individuals.
CR Anker JN, 2008, NAT MATER, V7, P442, DOI 10.1038/nmat2162
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Bingham JM, 2010, J AM CHEM SOC, V132, P17358, DOI 10.1021/ja1074272
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Chen HJ, 2013, CHEM SOC REV, V42, P2679, DOI 10.1039/c2cs35367a
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Dos Santos T., 2016, NEW ENGL J MED, V375, P16
   Edeling MA, 2014, P NATL ACAD SCI USA, V111, P4285, DOI 10.1073/pnas.1322036111
   Haes AJ, 2004, EXPERT REV MOL DIAGN, V4, P527, DOI 10.1586/14737159.4.4.527
   Hakkinen H, 2012, NAT CHEM, V4, P443, DOI [10.1038/nchem.1352, 10.1038/NCHEM.1352]
   Hall WP, 2011, NANO LETT, V11, P1098, DOI 10.1021/nl103994w
   Kathryn M. M., 2010, NANOTECHNOLOGY, V21, DOI DOI 10.1088/0957-4484/21/25/255503
   Lee KS, 2005, J PHYS CHEM B, V109, P20331, DOI 10.1021/jp054385p
   Mayer KM, 2011, CHEM REV, V111, P3828, DOI 10.1021/cr100313v
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Novo C, 2008, NAT NANOTECHNOL, V3, P598, DOI 10.1038/nnano.2008.246
   Novo C, 2009, J AM CHEM SOC, V131, P14664, DOI 10.1021/ja905216h
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Tadepalli S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16206
   Tian LM, 2012, LANGMUIR, V28, P17435, DOI 10.1021/la3034534
   Tian LM, 2012, ANAL CHEM, V84, P9928, DOI 10.1021/ac302332g
   Wang CZ, 2017, ADV MATER, V29, DOI 10.1002/adma.201604433
   Wang CZ, 2016, ACS APPL MATER INTER, V8, P26493, DOI 10.1021/acsami.6b07362
   World Health Organization, WHO DIR GEN BRIEFS M
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
NR 27
TC 12
Z9 12
U1 8
U2 18
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 2366-7478
J9 ADV BIOSYST
JI Adv. Biosyst.
PD SEP
PY 2017
VL 1
IS 9
AR 1700096
DI 10.1002/adbi.201700096
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA GW5HI
UT WOS:000446961900006
OA Bronze
DA 2020-07-08
ER

PT J
AU Yuan, SF
   Chan, JFW
   den-Haan, H
   Chik, KKH
   Zhang, AJ
   Chan, CCS
   Poon, VKM
   Yip, CCY
   Mak, WWN
   Zhu, Z
   Zou, ZJ
   Tee, KM
   Cai, JP
   Chan, KH
   de la Pena, J
   Perez-Sanchez, H
   Ceron-Carrasco, JP
   Yuen, KY
AF Yuan, Shuofeng
   Chan, Jasper Fuk-Woo
   den-Haan, Helena
   Chik, Kenn Ka-Heng
   Zhang, Anna Jinxia
   Chan, Chris Chung-Sing
   Poon, Vincent Kwok-Man
   Yip, Cyril Chik-Yan
   Mak, Winger Wing-Nga
   Zhu, Zheng
   Zou, Zijiao
   Tee, Kah-Meng
   Cai, Jian-Piao
   Chan, Kwok-Hung
   de la Pena, Jorge
   Perez-Sanchez, Horacio
   Ceron-Carrasco, Jose Pedro
   Yuen, Kwok-Yung
TI Structure-based discovery of clinically approved drugs as Zika virus
   NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection
   in vitro and in vivo
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Zika; Flavivirus; Novobiocin; Protease; Treatment; Molecular modelling
ID ANTIVIRAL ACTIVITY; NOVOBIOCIN; DISEASE; BROMOCRIPTINE; TRANSMISSION;
   BINDING
AB Zika virus (ZIKV) infection may be associated with severe complications in fetuses and adults, but treatment options are limited. We performed an in silico structure-based screening of a large chemical library to identify potential ZIKV NS2B-NS3 protease inhibitors. Clinically approved drugs belonging to different drug classes were selected among the 100 primary hit compounds with the highest predicted binding affinities to ZIKV NS2B-NS3-protease for validation studies. ZIKV NS2B-NS3 protease inhibitory activity was validated in most of the selected drugs and in vitro anti-ZIKV activity was identified in two of them (novobiocin and lopinavir-ritonavir). Molecular docking and molecular dynamics simulations predicted that novobiocin bound to ZIKV NS2B-NS3-protease with high stability. Dexamethasone-immunosuppressed mice with disseminated ZIKV infection and novobiocin treatment had significantly (P < 0.05) higher survival rate (100% vs 0%), lower mean blood and tissue viral loads, and less severe histopathological changes than untreated controls. This structure-based drug discovery platform should facilitate the identification of additional enzyme inhibitors of ZIKV. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Yuan, Shuofeng; Chan, Jasper Fuk-Woo; Chik, Kenn Ka-Heng; Zhang, Anna Jinxia; Chan, Chris Chung-Sing; Poon, Vincent Kwok-Man; Yip, Cyril Chik-Yan; Mak, Winger Wing-Nga; Zhu, Zheng; Zou, Zijiao; Tee, Kah-Meng; Cai, Jian-Piao; Chan, Kwok-Hung; Yuen, Kwok-Yung] Univ Hong Kong, Dept Microbiol, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; Yuen, Kwok-Yung] Univ Hong Kong, State Key Lab Emerging Infect Dis, Pokfulam, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; Yuen, Kwok-Yung] Univ Hong Kong, Res Ctr Inject & Immunol, Pokfulam, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; Yuen, Kwok-Yung] Univ Hong Kong, Carol Yu Ctr Infect, Pokfulam, Hong Kong, Peoples R China.
   [den-Haan, Helena; de la Pena, Jorge; Perez-Sanchez, Horacio; Ceron-Carrasco, Jose Pedro] Univ Catolica San Antonio Murcia UCAM, Bioinformat & High Performance Comp Res Grp BIO H, Comp Engn Dept, Murcia, Spain.
   [den-Haan, Helena] Villapharma Res SL, Parque Tecnol Fuente Alamo, Murcia, Spain.
   [Yuen, Kwok-Yung] Univ Hong Kong, Collaborat Innovat Ctr Diag & Treatment Infect Di, Pokfulam, Hong Kong, Peoples R China.
RP Perez-Sanchez, H; Ceron-Carrasco, JP (corresponding author), Univ Catolica San Antonio Murcia UCAM, Bioinformat & High Performance Comp Res Grp BIO H, Comp Engn Dept, Murcia, Spain.; Chan, JFW; Yuen, KY (corresponding author), Univ Hong Kong, State Key Lab Emerging Infect Dis, Carol Yu Ctr Infect, Queen Mary Hosp,Dept Microbiol,Li Ka Shing Fac Me, 102 Pokfulam Rd, Pokfulam, Hong Kong, Peoples R China.
EM jfwchan@hku.hk; hperez@ucam.edu; jpceron@ucam.edu; kyyuen@hku.hk
RI ZHU, ZHENG/P-2173-2016; Ceron-Carrasco, Jose Pedro/H-3705-2013; Chan,
   Jasper F. W./D-8007-2013; Perez-Sanchez, Horacio/O-5017-2016
OI ZHU, ZHENG/0000-0002-2035-0804; Ceron-Carrasco, Jose
   Pedro/0000-0003-0668-9227; Chan, Jasper F. W./0000-0001-6336-6657;
   Perez-Sanchez, Horacio/0000-0003-4468-7898; Yuan,
   Shuofeng/0000-0001-7996-1119; Yuen, Kwok-yung/0000-0002-2083-1552
FU Centro de Alto Rendimiento de la Region de Murcia [CFE-CAR-23/15];
   Consultancy Service for Enhancing Laboratory Surveillance of Emerging
   Infectious Diseases of the Department of Health, Hong Kong Special
   Administrative Region; Collaborative Innovation Center for Diagnosis and
   Treatment of Infectious Diseases; Ministry of Education of ChinaMinistry
   of Education, China; Fundacion Seneca del Centro de Coordinacion de la
   Investigation de la Region de Murcia [18946/JLI/13, 19419/PI/14-1]
FX The authors are grateful to the technical support provided by the staff
   at Department of Microbiology, The University of Hong Kong, and the
   computer resources and the technical support provided by Centro de Alto
   Rendimiento de la Region de Murcia within its Research Program
   (CFE-CAR-23/15), the Plataforma Andaluza de Bioinformatica of the
   University of Malaga, the supercomputing infrastructure of the NLHPC
   (ECM-02), the e-infrastructure program of the Research Council of
   Norway, and the supercomputer center of UiT - the Arctic University of
   Norway, and the super computing infrastructure of Poznan Supercomputing
   Center. This work was partly supported by the donations of Hui Hoy and
   Chow Sin Lan Charity Fund Limited; and funding from the Consultancy
   Service for Enhancing Laboratory Surveillance of Emerging Infectious
   Diseases of the Department of Health, Hong Kong Special Administrative
   Region; the Collaborative Innovation Center for Diagnosis and Treatment
   of Infectious Diseases, the Ministry of Education of China; and the
   Fundacion Seneca del Centro de Coordinacion de la Investigation de la
   Region de Murcia under Projects 18946/JLI/13 and 19419/PI/14-1.
CR Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Case D., 2017, AMBER 2017
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chan JFW, 2013, J INFECTION, V67, P606, DOI 10.1016/j.jinf.2013.09.029
   Chan JFW, 2017, TROP MED INT HEALTH, V22, P594, DOI 10.1111/tmi.12857
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Chan JFW, 2013, J INFECT DIS, V207, P1743, DOI 10.1093/infdis/jit123
   Chan JF, 2016, EMERG MICROBES INFEC, V5
   Chraibi S, 2016, J CLIN VIROL, V83, P61, DOI 10.1016/j.jcv.2016.08.299
   CIVITICO G, 1990, J MED VIROL, V31, P90, DOI 10.1002/jmv.1890310205
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   DROGE P, 1985, EMBO J, V4, P3241, DOI 10.1002/j.1460-2075.1985.tb04072.x
   DRUSANO GL, 1986, ANTIMICROB AGENTS CH, V30, P42, DOI 10.1128/AAC.30.1.42
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Flatman RH, 2006, ANTIMICROB AGENTS CH, V50, P1136, DOI 10.1128/AAC.50.4.1136-1142.2006
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   FURLINI G, 1983, J ANTIMICROB CHEMOTH, V12, P503, DOI 10.1093/jac/12.5.503
   Gonzalez-Molleda L, 2012, ANTIMICROB AGENTS CH, V56, P893, DOI 10.1128/AAC.05274-11
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Kato F, 2016, ANTIVIR RES, V131, P141, DOI 10.1016/j.antiviral.2016.04.014
   KIRBY WMM, 1956, ARCH INTERN MED, V98, P1, DOI 10.1001/archinte.1956.00250250007001
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   PESSINA A, 1992, ARCH VIROL, V122, P263, DOI 10.1007/BF01317188
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Sekiguchi JA, 1997, VIROLOGY, V235, P129, DOI 10.1006/viro.1997.8684
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Stierand K, 2010, ACS MED CHEM LETT, V1, P540, DOI 10.1021/ml100164p
   Stroganov OV, 2008, J CHEM INF MODEL, V48, P2371, DOI 10.1021/ci800166p
   Wu T, 2014, ANTIVIR RES, V107, P95, DOI 10.1016/j.antiviral.2014.05.003
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yuan SF, 2016, J ANTIMICROB CHEMOTH, V71, P2489, DOI 10.1093/jac/dkw194
   Zhang XW, 2015, J MICROENCAPSUL, V32, P496, DOI 10.3109/02652048.2015.1057251
   Zhou J, 2014, J INFECT DIS, V209, P1331, DOI 10.1093/infdis/jit504
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 47
TC 44
Z9 46
U1 5
U2 36
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD SEP
PY 2017
VL 145
BP 33
EP 43
DI 10.1016/j.antiviral.2017.07.007
PG 11
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA FH9QV
UT WOS:000411547700006
PM 28712942
DA 2020-07-08
ER

PT J
AU Lanko, K
   Eggermont, K
   Patel, A
   Kaptein, S
   Delang, L
   Verfaillie, CM
   Neyts, J
AF Lanko, Kristina
   Eggermont, Kristel
   Patel, Abdulsamie
   Kaptein, Suzanne
   Delang, Leen
   Verfaillie, Catherine M.
   Neyts, Johan
TI Replication of the Zika virus in different iPSC-derived neuronal cells
   and implications to assess efficacy of antivirals
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Zika virus; iPSC; Antivirals; Neuronal cells
ID INFECTION; BRAIN; RIBAVIRIN
AB Infections with the Zika virus (ZIKV) are responsible for congenital abnormalities and neurological disorders. We here demonstrate that ZIKV productively infects three types of human iPSC (induced pluripotent stem cells)-derived cells from the neural lineage, i.e. cortical and motor neurons as well as astrocytes. ZIKV infection results in all three cell types in the production of infectious virus particles and induces cytopathic effects (CPE). In cortical and motor neurons, an Asian isolate (PRVABC59) produced roughly 10-fold more virus than the prototypic African strain (MR766 strain). Viral replication and CPE is efficiently inhibited by the nucleoside polymerase inhibitor 7-deaza-2'-C-methyladenosine (7DMA). However, ribavirin and favipiravir, two molecules that inhibit ZIKV replication in Vero cells, did not inhibit ZIKV replication in the neuronal cells. These results highlight the need to assess the potential antiviral activity of novel ZIKV inhibitors in stem cell derived neuronal cultures. (C) 2017 The Authors. Published by Elsevier B.V.
C1 [Lanko, Kristina; Kaptein, Suzanne; Delang, Leen; Neyts, Johan] Univ Leuven, KU Leuven, Rega Inst Med Res, Lab Virol & Expt Chemotherapy, B-3000 Leuven, Belgium.
   [Eggermont, Kristel; Patel, Abdulsamie; Verfaillie, Catherine M.] Univ Leuven, KU Leuven, Stem Cell Inst, B-3000 Leuven, Belgium.
RP Neyts, J (corresponding author), Univ Leuven, Rega Inst Med Res, Herestr 49 Box, BE-3000 Leuven, Belgium.
EM johan.neyts@kuleuven.be
RI Lanko, Kristina M/D-9579-2018; Kaptein, Suzanne JF/O-4714-2019; Kaptein,
   Suzanne JF/O-8855-2018; Neyts, Johan/U-8267-2017; Delang,
   Leen/D-9548-2018; Verfaillie, Catherine/H-5148-2013
OI Lanko, Kristina M/0000-0002-0749-0079; Kaptein, Suzanne
   JF/0000-0002-7935-0219; Kaptein, Suzanne JF/0000-0002-7935-0219; Neyts,
   Johan/0000-0002-0033-7514; Delang, Leen/0000-0002-8874-675X; Patel,
   Abdulsamie/0000-0001-9119-7002; Verfaillie,
   Catherine/0000-0001-7564-4079
FU European Union's Horizon research and innovation programme under the
   Marie Sklodowska-Curie grantEuropean Union (EU) [642434]; ZIKAlliance
   grant [734548]; ZikaPLAN grant [734584]
FX This project has received funding from the European Union's Horizon 2020
   research and innovation programme under the Marie Sklodowska-Curie grant
   agreement No 642434, ZIKAlliance grant agreement No 734548 and ZikaPLAN
   grant agreement No 734584.
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cho H, 2013, NAT MED, V19, P458, DOI 10.1038/nm.3108
   Crance JM, 2003, ANTIVIR RES, V58, P73, DOI 10.1016/S0166-3542(02)00185-7
   Dang J., 2016, CELL STEM CELL
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015
   Gelpi E, 2005, J NEUROPATH EXP NEUR, V64, P506, DOI 10.1093/jnen/64.6.506
   Hamel R, 2017, INFECT GENET EVOL, V49, P134, DOI 10.1016/j.meegid.2017.01.015
   Hardy TA, 2011, CURR ALLERGY ASTHM R, V11, P197, DOI 10.1007/s11882-011-0190-y
   Kelley TW, 2003, AM J CLIN PATHOL, V119, P749, DOI 10.1309/PU4R76JJMG1F81RP
   Leyssen P, 2006, MOL PHARMACOL, V69, P1461, DOI 10.1124/mol.105.020057
   Ludlow M, 2016, ACTA NEUROPATHOL, V131, P159, DOI 10.1007/s00401-015-1511-3
   Madi Deepak, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, pS70, DOI 10.12980/APJTB.4.2014C1006
   Manzini MC, 2011, CURR OPIN GENET DEV, V21, P333, DOI 10.1016/j.gde.2011.01.006
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Molofsky AV, 2015, GLIA, V63, P1320, DOI 10.1002/glia.22836
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Olsen DB, 2004, ANTIMICROB AGENTS CH, V48, P3944, DOI 10.1128/AAC.48.10.3944-3953.2004
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Retallack H., 2016, BIORXIV COLD SPRING
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   WHO, 2017, ZIK SIT REP
   WHO, 2016, ZIK VIR OUTBR GLOB R
   Winkelmann ER, 2016, F1000RESEARCH, V5
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 39
TC 17
Z9 18
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD SEP
PY 2017
VL 145
BP 82
EP 86
DI 10.1016/j.antiviral.2017.07.010
PG 5
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA FH9QV
UT WOS:000411547700011
PM 28736077
OA Other Gold
DA 2020-07-08
ER

PT J
AU Andrei, G
   Carter, K
   Janeba, Z
   Sampath, A
   Schang, LM
   Tarbet, EB
   Hodge, RAV
   Bray, M
   Este, JA
AF Andrei, Graciela
   Carter, Kara
   Janeba, Zlatko
   Sampath, Aruna
   Schang, Luis M.
   Tarbet, E. Bart
   Hodge, R. Anthony Vere
   Bray, Mike
   Este, Jose A.
TI Highlights of the 30th International Conference on Antiviral Research
SO ANTIVIRAL RESEARCH
LA English
DT Article
ID CHRONIC HEPATITIS-C; DENGUE VIRUS; IN-VITRO; REPLICATION; NUCLEOSIDES;
   COMBINATION; MECHANISM; DIOXOLANE; THERAPY; PRODRUG
AB The 30th International Conference on Antiviral Research (ICAR) was held in Atlanta, GA, USA from May 18 to 21, 2017. This report provides an account of award lectures, invited keynote addresses and oral presentations during the meeting. The 2017 Gertrude Elion Memorial Lecture Award by Michael Sofia highlighted one of the most important accomplishments in recent drug discovery in antiviral research, the identification of the hepatitis C virus direct acting antiviral sofosbuvir and new alternatives to combat hepatitis B virus (HBV) infection. The Antonin Holy Lecture Award by David Chu on medicinal chemistry provided an overview of early developments of nucleoside analogs for the treatment of HIV and varicella zoster virus infection and how this knowledge serves to develop new drugs targeting HBV. Priscilla Yang gave the first ISAR Women in Science lecture. She reported on pharmacological validation of new antiviral targets for dengue, Zika and other flaviviruses. The William Prusoff Young Investigator Lecture Award by Maaike Everts described the Alabama Drug Discovery Alliance and the Antiviral Drug Discovery and Development Consortium, and how they are helping to accelerate the development of new antivirals. The 30th ICAR was a success in promoting new discoveries in antiviral drug development and research. The 31st ICAR will be held in Porto, Portugal, June 11-15, 2018. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Andrei, Graciela] Katholieke Univ Leuven, Rega Inst Med Res, Lab Virol & Chemotherapy, B-3000 Leuven, Belgium.
   [Carter, Kara] Sanofi, 270 Albany St, Cambridge, MA 02139 USA.
   [Janeba, Zlatko] Czech Acad Sci, Inst Organ Chem & Biochem, Flemingovo Nam 2, CZ-16610 Prague 6, Czech Republic.
   [Sampath, Aruna] Emergent BioSolut, 400 Profess Dr,Ste 400, Gaithersburg, MD 20879 USA.
   [Schang, Luis M.] Cornell Univ, Coll Vet Med, Baker Inst, 235 Hungerford Hill Rd, Ithaca, NY 14853 USA.
   [Tarbet, E. Bart] Utah State Univ, Inst Antiviral Res, Logan, UT 84322 USA.
   [Hodge, R. Anthony Vere] Vere Hodge Antivirals Ltd, Reigate, Surrey, England.
   [Este, Jose A.] Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, AIDS Res Inst Irsicaixa, Canyet S-N, Badalona, Spain.
   [Este, Jose A.] Int Soc Antiviral Res, Barcelona, Spain.
RP Este, JA (corresponding author), Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, AIDS Res Inst Irsicaixa, Canyet S-N, Badalona, Spain.
EM jaeste@irsicaixa.es
RI Andrei, Graciela/V-7721-2017; Este, Jose/B-5509-2008
OI Andrei, Graciela/0000-0003-2609-4896; Este, Jose/0000-0002-1436-5823;
   Tarbet, Bart/0000-0002-4255-9094; Janeba, Zlatko/0000-0003-4654-679X;
   Schang, Luis/0000-0002-5789-8590
CR Bird BH, 2016, ANTIVIR RES, V132, P66, DOI 10.1016/j.antiviral.2016.05.014
   Bonnelykke K, 2014, NAT GENET, V46, P51, DOI 10.1038/ng.2830
   Campos RK, 2017, J VIROL, V91, DOI 10.1128/JVI.01706-16
   Chen HC, 1996, ANTIMICROB AGENTS CH, V40, P2332, DOI 10.1128/AAC.40.10.2332
   Choi Y, 2000, J MED CHEM, V43, P2538, DOI 10.1021/jm990543n
   Chu CK, 2005, J MED CHEM, V48, P3949, DOI 10.1021/jm050060l
   Chu JJH, 2007, P NATL ACAD SCI USA, V104, P3520, DOI 10.1073/pnas.0611681104
   Clark M., 2005, CELL CHEM BIOL, V23, P443
   Clark MJ, 2016, CELL CHEM BIOL, V23, P443, DOI 10.1016/j.chembiol.2016.03.010
   De C, 2014, ANTIVIR RES, V110, P10, DOI 10.1016/j.antiviral.2014.07.007
   Everts M, 2017, ANNU REV PHARMACOL, V57, P155, DOI 10.1146/annurev-pharmtox-010716-104533
   Everts M, 2016, FUTURE VIROL, V11, P187, DOI 10.2217/fvl-2015-0011
   Everts M, 2011, PHARM RES-DORDR, V28, P1454, DOI 10.1007/s11095-011-0432-7
   Furman PA, 2001, ANTIMICROB AGENTS CH, V45, P158, DOI 10.1128/AAC.45.1.158-165.2001
   Gane EJ, 2010, LANCET, V376, P1467, DOI 10.1016/S0140-6736(10)61384-0
   Haasbach E, 2017, ANTIVIR RES, V142, P178, DOI 10.1016/j.antiviral.2017.03.024
   Hodge RAV, 2017, ANTIVIR RES, V137, P23, DOI 10.1016/j.antiviral.2016.10.014
   Hodge RAV, 2015, ANTIVIR RES, V123, P172, DOI 10.1016/j.antiviral.2015.09.015
   Hodge RAV, 2014, ANTIVIR RES, V111, P143, DOI 10.1016/j.antiviral.2014.08.009
   Le Pogam S, 2010, J INFECT DIS, V202, P1510, DOI 10.1086/656774
   Li GD, 2017, ANTIVIR RES, V142, P83, DOI 10.1016/j.antiviral.2017.02.014
   Lo MK, 2017, SCI REP-UK, V7, DOI 10.1038/srep43395
   Ma TW, 1996, J MED CHEM, V39, P2835, DOI 10.1021/jm960098l
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Monaco DC, 2016, J EXP MED, V213, P2049, DOI 10.1084/jem.20151984
   Peek SF, 2001, HEPATOLOGY, V33, P254, DOI 10.1053/jhep.2001.20899
   Rawal RK, 2013, BIOORG MED CHEM LETT, V23, P503, DOI 10.1016/j.bmcl.2012.11.027
   Ross BS, 2011, J ORG CHEM, V76, P8311, DOI 10.1021/jo201492m
   Schmidt AG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002627
NR 30
TC 5
Z9 6
U1 1
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD SEP
PY 2017
VL 145
BP 184
EP 196
DI 10.1016/j.antiviral.2017.07.017
PG 13
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA FH9QV
UT WOS:000411547700023
PM 28774800
OA Green Published
DA 2020-07-08
ER

PT J
AU Garza-Gonzlez, E
   Mendoza-Olazarn, S
   Roman-Campos, R
   Tellez-Marroquin, R
   Saldivar-Rodriguez, D
   Soria-Lpez, JA
   Guzman, A
   Flores-Treuio, S
   Camacho-Ortiz, A
AF Garza-Gonzalez, Elvira
   Mendoza-Olazaran, Soraya
   Roman-Campos, Raul
   Tellez-Marroquin, Ricardo
   Saldivar-Rodriguez, Donato
   Soria-Lopez, Juan A.
   Guzman, Abel
   Flores-Treuino, Samantha
   Camacho-Ortiz, Adrian
TI Rapid spread of an ongoing outbreak of Zika virus disease in pregnant
   women in a Mexican hospital
SO BRAZILIAN JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus disease; Congenital Zika virus syndrome; Microcephaly
AB In the first nine weeks of implementation of a Zika Virus Preparedness Plan in a Mexican Public Hospital, we cared for 221 pregnant women with any signal or symptom suggesting Zika virus infection and 99 (44.8%) patients were found to be positive for Zika virus.& para;& para;The median age of patients was 25.3 years (range 13-49). Symptoms in PCR-positive patients were rash (91.4%) followed by headache (53.1%), myalgia (46.9%), arthralgia (45.7%), pruritus (35.8%), retroocular pain (29.6%), conjunctivitis (21%), and fever (21%). The women's epidemiologic exposure history indicates local transmission and a community outbreak. (C) 2017 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda.
C1 [Garza-Gonzalez, Elvira; Mendoza-Olazaran, Soraya; Roman-Campos, Raul; Tellez-Marroquin, Ricardo; Saldivar-Rodriguez, Donato; Soria-Lopez, Juan A.; Guzman, Abel; Flores-Treuino, Samantha; Camacho-Ortiz, Adrian] Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Monterrey, Mexico.
RP Garza-Gonzlez, E (corresponding author), Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Monterrey, Mexico.
EM elvira_garza_gzz@yahoo.com
RI Flores-Trevino, Samantha/AAB-4537-2020; Flores-Trevino,
   Samantha/E-8601-2019
OI Flores-Trevino, Samantha/0000-0003-1259-7425; Flores-Trevino,
   Samantha/0000-0003-1259-7425; Mendoza-Olazaran,
   Soraya/0000-0001-5649-4810
FU U.S. Centers for Disease Control (CDC)United States Department of Health
   & Human ServicesCenters for Disease Control & Prevention - USA; Bureau
   for Global Health, U.S. Agency for International DevelopmentUnited
   States Agency for International Development (USAID)
FX This publication was made possible through support provided by the
   Bureau for Global Health, U.S. Agency for International Development,
   under the terms of an Interagency Agreement with the U.S. Centers for
   Disease Control (CDC).
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Jimenez Corona Maria Eugenia, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.a2fe1b3d6d71e24ad2b5afe982824053
   Madad SS, 2016, MMWR-MORBID MORTAL W, V65, P1161, DOI 10.15585/mmwr.mm6542a2
   Nunes ML, 2016, J PEDIAT-BRAZIL, V92, P230, DOI 10.1016/j.jped.2016.02.009
NR 7
TC 3
Z9 3
U1 0
U2 2
PU ELSEVIER BRAZIL
PI RIO DE JANEIRO
PA R SETE SETEMBRO, 111-16, RIO DE JANEIRO, RJ 20050-006, BRAZIL
SN 1413-8670
EI 1678-4391
J9 BRAZ J INFECT DIS
JI Braz. J. Infect. Dis.
PD SEP-OCT
PY 2017
VL 21
IS 5
BP 554
EP 556
DI 10.1016/j.bjid.2017.04.008
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA FL5KS
UT WOS:000414276300012
PM 28648813
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Mailles, A
   Stahl, JP
   Bloch, KC
AF Mailles, A.
   Stahl, J. -P.
   Bloch, K. C.
TI Update and new insights in encephalitis
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Review
DE Autoimmunity; Bornavirus; Chikungunya; Ebola; Encephalitis; Guidelines;
   Lassa; Naegleria fowleri; Next-generation sequencing; Zika
ID PRIMARY AMEBIC MENINGOENCEPHALITIS; EBOLA-VIRUS DISEASE; ASPARTATE
   RECEPTOR ENCEPHALITIS; CHIKUNGUNYA VIRUS; POWASSAN VIRUS;
   NAEGLERIA-FOWLERI; INFECTIOUS ENCEPHALITIS; CONSENSUS GUIDELINES;
   CEREBROSPINAL-FLUID; MULTIPLEX PCR
AB Infectious encephalitis is a rare but severe medical condition resulting from direct invasion of the brain by viruses, bacteria, fungi or parasites, or indirect post-infectious immune or inflammatory disorders when the infectious agent does not cross the bloodebrain barrier. Infectious encephalitis cases represent an interesting and accurate sentinel to follow up on trends in infectious diseases or to detect emerging infections. Using Pubmed and Embase, we searched the most relevant publications over the last years. We present here an update on the important findings and new data recently published about infectious encephalitis. (C) 2017 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Mailles, A.] Sante Publ France, 12 Rue Val Osne, F-94415 St Maurice, France.
   [Mailles, A.; Stahl, J. -P.] ESCMID Study Grp Infect Brain, Basel, Switzerland.
   [Stahl, J. -P.] Joseph Fourier Univ, Univ Hosp, Grenoble, France.
   [Bloch, K. C.] Vanderbilt Univ, Med Ctr, Nashville, TN USA.
RP Mailles, A (corresponding author), Sante Publ France, 12 Rue Val Osne, F-94415 St Maurice, France.
EM alexandra.mailles@santepubliquefrance.fr
RI Bloch, Karen/AAE-1479-2020; Stahl, Jean Paul/AAM-6425-2020
OI Stahl, Jean Paul/0000-0002-0086-3557; Mailles,
   Alexandra/0000-0002-8739-1168
CR Armangue T, 2014, ANN NEUROL, V75, P317, DOI 10.1002/ana.24083
   Baltagi SA, 2010, PEDIATR CRIT CARE ME, V11, P179, DOI 10.1097/PCC.0b013e3181cf4652
   Bandeira AC, 2016, IDCases, V5, P57, DOI 10.1016/j.idcr.2016.07.008
   Barcellos C, 2016, EMERG INFECT DIS, V22, P1894, DOI 10.3201/eid2211.160901
   Birge J, 2012, EMERG INFECT DIS, V18, P1669, DOI 10.3201/eid1810.120621
   Bloch KC, 2015, EMERG INFECT DIS, V21, P1562, DOI 10.3201/eid2109.150295
   Bowen L, 2016, NEUROLOGY, V86
   Bradshaw MJ, 2015, NEUROLOGY, V85, P2176, DOI 10.1212/WNL.0000000000002218
   Britton PN, 2016, EPIDEMIOL INFECT, V144, P2117, DOI 10.1017/S0950268816000340
   Britton PN, 2015, INTERN MED J, V45, P563, DOI 10.1111/imj.12749
   Bukowska-Osko I, 2017, ADV EXP MED BIOL, V944, P53, DOI 10.1007/5584_2016_42
   Bwaka MA, 1999, J INFECT DIS, V179, pS1, DOI 10.1086/514308
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Capewell LG, 2015, J PEDIAT INF DIS SOC, V4, pE68, DOI 10.1093/jpids/piu103
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Casolari S, 2008, SCAND J INFECT DIS, V40, P995, DOI 10.1080/00365540802419055
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   *CDC, 2001, MMWR-MORBID MORTAL W, V50, P761
   Chertow DS, 2016, ANN INTERN MED, V165, P301, DOI 10.7326/M15-3066
   Cope JR, 2016, CURR INFECT DIS REP, V18, DOI 10.1007/s11908-016-0539-4
   Cope JR, 2016, CLIN INFECT DIS, V62, P774, DOI 10.1093/cid/civ1021
   Cope JR, 2015, CLIN INFECT DIS, V60, pE36, DOI 10.1093/cid/civ017
   Crosby L, 2016, INT J INFECT DIS, V48, P78, DOI 10.1016/j.ijid.2016.05.010
   Dalmau J, 2007, ANN NEUROL, V61, P25, DOI 10.1002/ana.21050
   Dalmau J, 2011, LANCET NEUROL, V10, P63, DOI 10.1016/S1474-4422(10)70253-2
   de Greslan T, 2016, CLIN INFECT DIS, V63, P1076, DOI 10.1093/cid/ciw469
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   Gable MS, 2012, CLIN INFECT DIS, V54, P899, DOI 10.1093/cid/cir1038
   Gerardin P, 2016, NEUROLOGY, V86, P94, DOI 10.1212/WNL.0000000000002234
   Grahn A, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw198
   Granerod J, 2010, LANCET INFECT DIS, V10, P835, DOI 10.1016/S1473-3099(10)70222-X
   Guan HZ, 2016, J NEUROVIROL, V22, P240, DOI 10.1007/s13365-015-0390-7
   Haaskjold YL, 2016, EMERG INFECT DIS, V22, P1537, DOI 10.3201/eid2209.151621
   Hicar MD, 2011, PEDIATR INFECT DIS J, V30, P86, DOI 10.1097/INF.0b013e3181f2f492
   Hinten SR, 2008, VECTOR-BORNE ZOONOT, V8, P733, DOI 10.1089/vbz.2008.0022
   Hoffmann B, 2015, NEW ENGL J MED, V373, P154, DOI 10.1056/NEJMoa1415627
   Howlett P, 2016, EMERG INFECT DIS, V22, P150, DOI 10.3201/eid2201.151212
   IKERIONWU SE, 1978, J TROP MED HYG, V81, P134
   Jacobs M, 2016, LANCET, V388, P498, DOI 10.1016/S0140-6736(16)30386-5
   Kneen R, 2012, J INFECTION, V64, P449, DOI 10.1016/j.jinf.2011.11.013
   Kreuels B, 2014, NEW ENGL J MED, V371, P2394, DOI 10.1056/NEJMoa1411677
   Leber AL, 2016, J CLIN MICROBIOL, V54, P2251, DOI 10.1128/JCM.00730-16
   Linam WM, 2015, PEDIATRICS, V135, pE744, DOI 10.1542/peds.2014-2292
   Mailles A, 2009, CLIN INFECT DIS, V49, P1838, DOI 10.1086/648419
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mongkolrattanothai K, 2017, J PEDIAT INFECT DIS
   Nelson J, 2014, J CLIN MICROBIOL, V52, P3459, DOI 10.1128/JCM.01288-14
   Niemeyer B, 2017, EUR NEUROL, V77, P45, DOI 10.1159/000453396
   Nofchissey RA, 2013, AM J TROP MED HYG, V88, P1159, DOI 10.4269/ajtmh.12-0586
   Ohuabunwo C, 2014, INT J INFECT DIS, V2016, P23
   Pham NTK, 2017, CLIN LAB, V63, P91, DOI 10.7754/Clin.Lab.2016.160630
   Piantadosi A, 2016, CLIN INFECT DIS, V62, P707, DOI 10.1093/cid/civ1005
   Qureshi AI, 2015, CLIN INFECT DIS, V61, P1035, DOI 10.1093/cid/civ453
   Robin S, 2008, J CHILD NEUROL, V23, P1028, DOI 10.1177/0883073808314151
   Roze B, 2016, EURO SURVEILL, P21
   Sagui E, 2015, CLIN INFECT DIS, V61, P1627, DOI 10.1093/cid/civ606
   Salvucci A, 2014, PEDIATR NEUROL, V50, P507, DOI 10.1016/j.pediatrneurol.2014.01.012
   Salzberg SL, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000251
   Schabitz WR, 2014, NEUROLOGY, V83, P2309, DOI 10.1212/WNL.0000000000001072
   Schein F., 2016, INFECTION
   Schlottau K, 2017, EMERG INFECT DIS, V23, P477, DOI 10.3201/eid2303.161061
   Shaikh NJ, 2015, INDIAN J MED MICROBI, V33, P454, DOI 10.4103/0255-0857.158600
   Shakoor S, 2011, EMERG INFECT DIS, V17, P258, DOI 10.3201/eid1702.100442
   Sharma S, 2012, INDIAN PEDIATR, V49, P897, DOI 10.1007/s13312-012-0216-0
   Shi XD, 2016, INT J INFECT DIS, V49, P80, DOI 10.1016/j.ijid.2016.05.023
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Solis N, 2016, J CLIN VIROL, V83, P26, DOI 10.1016/j.jcv.2016.08.292
   Solomon T, 2012, J INFECTION, V64, P347, DOI 10.1016/j.jinf.2011.11.014
   Stahl JP, 2017, MED MALADIES INFECT, V47, P179, DOI 10.1016/j.medmal.2017.01.005
   Taraphdar D, 2015, INDIAN J MED MIC S15, V33, P3
   Tunkel AR, 2008, CLIN INFECT DIS, V47, P303, DOI 10.1086/589747
   Uyeki TM, 2016, NEW ENGL J MED, V374, P636, DOI 10.1056/NEJMoa1504874
   Venkatesan A, 2013, CLIN INFECT DIS, V57, P1114, DOI 10.1093/cid/cit458
   Westman G, 2016, CLIN MICROBIOL INFEC, V22, P934, DOI 10.1016/j.cmi.2016.07.028
   Wilson MR, 2014, NEW ENGL J MED, V370, P2408, DOI 10.1056/NEJMoa1401268
   Xu CL, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-149
   Yao M, 2016, J CLIN NEUROL, V12, P446, DOI 10.3988/jcn.2016.12.4.446
   Yoder JS, 2012, CLIN INFECT DIS, V55, pE79, DOI 10.1093/cid/cis626
NR 78
TC 10
Z9 10
U1 0
U2 24
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD SEP
PY 2017
VL 23
IS 9
BP 607
EP 613
DI 10.1016/j.cmi.2017.05.002
PG 7
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA FE0TU
UT WOS:000407933400007
PM 28501667
OA Bronze
DA 2020-07-08
ER

PT J
AU Zin, AA
   Tsui, I
   Rossetto, J
   Vasconcelos, Z
   Adachi, K
   Valderramos, S
   Halai, UA
   Pone, MVD
   Pone, SM
   Silveira, JCB
   Aibe, MS
   da Costa, ACC
   Zin, OA
   Belfort, R
   Brasil, P
   Nielsen-Saines, K
   Moreira, MEL
AF Zin, Andrea A.
   Tsui, Irena
   Rossetto, Julia
   Vasconcelos, Zilton
   Adachi, Kristina
   Valderramos, Stephanie
   Halai, Umme-Aiman
   da Silva Pone, Marcos Vinicius
   Pone, Sheila Moura
   Barros Silveira Filho, Joel Carlos
   Aibe, Mitsue S.
   da Costa, Ana Carolina C.
   Zin, Olivia A.
   Belfort, Rubens, Jr.
   Brasil, Patricia
   Nielsen-Saines, Karin
   Lopes Moreira, Maria Elisabeth
TI Screening Criteria for Ophthalmic Manifestations of Congenital Zika
   Virus Infection
SO JAMA PEDIATRICS
LA English
DT Article
ID INFANTS; VIREMIA
AB IMPORTANCE Current guidelines recommend screening eye examinations for infants with microcephaly or laboratory-confirmed Zika virus infection but not for all infants potentially exposed to Zika virus in utero.
   OBJECTIVE To evaluate eye findings in a cohort of infants whose mothers had polymerase chain reaction-confirmed Zika virus infection during pregnancy.
   DESIGN, SETTING, AND PARTICIPANTS In this descriptive case series performed from January 2 through October 30, 2016, infants were examined from birth to 1 year of age by a multidisciplinary medical team, including a pediatric ophthalmologist, from Fernandes Figueira Institute, a Ministry of Health referral center for high-risk pregnancies and infectious diseases in children in Rio de Janeiro, Brazil.
   PARTICIPANTS Mother-infant pairs from Rio de Janeiro, Brazil, who presented with suspected Zika virus infection during pregnancy were referred to our institution and had serum, urine, amniotic fluid, or placenta samples tested by real-time polymerase chain reaction for Zika virus.
   MAIN OUTCOMES AND MEASURES Description of eye findings, presence of microcephaly or other central nervous system abnormalities, and timing of infection in infants with confirmed Zika virus during pregnancy. Eye abnormalities were correlated with central nervous system findings, microcephaly, and the timing of maternal infection.
   RESULTS Of the 112 with polymerase chain reaction-confirmed Zika virus infection in maternal specimens, 24 infants (21.4%) examined had eye abnormalities (median age at first eye examination, 31 days; range, 0-305 days). Ten infants (41.7%) with eye abnormalities did not have microcephaly, and 8 (33.3%) did not have any central nervous system findings. Fourteen infants with eye abnormalities (58.3%) were born to women infected in the first trimester, 8 (33.3%) in the second trimester, and 2 (8.3%) in the third trimester. Optic nerve and retinal abnormalities were the most frequent findings. Eye abnormalities were statistically associated with microcephaly (odds ratio [OR], 19.1; 95% CI, 6.0-61.0), other central nervous system abnormalities (OR, 4.3; 95% CI, 1.6-11.2), arthrogryposis (OR, 29.0; 95% CI, 3.3-255.8), and maternal trimester of infection (first trimester OR, 5.1; 95% CI, 1.9-13.2; second trimester OR, 0.5; 95% CI, 0.2-1.2; and third trimester OR, 0.3; 95% CI, 0.1-1.2).
   CONCLUSIONS AND RELEVANCE Eye abnormalitiesmay be the only initial finding in congenital Zika virus infection. All infants with potential maternal Zika virus exposure at any time during pregnancy should undergo screening eye examinations regardless of the presence or absence of central nervous system abnormalities.
C1 [Zin, Andrea A.; Rossetto, Julia; Vasconcelos, Zilton; da Costa, Ana Carolina C.; Lopes Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Dept Pesquisa Clin, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, Brazil.
   [Tsui, Irena; Halai, Umme-Aiman] Univ Calif Los Angeles, Dept Ophthalmol, Los Angeles, CA USA.
   [Rossetto, Julia; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Dept Oftalmol, Sao Paulo, Brazil.
   [Adachi, Kristina; Nielsen-Saines, Karin] Univ Calif Los Angeles, Dept Med, Div Infect Dis, Los Angeles, CA 90024 USA.
   [Valderramos, Stephanie] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA.
   [da Silva Pone, Marcos Vinicius; Pone, Sheila Moura; Aibe, Mitsue S.] Fundacao Oswaldo Cruz, Dept Doencas Infecciosas, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, Brazil.
   [Barros Silveira Filho, Joel Carlos] Univ Unigranrio, Dept Oftalmol, Rio De Janeiro, Brazil.
   [Zin, Olivia A.] Hosp Fed Servidores Estado, Dept Oftalmol, Rio De Janeiro, Brazil.
   [Brasil, Patricia] Fundacao Oswaldo Cruz, Lab Doencas Febris Agudas, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
RP Zin, AA (corresponding author), Fundacao Oswaldo Cruz, Dept Pesquisa Clin, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, Brazil.
EM andreazin@iff.fiocruz.br
RI Vasconcelos, Zilton/AAD-5784-2019; Gaw, Stephanie/K-4592-2019; da Silva
   Pone, Marcos Vinicius/N-1285-2019
OI Vasconcelos, Zilton/0000-0002-2193-2224; Gaw,
   Stephanie/0000-0003-0891-6964; da Silva Pone, Marcos
   Vinicius/0000-0002-5152-2242; Moura Pone, Sheila/0000-0002-6246-8915
FU Brazilian National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq) [441098/2016-9]; National Institute of Allergy and Infectious
   DiseasesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI AI28697]; National Eye InstituteUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Eye Institute (NEI) [R21EY028318-01];
   Research to Prevent Blindness grantResearch to Prevent Blindness (RPB);
   Thrasher Research Fund [20164370]
FX This study was supported by grant 441098/2016-9 from the Brazilian
   National Council for Scientific and Technological Development, grant AI
   AI28697 from the National Institute of Allergy and Infectious Diseases,
   and grant R21EY028318-01 from the National Eye Institute. Dr Tsui was
   supported in part by an unrestricted Research to Prevent Blindness grant
   given to the Stein Eye Institute. Dr Adachi was supported in part by
   grant 20164370 from the Thrasher Research Fund.
CR [Anonymous], 2016, MMWR MORB MORTA 0819
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   de Oliveira Dias Joao Rafael, 2018, Retin Cases Brief Rep, V12, P382, DOI 10.1097/ICB.0000000000000518
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Freitas BDP, 2017, OPHTHALMOLOGY, V124, P407, DOI 10.1016/j.ophtha.2016.10.004
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Maa AY, 2017, TELEMED E-HEALTH, V23, P42, DOI 10.1089/tmj.2016.0039
   Mehrjardi MZ, 2016, JPN J RADIOL, V34, P765, DOI 10.1007/s11604-016-0588-5
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moshfeghi DM, 2016, JAMA OPHTHALMOL, V134, P945, DOI 10.1001/jamaophthalmol.2016.1303
   Pasquel Francisco J, 2015, J Diabetes Sci Technol, V10, P301, DOI 10.1177/1932296815624109
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasool N, 2016, JAMA OPHTHALMOL, V134, P1200, DOI 10.1001/jamaophthalmol.2016.2398
   Sadler TW, 2015, LANGMANS MED EMBRYOL
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Vasconcelos-Santos DV, 2016, JAMA OPHTHALMOL, V134, P946, DOI 10.1001/jamaophthalmol.2016.1313
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1219, DOI 10.1001/jamaophthalmol.2016.3623
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vinekar A, 2015, SEMIN FETAL NEONAT M, V20, P335, DOI 10.1016/j.siny.2015.05.002
NR 26
TC 34
Z9 34
U1 0
U2 5
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6203
EI 2168-6211
J9 JAMA PEDIATR
JI JAMA Pediatr.
PD SEP
PY 2017
VL 171
IS 9
BP 847
EP 854
DI 10.1001/jamapediatrics.2017.1474
PG 8
WC Pediatrics
SC Pediatrics
GA FG3XL
UT WOS:000410140700011
PM 28715527
OA Green Published
DA 2020-07-08
ER

PT J
AU Kim, H
   Yu, HM
   Lim, HW
   Yang, SC
   Roh, JY
   Chang, KS
   Shin, EH
   Ju, YR
   Lee, WG
AF Kim, Hyunwoo
   Yu, Hye Mi
   Lim, Hyung Woo
   Yang, Sung-Chan
   Roh, Jong Yul
   Chang, Kyu Sik
   Shin, E-Hyun
   Ju, Young Ran
   Lee, Wook-Gyo
TI Host-feeding pattern and dengue virus detection of Aedes albopictus
   (Diptera: Culicidae) captured in an urban park in Korea
SO JOURNAL OF ASIA-PACIFIC ENTOMOLOGY
LA English
DT Article
DE Dengue virus; Blood meal source; Bamboo forest; Urban park
ID FEVER; IDENTIFICATION; MOSQUITOS; ANIMALS
AB Aedes albopictus is well known to transmit dengue and chikungunya viruses. Recent report that Zika virus is meditated by this mosquito highlights the importance of Ae. albopictus to human health worldwide. To elucidate the transmission dynamics of pathogens through blood feeding behavior of Ae. albopictus, we investigated blood meal sources and examined the dengue virus infection rate in field-captured Ae. albopictus. This study was conducted in an urban park in Seoul, a metropolitan city with high population density and significant floating population and a region with high risk of dengue virus transmission. Mosquitoes were collected twice a month from May through October in 2015 using BG-Sentinel traps. The collected Ae. albopictus were used in blood meal source analysis and dengue virus detection, whereas in other captured mosquito species, only those fed on blood were used for blood meal source analysis. A total of 54,682 mosquitoes representing 7 genera and 12 species were collected. The blood meal sources for Ae. albopictus included mammals (71%), birds (26%), amphibians (2%), and fish (1%). In mammals, the major blood meal source was humans (61.1%). No dengue virus was detected in captured samples. However, since the results for blood meal source indicate that Ae. albopictus feed almost exclusively on humans, this mosquito is likely to become a major vector of dengue virus, once this virus enters the mosquito.
C1 [Kim, Hyunwoo; Yu, Hye Mi; Lim, Hyung Woo; Yang, Sung-Chan; Roh, Jong Yul; Chang, Kyu Sik; Shin, E-Hyun; Ju, Young Ran; Lee, Wook-Gyo] Korea Natl Inst Hlth, Div Med Entomol, Ctr Immunol & Pathol, Cheongju, South Korea.
   [Kim, Hyunwoo] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.
RP Lee, WG (corresponding author), Korea Natl Inst Hlth, Div Med Entomol, Ctr Immunol & Pathol, Cheongju, South Korea.
EM twinleo@cdc.go.kr
RI Chang, Kyu-Sik/R-6752-2019
FU Research of Korea Center for Disease Control and Prevention
   [2015-NI55001-00]
FX This research was supported by the Research of Korea Center for Disease
   Control and Prevention (grant number 2015-NI55001-00).
CR Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Boakye DA, 1999, MED VET ENTOMOL, V13, P282, DOI 10.1046/j.1365-2915.1999.00193.x
   Effler PV, 2005, EMERG INFECT DIS, V11, P742
   Egizi A, 2013, INFECT GENET EVOL, V16, P122, DOI 10.1016/j.meegid.2013.01.008
   Faraji A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003037
   Fonseca DM, 2013, PEST MANAG SCI, V69, P1351, DOI 10.1002/ps.3511
   Gurukumar KR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-10
   Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1
   Kent RJ, 2009, MOL ECOL RESOUR, V9, P4, DOI 10.1111/j.1755-0998.2008.02469.x
   Knudsen A. B., 1995, Parassitologia (Rome), V37, P91
   KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196
   Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2
   Kutsuna S, 2015, EMERG INFECT DIS, V21, P517, DOI [10.3201/eid2103.141662, 10.3201/eid2103/141662]
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Rasgon JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002198
   Ree H., 2003, KOREAN J ENTOMOL, V33
   REITER P, 1987, J AM MOSQUITO CONTR, V3, P494
   Richards SL, 2006, J MED ENTOMOL, V43, P543, DOI 10.1603/0022-2585(2006)43[543:HPOAAD]2.0.CO;2
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Tanaka K., 1979, DTIC DOCUMENT
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 23
TC 3
Z9 3
U1 1
U2 5
PU KOREAN SOC APPLIED ENTOMOLOGY
PI SUWON
PA NATL INST AGRICULTURAL SCIENCE & TECHNOLOGY, DIVISION ENTOMOLOGY, RDA,
   249 SEODUN-DONG, SUWON, 441-707, SOUTH KOREA
SN 1226-8615
EI 1876-7990
J9 J ASIA-PAC ENTOMOL
JI J. Asia-Pac. Entomol.
PD SEP
PY 2017
VL 20
IS 3
BP 809
EP 813
DI 10.1016/j.aspen.2017.05.007
PG 5
WC Entomology
SC Entomology
GA FS4HH
UT WOS:000419749200010
DA 2020-07-08
ER

PT J
AU Vatti, A
   Monsalve, DM
   Pacheco, Y
   Chang, C
   Anaya, JM
   Gershwin, ME
AF Vatti, Anup
   Monsalve, Diana M.
   Pacheco, Yovana
   Chang, Christopher
   Anaya, Juan-Manuel
   Gershwin, M. Eric
TI Original antigenic sin: A comprehensive review
SO JOURNAL OF AUTOIMMUNITY
LA English
DT Review
DE Vaccination; Bocavirus; Dengue; Influenza; Zika virus; Memory immune
   response; Antibody-dependent enhancement
ID DENGUE VIRUS-INFECTION; T-CELL RESPONSES; ANTIBODY-DEPENDENT
   ENHANCEMENT; PANDEMIC H1N1 2009; INFLUENZA-VIRUS; ZIKA VIRUS;
   CROSS-REACTIVITY; IMMUNE-RESPONSES; INDIVIDUAL CELLS; IMMUNOGLOBULIN-G
AB The concept of "original antigenic sin" was first proposed by Thomas Francis, Jr. in 1960. This phenomenon has the potential to rewrite what we understand about how the immune system responds to infections and its mechanistic implications on how vaccines should be designed. Antigenic sin has been demonstrated to occur in several infectious diseases in both animals and humans, including human influenza infection and dengue fever. The basis of "original antigenic sin" requires immunological memory, and our immune system ability to autocorrect. In the context of viral infections, it is expected that if we are exposed to a native strain of a pathogen, we should be able to mount a secondary immune response on subsequent exposure to the same pathogen. "Original antigenic sin" will not contradict this well-established immunological process, as long as the subsequent infectious antigen is identical to the original one. But "original antigenic sin" implies that when the epitope varies slightly, then the immune system relies on memory of the earlier infection, rather than mount another primary or secondary response to the new epitope which would allow faster and stronger responses. The result is that the immunological response may be inadequate against the new strain, because the immune system does not adapt and instead relies on its memory to mount a response. In the case of vaccines, if we only immunize to a single strain or epitope, and if that strain/epitope changes over time, then the immune system is unable to mount an accurate secondary response. In addition, depending of the first viral exposure the secondary immune response can result in an antibody-dependent enhancement of the disease or at the opposite, it could induce anergy. Both of them triggering loss of pathogen control and inducing aberrant clinical consequences. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Vatti, Anup; Chang, Christopher; Gershwin, M. Eric] Univ Calif Davis, Div Rheumatol Allergy & Clin Immunol, Suite 6501,451 Hlth Sci Dr, Davis, CA 95616 USA.
   [Monsalve, Diana M.; Pacheco, Yovana; Anaya, Juan-Manuel] Univ Rosario, Ctr Autoimmune Dis Res CREA, Sch Med & Hlth Sci, Carrera 24 63-C-69, Bogota, Colombia.
RP Gershwin, ME (corresponding author), Univ Calif Davis, Div Rheumatol Allergy & Clin Immunol, Sch Med, Davis, CA 95616 USA.
EM megershwin@ucdavis.edu
RI Pacheco Nieva, Yovana/J-2932-2018; Monsalve, Diana M./J-2374-2016
OI Pacheco Nieva, Yovana/0000-0002-0722-546X; Monsalve, Diana
   M./0000-0002-1145-1312
CR Adalja AA, 2010, EMERG INFECT DIS, V16, P1028, DOI [10.3201/eid1606.091563, 10.3201/eid1606.091653]
   Anaya JM, 2017, J AUTOIMMUN, V77, P123, DOI 10.1016/j.jaut.2016.12.007
   Anderson DE, 2001, CLIN IMMUNOL, V101, P152, DOI 10.1006/clim.2001.5114
   ANGELOVA LA, 1982, IMMUNOLOGY, V46, P183
   [Anonymous], 1958, NEW ENGL J MED, V258, P1016
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Berry JD, 1999, J INFECT DIS, V179, P180, DOI 10.1086/314538
   BEYER WEP, 1986, J HYG-CAMBRIDGE, V96, P513, DOI 10.1017/S0022172400066316
   Bopegamage S, 2016, VIRULENCE, V7, P495, DOI 10.1080/21505594.2016.1175701
   Chakradhar S, 2015, NAT MED, V21, P540, DOI 10.1038/nm0615-540
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Choi YS, 2011, CLIN VACCINE IMMUNOL, V18, P1519, DOI 10.1128/CVI.05053-11
   Craig SB, 2009, ANN TROP MED PARASIT, V103, P467, DOI 10.1179/136485909X435102
   CURRIER J, 1992, INT IMMUNOL, V4, P985, DOI 10.1093/intimm/4.9.985
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   deStFazekas Groth Webster RG, 1966, J EXP MED, V124, P331, DOI [10.1084/jem 124 3331, DOI 10.1084/JEM.124.3.331]
   DEUTSCH S, 1975, IMMUNOCHEMISTRY, V12, P191, DOI 10.1016/0019-2791(75)90231-1
   DEUTSCH S, 1972, EUR J IMMUNOL, V2, P374, DOI 10.1002/eji.1830020416
   DEUTSCH S, 1973, EUR J IMMUNOL, V3, P235, DOI 10.1002/eji.1830030411
   Duangchinda T, 2010, P NATL ACAD SCI USA, V107, P16922, DOI 10.1073/pnas.1010867107
   EAST IJ, 1980, MOL IMMUNOL, V17, P1539, DOI 10.1016/0161-5890(80)90179-0
   Elmastour F, 2016, VIRULENCE, V7, P527, DOI 10.1080/21505594.2016.1152442
   Fazekas de St Groth, 1966, J Exp Med, V124, P347, DOI 10.1084/jem.124.3.347
   Francis TJ, 1960, P AM PHILOS SOC, V104, P572, DOI DOI 10.1371/JOURNAL.PPAT.1005806
   Frias-Staheli N, 2014, J VIROL, V88, P2205, DOI 10.1128/JVI.03085-13
   Friberg H, 2011, SCI REP-UK, V1, DOI 10.1038/srep00051
   GOOD MF, 1993, PARASITE IMMUNOL, V15, P187, DOI 10.1111/j.1365-3024.1993.tb00599.x
   Gunther VJ, 2011, VACCINE, V29, P3895, DOI 10.1016/j.vaccine.2011.03.038
   Haaheim L R, 2003, Dev Biol (Basel), V115, P49
   HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154
   INOUYE S, 1984, MICROBIOL IMMUNOL, V28, P569, DOI 10.1111/j.1348-0421.1984.tb00709.x
   Kantola K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139096
   Kantola K, 2011, J INFECT DIS, V204, P1403, DOI 10.1093/infdis/jir525
   Kim JH, 2012, P NATL ACAD SCI USA, V109, P13751, DOI 10.1073/pnas.0912458109
   Kim JH, 2009, J IMMUNOL, V183, P3294, DOI 10.4049/jimmunol.0900398
   Klenerman P, 1998, NATURE, V394, P482
   Koraka P, 2007, MICROBES INFECT, V9, P940, DOI 10.1016/j.micinf.2007.03.012
   Kucharski AJ, 2012, THEOR POPUL BIOL, V81, P102, DOI 10.1016/j.tpb.2011.12.006
   KUNO G, 1993, T ROY SOC TROP MED H, V87, P103, DOI 10.1016/0035-9203(93)90444-U
   Lambert PH, 2005, NAT MED, V11, pS54, DOI 10.1038/nm1216
   Li XM, 2015, J GEN VIROL, V96, P3099, DOI 10.1099/jgv.0.000253
   Linderman SL, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005806
   Ma JL, 2011, J THEOR BIOL, V288, P29, DOI 10.1016/j.jtbi.2011.08.003
   Mangada MM, 2002, J INFECT DIS, V185, P1697, DOI 10.1086/340822
   MASUREL N, 1976, INFECT IMMUN, V13, P1023, DOI 10.1128/IAI.13.4.1023-1029.1976
   MCELHANEY JE, 1993, VACCINE, V11, P1055, DOI 10.1016/0264-410X(93)90133-I
   Midgley CM, 2011, J VIROL, V85, P410, DOI 10.1128/JVI.01826-10
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Nachbagauer R, 2017, NAT IMMUNOL, V18, P464, DOI 10.1038/ni.3684
   Ndifon W, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0627
   O'Donnell CD, 2014, CLIN VACCINE IMMUNOL, V21, P737, DOI 10.1128/CVI.00790-13
   Park MS, 2016, IMMUNE NETW, V16, P261, DOI 10.4110/in.2016.16.5.261
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reichert T, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-5
   Rothman Alan L, 2014, Curr Trop Med Rep, V1, P13
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Singh RAK, 2002, J IMMUNOL, V169, P6779, DOI 10.4049/jimmunol.169.12.6779
   Taylor A, 2015, IMMUNOL REV, V268, P340, DOI 10.1111/imr.12367
   THOMPSON MA, 1983, J EXP MED, V158, P112, DOI 10.1084/jem.158.1.112
   Tsuchiya H, 2000, J CLIN VIROL, V19, P205, DOI 10.1016/S1386-6532(00)00123-2
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   VIRELIZIER JL, 1974, J EXP MED, V140, P1571, DOI 10.1084/jem.140.6.1571
   WEBSTER RG, 1976, J INFECT DIS, V134, P48, DOI 10.1093/infdis/134.1.48
   WEBSTER RG, 1966, J IMMUNOL, V97, P177
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   WHITEHEAD RH, 1970, AM J TROP MED HYG, V19, P94, DOI 10.4269/ajtmh.1970.19.94
   YARCHOAN R, 1984, J IMMUNOL, V132, P928
   Zehn D, 2010, J IMMUNOL, V184, P6320, DOI 10.4049/jimmunol.1000149
   Zompi S, 2013, P NATL ACAD SCI USA, V110, P8761, DOI 10.1073/pnas.1306333110
NR 70
TC 41
Z9 42
U1 1
U2 6
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0896-8411
EI 1095-9157
J9 J AUTOIMMUN
JI J. Autoimmun.
PD SEP
PY 2017
VL 83
BP 12
EP 21
DI 10.1016/j.jaut.2017.04.008
PG 10
WC Immunology
SC Immunology
GA FG6FU
UT WOS:000410468400002
PM 28479213
DA 2020-07-08
ER

PT J
AU Leggett, RM
   Clark, MD
AF Leggett, Richard M.
   Clark, Matthew D.
TI A world of opportunities with nanopore sequencing
SO JOURNAL OF EXPERIMENTAL BOTANY
LA English
DT Review
DE Assembly; bioinformatics; diagnostics; nanopore; sequencing; technology;
   third-generation
ID REAL-TIME; GENOME ASSEMBLIES; ZIKA VIRUS; MINION; LONG; ALIGNMENT;
   IDENTIFICATION; PATHOGENS; METHYLATION; NONHYBRID
AB Oxford Nanopore Technologies' MinION sequencer was launched in pre-release form in 2014 and represents an exciting new sequencing paradigm. The device offers multi-kilobase reads and a streamed mode of operation that allows processing of reads as they are generated. Crucially, it is an extremely compact device that is powered from the USB port of a laptop computer, enabling it to be taken out of the lab and facilitating previously impossible in-field sequencing experiments to be undertaken. Many of the initial publications concerning the platform focused on provision of tools to access and analyse the new sequence formats and then demonstrating the assembly of microbial genomes. More recently, as throughput and accuracy have increased, it has been possible to begin work involving more complex genomes and metagenomes. With the release of the high-throughput GridION X5 and PromethION platforms, the sequencing of large genomes will become more cost efficient, and enable the leveraging of extremely long (> 100 kb) reads for resolution of complex genomic structures. This review provides a brief overview of nanopore sequencing technology, describes the growing range of nanopore bioinformatics tools, and highlights some of the most influential publications that have emerged over the last 2 years. Finally, we look to the future and the potential the platform has to disrupt work in human, microbiome, and plant genomics.
C1 [Leggett, Richard M.; Clark, Matthew D.] Earlham Inst, Norwich Res Pk, Norwich NR4 7UZ, Norfolk, England.
   [Clark, Matthew D.] Univ East Anglia, Norwich NR4 7TJ, Norfolk, England.
RP Leggett, RM (corresponding author), Earlham Inst, Norwich Res Pk, Norwich NR4 7UZ, Norfolk, England.
EM richard.leggett@earlham.ac.uk
OI Leggett, Richard/0000-0003-3044-4297; Clark, Matthew/0000-0002-8049-5423
FU BBSRCBiotechnology and Biological Sciences Research Council (BBSRC)
   [BB/N023196/1, BB/J010375/1, BB/CCG1720/1, BB/J004669/1]; ONT
FX In our MinION work, we are grateful for the contributions of other
   members of Earlham Institute's MinION taskforce, especially Darren
   Heavens, Yuxuan Lan, and Robert Davey, and also to the Platforms &
   Pipelines team, Tim Stitt, and the NBI Computing infrastructure for
   Science (CiS) group. We thank Ned Peel for commenting on a manuscript
   draft. We have also appreciated the expertise of the wider MinION
   community, particularly through our interactions with members of the
   MARC consortium. Our MinION work is supported by BBSRC TRDF award
   BB/N023196/1, BBSRC National Capability Grants BB/J010375/1 and
   BB/CCG1720/1, BBSRC Institute Strategic Programme Grant BB/J004669/1,
   and BBSRC Core Strategic Programme Grant BB/J004669/1. The authors have
   not received direct financial contributions from ONT, but have received
   a small number of free flowcells as part of the MAP and MARC programmes.
   RML is in receipt of travel and accommodation expenses to speak at an
   ONT conference and is on a PhD student advisory team with a member of
   ONT staff.
CR Ashton PM, 2015, NAT BIOTECHNOL, V33, P296, DOI 10.1038/nbt.3103
   Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021
   Boza V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178751
   Bradley P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10063
   Castro-Wallace SL, 2016, BIORXIV, DOI [10.1101/077651, DOI 10.1101/077651]
   Chaisson MJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-238
   Cheng SH, 2015, CLIN CHEM, V61, P1305, DOI 10.1373/clinchem.2015.245076
   Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]
   Datema E., 2016, BIORXIV, DOI [10.1101/084772, DOI 10.1101/084772]
   David M, 2017, BIOINFORMATICS, V33, P49, DOI 10.1093/bioinformatics/btw569
   Davis BM, 2013, CURR OPIN MICROBIOL, V16, P192, DOI 10.1016/j.mib.2013.01.011
   Deamer D, 2016, NAT BIOTECHNOL, V34, P518, DOI 10.1038/nbt.3423
   Deschamps S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28625
   Edwards A., 2016, EXTREME METAGENOMICS, DOI [10.1101/073965, DOI 10.1101/073965]
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0356-2
   Garalde DR, 2016, BIORXIV, DOI [10.1101/068809, DOI 10.1101/068809]
   Goodwin S, 2015, GENOME RES, V25, P1750, DOI 10.1101/gr.191395.115
   Goto Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep31324
   Green M. R., 2012, MOL CLONING LAB MANU
   Greninger AL, 2016, GENOME ANNOUNCEMENTS, V4
   Greninger AL, 2017, DIAGN MICR INFEC DIS, V87, P1, DOI 10.1016/j.diagmicrobio.2016.10.013
   Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0220-9
   Ip Camilla L C, 2015, F1000Res, V4, P1075, DOI 10.12688/f1000research.7201.1
   Istace B, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/giw018
   Jain M, 2017, BIORXIV, DOI DOI 10.1101/128835
   Jain Miten, 2017, F1000Res, V6, P760, DOI 10.12688/f1000research.11354.1
   Jain M, 2015, NAT METHODS, V12, P351, DOI [10.1038/NMETH.3290, 10.1038/nmeth.3290]
   Jansen H. J., 2017, BIORXIV, DOI [10.1101/101907, DOI 10.1101/101907]
   Johnson Sarah S, 2017, J Biomol Tech, V28, P2, DOI 10.7171/jbt.17-2801-009
   Judge K, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000085
   Karamitros T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157600
   Karlsson E, 2015, SCI REP-UK, V5, DOI 10.1038/srep11996
   Kielbasa SM, 2011, GENOME RES, V21, P487, DOI 10.1101/gr.113985.110
   Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116
   Laszlo AH, 2013, P NATL ACAD SCI USA, V110, P18904, DOI 10.1073/pnas.1310240110
   Leggett RM, 2016, BIOINFORMATICS, V32, P142, DOI 10.1093/bioinformatics/btv540
   Li H, 2016, BIOINFORMATICS, V32, P2103, DOI 10.1093/bioinformatics/btw152
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Loman NJ, 2015, NAT METHODS, V12, P733, DOI [10.1038/nmeth.3444, 10.1038/NMETH.3444]
   Loman NJ, 2014, BIOINFORMATICS, V30, P3399, DOI 10.1093/bioinformatics/btu555
   Loose M, 2016, NAT METHODS, V13, P751, DOI [10.1038/NMETH.3930, 10.1038/nmeth.3930]
   Lu HY, 2016, GENOM PROTEOM BIOINF, V14, P265, DOI 10.1016/j.gpb.2016.05.004
   Madoui MA, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1519-z
   Millard AD, 2015, GENOME ANNOUNCEMENTS, V3
   Cao MD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14515
   Cao MD, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0137-2
   Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196
   Norris AL, 2016, CANCER BIOL THER, V17, P246, DOI 10.1080/15384047.2016.1139236
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Quick J, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0677-2
   Rand AC, 2017, NAT METHODS, V14, P411, DOI 10.1038/nmeth.4189
   Schmidt K, 2017, J ANTIMICROB CHEMOTH, V72, P104, DOI 10.1093/jac/dkw397
   Schmidt MH, 2017, RECONSTRUCTING GIGAB, DOI [10.1101/129148., DOI 10.1101/129148, 10.1101/129148]
   Schreiber J, 2015, BIOINFORMATICS, V31, P1897, DOI 10.1093/bioinformatics/btv046
   Schreiber J, 2013, P NATL ACAD SCI USA, V110, P18910, DOI 10.1073/pnas.1310615110
   Simpson JT, 2017, NAT METHODS, V14, P407, DOI 10.1038/nmeth.4184
   Smith AM, 2017, BIORXIV, DOI [10.1101/132274, DOI 10.1101/132274]
   Sovic I, 2016, BIOINFORMATICS, V32, P2582, DOI 10.1093/bioinformatics/btw237
   Sovic I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11307
   Szalay T, 2015, NAT BIOTECHNOL, V33, P1087, DOI 10.1038/nbt.3360
   Travers KJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq543
   Turton JF, 2016, J MED MICROBIOL, V65, P538, DOI 10.1099/jmm.0.000248
   Tyson JR, 2017, BIORXIV, DOI DOI 10.1101/099143
   van der Helm E, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw1328
   Vaser R, 2017, GENOME RES, V27, P737, DOI 10.1101/gr.214270.116
   VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484
   Votintseva AA, 2017, J CLIN MICROBIOL, V55, P1285, DOI 10.1128/JCM.02483-16
   Walter MC, 2017, J BIOTECHNOL, V250, P16, DOI 10.1016/j.jbiotec.2016.12.006
   Wang J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00766
   Warren RL, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0076-3
   Watson M, 2015, BIOINFORMATICS, V31, P114, DOI 10.1093/bioinformatics/btu590
   Wei S, 2016, GENETICS, V202, P37, DOI 10.1534/genetics.115.182311
NR 73
TC 38
Z9 39
U1 2
U2 47
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0022-0957
EI 1460-2431
J9 J EXP BOT
JI J. Exp. Bot.
PD SEP 1
PY 2017
VL 68
IS 20
BP 5419
EP 5429
DI 10.1093/jxb/erx289
PG 11
WC Plant Sciences
SC Plant Sciences
GA FO8SZ
UT WOS:000417159100003
PM 28992056
OA Bronze
DA 2020-07-08
ER

PT J
AU Rossini, G
   Gaibani, P
   Vocale, C
   Cagarelli, R
   Landini, MP
AF Rossini, Giada
   Gaibani, Paolo
   Vocale, Caterina
   Cagarelli, Roberto
   Landini, Maria Paola
TI Comparison of Zika virus (ZIKV) RNA detection in plasma, whole blood and
   urine - Case series of travel-associated ZIKV infection imported to
   Italy, 2016
SO JOURNAL OF INFECTION
LA English
DT Article
DE Vector-borne infections; Zika virus RNA; Plasma; Whole blood; Urine
ID PCR; SPECIMENS; DIAGNOSIS; SALIVA
AB Objectives: The capability to detect ZIKV RNA is of crucial importance for cases confirmation. However, due to the short-lived viremia, the detection of ZIKV RNA in plasma/serum is challenging for samples collected more than one week after onset of clinical illness. We compared the window time and detection rate of ZIKV RNA in different specimen types (plasma, whole blood and urine) collected simultaneously at several times post-symptom onset.
   Methods: We examined the presence of ZIKV RNA in matched specimens of whole blood, plasma and urine collected in the same date (3-28 days after symptom onset) from 10 ZIKV infected patients.
   Results: ZIKV RNA was found in plasma as late as 10 days after symptoms onset and tested positive in all 5 (100%) and in 2 of 6(33,3%) plasma samples collected 1-5 and 6-10 days after symptoms onset, respectively. ZIKV RNA was positive in urine through the 21st day after symptom onset; the detection rate of ZIKV RNA in urine samples was 100% (11/11) for samples collected 1-10 days from symptoms onset, decreasing at later times of sampling. The detection rate of ZIKV RNA in whole blood was comparable to that in urine samples but extended the window of detection of ZIKV RNA up to 26 days after symptom onset.
C1 [Rossini, Giada; Gaibani, Paolo; Vocale, Caterina; Landini, Maria Paola] St Orsola Malpighi Hosp, Reg Reference Ctr Microbiol Emergencies CRREM, Unit Microbiol, Bologna, Italy.
   [Cagarelli, Roberto] Reg Hlth Author, Bologna, Italy.
RP Rossini, G (corresponding author), St Orsola Hosp, Reg Reference Ctr Microbiol Emergencies CRREM, Unit Clin Microbiol, Via Massarenti 9, I-40138 Bologna, Italy.
EM giada.rossini@unibo.it
RI Vocale, Caterina/AAK-9921-2020; Rossini, Giada/K-8815-2016; gaibani,
   paolo/K-7690-2016
OI Rossini, Giada/0000-0002-8917-6680; gaibani, paolo/0000-0003-3791-8635;
   Vocale, Caterina/0000-0001-7470-1713
FU Fondi Finalizzati LABP3 from Regione Emilia-Romagna
FX This study was supported by Fondi Finalizzati LABP3 from Regione
   Emilia-Romagna.
CR Barzon L., 2016, EURO SURVEILL, V21
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Edwards CJ, 2007, J CLIN VIROL, V39, P271, DOI 10.1016/j.jcv.2007.05.008
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Klungthong C, 2007, J CLIN MICROBIOL, V45, P2480, DOI 10.1128/JCM.00305-07
   Kong YY, 2006, J VIROL METHODS, V138, P123, DOI 10.1016/j.jviromet.2006.08.003
   Lanteri MC, 2014, TRANSFUSION, V54, P3232, DOI 10.1111/trf.12764
   Lustig Y, 2016, EUROSURVEILLANCE, V30, P21
   Lustig Y, 2016, J CLIN MICROBIOL, V54, P2294, DOI 10.1128/JCM.01283-16
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Paz-Bailey G, 2017, N ENGL J MED
   Pessoa R, 2016, EUROSURVEILLANCE, P21
NR 17
TC 14
Z9 15
U1 0
U2 15
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0163-4453
EI 1532-2742
J9 J INFECTION
JI J. Infect.
PD SEP
PY 2017
VL 75
IS 3
BP 242
EP 245
DI 10.1016/j.jinf.2017.05.021
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA FE2CB
UT WOS:000408022800007
PM 28648495
OA Bronze
DA 2020-07-08
ER

PT J
AU Hueston, L
   Ramirez, R
   Mahalingam, S
AF Hueston, Linda
   Ramirez, Ruben
   Mahalingam, Suresh
TI Enhancement of Zika Infection by Dengue Virus-Specific Antibody Is
   Associated With Low Levels of Antiviral Factors
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Letter
ID DEPENDENT ENHANCEMENT; MACROPHAGES; INTERLEUKIN-6
C1 [Hueston, Linda] Westmead Hosp, Ctr Infect Dis & Microbiol Lab Serv, Arbovirus Emerging Dis Unit, Westmead, NSW, Australia.
   [Hueston, Linda] Westmead Hosp, Inst Clin Pathol & Med Res CIDMLS ICPMR, Westmead, NSW, Australia.
   [Ramirez, Ruben] Univ Canberra, Fac Sci Appl, Canberra, ACT, Australia.
   [Mahalingam, Suresh] Griffith Univ, Inst Glyc, Emerging Viruses & Inflammat Res Grp, Gold Coast, Qld 4222, Australia.
RP Mahalingam, S (corresponding author), Griffith Univ, Inst Glyc, Emerging Viruses & Inflammat Res Grp, Gold Coast, Qld 4222, Australia.
EM s.mahalingam@griffith.edu.au
FU Australian National Health and Medical Research Council (NHMRC)National
   Health and Medical Research Council of Australia [APP1079086];
   NHMRCNational Health and Medical Research Council of Australia
   [APP1059167]
FX This study was supported by the Australian National Health and Medical
   Research Council (NHMRC) to S. M. (grant number APP1079086). S. M. is
   the recipient of an NHMRC Senior Research Fellowship (grant number
   APP1059167).
CR Boonnak K, 2011, J VIROL, V85, P1671, DOI 10.1128/JVI.00220-10
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   FAGBAMI AH, 1987, CYTOBIOS, V49, P49
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3
   Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rolph MS, 2011, J INFECT DIS, V204, P489, DOI 10.1093/infdis/jir271
   Ubol S, 2010, J INFECT DIS, V201, P923, DOI 10.1086/651018
NR 10
TC 5
Z9 6
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD SEP 1
PY 2017
VL 216
IS 5
BP 612
EP 614
DI 10.1093/infdis/jix344
PG 3
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FG6UY
UT WOS:000410532400014
PM 28931226
OA Bronze
DA 2020-07-08
ER

PT J
AU Castanha, PMS
   Nascimento, EJM
   Braga, C
   Cordeiro, MT
   de Carvalho, OV
   de Mendonca, LR
   Azevedo, EAN
   Franca, RFO
   Dhalia, R
   Marques, ETA
AF Castanha, Priscila M. S.
   Nascimento, Eduardo J. M.
   Braga, Cynthia
   Cordeiro, Marli T.
   de Carvalho, Otavio V.
   de Mendonca, Leila R.
   Azevedo, Elisa A. N.
   Franca, Rafael F. O.
   Dhalia, Rafael
   Marques, Ernesto T. A.
TI Enhancement of Zika Infection by Dengue-Specific Antibodies Does Not
   Alter the Production of Interleukin 6 in Fc gamma RII-Expressing K562
   Cells
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Letter
ID DEPENDENT ENHANCEMENT; VIRUS
C1 [Castanha, Priscila M. S.; Braga, Cynthia; Cordeiro, Marli T.; de Carvalho, Otavio V.; de Mendonca, Leila R.; Azevedo, Elisa A. N.; Franca, Rafael F. O.; Dhalia, Rafael; Marques, Ernesto T. A.] Fundacao Oswaldo Cruz, FIOCRUZ, Aggeu Magalhaes Res Ctr, Recife, PE, Brazil.
   [Castanha, Priscila M. S.] Univ Pernambuco, Inst Biol Sci, Fac Med Sci, Recife, PE, Brazil.
   [Braga, Cynthia] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Nascimento, Eduardo J. M.; Marques, Ernesto T. A.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA.
   [Nascimento, Eduardo J. M.; Marques, Ernesto T. A.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA 15260 USA.
RP Marques, ETA (corresponding author), Ctr Vaccine Res, 3501 Fifth Ave,9052 Biomed Sci Tower 3, Pittsburgh, PA 15261 USA.
EM marques@pitt.edu
RI Braga, Maria Cynthia/A-8204-2013; Dhalia, Rafael/AAD-5432-2020; Marques,
   Ernesto T. A/L-4967-2013; CASTANHA, PRISCILA/G-1785-2012
OI Braga, Maria Cynthia/0000-0002-7862-6455; Marques, Ernesto T.
   A/0000-0003-3826-9358; Freitas de Oliveira Franca,
   Rafael/0000-0002-1846-6007; CASTANHA, PRISCILA/0000-0002-1220-5308
FU Brazilian Federal Agency for Support and Evaluation of Graduate
   Education; Center for Vaccine Research, University of Pittsburgh;
   Fogarty Training Program [D43TW006592 Pitt GIDRTP/323 NIH]; National
   Council for Scientific and Technological DevelopmentNational Council for
   Scientific and Technological Development (CNPq) [482915/2010-2
   MCT/CNPq-321 14/2010]; Strategic Program to Support Health
   Research/PAPES VI [322 407697/2012-8]; National Institute of Allergy and
   Infectious Diseases, National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [U19 AI56541]
FX This work was supported by the Brazilian Federal Agency for Support and
   Evaluation of Graduate Education; Center for Vaccine Research,
   University of Pittsburgh; Fogarty Training Program (grant number
   D43TW006592 Pitt GIDRTP/323 NIH to P. M. S. C.); National Council for
   Scientific and Technological Development (grant number 482915/2010-2
   MCT/CNPq-321 14/2010); Strategic Program to Support Health
   Research/PAPES VI (grant number 322 407697/2012-8); and National
   Institute of Allergy and Infectious Diseases, National Institutes of
   Health (grant number U19 AI56541).
CR Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Halstead SB, 2017, EMERG INFECT DIS, V23, P569, DOI 10.3201/eid2304.161879
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Hueston L, 2017, J INFECT DIS, V216, P612, DOI 10.1093/infdis/jix344
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   Mahalingam S, 2017, LANCET INFECT DIS, V17, P686, DOI 10.1016/S1473-3099(17)30340-7
   Ng JKW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004031
NR 10
TC 4
Z9 4
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD SEP 1
PY 2017
VL 216
IS 5
BP 614
EP 615
DI 10.1093/infdis/jix346
PG 3
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FG6UY
UT WOS:000410532400015
PM 28931227
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Yoon, D
   Shin, SH
   Jang, HC
   Kim, ES
   Song, EH
   Moon, SM
   Shin, SY
   Choe, PG
   Sung, JJ
   Choi, EH
   Oh, MD
   Jee, Y
   Kim, NJ
AF Yoon, Doran
   Shin, Seung Hwan
   Jang, Hee-Chang
   Kim, Eu Suk
   Song, Eun Hee
   Moon, Song Mi
   Shin, So Youn
   Choe, Pyeong Gyun
   Sung, Jung-Joon
   Choi, Eun Hwa
   Oh, Myoung-don
   Jee, Youngmee
   Kim, Nam Joong
TI Epidemiology and Clinical Characteristics of Zika Virus Infections
   Imported into Korea from March to October 2016
SO JOURNAL OF KOREAN MEDICAL SCIENCE
LA English
DT Article
DE Zika Virus; Travel; Virus Shedding; Asia, Southeastern; Latin America;
   Korea
ID AEDES-AEGYPTI; MICRONESIA; ISOLATIONS; OUTBREAK; BRAZIL
AB Zika is a re-emerging, mosquito-borne viral infection, which has been recently shown to cause microcephaly and Guillain-Barre syndrome. Since 2015 the number of infected patients has increased significantly in South America. The purpose of this study was to identify the epidemiologic and clinical characteristics of patients with Zika virus (ZIKV) infections in Korea. Patients who had visited areas of risk and tested positive in the ZIKV reverse transcriptase polymerase chain reaction (RT-PCR) in blood, urine, or saliva specimens were included. The first Korean case of ZIKV infection was reported in March 2016, and 14 cases had been reported by October 2016. The median age of the patients was 34 years (19-64 years). Ten patients had been exposed in Southeast Asia and 4 in Latin America. Rash was the most common symptom (92.9%; 13/14), followed by myalgia (50.0%; 7/14), and arthralgia (28.6%, 4/14). There were no neurologic abnormalities and none of the patients was pregnant. Results of biochemical tests were normal. Positivity rates of RT-PCR for ZIKV in serum, urine, and saliva were 53.8%, 100.0%, and 83.3%, respectively in the first week of symptoms. In conclusion, 14 patients with ZIKV infections were reported in Korea by October 2016 and all of them had mild clinical symptoms.
C1 [Yoon, Doran; Kim, Eu Suk; Choe, Pyeong Gyun; Oh, Myoung-don; Kim, Nam Joong] Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.
   [Shin, Seung Hwan] Korea Ctr Dis Control & Prevent, Div Publ Hlth Preparedness & Response, Cheongju, South Korea.
   [Jang, Hee-Chang] Chonnam Natl Univ, Med Sch, Dept Internal Med, Gwangju, South Korea.
   [Song, Eun Hee] Univ Ulsan, Coll Med, Gangneung Asan Hosp, Dept Infect Dis, Kangnung, South Korea.
   [Moon, Song Mi] Gachon Univ, Gil Med Ctr, Dept Internal Med, Incheon, South Korea.
   [Shin, So Youn] Catholic Kwandong Univ, Coll Med, Int St Marys Hosp, Dept Infect Dis, Incheon, South Korea.
   [Sung, Jung-Joon] Seoul Natl Univ, Coll Med, Dept Neurol, Seoul, South Korea.
   [Choi, Eun Hwa] Seoul Natl Univ, Coll Med, Dept Pediat, Seoul, South Korea.
   [Jee, Youngmee] Korea Ctr Dis Control & Prevent, Natl Inst Hlth, Ctr Immunol & Pathol, Cheongju, South Korea.
RP Kim, NJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.
EM molder@unitel.co.kr
OI Choe, Pyoeng Gyun/0000-0001-6794-7918; Shin, Seung
   Hwan/0000-0003-3411-4455; Jang, Hee-Chang/0000-0002-3407-8493
FU Korea Centers for Disease Control and Prevention [2016P2400100]
FX This study was supported by the Korea Centers for Disease Control and
   Prevention (2016P2400100).
CR Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fisher D, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0737-9
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Jang HC, 2016, J KOREAN MED SCI, V31, P1173, DOI 10.3346/jkms.2016.31.7.1173
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LEE S-K, 1991, Korean Journal of Entomology, V21, P141
   Lee SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068512
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Woo Jong Jin, 2016, Journal of Bacteriology and Virology, V46, P330, DOI 10.4167/jbv.2016.46.4.330
   World Health Organization (WHO), ZIK SIT REP
NR 24
TC 1
Z9 1
U1 0
U2 7
PU KOREAN ACAD MEDICAL SCIENCES
PI SEOUL
PA 302 75 DONG DU ICHON, DONG YONGSAN KU, SEOUL 140 031, SOUTH KOREA
SN 1011-8934
EI 1598-6357
J9 J KOREAN MED SCI
JI J. Korean Med. Sci.
PD SEP
PY 2017
VL 32
IS 9
BP 1440
EP 1444
DI 10.3346/jkms.2017.32.9.1440
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA FF7IK
UT WOS:000409189500008
PM 28776338
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU O'Donnell, KL
   Bixby, MA
   Morin, KJ
   Bradley, DS
   Vaughan, JA
AF O'Donnell, Kyle L.
   Bixby, Mckenzie A.
   Morin, Kelsey J.
   Bradley, David S.
   Vaughan, Jefferson A.
TI Potential of a Northern Population of Aedes vexans (Diptera: Culicidae)
   to Transmit Zika Virus
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Aedes vexans; arbovirus; mosquito; Zika virus
ID WEST-NILE-VIRUS; VALLEY FEVER VIRUS; VECTOR COMPETENCE;
   DIROFILARIA-REPENS; ENCEPHALITIS-VIRUS; AMERICAN MOSQUITOS;
   FIELD-EVALUATION; DAKOTA; CALIFORNIA; SEEKING
AB Zika virus is an emerging arbovirus of humans in the western hemisphere. With its potential spread into new geographical areas, it is important to define the vector competence of native mosquito species. We tested the vector competency of Aedes vexans (Meigen) from the Lake Agassiz Plain of northwestern Minnesota and northeastern North Dakota. Aedes aegypti (L.) was used as a positive control for comparison. Mosquitoes were fed blood containing Zika virus and 2 wk later were tested for viral infection and dissemination. Aedes vexans (n = 60) were susceptible tomidgut infection (28% infection rate) but displayed a fairly restrictive midgut escape barrier (3% dissemination rate). Cofed Ae. aegypti (n = 22) displayed significantly higher rates of midgut infection (61%) and dissemination (22%). To test virus transmission, mosquitoes were inoculated with virus and 16-17 d later, tested for their ability to transmit virus into fluid-filled capillary tubes. Unexpectedly, the transmission rate was significantly higher for Ae. vexans (34%, n = 47) than for Ae. aegypti (5%, n = 22). The overall transmission potential for Ae. vexans to transmit Zika virus was 1%. Because of its wide geographic distribution, often extreme abundance, and aggressive human biting activity, Ae. vexans could serve as a potential vector for Zika virus in northern latitudes where the conventional vectors, Ae. aegypti and Ae. albopictus Skuse, cannot survive. However, Zika virus is a primate virus and humans are the only amplifying host species in northern latitudes. To serve as a vector of Zika virus, Ae. vexans must feed repeatedly on humans. Defining the propensity of Ae. vexans to feed repeatedly on humans will be key to understanding its role as a potential vector of Zika virus.
C1 [O'Donnell, Kyle L.; Bradley, David S.] Univ North Dakota, Sch Med & Hlth Sci, Dept Basic Sci, Grand Forks, ND 58202 USA.
   [Bixby, Mckenzie A.; Morin, Kelsey J.; Vaughan, Jefferson A.] Univ North Dakota, Dept Biol, Grand Forks, ND 58202 USA.
RP Vaughan, JA (corresponding author), Univ North Dakota, Dept Biol, Grand Forks, ND 58202 USA.
EM kyle.odonnell@und.edu; mckenzie.bixby@und.edu; kelsey.j.morin@und.edu;
   david.s.bradley@med.und.edu; jefferson.vaughan@email.und.edu
FU National Science FoundationNational Science Foundation (NSF) [RAPID
   1641002]; Center of Research Excellence for Avian Therapeutics for
   Infectious Disease (COREATID); National Institute of General Medical
   Sciences project grant entitled Center of Biomedical Research Excellence
   for In-Host Pathogen Interactions [P20GM113123]
FX We thank Mr. Steven Adkins for his technical assistance. The Zika virus
   used in this study was a kind gift from Dr. Pohland Mayo Clinic,
   Rochester, MN, USA. Aedes aegypti, strain COSTA RICA, MRA-726, was
   obtained through BEI Resources, NIAID, NIH: contributed by William G.
   Brogdon. This study was conducted under authority of University of North
   Dakota Institutional Biosafety Committee protocol 201605-022 and was
   supported in part from grants from the National Science Foundation
   (RAPID 1641002) (J.A.V.), the Center of Research Excellence for Avian
   Therapeutics for Infectious Disease (COREATID) (D.S.B.), and the
   National Institute of General Medical Sciences project grant entitled
   Center of Biomedical Research Excellence for In-Host Pathogen
   Interactions (P20GM113123) (D.S.B., J.A.V.). The content is solely the
   responsibility of the authors and does not necessarily represent the
   official views of the funding agencies. The funding agencies had no role
   in the study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Anderson JF, 2015, AM J TROP MED HYG, V92, P377, DOI 10.4269/ajtmh.14-0291
   Anderson SL, 2010, J AM MOSQUITO CONTR, V26, P108, DOI 10.2987/09-5935.1
   Andreadis TG, 2004, VECTOR-BORNE ZOONOT, V4, P360, DOI 10.1089/vbz.2004.4.360
   Balenghien T, 2006, J MED ENTOMOL, V43, P936, DOI 10.1603/0022-2585(2006)43[936:HBAHBA]2.0.CO;2
   Bell JA, 2005, VECTOR-BORNE ZOONOT, V5, P373, DOI 10.1089/vbz.2005.5.373
   Berec L, 2014, J MED ENTOMOL, V51, P76, DOI 10.1603/ME12255
   Boccolini D, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.35.30328
   Bockova E, 2015, PARASITOL RES, V114, P4487, DOI 10.1007/s00436-015-4692-8
   Bolling BG, 2005, J VECTOR ECOL, V30, P186
   BOORMAN J, 1987, MED VET ENTOMOL, V1, P211, DOI 10.1111/j.1365-2915.1987.tb00346.x
   Briegel H, 2001, J MED ENTOMOL, V38, P557, DOI 10.1603/0022-2585-38.4.557
   BRUST RA, 1980, CAN ENTOMOL, V112, P31, DOI 10.4039/Ent11231-1
   Burkett Douglas A., 2002, Korean Journal of Parasitology, V40, P45, DOI 10.3347/kjp.2002.40.1.45
   BURKOT TR, 1982, AM J TROP MED HYG, V31, P376, DOI 10.4269/ajtmh.1982.31.376
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Clarke JL, 1943, J ECON ENTOMOL, V36, P121, DOI 10.1093/jee/36.1.121
   Costa-da-Silva AL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171951
   Di Luca M., 2016, EUROSURVEILLANCE, V21, DOI [10.2807/1560-7917.ES.2016.21.18.30223., DOI 10.2807/1560-7917.ES.2016.21.18.30223.]
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   EASTON ER, 1986, J AM MOSQUITO CONTR, V2, P190
   Eisen L, 2008, J MED ENTOMOL, V45, P800, DOI 10.1603/0022-2585(2008)45[800:MSRCAA]2.0.CO;2
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Francuski L, 2016, J VECTOR ECOL, V41, P160, DOI 10.1111/jvec.12208
   Fyodorova MV, 2006, J MED ENTOMOL, V43, P552, DOI 10.1603/0022-2585(2006)43[552:EOPWNV]2.0.CO;2
   Goddard LB, 2002, EMERG INFECT DIS, V8, P1385, DOI 10.3201/eid0812.020536
   Greenberg JA, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.7501
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Hammon WM, 1943, J EXP MED, V78, P241, DOI 10.1084/jem.78.4.241
   Hart CE, 2017, EMERG INFECT DIS, V23, P559, DOI 10.3201/eid2303.161636
   Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437
   Henderson JP, 2006, J AM MOSQUITO CONTR, V22, P401, DOI 10.2987/8756-971X(2006)22[401:AAOTEO]2.0.CO;2
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Iranpour M, 2011, J AM MOSQUITO CONTR, V27, P363, DOI 10.2987/11-6169.1
   JENSEN T, 1994, J MED ENTOMOL, V31, P607, DOI 10.1093/jmedent/31.4.607
   Kemenesi G, 2015, VET PARASITOL, V214, P108, DOI 10.1016/j.vetpar.2015.09.010
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Luhken R, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-268
   MAGNARELLI LA, 1977, AM J TROP MED HYG, V26, P547, DOI 10.4269/ajtmh.1977.26.547
   McPhatter LP, 2012, J AM MOSQUITO CONTR, V28, P240, DOI 10.2987/12-6230R.1
   Meece JK, 2002, CLIN MED RES, V1, P37
   Mehus JO, 2013, VECTOR-BORNE ZOONOT, V13, P818, DOI 10.1089/vbz.2012.1193
   Merdic E, 2001, J AM MOSQUITO CONTR, V17, P275
   Merdic Enrih, 2014, Coll Antropol, V38, P423
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Ndiaye E, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1383-y
   Ramirez JL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001561
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   RODL P, 1979, FOLIA PARASIT, V26, P61
   ROOKER JR, 1994, J AM MOSQUITO CONTR, V10, P127
   RUSSO RJ, 1977, MOSQ NEWS, V37, P712
   Schofield S, 2007, J MED ENTOMOL, V44, P457, DOI 10.1603/0022-2585(2007)44[457:FEAMOR]2.0.CO;2
   Szalanski AL, 2006, ANN ENTOMOL SOC AM, V99, P157, DOI 10.1603/0013-8746(2006)099[0157:GSOAVD]2.0.CO;2
   TAKASHIMA I, 1983, ARCH VIROL, V76, P299, DOI 10.1007/BF01311197
   Tiawsirisup S, 2008, J MED ENTOMOL, V45, P452, DOI 10.1603/0022-2585(2008)45[452:VCOAVD]2.0.CO;2
   Turell MJ, 2013, J MED ENTOMOL, V50, P1111, DOI 10.1603/ME13049
   Turell MJ, 2010, J MED ENTOMOL, V47, P884, DOI 10.1603/ME10007
   Turell MJ, 2008, J AM MOSQUITO CONTR, V24, P502, DOI 10.2987/08-5791.1
   Vaidyanathan R, 1997, J MED ENTOMOL, V34, P346, DOI 10.1093/jmedent/34.3.346
   Vaughan JA, 2012, J MED ENTOMOL, V49, P1430, DOI 10.1603/ME12103
   Wang ZM, 2012, J MED ENTOMOL, V49, P1283, DOI 10.1603/ME11131
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yaghoobi-Ershadi M. R., 2016, B SOC PATHOL EXPT, V27, DOI [10.1007/s13149-016-0530-1, DOI 10.1007/S13149-016-0530-1.]
NR 70
TC 13
Z9 14
U1 0
U2 11
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD SEP
PY 2017
VL 54
IS 5
BP 1354
EP 1359
DI 10.1093/jme/tjx087
PG 6
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA FF6OS
UT WOS:000409133700035
PM 28499036
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Erat, T
   Ciftci, E
AF Erat, Tugba
   Ciftci, Ergin
TI The Current Situation of Zika Virus Infection: Is Turkey at Risk?
SO JOURNAL OF PEDIATRIC INFECTION
LA English
DT Review
DE Guillain-Barre syndrome; microcephaly; pregnancy; zika virus
ID OUTBREAK; ISLAND; FEVER
AB Zika virus infection is the first major infectious disease leading to human birth defects in 2015. Zika virus gives rise to babies microcephalic and threatens the health of children and future generations. Although there is no Zika virus infections reported yet in Turkey, the ability to travel to any far countries easily, causes the increasing the risk of Zika virus infection in Turkey. We know that Turkish people travel to outbreak areas from Turkey. This review describes the current understanding of the epidemiology, transmission, clinical characteristics, and diagnosis of Zika virus infection with scanning the recent literature.
C1 [Erat, Tugba; Ciftci, Ergin] Ankara Univ, Dept Pediat, Div Pediat Infect Dis, Sch Med, Ankara, Turkey.
RP Erat, T (corresponding author), Ankara Univ, Tip Fak, Cocuk Enfeksiyon Hastaliklari Bilim Dali, Ankara, Turkey.
EM tugbacancan84@hotmail.com
CR [Anonymous], 2016, ZIK VIR MICR GUID BA
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Centers for Disease Control and Prevention, ZIK VIR
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Kelser EA, 2016, MICROBES INFECT, V18, P163, DOI 10.1016/j.micinf.2015.12.003
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Martines Roosecelis Brasil, 2016, MMWR Morb Mortal Wkly Rep, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   Tappe D, 2014, EUROSURVEILLANCE, P19
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   WHO, ZIK VIR SIT REP
   World Health Organization, 2016, ZIK VIR DIS INT CAS
NR 38
TC 0
Z9 0
U1 0
U2 0
PU AVES YAYINCILIK, IBRAHIM KARA
PI ISTANBUL
PA BUYUKDERE CAD 105-9 34394 MECIDIYEKOY, SISLI, ISTANBUL, 00000, TURKEY
SN 1307-1068
EI 1308-5271
J9 J PEDIATR INFECT
JI J. Pediatr. Infect.
PD SEP
PY 2017
VL 11
IS 3
BP 135
EP 139
DI 10.5578/ced.201729
PG 5
WC Pediatrics
SC Pediatrics
GA VI7FV
UT WOS:000510624100005
OA Bronze
DA 2020-07-08
ER

PT J
AU Ishwarya, R
   Vaseeharan, B
   Anuradha, R
   Rekha, R
   Govindarajan, M
   Alharbi, NS
   Kadaikunnan, S
   Khaled, JM
   Benelli, G
AF Ishwarya, R.
   Vaseeharan, Baskaralingam
   Anuradha, Ramasamy
   Rekha, Ravichandran
   Govindarajan, Marimuthu
   Alharbi, Naiyf S.
   Kadaikunnan, Shine
   Khaled, Jamal M.
   Benelli, Giovanni
TI Eco-friendly fabrication of Ag nanostructures using the seed extract of
   Pedalium murex, an ancient Indian medicinal plant: Histopathological
   effects on the Zika virus vector Aedes aegypti and inhibition of
   biofilm-forming pathogenic bacteria
SO JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
LA English
DT Article
DE Ag nanoparticles; CLSM; Dengue; EPS assay; Microbial pathogens; TEM
ID SILVER NANOPARTICLES; GOLD NANOPARTICLES; LEAF EXTRACT; GREEN SYNTHESIS;
   ANTIBIOFILM ACTIVITY; ANOPHELES-STEPHENSI; MOSQUITO VECTORS;
   PSEUDOMONAS-AERUGINOSA; CULEX-QUINQUEFASCIATUS; BACILLUS-LICHENIFORMIS
AB The control of Zika virus mosquito vectors and well as the development of drugs in the fight against biofilmforming microbial pathogens, are timely and important challenges in current bionanoscience. Here we focused on the eco-friendly fabrication of Ag nanostructures using the seed extract of Pedalium murex, an ancient Indian medicinal plant. Initial confirmation of Ag nanoparticles (AgNPs) production was showed by a color change from transparent to dark brown. The UV Visible spectrum (476 nm), X-ray diffraction peaks (101, 200, 220 and 311) and Fourier transform infrared spectroscopy shed light on the production of green -capped AgNPs. Morphological structure analysis using HR-TEM showed that the AgNPs were mostly hexagonal in shape with rough edges, and a size of 20-30 nm. The larvicidal potential of P. murex seed extract and AgNPs fabricated using the P. murex seed extract (Pm-AgNPs) was tested on fourth instar mosquito larvae of the Zika virus vector Aedes aegypti. Maximum efficacy was achieved by Pm AgNPs against Ae. aegypti after 24 h (LC50 34.88; LC90 64.56 mg/ml), if compared to the P. murex seed extract. Histopathological analyses showed severe damages to the hindgut and larval muscles in NPs -treated Ae. aegypti larvae. The sub-MIC concentrations of Pm-AgNPs exhibited significant anti-biofilm activity against Gram positive (Enterococcus faecalis, Staphylococcus aureus) and Gram negative (Shigella sonnei, Pseudomonas aeruginosa) bacterial pathogens, as showed by EPS and MTP assays. Light and CLSM microscopic studies highlighted a significant impact of P. murex seed extract and Pm synthesized AgNPs on the surface topography and architecture of bacterial biofilm, both in Gram positive and Gram negative species. Overall, results reported here contribute to the development of reliable large-scale protocols for the green fabrication of effective mosquito larvicides and biofilm inhibitors.
C1 [Ishwarya, R.; Vaseeharan, Baskaralingam; Anuradha, Ramasamy; Rekha, Ravichandran] Alagappa Univ, Dept Anim Hlth & Management, Biomat & Biotechnol Anim Hlth Lab, Karaikkudi 630004, Tamil Nadu, India.
   [Govindarajan, Marimuthu] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [Alharbi, Naiyf S.; Kadaikunnan, Shine; Khaled, Jamal M.] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh 11451, Saudi Arabia.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
   [Benelli, Giovanni] Scuola Super Sant Anna, BioRobot Inst, Viale Rinaldo Piaggio 34, I-56025 Pisa, Italy.
RP Vaseeharan, B (corresponding author), Alagappa Univ, Dept Anim Hlth & Management, Biomat & Biotechnol Anim Hlth Lab, Karaikkudi 630004, Tamil Nadu, India.
EM vaseeharanb@gmail.com
RI GOVINDARAJAN, MARIMUTHU/A-8070-2019; Khaled, Jamal/D-8188-2017;
   /L-2836-2013; Alharbi, Naiyf S/B-9402-2019; Benelli,
   Giovanni/A-9100-2013
OI GOVINDARAJAN, MARIMUTHU/0000-0002-4662-8931; /0000-0001-7018-5379;
   Benelli, Giovanni/0000-0001-8971-6010
FU Department of Biotechnology (DBT), New Delhi, IndiaDepartment of
   Biotechnology (DBT) India [BT/PR7903/AAQ/3/ 638/2013]; Deanship of
   Scientific Research at King Saud UniversityDeanship of Scientific
   Research at King Saud University [RG-1438-091]
FX R.I. gratefully acknowledges the Alagappa University Research Fellowship
   (AURF), Alagappa University, Karaikudi, India. and this work was
   partially supported by Department of Biotechnology (DBT), New Delhi,
   India, under the Project grants code: BT/PR7903/AAQ/3/ 638/2013. The
   authors extend their appreciation to the Deanship of Scientific Research
   at King Saud University for funding this work through research group No.
   RG-1438-091.
CR Ajayi A., 2015, J PHARM BIOL SCI, V10, P76
   AlSalhi MS, 2016, INT J NANOMED, V11, P4439, DOI 10.2147/IJN.S113193
   Azarudeen RMST, 2017, J CLUST SCI, V28, P369, DOI 10.1007/s10876-016-1103-y
   Azarudeen RMST, 2017, J CLUST SCI, V28, P179, DOI 10.1007/s10876-016-1067-y
   Azarudeen RMST, 2016, RSC ADV, V6, P96573, DOI 10.1039/c6ra23208f
   Baghizadeh A, 2015, J MOL LIQ, V207, P159, DOI 10.1016/j.molliq.2015.03.029
   Banumathi B, 2017, PARASITOL RES, V116, P1637, DOI 10.1007/s00436-017-5438-6
   Benelli G, 2017, ENTOMOL GEN, V36, P309, DOI 10.1127/entomologia/2017/0496
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Benelli G, 2017, J CLUST SCI, V28, P287, DOI 10.1007/s10876-016-1088-6
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P3201, DOI 10.1007/s00436-015-4656-z
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Caraballo R, 2015, EPILEPTIC DISORD, V17, P194, DOI 10.1684/epd.2015.0741
   Dhand V, 2016, MAT SCI ENG C-MATER, V58, P36, DOI 10.1016/j.msec.2015.08.018
   Elumalai D., 2016, ENG AGR ENV FOOD EAE, V9, P1, DOI [DOI 10.1016/j.eaef.2015.08.002, DOI 10.1016/J.EAEF.2015.08.002]
   Ghosh S, 2012, INT J NANOMED, V7, P483, DOI 10.2147/IJN.S24793
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Gurunathan S, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-373
   Gutierrez M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073986
   Jayanthi S., 2017, J PHOTOCHEM PHOTOB B
   Jayaseelan C, 2011, PARASITOL RES, V109, P185, DOI 10.1007/s00436-010-2242-y
   Kalimuthu K, 2017, PROCESS SAF ENVIRON, V109, P82, DOI 10.1016/j.psep.2017.03.027
   Kalishwaralal K, 2010, COLLOID SURFACE B, V79, P340, DOI 10.1016/j.colsurfb.2010.04.014
   Kevin King, 2014, EMERG MED PRACT, V16, P5
   Khatami M, 2015, BIORESOURCES, V2, P19, DOI DOI 10.1186/S40643-015-0043-Y
   Khiralla GM, 2015, LWT-FOOD SCI TECHNOL, V63, P1001, DOI 10.1016/j.lwt.2015.03.086
   Kumar V, 2009, J CHEM TECHNOL BIOT, V84, P151, DOI 10.1002/jctb.2023
   Luo J, 2016, DRUG DES DEV THER, V10, DOI 10.2147/DDDT.S97221
   Mahyoub JA, 2017, J CLUST SCI, V28, P565, DOI 10.1007/s10876-016-1127-3
   Malaikozhundan B, 2016, BIOCATAL AGR BIOTECH, V8, P189, DOI 10.1016/j.bcab.2016.09.007
   Marimuthu S, 2011, PARASITOL RES, V108, P1541, DOI 10.1007/s00436-010-2212-4
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   Murugan K, 2016, PARASITOL RES, V115, P651, DOI 10.1007/s00436-015-4783-6
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Nasrollahzadeh M, 2015, J COLLOID INTERF SCI, V457, P141, DOI 10.1016/j.jcis.2015.07.004
   Nguyen TMT, 2013, ACTA CHIM SLOV, V60, P673
   Patil CD, 2012, PARASITOL RES, V111, P555, DOI 10.1007/s00436-012-2867-0
   Pavela R, 2016, TRENDS PLANT SCI, V21, P1000, DOI 10.1016/j.tplants.2016.10.005
   Pavela R, 2016, EXP PARASITOL, V167, P103, DOI 10.1016/j.exppara.2016.05.010
   Raj KJA, 2009, ACS APPL MATER INTER, V1, P2462, DOI 10.1021/am900437u
   Rajan R, 2015, IND CROP PROD, V70, P356, DOI 10.1016/j.indcrop.2015.03.015
   Rajashekar V., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P581, DOI 10.1016/S2221-1691(12)60101-4
   Rajkumari J, 2017, MICROB PATHOGENESIS, V107, P261, DOI 10.1016/j.micpath.2017.03.044
   Raju D, 2014, APPL NANOSCI, V4, P875, DOI 10.1007/s13204-013-0269-y
   Santhosh SB, 2015, J PHOTOCH PHOTOBIO B, V153, P184, DOI 10.1016/j.jphotobiol.2015.09.018
   Santhoshkumar T., 2011, PARASITOL RES, V110, P1815
   Sareen Sarah J., 2012, RES J RECENT SCI, V1, P52
   Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521
   Shanthi S, 2016, MICROB PATHOGENESIS, V93, P70, DOI 10.1016/j.micpath.2016.01.014
   Sivalingam Manju, 2014, Journal of the Fisheries Society of Taiwan, V41, P123
   Soni N, 2012, PARASITOL RES, V110, P175, DOI 10.1007/s00436-011-2467-4
   Su HL, 2009, BIOMATERIALS, V30, P5979, DOI 10.1016/j.biomaterials.2009.07.030
   Subramaniam J, 2016, ENVIRON SCI POLLUT R, V23, P7543, DOI 10.1007/s11356-015-6007-0
   Subramaniam J, 2015, ENVIRON SCI POLLUT R, V22, P20067, DOI 10.1007/s11356-015-5253-5
   Sujitha V, 2015, PARASITOL RES, V114, P3315, DOI 10.1007/s00436-015-4556-2
   Sundaravadivelan C, 2013, PARASITOL RES, V112, P303, DOI [10.1007/s00436-012-3138-9, 10.100]
   Swamavalli G. Cynthia Jemima, 2011, J NANOMATER, V5
   Swiatlo E, 2002, INFECT IMMUN, V70, P412, DOI 10.1128/IAI.70.1.412-415.2002
   Valli JS, 2012, MATER LETT, V82, P171, DOI 10.1016/j.matlet.2012.05.040
   Vaseeharan B, 2010, LETT APPL MICROBIOL, V50, P352, DOI 10.1111/j.1472-765X.2010.02799.x
   Vaseeharan B., 2012, NANOTECHNOL DEV, V2, P3
   Veerakumar K, 2014, PARASITOL RES, V113, P1775, DOI 10.1007/s00436-014-3823-y
   Vinoj G, 2015, ANTIMICROB AGENTS CH, V59, P763, DOI 10.1128/AAC.03047-14
   Xu H, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/48/485713
   Yildiz FH, 2009, TRENDS MICROBIOL, V17, P109, DOI 10.1016/j.tim.2008.12.004
NR 67
TC 19
Z9 19
U1 2
U2 10
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1011-1344
J9 J PHOTOCH PHOTOBIO B
JI J. Photochem. Photobiol. B-Biol.
PD SEP
PY 2017
VL 174
BP 133
EP 143
DI 10.1016/j.jphotobiol.2017.07.026
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA FI5OS
UT WOS:000412034300015
PM 28772238
DA 2020-07-08
ER

PT J
AU Luplertlop, N
   Suwanmanee, S
   Muangkaew, W
   Ampawong, S
   Kitisin, T
   Poovorawan, Y
AF Luplertlop, Natthanej
   Suwanmanee, San
   Muangkaew, Watcharamat
   Ampawong, Sumate
   Kitisin, Thitinan
   Poovorawan, Yong
TI The impact of Zika virus infection on human neuroblastoma (SH-SY5Y) cell
   line
SO JOURNAL OF VECTOR BORNE DISEASES
LA English
DT Article
DE Flavivirus; neuroblastoma cell; neuronal cell; SH-SY5Y; Zika virus
ID INHIBITION; TIM
AB Background & objectives: An increase in Zika virus (ZIKV) epidemic during the last decade has become a major global concern as the virus affects both newborns and adult humans. Earlier studies have shown the impact of ZIKV infection in developing human foetus. However, effective in vitro model of target cells for studying the ZIKV infection in adult human neurons is not available. This study aimed to establish the use of human neuroblastoma cell line (SH-SY5Y) for studying an infection of ZIKV in vitro.
   Methods: ZIKV growth kinetics, viral toxicity, and SH-SY5Y cell vialibity were determined after ZIKV infection in SH-SY5Y cells in vitro. ZIKV-infected SH-SY5Y cells were morphologically analysed and compared with non-human primate Vero cells. Furthermore, the susceptibility of SH-SY5Y cells to ZIKV infection was also determined.
   Results: The results showed that ZIKV efficiently infects SH-SY5Y cell lines in vitro. Gradual changes of several cellular homeostasis parameters including cell viability, cytotoxicity, and cell morphology were observed in ZIKV-infected SH-SY5Y cells when compared to mock-treated or non-human primate cells. Interestingly, ZIKV particles were detected in the nucleoplasmic compartment of the infected SH-SY5Y cells.
   Interpretation & conclusion: The results suggest that ZIKV particle can be detected in the nucleoplasmic compartment of the infected SH-SY5Y cells beside the known viral replicating cytoplasmic area. Hence, SH-SY5Y cells can be used as an in vitro adult human neuronal cell-based model, for further elucidating the ZIKV biology, and highlight other possible significance of Zika virus distribution through nuclear localization, which may correlate to the neuropathological defects in ZIKV-infected adult humans.
C1 [Luplertlop, Natthanej; Suwanmanee, San; Muangkaew, Watcharamat] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand.
   [Ampawong, Sumate] Mahidol Univ, Fac Trop Med, Dept Trop Pathol, Bangkok, Thailand.
   [Kitisin, Thitinan] Mahidol Univ, Fac Sci, Dept Anat, Bangkok, Thailand.
   [Poovorawan, Yong] Chulalongkorn Univ, Fac Med, Dept Biochem, Ctr Excellence Clin Virol, Bangkok, Thailand.
   [Poovorawan, Yong] Chulalongkorn Univ, Dept Surg, Fac Med, Bangkok, Thailand.
RP Luplertlop, N (corresponding author), Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand.
EM natthanej.lup@mahidol.ac.th
OI AMPAWONG, Sumate/0000-0002-5378-2996
FU National Science and Technology Development Agency; Thailand Research
   Fund (TRF) through the Royal Golden Jubilee Ph.D. programThailand
   Research Fund (TRF) [PHD/0001/2557]
FX The authors are thankful to the AFRIMS and the Ministry of Public
   Health, Thailand for providing ZIKV isolates. The research chair grant
   from the National Science and Technology Development Agency, and the
   scholarship from Thailand Research Fund (TRF) through the Royal Golden
   Jubilee Ph.D. program (Grant No. PHD/0001/2557) to N.L. and S.S. are
   gratefully acknowledged.
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Kinney RM, 2005, J VIROL, V79, P5116, DOI 10.1128/JVI.79.8.5116-5128.2005
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li C, 2016, J NANOMATER, V2016, P10, DOI DOI 10.3389/FPLS.2016.01356
   Liu CC, 2004, BIOTECHNOL BIOENG, V85, P482, DOI 10.1002/bit.10918
   Liu Y. L., 2013, J NANOMATER, V2013, P9, DOI DOI 10.1016/J.RESS.2013.09.001
   Luplerdlop N, 2006, EMBO REP, V7, P1176, DOI 10.1038/sj.embor.7400814
   Malkki H, 2016, NAT REV NEUROL, V12, DOI [10.1038/nrneurol.2016.30, 10.1038/nrneurol.2016.139, 10.1038/nrneurol.2016.151, 10.1038/nrneurol.2016.175, 10.1038/nrneurol.2016.22, 10.1038/nrneurol.2016.117, 10.1038/nrneurol.2016.78, 10.1038/nrneurol.2016.79, 10.1038/nrneurol.2016.58, 10.1038/nrneurol.2016.52]
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Moller-Tank S, 2014, J VIROL, V88, P6702, DOI 10.1128/JVI.00300-14
   MOORE DF, 1981, ANTIMICROB AGENTS CH, V20, P787, DOI 10.1128/AAC.20.6.787
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Plevka P, 2011, EMBO REP, V12, P602, DOI 10.1038/embor.2011.75
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Versteeg GA, 2010, CURR OPIN MICROBIOL, V13, P508, DOI 10.1016/j.mib.2010.05.009
NR 34
TC 6
Z9 6
U1 0
U2 6
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0972-9062
J9 J VECTOR DIS
JI J. Vector Borne Dis.
PD SEP
PY 2017
VL 54
IS 3
BP 207
EP 214
PG 8
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FM2AF
UT WOS:000414784900002
PM 29097635
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Wong, YH
   Goh, BC
   Lim, SY
   Teo, EW
   Lim, APC
   Dedon, PC
   Hanson, BJ
   MacAry, PA
   Lescar, J
AF Wong, Yee Hwa
   Goh, Boon Chong
   Lim, She Yah
   Teo, En Wei
   Lim, Angeline P. C.
   Dedon, Pete C.
   Hanson, Brendon J.
   MacAry, Paul A.
   Lescar, Julien
TI Structural Mimicry of the Dengue Virus Envelope Glycoprotein Revealed by
   the Crystallographic Study of an Idiotype-Anti-idiotype Fab Complex
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE dengue virus; idiotypic antibody; idiotype-anti-idiotype Fab complex;
   antigen mimicry; virus-antibody complex; X-ray crystallography
ID CRYSTAL-STRUCTURE; MOLECULAR-DYNAMICS; IDIOTOPE COMPLEX; REFINEMENT;
   RESTRAINTS; FUSION
AB A detailed understanding of the fine specificity of serotype-specific human antibodies is vital for the development and evaluation of new vaccines for pathogenic flaviviruses such as dengue virus (DENV) and Zika virus. In this study, we thoroughly characterize the structural footprint of an anti-idiotype antibody (E1) specific for a potent, fully human DENV serotype 1-specific antibody, termed HM14c10, derived from a recovered patient. The crystal structure at a resolution of 2.5 angstrom of a complex between the Fab fragments of E1 and HM14c10 provides the first detailed molecular comparison of an anti-idiotype paratope specific for a human antibody with its analogous epitope, a discontinuous quaternary structure located at the surface of the viral particle that spans adjacent envelope (E) proteins. This comparison reveals that the footprints left by E1 and E on HM14c10 largely overlap, explaining why the formation of binary complexes is mutually exclusive. Structural mimicry of the DENV E epitope by the E1 combining site is achieved via the formation of numerous interactions with heavy chain complementarity domain regions (CDRs) of HM14c10, while fewer interactions are observed with its light chain than for the E protein. We show that E1 can be utilized to detect HM14c10-like antibodies in sera from patients who recovered from DENV-1, infection suggesting that this is a public (common) idiotype. These data demonstrate the utility of employing an anti-idiotype antibody to monitor a patient's specific immune responses and suggest routes for the improvement of E "mimicry" by E1 by increasing its recognition of the Fab HM14c10 light chain CDRs.
   IMPORTANCE A chimeric yellow fever-dengue live-attenuated tetravalent vaccine is now being marketed. Dengue remains a significant public health problem, because protection conferred by this vaccine against the four circulating serotypes is uneven. Reliable tools must be developed to measure the immune responses of individuals exposed to DENV either via viral infection or through vaccination. Anti-idiotypic anti-bodies provide precision tools for analyzing the pharmacokinetics of antibodies in an immune response and also for measuring the amount of circulating anti-infective therapeutic antibodies. Here, we characterize how an anti-idiotypic antibody (E1) binds antibody HM14c10, which potently neutralizes DENV serotype 1. We report the crystal structure at a resolution of 2.5 angstrom of a complex between the Fab fragments of E1 and HM14c10 and provide the first detailed molecular comparison between the anti-idiotype surface and its analogous epitope located at the surface of the dengue virus particle.
C1 [MacAry, Paul A.; Lescar, Julien] Nanyang Technol Univ, Nanyang Inst Struct Biol, Sch Biol Sci, Singapore, Singapore.
   [Lim, She Yah; Lim, Angeline P. C.; Dedon, Pete C.] Singapore Alliance Res & Technol, Singapore, Singapore.
   [Teo, En Wei; Lim, Angeline P. C.; Dedon, Pete C.] Natl Univ Singapore, Dept Microbiol & Immunol, Singapore, Singapore.
RP MacAry, PA; Lescar, J (corresponding author), Nanyang Technol Univ, Nanyang Inst Struct Biol, Sch Biol Sci, Singapore, Singapore.
EM paul_macary@nuhs.edu.sg; julien@ntu.edu.sg
RI ; Goh, Boon Chong/L-2516-2016
OI Wong, Yee Hwa/0000-0002-2751-9721; Goh, Boon Chong/0000-0002-0292-0922
FU Ministry of Education SingaporeMinistry of Education, Singapore
   [RG62/12]; National Medical Research CouncilMedical Research Council UK
   (MRC) [NMRC/CBRG/0028/2014]; SMART scholarship; National Research
   Foundation [NRF370062-HUJ-NUS]
FX This work was supported by the Ministry of Education Singapore (Academic
   Research Fund Tier 1 complexity grant RG62/12 to J.L.), the National
   Medical Research Council (NMRC/CBRG/0028/2014 to J.L.), a SMART
   scholarship (to B.C.G.), and a National Research Foundation grant
   (NRF370062-HUJ-NUS to P.A.M.).
CR Aguiar M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005179
   Alfonso S, 2014, CLIN CANCER RES, V20, P3660, DOI 10.1158/1078-0432.CCR-13-1674
   BAN N, 1994, P NATL ACAD SCI USA, V91, P1604, DOI 10.1073/pnas.91.5.1604
   BENTLEY GA, 1990, NATURE, V348, P254, DOI 10.1038/348254a0
   Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x
   Braden BC, 1996, J MOL BIOL, V264, P137, DOI 10.1006/jmbi.1996.0629
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   Bryson S, 2008, J MOL BIOL, V382, P910, DOI 10.1016/j.jmb.2008.07.057
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   Eger C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150479
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   FIELDS BA, 1995, NATURE, V374, P739, DOI 10.1038/374739a0
   Henein S, 2017, J INFECT DIS, V215, P351, DOI 10.1093/infdis/jiw576
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   JERNE NK, 1982, EMBO J, V1, P243, DOI 10.1002/j.1460-2075.1982.tb01154.x
   JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   LESCAR J, 1995, J BIOL CHEM, V270, P18067, DOI 10.1074/jbc.270.30.18067
   Lim SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145381
   Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Rotkiewicz P, 2008, J COMPUT CHEM, V29, P1460, DOI 10.1002/jcc.20906
   SABIN AB, 1945, SCIENCE, V101, P640, DOI 10.1126/science.101.2634.640
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Schrodinger LLC, 2015, PYMOL MOL GRAPHICS S
   Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058
   Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888
   Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749
NR 30
TC 4
Z9 5
U1 0
U2 13
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD SEP
PY 2017
VL 91
IS 17
AR UNSP e00406-17
DI 10.1128/JVI.00406-17
PG 12
WC Virology
SC Virology
GA FD3II
UT WOS:000407426300008
PM 28637753
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Westra, SJ
AF Westra, Sjirk Jan
TI Prenatal screening for Zika encephalopathy with ultrasound: what is the
   optimal time window?
SO LANCET CHILD & ADOLESCENT HEALTH
LA English
DT Editorial Material
ID VIRUS-INFECTION; INFANTS; WOMEN; BIRTH
C1 [Westra, Sjirk Jan] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA.
RP Westra, SJ (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA.
EM swestra@partners.org
OI Westra, Sjirk/0000-0002-9952-6891
CR Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oliveira Melo A S, ULTRASOUND OBSTET GY, V47, P6
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Schaub B, 2017, LANCET CHILD ADOLESC, V1, P45, DOI 10.1016/S2352-4642(17)30001-9
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
NR 11
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2352-4642
J9 LANCET CHILD ADOLESC
JI Lancet Child. Adolesc. Health
PD SEP
PY 2017
VL 1
IS 1
BP 6
EP 8
DI 10.1016/S2352-4642(17)30002-0
PG 4
WC Pediatrics
SC Pediatrics
GA HE2QM
UT WOS:000453156800005
PM 30169228
OA Bronze
DA 2020-07-08
ER

PT J
AU Schaub, B
   Gueneret, M
   Jolivet, E
   Decatrelle, V
   Yazza, S
   Gueye, H
   Monthieux, A
   Juve, ML
   Gautier, M
   Najioullah, F
   Vouga, M
   Volumenie, JL
   Baud, D
AF Schaub, Bruno
   Gueneret, Michele
   Jolivet, Eugenie
   Decatrelle, Valerie
   Yazza, Soraya
   Gueye, Henriette
   Monthieux, Alice
   Juve, Marie-Laure
   Gautier, Manuella
   Najioullah, Fatiha
   Vouga, Manon
   Volumenie, Jean-Luc
   Baud, David
TI Ultrasound imaging for identification of cerebral damage in congenital
   Zika virus syndrome: a case series
SO LANCET CHILD & ADOLESCENT HEALTH
LA English
DT Article
ID FETAL; INFECTION; FETUSES
AB Background Zika virus is a novel teratogenic agent associated with cerebral anomalies. Because of the challenges associated with assessment of antenatal diagnosis and prognosis in fetuses, screening for other congenital infections mostly relies on ultrasound. We aimed to assess whether a similar approach might be adequate for Zika virus congenital syndrome provided that early markers of infection and adequate timing for screening are established.
   Methods For this case series we reviewed all pregnant women who had a laboratory-confirmed Zika virus infection in their first trimester or early second trimester and abnormal fetal ultrasound findings who were managed at the Pluridisciplinary Center for Prenatal Diagnosis of Martinique during the Zika virus epidemic (Jan 1, 2016, to Nov 10, 2016) in Martinique, a French Caribbean island. Ultrasound imaging was done with GE Healthcare Voluson E10 and E8 machines with abdominal and vaginal probes.
   Findings We analysed 14 cases of pregnant women with confirmed Zika virus infection and fetal abnormalities of the brain, and 31 ultrasound imaging results. Between 16 and 20 weeks of gestation, four (33%) of 12 fetuses had an abnormal ultrasound examination. Anomalies were detected in nine (90%) of the ten fetuses from whom ultrasound images were obtained between 20 and 24 weeks of gestation. All five remaining fetuses at 24-28 weeks of gestation, and all four after 28 weeks, had severe anomalies. Major anomalies identified were ventriculomegaly (12 fetuses, 86%), cortical atrophy (11, 79%), calcifications (ten, 71%; particularly located at the corticosubcortical junction), and anomalies of the corpus callosum (ten, 71%). Prenatal assessment of head circumference measurement by imaging was not an effective screening tool for congenital Zika virus infection, with microcephaly only identified in nine (64%) fetuses.
   Interpretation Ultrasound monitoring appears to be a good screening strategy to monitor Zika virus-exposed pregnancies. Public health efforts should focus on scanning at 22-26 weeks of gestation. Identification of ventriculomegaly, cortical atrophy, calcifications, and anomalies of the corpus callosum should prompt laboratory screening for Zika virus.
C1 [Schaub, Bruno; Gueneret, Michele; Jolivet, Eugenie; Decatrelle, Valerie; Yazza, Soraya; Gueye, Henriette; Monthieux, Alice; Juve, Marie-Laure; Gautier, Manuella; Volumenie, Jean-Luc] Univ Hosp Martinique, Maison Femme Mere & Enfant, Pluridisciplinary Ctr Prenatal Diag Martinique, Unit Obstet & Gynaecol, Fort De France, Martinique, France.
   [Schaub, Bruno] Univ Hosp Martinique, Maison Femme Mere & Enfant, Registre Malformat Antilles REMALAN, Fort De France, Martinique, France.
   [Najioullah, Fatiha] Univ Hosp Martinique, Serv Virol, Fort De France, Martinique, France.
   [Vouga, Manon; Baud, David] Univ Hosp, Dept Femme Mere Enfant, Maternofetal & Obstet Res Unit, Lausanne, Switzerland.
RP Schaub, B (corresponding author), Ctr Hosp & Univ Martinique, Maison Femme Mere & Enfant, Ctr Pluridisciplinaire Diagnost Prenatal Martiniq, F-97261 Fort De France, Martinique, France.
EM bruno.schaub@chu-martinique.fr
OI Baud, David/0000-0001-9914-6496
CR American College of Obstetricians and Gynecologists, 2015, Obstet Gynecol, V125, P1510, DOI 10.1097/01.AOG.0000466430.19823.53
   Benoist G, 2008, ULTRASOUND OBST GYN, V32, P900, DOI 10.1002/uog.6129
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Cignini P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147528
   Cignini P, 2014, J ULTRAS MED, V33, P1065, DOI 10.7863/ultra.33.6.1065
   Cohen-Sacher B, 2006, ULTRASOUND OBST GYN, V27, P494, DOI 10.1002/uog.2757
   Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   Guibaud L, 2009, ULTRASOUND OBST GYN, V34, P127, DOI 10.1002/uog.6456
   Hanna RM, 2011, NEUROLOGY, V76, P373, DOI 10.1212/WNL.0b013e318208f492
   Institut national de la statistique et des etudes economiques, 2015, REC POP MART 385 551
   Leibovitz Z, 2014, ULTRASOUND OBST GYN, V44, P575, DOI 10.1002/uog.13308
   Malinger G, 2011, PRENATAL DIAG, V31, P881, DOI 10.1002/pd.2795
   Malinger G, 2007, ULTRASOUND OBST GYN, V29, P109, DOI 10.1002/uog.3909
   Malinger G, 2011, FETAL DIAGN THER, V29, P117, DOI 10.1159/000321346
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V47, P530, DOI 10.1002/uog.15896
   Pomar L, 2017, ULTRASOUND OBST GYN, V49, P729, DOI 10.1002/uog.17404
   Quarello E, 2008, ULTRASOUND OBST GYN, V32, P44, DOI 10.1002/uog.5353
   Rubod C, 2005, PRENATAL DIAG, V25, P1181, DOI 10.1002/pd.1133
   Salomon LJ, 2006, ULTRASOUND OBST GYN, V28, P193, DOI 10.1002/uog.2733
   Sanin-Blair JE, 2017, FETAL DIAGN THER, V42, P153, DOI 10.1159/000454860
   Sante Publique France, 2016, SIT EP VIR ZIK ANT G
   Sarno M, 2017, ULTRASOUND OBST GYN, V50, P717, DOI 10.1002/uog.17303
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Vesnaver TV, 2017, BJOG-INT J OBSTET GY, V124, P521, DOI 10.1111/1471-0528.14423
   Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
   WHO, 2017, ZIK SIT REP
NR 35
TC 15
Z9 15
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2352-4642
J9 LANCET CHILD ADOLESC
JI Lancet Child. Adolesc. Health
PD SEP
PY 2017
VL 1
IS 1
BP 45
EP 55
DI 10.1016/S2352-4642(17)30001-9
PG 11
WC Pediatrics
SC Pediatrics
GA HE2QM
UT WOS:000453156800018
PM 30169227
DA 2020-07-08
ER

PT J
AU de Campos, TC
AF de Campos, Thana Cristina
TI Zika, public health, and the distraction of abortion
SO MEDICINE HEALTH CARE AND PHILOSOPHY
LA English
DT Article
DE Global health ethics; Neglected diseases; Research and development;
   Basic health care; Abortion
AB This paper suggests that the focus on abortion legalization in the aftermath of the Zika outbreak is distracting for policy and lawmakers from what needs to be done to address the outbreak effectively. Meeting basic health needs (i.e. preventive measures), together with research and development conducive to a vaccine or treatment for the Zika virus should be priorities.
C1 [de Campos, Thana Cristina] Univ Ottawa, Global Strategy Lab, Fac Law, Fauteux Hall 57 Louis Pasteur St, Ottawa, ON K1N 6N5, Canada.
   [de Campos, Thana Cristina] Univ Cambridge, Von Hugel Inst, St Edmunds Coll, Cambridge, England.
   [de Campos, Thana Cristina] Univ Oxford, Las Casas Inst, Blackfriars Hall, Oxford, England.
RP de Campos, TC (corresponding author), Univ Ottawa, Global Strategy Lab, Fac Law, Fauteux Hall 57 Louis Pasteur St, Ottawa, ON K1N 6N5, Canada.; de Campos, TC (corresponding author), Univ Cambridge, Von Hugel Inst, St Edmunds Coll, Cambridge, England.; de Campos, TC (corresponding author), Univ Oxford, Las Casas Inst, Blackfriars Hall, Oxford, England.
EM thana.campos@law.ox.ac.uk
CR Camosy C.C., 2016, IS CALL ZIKA VIRUS A
   Dawber A., 2016, ZIKA VIRUS FEAR IS P
   Diniz D., 2016, ZIKA VIRUS BRAZILIAN
   Gostin L.O., 2016, WHO MUST INCLUDE ACC
   Hollis A., 2008, INCENTIVES GLOBAL HL, P53
   Hotez P., 2016, WILL ZIKA BECOME 201
   Hunt Paul, 2007, WHO SPECIAL TOPICS S
   Miller M.E., 2016, ABORTION BANNED ZIKA
   Mora E., 2016, PLANNED PARENTHOOD I
   Office of the United Nations High Commissioner for Human Rights, 2016, UPH WOM HUM RIGHTS
   PAHO, 2016, NEGL TROP VECT BORN
   Parsons M., 2016, WEVE NEGLECTED DIS Z
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Romero S., 2016, SURGE ZIKA VIRUS HAS
   SARS, 2003, CERT 2003 SARS 2009
   Senra R., 2016, GROUP PREPARES ACTIO
   Victora C.G., 2016, LANCET, P2
   World Health Organization, 2016, IHR PROC PUBL HLTH E
   World Health Organization, 2016, WHO STAT 1 M INT HLT
   Yamin A.E., 2016, HLTH HUMAN RIGHTS ZI
NR 20
TC 3
Z9 3
U1 0
U2 11
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1386-7423
EI 1572-8633
J9 MED HEALTH CARE PHIL
JI Med. Health Care Philos.
PD SEP
PY 2017
VL 20
IS 3
BP 443
EP 446
DI 10.1007/s11019-016-9739-9
PG 4
WC Ethics; History & Philosophy Of Science
SC Social Sciences - Other Topics; History & Philosophy of Science
GA FE8AW
UT WOS:000408429000017
PM 27900645
OA Green Published
DA 2020-07-08
ER

PT J
AU Ha, YR
   Ryu, J
   Yeom, E
   Lee, SJ
AF Ha, Young-Ran
   Ryu, Jeongeun
   Yeom, Eunseop
   Lee, Sang-Joon
TI Comparison of the tracheal systems of Anopheles sinensis and Aedes togoi
   larvae using synchrotron X-ray microscopic computed tomography
   (respiratory system of mosquito larvae using SR-CT)
SO MICROSCOPY RESEARCH AND TECHNIQUE
LA English
DT Article
DE Aedes togoi; Anopheles sinensis; dorsal longitudinal trunks; tracheal
   system
ID GAS EXCHANGERS; BODY-SIZE; OXYGEN; SUSCEPTIBILITY; METAMORPHOSIS;
   TRANSMISSION; DROSOPHILA; SURVIVAL; INSECT
AB Mosquito-borne diseases, such as malaria, dengue fever, and Zika virus, are serious global health issues. Vector control may be an important strategy in reducing the mortality caused by these diseases. The respiratory system of mosquito larvae in the water has to inhale atmospheric oxygen as aquatic organisms. In this study, the three-dimensional (3D) structures of the dorsal longitudinal trunks (DLTs) of the tracheal systems of Anopheles sinensis and Aedes togoi were compared using synchrotron X-ray microscopic computed tomography. DLT respiratory frequencies were also investigated. Interestingly, the larvae of the two mosquito species exhibit tracheal systems that are both morphologically and functionally distinct. A. sinensis hangs horizontally under the water surface, and has a smaller DLT volume than A. togoi. In contrast, A. togoi hangs upside down using a siphon by fixing its tip to the water surface. The frequency of peristaltic movement in A. togoi is higher than that of A. sinensis. These differences in the structures and breathing behaviors of the respiratory systems of mosquito larvae provide new insights into the tracheal systems of mosquito larvae, which should help develop novel effective control strategies targeting mosquito larvae.
C1 [Ha, Young-Ran; Ryu, Jeongeun; Lee, Sang-Joon] Pohang Univ Sci & Technol, Ctr Biofluid & Biomim Res, Pohang 790784, South Korea.
   [Ryu, Jeongeun; Lee, Sang-Joon] Pohang Univ Sci & Technol, Dept Mech Engn, Pohang 790784, South Korea.
   [Yeom, Eunseop] Pusan Natl Univ, Sch Mech Engn, Pusan 609735, South Korea.
RP Lee, SJ (corresponding author), Pohang Univ Sci & Technol, Dept Mech Engn, Ctr Biofluid & Biomim Res, San 31, Pohang 790784, Kyungbook, South Korea.
EM sjlee@postech.ac.kr
RI Lee, Sang Joon/AAG-2448-2019; Yeom, Eunseop/AAR-8322-2020
OI LEE, SANG JOON/0000-0003-3286-5941
FU National Research Foundation of Korea - Korean government [MSIP]
   [2008-0061991]
FX National Research Foundation of Korea (grant funded by the Korean
   government [MSIP]), Grant Number: 2008-0061991
CR Aboelkassem Y, 2013, J FLUID STRUCT, V42, P187, DOI 10.1016/j.jfluidstructs.2013.06.003
   Batchelor G. K., 1967, INTRO FLUID DYNAMICS, V18
   BLUM F, 1946, HELV PHYSIOL PHARM A, V4, P43
   Bukhari T, 2009, AM J TROP MED HYG, V80, P758, DOI 10.4269/ajtmh.2009.80.758
   BURKETT BN, 1974, BIOL BULL-US, V147, P274, DOI 10.2307/1540449
   Callier V, 2011, P NATL ACAD SCI USA, V108, P14664, DOI 10.1073/pnas.1106556108
   Caraballo Hector, 2014, Emerg Med Pract, V16, P1
   CHRISTOPHERS SR, 1960, YELLOW FEVER MOSQUIT
   Clements A. N., 1992, BIOL MOSQUITOES DEV, V1
   CROSS JH, 1979, AM J TROP MED HYG, V28, P56, DOI 10.4269/ajtmh.1979.28.56
   FOX HM, 1953, J EXP BIOL, V30, P235
   Greenlee KJ, 2013, J EXP BIOL, V216, P2293, DOI 10.1242/jeb.082479
   Greenlee KJ, 2009, AM J PHYSIOL-REG I, V297, pR1343, DOI 10.1152/ajpregu.00231.2009
   Groenewald B, 2012, J EXP BIOL, V215, P2301, DOI 10.1242/jeb.070995
   Harrison JF, 1998, J EXP BIOL, V201, P1739
   Hinton HE, 1947, T ROYAL ENTOMOLOGICA, V98, P449, DOI [10.1111/j.1365-2311.1947.tb01222.x, DOI 10.1111/J.1365-2311.1947.TB01222.X]
   Ichikawa T, 2008, COMP BIOCHEM PHYS A, V150, P8, DOI 10.1016/j.cbpa.2008.02.012
   Junkum A, 2003, MEM I OSWALDO CRUZ, V98, P481, DOI 10.1590/S0074-02762003000400009
   KAN SP, 1973, AM J TROP MED HYG, V22, P179, DOI 10.4269/ajtmh.1973.22.179
   Keilin P., 1935, Parasitology Cambridge, V27, P257
   Kim BH, 2011, J EXP BIOL, V214, P1163, DOI 10.1242/jeb.048793
   Kirkton SD, 2007, ADV EXP MED BIOL, V618, P221
   LANG CA, 1963, J INSECT PHYSIOL, V9, P279, DOI 10.1016/0022-1910(63)90104-5
   LEE S, 2016, SCI REP UK, V6
   LIGHTON JRB, 1988, J EXP BIOL, V134, P363
   Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072
   Macfie J. W. S., 1917, Bulletin of Entomological Research London, V7, DOI 10.1017/S0007485300017624
   Maina JN, 2000, ANAT REC, V261, P25
   Maina JN, 2002, ADV ANAT EMBRYOL CEL, V163, P1
   Melnikovskii LA, 1997, J EXP THEOR PHYS+, V84, P758, DOI 10.1134/1.558208
   Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11
   Moussian B, 2006, DEVELOPMENT, V133, P163, DOI 10.1242/dev.02177
   Ohta I, 2014, MICROSCOPY-JPN, V63, P295, DOI 10.1093/jmicro/dfu015
   OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076
   Pendar H, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0259
   Pennycuick C. J., 1992, NEWTON RULES BIOL PH, Vix
   RASNITSYN SP, 1989, ZOOL ZH, V68, P155
   REITER P, 1978, MOSQ NEWS, V38, P334
   ROSEN L, 1978, SCIENCE, V199, P909, DOI 10.1126/science.203035
   Rothenbucher J, 2006, BASIC APPL ECOL, V7, P398, DOI 10.1016/j.baae.2006.05.005
   Saeung A, 2014, SE ASIAN J TROP MED, V45, P588
   Silberbush A, 2015, J VECTOR ECOL, V40, P425, DOI 10.1111/jvec.12186
   Simelane S. M., 2014, ABSTR APPL ANAL, V2014, P11
   Taylor Samuel E, 2013, Curr Protoc Essent Lab Tech, V95
   Tonar Z, 2003, J APPL BIOMED, V1, P149
   Webster MR, 2015, BIOINSPIR BIOMIM, V10, DOI 10.1088/1748-3190/10/6/066011
   Wigglesworth VB, 1933, J EXP BIOL, V10, P16
   WIGGLESWORTH VB, 1953, Q J MICROSC SCI, V94, P507
   Yi HL, 2014, INT J MOD PHYS B, V28, DOI 10.1142/S0217979214501690
NR 49
TC 2
Z9 2
U1 1
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1059-910X
EI 1097-0029
J9 MICROSC RES TECHNIQ
JI Microsc. Res. Tech.
PD SEP
PY 2017
VL 80
IS 9
BP 985
EP 993
DI 10.1002/jemt.22890
PG 9
WC Anatomy & Morphology; Biology; Microscopy
SC Anatomy & Morphology; Life Sciences & Biomedicine - Other Topics;
   Microscopy
GA FE0RY
UT WOS:000407928600002
PM 28497875
DA 2020-07-08
ER

PT J
AU Prue, CE
   Roth, JN
   Garcia-Williams, A
   Yoos, A
   Camperlengo, L
   DeWilde, L
   Lamtahri, M
   Prosper, A
   Harrison, C
   Witbart, L
   Guendel, I
   Wiegand, DM
   Lamens, NR
   Hillman, BA
   Davis, MS
   Ellis, EM
AF Prue, Christine E.
   Roth, Joseph N., Jr.
   Garcia-Williams, Amanda
   Yoos, Alison
   Camperlengo, Lena
   DeWilde, Leah
   Lamtahri, Mohammed
   Prosper, Andra
   Harrison, Cosme
   Witbart, Lauren
   Guendel, Irene
   Wiegand, Douglas M.
   Lamens, Natasha R.
   Hillman, Brae Anna
   Davis, Michelle S.
   Ellis, Esther M.
TI Awareness, Beliefs, and Actions Concerning Zika Virus Among Pregnant
   Women and Community Members - US Virgin Islands, November-December 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
AB What is already known about this topic?
   U.S.-based surveys conducted throughout 2016 have shown high levels of awareness of the Zika virus outbreak, moderate levels of concern about Zika, and low levels of knowledge about how Zika is transmitted.
   What is added by this report?
   Zika-related awareness, beliefs, and actions among residents of the U.S. Virgin Islands, who are not included in U.S.-based surveys, were assessed in interviews of pregnant women and community members. Multiple respondents reported hearing that Zika virus is transmitted by mosquitoes and causes microcephaly in babies. Fewer mentioned hearing about sexual transmission of Zika virus or what actions to take to prevent infection. Most respondents reported Zika virus as a serious concern although there were varying levels in perceptions of susceptibility and protective actions taken. Most pregnant women reported receiving interventions offered to them and most community members expressed support for several vector control approaches.
   What are implications for public health practice?
   The feedback from these interviews helped the U.S. Virgin Islands Department of Health identify information gaps that can be addressed through communication, education, and community engagement. Gathering feedback about key aspects of a response effort from community members is vital to ensure that interventions reach them and are translated into effective prevention programs.
C1 [Prue, Christine E.] CDC, Off Director, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Roth, Joseph N., Jr.] CDC, Div State & Local Readiness, Off Publ Hlth Preparedness & Response, Atlanta, GA 30333 USA.
   [Garcia-Williams, Amanda] CDC, Div Violence Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA.
   [Yoos, Alison] CDC, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA 30333 USA.
   [Camperlengo, Lena] CDC, Div Reprod Hlth, Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
   [DeWilde, Leah; Prosper, Andra; Harrison, Cosme; Guendel, Irene; Lamens, Natasha R.; Hillman, Brae Anna; Davis, Michelle S.; Ellis, Esther M.] US Virgin Isl Dept Hlth, Charlotte Amalie, VI USA.
   [Lamtahri, Mohammed] CDC, Off Publ Hlth Sci Serv, Ctr Surveillance Epidemiol & Lab Serv, Atlanta, GA 30333 USA.
   [Witbart, Lauren] CDC, Off Director, Off Publ Hlth Preparedness & Response, Atlanta, GA 30333 USA.
   [Wiegand, Douglas M.] CDC, Div Surveillance Hazard Evaluat & Field Studies, Natl Inst Occupat Safety & Hlth, Atlanta, GA 30333 USA.
RP Prue, CE (corresponding author), CDC, Off Director, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
EM cprue@cdc.gov
CR Abramson D, 2016, 1 NYU NY U COLL GLOB
   Annenberg Public Policy Center, 2016, HALF AM CONC ZIK WIL
   CDC, 1999, MMWR RECOMM REP, V48
   Guo Fangjian, 2017, Prev Med Rep, V7, P26, DOI 10.1016/j.pmedr.2017.05.003
   Harvard Opinion Research Program, 2016, PUBL VIEWS ZIK VIR O
   Henry J, 2016, KAISER HLTH TRACKING
   Ipsos Public Affairs, 2016, IPSOS REUT POLL ZIKA
   March of Dimes/ NORC at the University of Chicago, 2016, ZIKA VIRUS GAPS AM K
   Muhib FB, 2001, PUBLIC HEALTH REP, V116, P216, DOI 10.1093/phr/116.S1.216
   US Virgin Islands Department of Health, 2017, ZIKA WEEKL SURV REP
NR 10
TC 9
Z9 11
U1 0
U2 5
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD SEP 1
PY 2017
VL 66
IS 34
BP 909
EP 913
DI 10.15585/mmwr.mm6634a4
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FF2OG
UT WOS:000408736100004
PM 28859049
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Oh, Y
   Zhang, FR
   Wang, YQ
   Lee, EM
   Choi, IY
   Lim, H
   Mirakhori, F
   Li, RH
   Huang, LX
   Xu, TL
   Wu, H
   Li, C
   Qin, CF
   Wen, ZX
   Wu, QF
   Tang, HL
   Xu, ZH
   Jin, P
   Song, HJ
   Ming, GL
   Lee, G
AF Oh, Yohan
   Zhang, Feiran
   Wang, Yaqing
   Lee, Emily M.
   Choi, In Young
   Lim, Hotae
   Mirakhori, Fahimeh
   Li, Ronghua
   Huang, Luoxiu
   Xu, Tianlei
   Wu, Hao
   Li, Cui
   Qin, Cheng-Feng
   Wen, Zhexing
   Wu, Qing-Feng
   Tang, Hengli
   Xu, Zhiheng
   Jin, Peng
   Song, Hongjun
   Ming, Guo-li
   Lee, Gabsang
TI Zika virus directly infects peripheral neurons and induces cell death
SO NATURE NEUROSCIENCE
LA English
DT Article
ID EMBRYONIC STEM-CELLS; NEURAL CREST CELLS; IDENTIFICATION; PROGENITORS;
   DERIVATION; EXPOSURE; MODELS; BRAIN
AB Zika virus (ZIKV) infection is associated with neurological disorders of both the CNS and peripheral nervous systems (PNS), yet few studies have directly examined PNS infection. Here we show that intraperitoneally or intraventricularly injected ZIKV in the mouse can infect and impact peripheral neurons in vivo. Moreover, ZIKV productively infects stemcell- derived human neural crest cells and peripheral neurons in vitro, leading to increased cell death, transcriptional dysregulation and cell-type-specific molecular pathology.
C1 [Oh, Yohan; Choi, In Young; Lim, Hotae; Mirakhori, Fahimeh; Wen, Zhexing; Song, Hongjun; Ming, Guo-li; Lee, Gabsang] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD USA.
   [Oh, Yohan; Song, Hongjun; Ming, Guo-li; Lee, Gabsang] Adrienne Helis Malvin Med Res Fdn, New Orleans, LA USA.
   [Zhang, Feiran; Li, Ronghua; Huang, Luoxiu; Jin, Peng] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA.
   [Wang, Yaqing; Li, Cui; Wu, Qing-Feng; Xu, Zhiheng] Chinese Acad Sci, Inst Genet & Dev Biol, CAS Ctr Excellence Brain Sci & Intelligence Tech, State Key Lab Mol Dev Biol, Beijing, Peoples R China.
   [Lee, Emily M.; Tang, Hengli] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA.
   [Xu, Tianlei] Emory Univ, Dept Math & Comp Sci, Atlanta, GA 30322 USA.
   [Wu, Hao] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Biomath, Atlanta, GA 30322 USA.
   [Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.
   [Wen, Zhexing; Song, Hongjun; Ming, Guo-li; Lee, Gabsang] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.
   [Wen, Zhexing] Emory Univ, Sch Med, Dept Psychiat & Behav Sci Cell Biol & Neurol, Atlanta, GA 30322 USA.
   [Xu, Zhiheng] Beijing Inst Brain Disorders, Parkinsons Dis Ctr, Beijing, Peoples R China.
   [Song, Hongjun; Ming, Guo-li; Lee, Gabsang] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA.
   [Song, Hongjun] Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA.
   [Song, Hongjun] Univ Penn, Perelman Sch Med, Mahoney Inst Neurosci, Philadelphia, PA 19104 USA.
   [Song, Hongjun; Ming, Guo-li] Univ Penn, Perelman Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA.
   [Song, Hongjun] Univ Penn, Perelman Sch Med, Epigenet Inst, Philadelphia, PA 19103 USA.
   [Ming, Guo-li] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.
RP Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD USA.; Ming, GL (corresponding author), Adrienne Helis Malvin Med Res Fdn, New Orleans, LA USA.; Jin, P (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA.; Xu, ZH (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, CAS Ctr Excellence Brain Sci & Intelligence Tech, State Key Lab Mol Dev Biol, Beijing, Peoples R China.; Tang, HL (corresponding author), Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA.; Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.; Xu, ZH (corresponding author), Beijing Inst Brain Disorders, Parkinsons Dis Ctr, Beijing, Peoples R China.; Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA.; Ming, GL (corresponding author), Univ Penn, Perelman Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA.; Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.
EM tang@bio.fsu.edu; zhxu@genetics.ac.cn; peng.jin@emory.edu;
   gming@mail.med.upenn.edu
RI Wu, Hao/AAG-8660-2020; Wu, Hao/H-3899-2017; Wen, Zhexing/L-1228-2018;
   Oh, Yohan/C-9107-2013; Mirakhori, Fahimeh/AAF-5271-2020; Qin,
   Cheng-Feng/I-6839-2019
OI Wu, Hao/0000-0003-1269-7354; Wu, Hao/0000-0003-1269-7354; Wen,
   Zhexing/0000-0002-1518-3845; Oh, Yohan/0000-0002-9249-8664; Qin,
   Cheng-Feng/0000-0002-0632-2807; Xu, Zhiheng/0000-0002-4809-2851; Wu,
   Qing-Feng/0000-0003-3272-6247; Ming, Guo-li/0000-0002-2517-6075; Xu,
   Tianlei/0000-0001-9382-6917
FU New York Stem Cell Foundation; Maryland Stem Cell Research Funding
   (MSCRF); NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01NS093213, R01MH105128, R35NS097370,
   U19AI131130, U19MH106434, P01NS097206, R37NS047344, R21AI119530];
   National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31430037]; Chinese Academy of SciencesChinese
   Academy of Sciences [QYZDJ-SSW-SMC007]; Shanghai Brain-Intelligence
   Project from STCSM [16JC1420500]; Beijing Brain Project
   [Z161100002616004]; FSU Zika seed funding; Adelson Medical Research
   Foundation
FX We thank K.M. Christian for comments. We acknowledge the services of H.
   Zhang at Flow Cytometry Core Facility (JHSPH), W. Tang at Omega
   Bioservices (Omega Bio-tek, Inc.), and M. Zwick and B. Isett at the
   Emory Integrated Genomics Core (EIGC). This work was supported by grants
   from the Robertson Investigator Award from New York Stem Cell Foundation
   (G.L.), Maryland Stem Cell Research Funding (MSCRF; G.L., H.S. and
   G.-l.M.), NIH R01NS093213 (G.L.), R01MH105128 and R35NS097370 (G.-l.M.),
   U19AI131130 (G.-l.M., Z.W., H.T. and P.J.), U19MH106434, P01NS097206 and
   R37NS047344 (H.S.), R21AI119530 (H.T.), National Natural Science
   Foundation of China (31430037), Innovation Program of the Chinese
   Academy of Sciences (QYZDJ-SSW-SMC007), Shanghai Brain-Intelligence
   Project from STCSM (16JC1420500), Beijing Brain Project
   (Z161100002616004) to Z.X. and Y.W., FSU Zika seed funding (H.T.), and
   the Adelson Medical Research Foundation (G.-l.M.). The authors (G.L.,
   Y.O., G.-l.M. and H.S.) acknowledge the joint participation of the
   Adrienne Helis Malvin Medical Research Foundation.
CR Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Choi IY, 2016, CELL REP, V15, P2301, DOI 10.1016/j.celrep.2016.05.016
   Cleto Thais Lira, 2016, Pediatr Neurol, V65, pe1, DOI 10.1016/j.pediatrneurol.2016.08.011
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fuchs S, 2007, NEURODEGENER DIS, V4, P6, DOI 10.1159/000100354
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36
   Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365
   Lee G, 2010, NAT PROTOC, V5, P688, DOI 10.1038/nprot.2010.35
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Medina MT, 2016, J NEUROL SCI, V369, P271, DOI 10.1016/j.jns.2016.08.044
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oh Y, 2016, CELL STEM CELL, V19, P95, DOI 10.1016/j.stem.2016.05.002
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450
   Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439
   Wen ZX, 2017, GENE DEV, V31, P849, DOI 10.1101/gad.298216.117
   Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
NR 31
TC 35
Z9 36
U1 0
U2 18
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1097-6256
EI 1546-1726
J9 NAT NEUROSCI
JI Nat. Neurosci.
PD SEP
PY 2017
VL 20
IS 9
BP 1209
EP +
DI 10.1038/nn.4612
PG 6
WC Neurosciences
SC Neurosciences & Neurology
GA FF0JJ
UT WOS:000408587700006
PM 28758997
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Bonifay, T
   Douine, M
   Bonnefoy, C
   Hurpeau, B
   Nacher, M
   Djossou, F
   Epelboin, L
AF Bonifay, Timothee
   Douine, Maylis
   Bonnefoy, Clemence
   Hurpeau, Benoit
   Nacher, Mathieu
   Djossou, Felix
   Epelboin, Loic
TI Poverty and Arbovirus Outbreaks: When Chikungunya Virus Hits More
   Precarious Populations Than Dengue Virus in French Guiana
SO OPEN FORUM INFECTIOUS DISEASES
LA English
DT Article
DE chikungunya; dengue; French Guiana; poverty; precarity
ID EARLY-DIAGNOSIS; RISK-FACTORS; INFECTION; DISEASE
AB Background. Since 2013, 3 successive arbovirus outbreaks, dengue (DENV), chikungunya (CHIKV), and Zika virus, have occurred in French Guiana (FG). The primary objective of this study was to describe the socioeconomic indicators of the first patients infected with CHIKV during the outbreak of 2014. The secondary objective was to compare those patients with patient infected by DENV and with the local population.
   Methods. A monocentric, retrospective, case-control study was conducted in Cayenne hospital in FG comparing a group of patients infected with CHIKV in 2014 with a group infected with DENV in 2013. Children aged less than 15 years and pregnant women were excluded.
   Results. A total of 168 CHIKV patients were compared with 168 DENV patients. Factors associated with CHIKV were living in poor neighborhoods (82% vs 44%; odds ratio [OR], 5.81; 95% confidence interval [CI], 3.35-10.2), having a precarious status (54% vs 33%; OR, 2.37; 95% CI, 1.49-3.78), and being born abroad (70% vs 35%; OR, 4.35; 95% CI, 2.69-7.06).
   Conclusions. The present results suggest that early in the epidemic, the populations most at risk for CHIKV infection were the most socially vulnerable populations in the poorest neighborhoods, whereas DENV appeared to have affected a richer population and richer areas.
C1 [Bonifay, Timothee; Djossou, Felix; Epelboin, Loic] Ctr Hosp Andree Rosemon, Trop & Infect Dis Dept, Ave Flamboyants, F-97306 Cayenne, French Guiana, France.
   [Bonnefoy, Clemence; Nacher, Mathieu] Ctr Hosp Andree Rosemon, Emergency Dept, Cayenne, French Guiana, France.
   [Bonifay, Timothee; Bonnefoy, Clemence] Univ French West Indies, Dept Gen Med, Pointe a Pitre, Guadeloupe, France.
   [Bonifay, Timothee; Douine, Maylis] Ctr Invest Clin Antilles Guyane, Cayenne, French Guiana, France.
   [Douine, Maylis; Nacher, Mathieu; Djossou, Felix; Epelboin, Loic] Univ Guyane, Ecosyst Amazoniens & Pathol Trop, Equipe EA 3593, Cayenne, French Guiana, France.
   [Douine, Maylis; Hurpeau, Benoit] INSEE Direct Gen, Inst Natl Stat & Etud Econ, Paris, France.
RP Bonifay, T (corresponding author), Ctr Hosp Andree Rosemon, Trop & Infect Dis Dept, Ave Flamboyants, F-97306 Cayenne, French Guiana, France.
EM timothee.bon-ifay@gmail.com
RI Epelboin, LoAc/AAP-6477-2020; amsalu, ribka/G-8780-2019; Djossou,
   Felix/AAM-8640-2020
OI Epelboin, LoAc/0000-0002-3481-5991; Douine, Maylis/0000-0003-4616-6690
CR Adde A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004681
   Anand AM, 2016, J CLIN DIAGN RES, V10, pDC1, DOI 10.7860/JCDR/2016/15758.7562
   [Anonymous], 2010, LANCET INFECT DIS, V10, P1, DOI 10.1016/S1473-3099(09)70332-9
   Benach J, 2007, J EPIDEMIOL COMMUN H, V61, P276, DOI 10.1136/jech.2005.045237
   Bonnet-Galzy MC, 2015, OBSERVATOIRE NATL ZO, P37
   Carde E, 2012, MIGR SOC, V140, P35
   Chevreul Karine, 2010, Health Syst Transit, V12, P1
   da Silva-Nunes M, 2008, AM J TROP MED HYG, V79, P485, DOI 10.4269/ajtmh.2008.79.485
   Dhumeaux D., 2016, ANRS CNS, P108
   Douine M, 2017, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4557-4
   Douine M, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1367-6
   Epelboin L, 2017, Bull Soc Pathol Exot, V110, P165, DOI 10.1007/s13149-017-0559-9
   Flamand C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172267
   Gerardin P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-99
   Halstead SB, 2015, EMERG INFECT DIS, V21, P557, DOI 10.3201/eid2104.141723
   Honorio NA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000545
   Insee, CHIFFR CLES DEP GUYA
   InVS, 2015, SURV DENG B BIM PER
   Jeanne-Rose M, 2015, ENQUETE BUDGET FAMIL
   Kumarasamy V, 2007, SMJ Singapore Medical Journal, V48, P669
   Kwa B. H., 2008, Environment Development and Sustainability, V10, P209, DOI 10.1007/s10668-006-9060-5
   Manderson L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000332
   Mosnier E, 2015, B EPIDEMIOL HEBD, V11, P181
   Mosnier E, 2017, AM J TROP MED HYG, V96, P1248, DOI 10.4269/ajtmh.15-0906
   Moulin JJ, 2006, REV FRANCOPH PSYCHOO, V5, P115, DOI DOI 10.1007/s10332-006-0131-5
   Mulligan K, 2015, PATHOG GLOB HEALTH, V109, P10, DOI 10.1179/2047773214Y.0000000168
   Oviedo-Pastrana M, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-016-0169-1
   Pierret R., 2013, NOUVELLE REV SCI SOC, P307
   Raude J, 2009, HEALTH PLACE, V15, P689, DOI 10.1016/j.healthplace.2008.10.009
   Reidpath DD, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-1
   Siqueira JB, 2004, AM J TROP MED HYG, V71, P646, DOI 10.4269/ajtmh.2004.71.646
   Siqueira JB, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-361
   Spiegel JM, 2007, TROP MED INT HEALTH, V12, P503, DOI 10.1111/j.1365-3156.2007.01818.x
   The World Bank, GDP PER CAP CURR US
   Vega-Rua A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003780
   Waite L, 2009, GEOGR COMPASS, V3, P412, DOI 10.1111/j.1749-8198.2008.00184.x
   WHO, 2010, WORKING TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: FIRST WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1
NR 37
TC 7
Z9 7
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 2328-8957
J9 OPEN FORUM INFECT DI
JI Open Forum Infect. Dis.
PD FAL
PY 2017
VL 4
IS 4
DI 10.1093/ofid/ofx247
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FS1TH
UT WOS:000419560500065
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Deen, GF
   McDonald, SLR
   Marrinan, JE
   Sesay, FR
   Ervin, E
   Thorson, AE
   Xu, WB
   Stroher, U
   Ongpin, P
   Abad, N
   Ariyarajah, A
   Malik, T
   Liu, HT
   Ross, C
   Durski, KN
   Gaillard, P
   Morgan, O
   Formenty, P
   Knust, B
   Broutet, N
   Sahr, F
AF Deen, Gibrilla Fadlu
   McDonald, Suzanne L. R.
   Marrinan, Jaclyn E.
   Sesay, Foday R.
   Ervin, Elizabeth
   Thorson, Anna E.
   Xu, Wenbo
   Stroher, Ute
   Ongpin, Patricia
   Abad, Neetu
   Ariyarajah, Archchun
   Malik, Tasneem
   Liu, Hongtu
   Ross, Christine
   Durski, Kara N.
   Gaillard, Philippe
   Morgan, Oliver
   Formenty, Pierre
   Knust, Barbara
   Broutet, Nathalie
   Sahr, Foday
CA Sierra Leone Ebola Virus Persisten
TI Implementation of a study to examine the persistence of Ebola virus in
   the body fluids of Ebola virus disease survivors in Sierra Leone:
   Methodology and lessons learned
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID HUMAN-IMMUNODEFICIENCY-VIRUS; SEXUAL TRANSMISSION; SEMEN; HIV-1; MEN
AB Background
   The 2013-2016 West African Ebola virus disease epidemic was unprecedented in terms of the number of cases and survivors. Prior to this epidemic there was limited data available on the persistence of Ebola virus in survivors' body fluids and the potential risk of transmission, including sexual transmission.
   Methodology/Principal findings
   Given the urgent need to determine the persistence of Ebola virus in survivors' body fluids, an observational cohort study was designed and implemented during the epidemic response operation in Sierra Leone. This publication describes study implementation methodology and the key lessons learned. Challenges encountered during implementation included unforeseen duration of follow-up, complexity of interpreting and communicating laboratory results to survivors, and the urgency of translating research findings into public health practice. Strong community engagement helped rapidly implement the study during the epidemic. The study was conducted in two phases. The first phase was initiated within five months of initial protocol discussions and assessed persistence of Ebola virus in semen of 100 adult men. The second phase assessed the persistence of virus in multiple body fluids (semen or vaginal fluid, menstrual blood, breast milk, and urine, rectal fluid, sweat, saliva, tears), of 120 men and 120 women.
   Conclusion/Significance
   Data from this study informed national and global guidelines in real time and demonstrated the need to implement semen testing programs among Ebola virus disease survivors. The lessons learned and study tools developed accelerated the implementation of such programs in Ebola virus disease affected countries, and also informed studies examining persistence of Zika virus. Research is a vital component of the public health response to an epidemic of a poorly characterized disease. Adequate resources should be rapidly made available to answer critical research questions, in order to better inform response efforts.
C1 [Deen, Gibrilla Fadlu] Connaught Hosp, Clin Studies, Internal Med, Minist Hlth & Sanitat, Freetown, Sierra Leone.
   [McDonald, Suzanne L. R.; Marrinan, Jaclyn E.; Ariyarajah, Archchun; Gaillard, Philippe] WHO, EVD Res, Comprehens Care & Support EVD Survivors, Freetown, Sierra Leone.
   [Sesay, Foday R.; Sahr, Foday] 34 Mil Hosp, Sierra Leone Minist Def, Freetown, Sierra Leone.
   [Ervin, Elizabeth; Stroher, Ute; Knust, Barbara] Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA.
   [Thorson, Anna E.; Broutet, Nathalie] WHO, Dept Reprod Hlth & Res Family Womens & Childrens, Geneva, Switzerland.
   [Xu, Wenbo; Liu, Hongtu] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.
   [Xu, Wenbo; Liu, Hongtu] Chinese Ctr Dis Control & Prevent, Sierra Leone China Friendship Biol Safety Lab, Freetown, Sierra Leone.
   [Ongpin, Patricia] Joint United Nations Programme HIV AIDS, Strateg Informat, Freetown, Sierra Leone.
   [Abad, Neetu] Ctr Dis Control & Prevent, Social & Behav Res & Evaluat Branch, Div Sexually Transmitted Dis Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA.
   [Malik, Tasneem] Ctr Dis Control & Prevent, Off Global Act, Div Sexually Transmitted Dis Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA.
   [Ross, Christine] Ctr Dis Control & Prevent, HIV Care & Treatment Branch, Div Global HIV AIDS & TB, Ctr Global Hlth, Atlanta, GA USA.
   [Durski, Kara N.; Formenty, Pierre] WHO, Pandem & Epidem Dis Dept, Outbreaks & Hlth Emergencies, Geneva, Switzerland.
   [Morgan, Oliver] Ctr Dis Control & Prevent, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA USA.
RP McDonald, SLR (corresponding author), WHO, EVD Res, Comprehens Care & Support EVD Survivors, Freetown, Sierra Leone.
EM suzannamcdonald@yahoo.co.uk
RI Gaillard, Philippe/E-7256-2019; Kieny, Marie-Paule/Q-1238-2019
OI Zhang, Yong/0000-0002-2692-5437; Thorson, Anna/0000-0002-8703-6561
FU World Health OrganizationWorld Health Organization; United States
   Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA;
   Chinese Center for Disease Control and Prevention; Paul G. Allen Family
   Foundation; WHO's Ebola Response Programme; UNDP-UNFPA-UNICEF-WHO-World
   Bank Special Programme of Research, Development and Research Training in
   Human Reproduction - Sierra Leone Ebola Virus Persistence Study
FX Funding was provided by the World Health Organization (PF NB), the
   United States Centers for Disease Control and Prevention (BK OM STN),
   the Chinese Center for Disease Control and Prevention (WX HL WJL YZ GW
   ML), and the Paul G. Allen Family Foundation
   (http://www.pgafamilyfoundation.org/) (PF NB AET). The World Health
   Organization gratefully acknowledges the financial contribution of the
   WHO's Ebola Response Programme (PF), The Paul G. Allen Family Foundation
   (NB PF AET), and the UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme
   of Research, Development and Research Training in Human Reproduction
   (HRP) (NB) in support of the Sierra Leone Ebola Virus Persistence Study.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. The views
   expressed in this article are those of the authors and do not
   necessarily represent the official positions, decisions, policy or views
   of the Government of Sierra Leone Ministry of Health and Sanitation,
   Ministry of Defence, the World Health Organization, the United States
   Centers for Disease Control and Prevention, or the Chinese Center for
   Disease Control and Prevention.
CR Abad N, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005827
   Arias A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew016
   Arwady MA, 2014, MMWR-MORBID MORTAL W, V63, P1207
   Blackley DJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600378
   Centers for Disease Control and Prevention, 2014, EB VIR NP REAL TIM R
   Centers for Disease Control and Prevention, 2014, EB VIR VP40 REAL TIM
   Christie A, 2015, MMWR-MORBID MORTAL W, V64, P479
   De Roo A, 1998, TROP MED INT HEALTH, V3, P883
   Deen GF, 2015, N ENGL J MED
   Etard JF, 2017, LANCET INFECT DIS, V17, P545, DOI 10.1016/S1473-3099(16)30516-3
   Ferraretto X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088922
   Flint M, 2015, J INFECT DIS, V212, pS350, DOI 10.1093/infdis/jiv361
   Ghosn J, 2014, CLIN INFECT DIS, V58, P1763, DOI 10.1093/cid/ciu187
   Jacobs M, 2016, LANCET, V388, P498, DOI 10.1016/S0140-6736(16)30386-5
   KRIEGER JN, 1995, J UROLOGY, V154, P1035, DOI 10.1016/S0022-5347(01)66969-6
   Ksiazek TG, 1999, J INFECT DIS, V179, pS192, DOI 10.1086/514313
   [李阿茜 Li Aqian], 2014, [中华实验和临床病毒学杂志, Chinese Journal of Experimental and Clinical Virology], V28, P321
   Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773
   Pasquier C, 2003, J MED VIROL, V69, P344, DOI 10.1002/jmv.10295
   Rodriguez LL, 1999, J INFECT DIS, V179, pS170, DOI 10.1086/514291
   Sissoko D, 2017, LANCET GLOB HEALTH, V5, pE80, DOI 10.1016/S2214-109X(16)30243-1
   Spengler JR, 2015, J INFECT DIS, V212, pS346, DOI 10.1093/infdis/jiv187
   Thorson A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008859
   Tiffany A, 2016, CLIN INFECT DIS, V62, P1360, DOI 10.1093/cid/ciw158
   United Nations Development Group Western and Central Africa, 2015, SOC IMP EB VIR DIS W
   United Nations Economic Commission for Africa, 2015, SOC IMP EB AFR
   United States Department of State, 2011, REP INT REL FREED SI
   Uyeki TM, 2016, CLIN INFECT DIS, V62, P1552, DOI 10.1093/cid/ciw202
   Wang Q, 2016, BIOMED ENVIRON SCI, V29, P443, DOI 10.3967/bes2016.057
   WHO, 2016, INT GUID CLIN CAR SU
   WHO, 2016, INT ADV SEX TRANSM E
   WHO, 2015, WHO M SURV EB VIR DI
   Wolrd Health Organization, 2016, SIT REP EB VIR DIS
   World Health Organization, 2014, CLIN MAN PAT VIR HAE
   World Health Organization, 2015, WHO EB SIT REP
NR 35
TC 11
Z9 11
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD SEP
PY 2017
VL 11
IS 9
AR e0005723
DI 10.1371/journal.pntd.0005723
PG 18
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FI6YN
UT WOS:000412142800004
PM 28892501
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Salinas, S
   Constant, O
   Desmetz, C
   Barthelemy, J
   Lemaitre, JM
   Milhavet, O
   Nagot, N
   Foulongne, V
   Perrin, FE
   Saiz, JC
   Lecollinet, S
   Van de Perre, P
   Simonin, Y
AF Salinas, Sara
   Constant, Orianne
   Desmetz, Caroline
   Barthelemy, Jonathan
   Lemaitre, Jean-Marc
   Milhavet, Ollivier
   Nagot, Nicolas
   Foulongne, Vincent
   Perrin, Florence E.
   Saiz, Juan-Carlos
   Lecollinet, Sylvie
   Van de Perre, Philippe
   Simonin, Yannick
TI Deleterious effect of Usutu virus on human neural cells
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID WEST-NILE-VIRUS; HUMAN BRAIN; INFECTION; FLAVIVIRUS; MICE; INDUCTION;
   EMERGENCE; DEATH; SENSITIVITY; PROTECTS
AB In the last decade, the number of emerging Flaviviruses described worldwide has increased considerably. Among them Zika virus (ZIKV) and Usutu virus (USUV) are African mosquitoborne viruses that recently emerged. Recently, ZIKV has been intensely studied due to major outbreaks associated with neonatal death and birth defects, as well as neurological symptoms. USUV pathogenesis remains largely unexplored, despite significant human and veterinary associated disorders. Circulation of USUV in Africa was documented more than 50 years ago, and it emerged in Europe two decades ago, causing massive bird mortality. More recently, USUV has been described to be associated with neurological disorders in humans such as encephalitis and meningoencephalitis, highlighting USUV as a potential health threat. The aim of this study was to evaluate the ability of USUV to infect neuronal cells. Our results indicate that USUV efficiently infects neurons, astrocytes, microglia and IPSc-derived human neuronal stem cells. When compared to ZIKV, USUV led to a higher infection rate, viral production, as well as stronger cell death and anti-viral response. Our results highlight the need to better characterize the physiopathology related to USUV infection in order to anticipate the potential threat of USUV emergence.
C1 [Salinas, Sara; Constant, Orianne; Barthelemy, Jonathan; Nagot, Nicolas; Foulongne, Vincent; Van de Perre, Philippe; Simonin, Yannick] Univ Montpellier, Pathogenesis & Control Chron Infect, INSERM, EFS, Montpellier, France.
   [Desmetz, Caroline] Univ Montpellier, BioCommun CardioMetabol BC2M, Montpellier, France.
   [Lemaitre, Jean-Marc; Milhavet, Ollivier] Univ Montpellier, CHU Montpellier, INSERM, Inst Med Regeneratrice & Biotherapies,U1183, Montpellier, France.
   [Lemaitre, Jean-Marc; Milhavet, Ollivier] Infrastruct Natl INGESTEM, Plateforme CHU SAFE IPS, Montpellier, France.
   [Foulongne, Vincent; Van de Perre, Philippe] CHU Montpellier, Dept Bacteriol Virol, Montpellier, France.
   [Perrin, Florence E.] Univ Montpellier, INSERM, MMDN, U1198, Montpellier, France.
   [Saiz, Juan-Carlos] INIA, Dept Biotechnol, Madrid, Spain.
   [Lecollinet, Sylvie] INRA, ENVA, Anses Anim Hlth Lab, UPE,Virol UMR1161, Maisons Alfort, France.
RP Salinas, S; Simonin, Y (corresponding author), Univ Montpellier, Pathogenesis & Control Chron Infect, INSERM, EFS, Montpellier, France.
EM sara.salinas@inserm.fr; yannick.simonin@umantpellier.fr
RI Van de Perre, Philippe/B-9692-2008; LEMAITRE, Jean-Marc/I-4989-2016;
   Salinas, Sara/O-1856-2013; Lecollinet, Sylvie/M-1728-2019; Desmetz,
   Caroline/N-4892-2016; Salinas, Sara/O-1150-2019
OI Van de Perre, Philippe/0000-0002-3912-0427; Salinas,
   Sara/0000-0003-4492-2093; Desmetz, Caroline/0000-0002-8530-6011;
   Salinas, Sara/0000-0003-4492-2093; Lecollinet,
   Sylvie/0000-0001-8535-2133; simonin, yannick/0000-0002-3475-1369;
   PERRIN, Florence/0000-0002-7630-0515; Saiz,
   Juan-Carlos/0000-0001-8269-5544; Milhavet, Ollivier/0000-0001-6236-0499;
   LEMAITRE, Jean-Marc/0000-0002-6492-5219
FU La Region Languedoc-RoussillonRegion Occitanie; REACting
FX This work was funded by La Region Languedoc-Roussillon
   (http://www.midipyrenees.fr/-Accueil-Enseignement-superieur-Recherche-)
   and REACting
   (https://www.inserm.fr/zoom/reacting-une-approche-multidisciplinaire-pou
   r-relever-le-defi-des-crises-epidemiques). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x
   ALLERING L, 2012, EURO SURVEILL, V17
   Ashraf U, 2015, VIRUSES-BASEL, V7, P219, DOI 10.3390/v7010219
   Bakonyi T, 2004, VIROLOGY, V328, P301, DOI 10.1016/j.virol.2004.08.005
   Bakonyi T, 2007, J CLIN MICROBIOL, V45, P3870, DOI 10.1128/JCM.01390-07
   Barbic L, 2013, VECTOR-BORNE ZOONOT, V13, P772, DOI 10.1089/vbz.2012.1236
   Becker N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032604
   Best SM, 2017, AM SOC MICROBIOLOGY
   Blazquez AB, 2015, VIROLOGY, V482, P67, DOI 10.1016/j.virol.2015.03.020
   Blazquez AB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002509
   Buckley A, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-71
   Cacciotti G, 2015, VIROLOGY, V485, P189, DOI 10.1016/j.virol.2015.07.015
   Cadar D, 2017, EUROSURVEILLANCE, V22, P9, DOI [10.2807/1560-7917.es.2017.22.14.30501, 10.2807/1560-7917.ES.2017.22.14.30501]
   Campanella GSV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012700
   CAVRINI F, 2009, EURO SURVEILL, V14
   Cheeran MCJ, 2005, J NEUROVIROL, V11, P512, DOI 10.1080/13550280500384982
   Chvala S, 2004, J COMP PATHOL, V131, P176, DOI 10.1016/j.jcpa.2004.03.004
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Engel D, 2016, MBIO, V7, DOI 10.1128/mBio.01938-15
   Escribano-Romero E, 2015, VET MICROBIOL, V176, P365, DOI 10.1016/j.vetmic.2015.02.005
   Gaibani P, 2012, VECTOR-BORNE ZOONOT, V12, P431, DOI 10.1089/vbz.2011.0813
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Garigliany MM, 2014, VET J, V199, P191, DOI 10.1016/j.tvjl.2013.10.017
   Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474
   Grottola A, 2017, CLIN MICROBIOL INFEC, V23, P33, DOI 10.1016/j.cmi.2016.09.019
   Grottola A, 2016, CLIN MICROBIOL INFEC
   Hussmann KL, 2013, J VIROL, V87, P2814, DOI 10.1128/JVI.02577-12
   Iwasaki A, 2017, TRENDS MOL MED, V23, P227, DOI 10.1016/j.molmed.2017.01.004
   Jurado-Tarifa E, 2016, COMP IMMUNOL MICROB, V49, P58, DOI 10.1016/j.cimid.2016.10.001
   Karber G, 1931, N-S ARCH EX PATH PH, V162, P480, DOI 10.1007/BF01863914
   Kimura T, 2010, VET PATHOL, V47, P806, DOI 10.1177/0300985810372507
   King NJC, 2007, IMMUNOL CELL BIOL, V85, P33, DOI 10.1038/sj.icb.7100012
   Lazear HM, 2016, CELL HOST M IN PRESS, P1
   Lecollinet S, 2016, EMERG INFECT DIS, V22, P2225, DOI 10.3201/eid2212.161272
   Lelli R, 2008, ZOONOSES PUBLIC HLTH, V55, P361, DOI 10.1111/j.1863-2378.2008.01146.x
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Martin-Acebes MA, 2016, VACCINE, V34, P2066, DOI 10.1016/j.vaccine.2016.03.015
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Neal JW, 2014, J INFECTION, V69, P203, DOI 10.1016/j.jinf.2014.05.010
   Nikolay B, 2011, VECTOR-BORNE ZOONOT, V11, P1417, DOI 10.1089/vbz.2011.0631
   Nowakowski A, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/4956063
   Pauli G, 2014, TRANSFUS MED HEMOTH, V41, P73, DOI 10.1159/000357106
   PECORARI M, 2009, EURO SURVEILL, V14
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Pierro A, 2013, CLIN MICROBIOL INFEC, V19, pE451, DOI 10.1111/1469-0691.12241
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rijks J, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.45.30391
   Rizzoli A, 2007, VECTOR-BORNE ZOONOT, V7, P411, DOI 10.1089/vbz.2006.0626
   Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005
   Samuel MA, 2007, J VIROL, V81, P2614, DOI 10.1128/JVI.02311-06
   Santini M, 2015, J NEUROVIROL, V21, P92, DOI 10.1007/s13365-014-0300-4
   Scagnolari C, 2013, J GEN VIROL, V94, P789, DOI 10.1099/vir.0.046433-0
   Shresta S, 2004, J VIROL, V78, P2701, DOI 10.1128/JVI.78.6.2701-2710.2004
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8
   Sui YJ, 2006, EUR J NEUROSCI, V23, P957, DOI 10.1111/j.1460-9568.2006.04631.x
   Tamba M, 2011, VECTOR-BORNE ZOONOT, V11, P551, DOI 10.1089/vbz.2010.0055
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   van Kempen LCL, 2006, EUR J CANCER, V42, P728, DOI 10.1016/j.ejca.2006.01.004
   van Marle G, 2004, VIROLOGY, V329, P302, DOI 10.1016/j.virol.2004.08.024
   Vilibic-Cavlek T, 2014, INFECTION, V42, P689, DOI 10.1007/s15010-014-0625-1
   Wang HX, 2016, SCI CHINA INFORM SCI, V59, DOI 10.1007/s11432-016-5525-9
   Weissenbock H, 2004, ACTA NEUROPATHOL, V108, P453, DOI 10.1007/s00401-004-0916-1
   Weissenbock H, 2002, EMERG INFECT DIS, V8, P652, DOI 10.3201/eid0807.020094
   Weissenbock H, 2013, EMERG INFECT DIS, V19, P274, DOI 10.3201/eid1902.121191
   WILLIAMS MC, 1964, ANN TROP MED PARASIT, V58, P367, DOI 10.1080/00034983.1964.11686258
   Ye J, 2013, VACCINE, V31, P461, DOI 10.1016/j.vaccine.2012.11.015
   Zhang F, 2016, NUCL ACIDS RES
NR 74
TC 11
Z9 12
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD SEP
PY 2017
VL 11
IS 9
AR e0005913
DI 10.1371/journal.pntd.0005913
PG 21
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FI6YN
UT WOS:000412142800053
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Simonin, Y
   van Riel, D
   de Perre, PV
   Rockx, B
   Salinas, S
AF Simonin, Yannick
   van Riel, Debby
   de Perre, Philippe Van
   Rockx, Barry
   Salinas, Sara
TI Differential virulence between Asian and African lineages of Zika virus
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID NEURAL PROGENITORS; RESPONSES; CELLS
C1 [Simonin, Yannick; de Perre, Philippe Van; Salinas, Sara] Univ Montpellier, Pathogenesis & Control Chron Infect, Etab Francais Sang, INSERM, Montpellier, France.
   [van Riel, Debby; Rockx, Barry] Erasmus MC, Dept Virosci, Rotterdam, Netherlands.
   [de Perre, Philippe Van] CHU Montpellier, Dept Bacteriol Virol, Montpellier, France.
RP Simonin, Y; Salinas, S (corresponding author), Univ Montpellier, Pathogenesis & Control Chron Infect, Etab Francais Sang, INSERM, Montpellier, France.; Rockx, B (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.
EM yannick.simonin@umontpellier.fr; b.rockx@erasmusmc.nl;
   sara.salinas@inserm.fr
RI Salinas, Sara/O-1150-2019; Salinas, Sara/O-1856-2013; Van de Perre,
   Philippe/B-9692-2008
OI Salinas, Sara/0000-0003-4492-2093; Salinas, Sara/0000-0003-4492-2093;
   Van de Perre, Philippe/0000-0002-3912-0427; simonin,
   yannick/0000-0002-3475-1369; van Riel, Debby/0000-0001-9753-3564
FU REACting
FX This work was funded by REACting
   (https://www.inserm.fr/zoom/reacting-une-approche-multidisciplinaire-pou
   rrelever-le-defi-des-crises-epidemiques). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00292-17, 10.1128/msphere.00292-17]
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dowall SD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005704
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2017, INFECT GENET EVOL, V49, P134, DOI 10.1016/j.meegid.2017.01.015
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Kleber de Oliveira W, 2016, MMWR-MORBID MORTAL W, V65, P242
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Neal JW, 2014, J INFECTION, V69, P203, DOI 10.1016/j.jinf.2014.05.010
   Nutt C, 2017, LANCET, V389, P1595, DOI 10.1016/S0140-6736(17)31051-6
   Pompon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01282-6
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Sheridan MA, 2017, P NATL ACAD SCI USA, DOI DOI 10.1073/PNAS.1616097114
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Widman DG, 2017, MBIO, V8, DOI [10.1128/mBio.02014-16, 10.1128/mbio.02014-16]
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
NR 26
TC 44
Z9 44
U1 2
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD SEP
PY 2017
VL 11
IS 9
AR e0005821
DI 10.1371/journal.pntd.0005821
PG 8
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FI6YN
UT WOS:000412142800014
PM 28934211
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Allard, A
   Althouse, BM
   Hebert-Dufresne, L
   Scarpino, SV
AF Allard, Antoine
   Althouse, Benjamin M.
   Hebert-Dufresne, Laurent
   Scarpino, Samuel V.
TI The risk of sustained sexual transmission of Zika is underestimated
SO PLOS PATHOGENS
LA English
DT Article
ID VECTOR-BORNE TRANSMISSION; VIRUS OUTBREAK; INFECTION; MODEL; SEMEN;
   WOMEN; MICE
AB Pathogens often follow more than one transmission route during outbreaks-from needle sharing plus sexual transmission of HIV to small droplet aerosol plus fomite transmission of influenza. Thus, controlling an infectious disease outbreak often requires characterizing the risk associated with multiple mechanisms of transmission. For example, during the Ebola virus outbreak in West Africa, weighing the relative importance of funeral versus health care worker transmission was essential to stopping disease spread. As a result, strategic policy decisions regarding interventions must rely on accurately characterizing risks associated with multiple transmission routes. The ongoing Zika virus (ZIKV) outbreak challenges our conventional methodologies for translating case-counts into route-specific transmission risk. Critically, most approaches will fail to accurately estimate the risk of sustained sexual transmission of a pathogen that is primarily vectored by a mosquito-such as the risk of sustained sexual transmission of ZIKV. By computationally investigating a novel mathematical approach for multi-route pathogens, our results suggest that previous epidemic threshold estimates could under-estimate the risk of sustained sexual transmission by at least an order of magnitude. This result, coupled with emerging clinical, epidemiological, and experimental evidence for an increased risk of sexual transmission, would strongly support recent calls to classify ZIKV as a sexually transmitted infection.
C1 [Allard, Antoine] Ctr Recerca Matemet, Edifici C,Campus Bellaterra, Barcelona, Spain.
   [Althouse, Benjamin M.; Hebert-Dufresne, Laurent] Inst Dis Modeling, Bellevue, WA USA.
   [Althouse, Benjamin M.] Univ Washington, Seattle, WA 98195 USA.
   [Althouse, Benjamin M.] New Mexico State Univ, Las Cruces, NM 88003 USA.
   [Hebert-Dufresne, Laurent] Santa Fe Inst, Santa Fe, NM 87501 USA.
   [Hebert-Dufresne, Laurent] Univ Vermont, Burlington, VT USA.
   [Scarpino, Samuel V.] Northeastern Univ, Boston, MA 02115 USA.
RP Hebert-Dufresne, L (corresponding author), Inst Dis Modeling, Bellevue, WA USA.; Hebert-Dufresne, L (corresponding author), Santa Fe Inst, Santa Fe, NM 87501 USA.; Hebert-Dufresne, L (corresponding author), Univ Vermont, Burlington, VT USA.
EM laurent@santafe.edu
FU "la Caixa" FoundationLa Caixa Foundation
FX AA acknowledges support from "la Caixa" Foundation. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Agusto FB, 2017, ECOL COMPLEX, V29, P61, DOI 10.1016/j.ecocom.2016.12.007
   Allard A, 2017, P NATL ACAD SCI USA, V114, P8969, DOI 10.1073/pnas.1703073114
   Allard A, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036113
   Althaus CL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002157
   Anaya JM, 2017, J AUTOIMMUNITY
   Baumle AK, 2013, INT HDB DEMOGRAPHY S, P3
   Brauer Fred, 2016, Infect Dis Model, V1, P79, DOI 10.1016/j.idm.2016.08.001
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Chandra A., 2013, INT HDB DEMOGRAPHY S, P45
   Chevalier M, 2017, EMERGING INFECT DIS, V23
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Deckard DT, 2016, MMWR MORBIDITY MORTA, V65
   Ding CX, 2016, CHIN CONTR CONF, P2642, DOI 10.1109/ChiCC.2016.7553763
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   FELD SL, 1991, AM J SOCIOL, V96, P1464, DOI 10.1086/229693
   Folkers KM, 2017, PUBLIC HEALTH, V148, P66, DOI 10.1016/j.puhe.2017.02.018
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frieden TR, 2016, JAMA-J AM MED ASSOC, V316, P1443, DOI 10.1001/jama.2016.11941
   Gao D., 2016, SCI REPORTS, V6
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grills A, 2016, MMWR MORBIDITY MORTA, V65
   Grulich AE, 2003, AUST NZ J PUBL HEAL, V27, P155, DOI 10.1111/j.1467-842X.2003.tb00803.x
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Hethcote HW, 1984, LECT NOTES BIOMATHEM, V56
   Hills S. L, 2016, MMWR MORBIDITY MORTA, V65
   Jimenez A, 2017, MED REV, V31, P1, DOI DOI 10.1016/J.TMRV.2016.08.001
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lessler JT, 2016, B WHO, V1
   Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140
   Manore CA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005255
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Martinez LE, 2017, BIORXIV
   Maxian  O., 2017, EPIDEMICS
   Miller JC, 2017, INFECT DIS MODELLING
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Patino-Barbosa AM, 2015, SEX TRANSM INFECT, V91, P359, DOI 10.1136/sextrans-2015-052189
   Paz-Bailey G, 2017, NEW ENGLAND J MED
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Riou J, 2017, EPIDEMICS-NETH, V19, P43, DOI 10.1016/j.epidem.2017.01.001
   Teng Y, 2017, J INFECT
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   U S Food & Drugs Administration, 2017, BIOL GUID
   Uraki R, 2017, J INFECT DIS, V215, P1720, DOI 10.1093/infdis/jix204
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   US Centers for Disease Control and Prevention, 2017, SEX TRANS PREV
   Vasquez AM, 2016, AM J TRANSPLANT, V16, P2487, DOI 10.1111/ajt.13941
   Viennet E, 2016, PLOS CURRENTS OUTBRE
   Vinhaes ES, 2017, CLIN INFECT DIS, V64, P675, DOI 10.1093/cid/ciw770
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
   Zhang Q, 2017, P NATL ACAD SCI USA
NR 54
TC 25
Z9 25
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD SEP
PY 2017
VL 13
IS 9
AR e1006633
DI 10.1371/journal.ppat.1006633
PG 12
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA FI4TG
UT WOS:000411968300043
PM 28934370
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Avery, EJ
AF Avery, Elizabeth Johnson
TI Public information officers' social media monitoring during the Zika
   virus crisis, a global health threat surrounded by public uncertainty
SO PUBLIC RELATIONS REVIEW
LA English
DT Article
DE Social media; Social media monitoring; Crisis communication; Public
   information officers; Zika virus; Health communication
AB As Zika virus emerged as a global health concern in 2016, it was surrounded in public uncertainty regarding its transmission and health consequences. Health communicators were tasked with managing their own uncertainties and with incomplete information on the virus. Given the misinformation, rumors, and even conspiracy theories surrounding Zika virus, monitoring public awareness and understanding of the mysterious illness on social media could offer critical insight to crisis management. A survey (n = 226) was conducted with public information officers (PIOs) at local public health departments across the United States to reveal how they utilize and listen to social media during public health crises. In addition to an overall low rate of social media monitoring reported by PlOs, troublesome disparities exist based on community size served. However, there were positive relationships between social media monitoring and satisfaction with overall departmental crisis management as well as preparedness for Zika. These and many other monitoring trends are explored. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Avery, Elizabeth Johnson] Univ Tennessee, Sch Advertising & Publ Relat, 476 Commun Bldg, Knoxville, TN 37996 USA.
RP Avery, EJ (corresponding author), Univ Tennessee, Sch Advertising & Publ Relat, 476 Commun Bldg, Knoxville, TN 37996 USA.
EM ejavery@utk.edu
CR Allagui I, 2016, PUBLIC RELAT REV, V42, P20, DOI 10.1016/j.pubrev.2015.12.001
   Avery E. J., 2016, PUBLIC RELAT J, P10
   Avery E, 2010, J PUBLIC RELAT RES, V22, P336, DOI 10.1080/10627261003614427
   Avery EJ, 2009, HEALTH COMMUN, V24, P327, DOI 10.1080/10410230902889365
   Bodwell W, 2010, TECHNOL FORECAST SOC, V77, P193, DOI 10.1016/j.techfore.2009.07.004
   Charest F, 2016, PUBLIC RELAT REV, V42, P530, DOI 10.1016/j.pubrev.2016.03.008
   Cinnamon J, 2016, GEOFORUM, V75, P253, DOI 10.1016/j.geoforum.2016.07.019
   Curtis L, 2010, PUBLIC RELAT REV, V36, P90, DOI 10.1016/j.pubrev.2009.10.003
   DiStaso MW, 2012, GLOB MEDIA J-CAN ED, V5, P75
   Duggan M., 2015, SOCIAL MEDIA UPDATE
   Duhe S, 2015, PUBLIC RELAT REV, V41, P153, DOI 10.1016/j.pubrev.2014.11.002
   Faustino J., 2012, FINAL REPORT HUMAN F, P2012
   Fayon D., 2012, DEV SA PRESENCE INTE, P103
   Freberg K, 2012, PUBLIC RELAT REV, V38, P416, DOI 10.1016/j.pubrev.2012.01.008
   FREIMUTH VS, 1990, COMMUNICATION HLTH S, P171
   Hadi T. A., 2016, DISASTER MED PUBLIC, P1
   Kent ML, 2011, PUBLIC RELAT REV, V37, P536, DOI 10.1016/j.pubrev.2011.09.011
   Martins KAO, 2016, VACCINE, V34, P3711, DOI 10.1016/j.vaccine.2016.06.012
   Morrow J. A., 2014, WORKSH PRES ANN M AM
   Peterson E., 2006, ENGAGEMENT ELEMENTS
   Reuters, 2016, STUD FINDS PEOPL WRO
   Schultz F, 2011, PUBLIC RELAT REV, V37, P20, DOI 10.1016/j.pubrev.2010.12.001
   Sharma M., 2016, AM J INFECT IN PRESS
   Trust for America's Health, 2013, INV AM HLTH STAT BY
   US Department of Health and Human Services, 2016, HLTH RES SERV ADM
   Waters RD, 2011, PUBLIC RELAT REV, V37, P321, DOI 10.1016/j.pubrev.2011.03.002
   Wright D. K., 2011, PUBLIC RELAT J, V5, P1
NR 27
TC 13
Z9 13
U1 14
U2 69
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0363-8111
EI 1873-4537
J9 PUBLIC RELAT REV
JI Public Relat. Rev.
PD SEP
PY 2017
VL 43
IS 3
BP 468
EP 476
DI 10.1016/j.pubrev.2017.02.018
PG 9
WC Business; Communication
SC Business & Economics; Communication
GA EZ9QD
UT WOS:000405064000002
DA 2020-07-08
ER

PT J
AU de Oliveira, SR
   Caleffe, RRT
   Conte, H
AF de Oliveira, Stefany Rodrigues
   Tait Caleffe, Ronaldo Roberto
   Conte, Helio
TI Chemical control of Aedes aegypti: a review on effects on the
   environment and human health
SO REVISTA ELETRONICA EM GESTAO EDUCACAO E TECNOLOGIA AMBIENTAL
LA English
DT Review
DE Mosquitoes; Insecticides; Environmental; Toxicity
ID PESTICIDES; ORGANOPHOSPHATES; EXPOSURE
AB Aedes mosquitoes are known to be infected by arboviruses causing disease such as dengue, zika fever, and chikunguya fever, and subsequently transmit them, to humans through the bite of infected females. Chemical control is a measure adopted as part of sustainable management and integrated vector control for public health. There are four principal classes of insecticides used for controlling mosquitoes, all being neurotoxic: organochlorides, organophosphates, carbamates, and pyrethroids. The objective of this work was to review reports on the environmental effects of the insecticides most commonly used for controlling Ae. aegypti. This bibliographic study was conducted using articles and books available in the literature with no time restriction. The databases accessed were: Google Scholar, Pubmed, SciELO, and ScienceDirect. These insecticides exhibit toxicity to the environment, and may accumulate in food and water and in the body of vertebrates. Resistance to different insecticides is a problem when the mode of control is chemical, because insects survive insecticide application and higher doses are necessary for controlling the vectors. Considering these results, the ideal method would be the newly proposed means of mosquitoes control using technology related to modern biotechnology.
C1 [de Oliveira, Stefany Rodrigues; Tait Caleffe, Ronaldo Roberto] Univ Estadual Maringa, Dept Biotecnol Genet & Biol Celular, Biotecnol Ambiental, Maringa, Parana, Brazil.
   [Conte, Helio] Univ Estadual Maringa, Dept Biotecnol Genet & Biol Celular, Maringa, Parana, Brazil.
RP de Oliveira, SR (corresponding author), Univ Estadual Maringa, Dept Biotecnol Genet & Biol Celular, Biotecnol Ambiental, Maringa, Parana, Brazil.
EM s.r.oliveira@outlook.com; ronaldo_caleffe@hotmail.com;
   helconte@gmail.com
RI Conte, Helio/M-4811-2019
OI Conte, Helio/0000-0002-2090-0554
FU Araucaria foundationFundacao Araucaria; CAPESCAPES
FX The authors would like to thank the Araucaria foundation and CAPES for
   financial support.
CR BECKER N, 2003, MOSQUITOES THEIR CON, P498
   Bellinato DF, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8603263
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blankson-Arthur Sarah, 2011, Research Journal of Environment and Earth Sciences, V3, P350
   Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P279
   Castro Jr. Francisco P. de, 2013, Iheringia, Sér. Zool., V103, P118, DOI 10.1590/S0073-47212013000200006
   Crinnion W J, 2000, Altern Med Rev, V5, P432
   Dhouib IB, 2016, J APPL BIOMED, V14, P85, DOI 10.1016/j.jab.2016.01.001
   Ejaz S, 2004, EXP ONCOL, V26, P98
   Escamez JC, 2006, PRINCIPIOS URGENCIAS
   Flores Araceli Verônica, 2004, Ambient. soc., V7, P111, DOI 10.1590/S1414-753X2004000200007
   Fundacao Nacional da Saude Ministerio da Saude, 1998, INT AGR
   Griza FT, 2008, QUIM NOVA, V31, P1631, DOI 10.1590/S0100-40422008000700006
   Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018
   Jayaraj R, 2017, INTERDISCIPLINARY TO, V9, P90
   Jurewicz J, 2015, SYST BIOL REPROD MED, V61, P37, DOI 10.3109/19396368.2014.981886
   Lopes TF, 2014, REV INST MED TROP SP, V56, P369, DOI 10.1590/S0036-46652014000500001
   Lourenco-de-Oliveira R, 1994, PRINCIPAIS MOSQUITOS, P228, DOI DOI 10.7476/9788575412909
   Manjarres-Suarez Alejandra, 2013, Rev. costarric. salud pública, V22, P68
   Mitra Anindita, 2011, Research Journal of Environmental Toxicology, V5, P81, DOI 10.3923/rjet.2011.81.96
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Murphy AE, 2016, SCIINSIGT, V2, P1
   Nganchamung Thitirat, 2017, Rocz Panstw Zakl Hig, V68, P175
   Palchick Susan, 1996, P502
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Rivero J, 2016, TOXICOL LETT, V246, P42, DOI 10.1016/j.toxlet.2016.02.003
   Rose RI, 2001, EMERG INFECT DIS, V7, P17, DOI 10.3201/eid0701.010103
   Rothwell JT, 2001, PEST MANAG SCI, V57, P993, DOI 10.1002/ps.372
   Soo KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154760
   Teixeira CF, 2003, REV SAUDE PUBL, V37, P417, DOI 10.1590/s0034-89102003000400005
   Wang A, 2014, OCCUP ENVIRON MED, V71, P275, DOI 10.1136/oemed-2013-101394
   Ware GW, 2000, INTRO INSECTICIDES, P496
NR 32
TC 0
Z9 0
U1 0
U2 4
PU UNIV FEDERAL SANTA MARIA
PI SANTA MARIA
PA CIDADE UNIV, BAIRRO CAMOBI, SANTA MARIA, RS 97105-900, BRAZIL
SN 2236-1170
J9 REV ELECTRON GEST ED
JI Rev. Electron. Gest. Educ. Technol. Ambient.
PD SEP-DEC
PY 2017
VL 21
IS 3
BP 240
EP 247
DI 10.5902/2236117029795
PG 8
WC Environmental Studies
SC Environmental Sciences & Ecology
GA GR4DK
UT WOS:000442550800006
OA Other Gold
DA 2020-07-08
ER

PT J
AU Katip, W
   Wientong, P
AF Katip, Wasan
   Wientong, Purida
TI CLINICAL CHARACTERISTICS AND METEOROLOGICAL PATTERNS OF ZIKA VIRUS
   INFECTION IN CHIANG MAI PROVINCE, THAILAND
SO SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Article
DE Zika virus infection; clinical manifestation; meteorological pattern;
   Chiang Mai; Thailand
ID TRAVELERS; DENGUE; MICRONESIA; OUTBREAK; FEVER
AB Zika virus is an emerging mosquito-borne pathogen, with outbreaks occurring worldwide. However, clinical characteristics and meteorological pat terns of Zika infection are not well established. In 19 cases of confirmed Zika infection in Chiang Mai from June - November 2016, rash was the most common (89%) symptom, followed by conjunctivitis (53%), fever (47%), arthralgia, headache and malaise/fatigue (each 37%), and myalgia (32%). Zika-infected subjects had visited a Zika virus-infected area within the previous two weeks or resided within a 100-m radius of an individual with Zika infection. Emergence of Zika virus cases followed onset of rainfall by approximately one month.
C1 [Katip, Wasan; Wientong, Purida] Chiang Mai Univ, Fac Pharm, Dept Pharmaceut Care, Chiang Mai 50200, Thailand.
RP Katip, W (corresponding author), Chiang Mai Univ, Fac Pharm, Dept Pharmaceut Care, Chiang Mai 50200, Thailand.
EM wasankatip@gmail.com
RI Katip, Wasan/Q-3892-2019
OI Katip, Wasan/0000-0001-7665-8819
CR [Anonymous], 2016, MMWR-MORBID MORTAL W, V65, P474, DOI 10.15585/mmwr.mm6518e1
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Centers for Disease Control and Prevention, ZIK VIR SYMPT TEST T
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Meltzer E, 2016, AM J MED, V129, P1126, DOI 10.1016/j.amjmed.2016.04.034
   [Ministry of Public Health Thailand Bureau of Emerging Infectious Disease (BEID)], 2014, SIT ZIK VIR DIS THAI
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Schwartz E, 1996, AM J MED, V101, P516, DOI 10.1016/S0002-9343(96)00278-1
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Wilder-Smith A, 2005, NEW ENGL J MED, V353, P924, DOI 10.1056/NEJMra041927
NR 19
TC 1
Z9 1
U1 0
U2 8
PU SOUTHEAST ASIAN MINISTERS EDUC ORGANIZATION
PI BANGKOK
PA SEAMEO-TROPMED, 420-6 RAJVITHI RD,, BANGKOK 10400, THAILAND
SN 0125-1562
J9 SE ASIAN J TROP MED
JI Southeast Asian J. Trop. Med. Public Health
PD SEP
PY 2017
VL 48
IS 5
BP 993
EP 998
PG 6
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Tropical Medicine
SC Public, Environmental & Occupational Health; Infectious Diseases;
   Tropical Medicine
GA FL5KN
UT WOS:000414275800005
DA 2020-07-08
ER

PT J
AU Custer, B
   Goncalez, T
   Gao, K
   Brambilla, DJ
   Proietti, AC
   Mendrone, A
   Loureiro, P
   Lopes, ME
   Capuani, L
   Busch, MP
   Sabino, E
AF Custer, Brian
   Goncalez, Thelma
   Gao, Kui
   Brambilla, Donald J.
   Proietti, Anna Carneiro
   Mendrone, Alfredo
   Loureiro, Paula
   Lopes, Maria Esther
   Capuani, Ligia
   Busch, Michael Paul
   Sabino, Ester
CA REDS-III Int-Brazil
TI Zika, Chikungunya and Dengue Virus Incident Infections in Blood Donors
   in Brazil in 2016: Implications for Blood Safety and Public Health
   Surveillance
SO TRANSFUSION
LA English
DT Meeting Abstract
CT AABB Annual Meeting
CY OCT 07-10, 2017
CL San Diego, CA
SP AABB
C1 [Custer, Brian; Goncalez, Thelma; Busch, Michael Paul] Blood Syst Res Inst, San Francisco, CA USA.
   [Gao, Kui] Grifols Diagnost Solut Inc, Emeryville, CA USA.
   [Brambilla, Donald J.] RTI Int, Res Triangle Pk, NC USA.
   [Proietti, Anna Carneiro] Hemominas, Belo Horizonte, MG, Brazil.
   [Mendrone, Alfredo; Capuani, Ligia] Fundacao Pro Sangue, Sao Paulo, Brazil.
   [Loureiro, Paula] Univ Pernambuco, Fac Ciencias Med, Recife, PE, Brazil.
   [Lopes, Maria Esther] HEMORIO, Rio De Janeiro, Brazil.
   [Sabino, Ester] Univ Sao Paulo, Sao Paulo, Brazil.
   [REDS-III Int-Brazil] NHLBI, Bldg 10, Bethesda, MD 20892 USA.
RI Loureiro, Paula/A-2965-2013; Sabino, Ester Cerdeira/F-7750-2010
OI Loureiro, Paula/0000-0003-1849-0047; Sabino, Ester
   Cerdeira/0000-0003-2623-5126
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD SEP
PY 2017
VL 57
SU 3
SI SI
MA C11-A01C
BP 26A
EP 27A
PG 2
WC Hematology
SC Hematology
GA FF5UQ
UT WOS:000409065000063
DA 2020-07-08
ER

PT J
AU Lemke, G
AF Lemke, Greg
TI Phosphatidylserine Is the Signal for TAM Receptors and Their Ligands
SO TRENDS IN BIOCHEMICAL SCIENCES
LA English
DT Review
ID INNATE IMMUNE-RESPONSES; TYROSINE KINASE; APOPTOTIC CELLS; PHOSPHOLIPID
   FLIPPASES; STRUCTURAL BASIS; VIRUS ENTRY; ZIKA VIRUS; EXPOSURE; FAMILY;
   PHAGOCYTOSIS
AB Nature repeatedly repurposes, in that molecules that serve as metabolites, energy depots, or polymer subunits are atthe same time used to deliver signals within and between cells. The preeminent example of this repurposing is ATP, which functions as a building block for nucleic acids, an energy source for enzymatic reactions, a phosphate donorto regulate intracellular signaling, and a neurotransmitter to control the activity of neurons. A series of recent studies now consolidates the view that phosphatidylserine (PtdSer), a common phospholipid constituent of membrane bilayers, is similarly repurposed for use as a signal between cells and that the ligands and receptors of the Tyro3/Axl/Mer (TAM) fam ily of receptortyrosine kinases (RTKs) are prominent transducers of this signal.
C1 [Lemke, Greg] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA.
   [Lemke, Greg] Salk Inst Biol Studies, Immunobiol & Microbial Pathogenesis Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.
RP Lemke, G (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA.; Lemke, G (corresponding author), Salk Inst Biol Studies, Immunobiol & Microbial Pathogenesis Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.
EM lemke@salk.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 NS085296, RO1 A1101400];
   Charitable Trust [2017-PG-MED001]; HKT foundations
FX The author thanks Paqui Gonzalez, Kaisa Happonen, Erin Lew, and Sheng
   Miao for helpful comments on and corrections to the manuscript. Work in
   his laboratory is supported by grants from the NIH (R01 NS085296 and RO1
   A1101400), the Leona M. and Harry B. Helmsley Charitable Trust
   (#2017-PG-MED001 to the Salk Institute), and the Nomis, H.N. and Frances
   C. Berger, Fritz B. Burns, and HKT foundations.
CR Altan-Bonnett N, 2017, TRENDS CELL BIOL, V27, P201, DOI 10.1016/j.tcb.2016.09.011
   Andersen JP, 2016, FRONT PHYSIOL, V7, DOI [10.3339/fphys.2016.00275, 10.3389/fphys.2016.00275]
   Bandyopadhyay PK, 2008, VITAM HORM, V78, P157, DOI 10.1016/S0083-6729(07)00008-8
   Berkner KL, 2008, VITAM HORM, V78, P131, DOI 10.1016/S0083-6729(07)00007-6
   Bevers EM, 2016, PHYSIOL REV, V96, P605, DOI 10.1152/physrev.00020.2015
   Bhattacharyya S, 2013, CELL HOST MICROBE, V14, P136, DOI 10.1016/j.chom.2013.07.005
   Birge RB, 2016, CELL DEATH DIFFER, V23, P962, DOI 10.1038/cdd.2016.11
   Brindley MA, 2011, VIROLOGY, V415, P83, DOI 10.1016/j.virol.2011.04.002
   Brown GC, 2014, NAT REV NEUROSCI, V15, P209, DOI 10.1038/nrn3710
   Brunner JD, 2014, NATURE, V516, P207, DOI 10.1038/nature13984
   Burstyn-Cohen T, 2012, NEURON, V76, P1123, DOI 10.1016/j.neuron.2012.10.015
   Burstyn-Cohen T, 2009, J CLIN INVEST, V119, P2942, DOI 10.1172/JCI39325
   Ceridono M, 2011, TRAFFIC, V12, P72, DOI 10.1111/j.1600-0854.2010.01125.x
   Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776
   D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645
   Dransfield I, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.18
   Elliott MR, 2016, DEV CELL, V38, P147, DOI 10.1016/j.devcel.2016.06.029
   Fischer K, 2006, BLOOD, V108, P4094, DOI 10.1182/blood-2006-03-011742
   Fourgeaud L, 2016, NATURE, V532, P240, DOI 10.1038/nature17630
   Freeman GJ, 2010, IMMUNOL REV, V235, P172, DOI 10.1111/j.0105-2896.2010.00903.x
   Fujii T, 2015, P NATL ACAD SCI USA, V112, P12800, DOI 10.1073/pnas.1516594112
   Fujimori T, 2015, MUCOSAL IMMUNOL, V8, P1021, DOI 10.1038/mi.2014.129
   Furie B, 1999, BLOOD, V93, P1798, DOI 10.1182/blood.V93.6.1798.406k22_1798_1808
   Futter CE, 2007, TRAFFIC, V8, P951, DOI 10.1111/j.1600-0854.2007.00590.x
   Gal A, 2000, NAT GENET, V26, P270
   Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419
   Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661
   Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001
   Graham DK, 2014, NAT REV CANCER, V14, P769, DOI 10.1038/nrc3847
   Hoeppner DJ, 2001, NATURE, V412, P202, DOI 10.1038/35084103
   Hong S, 2016, CURR OPIN NEUROBIOL, V36, P128, DOI 10.1016/j.conb.2015.12.004
   Huang MD, 2003, NAT STRUCT BIOL, V10, P751, DOI 10.1038/nsb971
   Janes PW, 2012, SEMIN CELL DEV BIOL, V23, P43, DOI 10.1016/j.semcdb.2012.01.001
   Jorissen BL, 2001, NUTR NEUROSCI, V4, P121, DOI 10.1080/1028415X.2001.11747356
   Kalafatis M, 1996, CRIT REV EUKAR GENE, V6, P87, DOI 10.1615/CritRevEukarGeneExpr.v6.i1.60
   Kariolis MS, 2014, NAT CHEM BIOL, V10, P977, DOI [10.1038/NCHEMBIO.1636, 10.1038/nchembio.1636]
   Kim YE, 2010, NAT PROTOC, V5, P1396, DOI 10.1038/nprot.2010.101
   Kodigepalli KM, 2015, FEBS LETT, V589, P3, DOI 10.1016/j.febslet.2014.11.036
   KORNBERG RD, 1971, BIOCHEMISTRY-US, V10, P1111
   Kuchroo VK, 2008, NAT REV IMMUNOL, V8, P577, DOI 10.1038/nri2366
   Kulman JD, 2006, P NATL ACAD SCI USA, V103, P15794, DOI 10.1073/pnas.0607543103
   Kurotaki D, 2015, MICROBIOL IMMUNOL, V59, P55, DOI 10.1111/1348-0421.12228
   Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303
   Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076
   Lemke G, 2010, ANN NY ACAD SCI, V1209, P23, DOI 10.1111/j.1749-6632.2010.05744.x
   Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234
   Lew ED, 2014, ELIFE, V3, DOI 10.7554/eLife.03385
   Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554
   Malvezzi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3367
   Mastellos DC, 2014, EXP NEUROL, V261, P469, DOI 10.1016/j.expneurol.2014.06.019
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164
   Miner JJ, 2015, NAT MED, V21, P1464, DOI 10.1038/nm.3974
   Moller-Tank S, 2014, VIROLOGY, V468, P565, DOI 10.1016/j.virol.2014.09.009
   Nagata S, 2016, CELL DEATH DIFFER, V23, P952, DOI 10.1038/cdd.2016.7
   Neher JJ, 2013, P NATL ACAD SCI USA, V110, pE4098, DOI 10.1073/pnas.1308679110
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Ogden CA, 2006, CURR DIRECT AUTOIMMU, V9, P120
   Ory S, 2013, J NEUROSCI, V33, P3545, DOI 10.1523/JNEUROSCI.3654-12.2013
   Paidassi H, 2008, J IMMUNOL, V180, P2329, DOI 10.4049/jimmunol.180.4.2329
   Parinot C, 2016, ADV EXP MED BIOL, V854, P259, DOI 10.1007/978-3-319-17121-0_35
   Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329
   Park SY, 2008, CELL DEATH DIFFER, V15, P192, DOI 10.1038/sj.cdd.4402242
   Park SY, 2009, J CELL SCI, V122, P3365, DOI 10.1242/jcs.049569
   Penberthy KK, 2016, IMMUNOL REV, V269, P44, DOI 10.1111/imr.12376
   Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011
   Ravichandran KS, 2011, IMMUNITY, V35, P445, DOI 10.1016/j.immuni.2011.09.004
   Reddien PW, 2001, NATURE, V412, P198, DOI 10.1038/35084096
   Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034
   Rothlin CV, 2015, ANNU REV IMMUNOL, V33, P355, DOI 10.1146/annurev-immunol-032414-112103
   Ruggiero L, 2012, P NATL ACAD SCI USA, V109, P8145, DOI 10.1073/pnas.1121101109
   Sasaki T, 2006, EMBO J, V25, P80, DOI 10.1038/sj.emboj.7600912
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603
   Segawa K, 2016, J BIOL CHEM, V291, P762, DOI 10.1074/jbc.M115.690727
   Segawa K, 2014, SCIENCE, V344, P1164, DOI 10.1126/science.1252809
   Shimojima M, 2006, J VIROL, V80, P10109, DOI 10.1128/JVI.01157-06
   Shiratsuchi A, 1997, J BIOL CHEM, V272, P2354, DOI 10.1074/jbc.272.4.2354
   Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014
   Silva EAC, 2013, IMMUNITY, V39, P160, DOI 10.1016/j.immuni.2013.06.010
   Stafford DW, 2005, J THROMB HAEMOST, V3, P1873, DOI 10.1111/j.1538-7836.2005.01419.x
   Stenflo J, 1999, CRIT REV EUKAR GENE, V9, P59, DOI 10.1615/CritRevEukaryotGeneExpr.v9.i1.50
   STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0
   Suzuki J, 2016, P NATL ACAD SCI USA, V113, P9509, DOI 10.1073/pnas.1610403113
   Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758
   Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937
   Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583
   Tsou WI, 2014, J BIOL CHEM, V289, P25750, DOI 10.1074/jbc.M114.569020
   Tufail Y, 2017, NEURON, V93, P574, DOI 10.1016/j.neuron.2016.12.021
   Van Horn WD, 2013, CRIT REV BIOCHEM MOL, V48, P357, DOI 10.3109/10409238.2013.791659
   van Meer G, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004671
   Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283
   VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I
   Wang CP, 2003, J THROMB HAEMOST, V1, P118, DOI 10.1046/j.1538-7836.2003.00069.x
   Whitlock JM, 2017, ANNU REV PHYSIOL, V79, P119, DOI 10.1146/annurev-physiol-022516-034031
   Zagorska A, 2014, NAT IMMUNOL, V15, P920, DOI 10.1038/ni.2986
NR 97
TC 22
Z9 24
U1 6
U2 19
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0968-0004
EI 1362-4326
J9 TRENDS BIOCHEM SCI
JI Trends Biochem.Sci.
PD SEP
PY 2017
VL 42
IS 9
BP 738
EP 748
DI 10.1016/j.tibs.2017.06.004
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA FG4DI
UT WOS:000410177700009
PM 28734578
OA Green Accepted
DA 2020-07-08
ER

PT J
AU King, NJC
   Teixeira, MM
   Mahalingam, S
AF King, Nicholas J. C.
   Teixeira, Mauro M.
   Mahalingam, Suresh
TI Zika Virus: Mechanisms of Infection During Pregnancy
SO TRENDS IN MICROBIOLOGY
LA English
DT Editorial Material
ID CELLS
AB Immune status changes during pregnancy, with pro-inflammatory and anti-inflammatory contexts at different stages, making pregnant women potentially more susceptible to various infections. Infection by Zika virus during pregnancy can cause developmental damage to the fetus, and the altered immune response during pregnancy could contribute to disease during Zika infection.
C1 [King, Nicholas J. C.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney Med Sch,Charles Perkins Ctr, Discipline Pathol,Bosch Inst,Sch Med Sci, Camperdown, NSW, Australia.
   [Teixeira, Mauro M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
   [Mahalingam, Suresh] Griffith Univ, Inst Glyc, Gold Coast Campus, Southport, Qld 4222, Australia.
RP Mahalingam, S (corresponding author), Griffith Univ, Inst Glyc, Gold Coast Campus, Southport, Qld 4222, Australia.
EM s.mahalingam@griffith.edu.au
RI Teixeira, Mauro M/A-4587-2008; King, Nicholas JC/C-4138-2011
OI Teixeira, Mauro M/0000-0002-6944-3008; King, Nicholas
   JC/0000-0002-3877-9772
CR Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Cavalcanti LPD, 2016, J INFECT DEV COUNTR, V10, P563, DOI 10.3855/jidc.8575
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Kourtis AP, 2014, NEW ENGL J MED, V370, P2211, DOI 10.1056/NEJMra1213566
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Xavier-Neto J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005363
NR 13
TC 4
Z9 4
U1 0
U2 24
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0966-842X
EI 1878-4380
J9 TRENDS MICROBIOL
JI Trends Microbiol.
PD SEP
PY 2017
VL 25
IS 9
BP 701
EP 702
DI 10.1016/j.tim.2017.05.005
PG 2
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA FE0AS
UT WOS:000407883800002
PM 28578821
DA 2020-07-08
ER

PT J
AU Jungmann, P
   Pires, P
   Araujo, E
AF Jungmann, Patricia
   Pires, Pedro
   Araujo Junior, Edward
TI Early insights into Zika's microcephaly physiopathology from the
   epicenter of the outbreak: teratogenic apoptosis in the central nervous
   system
SO ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
LA English
DT Editorial Material
DE Intrauterine infection; Zika virus; microcephaly; ultrasound; apoptosis
ID INFECTION; FETUSES
AB Fetal infection by the Zika virus has been implicated in the exceptional rise in the number of microcephalic newborns recorded by the end of 2015 in Brazil. The mechanism by which this teratogenic effect is produced in the developing brain has not been fully established. Very early in the outbreak, we addressed this question by evaluating available initial data from a gestational and postnatal clinical investigation in the Brazilian state of Pernambuco. The present study was undertaken to test the hypothesis that the subtractive dysmorphic brain malformations observed in Zika-related microcephaly are primarily due to the massive induction of apoptosis of neuroprogenitor cells. We designed a physiopathological algorithm based on the examination of the following medical findings: epidemiological data, ultrasound images, computed tomography scans, placental tissue, cerebral fluid analysis, eye fundoscopy, neurological examination and necroscopy findings.
C1 [Jungmann, Patricia] Univ Pernambuco, Dept Pathol, Recife, PE, Brazil.
   [Pires, Pedro] Univ Pernambuco, Dept Maternal & Child Care, Recife, PE, Brazil.
   [Araujo Junior, Edward] Fed Univ Sao Paulo EPM UNIFESP, Paulista Sch Med, Dept Obstet, Sao Paulo, Brazil.
RP Araujo, E (corresponding author), Rua Napoleao Barros 875, Sao Paulo, SP, Brazil.
EM araujojred@terra.com.br
RI Junior, Edward Araujo/E-1228-2012
OI Junior, Edward Araujo/0000-0002-6145-2532
CR Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Knowles JK, 2012, PERINATAL BRAIN DEV, P41
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Sarno M, 2016, ULTRASOUND OBSTET GY
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Werner H, 2016, ULTRASOUND OBST GYN, V47, P657, DOI 10.1002/uog.15901
   World Health Organization-Pan American Health Organisation, 2016, PREL GUID SURV MICR
NR 12
TC 3
Z9 3
U1 0
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0001-6349
EI 1600-0412
J9 ACTA OBSTET GYN SCAN
JI Acta Obstet. Gynecol. Scand.
PD SEP
PY 2017
VL 96
IS 9
BP 1039
EP 1044
DI 10.1111/aogs.13184
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FD7ZV
UT WOS:000407745700002
PM 28646619
OA Bronze
DA 2020-07-08
ER

PT J
AU Kaye, D
AF Kaye, Donald
TI Pregnancy Outcomes After Maternal Zika Virus Infection During
   Pregnancy-US Territories, 1 January 2016 to 25 April 2017
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD SEP 1
PY 2017
VL 65
IS 5
BP II
EP II
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FD8XW
UT WOS:000407808400006
DA 2020-07-08
ER

PT J
AU Kaye, D
AF Kaye, Donald
TI Puerto Rico Declares Zika Outbreak Over, CDC Maintains Travel Warning
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD SEP 1
PY 2017
VL 65
IS 5
BP II
EP II
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FD8XW
UT WOS:000407808400005
DA 2020-07-08
ER

PT J
AU Ronit, A
AF Ronit, Andreas
TI The Response of the Peer Review System to the Ebola and Zika Virus
   Epidemic
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Letter
C1 [Ronit, Andreas] Univ Copenhagen, Rigshosp, Dept Infect Dis, Copenhagen, Denmark.
RP Ronit, A (corresponding author), Copenhagen Univ Hosp, Dept Infect Dis 8632, Blegdamsvej 9B, DK-2100 Copenhagen O, Denmark.
EM andreas.ronit@regionh.dk
FU GileadGilead Sciences
FX A. R. has received travel grants from Gilead. The author has submitted
   the ICMJE Form for Disclosure of Potential Conflicts of Interest.
   Conflicts that the editors consider relevant to the content of the
   manuscript have been disclosed.
CR Berg JM, 2016, SCIENCE, V352, P899, DOI 10.1126/science.aaf9133
   Powell K, 2016, NATURE, V530, P148, DOI 10.1038/530148a
   Ronit A, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01951-2016
NR 3
TC 0
Z9 1
U1 0
U2 10
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD SEP 1
PY 2017
VL 65
IS 5
BP 872
EP 873
DI 10.1093/cid/cix444
PG 2
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FD8XW
UT WOS:000407808400032
PM 29017275
OA Bronze
DA 2020-07-08
ER

PT J
AU Hussain, S
   Rasool, ST
AF Hussain, Snawar
   Rasool, Sahibzada Tasleem
TI Analysis of synonymous codon usage in Zika virus
SO ACTA TROPICA
LA English
DT Article
DE Zika virus; Zoonotic; Guillain-Barre syndrome; Microcephaly; Relative
   synonymous codon usage; Codon adaptation index
ID NUCLEOTIDE COMPOSITION; MUTATION PRESSURE; YELLOW-FEVER; BIAS; RNA;
   INTERFERON; SELECTION; HOST; GENOME; TRANSMISSION
AB Zika virus is a zoonotic pathogen, which have made frequent incursion into the human population in Africa and South East Asia over the course of several decades but never reached to the pandemic proportions until the most recent outbreak. Viruses are solely dependent on host synthetic machinery for their replication cycle; therefore, replication and persistence in a host species of different genetic background requires certain degree of adaptation. These adaptations are necessary to avoid detection from host immune surveillance and maximize the utilization of available resources for efficient viral replication. Study of genomic composition and codon usage pattern not only offer an insight into the adaptation of viruses to their new host, but may also provide some information about pathogenesis and spread of the virus. To elucidate the genetic features and synonymous codon usage bias in ZIKV genome, a comprehensive analysis was performed on 80 full-length ZIKV sequences. Our analyses shows that the overall extent of codon usage bias in ZIKV genome is low and affected by nucleotide composition, protein properties, natural selection, and gene expression level.
C1 [Hussain, Snawar; Rasool, Sahibzada Tasleem] King Faisal Univ, Dept Biomed Sci, Coll Clin Pharm, POB 400, Al Hasa 31982, Saudi Arabia.
RP Hussain, S (corresponding author), King Faisal Univ, Dept Biomed Sci, Coll Clin Pharm, POB 400, Al Hasa 31982, Saudi Arabia.
EM shhussain@kfu.edu.sa
RI HUSSAIN, SNAWAR/M-4373-2016
OI HUSSAIN, SNAWAR/0000-0002-9765-0565
FU Deanship of Scientific Research, King Faisal University [160009]
FX We thank College of Clinical Pharmacy for providing necessary support to
   conduct this research. This research was supported by Deanship of
   Scientific Research, King Faisal University grant #160009.
CR Akashi H, 1997, GENE, V205, P269, DOI 10.1016/S0378-1119(97)00400-9
   Arjona A, 2007, J IMMUNOL, V179, P8403, DOI 10.4049/jimmunol.179.12.8403
   BENNETZEN JL, 1982, J BIOL CHEM, V257, P3026
   BERNARDI G, 1986, J MOL EVOL, V24, P1, DOI 10.1007/BF02099946
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   BULMER M, 1991, GENETICS, V129, P897
   Butt AM, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.106
   Butt AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090905
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chen SL, 2004, P NATL ACAD SCI USA, V101, P3480, DOI 10.1073/pnas.0307827100
   Cristina J, 2016, VIRUS RES, V223, P147, DOI 10.1016/j.virusres.2016.06.022
   D'Onofrio G, 2002, GENE, V300, P179, DOI 10.1016/S0378-1119(02)01045-4
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Freire CCM, 2015, BIORXIV
   Greenbaum BD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005969
   Greenbaum BD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000079
   Gu WJ, 2004, VIRUS RES, V101, P155, DOI 10.1016/j.virusres.2004.01.006
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442
   Hooper SD, 2000, NUCLEIC ACIDS RES, V28, P3517, DOI 10.1093/nar/28.18.3517
   Hou Zhuo-Cheng, 2002, Acta Genetica Sinica, V29, P747
   Jenkins GM, 2003, VIRUS RES, V92, P1, DOI 10.1016/S0168-1702(02)00309-X
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P254, DOI 10.1016/0035-9203(77)90020-7
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Kunec D, 2016, CELL REP, V14, P55, DOI 10.1016/j.celrep.2015.12.011
   Luo GX, 2003, J VIROL, V77, P3312, DOI 10.1128/JVI.77.5.3312-3318.2003
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Munoz-Jordan JL, 2010, CURR TOP MICROBIOL, V338, P35, DOI 10.1007/978-3-642-02215-9_3
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nguyen KL, 2004, VIROLOGY, V319, P163, DOI 10.1016/j.virol.2003.11.021
   Niemeyer D, 2013, J VIROL, V87, P12489, DOI 10.1128/JVI.01845-13
   Novembre JA, 2002, MOL BIOL EVOL, V19, P1390, DOI 10.1093/oxfordjournals.molbev.a004201
   Overby AK, 2010, J VIROL, V84, P8470, DOI 10.1128/JVI.00176-10
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899
   Presnyak V, 2015, CELL, V160, P1111, DOI 10.1016/j.cell.2015.02.029
   Puigbo P, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-38
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Romero H, 2000, NUCLEIC ACIDS RES, V28, P2084, DOI 10.1093/nar/28.10.2084
   Sau K, 2005, VIRUS RES, V113, P123, DOI 10.1016/j.virusres.2005.05.001
   Shackelton LA, 2006, J MOL EVOL, V62, P551, DOI 10.1007/s00239-005-0221-1
   SHARP PM, 1986, J MOL EVOL, V24, P28, DOI 10.1007/BF02099948
   SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281
   Simmonds Peter, 2012, BMC Res Notes, V5, P50, DOI 10.1186/1756-0500-5-50
   Solovyov A., 2010, PLOS CURR, V2, DOI [10.1371/currents.RRN1147, DOI 10.1371/CURRENTS.RRN1147]
   SUEOKA N, 1988, P NATL ACAD SCI USA, V85, P2653, DOI 10.1073/pnas.85.8.2653
   Tao P, 2009, VIRUS GENES, V38, P104, DOI 10.1007/s11262-008-0296-z
   Tappe D., 2014, EUROSURVEILLANCE, P19
   Valencia A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151001
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Wang M, 2011, VIRUS GENES, V42, P245, DOI 10.1007/s11262-011-0574-z
   Wang M, 2011, ARCH VIROL, V156, P153, DOI 10.1007/s00705-010-0848-0
   Wilson JR, 2008, J VIROL, V82, P8262, DOI 10.1128/JVI.00226-08
   WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9
   Yin X, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-356
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Ze-Ze L, 2016, IDCases, V4, P46, DOI 10.1016/j.idcr.2016.03.004
   Zhang APP, 2012, VIRULENCE, V3, P440, DOI 10.4161/viru.21302
   Zhong J, 2007, VIRUS GENES, V35, P767, DOI 10.1007/s11262-007-0159-z
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 68
TC 5
Z9 5
U1 0
U2 20
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD SEP
PY 2017
VL 173
BP 136
EP 146
DI 10.1016/j.actatropica.2017.06.006
PG 11
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FC1AY
UT WOS:000406571000020
PM 28606821
DA 2020-07-08
ER

PT J
AU Richard, V
   Paoaafaite, T
   Cao-Lormeau, V
AF Richard, Vaea
   Paoaafaite, Tuterarii
   Cao-Lormeau, Van-Mai
TI Acquittal of Culex quinquefasciatus in transmitting Zika virus during
   the French Polynesian outbreak
SO ACTA TROPICA
LA English
DT Letter
ID CULICIDAE; DIPTERA
C1 [Richard, Vaea; Paoaafaite, Tuterarii; Cao-Lormeau, Van-Mai] Inst Louis Malarde, BP 30, F-98713 Tahiti, French Polynesi, France.
RP Richard, V (corresponding author), Inst Louis Malarde, BP 30, F-98713 Tahiti, French Polynesi, France.
EM vrichard@ilm.pf
RI Cao-Lormeau, Van-Mai/H-4879-2018
OI Cao-Lormeau, Van-Mai/0000-0001-5606-7480; Richard,
   Vaea/0000-0001-8132-0740
CR Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   da Silva LRC, 2016, REV SOC BRAS MED TRO, V49, P267, DOI 10.1590/0037-8682-0150-2016
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   HUANG G, 1992, J MED ENTOMOL, V29, P911, DOI 10.1093/jmedent/29.6.911
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leal Walter S, 2016, F1000Res, V5, P2546
   Luo Q, 1993, Zhonghua Liu Xing Bing Xue Za Zhi, V14, P67
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Vazeille-Falcoz M, 1999, AM J TROP MED HYG, V60, P319, DOI 10.4269/ajtmh.1999.60.319
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
NR 13
TC 7
Z9 8
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD SEP
PY 2017
VL 173
BP 200
EP 201
DI 10.1016/j.actatropica.2017.04.036
PG 2
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FC1AY
UT WOS:000406571000028
PM 28476603
DA 2020-07-08
ER

PT J
AU Pawitwar, SS
   Dhar, S
   Tiwari, S
   Ojha, CR
   Lapierre, J
   Martins, K
   Rodzinski, A
   Parira, T
   Paudel, I
   Li, JJ
   Dutta, RK
   Silva, MR
   Kaushik, A
   El-Hage, N
AF Pawitwar, Shashank S.
   Dhar, Supurna
   Tiwari, Sneham
   Ojha, Chet Raj
   Lapierre, Jessica
   Martins, Kyle
   Rodzinski, Alexandra
   Parira, Tiyash
   Paudel, Iru
   Li, Jiaojiao
   Dutta, Rajib Kumar
   Silva, Monica R.
   Kaushik, Ajeet
   El-Hage, Nazira
TI Overview on the Current Status of Zika Virus Pathogenesis and Animal
   Related Research
SO JOURNAL OF NEUROIMMUNE PHARMACOLOGY
LA English
DT Review
DE Zika virus (ZIKV); ZIKV animal models; Autophagy; ZIKV pathology; ZIKV
   diagnosis; Vaccine; Neurological disorders
ID WEST-NILE-VIRUS; SEXUAL TRANSMISSION; DENGUE VIRUS; CROSS-REACTIVITY;
   HUMAN-ANTIBODIES; MOSQUITO-BORNE; GOLDEN-HAMSTER; STEM-CELLS; INFECTION;
   DISEASE
AB There is growing evidence that Zika virus (ZIKV) infection is linked with activation of Guillan-Barre, syndrome (GBS) in adults infected with the virus and microcephaly in infants following maternal infection. With the recent outpour in publications by numerous research labs, the association between microcephaly in newborns and ZIKV has become very apparent in which large numbers of viral particles were found in the central nervous tissue of an electively aborted microcephalic ZIKV-infected fetus. However, the underlying related mechanisms remain poorly understood. Thus, development of ZIKV-infected animal models are urgently required. The need to develop drugs and vaccines of high efficacy along with efficient diagnostic tools for ZIKV treatment and management raised the demand for a very selective animal model for exploring ZIKV pathogenesis and related mechanisms. In this review, we describe recent advances in animal models developed for studying ZIKV pathogenesis and evaluating potential interventions against human infection, including during pregnancy. The current research directions and the scientific challenges ahead in developing effective vaccines and therapeutics are also discussed.
C1 [Pawitwar, Shashank S.; Rodzinski, Alexandra; Paudel, Iru; Li, Jiaojiao; Silva, Monica R.] Florida Int Univ, Dept Cellular Biol & Pharmacol, Herbert Wertheim Coll Med, Miami, FL 33199 USA.
   [Tiwari, Sneham; Ojha, Chet Raj; Lapierre, Jessica; Parira, Tiyash; Dutta, Rajib Kumar; Kaushik, Ajeet; El-Hage, Nazira] Florida Int Univ, Herbert Wertheim Coll Med, Deparment Immunol, Miami, FL 33199 USA.
   [Dhar, Supurna; Martins, Kyle] Florida Int Univ, Dept Human & Mol Genet, Herbert Wertheim Coll Med, Miami, FL 33199 USA.
RP El-Hage, N (corresponding author), Florida Int Univ, Herbert Wertheim Coll Med, Deparment Immunol, Miami, FL 33199 USA.
EM nelhage@fiu.edu
RI Dutta, Rajib/W-3358-2019; Kaushik, Ajeet/K-1289-2018
OI Dutta, Rajib/0000-0001-6570-9238; Kaushik, Ajeet/0000-0003-4206-1541;
   Pawitwar, Shashank/0000-0003-2651-810X; Ojha, Chet
   Raj/0000-0002-6816-8892
FU Florida Department of Health: Zika Research Grant Initiative [7ZK09];
   National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R01 DA036154,
   R01 DA036154-S1, R01 DA034547, R01 ES023779, R01 GM055425, R15
   AI111210]; National Institute of General Medical Sciences (NIGMS)
   Research Initiative for Scientific Enhancement (RISE) [R25 GM061347];
   National Science Foundation (NSF)National Science Foundation (NSF)
   [1408063]; Florida International University; McKnight Fellowship;
   Herbert Wertheim College of Medicine Teaching Assistance
FX This review was written as part of the curriculum for the course GMS
   6939, offered to the Ph.D. graduate students in the Biomedical Science
   Program at Florida International University. We gratefully acknowledge
   the support of the Florida Department of Health: Zika Research Grant
   Initiative # 7ZK09 and the National Institutes of Health (NIH) grants
   R01 DA036154 to NEH and JL; R01 DA036154-S1 to JL; R01 DA034547 to AK
   and ST; R01 ES023779 to SP and JJL; R01 GM055425 to SP; and R15 AI111210
   to MP and KM; the National Institute of General Medical Sciences (NIGMS)
   Research Initiative for Scientific Enhancement (RISE) Program R25
   GM061347 to MRS; the National Science Foundation (NSF) 1408063 to AR;
   Florida International University Graduate School Presidential Fellowship
   to CO and TP; the McKnight Fellowship to LG; and the Herbert Wertheim
   College of Medicine Teaching Assistance to SD, RD, IP and AC. SP, AK,
   and NEH critically revised the work and figures for important
   intellectual content. In addition, we thank Luis Garbinski, Allen Caobi
   and Mairyn Piloto, in the Biomedical Sciences Program at Florida
   International University, for assisting with the animal models depicted
   in Table 2.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aliota M. T., 2016, PLOS NEGLECT TROP D, V10, DOI DOI 10.1371/JOURNAL.PNTD.0004750
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Boadle A., 2016, BRAZIL REPORTS ZIKA
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Briant L, 2014, VIROLOGY, V464, P26, DOI 10.1016/j.virol.2014.06.023
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cavalcanti MG, 2017, INT J INFECT DIS, V57, P70, DOI 10.1016/j.ijid.2017.01.042
   Centres for Disease Control and Prevention, 2016, NAT CTR EM ZOON INF
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Cohen J, 2016, SCIENCE, V351, P543, DOI 10.1126/science.351.6273.543
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Delatte H, 2008, VECTOR-BORNE ZOONOT, V8, P25, DOI 10.1089/vbz.2007.0649
   Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532
   Diamond MS, 2015, CELL, V162, P488, DOI 10.1016/j.cell.2015.07.005
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dickens BL, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw103
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   European Centre for Disease Prevention and Control, 2016, REP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Fan ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109755
   Fauci AS, 2016, TESTIMONY HOUSE DEMO
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856
   Fox M, 2016, NBC NEWS
   Fox M, 2015, NBC NEWS
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Gao MM, 2014, CELL RES, V24, P380, DOI 10.1038/cr.2014.2
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Halstead SB, 2016, VACCINE, V34, P1643, DOI 10.1016/j.vaccine.2016.02.004
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141253, 10.3201/eid2011.141380]
   Hayden EC, 2016, RACE IS DEV ZIKA VAC
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hulo C, 2011, NUCLEIC ACIDS RES, V39, pD576, DOI 10.1093/nar/gkq901
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Kaushik A, 2016, TRENDS BIOTECHNOL
   Kenney JL, 2014, ADV VIRUS RES, V89, P39, DOI 10.1016/B978-0-12-800172-1.00002-1
   Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9
   Kimura T, 2010, VET PATHOL, V47, P806, DOI 10.1177/0300985810372507
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kuno G, 2001, ACTA VIROL, V45, P139
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   LEE VH, 1972, B WORLD HEALTH ORGAN, V46, P669
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Maron DF, 2016, ZIKA VACCINE COULD S
   Marrs C, 2016, AM J PERINAT, V33, P625, DOI 10.1055/s-0036-1580089
   Marthiens V, 2013, NAT CELL BIOL, V15, P731, DOI 10.1038/ncb2746
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mendola P, 2002, MENT RETARD DEV D R, V8, P188, DOI 10.1002/mrdd.10033
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mochida GH, 2009, SEMIN PEDIATR NEUROL, V16, P120, DOI 10.1016/j.spen.2009.07.001
   Mochida GH, 2001, CURR OPIN NEUROL, V14, P151, DOI 10.1097/00019052-200104000-00003
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nabel GJ, 2013, NEW ENGL J MED, V368, P551, DOI 10.1056/NEJMra1204186
   Nah JJ, 2015, CLIN EXP VACCINE RES, V4, P130, DOI 10.7774/cevr.2015.4.2.130
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Nigg EA, 2011, NAT CELL BIOL, V13, P1154, DOI 10.1038/ncb2345
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pan American Health Organization / World Health Organization (PAHO/ WHO), 2015, NEUR SYNDR CONG MALF
   Fontes CAP, 2016, NEURORADIOLOGY, V58, P837, DOI 10.1007/s00234-016-1687-9
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001
   Plotkin SA, 2016, CLIN MICROBIOL INFEC, V22, P294, DOI 10.1016/j.cmi.2016.03.001
   Plotkin SA, 2015, NEW ENGL J MED, V373, P297, DOI 10.1056/NEJMp1506820
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Pronker ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057755
   Pylro VS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004817
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shah A, 2016, NEUROTOX RES, V30, P131, DOI 10.1007/s12640-016-9635-3
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Shuaib W, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.02.027
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sun LH, 2016, WAHINGTON POST
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tang-Wing C, AEDES AEGYPTI MOSQUI
   Tesh RB, 2005, J INFECT DIS, V192, P287, DOI 10.1086/431153
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011
   Tonry JH, 2005, AM J TROP MED HYG, V72, P320, DOI 10.4269/ajtmh.2005.72.320
   Unni SK, 2011, MICROBES INFECT, V13, P312, DOI 10.1016/j.micinf.2011.01.002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wang H, 2009, J NEUROVIROL, V15, P293, DOI 10.1080/13550280902973978
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   WHO, 2016, SURV ZIK VIR FECT MI, P9
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xiao SY, 2001, EMERG INFECT DIS, V7, P714
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 134
TC 7
Z9 8
U1 1
U2 44
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1557-1890
EI 1557-1904
J9 J NEUROIMMUNE PHARM
JI J. Neuroimmune Pharm.
PD SEP
PY 2017
VL 12
IS 3
BP 371
EP 388
DI 10.1007/s11481-017-9743-8
PG 18
WC Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA FB7ZR
UT WOS:000406359000001
PM 28444557
DA 2020-07-08
ER

PT J
AU Silver, MK
   Shao, J
   Zhu, BQ
   Chen, MJ
   Xia, YK
   Kaciroti, N
   Lozoff, B
   Meeker, JD
AF Silver, Monica K.
   Shao, Jie
   Zhu, Binquan
   Chen, Minjian
   Xia, Yankai
   Kaciroti, Niko
   Lozoff, Betsy
   Meeker, John D.
TI Prenatal naled and chlorpyrifos exposure is associated with deficits in
   infant motor function in a cohort of Chinese infants
SO ENVIRONMENT INTERNATIONAL
LA English
DT Article
DE Organophosphate; Pesticide; Peabody, PDMS-2; Motor development;
   Neurodevelopment
ID ORGANOPHOSPHATE PESTICIDE EXPOSURE; DEVELOPMENTAL NEUROTOXICITY;
   AMNIOTIC-FLUID; CRITICAL PERIODS; PREGNANT-WOMEN; CHILDREN;
   NEURODEVELOPMENT; BLOOD; DETERMINANTS; METABOLITE
AB Background: Organophosphate insecticides (OPs) are used worldwide, yet despite nearly ubiquitous exposure in the general population, few have been studied outside the laboratory. Fetal brains undergo rapid growth and development, leaving them susceptible to long-term effects of neurotoxic OPs. The objective here was to investigate the extent to which prenatal exposure to OPs affects infant motor development.
   Methods: 30 OPs were measured in umbilical cord blood using gas chromatography tandem mass spectrometry in a cohort of Chinese infants. Motor function was assessed at 6-weeks and 9-months using Peabody Developmental Motor Scales 2nd edition (PDMS-2) (n = 199). Outcomes included subtest scores: reflexes, stationary, locomotion, grasping, visual-motor integration (V-M), composite scores: gross (GM), fine (FM), total motor (TM), and standardized motor quotients: gross (GMQ), fine (FMQ), total motor (TMQ).
   Results: Naled, methamidophos, trichlorfon, chlorpyrifos, and phorate were detected in = 10% of samples. Prenatal naled and chlorpyrifos were associated with decreased 9-month motor function. Scores were 0.55, 0.85, and 0.90 points lower per 1 ng/mL increase in log-naled, for V-M (p = 0.04), FM (p = 0.04), and FMQ (p = 0.08), respectively. For chlorpyrifos, scores were 0.50, 1.98, 0.80, 1.91, 3.49, 2.71, 6.29, 2.56, 2.04, and 2.59 points lower for exposed versus unexposed infants, for reflexes (p = 0.04), locomotion (p = 0.02), grasping (p = 0.05), V-M (p < 0.001), GM (p = 0.007), FM (p = 0.002), TM (p < 0.001), GMQ (p = 0.01), FMQ (p = 0.07), and TMQ (p = 0.008), respectively. Girls appeared to be more sensitive to the negative effects of OPs on 9-month motor function than boys.
   Conclusions: We found deficits in 9-month motor function in infants with prenatal exposure to naled and chlorpyrifos. Naled is being aerially sprayed to combat mosquitoes carrying Zika virus, yet this is the first nonoccupational human study of its health effects. Delays in early-motor skill acquisition may be detrimental for downstream development and cognition.
C1 [Silver, Monica K.; Meeker, John D.] Univ Michigan, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA.
   [Shao, Jie; Zhu, Binquan] Zhejiang Univ, Sch Med, Childrens Hosp, Dept Child Hlth Care, Hangzhou 310003, Zhejiang, Peoples R China.
   [Chen, Minjian; Xia, Yankai] Nanjing Med Univ, Inst Toxicol, Nanjing 210029, Jiangsu, Peoples R China.
   [Kaciroti, Niko; Lozoff, Betsy] Univ Michigan, Ctr Human Growth & Dev, Ann Arbor, MI 48109 USA.
   [Kaciroti, Niko] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA.
RP Meeker, JD (corresponding author), Univ Michigan, Sch Publ Hlth, 1835 SPH 1,1415 Washington Hts, Ann Arbor, MI 48109 USA.
EM meekerj@umich.edu
OI Kaciroti, Niko/0000-0001-8843-8231; Meeker, John/0000-0001-8357-5085;
   Silver, Monica K./0000-0002-5920-6906
FU National Institute of Environmental Health Sciences (NIEHS)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Environmental Health Sciences (NIEHS)
   [R01ES021465]; National Institute of Child Health and Development
   (NICHD)United States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [P01HD39386];
   National Natural Science Foundation of China (NNSFC)National Natural
   Science Foundation of China [81273085]
FX This study was supported by R01ES021465 from the National Institute of
   Environmental Health Sciences (NIEHS), P01HD39386 from the National
   Institute of Child Health and Development (NICHD), and 81273085 from the
   National Natural Science Foundation of China (NNSFC).
CR Abdel-Rahman AA, 2002, ARCH TOXICOL, V76, P452, DOI 10.1007/s00204-002-0366-2
   Abdollahi M, 2012, TOXICOL APPL PHARM, V258, P309, DOI 10.1016/j.taap.2011.11.014
   Aldridge JE, 2004, ENVIRON HEALTH PERSP, V112, P148, DOI 10.1289/ehp.6713
   [Anonymous], 2013, DPOC TLVS BEIS OTH W
   Bai L, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-10
   Barr DB, 1999, TOXICOL IND HEALTH, V15, P168, DOI 10.1191/074823399678846556
   Bouchard MF, 2011, ENVIRON HEALTH PERSP, V119, P1189, DOI 10.1289/ehp.1003185
   Bradman A, 2003, ENVIRON HEALTH PERSP, V111, P1779, DOI 10.1289/ehp.6259
   Bradman A, 2011, INT J ENV RES PUB HE, V8, P1061, DOI 10.3390/ijerph8041061
   California Environmental Protection Agency, 2004, SUMM TOX DAT NAL CHE
   Carlson BM, 2014, HUMAN EMBRYOLOGY DEV
   Clearfield MW, 2011, INFANT BEHAV DEV, V34, P15, DOI 10.1016/j.infbeh.2010.04.008
   Clearfield MW, 2004, J EXP CHILD PSYCHOL, V89, P214, DOI 10.1016/j.jecp.2004.07.003
   Dam K, 2000, DEV BRAIN RES, V121, P179, DOI 10.1016/S0165-3806(00)00044-4
   Dambska M., 1999, NORMAL PATHOLOGIC DE
   De Felice A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121663
   Ding GD, 2014, SCI TOTAL ENVIRON, V472, P289, DOI 10.1016/j.scitotenv.2013.11.067
   Eddleston M, 2008, LANCET, V371, P597, DOI 10.1016/S0140-6736(07)61202-1
   Engel SM, 2007, AM J EPIDEMIOL, V165, P1397, DOI 10.1093/aje/kwm029
   Engel SM, 2011, ENVIRON HEALTH PERSP, V119, P1182, DOI 10.1289/ehp.1003183
   Eskenazi B, 2007, ENVIRON HEALTH PERSP, V115, P792, DOI 10.1289/ehp.9828
   Eskenazi B, 2010, ENVIRON HEALTH PERSP, V118, P1775, DOI 10.1289/ehp.1002234
   Extension Toxicology Network, 1993, NAL PEST INF PROF
   Folio M. R., 1983, PEAB DEV MOT SCAL AC
   FOLIO MR, 2000, PEABODY DEV MOTOR SC
   Frieden TR, 2016, JAMA-J AM MED ASSOC, V316, P1443, DOI 10.1001/jama.2016.11941
   Garcia SJ, 2005, ENVIRON TOXICOL PHAR, V19, P455, DOI 10.1016/j.etap.2004.12.007
   Garcia SJ, 2003, ENVIRON HEALTH PERSP, V111, P297, DOI 10.1289/ehp.5791
   Garcia SJ, 2002, DEV BRAIN RES, V133, P151, DOI 10.1016/S0165-3806(02)00283-3
   Garcia SJ, 2001, BRAIN RES, V891, P54, DOI 10.1016/S0006-8993(00)03189-9
   Handal AJ, 2008, EPIDEMIOLOGY, V19, P851, DOI 10.1097/EDE.0b013e318187cc5d
   Harari R, 2010, ENVIRON HEALTH PERSP, V118, P890, DOI 10.1289/ehp.0901582
   Huang J., 2001, FARM PESTICIDE RICE
   Kamanyire R, 2004, OCCUP MED-OXFORD, V54, P69, DOI 10.1093/occmed/kqh018
   Koutroulakis D, 2014, REPROD TOXICOL, V46, P98, DOI 10.1016/j.reprotox.2014.03.010
   Liao W, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-72
   Marks AR, 2010, ENVIRON HEALTH PERSP, V118, P1768, DOI 10.1289/ehp.1002056
   National Pesticide Information Center, 2010, CHLORP GEN FACT SHEE
   Needham LL, 1995, TOXICOL LETT, V82-3, P373, DOI 10.1016/0378-4274(95)03568-0
   Neta G, 2010, ENVIRON SCI TECHNOL, V44, P5641, DOI 10.1021/es1009778
   Noritz GH, 2013, PEDIATRICS, V131, pE2016, DOI 10.1542/peds.2013-1056
   Perez JJ, 2010, J CHROMATOGR B, V878, P2554, DOI 10.1016/j.jchromb.2010.03.015
   Philibin SD, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00060
   Rauh V, 2011, ENVIRON HEALTH PERSP, V119, P1196, DOI 10.1289/ehp.1003160
   Rauh VA, 2006, PEDIATRICS, V118, pE1845, DOI 10.1542/peds.2006-0338
   Shelton JF, 2014, ENVIRON HEALTH PERSP, V122, P1103, DOI 10.1289/ehp.1307044
   Silver MK, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13010094
   Slotkin TA, 2007, BRAIN RES BULL, V72, P232, DOI 10.1016/j.brainresbull.2007.01.005
   Slotkin TA, 2007, REPROD TOXICOL, V23, P421, DOI 10.1016/j.reprotox.2006.07.010
   Snider L, 2009, PEDIATR PHYS THER, V21, P2, DOI 10.1097/PEP.0b013e3181957bdc
   Munoz-Quezada MT, 2013, NEUROTOXICOLOGY, V39, P158, DOI 10.1016/j.neuro.2013.09.003
   ThermoScientific, 2010, RAP AN PEST DIFF MAT
   Torres-Altoro MI, 2011, J NEUROCHEM, V119, P303, DOI 10.1111/j.1471-4159.2011.07428.x
   Tzatzarakis M, 2009, TOXICOL LETT, V189, pS156, DOI 10.1016/j.toxlet.2009.06.763
   U. S. Centers for Disease Control and Prevention, 2016, PAR LIC HEAD LIC TRE
   U. S. Environmental Protection Agency, 2016, NAL MOSQ CONTR
   U.S. Environmental Protection Agency, 2015, EPA REV CHLORP ASS S
   U.S. Environmental Protection Agency (EPA), 2011, PEST IND SAL US 2006
   Whyatt RM, 2003, ENVIRON HEALTH PERSP, V111, P749, DOI 10.1289/ehp.5768
   Wickerham EL, 2012, ENVIRON INT, V47, P80, DOI 10.1016/j.envint.2012.06.007
   Yan XY, 2009, HUM ECOL RISK ASSESS, V15, P948, DOI 10.1080/10807030903153089
   Young JG, 2005, NEUROTOXICOLOGY, V26, P199, DOI 10.1016/j.neuro.2004.10.004
   Zhang W., 2011, P INT ACAD ECOL ENV, V1, P125, DOI DOI 10.0000/ISSN-2220-8860-PIAEES-2011-V1-0012
   Zhang YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109159
   Zurich MG, 2004, TOXICOL APPL PHARM, V201, P97, DOI 10.1016/j.taap.2004.05.003
NR 65
TC 20
Z9 20
U1 0
U2 37
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0160-4120
EI 1873-6750
J9 ENVIRON INT
JI Environ. Int.
PD SEP
PY 2017
VL 106
BP 248
EP 256
DI 10.1016/j.envint.2017.05.015
PG 9
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA FB5IS
UT WOS:000406175300022
PM 28602489
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Musso, D
   Rouault, E
   Teissier, A
   Lanteri, MC
   Zisou, K
   Broult, J
   Grange, E
   Nhan, TX
   Aubry, M
AF Musso, Didier
   Rouault, Eline
   Teissier, Anita
   Lanteri, Marion C.
   Zisou, Karen
   Broult, Julien
   Grange, Emilie
   Tu-Xuan Nhan
   Aubry, Maite
TI Molecular detection of Zika virus in blood and RNA load determination
   during the French Polynesian outbreak
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE arbovirus; French Polynesia; RNA load; RT-PCR; Zika virus
ID SEXUAL TRANSMISSION; DENGUE; FEVER; VIREMIA; STATES
AB Zika virus (ZIKV) viremia is reported as low and transient; however, these estimates rely on limited data. We report RNA loads in sera collected from symptomatic patients during the 2013-2014 French Polynesian ZIKV outbreak. We performed molecular detection of ZIKV RNA in sera from 747 patients presenting with suspected acute phase ZIKV infection. Among patients with confirmed infection, we analyzed the duration of viremia, assessed viral RNA loads and recorded the main clinical symptoms. A total of 210/747 (28.1%) sera tested positive using a ZIKV-specific RT-PCR. Viral RNA loads in symptomatic patients that ranged from 5 to 3.7 x 10(6) copies/mL (mean 9.9 x 10(4) copies/mL) were not related to a particular clinical presentation, and were significantly lower than those previously obtained from asymptomatic ZIKV infected blood donors. The rate of detection of ZIKV RNA in sera from suspected cases of acute phase ZIKV infection was low. ZIKV RNA loads were lower in symptomatic patients compared to asymptomatic blood donors and were lower than RNA loads usually reported in dengue infections. As there is no abrupt onset of symptoms in ZIKV infections, we suggest that infected patients sought for medical attention when viremia was already decreasing or had resolved.
C1 [Musso, Didier; Rouault, Eline; Zisou, Karen; Grange, Emilie; Tu-Xuan Nhan] Inst Louis Malarde, Lab Biol Med, POB 30, F-98713 Tahiti, French Polynesi, France.
   [Musso, Didier; Teissier, Anita; Aubry, Maite] Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti, French Polynesi, France.
   [Lanteri, Marion C.] Blood Syst Res Inst, San Francisco, CA USA.
   [Lanteri, Marion C.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.
   [Broult, Julien] Ctr Transfus Sanguine, Tahiti, French Polynesi, France.
RP Musso, D (corresponding author), Inst Louis Malarde, Lab Biol Med, POB 30, F-98713 Tahiti, French Polynesi, France.
EM dmusso@ilm.pf
RI Musso, Didier/AAO-8178-2020; Musso, Didier/P-7809-2016
OI Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971;
   Aubry, Maite/0000-0002-9913-5794
CR [Anonymous], 2016, MMWR-MORBID MORTAL W, V65, P474, DOI 10.15585/mmwr.mm6518e1
   Appassakij H, 2013, TRANSFUSION, V53, P2567, DOI 10.1111/j.1537-2995.2012.03960.x
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Bel M., 2007, ZIKA VIRUS INFORM CL
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Disease Control and Prevention, 2016, GUID US LAB TEST ZIK
   Chen L. H., 2005, Dengue Bulletin, V29, P18
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Dyer O, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4740
   Food and Drug Administration (FDA), 2016, REC DON SCREEN DEF P
   Fox A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000967
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gubler DJ, 2007, FLAVIVIRUSES FIELD V, V34, P1155
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lanteri MC, 2014, TRANSFUSION, V54, P3232, DOI 10.1111/trf.12764
   Mallet HP, 2015, BISES B INFORM SANIT, V13, P1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Murgue B, 2000, J MED VIROL, V60, P432, DOI 10.1002/(SICI)1096-9071(200004)60:4&lt;432::AID-JMV11&gt;3.0.CO;2-7
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Sudiro TM, 2001, J MED VIROL, V63, P29, DOI 10.1002/1096-9071(200101)63:1&lt;29::AID-JMV1004&gt;3.0.CO;2-S
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Waggoner JJ, 2016, CLIN INFECT DIS
   Wang WK, 2003, VIROLOGY, V305, P330, DOI 10.1006/viro.2002.1704
   WATERMAN SH, 1989, CLIN DERMATOL, V7, P117, DOI 10.1016/0738-081X(89)90034-5
   World Health Organization, 2016, LAB TEST ZIK VIR INF
   World Health Organization, 2016, SIT REP ZIK VIR MICR
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
   Zou SMA, 2010, J INFECT DIS, V202, P1354, DOI 10.1086/656602
NR 49
TC 33
Z9 34
U1 0
U2 37
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD SEP
PY 2017
VL 89
IS 9
BP 1505
EP 1510
DI 10.1002/jmv.24735
PG 6
WC Virology
SC Virology
GA FA8NL
UT WOS:000405702600001
PM 27859375
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bedin, F
   Boulet, L
   Voilin, E
   Theillet, G
   Rubens, A
   Rozand, C
AF Bedin, Frederic
   Boulet, Laurent
   Voilin, Elodie
   Theillet, Gerald
   Rubens, Agnes
   Rozand, Christine
TI Paper-based point-of-care testing for cost-effective diagnosis of acute
   flavivirus infections
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE arbovirus; diagnosis; fluidics; NS1
ID DENGUE VIRUS; NS1 PROTEIN; ZIKA VIRUS; FLOW; ANTIGEN; IMMUNOASSAY;
   CIRCULATION; BRAZIL; ASSAY
AB Flavivirus infections are a serious healthcare concern in tropical and subtropical countries. Although well-established laboratory tests can provide early diagnosis of acute dengue or Zika infections, access to these tests is limited in developing countries, presenting an urgent need to develop simple, rapid, and robust diagnostic tools. Microfluidic Paper-based Analytical Devices (mu PAD), are typically rapid, cost-effective, user-friendly, and they can be used as diagnostic tools for the diagnosis of these infections at Point of Care settings. Early and prompt diagnosis is crucial to improve patient management and reduce the risk of complications. In the present study, we developed and evaluated a wax-printed paper-based device for the detection of the dengue and Zika non-structural NS1 viral protein in blood and plasma. Experiments have been carried out to increase specificity, while maintaining the required sensitivity. As a consequence, the quality of the raw materials and the washing steps were proved to be crucial. The mu PAD was able to detect specifically in 6-8 min 10 ng/mL of protein in various sample types. A prototype for the differential detection of dengue and/or Zika NS1 protein was developed. The reading of the results was simplified by using a dedicated application on a smartphone.
C1 [Bedin, Frederic; Boulet, Laurent; Voilin, Elodie; Theillet, Gerald; Rubens, Agnes; Rozand, Christine] BioMerieux SA, Innovat, Chemin Orme, Marcy Letoile, France.
RP Bedin, F (corresponding author), BioMerieux SA, Innovat, Chemin Orme, Marcy Letoile, France.
EM frederic.bedin@biomerieux.com
CR Acestor N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044269
   Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Bedin F, 2007, Med Trop (Mars), V67, P281
   Cassano CL, 2013, MICROFLUID NANOFLUID, V15, P173, DOI 10.1007/s10404-013-1140-x
   Connelly JT, 2015, ANAL CHEM, V87, P7595, DOI 10.1021/acs.analchem.5b00411
   de la Cruz-Hernandez SI, 2013, AM J TROP MED HYG, V88, P446, DOI 10.4269/ajtmh.12-0023
   Mota MTD, 2016, BRAZ J MICROBIOL, V47, P38, DOI 10.1016/j.bjm.2016.10.008
   Dussart P, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000280
   Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999
   Fu E, 2012, ANAL CHEM, V84, P4574, DOI 10.1021/ac300689s
   Hajra A, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12607
   Hu J, 2014, BIOSENS BIOELECTRON, V54, P585, DOI 10.1016/j.bios.2013.10.075
   Kumar AA, 2015, ANGEW CHEM INT EDIT, V54, P5835, DOI 10.1002/anie.201411741
   Lee TH, 2017, EXPERT REV ANTI-INFE, V15, P67, DOI 10.1080/14787210.2017.1248405
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Martinez AW, 2007, ANGEW CHEM INT EDIT, V46, P1318, DOI 10.1002/anie.200603817
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   Parolo C, 2013, CHEM SOC REV, V42, P450, DOI 10.1039/c2cs35255a
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   PRYOR MJ, 1993, VIROLOGY, V194, P769, DOI 10.1006/viro.1993.1318
   Rozand C, 2014, EUR J CLIN MICROBIOL, V33, P147, DOI 10.1007/s10096-013-1945-2
   Sastre P, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0831-4
   Schilling KM, 2013, LAB CHIP, V13, P628, DOI 10.1039/c2lc40984d
   Steidel M, 2012, J MED VIROL, V84, P490, DOI 10.1002/jmv.23204
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Teoh BT, 2016, SCI REP-UK, V6, DOI 10.1038/srep27663
   Vazquez S, 2010, DIAGN MICR INFEC DIS, V68, P46, DOI 10.1016/j.diagmicrobio.2010.04.006
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   Wu G, 2012, B WORLD HEALTH ORGAN, V90, P914, DOI 10.2471/BLT.12.102780
   Yu L, 2015, BIOSENS BIOELECTRON, V69, P307, DOI 10.1016/j.bios.2015.02.035
   Zhang Y, 2015, LAB CHIP, V15, P1465, DOI 10.1039/c4lc01127a
NR 32
TC 17
Z9 17
U1 1
U2 51
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD SEP
PY 2017
VL 89
IS 9
BP 1520
EP 1527
DI 10.1002/jmv.24806
PG 8
WC Virology
SC Virology
GA FA8NL
UT WOS:000405702600003
PM 28295400
OA Bronze
DA 2020-07-08
ER

PT J
AU Han, JF
   Qiu, Y
   Yu, JY
   Wang, HJ
   Deng, YQ
   Li, XF
   Zhao, H
   Sun, HX
   Qin, CF
AF Han, Jian-Feng
   Qiu, Yang
   Yu, Jiu-Yang
   Wang, Hong-Jiang
   Deng, Yong-Qiang
   Li, Xiao-Feng
   Zhao, Hui
   Sun, Han-Xiao
   Qin, Cheng-Feng
TI Immunization with truncated envelope protein of Zika virus induces
   protective immune response in mice
SO SCIENTIFIC REPORTS
LA English
DT Article
ID GENOMIC CHARACTERIZATION; DENGUE VIRUS; INFECTION; ANTIBODY; DISEASE
AB The global spread of Zika virus (ZIKV) as well as its unexpected link to infant microcephaly have resulted in serious public health concerns. No antiviral drugs against ZIKV is currently available, and vaccine development is of high priority to prepare for potential ZIKV pandemic. In the present study, a truncated E protein with the N-terminal 90% region reserved (E90) from a contemporary ZIKV strain was cloned and expressed in Escherichia coli, purified by a Ni-NTA column, and characterized by Western blotting assays. Immunization with recombinant E90 induced robust ZIKV-specific humoral response in adult BALB/c mice. Passive transfer of the antisera from E90-immunized mice conferred full protection against lethal ZIKV challenge in a neonatal mice model. Our results indicate that recombinant ZIKV E90 described here represents as a promising ZIKV subunit vaccine that deserves further clinical development.
C1 [Han, Jian-Feng; Qiu, Yang; Wang, Hong-Jiang; Deng, Yong-Qiang; Li, Xiao-Feng; Zhao, Hui; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Yu, Jiu-Yang; Sun, Han-Xiao] Jinan Univ, Guangzhou 510632, Guangdong, Peoples R China.
   [Qiu, Yang; Qin, Cheng-Feng] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.
RP Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.; Sun, HX (corresponding author), Jinan Univ, Guangzhou 510632, Guangdong, Peoples R China.; Qin, CF (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.
EM sunhx718@126.com; qincf@bmi.ac.cn
RI Qin, Cheng-Feng/I-6839-2019; Qiu, Yang/AAQ-4435-2020
OI Qin, Cheng-Feng/0000-0002-0632-2807; 
FU NFSC-NRF [81661148054]; National Key Research and Development Project of
   China [2016YFD0500304]; National Natural Science Foundation of China
   (NSFC)National Natural Science Foundation of China [31770190]; State Key
   Laboratory of Pathogen and Biosecurity [PBS2006-01]; NSFC Excellent
   Young Scientist [81522025]; Innovative Research Group [81621005]; UK
   Academy of Medical Sciences; NSFC of ChinaNational Natural Science
   Foundation of China [81661130162]
FX This work was supported by the NFSC-NRF joint research grant (No.
   81661148054), the National Key Research and Development Project of China
   (No. 2016YFD0500304), National Natural Science Foundation of China
   (NSFC) (No. 31770190) and the special grant from State Key Laboratory of
   Pathogen and Biosecurity (PBS2006-01). C.-F.Q. was supported by the NSFC
   Excellent Young Scientist (No. 81522025), Innovative Research Group (No.
   81621005), and Newton Advanced Fellowship from the UK Academy of Medical
   Sciences and the NSFC of China (No. 81661130162).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Coller BAG, 2011, VACCINE, V29, P7267, DOI 10.1016/j.vaccine.2011.07.021
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durbin AP, 2016, TRENDS IMMUNOL, V37, P635, DOI 10.1016/j.it.2016.08.006
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Kim E, 2016, EBIOMEDICINE
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Li HY, 2013, VACCINE, V31, P3281, DOI 10.1016/j.vaccine.2013.05.019
   Li XF, 2016, SCI CHINA LIFE SCI, V59, P440, DOI 10.1007/s11427-016-5020-y
   Liu G, 2015, CLIN VACCINE IMMUNOL, V22, P516, DOI 10.1128/CVI.00770-14
   Manoff SB, 2015, VACCINE, V33, P7126, DOI 10.1016/j.vaccine.2015.09.101
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Trip RA., 2016, EXPERT REV VACCINES, V6, P1
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
NR 24
TC 14
Z9 14
U1 0
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 30
PY 2017
VL 7
AR 10047
DI 10.1038/s41598-017-10595-5
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FF0WS
UT WOS:000408622400141
PM 28855646
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mata, VE
   Passos, SRL
   Hokerberg, YHM
   Berardinelli, GM
   dos Santos, MAB
   Fukuoka, LVB
   Maciel, ACFSR
   Rodrigues, CDD
   Santos, AD
   de Oliveira, RDC
AF Mata, Veronica Elizabeth
   Lambert Passos, Sonia Regina
   Marques Hokerberg, Yara Hahr
   Berardinelli, Guilherme Migueis
   Borges dos Santos, Maria Angelica
   Boas Fukuoka, Levy Vilas
   Seixas Rangel Maciel, Anna Carolina Fontoura
   dos Santos Rodrigues, Cintia Damasceno
   Santos, Aline da Silva
   Carvalhaes de Oliveira, Raquel de Vasconcellos
TI Accuracy and reliability of an NS1 rapid immunochromatographic test for
   DENV-1 diagnosis at the point of care and in the laboratory
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Dengue; Sensitivity and specificity; Diagnosis; Point-of-care systems;
   NS1; Reproducibility of results
ID DENGUE DIAGNOSIS; SPECIFICITY; ANTIGEN
AB Background: Rapid immunochromatographic tests (ICT) for dengue non-structural protein 1 (NS1) have shown good performance for diagnosing acute-phase dengue in serum in laboratory settings, but rarely have been assessed in whole blood and at point of care (POC). This study compare the accuracy and inter-and intra-observer reliability of the NS1 Bioeasy(TM) ICT in whole blood at POC versus serum in the laboratory, during a DENV-1 epidemic.
   Methods: Cross-sectional study involving 144 adults spontaneously demanding care in an emergency department within 4 days of onset of acute febrile illness. Accuracy of NS1 Bioeasy (TM) ICT was compared in whole blood and serum, both at 15 and 30 min, blinded to the reference RT-PCR or NS1 ELISA. Non-dengue patients were also tested for Zika virus with RT-PCR. Reliability of whole blood and serum readings by the same or different observers was measured by simple kappa (95% CI).
   Results: At 15 min, sensitivity (Sn) of NS1 Bioeasy (TM) ICT in whole blood/POC was 76.7% (95% CI: 68.0-84.1) and specificity (Sp) was 87.0% (95% CI: 66.4-97.2). Sn in serum/ laboratory was 82% (95% CI: 74.1-88.6) and Sp 100% (95% CI: 85.8-100). Positive likelihood ratio was 5.9 (95% CI: 2.0-17.0) for whole blood/POC and 19.8 (95% CI: 2.9-135.1) for serum/ laboratory. Reliability of matched readings of whole blood/POC and serum/ laboratory by the same observer (k = 0.83, 95% CI: 0.74-0.93) or different observers (k = 0.81, 95% CI: 0.72-0.92) was almost perfect, with higher discordant levels in the absence of dengue. Results did not differ statistically at 5%.
   Conclusions: NS1 Bioeasy (TM) ICT in DENV-1 epidemics is a potentially confirmatory test. Invalid results at 15 min should be reread at 30 min. To optimize impact of implementing ICT in the management of false-negatives it should be incorporated into an algorithm according to setting and available specimen.
C1 [Mata, Veronica Elizabeth; Lambert Passos, Sonia Regina; Marques Hokerberg, Yara Hahr; Berardinelli, Guilherme Migueis; Boas Fukuoka, Levy Vilas; Seixas Rangel Maciel, Anna Carolina Fontoura; Carvalhaes de Oliveira, Raquel de Vasconcellos] Av Brasil 4036 Sala 201 A, BR-21040361 Rio De Janeiro, RJ, Brazil.
   [Borges dos Santos, Maria Angelica] Rua Leopoldo Bulhoes 1480 Sala 601, BR-21040361 Rio De Janeiro, RJ, Brazil.
   [dos Santos Rodrigues, Cintia Damasceno; Santos, Aline da Silva] Av Brasil 4365, BR-21040360 Rio De Janeiro, RJ, Brazil.
RP Mata, VE (corresponding author), Av Brasil 4036 Sala 201 A, BR-21040361 Rio De Janeiro, RJ, Brazil.
EM veronica.mata@ini.fiocruz.br
OI Passos, Sonia/0000-0001-9947-2291
CR Abramson Joseph H, 2011, Epidemiol Perspect Innov, V8, P1, DOI 10.1186/1742-5573-8-1
   Andries AC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001993
   [Anonymous], 2014, MEDCALC STAT SOFTW V
   [Anonymous], 2015, DENG ED TEST BIOEAS
   [Anonymous], 2016, IVB DENG AG NS1 ORAN
   [Anonymous], 2012, SER EL CLASS DENG VI
   [Anonymous], 2008, PLAT DENG NS1 AG
   Martinez-Vega RA, 2009, BIOMEDICA, V29, P616, DOI 10.7705/biomedica.v29i4.139
   Buonora SN, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1368-7
   BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V
   Constenla Dagna, 2015, Value Health Reg Issues, V8, P80, DOI 10.1016/j.vhri.2015.06.001
   Dussart P, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000280
   FAGAN TJ, 1975, NEW ENGL J MED, V293, P257
   Ferraz FO, 2013, J CLIN VIROL, V58, P41, DOI 10.1016/j.jcv.2013.06.015
   Fry SR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001199
   Gan VC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090037
   Goodman C, 2005, ADV MED
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Hang VT, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000360
   Hunsperger EA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003171
   Korevaar DA, 2015, RADIOLOGY, V274, P781, DOI 10.1148/radiol.14141160
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Matheus S, 2016, EMERG INFECT DIS, V22, P1691, DOI 10.3201/eid2209.160725
   Organizacao Mundial da Saude, 2009, DENG DIR DIAGN TRAT, P11
   Osorio L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-361
   Pai NP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001306
   Pal S, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-23
   Palamountain KM, 2012, J INFECT DIS, V205, pS181, DOI 10.1093/infdis/jis203
   Peeling RW, 2010, CLIN MICROBIOL INFEC, V16, P1062, DOI 10.1111/j.1469-0691.2010.03279.x
   Pok KY, 2010, VECTOR-BORNE ZOONOT, V10, P1009, DOI 10.1089/vbz.2008.0176
   Lima MDQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000738
   R Core Team, 2015, R ID AMB COMP EST
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   Trajman A, 2007, SCAND J CLIN LAB INV, V68, P77
   Tricou V, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-142
NR 37
TC 4
Z9 4
U1 0
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD AUG 29
PY 2017
VL 17
AR 594
DI 10.1186/s12879-017-2679-z
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA FF2IH
UT WOS:000408720600002
PM 28851293
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Corry, J
   Arora, N
   Good, CA
   Sadovsky, Y
   Coyne, CB
AF Corry, Jacqueline
   Arora, Nitin
   Good, Charles A.
   Sadovsky, Yoel
   Coyne, Carolyn B.
TI Organotypic models of type III interferon-mediated protection from Zika
   virus infections at the maternal-fetal interface
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE placenta; Zika virus; organotypic models; type III interferon;
   trophoblast
ID LAMBDA; BRAIN
AB Protecting the fetus from the hematogenous spread of viruses requires multifaceted layers of protection and relies heavily on trophoblasts, the fetal-derived cells that comprise the placental barrier. We showed previously that trophoblasts isolated from full-term placentas resist infection by diverse viruses, including Zika virus (ZIKV), and transfer this resistance to nonplacental cells through the activity of paracrine effectors, including the constitutive release of type III interferons (IFNs). Here, we developed 3D cell-line-based models of human syncytiotrophoblasts, cells that lie in direct contact with maternal blood, and show that these cells recapitulate the antiviral properties of primary trophoblasts through the constitutive release of type III IFNs (IFN lambda 1 and IFN lambda 2) and become resistant to ZIKV infection. In addition, using organotypic human midgestation chorionic villous explants, we show that syncytiotrophoblasts isolated from the second trimester of pregnancy also constitutively release type III IFNs and use these IFNs in autocrine and paracrine manners to restrict ZIKV infection. Collectively, these data provide important insights into the defense mechanisms used by syncytiotrophoblasts at various stages of human gestation to resist ZIKV infection and new human models to study the role of type III IFNs in the vertical transmission of ZIKV and other viruses associated with congenital disease.
C1 [Corry, Jacqueline; Arora, Nitin; Good, Charles A.; Coyne, Carolyn B.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15213 USA.
   [Corry, Jacqueline; Arora, Nitin; Good, Charles A.; Coyne, Carolyn B.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Ctr Microbial Pathogenesis, Pittsburgh, PA 15224 USA.
   [Sadovsky, Yoel] Univ Pittsburgh, Magee Womens Res Inst, Sch Med, Pittsburgh, PA 15213 USA.
   [Sadovsky, Yoel] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15213 USA.
RP Coyne, CB (corresponding author), Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15213 USA.; Coyne, CB (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Ctr Microbial Pathogenesis, Pittsburgh, PA 15224 USA.
EM coynec2@pitt.edu
RI Corry, Jacqueline/I-7899-2016
OI Corry, Jacqueline/0000-0003-1942-1529; Arora, Nitin/0000-0001-6840-4333;
   Sadovsky, Yoel/0000-0003-2969-6737
FU Burroughs Wellcome Investigators in the Pathogenesis of Infectious
   Disease AwardBurroughs Wellcome Fund;  [P30CA047904];  [NIH
   R01-AI081759];  [R01-HD075665];  [T32-AI049820]
FX We thank Judy Ziegler (Magee Women's Research Institute) for technical
   support, and the University of Pittsburgh Cancer Institute Luminex Core
   Facility, which receives funding from P30CA047904. This project also
   used the University of Pittsburgh Cancer Institute Tissue and Research
   Pathology/Health Sciences Tissue Bank shared resource, which is
   supported in part by Award P30CA047904; and Grants NIH R01-AI081759 (to
   C.B.C.), R01-HD075665 (to C.B.C. and Y.S.), and T32-AI049820 (to J.C.).
   C.B.C. is supported by a Burroughs Wellcome Investigators in the
   Pathogenesis of Infectious Disease Award.
CR Arora N, 2017, CELL HOST MICROBE, V21, P561, DOI 10.1016/j.chom.2017.04.007
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bayer A, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.07.060
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   Jewell NA, 2010, J VIROL, V84, P11515, DOI 10.1128/JVI.01703-09
   Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Maltepe E, 2010, J CLIN INVEST, V120, P1016, DOI 10.1172/JCI41211
   Marukian S, 2011, HEPATOLOGY, V54, P1913, DOI 10.1002/hep.24580
   McConkey CA, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501462
   Nice TJ, 2015, SCIENCE, V347, P269, DOI 10.1126/science.1258100
   Ouyang YS, 2016, PLACENTA, V47, P86, DOI 10.1016/j.placenta.2016.09.008
   Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
NR 20
TC 33
Z9 33
U1 1
U2 10
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 29
PY 2017
VL 114
IS 35
BP 9433
EP 9438
DI 10.1073/pnas.1707513114
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FE9PQ
UT WOS:000408536000059
PM 28784796
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Rodrigues, LC
   Paixao, ES
AF Rodrigues, Laura C.
   Paixao, Enny S.
TI Risk of Zika-related microcephaly: stable or variable?
SO LANCET
LA English
DT Editorial Material
ID BIRTH-DEFECTS; BRAZIL
C1 [Rodrigues, Laura C.; Paixao, Enny S.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England.
RP Rodrigues, LC (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England.
EM laura.rodrigues@lshtm.ac.uk
FU European Union's Horizon research and innovation programme under
   Zika-PLAN [734584]
FX LCR is partially funded by the European Union's Horizon 2020 research
   and innovation programme under Zika-PLAN grant agreement number 734584.
   We declare no competing interests.
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brazilian Ministry of Health, 2017, INF EP NO6 SEM EP 45
   Butler D, 2016, NATURE, V535, P475, DOI 10.1038/nature.2016.20309
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Funk S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005173
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Oliveira WK, 2017, LANCET
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Situation report Zika virus microcephaly Guillain Barre syndrome, SIT REP ZIK VIR MICR
   TEIXEIRA MG, 1999, INF EPIDEMIOL SUS, V8, P5, DOI DOI 10.5123/S0104-16731999000400002
NR 12
TC 4
Z9 5
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD AUG 26
PY 2017
VL 390
IS 10097
BP 824
EP 826
DI 10.1016/S0140-6736(17)31478-2
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA FE6PF
UT WOS:000408330700005
PM 28647174
OA Bronze
DA 2020-07-08
ER

PT J
AU de Oliveira, WK
   de Franca, GVA
   Carmo, EH
   Duncan, BB
   Kuchenbecker, RD
   Schmidt, MI
AF de Oliveira, Wanderson Kleber
   Araujo de Franca, Giovanny Vinicius
   Carmo, Eduardo Hage
   Duncan, Bruce Bartholow
   Kuchenbecker, Ricardo de Souza
   Schmidt, Maria Ines
TI Infection-related microcephaly after the 2015 and 2016 Zika virus
   outbreaks in Brazil: a surveillance-based analysis
SO LANCET
LA English
DT Article
ID HISTORY; JANUARY
AB Background On Nov 11, 2015, the Brazilian Ministry of Health declared a Public Health Emergency of National Concern in response to an increased number of microcephaly cases, possibly related to previous Zika virus outbreaks. We describe the course of the dual epidemics of the Zika virus infection during pregnancy and microcephaly in Brazil up to Nov 12, 2016, the first anniversary of this declaration.
   Methods We used secondary data for Zika virus and microcephaly cases obtained through the Brazilian Ministry of Health's surveillance systems from Jan 1, 2015, to Nov 12, 2016. We deemed possible Zika virus infections during pregnancy as all suspected cases of Zika virus disease and all initially suspected, but later discarded, cases of dengue and chikungunya fever. We defined confirmed infection-related microcephaly in liveborn infants as the presence of a head circumference of at least 2 SDs below the mean for their age and sex, accompanied by diagnostic imaging consistent with an infectious cause, or laboratory, clinical, or epidemiological results positive for Zika virus or STORCH (infectious agents known to cause congenital infection, mainly syphilis, toxoplasmosis, cytomegalovirus, and herpes simplex virus). We excluded cases of congenital anomalies or death without microcephaly. We analyse the spatial clustering of these diseases in Brazil to obtain the kernel density estimation.
   Findings Two distinct waves of possible Zika virus infection extended across all Brazilian regions in 2015 and 2016. 1 673 272 notified cases were reported, of which 41 473 (2.5%) were in pregnant women. During this period, 1950 cases of infection-related microcephaly were confirmed. Most cases (1373 [ 70.4%]) occurred in the northeast region after the first wave of Zika virus infection, with peak monthly occurrence estimated at 49.9 cases per 10 000 livebirths. After a major, well documented second wave of Zika virus infection in all regions of Brazil from September, 2015, to September, 2016, occurrence of microcephaly was much lower than that following the first wave of Zika virus infection, reaching epidemic levels in all but the south of Brazil, with estimated monthly peaks varying from 3.2 cases to 15 cases per 10 000 livebirths.
   Interpretation The distribution of infection-related microcephaly after Zika virus outbreaks has varied across time and Brazilian regions. Reasons for these apparent differences remain to be elucidated.
C1 [de Oliveira, Wanderson Kleber; Araujo de Franca, Giovanny Vinicius; Carmo, Eduardo Hage] Brazilian Minist Hlth, Secretariat Hlth Surveillance, Brasilia, DF, Brazil.
   [de Oliveira, Wanderson Kleber; Duncan, Bruce Bartholow; Kuchenbecker, Ricardo de Souza; Schmidt, Maria Ines] Univ Fed Rio Grande do Sul, Postgrad Program Epidemiol, Porto Alegre, RS, Brazil.
RP de Oliveira, WK (corresponding author), Fundacao Oswaldo Cruz, Ctr Data & Knowledge Integrat Hlth, Goncalo Moniz Inst, Parque Tecnol Bahia, BR-41745715 Salvador, BA, Brazil.
EM wkoliveira@gmail.com
RI amsalu, ribka/G-8780-2019; Kuchenbecker, Ricardo/I-4009-2013; de Franca,
   Giovanny Vinicius Araujo/L-7385-2018; Schmidt, Maria/V-3196-2019;
   Oliveira, Wanderson/D-7140-2016
OI Kuchenbecker, Ricardo/0000-0002-4707-3683; de Franca, Giovanny Vinicius
   Araujo/0000-0002-7530-2017; Oliveira, Wanderson/0000-0002-9662-1930
CR Bierlaire D, 2017, TRANSFUSION, V57, P729, DOI 10.1111/trf.14028
   BITHELL JF, 1990, STAT MED, V9, P691, DOI 10.1002/sim.4780090616
   BRASIL, 2016, GUIA VIG SAUD
   BRASIL, 2016, PORT DEP INF SIST UN
   BRASIL, 2016, PORT SECR VIG SAUD M
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Castilla EE, 2004, COMMUNITY GENET, V7, P76, DOI 10.1159/000080776
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Lopez-Camelo JS, 2015, ECLAMC FINAL DOCUMEN
   Maurice J, 2016, LANCET, V388, P449, DOI 10.1016/S0140-6736(16)31207-7
   Mo Y, 2016, BRIT MED BULL, V119, P25, DOI 10.1093/bmb/ldw023
   Moore CA, 2016, JAMA PEDIAT, V374, P1552
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Pan American Health Organization, GUID SURV ZIK VIR DI
   Rodriguez-Morales AJ, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0128-2
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   WHO, 2015, RAP ADV GUID SCREEN
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   World Health Organization, 2016, EM HIST ZIK VIR
   World Health Organization (WHO), 2016, WHO SIT REP ZIK VIR
NR 29
TC 92
Z9 95
U1 2
U2 27
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD AUG 26
PY 2017
VL 390
IS 10097
BP 861
EP 870
DI 10.1016/S0140-6736(17)31368-5
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA FE6PF
UT WOS:000408330700024
PM 28647172
OA Bronze
DA 2020-07-08
ER

PT J
AU Tambo, E
   Madjou, G
   Khayeka-Wandabwa, C
   Olalubi, OA
   Chengho, CF
   Khater, EIM
AF Tambo, Ernest
   Madjou, Ghislaine
   Khayeka-Wandabwa, Christopher
   Olalubi, Oluwasogo A.
   Chengho, Chryseis F.
   Khater, Emad I. M.
TI Ethical, legal and societal considerations on Zika virus epidemics
   complications in scaling-up prevention and control strategies
SO PHILOSOPHY ETHICS AND HUMANITIES IN MEDICINE
LA English
DT Editorial Material
DE Zika virus; Epidemics; Ethical; Legal; Abortion; Mental; Reproductive;
   Programs
ID GUILLAIN-BARRE-SYNDROME; PUBLIC-HEALTH; INFECTION; HISTORY; US
AB Much of the fear and uncertainty around Zika epidemics stem from potential association between Zika virus (ZIKV) complications on infected pregnant women and risk of their babies being born with microcephaly and other neurological abnormalities. However, much remains unknown about its mode of transmission, diagnosis and long-term pathogenesis. Worries of these unknowns necessitate the need for effective and efficient psychosocial programs and medical-legal strategies to alleviate and mitigate ZIKV related burdens. In this light, local and global efforts in maintaining fundamental health principles of moral, medical and legal decision-making policies, and interventions to preserve and promote individual and collectiveHuman Rights, autonomy, protection of the most vulnerable, equity, dignity, integrity and beneficence that should not be confused and relegated by compassionate humanitarian assistance and support. This paper explores the potential medical and ethical-legal implications of ZIKV epidemics emergency response packages and strategies alongside optimizing reproductive and mental health policies, programs and best practice measures. Further long-term cross-borders operational research is required in elucidating Zika-related population-based epidemiology, ethical-medical and societal implications in guiding evidence-based local and global ZIKV maternal-child health complications related approaches and interventions. Core programs and interventions including future Zika safe and effective vaccines for global Zika immunization program in most vulnerable and affected countries and worldwide should be prioritized.
C1 [Tambo, Ernest] Univ Montagnes, Higher Inst Hlth Sci, Dept Biochem & Pharmaceut Sci, Bangangte, Cameroon.
   [Tambo, Ernest; Madjou, Ghislaine] Africa DISCoR Inst, Africa Dis Intelligence & Surveillance Commun & R, Yaounde, Cameroon.
   [Khayeka-Wandabwa, Christopher] Tianjin Univ, SPST, 92 Weijin Rd, Tianjin 300072, Peoples R China.
   [Khayeka-Wandabwa, Christopher] APHRC, Nairobi, Kenya.
   [Chengho, Chryseis F.] Kwara State Univ KWASU, Dept Publ Hlth, Malete, Nigeria.
   [Chengho, Chryseis F.] Coventry Univ, Dept Life Sci, Leicester, Leics, England.
   [Tambo, Ernest; Khater, Emad I. M.] Publ Hlth Pests Lab PHPL Jeddah Governorate, Jeddah, Saudi Arabia.
   [Khater, Emad I. M.] Ain Shams Univ, Fac Sci, Dept Entomol, Cairo, Egypt.
RP Tambo, E (corresponding author), Univ Montagnes, Higher Inst Hlth Sci, Dept Biochem & Pharmaceut Sci, Bangangte, Cameroon.; Tambo, E (corresponding author), Africa DISCoR Inst, Africa Dis Intelligence & Surveillance Commun & R, Yaounde, Cameroon.; Tambo, E (corresponding author), Publ Hlth Pests Lab PHPL Jeddah Governorate, Jeddah, Saudi Arabia.
EM tambo0711@gmail.com
RI OLALUBI, Oluwasogo/AAD-2370-2019; Khater, Emad I. M./D-4248-2009
OI Khater, Emad I. M./0000-0002-7510-6294
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Alvarado-Socarras JL, 2016, ULTRASOUND OBST GYN, V47, P525, DOI 10.1002/uog.15885
   Brasil P., 2016, NEW ENGLAND J MED
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Burd I, 2016, J ASSIST REPROD GEN, V33, P439, DOI 10.1007/s10815-016-0687-3
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, CHIK VIR HOM SYMPT D
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Check Hayden Erika, 2016, Nature, V530, P142, DOI 10.1038/530142a
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   Diniz D, 2016, INT J GAENYCOL OBSTE, V216, P105
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Elachola H, 2016, LANCET, V387, P630, DOI 10.1016/S0140-6736(16)00274-9
   Galindo-Fraga A, 2015, REV INVEST CLIN, V67, P329
   Griggs D, 2013, NATURE, V495, P305, DOI 10.1038/495305a
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1322
   Harris LH, 2016, AM J BIOETHICS, V16, P1, DOI 10.1080/15265161.2016.1177367
   Hodge JG, 2016, DISASTER MED PUBLIC, V10, P713, DOI 10.1017/dmp.2016.34
   Iacobucci G, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1155
   Laperriere V, 2011, PREV VET MED, V98, P99, DOI 10.1016/j.prevetmed.2010.10.013
   Leite M., OUTBREAK ZIKA VIRUS
   Li XF, 2016, SCI CHINA LIFE SCI, V59, P440, DOI 10.1007/s11427-016-5020-y
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i306
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Mohapatra S., 2016, PUBLIC HLTH RESPONSE
   Niang M, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1208-7
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Omer SB, 2016, JAMA-J AM MED ASSOC, V315, P1227, DOI 10.1001/jama.2016.2237
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Reef SE, 2009, INT J INFECT DIS S1, V204, pS24
   Reyna-Villasmil E, 2016, MED CLIN-BARCELONA, V146, P331, DOI 10.1016/j.medcli.2016.02.002
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Tambo E, 2017, J PARASITE EPIDEMIOL, V2, P50
   Tambo E, 2016, J INFECT PUBLIC HEAL, V9, P240, DOI 10.1016/j.jiph.2016.02.005
   Tambo E, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-29
   van Doorn PA, 2010, J CLIN IMMUNOL, V30, pS74, DOI 10.1007/s10875-010-9407-4
   Wauquier N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000837
   Weatherhead JE, 2016, CURRENT TROPICAL MED, V3, P120
   WHO, 2016, ZIK SIT REP NEUR SYN
   Woodward A, 2016, LANCET, V387, P1886, DOI 10.1016/S0140-6736(16)00349-4
   World Health Organization, 2016, ZIK SIT REP, P12
   World Health Organization (WHO), 2016, ZIK STRAT RESP FRAM
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
NR 51
TC 1
Z9 1
U1 0
U2 20
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1747-5341
J9 PHILOS ETHICS HUM ME
JI Philos. Ethics Humanit. Med.
PD AUG 25
PY 2017
VL 12
AR UNSP 3
DI 10.1186/s13010-017-0046-8
PG 8
WC Ethics; History & Philosophy Of Science; Medical Ethics; Philosophy
SC Social Sciences - Other Topics; History & Philosophy of Science; Medical
   Ethics; Philosophy
GA FE8QI
UT WOS:000408469800001
PM 28841899
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ferreira, AC
   Zaverucha-do-Valle, C
   Reis, PA
   Barbosa-Lima, G
   Vieira, YR
   Mattos, M
   Silva, PD
   Sacramento, C
   Neto, HCDF
   Campanati, L
   Tanuri, A
   Bruning, K
   Bozza, FA
   Bozza, PT
   Souza, TML
AF Ferreira, Andre C.
   Zaverucha-do-Valle, Camila
   Reis, Patricia A.
   Barbosa-Lima, Giselle
   Vieira, Yasmine Rangel
   Mattos, Mayara
   Silva, Priscila de Paiva
   Sacramento, Carolina
   de Castro Faria Neto, Hugo C.
   Campanati, Loraine
   Tanuri, Amilcar
   Bruning, Karin
   Bozza, Fernando A.
   Bozza, Patricia T.
   Souza, Thiago Moreno L.
TI Sofosbuvir protects Zika virus-infected mice from mortality, preventing
   short- and long-term sequelae
SO SCIENTIFIC REPORTS
LA English
DT Article
ID INHIBITORS; BRAIN; DISEASE; SCREEN; DRUGS; CELLS
AB Zika virus (ZIKV) causes significant public health concerns because of its association with congenital malformations, neurological disorders in adults, and, more recently, death. Considering the necessity to mitigate ZIKV-associated diseases, antiviral interventions are an urgent necessity. Sofosbuvir, a drug in clinical use against hepatitis C virus (HCV), is among the FDA-approved substances endowed with anti-ZIKV activity. In this work, we further investigated the in vivo activity of sofosbuvir against ZIKV. Neonatal Swiss mice were infected with ZIKV (2 x 10(7) PFU) and treated with sofosbuvir at 20 mg/kg/day, a concentration compatible with pre-clinical development of this drug. We found that sofosbuvir reduced acute levels of ZIKV from 60 to 90% in different anatomical compartments, such as the blood plasma, spleen, kidney, and brain. Early treatment with sofosbuvir doubled the percentage and time of survival of ZIKV-infected animals. Sofosbuvir also prevented the acute neuromotor impairment triggered by ZIKV. In the long-term behavioural analysis of ZIKV-associated sequelae, sofosbuvir prevented loss of hippocampal-and amygdala-dependent memory. Our results indicate that sofosbuvir inhibits ZIKV replication in vivo, which is consistent with the prospective necessity of antiviral drugs to treat ZIKV-infected individuals.
C1 [Ferreira, Andre C.; Zaverucha-do-Valle, Camila; Reis, Patricia A.; Mattos, Mayara; Silva, Priscila de Paiva; Sacramento, Carolina; de Castro Faria Neto, Hugo C.; Bozza, Fernando A.; Bozza, Patricia T.; Souza, Thiago Moreno L.] Fundacao Oswaldo Cruz, FIOCRUZ, Inst Oswaldo Cruz, Lab Imunofarmacol, Rio De Janeiro, RJ, Brazil.
   [Zaverucha-do-Valle, Camila; Barbosa-Lima, Giselle; Vieira, Yasmine Rangel; Bozza, Fernando A.; Souza, Thiago Moreno L.] Fiocruz MS, Inst Nacl Infectol, Rio De Janeiro, RJ, Brazil.
   [Campanati, Loraine] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, RJ, Brazil.
   [Tanuri, Amilcar] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, RJ, Brazil.
   [Bruning, Karin] BMK Consortium Blanver Farmoquim Ltda Microbiol Q, Taboao Da Serra, SP, Brazil.
   [Souza, Thiago Moreno L.] Fiocruz MS, Natl Inst Sci & Technol Innovat Neglected Dis INC, Ctr Technol Dev Hlth CDTS, Rio De Janeiro, RJ, Brazil.
RP Souza, TML (corresponding author), Fundacao Oswaldo Cruz, FIOCRUZ, Inst Oswaldo Cruz, Lab Imunofarmacol, Rio De Janeiro, RJ, Brazil.; Souza, TML (corresponding author), Fiocruz MS, Inst Nacl Infectol, Rio De Janeiro, RJ, Brazil.; Souza, TML (corresponding author), Fiocruz MS, Natl Inst Sci & Technol Innovat Neglected Dis INC, Ctr Technol Dev Hlth CDTS, Rio De Janeiro, RJ, Brazil.
EM tmoreno@cdts.fiocruz.br
RI Souza, Thiago Moreno L./G-2900-2012; Bozza, Fernando A/A-2618-2013;
   Campanati, Loraine/V-2632-2018
OI Souza, Thiago Moreno L./0000-0003-2212-3899; Bozza, Fernando
   A/0000-0003-4878-0256; Campanati, Loraine/0000-0001-9172-1951; Bozza,
   Patricia/0000-0001-8349-9529
FU Conselho Nacional de Desenvolvimento e Pesquisa (CNPq)National Council
   for Scientific and Technological Development (CNPq); Fundacao de Amparo
   a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
FX Thanks are due to Drs. Carlos M. Morel, Marcio L. Rodrigues, Renata
   Curi, and Fabricia Pimenta for their strong advisement and support
   regarding the technological development underlying this project. This
   work was supported by Conselho Nacional de Desenvolvimento e Pesquisa
   (CNPq), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ). The BMK consortium did not provide funding for this project.
CR [Anonymous], 2017, STUD HEP C TREATM PR
   Coelho SVA, 2017, J VIROL METHODS, V246, P65, DOI 10.1016/j.jviromet.2017.04.011
   Au-TGA Australian Therapeutic Goods and Administration, 2015, AUSTR THER GOODS ADM
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CDC, 2016, REV DIAGN TEST ZIK C
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Chia R, 2005, NAT GENET, V37, P1181, DOI 10.1038/ng1665
   Dean A. G., 2014, OPENEPI OPEN SOURCE
   Delvecchio R., 2016, CHLOROQUINE INHIBITS, DOI [10.1101/051268, DOI 10.1101/051268(2016)]
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Elfiky AA, 2016, J MED VIROL, V88, P2044, DOI 10.1002/jmv.24678
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Fernandes NCCA, 2017, EXP TOXICOL PATHOL, V69, P63, DOI 10.1016/j.etp.2016.11.004
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   Kilkenny C, 2012, OSTEOARTHR CARTILAGE, V20, P256, DOI 10.1016/j.joca.2012.02.010
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Muthuri SG, 2014, LANCET RESP MED, V2, P395, DOI 10.1016/S2213-2600(14)70041-4
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Solomon T, 2016, LANCET INFECT DIS, V16, P402, DOI 10.1016/S1473-3099(16)00125-0
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Stauft C. B., 2016, BIORXIV, DOI [10.1101/075747,075747, DOI 10.1101/075747,075747(2016)]
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 36
TC 34
Z9 37
U1 1
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 25
PY 2017
VL 7
AR 9409
DI 10.1038/s41598-017-09797-8
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FE8IF
UT WOS:000408448100002
PM 28842610
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Iannetta, M
   Lalle, E
   Musso, M
   Carletti, F
   Scorzolini, L
   D'Abramo, A
   Chinello, P
   Castilletti, C
   Ippolito, G
   Capobianchi, MR
   Nicastri, E
AF Iannetta, M.
   Lalle, E.
   Musso, M.
   Carletti, F.
   Scorzolini, L.
   D'Abramo, A.
   Chinello, P.
   Castilletti, C.
   Ippolito, G.
   Capobianchi, M. R.
   Nicastri, E.
TI Persistent detection of dengue virus RNA in vaginal secretion of a woman
   returning from Sri Lanka to Italy, April 2017
SO EUROSURVEILLANCE
LA English
DT Article
ID ZIKA VIRUS; PREGNANCY
AB We describe the dynamics of dengue virus (DENV) infection in a woman in her mid-30(s) who developed fever after returning from Sri Lanka to Italy in April 2017. Laboratory testing demonstrated detectable DENV-RNA in plasma, urine, saliva, vaginal secretion. Persistent shedding of DENV-RNA was demonstrated in vaginal secretion, and DENV-RNA was detectable in the pelleted fraction up to 18 days from symptom onset. These findings give new insights into DENV vaginal shedding and vertical transmission.
C1 [Iannetta, M.; Lalle, E.; Musso, M.; Carletti, F.; Scorzolini, L.; D'Abramo, A.; Chinello, P.; Castilletti, C.; Ippolito, G.; Capobianchi, M. R.; Nicastri, E.] IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Rome, Italy.
RP Iannetta, M (corresponding author), IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Rome, Italy.
EM marco.iannetta@inmi.it
RI Castilletti, Concetta/B-6545-2016; D'Abramo, Alessandra/AAA-3054-2019;
   Castilletti, Concetta/AAA-8408-2019; nicastri, emanuele/K-7780-2016;
   Iannetta, Marco/M-4619-2019; Iannetta, Marco/B-5596-2017
OI Castilletti, Concetta/0000-0001-9819-236X; D'Abramo,
   Alessandra/0000-0002-5160-9743; Castilletti,
   Concetta/0000-0001-9819-236X; nicastri, emanuele/0000-0002-5606-8712;
   Iannetta, Marco/0000-0002-6938-8627; Iannetta,
   Marco/0000-0002-6938-8627; lalle, eleonora/0000-0002-7063-9905; PERNO,
   CARLO FEDERICO/0000-0002-0825-5388; Ippolito,
   Giuseppe/0000-0002-1076-2979; CHINELLO, PIERANGELO/0000-0002-7341-9000
FU Ricerca Corrente of the Italian Ministry of Health
FX This study was funded by Ricerca Corrente of the Italian Ministry of
   Health.
CR Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Carles G, 1999, CLIN INFECT DIS, V28, P637, DOI 10.1086/515144
   Carroll I Dale, 2007, Travel Med Infect Dis, V5, P183, DOI 10.1016/j.tmaid.2006.11.002
   Castro Marcia C, 2017, Lancet Infect Dis, V17, pe70, DOI 10.1016/S1473-3099(16)30545-X
   Chan JF, 2016, EMERG MICROBES INFEC, V5
   Chye JK, 1997, CLIN INFECT DIS, V25, P1374, DOI 10.1086/516126
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   Perez S, 2016, EUROSURVEILLANCE, V21, P1, DOI 10.2807/1560-7917.ES.2016.21.24.30261
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Waduge R, 2006, J CLIN VIROL, V37, P27, DOI 10.1016/j.jcv.2006.06.002
   Xiong YQ, 2017, J CLIN VIROL, V94, P42, DOI 10.1016/j.jcv.2017.07.008
   Yin XR, 2016, REV INST MED TROP SP, V58, DOI [10.1590/S1678-9946201658090, 10.1590/s1678-9946201658090]
NR 16
TC 7
Z9 7
U1 0
U2 5
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD AUG 24
PY 2017
VL 22
IS 34
BP 2
EP 5
AR 30600
DI 10.2807/1560-7917.ES.2017.22.34.30600
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA FE8EM
UT WOS:000408438400001
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chen, J
   Yang, YF
   Chen, J
   Zhou, XH
   Dong, ZG
   Chen, TY
   Yang, Y
   Zou, P
   Jiang, B
   Hu, YW
   Lu, L
   Zhang, XY
   Liu, J
   Xu, JQ
   Zhu, TY
AF Chen, Jian
   Yang, Yi-feng
   Chen, Jun
   Zhou, Xiaohui
   Dong, Zhaoguang
   Chen, Tianyue
   Yang, Yu
   Zou, Peng
   Jiang, Biao
   Hu, Yunwen
   Lu, Lu
   Zhang, Xiaoyan
   Liu, Jia
   Xu, Jianqing
   Zhu, Tongyu
TI Zika virus infects renal proximal tubular epithelial cells with
   prolonged persistency and cytopathic effects
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE cytopathic effects; prolonged persistency; renal proximal tubular
   epithelial cells; urinary system; Zika virus
ID MALE SEXUAL TRANSMISSION; GUILLAIN-BARRE-SYNDROME; NEURAL PROGENITORS;
   URINE; LEADS; EPIDEMIC; RNA
AB Zika virus (ZIKV) infection can cause fetal developmental abnormalities and Guillain-Barre syndrome in adults. Although progress has been made in understanding the link between ZIKV infection and microcephaly, the pathology of ZIKV, particularly the viral reservoirs in human, remains poorly understood. Several studies have shown that compared to serum samples, patients' urine samples often have a longer duration of ZIKV persistency and higher viral load. This finding suggests that an independent viral reservoir may exist in the human urinary system. Despite the clinical observations, the host cells of ZIKV in the human urinary system are poorly characterized. In this study, we demonstrate that ZIKV can infect renal proximal tubular epithelial cells (RPTEpiCs) in immunodeficient mice in vivo and in both immortalized and primary human renal proximal tubular epithelial cells (hRPTEpiCs) in vitro. Importantly, ZIKV infection in mouse kidneys caused caspase-3-mediated apoptosis of renal cells. Similarly, in vitro infection of immortalized and primary hRPTEpiCs resulted in notable cytopathic effects. Consistent with the clinical observations, we found that ZIKV infection can persist with prolonged duration in hRPTEpiCs. RNA-Seq analyses of infected hRPTEpiCs revealed a large number of transcriptional changes in response to ZIKV infection, including type I interferon signaling genes and anti-viral response genes. Our results suggest that hRPTEpiCs are a potential reservoir of ZIKV in the human urinary system, providing a possible explanation for the prolonged persistency of ZIKV in patients' urine.
C1 [Chen, Jian; Zhou, Xiaohui; Dong, Zhaoguang; Chen, Tianyue; Yang, Yu; Zou, Peng; Hu, Yunwen; Lu, Lu; Zhang, Xiaoyan; Xu, Jianqing; Zhu, Tongyu] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Sci Res Ctr, Shanghai 201508, Peoples R China.
   [Yang, Yi-feng; Jiang, Biao; Liu, Jia] ShanghaiTech Univ, Shanghai Inst Adv Immunochem Studies, Shanghai 201210, Peoples R China.
   [Chen, Jun] Uppsala Univ, Evolutionary Biol Ctr, Dept Ecol & Genet, S-75236 Uppsala, Sweden.
   [Zhang, Xiaoyan; Xu, Jianqing] Fudan Univ, Minist Educ Hlth, Key Lab Med Mol Virol, Inst Biomed Sci, Shanghai 200032, Peoples R China.
   [Zhu, Tongyu] Fudan Univ, Zhongshan Hosp, Dept Urol, Shanghai 200032, Peoples R China.
   [Zhu, Tongyu] Fudan Univ, Zhongshan Hosp, Shanghai Key Lab Organ Transplantat, Shanghai 200032, Peoples R China.
RP Xu, JQ; Zhu, TY (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Sci Res Ctr, Shanghai 201508, Peoples R China.; Liu, J (corresponding author), ShanghaiTech Univ, Shanghai Inst Adv Immunochem Studies, Shanghai 201210, Peoples R China.; Xu, JQ (corresponding author), Fudan Univ, Minist Educ Hlth, Key Lab Med Mol Virol, Inst Biomed Sci, Shanghai 200032, Peoples R China.; Zhu, TY (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Urol, Shanghai 200032, Peoples R China.; Zhu, TY (corresponding author), Fudan Univ, Zhongshan Hosp, Shanghai Key Lab Organ Transplantat, Shanghai 200032, Peoples R China.
EM liujia@shanghaitech.edu.cn; xujianqing@shphc.org.cn;
   zhutongyu@shaphc.org
RI Lu, Lu/K-7070-2014
OI Lu, Lu/0000-0002-2255-0391
FU Natural Science Foundation of ChinaNational Natural Science Foundation
   of China [81430030]; ShanghaiTech University; National Basic Research
   Program of ChinaNational Basic Research Program of China [2014CB542502];
   Shanghai ShenKang Hospital Development Center [SHDC12014104]; Shanghai
   Public Health Clinical Center [2016-28 ksf0730]; Technology Service
   Platform for Detecting High level Biological Safety Pathogenic
   Microorganism (Shanghai Science and Technology Commission) [15DZ2290200]
FX This work was supported by the Natural Science Foundation of China
   (81430030), ShanghaiTech University (Startup Fund to BJ and JL),
   National Basic Research Program of China (2014CB542502), Shanghai
   ShenKang Hospital Development Center (SHDC12014104), Shanghai Public
   Health Clinical Center (2016-28 ksf0730), and the Technology Service
   Platform for Detecting High level Biological Safety Pathogenic
   Microorganism (15DZ2290200, Shanghai Science and Technology Commission).
CR Alcendor DJ, 2017, J INFECT DIS
   Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   [Anonymous], 2016, MMWR-MORBID MORTAL W, V65, P474, DOI 10.15585/mmwr.mm6518e1
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Lamb LE, 2016, INT UROL NEPHROL, V48, P2025, DOI 10.1007/s11255-016-1424-7
   Lamb LE, 2016, INT UROL NEPHROL, V48, P1961, DOI 10.1007/s11255-016-1406-9
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Visseaux B, 2016, LANCET INFECT DIS, V16, P1220, DOI 10.1016/S1473-3099(16)30387-5
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wiwanitkit V, 2016, INT UROL NEPHROL, V48, P2023, DOI 10.1007/s11255-016-1417-6
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
NR 56
TC 14
Z9 14
U1 0
U2 5
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD AUG 23
PY 2017
VL 6
AR e77
DI 10.1038/emi.2017.67
PG 7
WC Immunology; Microbiology
SC Immunology; Microbiology
GA FF9VJ
UT WOS:000409365800005
PM 28831192
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Olmo, IG
   Carvalho, TG
   Costa, VV
   Alves-Silva, J
   Ferrari, CZ
   Izidoro-Toledo, TC
   da Silva, JF
   Teixeira, AL
   Souza, DG
   Marques, JT
   Teixeira, MM
   Vieira, LB
   Ribeiro, FM
AF Olmo, Isabella G.
   Carvalho, Toniana G.
   Costa, Vivian V.
   Alves-Silva, Juliana
   Ferrari, Carolina Z.
   Izidoro-Toledo, Tatiane C.
   da Silva, Juliana F.
   Teixeira, Antonio L.
   Souza, Danielle G.
   Marques, Joao T.
   Teixeira, Mauro M.
   Vieira, Luciene B.
   Ribeiro, Fabiola M.
TI Zika Virus Promotes neuronal cell Death in a non-cell autonomous Manner
   by Triggering the release of neurotoxic Factors
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE Zika virus; N-methyl-D-aspartate receptors; GluN2B; tumor necrosis
   factor-alpha; interleukin-1 beta
ID NECROSIS-FACTOR-ALPHA; EXTRASYNAPTIC NMDA RECEPTORS;
   ENDOPLASMIC-RETICULUM STRESS; RAT HIPPOCAMPAL-NEURONS;
   ENCEPHALITIS-VIRUS; TNF-ALPHA; SYNAPTIC PLASTICITY; DIFFERENTIAL ROLES;
   HUMAN NEUROSPHERES; GLUTAMATE RELEASE
AB Zika virus (ZIKV) has recently caused a worldwide outbreak of infections associated with severe neurological complications, including microcephaly in infants born from infected mothers. ZIKV exhibits high neurotropism and promotes neuroinflammation and neuronal cell death. We have recently demonstrated that N-methyl-d-aspartate receptor (NMDAR) blockade by memantine prevents ZIKV-induced neuronal cell death. Here, we show that ZIKV induces apoptosis in a non-cell autonomous manner, triggering cell death of uninfected neurons by releasing cytotoxic factors. Neuronal cultures infected with ZIKV exhibit increased levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-1 eta (IL-1 beta), and glutamate. Moreover, infected neurons exhibit increased expression of GluN2B and augmented intracellular Ca2+ concentration. Blockade of GluN2B-containing NMDAR by ifenprodil normalizes Ca2+ levels and rescues neuronal cell death. Notably, TNF-alpha and IL-1 beta blockade decreases ZIKV-induced Ca2+ flux through GluN2B-containing NMDARs and reduces neuronal cell death, indicating that these cytokines might contribute to NMDAR sensitization and neurotoxicity. In addition, ZIKV-infected cultures treated with ifenprodil exhibits increased activation of the neuroprotective pathway including extracellular signal-regulated kinase and cAMP response element-binding protein, which may underlie ifenprodil-mediated neuroprotection. Together, our data shed some light on the neurotoxic mechanisms triggered by ZIKV and begin to elucidate how GluN2Bcontaining NMDAR blockade can prevent neurotoxicity.
C1 [Olmo, Isabella G.; Carvalho, Toniana G.; Costa, Vivian V.; Alves-Silva, Juliana; Izidoro-Toledo, Tatiane C.; Marques, Joao T.; Teixeira, Mauro M.; Ribeiro, Fabiola M.] Univ Fed Minas Gerais, Dept Biochem & Immunol, Inst Biol Sci ICB, Belo Horizonte, MG, Brazil.
   [Ferrari, Carolina Z.; Vieira, Luciene B.] Univ Fed Minas Gerais, Dept Pharmacol, ICB, Belo Horizonte, MG, Brazil.
   [da Silva, Juliana F.] Inst Educ & Res Santa Casa, Belo Horizonte, MG, Brazil.
   [Teixeira, Antonio L.] UT Hlth, Neuropsychiat Program, Dept Psychiat & Behav Sci, Houston, TX USA.
   [Souza, Danielle G.] Univ Fed Minas Gerais, Dept Microbiol, ICB, Belo Horizonte, MG, Brazil.
RP Ribeiro, FM (corresponding author), Univ Fed Minas Gerais, Dept Biochem & Immunol, Inst Biol Sci ICB, Belo Horizonte, MG, Brazil.
EM fmribeiro@icb.ufmg.br
RI Marques, Joao T/F-7683-2012; Ribeiro, Fabiola/E-8831-2013; Costa, Vivian
   VVC/I-2499-2018; Teixeira, Antonio L/N-3315-2014; Olmo, Isabella
   Guimaraes/W-5050-2019; Vieira, Luciene B/F-1655-2013
OI Marques, Joao T/0000-0002-3457-3320; Ribeiro,
   Fabiola/0000-0001-7042-9433; Costa, Vivian VVC/0000-0002-0175-642X;
   Teixeira, Antonio L/0000-0002-9621-5422; Olmo, Isabella
   Guimaraes/0000-0002-0007-3280; Vieira, Luciene B/0000-0002-3496-6749;
   Zaniboni Ferrari, Carolina/0000-0001-8817-4774; DE CARVALHO,
   TONIANA/0000-0002-6475-9222
FU FINEPCiencia Tecnologia e Inovacao (FINEP); FAPEMIGMinas Gerais State
   Research Foundation (FAPEMIG)
FX This work was supported by FINEP and FAPEMIG grants to FR.
CR BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chandler LJ, 2001, J BIOL CHEM, V276, P2627, DOI 10.1074/jbc.M003390200
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Chen CJ, 2012, GLIA, V60, P487, DOI 10.1002/glia.22282
   Costa VV, 2017, MBIO, V8, DOI [10.1128/mBio.00350-17, 10.1128/mbio.00350-17]
   Costa VV, 2014, MED MICROBIOL IMMUN, V203, P231, DOI 10.1007/s00430-014-0334-5
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dong YL, 2017, J NEUROIMMUNOL, V307, P7, DOI 10.1016/j.jneuroim.2017.03.005
   Doria JG, 2013, BRIT J PHARMACOL, V169, P909, DOI 10.1111/bph.12164
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Groc L, 2006, P NATL ACAD SCI USA, V103, P18769, DOI 10.1073/pnas.0605238103
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835
   Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911
   Harris AZ, 2007, J PHYSIOL-LONDON, V584, P509, DOI 10.1113/jphysiol.2007.137679
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   Ignatowski TA, 1997, J NEUROIMMUNOL, V79, P84, DOI 10.1016/S0165-5728(97)00107-0
   Ivanov A, 2006, J PHYSIOL-LONDON, V572, P789, DOI 10.1113/jphysiol.2006.105510
   Jara JH, 2007, J NEUROCHEM, V100, P1407, DOI 10.1111/j.1471-4159.2006.04330.x
   Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kumar M, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-73
   Lau D, 2009, J NEUROSCI, V29, P4420, DOI 10.1523/JNEUROSCI.0802-09.2009
   Leveille F, 2008, FASEB J, V22, P4258, DOI 10.1096/fj.08-107268
   Leveille F, 2010, J NEUROSCI, V30, P2623, DOI 10.1523/JNEUROSCI.5115-09.2010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Liao CL, 1997, J VIROL, V71, P5963, DOI 10.1128/JVI.71.8.5963-5971.1997
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   LIU T, 1994, STROKE, V25, P1481, DOI 10.1161/01.STR.25.7.1481
   Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Martel MA, 2009, NEUROSCIENCE, V158, P334, DOI 10.1016/j.neuroscience.2008.01.080
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MODY I, 1995, TRENDS PHARMACOL SCI, V16, P356, DOI 10.1016/S0165-6147(00)89070-7
   MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0
   NICHOLLS DG, 1987, J NEUROCHEM, V49, P50, DOI 10.1111/j.1471-4159.1987.tb03393.x
   Olmos G, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/861231
   Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504
   Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005
   Parquet MC, 2002, ARCH VIROL, V147, P1105, DOI 10.1007/s00705-002-0806-6
   Parquet MD, 2001, FEBS LETT, V500, P17
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petralia RS, 2012, SCI WORLD J, DOI 10.1100/2012/267120
   Pickering M, 2005, EXP PHYSIOL, V90, P663, DOI 10.1113/expphysiol.2005.030734
   Prow NA, 2008, J NEUROCHEM, V105, P1276, DOI 10.1111/j.1471-4159.2008.05230.x
   RANDALL RD, 1992, J NEUROSCI, V12, P1882
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Shrestha B, 2003, J VIROL, V77, P13203, DOI 10.1128/JVI.77.24.13203-13213.2003
   Steigerwald F, 2000, J NEUROSCI, V20, P4573, DOI 10.1523/JNEUROSCI.20-12-04573.2000
   Su HL, 2002, J VIROL, V76, P4162, DOI 10.1128/JVI.76.9.4162-4171.2002
   Szymocha R, 2000, J VIROL, V74, P6433, DOI 10.1128/JVI.74.14.6433-6441.2000
   Takeuchi H, 2006, J BIOL CHEM, V281, P21362, DOI 10.1074/jbc.M600504200
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thomas CG, 2006, J NEUROPHYSIOL, V95, P1727, DOI 10.1152/jn.00771.2005
   Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346
   Tovar KR, 1999, J NEUROSCI, V19, P4180
   Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306
   Vanhoutte P, 2003, CURR OPIN NEUROBIOL, V13, P366, DOI 10.1016/S0959-4388(03)00073-4
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Viviani B, 2003, J NEUROSCI, V23, P8692
   Weaver-Mikaere L, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-153
   Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025
   Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604
NR 76
TC 24
Z9 24
U1 0
U2 28
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD AUG 23
PY 2017
VL 8
AR 1016
DI 10.3389/fimmu.2017.01016
PG 14
WC Immunology
SC Immunology
GA FE5AZ
UT WOS:000408225700002
PM 28878777
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ali, M
   Folz, R
   Miller, K
   Johnson, BR
   Kiarie, J
AF Ali, Moazzam
   Folz, Rachel
   Miller, Kelsey
   Johnson, Brooke Ronald, Jr.
   Kiarie, James
TI A study protocol for facility assessment and follow-up evaluations of
   the barriers to access, availability, utilization and readiness of
   contraception, abortion and postabortion services in Zika affected areas
   (vol 14, 18, 2017)
SO REPRODUCTIVE HEALTH
LA English
DT Correction
C1 [Ali, Moazzam; Folz, Rachel; Miller, Kelsey; Johnson, Brooke Ronald, Jr.; Kiarie, James] WHO, Dept Reprod Hlth & Res, Ave Appia 20, CH-1211 Geneva 27, Switzerland.
RP Ali, M (corresponding author), WHO, Dept Reprod Hlth & Res, Ave Appia 20, CH-1211 Geneva 27, Switzerland.
EM alimoa@who.int
OI kiarie, james/0000-0003-4180-7858
FU World Health OrganizationWorld Health Organization [001]
CR Ali M, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0283-8
   Ali Moazzam, STUDY PROTOCOL FACIL
NR 2
TC 0
Z9 0
U1 0
U2 1
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1742-4755
J9 REPROD HEALTH
JI Reprod. Health
PD AUG 22
PY 2017
VL 14
AR 97
DI 10.1186/s12978-017-0366-6
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FF1YR
UT WOS:000408695600001
PM 28830559
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lyon, J
AF Lyon, Jeff
TI Vaccines Protect Fetus From Zika
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 1
U2 1
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD AUG 22
PY 2017
VL 318
IS 8
BP 689
EP 689
DI 10.1001/jama.2017.11200
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA FE3DE
UT WOS:000408095800004
PM 28829857
DA 2020-07-08
ER

PT J
AU Saiz, JC
   Martin-Acebes, MA
   Bueno-Mari, R
   Salomon, OD
   Villamil-Jimenez, LC
   Heukelbach, J
   Alencar, CH
   Armstrong, PK
   Ortiga-Carvalho, TM
   Mendez-Otero, R
   Rosado-de-Castro, PH
   Pimentel-Coelho, PM
AF Saiz, Juan-Carlos
   Martin-Acebes, Miguel A.
   Bueno-Mari, Ruben
   Salomon, Oscar D.
   Villamil-Jimenez, Luis C.
   Heukelbach, Jorg
   Alencar, Carlos H.
   Armstrong, Paul K.
   Ortiga-Carvalho, Tania M.
   Mendez-Otero, Rosalia
   Rosado-de-Castro, Paulo H.
   Pimentel-Coelho, Pedro M.
TI Zika Virus: What Have We Learnt Since the Start of the Recent Epidemic?
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Review
DE flavivirus; epidemiology; microcephaly; Guillain-Barre syndrome;
   antivirals
ID GUILLAIN-BARRE-SYNDROME; VECTOR-BORNE TRANSMISSION; SMALL-MOLECULE
   INHIBITORS; AEDES-AEGYPTI MOSQUITOS; NEURAL PROGENITORS; VERTICAL
   TRANSMISSION; CEREBRAL ORGANOIDS; NS2B-NS3 PROTEASE; CROSS-REACTIVITY;
   STRUCTURAL BASIS
AB Zika is a viral disease transmitted mainly by mosquitoes of the genus Aedes. In recent years, it has expanded geographically, changing from an endemic mosquito-borne disease across equatorial Asia and Africa, to an epidemic disease causing large outbreaks in several areas of the world. With the recent Zika virus (ZIKV) outbreaks in the Americas, the disease has become a focus of attention of public health agencies and of the international research community, especially due to an association with neurological disorders in adults and to the severe neurological and ophthalmological abnormalities found in fetuses and newborns of mothers exposed to ZIKV during pregnancy. A large number of studies have been published in the last 3 years, revealing the structure of the virus, how it is transmitted and how it affects human cells. Many different animal models have been developed, which recapitulate several features of ZIKV disease and its neurological consequences. Moreover, several vaccine candidates are now in active preclinical development, and three of them have already entered phase I clinical trials. Likewise, many different compounds targeting viral and cellular components are being tested in in vitro and in experimental animal models. This review aims to discuss the current state of this rapidly growing literature from a multidisciplinary perspective, as well as to present an overview of the public health response to Zika and of the perspectives for the prevention and treatment of this disease.
C1 [Saiz, Juan-Carlos; Martin-Acebes, Miguel A.] Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Biotechnol, Madrid, Spain.
   [Bueno-Mari, Ruben] Labs Lokimica, Dept Invest Desarrollo I D, Valencia, Spain.
   [Salomon, Oscar D.] Inst Nacl Med Trop, Puerto Iguazu, Argentina.
   [Villamil-Jimenez, Luis C.] Univ La Salle, Grp Epidemiol & Salud Publ, Bogota, Colombia.
   [Heukelbach, Jorg; Alencar, Carlos H.] Univ Fed Ceara, Sch Med, Dept Community Hlth, Fortaleza, Ceara, Brazil.
   [Heukelbach, Jorg] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Div Trop Hlth & Med, Townsville, Qld, Australia.
   [Armstrong, Paul K.] Western Australia Dept Hlth, Communicable Dis Control Directorate, Perth, WA, Australia.
   [Ortiga-Carvalho, Tania M.; Mendez-Otero, Rosalia; Pimentel-Coelho, Pedro M.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.
   [Rosado-de-Castro, Paulo H.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil.
   [Rosado-de-Castro, Paulo H.] Inst DOr Pesquisa & Ensino, Rio De Janeiro, Brazil.
RP Pimentel-Coelho, PM (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.
EM pedrompc@biof.ufrj.br
RI de Castro, Paulo Henrique Rosado/F-9310-2013; Martin-Acebes, Miguel
   A./L-2258-2014; Mendez-Otero, Rosalia/AAL-7551-2020; Ortiga-Carvalho,
   Tania/D-5093-2011; Pimentel-Coelho, Pedro M/K-1994-2015;
   Pimentel-Coelho, Pedro Moreno/AAM-9106-2020
OI de Castro, Paulo Henrique Rosado/0000-0003-0091-9714; Martin-Acebes,
   Miguel A./0000-0001-6015-3613; Mendez-Otero,
   Rosalia/0000-0002-1798-9930; Ortiga-Carvalho, Tania/0000-0002-0225-1132;
   Pimentel-Coelho, Pedro M/0000-0002-2414-3386; Pimentel-Coelho, Pedro
   Moreno/0000-0002-2414-3386; Villamil Jimenez, Luis
   Carlos/0000-0001-9287-2727; Alencar, Carlos
   Henrique/0000-0003-2967-532X; Heukelbach, Jorg/0000-0002-7845-5510;
   Saiz, Juan-Carlos/0000-0001-8269-5544
FU FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [e-26/201.341/2016]; INIAInstituto de
   Investigacion Agropecuaria (INIA) [PR-d-C, PP-C ZIKA-BIO-2016-2,
   RTA2013-0013-C04-01-E, RTA2015-00009]; MINECO [AGL2014-56518-JIN]
FX e-26/201.341/2016 from FAPERJ to TO-C, PR-d-C and PP-C ZIKA-BIO-2016-2,
   RTA2013-0013-C04-01-E, and RTA2015-00009 from INIA to J-CS.
   AGL2014-56518-JIN from MINECO to MM-A.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Ahmad SSY, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1062
   Ahmed Azam, 2016, NY TIMES
   Ahmed QA, 2017, TRAVEL MED INFECT DI, V15, P63, DOI 10.1016/j.tmaid.2016.12.004
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Al-Abdely HM, 2016, SAUDI MED J, V37, P831, DOI 10.15537/smj.2016.8.15676
   Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014
   Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Attaway DF, 2017, J INFECT PUBLIC HEAL, V10, P120, DOI 10.1016/j.jiph.2016.09.008
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Balasubramanian A, 2017, ANTIVIR RES, V137, P141, DOI 10.1016/j.antiviral.2016.11.015
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Beisel U, 2013, SCI CULT-UK, V22, P38, DOI 10.1080/09505431.2013.776364
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bennett KL, 2016, MOL ECOL, V25, P4337, DOI 10.1111/mec.13762
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Blazquez Ana-Belen, 2016, World J Virol, V5, P135
   Boccolini D, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.35.30328
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Cao XC, 2016, NUCLEIC ACIDS RES, V44, P10505, DOI 10.1093/nar/gkw941
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Caprara A, 2016, GLOB HEALTH PROMOT, V23, P89, DOI 10.1177/1757975916673965
   Carlson CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004968
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   CASALS JORDI, 1957, TRANS NEW YORK ACAD SCI, V19, P219
   CDC, 2017, ZIK VIR WOM THEIR PA
   CDNA, 2016, ZIK VER INF NAT GUID
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Cavalcanti LPD, 2016, J INFECT DEV COUNTR, V10, P563, DOI 10.3855/jidc.8575
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Dittmer DP, 2016, SCIENCE, V353, P1375, DOI 10.1126/science.aai8117
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   ECDC, 2016, ZIK VIR EP AM POT AS
   ECDC, 2015, RAP RISK ASS ZIK VIR
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   El Ghouzzi V, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.266
   Escobar LE, 2016, SCI REP-UK, V6, DOI 10.1038/srep39150
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Fernandes NCCA, 2017, EXP TOXICOL PATHOL, V69, P63, DOI 10.1016/j.etp.2016.11.004
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Fischer S, 2017, B ENTOMOL RES, V107, P225, DOI [10.1017/s0007485316000869, 10.1017/S0007485316000869]
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca RFO, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004760
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gardner LM, 2016, LANCET INFECT DIS, V16, P522, DOI 10.1016/S1473-3099(16)00176-6
   Gong Z, 2016, TRENDS MICROBIOL, V24, P521, DOI 10.1016/j.tim.2016.05.002
   Goo L, 2016, MBIO, V7, DOI [10.1128/mBio.01396-16, 10.1128/mbio.01396-16]
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gruba N, 2016, FEBS LETT, V590, P3459, DOI 10.1002/1873-3468.12443
   Guedes D. R. D., 2016, ZIKA VIRUS REPLICATI, DOI 10.1101/073197
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Guzzetta G, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.15.30199
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Hamel R, 2017, INFECT GENET EVOL, V49, P134, DOI 10.1016/j.meegid.2017.01.015
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hart CE, 2017, EMERG INFECT DIS, V23, P559, DOI 10.3201/eid2303.161636
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hercik K, 2017, ANTIVIR RES, V137, P131, DOI 10.1016/j.antiviral.2016.11.020
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Ikejezie J, 2017, MMWR-MORBID MORTAL W, V66, P329, DOI 10.15585/mmwr.mm6612a4
   Jeffries Claire L, 2016, Curr Trop Med Rep, V3, P20
   Jian Y, 2016, ECOL APPL, V26, P2609, DOI 10.1002/eap.1405
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kuivanen S, 2017, ANTIVIR RES, V139, P117, DOI 10.1016/j.antiviral.2016.12.022
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lebrun G, 2009, EMERG INFECT DIS, V15, P495, DOI 10.3201/eid1503.071482
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Leis A Arturo, 2012, Front Neurol, V3, P37, DOI 10.3389/fneur.2012.00037
   Lennemann NJ, 2017, AUTOPHAGY, V13, P322, DOI 10.1080/15548627.2016.1265192
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li G, 2017, P NATL ACAD SCI USA, V114, pE376, DOI 10.1073/pnas.1619735114
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Li X, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2170-2
   Li YK, 2017, DNA CELL BIOL, V36, P109, DOI 10.1089/dna.2016.3532
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Lu GF, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01967-16, 10.1128/aac.01967-16]
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martin-Acebes Miguel A, 2012, World J Virol, V1, P51, DOI 10.5501/wjv.v1.i2.51
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Menendez-Arias L, 2014, CURR OPIN VIROL, V8, pIV, DOI 10.1016/j.coviro.2014.08.002
   Merino-Ramos T, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00376-17, 10.1128/aac.00376-17]
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Misslin R, 2016, ANN NY ACAD SCI, V1382, P56, DOI 10.1111/nyas.13084
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monaghan Andrew J, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.50dfc7f46798675fc63e7d7da563da76
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Mossenta M, 2017, BIOCHEM BIOPH RES CO, V492, P579, DOI 10.1016/j.bbrc.2017.01.022
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Moulin E, 2016, New Microbes New Infect, V11, P6, DOI 10.1016/j.nmni.2016.02.003
   Munoz AG, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0146-1
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Offerdahl DK, 2017, VIROLOGY, V501, P54, DOI 10.1016/j.virol.2016.11.002
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Penot P, 2017, EUROSURVEILLANCE, V22, P8, DOI 10.2807/1560-7917.ES.2017.22.3.30444
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Camara DCP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157120
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Prisant N, 2017, CLIN INFECT DIS, V64, P107, DOI 10.1093/cid/ciw669
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   RAVI V, 1994, ACTA NEUROL SCAND, V90, P67
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Robert MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161365
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Rolfe AJ, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0110-x
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roze B, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.16.30205
   Rut W, 2017, ANTIVIR RES, V139, P88, DOI 10.1016/j.antiviral.2016.12.018
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Sahoo Maheswata, 2016, Genomics & Informatics, V14, P104, DOI 10.5808/GI.2016.14.3.104
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00411-17, 10.1128/aac.00411-17]
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   Samy AM, 2016, MEM I OSWALDO CRUZ, V111, P559, DOI 10.1590/0074-02760160149
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Steinhagen K., 2015, EUROSURVEILLANCE, V2016, P21, DOI DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Stephen P, 2016, J AM CHEM SOC, V138, P16212, DOI 10.1021/jacs.6b10399
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   SVS/MS, 2017, B EPIDEMIOLOGICO
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   The Pan American Health Organization [PAHO]/World Health Organization [WHO], 2015, ZIK VIR INF
   Thompson AJ, 2007, IMMUNOL CELL BIOL, V85, P435, DOI 10.1038/sj.icb.7100100
   Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2
   Tiwari SK, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.9
   Vannice KS, 2019, VACCINE, V37, P7443, DOI 10.1016/j.vaccine.2016.10.034
   Vazquez-Calvo A., 2017, EMERG MICRO IN PRESS
   Vazquez-Calvo A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01314
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Verma R, 2014, J NEUROL SCI, V346, P26, DOI 10.1016/j.jns.2014.08.044
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Walther D, 2017, ACTA TROP, V166, P186, DOI 10.1016/j.actatropica.2016.11.024
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wang S, 2017, CELL RES, V27, P158, DOI 10.1038/cr.2016.144
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   WHO, 2016, ZIK CDCD INT RESP PL
   WHO, 2016, RISK COMM CONT ZIK V
   WHO, 2017, WHO VACC PIP TRACK
   WHO, 2016, PREV SEX TRANSM ZIK
   WHO, 2016, AIRCR DIS MOSQ CONTR
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wolf B, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.160231
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization, 2016, SURV ZIK VIR INF MIC
   World Health Organization, 2014, SAF IMM PREGN REV EV
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xavier-Neto J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005363
   Xu HT, 2017, J ANTIMICROB CHEMOTH, V72, P727, DOI 10.1093/jac/dkw514
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhang CY, 2017, BIOCHEM BIOPH RES CO, V492, P624, DOI 10.1016/j.bbrc.2016.11.098
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zhou H, 2017, ONCOTARGET, V8, P14830, DOI 10.18632/oncotarget.14780
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 261
TC 27
Z9 27
U1 0
U2 45
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD AUG 22
PY 2017
VL 8
AR 1554
DI 10.3389/fmicb.2017.01554
PG 25
WC Microbiology
SC Microbiology
GA FE4TI
UT WOS:000408205800001
PM 28878742
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Allard, A
   Althouse, BM
   Scarpino, SV
   Hebert-Dufresne, L
AF Allard, Antoine
   Althouse, Benjamin M.
   Scarpino, Samuel V.
   Hebert-Dufresne, Laurent
TI Asymmetric percolation drives a double transition in sexual contact
   networks
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE phase transition; Zika virus; percolation; complex networks;
   mathematical epidemiology
ID ZIKA VIRUS OUTBREAK; TRANSMISSION; INFECTION; DYNAMICS; RISK
AB Zika virus (ZIKV) exhibits unique transmission dynamics in that it is concurrently spread by a mosquito vector and through sexual contact. Due to the highly asymmetric durations of infectiousness between males and females-it is estimated that males are infectious for periods up to 10 times longer than females-we show that this sexual component of ZIKV transmission behaves akin to an asymmetric percolation process on the network of sexual contacts. We exactly solve the properties of this asymmetric percolation on random sexual contact networks and show that this process exhibits two epidemic transitions corresponding to a core-periphery structure. This structure is not present in the underlying contact networks, which are not distinguishable from random networks, and emerges because of the asymmetric percolation. We provide an exact analytical description of this double transition and discuss the implications of our results in the context of ZIKV epidemics. Most importantly, our study suggests a bias in our current ZIKV surveillance, because the community most at risk is also one of the least likely to get tested.
C1 [Allard, Antoine] Ctr Recerca Matemat, E-08193 Bellaterra, Barcelona, Spain.
   [Althouse, Benjamin M.; Hebert-Dufresne, Laurent] Inst Dis Modeling, Bellevue, WA 98005 USA.
   [Althouse, Benjamin M.] Univ Washington, Informat Sch, Seattle, WA 98105 USA.
   [Althouse, Benjamin M.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.
   [Scarpino, Samuel V.] Univ Vermont, Dept Math & Stat, Burlington, VT 05405 USA.
   [Scarpino, Samuel V.] Univ Vermont, Complex Syst Ctr, Burlington, VT 05405 USA.
   [Hebert-Dufresne, Laurent] Santa Fe Inst, Santa Fe, NM 87501 USA.
   [Hebert-Dufresne, Laurent] Univ Vermont, Dept Comp Sci, Burlington, VT 05405 USA.
RP Hebert-Dufresne, L (corresponding author), Inst Dis Modeling, Bellevue, WA 98005 USA.; Hebert-Dufresne, L (corresponding author), Santa Fe Inst, Santa Fe, NM 87501 USA.; Hebert-Dufresne, L (corresponding author), Univ Vermont, Dept Comp Sci, Burlington, VT 05405 USA.
EM laurent@santafe.edu
FU Fonds de recherche du Quebec-Nature et technologies; Bill and Melinda
   Gates through the Global Good Fund; James S. McDonnell Foundation;
   National Science FoundationNational Science Foundation (NSF)
   [DMS-1622390]
FX A.A. acknowledges support from the Fonds de recherche du Quebec-Nature
   et technologies. B.M.A. and L.H.-D. thank Bill and Melinda Gates for
   their support of this work and their sponsorship through the Global Good
   Fund. L.H.-D. acknowledges the Santa Fe Institute, the James S.
   McDonnell Foundation Postdoctoral Fellowship, and National Science
   Foundation Grant DMS-1622390. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Allard A, 2016, BIORXIV090324
   Allard A, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.062807
   Allard A, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036113
   Althaus CL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002157
   Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Althouse BM, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0575
   Althouse BM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001928
   Bhat U, 2017, PHYS REV E, V95, DOI 10.1103/PhysRevE.95.012314
   Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0
   Cai WR, 2015, NAT PHYS, V11, P936, DOI 10.1038/NPHYS3457
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Colomer-de-Simon P, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.041020
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dodds PS, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.218701
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Folkers KM, 2017, PUBLIC HEALTH, V148, P66, DOI 10.1016/j.puhe.2017.02.018
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gross T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.208701
   Hebert-Dufresne L, 2015, P NATL ACAD SCI USA, V112, P10551, DOI 10.1073/pnas.1507820112
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Marceau V, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036116
   Miller Joel C, 2017, Infect Dis Model, V2, P35, DOI 10.1016/j.idm.2016.12.003
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128
   Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.026118, 10.1103/PhysRevE.64.025102]
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   PADIAN NS, 1991, JAMA-J AM MED ASSOC, V266, P1664
   Pan American Health Organization/WHO, 2017, ZIK EP REP COL MARCH
   Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Scarpino SV, 2016, NAT PHYS, V12, P1042, DOI [10.1038/NPHYS3832, 10.1038/nphys3832]
   Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 39
TC 14
Z9 14
U1 0
U2 5
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 22
PY 2017
VL 114
IS 34
BP 8969
EP 8973
DI 10.1073/pnas.1703073114
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FE3CZ
UT WOS:000408095300038
PM 28790185
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Biner, D
   Grosch, J
   Ermel, A
   Brown, D
   Ortoleva, P
AF Biner, Daniel
   Grosch, Jason
   Ermel, Aaron
   Brown, Darron
   Ortoleva, Peter
TI Computational physics-based broadly neutralizing vaccine design-From
   epitope identification and assessment to predicted nanoparticle
   immunogenicity: Zika virus
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 254th National Meeting and Exposition of the American-Chemical-Society
   (ACS) on Chemistry's Impact on the Global Economy
CY AUG 20-24, 2017
CL Washington, DC
SP Amer Chem Soc
C1 [Biner, Daniel] Indiana Univ, Chem, Bloomington, IN USA.
   [Ermel, Aaron; Brown, Darron] Indiana Univ Sch Med, Indianapolis, IN 46202 USA.
EM dbiner@indiana.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 20
PY 2017
VL 254
MA 263
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA GC1FS
UT WOS:000429525603801
DA 2020-07-08
ER

PT J
AU Kim, S
   Nierode, G
   Yu, YL
   Dordick, J
   Linhardt, R
AF Kim, So
   Nierode, Greg
   Yu, Yanlei
   Dordick, Jonathan
   Linhardt, Robert
TI Glycosaminoglycan composition analysis of human fetal neural cells and
   their binding interactions with Zika virus envelope protein
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 254th National Meeting and Exposition of the American-Chemical-Society
   (ACS) on Chemistry's Impact on the Global Economy
CY AUG 20-24, 2017
CL Washington, DC
SP Amer Chem Soc
C1 [Dordick, Jonathan] Rensselaer Polytech Inst, Ctr Biotechnol, Troy, NY USA.
   [Kim, So; Yu, Yanlei] Rensselaer Polytech Inst, Troy, NY USA.
   [Linhardt, Robert] Rensselaer Polytech Inst, Chem, Albany, NY USA.
EM pigey.togepi.kimmie@gmail.com
RI Yu, Yanlei/AAQ-4432-2020
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 20
PY 2017
VL 254
MA 58
PG 2
WC Chemistry, Multidisciplinary
SC Chemistry
GA GC1FS
UT WOS:000429525601511
DA 2020-07-08
ER

PT J
AU Lee, H
   Ren, JH
   Nocadello, S
   Ojeda, I
   Light, S
   Minasov, G
   Nagarathnam, D
   Anderson, W
   Johnson, M
AF Lee, Hyun
   Ren, Jinhong
   Nocadello, Salvatore
   Ojeda, Isabel
   Light, Samuel
   Minasov, George
   Nagarathnam, Dhanapalan
   Anderson, Wayne
   Johnson, Michael
TI Identification of novel small molecule inhibitors against NS2B/NS3
   serine protease from Zika virus
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 254th National Meeting and Exposition of the American-Chemical-Society
   (ACS) on Chemistry's Impact on the Global Economy
CY AUG 20-24, 2017
CL Washington, DC
SP Amer Chem Soc
C1 [Anderson, Wayne] Northwestern Univ, Sch Med, Chicago, IL USA.
   [Lee, Hyun; Johnson, Michael] Univ Illinois, Dept Med Chem & Pharmacognosy, Chicago, IL USA.
   [Ren, Jinhong; Ojeda, Isabel] Univ Illinois, Chicago, IL USA.
   [Nocadello, Salvatore; Light, Samuel; Minasov, George] Northwestern Univ, Chicago, IL 60611 USA.
   [Nagarathnam, Dhanapalan] DNSK Int, Hamden, CT USA.
   [Lee, Hyun; Ren, Jinhong; Johnson, Michael] Novalex Therapeut Inc, Chicago, IL USA.
EM danielhl@uic.edu
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 20
PY 2017
VL 254
MA 271
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA GC1QM
UT WOS:000429556701389
DA 2020-07-08
ER

PT J
AU Pokhrel, L
AF Pokhrel, Lok
TI Engineering hybrid nanosystem as a novel sustainable tool for Zika
   vector Aedes aegypti control
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 254th National Meeting and Exposition of the American-Chemical-Society
   (ACS) on Chemistry's Impact on the Global Economy
CY AUG 20-24, 2017
CL Washington, DC
SP Amer Chem Soc
C1 [Pokhrel, Lok] Temple Univ, Div Environm Hlth, Philadelphia, PA 19122 USA.
EM lokraj123@gmail.com
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 20
PY 2017
VL 254
MA 194
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA GC1FS
UT WOS:000429525603124
DA 2020-07-08
ER

PT J
AU Shan, C
AF Shan, Chao
TI A live-attenuated Zika virus vaccine candidate induces sterilizing
   immunity in mouse models
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 254th National Meeting and Exposition of the American-Chemical-Society
   (ACS) on Chemistry's Impact on the Global Economy
CY AUG 20-24, 2017
CL Washington, DC
SP Amer Chem Soc
C1 [Shan, Chao] Univ Texas Med Branch, Galveston, TX 77555 USA.
EM chshan@UTMB.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 20
PY 2017
VL 254
MA 142
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA GC1FS
UT WOS:000429525601399
DA 2020-07-08
ER

PT J
AU Sizochenko, N
AF Sizochenko, Natalia
TI Deep learning vs Zika virus: At the crossroads of computational
   chemistry, systems biology, data mining and computer science
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 254th National Meeting and Exposition of the American-Chemical-Society
   (ACS) on Chemistry's Impact on the Global Economy
CY AUG 20-24, 2017
CL Washington, DC
SP Amer Chem Soc
C1 [Sizochenko, Natalia] Jackson State Univ, Interdisciplinary Ctr Nanotox, Jackson, MS USA.
EM sizochenko@icnanotox.org
NR 0
TC 0
Z9 0
U1 1
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 20
PY 2017
VL 254
MA 26
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA GC1FS
UT WOS:000429525600026
DA 2020-07-08
ER

PT J
AU Sizochenko, N
   Leszczynski, J
AF Sizochenko, Natalia
   Leszczynski, Jerzy
TI Stopping Zika virus: Computational search for deactivating agents
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 254th National Meeting and Exposition of the American-Chemical-Society
   (ACS) on Chemistry's Impact on the Global Economy
CY AUG 20-24, 2017
CL Washington, DC
SP Amer Chem Soc
C1 [Leszczynski, Jerzy] Jackson State Univ, Dept Chem, POB 17910, Jackson, MS 39217 USA.
   [Sizochenko, Natalia] Jackson State Univ, Interdisciplinary Ctr Nanotox, Jackson, MS USA.
EM sizochenko@icnanotox.org
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 20
PY 2017
VL 254
MA 132
PG 2
WC Chemistry, Multidisciplinary
SC Chemistry
GA GC1FS
UT WOS:000429525602813
DA 2020-07-08
ER

PT J
AU Lee, CT
   Bendriem, RM
   Wu, WW
   Shen, RF
AF Lee, Chun-Ting
   Bendriem, Raphael M.
   Wu, Wells W.
   Shen, Rong-Fong
TI 3D brain Organoids derived from pluripotent stem cells: promising
   experimental models for brain development and neurodegenerative
   disorders
SO JOURNAL OF BIOMEDICAL SCIENCE
LA English
DT Review
DE 3D brain organoids; Induced pluripotent stem cells; Brain development;
   Neocortex; Neurodevelopmental disorder; Neurodegenerative disorder;
   Microcephaly; Drugs; Autism; Alzheimer's disease
ID PRENATAL COCAINE EXPOSURE; ZIKA VIRUS-INFECTION; DIRECTED
   DIFFERENTIATION; HUMAN ES; NEURAL PROGENITORS; CEREBRAL ORGANOIDS;
   MICROGLIA; EVOLUTION; GENETICS; CHILDREN
AB Three-dimensional (3D) brain organoids derived from human pluripotent stem cells (hPSCs), including embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), appear to recapitulate the brain's 3D cytoarchitectural arrangement and provide new opportunities to explore disease pathogenesis in the human brain. Human iPSC (hiPSC) reprogramming methods, combined with 3D brain organoid tools, may allow patient-derived organoids to serve as a preclinical platform to bridge the translational gap between animal models and human clinical trials. Studies using patient-derived brain organoids have already revealed novel insights into molecular and genetic mechanisms of certain complex human neurological disorders such as microcephaly, autism, and Alzheimer's disease. Furthermore, the combination of hiPSC technology and small-molecule high-throughput screening (HTS) facilitates the development of novel pharmacotherapeutic strategies, while transcriptome sequencing enables the transcriptional profiling of patient-derived brain organoids. Finally, the addition of CRISPR/Cas9 genome editing provides incredible potential for personalized cell replacement therapy with genetically corrected hiPSCs. This review describes the history and current state of 3D brain organoid differentiation strategies, a survey of applications of organoids towards studies of neurodevelopmental and neurodegenerative disorders, and the challenges associated with their use as in vitro models of neurological disorders.
C1 [Lee, Chun-Ting; Wu, Wells W.; Shen, Rong-Fong] US FDA, Facil Biotechnol Resources, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.
   [Bendriem, Raphael M.] Weill Cornell Med, Ctr Neurogenet, Feil Family Brain & Mind Res Inst, New York, NY 10021 USA.
   [Lee, Chun-Ting] US FDA, Ctr Biol Evaluat & Res, Bldg 52,Rm 1121,10903 New Hampshire Ave, Silver Spring, MD 20993 USA.
RP Lee, CT (corresponding author), US FDA, Facil Biotechnol Resources, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.; Lee, CT (corresponding author), US FDA, Ctr Biol Evaluat & Res, Bldg 52,Rm 1121,10903 New Hampshire Ave, Silver Spring, MD 20993 USA.
EM Chun-Ting.Lee@fda.hhs.gov
CR Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346
   Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005
   Bandstra ES, 2004, SUBST USE MISUSE, V39, P25, DOI 10.1081/JA-120027765
   Barrera JA, 2010, DEV CELL, V18, P913, DOI 10.1016/j.devcel.2010.05.017
   Behnke M, 2013, PEDIATRICS, V131, pE1009, DOI 10.1542/peds.2012-3931
   Bertram L, 2005, J CLIN INVEST, V115, P1449, DOI 10.1172/JCI24761
   Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7
   Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915
   Byron SA, 2016, NAT REV GENET, V17, P257, DOI 10.1038/nrg.2016.10
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112
   Campion D, 1999, AM J HUM GENET, V65, P664, DOI 10.1086/302553
   Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529
   Chen H, 2014, CELL STEM CELL, V14, P796, DOI 10.1016/j.stem.2014.02.004
   Chiriboga CA, 1999, PEDIATRICS, V103, P79, DOI 10.1542/peds.103.1.79
   Chiriboga CA, 2007, NEUROTOXICOL TERATOL, V29, P323, DOI 10.1016/j.ntt.2006.12.002
   Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800
   Courchesne E, 2011, JAMA-J AM MED ASSOC, V306, P2001, DOI 10.1001/jama.2011.1638
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cunningham CL, 2013, J NEUROSCI, V33, P4216, DOI 10.1523/JNEUROSCI.3441-12.2013
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   DelaneyBlack V, 1996, PEDIATRICS, V98, P735
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Ebert AD, 2010, NAT REV DRUG DISCOV, V9, P1, DOI 10.1038/nrd3000
   Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002
   Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208
   Engle SJ, 2014, J BIOL CHEM, V289, P4562, DOI 10.1074/jbc.R113.529156
   Escott-Price V, 2015, BRAIN, V138, P3673, DOI 10.1093/brain/awv268
   Faheem M, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S1-S4
   Florio M, 2014, DEVELOPMENT, V141, P2182, DOI 10.1242/dev.090571
   Franco SJ, 2013, NEURON, V77, P19, DOI 10.1016/j.neuron.2012.12.022
   Frank DA, 1998, ANN NY ACAD SCI, V846, P40, DOI 10.1111/j.1749-6632.1998.tb09725.x
   Gandal MJ, 2016, NAT NEUROSCI, V19, P1397, DOI 10.1038/nn.4409
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Ginhoux F, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00045
   Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637
   Girirajan S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002334
   Gonzalez-Mantilla AJ, 2016, JAMA PSYCHIAT, V73, P275, DOI 10.1001/jamapsychiatry.2015.2692
   Gratten J, 2014, NAT NEUROSCI, V17, P782, DOI 10.1038/nn.3708
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hendriks WT, 2016, CELL STEM CELL, V18, P53, DOI 10.1016/j.stem.2015.12.002
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hibaoui Y, 2014, EMBO MOL MED, V6, P259, DOI 10.1002/emmm.201302848
   Hill RS, 2005, NATURE, V437, P64, DOI 10.1038/nature04103
   Hogberg HT, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt365
   Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373
   Hong S, 2016, CURR OPIN NEUROBIOL, V36, P128, DOI 10.1016/j.conb.2015.12.004
   Inglese J, 2007, NAT CHEM BIOL, V3, P466, DOI 10.1038/nchembio.2007.17
   Javaherian A, 2009, CEREB CORTEX, V19, pI70, DOI 10.1093/cercor/bhp029
   Orqueda AJ, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/5934782
   Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110
   Kim YH, 2015, NAT PROTOC, V10, P985, DOI 10.1038/nprot.2015.065
   Kindberg AA, 2014, DIS MODEL MECH, V7, P1397, DOI 10.1242/dmm.017251
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   La Cognata V, 2017, HUM GENET, V136, P13, DOI 10.1007/s00439-016-1749-4
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lange C, 2016, EMBO J, V35, P924, DOI 10.15252/embj.201592372
   Lee CT, 2017, NEUROPSYCHOPHARMACOL, V42, P774, DOI 10.1038/npp.2016.156
   Lee CT, 2015, ONCOTARGET, V6, P18238, DOI 10.18632/oncotarget.4853
   Lee CT, 2015, RESTOR NEUROL NEUROS, V33, P347, DOI 10.3233/RNN-140488
   Lee CT, 2015, CELL REP, V10, P616, DOI 10.1016/j.celrep.2014.12.050
   Lee CT, 2011, SYNAPSE, V65, P21, DOI 10.1002/syn.20814
   Lee CT, 2008, PLOS MED, V5, P987, DOI 10.1371/journal.pmed.0050117
   Lee H, 2007, STEM CELLS, V25, P1931, DOI 10.1634/stemcells.2007-0097
   Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063
   Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410
   Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030
   Marchetto MC, 2017, MOL PSYCHIATR, V22, P820, DOI 10.1038/mp.2016.95
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   Martignoni M, 2006, EXPERT OPIN DRUG MET, V2, P875, DOI 10.1517/17425255.2.6.875
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McCarroll SA, 2013, NEURON, V80, P578, DOI 10.1016/j.neuron.2013.10.046
   Megraw TL, 2011, TRENDS CELL BIOL, V21, P470, DOI 10.1016/j.tcb.2011.04.007
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Merikangas AK, 2009, TRENDS GENET, V25, P536, DOI 10.1016/j.tig.2009.10.006
   Minnes Sonia, 2011, Addict Sci Clin Pract, V6, P57
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Muffat J, 2016, NAT MED, V22, P1358, DOI 10.1038/nm.4189
   Nie J, 2017, EMBO REP, V18, P367, DOI 10.15252/embr.201643732
   O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613
   Pandya H, 2017, NAT NEUROSCI, V20, P753, DOI 10.1038/nn.4534
   Parikshak NN, 2015, NAT REV GENET, V16, P441, DOI 10.1038/nrg3934
   Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]
   Pinto AM, 2016, EXPERT REV MOL DIAGN, V16, P1037, DOI 10.1080/14737159.2016.1224181
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rabbani B, 2016, MOL BIOSYST, V12, P1818, DOI 10.1039/c6mb00115g
   Raja WK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161969
   Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719
   Rando K, 2013, BIOL PSYCHIAT, V74, P482, DOI 10.1016/j.biopsych.2013.04.030
   Rivkin MJ, 2008, PEDIATRICS, V121, P741, DOI 10.1542/peds.2007-1399
   Ryan SD, 2013, CELL, V155, P1351, DOI 10.1016/j.cell.2013.11.009
   Salter MW, 2014, CELL, V158, P15, DOI 10.1016/j.cell.2014.06.008
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026
   Schwartz MP, 2015, P NATL ACAD SCI USA, V112, P12516, DOI 10.1073/pnas.1516645112
   Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694
   Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041
   Singer LT, 2002, JAMA-J AM MED ASSOC, V287, P1952, DOI 10.1001/jama.287.15.1952
   Smith C, 2016, COLD SPRING HARB PRO
   Stoner R, 2014, NEW ENGL J MED, V370, P1209, DOI 10.1056/NEJMoa1307491
   Surasombatpattana P, 2011, INFECT GENET EVOL, V11, P1664, DOI 10.1016/j.meegid.2011.06.009
   Takebe T, 2015, CELL STEM CELL, V16, P556, DOI 10.1016/j.stem.2015.03.004
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thompson BL, 2009, NAT REV NEUROSCI, V10, P303, DOI 10.1038/nrn2598
   Tronick EZ, 1996, PEDIATRICS, V98, P76
   Tay TL, 2017, J PHYSIOL-LONDON, V595, P1929, DOI 10.1113/JP272134
   van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245
   Vasudevan A, 2008, NAT NEUROSCI, V11, P429, DOI 10.1038/nn2074
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wake H, 2013, TRENDS NEUROSCI, V36, P209, DOI 10.1016/j.tins.2012.11.007
   Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402
   Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310
   Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716
   Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930
   Yan YP, 2005, STEM CELLS, V23, P781, DOI 10.1634/stemcells.2004-0365
   Yin XL, 2016, CELL STEM CELL, V18, P25, DOI 10.1016/j.stem.2015.12.005
   Zhang H, 2012, J NEUROCHEM, V120, P9, DOI 10.1111/j.1471-4159.2011.07519.x
   Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129
   Zielinski BA, 2014, BRAIN, V137, P1799, DOI 10.1093/brain/awu083
NR 121
TC 38
Z9 39
U1 9
U2 63
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1021-7770
EI 1423-0127
J9 J BIOMED SCI
JI J. Biomed. Sci.
PD AUG 20
PY 2017
VL 24
AR 59
DI 10.1186/s12929-017-0362-8
PG 12
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA FE0JM
UT WOS:000407906600001
PM 28822354
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cohen, J
AF Cohen, Jon
TI INFECTIOUS DISEASES Where has all the Zika gone?
SO SCIENCE
LA English
DT News Item
NR 0
TC 12
Z9 12
U1 0
U2 5
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD AUG 18
PY 2017
VL 357
IS 6352
BP 631
EP 632
DI 10.1126/science.357.6352.631
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FD8SE
UT WOS:000407793600009
PM 28818921
DA 2020-07-08
ER

PT J
AU Saucereau, Y
   Moro, CV
   Dieryckx, C
   Dupuy, JW
   Tran, FH
   Girard, V
   Potier, P
   Mavingui, P
AF Saucereau, Yoann
   Moro, Claire Valiente
   Dieryckx, Cindy
   Dupuy, Jean-William
   Tran, Florence-Helene
   Girard, Vincent
   Potier, Patrick
   Mavingui, Patrick
TI Comprehensive proteome profiling in Aedes albopictus to decipher
   Wolbachia-arbovirus interference phenomenon
SO BMC GENOMICS
LA English
DT Article
DE Aedes albopictus; Wolbachia; Viral inhibition; Proteome; Glycolysis;
   Metabolism; miRNA
ID DENGUE VIRUS; CYTOPLASMIC INCOMPATIBILITY; CHIKUNGUNYA VIRUS; INFECTION;
   AEGYPTI; MICRORNA; METHYLTRANSFERASE; REPLICATION; ACTIVATION; INVASION
AB Background: Aedes albopictus is a vector of arboviruses that cause severe diseases in humans such as Chikungunya, Dengue and Zika fevers. The vector competence of Ae. albopictus varies depending on the mosquito population involved and the virus transmitted. Wolbachia infection status in believed to be among key elements that determine viral transmission efficiency. Little is known about the cellular functions mobilized in Ae. albopictus during co-infection by Wolbachia and a given arbovirus. To decipher this tripartite interaction at the molecular level, we performed a proteome analysis in Ae. albopictus C6/36 cells mono-infected by Wolbachia wAlbB strain or Chikungunya virus (CHIKV), and bi-infected.
   Results: We first confirmed significant inhibition of CHIKV by Wolbachia. Using two-dimensional gel electrophoresis followed by nano liquid chromatography coupled with tandem mass spectrometry, we identified 600 unique differentially expressed proteins mostly related to glycolysis, translation and protein metabolism. Wolbachia infection had greater impact on cellular functions than CHIKV infection, inducing either up or down-regulation of proteins associated with metabolic processes such as glycolysis and ATP metabolism, or structural glycoproteins and capsid proteins in the case of bi-infection with CHIKV. CHIKV infection inhibited expression of proteins linked with the processes of transcription, translation, lipid storage and miRNA pathways.
   Conclusions: The results of our proteome profiling have provided new insights into the molecular pathways involved in tripartite Ae. albopictus-Wolbachia-CHIKV interaction and may help defining targets for the better implementation of Wolbachia-based strategies for disease transmission control.
C1 [Saucereau, Yoann; Moro, Claire Valiente; Tran, Florence-Helene; Potier, Patrick; Mavingui, Patrick] Univ Lyon, Lyon, France.
   [Saucereau, Yoann; Moro, Claire Valiente; Tran, Florence-Helene; Potier, Patrick; Mavingui, Patrick] Univ Lyon 1, Villeurbanne, France.
   [Saucereau, Yoann; Moro, Claire Valiente; Tran, Florence-Helene; Potier, Patrick; Mavingui, Patrick] CNRS, UMR5557, Ecol Microbienne, Villeurbanne, France.
   [Saucereau, Yoann; Moro, Claire Valiente; Tran, Florence-Helene; Potier, Patrick; Mavingui, Patrick] INRA, UMR1418, Villeurbanne, France.
   [Dieryckx, Cindy; Girard, Vincent] CNRS, Plateforme Proteom, Lab Mixte UMR 5240, Lyon, France.
   [Dupuy, Jean-William] Univ Bordeaux, Plateforme Proteome, Ctr Genom Fonct, F-33000 Bordeaux, France.
   [Mavingui, Patrick] Univ La Reunion, Plateforme Technol CYROI, Unite Mixte Proc Infect Milieu Insulaire Trop PIM, CNRS 9192,INSERM U1187,IRD 249, 2 Rue Maxime Riviere, F-97490 St Clotilde, Reunion, France.
RP Mavingui, P (corresponding author), Univ Lyon, Lyon, France.; Mavingui, P (corresponding author), Univ Lyon 1, Villeurbanne, France.; Mavingui, P (corresponding author), CNRS, UMR5557, Ecol Microbienne, Villeurbanne, France.; Mavingui, P (corresponding author), INRA, UMR1418, Villeurbanne, France.; Mavingui, P (corresponding author), Univ La Reunion, Plateforme Technol CYROI, Unite Mixte Proc Infect Milieu Insulaire Trop PIM, CNRS 9192,INSERM U1187,IRD 249, 2 Rue Maxime Riviere, F-97490 St Clotilde, Reunion, France.
EM patrick.mavingui@cnrs.fr
RI Dupuy, Jean-William JWD/F-5335-2012
OI Dupuy, Jean-William JWD/0000-0002-2448-4797; valiente moro,
   claire/0000-0002-7193-405X
FU Region Rhone-AlpesRegion Auvergne-Rhone-Alpes; ERA-NET BiodivERsA
   [ANR-13-EBID-0007-01, FWF I-1437]; DFG part of BiodivERsAGerman Research
   Foundation (DFG) [KL 2087/6-1]
FX This work was partially supported by the Region Rhone-Alpes and by
   ERA-NET BiodivERsA with the national funders ANR-13-EBID-0007-01, FWF
   I-1437, and DFG KL 2087/6-1 as part of the 2012-2013 BiodivERsA call for
   research proposals.
CR Baldridge GD, 2014, MOL MICROBIOL, V94, P537, DOI 10.1111/mmi.12768
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856
   Brennan LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002083
   BUCKLEY SM, 1969, P SOC EXP BIOL MED, V131, P625, DOI 10.3181/00379727-131-33940
   Catusse J, 2008, P NATL ACAD SCI USA, V105, P10262, DOI 10.1073/pnas.0800585105
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Delisle E, 2015, EURO SURVEILL B EUR, V20
   Dobson SL, 2004, HEREDITY, V93, P135, DOI 10.1038/sj.hdy.6800458
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398
   Avila-Bonilla RG, 2017, VIRUS RES, V232, P139, DOI 10.1016/j.virusres.2017.03.005
   Gerardin P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-99
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Hughes GL, 2012, APPL ENVIRON MICROB, V78, P1491, DOI 10.1128/AEM.06751-11
   Hussain M, 2012, NUCLEIC ACIDS RES, V40, P2210, DOI 10.1093/nar/gkr848
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   IUCN/ SSC Invasive Species Specialist Group, ISSG DAT EC AED ALB
   Johnson KN, 2015, VIRUSES-BASEL, V7, P5705, DOI 10.3390/v7112903
   Kittayapong P, 2000, J MED ENTOMOL, V37, P340, DOI 10.1603/0022-2585(2000)037[0340:DADOWI]2.0.CO;2
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lee RCH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003544
   Lee RCH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002050
   Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754
   Miesen P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004452
   Minard G, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00970
   Molloy JC, 2015, VIRUSES-BASEL, V7, P4624, DOI 10.3390/v7082836
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Mousson L, 2010, MOL ECOL, V19, P1953, DOI 10.1111/j.1365-294X.2010.04606.x
   Mousson L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001989
   Ogino T, 2001, BIOCHEM BIOPH RES CO, V285, P447, DOI 10.1006/bbrc.2001.5160
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   Patramool S, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-138
   PAUL SD, 1969, INDIAN J MED RES, V57, P339
   Rainey SM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005536
   Raquin V, 2015, PLOS ONE, V10
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Roiz D, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003854
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Su JX, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-1966-2
   Succo T, 2016, EURO SURVEILL B EUR, V21
   Tchankouo-Nguetcheu S, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-264
   Tchankouo-Nguetcheu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013149
   Tortosa P, 2008, INSECT MOL BIOL, V17, P677, DOI 10.1111/j.1365-2583.2008.00842.x
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262
   Weiss B, 2011, TRENDS PARASITOL, V27, P514, DOI 10.1016/j.pt.2011.05.001
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   YEN JH, 1971, NATURE, V232, P657, DOI 10.1038/232657a0
   Zhang GM, 2014, INSECT BIOCHEM MOLEC, V53, P81, DOI 10.1016/j.ibmb.2014.08.003
   Zhang GM, 2013, P NATL ACAD SCI USA, V110, P10276, DOI 10.1073/pnas.1303603110
   Zouache K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006388
NR 58
TC 9
Z9 9
U1 0
U2 11
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2164
J9 BMC GENOMICS
JI BMC Genomics
PD AUG 18
PY 2017
VL 18
AR 635
DI 10.1186/s12864-017-3985-y
PG 14
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA FE2HO
UT WOS:000408037600004
PM 28821226
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Goodridge, K
   Reveiz, L
   Elias, V
AF Goodridge, Keisha
   Reveiz, Ludovic
   Elias, Vanessa
TI An overview of financial sources being utilized to support Zika Virus
   published research
SO PLOS ONE
LA English
DT Article
AB Background
   Since its initial detection in Brazil in 2015, Zika Virus (ZIKV) has spread rapidly throughout most of the Caribbean and South, Central and North America. An upsurge in congenital syndrome associated with ZIKV and Guillain-Barre Syndrome (GBS) has been associated with the increase in ZIKV. This amplification in numbers led to the need for funded research initiatives focusing on various countries globally and on specific experimental types.
   Objectives
   To determine the financial institutions involved in the production of primary research into the ZIKV epidemic. This research also intends to draw attention to the investigative areas that are dominating, experimental types being conducted and the geographical areas that are producing the bulk of the research utilizing available funds.
   Methods
   A cross sectional search of published primary research was conducted using Pan American Health Organization (PAHO) Zika platform and PubMed between January 2007 and October 2016. Titles, abstract and full articles were assed and one researcher extracted data. Information was crossed checked by a second researcher to ensure accuracy.
   Findings
   268 articles were included and investigations occurred across 48 countries with Brazil and USA dominating the research. Applied Research and Laboratory based studies were most frequently utilized. 38.1% of articles did not report financial sources. Public institutions were the major known contributors. Other financiers included private, non-profits and mixed funders exclusive of public sources. 156 individual financial bodies assisted with National Institute of Health being most frequently mentioned followed by The National Council for Scientific and Technological Development (CNPq) and the Institut Pasteur. Virus, vectors and reservoirs was most frequently used (99/268, 36.9%) followed by clinical management (70/268, 26.1%) and epidemiology (46/268, 17.2%).
   Interpretation
   The evidence suggests international efforts to fund ZIKV research and a need to foster collaborative and synchronized priority setting for resource allocation.
C1 [Goodridge, Keisha; Reveiz, Ludovic; Elias, Vanessa] Pan Amer Hlth Org, Knowledge Management Bioeth & Res Off, Washington, DC 20037 USA.
RP Goodridge, K; Reveiz, L (corresponding author), Pan Amer Hlth Org, Knowledge Management Bioeth & Res Off, Washington, DC 20037 USA.
EM keisha_ridge@hotmail.com; reveizl@paho.org
FU Pan American Health Organization (PAHO)
FX This research was supported by the Pan American Health Organization
   (PAHO). This paper could not have been written without the input and
   supervision of Dr. Reveiz and the participation from Miss Elias.
CR [Anonymous], 2016, ZIKA VIRUS OUTBREAK
   [Anonymous], 2016, FUNDING INITIATIVES
   [Anonymous], 2014, RESOURCES RESULTS 5
   [Anonymous], 2015, ZIK VIR INF
   Buekens P, 2009, J BIOMED INFORM, V42, P377
   Longuere K-S, 2016, ARTICLE GLOBAL RES P
   PAHO WHO, 2016, SCI CALL INT RES ZIK
   PAHO/WHO, 2017, REG ZIK EP UPD
   Pellerin C., 2016, DOD ADDS FUNDING ENH
   Reveiz L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056410
   Viergever RF, 2010, HEAL RES POLICY SYST, V8, P25
   World Health O, 2016, ZIK VIR RES AG
NR 12
TC 2
Z9 2
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 17
PY 2017
VL 12
IS 8
AR e0183134
DI 10.1371/journal.pone.0183134
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FD9QG
UT WOS:000407856600072
PM 28817610
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU de Laval, F
   Matheus, S
   Briolant, S
AF de laval, Franck
   Matheus, Severine
   Briolant, Sebastien
TI Kinetics of Zika Viral Load in Semen
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
ID VIRUS
C1 [de laval, Franck] Mil Ctr Epidemiol & Publ Hlth, Marseille, France.
   [Matheus, Severine] Inst Pasteur French Guiana, Cayenne, French Guiana.
   [Briolant, Sebastien] French Armed Forces Biomed Res Inst, Marseille, France.
RP Briolant, S (corresponding author), French Armed Forces Biomed Res Inst, Marseille, France.
EM sbriolant@wanadoo.fr
RI Rousset, Dominique/S-5400-2019
OI Rousset, Dominique/0000-0002-1473-3147
FU Direction du Service de Sante des Armees [2016RC10]; European
   UnionEuropean Union (EU) [653316]
FX Supported by a grant (2016RC10) from the Direction du Service de Sante
   des Armees and by the European Virus Archive goes Global project through
   a grant (653316) from Horizon 2020 of the European Union.
CR BARZON L, 2016, EUROSURVEILLANCE, V21, P2
   de Laval F, 2016, LANCET, V388, P868, DOI 10.1016/S0140-6736(16)31429-5
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
NR 5
TC 17
Z9 18
U1 0
U2 7
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD AUG 17
PY 2017
VL 377
IS 7
BP 697
EP 699
DI 10.1056/NEJMc1612600
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA FD7FG
UT WOS:000407691400016
PM 28813216
OA Bronze
DA 2020-07-08
ER

PT J
AU Wijesundara, DK
   Yu, WB
   Quah, BJC
   Eldi, P
   Hayball, JD
   Diener, KR
   Voskoboinik, I
   Gowans, EJ
   Grubor-Bauk, B
AF Wijesundara, Danushka K.
   Yu, Wenbo
   Quah, Ben J. C.
   Eldi, Preethi
   Hayball, John D.
   Diener, Kerrilyn R.
   Voskoboinik, Ilia
   Gowans, Eric J.
   Grubor-Bauk, Branka
TI Cytolytic DNA vaccine encoding lytic perforin augments the maturation
   of- and antigen presentation by- dendritic cells in a time-dependent
   manner
SO SCIENTIFIC REPORTS
LA English
DT Article
ID IN-VIVO; CROSS-PRESENTATION; B-LYMPHOCYTES; SELF-ANTIGENS; PLASMID DNA;
   ZIKA VIRUS; IMMUNIZATION; RESPONSES; CD8(+); IMMUNOGENICITY
AB The use of cost-effective vaccines capable of inducing robust CD8(+) T cell immunity will contribute significantly towards the elimination of persistent viral infections and cancers worldwide. We have previously reported that a cytolytic DNA vaccine encoding an immunogen and a truncated mouse perforin (PRF) protein significantly augments anti-viral T cell (including CD8(+) T cell) immunity. Thus, the current study investigated whether this vaccine enhances activation of dendritic cells (DCs) resulting in greater priming of CD8(+) T cell immunity. In vitro data showed that transfection of HEK293T cells with the cytolytic DNA resulted in the release of lactate dehydrogenase, indicative of necrotic/lytic cell death. In vitro exposure of this lytic cell debris to purified DCs from naive C57BL/6 mice resulted in maturation of DCs as determined by up-regulation of CD80/CD86. Using activation/proliferation of adoptively transferred OT-I CD8(+) T cells to measure antigen presentation by DCs in vivo, it was determined that cytolytic DNA immunisation resulted in a time-dependent increase in the proliferation of OT-I CD8(+) T cells compared to canonical DNA immunisation. Overall, the data suggest that the cytolytic DNA vaccine increases the activity of DCs which has important implications for the design of DNA vaccines to improve their translational prospects.
C1 [Wijesundara, Danushka K.; Gowans, Eric J.; Grubor-Bauk, Branka] Univ Adelaide, Basil Hetzel Inst Translat Hlth Res, Virol Lab, Adelaide, SA, Australia.
   [Yu, Wenbo] Ctr Canc Biol, Translat Oncol Lab, Adelaide, SA, Australia.
   [Quah, Ben J. C.] John Curtin Sch Med Res, Canc & Vasc Biol Lab, Canberra, ACT, Australia.
   [Eldi, Preethi; Hayball, John D.; Diener, Kerrilyn R.] Sansom Inst Hlth Res, Expt Therapeut Lab, Adelaide, SA, Australia.
   [Eldi, Preethi; Hayball, John D.; Diener, Kerrilyn R.] Univ South Australia, Sch Pharm & Med Sci, Adelaide, SA, Australia.
   [Hayball, John D.; Diener, Kerrilyn R.] Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia.
   [Hayball, John D.; Diener, Kerrilyn R.] Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia.
   [Voskoboinik, Ilia] Peter MacCallum Canc Ctr, Killer Cell Biol Lab, Melbourne, Vic, Australia.
RP Wijesundara, DK (corresponding author), Univ Adelaide, Basil Hetzel Inst Translat Hlth Res, Virol Lab, Adelaide, SA, Australia.
EM danushka.wijesundara@adelaide.edu.au
RI ; Hayball, John/F-4137-2013
OI Quah, Ben/0000-0003-2938-5007; , Ilia/0000-0002-6410-009X; Hayball,
   John/0000-0002-3089-4506; Diener, Kerrilyn/0000-0001-8417-5542; Eldi,
   Preethi/0000-0003-0772-3095; Wijesundara, Danushka/0000-0002-0740-8362;
   Grubor-Bauk, Branka/0000-0002-4642-105X
FU National Health and Medical Research Council (NHMRC) AustraliaNational
   Health and Medical Research Council of Australia [APP1026293, 543139,
   543143]; Australian-Indian biotechnology fund [BF040005]; Hospital
   Research Foundation (THRF); THRF
FX Grants APP1026293, 543139 and 543143 from the National Health and
   Medical Research Council (NHMRC) Australia, grant BF040005 from the
   Australian-Indian biotechnology fund and a grant from the Hospital
   Research Foundation (THRF) supported the research in this study. THRF
   supports an early career fellowship for Danushka Wijesundara.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Akbari O, 1999, J EXP MED, V189, P169, DOI 10.1084/jem.189.1.169
   Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724
   BIRNBOIM HC, 1983, METHOD ENZYMOL, V100, P243
   Brennan AJ, 2011, IMMUNITY, V34, P879, DOI 10.1016/j.immuni.2011.04.007
   Bursch LS, 2009, J IMMUNOL, V182, P4657, DOI 10.4049/jimmunol.0803656
   Chan Francis Ka-Ming, 2013, Methods Mol Biol, V979, P65, DOI 10.1007/978-1-62703-290-2_7
   Cho JH, 2001, J IMMUNOL, V167, P5549, DOI 10.4049/jimmunol.167.10.5549
   Colluru VT, 2016, ONCOTARGET, V7, P67901, DOI 10.18632/oncotarget.12178
   Corr M, 1999, J IMMUNOL, V163, P4721
   den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685
   Elnekave M, 2010, J IMMUNOL, V185, P3463, DOI 10.4049/jimmunol.1001825
   Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200
   Gargett T, 2014, CLIN TRANSL IMMUNOL, V3, DOI 10.1038/cti.2014.13
   Gargett T, 2014, IMMUNOL CELL BIOL, V92, P359, DOI 10.1038/icb.2013.93
   Grubor-Bauk B, 2016, GENE THER, V23, P26, DOI 10.1038/gt.2015.86
   Gummow J, 2015, J VIROL, V89, P7991, DOI 10.1128/JVI.00803-15
   Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206
   Holmes K, 2001, Curr Protoc Immunol, VChapter 5, DOI 10.1002/0471142735.im0503s44
   Hovav AH, 2007, J IMMUNOL, V179, P6725, DOI 10.4049/jimmunol.179.10.6725
   Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254
   Jorritsma SHT, 2016, VACCINE, V34, P5488, DOI 10.1016/j.vaccine.2016.09.062
   Kaplan DH, 2010, TRENDS IMMUNOL, V31, P446, DOI 10.1016/j.it.2010.08.006
   Kim TJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6317
   Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Melcher A, 1998, NAT MED, V4, P581, DOI 10.1038/nm0598-581
   Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002
   Porgador A, 1998, J EXP MED, V188, P1075, DOI 10.1084/jem.188.6.1075
   Quah B. J., 2010, J VIS EXP
   Romani N, 2012, CURR TOP MICROBIOL, V351, P113, DOI 10.1007/82_2010_118
   Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423
   Trimble CL, 2015, LANCET, V386, P2078, DOI 10.1016/S0140-6736(15)00239-1
   Voskoboinik I, 2005, J BIOL CHEM, V280, P8426, DOI 10.1074/jbc.M413303200
   Zanetti M, 2004, IMMUNOL REV, V199, P264, DOI 10.1111/j.0105-2896.2004.00152.x
NR 35
TC 6
Z9 6
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 17
PY 2017
VL 7
AR 8530
DI 10.1038/s41598-017-08063-1
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FD9SY
UT WOS:000407863600041
PM 28819257
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Reperant, LA
   Osterhaus, ADME
AF Reperant, Leslie A.
   Osterhaus, Albert D. M. E.
TI AIDS, Avian flu, SARS, MERS, Ebola, Zika... what next?
SO VACCINE
LA English
DT Article; Proceedings Paper
CT 10th Annual Vaccine Congress
CY SEP 04-07, 2016
CL Amsterdam, NETHERLANDS
DE Emerging; Epidemics; Virus; Preparedness
ID ACUTE RESPIRATORY SYNDROME; SYNDROME CORONAVIRUS; FUNCTIONAL RECEPTOR;
   INFLUENZA; VACCINE; VIRUS; TRIAL; RETROVIRUS; INFECTION; RESPONSES
AB Emerging infections have threatened humanity since times immemorial. The dramatic anthropogenic, behavioral and social changes that have affected humanity and the environment in the past century have accelerated the intrusion of novel pathogens into the global human population, sometimes with devastating consequences. The AIDS and influenza pandemics have claimed and will continue to claim millions of lives. The recent SARS and Ebola epidemics have threatened populations across borders. The emergence of MERS may well be warning signals of a nascent pandemic threat, while the potential for geographical spread of vector-borne diseases, such as Zika, but also Dengue and Chikungunya is unprecedented. Novel technologies and innovative approaches have multiplied to address and improve response preparedness towards the increasing yet unpredictable. threat posed by emerging pathogens. (C) 2017 Published by Elsevier Ltd.
C1 [Reperant, Leslie A.; Osterhaus, Albert D. M. E.] Artemis One Hlth Res Fdn, Utrecht, Netherlands.
   [Osterhaus, Albert D. M. E.] Univ Vet Med, Res Ctr Emerging Infect & Zoonoses, Hannover, Germany.
RP Osterhaus, ADME (corresponding author), Univ Vet Med, Res Ctr Emerging Infect & Zoonoses, Hannover, Germany.
EM Albert.Osterhaus@tiho-hannover.de
CR BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183
   Borducchi EN, 2016, NATURE, V540, P284, DOI 10.1038/nature20583
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Chan M., 2015, WOMEN SCI LECT SERIE
   Chappell KJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006037
   Chen HL, 2009, EMERG INFECT DIS, V15, P1849, DOI 10.3201/eid1511.090868
   Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650
   Cleaveland S, 2001, PHILOS T R SOC B, V356, P991, DOI 10.1098/rstb.2001.0889
   DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0
   Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4
   de Swart RL, 2012, CURR OPIN VIROL, V2, P330, DOI 10.1016/j.coviro.2012.02.010
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   Fouchier RAM, 2003, NATURE, V423, P240, DOI 10.1038/423240a
   Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130
   Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413
   Haagmans BL, 2016, SCIENCE, V351, P77, DOI 10.1126/science.aad1283
   Haagmans BL, 2004, NAT MED, V10, P290, DOI 10.1038/nm1001
   Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Khan SU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042689
   KILEY MP, 1982, INTERVIROLOGY, V18, P24, DOI 10.1159/000149300
   Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   Liang XF, 2010, LANCET, V375, P56, DOI 10.1016/S0140-6736(09)62003-1
   Lin JT, 2007, ANTIVIR THER, V12, P1107
   Martin JE, 2008, VACCINE, V26, P6338, DOI 10.1016/j.vaccine.2008.09.026
   Olival KJ, 2014, VIRUSES-BASEL, V6, P1759, DOI 10.3390/v6041759
   Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498
   Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005
   Reperant LA., 2014, A D M E RECENT ADV I, V6, P47
   Reperant Leslie A, 2014, F1000Prime Rep, V6, P47, DOI 10.12703/P6-47
   Reperant LA, 2013, CURR TOP MICROBIOL, V365, P49, DOI 10.1007/82_2012_269
   Reperant LA, 2012, VACCINE, V30, P4419, DOI 10.1016/j.vaccine.2012.04.049
   Sanders John W., 2008, Science Progress, V91, P1, DOI 10.3184/003685008X284628
   Sims LD, 2013, CURR TOP MICROBIOL, V365, P281, DOI 10.1007/82_2012_254
   Smalley C, 2016, VACCINE, V34, P2976, DOI 10.1016/j.vaccine.2016.03.076
   Song HD, 2005, P NATL ACAD SCI USA, V102, P2430, DOI 10.1073/pnas.0409608102
   Tripp RA, 2016, EXPERT REV VACCINES, V15, P1083, DOI 10.1080/14760584.2016.1192474
   Wang QH, 2014, CELL HOST MICROBE, V16, P328, DOI 10.1016/j.chom.2014.08.009
   Waters CN, 2016, SCIENCE, V351, P137, DOI 10.1126/science.aad2622
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
NR 41
TC 15
Z9 16
U1 6
U2 72
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD AUG 16
PY 2017
VL 35
IS 35
SI SI
BP 4470
EP 4474
DI 10.1016/j.vaccine.2017.04.082
PN A
PG 5
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA FG3DQ
UT WOS:000410017400006
PM 28633891
OA Green Published
DA 2020-07-08
ER

PT J
AU Adegoke, O
   Morita, M
   Kato, T
   Ito, M
   Suzuki, T
   Park, EY
AF Adegoke, Oluwasesan
   Morita, Masahiro
   Kato, Tatsuya
   Ito, Masahito
   Suzuki, Tetsuro
   Park, Enoch Y.
TI Localized surface plasmon resonance-mediated fluorescence signals in
   plasmonic nanoparticle-quantum dot hybrids for ultrasensitive Zika virus
   RNA detection via hairpin hybridization assays
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article
DE Molecular beacon; Surface plasmon resonance; Plasmonic nanoparticle;
   Quantum dot; Zika virus
ID L-CYSTEINE; TRANSMISSION; SPECTROSCOPY; EMERGENCE; CORE; PCR
AB The current epidemic caused by the Zika virus (ZIKV) and the devastating effects of this virus on fetal development, which result in an increased incidence of congenital microcephaly symptoms, have prompted the World Health Organization (WHO) to declare the ZIKV a public health issue of global concern. Efficient probes that offer high detection sensitivity and specificity are urgently required to aid in the point-of-care treatment of the virus. In this study, we show that localized surface plasmon resonance (LSPR) signals from plasmonic nanoparticles (NPs) can be used to mediate the fluorescence signal from semiconductor quantum dot (Qdot) nanocrystals in a molecular beacon (MB) biosensor probe for ZIKV RNA detection. Four different plasmonic NPs functionalized with 3-mercaptopropionic acid (MPA), namely MPA-AgNPs, MPA-AuNPs, core/shell (CS) Au/AgNPs, and alloyed AuAgNPs, were synthesized and conjugated to L-glutathione-capped CdSeS alloyed Qdots to form the respective LSPR-mediated fluorescence nanohybrid. The concept of the plasmonic NP-Qdot-MB biosensor involves using LSPR from the plasmonic NPs to mediate a fluorescence signal to the Qdots, triggered by the hybridization of the target ZIKV RNA with the DNA loop sequence of the MB. The extent of the fluorescence enhancement based on ZIKV RNA detection was proportional to the LSPR-mediated fluorescence signal. The limits of detection (LODs) of the nanohybrids were as follows: alloyed AuAgNP-Qdot646-MB (1.7 copies/mL)) > CS Au/AgNP-Qdot646-MB (LOD =2.4 copies/mL) > AuNP-Qdot646-MB (LOD =2.9 copies/mL) > AgNP-Qdot646-MB (LOD =7.6 copies/mL). The LSPR-mediated fluorescence signal was stronger for the bimetallic plasmonic NP-Qdots than the single metallic plasmonic NP-Qdots. The plasmonic NP-Qdot-MB biosensor probes exhibited excellent selectivity toward ZIKV RNA and could serve as potential diagnostic probes for the point-of care detection of the virus.
C1 [Adegoke, Oluwasesan; Kato, Tatsuya; Park, Enoch Y.] Shizuoka Univ, Res Inst Green Sci & Technol, Biotechnol Lab, Suruga Ku, 836 Ohya, Shizuoka 4228529, Japan.
   [Morita, Masahiro; Kato, Tatsuya; Park, Enoch Y.] Shizuoka Univ, Dept Appl Biol Chem, Suruga Ku, 836 Ohya, Shizuoka 4228529, Japan.
   [Ito, Masahito; Suzuki, Tetsuro] Hamamatsu Univ Sch Med, Dept Virol & Parasitol, 1-20-1 Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan.
   [Kato, Tatsuya; Park, Enoch Y.] Shizuoka Univ, Grad Sch Sci & Technol, Biotechnol Lab, Suruga Ku, 836 Ohya, Shizuoka 4228529, Japan.
RP Park, EY (corresponding author), Shizuoka Univ, Grad Sch Sci & Technol, Biotechnol Lab, Suruga Ku, 836 Ohya, Shizuoka 4228529, Japan.
EM adegoke.sesan@mailbox.co.za; nnndrum@yahoo.co.jp;
   kato.tatsuya@shizuoka.ac.jp; mito557@hama-med.ac.jp;
   tesuzuki@hama-med.ac.jp; park.enoch@shizuoka.ac.jp
RI Kato, Tatsuya/E-3095-2010
OI Kato, Tatsuya/0000-0001-7990-2557; Adegoke,
   Oluwasesan/0000-0002-8087-460X
FU Japan Society for the Promotion of Science (JSPS)Ministry of Education,
   Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for
   the Promotion of Science [26-04354]
FX We thank Professor Kouichi Morita of Institute of tropical medicine
   Nagasaki University for providing ZIKV strain PRVABC-59. OA thanks the
   Japan Society for the Promotion of Science (JSPS) for a post-doctoral
   fellowship (No. 26-04354). This work was supported by the Grant-in-Aid
   for JSPS fellows (No. 26-04354).
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   Adegoke O, 2016, NANOSCALE RES LETT, V11, DOI 10.1186/s11671-016-1748-3
   Adegoke O, 2016, J MATER CHEM B, V4, P1489, DOI 10.1039/c5tb02449h
   Adegoke O, 2015, OPT MATER, V46, P548, DOI 10.1016/j.optmat.2015.05.024
   Anker JN, 2008, NAT MATER, V7, P442, DOI 10.1038/nmat2162
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   BARZON L, 2016, EUROSURVEILLANCE, V21, P2
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chen HM, 2006, CHEM PHYS LETT, V421, P118, DOI 10.1016/j.cplett.2006.01.043
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Fagbami A. H., 1979, J HYG LAND, P83
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Gebre Y, 2016, ASIAN PAC J TROP BIO, V6, P815, DOI 10.1016/j.apjtb.2016.08.008
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hall WP, 2011, J PHYS CHEM C, V115, P1410, DOI 10.1021/jp106912p
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Hutter E, 2003, J PHYS CHEM B, V107, P6497, DOI 10.1021/jp0342834
   Kaszuba M, 2010, PHILOS T R SOC A, V368, P4439, DOI 10.1098/rsta.2010.0175
   Khan MAM, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-434
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.16.171082
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Law WC, 2011, ACS NANO, V5, P4858, DOI 10.1021/nn2009485
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li T, 2010, ANAL BIOANAL CHEM, V398, P689, DOI 10.1007/s00216-010-3915-1
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pan DC, 2007, J PHYS CHEM C, V111, P5661, DOI 10.1021/jp0678047
   Pardee K, 2014, CELL, V159, P940, DOI 10.1016/j.cell.2014.10.004
   Patel VR, 2011, J ADV PHARM TECHNOL, V2, P81, DOI 10.4103/2231-4040.82950
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rademeyer P, 2015, LAB CHIP, V15, P417, DOI 10.1039/c4lc01206b
   Sharma B, 2015, J ALLOY COMPD, V649, P11, DOI 10.1016/j.jallcom.2015.06.160
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   SLOT JW, 1988, METHOD MICROBIOL, V20, P211, DOI 10.1016/S0580-9517(08)70053-9
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   World Health Organization, DIR GEN SUMM OUTC EM
   World Health Organization, 2016, EM HIST ZIK VIR
NR 41
TC 24
Z9 24
U1 11
U2 257
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
EI 1873-4235
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD AUG 15
PY 2017
VL 94
BP 513
EP 522
DI 10.1016/j.bios.2017.03.046
PG 10
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA EU7FS
UT WOS:000401201300068
PM 28343104
DA 2020-07-08
ER

PT J
AU Ramalho, FS
   Yamamoto, AY
   da Silva, LL
   Figueiredo, LTM
   Rocha, LB
   Neder, L
   Teixeira, SR
   Apolinario, LA
   Ramalho, LNZ
   Silva, DM
   Coutinho, CM
   Melli, PP
   Augusto, MJ
   Santoro, LB
   Duarte, G
   Mussi-Pinhata, MM
AF Ramalho, Fernando S.
   Yamamoto, Aparecida Y.
   da Silva, Luis L.
   Figueiredo, Luiz T. M.
   Rocha, Lenaldo B.
   Neder, Luciano
   Teixeira, Sara R.
   Apolinario, Leticia A.
   Ramalho, Leandra N. Z.
   Silva, Deisy M.
   Coutinho, Conrado M.
   Melli, Patricia P.
   Augusto, Marlei J.
   Santoro, Ligia B.
   Duarte, Geraldo
   Mussi-Pinhata, Marisa M.
TI Congenital Zika Virus Infection Induces Severe Spinal Cord Injury
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; flavivirus; spinal cord injury; cortical atrophy; cerebellar
   aplasia
ID BRAIN
AB We report 2 fatal cases of congenital Zika virus (ZIKV) infection. Brain anomalies, including atrophy of the cerebral cortex and brainstem, and cerebellar aplasia were observed. The spinal cord showed architectural distortion, severe neuronal loss, and microcalcifications. The ZIKV proteins and flavivirus-like particles were detected in cytoplasm of spinal neurons, and spinal cord samples were positive for ZIKV RNA.
C1 [Ramalho, Fernando S.; Neder, Luciano; Apolinario, Leticia A.; Ramalho, Leandra N. Z.; Silva, Deisy M.; Augusto, Marlei J.; Santoro, Ligia B.] Univ Fed Triangulo Mineiro, Dept Pathol, Uberaba, Brazil.
   [Yamamoto, Aparecida Y.; Mussi-Pinhata, Marisa M.] Univ Fed Triangulo Mineiro, Dept Pediat, Uberaba, Brazil.
   [da Silva, Luis L.] Univ Fed Triangulo Mineiro, Dept Cell & Mol Biol, Uberaba, Brazil.
   [Figueiredo, Luiz T. M.; Teixeira, Sara R.] Univ Fed Triangulo Mineiro, Dept Med, Uberaba, Brazil.
   [Rocha, Lenaldo B.] Univ Fed Triangulo Mineiro, Inst Biol & Nat Sci, Uberaba, Brazil.
   [Coutinho, Conrado M.; Melli, Patricia P.; Duarte, Geraldo] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Gynecol & Obstet, Ribeirao Preto, Brazil.
RP Ramalho, FS (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pathol, BR-14049900 Ribeirao Preto, SP, Brazil.
EM framalho@fmrp.usp.br
RI Ramalho, Leandra/A-3983-2010; Rocha, Lenaldo B/D-2382-2011;
   Mussi-Pinhata, Marisa/G-6568-2012; daSilva, Luis LP/A-9949-2010; Duarte,
   Geraldo/J-7906-2012; Coutinho, Conrado Milani/I-2991-2019; daSilva, Luis
   L P/AAD-5657-2019; Ramalho, Fernando Silva/G-3817-2012; Reis Teixeira,
   Sara/N-7236-2016
OI Ramalho, Leandra/0000-0002-3486-5294; Rocha, Lenaldo
   B/0000-0002-4345-6994; Mussi-Pinhata, Marisa/0000-0001-8985-1570;
   daSilva, Luis LP/0000-0003-3558-0087; Coutinho, Conrado
   Milani/0000-0003-1966-0466; daSilva, Luis L P/0000-0003-3558-0087;
   Ramalho, Fernando Silva/0000-0002-7529-466X; Reis Teixeira,
   Sara/0000-0001-5845-058X
FU Fundacao de Apoio ao Ensino, Pesquisa e Assistencia of the University
   Hospital of the Ribeirao Preto Medical School
FX This work was supported by Fundacao de Apoio ao Ensino, Pesquisa e
   Assistencia of the University Hospital of the Ribeirao Preto Medical
   School.
CR da Silva LRC, 2016, REV SOC BRAS MED TRO, V49, P267, DOI 10.1590/0037-8682-0150-2016
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Fernandes NCCA, 2017, EXP TOXICOL PATHOL, V69, P63, DOI 10.1016/j.etp.2016.11.004
   HAGEMAN G, 1983, NEUROPEDIATRICS, V14, P6, DOI 10.1055/s-2008-1059546
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
NR 12
TC 6
Z9 6
U1 1
U2 7
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD AUG 15
PY 2017
VL 65
IS 4
BP 687
EP 690
DI 10.1093/cid/cix374
PG 4
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FC2MB
UT WOS:000406670800024
PM 28444144
OA Bronze
DA 2020-07-08
ER

PT J
AU Laroche, M
   Berenger, JM
   Delaunay, P
   Charrel, R
   Pradines, B
   Berger, F
   Ranque, S
   Bitam, I
   Davoust, B
   Raoult, D
   Parola, P
AF Laroche, Maureen
   Berenger, Jean-Michel
   Delaunay, Pascal
   Charrel, Remi
   Pradines, Bruno
   Berger, Franck
   Ranque, Stephane
   Bitam, Idir
   Davoust, Bernard
   Raoult, Didier
   Parola, Philippe
TI Medical Entomology: A Reemerging Field of Research to Better Understand
   Vector-Borne Infectious Diseases
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE ticks; mosquitoes; fleas; lice; bedbugs
ID MALDI-TOF MS; RANDOMIZED CONTROLLED-TRIAL; RICKETTSIA-FELIS INFECTION;
   DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; SALEHABAD VIRUS
   COMPLEX; IXODES-RICINUS TICKS; FRENCH-WEST-INDIES; TOSCANA-VIRUS;
   MALARIA TRANSMISSION
AB In the last decade, the Chikungunya and Zika virus outbreaks have turned public attention to the possibility of the expansion of vector-borne infectious diseases worldwide. Medical entomology is focused on the study of arthropods involved in human health. We review here some of the research approaches taken by the medical entomology team of the University Hospital Institute (UHI) Mediterranee Infection of Marseille, France, with the support of recent or representative studies. We propose our approaches to technical innovations in arthropod identification and the detection of microorganisms in arthropods, the use of arthropods as epidemiological or diagnostic tools, entomological investigations around clinical cases or within specific populations, and how we have developed experimental models to decipher the interactions between arthropods, microorganisms, and humans.
C1 [Laroche, Maureen; Berenger, Jean-Michel; Pradines, Bruno; Ranque, Stephane; Davoust, Bernard; Raoult, Didier; Parola, Philippe] Aix Marseille Univ, CNRS 7278, IRD 198, Dakar, Senegal.
   [Laroche, Maureen; Berenger, Jean-Michel; Pradines, Bruno; Ranque, Stephane; Davoust, Bernard; Raoult, Didier; Parola, Philippe] AP HM, INSERM 1095, IRD 198, URMITE,IHU Mediterranee Infect, Marseille, France.
   [Delaunay, Pascal] Univ Nice Sophia Antipolis, INSERM, Ctr Mediterraneen Med Mol, CHU Nice,Hop Archet,Serv Parasitol Mycol,U1065, Nice, France.
   [Charrel, Remi] EPV Aix Marseille Univ, UMR Emergence Pathol Virales, IRD 190,Inserm 1207,EHESP, AP HM,IHU Mediterranee Infect, Nice, France.
   [Pradines, Bruno] Inst Rech Biomed Armees, Unite Parasitol & Entomol, Marseille, France.
   [Pradines, Bruno] Ctr Natl Reference Paludisme, Marseille, France.
   [Berger, Franck] Ctr Epidemiol & Sante Publ Armees, GSBDD Marseille Aubagne, Marseille, France.
   [Bitam, Idir] Univ Sci & Technol Houari Boumediene, Fac Sci Biol, Lab Biodiversite & Environm Interact Genomes, Bab Ezzouar, Algeria.
RP Parola, P (corresponding author), IHU Mediterranee Infect, URMITE, 19-21 Blvd Jean Moulin, F-13005 Marseille, France.
EM philippe.parola@univ-amu.fr
RI Berenger, Jean-Michel/W-3619-2019; LAROCHE, Maureen/AAB-7662-2020;
   Ranque, Stephane/K-2317-2015
OI LAROCHE, Maureen/0000-0002-5764-2421; Ranque,
   Stephane/0000-0003-3293-5276
FU IHU Mediterranee Infection
FX This article appears as part of the supplement "Emerging Concepts and
   Strategies in Clinical Microbiology and Infectious Diseases," sponsored
   by IHU Mediterranee Infection.
CR Adde A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004681
   Alexander J. O., 2012, ARTHROPODS HUMAN SKI
   Alkan C, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.07.012
   Alkan C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004519
   Alkan C, 2015, J VIROL, V89, P11773, DOI 10.1128/JVI.01543-15
   Alkan C, 2015, J VIROL, V89, P4080, DOI 10.1128/JVI.03027-14
   Alwassouf S, 2016, J GEN VIROL, V97, P2816, DOI 10.1099/jgv.0.000592
   Angelakis E, 2016, TRENDS PARASITOL, V32, P554, DOI 10.1016/j.pt.2016.04.009
   Angelakis E, 2013, AM J TROP MED HYG, V89, P986, DOI 10.4269/ajtmh.13-0182
   Aubry C, 2016, TICKS TICK-BORNE DIS, V7, P475, DOI 10.1016/j.ttbdis.2016.02.003
   Benkouiten S, 2014, JAMA DERMATOL, V150, P273, DOI 10.1001/jamadermatol.2013.6398
   Benredjem W, 2014, EMERG INFECT DIS, V20, P1776, DOI 10.3201/eid2010.140265
   Bernardeschi C, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f138
   Bichaud L, 2016, J GEN VIROL, V97, P602, DOI 10.1099/jgv.0.000389
   Bichaud L, 2013, EMERG INFECT DIS, V19, P322, DOI 10.3201/eid1902.121463
   Boutellis A, 2012, VECTOR-BORNE ZOONOT, V12, P564, DOI 10.1089/vbz.2011.0845
   Brouqui P, 2006, ANN NY ACAD SCI, V1078, P223, DOI 10.1196/annals.1374.041
   BRUNHES J, 2000, MOUSTIQUES AFRIQUE M
   Cannet A, 2016, MEM I OSWALDO CRUZ, V111, P495, DOI 10.1590/0074-02760160100
   Charrel RN, 2007, EMERG INFECT DIS, V13, P465, DOI 10.3201/eid1303.061086
   Charrel Remi N, 2012, World J Virol, V1, P135, DOI 10.5501/wjv.v1.i5.135
   Charrel RN, 2009, VECTOR-BORNE ZOONOT, V9, P519, DOI 10.1089/vbz.2008.0131
   Corbel V, 2012, LANCET INFECT DIS, V12, P617, DOI 10.1016/S1473-3099(12)70081-6
   Cuisance D, 2004, COMP IMMUNOL MICROB, V27, P377, DOI 10.1016/j.cimid.2004.03.007
   de Santi VP, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1088-x
   Del Giudice P, 2008, EMERG INFECT DIS, V14, P1759, DOI 10.3201/eid1411.080288
   Delaunay P, 2012, J TRAVEL MED, V19, P373, DOI 10.1111/j.1708-8305.2012.00653.x
   Delaunay P, 2011, CLIN INFECT DIS, V52, P200, DOI 10.1093/cid/ciq102
   Delaunay P, 2009, EMERG INFECT DIS, V15, P989, DOI 10.3201/eid1506.081480
   Dieme C, 2015, P NATL ACAD SCI USA, V112, P8088, DOI 10.1073/pnas.1413835112
   Doucoure S, 2012, AM J TROP MED HYG, V87, P504, DOI 10.4269/ajtmh.2012.11-0477
   Drali R, 2014, EMERG INFECT DIS, V20, P907, DOI 10.3201/eid2005.131242
   Drali R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058088
   Drali R, 2012, J CLIN MICROBIOL, V50, P2229, DOI 10.1128/JCM.00808-12
   Edouard S, 2013, EMERG INFECT DIS, V19, P337, DOI 10.3201/eid1902.120863
   Es-Sette N, 2014, J VECTOR DIS, V51, P86
   Estrada-Pena A., 2004, TICKS DOMESTIC ANIMA
   Fang Q, 2002, EXP APPL ACAROL, V28, P69, DOI 10.1023/A:1025389914156
   Faran ME, 1981, HDB AMAZONIAN SPECIE
   Fotso AF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002984
   Giribet G, 2012, ANNU REV ENTOMOL, V57, P167, DOI 10.1146/annurev-ento-120710-100659
   Girod R, 2006, J MED ENTOMOL, V43, P1082, DOI 10.1603/0022-2585(2006)43[1082:MTAIRO]2.0.CO;2
   Girod R, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004876
   Kelly PJ, 2006, EMERG INFECT DIS, V12, P224, DOI 10.3201/eid1202.050903
   Kernif T, 2012, TICKS TICK-BORNE DIS, V3, P379, DOI 10.1016/j.ttbdis.2012.10.012
   Kernif T, 2012, INFECT DIS CLIN N AM, V26, P455, DOI 10.1016/j.idc.2012.03.007
   Lafri I, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004351
   Laroche M, 2015, B ACAD VET FRANCE, V168, P245
   Laroche M, 2017, MALARIA J, V16, DOI 10.1186/s12936-016-1657-z
   Lequime S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006111
   Leulmi H, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003789
   Leulmi H, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003152
   Lv JZ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-93
   Machault V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050674
   Machault V, 2011, GEOSPATIAL HEALTH, V5, P151, DOI 10.4081/gh.2011.167
   Mathison BA, 2014, CLIN MICROBIOL REV, V27, P48, DOI 10.1128/CMR.00008-13
   Mediannikov O, 2013, EMERG INFECT DIS, V19, P1775, DOI 10.3201/eid1911.130361
   Mourou JR, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-40
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Ndiath MO, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0898-6
   Niare S, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1152-6
   Norris DE, 2002, INT J PARASITOL, V32, P1607, DOI 10.1016/S0020-7519(02)00189-3
   Pages F, 2010, CLIN MICROBIOL INFEC, V16, P209, DOI 10.1111/j.1469-0691.2009.03132.x
   Parola P, 1998, NEW ENGL J MED, V338, P1391, DOI 10.1056/NEJM199805073381918
   Parola P, 2005, CLIN MICROBIOL REV, V18, P719, DOI 10.1128/CMR.18.4.719-756.2005
   Parola P, 2003, ANN TROP MED PARASIT, V97, P535, DOI 10.1179/000349803225001382
   Parola P, 1999, AM J TROP MED HYG, V60, P888, DOI 10.4269/ajtmh.1999.60.888
   Parola P, 2006, EMERG INFECT DIS, V12, P1493, DOI 10.3201/eid1210.060610
   Parola P, 2016, LANCET INFECT DIS, V16, P1112, DOI 10.1016/S1473-3099(16)30331-0
   Parola P, 2013, CLIN MICROBIOL REV, V26, P657, DOI 10.1128/CMR.00032-13
   Parola P, 2009, ANN NY ACAD SCI, V1166, P49, DOI 10.1111/j.1749-6632.2009.04518.x
   Regier Y, 2016, PARASITE VECTOR, V9, P1
   Sakhria Sonia, 2014, Parasit Vectors, V7, P476, DOI 10.1186/s13071-014-0476-8
   Sakhria S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002429
   Salazar R, 2015, AM J TROP MED HYG, V92, P331, DOI 10.4269/ajtmh.14-0483
   Sambou M, 2015, J CLIN MICROBIOL, V53, P410, DOI 10.1128/JCM.01855-14
   Sarr JB, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-212
   Seng P, 2010, FUTURE MICROBIOL, V5, P1733, DOI [10.2217/fmb.10.127, 10.2217/FMB.10.127]
   Simon F, 2008, MED CLIN N AM, V92, P1323, DOI 10.1016/j.mcna.2008.07.008
   Smith JL, 2004, AM J TROP MED HYG, V70, P339, DOI 10.4269/ajtmh.2004.70.339
   Socolovschi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048254
   Trape JF, 2011, LANCET INFECT DIS, V11, P925, DOI 10.1016/S1473-3099(11)70194-3
   Veracx A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045903
   Vezenegho SB, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-384
   Yssouf A, 2016, FUTURE MICROBIOL, V11, P549, DOI 10.2217/fmb.16.5
   Yssouf A, 2015, TICKS TICK-BORNE DIS, V6, P579, DOI 10.1016/j.ttbdis.2015.04.013
   Yssouf A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003473
   Yssouf A, 2014, COMP IMMUNOL MICROB, V37, P153, DOI 10.1016/j.cimid.2014.05.002
   Yssouf A, 2014, PARASITOL RES, V113, P2375, DOI 10.1007/s00436-014-3876-y
   Yssouf A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072380
   Yssouf A, 2013, J CLIN MICROBIOL, V51, P522, DOI 10.1128/JCM.02665-12
   Zhioua E, 2010, J GEN VIROL, V91, P1275, DOI 10.1099/vir.0.019240-0
NR 92
TC 4
Z9 6
U1 0
U2 25
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD AUG 15
PY 2017
VL 65
SU 1
BP S30
EP S38
DI 10.1093/cid/cix463
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FC2MH
UT WOS:000406671400005
PM 28859353
OA Bronze
DA 2020-07-08
ER

PT J
AU Best, K
   Guedj, J
   Madelain, V
   de Lamballerie, X
   Lim, SY
   Osuna, CE
   Whitney, JB
   Perelson, AS
AF Best, Katharine
   Guedj, Jeremie
   Madelain, Vincent
   de Lamballerie, Xavier
   Lim, So-Yon
   Osuna, Christa E.
   Whitney, James B.
   Perelson, Alan S.
TI Zika plasma viral dynamics in nonhuman primates provides insights into
   early infection and antiviral strategies
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE Zika virus; mathematical modeling; viral dynamics; antiviral therapy
ID A VIRUS-INFECTION; MODEL SELECTION; CELL TROPISM; RHESUS; TRANSMISSION;
   KINETICS; EFFICACY; TRAVELERS; EPIDEMIC; OUTBREAK
AB The recent outbreak of Zika virus (ZIKV) has been associated with fetal abnormalities and neurological complications, prompting global concern. Here we present a mathematical analysis of the within-host dynamics of plasma ZIKV burden in a nonhuman primate model, allowing for characterization of the growth and clearance of ZIKV within individual macaques. We estimate that the eclipse phase for ZIKV, the time between cell infection and viral production, is most likely short (similar to 4 h), the median within-host basic reproductive number R-0 is 10.7, the rate of viral production is rapid (> 25,000 virions d-1), and the lifetime of an infected cell while producing virus is similar to 5 h. We also estimate that the minimum number of virions produced by an infected cell over its lifetime is similar to 5,500. We assess the potential effect of an antiviral treatment that blocks viral replication, showing that the median time to undetectable plasma viral load (VL) can be reduced from similar to 5 d to similar to 3 d with a drug concentration similar to 15 times the drug's EC50 when treatment is given prophylactically starting at the time of infection. In the case of favipiravir, a polymerase inhibitor with activity against ZIKV, we predict a dose of 150 mg/kg given twice a day initiated at the time of infection can reduce the peak median VL by similar to 3 logs and shorten the time to undetectable median VL by similar to 2 d, whereas treatment given 2 d postinfection is mostly ineffective in accelerating plasma VL loss in macaques.
C1 [Best, Katharine; Perelson, Alan S.] Los Alamos Natl Lab, Theoret Biol & Biophys, Los Alamos, NM 87545 USA.
   [Guedj, Jeremie; Madelain, Vincent] Univ Paris Diderot, Sorbonne Paris Cite, INSERM, UMR 1137,Infect,Antimicrobials,Modelling,Evolut, F-75018 Paris, France.
   [de Lamballerie, Xavier] Aix Marseille Univ, Inst Rech Dev 190, Ecole Hautes Etud Sante Publ, INSERM 1207,UMR Emergence Pathol Virales, F-13385 Marseille, France.
   [de Lamballerie, Xavier] Inst Hosp Univ Mediterranee Infect, UMR Emergence Pathol Virales, F-13385 Marseille, France.
   [Lim, So-Yon; Osuna, Christa E.; Whitney, James B.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.
   [Whitney, James B.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.
RP Perelson, AS (corresponding author), Los Alamos Natl Lab, Theoret Biol & Biophys, Los Alamos, NM 87545 USA.
EM asp@lanl.gov
RI Perelson, Alan S/Z-1959-2019; Guedj, Jeremie/A-6842-2017
OI Perelson, Alan S/0000-0002-2455-0002; Guedj,
   Jeremie/0000-0002-5534-5482; Osuna, Christa/0000-0003-2761-2456
FU US Department of EnergyUnited States Department of Energy (DOE)
   [DE-AC52-06NA25396]; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01-AI078881,
   R01-OD0110955, R01-AI028433]; European UnionEuropean Union (EU) [666092,
   734548]
FX We thank France Mentre for advice on the model averaging approach.
   Portions of this work were done under the auspices of the US Department
   of Energy under Contract DE-AC52-06NA25396. This work was also supported
   by NIH Grants R01-AI078881, R01-OD0110955, and R01-AI028433 (to A.S.P.)
   and the European Union's Horizon 2020 research and innovation program
   under Grants 666092 (to J.G.) and 734548 (to X.d.L.).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Ajuebor MN, 1998, J LEUKOCYTE BIOL, V63, P108
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Ascher D, 1999, NUMERICAL PYTHON
   Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05
   Banerjee S, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0130
   Barr KL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004931
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Ben-Shachar R, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.0886
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Buckland ST, 1997, BIOMETRICS, V53, P603, DOI 10.2307/2533961
   Burnham K. P., 2002, MODEL SELECTION MULT
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Canini L, 2014, J PHARMACOKINET PHAR, V41, P431, DOI 10.1007/s10928-014-9363-3
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Clapham HE, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004951
   Clapham HE, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0094
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Guedj J, 2014, HEPATOLOGY, V59, P1706, DOI 10.1002/hep.26989
   Hadjichrysanthou C, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0289
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Lim S-Y, 2016, BCX4430 BROAD SPECTR
   Louie M, 2003, J INFECT DIS, V187, P896, DOI 10.1086/368164
   Madelain V, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01305-16, 10.1128/aac.01305-16]
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Mullen KM, 2011, J STAT SOFTW, V40, P1
   Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Perelson AS, 2015, NAT REV GASTRO HEPAT, V12, P437, DOI 10.1038/nrgastro.2015.97
   Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700
   Pinheiro J. C., 2000, MIXED EFFECTS MODELS
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Ribeiro RM, 2010, J VIROL, V84, P6096, DOI 10.1128/JVI.00127-10
   Rosenbloom DIS, 2012, NAT MED, V18, P1378, DOI 10.1038/nm.2892
   Samson A, 2006, COMPUT STAT DATA AN, V51, P1562, DOI 10.1016/j.csda.2006.05.007
   Sleeman K, 2010, ANTIMICROB AGENTS CH, V54, P2517, DOI 10.1128/AAC.01739-09
   Smith AM, 2011, WIRES SYST BIOL MED, V3, P429, DOI 10.1002/wsbm.129
   Smith AM, 2010, J MATH BIOL, V60, P711, DOI 10.1007/s00285-009-0281-8
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Stafford MA, 2000, J THEOR BIOL, V203, P285, DOI 10.1006/jtbi.2000.1076
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
NR 66
TC 29
Z9 29
U1 0
U2 11
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 15
PY 2017
VL 114
IS 33
BP 8847
EP 8852
DI 10.1073/pnas.1704011114
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FD6AG
UT WOS:000407610400073
PM 28765371
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Hall, NB
   Broussard, K
   Evert, N
   Canfield, M
AF Hall, Noemi Borsay
   Broussard, Kelly
   Evert, Nicole
   Canfield, Mark
TI Zika Virus-Associated Neonatal Birth Defects Surveillance - Texas,
   January 2016-July 2017
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID STATES
C1 [Hall, Noemi Borsay] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
   [Hall, Noemi Borsay; Broussard, Kelly; Evert, Nicole; Canfield, Mark] Texas Dept State Hlth Serv, Austin, TX 78714 USA.
RP Hall, NB (corresponding author), CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.; Hall, NB (corresponding author), Texas Dept State Hlth Serv, Austin, TX 78714 USA.
EM lyo3@cdc.gov
CR Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reagan-Steiner S, 2017, MMWR-MORBID MORTAL W, V66, P636, DOI 10.15585/mmwr.mm6624a3
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
NR 3
TC 10
Z9 10
U1 0
U2 4
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD AUG 11
PY 2017
VL 66
IS 31
BP 835
EP 836
DI 10.15585/mmwr.mm6631a5
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FD2ST
UT WOS:000407385800005
PM 28796762
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Huang, YJS
   Lyons, AC
   Hsu, WW
   Park, SL
   Higgs, S
   Vanlandingham, DL
AF Huang, Yan-Jang S.
   Lyons, Amy C.
   Hsu, Wei-Wen
   Park, So Lee
   Higgs, Stephen
   Vanlandingham, Dana L.
TI Differential outcomes of Zika virus infection in Aedes aegypti orally
   challenged with infectious blood meals and infectious protein meals
SO PLOS ONE
LA English
DT Article
ID JUVENILE-HORMONE; YELLOW-FEVER; MOSQUITO; TRANSMISSION; DIPTERA
AB Background
   Infection of mosquitoes is an essential step for the transmission of mosquito-borne arboviruses in nature. Engorgement of infectious blood meals from viremic infected vertebrate hosts allows the entry of viruses and initiates infection of midgut epithelial cells. Historically, the infection process of arboviruses in mosquitoes has been studied through the engorgement of mosquitoes from viremic laboratory animals or from artificial feeders containing blood mixed with viruses harvested from cell cultures. The latter approach using so-called artificial blood meals is more frequently used since it is readily optimized to maximize viral titer, negates the use of animals and can be used with viruses for which there are no small animal models. Use of artificial blood meals has enabled numerous studies on mosquito infections with a wide variety of viruses; however, as described here, with suitable modification it can also be used to study the interplay between infection, specific blood components, and physiological consequences associated with blood engorgement. For hematophagous female mosquitoes, blood is the primary nutritional source supporting all physiological process including egg development, and also influences neurological processes and behaviors such as host-seeking. Interactions between these blood-driven vector biological processes and arbovirus infection that is mediated via blood engorgement have not yet been specifically studied. This is in part because presentation of virus in whole blood inevitably induces enzymatic digestion processes, hormone driven oogenesis, and other biological changes. In this study, the infection process of Zika virus (ZIKV) in Aedes aegypti was characterized by oral exposure via viral suspension meals within minimally bovine serum albumin complemented medium or within whole blood. The use of bovine serum albumin in infectious meals provides an opportunity to evaluate the role of serum albumin during the process of flavivirus infection in mosquitoes.
   Methods
   Infectious whole blood meals and infectious bovine serum albumin meals containing ZIKV were orally presented to two different groups of Ae. aegypti through membrane feeding. At 7 and 14 days post infection, infectious viruses were detected and viral dissemination from gut to other mosquito tissues was analyzed in orally challenged mosquitoes with 50% tissue culture infectious dose method on Vero76 cells.
   Results/Conclusions
   Zika virus infection was significantly impaired among mosquitoes orally challenged with infectious protein meals as compared to infectious whole blood meals. These results indicate the importance of the blood meal in the infection process of arboviruses in mosquitoes. It provides the basis for future studies to identify critical components in the blood of vertebrate hosts that facilitate arbovirus infection in mosquitoes.
C1 [Huang, Yan-Jang S.; Lyons, Amy C.; Park, So Lee; Higgs, Stephen; Vanlandingham, Dana L.] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA.
   [Huang, Yan-Jang S.; Lyons, Amy C.; Park, So Lee; Higgs, Stephen; Vanlandingham, Dana L.] Kansas State Univ, Biosecur Res Inst, Manhattan, KS 66506 USA.
   [Hsu, Wei-Wen] Kansas State Univ, Dept Stat, Coll Arts & Sci, Manhattan, KS 66506 USA.
RP Vanlandingham, DL (corresponding author), Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA.; Vanlandingham, DL (corresponding author), Kansas State Univ, Biosecur Res Inst, Manhattan, KS 66506 USA.
EM dlvanlan@vet.k-state.edu
CR BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   BOROVSKY D, 1992, J MED ENTOMOL, V29, P619, DOI 10.1093/jmedent/29.4.619
   Bottino-Rojas V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135985
   Cosgrove JB, 1996, MED VET ENTOMOL, V10, P260, DOI 10.1111/j.1365-2915.1996.tb00740.x
   Davis NC, 1933, J EXP MED, V58, P211, DOI 10.1084/jem.58.2.211
   Dong SZ, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3775-6
   Feitosa FM, 2006, J INSECT SCI, V6
   FELIX CR, 1991, INSECT BIOCHEM, V21, P197, DOI 10.1016/0020-1790(91)90050-O
   Gonzales KK, 2015, PEERJ, V3, DOI 10.7717/peerj.938
   Grimaldi David, 2005, pi
   Hernandez-Martinez S, 2015, J INSECT PHYSIOL, V72, P22, DOI 10.1016/j.jinsphys.2014.11.003
   Higgs S, 2005, P NATL ACAD SCI USA, V102, P8871, DOI 10.1073/pnas.0503835102
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Huang YJS, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-60
   Hussain M, 2013, INSECT BIOCHEM MOLEC, V43, P146, DOI 10.1016/j.ibmb.2012.11.005
   KOGAN PH, 1990, J MED ENTOMOL, V27, P709, DOI 10.1093/jmedent/27.4.709
   Lequime S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005548
   Majorek KA, 2012, MOL IMMUNOL, V52, P174, DOI 10.1016/j.molimm.2012.05.011
   Merrill MH, 1935, J EXP MED, V62, P687, DOI 10.1084/jem.62.5.687
   Nuckols JT, 2015, J MED ENTOMOL, V52, P447, DOI 10.1093/jme/tjv017
   Pitts RJ, 2014, J INSECT PHYSIOL, V64, P1, DOI 10.1016/j.jinsphys.2014.02.012
   SHAPIRO AB, 1986, J INSECT PHYSIOL, V32, P867, DOI 10.1016/0022-1910(86)90102-2
   WATTS DM, 1973, SCIENCE, V182, P1140, DOI 10.1126/science.182.4117.1140
   Whitman L, 1937, J EXP MED, V66, P133, DOI 10.1084/jem.66.2.133
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P1109, DOI 10.1016/S1473-3099(17)30494-2
NR 25
TC 3
Z9 3
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 10
PY 2017
VL 12
IS 8
AR e0182386
DI 10.1371/journal.pone.0182386
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FD2WT
UT WOS:000407396200050
PM 28796799
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wang, LP
   Zhao, HY
   Oliva, SM
   Zhu, HP
AF Wang, Liping
   Zhao, Hongyong
   Oliva, Sergio Muniz
   Zhu, Huaiping
TI Modeling the transmission and control of Zika in Brazil
SO SCIENTIFIC REPORTS
LA English
DT Article
ID AEDES-AEGYPTI; CYTOPLASMIC INCOMPATIBILITY; VIRUS OUTBREAK; DENGUE
   VIRUS; WOLBACHIA; VECTOR; ESTABLISHMENT; MOSQUITOS; INVASION
AB Zika virus, a reemerging mosquito-borne flavivirus, started spread across Central and Southern America and more recently to North America. The most serious impacted country is Brazil. Based on the transmission mechanism of the virus and assessment of the limited data on the reported suspected cases, we establish a dynamical model which allows us to estimate the basic reproduction number R-0 = 2.5020. The wild spreading of the virus make it a great challenge to public health to control and prevention of the virus. We formulate two control models to study the impact of releasing transgenosis mosquitoes (introducing bacterium Wolbachia into Aedes aegypti) on the transmission of Zika virus in Brazil. Our models and analysis suggest that simultaneously releasing Wolbachia-harboring female and male mosquitoes will achieve the target of population replacement, while releasing only Wolbachia-harboring male mosquitoes will suppress or even eradicate wild mosquitoes eventually. We conclude that only releasing male Wolbachia mosquitoes is a better strategy for control the spreading of Zika virus in Brazil.
C1 [Wang, Liping; Zhao, Hongyong] Nanjing Univ Aeronaut & Astronaut, Dept Math, Nanjing 210016, Jiangsu, Peoples R China.
   [Oliva, Sergio Muniz] Univ Sao Paulo, Inst Matemat & Estat, Dept Matemat Aplicada, Rua Matao 1010,Cidade Univ, BR-05508090 Sao Paulo, SP, Brazil.
   [Zhu, Huaiping] York Univ, Lamps, Toronto, ON M3J IP3, Canada.
   [Zhu, Huaiping] York Univ, Dept Math & Stat, Toronto, ON M3J IP3, Canada.
RP Zhao, HY (corresponding author), Nanjing Univ Aeronaut & Astronaut, Dept Math, Nanjing 210016, Jiangsu, Peoples R China.
EM hyzhao1967@126.com
RI Oliva, Sergio M/E-8480-2012
OI Oliva, Sergio M/0000-0002-5284-0613; Zhu, Huaiping/0000-0003-2718-595X
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [11571170, 61174155]; Funding of Jiangsu Innovation
   Program for Graduate Education [KYZZ16_0162]; CIHRCanadian Institutes of
   Health Research (CIHR); NSERC of CanadaNatural Sciences and Engineering
   Research Council of Canada
FX We are very grateful to anonymous referees and editor for careful
   reading and helpful suggestions which led to an improvement of our
   original manuscript. The work is partially supported by National Natural
   Science Foundation of China under Grant 11571170 and Grant 61174155,
   Funding of Jiangsu Innovation Program for Graduate Education KYZZ16_0162
   and CIHR and NSERC of Canada.
CR Aliota M. T., 2016, PLOS NEGLECTED TROPI, V6
   Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brazil Ministry of Health, ZIK CAS BRAZ MIN HLT
   Briggs G., 2010, PLOS PATHOG, V6
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   CASPARI E, 1959, EVOLUTION, V13, P568, DOI 10.2307/2406138
   Chikaki E, 2009, J INFECT DEV COUNTR, V3, P711, DOI 10.3855/jidc.616
   Chowell G, 2007, MATH BIOSCI, V208, P571, DOI 10.1016/j.mbs.2006.11.011
   Medeiros LCD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000942
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eshita Y., 2007, PESTICIDE CHEM, P217, DOI DOI 10.1002/9783527611249.CH23
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Funk S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005173
   Gao D., 2016, SCI REPORTS, V6
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hancock W. T., 2014, EMERG INFECT DIS, V20, P1085
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Keeling MJ, 2003, HEREDITY, V91, P382, DOI 10.1038/sj.hdy.6800343
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   LAVEN H, 1951, EVOLUTION, V5, P370, DOI 10.1111/j.1558-5646.1951.tb02795.x
   Majumder M. S., 2016, JMIR PUBLIC HLTH SUR, V2
   Manore CA, 2014, J THEOR BIOL, V356, P174, DOI 10.1016/j.jtbi.2014.04.033
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1180
   Mehta N., BRAZIL RELEASES WOLB
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Ndii MZ, 2012, ANZIAM J, V53, P213, DOI 10.1017/S1446181112000132
   Nishiura H, 2016, EPIDEMICS-NETH, V15, P66, DOI 10.1016/j.epidem.2016.03.001
   O'Connor L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001797
   ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699
   Pandey A, 2013, MATH BIOSCI, V246, P252, DOI 10.1016/j.mbs.2013.10.007
   Qi RF, 2008, ACTA BIOCH BIOPH SIN, V40, P91, DOI 10.1111/j.1745-7270.2008.00382.x
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shi BY, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0719-y
   Sinkins SP, 2004, INSECT BIOCHEM MOLEC, V34, P723, DOI 10.1016/j.ibmb.2004.03.025
   Turley A. P., 2009, PLOS NEGLECT TROP D, V3, P935
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Wilder-Smith A, 2004, TROP MED INT HEALTH, V9, P305, DOI 10.1046/j.1365-3156.2003.01177.x
   World Health Organization, CAS DEF ZIK VIR
   World Health Organization, ZIK CAS WHO
   World Health Organization, 2016, WHO STAT 1 M INT HLT
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040
   Yeap HL, 2011, GENETICS, V187, P583, DOI 10.1534/genetics.110.122390
   Yebakima A, 2004, TROP MED INT HEALTH, V9, P582, DOI 10.1111/j.1365-3156.2004.01241.x
   YEN JH, 1971, NATURE, V232, P657, DOI 10.1038/232657a0
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang XH, 2015, NONLINEAR ANAL-REAL, V22, P236, DOI 10.1016/j.nonrwa.2014.09.004
NR 57
TC 14
Z9 14
U1 1
U2 27
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 10
PY 2017
VL 7
AR 7721
DI 10.1038/s41598-017-07264-y
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FD2YG
UT WOS:000407400100008
PM 28798323
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Yang, M
   Lai, HF
   Sun, HY
   Chen, Q
AF Yang, Ming
   Lai, Huafang
   Sun, Haiyan
   Chen, Qiang
TI Virus- like particles that display Zika virus envelope protein domain
   III induce potent neutralizing immune responses in mice
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ANTIBODY-DEPENDENT ENHANCEMENT; HEPADNAVIRUS CORE PROTEINS;
   HEPATITIS-B-VIRUS; DENGUE VIRUS; MONOCLONAL-ANTIBODIES; STRUCTURAL
   BASIS; INFECTION; IMMUNIZATION; EXPRESSION; EPITOPES
AB Several Zika virus (ZIKV) vaccine candidates have recently been described which use inactivated whole virus, DNA or RNA that express the virus' Envelope (E) glycoprotein as the antigen. These were successful in stimulating production of virus-targeted antibodies that protected animals against ZIKV challenges, but their use potentially will predispose vaccinated individuals to infection by the related Dengue virus (DENV). We have devised a virus like particle (VLP) carrier based on the hepatitis B core antigen (HBcAg) that displays the ZIKV E protein domain III (zDIII), and shown that it can be produced quickly and easily purified in large quantities from Nicotiana benthamiana plants. HBcAg-zDIII VLPs are shown to be highly immunogenic, as two doses elicited potent humoral and cellular responses in mice that exceed the threshold correlated with protective immunity against multiple strains of Zika virus. Notably, HBcAg-zDIII VLPs-elicited antibodies did not enhance the infection of DENV in Fc gamma receptor-expressing cells, offsetting the concern of ZIKV vaccines inducing cross-reactive antibodies and sensitizing people to subsequent DENV infection. Thus, our zDIII-based vaccine offers improved safety and lower cost production than other current alternatives, with equivalent effectiveness.
C1 [Yang, Ming; Lai, Huafang; Sun, Haiyan; Chen, Qiang] Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA.
   [Chen, Qiang] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.
RP Chen, Q (corresponding author), Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA.; Chen, Q (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.
EM qiang.chen.4@asu.edu
RI Yang, Ming/J-9215-2019
OI chen, qiang/0000-0003-1498-7013
FU National Institute of Allergy and Infectious Diseases (NIAID)United
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID); Biodesign Seed Fund
FX The authors thank Dr. M. Diamond of Washington University Medical School
   for the gift of anti-ZIKV mAbs and J. Kilbourne for her technical
   assistance in animal studies. We also thank J. Caspermeyer for the
   critical reading of the manuscript. This work was supported in part by a
   grant from National Institute of Allergy and Infectious Diseases (NIAID)
   # 4 to QC and a Biodesign Seed Fund.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Attar N., 2016, NAT REV MICROBIOL, V14, P62, DOI DOI 10.1038/NRMICR0.2015.28
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Belmusto-Worn VE, 2005, AM J TROP MED HYG, V72, P189, DOI 10.4269/ajtmh.2005.72.189
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Billaud JN, 2007, VACCINE, V25, P1593, DOI 10.1016/j.vaccine.2006.11.013
   BROWN AL, 1991, VACCINE, V9, P595, DOI 10.1016/0264-410X(91)90248-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen Q, 2013, ADV TECH BIOL MED, V1, DOI [10.4172/atbm.1000103, DOI 10.4172/ATBM.1000103]
   Chen Q., 2013, MOL VACCINES, P153, DOI DOI 10.1007/978-3-7091-1419-3_8
   Chen Q, 2016, F1000RESEARCH, V5
   Chen Q, 2013, HUM VACC IMMUNOTHER, V9, P26, DOI 10.4161/hv.22218
   Chen Q, 2011, HUM VACCINES, V7, P331, DOI 10.4161/hv.7.3.14262
   Chu XJ, 2016, INT J NANOMED, V11, P2417, DOI 10.2147/IJN.S102467
   Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002
   Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2016, NAT IMMUNOL
   Dent M, 2016, J GEN VIROL, V97, P3280, DOI 10.1099/jgv.0.000635
   Fulton A, 2015, J CHROMATOGR A, V1389, P128, DOI 10.1016/j.chroma.2015.02.013
   Giritch A, 2006, P NATL ACAD SCI USA, V103, P14701, DOI 10.1073/pnas.0606631103
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   He JY, 2014, BIOMED RES INT, DOI 10.1155/2014/952865
   He JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093541
   He JY, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/106783
   Heinz FX, 2007, VACCINE, V25, P7559, DOI 10.1016/j.vaccine.2007.08.024
   Huang Z, 2009, BIOTECHNOL BIOENG, V103, P706, DOI 10.1002/bit.22299
   Lai HF, 2012, PLANT CELL REP, V31, P573, DOI 10.1007/s00299-011-1196-6
   Lai HF, 2012, PLANT BIOTECHNOL J, V10, P95, DOI 10.1111/j.1467-7652.2011.00649.x
   Lai HF, 2010, P NATL ACAD SCI USA, V107, P2419, DOI 10.1073/pnas.0914503107
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Leuzinger K, 2013, JOVE-J VIS EXP, DOI 10.3791/50521
   Lin HE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001447
   MORENS DM, 1994, CLIN INFECT DIS, V19, P500, DOI 10.1093/clinids/19.3.500
   Nandi S, 2016, MABS-AUSTIN, V8, P1456, DOI 10.1080/19420862.2016.1227901
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Pardi N, 2017, METHODS MOL BIOL, V1499, P109, DOI 10.1007/978-1-4939-6481-9_6
   Phoolcharoen W, 2011, P NATL ACAD SCI USA, V108, P20695, DOI 10.1073/pnas.1117715108
   Ruedl C, 2005, J VIROL, V79, P717, DOI 10.1128/JVI.79.2.717-724.2005
   Saito Y, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1873-8
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Santi L, 2008, VACCINE, V26, P1846, DOI 10.1016/j.vaccine.2008.01.053
   SCHODEL F, 1994, J EXP MED, V180, P1037, DOI 10.1084/jem.180.3.1037
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sukupolvi-Petty S, 2010, J VIROL, V84, P9227, DOI 10.1128/JVI.01087-10
   Suthar MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003541
   Tuse D, 2014, BIOMED RES INT, DOI 10.1155/2014/256135
   Ulrich R, 1998, ADV VIRUS RES, V50, P141, DOI 10.1016/S0065-3527(08)60808-8
   Whitacre DC, 2009, EXPERT REV VACCINES, V8, P1565, DOI 10.1586/ERV.09.121
   Yang M, 2017, VACCINE, V35, P4287, DOI 10.1016/j.vaccine.2017.04.052
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 53
TC 40
Z9 41
U1 1
U2 20
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 9
PY 2017
VL 7
AR 7679
DI 10.1038/s41598-017-08247-9
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FD1JS
UT WOS:000407294200036
PM 28794424
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Crowe, JE
AF Crowe, James E., Jr.
TI Principles of Broad and Potent Antiviral Human Antibodies: Insights for
   Vaccine Design
SO CELL HOST & MICROBE
LA English
DT Review
ID HUMAN MONOCLONAL-ANTIBODIES; RESPIRATORY SYNCYTIAL VIRUS; MEMORY
   B-CELLS; NEUTRALIZING HUMAN-ANTIBODIES; DENGUE VIRUS; STRUCTURAL BASIS;
   CROSS-NEUTRALIZATION; ZIKA VIRUS; COMPUTATIONAL DESIGN; AFFINITY
   MATURATION
AB Antibodies are the principal immune effectors that mediate protection against reinfection following viral infection or vaccination. Robust techniques for human mAb isolation have been developed in the last decade. The study of human mAbs isolated from subjects with prior immunity has become a mainstay for rational structure-based, next-generation vaccine development. The plethora of detailed molecular and genetic studies coupling the structure of antigen-antibody complexes with their antiviral function has begun to reveal common principles of critical interactions on which we can build better vaccines and therapeutic antibodies. This review outlines the approaches to isolating and studying human antiviral mAbs and discusses the common principles underlying the basis for their activity. This review also examines progress toward the goal of achieving a comprehensive understanding of the chemical and physical basis for molecular recognition of viral surface proteins in order to build predictive molecular models that can be used for vaccine design.
C1 [Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, Nashville, TN 37232 USA.
   [Crowe, James E., Jr.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA.
   [Crowe, James E., Jr.] Vanderbilt Univ, Dept Pediat, Sch Med, Nashville, TN 37232 USA.
RP Crowe, JE (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, Nashville, TN 37232 USA.; Crowe, JE (corresponding author), Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA.; Crowe, JE (corresponding author), Vanderbilt Univ, Dept Pediat, Sch Med, Nashville, TN 37232 USA.
EM james.crowe@vanderbilt.edu
RI Crowe, James E./B-5549-2009
OI Crowe, James E./0000-0002-0049-1079
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI127828, R01 AI114816, U19
   AI109711, U19 AI117905, HHSN272201400024C]; Moderna;
   SanofiSanofi-Aventis; Inovio; MedimmuneAstraZeneca; Profectus; Arbutus;
   Avatar
FX The ideas presented here were birthed and shaped in a large community of
   scientists. First, I want to thank the many current and previous members
   of my laboratory who have created much of the new knowledge reviewed
   here. I also am deeply indebted to many collaborators and colleagues in
   this field who designed and performed much of the work I review here,
   including many current and past members of the laboratories of Ian
   Wilson, Andrew Ward, and Erica Saphire at Scripps; Sheemei Lok at Duke
   NUS Singapore; Ben Spiller and Jens Meiler at Vanderbilt; Ted Jardetsky
   at Stanford; Michael Diamond and Daved Fremont at Washington University
   in St. Louis; Michael Rossmann and Richard Kuhn at Purdue; Ben Doranz at
   Integral Molecular; Peter Palese, Adolfo Garcia-Sastre, and Chris Basler
   at Mount Sinai, New York; and Ralph Baric and Aravinda de Silva at
   University of North Carolina, Chapel Hill. The work was supported by NIH
   grants R01 AI127828, R01 AI114816, U19 AI109711, and U19 AI117905 and
   NIH contract HHSN272201400024C. J.E.C. holds the Ann Scott Carell Chair
   at Vanderbilt University Medical Center. J.E.C. is a member of the
   scientific advisory boards of PaxVax, Meissa Vaccines, GigaGen, and
   CompuVax and has participated in advisory boards for Sanofi, Novavax,
   and Takeda. His laboratory has had recent sponsored research agreements
   with Moderna and Sanofi. His laboratory has current or recent federal
   consortium grants in which commercial parties are collaborators,
   including Inovio, Medimmune, Profectus, Arbutus, Avatar, and Moderna.
   Vanderbilt University has licensed materials for which he is inventor or
   co-inventor to GlaxoSmithKline, Takeda, Sanofi, Mapp Biopharmaceutical,
   Ridgeback Biotherapeutics, Novavax, Kerafast, and NewLink Genetics.
CR Babcook JS, 1996, P NATL ACAD SCI USA, V93, P7843, DOI 10.1073/pnas.93.15.7843
   Bangaru S, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86673
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   BARBAS CF, 1992, P NATL ACAD SCI USA, V89, P10164, DOI 10.1073/pnas.89.21.10164
   Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071
   Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004
   Bornholdt ZA, 2016, SCIENCE, V351, P1078, DOI 10.1126/science.aad5788
   Boutz DR, 2014, ANAL CHEM, V86, P4758, DOI 10.1021/ac4037679
   Briney BS, 2012, GENES IMMUN, V13, P523, DOI 10.1038/gene.2012.28
   Briney B, 2016, CELL, V166, P1459, DOI 10.1016/j.cell.2016.08.005
   Briney BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100839
   Briney BS, 2012, IMMUNOLOGY, V137, P56, DOI 10.1111/j.1365-2567.2012.03605.x
   Briney BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036750
   Chung AW, 2015, CELL, V163, P988, DOI 10.1016/j.cell.2015.10.027
   Correia BE, 2014, NATURE, V507, P201, DOI 10.1038/nature12966
   Corti D, 2013, NATURE, V501, P439, DOI 10.1038/nature12442
   Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669
   Crowe JE, 2015, EXPERT REV VACCINES, V14, P1421, DOI 10.1586/14760584.2015.1082427
   CROWE JE, 1994, P NATL ACAD SCI USA, V91, P1386, DOI 10.1073/pnas.91.4.1386
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   deCamp A, 2014, J VIROL, V88, P2489, DOI 10.1128/JVI.02853-13
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Edmonds TG, 2010, VIROLOGY, V408, P1, DOI 10.1016/j.virol.2010.08.028
   Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414
   Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491
   Ermler ME, 2017, J VIROL, V91, DOI 10.1128/JVI.00286-17
   Escolano A, 2016, CELL, V166, P1445, DOI 10.1016/j.cell.2016.07.030
   Ettayebi K, 2016, SCIENCE, V353, P1387, DOI 10.1126/science.aaf5211
   Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Fibriansah G, 2014, EMBO MOL MED, V6, P358, DOI 10.1002/emmm.201303404
   Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617
   Flyak AI, 2016, CELL, V164, P392, DOI 10.1016/j.cell.2015.12.022
   Flyak AI, 2015, CELL, V160, P893, DOI 10.1016/j.cell.2015.01.031
   Fox JM, 2015, CELL, V163, P1095, DOI 10.1016/j.cell.2015.10.050
   Gilchuk I, 2016, CELL, V167, P684, DOI 10.1016/j.cell.2016.09.049
   Hai R, 2012, J VIROL, V86, P5774, DOI 10.1128/JVI.00137-12
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Hashiguchi T, 2015, CELL, V160, P904, DOI 10.1016/j.cell.2015.01.041
   Heeney Jonathan L, 2006, Nat Immunol, V7, P1281, DOI 10.1038/ni1206-1281
   Hong MS, 2013, J VIROL, V87, P12471, DOI 10.1128/JVI.01388-13
   Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544
   KANG AS, 1991, P NATL ACAD SCI USA, V88, P4363, DOI 10.1073/pnas.88.10.4363
   Koday MT, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005409
   KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0
   Krause JC, 2012, J VIROL, V86, P6334, DOI 10.1128/JVI.07158-11
   Krause JC, 2011, J IMMUNOL, V187, P3704, DOI 10.4049/jimmunol.1101823
   Krause JC, 2011, J VIROL, V85, P10905, DOI 10.1128/JVI.00700-11
   Krause JC, 2010, J VIROL, V84, P3127, DOI 10.1128/JVI.02184-09
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kwakkenbos MJ, 2010, NAT MED, V16, P123, DOI 10.1038/nm.2071
   LARRICK JW, 1989, BIOCHEM BIOPH RES CO, V160, P1250, DOI 10.1016/S0006-291X(89)80138-X
   Laurie KL, 2015, CLIN VACCINE IMMUNOL, V22, P957, DOI 10.1128/CVI.00278-15
   Lee PS, 2015, CURR TOP MICROBIOL, V386, P323, DOI 10.1007/82_2014_413
   Lee PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4614
   Macagno A, 2010, J VIROL, V84, P1005, DOI 10.1128/JVI.01809-09
   Mascola JR, 2005, J VIROL, V79, P10103, DOI 10.1128/JVI.79.16.10103-10107.2005
   MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0
   McLinden RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077756
   Mousa JJ, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.271
   Mousa JJ, 2016, P NATL ACAD SCI USA, V113, pE6849, DOI 10.1073/pnas.1609449113
   MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993
   Navis M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004337
   Pappas L, 2014, NATURE, V516, P418, DOI 10.1038/nature13764
   Pinna D, 2009, EUR J IMMUNOL, V39, P1260, DOI 10.1002/eji.200839129
   Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862
   Plotkin SA, 2013, CLIN INFECT DIS, V56, P1458, DOI 10.1093/cid/cit048
   Plotkin SA, 2012, CLIN INFECT DIS, V54, P1615, DOI 10.1093/cid/cis238
   Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10
   PRINCE GA, 1985, VIRUS RES, V3, P193, DOI 10.1016/0168-1702(85)90045-0
   Purtha WE, 2011, J EXP MED, V208, P2599, DOI 10.1084/jem.20110740
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sarzotti-Kelsoe M, 2014, J IMMUNOL METHODS, V409, P131, DOI 10.1016/j.jim.2013.11.022
   Schmidt AG, 2013, P NATL ACAD SCI USA, V110, P264, DOI 10.1073/pnas.1218256109
   Shi B, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-30
   Smith SA, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.AID-0027-2014
   Smith SA, 2015, CELL HOST MICROBE, V18, P86, DOI 10.1016/j.chom.2015.06.009
   Smith SA, 2014, J VIROL, V88, P12233, DOI 10.1128/JVI.00247-14
   Smith SA, 2013, J INFECT DIS, V207, P1898, DOI 10.1093/infdis/jit119
   Smith SA, 2012, J VIROL, V86, P2665, DOI 10.1128/JVI.06335-11
   Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10
   Steichen JM, 2016, IMMUNITY, V45, P483, DOI 10.1016/j.immuni.2016.08.016
   Strauch EM, 2017, NAT BIOTECHNOL, V35, P667, DOI 10.1038/nbt.3907
   Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566
   SZARDENINGS M, 1990, GENE, V94, P1, DOI 10.1016/0378-1119(90)90460-9
   Thornburg NJ, 2016, J CLIN INVEST, V126, P1482, DOI 10.1172/JCI85317
   Thornburg NJ, 2013, J CLIN INVEST, V123, P4405, DOI 10.1172/JCI69377
   Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942
   Tian M, 2016, CELL, V166, P1471, DOI 10.1016/j.cell.2016.07.029
   Tomaras GD, 2017, IMMUNOL REV, V275, P245, DOI 10.1111/imr.12514
   Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080
   Tsibane T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003067
   U.S.F.D.A, 2007, GUID IND CLIN DAT NE
   Wang H, 2016, CELL, V164, P258, DOI 10.1016/j.cell.2015.12.044
   Wec AZ, 2016, SCIENCE, V354, P350, DOI 10.1126/science.aag3267
   Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470
   Weinstein JA, 2009, SCIENCE, V324, P807, DOI 10.1126/science.1170020
   Weitkamp JH, 2003, J IMMUNOL METHODS, V275, P223, DOI 10.1016/S0022-1759(03)00013-9
   Wen XW, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.272
   Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108
   Willis JR, 2016, P NATL ACAD SCI USA, V113, P4446, DOI 10.1073/pnas.1518405113
   Willis JR, 2015, J CLIN INVEST, V125, P2523, DOI 10.1172/JCI80693
   Winarski KL, 2015, P NATL ACAD SCI USA, V112, P9346, DOI 10.1073/pnas.1502762112
   Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890
   Wu N.C., 2017, J MOL BIOL
   Xu GJ, 2015, SCIENCE, V348, DOI 10.1126/science.aaa0698
   Xu R, 2013, NAT STRUCT MOL BIOL, V20, P363, DOI 10.1038/nsmb.2500
   Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430
   Yu XC, 2008, NATURE, V455, P532, DOI 10.1038/nature07231
   Yu XC, 2008, J IMMUNOL METHODS, V336, P142, DOI 10.1016/j.jim.2008.04.008
   Zwick MB, 2004, J VIROL, V78, P3155, DOI 10.1128/JVI.78.6.3155-3161.2004
NR 113
TC 30
Z9 32
U1 1
U2 22
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD AUG 9
PY 2017
VL 22
IS 2
BP 193
EP 206
DI 10.1016/j.chom.2017.07.013
PG 14
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA FD1BV
UT WOS:000407273300008
PM 28799905
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Guedes, DRD
   Paiva, MHS
   Donato, MMA
   Barbosa, PP
   Krokovsky, L
   Rocha, SWD
   La Saraiva, K
   Crespo, MM
   Rezende, TM
   Wallau, GL
   Barbosa, RMR
   Oliveira, CMF
   Melo-Santos, MAV
   Pena, L
   Cordeiro, MT
   Franca, RFD
   de Oliveira, ALS
   Peixoto, CA
   Leal, WS
   Ayres, CFJ
AF Guedes, Duschinka R. D.
   Paiva, Marcelo H. S.
   Donato, Mariana M. A.
   Barbosa, Priscilla P.
   Krokovsky, Larissa
   Rocha, Sura W. dos S.
   La Saraiva, Karina
   Crespo, Monica M.
   Rezende, Tatiana M. T.
   Wallau, Gabriel L.
   Barbosa, Rosangela M. R.
   Oliveira, Claudia M. F.
   Melo-Santos, Maria A. V.
   Pena, Lindomar
   Cordeiro, Marli T.
   Franca, Rafael F. de O.
   de Oliveira, Andre L. S.
   Peixoto, Christina A.
   Leal, Walter S.
   Ayres, Constancia F. J.
TI Zika virus replication in the mosquito Culex quinquefasciatus in Brazil
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE Aedes; Culex; microcephaly; vector competence; Zika
ID AEDES-AEGYPTI MOSQUITOS; PIPIENS MOSQUITOS; FEDERATED STATES; YAP STATE;
   INFECTION; MICRONESIA; EPIDEMIC; VECTOR; SUSCEPTIBILITY; SURVEILLANCE
AB Zika virus (ZIKV) is a flavivirus that has recently been associated with an increased incidence of neonatal microcephaly and other neurological disorders. The virus is primarily transmitted by mosquito bite, although other routes of infection have been implicated in some cases. The Aedes aegypti mosquito is considered to be the main vector to humans worldwide; however, there is evidence that other mosquito species, including Culex quinquefasciatus, transmit the virus. To test the potential of Cx. quinquefasciatus to transmit ZIKV, we experimentally compared the vector competence of laboratory-reared Ae. aegypti and Cx. quinquefasciatus. Interestingly, we were able to detect the presence of ZIKV in the midgut, salivary glands and saliva of artificially fed Cx. quinquefasciatus. In addition, we collected ZIKV-infected Cx. quinquefasciatus from urban areas with high microcephaly incidence in Recife, Brazil. Corroborating our experimental data from artificially fed mosquitoes, ZIKV was isolated from field-caught Cx. quinquefasciatus, and its genome was partially sequenced. Collectively, these findings indicate that there may be a wider range of ZIKV vectors than anticipated.
C1 [Guedes, Duschinka R. D.; Paiva, Marcelo H. S.; Donato, Mariana M. A.; Barbosa, Priscilla P.; Krokovsky, Larissa; Rocha, Sura W. dos S.; La Saraiva, Karina; Crespo, Monica M.; Rezende, Tatiana M. T.; Barbosa, Rosangela M. R.; Oliveira, Claudia M. F.; Melo-Santos, Maria A. V.; Peixoto, Christina A.; Ayres, Constancia F. J.] Fundacao Oswaldo Cruz Fiocruz, Inst Aggeu Magalhaes, Dept Entomol, BR-50760420 Recife, PE, Brazil.
   [Paiva, Marcelo H. S.] Univ Fed Pernambuco, Ctr Acad Agreste, Nucleo Ciencias Vida, BR-55002970 Caruaru, Brazil.
   [Pena, Lindomar; Cordeiro, Marli T.; Franca, Rafael F. de O.] Fundacao Oswaldo Cruz Fiocruz, Inst Aggeu Magalhaes, Lab Virol & Terapia Expt, BR-50670420 Recife, PE, Brazil.
   [de Oliveira, Andre L. S.] Fundacao Oswaldo Cruz Fiocruz, Inst Aggeu Magalhaes, Nucleo Estat & Geoprocessamento, BR-50670420 Recife, PE, Brazil.
   [Leal, Walter S.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.
RP Ayres, CFJ (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Inst Aggeu Magalhaes, Dept Entomol, BR-50760420 Recife, PE, Brazil.
EM tans@cpqam.fiocruz.br
RI Barbosa, Rosangela/AAC-3339-2020; Wallau, Gabriel Luz/B-5911-2008;
   Rocha, Sura/R-8479-2018; Ayres, Constancia/AAQ-3448-2020; PEIXOTO,
   CHRISTINA/AAD-9608-2019
OI Barbosa, Rosangela/0000-0002-1171-598X; Wallau, Gabriel
   Luz/0000-0002-1419-5713; Rocha, Sura/0000-0003-2312-085X; 
FU Fundacao de Amparo a Pesquisa do Estado de Pernambuco (FACEPE)
   [APQ-1608-2.13/15, APQ-0085-2.13/16, APQ-345-2.13/13, APQ-0078-2.02/16];
   Brazilian National Council for Research and Development (CNPq)National
   Council for Scientific and Technological Development (CNPq)
   [441100/2016-3]; National Institute of Allergy and Infectious Diseases
   at the National Institutes of HealthUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [R01AI095514,
   1R21AI128931-01]; CNPqNational Council for Scientific and Technological
   Development (CNPq)
FX This work was partially supported by the Fundacao de Amparo a Pesquisa
   do Estado de Pernambuco (FACEPE; APQ-1608-2.13/15 and APQ-0085-2.13/16
   to CFJA; APQ-345-2.13/13 to MAVMS and APQ-0078-2.02/16 to GLW), the
   Brazilian National Council for Research and Development (CNPq; grant
   441100/2016-3) and the National Institute of Allergy and Infectious
   Diseases at the National Institutes of Health (R01AI095514 and
   1R21AI128931-01 to WSL). CFJA and CAP were supported by productivity
   fellowships from CNPq. We thank the insectary staff at the IAM for
   technical assistance, the Program for Technological Development in Tools
   for Health (PDTIS-FIOCRUZ) for allowing us to use their facilities, the
   staff of the Pernambuco State Health Department for sharing recent data
   on microcephaly and for assisting with surveillance and the Platform of
   Statistic and Geographical Information Systems (Nucleo de Estatistica e
   Geoprocessamento, NEG) for helping us with the GIS technologies and
   statistical analyses (George Tadeu Nunes Diniz).
CR Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Amorim LB, 2013, PEST MANAG SCI, V69, P1307, DOI 10.1002/ps.3502
   Amraoui F, 2016, EURO SURVEILL, V21
   Araujo AP, 2017, BIOL CONTROL, V41, P339
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Boccolini D, 2016, EUROSURVEILLANCE, V21
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Chow VTK, 1998, AM J TROP MED HYG, V58, P578, DOI 10.4269/ajtmh.1998.58.578
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Cornet M, 1979, CAH ORSTOM, V17, P7
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Chalegre KDD, 2009, APPL ENVIRON MICROB, V75, P1044, DOI 10.1128/AEM.02032-08
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0356-2
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Flies EJ, 2015, VECTOR-BORNE ZOONOT, V15, P397, DOI 10.1089/vbz.2014.1759
   Fontaine A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24885
   Girard YA, 2005, J MED ENTOMOL, V42, P429, DOI 10.1603/0022-2585(2005)042[0429:USOWNV]2.0.CO;2
   Girard YA, 2007, AM J TROP MED HYG, V76, P118, DOI 10.4269/ajtmh.2007.76.118
   Goertz GP, 2016, J VIROL, V90, P10145, DOI 10.1128/JVI.00930-16
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Hall-Mendelin S, 2010, P NATL ACAD SCI USA, V107, P11255, DOI 10.1073/pnas.1002040107
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Leal Walter S, 2016, F1000Res, V5, P2546
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Donato MAM, 2015, TISSUE CELL, V47, P515, DOI 10.1016/j.tice.2015.07.001
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moron AF, 2016, BJOG-INT J OBSTET GY, V123, P1265, DOI 10.1111/1471-0528.14072
   Nasci RS, 2001, EMERG INFECT DIS, V7, P626
   Nunes AT, 2016, PROTEOMICS, V16, P2582, DOI 10.1002/pmic.201600126
   Pilotte N, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004641
   REGIS L, 1995, MEM I OSWALDO CRUZ, V90, P115, DOI 10.1590/S0074-02761995000100022
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   ROSEN L, 1987, AM J TROP MED HYG, V37, pS69, DOI 10.4269/ajtmh.1987.37.69S
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   Savage HM, 1998, AM J TROP MED HYG, V58, P519, DOI 10.4269/ajtmh.1998.58.519
   Scheuermann RH, 2016, NATURE, V531, P173, DOI 10.1038/531173a
   SUCHARIT S, 1989, Southeast Asian Journal of Tropical Medicine and Public Health, V20, P611
   Wang ZM, 2012, VECTOR-BORNE ZOONOT, V12, P605, DOI 10.1089/vbz.2011.0660
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 56
TC 78
Z9 82
U1 1
U2 22
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD AUG 9
PY 2017
VL 6
AR e69
DI 10.1038/emi.2017.59
PG 11
WC Immunology; Microbiology
SC Immunology; Microbiology
GA FD4BU
UT WOS:000407477100004
PM 28790458
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Shelby, T
   Banerjee, T
   Zegar, I
   Santra, S
AF Shelby, Tyler
   Banerjee, Tuhina
   Zegar, Irene
   Santra, Santimukul
TI Highly Sensitive, Engineered Magnetic Nanosensors to Investigate the
   Ambiguous Activity of Zika Virus and Binding Receptors
SO SCIENTIFIC REPORTS
LA English
DT Article
ID PHOSPHATIDYLSERINE RECEPTORS; AXL; INFECTION; CELLS; ENTRY;
   HEAT-SHOCK-PROTEIN-70
AB The aim of this research is twofold: 1) to shed light on zika's binding and entry mechanism while 2) demonstrating the effectiveness of our magnetic relaxation platform to achieve this goal. Magnetic relaxation-sensitive nanoparticles (MRNPs) are used in a novel fashion to analyze binding interactions between the zika envelope protein (ZENV) and proposed host cell receptors: AXL, HSP70, and TIM-1. Computational analysis is also utilized to examine these binding interactions for the first time. In addition, the role of crizotinib as a potential binding inhibitor is demonstrated and the possibility of ligand-independent phosphatidylserine-mediated binding is explored. Our findings suggest that while the extracellular domain of AXL has the highest affinity for ZENV; HSP70, TIM-1, and phosphatidylserine might also play active roles in zika tropism, which offers a potential explanation for the variety of zika-associated symptoms. This is, to our knowledge, the first time that MRNPs have been used to examine and quantify host-zika interactions. Our magnetic relaxation platform allows for timely and sensitive analysis of these intricate binding relationships, and it is easily customizable for further examination of additional host-pathogen interactions.
C1 [Shelby, Tyler; Banerjee, Tuhina; Zegar, Irene; Santra, Santimukul] Pittsburg State Univ, Dept Chem, 1701 S Broadway St, Pittsburg, KS 66762 USA.
RP Santra, S (corresponding author), Pittsburg State Univ, Dept Chem, 1701 S Broadway St, Pittsburg, KS 66762 USA.
EM ssantra@pittstate.edu
OI Santra, Santimukul/0000-0002-5047-5245
FU Kansas INBRE [K-INBRE P20 GM103418]; ACS PRFAmerican Cancer
   SocietyAmerican Chemical Society [56629-UNI7]; PSU Polymer Chemistry
   Initiative
FX This project was supported by the Kansas INBRE Bridging grant and
   Star-Trainee award(K-INBRE P20 GM103418), ACS PRF (56629-UNI7) and PSU
   Polymer Chemistry Initiative, all to SS.
CR Banerjee T, 2016, ACS INFECT DIS, V2, P667, DOI 10.1021/acsinfecdis.6b00108
   Barr KL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004931
   BELLOSTA P, 1995, MOL CELL BIOL, V15, P614
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Brindley MA, 2011, VIROLOGY, V415, P83, DOI 10.1016/j.virol.2011.04.002
   Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004
   Das S, 2009, VIROLOGY, V385, P47, DOI 10.1016/j.virol.2008.10.025
   Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398
   Heiring C, 2004, J BIOL CHEM, V279, P6952, DOI 10.1074/jbc.M311750200
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921
   Korshunov VA, 2012, CLIN SCI, V122, P361, DOI 10.1042/CS20110411
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Messoussi A, 2014, MOLECULES, V19, P16223, DOI 10.3390/molecules191016223
   Meyer AS, 2015, CELL SYST, V1, P25, DOI 10.1016/j.cels.2015.06.002
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Moller-Tank S, 2014, VIROLOGY, V468, P565, DOI 10.1016/j.virol.2014.09.009
   Morizono K, 2014, J VIROL, V88, P4275, DOI 10.1128/JVI.03287-13
   Morizono K, 2011, CELL HOST MICROBE, V9, P286, DOI 10.1016/j.chom.2011.03.012
   Myers SH, 2016, J MED CHEM, V59, P3593, DOI 10.1021/acs.jmedchem.5b01273
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Santra S, 2009, SMALL, V5, P1862, DOI 10.1002/smll.200900389
   Shelby T, 2016, NANOSCALE, V8, P19605, DOI 10.1039/c6nr05889b
   SHUKLA S, 2016, FRONT MICROBIOL, V7
   Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206
   Valle JRD, 2005, J VIROL, V79, P4557, DOI 10.1128/JVI.79.8.4557-4567.2005
   Van Durme J, 2011, BIOINFORMATICS, V27, P1711, DOI 10.1093/bioinformatics/btr254
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Yuan S, 2015, PROTEIN CELL, V6, P814, DOI 10.1007/s13238-015-0220-y
NR 35
TC 7
Z9 8
U1 1
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 7
PY 2017
VL 7
AR 7377
DI 10.1038/s41598-017-07620-y
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FC8GP
UT WOS:000407080100007
PM 28785095
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zhou, T
   Tan, L
   Cederquist, GY
   Fan, YJ
   Hartley, BJ
   Mukherjee, S
   Tomishima, M
   Brennand, KJ
   Zhang, QS
   Schwartz, RE
   Evans, T
   Studer, L
   Chen, SB
AF Zhou, Ting
   Tan, Lei
   Cederquist, Gustav Y.
   Fan, Yujie
   Hartley, Brigham J.
   Mukherjee, Suranjit
   Tomishima, Mark
   Brennand, Kristen J.
   Zhang, Qisheng
   Schwartz, Robert E.
   Evans, Todd
   Studer, Lorenz
   Chen, Shuibing
TI High-Content Screening in hPSC-Neural Progenitors Identifies Drug
   Candidates that Inhibit Zika Virus Infection in Fetal-like Organoids and
   Adult Brain
SO CELL STEM CELL
LA English
DT Article
AB Zika virus (ZIKV) infects fetal and adult human brain and is associated with serious neurological complications. To date, no therapeutic treatment is available to treat ZIKV-infected patients. We performed a high-content chemical screen using human pluripotent stem cell-derived cortical neural progenitor cells (hNPCs) and found that hippeastrine hydrobromide (HH) and amodiaquine dihydrochloride dihydrate (AQ) can inhibit ZIKV infection in hNPCs. Further validation showed that HH also rescues ZIKV-induced growth and differentiation defects in hNPCs and human fetal-like forebrain organoids. Finally, HH and AQ inhibit ZIKV infection in adult mouse brain in vivo. Strikingly, HH suppresses viral propagation when administered to adult mice with active ZIKV infection, highlighting its therapeutic potential. Our approach highlights the power of stem cell-based screens and validation in human forebrain organoids and mouse models in identifying drug candidates for treating ZIKV infection and related neurological complications in fetal and adult patients.
C1 [Zhou, Ting; Tan, Lei; Fan, Yujie; Mukherjee, Suranjit; Evans, Todd; Chen, Shuibing] Weill Cornell Med Coll, Dept Surg, 1300 York Ave, New York, NY 10065 USA.
   [Chen, Shuibing] Weill Cornell Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10065 USA.
   [Cederquist, Gustav Y.; Tomishima, Mark; Studer, Lorenz] Ctr Stem Cell Biol, New York, NY 10065 USA.
   [Cederquist, Gustav Y.; Tomishima, Mark; Studer, Lorenz] Sloan Kettering Inst Canc Res, Dev Biol Program, New York, NY 10065 USA.
   [Cederquist, Gustav Y.] Weill Cornell Rockefeller, Sloan Kettering Tri Inst MD PhD Program, New York, NY 10065 USA.
   [Hartley, Brigham J.; Brennand, Kristen J.] Icahn Sch Med Mt Sinai, Dept Psychiat & Neurosci, 1425 Madison Ave, New York, NY 10029 USA.
   [Zhang, Qisheng] Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, 125 Mason Farm Rd, Chapel Hill, NC 27599 USA.
   [Schwartz, Robert E.] Weill Cornell Med Coll, Dept Med, 1300 York Ave, New York, NY 10065 USA.
   [Mukherjee, Suranjit] Weill Cornell Med Coll, Dept Pharmacol, 1300 York Ave, New York, NY 10065 USA.
   [Schwartz, Robert E.] Weill Cornell Med Coll, Physiol Biophys & Syst Biol, 1300 York Ave, New York, NY 10065 USA.
RP Chen, SB (corresponding author), Weill Cornell Med Coll, Dept Surg, 1300 York Ave, New York, NY 10065 USA.; Chen, SB (corresponding author), Weill Cornell Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10065 USA.; Studer, L (corresponding author), Ctr Stem Cell Biol, New York, NY 10065 USA.; Studer, L (corresponding author), Sloan Kettering Inst Canc Res, Dev Biol Program, New York, NY 10065 USA.
EM studerl@mskcc.org; shc2034@med.cornell.edu
OI tan, lei/0000-0002-8473-4911; Studer, Lorenz/0000-0003-0741-7987; Zhang,
   Qisheng/0000-0001-9808-5038
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [DP2 DK098093-01, DP3DK111907-01,
   R01MH101454, R01MH106056, 1R21AI117213, 1K08DK101754]; Family Friendly
   Postdoctoral (FFPI) program at Weill Cornell; F30 predoctoral fellowship
   from the National Institute of Mental Health [F30 MH113343-01A1];
   training grant from the National Institute of General Medical Sciences
   [T32GM007739]; Brain and Behavior Research Foundation; Brain Research
   Foundation; New York Stem Cell Foundation; NYSTEM Shared Facility
   contract [C029156, C029153]; Core support grant from NCI/NIH
   [P30CA008748]
FX S.C. is funded by the NIH (grants DP2 DK098093-01 and DP3DK111907-01).
   S.C. and K.J.B. are New York Stem Cell Foundation Robertson
   Investigators. T.Z. is funded by a Family Friendly Postdoctoral (FFPI)
   program at Weill Cornell. G.Y.C. is supported by an F30 predoctoral
   fellowship from the National Institute of Mental Health (F30
   MH113343-01A1) and a training grant from the National Institute of
   General Medical Sciences (T32GM007739) to the Weill
   Cornell/Rockefeller/Sloan Kettering Tri-Institutional MD-PhD Program.
   K.J.B. is funded by the Brain and Behavior Research Foundation, the
   Brain Research Foundation, the NIH (grants R01MH101454 and R01MH106056),
   and the New York Stem Cell Foundation. R.E.S. is funded by the NIH
   (grants 1R21AI117213 and 1K08DK101754). This study was also supported by
   a NYSTEM Shared Facility contract to T.E. and S.C. (C029156) and M.T.
   (C029153) and by the Core support grant from NCI/NIH (P30CA008748). We
   thank Drs. Charles M. Rice and Margaret R. MacDonald for providing the
   ZIKV FSS13025 strain. We are also very grateful for technical support
   provided by Harold S. Ralph in the Cell Screening Core Facility and Tuo
   Zhang and Jenny Xiang in the Genomic Core Facility at Weill Cornell
   Medical College.
CR Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bershteyn M, 2013, CELL, V155, P19, DOI 10.1016/j.cell.2013.09.010
   Boonyasuppayakorn S, 2014, ANTIVIR RES, V106, P125, DOI 10.1016/j.antiviral.2014.03.014
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chen DZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14972
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   He J, 2013, INFLUENZA OTHER RESP, V7, P922, DOI 10.1111/irv.12035
   Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   OLLIARO P, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000016
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Topol A, 2015, JOVE-J VIS EXP, DOI 10.3791/52495
   Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 26
TC 62
Z9 62
U1 1
U2 27
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1934-5909
EI 1875-9777
J9 CELL STEM CELL
JI Cell Stem Cell
PD AUG 3
PY 2017
VL 21
IS 2
BP 274
EP +
DI 10.1016/j.stem.2017.06.017
PG 15
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA FC5EE
UT WOS:000406863800015
PM 28736217
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Munjal, A
   Khandia, R
   Dhama, K
   Sachan, S
   Karthik, K
   Tiwari, R
   Malik, YS
   Kumar, D
   Singh, RK
   Iqbal, HMN
   Joshi, SK
AF Munjal, Ashok
   Khandia, Rekha
   Dhama, Kuldeep
   Sachan, Swati
   Karthik, Kumaragurubaran
   Tiwari, Ruchi
   Malik, Yashpal S.
   Kumar, Deepak
   Singh, Raj K.
   Iqbal, Hafiz M. N.
   Joshi, Sunil K.
TI Advances in Developing Therapies to Combat Zika Virus: Current Knowledge
   and Future Perspectives
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Review
DE Zika virus; drugs; therapies; microcephaly; Guillain-Barre Syndrome
ID INHIBITS ZIKA; DENGUE VIRUS; CRYSTAL-STRUCTURE; ANTIVIRAL ACTIVITY;
   NS2B-NS3 PROTEASE; JAPANESE ENCEPHALITIS; POTENTIAL INHIBITORS; NEURAL
   PROGENITORS; CROSS-REACTIVITY; NS3 HELICASE
AB Zika virus (ZIKV) remained largely quiescent for nearly six decades after its first appearance in 1947. ZIKV reappeared after 2007, resulting in a declaration of an international "public health emergency" in 2016 by the World Health Organization (WHO). Until this time, ZIKV was considered to induce only mild illness, but it has now been established as the cause of severe clinical manifestations, including fetal anomalies, neurological problems, and autoimmune disorders. Infection during pregnancy can cause congenital brain abnormalities, including microcephaly and neurological degeneration, and in other cases, Guillain-Barre syndrome, making infections with ZIKV a substantial public health concern. Genomic and molecular investigations are underway to investigate ZIKV pathology and its recent enhanced pathogenicity, as well as to design safe and potent vaccines, drugs, and therapeutics. This review describes progress in the design and development of various antiZIKV therapeutics, including drugs targeting virus entry into cells and the helicase protein, nucleosides, inhibitors of NS3 protein, small molecules, methyltransferase inhibitors, interferons, repurposed drugs, drugs designed with the aid of computers, neutralizing antibodies, convalescent serum, antibodies that limit antibody-dependent enhancement, and herbal medicines. Additionally, covalent inhibitors of viral protein expression and anti-Toll-like receptor molecules are discussed. To counter ZIKV-associated disease, we need to make rapid progress in developing novel therapies that work effectually to inhibit ZIKV.
C1 [Munjal, Ashok; Khandia, Rekha] Barkatullah Univ, Dept Biochem & Genet, Bhopal, India.
   [Dhama, Kuldeep] ICAR Indian Vet Res Inst, Div Pathol, Bareilly, Uttar Pradesh, India.
   [Sachan, Swati] ICAR Indian Vet Res Inst, Immunol Sect, Bareilly, Uttar Pradesh, India.
   [Karthik, Kumaragurubaran] Tamil Nadu Vet & Anim Sci Univ, Cent Univ Lab, Madras, Tamil Nadu, India.
   [Tiwari, Ruchi] UP Pandit Deen Dayal Upadhayay Pashu Chikitsa Vig, Coll Vet Sci, Dept Vet Microbiol & Immunol, Mathura, India.
   [Malik, Yashpal S.] ICAR Indian Vet Res Inst, Div Biol Standardizat, Bareilly, Uttar Pradesh, India.
   [Kumar, Deepak] ICAR Indian Vet Res Inst, Div Vet Biotechnol, Bareilly, Uttar Pradesh, India.
   [Singh, Raj K.] ICAR Indian Vet Res Inst, Bareilly, Uttar Pradesh, India.
   [Iqbal, Hafiz M. N.] Tecnol Monterrey, Sch Engn & Sci, Campus Monterrey, Monterrey, Mexico.
   [Joshi, Sunil K.] Old Dominion Univ, Cellular Immunol Lab, Frank Reidy Res Ctr Bioelect, Norfolk, VA USA.
RP Dhama, K (corresponding author), ICAR Indian Vet Res Inst, Div Pathol, Bareilly, Uttar Pradesh, India.
EM kdhama@rediffmail.com
RI Iqbal, Hafiz M.N./J-5423-2014; Malik, Yashpal Singh/AAI-2259-2019;
   Dhama, Kuldeep/B-7852-2015
OI Iqbal, Hafiz M.N./0000-0003-4855-2720; Dhama,
   Kuldeep/0000-0001-7469-4752
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Akpovwa H, 2016, CELL BIOCHEM FUNCT, V34, P191, DOI 10.1002/cbf.3182
   Alam A, 2017, BIOMED PHARMACOTHER, V91, P1152, DOI 10.1016/j.biopha.2017.05.045
   Albulescu IC, 2017, ANTIVIR RES, V143, P230, DOI 10.1016/j.antiviral.2017.04.016
   Alexandre KB, 2011, J VIROL, V85, P9039, DOI 10.1128/JVI.02675-10
   Ali A, 2017, ASIAN PAC J TROP MED, V10, P301, DOI 10.1016/j.apjtm.2017.03.020
   Apostol J. G., 2012, International Journal of Pharmaceutical Frontier Research, V2, P1
   Arduin E, 2015, MOL IMMUNOL, V63, P456, DOI 10.1016/j.molimm.2014.09.017
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Baehner M, 2015, Antibody fc variants, Patent No. [US 8,969,526 B2, 8969526]
   Balasubramanian A, 2017, ANTIVIR RES, V137, P141, DOI 10.1016/j.antiviral.2016.11.015
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barreyro FJ, 2015, LIVER INT, V35, P953, DOI 10.1111/liv.12570
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Basak SC, 2016, CURR COMPUT-AID DRUG, V12, P2, DOI 10.2174/1573409912999160315115502
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Butler T., 2001, Carba-nucleoside analogs for antiviral treatment. US, Patent No. [8012942B2, 8012942]
   Byler KG, 2016, J MOL GRAPH MODEL, V69, P78, DOI 10.1016/j.jmgm.2016.08.011
   Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P15, DOI 10.1128/AAC.01429-12
   Cai L, 2017, ARCH VIROL, V162, P2847, DOI 10.1007/s00705-017-3436-8
   Canales E., 2011, Inhibitors of flaviviridae viruses, Patent No. [WO2011088345A1, 2011088345]
   Cao RY, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx009
   Cao XC, 2016, NUCLEIC ACIDS RES, V44, P10505, DOI 10.1093/nar/gkw941
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Charles Anu Susan, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.4ab8bc87c945eb41cd8a49e127082620
   Chen LM, 2017, ANTIVIR RES, V141, P140, DOI 10.1016/j.antiviral.2017.02.009
   Cheng FX, 2016, TRENDS MOL MED, V22, P919, DOI 10.1016/j.molmed.2016.09.006
   Ching S, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1017-0
   Cho A., 2009, Carba-nucleoside analogs for antiviral treatment, Patent No. [WO2009132123A1, 2009132123]
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Contreras D, 2016, JOVE-J VIS EXP, DOI 10.3791/54767
   Costa VV, 2017, MBIO, V8, DOI [10.1128/mBio.00350-17, 10.1128/mbio.00350-17]
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Cox Bryan D., 2015, Antiviral Chemistry & Chemotherapy, V24, P118, DOI 10.1177/2040206616653873
   Crance JM, 2003, ANTIVIR RES, V58, P73, DOI 10.1016/S0166-3542(02)00185-7
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dar HA, 2017, INFECT GENET EVOL, V51, P143, DOI 10.1016/j.meegid.2017.03.027
   de Wispelaere M, 2017, ANTIVIR RES, V139, P171, DOI 10.1016/j.antiviral.2016.12.017
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Deng Yichu, 2016, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V28, P106, DOI 10.3760/cma.j.issn.2095-4352.2016.02.005
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Doller A, 2007, J AM SOC NEPHROL, V18, P581, DOI 10.1681/ASN.2006060568
   Duan WQ, 2017, EMBO J, V36, P919, DOI 10.15252/embj.201696241
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Ekins S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005023
   Estoppey D, 2017, CELL REP, V19, P451, DOI 10.1016/j.celrep.2017.03.071
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Fajardo A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2015.01667
   Feranchuk S., 2016, VIRTUAL SCREENING IN, DOI 10.1101/060798
   Fernando S, 2016, MOL BIOTECHNOL, V58, P801, DOI 10.1007/s12033-016-9979-1
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freire C. C. d, 2015, BIORXIV, DOI [10.1101/032839, DOI 10.1101/032839]
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Goebel S, 2016, J VIROL METHODS, V238, P13, DOI 10.1016/j.jviromet.2016.09.015
   Gomez-Calderon C, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1562-1
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Gupta AK, 2016, SCI REP-UK, V6, DOI 10.1038/srep32713
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hamer DH, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0571-z
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Hercik K, 2017, ARCH VIROL, V162, P2091, DOI 10.1007/s00705-017-3345-x
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   IDENIX PHARM INC, 2004, Patent No. 6812219
   Jemielity S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003232
   Jiang Wen-Ling, 2005, Di Yi Jun Yi Da Xue Xue Bao, V25, P454
   Johansen LM, 2008, WO, Patent No. 2008033466
   Kam YW, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92428
   Khandia R, 2017, INT J PHARMACOL, V13, P370, DOI 10.3923/ijp.2017.370.377
   Kiat TS, 2006, BIOORG MED CHEM LETT, V16, P3337, DOI 10.1016/j.bmcl.2005.12.075
   Kok WM, 2016, EXPERT OPIN DRUG DIS, V11, P433, DOI 10.1517/17460441.2016.1160887
   Kouznetsova J, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.88
   Kuhnel D, 2017, TRANSFUSION, V57, P802, DOI 10.1111/trf.13964
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   LENNARD L, 1992, EUR J CLIN PHARMACOL, V43, P329, DOI 10.1007/BF02220605
   Leonardi W, 2016, SCI REP-UK, V6, DOI 10.1038/srep34475
   Levendosky K, 2015, ANTIMICROB AGENTS CH, V59, P7290, DOI 10.1128/AAC.01816-15
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Lim HJ, 2017, BIOTECHNOL LETT, V39, P415, DOI 10.1007/s10529-016-2261-6
   Lim L., 2016, BIORXIV, DOI [10.1101/078543, DOI 10.1101/078543]
   Lu GF, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01967-16, 10.1128/aac.01967-16]
   Mangia A, 2014, DIGEST LIVER DIS, V46, pS179, DOI 10.1016/j.dld.2014.09.026
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147
   Meneses R, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-8
   Merino-Ramos T, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00376-17, 10.1128/aac.00376-17]
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mounce BC, 2017, ANTIVIR RES, V142, P148, DOI 10.1016/j.antiviral.2017.03.014
   Mukherjee S., 2016, COMMUNIT ACQUIR INFE, V3, P31, DOI [10.4103/2225-6482.184908, DOI 10.4103/2225-6482.184908]
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nixon B, 2013, J VIROL, V87, P6257, DOI 10.1128/JVI.00012-13
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   O'Keefe BR, 2010, J VIROL, V84, P2511, DOI 10.1128/JVI.02322-09
   Onawole AT, 2017, J MOL GRAPH MODEL, V73, P54, DOI 10.1016/j.jmgm.2017.01.018
   Otto M., 2004, Antiviral agents for treatment of flaviviridae infections, Patent No. [US20040266723A1, 20040266723]
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Parida MM, 2002, J ETHNOPHARMACOL, V79, P273, DOI 10.1016/S0378-8741(01)00395-6
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Raghavan P. R., 2016, J IMMUNOL TECH INFEC, V5, P4
   Rainey MM, 2010, GENETICS, V185, P1221, DOI 10.1534/genetics.110.117846
   Ramharack P, 2018, J BIOMOL STRUCT DYN, V36, P1118, DOI 10.1080/07391102.2017.1313175
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Reznik SE, 2017, INT J INFECT DIS, V55, P29, DOI 10.1016/j.ijid.2016.12.011
   Richard AS, 2015, P NATL ACAD SCI USA, V112, P14682, DOI 10.1073/pnas.1508095112
   Robert-Gero M., 1989, NATO ASI SER, V171, DOI [10.1007/978-1-4613-1575-9_110, DOI 10.1007/978-1-4613-1575-9_110]
   Roy A., 2016, BIORXIV, DOI [10.1101/074559, DOI 10.1101/074559]
   Roy S, 2015, PHARMACOGN RES, V7, P263, DOI 10.4103/0974-8490.157977
   Rut W, 2017, ANTIVIR RES, V139, P88, DOI 10.1016/j.antiviral.2016.12.018
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Sahoo Maheswata, 2016, Genomics & Informatics, V14, P104, DOI 10.5808/GI.2016.14.3.104
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00411-17, 10.1128/aac.00411-17]
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Saxena Shailendra K., 2016, VirusDisease, V27, P111, DOI 10.1007/s13337-016-0307-y
   Scaturro P, 2014, J VIROL, V88, P11540, DOI 10.1128/JVI.01745-14
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Silverman JA, 2003, ANTIMICROB AGENTS CH, V47, P2538, DOI 10.1128/AAC.47.8.2538-2544.2003
   Singh RK, 2016, VET QUART, V36, P150, DOI 10.1080/01652176.2016.1188333
   Sirohi D, 2017, MBIO, V8, DOI 10.1128/mBio.00916-17
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Sommadossi J. P., 2011, Compounds and pharmaceutical compositions for the treatment of viral infections, Patent No. [US7951789B2, 7951789]
   Sriwilaijaroen N, 2012, ANTIVIR RES, V94, P139, DOI 10.1016/j.antiviral.2012.02.013
   Stephen P, 2016, J AM CHEM SOC, V138, P16212, DOI 10.1021/jacs.6b10399
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Takebe Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064449
   Tan CW, 2017, ANTIVIR RES, V143, P186, DOI 10.1016/j.antiviral.2017.04.017
   Tang LIC, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-3
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Varghese FS, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02227-16, 10.1128/aac.02227-16]
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wang S, 2017, CELL RES, V27, P158, DOI 10.1038/cr.2016.144
   Williams KL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003157
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Xu Xiaojun, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.9aa2e1fb61b0f632f58a098773008c4b
   Zasloff M, 2011, P NATL ACAD SCI USA, V108, P15978, DOI 10.1073/pnas.1108558108
   Zhang CY, 2017, BIOCHEM BIOPH RES CO, V492, P624, DOI 10.1016/j.bbrc.2016.11.098
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 154
TC 50
Z9 51
U1 3
U2 26
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD AUG 3
PY 2017
VL 8
AR 1469
DI 10.3389/fmicb.2017.01469
PG 19
WC Microbiology
SC Microbiology
GA FC5BA
UT WOS:000406854500001
PM 28824594
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Winkler, CW
   Woods, TA
   Rosenke, R
   Scott, DP
   Best, SM
   Peterson, KE
AF Winkler, Clayton W.
   Woods, Tyson A.
   Rosenke, Rebecca
   Scott, Dana P.
   Best, Sonja M.
   Peterson, Karin E.
TI Sexual and Vertical Transmission of Zika Virus in anti-interferon
   receptor-treated Rag1-deficient mice
SO SCIENTIFIC REPORTS
LA English
DT Article
ID MOUSE MODEL; INFECTION; PREGNANCY; BRAIN; SEMEN; CELLS
AB Although Zika virus (ZIKV) is primarily transmitted to humans by the Aedes aegypti mosquito, human-to-human transmission has also been observed from males-to-females as well as mother-to-offspring. In the current study, we studied both sexual transmission (STx) and vertical transmission (VTx) of ZIKV using anti-IFNAR1-treatment of Rag1(-/-) (AIR) mice. These mice have suppressed type I IFN responses and lack adaptive immune responses, leading to a prolonged infection prior to clinical disease. STx of ZIKV from infected AIR males to naive Ifnar1(-/-) females was observed with greater than 50% incidence, with infection observed in the vaginal tract at early time points. In the case of a resulting pregnancy, virus was also found in the uterus and placental tissue. In additional studies, VTx of virus was observed in AIR female mice. Specifically, peripheral ZIKV infection of pregnant AIR females resulted in detectable virus in brain and/or lymph nodes of fetuses and/or pups. VTx of ZIKV was stochastic, in that not all fetuses/pups within the same dam had detectable virus and infection was not associated with breakdown of maternal/fetal placental barrier. This provides a new model to study the barriers to STx and VTx of ZIKV and the immune responses essential to preventing transmission.
C1 [Winkler, Clayton W.; Woods, Tyson A.; Peterson, Karin E.] NIAID, NIH, Rocky Mt Labs, Lab Persistent Viral Dis, Hamilton, MT 59840 USA.
   [Rosenke, Rebecca; Scott, Dana P.] NIAID, NIH, Rocky Mt Vet Branch, Rocky Mt Labs, Hamilton, MT 59840 USA.
   [Best, Sonja M.] NIAID, NIH, Rocky Mt Labs, Lab Virol, Hamilton, MT 59840 USA.
RP Peterson, KE (corresponding author), NIAID, NIH, Rocky Mt Labs, Lab Persistent Viral Dis, Hamilton, MT 59840 USA.
EM petersonka@niaid.nih.gov
RI Winkler, Clayton/F-8031-2018
OI Winkler, Clayton/0000-0002-4460-3378
FU National Institute of Allergy and Infectious Diseases, Division of
   Intramural ResearchUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID)
FX This work was supported by the National Institute of Allergy and
   Infectious Diseases, Division of Intramural Research. The authors would
   like to thank Ryan Kissinger and Anita Mora for assistance with
   graphics, Nancy Kurtz and Dan Long for assistance with histology, Brent
   Race and Katie Phillips for assistance/guidance with ultrasound analysis
   and Gail Sturdevant for assistance with vaginal swabs. We also thank the
   RMVB staff, particularly Donna Norton, Shelby Malingo and Maarit von
   Kutzleben for outstanding care and husbandry of the immunocompromised
   mice used in these studies.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Bayer SA, 1991, NEOCORTICAL DEV
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Butchi NB, 2008, J IMMUNOL, V180, P7604, DOI 10.4049/jimmunol.180.11.7604
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Ornelas AMM, 2017, ANN NEUROL, V81, P152, DOI 10.1002/ana.24839
   Penn D, 1998, ETHOLOGY, V104, P685, DOI 10.1111/j.1439-0310.1998.tb00102.x
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Siu R, 2016, NEUROLOGY, V87, P1623, DOI 10.1212/WNL.0000000000003038
   Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4
   Vazquez MI, 2015, CYTOKINE, V74, P318, DOI 10.1016/j.cyto.2015.02.007
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Winkler C, 2015, ACTA NEUROPATHOL, V130, P233, DOI 10.1007/s00401-015-1433-0
   Wu J, 2016, CHINESE MED J-PEKING, V129, P2347, DOI 10.4103/0366-6999.190672
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 27
TC 22
Z9 22
U1 0
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 3
PY 2017
VL 7
AR 7176
DI 10.1038/s41598-017-07099-7
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FC5NR
UT WOS:000406889500005
PM 28775298
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Leslie, TE
   Carson, M
   van Coeverden, E
   De Klein, K
   Braks, M
   Krumeich, A
AF Leslie, Teresa E.
   Carson, Marianne
   van Coeverden, Els
   De Klein, Kirsten
   Braks, Marieta
   Krumeich, Anja
TI An analysis of community perceptions of mosquito-borne disease control
   and prevention in Sint Eustatius, Caribbean Netherlands
SO GLOBAL HEALTH ACTION
LA English
DT Article
DE Dengue; Chikungunya; Zika; community participation; prevention
ID AEDES-AEGYPTI; PUERTO-RICO; HONEY-BEES; KNOWLEDGE; DENGUE; PERMETHRIN;
   ATTITUDES; BEHAVIOR
AB Background: In the Caribbean, mosquito-borne diseases are a public health threat. In Sint Eustatius, dengue, Chikungunya and Zika are now endemic. To control and prevent mosquito-borne diseases, the Sint Eustatius Public Health Department relies on the community to assist with the control of Aedes aegypti mosquito. Unfortunately, community based interventions are not always simple, as community perceptions and responses shape actions and influence behavioural responses
   Objective: The aim of this study was to determine how the Sint Eustatius population perceives the Aedes aegypti mosquito, mosquito-borne diseases and prevention and control measures and hypothesized that increased knowledge of the virus, vector, control and prevention should result in a lower AQ1 prevalence and incidence of mosquito-borne diseases.
   Methods: This study was conducted in Sint Eustatius island in the Eastern Caribbean. We combined qualitative and quantitative designs. We conducted interviews and focus groups discussions among community member and health professional in 2013 and 2015. We also conducted cross-sectional survey to assess local knowledge on the vector, virus, and control and prevention.
   Results: The population is knowledgeable; (C) however, mosquito-borne diseases are not the highest health priority. While local knowledge is sometimes put into action, it happens on the 20 household/individual level as opposed to the community level. After the 2014 CHIK outbreak, there was an increase in knowledge about mosquito control and mosquito-borne diseases. Discussion: In the context of Sint Eustatius, when controlling the Aedes population it may be a strategic option to focus on the household level rather than the community and build collaborations with households by supporting them when they actively practice mosquito 25 control. To further increase the level of knowledge on the significance of mosquito-borne diseases, it may also be an option to contextualize the issue of the virus, vector, prevention and control into a broader context.
   Conclusion: As evidenced by the increasing number of mosquito-borne diseases on the island, it appears that knowledge amongst the lay community may not be transferred into 30 action. This may be attributed to the perception of the Sint Eustatius populations that mosquitoes and the viruses they carry are not a high priority in comparison to other health concerns.
C1 [Leslie, Teresa E.] Eastern Caribbean Publ Hlth Fdn, Sint Eustaitus, Caribbean Nethe, Netherlands.
   [Carson, Marianne] Royal Vet Coll, Pathobiol & Populat Studies, London, England.
   [van Coeverden, Els; De Klein, Kirsten] Wageningen Univ, Dept Social Sci, Wageningen, Netherlands.
   [Braks, Marieta] RIVM, Bilthoven, Netherlands.
   [Krumeich, Anja] Univ Maastricht, Hlth Med & Life Sci, Maastricht, Netherlands.
RP Leslie, TE (corresponding author), Eastern Caribbean Publ Hlth Fdn, Sint Eustaitus, Caribbean Nethe, Netherlands.
EM tleslie612@gmail.com
CR Aertsens J, 2011, BRIT FOOD J, V113, P1353, DOI 10.1108/00070701111179988
   [Anonymous], 2012, GLOB STRAT DENG PREV
   Banerjee S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138082
   Couch WJ, 2013, THESIS
   COX RL, 1984, ENVIRON ENTOMOL, V13, P375, DOI 10.1093/ee/13.2.375
   Das JK, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-24
   Davidson AR, 1995, ATTITUDE STRENGTH AN, V4, P315
   Fabrigar LR, 2006, J PERS SOC PSYCHOL, V90, P556, DOI 10.1037/0022-3514.90.4.556
   Frankel R M, 2000, Educ Health (Abingdon), V13, P251
   Ghosh A, 2013, J MOSQUITO RES, V3, P54, DOI DOI 10.5376/JMR.2013.03.0007
   Gubler DJ, 1996, ACTA TROP, V61, P169, DOI 10.1016/0001-706X(95)00103-L
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Guzman MG, 2013, DENGUE AM REGION
   Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039
   Kasai S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002948
   Kleinman A., 1988, ILLNESS NARRATIVES S
   Kulkarni RR, 2017, INT J COMMUNITY MED, V4, P1039
   Kumar R, 2003, J EPIDEMIOL COMMUN H, V57, P392, DOI 10.1136/jech.57.5.392
   Lakshman M., 2000, Indian Journal of Pediatrics, V67, P358, DOI 10.1007/BF02820688
   Leslie T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095002
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   PAHO, 2007, PAHO HLTH AM CTRIES, V2, P495
   PAHO, 2012, NETH ANT HLTH AM COU
   Parks W., 2004, PLANNING SOCIAL MOBI
   Perez-Guerra CL, 2009, REV PANAM SALUD PUBL, V25, P218, DOI 10.1590/S1020-49892009000300005
   Perez-Guerra CL, 2005, REV PANAM SALUD PUBL, V17, P243, DOI 10.1590/S1020-49892005000400005
   Phuanukoonnon S, 2006, ACTA TROP, V99, P6, DOI 10.1016/j.actatropica.2006.05.012
   Reeves S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1020
   Ryan G. W., 2003, FIELD METHOD, V15, P85, DOI DOI 10.1177/1525822X02239569
   Shuaib F, 2010, W INDIAN MED J, V59, P139
   Spiegel Jerry, 2005, EcoHealth, V2, P273, DOI 10.1007/s10393-005-8388-x
   Stewart D.W., 2006, FOCUS GROUPS THEORY
   Ibarra AMS, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1135
   Whiteford LM, 1997, MED ANTHROPOL Q, V11, P202, DOI 10.1525/maq.1997.11.2.202
   WHO-World Health Organization, 2013, GLOB AL RESP IMP DEN
   Wood W., 1995, ATTITUDE STRENGTH AN, P283
   World Health Organization, 2009, INT MAN STRAT DENG P
   World Health Organization, GUID DIAGN TREATM PR
   Yang T, 2013, J MED ENTOMOL, V50, P585, DOI 10.1603/ME12198
   Zaidi SHN, 2012, J PUBLIC HLTH RES DE, V3, P57
NR 40
TC 6
Z9 7
U1 0
U2 8
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1654-9880
J9 GLOBAL HEALTH ACTION
JI Glob. Health Action
PD AUG 2
PY 2017
VL 10
IS 1
AR 1350394
DI 10.1080/16549716.2017.1350394
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FD2BU
UT WOS:000407341200001
PM 28766466
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Krystosik, AR
   Curtis, A
   Buritica, P
   Ajayakumar, J
   Squires, R
   Davalos, D
   Pacheco, R
   Bhatta, MP
   James, MA
AF Krystosik, Amy R.
   Curtis, Andrew
   Buritica, Paola
   Ajayakumar, Jayakrishnan
   Squires, Robert
   Davalos, Diana
   Pacheco, Robinson
   Bhatta, Madhav P.
   James, Mark A.
TI Community context and sub-neighborhood scale detail to explain dengue,
   chikungunya and Zika patterns in Cali, Colombia
SO PLOS ONE
LA English
DT Article
ID GOOGLE STREET VIEW; AEDES-AEGYPTI; INFORMATION-SYSTEMS; SEXUAL
   TRANSMISSION; VIRUS TRANSMISSION; PUBLIC-HEALTH; MAPPING ZIKA; BURDEN;
   SURVEILLANCE; INFECTION
AB Background
   Cali, Colombia has experienced chikungunya and Zika outbreaks and hypoendemic dengue. Studies have explained Cali's dengue patterns but lack the sub-neighborhood-scale detail investigated here.
   Methods
   Spatial-video geonarratives (SVG) with Ministry of Health officials and Community Health Workers were collected in hotspots, providing perspective on perceptions of why dengue, chikungunya and Zika hotspots exist, impediments to control, and social outcomes. Using spatial video and Google Street View, sub-neighborhood features possibly contributing to incidence were mapped to create risk surfaces, later compared with dengue, chikungunya and Zika case data.
   Results
   SVG captured insights in 24 neighborhoods. Trash and water risks in Calipso were mapped using SVG results. Perceived risk factors included proximity to standing water, canals, poverty, invasions, localized violence and military migration. These risks overlapped case density maps and identified areas that are suitable for transmission but are possibly under-reporting to the surveillance system.
   Conclusion
   Resulting risk maps with local context could be leveraged to increase vector-control efficiency-targeting key areas of environmental risk.
C1 [Krystosik, Amy R.; Bhatta, Madhav P.; James, Mark A.] Kent State Univ, Coll Publ Hlth, Dept Biostat Environm Hlth Sci & Epidemiol, Kent, OH 44242 USA.
   [Curtis, Andrew; Ajayakumar, Jayakrishnan; Squires, Robert] Kent State Univ, Dept Geog, Hlth & Hazards Lab, Kent, OH 44242 USA.
   [Buritica, Paola; Pacheco, Robinson] Univ Libre, Grp Invest Epidemiol & Serv GRIEPIS, Cali, Colombia.
   [Davalos, Diana; Pacheco, Robinson] Univ ICESI, Dept Publ Hlth & Community Med, Cali, Valle Del Cauca, Colombia.
   [Davalos, Diana; Pacheco, Robinson] FVL, Ctr Clin Res, Cali, Valle Del Cauca, Colombia.
   [Krystosik, Amy R.] Stanford Univ, Sch Med, Dept Pediat Infect Dis, Stanford, CA 94305 USA.
RP Krystosik, AR (corresponding author), Kent State Univ, Coll Publ Hlth, Dept Biostat Environm Hlth Sci & Epidemiol, Kent, OH 44242 USA.; Krystosik, AR (corresponding author), Stanford Univ, Sch Med, Dept Pediat Infect Dis, Stanford, CA 94305 USA.
EM akrystos@stanford.edu
RI Curtis, Andrew/U-8674-2019
CR Adhvaryu A, 2015, AM ECON J-ECON POLIC, V7, P29, DOI 10.1257/pol.20120262
   Villar LA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003499
   Armitage Cadavid M, 2015, CALI IN NUMBERS
   Aviles G, 1999, EMERG INFECT DIS, V5, P575, DOI 10.3201/eid0504.990424
   Barreto ML, 2011, LANCET, V377, P1877, DOI 10.1016/S0140-6736(11)60202-X
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Cardona-Ospina JA, 2015, J CLIN VIROL, V70, P14, DOI 10.1016/j.jcv.2015.07.001
   Casas I, 2016, J TRANSPORT HLTH
   Rodriguez RC, 2016, AM J TROP MED HYG, V94, P1065, DOI 10.4269/ajtmh.15-0280
   Centers for Disease Control and Prevention, 2016, FREQ ASK QUEST
   Centers for Disease Control and Prevention, 2016, GEOGR DISTR CHIK VIR
   Chaikoolvatana A., 2013, Dengue Bulletin, V37, P123
   Chretien JP, 2007, AM J TROP MED HYG, V76, P405, DOI 10.4269/ajtmh.2007.76.405
   Curtis A, 2016, ANN AM ASSOC GEOGR, P1
   Curtis A, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13020187
   Curtis A, 2015, INT J HEALTH GEOGR, V14, DOI 10.1186/s12942-015-0014-8
   Curtis A, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-21
   Curtis A, 2012, APPL GEOGR, V32, P393, DOI 10.1016/j.apgeog.2011.06.002
   Curtis A, 2011, URBAN GEOGR, V32, P488, DOI 10.2747/0272-3638.32.4.488
   Curtis JW, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-53
   Delmelle E, 2016, ACTA TROP, V164, P169, DOI 10.1016/j.actatropica.2016.08.028
   Delmelle EM, 2014, APPL GEOGR, V52, P144, DOI 10.1016/j.apgeog.2014.05.007
   Dickin SK, 2014, APPL GEOGR, V46, P71, DOI 10.1016/j.apgeog.2013.11.003
   Ferreira-de-Brito A, 2016, MEMORIAS I O CRUZ
   Fredericks AC, 2014, ANN GLOB HEALTH, V80, P466, DOI 10.1016/j.aogh.2015.02.006
   Freour T., 2016, EURO SURVEILL, V21
   Garcia-Rejon J, 2008, AM J TROP MED HYG, V79, P940, DOI 10.4269/ajtmh.2008.79.940
   Globovision, 2015, COL ANN END CHIK EP
   GRIEW P, 2013, INT J BEHAV NUTR PHY, V10, P1
   Gualberto Danny, 2015, Advances in Environmental Biology, V9, P1
   Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013
   Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6
   Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2
   Hagenlocher M, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-36
   Hamer GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023767
   Hernandez M, 2016, BIOMEDICA, V36, P98, DOI 10.7705/biomedica.v36i0.2934
   Instituto Nacional de Salud, 2016, B EP SEM
   Instituto Nacional de Salud, 2016, B EP SEM 30, V30
   Instituto National de Salud, 2015, EP B
   Jeelani S, 2015, PUBLIC HEALTH, V129, P790, DOI 10.1016/j.puhe.2015.02.026
   Jimenez-Canizales Carlos E, 2015, Recent Pat Antiinfect Drug Discov, V10, P64
   Kienberger S, 2013, GEOSPATIAL HEALTH, V8, P313, DOI 10.4081/gh.2013.76
   LaBeaud AD, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-1
   Laiton-Donato K, 2016, BIOMEDICA, V36, P25, DOI 10.7705/biomedica.v36i0.2990
   Lee VJ, 2012, PLOS NEGL TROP DIS, V6, DOI 10.1371/journal.pntd.0001786
   Lourenco-de-Oliveira R, 2002, MEM I OSWALDO CRUZ, V97, P799, DOI 10.1590/S0074-02762002000600009
   Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Ministerio de Salud y Proteccio A n Social, 2015, MIN SAL PROT SOC 201
   Ministerio de Salud y Proteccio A n Social, PATT END DENG 2008 2
   Morrison AC, 2004, J MED ENTOMOL, V41, P1123, DOI 10.1603/0022-2585-41.6.1123
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Ndeffo-Mbah ML, 2016, SCI REPORTS, P6
   NNBaR Sultana, 2013, ENTOMOLOGICAL INVEST
   Nsoesie EO, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.20.30234
   Pan American Health Organization, 2015, PAIS TERR CON CAS CO
   Pan American Health Organization, 2011, PREP RESP CHIK VIR I
   Paniz-Mondolfi AE, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0157-x
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   PENCHANSKY R, 1981, MED CARE, V19, P127, DOI 10.1097/00005650-198102000-00001
   Pontes RJS, 2000, AM J TROP MED HYG, V62, P378, DOI 10.4269/ajtmh.2000.62.378
   Powers AM, 2015, J GEN VIROL, V96, P1, DOI 10.1099/vir.0.070136-0
   Quintero J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-38
   Restrepo AC, 2014, TROP MED INT HEALTH, V19, P863, DOI 10.1111/tmi.12325
   Rodriguez-Morales AJ, 2017, INFECTION, V45, P93, DOI 10.1007/s15010-016-0948-1
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P286, DOI 10.1016/j.tmaid.2016.03.018
   Rodriguez-Morales AJ, 2016, INT J INFECT DIS, V48, P70, DOI 10.1016/j.ijid.2016.05.012
   Rodriguez-Morales Alfonso J, 2016, F1000Res, V5, P568, DOI 10.12688/f1000research.8436.1
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P62, DOI 10.1016/j.tmaid.2015.06.009
   Rodriguez-Morales AJ, 2015, TRAVEL MED INFECT DI, V13, P256, DOI 10.1016/j.tmaid.2015.05.007
   Ruiz-Moreno D., 2012, PLoS Neglected Tropical Diseases, V6, pe1918, DOI 10.1371/journal.pntd.0001918
   Rundle AG, 2011, AM J PREV MED, V40, P94, DOI 10.1016/j.amepre.2010.09.034
   Sarti E, 2016, INT J INFECT DIS, V44, P44, DOI 10.1016/j.ijid.2016.01.015
   Secretaria de Salud, 2016, VIR ZIK CAL DESC SUS
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   Smiley LS, 2017, TROPICAL MED INFECT, V2
   Soumahoro M-K, 2010, EMERGING INFECT DIS, V16
   Spiegel Jerry, 2005, EcoHealth, V2, P273, DOI 10.1007/s10393-005-8388-x
   Tami A, 2016, TRAVEL MED INFECT DI, V14, P9, DOI 10.1016/j.tmaid.2016.01.002
   Tapia-Conyer R, 2009, J CLIN VIROL, V46, pS3, DOI 10.1016/S1386-6532(09)70286-0
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002
   Thiboutot MM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000623
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Wen TH, 2015, APPL GEOGR, V62, P256, DOI 10.1016/j.apgeog.2015.05.003
   WHO, 2015, CHIK FACT SHEET, V17, P50
   WHO, WHO DIR GEN SUMM OUT, V32, P43
   WHO, 2016, ZIK SIT REP, V15, P41
   Yoon IK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001730
   Zambrano LI, 2016, J INFECT PUBLIC HLTH
NR 90
TC 14
Z9 14
U1 2
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 2
PY 2017
VL 12
IS 8
AR e0181208
DI 10.1371/journal.pone.0181208
PG 25
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FC3VT
UT WOS:000406768200020
PM 28767730
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Covington, D
   Buus, R
AF Covington, Deborah
   Buus, Rebecca
TI ZIKA Virus: Implications for Pregnancy Exposure Registries
SO PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
LA English
DT Meeting Abstract
C1 [Covington, Deborah; Buus, Rebecca] Evidera, Wilmington, NC USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1053-8569
EI 1099-1557
J9 PHARMACOEPIDEM DR S
JI Pharmacoepidemiol. Drug Saf.
PD AUG
PY 2017
VL 26
SU 2
MA 498
BP 301
EP 301
PG 1
WC Public, Environmental & Occupational Health; Pharmacology & Pharmacy
SC Public, Environmental & Occupational Health; Pharmacology & Pharmacy
GA GL4FM
UT WOS:000437104300096
DA 2020-07-08
ER

PT J
AU Yang, H
   Chada, K
   Huang, Y
   Forshee, R
   Anderson, S
AF Yang, Hong
   Chada, Kinnera
   Huang, Yin
   Forshee, Richard
   Anderson, Steve
TI Risk Assessment for Transfusion-Transmission of ZIKA Virus (TTZIKV) in
   Puerto Rico
SO PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
LA English
DT Meeting Abstract
C1 [Yang, Hong; Chada, Kinnera; Huang, Yin; Forshee, Richard; Anderson, Steve] US FDA, Silver Spring, MD USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1053-8569
EI 1099-1557
J9 PHARMACOEPIDEM DR S
JI Pharmacoepidemiol. Drug Saf.
PD AUG
PY 2017
VL 26
SU 2
MA 1017
BP 612
EP 612
PG 1
WC Public, Environmental & Occupational Health; Pharmacology & Pharmacy
SC Public, Environmental & Occupational Health; Pharmacology & Pharmacy
GA GL4FM
UT WOS:000437104300613
DA 2020-07-08
ER

PT J
AU Rogers, TF
   Goodwin, EC
   Briney, B
   Sok, D
   Beutler, N
   Strubel, A
   Nedellec, R
   Le, K
   Brown, ME
   Burton, DR
   Walker, LM
AF Rogers, Thomas F.
   Goodwin, Eileen C.
   Briney, Bryan
   Sok, Devin
   Beutler, Nathan
   Strubel, Alexander
   Nedellec, Rebecca
   Le, Khoa
   Brown, Michael E.
   Burton, Dennis R.
   Walker, Laura M.
TI Zika virus activates de novo and cross-reactive memory B cell responses
   in dengue-experienced donors
SO SCIENCE IMMUNOLOGY
LA English
DT Article
ID ORIGINAL ANTIGENIC SIN; ANTIBODY-DEPENDENT ENHANCEMENT; NEUTRALIZING
   HUMAN-ANTIBODIES; MONOCLONAL-ANTIBODIES; ENVELOPE PROTEIN; HIGH
   SPECIFICITY; STRUCTURAL BASIS; INFECTION; VACCINE; POTENT
AB Zika virus (ZIKV) shares a high degree of homology with dengue virus (DENV), suggesting that preexisting immunity to DENV could affect immune responses to ZIKV. We have tracked the evolution of ZIKV-induced B cell responses in three DENV-experienced donors. The acute antibody (plasmablast) responses were characterized by relatively high somatic hypermutation and a bias toward DENV binding and neutralization, implying the early activation of DENV clones. A DENV-naive donor in contrast showed a classical primary plasmablast response. Five months after infection, the DENV-experienced donors developed potent type-specific ZIKV neutralizing antibody responses in addition to DENV cross-reactive responses. Because cross-reactive responses were poorly neutralizing and associated with enhanced ZIKV infection in vitro, preexisting DENV immunity could negatively affect protective antibody responses to ZIKV. The observed effects are epitope-dependent, suggesting that a ZIKV vaccine should be carefully designed for DENV-seropositive populations.
C1 [Rogers, Thomas F.; Briney, Bryan; Sok, Devin; Beutler, Nathan; Strubel, Alexander; Nedellec, Rebecca; Le, Khoa; Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.
   [Goodwin, Eileen C.; Brown, Michael E.; Walker, Laura M.] Adimab LLC, Lebanon, NH 03766 USA.
   [Burton, Dennis R.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.
RP Burton, DR (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.; Walker, LM (corresponding author), Adimab LLC, Lebanon, NH 03766 USA.; Burton, DR (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.
EM burton@scripps.edu; laura.walker@adimab.com
OI Burton, Dennis/0000-0001-6711-9864; Strubel,
   Alexander/0000-0002-8175-962X; Beutler, Nathan/0000-0003-3240-9524
FU Defense Advanced Research Projects Agency (DARPA)United States
   Department of DefenseDefense Advanced Research Projects Agency (DARPA)
   [W31P4Q-13-1-0011]
FX This work was supported by a grant from the Defense Advanced Research
   Projects Agency (DARPA) Autonomous Diagnostics to Enable Prevention and
   Therapeutics: Prophylactic Options to Environmental and Contagious
   Threats (ADEPT-PROTECT) program (W31P4Q-13-1-0011).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blanchard-Rohner G, 2009, BLOOD, V114, P4998, DOI 10.1182/blood-2009-03-211052
   Bornholdt ZA, 2016, SCIENCE, V351, P1078, DOI 10.1126/science.aad5788
   Brien James D, 2013, Curr Protoc Microbiol, V31, DOI 10.1002/9780471729259.mc15d03s31
   Briney B, 2016, SCI REP-UK, V6, DOI 10.1038/srep23901
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Castanha P. M. S., 2016, J INFECT DIS, V2016, P1
   Choi YS, 2011, CLIN VACCINE IMMUNOL, V18, P1519, DOI 10.1128/CVI.05053-11
   Dejnirattisai W., 2017, SCI IMMUNOL, V2
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   DESTGROTH SF, 1966, J EXP MED, V124, P331, DOI 10.1084/jem.124.3.331
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Durbin AP, 2016, TRENDS IMMUNOL, V37, P635, DOI 10.1016/j.it.2016.08.006
   Fuss Ivan J, 2009, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0701s85
   Garcia-Bates TM, 2013, J IMMUNOL, V190, P80, DOI 10.4049/jimmunol.1103350
   GENTRY MK, 1982, AM J TROP MED HYG, V31, P548, DOI 10.4269/ajtmh.1982.31.548
   Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13
   HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Kim JH, 2009, J IMMUNOL, V183, P3294, DOI 10.4049/jimmunol.0900398
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lee FEH, 2011, J IMMUNOL, V186, P5514, DOI 10.4049/jimmunol.1002932
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   McHeyzer-Williams LJ, 2015, NAT IMMUNOL, V16, P296, DOI 10.1038/ni.3095
   Midgley CM, 2011, J VIROL, V85, P410, DOI 10.1128/JVI.01826-10
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06
   Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Priyamvada L, 2016, J VIROL, V90, P5574, DOI 10.1128/JVI.03203-15
   Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Simmons CP, 2007, J INFECT DIS, V196, P416, DOI 10.1086/519170
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017
   Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890
   Wrammert J, 2012, J VIROL, V86, P2911, DOI 10.1128/JVI.06075-11
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zuccarino-Catania GV, 2014, NAT IMMUNOL, V15, P631, DOI 10.1038/ni.2914
NR 56
TC 37
Z9 37
U1 0
U2 4
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 2470-9468
J9 SCI IMMUNOL
JI Sci. Immunol.
PD AUG
PY 2017
VL 2
IS 14
AR eaan6809
DI 10.1126/sciimmunol.aan6809
PG 12
WC Immunology
SC Immunology
GA GI4FN
UT WOS:000434326500004
PM 28821561
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Tekola, B
   Myers, L
   Lubroth, J
   Plee, L
   Calistri, P
   Pinto, J
AF Tekola, B.
   Myers, L.
   Lubroth, J.
   Plee, L.
   Calistri, P.
   Pinto, J.
TI International health threats and global early warning and response
   mechanisms
SO REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES
LA English
DT Article
DE Early detection; Early warning; Food and Agriculture Organization of the
   United Nations; Global health; One Health; Preparedness; Prevention;
   Response; Surveillance
ID DISEASE
AB The global community continues to incur the high costs of crisis mitigation and emergency response to outbreaks of emerging infectious diseases, such as those caused by the H5N1 highly pathogenic avian influenza virus, Ebola virus, Nipah virus, Zika virus or the Middle East respiratory syndrome coronavirus. These viruses are particularly dangerous in regions associated with poor development indicators and high vulnerability. The drivers of these disease crises include failures in the way that animal diseases are detected and reported and failures in the way in which disease response is implemented by animal health and public health systems. In addition, the lack of a coordinated response hampers disease control efforts.
   A comprehensive approach for disease prevention, detection and response, however, requires a coordinated and joint effort among governments, communities, donors and international networks to invest effectively in prevention systems that can identify early signals of the emergence, spillover and spread of animal pathogens at the local level. These signals include trade bans, market closures, civil unrest, heavy rains and droughts associated with climate change, and livestock intensification or changes in consumer behaviour.
   The global community needs to increase its investment in early warning and detection systems that can provide information that enables action to be taken at the national, regional and global levels in the event of an outbreak of a transboundary animal disease (TAD). Like any preventive measure, an early warning system requires financial resources, but these are insignificant when compared to the losses that are avoided. Building a global early warning and effective response system for outbreaks is value for money, as the benefits far outweigh the costs.
   The goal of the Food and Agriculture Organization of the United Nations (FAO) is to end hunger and poverty, which is a challenging and complex task. Building global capacity to prepare for and respond to TADs is an important element of the FAO's strategic objective to increase the resilience of livelihoods to threats and crises. Each year, livestock, and the people who rely upon them for their livelihoods, are confronted with animal disease and crises. They can strike suddenly, causing obvious illness and death, or emerge insidiously and become well established before becoming apparent. Animal disease emergencies threaten the production of, and access to, food; consequently, one of the FAO's missions is to help countries to prepare for and respond to animal health disasters.
C1 [Tekola, B.; Myers, L.; Lubroth, J.; Plee, L.; Calistri, P.; Pinto, J.] United Nations, FAO, Anim Prod & Hlth Div, Rome, Italy.
RP Tekola, B (corresponding author), United Nations, FAO, Anim Prod & Hlth Div, Rome, Italy.
EM b.tekola@fao.org
CR Brownstein JS, 2008, PLOS MED, V5, P1019, DOI 10.1371/journal.pmed.0050151
   FAO-Food and Agriculture Organization; World Organization for Animal Health (OIE) and World Health Organization (WHO), 2013, GLEWS JOINT FAO OIE
   Food and Agriculture Organization of the United Nations (FAO), 2011, GOOD EM MAN PRACT ES
   Food and Agriculture Organization of the United Nations (FAO), 2014, CMC AH ACT REP
   Food and Agriculture Organization of the United Nations (FAO of the UN), 2013, WORLD LIV 2013 CHANG
   Jones BA, 2013, P NATL ACAD SCI USA, V110, P8399, DOI 10.1073/pnas.1208059110
   Karesh WB, 2012, LANCET, V380, P1936, DOI 10.1016/S0140-6736(12)61678-X
   Knight-Jones TJD, 2013, PREV VET MED, V112, P161, DOI 10.1016/j.prevetmed.2013.07.013
   Tambi NE, 2006, REV SCI TECH OIE, V25, P999, DOI 10.20506/rst.25.3.1710
   World Organisation for Animal Health (OIE), 2013, OIE PVS EV REP
NR 10
TC 1
Z9 1
U1 11
U2 28
PU OFFICE INT EPIZOOTIES
PI PARIS
PA 12 RUE DE PRONY, 75017 PARIS, FRANCE
SN 0253-1933
J9 REV SCI TECH OIE
JI Rev. Sci. Tech. Off. Int. Epizoot.
PD AUG
PY 2017
VL 36
IS 2
BP 657
EP 670
DI 10.20506/rst.36.2.2683
PG 14
WC Veterinary Sciences
SC Veterinary Sciences
GA FS6SZ
UT WOS:000419928700024
PM 30152454
DA 2020-07-08
ER

PT J
AU Chung, HN
   Rodriguez, SD
   Carpenter, VK
   Vulcan, J
   Bailey, CD
   Nageswara-Rao, M
   Li, YY
   Attardo, GM
   Hansen, IA
AF Chung, Hae-Na
   Rodriguez, Stacy D.
   Carpenter, Victoria K.
   Vulcan, Julia
   Bailey, C. Donovan
   Nageswara-Rao, Madhugiri
   Li, Yiyi
   Attardo, Geoffrey M.
   Hansen, Immo A.
TI Fat Body Organ Culture System in Aedes Aegypti, a Vector of Zika Virus
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Infectious Diseases; Issue 126; Fat body; organ culture; mosquitoes;
   Aedes aegypti; nutrition; vitellogenesis
ID AMINO-ACID TRANSPORTERS; HUMAN IMMUNE-RESPONSES; JUVENILE-HORMONE;
   MALARIA VACCINES; MOSQUITO; VITELLOGENESIS; ACCUMULATION; REPRODUCTION;
   EXPRESSION; ANAUTOGENY
AB The insect fat body plays a central role in insect metabolism and nutrient storage, mirroring functions of the liver and fat tissue in vertebrates. Insect fat body tissue is usually distributed throughout the insect body. However, it is often concentrated in the abdomen and attached to the abdominal body wall.
   The mosquito fat body is the sole source of yolk proteins, which are critical for egg production. Therefore, the in vitro culture of mosquito fat body tissues represents an important system for the study of mosquito physiology, metabolism, and, ultimately, egg production. The fat body culture process begins with the preparation of solutions and reagents, including amino acid stock solutions, Aedes physiological saline salt stock solution (APS), calcium stock solution, and fat body culture medium. The process continues with fat body dissection, followed by an experimental treatment. After treatment, a variety of different analyses can be performed, including RNA sequencing (RNA-Seq), qPCR, Western blots, proteomics, and metabolomics.
   In our example experiment, we demonstrate the protocol through the excision and culture of fat bodies from the yellow fever mosquito, Aedes aegypti, a principal vector of arboviruses including dengue, chikungunya, and Zika. RNA from fat bodies cultured under a physiological condition known to upregulate yolk proteins versus the control were subject to RNA-Seq analysis to demonstrate the potential utility of this procedure for investigations of gene expression.
C1 [Chung, Hae-Na; Rodriguez, Stacy D.; Vulcan, Julia; Bailey, C. Donovan; Nageswara-Rao, Madhugiri; Hansen, Immo A.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.
   [Carpenter, Victoria K.] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC 27706 USA.
   [Li, Yiyi] New Mexico State Univ, Dept Comp Sci, Las Cruces, NM 88003 USA.
   [Attardo, Geoffrey M.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Hansen, Immo A.] New Mexico State Univ, Inst Appl Biosci, Las Cruces, NM 88003 USA.
RP Hansen, IA (corresponding author), New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.; Hansen, IA (corresponding author), New Mexico State Univ, Inst Appl Biosci, Las Cruces, NM 88003 USA.
EM immoh@nmsu.edu
OI Attardo, Geoffrey/0000-0001-6265-2969
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [SC1AI109055]; NMSU HHMI [52008103];
   NSF PGR [1238731]
FX This research was supported by NIH grant #SC1AI109055, the 2014 NMSU
   HHMI grant #52008103, and NSF PGR grant #1238731. We thank the
   participants of the NMSU Spring 2015 BIOL302 Molecular Methods class and
   Lavesh Bhatia for their technical support with the fat body culture
   experiments.
CR Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356
   Attardo GM, 2006, J EXP BIOL, V209, P3071, DOI 10.1242/jeb.02349
   Attardo GM, 2003, P NATL ACAD SCI USA, V100, P13374, DOI 10.1073/pnas.2235649100
   Benelli G, 2016, PARASITOL RES, V115, P1747, DOI 10.1007/s00436-016-4971-z
   Boudko DY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9546
   Carpenter VK, 2012, J INSECT PHYSIOL, V58, P513, DOI 10.1016/j.jinsphys.2012.01.005
   Chandrasekar R., 2009, SHORT VIEWS INSECT M
   CHOMCZYNSKI P, 1995, BIOTECHNIQUES, V19, P942
   Clements A. N., 1992, BIOL MOSQUITOES, V2
   Fleischer J, 2015, CELL TISSUE RES, V361, P697, DOI 10.1007/s00441-015-2165-0
   FRINGS S, 1988, J MEMBRANE BIOL, V105, P233, DOI 10.1007/BF01871000
   Froese A, 2014, J COMP PHYSIOL A, V200, P183, DOI 10.1007/s00359-013-0877-8
   Fujiwara T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089132
   Hansen IA, 2005, J BIOL CHEM, V280, P20565, DOI 10.1074/jbc.M500712200
   Hansen IA, 2004, P NATL ACAD SCI USA, V101, P10626, DOI 10.1073/pnas.0403460101
   Hansen IA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00103
   HAYES RO, 1953, J ECON ENTOMOL, V46, P624, DOI 10.1093/jee/46.4.624
   Hughes GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036277
   Hugo LE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058656
   JONES KH, 1985, J HISTOCHEM CYTOCHEM, V33, P77, DOI 10.1177/33.1.2578146
   JUDY KJ, 1973, P NATL ACAD SCI USA, V70, P1509, DOI 10.1073/pnas.70.5.1509
   LARSEN WP, 1967, J INSECT PHYSIOL, V13, P613, DOI 10.1016/0022-1910(67)90072-8
   Long CA, 2016, CURR OPIN MICROBIOL, V32, P96, DOI 10.1016/j.mib.2016.04.006
   MARKS EP, 1970, GEN COMP ENDOCR, V15, P289, DOI 10.1016/0016-6480(70)90078-X
   MENDIS KN, 1990, INT J PARASITOL, V20, P497, DOI 10.1016/0020-7519(90)90197-U
   Newby G, 2016, LANCET, V387, P1775, DOI 10.1016/S0140-6736(16)00230-0
   POSTLETHWAIT JH, 1979, J INSECT PHYSIOL, V25, P455, DOI 10.1016/0022-1910(79)90014-3
   Price DP, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0863-9
   Price DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022573
   Raikhel A. S., 1997, The molecular biology of insect disease vectors: a methods manual., P507
   Raikhel AS, 2002, INSECT BIOCHEM MOLEC, V32, P1275, DOI 10.1016/S0965-1748(02)00090-5
   RAIKHEL AS, 1992, ANNU REV ENTOMOL, V37, P217, DOI 10.1146/annurev.en.37.010192.001245
   SPIELMAN A, 1971, J INSECT PHYSIOL, V17, P1807, DOI 10.1016/0022-1910(71)90125-9
   Strober W, 2001, CURR PROTOC IMMUN AB, VA3B
   UCHIDA K, 1990, J MED ENTOMOL, V27, P302, DOI 10.1093/jmedent/27.3.302
   Uchida K, 2001, J MED ENTOMOL, V38, P572, DOI 10.1603/0022-2585-38.4.572
   Yewhalaw D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016066
NR 37
TC 2
Z9 2
U1 0
U2 3
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD AUG
PY 2017
IS 126
AR e55508
DI 10.3791/55508
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FM8VM
UT WOS:000415369500018
PM 28872112
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Ross, PA
   Axford, JK
   Richardson, KM
   Endersby-Harshman, NM
   Hoffmann, AA
AF Ross, Perran A.
   Axford, Jason K.
   Richardson, Kelly M.
   Endersby-Harshman, Nancy M.
   Hoffmann, Ary A.
TI Maintaining Aedes aegypti Mosquitoes Infected with Wolbachia
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Basic Protocol; Issue 126; Insect rearing; mosquito; Aedes aegypti;
   dengue; Zika; Wolbachia; fitness; blood feeding
ID ZIKA VIRUS; BODY-SIZE; DENGUE; ESTABLISHMENT; COLONIZATION; POPULATION;
   MALES; COMPETITIVENESS; TRANSMISSION; CHIKUNGUNYA
AB Aedes aegypti mosquitoes experimentally infected with Wolbachia are being utilized in programs to control the spread of arboviruses such as dengue, chikungunya and Zika. Wolbachia-infected mosquitoes can be released into the field to either reduce population sizes through incompatible matings or to transform populations with mosquitoes that are refractory to virus transmission. For these strategies to succeed, the mosquitoes released into the field from the laboratory must be competitive with native mosquitoes. However, maintaining mosquitoes in the laboratory can result in inbreeding, genetic drift and laboratory adaptation which can reduce their fitness in the field and may confound the results of experiments. To test the suitability of different Wolbachia infections for deployment in the field, it is necessary to maintain mosquitoes in a controlled laboratory environment across multiple generations. We describe a simple protocol for maintaining Ae. aegypti mosquitoes in the laboratory, which is suitable for both Wolbachia-infected and wild-type mosquitoes. The methods minimize laboratory adaptation and implement outcrossing to increase the relevance of experiments to field mosquitoes. Additionally, colonies are maintained under optimal conditions to maximize their fitness for open field releases.
C1 [Ross, Perran A.; Axford, Jason K.; Richardson, Kelly M.; Endersby-Harshman, Nancy M.; Hoffmann, Ary A.] Bio21 Inst, Sch BioSci, Parkville, Vic, Australia.
   [Ross, Perran A.; Axford, Jason K.; Richardson, Kelly M.; Endersby-Harshman, Nancy M.; Hoffmann, Ary A.] Univ Melbourne, Melbourne, Vic, Australia.
RP Ross, PA (corresponding author), Bio21 Inst, Sch BioSci, Parkville, Vic, Australia.; Ross, PA (corresponding author), Univ Melbourne, Melbourne, Vic, Australia.
EM paross@student.unimelb.edu.au
RI Ross, Perran/L-5778-2019; Hoffmann, Ary/R-2972-2019
OI Ross, Perran/0000-0001-7645-7523; Hoffmann, Ary/0000-0001-9497-7645
FU National Health and Medical Research CouncilNational Health and Medical
   Research Council of Australia; Wellcome TrustWellcome Trust; Australian
   Government Research Training Program ScholarshipAustralian
   GovernmentDepartment of Industry, Innovation and Science
FX We acknowledge Heng Lin Yeap, Chris Paton, Petrina Johnson and Clare
   Doig for their contributions to the development of our colony
   maintenance methods, and three anonymous reviewers for their suggestions
   which helped to improve the manuscript. Our research is supported by a
   program grant and fellowship to AAH from the National Health and Medical
   Research Council and a translation grant from the Wellcome Trust. PAR is
   a recipient of an Australian Government Research Training Program
   Scholarship.
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Axford JK, 2016, AM J TROP MED HYG, V94, P507, DOI 10.4269/ajtmh.15-0608
   BARKERHUDSON P, 1988, J MED ENTOMOL, V25, P178, DOI 10.1093/jmedent/25.3.178
   Benedict MQ, 2003, TRENDS PARASITOL, V19, P349, DOI 10.1016/S1471-4922(03)00144-2
   BENTLEY MD, 1989, ANNU REV ENTOMOL, V34, P401, DOI 10.1146/annurev.en.34.010189.002153
   BRIEGEL H, 1990, J INSECT PHYSIOL, V36, P165, DOI 10.1016/0022-1910(90)90118-Y
   Calkins CO, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P269, DOI 10.1007/1-4020-4051-2_10
   Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135
   Caragata EP, 2014, MICROB ECOL, V67, P205, DOI 10.1007/s00248-013-0339-4
   Carvalho B. M., 2016, B ENTOMOL RES, P1
   Carvalho DO, 2014, JOVE-J VIS EXP, DOI 10.3791/3579
   CHEONG WH, 1967, B WORLD HEALTH ORGAN, V36, P586
   Corbin C, 2017, HEREDITY, V118, P10, DOI 10.1038/hdy.2016.71
   DAY JF, 1984, J MED ENTOMOL, V21, P732, DOI 10.1093/jmedent/21.6.732
   Degner EC, 2016, AM J TROP MED HYG, V94, P780, DOI 10.4269/ajtmh.15-0893
   Faull KJ, 2015, J VECTOR ECOL, V40, P292, DOI 10.1111/jvec.12167
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Garcia Gde A., 2016, PLOS ONE, V11, DOI DOI 10.1371/JOURNAL.PONE.0160196
   Gjullin CM, 1941, J CELL COMPAR PHYSL, V17, P193, DOI 10.1002/jcp.1030170205
   Gonzales KK, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121267
   GROVER KK, 1976, ENTOMOL EXP APPL, V20, P8, DOI 10.1111/j.1570-7458.1976.tb02611.x
   Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoffmann AA, 2015, EVOL APPL, V8, P751, DOI 10.1111/eva.12286
   Imam Hashmat, 2014, Trop Parasitol, V4, P53, DOI 10.4103/2229-5070.129167
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lee SF, 2012, APPL ENVIRON MICROB, V78, P4740, DOI 10.1128/AEM.00069-12
   Leftwich PT, 2016, EVOL APPL, V9, P212, DOI 10.1111/eva.12280
   LORENZ L, 1984, AM J TROP MED HYG, V33, P690, DOI 10.4269/ajtmh.1984.33.690
   Mains JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep33846
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   MCDONALD PT, 1977, AM J TROP MED HYG, V26, P553, DOI 10.4269/ajtmh.1977.26.553
   McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968
   McMeniman CJ, 2011, J MED ENTOMOL, V48, P76, DOI 10.1603/ME09188
   McMeniman CJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000748
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   MEOLA ROGER, 1964, ANN ENTOMOL SOC AMER, V57, P468, DOI 10.1093/aesa/57.4.468
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   MORLAN HARVEY B., 1962, MOSQUITO NEWS, V22, P295
   Munstermann L. E., 1997, The molecular biology of insect disease vectors: a methods manual., P13
   O'Connor L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001797
   Ponlawat A, 2009, AM J TROP MED HYG, V80, P395, DOI 10.4269/ajtmh.2009.80.395
   RAI KS, 1973, B WORLD HEALTH ORGAN, V48, P49
   Richardson K, 2011, J MED ENTOMOL, V48, P914, DOI 10.1603/ME10204
   Richardson KM, 2013, AUSTRAL ECOL, V38, P219, DOI 10.1111/j.1442-9993.2012.02394.x
   Ross PA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006006
   Ross PA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004320
   Scott TW, 2000, J MED ENTOMOL, V37, P77, DOI 10.1603/0022-2585-37.1.77
   SEAWRIGHT JA, 1977, MOSQ NEWS, V37, P615
   Segoli M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003294
   Spitzen Jeroen, 2005, Proceedings of the Section Experimental and Applied Entomology of the Netherlands Entomological Society (N.E.V.), V16, P95
   Suh E., 2016, J MED ENTOMOL
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x
   Turley AP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000516
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Watson TM, 2000, J AM MOSQUITO CONTR, V16, P138
   Williges E, 2008, J AM MOSQUITO CONTR, V24, P591, DOI 10.2987/5714.1
   Wong J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001015
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   Yeap HL, 2011, GENETICS, V187, P583, DOI 10.1534/genetics.110.122390
   Yeap HL, 2013, AM J TROP MED HYG, V89, P78, DOI 10.4269/ajtmh.12-0719
   Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135194
NR 66
TC 9
Z9 9
U1 0
U2 10
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD AUG
PY 2017
IS 126
AR e56124
DI 10.3791/56124
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FM8VM
UT WOS:000415369500077
PM 28829414
OA Green Published
DA 2020-07-08
ER

PT J
AU Rishu, AH
   Marinoff, N
   Julien, L
   Dumitrascu, M
   Marten, N
   Eggertson, S
   Willems, S
   Ruddell, S
   Lane, D
   Light, B
   Stelfox, HT
   Jouvet, P
   Hall, R
   Reynolds, S
   Daneman, N
   Fowler, RA
AF Rishu, Asgar H.
   Marinoff, Nicole
   Julien, Lisa
   Dumitrascu, Mariana
   Marten, Nicole
   Eggertson, Shauna
   Willems, Su
   Ruddell, Stacy
   Lane, Dan
   Light, Bruce
   Stelfox, Henry T.
   Jouvet, Philippe
   Hall, Richard
   Reynolds, Steven
   Daneman, Nick
   Fowler, Robert A.
CA Canadian Critical Care Trials Grp
TI Time required to initiate outbreak and pandemic observational research
SO JOURNAL OF CRITICAL CARE
LA English
DT Article
DE Outbreak; Pandemic; Research; Canada; Critical; Intensive care
ID CRITICALLY-ILL PATIENTS; ACUTE RESPIRATORY SYNDROME; ETHICS COMMITTEE
   APPROVAL; HEALTH-SERVICES RESEARCH; CLINICAL-TRIALS; CRITICAL-CARE;
   REVIEWS; ILLNESS; CANADA; EBOLA
AB Purpose: Observational research focused upon emerging infectious diseases such as Ebola virus, Middle East respiratory syndrome, and Zika virus has been challenging to quickly initiate. We aimed to determine the duration of start-up procedures and barriers encountered for an observational study focused upon such infectious outbreaks.
   Materials and methods: At 1 pediatric and 5 adult intensive care units, we measured durations from protocol receipt to a variety of outbreak researchmilestones, including research ethics board (REB) approval, data sharing agreement (DSA) execution, and patient study screening initiation.
   Results: The median (interquartile range) time from site receipt of the protocol to REB submission was 73 (30126) days; to REB approval, 158 (42-188) days; to DSA completion, 276 (186-312) days; and to study screening initiation, 293 (269-391) days. The median time from REB submission to REB approval was 43 (13-85) days. The median time for all start-up procedures was 335 (188-335) days.
   Conclusions: There is a lengthy start-up period required for outbreak-focused research. Completing DSAs was the most time-consuming step. A reactive approach to newly emerging threats such as Ebola virus, Middle East respiratory syndrome, and Zika virus will likely not allow sufficient time to initiate research before most outbreaks are advanced. (C) 2017 The Authors. Published by Elsevier Inc.
C1 [Rishu, Asgar H.; Marinoff, Nicole] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON M4N 3M5, Canada.
   [Julien, Lisa; Hall, Richard] Dalhousie Univ, Div Crit Care Med, Halifax, NS B3H 1V7, Canada.
   [Julien, Lisa; Hall, Richard] Capital Dist Hlth Author, Halifax, NS B3H 1V7, Canada.
   [Dumitrascu, Mariana; Jouvet, Philippe] Univ Montreal, Hop Ste Justine, Dept Pediat & Soins Intensifs, Montreal, PQ H3T 1C5, Canada.
   [Marten, Nicole; Eggertson, Shauna; Light, Bruce] Univ Manitoba, St Boniface Hosp, Sect Crit Care Med, Winnipeg, MB R2H 2A6, Canada.
   [Willems, Su; Reynolds, Steven] Univ British Columbia, Royal Columbian Hosp, Dept Crit Care Med, Vancouver, BC V3L 3W7, Canada.
   [Ruddell, Stacy; Lane, Dan; Stelfox, Henry T.] Univ Calgary, Foothills Hosp, Dept Crit Care Med, Calgary, AB T2N 2T9, Canada.
   [Daneman, Nick] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med & Clin Epidemiol, Div Infect Dis, Toronto, ON M4N 3M5, Canada.
   [Fowler, Robert A.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Inst Hlth Policy Management & Evaluat, Dept Med, Toronto, ON M4N 3M5, Canada.
   [Fowler, Robert A.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Inst Hlth Policy Management & Evaluat, Dept Crit Care Med, Toronto, ON M4N 3M5, Canada.
RP Fowler, RA (corresponding author), Univ Toronto, Dept Med, 2075 Bayview Ave,Room D478, Toronto, ON M4N 3M5, Canada.; Fowler, RA (corresponding author), Univ Toronto, Interdept Div Crit Care Med, 2075 Bayview Ave,Room D478, Toronto, ON M4N 3M5, Canada.; Fowler, RA (corresponding author), Sunnybrook Med Ctr, Dept Crit Care Med, 2075 Bayview Ave,Room D478, Toronto, ON M4N 3M5, Canada.
EM rob.fowler@sunnybrook.ca
RI Lane, Daniel/AAP-5710-2020; Jouvet, Philippe A/H-3293-2018
OI Lane, Daniel/0000-0001-8600-8895; Jouvet, Philippe A/0000-0001-5684-3398
FU Public Health Agency of Canada; Canadian Critical Care Trials Group;
   Heart and Stroke Foundation (Ontario office)
FX This work was supported by the Public Health Agency of Canada, Canadian
   Critical Care Trials Group, and Heart and Stroke Foundation (Ontario
   office).
CR [Anonymous], IDATAFAX US GUID
   Aoyama K, 2015, LANCET RESP MED, V3, P503, DOI 10.1016/S2213-2600(15)00237-4
   Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742
   Christian MD, 2006, CAN MED ASSOC J, V175, P1377, DOI 10.1503/cmaj.060911
   Cook D, 2010, CRIT CARE MED, V38, pE138, DOI 10.1097/CCM.0b013e3181cbaff4
   De Feo G, 2015, J MED ETHICS, V41, P799, DOI 10.1136/medethics-2012-100803
   Dziak K, 2005, HEALTH SERV RES, V40, P279, DOI 10.1111/j.1475-6773.2005.00353.x
   Eastman N, 2010, INTENS CARE MED, V36, P1076, DOI 10.1007/s00134-010-1862-0
   Fowler RA, 2003, JAMA-J AM MED ASSOC, V290, P367, DOI 10.1001/jama.290.3.367
   Fowler RA, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0852-6
   Fowler RA, 2010, CRIT CARE MED, V38, pE120, DOI 10.1097/CCM.0b013e3181d20c77
   Gobat NH, 2015, TRIALS, V16, DOI 10.1186/s13063-015-1110-6
   Green LA, 2006, HEALTH SERV RES, V41, P214, DOI 10.1111/j.1475-6773.2005.00458.x
   Hall DE, 2015, JAMA SURG, V150, P103, DOI 10.1001/jamasurg.2014.956
   Kaufmann P, 2015, ACAD MED, V90, P321, DOI 10.1097/ACM.0000000000000562
   Kenyon GM, 2011, BRIT J NEUROSURG, V25, P352, DOI 10.3109/02688697.2010.551675
   Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254
   Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496
   Levy MM, 2005, AM J RESP CRIT CARE, V171, P518, DOI 10.1164/rccm.200405-621WS
   Moser B, 2008, J SCI MED SPORT, V11, P518, DOI 10.1016/j.jsams.2007.11.002
   Neff MJ, 2008, RESP CARE, V53, P1350
   Orchard J, 2008, J SCI MED SPORT, V11, P239, DOI 10.1016/j.jsams.2007.07.001
   Rishu A, 2014, CRIT CARE M IN PRESS
   Schieffelin JS, 2014, NEW ENGL J MED, V371, P2092, DOI 10.1056/NEJMoa1411680
   Wang-Gillam A, 2010, J CLIN ONCOL, V28, P3803, DOI 10.1200/JCO.2010.28.1824
NR 25
TC 8
Z9 8
U1 0
U2 0
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0883-9441
EI 1557-8615
J9 J CRIT CARE
JI J. Crit. Care
PD AUG
PY 2017
VL 40
BP 7
EP 10
DI 10.1016/j.jcrc.2017.02.009
PG 4
WC Critical Care Medicine
SC General & Internal Medicine
GA FM6XC
UT WOS:000415204800003
PM 28288355
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Petersen, J
   Simons, H
   Patel, D
   Freedman, J
AF Petersen, Jakob
   Simons, Hilary
   Patel, Dipti
   Freedman, Joanne
TI Early detection of perceived risk among users of a UK travel health
   website compared with internet search activity and media coverage during
   the 2015-2016 Zika virus outbreak: an observational study
SO BMJ OPEN
LA English
DT Article
ID PUBLIC-HEALTH; INFORMATION; BIOSURVEILLANCE; INFODEMIOLOGY;
   SURVEILLANCE; CHALLENGES; BEHAVIOR; RECORDS
AB Objectives The Zika virus (ZIKV) outbreak in the Americas in 2015-2016 posed a novel global threat due to the association with congenital malformations and its rapid spread. Timely information about the spread of the disease was paramount to public health bodies issuing travel advisories. This paper looks at the online interaction with a national travel health website during the outbreak and compares this to trends in internet searches and news media output.
   Methods Time trends were created for weekly views of ZIKV-related pages on a UK travel health website, relative search volumes for 'Zika' on Google UK, ZIKV-related items aggregated by Google UK News and rank of ZIKV travel advisories among all other pages between 15 November 2015 and 20 August 2016.
   Results Time trends in traffic to the travel health website corresponded with Google searches, but less so with media items due to intense coverage of the Rio Olympics. Travel advisories for pregnant women were issued from 7 December 2015 and began to increase in popularity (rank) from early January 2016, weeks before a surge in interest as measured by Google searches/news items at the end of January 2016.
   Conclusions The study showed an amplification of perceived risk among users of a national travel health website weeks before the initial surge in public interest. This suggests a potential value for tools to detect changes in online information seeking behaviours for predicting periods of high demand where the routine capability of travel health services could be exceeded.
C1 [Petersen, Jakob; Patel, Dipti] Univ Coll London Hosp NHS Fdn Trust, Natl Travel Hlth Network & Ctr, London, England.
   [Simons, Hilary] Univ Liverpool Liverpool Sch Trop Med, Natl Travel Hlth Network & Ctr, Liverpool, Merseyside, England.
   [Freedman, Joanne] Publ Hlth England, Travel & Migrant Hlth Sect, London, England.
RP Petersen, J (corresponding author), Univ Coll London Hosp NHS Fdn Trust, Natl Travel Hlth Network & Ctr, London, England.
EM jakob.petersen1@nhs.net
OI Freedman, Joanne/0000-0002-7840-473X
CR Alicino C, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0090-9
   Chan EH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001206
   Charles-Smith LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139701
   Eysenbach G, 2002, AM J MED, V113, P763, DOI 10.1016/S0002-9343(02)01473-0
   Eysenbach G, 2011, AM J PREV MED, V40, pS154, DOI 10.1016/j.amepre.2011.02.006
   Fu KW, 2016, AM J INFECT CONTROL, V44
   Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634
   Hilton S, 2011, J EPIDEMIOL COMMUN H, V65, P941, DOI 10.1136/jech.2010.119875
   Hoffman SJ, 2016, J CLIN EPIDEMIOL, V75, P47, DOI 10.1016/j.jclinepi.2015.12.010
   Hossain L, 2016, EPIDEMIOL INFECT, V144, P2136, DOI 10.1017/S095026881600039X
   Kato M, 2016, J MASS COMMUNICATION, V06
   Klembczyk JJ, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5585
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Muller O, 2016, EUR J INFORM SYST, V25, P289, DOI 10.1057/ejis.2016.2
   Nuti SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109583
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Reintjes R, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0151258, 10.1371/journal.pone.0]
   Santillana M, 2016, SCI REP-UK, V6, DOI 10.1038/srep25732
   Shmueli G, 2010, TECHNOMETRICS, V52, P39, DOI 10.1198/TECH.2010.06134
   Southwell BG, 2016, EMERG INFECT DIS, V22, P1320, DOI 10.3201/eid2207.160415
   Southwell BG, 2013, INFECTIOUS DISEASE SURVEILLANCE, 2ND EDITION, P607
   Tausczik Y, 2012, HEALTH COMMUN, V27, P179, DOI 10.1080/10410236.2011.571759
   Towers S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129179
   Tran T, ARXIV160704318 CS
   Velsko S, 2016, HEALTH SECUR, V14, P189, DOI 10.1089/hs.2015.0063
   WHO, 2016, ZIK SIT REP 14 APR 2
   WHO, 2016, ZIK SIT REP 25 AUG 2
   Wilder-Smith A, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31620
   Wojcik OP, 2014, EMERG THEMES EPIDEMI, V11, DOI 10.1186/1742-7622-11-7
   Zuckerman J, 2012, PRINCIPLES PRACTICE
NR 30
TC 2
Z9 2
U1 1
U2 6
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2044-6055
J9 BMJ OPEN
JI BMJ Open
PD AUG
PY 2017
VL 7
IS 8
AR e015831
DI 10.1136/bmjopen-2017-015831
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA FI2UT
UT WOS:000411802700107
PM 28860226
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Newman, C
   Friedrich, TC
   O'Connor, DH
AF Newman, Christina
   Friedrich, Thomas C.
   O'Connor, David H.
TI Macaque monkeys in Zika virus research: 1947-present
SO CURRENT OPINION IN VIROLOGY
LA English
DT Article
ID VECTOR-BORNE TRANSMISSION; MALE SEXUAL TRANSMISSION; AEDES-AEGYPTI;
   ANIMAL-MODELS; DENGUE VIRUS; INFECTION; ENHANCEMENT; RHESUS; BRAZIL;
   PATHOGENESIS
AB Zika virus was first isolated in 1947 from an exotic rhesus macaque. Nearly 70 years later, the emergence of Zika virus in the Americas and its newly described association with birth defects has motivated the development of captive macaque monkey models of human Zika virus infection. This review describes similarities between macaque and human Zika virus pathogenesis and discusses specific advantages and disadvantages of using macaques instead of other laboratory animal models. In particular, macaques provide an outstanding model for understanding in utero Zika virus infections that are essential for evaluating preclinical interventions for use in pregnancy.
C1 [Newman, Christina; O'Connor, David H.] Univ Wisconsin, Dept Pathol & Lab Med, Sch Med & Publ Hlth, 3170 Med Fdn Centennial Bldg MFCB, Madison, WI 53705 USA.
   [Friedrich, Thomas C.] Univ Wisconsin, Dept Pathobiol Sci, Sch Vet Med, 2015 Linden Dr, Madison, WI 53706 USA.
   [Friedrich, Thomas C.; O'Connor, David H.] WNPRC, 1220 Capitol Court, Madison, WI 53715 USA.
RP O'Connor, DH (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, Sch Med & Publ Hlth, 3170 Med Fdn Centennial Bldg MFCB, Madison, WI 53705 USA.; O'Connor, DH (corresponding author), WNPRC, 1220 Capitol Court, Madison, WI 53715 USA.
EM dhoconno@wisc.edu
FU DHHS/PHS/NIH [R01A1116382-01A1, P51OD011106]
FX Financial support for this work was provided by the DHHS/PHS/NIH
   (R01A1116382-01A1 to DHO) and P51OD011106 awarded to the WNPRC,
   Madison-Wisconsin.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barry PA, 2006, ILAR J, V47, P49, DOI 10.1093/ilar.47.1.49
   Bierlaire D, 2017, TRANSFUSION, V57, P729, DOI 10.1111/trf.14028
   BLANKENSHIP TN, 1993, CELL TISSUE RES, V272, P227, DOI 10.1007/BF00302728
   Branswell H, 2017, THEYRE JUST HIDING E
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Carter AM, 2007, PLACENTA, V28, pS41, DOI 10.1016/j.placenta.2006.11.002
   Centers for Disease Control and Prevention, 2017, OUTC PREGN LAB EV PO
   CHEZ RA, 1972, J MED PRIMATOL, V1, P230
   Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Cox J, 2012, J VIROL, V86, P7637, DOI 10.1128/JVI.00534-12
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Darbellay J, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.133
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Furukawa S, 2014, J TOXICOL PATHOL, V27, P11, DOI 10.1293/tox.2013-0060
   Gardner MB, 2008, ILAR J, V49, P220, DOI 10.1093/ilar.49.2.220
   Globo Comunicacao e Participacoes S.A, 2015, ID VIR CAUS DOEN MIS
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Grigsby PL, 2016, SEMIN REPROD MED, V34, P11, DOI 10.1055/s-0035-1570031
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Kawiecki AB, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0749-x
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moreira J, 2017, CLIN MICROBIOL INFEC, P1
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Moureau G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117849
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   National Academy of Sciences, 2003, INT PERSP FUT NONH P
   Newman CM, 2017, BIORXIV
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Ockenfels B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003197
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pacheco O, 2016, N ENGL J MED
   Pan American Health Organization, 2017, REG ZIK VIR EP UPD A
   Patten AR, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00093
   Paz-Bailey G, 2017, N ENGL J MED
   Pingen M, 2016, IMMUNITY, V44, P1455, DOI 10.1016/j.immuni.2016.06.002
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024
   Schwartz DA, 2017, ARCH GYNECOL OBSTET, V295, P1361, DOI 10.1007/s00404-017-4361-5
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Ventura CV, 2016, OSLI RETINA, V47, P952, DOI 10.3928/23258160-20161004-09
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zika Experimental Science Team (ZEST), 2017, ZIKV023 ZEST
NR 88
TC 9
Z9 9
U1 1
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1879-6257
J9 CURR OPIN VIROL
JI Curr. Opin. Virol.
PD AUG
PY 2017
VL 25
BP 34
EP 40
DI 10.1016/j.coviro.2017.06.011
PG 7
WC Virology
SC Virology
GA FJ6KF
UT WOS:000412866000008
PM 28750247
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Vilibic-Cavlek, T
   Betica-Radic, L
   Venturi, G
   Fortuna, C
   Djuricic, S
   Salvia-Milos, A
   Tabain, I
   Barbic, L
   Stevanovic, V
   Listes, E
   Savini, G
AF Vilibic-Cavlek, Tatjana
   Betica-Radic, Ljiljana
   Venturi, Giulietta
   Fortuna, Claudia
   Djuricic, Stjepan
   Salvia-Milos, Antonella
   Tabain, Irena
   Barbic, Ljubo
   Stevanovic, Vladimir
   Listes, Eddy
   Savini, Giovanni
TI First detection of Zika virus infection in a Croatian traveler returning
   from Brazil, 2016
SO JOURNAL OF INFECTION IN DEVELOPING COUNTRIES
LA English
DT Article
DE Zika virus; imported; Croatia
ID WEST-NILE-VIRUS; DENGUE; CHIKUNGUNYA; OUTBREAK; ARBOVIRUSES;
   COINFECTION; EPIDEMIC; ANTIBODY; PACIFIC; ISLAND
AB In the last few years, several imported cases of Zika virus (ZIKV) infection were reported in European countries. We report the first imported ZIKV infection case in a Croatian traveler returning from Brazil. The patient presented with a low-grade fever, pruritic rash, general weakness, myalgia, arthralgia and edema of the legs and recovered completely within a week. ZIKV infection was confirmed by detection of IgM/IgG antibodies using enzyme-linked immunosorbent assay ( ELISA) and confirmed by plaque-reduction neutralization test (PRNT). ZIKV IgM antibodies cross-reacted with dengue virus (DENV), West Nile virus (WNV) and tick-borne encephalitis virus (TBEV) in ELISA. In indirect immunofluorescence assay (IFA), IgM cross-reactivity was found only with DENV-3. ZIKV IgG antibodies cross-reacted with DENV in both ELISA and IFA. PRNT for DENV was negative. Control serology performed on days 64 and 98 after disease onset showed a decline in cross-reactive heterologous DENV IgG antibodies compared to persistently high titer of homologous ZIKV IgG antibodies.
C1 [Vilibic-Cavlek, Tatjana; Tabain, Irena] Croatian Natl Inst Publ Hlth, Dept Virol, Rockefellerova 12, Zagreb 10000, Croatia.
   [Vilibic-Cavlek, Tatjana] Univ Zagreb, Sch Med, Dept Microbiol, Zagreb, Croatia.
   [Betica-Radic, Ljiljana; Djuricic, Stjepan; Salvia-Milos, Antonella] Gen Hosp Dubrovnik, Dept Infect Dis, Dubrovnik, Croatia.
   [Venturi, Giulietta; Fortuna, Claudia] Ist Super Sanita, Dipartimento Malattie Infett Parassitarie & Immun, Rome, Italy.
   [Barbic, Ljubo; Stevanovic, Vladimir] Univ Zagreb, Dept Microbiol & Infect Dis Clin, Fac Vet Med, Zagreb, Croatia.
   [Listes, Eddy] Reg Inst Split, Croatian Vet Inst, Split, Croatia.
   [Savini, Giovanni] Ist Zooprofillat Sperimentale G Caporale, Lab Referenza OIE West Nile Fever, Teramo, Italy.
RP Vilibic-Cavlek, T (corresponding author), Croatian Natl Inst Publ Hlth, Dept Virol, Rockefellerova 12, Zagreb 10000, Croatia.
EM tatjana.vilibic-cavlek@hzjz.hr
RI FORTUNA, CLAUDIA/O-9446-2015; Radic, Ljiljana Betica/AAG-8541-2020;
   VENTURI, GIULIETTA/O-8123-2015; Vilibic-Cavlek, Tatjana/AAI-2010-2019
OI FORTUNA, CLAUDIA/0000-0001-8878-4505; Radic, Ljiljana
   Betica/0000-0002-8778-106X; VENTURI, GIULIETTA/0000-0002-9078-8350; 
CR Baronti C, 2014, GENOME ANNOUNC, V2
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   De Smet B, 2016, J CLIN VIROL, V80, P8, DOI 10.1016/j.jcv.2016.04.009
   Di Luca M., 2016, EUROSURVEILLANCE, V21, P18
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   European Centre for Disease Prevention and Control, 2016, ZIK VIR INF CAS DEF
   Koraka P, 2002, MICROBES INFECT, V4, P1209, DOI 10.1016/S1286-4579(02)01647-7
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   Maria AT, 2016, EURO SURVEILL, V21
   Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Niedrig M, 2007, J VIROL METHODS, V139, P103, DOI 10.1016/j.jviromet.2006.09.009
   Parreira R., 2014, Eurosurveillance, V19, P20730, DOI 10.2807/1560-7917.ES2014.19.10.20730
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Sampathkumar P, 2016, MAYO CLIN PROC, V91, P514, DOI 10.1016/j.mayocp.2016.02.017
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Vilibic-Cavlek T, 2014, INFECTION, V42, P689, DOI 10.1007/s15010-014-0625-1
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Ze-Ze L, 2016, IDCases, V4, P46, DOI 10.1016/j.idcr.2016.03.004
NR 33
TC 0
Z9 0
U1 0
U2 5
PU J INFECTION DEVELOPING COUNTRIES
PI TRAMANIGLIO
PA JIDC CENT OFF PORTO CONTE RICERCHE RES CTR, S P 55, PORTO CONTE CAPO
   CACCIA KM 8.400 LOC, TRAMANIGLIO, 07041, ITALY
SN 1972-2680
J9 J INFECT DEV COUNTR
JI J. Infect. Dev. Ctries.
PD AUG
PY 2017
VL 11
IS 8
BP 662
EP 667
DI 10.3855/jidc.9410
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA FJ7KL
UT WOS:000412935900012
PM 31085829
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Fitzpatrick, C
   Haines, A
   Bangert, M
   Farlow, A
   Hemingway, J
   Velayudhan, R
AF Fitzpatrick, Christopher
   Haines, Alexander
   Bangert, Mathieu
   Farlow, Andrew
   Hemingway, Janet
   Velayudhan, Raman
TI An economic evaluation of vector control in the age of a dengue vaccine
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID COST-EFFECTIVENESS; AEDES-AEGYPTI; DEVELOPING-COUNTRIES;
   HEMORRHAGIC-FEVER; OUTBREAK; AMERICA; EPIDEMIC; DYNAMICS; DISEASE; RISK
AB Introduction
   Dengue is a rapidly emerging vector-borne Neglected Tropical Disease, with a 30-fold increase in the number of cases reported since 1960. The economic cost of the illness is measured in the billions of dollars annually. Environmental change and unplanned urbanization are conspiring to raise the health and economic cost even further beyond the reach of health systems and households. The health-sector response has depended in large part on control of the Aedes aegypti and Ae. albopictus (mosquito) vectors. The cost-effectiveness of the first-ever dengue vaccine remains to be evaluated in the field. In this paper, we examine how it might affect the cost-effectiveness of sustained vector control.
   Methods
   We employ a dynamic Markov model of the effects of vector control on dengue in both vectors and humans over a 15-year period, in six countries: Brazil, Columbia, Malaysia, Mexico, the Philippines, and Thailand. We evaluate the cost (direct medical costs and control programme costs) and cost-effectiveness of sustained vector control, outbreak response and/or medical case management, in the presence of a (hypothetical) highly targeted and low cost immunization strategy using a (non-hypothetical) medium-efficacy vaccine.
   Results
   Sustained vector control using existing technologies would cost little more than outbreak response, given the associated costs of medical case management. If sustained use of existing or upcoming technologies (of similar price) reduce vector populations by 70-90%, the cost per disability-adjusted life year averted is 2013 US$ 679-1331 (best estimates) relative to no intervention. Sustained vector control could be highly cost-effective even with less effective technologies (50-70% reduction in vector populations) and in the presence of a highly targeted and low cost immunization strategy using a medium-efficacy vaccine.
   Discussion
   Economic evaluation of the first-ever dengue vaccine is ongoing. However, even under very optimistic assumptions about a highly targeted and low cost immunization strategy, our results suggest that sustained vector control will continue to play an important role in mitigating the impact of environmental change and urbanization on human health. If additional benefits for the control of other Aedes borne diseases, such as Chikungunya, yellow fever and Zika fever are taken into account, the investment case is even stronger. High-burden endemic countries should proceed to map populations to be covered by sustained vector control.
C1 [Fitzpatrick, Christopher; Haines, Alexander; Bangert, Mathieu; Velayudhan, Raman] World Hlth Org, Dept Control Neglected Trop Dis, Geneva, Switzerland.
   [Haines, Alexander] Royal Coll Physicians, Natl Guideline Ctr, London, England.
   [Farlow, Andrew] Univ Oxford, Oxford Martin Sch, Oxford, England.
   [Hemingway, Janet] Univ Liverpool Liverpool Sch Trop Med, Dept Vector Biol, Liverpool, Merseyside, England.
   [Haines, Alexander] Univ Hlth Network, Toronto Hlth Econ & Technol Assessment Collaborat, Toronto, ON, Canada.
RP Fitzpatrick, C (corresponding author), World Hlth Org, Dept Control Neglected Trop Dis, Geneva, Switzerland.
EM fitzpatrickc@who.int
RI Bangert, Mathieu/K-7233-2019
OI Bangert, Mathieu/0000-0003-1320-8145; Squire,
   Stephen/0000-0001-7173-9038; Haines, Alexander/0000-0001-5598-8907
FU World Health OrganizationWorld Health Organization [001]
CR Abubakar Sazaly, 2002, Malays J Pathol, V24, P23
   Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Aguiar M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005179
   Ahmed S, 2013, JCPSP-J COLL PHYSICI, V23, P463, DOI 07.2013/JCPSP.463467
   Andersson N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3267
   Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085
   Armien B, 2008, AM J TROP MED HYG, V79, P364, DOI 10.4269/ajtmh.2008.79.364
   Balmaseda A, 2010, J INFECT DIS, V201, P5, DOI 10.1086/648592
   Baly A, 2007, T ROY SOC TROP MED H, V101, P578, DOI 10.1016/j.trstmh.2007.01.002
   Baly A, 2012, TROP MED INT HEALTH, V17, P123, DOI 10.1111/j.1365-3156.2011.02881.x
   Barmak DH, 2014, EPIDEMIOL INFECT, V142, P545, DOI 10.1017/S0950268813001301
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848
   Brady OJ, 2015, EPIDEMICS-NETH, V11, P92, DOI 10.1016/j.epidem.2015.03.002
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Carrasco LR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001426
   Chen SC, 2012, SCI TOTAL ENVIRON, V431, P385, DOI 10.1016/j.scitotenv.2012.05.012
   Chowell G, 2007, MATH BIOSCI, V208, P571, DOI 10.1016/j.mbs.2006.11.011
   Constenla D, 2015, PHARMACOECONOMICS, V33, P1107, DOI 10.1007/s40273-015-0294-7
   Ditsuwan T, 2012, TROP MED INT HEALTH, V17, P767, DOI 10.1111/j.1365-3156.2012.02997.x
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Durham DP, 2013, VACCINE, V31, P3957, DOI 10.1016/j.vaccine.2013.06.036
   Edejer TT-T, 2003, MAKING CHOICES HEALT
   Endy TP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000975
   Erlanger TE, 2008, MED VET ENTOMOL, V22, P203, DOI 10.1111/j.1365-2915.2008.00740.x
   Flasche S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002181
   Focks DA, 1997, AM J TROP MED HYG, V56, P159, DOI 10.4269/ajtmh.1997.56.159
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Huy R, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-155
   Iturrino-Monge R, 2006, REV PANAM SALUD PUBL, V20, P39, DOI 10.1590/S1020-49892006000700005
   Karl S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-447
   Kikuti M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003937
   L'Azou M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003260
   Lee BY, 2011, AM J TROP MED HYG, V84, P764, DOI 10.4269/ajtmh.2011.10-0624
   Lee JS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003810
   Louis VR, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-50
   Lum LCS, 2008, AM J TROP MED HYG, V78, P862, DOI 10.4269/ajtmh.2008.78.862
   Luz PM, 2011, LANCET, V377, P1673, DOI 10.1016/S0140-6736(11)60246-8
   McConnell K. John, 2003, Rev Panam Salud Publica, V14, P9, DOI 10.1590/S1020-49892003000600003
   Meltzer MI, 1998, AM J TROP MED HYG, V59, P265, DOI 10.4269/ajtmh.1998.59.265
   MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395
   Mulligan K, 2015, PATHOG GLOB HEALTH, V109, P10, DOI 10.1179/2047773214Y.0000000168
   Ong A, 2007, INT J INFECT DIS, V11, P263, DOI 10.1016/j.ijid.2006.02.012
   Ooi EE, 2009, CAD SAUDE PUBLICA, V25, pS115, DOI 10.1590/S0102-311X2009001300011
   Packierisamy PR, 2015, AM J TROP MED HYG, V93, P1020, DOI 10.4269/ajtmh.14-0667
   Padmanabha H, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001799
   PAHO WHO &VERBAR; Dengue &VERBAR;, DENG ANN CAS REP DEN
   Pang T, 2016, LANCET INFECT DIS, V16, P880, DOI 10.1016/S1473-3099(16)30167-0
   Pepin KM, 2013, EMERG INFECT DIS, V19, P542, DOI 10.3201/eid1904.120117
   Tam PT, 2012, AM J TROP MED HYG, V87, P554, DOI 10.4269/ajtmh.2012.12-0101
   Pontes RJS, 2000, AM J TROP MED HYG, V62, P378, DOI 10.4269/ajtmh.2000.62.378
   Ranson H., 2010, TROPIKA, V1
   Reich NG, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0414
   Reiner RC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004588
   Seki Naomi, 2015, Nihon Koshu Eisei Zasshi, V62, P238, DOI 10.11236/jph.62.5_238
   Shepard DS, 2014, AM J TROP MED HYG, V91, P1235, DOI 10.4269/ajtmh.14-0002
   Shepard DS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002055
   Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503
   Shepard DS, 2004, VACCINE, V22, P1275, DOI 10.1016/j.vaccine.2003.09.019
   Shim E, 2016, AM J TROP MED HYG, V95, P1137, DOI 10.4269/ajtmh.16-0194
   Siriyasatien P, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1034-5
   Stahl HC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1048
   Suaya JA, 2007, TROP MED INT HEALTH, V12, P1026, DOI 10.1111/j.1365-3156.2007.01889.x
   Suaya JA, 2009, AM J TROP MED HYG, V80, P846, DOI 10.4269/ajtmh.2009.80.846
   Tozan Y., 2015, EXPERT REV VACCINES
   Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000858
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Webb JLA, 2016, LANCET, V388, P556, DOI 10.1016/S0140-6736(16)31225-9
   WHO IRIS, DENG GUID DIAGN TREA
   WHO (World Health Organization), 2008, GLOBAL BURDEN DIS
   World Bank, 2009, AFR MAK DEV CLIM RES
   Xiao JP, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0131-z
   Ye YXH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003894
NR 76
TC 14
Z9 14
U1 0
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD AUG
PY 2017
VL 11
IS 8
AR e0005785
DI 10.1371/journal.pntd.0005785
PG 27
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FH3SD
UT WOS:000411068800021
PM 28806786
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Pless, E
   Gloria-Soria, A
   Evans, BR
   Kramer, V
   Bolling, BG
   Tabachnick, WJ
   Powell, JR
AF Pless, Evlyn
   Gloria-Soria, Andrea
   Evans, Benjamin R.
   Kramer, Vicki
   Bolling, Bethany G.
   Tabachnick, Walter J.
   Powell, Jeffrey R.
TI Multiple introductions of the dengue vector, Aedes aegypti, into
   California
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID STRONGYLOIDES-STERCORALIS; DOGS; VACCINATION; INFECTIONS; DIVERSITY;
   BENEFITS; HUMANS; RABIES; SPP.
AB The yellow fever mosquito Aedes aegypti inhabits much of the tropical and subtropical world and is a primary vector of dengue, Zika, and chikungunya viruses. Breeding populations of A. aegypti were first reported in California (CA) in 2013. Initial genetic analyses using 12 microsatellites on collections from Northern CA in 2013 indicated the South Central US region as the likely source of the introduction. We expanded genetic analyses of CA A. aegypti by: (a) examining additional Northern CA samples and including samples from Southern CA, (b) including more southern US populations for comparison, and (c) genotyping a subset of samples at 15,698 SNPs. Major results are: (1) Northern and Southern CA populations are distinct. (2) Northern populations are more genetically diverse than Southern CA populations. (3) Northern and Southern CA groups were likely founded by two independent introductions which came from the South Central US and Southwest US/northern Mexico regions respectively. (4) Our genetic data suggest that the founding events giving rise to the Northern CA and Southern CA populations likely occurred before the populations were first recognized in 2013 and 2014, respectively. (5) A Northern CA population analyzed at multiple time-points (two years apart) is genetically stable, consistent with permanent in situ breeding. These results expand previous work on the origin of California A. aegypti with the novel finding that this species entered California on multiple occasions, likely some years before its initial detection. This work has implications for mosquito surveillance and vector control activities not only in California but also in other regions where the distribution of this invasive mosquito is expanding.
C1 [Pless, Evlyn; Gloria-Soria, Andrea; Evans, Benjamin R.; Powell, Jeffrey R.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.
   [Kramer, Vicki] Calif Dept Publ Hlth, Vector Borne Dis Sect, Sacramento, CA USA.
   [Bolling, Bethany G.] Texas Dept State Hlth Serv, Arbovirus Entomol Lab, Austin, TX USA.
   [Tabachnick, Walter J.] Univ Florida, Florida Med Entomol Lab, Dept Entomol & Nematol, Vero Beach, FL USA.
RP Pless, E (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.
EM evlyn.pless@yale.edu
RI Gloria-Soria, Andrea/AAJ-3304-2020
OI Gloria-Soria, Andrea/0000-0002-5401-3988; Evans,
   Benjamin/0000-0003-2069-4938
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [RO1 AI101112]
FX Financial support for this project was provided by NIH grant RO1
   AI101112 to JRP. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Beknazarova M, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5040059
   Bisoffi Z, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002214
   Buonfrate D, 2017, PARASITOLOGY, P1
   CHOMEL B, 1988, REV INFECT DIS, V10, pS697
   Cleaveland S, 2006, VET MICROBIOL, V117, P43, DOI 10.1016/j.vetmic.2006.04.009
   Ferreira A, 2006, VET PARASITOL, V136, P137, DOI 10.1016/j.vetpar.2005.10.022
   FISHBEIN DB, 1991, VACCINE, V9, P581, DOI 10.1016/0264-410X(91)90246-3
   GENTA RM, 1989, T ROY SOC TROP MED H, V83, P539, DOI 10.1016/0035-9203(89)90284-8
   GENTA RM, 1986, T ROY SOC TROP MED H, V80, P34, DOI 10.1016/0035-9203(86)90190-2
   GEORGI JR, 1974, AM J TROP MED HYG, V23, P899, DOI 10.4269/ajtmh.1974.23.899
   Goncalves ALR, 2007, VET PARASITOL, V147, P132, DOI 10.1016/j.vetpar.2007.03.016
   GROVE DI, 1982, T ROY SOC TROP MED H, V76, P833, DOI 10.1016/0035-9203(82)90120-1
   Guo JG, 2006, AM J TROP MED HYG, V74, P335, DOI 10.4269/ajtmh.2006.74.335
   Hasegawa H, 2010, PARASITOL INT, V59, P407, DOI 10.1016/j.parint.2010.05.007
   Hasegawa H, 2009, PARASITOL RES, V104, P869, DOI 10.1007/s00436-008-1269-9
   Hunt VL, 2016, NATURE GENETICS
   Kearns TM, 2015, PLOS NEGLECT TROP D, V9, P1
   Kikuchi T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005253
   Lok JB, 2006, WORMBOOK ONLINE REV, P1
   Pakdee W, 2012, SE ASIAN J TROP MED, V43, P1333
   Schar F, 2014, PARASITOL INT, V63, P597, DOI 10.1016/j.parint.2014.03.007
   Schar F, 2014, PARASITOL INT, V63, P533, DOI 10.1016/j.parint.2014.01.010
   Takano Y., 2009, Tropical Medicine and Health, V37, P149, DOI 10.2149/tmh.2009-16
   Thamsborg SM, 2017, PARASITOLOGY, V144, P274, DOI 10.1017/S0031182016001116
   Umur S, 2017, TURKISH J VET ANIMAL, P41
   Wang H, 2015, HEMOGLOBIN, V98, P110
NR 26
TC 23
Z9 24
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD AUG
PY 2017
VL 11
IS 8
AR e0005718
DI 10.1371/journal.pntd.0005718
PG 21
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FH3SD
UT WOS:000411068800012
PM 28796789
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Styczynski, AR
   Malta, JMAS
   Krow-Lucal, ER
   Percio, J
   Nobrega, ME
   Vargas, A
   Lanzieri, TM
   Leite, PL
   Staples, JE
   Fischer, MX
   Powers, AM
   Chang, GJJ
   Burns, PL
   Borland, EM
   Ledermann, JP
   Mossel, EC
   Schonberger, LB
   Belay, EB
   Salinas, JL
   Badaro, RD
   Sejvar, JJ
   Coelho, GE
AF Styczynski, Ashley R.
   Malta, Juliane M. A. S.
   Krow-Lucal, Elisabeth R.
   Percio, Jadher
   Nobrega, Martha E.
   Vargas, Alexander
   Lanzieri, Tatiana M.
   Leite, Priscila L.
   Staples, J. Erin
   Fischer, Marc X.
   Powers, Ann M.
   Chang, Gwong-Jen J.
   Burns, P. L.
   Borland, Erin M.
   Ledermann, Jeremy P.
   Mossel, Eric C.
   Schonberger, Lawrence B.
   Belay, Ermias B.
   Salinas, Jorge L.
   Badaro, Roberto D.
   Sejvar, James J.
   Coelho, Giovanini E.
TI Increased rates of Guillain-Barre A syndrome associated with Zika virus
   outbreak in the Salvador metropolitan area, Brazil
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID DENGUE VIRUSES; INFECTION; DIAGNOSIS; EPIDEMIOLOGY; TRANSMISSION;
   CHIKUNGUNYA; WORLDWIDE
AB In mid-2015, Salvador, Brazil, reported an outbreak of Guillain-Barre A syndrome (GBS), coinciding with the introduction and spread of Zika virus (ZIKV). We found that GBS incidence during April-July 2015 among those >= 12 years of age was 5.6 cases/100,000 population/year and increased markedly with increasing age to 14.7 among those >= 60 years of age. We conducted interviews with 41 case-patients and 85 neighborhood controls and found no differences in demographics or exposures prior to GBS-symptom onset. A higher proportion of case-patients (83%) compared to controls (21%) reported an antecedent illness (OR 18.1, CI 6.9-47.5), most commonly characterized by rash, headache, fever, and myalgias, within a median of 8 days prior to GBS onset. Our investigation confirmed an outbreak of GBS, particularly in older adults, that was strongly associated with Zika-like illness and geo-temporally associated with ZIKV transmission, suggesting that ZIKV may result in severe neurologic complications.
EM Yxn2@cdc.gov
RI Borland, Erin/K-6607-2019
OI PERCIO, JADHER/0000-0002-3641-8105; Borland, Erin/0000-0001-8631-9466;
   Nobrega, Martha/0000-0003-4615-2280
FU Global Disease Detection Operations Center of the Centers for Disease
   Control and Prevention; Municipal Secretary of Health of Bahia and
   Salvador
FX Funding for this investigation was provided by the Global Disease
   Detection Operations Center of the Centers for Disease Control and
   Prevention. All authors from the Centers for Disease Control and
   Prevention had direct involvement in the investigational design, data
   collection, analysis, interpretation, and writing of the report. No
   payment has been received from a pharmaceutical or other commercial
   company. ARS had full access to all the data in the study and had final
   responsibility for the decision to submit the report for publication.
   The funders provided input regarding study design but had no role in
   data collection and analysis, decision to publish, or preparation of the
   manuscript.; We are grateful to Myrian Carvalho, Raquel Miranda, Nena
   Lentini, and Aristides Barbosa who helped facilitate the logistics of
   the investigation, and we would like to thank the Municipal Secretary of
   Health of Bahia and Salvador for their support of the investigation.
   Disclaimer: The findings and conclusions in this report are those of the
   authors and do not necessarily represent the official position of the
   Centers for Disease Control and Prevention.
CR Barcellos C, 2016, EMERG INFECT DIS, V22, P1894, DOI 10.3201/eid2211.160901
   Bradley K B C, 2016, ZIKA VIRUS DIS ZIKA
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dourado ME, 2012, ACTA NEUROL SCAND, V125, P47, DOI 10.1111/j.1600-0404.2011.01503.x
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2
   Instituto Brasileiro de Geografia e Estat A o stica, 2016, POP EST 2015
   Lebrun G, 2009, EMERG INFECT DIS, V15, P495, DOI 10.3201/eid1503.071482
   Leis A Arturo, 2012, Front Neurol, V3, P37, DOI 10.3389/fneur.2012.00037
   Mallet H. P., 2016, Bulletin Epidemiologique Hebdomadaire, P367
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pan American Health Organization, 2016, INT ZIK VIR DIS CAS
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Paradiso G, 1999, ANN NEUROL, V46, P701, DOI 10.1002/1531-8249(199911)46:5<701::AID-ANA4>3.0.CO;2-7
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rocha MSG, 2004, ARQ NEURO-PSIQUIAT, V62, P33, DOI 10.1590/S0004-282X2004000100006
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Suryapranata FST, 2016, AM J TROP MED HYG, V94, P1380, DOI 10.4269/ajtmh.15-0070
   Tam CC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000344
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   van Koningsveld R, 2007, LANCET NEUROL, V6, P589, DOI 10.1016/S1474-4422(07)70130-8
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Wakerley BR, 2013, EXPERT REV CLIN IMMU, V9, P627, DOI 10.1586/1744666X.2013.811119
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Wong AHY, 2014, J NEUROL SCI, V344, P60, DOI 10.1016/j.jns.2014.06.021
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 45
TC 30
Z9 34
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD AUG
PY 2017
VL 11
IS 8
AR e0005869
DI 10.1371/journal.pntd.0005869
PG 13
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FH3SD
UT WOS:000411068800056
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zuleger, CL
   Kang, C
   Ranheim, EA
   Kurzman, ID
   Macklin, MD
   Newton, MA
   Wolchok, JD
   Vail, DM
   Eriksson, E
   Albertini, MR
AF Zuleger, Cindy L.
   Kang, Chulhi
   Ranheim, Erik A.
   Kurzman, Ilene D.
   Macklin, Michael D.
   Newton, Michael A.
   Wolchok, Jedd D.
   Vail, David M.
   Eriksson, Elof
   Albertini, Mark R.
TI Pilot study of safety and feasibility of DNA microseeding for treatment
   of spontaneous canine melanoma
SO VETERINARY MEDICINE AND SCIENCE
LA English
DT Article
DE canine melanoma; comparative oncology; DNA vaccine; microseeding;
   tattooing
ID T-CELL RESPONSES; IN-VIVO; MALIGNANT-MELANOMA; INTRADERMAL VACCINATION;
   HUMAN TYROSINASE; GENE-TRANSFER; ZIKA VIRUS; DOGS; EXPRESSION;
   PROTECTION
AB Spontaneous canine malignant melanoma provides an excellent pre-clinical model to study DNA vaccines for melanoma immunotherapy. A USDA-approved xenogeneic human tyrosinase (huTYR) plasmid DNA vaccine delivered intramuscularly induces detectable immune responses and has clinical activity in some dogs with melanoma. The objective of this pilot study was to evaluate the feasibility, safety and immunogenicity of huTYR plasmid DNA administered to the skin via microseeding in dogs with spontaneous melanoma. DNA microseeding utilizes a modified tattooing device as an alternate and potentially more potent delivery method for DNA immunization. DNA was delivered to shaved inner thigh skin of six companion dogs with melanoma approximately every 14days for a planned total of four vaccination time points. An anti-huTYR ELISA was used to test pre- and post-treatment sera. Biopsies of treated skin were obtained for detection of huTYR transgene expression. DNA microseeding was well tolerated with no significant toxicity detected beyond local site irritation, and there were no signs of autoimmunity. huTYR-expressing cells were observed in biopsies of huTYR DNA microseeding sites. Increased humoral anti-huTYR antibodies were seen in two of five evaluable dogs following microseeding compared to baseline. DNA microseeding is well tolerated in companion dogs with melanoma. Further investigation is needed to determine if combining DNA microseeding with other immunotherapy regimens potentiates this delivery platform for cancer immunotherapy.
C1 [Zuleger, Cindy L.; Kang, Chulhi; Ranheim, Erik A.; Macklin, Michael D.; Newton, Michael A.; Vail, David M.; Albertini, Mark R.] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA.
   [Zuleger, Cindy L.; Macklin, Michael D.; Albertini, Mark R.] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI USA.
   [Ranheim, Erik A.] Univ Wisconsin, Dept Pathol, Sch Med & Publ Hlth, Madison, WI 53706 USA.
   [Kurzman, Ilene D.; Vail, David M.] Univ Wisconsin, Sch Vet Med, Dept Med Sci, Madison, WI 53706 USA.
   [Newton, Michael A.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biostat & Med Informat, Madison, WI USA.
   [Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.
   [Eriksson, Elof] Harvard Med Sch, Brigham & Womens Hosp, Div Plast Surg, Boston, MA USA.
   [Albertini, Mark R.] William S Middleton Mem Vet Adm Med Ctr, Med Serv, Madison, WI USA.
RP Albertini, MR (corresponding author), Univ Wisconsin, Clin Sci Ctr, Room K6-530,600 Highland Ave, Madison, WI 53792 USA.
EM mralbert@wisc.edu
FU National Cancer InstituteUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) [P30 CA014520]; University of Wisconsin (UW) Dermatology
   Department & The Skin Disease Research Center (SDRC) Core Grant from the
   National Institute of Arthritis and Musculoskeletal and Skin Diseases of
   the National Institutes of Health [1P30AR066524]; UW Institute for
   Clinical and Translational Research (ICTR) through the NIH National
   Center for Advancing Translational Sciences (NCATS) [UL1TR000427]
FX Supported in part by Grant P30 CA014520 from the National Cancer
   Institute, by the University of Wisconsin (UW) Dermatology Department &
   The Skin Disease Research Center (SDRC) Core Grant 1P30AR066524 from the
   National Institute of Arthritis and Musculoskeletal and Skin Diseases of
   the National Institutes of Health, by the UW Institute for Clinical and
   Translational Research (ICTR) through the NIH National Center for
   Advancing Translational Sciences (NCATS) Grant UL1TR000427, and by
   resources at the William S. Middleton Memorial Veterans Hospital,
   Madison, WI. The content is solely the responsibility of the authors and
   does not necessarily represent the official views of the NIH or the
   views of the Dept. of Veterans Affairs or the United States Government.
CR Alexander AN, 2006, CANCER IMMUNOL IMMUN, V55, P433, DOI 10.1007/s00262-005-0025-6
   Bergman PJ, 2003, CLIN CANCER RES, V9, P1284
   Bins AD, 2005, NAT MED, V11, P899, DOI 10.1038/nm1264
   ClinicalTrials. gov A service of the U. S. national institutes of health, 2016, SERV US NAT I HLTH
   Cormier JN, 1998, J IMMUNOTHER, V21, P27, DOI 10.1097/00002371-199801000-00003
   DeMuth PC, 2013, NAT MATER, V12, P367, DOI [10.1038/NMAT3550, 10.1038/nmat3550]
   Eriksson E, 1998, J SURG RES, V78, P85, DOI 10.1006/jsre.1998.5325
   Frost JD, 1997, CANCER, V80, P317, DOI 10.1002/(SICI)1097-0142(19970715)80:2<317::AID-CNCR21>3.0.CO;2-W
   Glikin Gerardo Claudio, 2014, ScientificWorldJournal, V2014, P718520, DOI 10.1155/2014/718520
   Gordon IK, 2010, ILAR J, V51, P214, DOI 10.1093/ilar.51.3.214
   Goubier A, 2008, VACCINE, V26, P2186, DOI 10.1016/j.vaccine.2008.01.059
   Grosenbaugh DA, 2011, AM J VET RES, V72, P1631, DOI 10.2460/ajvr.72.12.1631
   HELFAND SC, 1994, J IMMUNOTHER, V16, P188, DOI 10.1097/00002371-199410000-00003
   Helfand SC, 1996, CELL IMMUNOL, V167, P99, DOI 10.1006/cimm.1996.0012
   Hill PB, 2001, VET IMMUNOL IMMUNOP, V81, P187, DOI 10.1016/S0165-2427(01)00310-5
   Kis EE, 2012, VACCINE, V30, P523, DOI 10.1016/j.vaccine.2011.11.020
   Kutzler MA, 2016, MUCOSAL IMMUNOL, V9, P13, DOI 10.1038/mi.2015.31
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lembcke LM, 2012, J EQUINE VET SCI, V32, P607, DOI 10.1016/j.jevs.2012.02.011
   Liao Jack C F, 2006, Cancer Immun, V6, P8
   Marsella R, 2003, CLIN DERMATOL, V21, P122, DOI 10.1016/S0738-081X(02)00369-3
   Morris ZS, 2016, CANCER RES, V76, P3929, DOI 10.1158/0008-5472.CAN-15-2644
   Morrison C, 2016, NAT REV DRUG DISCOV, V15, P521, DOI 10.1038/nrd.2016.159
   NABEL EG, 1992, HUM GENE THER, V3, P649, DOI 10.1089/hum.1992.3.6-649
   Nguyen SM, 2015, VET COMP ONCOL, V13, P176, DOI 10.1111/vco.12032
   Nuttall TJ, 2002, CLIN EXP ALLERGY, V32, P789, DOI 10.1046/j.1365-2222.2002.01356.x
   Olivry T, 2006, VET DERMATOL, V17, P95, DOI 10.1111/j.1365-3164.2006.00502.x
   Oosterhuis K, 2012, CURR TOP MICROBIOL, V351, P221, DOI 10.1007/82_2010_117
   Ottnod JM, 2013, VET COMP ONCOL, V11, P219, DOI 10.1111/vco.12057
   Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273
   Patel Dipa, 2007, Human Antibodies, V16, P127
   Pellin M. A., 2016, VET COMP ONCOLOGY
   Phillips JC, 2012, AM J VET RES, V73, P272, DOI 10.2460/ajvr.73.2.272
   Piliang MP, 2011, CLIN LAB MED, V31, P281, DOI 10.1016/j.cll.2011.03.005
   Piras L. A., 2016, VET COMP ONCOLOGY
   Ramos-Vara JA, 2011, VET PATHOL, V48, P443, DOI 10.1177/0300985810382095
   Rogers RS, 1997, MAYO CLIN PROC, V72, P362, DOI 10.4065/72.4.362
   Tobin DJ, 2003, BRIT J DERMATOL, V149, P938, DOI 10.1111/j.1365-2133.2003.05610.x
   ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302
   Vail D. M., 2011, TUMOR MODELS CANC RE
   van den Berg JH, 2009, HUM GENE THER, V20, P181, DOI [10.1089/hum.2008.073, 10.1089/hgt.2008.073]
   Verstrepen BE, 2008, VACCINE, V26, P3346, DOI 10.1016/j.vaccine.2008.03.091
   Veterinary cooperative oncology group, 2011, VET COMP ONCOLOGY
   Wahren B, 2014, VACCINES-BASEL, V2, P785, DOI 10.3390/vaccines2040785
NR 44
TC 3
Z9 3
U1 1
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
EI 2053-1095
J9 VET MED SCI
JI Vet. Med. Sci.
PD AUG
PY 2017
VL 3
IS 3
BP 134
EP 145
DI 10.1002/vms3.65
PG 12
WC Veterinary Sciences
SC Veterinary Sciences
GA FD7BA
UT WOS:000407680400002
PM 29067210
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Donohue, MJ
   Macomber, PSH
   Okimoto, D
   Lerner, DT
AF Donohue, Mary J.
   Macomber, Patricia S. H.
   Okimoto, Darren
   Lerner, Darren T.
TI Survey of Rainwater Catchment Use and Practices on Hawaii Island
SO JOURNAL OF CONTEMPORARY WATER RESEARCH & EDUCATION
LA English
DT Article
DE Zika virus; dengue virus; rat lungworm disease; rainwater harvesting;
   Sea Grant
ID CISTERN WATER; OUTBREAK; QUALITY
AB The harvesting of rainwater for domestic use on Hawaii Island is widespread, particularly in areas not served by municipal water. Rainwater catchment is currently unregulated in Hawaii with the responsibility of installing and maintaining appropriate systems on owners and users. Well-designed and maintained rainwater catchment systems are more likely to provide water free of pathogens than poorly designed or maintained systems. We conducted outreach to rural Hawaii Island communities on rainwater catchment best practices and explored household uses and practices associated with these systems via survey of 110 individuals. Nearly 90% (N=96) of all survey respondents used harvested rainwater as a potable water source or for bathing, and we estimate only 66% of those systems may reasonably be expected to produce safe drinking water. Reported testing frequency of captured rainwater falls below recommended levels and varies significantly with rainwater use and system adequacy. Outreach was effective in changing perceptions on rainwater catchment as evidenced by individuals' reported beliefs before and after engagement. The majority (N=75) of all survey respondents reported they will change how they maintain their catchment systems, and over 50% (N=61) reported they will change their catchment system elements, as a result of outreach. We conclude there is a demonstrated need for ongoing, professional, evidence-based outreach programs to serve rainwater catchment system users in Hawaii.
C1 [Donohue, Mary J.; Okimoto, Darren; Lerner, Darren T.] Univ Hawaii Manoa, Sch Ocean & Earth Sci & Technol, Univ Hawaii Sea Grant Coll Program, Honolulu, HI USA.
   [Donohue, Mary J.; Lerner, Darren T.] Univ Hawaii Manoa, Water Resources Res Ctr, Honolulu, HI 96822 USA.
   [Macomber, Patricia S. H.] Tried Serv, Keaau, HI USA.
RP Donohue, MJ (corresponding author), Univ Hawaii Sea Grant Coll Program, 2525 Correa Rd,Hawaii Inst Geophys Room 238, Honolulu, HI 96822 USA.
EM donohuem@hawaii.edu; macomber@hawaii.edu; okimotod@hawaii.edu;
   lerner@hawaii.edu
FU United States Geological SurveyUnited States Geological Survey; National
   Institutes of Water Resources [G16AC00335]; United States Department of
   Agriculture (USDA), National Institute of Food and Agriculture
   (NIFA)United States Department of Agriculture (USDA) [2014-46100-22345];
   National Oceanic and Atmospheric Administration, Project A/AS-1 -
   University of Hawaii Sea Grant College Program, SOEST from NOAA Office
   of Sea Grant, Department of Commerce [NA14OAR4170071]
FX We thank Chantal Chung, Matthew Gonser, Timothy Pope, and the late
   Robert Howerton who conducted rainwater catchment workshops on Hawaii
   Island in 2015. We also thank Chantal Chung for project administrative
   and logistical support. We thank Jason D. Baker for statistical
   assistance. We thank the University of Hawaii Sea Grant College Program
   for overall project support including administrative, information
   technology, and communications assistance. The American Rainwater
   Catchment Systems Association (ARCSA) provided significant in-kind
   project support through ongoing collaboration including the
   participation and expertise of ARCSA Education Coordinator, Mr. Timothy
   Pope. This work was funded in part by the United States Geological
   Survey, National Institutes of Water Resources Grant to the Water
   Resources Research Center of the University of Hawaii, Grant No.
   G16AC00335 as well as a United States Department of Agriculture (USDA),
   National Institute of Food and Agriculture (NIFA) outreach grant
   (2014-46100-22345) to M.J. Donohue. This work was also funded in part by
   a grant/cooperative agreement from the National Oceanic and Atmospheric
   Administration, Project A/AS-1, which is sponsored by the University of
   Hawaii Sea Grant College Program, SOEST, under Institutional Grant No.
   NA14OAR4170071 from NOAA Office of Sea Grant, Department of Commerce.
   The views expressed herein are those of the author(s) and do not
   necessarily reflect the views of NOAA or any of its subagencies.
   UNIHI-SEAGRANT-JC-15-04.
CR Abdelkhaleq RA, 2007, WA SCI TECHNOL, V7, P85, DOI 10.2166/ws.2007.010
   Ahmed W, 2011, J ENVIRON QUAL, V40, P13, DOI 10.2134/jeq2010.0345
   Centers for Disease Control and Prevention, 2016, ZIK VIR TRANSM RISKS
   Centers for Disease Control and Prevention (CDC), 2016, ZIK VIR CAS COUNTS U
   Chen H. T., 1935, Annales de Parasitologie Paris, V13, P312
   College of Tropical Agriculture & Human Resources Hawai'i (CTAHR), 2009, RAINW CATCHM SOL
   Crabtree KD, 1996, WATER RES, V30, P208, DOI 10.1016/0043-1354(95)00100-Y
   CUNLIFFE D, 1998, NATL ENV HLTH FORUM, V3
   Davis G. A, 2003, J EXTENSION, V41
   Department of Business Economic Development and Tourism, 2012, DBEDT 2040 SER
   Department of Business Economic Development and Tourism, 2016, STAT HAW 2015 DAT BO
   Department of Water Supply County of Hawaii, 2010, HAW COUNT WAT US DEV
   FEWTRELL L, 2007, URBAN WATER J, V4, P253, DOI DOI 10.1080/15730620701526097
   Flanagan S., 2013, WATERLINES, V32, P124
   Han M, 2010, WATER SCI TECHNOL, V62, P148, DOI 10.2166/wst.2010.299
   Hawaii State Department of Health, 2016, DENG FEV FREQ ASK QU
   Hawaii State Department of Health, 2015, CONTR MOSQ BREED RAI
   Hill LG, 2005, AM J EVAL, V26, P501, DOI 10.1177/1098214005281356
   Hollingsworth RG, 2007, PAC SCI, V61, P457, DOI 10.2984/1534-6188(2007)61[457:DOPCMP]2.0.CO;2
   KOPLAN JP, 1978, J HYG-CAMBRIDGE, V81, P303, DOI 10.1017/S0022172400025146
   KORICH DG, 1990, APPL ENVIRON MICROB, V56, P1423, DOI 10.1128/AEM.56.5.1423-1428.1990
   Loper S.A., 2015, DEAC0576RL01830 PAC
   LYE DJ, 1987, WATER RESOUR BULL, V23, P1063
   Macomber P.S.H., 2010, COLL TROPICAL AGR HU
   MCANULTY JM, 1994, JAMA-J AM MED ASSOC, V272, P1597, DOI 10.1001/jama.272.20.1597
   National Sanitation Foundation, 2016, NSF ANSI 55 ULTR MIC
   Pacey A., 1986, RAINWATER HARVESTING
   Pandey DN, 2003, CURR SCI INDIA, V85, P46
   Pathak N., 2005, RAINWATER HARVESTING
   Quigley N, 2016, AUSTRALAS J WAT RESO, V20, P65, DOI 10.1080/13241583.2016.1173314
   Rockwell S. K., 1989, J EXTENSION, V27
   Western Rural Development Center, 2010, POP BRIEF TRENDS W U
   YAZIZ MI, 1989, WATER RES, V23, P761, DOI 10.1016/0043-1354(89)90211-X
NR 33
TC 2
Z9 2
U1 2
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1936-704X
J9 J CONTEMP WAT RES ED
JI J. Contemp. Wat. Res. Educ.
PD AUG
PY 2017
VL 161
IS 1
BP 33
EP 47
DI 10.1111/j.1936-704X.2017.3250.x
PG 15
WC Water Resources
SC Water Resources
GA FH3NV
UT WOS:000411056200003
OA Bronze
DA 2020-07-08
ER

PT J
AU Prakalapakorn, SG
   Meaney-Delman, D
   Honein, MA
   Rasmussen, SA
AF Prakalapakorn, S. Grace
   Meaney-Delman, Dana
   Honein, Margaret A.
   Rasmussen, Sonja A.
TI The eyes as a window to improved understanding of the prenatal effects
   of Zika virus infection
SO JOURNAL OF AAPOS
LA English
DT Editorial Material
ID BIRTH-DEFECTS; RUBELLA; INFANTS; BRAZIL; MANIFESTATIONS; PREGNANCY;
   COLOMBIA; UPDATE
C1 [Prakalapakorn, S. Grace] Duke Univ, Dept Ophthalmol, Durham, NC USA.
   [Meaney-Delman, Dana; Honein, Margaret A.; Rasmussen, Sonja A.] Ctr Dis Control & Prevent, 1600 Clifton Rd,MS E-33, Atlanta, GA 30333 USA.
RP Rasmussen, SA (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd,MS E-33, Atlanta, GA 30333 USA.
EM skr9@cdc.gov
OI Prakalapakorn, Sasapin/0000-0001-6788-7425
FU NEI NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [K23
   EY024268]
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   CHESS S, 1971, J AUTISM CHILD SCHIZ, V1, P33, DOI 10.1007/BF01537741
   COLLIS WJ, 1970, ARCH OPHTHALMOL-CHIC, V84, P33, DOI 10.1001/archopht.1970.00990040035009
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   Gregg NM, 1944, T OPHTHALMOL SOC AUS, V4, P119
   Gregg NM, 1941, T OPHTHALMOL SOC AUS, V3, P35
   Igbinosa Irogue I, 2017, Am Fam Physician, V95, P507
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Marks EO, 1946, T OPHTHAL SOC AUST, V6, P122
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   PLOTKIN SA, 1965, J PEDIATR-US, V67, P182, DOI 10.1016/S0022-3476(65)80240-2
   Plotkin SA, 2006, CLIN INFECT DIS, V43, pS164, DOI 10.1086/505950
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rasmussen SA, 2009, BIRTH DEFECTS RES A, V85, P82, DOI 10.1002/bdra.20506
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Shapiro-Mendoza CK, 2016, PREGNANCY OUTCOMES M
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Ventura LO, 2017, J AAPOS, V21
   Vercosa I, 2017, J AAPOS, V21, P300, DOI 10.1016/j.jaapos.2017.05.024
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zin AA, 2017, JAMA PEDIAT
NR 25
TC 3
Z9 3
U1 0
U2 2
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1091-8531
EI 1528-3933
J9 J AAPOS
JI J. AAPOS
PD AUG
PY 2017
VL 21
IS 4
BP 259
EP 261
DI 10.1016/j.jaapos.2017.07.001
PG 3
WC Ophthalmology; Pediatrics
SC Ophthalmology; Pediatrics
GA FG1OM
UT WOS:000409565500001
PM 28709964
OA Bronze
DA 2020-07-08
ER

PT J
AU Collins, MH
   Metz, SW
AF Collins, Matthew H.
   Metz, Stefan W.
TI Progress and Works in Progress: Update on Flavivirus Vaccine Development
SO CLINICAL THERAPEUTICS
LA English
DT Review
DE dengue; flavivirus; immunization; immunologic imemory; vaccine
   development; Zika
ID WEST-NILE-VIRUS; TICK-BORNE ENCEPHALITIS; TETRAVALENT DENGUE VACCINE;
   YELLOW-FEVER VACCINE; NONSTRUCTURAL PROTEIN NS1; ZIKA VIRUS; JAPANESE
   ENCEPHALITIS; PROTECTIVE EFFICACY; DNA VACCINE; NEUTRALIZING ANTIBODIES
AB Most areas of the globe are endemic for at least one flavivirus, putting billions at risk for infection. This diverse group of viral pathogens causes a range of manifestations in humans from asymptomatic infection to hemorrhagic fever to encephalitis to birth defects and even death. Many flaviviruses are transmitted by mosquitos and have expanded in geographic distribution in recent years, with dengue virus being the most prevalent, infecting approximately 400 million people each year. The explosive emergence of Zika virus in Latin America in 2014 refocused international attention on this medically important group of viruses. Meanwhile, yellow fever has caused major outbreaks in Africa and South America since 2015 despite a reliable vaccine. There is no vaccine for Zika yet, and the only licensed dengue vaccine performs suboptimally in certain contexts. Further lessons are found when considering the experience with Japanese encephalitis virus, West Nile virus, and tickborne encephalitis virus, all of which now have protective vaccination in human or veterinary populations. Thus, vaccination is a mainstay of public health strategy for combating flavivirus infections; however, numerous challenges exist along the path from development to delivery of a tolerable and effective vaccine. Nevertheless, intensification of investment and effort in this area holds great promise for significantly reducing the global burden of disease attributable to flavivirus infection. (C) 2017 Elsevier HS Journals, Inc. All rights reserved.
C1 [Collins, Matthew H.] Univ N Carolina, Dept Med, Div Infect Dis, CB 7292,160 Dent Circle,9024 Burnett Womack, Chapel Hill, NC 27599 USA.
   [Metz, Stefan W.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.
RP Collins, MH (corresponding author), Univ N Carolina, Dept Med, Div Infect Dis, CB 7292,160 Dent Circle,9024 Burnett Womack, Chapel Hill, NC 27599 USA.
EM matthew.collins@unchealth.unc.edu
RI Metz, Stefan/J-1974-2019
OI Metz, Stefan/0000-0002-9249-2844
FU National Institute of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [5T32AI007151-39,
   1-R01-AI107731-01, U19 AI109784-01]
FX This research was funded by the grants 5T32AI007151-39 (Dr. Margolis,
   principal investigator), 1-R01-AI107731-01 (Dr. de Silva, principal
   investigator), and U19 AI109784-01 (Dr. Ting, principal investigator)
   from the National Institute of Health.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aguiar M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005179
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Allwinn R, 2002, MED MICROBIOL IMMUN, V190, P199, DOI 10.1007/s00430-001-0107-9
   ANDO K, 1956, AM J HYG, V63, P230
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barnett ED, 2007, CLIN INFECT DIS, V44, P850, DOI 10.1086/511869
   Barrett ADT, 1997, BIOLOGICALS, V25, P17, DOI 10.1006/biol.1997.0056
   Barrett ADT, 2016, NEW ENGL J MED, V375, P301, DOI 10.1056/NEJMp1606997
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Belmusto-Worn VE, 2005, AM J TROP MED HYG, V72, P189, DOI 10.4269/ajtmh.2005.72.189
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   BHAMARAPRAVATI N, 1987, B WORLD HEALTH ORGAN, V65, P189
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Biedenbender R, 2011, J INFECT DIS, V203, P75, DOI 10.1093/infdis/jiq003
   Blair PJ, 2006, VACCINE, V24, P1427, DOI 10.1016/j.vaccine.2005.09.032
   Block OKT, 2010, VACCINE, V28, P8085, DOI 10.1016/j.vaccine.2010.10.004
   Blumberg EA, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14083
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Butterworth MK, 2017, ENVIRON HEALTH PERSP, V125, P579, DOI 10.1289/EHP218
   Campbell GL, 2011, B WORLD HEALTH ORGAN, V89
   Campi-Azevedo AC, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-391
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Castanha PM, 2016, J INFECT DIS, V215, pjiw638
   Chahal JS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00193-w
   Chahal JS, 2016, P NATL ACAD SCI USA, V113, pE4133, DOI 10.1073/pnas.1600299113
   Chambers TJ, 1999, J VIROL, V73, P3095, DOI 10.1128/JVI.73.4.3095-3101.1999
   Chowdhury PR, 2015, CLIN INFECT DIS, V61, pS586, DOI 10.1093/cid/civ603
   Coller BAG, 2011, VACCINE, V29, P7267, DOI 10.1016/j.vaccine.2011.07.021
   Collins M, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.82
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Collucci C, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i6157
   Corbett KS, 2015, J INFECT DIS, V211, P590, DOI 10.1093/infdis/jiu481
   Costa SM, 2007, VIROLOGY, V358, P413, DOI 10.1016/j.virol.2006.08.052
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   DEMICHELI V, 2009, COCHRANE DB SYST REV, V1
   Dengue vaccine: WHO position paper-July 2016, 2016, HEAL SECT SECR LEAG, V91, P349
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   DOSSANTOS CND, 1995, VIRUS RES, V35, P35
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Durbin Anna P, 2016, J Infect Dis, V214, P832, DOI 10.1093/infdis/jiw067
   Durbin AP, 2013, J INFECT DIS, V207, P697, DOI 10.1093/infdis/jis749
   El Garch H, 2008, VET IMMUNOL IMMUNOP, V123, P230, DOI 10.1016/j.vetimm.2008.02.002
   FALGOUT B, 1990, J VIROL, V64, P4356, DOI 10.1128/JVI.64.9.4356-4363.1990
   Ferguson M, 2007, VACCINE, V25, P5233, DOI 10.1016/j.vaccine.2007.05.034
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Feroldi E, 2016, J INFECT DIS, V215, pjiw533
   Fibriansah G, 2014, EMBO MOL MED, V6, P358, DOI 10.1002/emmm.201303404
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gallichotte EN, 2015, MBIO, V6, DOI 10.1128/mBio.01461-15
   Gold CA, 2016, JAMA NEUROL, V73, P905, DOI 10.1001/jamaneurol.2016.1268
   Gotuzzo E, 2013, AM J TROP MED HYG, V89, P434, DOI 10.4269/ajtmh.13-0264
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Gould LH, 2005, J VIROL, V79, P14606, DOI 10.1128/JVI.79.23.14606-14613.2005
   Guirakhoo F, 2004, J VIROL, V78, P4761, DOI 10.1128/JVI.78.9.4761-4775.2004
   Guy B, 2016, NAT REV MICROBIOL, V14, P45, DOI 10.1038/nrmicro.2015.2
   Guy B, 2011, VACCINE, V29, P7229, DOI 10.1016/j.vaccine.2011.06.094
   Guy B, 2010, VACCINE, V28, P632, DOI 10.1016/j.vaccine.2009.09.098
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Guzman MG, 2010, EXPERT REV VACCINES, V9, P137, DOI 10.1586/ERV.09.139
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Haglund M, 2003, VACCINE, V21, pS11, DOI 10.1016/S0264-410X(02)00811-3
   HAHN CS, 1987, P NATL ACAD SCI USA, V84, P2019, DOI 10.1073/pnas.84.7.2019
   Halstead SB, 2015, F1000RESEARCH, V4
   Halstead SB, 2017, EMERG INFECT DIS, V23, P569, DOI 10.3201/eid2304.161879
   Halstead SB, 2016, AM J TROP MED HYG, V95, P741, DOI 10.4269/ajtmh.16-0222
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Hayden MH, 2015, AM J TROP MED HYG, V93, P397, DOI 10.4269/ajtmh.15-0128
   Hegde NR, 2017, HUM VACC IMMUNOTHER, V13, P1320, DOI 10.1080/21645515.2017.1285472
   Heinz FX, 2007, VACCINE, V25, P7559, DOI 10.1016/j.vaccine.2007.08.024
   Henein S, 2017, J INFECT DIS, V215, P351, DOI 10.1093/infdis/jiw576
   HOKE CH, 1988, NEW ENGL J MED, V319, P608, DOI 10.1056/NEJM198809083191004
   Hotez PJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002808
   Houghton-Triviño Natalia, 2008, Rev. salud pública, V10, P299
   Jean K, 2016, AM J TROP MED HYG, V95, P1435, DOI 10.4269/ajtmh.16-0401
   Katz LM, 2017, ARCH PATHOL LAB MED, V141, P85, DOI 10.5858/arpa.2016-0430-RA
   Kiermayr S, 2009, J VIROL, V83, P8482, DOI 10.1128/JVI.00660-09
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Kiran SK, 2015, EMERG INFECT DIS, V21, P146, DOI 10.3201/eid2101.141227
   Kirkpatrick BD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1517
   Kirkpatrick BD, 2015, J INFECT DIS, V212, P702, DOI 10.1093/infdis/jiv082
   Kollaritsch H, 2011, BACKGROUND DOCUMENT
   Kollaritsch H, 2012, EXPERT REV VACCINES, V11, P1103, DOI [10.1586/erv.12.86, 10.1586/ERV.12.86]
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lang J, 1999, AM J TROP MED HYG, V60, P1045, DOI 10.4269/ajtmh.1999.60.1045
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lazear HM, 2016, JAMA-J AM MED ASSOC, V315, P1945, DOI 10.1001/jama.2016.2899
   Ledgerwood JE, 2011, J INFECT DIS, V203, P1396, DOI 10.1093/infdis/jir054
   Ledizet M, 2005, VACCINE, V23, P3915, DOI 10.1016/j.vaccine.2005.03.006
   Li JQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19953
   Li XF, 2013, J VIROL, V87, P13694, DOI 10.1128/JVI.00931-13
   Lieberman MM, 2007, VACCINE, V25, P414, DOI 10.1016/j.vaccine.2006.08.018
   Lieberman MM, 2009, CLIN VACCINE IMMUNOL, V16, P1332, DOI 10.1128/CVI.00119-09
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Lin YS, 2011, EXP BIOL MED, V236, P515, DOI 10.1258/ebm.2011.010339
   Liu Y, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.74
   Loew-Baselli A, 2006, VACCINE, V24, P5256, DOI 10.1016/j.vaccine.2006.03.061
   Lu H, 2013, MOL IMMUNOL, V54, P109, DOI 10.1016/j.molimm.2012.11.007
   Magnusson SE, 2014, VACCINE, V32, P800, DOI 10.1016/j.vaccine.2013.12.030
   Marlow Mariel A, 2017, MMWR Morb Mortal Wkly Rep, V66, P117, DOI 10.15585/mmwr.mm6604a6
   Marston HD, 2016, NEW ENGL J MED, V375, P1209, DOI 10.1056/NEJMp1607762
   Martin JF, 2003, VACCINE, V21, P587, DOI 10.1016/S0264-410X(02)00564-9
   Martins RM, 2013, HUM VACC IMMUNOTHER, V9, P879, DOI 10.4161/hv.22982
   Mathew A, 2011, J INFECT DIS, V204, P1514, DOI 10.1093/infdis/jir607
   Metz SW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005071
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Moloney A, 2009, LANCET, V374, P677, DOI 10.1016/S0140-6736(09)61545-2
   Monath TP, 2003, J INFECT DIS, V188, P1213, DOI 10.1086/378356
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Moreira R, 2016, B WORLD HEALTH ORGAN, V94, P716, DOI 10.2471/BLT.16.031016
   Morrison D, 2010, J INFECT DIS, V201, P370, DOI 10.1086/649916
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nabel GJ, 2013, NEW ENGL J MED, V368, P551, DOI 10.1056/NEJMra1204186
   Ng T, 2003, Dev Biol (Basel), V114, P221
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Omer SB, 2016, JAMA-J AM MED ASSOC, V315, P1227, DOI 10.1001/jama.2016.2237
   Orenstein WA, 2017, P NATL ACAD SCI USA, V114, P4031, DOI 10.1073/pnas.1704507114
   Osorio JE, 2015, VACCINE, V33, P7112, DOI 10.1016/j.vaccine.2015.11.022
   Osorio JE, 2014, LANCET INFECT DIS, V14, P830, DOI 10.1016/S1473-3099(14)70811-4
   PAHO WHO, 2017, REG ZIK EP UPD AM
   Pang Tikki, 2017, Lancet Infect Dis, V17, pe79, DOI 10.1016/S1473-3099(16)30471-6
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Pfister M, 2005, AM J TROP MED HYG, V72, P339, DOI 10.4269/ajtmh.2005.72.339
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Pinto AK, 2013, J VIROL, V87, P1926, DOI 10.1128/JVI.02903-12
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Quam MB, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw059
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Raviprakash K, 2000, VACCINE, V18, P2426, DOI 10.1016/S0264-410X(99)00570-8
   Raviprakash K, 2001, VIROLOGY, V290, P74, DOI 10.1006/viro.2001.1136
   Rezza G, 2014, PATHOG GLOB HEALTH, V108, P349, DOI 10.1179/2047773214Y.0000000163
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Rothman AL, 2004, J CLIN INVEST, V113, P946, DOI [10.1172/JCI200421512, 10.1172/JCI21512]
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   SAGE Working Group on Japanese encephalitis vaccines, 2014, BACKGR PAP JAP ENC V
   Sampathkumar P, 2016, MAYO CLIN PROC, V91, P514, DOI 10.1016/j.mayocp.2016.02.017
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schlick P, 2010, VACCINE, V28, P5903, DOI 10.1016/j.vaccine.2010.06.045
   Schneeweiss A, 2011, VACCINE, V29, P6352, DOI 10.1016/j.vaccine.2011.04.116
   Schosser R, 2014, VACCINE, V32, P2375, DOI 10.1016/j.vaccine.2014.01.072
   Seligman SJ, 2004, LANCET, V363, P2073, DOI 10.1016/S0140-6736(04)16459-3
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Simmons CP, 2015, NEW ENGL J MED, V373, P1263, DOI 10.1056/NEJMe1509442
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Smit R, 2015, EXPERT REV VACCINES, V14, P737, DOI 10.1586/14760584.2015.985661
   Solomon T, 2003, BMJ-BRIT MED J, V326, P865, DOI 10.1136/bmj.326.7394.865
   Speer SD, 2016, SCIENCE, V353, P750, DOI 10.1126/science.aah6187
   SRIVASTAVA AK, 1995, VACCINE, V13, P1251, DOI 10.1016/0264-410X(94)00059-V
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stiasny K, 2009, VACCINE, V27, P7021, DOI 10.1016/j.vaccine.2009.09.069
   STOKES ADRIAN, 1928, AMER JOUR TROP MED, V8, P103
   Suss J, 2008, EUROSURVEILLANCE, V13, P717
   Suss J, 2010, TICKS TICK-BORNE DIS, V1, P1, DOI [10.1016/j.ttbdis.2010.01.003, 10.1016/j.ttbdis.2010.10.007]
   Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888
   Tepper NK, 2016, MMWR-MORBID MORTAL W, V65, P311, DOI 10.15585/mmwr.mm6512e1
   Thisyakorn Usa, 2014, Ther Adv Vaccines, V2, P3, DOI 10.1177/2051013613507862
   Thomas RE, 2012, AM J TROP MED HYG, V86, P359, DOI 10.4269/ajtmh.2012.11-0525
   Thomas SJ, 2016, NEW ENGL J MED, V375, P1212, DOI 10.1056/NEJMp1609300
   Thomas SJ, 2015, AM J PREV MED, V49, pS334, DOI 10.1016/j.amepre.2015.09.006
   TIGERTT WD, 1956, AM J HYG, V63, P238, DOI 10.1093/oxfordjournals.aje.a119807
   Tsarev SA, 2000, VACCINE, V18, P36, DOI 10.1016/S0264-410X(00)00039-6
   Uchil PD, 2001, AM J TROP MED HYG, V65, P242, DOI 10.4269/ajtmh.2001.65.242
   Ulbert S, 2014, FUTURE MICROBIOL, V9, P1221, DOI [10.2217/FMB.14.67, 10.2217/fmb.14.67]
   Valdes I, 2017, ARCH VIROL
   Vashishtha VM, 2013, INDIAN PEDIATR, V50, P1095, DOI 10.1007/s13312-013-0292-9
   Versiani AF, 2017, J NANOBIOTECHNOL, V15, DOI 10.1186/s12951-017-0259-4
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wan SW, 2013, J FORMOS MED ASSOC, V112, P3, DOI 10.1016/j.jfma.2012.11.006
   Wang T, 2001, J IMMUNOL, V167, P5273, DOI 10.4049/jimmunol.167.9.5273
   Watts DM, 2007, VACCINE, V25, P2913, DOI 10.1016/j.vaccine.2006.08.008
   Weiskopf D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00093
   Weiskopf D, 2011, J IMMUNOL, V187, P4268, DOI 10.4049/jimmunol.1101970
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Whiteman MC, 2010, VACCINE, V28, P1075, DOI 10.1016/j.vaccine.2009.10.112
   Who Publication, 2011, Vaccine, V29, P8769, DOI 10.1016/j.vaccine.2011.07.024
   Widman DG, 2010, AM J TROP MED HYG, V82, P1160, DOI 10.4269/ajtmh.2010.09-0310
   Wilder-Smith A, 2015, SCIENCE, V350, P626, DOI 10.1126/science.aab4047
   Williams KL, 2012, VIROLOGY, V429, P12, DOI 10.1016/j.virol.2012.03.003
   Wu SF, 2003, VACCINE, V21, P3919, DOI 10.1016/S0264-410X(03)00310-4
   Yu YX, 2010, VACCINE, V28, P3635, DOI 10.1016/j.vaccine.2010.02.105
   Zent O, 2005, J TRAVEL MED, V12, P85
NR 201
TC 27
Z9 28
U1 0
U2 14
PU ELSEVIER
PI BRIDGEWATER
PA 685 ROUTE 202-206, BRIDGEWATER, NJ 08807 USA
SN 0149-2918
EI 1879-114X
J9 CLIN THER
JI Clin. Ther.
PD AUG
PY 2017
VL 39
IS 8
BP 1519
EP 1536
DI 10.1016/j.clinthera.2017.07.001
PG 18
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA FG0HC
UT WOS:000409399200003
PM 28754189
OA Bronze
DA 2020-07-08
ER

PT J
AU Li, Y
   Phoo, WW
   Loh, YR
   Zhang, ZZ
   Ng, EY
   Wang, WL
   Keller, TH
   Luo, DH
   Kang, CB
AF Li, Yan
   Phoo, Wint Wint
   Loh, Ying Ru
   Zhang, Zhenzhen
   Ng, Elizabeth Yihui
   Wang, Weiling
   Keller, Thomas H.
   Luo, Dahai
   Kang, CongBao
TI Structural characterization of the linked NS2B-NS3 protease of Zika
   virus
SO FEBS LETTERS
LA English
DT Article
DE drug discovery; NMR; protease; protein dynamics; structure; Zika virus
ID WEST-NILE-VIRUS; DENGUE VIRUS; NS3 PROTEASE; CRYSTAL-STRUCTURE;
   INHIBITORS; HELICASE; BINDING; NMR; CONFORMATION; ACTIVATION
AB The Zika virus (ZIKV) NS2B-NS3 protease is an important drug target. The conventional flaviviral protease constructs used for structural studies contain the NS2B cofactor region linked to the NS3 protease domain via a glycine-rich flexible linker. Here, we examined the structural dynamics of this conventional Zika protease (gZiPro) using NMR spectroscopy. Although the glycine-rich linker in gZiPro does not alter the overall folding of the protease in solution, gZiPro is not homogenous in ion exchange chromatography. Compared to the unlinked protease construct, the artificial linker affects the chemical environment of many residues including H51 in the catalytic triad. Our study provides a direct comparison of ZIKV protease constructs with and without an artificial linker.
C1 [Li, Yan; Loh, Ying Ru; Ng, Elizabeth Yihui; Wang, Weiling; Keller, Thomas H.; Kang, CongBao] ASTAR, Expt Therapeut Ctr, 31 Biopolis Way,Nanos 03-01, Singapore 138669, Singapore.
   [Phoo, Wint Wint; Zhang, Zhenzhen; Luo, Dahai] Nanyang Technol Univ, Lee Kong Chian Sch Med, EMB 03-07,59 Nanyang Dr, Singapore 636921, Singapore.
   [Phoo, Wint Wint; Zhang, Zhenzhen; Luo, Dahai] Nanyang Technol Univ, NTU Inst Struct Biol, Singapore, Singapore.
   [Phoo, Wint Wint] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.
RP Kang, CB (corresponding author), ASTAR, Expt Therapeut Ctr, 31 Biopolis Way,Nanos 03-01, Singapore 138669, Singapore.; Luo, DH (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, EMB 03-07,59 Nanyang Dr, Singapore 636921, Singapore.
EM luodahai@ntu.edu.sg; cbkang@etc.a-star.edu.sg
RI Kang, Congbao/AAP-7572-2020; Li, Yan/G-4642-2013; Luo, Dahai/J-6022-2012
OI Kang, Congbao/0000-0002-9886-9374; Li, Yan/0000-0003-1963-839X; Luo,
   Dahai/0000-0001-7637-7275; Keller, Thomas/0000-0002-7553-6235
FU Lee Kong Chian School of Medicine, Nanyang Technological
   UniversityNanyang Technological University; National Medical Research
   CouncilMedical Research Council UK (MRC) [CBRG15May045]; National
   Research Foundation [NRF2016NRF-CRP001063]; A*STAR JCOAgency for Science
   Technology & Research (ASTAR) [1431AFG102/1331A028]
FX This work was supported by (1) a start-up grant from Lee Kong Chian
   School of Medicine, Nanyang Technological University, (2) National
   Medical Research Council grant CBRG15May045, (3) National Research
   Foundation grant NRF2016NRF-CRP001063 to DL (4) A*STAR JCO grant
   (1431AFG102/1331A028) to CK.
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   Clum S, 1997, J BIOL CHEM, V272, P30715, DOI 10.1074/jbc.272.49.30715
   de la Cruz L, 2014, FEBS J, V281, P1517, DOI 10.1111/febs.12729
   de la Cruz L, 2011, J AM CHEM SOC, V133, P19205, DOI 10.1021/ja208435s
   Ekonomiuk D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000356
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Kang CB, 2013, ANTIVIR RES, V97, P137, DOI 10.1016/j.antiviral.2012.11.008
   Kim YM, 2013, J BIOL CHEM, V288, P12891, DOI 10.1074/jbc.M112.442723
   Kuiper B. D., 2017, BIOCH BIOPHYS RES CO
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Li Kuohan, 2014, Virologica Sinica, V29, P74, DOI 10.1007/s12250-014-3438-6
   Li Y, 1848, BIOCHIM BIOPHYS ACTA, V2015, P2244
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Mahawaththa MC, 2017, ANTIVIR RES, V142, P141, DOI 10.1016/j.antiviral.2017.03.011
   Nitsche C, 2014, CHEM REV, V114, P11348, DOI 10.1021/cr500233q
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Robin G, 2009, J MOL BIOL, V385, P1568, DOI 10.1016/j.jmb.2008.11.026
   Shannon AE, 2016, PROTEIN EXPRES PURIF, V119, P124, DOI 10.1016/j.pep.2015.11.022
   Su XC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000561
   Su XC, 2009, FEBS J, V276, P4244, DOI 10.1111/j.1742-4658.2009.07132.x
   Vogel G, 2016, SCIENCE, V354, P1088, DOI 10.1126/science.354.6316.1088
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
NR 30
TC 10
Z9 10
U1 1
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD AUG
PY 2017
VL 591
IS 15
BP 2338
EP 2347
DI 10.1002/1873-3468.12741
PG 10
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA FF9BH
UT WOS:000409311300013
PM 28675775
OA Bronze
DA 2020-07-08
ER

PT J
AU Sebrango-Rodriguez, CR
   Martinez-Bello, DA
   Sanchez-Valdes, L
   Thilakarathne, PJ
   Del Fava, E
   Van Der Stuyft, P
   Lopez-Quilez, A
   Shkedy, Z
AF Sebrango-Rodriguez, C. R.
   Martinez-Bello, D. A.
   Sanchez-Valdes, L.
   Thilakarathne, P. J.
   Del Fava, E.
   Van Der Stuyft, P.
   Lopez-Quilez, A.
   Shkedy, Z.
TI Real-time parameter estimation of Zika outbreaks using model averaging
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Five-parameter logistic; four-parameter Gompertz; Richards;
   three-parameter logistic; Weibull
ID INFORMATION CRITERION; REPRODUCTION NUMBER; GROWTH; INFECTION;
   SELECTION; EPIDEMIC; DENGUE
AB Early prediction of the final size of any epidemic and in particular for Zika disease outbreaks can be useful for health authorities in order to plan the response to the outbreak. The Richards model is often been used to estimate epidemiological parameters for arboviral diseases based on the reported cumulative cases in single-and multi-wave outbreaks. However, other non-linear models can also fit the data as well. Typically, one follows the so called post selection estimation procedure, i.e., selects the best fitting model out of the set of candidate models and ignores the model uncertainty in both estimation and inference since these procedures are based on a single model. In this paper we focus on the estimation of the final size and the turning point of the epidemic and conduct a real-time prediction for the final size of the outbreak using several nonlinear models in which these parameters are estimated via model averaging. The proposed method is applied to Zika outbreak data in four cities from Colombia, during the outbreak ocurred in 2015-2016.
C1 [Sebrango-Rodriguez, C. R.; Sanchez-Valdes, L.] Univ Sancti Spiritus Jose Marti Perez, Ave Martires 360, Sancti Spiritus, Cuba.
   [Sebrango-Rodriguez, C. R.; Shkedy, Z.] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat I BioSt, Agoralaan,Bldg D, B-3590 Diepenbeek, Belgium.
   [Martinez-Bello, D. A.; Lopez-Quilez, A.] Univ Valencia, Fac Math, Dept Stat & Operat Res, C Dr Moliner 50, E-46100 Valencia, Spain.
   [Sanchez-Valdes, L.] Ctr Inmunol Mol, Calle 16 Esq 15 Atabey, Havana, Cuba.
   [Thilakarathne, P. J.] Katholieke Univ Leuven, Interuniv Inst Biostat & Stat Bioinformat, Kapucijnenvoer 35,Blok D,Box 7001, B-3000 Leuven, Belgium.
   [Del Fava, E.] Bocconi Univ, Carlo F Dondena Ctr Res Social Dynam, Via Guglielmo Rontgen 1, I-20136 Milan, Italy.
   [Van Der Stuyft, P.] Inst Trop Med, Unit Gen Epidemiol & Dis Control, Antwerp, Belgium.
   [Van Der Stuyft, P.] Univ Ghent, Dept Publ Hlth, Ghent, Belgium.
RP Martinez-Bello, DA (corresponding author), Univ Valencia, Fac Math, Dept Stat & Operat Res, C Dr Moliner 50, E-46100 Valencia, Spain.
EM danieladyro@gmail.com
RI Lopez-Quilez, Antonio/H-5945-2011; Del Fava, Emanuele/D-6181-2014;
   Shkedy, Ziv/AAQ-3096-2020
OI Lopez-Quilez, Antonio/0000-0002-7022-9260; Del Fava,
   Emanuele/0000-0001-7352-8525; Shkedy, Ziv/0000-0002-6306-0823;
   Martinez-Bello, Daniel Adyro/0000-0003-3219-0753
FU COLCIENCIASDepartamento Administrativo de Ciencia, Tecnologia e
   Innovacion Colciencias [646-2014]
FX This research received no specific grant from any funding agency,
   commercial or not-for-profit sectors. D.A. Martinez Bello acknowledges
   the support of COLCIENCIAS by the grant 646-2014.
CR Akaike H, 1973, P 2 INT S INF THEOR, DOI DOI 10.1007/978-1-4612-1694-0_15
   Burnham K. P., 2002, MODEL SELECTION MULT
   Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644
   Claeskens G., 2008, MODEL SELECTION MODE
   Faes C, 2007, RISK ANAL, V27, P111, DOI 10.1111/j.1539-6924.2006.00863.x
   Hsieh YH, 2009, TROP MED INT HEALTH, V14, P628, DOI 10.1111/j.1365-3156.2009.02277.x
   Hsieh YH, 2006, EMERG INFECT DIS, V12, P122, DOI 10.3201/eid1201.050396
   Hsieh YH, 2004, EMERG INFECT DIS, V10, P1165, DOI 10.3201/eid1006.031023
   Hsieh YH, 2009, SERIES CONT APPL MAT, V11, P216, DOI DOI 10.1142/9789814261265_
   Hsieh YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140810
   Hsieh YH, 2013, TROP MED INT HEALTH, V18, P830, DOI 10.1111/tmi.12105
   Hsieh YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023853
   Hsieh YH, 2009, AM J TROP MED HYG, V80, P66, DOI 10.4269/ajtmh.2009.80.66
   Jorgensen M., 1981, NZ STAT, V16, P5
   Liao JJZ, 2009, J CHEMOMETR, V23, P248, DOI 10.1002/cem.1218
   Lin D., 2012, MODELING DOSE RESPON
   MacDougall J, 2006, STAT BIOL HEALTH, P127
   Moon H, 2005, RISK ANAL, V25, P1147, DOI 10.1111/j.1539-6924.2005.00676.x
   Nishiura H, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-15
   Pinheiro J, 2016, LINEAR NONLINEAR MIX
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304
   R Core Team, 2016, R LANG ENV STAT COMP
   RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290
   Rozema E., 2007, COLL MATH J, V38, P246, DOI DOI 10.1080/07468342.2007.11922245
   Seber G. A. F., 1989, NONLINEAR REGRESSION
   Tsoularis A, 2002, MATH BIOSCI, V179, P21, DOI 10.1016/S0025-5564(02)00096-2
   Wang XS, 2012, J THEOR BIOL, V313, P12, DOI 10.1016/j.jtbi.2012.07.024
   Wellock IJ, 2004, ANIM SCI, V78, P379, DOI 10.1017/S1357729800058781
   Zhou GF, 2003, EMERG INFECT DIS, V9, P1608
NR 30
TC 4
Z9 4
U1 0
U2 8
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD AUG
PY 2017
VL 145
IS 11
BP 2313
EP 2323
DI 10.1017/S0950268817001078
PG 11
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA FF6MC
UT WOS:000409124100016
PM 28566102
OA Bronze
DA 2020-07-08
ER

PT J
AU Adebayo, G
   Neumark, Y
   Gesser-Edelsburg, A
   Abu Ahmad, W
   Levine, H
AF Adebayo, Gbenga
   Neumark, Yehuda
   Gesser-Edelsburg, Anat
   Abu Ahmad, Wiessam
   Levine, Hagai
TI Zika pandemic online trends, incidence and health risk communication: a
   time trend study
SO BMJ GLOBAL HEALTH
LA English
DT Article
ID GOOGLE TRENDS; DISEASE; EBOLA
AB Objectives We aimed to describe the online search trends of Zika and examine their association with Zika incidence, assess the content of Zika-related press releases issued by leading health authorities and examine the association between online trends and press release timing.
   Design Using Google Trends, the 1 May 2015 to 30 May 2016 online trends of Zika and associated search terms were studied globally and in the five countries with the highest numbers of suspected cases. Correlations were then examined between online trends and Zika incidence in these countries. All Zika-related press releases issued by WHO/Pan America Health Organization (PAHO) and Centers for Disease Control and Prevention (CDC) during the study period were assessed for transparency, uncertainty and audience segmentation. Witte's Extended Parallel Process Model was applied to assess self-efficacy, response efficacy, susceptibility and severity. AutoRegressive Integrated Moving Average with an eXogenous predictor variable (ARIMAX) (p, d, q) regression modelling was used to quantify the association between online trends and the timing of press releases.
   Results Globally, Zika online search trends were low until the beginning of 2016, when interest rose steeply. Strong correlations (r=0.748-0.922; p<0.001) were observed between online trends and the number of suspected Zika cases in four of the five countries studied. Compared with press releases issued by WHO/PAHO, CDC press releases were significantly more likely to provide contact details and links to other resources, include figures/graphs, be risk-advisory in nature and be more readable and briefer. ARIMAX modelling results indicate that online trends preceded by 1 week press releases by WHO (stationary-R-2=0.345; p<0.001) and CDC (stationary-R-2=0.318; p=0.014).
   Conclusions These results suggest that online trends can aid in pandemic surveillance. Identification of shortcomings in the content and timing of Zika press releases can help guide health communication efforts in the current pandemic and future public health emergencies.
C1 [Adebayo, Gbenga; Neumark, Yehuda; Abu Ahmad, Wiessam; Levine, Hagai] Hebrew Univ Jerusalem, Hadassah Braun Sch Publ Hlth & Community Med, Jerusalem, Israel.
   [Gesser-Edelsburg, Anat] Univ Haifa, Sch Publ Hlth, Haifa, Israel.
RP Adebayo, G (corresponding author), Hebrew Univ Jerusalem, Hadassah Braun Sch Publ Hlth & Community Med, Jerusalem, Israel.
EM gbenga.adebayo@mail.huji.ac.il
RI Levine, Hagai/B-4329-2012
OI Levine, Hagai/0000-0002-5597-4916; Adebayo, Gbenga/0000-0002-6410-3637
FU Pears Foundation scholarship
FX This research was conducted in the framework of Gbenga Adebayo's
   International MPH thesis at the Hebrew University-Hadassah Braun School
   of Public Health and Community Medicine, under the guidance of Dr Hagai
   Levine and Professor Yehuda Neumark. His studies were supported by a
   Pears Foundation scholarship.
CR Ahmed Azam, 2016, NY TIMES
   Alicino C, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0090-9
   [Anonymous], 2016, LANCET, V388, P437, DOI 10.1016/S0140-6736(16)31204-1
   [Anonymous], 2016, ZIK OUTBR WHOS GLOB
   Ashwell DJ, 2016, PUBLIC UNDERST SCI, V25, P379, DOI 10.1177/0963662514556144
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Belluz J., WHO JUST DECLARED PU
   Carneiro HA, 2009, CLIN INFECT DIS, V49, P1557, DOI 10.1086/630200
   CDC, 2016, REV DIAGN TEST ZIK C
   Central Bureau of Statistics, 2015, CAR NETH POP TRENDS
   CIA-Central Intelligence Agency, 2016, WORLD FACTBOOK
   Coombes R, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2899
   Covello VT, 2003, J HEALTH COMMUN, V8, P5, DOI 10.1080/10810730390224802
   Earle T.C., 1995, SOCIAL TRUST COSMOPO
   Flesch RF, WRITE PLAIN ENGLISH
   Fung ICH, 2014, LANCET, V384, P2207, DOI 10.1016/S0140-6736(14)62418-1
   Gesser-Edelsburg A, 2014, DISASTER MED PUBLIC, V8, P158, DOI 10.1017/dmp.2014.27
   Glik DC, 2007, ANNU REV PUBL HEALTH, V28, P33, DOI 10.1146/annurev.publhealth.28.021406.144123
   Heymann DL, 2008, CONTROL COMMUNICABLE
   Iheozor-Ejiofor Z, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010856.pub2
   Jacobsen KH, 2016, ECOHEALTH, V13, P200, DOI 10.1007/s10393-016-1100-5
   Jozuka E., 2016, SINGAPORES ZIKA CASE
   Kincaid JP, 1975, TECH TRAIN, V49
   LaVoie NR, 2013, HEALTH COMMUN, V28, P53, DOI 10.1080/10410236.2012.728467
   Lofstedt R., 2005, RISK MANAGEMENT POST
   Marston C, 2013, LANCET, V382, P69
   McComas KA, 2001, RISK ANAL, V21, P467, DOI 10.1111/0272-4332.213126
   McInnes N, 2011, INFORM HEALTH SOC CA, V36, P173, DOI 10.3109/17538157.2010.542529
   McNeil Jr Donald G., 2016, NY TIMES
   Merrick J, 2013, HLTH RISK COMMUNICAT
   Mondor L, 2012, EMERG INFECT DIS, V18, P1184, DOI 10.3201/eid1807.120249
   Moss R, 2016, INFLUENZA OTHER RESP, V10, P314, DOI 10.1111/irv.12376
   Netmarketshare. com, 2016, SEARCH ENG MARK SHAR
   Neumark Y, 2012, ISR J HEALTH POLICY, V1, DOI 10.1186/2045-4015-1-38
   Nowotny Helga, 2001, RETHINKING SCI KNOWL
   Nuti SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109583
   PAHO, 2009, PAHO REG COUNTR POP
   PAHO, 2016, ZIK AM EP CURV
   PAHO, 2016, CARR MOSQ AW WEEK LA
   PAHO, 2016, SPAN SPEAK COUNTR AM
   PAHO/WHO, 2015, EP AL ZIK VIR INF
   Pan American Health Organization/ World Health Organization, 2016, CUM ZIK SUSP CONF CA
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rosenkrantz AB, 2016, AM J ROENTGENOL, V206, P113, DOI 10.2214/AJR.15.14840
   Schroeder JC, 2010, ENVIRON HEALTH PERSP, V118, pA58, DOI 10.1289/ehp.1001913
   Seifter A, 2010, GEOSPATIAL HEALTH, V4, P135, DOI 10.4081/gh.2010.195
   Troelstra SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148489
   WHO, 2016, ZIK VIR OL PAR GAM R
   WHO, HIST ZIK VIR
   Willson TJ, 2015, LARYNGOSCOPE, V125, P2447, DOI 10.1002/lary.25420
   Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506
   World Health Organization, 2008, WHO REP GLOB TOB EP, P1, DOI DOI 10.1136/IP.2007.018143
   World Health Organization, 2016, RISK COMM CONT ZIK V, V4, P1
   World Health Organization, 2016, WHO ZIK FACT SHEET
   World Health Organization, 2005, INT HLTH REG, P82
   World Health Organization, 2004, OUTBR COMM BEST PRAC, P21
   World Health Organization, 2016, SIT REP ZIK VIR MICR
   World Health Organization. Fifth meeting of the Emergency Committee under the International Health Regulations, 2005, 5 M EM COMM INT HLTH
NR 58
TC 3
Z9 3
U1 3
U2 10
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2059-7908
J9 BMJ GLOB HEALTH
JI BMJ Glob. Health
PD AUG
PY 2017
VL 2
IS 3
AR UNSP e000296
DI 10.1136/bmjgh-2017-000296
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FF2TM
UT WOS:000408749700012
PM 29082006
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Terradas, G
   McGraw, EA
AF Terradas, Gerard
   McGraw, Elizabeth A.
TI Wolbachia-mediated virus blocking in the mosquito vector Aedes aegypti
SO CURRENT OPINION IN INSECT SCIENCE
LA English
DT Article
ID LIFE-SHORTENING WOLBACHIA; DENGUE VIRUS; CYTOPLASMIC INCOMPATIBILITY;
   ANTIVIRAL PROTECTION; TOLL PATHWAY; INFECTION; HOST; ACTIVATION;
   ESTABLISHMENT; RECOGNITION
AB Viruses transmitted by mosquitoes such as dengue, Zika and West Nile cause a threat to global health due to increased geographical range and frequency of outbreaks. The bacterium Wolbachia pipientis may be the solution reducing disease transmission. Though commonly missing in vector species, the bacterium was artificially and stably introduced into Aedes aegypti to assess its potential for biocontrol. When infected with Wolbachia, mosquitoes become refractory to infection by a range of pathogens, including the aforementioned viruses. How the bacterium is conferring this phenotype remains unknown. Here we discuss current hypotheses in the field for the mechanistic basis of pathogen blocking and evaluate the evidence from mosquitoes and related insects.
C1 [Terradas, Gerard; McGraw, Elizabeth A.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3800, Australia.
RP McGraw, EA (corresponding author), Monash Univ, Sch Biol Sci, Melbourne, Vic 3800, Australia.
EM beth.mcgraw@monash.edu
OI Terradas, Gerard/0000-0003-4285-4007
CR Bian GW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002250
   Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Blair CD, 2011, FUTURE MICROBIOL, V6, P265, DOI [10.2217/FMB.11.11, 10.2217/fmb.11.11]
   Blanc M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000598
   Bourtzis K, 2000, INSECT MOL BIOL, V9, P635, DOI 10.1046/j.1365-2583.2000.00224.x
   Braquart-Varnier C, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01424
   Braquart-Varnier C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003286
   Buchon N, 2014, NAT REV IMMUNOL, V14, P796, DOI 10.1038/nri3763
   Campbell CL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-47
   Caragata EP, 2014, MICROB ECOL, V67, P205, DOI 10.1007/s00248-013-0339-4
   Caragata EP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003459
   Caragata EP, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005158
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carro AC, 2013, VIRUS RES, V174, P78, DOI 10.1016/j.virusres.2013.03.005
   Cho KO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022703
   Chrostek E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099025
   Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237
   Fansiri T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003621
   Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Hedges LM, 2012, APPL ENVIRON MICROB, V78, P6773, DOI 10.1128/AEM.01650-12
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043
   Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001296
   Hussain M, 2013, RNA BIOL, V10, P1868, DOI 10.4161/rna.27392
   Hussain M, 2011, P NATL ACAD SCI USA, V108, P9250, DOI 10.1073/pnas.1105469108
   Johnson KN, 2015, VIRUSES-BASEL, V7, P5705, DOI 10.3390/v7112903
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Jupatanakul N, 2014, VIRUSES-BASEL, V6, P4294, DOI 10.3390/v6114294
   Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143
   Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531
   Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754
   McFarlane M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002994
   McGraw EA, 2004, CURR OPIN MICROBIOL, V7, P67, DOI 10.1016/j.mib.2003.12.003
   McGraw EA, 2002, P NATL ACAD SCI USA, V99, P2918, DOI 10.1073/pnas.052466499
   McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Molloy JC, 2016, APPL ENVIRON MICROB, V82, P3109, DOI 10.1128/AEM.00275-16
   Molloy JC, 2015, VIRUSES-BASEL, V7, P4624, DOI 10.3390/v7082836
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Nakamoto M, 2012, IMMUNITY, V36, P658, DOI 10.1016/j.immuni.2012.03.003
   Ocampo CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061187
   Oliveira JHM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001320
   Osborne SE, 2012, APPL ENVIRON MICROB, V78, P6922, DOI 10.1128/AEM.01727-12
   Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   Pannebakker BA, 2007, P NATL ACAD SCI USA, V104, P213, DOI 10.1073/pnas.0607845104
   Paradkar PN, 2012, P NATL ACAD SCI USA, V109, P18915, DOI 10.1073/pnas.1205231109
   Ponton F, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2029
   Rainey SM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005536
   Rances E, 2013, J VIROL, V87, P11945, DOI 10.1128/JVI.01522-13
   Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Scheitz CJF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072726
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002
   Terradas G, 2017, SCI REP-UK, V7, DOI 10.1038/srep43847
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Voronin D, 2012, P NATL ACAD SCI USA, V109, pE1638, DOI 10.1073/pnas.1203519109
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   White PM, 2017, GENETICS, V205, P1473, DOI 10.1534/genetics.116.198903
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Xi ZY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-1
   Ye J, 2013, VACCINE, V31, P461, DOI 10.1016/j.vaccine.2012.11.015
   Ye YXH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002362
   YEN JH, 1973, J INVERTEBR PATHOL, V22, P242, DOI 10.1016/0022-2011(73)90141-9
   Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102
   Zhang GM, 2013, P NATL ACAD SCI USA, V110, P10276, DOI 10.1073/pnas.1303603110
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 72
TC 20
Z9 20
U1 0
U2 21
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2214-5745
EI 2214-5753
J9 CURR OPIN INSECT SCI
JI Curr. Opin. Insect Sci.
PD AUG
PY 2017
VL 22
BP 37
EP 44
DI 10.1016/j.cois.2017.05.005
PG 8
WC Biology; Ecology; Entomology
SC Life Sciences & Biomedicine - Other Topics; Environmental Sciences &
   Ecology; Entomology
GA FF3HB
UT WOS:000408785000007
PM 28805637
DA 2020-07-08
ER

PT J
AU Stone, CM
   Schwab, SR
   Fonseca, DM
   Fefferman, NH
AF Stone, Chris M.
   Schwab, Samantha R.
   Fonseca, Dina M.
   Fefferman, Nina H.
TI Human movement, cooperation and the effectiveness of coordinated vector
   control strategies
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Article
DE metapopulation; commuting patterns; Zika virus; Aedes aegypti; larval
   control
ID AEDES-AEGYPTI; DENGUE TRANSMISSION; SPATIAL HETEROGENEITY; BORNE
   DISEASES; DYNAMICS; DISPERSAL; MOSQUITOS; MODEL; ERADICATION; SURVIVAL
AB Vector-borne disease transmission is often typified by highly focal transmission and influenced by movement of hosts and vectors across different scales. The ecological and environmental conditions (including those created by humans through vector control programmes) that result in metapopulation dynamics remain poorly understood. The development of control strategies that would most effectively limit outbreaks given such dynamics is particularly urgent given the recent epidemics of dengue, chikungunya and Zika viruses. We developed a stochastic, spatial model of vector-borne disease transmission, allowing for movement of hosts between patches. Our model is applicable to arbovirus transmission by Aedes aegypti in urban settings and was parametrized to capture Zika virus transmission in particular. Using simulations, we investigated the extent to which two aspects of vector control strategies are affected by human commuting patterns: the extent of coordination and cooperation between neighbouring communities. We find that transmission intensity is highest at intermediate levels of host movement. The extent to which coordination of control activities among neighbouring patches decreases the prevalence of infection is affected by both how frequently humans commute and the proportion of neighbouring patches that commits to vector surveillance and control activities. At high levels of host movement, patches that do not contribute to vector control may act as sources of infection in the landscape, yet have comparable levels of prevalence as patches that do cooperate. This result suggests that real cooperation among neighbours will be critical to the development of effective pro-active strategies for vector-borne disease control in today's commuter-linked communities.
C1 [Stone, Chris M.] Univ Illinois, Illinois Nat Hist Survey, Champaign, IL 61820 USA.
   [Stone, Chris M.; Fefferman, Nina H.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.
   [Schwab, Samantha R.] Rutgers State Univ, Program Ecol & Evolutionary Biol, New Brunswick, NJ USA.
   [Fonseca, Dina M.] Rutgers State Univ, Ctr Vector Biol, New Brunswick, NJ USA.
RP Stone, CM (corresponding author), Univ Illinois, Illinois Nat Hist Survey, Champaign, IL 61820 USA.; Stone, CM (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.
EM cstone@illinois.edu
RI ; Fonseca, Dina/B-9951-2011
OI Schwab, Samantha/0000-0002-4338-4943; Fonseca, Dina/0000-0003-4726-7100
FU National Science Foundation (NSF) RAPID [1640951]
FX This work was supported by National Science Foundation (NSF) RAPID grant
   no. 1640951.
CR Acevedo MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127552
   Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Adams B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006763
   Benedict MQ, 2003, TRENDS PARASITOL, V19, P349, DOI 10.1016/S1471-4922(03)00144-2
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Braks MAH, 2006, MED VET ENTOMOL, V20, P53, DOI 10.1111/j.1365-2915.2006.00612.x
   Cheng Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep33755
   Cosner C, 2009, J THEOR BIOL, V258, P550, DOI 10.1016/j.jtbi.2009.02.016
   Couret J, 2014, BMC ECOL, V14, DOI 10.1186/1472-6785-14-3
   Dickinson K, 2012, VECTOR-BORNE ZOONOT, V12, P886, DOI 10.1089/vbz.2011.0810
   Dommar CJ, 2014, ACTA TROP, V129, P61, DOI 10.1016/j.actatropica.2013.08.004
   DYE C, 1986, T ROY SOC TROP MED H, V80, P69, DOI 10.1016/0035-9203(86)90199-9
   Egizi A, 2016, MOL ECOL, V25, P3033, DOI 10.1111/mec.13653
   Favier C, 2005, P ROY SOC B-BIOL SCI, V272, P1171, DOI 10.1098/rspb.2004.3020
   Fenichel EP, 2011, P NATL ACAD SCI USA, V108, P6306, DOI 10.1073/pnas.1011250108
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Fillinger U, 2006, TROP MED INT HEALTH, V11, P1629, DOI 10.1111/j.1365-3156.2006.01733.x
   Flaxman AD, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000328
   Funk S, 2016, PLOS NEGL TROP DIS, V10
   Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x
   Grenfell B, 1997, TRENDS ECOL EVOL, V12, P395, DOI 10.1016/S0169-5347(97)01174-9
   Gubler DJ, 1996, ACTA TROP, V61, P169, DOI 10.1016/0001-706X(95)00103-L
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Honorio NA, 2003, MEM I OSWALDO CRUZ, V98, P191, DOI 10.1590/S0074-02762003000200005
   Horner MW, 2007, ANN REGIONAL SCI, V41, P315, DOI 10.1007/s00168-006-0098-y
   Lee S, 2015, J THEOR BIOL, V374, P152, DOI 10.1016/j.jtbi.2015.03.005
   Levinson D, 2005, TRANSPORTATION, V32, P187, DOI 10.1007/s11116-004-5507-4
   Lutambi AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097065
   Lyons G, 2008, TRANSPORT REV, V28, P181, DOI 10.1080/01441640701559484
   Manore CA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005255
   Mantyka-Pringle CS, 2012, GLOBAL CHANGE BIOL, V18, P1239, DOI 10.1111/j.1365-2486.2011.02593.x
   Muir LE, 1998, AM J TROP MED HYG, V58, P277, DOI 10.4269/ajtmh.1998.58.277
   Noor AM, 2009, LANCET, V373, P58, DOI 10.1016/S0140-6736(08)61596-2
   PANT CP, 1973, J MED ENTOMOL, V10, P219, DOI 10.1093/jmedent/10.2.219
   Perkins TA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003327
   Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2
   Prosper O, 2012, J THEOR BIOL, V303, P1, DOI 10.1016/j.jtbi.2012.02.010
   Reiner RC, 2014, EPIDEMICS-NETH, V6, P30, DOI 10.1016/j.epidem.2013.12.003
   Renault P, 2007, AM J TROP MED HYG, V77, P727
   Ruktanonchai NW, 2016, MATH BIOSCI, V279, P90, DOI 10.1016/j.mbs.2016.06.012
   Shragai T, 2017, ANN NY ACAD SCI, V1399, P61, DOI 10.1111/nyas.13306
   Smith DL, 2004, PLOS BIOL, V2, P1957, DOI 10.1371/journal.pbio.0020368
   SOPER FL, 1963, AM J PUBLIC HEALTH N, V53, P7, DOI 10.2105/AJPH.53.1.7
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Stone C, 2017, DRYAD DIGITAL REPOSI
   Thompson KM, 2007, LANCET, V369, P1363, DOI 10.1016/S0140-6736(07)60532-7
   Tizzoni M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003716
   TRPIS M, 1986, AM J TROP MED HYG, V35, P1263, DOI 10.4269/ajtmh.1986.35.1263
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a
   Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338
   Xia YC, 2004, AM NAT, V164, P267, DOI 10.1086/422341
   Yakob L, 2008, J APPL ECOL, V45, P1258, DOI 10.1111/j.1365-2664.2008.01498.x
NR 53
TC 6
Z9 6
U1 0
U2 17
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
EI 1742-5662
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD AUG 1
PY 2017
VL 14
IS 133
AR 20170336
DI 10.1098/rsif.2017.0336
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FF2WH
UT WOS:000408757000012
PM 28855386
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Zhao, B
   Lucas, KJ
   Saha, TT
   Ha, JS
   Ling, L
   Kokoza, VA
   Roy, S
   Raikhel, AS
AF Zhao, Bo
   Lucas, Keira J.
   Saha, Tusar T.
   Ha, Jisu
   Ling, Lin
   Kokoza, Vladimir A.
   Roy, Sourav
   Raikhel, Alexander S.
TI MicroRNA-275 targets sarco/endoplasmic reticulum Ca2+ adenosine
   triphosphatase (SERCA) to control key functions in the mosquito gut
SO PLOS GENETICS
LA English
DT Article
ID AEDES-AEGYPTI; GENE-EXPRESSION; TRANSLATION; VECTOR; RNA; CA2+-ATPASE;
   INHIBITORS; DROSOPHILA; SYSTEM; ACTIVATION
AB The yellow fever mosquito Aedes aegypti is the major vector of arboviruses, causing numerous devastating human diseases, such as dengue and yellow fevers, Chikungunya and Zika. Female mosquitoes need vertebrate blood for egg development, and repeated cycles of blood feeding are tightly linked to pathogen transmission. The mosquito's posterior midgut (gut) is involved in blood digestion and also serves as an entry point for pathogens. Thus, the mosquito gut is an important tissue to investigate. The miRNA aae-miR-275 (miR-275) has been shown to be required for normal blood digestion in the female mosquito; however, the mechanism of its action has remained unknown. Here, we demonstrate that miR-275 directly targets and positively regulates sarco/endoplasmic reticulum Ca2+ adenosine triphosphatase, which is implicated in active transport of Ca2+ from the cytosol to the sarco/endoplasmic reticulum. We utilized a combination of the gut-specific yeast transcription activator protein Gal4/upstream activating sequence (Gal4/UAS) system and miRNA Tough Decoy technology to deplete the endogenous level of miR-275 in guts of transgenic mosquitoes. This gut-specific reduction of miR-275 post blood meal decreased SERCA mRNA and protein levels of the digestive enzyme late trypsin. It also resulted in a significant reduction of gut microbiota. Moreover, the decrease of miR-275 and SERCA correlated with defects in the Notch signaling pathway and assembly of the gut actin cytoskeleton. The adverse phenotypes caused by miR-275 silencing were rescued by injections of miR-275 mimic. Thus, we have discovered that miR-275 directly targets SERCA, and the maintenance of its level is critical for multiple gut functions in mosquitoes.
C1 [Zhao, Bo; Lucas, Keira J.; Saha, Tusar T.; Ha, Jisu; Ling, Lin; Kokoza, Vladimir A.; Roy, Sourav; Raikhel, Alexander S.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.
   [Zhao, Bo; Lucas, Keira J.; Saha, Tusar T.; Ha, Jisu; Ling, Lin; Kokoza, Vladimir A.; Roy, Sourav; Raikhel, Alexander S.] Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA.
   [Ha, Jisu] Univ Calif Riverside, Grad Program Genet Genom & Bioinformat, Riverside, CA 92521 USA.
RP Raikhel, AS (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.; Raikhel, AS (corresponding author), Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA.
EM alexander.raikhel@ucr.edu
FU NIH grantUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [RO1 AI113729]
FX This work was supported by NIH grant RO1 AI113729 to ASR. The funder had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Akbari OS, 2013, G3-GENES GENOM GENET, V3, P1493, DOI 10.1534/g3.113.006742
   Asahi M, 2003, P NATL ACAD SCI USA, V100, P5040, DOI 10.1073/pnas.0330962100
   Bak RO, 2013, MOL THER, V21, P1478, DOI 10.1038/mt.2013.113
   Bak RO, 2013, RNA, V19, P280, DOI 10.1261/rna.034850.112
   Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823
   Bryant B, 2010, P NATL ACAD SCI USA, V107, P22391, DOI 10.1073/pnas.1016230107
   Bublitz M, 2013, J BIOL CHEM, V288, P10759, DOI 10.1074/jbc.R112.436550
   Chevalier B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9386
   Clark RI, 2015, CELL REP, V12, P1656, DOI 10.1016/j.celrep.2015.08.004
   Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691
   Elliott David A., 2008, V420, P79, DOI 10.1007/978-1-59745-583-1_5
   Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103
   Gendrin M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6921
   Giniger E, 1998, NEURON, V20, P667, DOI 10.1016/S0896-6273(00)81007-7
   Gurha P, 2012, CIRCULATION, V125, P2751, DOI 10.1161/CIRCULATIONAHA.111.044354
   Haraguchi T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1317
   Haraguchi T, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp040
   Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244
   Hovnanian A., 2007, V45, P337
   Hussain M, 2013, INSECT BIOCHEM MOLEC, V43, P146, DOI 10.1016/j.ibmb.2012.11.005
   Hussain M, 2011, P NATL ACAD SCI USA, V108, P9250, DOI 10.1073/pnas.1105469108
   Imbimbo BP, 2008, CURR TOP MED CHEM, V8, P54, DOI 10.2174/156802608783334015
   Isoe J, 2009, INSECT BIOCHEM MOLEC, V39, P903, DOI 10.1016/j.ibmb.2009.10.008
   Kokoza VA, 2011, INSECT BIOCHEM MOLEC, V41, P637, DOI 10.1016/j.ibmb.2011.04.004
   Li S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-581
   Liu SP, 2014, P NATL ACAD SCI USA, V111, P14460, DOI 10.1073/pnas.1416278111
   Lucas KJ, 2015, CURR OPIN INSECT SCI, V11, P1, DOI 10.1016/j.cois.2015.06.004
   Lucas KJ, 2015, RNA BIOL, V12, P1383, DOI 10.1080/15476286.2015.1101525
   Lucas KJ, 2013, TRENDS PARASITOL, V29, P295, DOI 10.1016/j.pt.2013.04.003
   Niepmann M, 2009, CELL CYCLE, V8, P1473, DOI 10.4161/cc.8.10.8349
   Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001
   Periasamy M, 2007, MUSCLE NERVE, V35, P430, DOI 10.1002/mus.20745
   Periz G, 1999, EMBO J, V18, P5983, DOI 10.1093/emboj/18.21.5983
   Pumpuni CB, 1996, AM J TROP MED HYG, V54, P214, DOI 10.4269/ajtmh.1996.54.214
   Roti G, 2013, CANCER CELL, V23, P390, DOI 10.1016/j.ccr.2013.01.015
   Roy S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005450
   Stammers AN, 2015, CAN J PHYSIOL PHARM, V93, P843, DOI 10.1139/cjpp-2014-0463
   Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5
   Vasudevan S, 2008, CELL CYCLE, V7, P1545, DOI 10.4161/cc.7.11.6018
   Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460
   Yeh TH, 2015, DEV DYNAM, V244, P852, DOI 10.1002/dvdy.24292
   Zhang Y, 2016, P NATL ACAD SCI USA, V113, pE4828, DOI 10.1073/pnas.1609792113
   Zhao B, 2016, INSECT BIOCHEM MOLEC, V77, P69, DOI 10.1016/j.ibmb.2016.08.003
   Zhao B, 2014, INSECT BIOCHEM MOLEC, V54, P1, DOI 10.1016/j.ibmb.2014.08.001
NR 44
TC 6
Z9 6
U1 0
U2 19
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7404
J9 PLOS GENET
JI PLoS Genet.
PD AUG
PY 2017
VL 13
IS 8
AR e1006943
DI 10.1371/journal.pgen.1006943
PG 19
WC Genetics & Heredity
SC Genetics & Heredity
GA FF2YX
UT WOS:000408763800019
PM 28787446
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU de Oliveira, SP
   de Oliveira, CD
   Sant'Anna, MRV
   Dutra, HLC
   Caragata, EP
   Moreira, LA
AF de Oliveira, Sofia Pimenta
   de Oliveira, Caroline Dantas
   Viana Sant'Anna, Mauricio Roberto
   Carneiro Dutra, Heverton Leandro
   Caragata, Eric Pearce
   Moreira, Luciano Andrade
TI Wolbachia infection in Aedes aegypti mosquitoes alters blood meal
   excretion and delays oviposition without affecting trypsin activity
SO INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY
LA English
DT Article
DE Wolbachia; Aedes aegypti; Digestion; Oogenesis; Blood feeding; Excretion
ID YELLOW-FEVER MOSQUITO; AMINO-ACIDS; FAT-BODY; INSULIN; DIPTERA; DENGUE;
   VIRUS; CULICIDAE; HOST; GENE
AB Blood feeding in Aedes aegypti is essential for reproduction, but also permits the mosquito to act as a vector for key human pathogens such as the Zika and dengue viruses. Wolbachia pipientis is an endosymbiotic bacterium that can manipulate the biology of Aedes aegypti mosquitoes, making them less competent hosts for many pathogens. Yet while Wolbachia affects other aspects of host physiology, it is unclear whether it influences physiological processes associated with blood meal digestion. To that end, we examined the effects of wMel Wolbachia infection in Ae. aegypti, on survival post-blood feeding, blood meal excretion, rate of oviposition, expression levels of key genes involved in oogenesis, and activity levels of trypsin blood digestion enzymes. We observed that wMel infection altered the rate and duration of blood meal excretion, delayed the onset of oviposition and was associated with a greater number of eggs being laid later. wMel-infected Ae. aegypti also had lower levels of key yolk protein precursor genes necessary for oogenesis. However, all of these effects occurred without a change in trypsin activity. These results suggest that Wolbachia infection may disrupt normal metabolic processes associated with blood feeding and reproduction in Ae. aegypti. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [de Oliveira, Sofia Pimenta; de Oliveira, Caroline Dantas; Carneiro Dutra, Heverton Leandro; Caragata, Eric Pearce; Moreira, Luciano Andrade] Ctr Pesquisas Rene Rachou Fiocruz, Grp Mosquitos Vetores Endossimbiontes & Interacao, Belo Horizonte, MG, Brazil.
   [Viana Sant'Anna, Mauricio Roberto] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.
   [Carneiro Dutra, Heverton Leandro] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA.
RP Caragata, EP (corresponding author), Ctr Pesquisas Rene Rachou Fiocruz, Grp Mosquitos Vetores Endossimbiontes & Interacao, Belo Horizonte, MG, Brazil.
EM e.caragata@gmail.com
RI Dutra, Heverton Leandro Carneiro/V-7517-2019; Oliveira,
   Caroline/D-8667-2014
OI Dutra, Heverton Leandro Carneiro/0000-0002-0917-4512; Dantas de
   Oliveira, Caroline/0000-0001-5849-6457
FU CNPq/Ciencia sem fronteiras fellowships; FAPEMIGMinas Gerais State
   Research Foundation (FAPEMIG)
FX This project was supported by CNPq/Ciencia sem fronteiras fellowships to
   EPC and SPO [2013-2016], and a FAPEMIG grant to EPC and LAM [2015-2017].
   LAM is a fellow from CNPq.
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   Attardo GM, 2005, INSECT BIOCHEM MOLEC, V35, P661, DOI 10.1016/j.ibmb.2005.02.013
   Audsley MD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005426
   BARILLASMURY CV, 1995, INSECT BIOCHEM MOLEC, V25, P241, DOI 10.1016/0965-1748(94)00061-L
   Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Brown MR, 2008, P NATL ACAD SCI USA, V105, P5716, DOI 10.1073/pnas.0800478105
   Brownlie JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000368
   Caragata EP, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3441-4
   Caragata EP, 2014, MICROB ECOL, V67, P205, DOI 10.1007/s00248-013-0339-4
   Caragata EP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003459
   Caragata EP, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005158
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Dutra HLC, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1559-5
   Dutra HLC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003689
   Castillo J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002274
   Coon KL, 2016, MOL ECOL, V25, P5806, DOI 10.1111/mec.13877
   do Vale VF, 2007, J INSECT PHYSIOL, V53, P1151, DOI 10.1016/j.jinsphys.2007.06.005
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Evans O, 2009, J EXP BIOL, V212, P1436, DOI 10.1242/jeb.028951
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Gaio Analiz de O, 2011, Parasit Vectors, V4, P105, DOI 10.1186/1756-3305-4-105
   Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009
   Gulia-Nuss M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020401
   Hansen IA, 2004, P NATL ACAD SCI USA, V101, P10626, DOI 10.1073/pnas.0403460101
   Hansen IA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00103
   Harrington LC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003048
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Ikeya T, 2009, P ROY SOC B-BIOL SCI, V276, P3799, DOI 10.1098/rspb.2009.0778
   Joshi D, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-336
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kremer N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000630
   McMeniman CJ, 2011, J MED ENTOMOL, V48, P76, DOI 10.1603/ME09188
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Naksathit AT, 1999, J MED ENTOMOL, V36, P18, DOI 10.1093/jmedent/36.1.18
   NORIEGA FG, 1994, INSECT BIOCHEM MOLEC, V24, P627, DOI 10.1016/0965-1748(94)90099-X
   Noriega FG, 2001, J INSECT PHYSIOL, V47, P515, DOI 10.1016/S0022-1910(00)00145-1
   Oliveira JHM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001320
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   Pietri JE, 2015, DEV COMP IMMUNOL, V53, P134, DOI 10.1016/j.dci.2015.06.012
   Raikhel AS, 2002, INSECT BIOCHEM MOLEC, V32, P1275, DOI 10.1016/S0965-1748(02)00090-5
   Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548
   Riehle MA, 1999, INSECT BIOCHEM MOLEC, V29, P855, DOI 10.1016/S0965-1748(99)00084-3
   Ross PA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004320
   Roy SG, 2007, INSECT BIOCHEM MOLEC, V37, P1317, DOI 10.1016/j.ibmb.2007.08.004
   Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89
   Serbus LR, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004777
   Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   XUE RD, 1995, J MED ENTOMOL, V32, P471, DOI 10.1093/jmedent/32.4.471
   Ye YXH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003894
   Zhou GL, 2004, J INSECT PHYSIOL, V50, P337, DOI 10.1016/j.jinsphys.2004.02.003
   Zhou H, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00166
   Ziegler R, 2001, J INSECT PHYSIOL, V47, P623, DOI 10.1016/S0022-1910(00)00158-X
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 63
TC 2
Z9 2
U1 0
U2 16
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0965-1748
EI 1879-0240
J9 INSECT BIOCHEM MOLEC
JI Insect Biochem. Mol. Biol.
PD AUG
PY 2017
VL 87
BP 65
EP 74
DI 10.1016/j.ibmb.2017.06.010
PG 10
WC Biochemistry & Molecular Biology; Entomology
SC Biochemistry & Molecular Biology; Entomology
GA FE5ZG
UT WOS:000408289200007
PM 28655666
DA 2020-07-08
ER

PT J
AU Paciorkowski, AR
AF Paciorkowski, Alex R.
TI Congenital Zika syndrome: an epidemic of neurologic disability
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Editorial Material
ID VIRUS-INFECTION
C1 [Paciorkowski, Alex R.] Univ Rochester, Med Ctr, Neurogenet Consultat Serv, Dept Neurol, Rochester, NY 14627 USA.
   [Paciorkowski, Alex R.] Univ Rochester, Med Ctr, Neurogenet Consultat Serv, Dept Pediat, Rochester, NY 14627 USA.
   [Paciorkowski, Alex R.] Univ Rochester, Med Ctr, Neurogenet Consultat Serv, Dept Biomed Genet, Rochester, NY 14627 USA.
   [Paciorkowski, Alex R.] Univ Rochester, Med Ctr, Neurogenet Consultat Serv, Dept Neurosci, Rochester, NY 14627 USA.
RP Paciorkowski, AR (corresponding author), 601 Elmwood Ave, Rochester, NY 14642 USA.
EM Alex_Paciorkowski@urmc.rochester.edu
CR Alcantara D, 2014, AM J MED GENET C, V166, P124, DOI 10.1002/ajmg.c.31397
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789
   Pan American Health Organization World Health Organization, 2017, ZUJ CUM CAS
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   van der Linden V, 2017, ARQ NEURO-PSIQUIAT, V75, P381, DOI [10.1590/0004-282x20170066, 10.1590/0004-282X20170066]
NR 7
TC 0
Z9 0
U1 0
U2 2
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD AUG
PY 2017
VL 75
IS 8
BP 605
EP 605
DI 10.1590/0004-282X20170104
PG 1
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA FD8TA
UT WOS:000407795800017
PM 28813092
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Nguyen, L
AF Nguyen, L.
TI Zika virus-associated microcephaly is caused by stress-induced unfolded
   protein response
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
CT ISN-ESN Meeting
CY AUG 20-24, 2017
CL Paris, FRANCE
SP Int Soc Neurochemistry, Amer Soc Neurochemistry, ESN
C1 [Nguyen, L.] Univ Liege, GIGA Neurosci, Liege, Belgium.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD AUG
PY 2017
VL 142
SU 1
SI SI
MA S17-02
BP 46
EP 46
PG 1
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA FD3HY
UT WOS:000407425300077
DA 2020-07-08
ER

PT J
AU Shirley, DAT
   Nataro, JP
AF Shirley, Debbie-Ann T.
   Nataro, James P.
TI Zika Virus Infection
SO PEDIATRIC CLINICS OF NORTH AMERICA
LA English
DT Article
DE Zika; Microcephaly; Congenital; Mosquito; Travel; Sexual transmission
ID MALE SEXUAL TRANSMISSION; UPDATE INTERIM GUIDANCE;
   GUILLAIN-BARRE-SYNDROME; BIRTH-DEFECTS; UNITED-STATES; RISK-FACTORS;
   CASE SERIES; INFANTS; BRAZIL; BRAIN
AB In less than 2 years since entry into the Americas, we have witnessed the emergent spread of Zika virus into large subsets of immunologically naive human populations and then encountered the devastating effects of microcephaly and brain anomalies that can arise from in utero infection with the virus. Diagnostic evaluation and management of affected infants continues to evolve as our understanding of Zika virus rapidly advances. The development of a safe and effective vaccine holds the potential to attenuate the spread of infection and limit the impact of congenital infection.
C1 [Shirley, Debbie-Ann T.; Nataro, James P.] Univ Virginia, Dept Pediat, Sch Med, Box 800386, Charlottesville, VA 22908 USA.
RP Shirley, DAT (corresponding author), Univ Virginia, Dept Pediat, Sch Med, Box 800386, Charlottesville, VA 22908 USA.
EM ds3ru@virginia.edu
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   [Anonymous], 2016, CDC CONCL ZIK CAUS M
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brent C, 2016, MMWR-MORBID MORTAL W, V65, P981, DOI 10.15585/mmwr.mm6536e4
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CDC, 2017, CAS COUNTS US
   CDC, CONG MICR CAS DEF
   Centers for Disease Control and Prevention (CDC), 2016, FLOR INV LINKS 4 REC
   Cetron M, 2016, MMWR-MORBID MORTAL W, V65, P267, DOI 10.15585/mmwr.mm6510e1
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Paula Freitas B, 2016, JAMA OPHTHALMOL
   de Souza AS, 2016, CLIN INFECT DIS, V63, P1622, DOI 10.1093/cid/ciw613
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Goodman Alyson B, 2016, MMWR Morb Mortal Wkly Rep, V65, P1082, DOI 10.15585/mmwr.mm6539e2
   Grant GB, 2015, MMWR-MORBID MORTAL W, V64, P1052, DOI 10.15585/mmwr.mm6437a5
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   HURWITZ ES, 1982, PEDIATRICS, V70, P895
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Ndeffo-Mbah ML, 2016, ANN INTERN MED, V165, P551, DOI 10.7326/M16-0919
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nogueira ML, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14047
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pacheco O, 2016, N ENGL J MED
   PAHO/WHO, 2016, CAS DEF
   Pan American Health Organization, 2015, EP AL INCR MICR NE B
   Pan American Health Organization World Health Organization, 2015, NEUR SYNDR CONG MALF
   Pan American Health Organization/ World Health Organization, 2016, ZIK EP
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pfaender S, 2017, VIRUS RES, V228, P58, DOI 10.1016/j.virusres.2016.11.025
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   RUSSELL LJ, 1984, AM J MED GENET, V17, P509, DOI 10.1002/ajmg.1320170213
   Sarno M, 2016, ULTRASOUND OBSTET GY
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   de Araujo JSS, 2016, B WORLD HEALTH ORGAN, V94, P835, DOI 10.2471/BLT.16.170639
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   U.S. Department of Health & Human Services, 2016, HHS DECL PUBL HLTH E
   UNOS, 2016, GUID ORG DON TRANSPL
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Vinhaes ES, 2017, CLIN INFECT DIS, V64, P675, DOI 10.1093/cid/ciw770
   WHO, 2017, WORLD HLTH ORG ZIK S
   World Health Organisation Guideline, 2016, GUID INF FEED AR ZIK
   World Health Organization, 2016, WHO STAT 1 M INT HLT
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
NR 104
TC 4
Z9 5
U1 0
U2 4
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0031-3955
EI 1557-8240
J9 PEDIATR CLIN N AM
JI Pediatr. Clin. N. Am.
PD AUG
PY 2017
VL 64
IS 4
BP 937
EP +
DI 10.1016/j.pcl.2017.03.012
PG 16
WC Pediatrics
SC Pediatrics
GA FE2UG
UT WOS:000408071700015
PM 28734519
DA 2020-07-08
ER

PT J
AU Ridley, DB
   Moe, JL
   Hamon, N
AF Ridley, David B.
   Moe, Jeffrey L.
   Hamon, Nick
TI A Voucher System To Speed Review Could Promote A New Generation Of
   Insecticides To Fight Vector-Borne Diseases
SO HEALTH AFFAIRS
LA English
DT Article
ID INNOVATION; MARKET; RECOMMENDATIONS; COSTS
AB Many in the scientific community are concerned about the potential increase in prevalence of insect-borne diseases such as Chagas disease, Chikungunya, dengue fever, malaria, and Zika in the United States and around the world. Beyond vaccines and drugs to prevent and treat these diseases, a comprehensive approach to fighting these diseases should include control of disease-carrying vectors, such as mosquitoes. Vector-control methods, such as using insecticides to treat bed nets and spray the walls of homes, have prevented millions of deaths from malaria. However, mosquitoes are becoming resistant to insecticides, and no new class of insecticides for vector control has been introduced in decades. We recommend the creation of a new type of incentive for the development and commercialization of safe new insecticides: a Vector Expedited Review Voucher, to be awarded to a sponsor that introduces a novel insecticide for public health use. The voucher could be redeemed to expedite registration of a second, more profitable, product by the US Environmental Protection Agency.
C1 [Ridley, David B.] Duke Univ, Fuqua Sch Business, Hlth Sect Management, Durham, NC 27706 USA.
   [Moe, Jeffrey L.] Duke Global Hlth Inst, Practice Global Hlth, Durham, NC USA.
   [Hamon, Nick] Innovat Vector Control Consortium, Liverpool, Merseyside, England.
RP Ridley, DB (corresponding author), Duke Univ, Fuqua Sch Business, Hlth Sect Management, Durham, NC 27706 USA.
EM david.ridley@duke.edu
FU Innovative Vector Control Consortium (IVCC), in Liverpool, United
   Kingdom; Bill and Melinda Gates FoundationGates Foundation
FX David Ridley and Jeffrey Moe received funding from the Innovative Vector
   Control Consortium (IVCC), in Liverpool, United Kingdom, which is funded
   by foundations including the Bill and Melinda Gates Foundation. Nick
   Hamon is CEO of IVCC. The authors are grateful for helpful insights and
   edits from Greg Ciccarelli, Mathias Mondy, and Dana Randall.
CR Berndt ER, 2007, HEALTH ECON, V16, P491, DOI 10.1002/hec.1176
   Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535
   Centers for Disease Control and Prevention, INS TREAT BED NETS
   DiMasi JA, 2016, J HEALTH ECON, V47, P20, DOI 10.1016/j.jhealeco.2016.01.012
   Environmental Protection Agency, PEST REG
   Gans JS, 2013, J IND ECON, V61, P789, DOI 10.1111/joie.12026
   Hemingway J, 2015, NATURE, V526, P198, DOI 10.1038/526198a
   Kesselheim AS, 2015, JAMA-J AM MED ASSOC, V314, P1687, DOI 10.1001/jama.2015.11845
   KPMG, 2016, COST CAP STUD 2015 V
   Mahmoud A, 2009, HEALTH AFFAIR, V28, P1726, DOI 10.1377/hlthaff.28.6.1726
   McDougall P., 2016, COST NEW AGROCHEMICA
   McDougall Phillips, 2013, AGRISERVICE IND OVER
   McDougall Phillips, 2011, AGRISERVICE PRODUCT
   McMichael AJ, 2013, N ENGL J MED, V368
   National Pesticide Information Cen-ter, PYR GEN FACT SHEET
   Outterson K, 2016, HEALTH AFFAIR, V35, P784, DOI 10.1377/hlthaff.2015.1139
   Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004
   Regnier SA, 2015, NAT REV DRUG DISCOV, V14, P594, DOI 10.1038/nrd4697
   Ridley DB, 2016, HEALTH AFFAIR, V35, P776, DOI 10.1377/hlthaff.2015.1314
   Ridley DB, 2006, HEALTH AFFAIR, V25, P313, DOI 10.1377/hlthaff.25.2.313
   TABASHNIK BE, 1989, J ECON ENTOMOL, V82, P1263, DOI 10.1093/jee/82.5.1263
   Trape JF, 2011, LANCET INFECT DIS, V11, P925, DOI 10.1016/S1473-3099(11)70194-3
   World Health Organization, MAL FACT SHEET
   World Health Organization, 2014, MED CTR POL, P2
NR 24
TC 6
Z9 6
U1 1
U2 2
PU PROJECT HOPE
PI BETHESDA
PA 7500 OLD GEORGETOWN RD, STE 600, BETHESDA, MD 20814-6133 USA
SN 0278-2715
J9 HEALTH AFFAIR
JI Health Aff.
PD AUG
PY 2017
VL 36
IS 8
BP 1461
EP 1468
DI 10.1377/hlthaff.2016.1640
PG 8
WC Health Care Sciences & Services; Health Policy & Services
SC Health Care Sciences & Services
GA FC8GQ
UT WOS:000407080200015
PM 28784739
DA 2020-07-08
ER

PT J
AU Hagmann, SHF
AF Hagmann, Stefan H. F.
TI Clinical Impact of Non-Congenital Zika Virus Infection in Infants and
   Children
SO CURRENT INFECTIOUS DISEASE REPORTS
LA English
DT Review
DE Zika Children; Non-congenital; Perinatal; Breast milk; Complications
ID HUMAN BREAST-MILK; VERTICAL TRANSMISSION; DENGUE; DISEASE; PREGNANCY;
   OUTBREAK; ISLAND
AB Purpose of Review While the Zika virus (ZIKV) has been noted for its distinct neurotropism and identified as a significant cause for a congenital infection syndrome, there has been increased recognition of the importance to better understand the clinical impact of non-congenital ZIKV infection in infants and children. This article reviews reports of perinatal and breast milk transmission of ZIKV and summarizes current clinical outcome data of pediatric non-congenital ZIKV infection.
   Recent Findings Perinatal transmission and presence of infective ZIKV particles in breast milk have been reported. Most symptomatic non-congenital ZIKV infection in infants and children is mild and self-limited, but long-term follow-up studies are lacking.
   Summary The mechanism and impact of perinatal and breast milk transmission is unclear. The current WHO infant feeding guidelines in areas of ZIKV transmission support breastfeeding. Unless any scientific data raise concern regarding transmission via breastfeeding, the current guidelines should continue to be followed. Prospective population-based cohort studies to investigate maternal, perinatal, infant, and child outcomes are needed.
C1 [Hagmann, Stefan H. F.] Northwell Hlth, Steven & Alexandra Cohen Childrens Med Ctr, Div Pediat Infect Dis, 269-01 76th Ave, New Hyde Pk, NY 11040 USA.
RP Hagmann, SHF (corresponding author), Northwell Hlth, Steven & Alexandra Cohen Childrens Med Ctr, Div Pediat Infect Dis, 269-01 76th Ave, New Hyde Pk, NY 11040 USA.
EM shagmann@northwell.edu
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Adam I, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-153
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Besnard M, 2017, EMERG INFECT DIS, V23, P1421, DOI 10.3201/eid2308.170198
   Blohm GM, 2017, MICROBIOL RESOUR ANN, V5, DOI [10.1128/genomeA.00231-17, 10.1128/genomea.00231-17]
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cavalcanti MG, 2017, INT J INFECT DIS, V57, P70, DOI 10.1016/j.ijid.2017.01.042
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P877
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Couto A. Mallmann, 2010, Morbidity and Mortality Weekly Report, V59, P130
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Fritel X, 2010, EMERG INFECT DIS, V16, P418, DOI 10.3201/eid1603.091403
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Goodman Alyson B, 2016, MMWR Morb Mortal Wkly Rep, V65, P1082, DOI 10.15585/mmwr.mm6539e2
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hinckley AF, 2007, PEDIATRICS, V119, pE666, DOI 10.1542/peds.2006-2107
   Hotez PJ, 2016, JAMA PEDIATR, V170, P787, DOI 10.1001/jamapediatrics.2016.1465
   Kapogiannis BG, 2017, JAMA PEDIATR, V171, P478, DOI 10.1001/jamapediatrics.2017.0002
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Kuhn S, 2011, CAN MED ASSOC J, V183, pE243, DOI 10.1503/cmaj.100619
   Li JH, 2017, CLIN INFECT DIS, V64, P1445, DOI 10.1093/cid/cix137
   Lozier M, 2016, MMWR-MORBID MORTAL W, V65, P1219, DOI 10.15585/mmwr.mm6544a4
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MOORE CA, 1990, J PEDIATR-US, V116, P383, DOI 10.1016/S0022-3476(05)82825-2
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   National Institutes of Health, NIH LAUNCH LARG STUD
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Safadi MAP, 2017, PEDIATR INFECT DIS J, V36, P333, DOI 10.1097/INF.0000000000001449
   Pfaender S, 2017, VIRUS RES, V228, P58, DOI 10.1016/j.virusres.2016.11.025
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   Stewart RD, 2013, CASE REP INFECT DIS, DOI 10.1155/2013/351872
   Tan PC, 2008, OBSTET GYNECOL, V111, P1111, DOI 10.1097/AOG.0b013e31816a49fc
   World Health Organisation Guideline, 2016, GUID INF FEED AR ZIK
   World Health Organization, SIT REP ZIK VIR
   World Health Organization (WHO), 2005, WHO STAT 1 M INT HLT
NR 50
TC 9
Z9 9
U1 0
U2 6
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1523-3847
EI 1534-3146
J9 CURR INFECT DIS REP
JI Curr. Infect. Dis. Rep.
PD AUG
PY 2017
VL 19
IS 8
AR 29
DI 10.1007/s11908-017-0584-7
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA FD3RA
UT WOS:000407448900004
PM 28639081
OA Green Published
DA 2020-07-08
ER

PT J
AU Lyerly, AD
   Robin, SG
   Jaffe, E
AF Lyerly, Anne Drapkin
   Robin, Samantha G.
   Jaffe, Elana
TI Rubella and Zika Vaccine Research-A Cautionary Tale About Caution
SO JAMA PEDIATRICS
LA English
DT Editorial Material
ID UNITED-STATES; PREGNANCY
C1 [Lyerly, Anne Drapkin; Jaffe, Elana] Univ North Carolina Chapel Hill, Ctr Bioeth, Chapel Hill, NC 27599 USA.
   [Lyerly, Anne Drapkin; Jaffe, Elana] Univ North Carolina Chapel Hill, Dept Social Med, Chapel Hill, NC 27599 USA.
   [Robin, Samantha G.] Univ North Carolina Chapel Hill, Sch Med, Chapel Hill, NC 27599 USA.
RP Lyerly, AD (corresponding author), Univ North Carolina Chapel Hill, 7240,333 MacNider,333 South Columbia St, Chapel Hill, NC 27599 USA.
EM alyerly@emailunc.edu
FU Wellcome TrustWellcome Trust; National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [R01AI108368]
FX Dr Lyerly and Ms Jaffe receive grant support from Wellcome Trust and
   grant R01AI108368 from the National Institutes of Health.
CR Beigi RH, 2014, CLIN INFECT DIS, V59, pS408, DOI 10.1093/cid/ciu708
   Chang S, 2008, VACCINE, V26, P2428, DOI 10.1016/j.vaccine.2008.02.052
   COCHI SL, 1989, AM J EPIDEMIOL, V129, P349, DOI 10.1093/oxfordjournals.aje.a115138
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Metcalf CJ, 2016, PLOS CURR, V8
   Omer SB, 2016, JAMA-J AM MED ASSOC, V315, P1227, DOI 10.1001/jama.2016.2237
   PREBLUD SR, 1980, J INFECT DIS, V142, P776, DOI 10.1093/infdis/142.5.776
   1990, MMWR RECOMM REP, V39, P1
NR 8
TC 1
Z9 1
U1 1
U2 3
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6203
EI 2168-6211
J9 JAMA PEDIATR
JI JAMA Pediatr.
PD AUG
PY 2017
VL 171
IS 8
BP 719
EP 720
DI 10.1001/jamapediatrics.2017.1496
PG 2
WC Pediatrics
SC Pediatrics
GA FC7FA
UT WOS:000407005400004
PM 28654956
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Win, AZ
AF Win, A. Z.
TI Challenges for Zika prevention in Myanmar
SO QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
LA English
DT Editorial Material
C1 [Win, A. Z.] Notre Dame Namur Univ, 1500 Ralston Ave, Belmont, CA 94002 USA.
RP Win, AZ (corresponding author), Notre Dame Namur Univ, 1500 Ralston Ave, Belmont, CA 94002 USA.
EM aungzwin@gmail.com
CR Gerin R., MYANMAR GOVT TAKES M
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Liang Y., OUTBREAK DENGUE FEVE
   Myint SYS, MYANMAR HLTH AUTHORI
   Myint SYS., GOVT LAUNCHES ZIKA V
   Nyein N., ZIKA VIRUS RISK CONS
   World Bank, WORLD BANK HOSP BEDS
   World Bank, WORLD BANK OUT OF PO
NR 8
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1460-2725
EI 1460-2393
J9 QJM-INT J MED
JI QJM-An Int. J. Med.
PD AUG
PY 2017
VL 110
IS 8
BP 481
EP 482
DI 10.1093/qjmed/hcx130
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA FC9QZ
UT WOS:000407177500003
PM 28899079
OA Other Gold
DA 2020-07-08
ER

PT J
AU Santa Maria, F
   Laughhunn, A
   Lanteri, MC
   Aubry, M
   Musso, D
   Stassinopoulos, A
AF Santa Maria, Felicia
   Laughhunn, Andrew
   Lanteri, Marion C.
   Aubry, Maite
   Musso, Didier
   Stassinopoulos, Adonis
TI Inactivation of Zika virus in platelet components using amotosalen and
   ultraviolet A illumination
SO TRANSFUSION
LA English
DT Article
ID WEST-NILE-VIRUS; BLOOD-TRANSFUSION; PHOTOCHEMICAL INACTIVATION; PATHOGEN
   INACTIVATION; FRENCH-POLYNESIA; DENGUE VIRUS; PLASMA; LIGHT;
   TRANSMISSION; CHIKUNGUNYA
AB BACKGROUND: Concerned over the risk of Zika virus (ZIKV) transfusion transmission, public health agencies recommended the implementation of mitigation strategies for its prevention. Those strategies included the use of pathogen inactivation for the treatment of plasma and platelets. The efficacy of amotosalen/ultraviolet A to inactivate ZIKV in plasma had been previously demonstrated, and the efficacy of inactivation in platelets with the same technology was assumed. These studies quantify ZIKV inactivation in platelet components using amotosalen/ultraviolet A.
   STUDY DESIGN AND METHODS: Platelet components were spiked with ZIKV, and ZIKV infectious titers and RNA loads were measured by cell culture-based assays and real-time polymerase chain reaction in spiked platelet components before and after photochemical treatment using amotosalen/ultraviolet A.
   RESULTS: The mean ZIKV infectivity titers and RNA loads in platelet components before inactivation were either 4.9 log(10) plaque forming units per milliliter, or 4.4 log(10) 50% tissue culture infective dose per milliliter and 7.5 log(10) genome equivalents per milliliter, respectively. No infectivity was detected immediately after amotosalen/ultraviolet A treatment. No replicative virus remained after treatment, as demonstrated by multiple passages on Vero cell cultures; and ZIKV RNA was not detected from the first passage after inactivation. Additional experiments in this study demonstrated efficient inactivation to the limit of detection in platelets manufactured in 65% platelet additive solution, 35% plasma, or 100% plasma.
   CONCLUSION: As previously demonstrated for plasma, robust levels of ZIKV inactivation were achieved in platelet components. With inactivation of higher levels of ZIKV than those reported in asymptomatic, RNA-reactive blood donors, the pathogen-inactivation system using amotosalen/ultraviolet A offers the potential to mitigate the risk of ZIKV transmission by plasma and platelet transfusion.
C1 [Santa Maria, Felicia; Laughhunn, Andrew; Lanteri, Marion C.; Stassinopoulos, Adonis] Cerus Corp, 2550 Stanwell Dr, Concord, CA 94520 USA.
   [Aubry, Maite; Musso, Didier] Inst Louis Malarde, Pole Rech & Veille Malad Infect Emergentes, Tahiti, French Polynesi, France.
RP Stassinopoulos, A (corresponding author), Cerus Corp, 2550 Stanwell Dr, Concord, CA 94520 USA.
EM adonis@cerus.com
RI Musso, Didier/P-7809-2016; Musso, Didier/AAO-8178-2020
OI Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971;
   Aubry, Maite/0000-0002-9913-5794
FU Cerus Corporation, Concord, California
FX This study was funded in part by Cerus Corporation, Concord, California.
CR AABB, AABB ASS B, V16-07
   Allain JP, 2005, TRANSFUS MED REV, V19, P110, DOI 10.1016/j.tmrv.2004.11.005
   [Anonymous], 2016, REV REC RED RISK ZIK
   Aubry M, 2015, VOX SANG S1, V109, P189
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Bakkour S, 2016, TRANSFUSION, V56, P410, DOI 10.1111/trf.13360
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Bierlaire D, 2017, TRANSFUSION, V57, P729, DOI 10.1111/trf.14028
   Chuang Vivien W. M., 2008, Hong Kong Medical Journal, V14, P170
   CORDEL H, 2006, EUROSURVEILLANCE, V11, P2944
   Dodd RY, 2015, TRANSFUS MED REV, V29, P153, DOI 10.1016/j.tmrv.2015.03.001
   Dupuis K, 2012, TRANSFUSION, V52, P2012
   Epstein JS, 2003, TRANSFUSION, V43, P1347, DOI 10.1046/j.1537-2995.2003.00584.x
   Faddy HM, 2016, TRANSFUSION, V56, P1548, DOI 10.1111/trf.13519
   Food and Drug Administration (FDA), 2016, REC DON SCREEN DEF P
   Fryk JJ, 2016, TRANSFUSION, V56, P2278, DOI 10.1111/trf.13729
   Galel SA, 2017, TRANSFUSION, V57, P762, DOI 10.1111/trf.14029
   Gallian P, 2006, VOX SANG, V91, P345, DOI 10.1111/j.1423-0410.2006.00844.x
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Groves JA, 2017, TRANSFUSION, V57, P850, DOI 10.1111/trf.14018
   Hoad VC, 2015, MED J AUSTRALIA, V202, P267, DOI 10.5694/mja14.01522
   Irsch J, 2011, TRANSFUS MED HEMOTH, V38, P19, DOI 10.1159/000323937
   Karim F, 2016, TRANSFUS APHER SCI
   Laughhunn A, 2016, VOX SANG S, V111, P7
   Laughhunn A, 2017, TRANSFUSION, V57, P779, DOI 10.1111/trf.13993
   Levi JE, 2016, J INFECT DIS, V213, P689, DOI 10.1093/infdis/jiv322
   Lily L, 2005, TRANSFUSION, V45, P580
   LIN L, 1993, BLOOD, V82, P292, DOI 10.1182/blood.V82.1.292.bloodjournal821292
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2017, ISBT SCI SERIES, V12, P254
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2014, TRANSFUSION, V54, P2924, DOI 10.1111/trf.12713
   Oh HB, 2015, TRANSFUSION, V55, P1655, DOI 10.1111/trf.13054
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Report S, 2017, ZIK VIR MICR GUILL B
   Richard V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138161
   Singh Y, 2006, TRANSFUSION, V46, P1168, DOI 10.1111/j.1537-2995.2006.00867.x
   Stone M, 2017, TRANSFUSION, V57, P734, DOI 10.1111/trf.14031
   Tan LK, 2013, ADV INFECT DIS, V3, P1
   Trosemeier J-H, 2016, GENOME ANNOUNC, V4
   Tsetsarkin KA, 2013, AM J TROP MED HYG, V88, P1163, DOI 10.4269/ajtmh.12-0603
   US Food and Drug Administration (FDA), 2016, INTERCEPT BLOOD SYST
   Williamson PC, 2017, TRANSFUSION, V57, P770, DOI 10.1111/trf.14041
   World Health Organization, 2016, MAINT SAF AD BLOOD S
NR 46
TC 15
Z9 15
U1 1
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD AUG
PY 2017
VL 57
IS 8
BP 2016
EP 2025
DI 10.1111/trf.14161
PG 10
WC Hematology
SC Hematology
GA FD0WW
UT WOS:000407260400026
PM 28671343
OA Other Gold
DA 2020-07-08
ER

PT J
AU Raboni, SM
   Bonfim, C
   Almeida, BM
   Zanluca, C
   Koishi, AC
   Rodrigues, PRVP
   Kay, CK
   Ribeiro, LL
   Scola, RH
   dos Santos, CND
AF Raboni, Sonia M.
   Bonfim, Carmem
   Almeida, Bernardo M.
   Zanluca, Camila
   Koishi, Andrea C.
   Rodrigues, Paula R. V. P.
   Kay, Claudia K.
   Ribeiro, Lisandro L.
   Scola, Rosana H.
   Duarte dos Santos, Claudia N.
TI Flavivirus cross-reactivity in serological tests and Guillain-Barre
   syndrome in a hematopoietic stem cell transplant patient: A case report
SO TRANSPLANT INFECTIOUS DISEASE
LA English
DT Article
DE Dengue virus; Guillain-Barre syndrome; hematopoietic stem cell
   transplantation; Zika virus
ID ZIKA-VIRUS; DENGUE-FEVER; INFECTION; PCR
AB Serological diagnosis of flavivirus infection is a challenge, particularly in the context of a disease associated with immune response enhancement in a transplant patient, where aspects such as previous flavivirus infections may be involved with the outcome. We report a case of a pediatric patient who developed Guillain-Barre syndrome (GBS) after matched-unrelated hematopoietic stem cell transplantation (HSCT). The patient lives in a Brazilian region that is experiencing an epidemic of Zika virus (ZIKV) and dengue virus (DENV). Because an increasing number of cases of GBS, likely triggered by ZIKV infection, are being reported in Brazil, samples from the patient were tested for both ZIKV and DENV infection. Serological assays strongly suggested a recent ZIKV infection, although infection by DENV or co-infection with both viruses cannot be ruled out. The presence of anti-DENV immunoglobulin-G in donor serum led to the hypothesis that antibodies from the donor could have enhanced the severity of the ZIKV infection. This hypothesis is in agreement with the recent findings that DENV sero-cross-reactivity drives antibody-dependent enhancement of ZIKV infection. These findings highlight the need for discussion of the indication to perform previous flavivirus tests in HSCT donors, especially in areas where ZIKV and other flaviviruses co-circulate.
C1 [Raboni, Sonia M.] Univ Fed Parana, Lab Virol, Curitiba, Parana, Brazil.
   [Bonfim, Carmem; Ribeiro, Lisandro L.] Univ Fed Parana, Bone Marrow Transplant Div, Curitiba, Parana, Brazil.
   [Almeida, Bernardo M.] Univ Fed Parana, Hosp Epidemiol Div, Curitiba, Parana, Brazil.
   [Zanluca, Camila; Koishi, Andrea C.; Duarte dos Santos, Claudia N.] Fundacao Oswaldo Cruz, Inst Carlos Chagas, Mol Virol Lab, Rio De Janeiro, Brazil.
   [Rodrigues, Paula R. V. P.; Kay, Claudia K.; Scola, Rosana H.] Univ Fed Parana, Div Neurol, Neuromuscular Dis Serv, Curitiba, Parana, Brazil.
RP Raboni, SM (corresponding author), Univ Fed Parana, Hosp Clin, Virol Lab, Curitiba, Parana, Brazil.
EM sraboni@ufpr.br
RI Raboni, Sonia M/AAF-7142-2020; Duarte dos Santos, Claudia/E-1857-2018;
   Santos, Claudia Duarte dos/P-4868-2019; Koishi, Andrea/N-2484-2013
OI Raboni, Sonia M/0000-0001-7907-7585; Duarte dos Santos,
   Claudia/0000-0001-8707-6638; Santos, Claudia Duarte
   dos/0000-0001-8707-6638; Koishi, Andrea/0000-0002-3542-1353; Zanluca,
   Camila/0000-0001-7350-9105
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen TY, 2007, ANN EMERG MED, V50, P94, DOI 10.1016/j.annemergmed.2007.02.026
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   dos Santos CND, 2016, TRENDS PARASITOL, V32, P508, DOI 10.1016/j.pt.2016.03.008
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Mishra Vikas, 2015, J Assoc Physicians India, V63, P94
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Ralapanawa Dissanayake Mudiyanselage Priyantha Udaya Kumara, 2015, BMC Res Notes, V8, P729, DOI 10.1186/s13104-015-1672-0
   Rodriguez V, 2002, BONE MARROW TRANSPL, V29, P515, DOI 10.1038/sj.bmt.1703412
   Sanchez-Seco MP, 2005, J VIROL METHODS, V126, P101, DOI 10.1016/j.jviromet.2005.01.025
   Simon O, 2016, J CLIN VIROL, V77, P29, DOI 10.1016/j.jcv.2016.01.016
   Siu R, 2016, NEUROLOGY, V87, P1623, DOI 10.1212/WNL.0000000000003038
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Thiery G, 2016, INTENS CARE MED, V42, P1485, DOI 10.1007/s00134-016-4364-x
   Verma R, 2014, J NEUROL SCI, V346, P26, DOI 10.1016/j.jns.2014.08.044
   Wen PY, 1997, NEUROLOGY, V49, P1711, DOI 10.1212/WNL.49.6.1711
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 24
TC 8
Z9 8
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1398-2273
EI 1399-3062
J9 TRANSPL INFECT DIS
JI Transpl. Infect. Dis.
PD AUG
PY 2017
VL 19
IS 4
AR e12700
DI 10.1111/tid.12700
PG 5
WC Immunology; Infectious Diseases; Transplantation
SC Immunology; Infectious Diseases; Transplantation
GA FD0HG
UT WOS:000407219800001
PM 28306183
OA Bronze
DA 2020-07-08
ER

PT J
AU Raboni, SM
   dos Santos, CND
AF Raboni, Sonia M.
   Duarte dos Santos, Claudia N.
TI Flavivirus cross-reactivity, Guillain-Barre syndrome, and hematopoietic
   stem cell transplant patient: Comment response
SO TRANSPLANT INFECTIOUS DISEASE
LA English
DT Letter
DE dengue; flavivirus cross-reactivity; Guillain-Barre syndrome; Zika virus
C1 [Raboni, Sonia M.] Univ Fed Parana, Lab Virol, Curitiba, Parana, Brazil.
   [Duarte dos Santos, Claudia N.] Fundacao Oswaldo Cruz, Inst Carlos Chagas, Mol Virol Lab, Curitiba, Parana, Brazil.
RP Raboni, SM (corresponding author), Univ Fed Parana, Lab Virol, Curitiba, Parana, Brazil.
EM sraboni@ufpr.br
RI Raboni, Sonia M/AAF-7142-2020
OI Raboni, Sonia M/0000-0001-7907-7585
CR Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Joob B, 2017, TRANSPL INFECT DIS, P19
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Raboni SM, 2017, TRANSPL INFECT DIS, P19
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
NR 6
TC 1
Z9 1
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1398-2273
EI 1399-3062
J9 TRANSPL INFECT DIS
JI Transpl. Infect. Dis.
PD AUG
PY 2017
VL 19
IS 4
AR e12719
DI 10.1111/tid.12719
PG 1
WC Immunology; Infectious Diseases; Transplantation
SC Immunology; Infectious Diseases; Transplantation
GA FD0HG
UT WOS:000407219800019
PM 28474860
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Zika Virus Meningoencephalitis
SO MAYO CLINIC PROCEEDINGS
LA English
DT Letter
ID DISEASE; DENGUE
C1 [Joob, Beuy] Sanitat I Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Joob, B (corresponding author), Sanitat I Med Acad Ctr, Bangkok, Thailand.
CR Araujo FMC, 2012, NEUROLOGY, V78, P736, DOI 10.1212/WNL.0b013e31824b94e9
   Duca LM, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0557-x
   Limkittikul K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003241
   Schwartzmann PV, 2017, MAYO CLIN PROC, V92, P460, DOI 10.1016/j.mayocp.2016.12.019
NR 4
TC 1
Z9 1
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0025-6196
EI 1942-5546
J9 MAYO CLIN PROC
JI Mayo Clin. Proc.
PD AUG
PY 2017
VL 92
IS 8
BP 1313
EP 1313
DI 10.1016/j.mayocp.2017.05.019
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA FC2PV
UT WOS:000406681400021
PM 28778266
OA Bronze
DA 2020-07-08
ER

PT J
AU Schwartzmann, PV
   Simoes, MV
   Figueiredo, LTM
AF Schwartzmann, Pedro V.
   Simoes, Marcus Vinicius
   Moraes Figueiredo, Luiz Tadeu
TI In Reply-Zika Virus Meningoencelphalitis
SO MAYO CLINIC PROCEEDINGS
LA English
DT Letter
ID IDENTIFICATION
C1 [Schwartzmann, Pedro V.; Simoes, Marcus Vinicius; Moraes Figueiredo, Luiz Tadeu] Univ Sao Paulo, Sao Paulo, Brazil.
RP Schwartzmann, PV (corresponding author), Univ Sao Paulo, Sao Paulo, Brazil.
CR Bastos MD, 2012, AM J TROP MED HYG, V86, P732, DOI 10.4269/ajtmh.2012.11-0485
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Joob B, 2017, MAYO CLIN PROC, V92, P1313, DOI 10.1016/j.mayocp.2017.05.019
   Schwartzmann PV, 2017, MAYO CLIN PROC, V92, P460, DOI 10.1016/j.mayocp.2016.12.019
NR 4
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0025-6196
EI 1942-5546
J9 MAYO CLIN PROC
JI Mayo Clin. Proc.
PD AUG
PY 2017
VL 92
IS 8
BP 1313
EP 1314
DI 10.1016/j.mayocp.2017.05.018
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA FC2PV
UT WOS:000406681400022
PM 28778267
OA Bronze
DA 2020-07-08
ER

PT J
AU Fernandes, RS
   Campos, SS
   Ribeiro, PS
   Raphael, LMS
   Bonaldo, MC
   Lourenco-de-Oliveira, R
AF Fernandes, Rosilainy Surubi
   Campos, Stephanie Silva
   Ribeiro, Paulino Siqueira
   Raphael, Lidiane M. S.
   Bonaldo, Myrna C.
   Lourenco-de-Oliveira, Ricardo
TI Culex quinquefasciatus from areas with the highest incidence of
   microcephaly associated with Zika virus infections in the Northeast
   Region of Brazil are refractory to the virus
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Culex quinquefasciatus; Zika virus; vector competence; Brazil
ID TRANSMISSION
AB Zika virus (ZIKV) is widely distributed in Brazil and the Northeast Region (NE) is the most affected zone, showing the highest incidence of microcephaly associated with ZIKV congenital infections worldwide. We report attempts to infect three populations of Culex quinquefasciatus from severely affected sites in the NE and Southeast Region (SE) of Brazil with three strains of ZIKV isolated from these localities. An Aedes aegypti population from the SE was used as a positive control. All tested Cx. quinquefasciatus populations were refractory to the ZIKV isolates. For these reasons, we believe Cx. quinquefasciatus should not be considered a potential vector of ZIKV in Brazil.
C1 [Fernandes, Rosilainy Surubi; Campos, Stephanie Silva; Ribeiro, Paulino Siqueira; Lourenco-de-Oliveira, Ricardo] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, RJ, Brazil.
   [Raphael, Lidiane M. S.; Bonaldo, Myrna C.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, RJ, Brazil.
RP Lourenco-de-Oliveira, R (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, RJ, Brazil.
EM lourenco@ioc.fiocruz.br
FU European Union's Horizon 2020 Research and Innovation Programme
   (ZIKAlliance) [734548]; CAPES-COFECUBCAPES [799/14]; FAPERJCarlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ) [E-26/102.351/2013, E-26/201.335/2016]; CNPqNational Council
   for Scientific and Technological Development (CNPq) [309577/2013-6];
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [1UO1 AI115595-01]
FX European Union's Horizon 2020 Research and Innovation Programme
   (ZIKAlliance 734548), CAPES-COFECUB (799/14), FAPERJ (E-26/102.351/2013,
   E-26/201.335/2016), CNPq (309577/2013-6), NIH (1UO1 AI115595-01). The
   funders had no role in the study design, data collection, and analysis,
   decision to publish or preparation of the manuscript.
CR Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, P1, DOI DOI 10.1371/J0URNAL.PNTD.0005048
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, P1, DOI DOI 10.1371/J0URNAL.PNTD.0004993
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, P1
   Hart CE, 2017, EMERG INFECT DIS, V23, P559, DOI 10.3201/eid2303.161636
   Lambrechts L, 2011, TRENDS PARASITOL, V27, P111, DOI 10.1016/j.pt.2010.12.001
   Liu Z, 2017, EMERG INFECT DIS, V23
   Possas C, 2017, MEM I OSWALDO CRUZ, V112, P319, DOI 10.1590/0074-02760160510
   Tabachnick WJ, 2013, INT J ENV RES PUB HE, V10, P249, DOI 10.3390/ijerph10010249
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 15
TC 16
Z9 17
U1 0
U2 7
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD AUG
PY 2017
VL 112
IS 8
BP 577
EP 579
DI 10.1590/0074-02760170145
PG 3
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FC4JY
UT WOS:000406807300009
PM 28767975
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Trujillo-Ocampo, A
   Cazares-Raga, FE
   del Angel, RM
   Medina-Ramirez, F
   Santos-Argumedo, L
   Rodriguez, MH
   Hernandez-Hernandez, FD
AF Trujillo-Ocampo, Abel
   Elena Cazares-Raga, Febe
   Maria del Angel, Rosa
   Medina-Ramirez, Fernando
   Santos-Argumedo, Leopoldo
   Rodriguez, Mario H.
   de la Cruz Hernandez-Hernandez, Fidel
TI Participation of 14-3-3 epsilon and 14-3-3 zeta proteins in the
   phagocytosis, component of cellular immune response, in Aedes mosquito
   cell lines
SO PARASITES & VECTORS
LA English
DT Article
DE Aag-2; Ae. aegypti; C6/36 HT; Ae. albopictus; 14-3-3 epsilon; 14-3-3
   zeta; DsiRNA; 14-3-3 inhibitor; Phagocytosis
ID JNK-LIKE PROTEIN; RNA INTERFERENCE; DENGUE-VIRUS; PHAGOSOME MATURATION;
   PERSISTENT INFECTION; EXPRESSION ANALYSIS; INNATE IMMUNITY;
   FLOW-CYTOMETRY; BOMBYX-MORI; AEGYPTI
AB Background: Better knowledge of the innate immune system of insects will improve our understanding of mosquitoes as potential vectors of diverse pathogens. The ubiquitously expressed 14-3-3 protein family is evolutionarily conserved from yeast to mammals, and at least two isoforms of 14-3-3, the epsilon and zeta, have been identified in insects. These proteins have been shown to participate in both humoral and cellular immune responses in Drosophila. As mosquitoes of the genus Aedes are the primary vectors for arboviruses, causing several diseases such as dengue fever, yellow fever, Zika and chikungunya fevers, cell lines derived from these mosquitoes, Aag-2 from Aedes aegypti and C6/36 HT from Aedes albopictus, are currently used to study the insect immune system. Here, we investigated the role of 14-3-3 proteins (epsilon and zeta isoform) in phagocytosis, the main cellular immune responses executed by the insects, using Aedes spp. cell lines.
   Results: We evaluated the mRNA and protein expression of 14-3-3 epsilon and 14-3-3 zeta in C6/36 HT and Aag-2 cells, and demonstrated that both proteins were localised in the cytoplasm. Further, in C6/36 HT cells treated with a 14-3-3 specific inhibitor we observed a notable modification of cell morphology with filopodia-like structure caused through cytoskeleton reorganisation (co-localization of 14-3-3 proteins with F-actin), more importantly the decrease in Salmonella typhimurium, Staphylococcus aureus and E. coli phagocytosis and reduction in phagolysosome formation. Additionally, silencing of 14-3-3 epsilon and 14-3-3 zeta expression by mean of specific DsiRNA confirmed the decreased phagocytosis and phagolysosome formation of pHrodo labelled E. coli and S. aureus bacteria by Aag-2 cells.
   Conclusion: The 14-3-3 epsilon and 14-3-3 zeta proteins modulate cytoskeletal remodelling, and are essential for phagocytosis of Gram-positive and Gram-negative bacteria in Aedes spp. cell lines.
C1 [Trujillo-Ocampo, Abel; Elena Cazares-Raga, Febe; Maria del Angel, Rosa; Medina-Ramirez, Fernando; de la Cruz Hernandez-Hernandez, Fidel] CINVESTAV, IPN, Ctr Invest & Estudios Avanzados, Dept Infectom & Patogenesis Mol, Mexico City, DF, Mexico.
   [Santos-Argumedo, Leopoldo] CINVESTAV, IPN, Ctr Invest & Estudios Avanzados, Dept Biomd Mol, Mexico City, DF, Mexico.
   [Rodriguez, Mario H.] Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico.
RP Hernandez-Hernandez, FD (corresponding author), CINVESTAV, IPN, Ctr Invest & Estudios Avanzados, Dept Infectom & Patogenesis Mol, Mexico City, DF, Mexico.
EM cruzcruz@cinvestav.mx
RI Hernandez-Hernandez, Fidel/I-5193-2012; del Angel, Rosa M/A-5809-2008
OI Hernandez-Hernandez, Fidel/0000-0002-7276-7513; del Angel, Rosa
   M/0000-0002-6785-2035
FU Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico)Consejo
   Nacional de Ciencia y Tecnologia (CONACyT) [CB-83866]; Centro de
   Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional
   (CINVESTAV-IPN); CONACyT, MexicoConsejo Nacional de Ciencia y Tecnologia
   (CONACyT) [290564]
FX We thank the Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico)
   by the grant (CB-83866) to FCHH, Centro de Investigacion y de Estudios
   Avanzados del Instituto Politecnico Nacional (CINVESTAV-IPN). Abel
   Trujillo-Ocampo received a Ph.D. scholarship from CONACyT, Mexico
   (290564).
CR Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008
   Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005
   Alcala AC, 2016, VIROLOGY, V488, P278, DOI 10.1016/j.virol.2015.11.020
   Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110
   Birkenfeld J, 2003, BIOCHEM J, V369, P45, DOI 10.1042/BJ20021152
   Boulais J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.80
   Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856
   Bustad HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049671
   Chen XQ, 2002, BIOCHEM BIOPH RES CO, V296, P657
   Colas C, 2014, J IMMUNOL METHODS, V412, P1, DOI 10.1016/j.jim.2014.06.008
   Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301
   Erwig LP, 2006, P NATL ACAD SCI USA, V103, P12825, DOI 10.1073/pnas.0605331103
   Etchegaray JI, 2016, J NEUROSCI, V36, P3170, DOI 10.1523/JNEUROSCI.1912-15.2016
   Ferl RJ, 2002, GENOME BIOL, V3
   Barletta ABF, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-148
   Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445
   Freeman SA, 2014, IMMUNOL REV, V262, P193, DOI 10.1111/imr.12212
   Avila-Bonilla RG, 2017, VIRUS RES, V232, P139, DOI 10.1016/j.virusres.2017.03.005
   Gao Y, 1999, INSECT MOL BIOL, V8, P311, DOI 10.1046/j.1365-2583.1999.83119.x
   Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165
   Gohla A, 2002, CURR BIOL, V12, P1704, DOI 10.1016/S0960-9822(02)01184-3
   Gonzalez-Calixto C, 2015, J PROTEOMICS, V119, P45, DOI 10.1016/j.jprot.2014.11.019
   Gotthardt D, 2006, MOL CELL PROTEOMICS, V5, P2228, DOI 10.1074/mcp.M600113-MCP200
   Govindarajan M., 2016, ARTIF CELL NANOMED B, P1
   Haine ER, 2008, SCIENCE, V322, P1257, DOI 10.1126/science.1165265
   Hillyer JF, 2005, CELL MICROBIOL, V7, P39, DOI 10.1111/j.1462-5822.2004.00430.x
   Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   Kaiser M, 2010, CHEMBIOCHEM, V11, P2085, DOI 10.1002/cbic.201000483
   Kim Sun Am, 2009, Entomological Research, V39, P129, DOI 10.1111/j.1748-5967.2009.00214.x
   Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034
   Kohler RS, 2017, GYNECOL ONCOL, V145, P159, DOI 10.1016/j.ygyno.2017.02.016
   Kong LY, 2007, BBA-GEN SUBJECTS, V1770, P1598, DOI 10.1016/j.bbagen.2007.08.005
   LAN Q, 1990, AM J TROP MED HYG, V43, P669, DOI 10.4269/ajtmh.1990.43.669
   Leger P, 2013, J VIROL, V87, P1631, DOI 10.1128/JVI.02795-12
   Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615
   Liang SF, 2009, J CHROMATOGR B, V877, P627, DOI 10.1016/j.jchromb.2009.01.023
   Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332
   Miksa M, 2009, J IMMUNOL METHODS, V342, P71, DOI 10.1016/j.jim.2008.11.019
   Mizutani T, 2003, INSECT MOL BIOL, V12, P491, DOI 10.1046/j.1365-2583.2003.00435.x
   Mizutani T, 2003, INSECT MOL BIOL, V12, P61, DOI 10.1046/j.1365-2583.2003.00387.x
   Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470
   Mosso C, 2008, VIROLOGY, V378, P193, DOI 10.1016/j.virol.2008.05.012
   Neaga A, 2013, J IMMUNOL METHODS, V390, P9, DOI 10.1016/j.jim.2011.06.027
   Nibbering P. H., 1996, Frontiers in Bioscience (online), V1, pA25
   Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5
   Obsil T, 2011, SEMIN CELL DEV BIOL, V22, P663, DOI 10.1016/j.semcdb.2011.09.001
   Oliva-Ramirez J, 2014, IMMUNOLOGY, V143, P490, DOI 10.1111/imm.12329
   Oliver JD, 2011, J INVERTEBR PATHOL, V108, P126, DOI 10.1016/j.jip.2011.07.004
   PELEG J, 1972, TISSUE CELL, V4, P55, DOI 10.1016/S0040-8166(72)80006-5
   Roth D, 1999, FEBS LETT, V460, P411, DOI 10.1016/S0014-5793(99)01383-6
   Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/BJ20031797
   Scott JC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000848
   Shandala T, 2011, J CELL SCI, V124, P2165, DOI 10.1242/jcs.080598
   SINGH KRP, 1967, ACTA VIROL, V11, P517
   Skoulakis EMC, 1998, MOL NEUROBIOL, V16, P269, DOI 10.1007/BF02741386
   Stuart LM, 2007, NATURE, V445, P95, DOI 10.1038/nature05380
   Stuart LM, 2008, NAT REV IMMUNOL, V8, P131, DOI 10.1038/nri2240
   Tabunoki H, 2008, NEUROSCI RES, V61, P271, DOI 10.1016/j.neures.2008.03.007
   Tak H, 2007, CELL SIGNAL, V19, P2379, DOI 10.1016/j.cellsig.2007.07.016
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Trujillo-Ocampo A, 2016, ARCH INSECT BIOCHEM, V93, P143, DOI 10.1002/arch.21348
   Tsai KN, 2007, VIRUS RES, V124, P139, DOI 10.1016/j.virusres.2006.10.013
   Ulvila J, 2011, APMIS, V119, P651, DOI 10.1111/j.1600-0463.2011.02792.x
   Ulvila J, 2011, J LEUKOCYTE BIOL, V89, P649, DOI 10.1189/jlb.0410195
   Wu H, 2010, ANGEW CHEM INT EDIT, V49, P6528, DOI 10.1002/anie.201003257
NR 66
TC 1
Z9 4
U1 1
U2 7
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD AUG 1
PY 2017
VL 10
AR 362
DI 10.1186/s13071-017-2267-5
PG 12
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FC7WY
UT WOS:000407054400002
PM 28764795
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Torquato, RJS
   Lu, S
   Martins, NH
   Tanaka, AS
   Pereira, PJB
AF Torquato, Ricardo J. S.
   Lu, Stephen
   Martins, Nadia Helena
   Tanaka, Aparecida S.
   Barbosa Pereira, Pedro Jose
TI High-resolution structure of a Kazal-type serine protease inhibitor from
   the dengue vector Aedes aegypti
SO ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS
LA English
DT Article
DE anticoagulants; thrombin; trypsin; salivary glands; protein-protein
   interactions; Kazal inhibitor; Aedes aegypti; Dengue fever; Yellow
   fever; Zika virus
ID LEECH HIRUDO-MEDICINALIS; HUMAN ALPHA-THROMBIN; MAST-CELL TRYPTASE;
   CRYSTAL-STRUCTURE; FUNCTIONAL-CHARACTERIZATION; ELASTASE INHIBITOR;
   COMPLEX; HEMIPTERA; TRYPSIN; ANTICOAGULANT
AB Blood-feeding exoparasites are rich sources of protease inhibitors, and the mosquito Aedes aegypti, which is a vector of Dengue virus, Yellow fever virus, Chikungunya virus and Zika virus, is no exception. AaTI is a single-domain, noncanonical Kazal-type serine proteinase inhibitor from A. aegypti that recognizes both digestive trypsin-like serine proteinases and the central protease in blood clotting, thrombin, albeit with an affinity that is three orders of magnitude lower. Here, the 1.4 angstrom resolution crystal structure of AaTI is reported from extremely tightly packed crystals (similar to 22% solvent content), revealing the structural determinants for the observed inhibitory profile of this molecule.
C1 [Torquato, Ricardo J. S.; Lu, Stephen; Tanaka, Aparecida S.] Univ Fed Sao Paulo, UNIFESP, Escola Paulista Med, Dept Biochem, Rua 3 Maio 100, BR-04044020 Sao Paulo, SP, Brazil.
   [Martins, Nadia Helena] Lab Nacl Biociencias LNBio, Caixa Postal 6192, BR-13083970 Campinas, SP, Brazil.
   [Barbosa Pereira, Pedro Jose] Univ Porto, IBMC, Rua Alfredo Allen 208, P-4200135 Oporto, Portugal.
   [Barbosa Pereira, Pedro Jose] Univ Porto, Inst Invest & Inovacao Saude, Rua Alfredo Allen 208, P-4200135 Oporto, Portugal.
RP Tanaka, AS (corresponding author), Univ Fed Sao Paulo, UNIFESP, Escola Paulista Med, Dept Biochem, Rua 3 Maio 100, BR-04044020 Sao Paulo, SP, Brazil.; Pereira, PJB (corresponding author), Univ Porto, IBMC, Rua Alfredo Allen 208, P-4200135 Oporto, Portugal.; Pereira, PJB (corresponding author), Univ Porto, Inst Invest & Inovacao Saude, Rua Alfredo Allen 208, P-4200135 Oporto, Portugal.
EM tanaka.bioq@epm.br; ppereira@ibmc.up.pt
RI Lu, Stephen/K-3162-2016; Torquato, Ricardo JS/D-7945-2018; Tanaka,
   Aparecida S/L-8754-2017; Pereira, Pedro/F-8972-2011
OI Tanaka, Aparecida S/0000-0001-9407-805X; Pereira,
   Pedro/0000-0003-0969-5438
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [12/03657-8]; CNPqNational Council for Scientific and Technological
   Development (CNPq) [478504/2013-6, 400835/2014-2, 308780/2013-2];
   Special Visiting Researcher Program (PVE - Bolsa Pesquisador Visitante
   Especial) [400835/2014-2]; FCT - Fundacao para a Ciencia e a Tecnologia
   in the form of the 'Institute for Research and Innovation in Health
   Sciences' project [POCI-01-0145-FEDER-007274]; European Regional
   Development Fund (FEDER) through the COMPETE - Operational Programme for
   Competitiveness and Internationalization (POCI), PORTUGALEuropean Union
   (EU); Structured program on bioengineered therapies for infectious
   diseases and tissue regeneration [Norte-01-0145-FEDER-000012]; Norte
   Portugal Regional Operational Programme [NORTE 2020]; FEDEREuropean
   Union (EU); CNPqNational Council for Scientific and Technological
   Development (CNPq)
FX This work was supported by research grants from FAPESP (12/03657-8) and
   from CNPq (478504/2013-6, 400835/2014-2 and 308780/2013-2). PJBP also
   acknowledges the financial support received through the Special Visiting
   Researcher Program (PVE - Bolsa Pesquisador Visitante Especial) with
   reference 400835/2014-2. This work was funded in part by Portuguese
   funds through FCT - Fundacao para a Ciencia e a Tecnologia in the form
   of the 'Institute for Research and Innovation in Health Sciences'
   project (POCI-01-0145-FEDER-007274), co-funded by the European Regional
   Development Fund (FEDER) through the COMPETE 2020 - Operational
   Programme for Competitiveness and Internationalization (POCI), PORTUGAL
   2020. Support from the 'Structured program on bioengineered therapies
   for infectious diseases and tissue regeneration'
   (Norte-01-0145-FEDER-000012), funded by the Norte Portugal Regional
   Operational Programme (NORTE 2020) under the PORTUGAL 2020 Partnership
   Agreement through FEDER, is also acknowledged. AST is a research fellow
   of the CNPq.
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Corral-Rodriguez MA, 2010, J MED CHEM, V53, P3847, DOI 10.1021/jm901743x
   Corral-Rodriguez MA, 2009, INSECT BIOCHEM MOLEC, V39, P579, DOI 10.1016/j.ibmb.2009.07.003
   Araujo RN, 2007, INT J PARASITOL, V37, P1351, DOI 10.1016/j.ijpara.2007.04.017
   ASCENZI P, 1992, J MOL BIOL, V225, P177, DOI 10.1016/0022-2836(92)91034-M
   BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x
   Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835
   Campos ITN, 2012, ACTA CRYSTALLOGR D, V68, P695, DOI 10.1107/S0907444912009067
   Campos ITN, 2004, FEBS LETT, V577, P512, DOI 10.1016/j.febslet.2004.10.052
   Campos ITN, 2002, INSECT BIOCHEM MOLEC, V32, P991, DOI 10.1016/S0965-1748(02)00035-8
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   FINK E, 1986, BIOL CHEM H-S, V367, P1235, DOI 10.1515/bchm3.1986.367.2.1235
   FRIEDRICH T, 1993, J BIOL CHEM, V268, P16216
   GRUTTER MG, 1990, EMBO J, V9, P2361, DOI 10.1002/j.1460-2075.1990.tb07410.x
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Guimaraes BG, 2009, J SYNCHROTRON RADIAT, V16, P69, DOI 10.1107/S0909049508034870
   Hemmi H, 2005, BIOCHEMISTRY-US, V44, P9626, DOI 10.1021/bi0472806
   Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477
   Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91
   LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113
   Lovato DV, 2006, BIOCHIMIE, V88, P673, DOI 10.1016/j.biochi.2005.11.011
   Morenweiser R, 1997, J BIOL CHEM, V272, P19938, DOI 10.1074/jbc.272.32.19938
   MUHLHAHN P, 1994, FEBS LETT, V355, P290, DOI 10.1016/0014-5793(94)01225-3
   Noriega FG, 1999, J INSECT PHYSIOL, V45, P613, DOI 10.1016/S0022-1910(99)00052-9
   Offermann LR, 2015, J AGR FOOD CHEM, V63, P9150, DOI 10.1021/acs.jafc.5b03534
   Paim RMM, 2011, INT J PARASITOL, V41, P765, DOI 10.1016/j.ijpara.2011.01.014
   Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047
   Rawlings ND, 2016, NUCLEIC ACIDS RES, V44, pD343, DOI 10.1093/nar/gkv1118
   RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143
   Richardson JL, 2000, EMBO J, V19, P5650, DOI 10.1093/emboj/19.21.5650
   RYDEL TJ, 1990, SCIENCE, V249, P277, DOI 10.1126/science.2374926
   Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360
   Soares TS, 2012, VET PARASITOL, V187, P521, DOI 10.1016/j.vetpar.2012.01.027
   SOMMERHOFF CP, 1994, BIOL CHEM H-S, V375, P685, DOI 10.1515/bchm3.1994.375.10.685
   Stubbs MT, 1997, J BIOL CHEM, V272, P19931, DOI 10.1074/jbc.272.32.19931
   Takac P, 2006, J EXP BIOL, V209, P343, DOI 10.1242/jeb.02003
   Trillo-Muyo S, 2013, ACTA CRYSTALLOGR D, V69, P464, DOI 10.1107/S0907444912050135
   VANDELOCHT A, 1995, EMBO J, V14, P5149, DOI 10.1002/j.1460-2075.1995.tb00199.x
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Waisberg M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004338
   Watanabe RMO, 2011, BIOCHIMIE, V93, P618, DOI 10.1016/j.biochi.2010.12.006
   Watanabe RMO, 2010, BIOCHIMIE, V92, P933, DOI 10.1016/j.biochi.2010.03.024
   Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749
NR 47
TC 1
Z9 1
U1 0
U2 9
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
EI 2053-230X
J9 ACTA CRYSTALLOGR F
JI Acta Crystallogr. F-Struct. Biol. Commun.
PD AUG
PY 2017
VL 73
BP 469
EP 475
DI 10.1107/S2053230X17010007
PN 8
PG 7
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA FC5HD
UT WOS:000406871600005
PM 28777090
OA Green Published
DA 2020-07-08
ER

PT J
AU Wetsman, N
AF Wetsman, Nicole
TI The missing pieces: Lack of Zika data from Africa complicates search for
   answers
SO NATURE MEDICINE
LA English
DT Editorial Material
ID VIRUS
CR Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Herrera BB, 2017, J INFECT DIS, V215, P1546, DOI 10.1093/infdis/jix182
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Posen HJ, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000087
   Zhang F., 2010, NUCLEIC ACIDS RES, V44, P8610
NR 6
TC 4
Z9 4
U1 0
U2 3
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD AUG
PY 2017
VL 23
IS 8
BP 904
EP 906
DI 10.1038/nm0817-904
PG 3
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA FC6JY
UT WOS:000406947600002
PM 28777794
DA 2020-07-08
ER

PT J
AU Hou, SM
   Kumar, A
   Xu, ZK
   Airo, AM
   Stryapunina, I
   Wong, CP
   Branton, W
   Tchesnokov, E
   Gotte, M
   Power, C
   Hobman, TC
AF Hou, Shangmei
   Kumar, Anil
   Xu, Zaikun
   Airo, Adriana M.
   Stryapunina, Iryna
   Wong, Cheung Pang
   Branton, William
   Tchesnokov, Egor
   Gotte, Matthias
   Power, Christopher
   Hobman, Tom C.
TI Zika Virus Hijacks Stress Granule Proteins and Modulates the Host Stress
   Response
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE Zika virus; unfolded protein response; translational arrest; stress
   granules; G3BP1; Caprin-1; capsid protein; NS3; NS4A
ID WEST-NILE; RNA; INFECTION; TRANSLATION; AGGREGATION; INHIBITION;
   PATHWAY; BRAZIL; CELLS; TIA-1
AB Zika virus (ZIKV), a member of the Flaviviridae family, has recently emerged as an important human pathogen with increasing economic and health impact worldwide. Because of its teratogenic nature and association with the serious neurological condition Guillain-Barre syndrome, a tremendous amount of effort has focused on understanding ZIKV pathogenesis. To gain further insights into ZIKV interaction with host cells, we investigated how this pathogen affects stress response pathways. While ZIKV infection induces stress signaling that leads to phosphorylation of eIF2 alpha and cellular translational arrest, stress granule (SG) formation was inhibited. Further analysis revealed that the viral proteins NS3 and NS4A are linked to translational repression, whereas expression of the capsid protein, NS3/NS2B-3, and NS4A interfered with SG formation. Some, but not all, flavivirus capsid proteins also blocked SG assembly, indicating differential interactions between flaviviruses and SG biogenesis pathways. Depletion of the SG components G3BP1, TIAR, and Caprin-1, but not TIA-1, reduced ZIKV replication. Both G3BP1 and Caprin-1 formed complexes with capsid, whereas viral genomic RNA stably interacted with G3BP1 during ZIKV infection. Taken together, these results are consistent with a scenario in which ZIKV uses multiple viral components to hijack key SG proteins to benefit viral replication.
   IMPORTANCE There is a pressing need to understand ZIKV pathogenesis in order to advance the development of vaccines and therapeutics. The cellular stress response constitutes one of the first lines of defense against viral infection; therefore, understanding how ZIKV evades this antiviral system will provide key insights into ZIKV biology and potentially pathogenesis. Here, we show that ZIKV induces the stress response through activation of the UPR (unfolded protein response) and PKR (protein kinase R), leading to host translational arrest, a process likely mediated by the viral proteins NS3 and NS4A. Despite the activation of translational shutoff, formation of SG is strongly inhibited by the virus. Specifically, ZIKV hijacks the core SG proteins G3BP1, TIAR, and Caprin-1 to facilitate viral replication, resulting in impaired SG assembly. This process is potentially facilitated by the interactions of the viral RNA with G3BP1 as well as the viral capsid protein with G3BP1 and Caprin-1. Interestingly, expression of capsid proteins from several other flaviviruses also inhibited SG formation. Taken together, the present study provides novel insights into how ZIKV modulates cellular stress response pathways during replication.
C1 [Hou, Shangmei; Kumar, Anil; Xu, Zaikun; Stryapunina, Iryna; Hobman, Tom C.] Univ Alberta, Dept Cell Biol, Edmonton, AB, Canada.
   [Airo, Adriana M.; Wong, Cheung Pang; Tchesnokov, Egor; Gotte, Matthias; Hobman, Tom C.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada.
   [Branton, William; Power, Christopher] Univ Alberta, Dept Med, Edmonton, AB, Canada.
   [Gotte, Matthias; Hobman, Tom C.] Li Ka Shing Inst Virol, Edmonton, AB, Canada.
   [Hobman, Tom C.] Women & Childrens Hlth Res Inst, Edmonton, AB, Canada.
RP Hobman, TC (corresponding author), Univ Alberta, Dept Cell Biol, Edmonton, AB, Canada.; Hobman, TC (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada.; Hobman, TC (corresponding author), Li Ka Shing Inst Virol, Edmonton, AB, Canada.; Hobman, TC (corresponding author), Women & Childrens Hlth Res Inst, Edmonton, AB, Canada.
EM tom.hobman@ualberta.ca
OI Kumar, Anil/0000-0002-6179-4516; Branton, William/0000-0002-3259-2544
FU Canadian Institutes of Health ResearchCanadian Institutes of Health
   Research (CIHR) [CIHR MOP-125903, PJT-148699, ZV1-149782]; Li Ka Shing
   Institute of Virology; Women & Children's Health Research Institute
   (WCHRI); WCHRI graduate studentship; Alberta Innovates-Health Solutions;
   CIHRCanadian Institutes of Health Research (CIHR); CIHRCanadian
   Institutes of Health Research (CIHR) [MOP-126149]; Canada Research Chair
   awardNatural Resources CanadaCanadian Forest ServiceCanada Research
   Chairs
FX This work was funded by grants from the Canadian Institutes of Health
   Research (CIHR MOP-125903; PJT-148699; ZV1-149782), the Li Ka Shing
   Institute of Virology, and the Women & Children's Health Research
   Institute (WCHRI) to T.C.H. S.H. is the recipient of a WCHRI graduate
   studentship. A.K. is funded by a postdoctoral fellowship from the
   Alberta Innovates-Health Solutions. A.M.A. is the recipient of a
   doctoral scholarship from CIHR. M.G. is funded by CIHR MOP-126149.
   T.C.H. holds a Canada Research Chair award.
CR Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Ambrose RL, 2011, J VIROL, V85, P2723, DOI 10.1128/JVI.02050-10
   Anderson P, 2002, J CELL SCI, V115, P3227
   Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694
   Ariumi Y, 2011, J VIROL, V85, P6882, DOI 10.1128/JVI.02418-10
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Bartoli Kristen M, 2011, Int J Cell Biol, V2011, P939848, DOI 10.1155/2011/939848
   Basu M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006240
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036
   Bhattacharyya S, 2014, J GEN VIROL, V95, P71, DOI 10.1099/vir.0.057265-0
   Bidet K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004242
   Bieniossek C., 2008, CURR PROTOC PROTEIN
   Bordeleau ME, 2005, P NATL ACAD SCI USA, V102, P10460, DOI 10.1073/pnas.0504249102
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cencic R, 2016, TRANSLATION, V4, DOI 10.1080/21690731.2015.1137381
   Courtney SC, 2012, J VIROL, V86, P3647, DOI 10.1128/JVI.06549-11
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Emara MM, 2007, P NATL ACAD SCI USA, V104, P9041, DOI 10.1073/pnas.0703348104
   Garaigorta U, 2012, J VIROL, V86, P11043, DOI 10.1128/JVI.07101-11
   Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hamel R, 2017, INFECT GENET EVOL, V49, P134, DOI 10.1016/j.meegid.2017.01.015
   Ivanov PA, 2003, CELL BIOL INT, V27, P207, DOI 10.1016/S1065-6995(02)00341-4
   Katoh H, 2013, J VIROL, V87, P489, DOI 10.1128/JVI.02186-12
   Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431
   Khaperskyy DA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004217
   Khaperskyy DA, 2012, FASEB J, V26, P1629, DOI 10.1096/fj.11-196915
   Kong YW, 2008, P NATL ACAD SCI USA, V105, P8866, DOI 10.1073/pnas.0800650105
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Li W, 2002, J VIROL, V76, P11989, DOI 10.1128/JVI.76.23.11989-12000.2002
   Lindquist ME, 2010, J VIROL, V84, P12274, DOI 10.1128/JVI.00260-10
   Lloyd RE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002741
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Matsuki H, 2013, GENES CELLS, V18, P135, DOI 10.1111/gtc.12023
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Ng CS, 2013, J VIROL, V87, P9511, DOI 10.1128/JVI.03248-12
   Pena J, 2011, J BIOL CHEM, V286, P14226, DOI 10.1074/jbc.M111.222703
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Roth H, 2017, MBIO, V8, DOI [10.1128/mbio.02150-16, 10.1128/mBio.02150-16]
   Ruggieri A, 2012, CELL HOST MICROBE, V12, P71, DOI 10.1016/j.chom.2012.05.013
   SAMSON F, 1979, J PHARMACOL EXP THER, V208, P411
   SCHMIDT TGM, 1994, J CHROMATOGR A, V676, P337, DOI 10.1016/0021-9673(94)80434-6
   Shang J, 2011, METHOD ENZYMOL, V491, P293, DOI 10.1016/B978-0-12-385928-0.00016-X
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128
   Tu YC, 2012, J VIROL, V86, P10347, DOI 10.1128/JVI.00525-12
   Umareddy I, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-91
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vivithanaporn P, 2016, AIDS, V30, P543, DOI 10.1097/QAD.0000000000000955
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Ward AM, 2014, METHODS MOL BIOL, V1138, P253, DOI 10.1007/978-1-4939-0348-1_16
   White JP, 2007, CELL HOST MICROBE, V2, P295, DOI 10.1016/j.chom.2007.08.006
   White JP, 2012, TRENDS MICROBIOL, V20, P175, DOI 10.1016/j.tim.2012.02.001
   White JP, 2011, J VIROL, V85, P12442, DOI 10.1128/JVI.05888-11
   You J, 2015, J VIROL, V89, P12349, DOI 10.1128/JVI.01365-15
   Yu CY, 2006, J VIROL, V80, P11868, DOI 10.1128/JVI.00879-06
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhao YQ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004682
NR 67
TC 29
Z9 31
U1 0
U2 10
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD AUG
PY 2017
VL 91
IS 16
AR UNSP e00474-17
DI 10.1128/JVI.00474-17
PG 21
WC Virology
SC Virology
GA FB8RN
UT WOS:000406406600017
PM 28592527
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Hilgard, J
   Jamieson, KH
AF Hilgard, Joseph
   Jamieson, Kathleen Hall
TI Does a Scientific Breakthrough Increase Confidence in Science? News of a
   Zika Vaccine and Trust in Science
SO SCIENCE COMMUNICATION
LA English
DT Article
DE Zika; trust; public perception of scientists; media portrayal of
   science; mass media
AB How can public support for science be encouraged? In early August 2016, a Zika vaccine entered its first human trial. Extensive media coverage followed. Using repeated cross-sectional surveys, we observed that, following this media coverage, survey respondents reported greater attention to Zika news and an increased trust in science as providing solutions to problems. Whereas the increase in attention was long-lived, lasting 6 weeks or more, the increase in trust was short-lived, lasting only 2 weeks. This result provides insight into the duration of media effects and suggests conditions that facilitate trust in science.
C1 [Hilgard, Joseph; Jamieson, Kathleen Hall] Univ Penn, Annenberg Publ Policy Ctr, 202 S 36th St, Philadelphia, PA 19104 USA.
   [Jamieson, Kathleen Hall] Univ Penn, Annenberg Sch Commun, Commun, Philadelphia, PA 19104 USA.
RP Hilgard, J (corresponding author), Univ Penn, Annenberg Publ Policy Ctr, 202 S 36th St, Philadelphia, PA 19104 USA.
EM jhilgard@gmail.com
FU Science of Science Communication endowment of the Annenberg Public
   Policy Center of the University of Pennsylvania; Annenberg Foundation
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: The
   Annenberg Science Knowledge survey was funded by the Science of Science
   Communication endowment of the Annenberg Public Policy Center of the
   University of Pennsylvania. The endowment was created from revenue
   generated by the APPC endowment funded by the Annenberg Foundation and
   managed by the University of Pennsylvania.
CR Allum N, 2008, PUBLIC UNDERST SCI, V17, P35, DOI 10.1177/0963662506070159
   Bolsen T, 2015, ANN AM ACAD POLIT SS, V658, P271, DOI 10.1177/0002716214558393
   Dutton S., 2014, CBS NEWS, pJan
   Hill SJ, 2013, POLIT COMMUN, V30, P521, DOI 10.1080/10584609.2013.828143
   Jasanoff S, 1997, PUBLIC UNDERST SCI, V6, P221, DOI 10.1088/0963-6625/6/3/002
   Kenski Kate, 2010, OBAMA VICTORY MEDIA
   Lumley T., 2016, SURVEY ANAL COMPLEX
   Master Z, 2013, SCI ENG ETHICS, V19, P321, DOI 10.1007/s11948-011-9327-6
   National Science Board, 2016, SCI ENG IND 2016
   Scheufele DA, 2009, NAT NANOTECHNOL, V4, P91, DOI [10.1038/nnano.2008.361, 10.1038/NNANO.2008.361]
   Smith Tom, 2013, GEN SOCIAL SURVEY 20
NR 11
TC 4
Z9 4
U1 1
U2 10
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1075-5470
EI 1552-8545
J9 SCI COMMUN
JI Sci. Commun.
PD AUG
PY 2017
VL 39
IS 4
BP 548
EP 560
DI 10.1177/1075547017719075
PG 13
WC Communication
SC Communication
GA FC0VF
UT WOS:000406556100007
DA 2020-07-08
ER

PT J
AU Lima, NS
   Rolland, M
   Modjarrad, K
   Trautmann, L
AF Lima, Noemia S.
   Rolland, Morgane
   Modjarrad, Kayvon
   Trautmann, Lydie
TI T Cell Immunity and Zika Virus Vaccine Development
SO TRENDS IN IMMUNOLOGY
LA English
DT Review
ID WEST-NILE-VIRUS; ANTIBODY-DEPENDENT ENHANCEMENT; TETRAVALENT DENGUE
   VACCINE; ORIGINAL ANTIGENIC SIN; CROSS-REACTIVITY; PROTECTIVE EFFICACY;
   ENCEPHALITIS-VIRUS; RESPONSES; CD4(+); INFECTION
AB The recent Zika virus (ZIKV) epidemic has created an urgent need for a safe and effective vaccine. There is still a dearth of knowledge about ZIKV immunity, but years of investigation into the immunobiology of other flaviviruses has helped to accelerate the development of a ZIKV vaccine. Although the humoral immune response generates the primary correlate of protection from disease, robust T cell responses could enhance ZIKV vaccine efficacy. Additionally, pre-existing immunity to related flaviviruses could generate cross-reactive T cells that may affect immune responses upon vaccination. In this review, we summarize the key discoveries in the area of flavivirus T cell immunity and postulate on how these findings can inform ZIKV vaccine strategies for inducing protective immunity.
C1 [Lima, Noemia S.; Rolland, Morgane; Modjarrad, Kayvon; Trautmann, Lydie] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA.
   [Lima, Noemia S.; Rolland, Morgane; Modjarrad, Kayvon; Trautmann, Lydie] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA.
RP Trautmann, L (corresponding author), Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA.; Trautmann, L (corresponding author), Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA.
EM ltrautmann@hivresearch.org
OI Trautmann, Lydie/0000-0002-3012-0009
FU Henry M. Jackson Foundation for the Advancement of Military Medicine,
   Inc. [W81XWH-07-2-0067, W81XWH-11-0174]; US Department of Defense
   (DOD)United States Department of Defense [W81XWH-07-2-0067,
   W81XWH-11-0174]; US Defense Health Agency Funding [0130602D16]; US
   National Institute of Allergy and Infectious Diseases through US Army
   [Y1-AI-264-217]
FX We thank Randy Thompson for helping with the graphical design and Yifan
   Li for plotting the comparison of flaviviruses sequences. This work was
   supported by a cooperative agreement (W81XWH-07-2-0067 and
   W81XWH-11-0174) between the Henry M. Jackson Foundation for the
   Advancement of Military Medicine, Inc., and the US Department of Defense
   (DOD). This research was funded, in part, by the US Defense Health
   Agency Funding (0130602D16) and by the US National Institute of Allergy
   and Infectious Diseases through an Interagency Agreement with the US
   Army (Y1-AI-264-217). The content is solely the responsibility of the
   authors and does not necessarily represent the official views of the US
   Department of Defense or the Department of the Army.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Akondy RS, 2015, P NATL ACAD SCI USA, V112, P3050, DOI 10.1073/pnas.1500475112
   Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903
   Angelo MA, 2017, J VIROL, V91, DOI 10.1128/JVI.02147-16
   Barba-Spaeth G, 2005, J EXP MED, V202, P1179, DOI 10.1084/jem.20051352
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Barrett ADT, 2009, CURR OPIN IMMUNOL, V21, P308, DOI 10.1016/j.coi.2009.05.018
   Bashyam HS, 2006, J IMMUNOL, V176, P2817, DOI 10.4049/jimmunol.176.5.2817
   Bassi MR, 2015, J IMMUNOL, V194, P1141, DOI 10.4049/jimmunol.1402605
   Blom K, 2013, J IMMUNOL, V190, P2150, DOI 10.4049/jimmunol.1202234
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de Alwis R, 2016, J VIROL, V90, P4771, DOI 10.1128/JVI.02892-15
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Duangchinda T, 2010, P NATL ACAD SCI USA, V107, P16922, DOI 10.1073/pnas.1010867107
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Ferguson NM, 2016, SCIENCE, V353, P1033, DOI 10.1126/science.aaf9590
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   Friberg H, 2011, SCI REP-UK, V1, DOI 10.1038/srep00051
   Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Guy B, 2008, VACCINE, V26, P5712, DOI 10.1016/j.vaccine.2008.08.019
   Guy B, 2016, NAT REV MICROBIOL, V14, P45, DOI 10.1038/nrmicro.2015.2
   Guy B, 2011, VACCINE, V29, P7229, DOI 10.1016/j.vaccine.2011.06.094
   Guy B, 2010, VACCINE, V28, P632, DOI 10.1016/j.vaccine.2009.09.098
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Harenberg A, 2013, HUM VACC IMMUNOTHER, V9, P2317, DOI 10.4161/hv.25562
   Hickman HD, 2017, IMMUNITY, V46, P13, DOI 10.1016/j.immuni.2016.12.020
   Hughes HR, 2012, VIROLOGY, V424, P129, DOI 10.1016/j.virol.2011.12.012
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   James EA, 2013, J VIROL, V87, P12794, DOI 10.1128/JVI.01160-13
   Kaabinejadian S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066298
   Kohler S, 2012, EUR J IMMUNOL, V42, P2363, DOI 10.1002/eji.201142306
   Larena M, 2011, J VIROL, V85, P5446, DOI 10.1128/JVI.02611-10
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li JQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19953
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Mangada MM, 2005, J IMMUNOL, V175, P2676, DOI 10.4049/jimmunol.175.4.2676
   Marston HD, 2016, NEW ENGL J MED, V375, P1209, DOI 10.1056/NEJMp1607762
   Mathew A, 2014, FUTURE MICROBIOL, V9, P411, DOI 10.2217/fmb.13.171
   MATHEWS JH, 1992, J VIROL, V66, P6555, DOI 10.1128/JVI.66.11.6555-6562.1992
   McCracken M. K., 2017, PLOS PATHOG, V13
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Muyanja E, 2014, J CLIN INVEST, V124, P3147, DOI 10.1172/JCI75429
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Olagnier D, 2016, J MOL BIOL, V428, P3429, DOI 10.1016/j.jmb.2016.04.024
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Paz-Bailey G, 2017, N ENGL J MED
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Prestwood TR, 2012, J VIROL, V86, P12561, DOI 10.1128/JVI.06743-11
   Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629
   Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Rivino L, 2017, IMMUNOLOGY, V150, P146, DOI 10.1111/imm.12681
   Rivino L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0526
   Rivino L, 2013, J VIROL, V87, P2693, DOI 10.1128/JVI.02675-12
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rothman AL, 2015, VACCINE, V33, P7083, DOI 10.1016/j.vaccine.2015.09.104
   Rothman Alan L, 2014, Curr Trop Med Rep, V1, P13
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Schwaiger J, 2014, J VIROL, V88, P7828, DOI 10.1128/JVI.00196-14
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shrestha B, 2004, J VIROL, V78, P8312, DOI 10.1128/jvi.78.15.8312-8321.2004
   Simmons M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152811
   Singh R, 2010, J INFECT DIS, V202, P223, DOI 10.1086/653486
   Sitati EM, 2006, J VIROL, V80, P12060, DOI 10.1128/JVI.01650-06
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   Srikiatkhachorn A, 2016, EXPERT REV VACCINES, V15, P455, DOI 10.1586/14760584.2016.1116949
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thomas SJ, 2016, NEW ENGL J MED, V375, P1212, DOI 10.1056/NEJMp1609300
   Turtle L, 2016, J EXP MED, V213, P1331, DOI 10.1084/jem.20151517
   Vaughan K, 2010, VIRAL IMMUNOL, V23, P259, DOI 10.1089/vim.2010.0006
   Weiskopf D, 2015, J INFECT DIS, V212, P1743, DOI 10.1093/infdis/jiv289
   Weiskopf D, 2015, P NATL ACAD SCI USA, V112, pE4256, DOI 10.1073/pnas.1505956112
   Weiskopf D, 2015, J VIROL, V89, P120, DOI 10.1128/JVI.02129-14
   Weiskopf D, 2014, J VIROL, V88, P11383, DOI 10.1128/JVI.01108-14
   Weiskopf D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00093
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Weiskopf D, 2011, J IMMUNOL, V187, P4268, DOI 10.4049/jimmunol.1101970
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Xu X, 2016, PLOS CURR, V8
   Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Zellweger RM, 2014, J IMMUNOL, V193, P4117, DOI 10.4049/jimmunol.1401597
   Zellweger RM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003723
   Zivna I, 2002, J IMMUNOL, V168, P5959, DOI 10.4049/jimmunol.168.11.5959
NR 111
TC 13
Z9 13
U1 0
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4906
EI 1471-4981
J9 TRENDS IMMUNOL
JI Trends Immunol.
PD AUG
PY 2017
VL 38
IS 8
BP 594
EP 605
DI 10.1016/j.it.2017.05.004
PG 12
WC Immunology
SC Immunology
GA FB9MB
UT WOS:000406462100007
PM 28579320
DA 2020-07-08
ER

PT J
AU Musso, D
   Lanteri, MC
AF Musso, Didier
   Lanteri, Marion C.
TI Zika virus in Singapore: unanswered questions
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
C1 [Musso, Didier] Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti 98713, French Polynesi, France.
   [Lanteri, Marion C.] Blood Syst Res Inst, San Francisco, CA USA.
   [Lanteri, Marion C.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.
   [Lanteri, Marion C.] Cerus Corp, Concord, CA USA.
RP Musso, D (corresponding author), Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti 98713, French Polynesi, France.
EM dmusso@ilm.pf
RI Musso, Didier/P-7809-2016; Musso, Didier/AAO-8178-2020
OI Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971
CR Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Duong V, 2017, EMERG INFECT DIS, V23, P296, DOI 10.3201/eid2302.161432
   Ellison DW, 2016, GENOME ANNOUNC, V4
   Fisher D, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0737-9
   Mallet HP, 2015, BISES B INFORM SANIT, V13, P1
   Maurer-Stroh S, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.38.30347
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Seltenrich N, 2016, ENVIRON HEALTH PERSP, V124, pA167, DOI 10.1289/ehp.124-A167
   Singapore Zika Study Group, 2017, LANCET INFECT DIS
   WHO, 2017, ZIK SIT REP ZIK VIR
   Wikan N, 2017, ASIAN PAC J TROP MED, V10, P1, DOI 10.1016/j.apjtm.2016.11.013
NR 13
TC 5
Z9 5
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD AUG
PY 2017
VL 17
IS 8
BP 782
EP 783
DI 10.1016/S1473-3099(17)30251-7
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA FB0TC
UT WOS:000405856500003
PM 28527891
OA Bronze
DA 2020-07-08
ER

PT J
AU Okere, AU
   Onyechi, KCN
   Eseadi, C
AF Okere, Anthony Ukachukwu
   Onyechi, Kay Chinonyelum Nwamaka
   Eseadi, Chiedu
TI Combating Zika virus through health counseling interventions
SO JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION
LA English
DT Article
DE Zika virus; Health counseling; Interventions; Commit and ACT; Prosocial
   counseling
ID INFECTION; CELLS; MODEL
AB Previous research efforts on Zika virus (ZikV) appear to have only focused on biomedical interventions for the patients without realizing that their culture of silence to the psychological aspect is highly reprehensible. The role and importance of health counseling cannot be overemphasized given how it helped in the fight against the Ebola virus disease. It is possible that mental health counselors and clinical psychologists around the world, Nigeria, and Pakistan can provide health counseling intervention that is culturally acceptable, effective and instrumental in tackling ZikV, its spread, and the horrific psychological impacts of the disease. Research is needed to understand the relevance and effectiveness of health counseling interventions in the Zika context.
C1 [Okere, Anthony Ukachukwu; Onyechi, Kay Chinonyelum Nwamaka; Eseadi, Chiedu] Univ Nigeria, Dept Educ Fdn, Guidance & Counseling Unit, Nsukka, Enugu State, Nigeria.
RP Eseadi, C (corresponding author), Univ Nigeria, Dept Educ Fdn, Guidance & Counseling Unit, Nsukka, Enugu State, Nigeria.
EM chiedu.eseadi@unn.edu.ng
RI Chiedu, Eseadi/J-3078-2015
OI Chiedu, Eseadi/0000-0003-1711-7558
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Aman MJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004702
   [Anonymous], 2016, REC TOOLK SUPP COUNT
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   British Psychological Society, 2014, COMM ACT EB
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   European Centre for Disease Control and Prevention, 2014, INF PREV CONTR MEAS
   Goodnough LT, 2017, ANESTH ANALG, V124, P282, DOI [10.1213/ANE.0000000000001770, 10.1213/ane.0000000000001770]
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Hercik K, 2017, ANTIVIR RES, V137, P131, DOI 10.1016/j.antiviral.2016.11.020
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Quanquin N, 2017, CURR OPIN PEDIATR, V29, P114, DOI 10.1097/MOP.0000000000000441
   Quebec Nosocomial Infection Committee, 2014, EB VIR DIS PREV CONT
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   WHO, 2016, BRIEF ZIK VIR
   Zhang GM, 2016, J GEN VIROL, V97, P3427, DOI 10.1099/jgv.0.000653
NR 24
TC 0
Z9 0
U1 0
U2 6
PU PAKISTAN MEDICAL ASSOC
PI KARACHI
PA PMA HOUSE, AGA KHAN III RD, KARACHI, 00000, PAKISTAN
SN 0030-9982
J9 J PAK MED ASSOC
JI J. Pak. Med. Assoc.
PD AUG
PY 2017
VL 67
IS 8
BP 1262
EP 1265
PG 4
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA FB1ZR
UT WOS:000405943300023
PM 28839316
DA 2020-07-08
ER

PT J
AU Rahman, SU
   Mao, YH
   Tao, SH
AF Rahman, Siddiq Ur
   Mao, Yuanhui
   Tao, Shiheng
TI Codon usage bias and evolutionary analyses of Zika virus genomes
SO GENES & GENOMICS
LA English
DT Article
DE Zika virus; Flaviviridae; Aedes aegypti; Codon usage bias; Evolution
ID DETAILED COMPARATIVE-ANALYSIS; NUCLEOTIDE COMPOSITION; ADAPTATION;
   SELECTION; PATTERNS; HOST; DEOPTIMIZATION; OUTBREAK; DENGUE
AB Zika virus (ZIKV) is a member of the family Flaviviridae and contains a single-stranded RNA genome with positive-polarity. Like Dengue, Zika virus uses Aedes aegypti mosquito as a vector to infect human with a wide range of clinical signs, from asymptomatic to influenza-like syndrome. Despite significant progress in genomic analyses, how a viral relationship with two different hosts affect the overall fitness, constancy, and dodging of hosts immune system are elusive. Here we analyzed Zika virus codon-based evolution using eleven strains from different geographical locations. The overall codon usage was similar and slightly bias among all strains. An occurrence of A-ending in highly-preferred codons and analysis by various approaches strongly suggests that mutational bias is the main force shaping codon usage in this virus. However, natural selection and geographical realities cannot be ignored in marginal influence on codon usage. The viral genomes naturally favor Aedes aegypti over human host for tRNA pool in translation. Such findings will assist researchers in understanding elements contribute to viral adaptation and evolutionary setup with hosts.
C1 [Rahman, Siddiq Ur; Mao, Yuanhui; Tao, Shiheng] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.
   [Rahman, Siddiq Ur; Mao, Yuanhui; Tao, Shiheng] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.
   [Rahman, Siddiq Ur; Mao, Yuanhui; Tao, Shiheng] Northwest A&F Univ, Bioinformat Ctr, Yangling, Shaanxi, Peoples R China.
RP Tao, SH (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.; Tao, SH (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.; Tao, SH (corresponding author), Northwest A&F Univ, Bioinformat Ctr, Yangling, Shaanxi, Peoples R China.
EM shihengt@nwsuaf.edu.cn
RI Rahman, Siddiq Ur/AAP-1706-2020
CR Ai JW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.42
   Aragones L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000797
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Burns CC, 2006, J VIROL, V80, P3259, DOI 10.1128/JVI.80.7.3259-3272.2006
   Butt AM, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.106
   Butt AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090905
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787
   Chaney JL, 2015, ANNU REV BIOPHYS, V44, P143, DOI 10.1146/annurev-biophys-060414-034333
   Comeron JM, 1998, J MOL EVOL, V47, P268, DOI 10.1007/PL00006384
   Cristina J, 2016, VIRUS RES, V223, P147, DOI 10.1016/j.virusres.2016.06.022
   Cristina J, 2015, VIRUS RES, V196, P87, DOI 10.1016/j.virusres.2014.11.005
   Das B, 2013, INFECT GENET EVOL, V16, P401, DOI 10.1016/j.meegid.2013.03.016
   Dieng H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011790
   Goni N, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-263
   Hu CY, 2014, GENE, V545, P5, DOI 10.1016/j.gene.2014.05.018
   Hu JS, 2011, INFECT GENET EVOL, V11, P2098, DOI 10.1016/j.meegid.2011.08.025
   Costafreda MI, 2014, J VIROL, V88, P5029, DOI 10.1128/JVI.00087-14
   Jenkins GM, 2003, VIRUS RES, V92, P1, DOI 10.1016/S0168-1702(02)00309-X
   Kattoor JJ, 2015, INFECT GENET EVOL, V34, P17, DOI 10.1016/j.meegid.2015.06.018
   Kumar N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154376
   Lara-Ramirez EE, 2014, BIOMED RES INT, DOI 10.1155/2014/851425
   Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI 10.1093/nar/gkr201
   Ma MR, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-544
   Moratorio G, 2013, INFECT GENET EVOL, V14, P396, DOI 10.1016/j.meegid.2013.01.001
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Mueller S, 2006, J VIROL, V80, P9687, DOI 10.1128/JVI.00738-06
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nakamura Y, 1999, NUCLEIC ACIDS RES, V27, P292, DOI 10.1093/nar/27.1.292
   Nasrullah I, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0456-4
   Novembre JA, 2002, MOL BIOL EVOL, V19, P1390, DOI 10.1093/oxfordjournals.molbev.a004201
   Martins VEP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041386
   Puigbo P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-65
   Puigbo P, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-38
   Quax TEF, 2015, MOL CELL, V59, P149, DOI 10.1016/j.molcel.2015.05.035
   RoyChoudhury S, 2010, VIRUS RES, V148, P31, DOI 10.1016/j.virusres.2009.11.018
   Russell PK, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004589
   Schubert AM, 2010, INFECT GENET EVOL, V10, P129, DOI 10.1016/j.meegid.2009.11.004
   Serres-Giardi L, 2012, PLANT CELL, V24, P1379, DOI 10.1105/tpc.111.093674
   Sharp PM, 2010, PHILOS T R SOC B, V365, P1203, DOI 10.1098/rstb.2009.0305
   SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P7737, DOI 10.1093/nar/14.19.7737
   Shen WL, 2015, BIOINFORMATICS, V31, P3081, DOI 10.1093/bioinformatics/btv329
   Singh NK, 2016, VIRUS RES, V221, P58, DOI 10.1016/j.virusres.2016.05.008
   Tao P, 2009, VIRUS GENES, V38, P104, DOI 10.1007/s11262-008-0296-z
   Tatarinova TV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-308
   Valencia A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151001
   van Hemert F, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0551-1
   van Weringh A, 2011, MOL BIOL EVOL, V28, P1827, DOI 10.1093/molbev/msr005
   Wang M, 2011, VIRUS GENES, V42, P245, DOI 10.1007/s11262-011-0574-z
   Weaver SC, 2006, CURR TOP MICROBIOL, V299, P285
   Wong EHM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-253
   WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9
   Wu YQ, 2015, GENES-BASEL, V6, P1125, DOI 10.3390/genes6041125
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhou JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077239
   Zhou JH, 2012, VIRUS GENES, V44, P475, DOI 10.1007/s11262-012-0731-z
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 59
TC 3
Z9 3
U1 3
U2 20
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1976-9571
EI 2092-9293
J9 GENES GENOM
JI Genes Genom.
PD AUG
PY 2017
VL 39
IS 8
BP 855
EP 866
DI 10.1007/s13258-017-0549-0
PG 12
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA FB5AW
UT WOS:000406154800004
DA 2020-07-08
ER

PT J
AU Heck, E
   Cavanagh, HD
   Robertson, DM
AF Heck, E.
   Cavanagh, H. D.
   Robertson, D. M.
TI Zika Virus RNA in an Asymptomatic Donor's Vitreous: Risk of
   Transmission?
SO AMERICAN JOURNAL OF TRANSPLANTATION
LA English
DT Letter
ID INFECTION
C1 [Heck, E.; Cavanagh, H. D.; Robertson, D. M.] Univ Texas Southwestern Med Ctr Dallas, Dept Ophthalmol, Dallas, TX 75390 USA.
RP Robertson, DM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Ophthalmol, Dallas, TX 75390 USA.
EM danielle.robertson@utsouthwestern.edu
CR Couderc T, 2012, J INFECT DIS, V206, P851, DOI 10.1093/infdis/jis296
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
NR 5
TC 5
Z9 5
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1600-6135
EI 1600-6143
J9 AM J TRANSPLANT
JI Am. J. Transplant.
PD AUG
PY 2017
VL 17
IS 8
BP 2227
EP 2228
DI 10.1111/ajt.14334
PG 2
WC Surgery; Transplantation
SC Surgery; Transplantation
GA FB0JY
UT WOS:000405832600034
PM 28452113
OA Bronze
DA 2020-07-08
ER

PT J
AU Krow-Lucal, ER
   Novosad, SA
   Dunn, AC
   Brent, CR
   Savage, HM
   Faraji, A
   Peterson, D
   Dibbs, A
   Vietor, B
   Christensen, K
   Laven, JJ
   Godsey, MS
   Christensen, B
   Beyer, B
   Cortese, MM
   Johnson, NC
   Panella, AJ
   Biggerstaff, BJ
   Rubin, M
   Fridkin, SK
   Staples, JE
   Nakashima, AK
AF Krow-Lucal, Elisabeth R.
   Novosad, Shannon A.
   Dunn, Angela C.
   Brent, Carolyn R.
   Savage, Harry M.
   Faraji, Ary
   Peterson, Dallin
   Dibbs, Andrew
   Vietor, Brook
   Christensen, Kimberly
   Laven, Janeen J.
   Godsey, Marvin S., Jr.
   Christensen, Bryan
   Beyer, Brigette
   Cortese, Margaret M.
   Johnson, Nina C.
   Panella, Amanda J.
   Biggerstaff, Brad J.
   Rubin, Michael
   Fridkin, Scott K.
   Staples, J. Erin
   Nakashima, Allyn K.
TI Zika Virus Infection in Patient with No Known Risk Factors, Utah, USA,
   2016
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID UNITED-STATES; TRANSMISSION; AEGYPTI
AB In 2016, Zika virus disease developed in a man (patient A) who had no known risk factors beyond caring for a relative who died of this disease (index patient). We investigated the source of infection for patient A by surveying other family contacts, healthcare personnel, and community members, and testing samples for Zika virus. We identified 19 family contacts who had similar exposures to the index patient; 86 healthcare personnel had contact with the index patient, including 57 (66%) who had contact with body fluids. Of 218 community members interviewed, 28 (13%) reported signs/symptoms and 132 (61%) provided a sample. Except for patient A, no other persons tested had laboratory evidence of recent Zika virus infection. Of 5,875 mosquitoes collected, none were known vectors of Zika virus and all were negative for Zika virus. The mechanism of transmission to patient A remains unknown but was likely person-to-person contact with the index patient.
C1 [Krow-Lucal, Elisabeth R.; Novosad, Shannon A.; Brent, Carolyn R.; Christensen, Bryan; Cortese, Margaret M.; Johnson, Nina C.; Fridkin, Scott K.] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Krow-Lucal, Elisabeth R.] Ctr Dis Control & Prevent, Arboviral Dis Branch, Div Vector Borne Dis, Ctr Zoonot & Emerging Infect Dis, Ft Collins, CO USA.
   [Savage, Harry M.; Laven, Janeen J.; Godsey, Marvin S., Jr.; Panella, Amanda J.; Biggerstaff, Brad J.; Staples, J. Erin] Ctr Dis Control & Prevent, 3156 Rampart Rd,Mailstop P02, Ft Collins, CO 80521 USA.
   [Dunn, Angela C.; Peterson, Dallin; Christensen, Kimberly; Nakashima, Allyn K.] Utah Dept Hlth, Salt Lake City, UT 84116 USA.
   [Brent, Carolyn R.; Dibbs, Andrew] Salt Lake Cty Hlth Dept, Salt Lake City, UT USA.
   [Faraji, Ary] Salt Lake City Mosquito Abatement Dist, Salt Lake City, UT USA.
   [Vietor, Brook; Beyer, Brigette; Rubin, Michael] Univ Utah, Salt Lake City, UT USA.
RP Staples, JE (corresponding author), Ctr Dis Control & Prevent, 3156 Rampart Rd,Mailstop P02, Ft Collins, CO 80521 USA.
EM estaples@cdc.gov
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brent C, 2016, MMWR-MORBID MORTAL W, V65, P981, DOI 10.15585/mmwr.mm6536e4
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Centers for Disease Control and Prevention, 2016, DIAGN TESTS ZIK VIR
   Centers for Disease Control and Prevention, 2016, GUID US LAB TEST ZIK
   Centers for Disease Control and Prevention, 2016, HEALTHC EXP ZIK INF
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Federal Register, 2016, FED REG, V87, P67862
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Hahn MB, 2016, J MED ENTOMOL, V53, P1169, DOI 10.1093/jme/tjw072
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LENNETTE E, 1995, DIAGNOSTIC PROCEDURE
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   SCHERER WF, 1980, AM J TROP MED HYG, V29, P1359
   Siegel JD, 2007, 2007 GUIDELINE ISOLA
   Sun JF, 2016, JAMA OPHTHALMOL, V134, P1330, DOI 10.1001/jamaophthalmol.2016.3417
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
NR 27
TC 4
Z9 4
U1 0
U2 7
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD AUG
PY 2017
VL 23
IS 8
BP 1260
EP 1267
DI 10.3201/eid2308.170479
PG 8
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA FA8CG
UT WOS:000405673200004
PM 28726601
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Brooks, T
   Roy-Burman, A
   Tuholske, C
   Busch, MP
   Bakkour, S
   Stone, M
   Linnen, JM
   Gao, K
   Coleman, J
   Bloch, EM
AF Brooks, Trevor
   Roy-Burman, Arup
   Tuholske, Cascade
   Busch, Michael P.
   Bakkour, Sonia
   Stone, Mars
   Linnen, Jeffrey M.
   Gao, Kui
   Coleman, Jayleen
   Bloch, Evan M.
TI Real-Time Evolution of Zika Virus Disease Outbreak, Roatan, Honduras
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
AB A Zika virus disease outbreak occurred in Roatan, Honduras, during September 2015-July 2016. Blood samples and clinical information were obtained from 183 patients given a clinical diagnosis of suspected dengue virus infection. A total of 79 patients were positive for Zika virus, 13 for chikungunya virus, and 6 for dengue virus.
C1 [Brooks, Trevor; Roy-Burman, Arup; Busch, Michael P.] Univ Calif San Francisco, Sch Med, 505 Parnassus Ave, San Francisco, CA 94143 USA.
   [Tuholske, Cascade] Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA.
   [Busch, Michael P.; Bakkour, Sonia; Stone, Mars; Bloch, Evan M.] Blood Syst Res Inst, San Francisco, CA USA.
   [Linnen, Jeffrey M.; Gao, Kui] Hologic Inc, San Diego, CA USA.
   [Coleman, Jayleen] Publ Hosp Roatan, Coxen Hole, Honduras.
   [Bloch, Evan M.] Johns Hopkins Sch Med, Baltimore, MD USA.
RP Brooks, T (corresponding author), Univ Calif San Francisco, Sch Med, 505 Parnassus Ave, San Francisco, CA 94143 USA.
EM trevor.brooks@ucsf.edu
RI Bloch, Evan/G-7676-2018
OI Bloch, Evan/0000-0001-8181-9517
FU Doris Duke International Clinical Research Fellowship; Broom Center for
   Demography; National Center for Advancing Translational SciencesUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Center for Advancing Translational
   Sciences (NCATS); National Institutes of HealthUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USA [UL1
   TR000004]
FX This study was supported by a Doris Duke International Clinical Research
   Fellowship, the Broom Center for Demography, and the National Center for
   Advancing Translational Sciences, National Institutes of Health (grant
   UL1 TR000004).
CR Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   National Statistics Institute, 2013, CENS POP HOUS 2013
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Stone M, 2017, TRANSFUSION, V57, P734, DOI 10.1111/trf.14031
   World Health Organization, 2016, ZIK SIT REP
NR 7
TC 8
Z9 8
U1 0
U2 8
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD AUG
PY 2017
VL 23
IS 8
BP 1360
EP 1363
DI 10.3201/eid2308.161944
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA FA8CG
UT WOS:000405673200017
PM 28514227
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Merino-Ramos, T
   de Oya, NJ
   Saiz, JC
   Martin-Acebes, MA
AF Merino-Ramos, Teresa
   Jimenez de Oya, Nereida
   Saiz, Juan-Carlos
   Martin-Acebes, Miguel A.
TI Antiviral Activity of Nordihydroguaiaretic Acid and Its Derivative
   Tetra-O-Methyl Nordihydroguaiaretic Acid against West Nile Virus and
   Zika Virus
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
DE West Nile virus; antiviral agents; flavivirus; lipid; Zika virus
ID HEPATITIS-C VIRUS; GENE-EXPRESSION; LIPID-SYNTHESIS; DENGUE VIRUS;
   PHASE-I; METABOLISM; REPLICATION; INHIBITION; TERAMEPROCOL; NDGA
AB Flaviviruses are positive-strand RNA viruses distributed all over the world that infect millions of people every year and for which no specific antiviral agents have been approved. These viruses include the mosquito-borne West Nile virus (WNV), which is responsible for outbreaks of meningitis and encephalitis. Considering that nordihydroguaiaretic acid (NDGA) has been previously shown to inhibit the multiplication of the related dengue virus and hepatitis C virus, we have evaluated the effect of NDGA, and its methylated derivative tetra-O-methyl nordihydroguaiaretic acid (M4N), on the infection of WNV. Both compounds inhibited the infection of WNV, likely by impairing viral replication. Since flavivirus multiplication is highly dependent on host cell lipid metabolism, the antiviral effect of NDGA has been previously related to its ability to disturb the lipid metabolism, probably by interfering with the sterol regulatory element-binding proteins (SREBP) pathway. Remarkably, we observed that other structurally unrelated inhibitors of the SREBP pathway, such as PF-429242 and fatostatin, also reduced WNV multiplication, supporting that the SREBP pathway may constitute a druggable target suitable for antiviral intervention against flavivirus infection. Moreover, treatment with NDGA, M4N, PF-429242, and fatostatin also inhibited the multiplication of the mosquito-borne flavivirus Zika virus (ZIKV), which has been recently associated with birth defects (microcephaly) and neurological disorders. Our results point to SREBP inhibitors, such as NDGA and M4N, as potential candidates for further antiviral development against medically relevant flaviviruses.
C1 [Merino-Ramos, Teresa; Jimenez de Oya, Nereida; Saiz, Juan-Carlos; Martin-Acebes, Miguel A.] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotechnol, Madrid, Spain.
RP Martin-Acebes, MA (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotechnol, Madrid, Spain.
EM martin.mangel@inia.es
RI de Oya, Nereida Jimenez/T-6449-2019; Jimenez de Oya,
   Nereida/K-8470-2016; Martin-Acebes, Miguel A./L-2258-2014
OI de Oya, Nereida Jimenez/0000-0003-3129-813X; Jimenez de Oya,
   Nereida/0000-0003-3129-813X; Martin-Acebes, Miguel
   A./0000-0001-6015-3613; Saiz, Juan-Carlos/0000-0001-8269-5544
FU "Formacion de Personal Investigador (FPI)" fellowship from INIA; 
   [RTA2013-00013-C04-2014];  [ZIKA-BIO-2016-01];  [PLATESA
   (P2013/ABI-2906)];  [RTA2015-00009];  [AGL2014-56518-JIN]
FX This work was supported by grants RTA2013-00013-C04-2014,
   ZIKA-BIO-2016-01, PLATESA (P2013/ABI-2906), and RTA2015-00009 to J.-C.S.
   and AGL2014-56518-JIN to M.A.M.-A. T.M.-R. is a recipient of a
   "Formacion de Personal Investigador (FPI)" fellowship from INIA.
CR Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Arteaga S, 2005, J ETHNOPHARMACOL, V98, P231, DOI 10.1016/j.jep.2005.02.002
   BELL RL, 1992, INT J IMMUNOPHARMACO, V14, P505, DOI 10.1016/0192-0561(92)90182-K
   BHATTACHERJEE P, 1988, ANN NY ACAD SCI, V524, P307, DOI DOI 10.1111/J.1749-6632.1988.TB38554.X
   Blanchet M, 2015, ANTIVIR RES, V115, P94, DOI 10.1016/j.antiviral.2014.12.017
   Blazquez AB, 2016, FRONT MICROBIOL, V7, DOI [10.3389/fmicb.2016.00296, 10.3389/fmicb.2010.00296]
   Blazquez Ana-Belen, 2016, World J Virol, V5, P135
   Blazquez AB, 2010, VIRUS RES, V151, P240, DOI 10.1016/j.virusres.2010.04.009
   Calland N, 2015, J VIROL, V89, P10053, DOI 10.1128/JVI.01473-15
   Chen HS, 1998, J MED CHEM, V41, P3001, DOI 10.1021/jm980182w
   Chen QQ, 2009, CURR TOP MED CHEM, V9, P1636, DOI 10.2174/156802609789941915
   Craigo J, 2000, ANTIVIR RES, V47, P19, DOI 10.1016/S0166-3542(00)00089-9
   Grossman SA, 2012, NEURO-ONCOLOGY, V14, P511, DOI 10.1093/neuonc/nor230
   Hawkins JL, 2008, J PHARMACOL EXP THER, V326, P801, DOI 10.1124/jpet.108.139626
   Hwu JR, 2008, BIOORG MED CHEM LETT, V18, P1884, DOI 10.1016/j.bmcl.2008.02.018
   Jordan TX, 2016, CURR OPIN VIROL, V19, P7, DOI 10.1016/j.coviro.2016.05.007
   Kamisuki S, 2009, CHEM BIOL, V16, P882, DOI 10.1016/j.chembiol.2009.07.007
   Khanna N, 2008, SEX TRANSM DIS, V35, P577, DOI 10.1097/OLQ.0b013e31816766af
   Kimura K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148685
   Lambert JD, 2001, J CHROMATOGR B, V754, P85, DOI 10.1016/S0378-4347(00)00592-2
   Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000
   Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333
   Lu JM, 2010, MED SCI MONITOR, V16, pRA93
   Martin-Acebes MA, 2016, PROG LIPID RES, V64, P123, DOI 10.1016/j.plipres.2016.09.005
   Martin-Acebes Miguel A, 2012, World J Virol, V1, P51, DOI 10.5501/wjv.v1.i2.51
   Martin-Acebes MA, 2014, J VIROL, V88, P12041, DOI 10.1128/JVI.02061-14
   Martin-Acebes MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024970
   Martin-Acebes MA, 2011, J GEN VIROL, V92, P831, DOI 10.1099/vir.0.027185-0
   Merino-Ramos T, 2016, ANTIMICROB AGENTS CH, V60, P307, DOI 10.1128/AAC.01578-15
   Merino-Ramos T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108056
   Muller PY, 2012, NAT REV DRUG DISCOV, V11, P751, DOI 10.1038/nrd3801
   Nour AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003585
   Park R, 2005, CLIN CANCER RES, V11, P4601, DOI 10.1158/1078-0432.CCR-04-2188
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   Petrovic T, 2013, EUROSURVEILLANCE, V18, P7, DOI 10.2807/1560-7917.ES2013.18.44.20622
   Pollara JJ, 2010, ANTIVIR RES, V88, P287, DOI 10.1016/j.antiviral.2010.09.017
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   SALARI H, 1984, PROSTA LEUKOTR MED, V13, P53, DOI 10.1016/0262-1746(84)90102-1
   Shao W, 2012, CELL METAB, V16, P414, DOI 10.1016/j.cmet.2012.09.002
   Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8
   Soto-Acosta R, 2014, ANTIVIR RES, V109, P132, DOI 10.1016/j.antiviral.2014.07.002
   Syed GH, 2011, HEPATOLOGY, V54, P1936, DOI 10.1002/hep.24619
   Uchida L, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8020046
   van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244
   Villareal VA, 2015, ANTIVIR RES, V124, P110, DOI 10.1016/j.antiviral.2015.10.013
   Wang GL, 2009, BIOCHEM BIOPH RES CO, V380, P644, DOI 10.1016/j.bbrc.2009.01.163
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
NR 47
TC 22
Z9 22
U1 0
U2 9
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD AUG
PY 2017
VL 61
IS 8
AR e00376-17
DI 10.1128/AAC.00376-17
PG 10
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA FB6NJ
UT WOS:000406259400038
PM 28507114
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Aliota, MT
   Bassit, L
   Bradrick, SS
   Cox, B
   Garcia-Blanco, MA
   Gavegnano, C
   Friedrich, TC
   Golos, TG
   Griffin, DE
   Haddow, AD
   Kallas, EG
   Kitron, U
   Lecuit, M
   Magnani, DM
   Marrs, C
   Mercer, N
   McSweegan, E
   Ng, LFP
   O'Connor, DH
   Osorio, JE
   Ribeiro, GS
   Ricciardi, M
   Rossi, SL
   Saade, G
   Schinazi, RF
   Schott-Lerner, GO
   Shan, C
   Shi, PY
   Watkins, DI
   Vasilakis, N
   Weaver, SC
AF Aliota, Matthew T.
   Bassit, Leda
   Bradrick, Shelton S.
   Cox, Bryan
   Garcia-Blanco, Mariano A.
   Gavegnano, Christina
   Friedrich, Thomas C.
   Golos, Thaddeus G.
   Griffin, Diane E.
   Haddow, Andrew D.
   Kallas, Esper G.
   Kitron, Uriel
   Lecuit, Marc
   Magnani, Diogo M.
   Marrs, Caroline
   Mercer, Natalia
   McSweegan, Edward
   Ng, Lisa F. P.
   O'Connor, David H.
   Osorio, Jorge E.
   Ribeiro, Guilherme S.
   Ricciardi, Michael
   Rossi, Shannan L.
   Saade, George
   Schinazi, Raymond F.
   Schott-Lerner, Geraldine O.
   Shan, Chao
   Shi, Pei-Yong
   Watkins, David I.
   Vasilakis, Nikos
   Weaver, Scott C.
TI Zika in the Americas, year 2: What have we learned? What gaps remain? A
   report from the Global Virus Network
SO ANTIVIRAL RESEARCH
LA English
DT Review
DE Zika virus; Arbovirus; Congenital manifestations; Maternal-fetal
   transmission; Antiviral therapy; Vaccines
ID GUILLAIN-BARRE-SYNDROME; MALE SEXUAL TRANSMISSION; UNITED-STATES; CELL
   TROPISM; PROLONGED DETECTION; NEURAL PROGENITORS; CEREBRAL ORGANOIDS;
   BORNE TRANSMISSION; INTERIM GUIDANCE; REPRODUCTIVE AGE
AB In response to the outbreak of Zika virus (ZIKV) infection in the Western Hemisphere and the recognition of a causal association with fetal malformations, the Global Virus Network (GVN) assembled an international taskforce of virologists to promote basic research, recommend public health measures and encourage the rapid development of vaccines, antiviral therapies and new diagnostic tests. In this article, taskforce members and other experts review what has been learned about ZIKV-induced disease in humans, its modes of transmission and the cause and nature of associated congenital manifestations. After describing the make-up of the taskforce, we summarize the emergence of ZIKV in the Americas, Africa and Asia, its spread by mosquitoes, and current control measures. We then review the spectrum of primary ZIKV-induced disease in adults and children, sites of persistent infection and sexual transmission, then examine what has been learned about maternal-fetal transmission and the congenital Zika syndrome, including knowledge obtained from studies in laboratory animals. Subsequent sections focus on vaccine development, antiviral therapeutics and new diagnostic tests. After reviewing current understanding of the mechanisms of emergence of Zika virus, we consider the likely future of the pandemic. (C) 2017 Published by Elsevier B.V.
C1 [Griffin, Diane E.; Haddow, Andrew D.; Kallas, Esper G.; Lecuit, Marc; Mercer, Natalia; McSweegan, Edward; Ng, Lisa F. P.; Osorio, Jorge E.; Schinazi, Raymond F.; Watkins, David I.; Weaver, Scott C.] Global Virus Network, 725 West Lombard St, Baltimore, MD 21201 USA.
   [Aliota, Matthew T.; Friedrich, Thomas C.; Osorio, Jorge E.] Univ Wisconsin Madison, Dept Pathobiol Sci, Madison, WI 53706 USA.
   [Bassit, Leda; Cox, Bryan; Gavegnano, Christina; Schinazi, Raymond F.] Emory Univ, Ctr AIDS Res, Sch Med, Dept Pediat, Atlanta, GA 30322 USA.
   [Bradrick, Shelton S.; Garcia-Blanco, Mariano A.; Schott-Lerner, Geraldine O.; Shan, Chao; Shi, Pei-Yong] Univ Texas Med Branch, Inst Human Infect & Immun, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Friedrich, Thomas C.; Golos, Thaddeus G.; O'Connor, David H.] Univ Wisconsin Madison, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA.
   [Golos, Thaddeus G.] Univ Wisconsin Madison, Dept Comparat Biosci, Madison, WI 53706 USA.
   [Golos, Thaddeus G.] Univ Wisconsin Madison, Dept Obstet & Gynecol, Madison, NJ 53706 USA.
   [Griffin, Diane E.] Johns Hopkins Bloomberg Sch Publ Hlth, Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.
   [Haddow, Andrew D.] US Army, Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA.
   [Kallas, Esper G.] Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, Sao Paulo, Brazil.
   [Kitron, Uriel] Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA.
   [Lecuit, Marc] Inst Pasteur, Biol Infect Unit, Paris, France.
   [Lecuit, Marc] INSERM, Unit 1117, Paris, France.
   [Lecuit, Marc] Paris Descartes Univ, Necker Enfants Malades Univ Hosp, Inst Imagine, Sorbonne Paris Cite,Div Infect Dis & Trop Med, Paris, France.
   [Magnani, Diogo M.; Ricciardi, Michael; Watkins, David I.] Univ Miami, Dept Pathol, Miami, FL 33101 USA.
   [Marrs, Caroline; Saade, George] Univ Texas Med Branch, Dept Obstet & Gynecol, Galveston, TX 77555 USA.
   [Ng, Lisa F. P.] ASTAR, Singapore Immunol Network, Singapore, Singapore.
   [O'Connor, David H.] Univ Wisconsin Madison, Dept Pathol & Lab Med, Madison, WI 53706 USA.
   [Ribeiro, Guilherme S.] Univ Fed Bahia, Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Ribeiro, Guilherme S.] Univ Fed Bahia, Inst Sailde Colet, Salvador, BA, Brazil.
   [Rossi, Shannan L.; Weaver, Scott C.] Univ Texas Med Branch, Inst Human Infect & Immun, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Vasilakis, Nikos] Univ Texas Med Branch, Inst Human Infect & Immun, Dept Pathol, Galveston, TX 77555 USA.
RP Weaver, SC (corresponding author), Global Virus Network, 725 West Lombard St, Baltimore, MD 21201 USA.; Weaver, SC (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
EM sweaver@utmb.edu
RI Haddow, Andrew D/C-5902-2008; Ribeiro, Guilherme/B-6624-2008; Lecuit,
   Marc/J-4073-2013; Lecuit, Marc/M-4126-2019
OI Haddow, Andrew D/0000-0002-8957-2608; Ribeiro,
   Guilherme/0000-0002-6798-2059; Lecuit, Marc/0000-0002-4491-1063; Lecuit,
   Marc/0000-0002-4491-1063; Garcia-Blanco, Mariano/0000-0001-8538-1997;
   Magnani, Diogo/0000-0002-1773-2406; Ng, Lisa/0000-0003-4071-5222;
   Kallas, Esper/0000-0003-2026-6925; Aliota, Matthew/0000-0002-6902-9149
FU U.S. National Institutes of HealthUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R01NS087539-S1,
   R21AI129607, R24AI120942, R01A1121452, R01 AI07157-01A1,
   R01AI116382-01A1S1, U01AI115577, P51 OD011106]
FX Work from the authors' laboratories was funded by in part by U.S.
   National Institutes of Health grants: R01NS087539-S1 (to DEG),
   R21AI129607 (to RFS), and R24AI120942, R01A1121452 (to SCW) R01
   AI07157-01A1 (to TGG), R01AI116382-01A1S1 (to DHO), U01AI115577 (to NV)
   and P51 OD011106 (to the WNPRC).
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Ali S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005135
   Aliota M. T., 2016, PLOS NEGLECT TROP D, V10, DOI DOI 10.1371/JOURNAL.PNTD.0004750
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   Amraoui F, 2016, EURO SURVEILL, V21
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P537, DOI 10.1590/0037-8682-0328-2016
   de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P553, DOI 10.1590/0037-8682-0245-2016
   Azmi SA, 2015, J VECTOR DIS, V52, P252
   Barba-Spaeth G, 2016, NATURE, V539, DOI 10.1038/nature19780
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   BEARCROFT WGC, 1957, J PATHOL BACTERIOL, V74, P295, DOI 10.1002/path.1700740207
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Besnard M, 2014, EURO SURVEILL, V19
   Boccolini D, 2016, EURO SURVEILL, V21
   Bondarenko GI, 2007, J IMMUNOL, V179, P8042, DOI 10.4049/jimmunol.179.12.8042
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Buechler CR, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00392-16
   BULMER JN, 1984, CLIN EXP IMMUNOL, V57, P393
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carter AM, 2011, BEST PRACT RES CL OB, V25, P249, DOI 10.1016/j.bpobgyn.2010.10.010
   Cavalcanti MG, 2017, INT J INFECT DIS, V57, P70, DOI 10.1016/j.ijid.2017.01.042
   Chen JC, 2016, INT J INFECT DIS, V51, P139, DOI 10.1016/j.ijid.2016.07.015
   Cheng FX, 2016, TRENDS MOL MED, V22, P919, DOI 10.1016/j.molmed.2016.09.006
   Chimelli L, 2017, ACTA NEUROPATHOL
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Chua A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005269
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P47
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P149
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Cox Bryan D., 2015, Antiviral Chemistry & Chemotherapy, V24, P118, DOI 10.1177/2040206616653873
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   Cunha M. S., 2016, GENOME ANNOUNC, V4
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Daffis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000607
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Carvalho GC, 2014, J VECTOR ECOL, V39, P146, DOI 10.1111/j.1948-7134.2014.12081.x
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   DRAPER C C, 1965, West Afr Med J, V14, P16
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Duong V, 2017, EMERG INFECT DIS, V23, P296, DOI 10.3201/eid2302.161432
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Enders AC, 2007, PLACENTA, V28, P794, DOI 10.1016/j.placenta.2006.11.001
   Enders AC, 2001, PLACENTA, V22, P284, DOI 10.1053/plac.2001.0626
   EYROLLEGUIGNOT D, 2016, LANCET, V387, P2125, DOI DOI 10.1016/50140-6736(16)00651-6.PUBMED
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   FDA, 2017, ZIK VIR EM US AUTH
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Fields B. N., 2007, FIELDS VIROLOGY
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Galel SA, 2017, TRANSFUSION
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gavegnano Christina, 2017, Pathog Immun, V2, P199, DOI 10.20411/pai.v2i2.190
   Godoy AS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14764
   Goebel S, 2016, J VIROL METHODS, V238, P13, DOI 10.1016/j.jviromet.2016.09.015
   Golos TG, 2010, INT J DEV BIOL, V54, P431, DOI 10.1387/ijdb.082797tg
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guerbois M., 2016, J INFECT DIS
   Gulland A, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4812
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Guo XX, 2014, J AM MOSQUITO CONTR, V30, P309, DOI 10.2987/14-6439R.1
   Haddow A. D., 2017, EMERG INFECT DIS
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005083
   Haddow AD, 2016, B WORLD HEALTH ORGAN, V94, P711, DOI 10.2471/BLT.16.181503
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842
   Hanley K. A., 2013, INFECT GENET EVOL J
   Hanley Kathryn A., 2017, AM TROP MED HYG
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Herrera B. B., 2017, J INFECT DIS
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Katz LM, 2017, ARCH PATHOL LAB MED, V141, P85, DOI 10.5858/arpa.2016-0430-RA
   Kincaid E, 2016, NAT MED, V22, P824, DOI 10.1038/nm0816-824
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Li Y, 2017, CELL STEM CELL, V20, P385, DOI 10.1016/j.stem.2016.11.017
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Liu Y., 2017, NATURE
   Louis GMB, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.08.032
   Lozier M, 2016, MMWR-MORBID MORTAL W, V65, P1219, DOI 10.15585/mmwr.mm6544a4
   Ma WQ, 2017, CELL, V168, P542, DOI 10.1016/j.cell.2017.01.009
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Magnani D. M., 2017, PLOS NEGLEC IN PRESS
   Makhluf H, 2016, EXPERT OPIN DRUG DIS, V11, P921, DOI 10.1080/17460441.2016.1212013
   Mann A, 2011, NAT MED, V17, P394, DOI 10.1038/nm0411-394a
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Maurer-Stroh S., 2016, EURO SURVEILL, V21
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Molaei G, 2007, AM J TROP MED HYG, V77, P73
   Moreira J., 2017, CLIN MICROBIOL INFEC
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Muller W.J., 2016, JAMA
   Munoz-Jordan JL, 2010, VIRUSES-BASEL, V2, P676, DOI 10.3390/v2020676
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D., 2014, EURO SURVEILL, V19
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Nicastri E., 2016, EURO SURVEILL, V21
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Olson KE, 2016, ARBOVIRUSES: MOLECULAR BIOLOGY, EVOLUTION AND CONTROL, P315
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pacheco O, 2016, N ENGL J MED
   Pagani I, 2017, SCI REP-UK, V7, DOI 10.1038/srep44286
   PAHO, 2017, REG ZIK EP UPD AM 10
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Pardi N., 2017, NATURE
   Parke DW, 2016, OPHTHALMOLOGY, V123, P2432, DOI 10.1016/j.ophtha.2016.06.039
   Paz-Bailey G, 2017, N ENGL J MED
   Perkins TA, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.51
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen L.R., 2016, N ENGL J MED
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Ragan IK, 2017, VECTOR-BORNE ZOONOT, V17, P161, DOI 10.1089/vbz.2016.2099
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Richner JM, 2017, CELL
   Ritchie S, 2016, ARBOVIRUSES: MOLECULAR BIOLOGY, EVOLUTION AND CONTROL, P281
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Salchuddin AR, 2017, ASIAN PAC J TROP MED, V10, P201, DOI 10.1016/j.apjtm.2017.03.002
   Salje H, 2016, J INFECT DIS, V213, P604, DOI 10.1093/infdis/jiv470
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shan C, 2017, EBIOMEDICINE, V17, P157, DOI 10.1016/j.ebiom.2017.03.006
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Simoni MK, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12613
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMFM, 2015, AM J OBSTET GYNECOL
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Speer SD, 2016, SCIENCE, V353, P750, DOI 10.1126/science.aah6187
   Steinhagen K., 2015, EUROSURVEILLANCE, V2016, P21, DOI DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Stettler K., 2016, SCIENCE
   Strafela P, 2017, ARCH PATHOL LAB MED, V141, P73, DOI 10.5858/arpa.2016-0341-SA
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007
   Vasquez AM, 2016, MMWR-MORBID MORTAL W, V65, P375, DOI 10.15585/mmwr.mm6514e1
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Villar J, 2013, BJOG-INT J OBSTET GY, V120, P9, DOI 10.1111/1471-0528.12047
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Walker T, 2016, ARBOVIRUSES: MOLECULAR BIOLOGY, EVOLUTION AND CONTROL, P291
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Weisblum Y, 2017, J VIROL, V91, DOI [10.1128/jvi.01905-16, 10.1128/JVI.01905-16]
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   WHO, 2016, INT GUID UPD PREGN M
   WHO, 2016, ZIK SIT REP 6 OCT 20
   WHO, 2017, GUID INF FEED AR ZIK
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   Wildman DE, 2006, P NATL ACAD SCI USA, V103, P3203, DOI 10.1073/pnas.0511344103
   Williamson P. C., 2017, TRANSFUSION
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yang YJ, 2017, EBIOMEDICINE, V17, P145, DOI 10.1016/j.ebiom.2017.02.003
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zambrano H, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12630
   Zhang B., 2017, NAT MED
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 260
TC 54
Z9 54
U1 4
U2 35
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD AUG
PY 2017
VL 144
BP 223
EP 246
DI 10.1016/j.antiviral.2017.06.001
PG 24
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA FD3DH
UT WOS:000407413200023
PM 28595824
OA Green Accepted
DA 2020-07-08
ER

PT J
AU de Magalhaes-Barbosa, MC
   Prata-Barbosa, A
   Robaina, JR
   Raymundo, CE
   Lima-Setta, F
   da Cunha, AJLA
AF de Magalhaes-Barbosa, Maria Clara
   Prata-Barbosa, Arnaldo
   Robaina, Jaqueline Rodrigues
   Raymundo, Carlos Eduardo
   Lima-Setta, Fernanda
   Ledo Alves da Cunha, Antonio Jose
TI Prevalence of microcephaly in eight south-eastern and midwestern
   Brazilian neonatal intensive care units: 2011-2015
SO ARCHIVES OF DISEASE IN CHILDHOOD
LA English
DT Article
AB Objective To describe the prevalence of microcephaly in infants admitted to the neonatal intensive care units (NICUs) in eight private hospitals in south-eastern and midwestern Brazil, from 2011 to 2015.
   Design Observational, cross-sectional study in a cohort of neonates.
   Setting Eight private NICUs situated in the cities of Rio de Janeiro (RJ), Sao Paulo (SP) and Federal District of Brasilia (FDB).
   Patients Neonates up to 7 days of age and > 23 weeks of gestational age.
   Main outcome measures Primary outcomes were the annual prevalence of microcephaly and severe microcephaly, both overall and in subgroups according to gestational age, type of microcephaly (proportional or disproportional) and the NICU's location in RJ, SP or FDB.
   Results In this cohort of 8275 neonates admitted to eight private NICUs, the overall prevalence of microcephaly was 5.6% (95% CI 5.1% to 6.1%) and severe microcephaly, 1.5% (95% CI 1.2% to 1.7%). There was no annual variation in these overall estimates (p=0.48 and p=0.99, respectively), nor in the studied subgroups. Microcephaly prevalence was higher in extremely premature and term newborns (7.7% and 7.2%; p<0.001, respectively). Disproportional microcephaly was much more common than proportional microcephaly (prevalence 5.0% vs 0.6%; p<0.001).
   Conclusions The prevalence of microcephaly showed little variation from 2011 to 2015 in these south-eastern and midwestern Brazilian NICUs, suggesting that the impact of the Zika epidemic in neonates that occurred mainly in the north-eastern region in 2015 did not yet affect the infants of those regions during the studied period. These prevalence results can serve as a reference for comparisons with any future Zika outbreaks in the same or similar populations from these regions.
C1 [de Magalhaes-Barbosa, Maria Clara; Prata-Barbosa, Arnaldo; Robaina, Jaqueline Rodrigues; Raymundo, Carlos Eduardo; Lima-Setta, Fernanda] Inst DOr Pesquisa & Ensino IDOR, Rua Diniz Cordeiro 30, BR-22281100 Rio De Janeiro, RJ, Brazil.
   [Prata-Barbosa, Arnaldo] Univ Fed Rio de Janeiro, Inst Puericultura & Pediat Martagao Gesteira, Rio De Janeiro, RJ, Brazil.
   [Lima-Setta, Fernanda] Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Rio De Janeiro, RJ, Brazil.
   [Ledo Alves da Cunha, Antonio Jose] Univ Fed Rio de Janeiro, Fac Med, Rio De Janeiro, RJ, Brazil.
RP de Magalhaes-Barbosa, MC (corresponding author), Inst DOr Pesquisa & Ensino IDOR, Rua Diniz Cordeiro 30, BR-22281100 Rio De Janeiro, RJ, Brazil.
EM mariaclaramb@globo.com
RI da Cunha, Antonio Jose Ledo Alves/O-5914-2019; Prata-Barbosa,
   Arnaldo/B-2212-2009
OI da Cunha, Antonio Jose Ledo Alves/0000-0003-3592-1849; Prata-Barbosa,
   Arnaldo/0000-0002-4726-9782; de Magalhaes-Barbosa, Maria
   Clara/0000-0003-0959-0775
CR Brasil. Ministerio da Saude. Agencia Saude. Microcefalia. Ministerio da Saude divulga boletim epidemiologico, 2015, MICR MIN HLTH PUBL E
   Brasil. Ministerio da Saude. Centro de Operacoes de Emergencias em Saude Publica sobre Microcefalias. Monitoramento de Casos de Microcefalia no Brasil, 2016, 012015 MIN SAUD CTR
   Brasil. Ministerio da Saude. Centro de Operacoes de Emergencias em Saude Publica sobre Microcefalias. Monitoramento de Casos de Microcefalia no Brasil, 2016, 372016 MIN SAUD CTR
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2016, MIN SAUD SECR VIG SA
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cunha AJLA, 2016, EVOLUTION CASES MICR
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-92
   Longo S, 2014, EARLY HUM DEV, V90, pS42, DOI 10.1016/S0378-3782(14)70014-3
   Ministerio da Saude (BR). Departamento de Informatica do SUS (BR), 2014, EST VIT
   Ministerio da Saude (Brazil), 2016, PROT VIG RESP OC MIC
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rocha HAL, 2016, B WHO
   Soares de Araujo JS, 2016, B WHO
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   WHO, 2016, WHO STAT 2 M IHR EM
   World Health Organization, CHILD GROWTH STAND H
   World Health Organization. Centers for Disease Control and Prevention, 2014, INT CLEAR BIRTH DEF
NR 19
TC 2
Z9 2
U1 0
U2 2
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0003-9888
EI 1468-2044
J9 ARCH DIS CHILD
JI Arch. Dis. Child.
PD AUG
PY 2017
VL 102
IS 8
BP 728
EP 734
DI 10.1136/archdischild-2016-311541
PG 7
WC Pediatrics
SC Pediatrics
GA FB0TX
UT WOS:000405858700009
PM 28302630
DA 2020-07-08
ER

PT J
AU Wiwanitkit, S
   Wiwanitkit, V
AF Wiwanitkit, Somsri
   Wiwanitkit, Viroj
TI Cleft analysis of Zika virus non-structural protein 1
SO ASIAN PACIFIC JOURNAL OF TROPICAL BIOMEDICINE
LA English
DT Article
AB The non-structural protein 1 is an important molecule of the viruses in flavivirus group including to Zika virus. Recently, the NS1 of Zika virus was discovered. There is still no complete information of the molecular interaction of NS1 of Zika virus which can be the clue for explanation for its pathogenesis and further drug search. Here the authors report the cleft analysis of NS1 of Zika virus and the result can be useful for future development of good diagnostic tool and antiviral drug finding for management of Zika virus.
C1 [Wiwanitkit, Somsri] Wiwanitkit House, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Wiwanitkit, S (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM somsriwiwan@hotmail.com
CR Chen Yue, 2014, Bing Du Xue Bao, V30, P683
   Cox BD, 2016, ANTIVIR CHEM CHEMOTH
   GIBSON CA, 1988, VACCINE, V6, P7, DOI 10.1016/0264-410X(88)90004-7
   Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414
   Pikora M, 2015, ACTA BIOCHIM POL, V62, P629, DOI 10.18388/abp.2015_972
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
NR 6
TC 0
Z9 0
U1 0
U2 0
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 2221-1691
EI 2588-9222
J9 ASIAN PAC J TROP BIO
JI Asian Pac. Trop. Biomed.
PD AUG
PY 2017
VL 7
IS 8
BP 763
EP 764
DI 10.1016/j.apjtb.2017.07.007
PG 2
WC Tropical Medicine
SC Tropical Medicine
GA FF1DU
UT WOS:000408640800018
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Piovezan, R
   Acorinthe, JPO
   Visockas, A
   de Azevedo, TS
   Von Zuben, CJ
AF Piovezan, R.
   Acorinthe, J. Paulo O.
   Visockas, A.
   de Azevedo, T. S.
   Von Zuben, C. J.
TI Effect of heavy-equipment aided environmental nebulization on Aedes
   aegypti vectors of Dengue, Zika and Chikungunya in SAo Paulo, Brazil
SO BULLETIN OF ENTOMOLOGICAL RESEARCH
LA English
DT Article
DE Aedes aegypti; vector control; dengue; Zika; chikungunya
AB The control of dengue constitutes a great challenge for public health; however, the methods normally used have shown themselves to be insufficient to keep the indices of infestation of Aedes aegypti under control. Recently, beyond the large number of cases and deaths associated with dengue, new risks have arisen such as those represented by chikungunya fever and Zika. In the light of the great significance of these problems within the public health context, two areas in a municipality in the interior of the State of SAo Paulo, Brazil were selected in 2014. One of them, Bairro Cidade Nova, was submitted to the conventional method of nebulization with portable equipment, and the other, Bairro Jardim Europa, received the application of the insecticide by means of heavy-equipment coupled to the vehicle. During the project, 1355 mosquito eggs were collected, 1105 of them in Bairro Cidade Nova and 205 in Bairro Jardim Europa. After the applications with heavy-equipment in the months of March and April, the number of cases of the disease reported in the month of April for Bairro Jardim Europa was less than half that of Bairro Cidade Nova, which had received the conventional treatment. The nebulization with the heavy-equipment may constitute a viable and effective strategy for achieving better results in the control of Ae. aegypti.
C1 [Piovezan, R.; Von Zuben, C. J.] Univ Estadual Paulista, Dept Zool, Rio Claro, SP, Brazil.
   [Acorinthe, J. Paulo O.; Visockas, A.] Dept Environm Prefeitura Municipal Santa Barbara, Santa Barbara Doeste, SP, Brazil.
   [de Azevedo, T. S.] Univ Sao Paulo, Fac Saude Publ, Sao Paulo, SP, Brazil.
RP Piovezan, R (corresponding author), Univ Estadual Paulista, Dept Zool, Rio Claro, SP, Brazil.
EM piovezan.rafael@gmail.com
RI Azevedo, Thiago Azevedo T. S./F-8343-2012
CR Andrade C. F. S., 2010, REV VETORES PRAGAS, V27, P22
   Andrighetti Maria T. M., 2013, Revista de Patologia Tropical, V42, P81, DOI 10.5216/rpt.v42i1.23588
   Andriotti J.L.S., 2004, FUNDAMENTOS ESTATIST
   Brasil Ministerio da Saude, 2001, DENG INSTR PESS COMB
   Brasil Ministerio da Saude, 2002, PROGR NAC CONTR DENG
   Camara FP, 2007, REV SOC BRAS MED TRO, V40, P192, DOI 10.1590/S0037-86822007000200009
   CDC-Centers for Diseases Control and Prevention, 2016, CONCL ZIK CAUS MICR
   CEPAGRI-Centro de Pesquisas Meteorologicas e Climaticas Aplicadas a Agricultura, 2014, CLIM MUN PAUL
   Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11
   Forattini O.P., 2002, CULICIDOLOGIA MED ID, V2
   Golden Software INC, 1995, SURF WIND V 6 US GUI, V6
   Gringarten E, 2001, MATH GEOL, V33, P507, DOI 10.1023/A:1011093014141
   INSTITUTO BRASILEIRO DE GEOGRAFIA E ESTATISTICA. IBGE, 2013, CENS DEM
   Lima V L, 1999, Rev Saude Publica, V33, P566
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   PANNATIER Y, 1996, VARIOWIN SOFTWARE SP
   Pfeiffer DU, 2008, Spatial Analysis in Epidemiology, P1, DOI 10.1093/acprof:oso/9780198509882.001.0001
   Piovezan R., 2014, GEOGRAFIA, V39, P525
   Piovezan R, 2012, REV BRAS ENTOMOL, V56, P368, DOI 10.1590/S0085-56262012000300016
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Strahler A. N., 1989, GEOGRAFIA FISICA
   SUCEN, 2010, COORD CONTR DOENC PR
   SUCEN-SUPERINTENDENCIA DE CONTROLE DE ENDEMIAS, 2001, VIG CONTR AED AEG NO
   [WHO World Health Organization PAHO Pan American Health], 2016, DENG PAHO WHO DAT MA
   Zar J, 2010, BIOSTATISTICAL ANAL
NR 26
TC 0
Z9 0
U1 0
U2 7
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-4853
EI 1475-2670
J9 B ENTOMOL RES
JI Bull. Entomol. Res.
PD AUG
PY 2017
VL 107
IS 4
BP 478
EP 486
DI 10.1017/S0007485316001115
PG 9
WC Entomology
SC Entomology
GA FA7LM
UT WOS:000405628200007
PM 27974058
OA Green Published
DA 2020-07-08
ER

PT J
AU Li, Z
   Brecher, M
   Deng, YQ
   Zhang, J
   Sakamuru, S
   Liu, BB
   Huang, RL
   Koetzner, CA
   Allen, CA
   Jones, SA
   Chen, H
   Zhang, NN
   Tian, M
   Gao, FS
   Lin, QS
   Banavali, N
   Zhou, J
   Boles, N
   Xia, MH
   Kramer, LD
   Qin, CF
   Li, HM
AF Li, Zhong
   Brecher, Matthew
   Deng, Yong-Qiang
   Zhang, Jing
   Sakamuru, Srilatha
   Liu, Binbin
   Huang, Ruili
   Koetzner, Cheri A.
   Allen, Christina A.
   Jones, Susan A.
   Chen, Haiying
   Zhang, Na-Na
   Tian, Min
   Gao, Fengshan
   Lin, Qishan
   Banavali, Nilesh
   Zhou, Jia
   Boles, Nathan
   Xia, Menghang
   Kramer, Laura D.
   Qin, Cheng-Feng
   Li, Hongmin
TI Existing drugs as broad-spectrum and potent inhibitors for Zika virus by
   targeting NS2B-NS3 interaction
SO CELL RESEARCH
LA English
DT Article
DE Zika virus; inhibitor; protease; NS2B-NS3
ID PHOTODYNAMIC THERAPY; CRYSTAL-STRUCTURE; MOUSE MODEL; PROTEASE;
   INFECTION; MICE; IDENTIFICATION; DISCOVERY; CELLS; ACTIVATION
AB Recent outbreaks of Zika virus (ZIKV) highlight an urgent need for therapeutics. The protease complex NS2B-NS3 plays essential roles during flaviviral polyprotein processing, and thus represents an attractive drug target. Here, we developed a split luciferase complementation-based high-throughput screening assay to identify orthosteric inhibitors that directly target flavivirus NS2B-NS3 interactions. By screening a total of 2 816 approved and investigational drugs, we identified three potent candidates, temoporfin, niclosamide, and nitazoxanide, as flavivirus NS2B-NS3 interaction inhibitors with nanomolar potencies. Significantly, the most potent compound, temoporfin, not only inhibited ZIKV replication in human placental and neural progenitor cells, but also prevented ZIKV-induced viremia and mortality in mouse models. Structural docking suggests that temoporfin potentially binds NS3 pockets that hold critical NS2B residues, thus inhibiting flaviviral polyprotein processing in a non-competitive manner. As these drugs have already been approved for clinical use in other indications either in the USA or other countries, they represent promising and easily developed therapies for the management of infections by ZIKV and other flaviviruses.
C1 [Li, Zhong; Brecher, Matthew; Zhang, Jing; Liu, Binbin; Koetzner, Cheri A.; Jones, Susan A.; Gao, Fengshan; Banavali, Nilesh; Kramer, Laura D.; Li, Hongmin] New York State Dept Hlth, Wadsworth Ctr, 120 New Scotland Ave, Albany, NY 12208 USA.
   [Deng, Yong-Qiang; Zhang, Na-Na; Tian, Min; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept Virol, Beijing 100071, Peoples R China.
   [Sakamuru, Srilatha; Huang, Ruili; Xia, Menghang] NIH, Natl Ctr Adv Translat Sci, Bldg 10, Bethesda, MD 20892 USA.
   [Liu, Binbin] Guangdong Ocean Univ, Coll Food Sci & Technol, Dept Food Sci, Zhanjiang 524000, Guangdong, Peoples R China.
   [Allen, Christina A.; Boles, Nathan] Neural Stem Cell Inst, 1 Discovery Dr, Rensselaer, NY 12144 USA.
   [Chen, Haiying; Zhou, Jia] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Chem Biol Program, Galveston, TX 77555 USA.
   [Gao, Fengshan] Dalian Univ, Coll Life Sci & Technol, Dept Biochem & Mol Biol, Dalian 116622, Liaoning, Peoples R China.
   [Lin, Qishan] SUNY Albany, Ctr Funct Genom, Rensselaer, NY 12144 USA.
   [Banavali, Nilesh; Kramer, Laura D.; Li, Hongmin] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, POB 509,Empire State Plaza, Albany, NY 12201 USA.
   [Qin, Cheng-Feng] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou 510060, Guangdong, Peoples R China.
RP Li, HM (corresponding author), New York State Dept Hlth, Wadsworth Ctr, 120 New Scotland Ave, Albany, NY 12208 USA.; Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept Virol, Beijing 100071, Peoples R China.; Li, HM (corresponding author), SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, POB 509,Empire State Plaza, Albany, NY 12201 USA.; Qin, CF (corresponding author), Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou 510060, Guangdong, Peoples R China.
EM qincf@bmi.ac.cn; Hongmin.li@health.ny.gov
RI Qin, Cheng-Feng/I-6839-2019
OI Qin, Cheng-Feng/0000-0002-0632-2807; Li, Zhong/0000-0002-1039-7000;
   Banavali, Nilesh/0000-0003-2206-7049; Li, Hongmin/0000-0002-8684-5308
FU NIH Biodefense and Emerging Infectious Disease [AI055429]; National
   Natural Science Foundation of China (NSFC) Excellent Young Scientist
   [81522025]; Innovative Research Group [81621005]; National Key Research
   and Development Project of China [2016YFD0500304]; National Science and
   Technology Major Project of China [2017ZX09101005]; Newton Advanced
   Fellowship from the UK Academy of Medical Sciences [NAF003\1003];
   NSFCNational Natural Science Foundation of China [81661130162];
   Guangdong Ocean University; China Scholarship CouncilChina Scholarship
   Council; Wadsworth Center; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [DA038446]; Intramural
   Research Program of NCATS, NIH
FX We thank J Tang at the Wadsworth Center Tissue Culture Core facility for
   help in cell culture, E Eisele at the Biochemistry Core for assistance
   in CD experiments, and other core facilities at the Wadsworth Center,
   including the Applied Genomic Technologies Core for DNA sequencing, the
   Advanced Light Microscopy Core for immunofluorescence imaging, and the
   Tissue Culture Core for media. We also thank X Zhao at the University of
   Wisconsin-Madison for helpful discussion of neural progenitor cells. MB
   was partially supported by the NIH Biodefense and Emerging Infectious
   Disease training grant AI055429. CFQ was supported by the National
   Natural Science Foundation of China (NSFC) Excellent Young Scientist
   (81522025), Innovative Research Group (81621005), the National Key
   Research and Development Project of China (2016YFD0500304), the National
   Science and Technology Major Project of China (2017ZX09101005), and the
   Newton Advanced Fellowship from the UK Academy of Medical Sciences
   (NAF003\1003) and the NSFC (81661130162). BL was partially supported by
   a visiting scholarship sponsored by Guangdong Ocean University. FG was
   partially supported by a visiting scholarship sponsored by the China
   Scholarship Council. This work was partially supported by the Wadsworth
   Center flavivirus drug discovery seed funding (HL, NB, and LDK), by NIH
   grant DA038446 (JZ), and by the Intramural Research Program of NCATS,
   NIH (MX).
CR [Anonymous], 2016, SMALL MOL DRUG DISC
   Asnis D, 2009, AM J TROP MED HYG, V81, P449, DOI 10.4269/ajtmh.2009.81.449
   Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j
   Balderas-Acata JI, 2011, J BIOEQUIV AVAILAB, V3, P43
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Baud D, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30008-1
   Bi K, 2015, ANAL BIOANAL CHEM, V407, P5343, DOI 10.1007/s00216-015-8694-2
   Brecher Matthew, 2013, Virologica Sinica, V28, P326, DOI 10.1007/s12250-013-3390-x
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529
   CHAMBERS TJ, 1991, J VIROL, V65, P6042, DOI 10.1128/JVI.65.11.6042-6050.1991
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chappell KJ, 2008, J GEN VIROL, V89, P1010, DOI 10.1099/vir.0.83447-0
   Chen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076900
   Chen H, 2013, ANTIVIR RES, V97, P232, DOI 10.1016/j.antiviral.2012.12.012
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991
   Fang JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078425
   GalanPuchades MT, 1997, AM J TROP MED HYG, V56, P610, DOI 10.4269/ajtmh.1997.56.610
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Glanzmann T, 1998, PHOTOCHEM PHOTOBIOL, V67, P596, DOI 10.1111/j.1751-1097.1998.tb09099.x
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Green MD, 2011, NAT BIOTECHNOL, V29, P267, DOI 10.1038/nbt.1788
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103
   Jurgeit A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002976
   Krieger R, 2001, INHIBITORS UNCOUPLER
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Lorenz KJ, 2008, HNO, V56, P402, DOI 10.1007/s00106-007-1573-1
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Nayal M, 2006, PROTEINS, V63, P892, DOI 10.1002/prot.20897
   Niyomrattanakit P, 2004, J VIROL, V78, P13708, DOI 10.1128/JVI.78.24.13708-13716.2004
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   O'Connor AE, 2009, PHOTOCHEM PHOTOBIOL, V85, P1053, DOI 10.1111/j.1751-1097.2009.00585.x
   Pambudi S, 2013, BIOCHEM BIOPH RES CO, V440, P393, DOI 10.1016/j.bbrc.2013.09.078
   Phong WY, 2011, BIOSCIENCE REP, V31, P399, DOI 10.1042/BSR20100142
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P5, DOI 10.1016/j.tmaid.2016.01.011
   Rossignol JF, 2009, J BIOL CHEM, V284, P29798, DOI 10.1074/jbc.M109.029470
   Rossignol JF, 2014, ANTIVIR RES, V110, P94, DOI 10.1016/j.antiviral.2014.07.014
   Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004
   Shi ZX, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-10
   Sterling T, 2015, J CHEM INF MODEL, V55, P2324, DOI 10.1021/acs.jcim.5b00559
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Triesscheijn M, 2007, CANCER CHEMOTH PHARM, V60, P113, DOI 10.1007/s00280-006-0356-9
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   White Clinton A Jr, 2004, Expert Rev Anti Infect Ther, V2, P43
   Wu CF, 2003, J VIROL METHODS, V114, P45, DOI 10.1016/j.jviromet.2003.09.001
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Zhang F, 2016, NUCL ACIDS RES
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
   Zhang NN, 2016, HUM VACC IMMUNOTHER, V12, P3107, DOI 10.1080/21645515.2016.1219004
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
NR 72
TC 50
Z9 53
U1 0
U2 16
PU INST BIOCHEMISTRY & CELL BIOLOGY
PI SHANGHAI
PA SIBS, CAS, 319 YUEYANG ROAD, SHANGHAI, 200031, PEOPLES R CHINA
SN 1001-0602
EI 1748-7838
J9 CELL RES
JI Cell Res.
PD AUG
PY 2017
VL 27
IS 8
BP 1046
EP 1064
DI 10.1038/cr.2017.88
PG 19
WC Cell Biology
SC Cell Biology
GA FC2AO
UT WOS:000406639800010
PM 28685770
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Leal, MC
   van der Linden, V
   Bezerra, TP
   de Valois, L
   Borges, ACG
   Antunes, MMC
   Brandt, KG
   Moura, CX
   Rodrigues, LC
   Ximenes, CR
AF Leal, Mariana C.
   van der Linden, Vanessa
   Bezerra, Thiago P.
   de Valois, Luciana
   Borges, Adriana C. G.
   Antunes, Margarida M. C.
   Brandt, Katia G.
   Moura, Catharina X.
   Rodrigues, Laura C.
   Ximenes, Coeli R.
TI Characteristics of Dysphagia in Infants with Microcephaly Caused by
   Congenital Zika Virus Infection, Brazil, 2015
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID CEREBRAL-PALSY; ENDOSCOPIC EVALUATION; CHILDREN; ASPIRATION;
   PENETRATION; DISORDERS; GROWTH
AB We summarize the characteristics of dysphagia in 9 infants in Brazil with microcephaly caused by congenital Zika virus infection. The Schedule for Oral Motor Assessment, fiberoptic endoscopic evaluation of swallowing, and the videofluoroscopic swallowing study were used as noninstrumental and instrumental assessments. All infants had a degree of neurologic damage and showed abnormalities in the oral phase. Of the 9 infants, 8 lacked oral and upper respiratory tract sensitivity, leading to delays in initiation of the pharyngeal phase of swallowing. Those delays, combined with marked oral dysfunction, increased the risk for aspiration of food, particularly liquid foods. Dysphagia resulting from congenital Zika virus syndrome microcephaly can develop in infants > 3 months of age and is severe.
C1 [Leal, Mariana C.] Hosp Agamenon Magalhaes, Otolaryngol Div, Recife, PE, Brazil.
   [Leal, Mariana C.] Univ Fed Pernambuco, Otolaryngol, Recife, PE, Brazil.
   [Bezerra, Thiago P.; Antunes, Margarida M. C.; Brandt, Katia G.; Ximenes, Coeli R.] Univ Fed Pernambuco, Recife, PE, Brazil.
   [van der Linden, Vanessa] Hosp Barao de Lucena, Recife, PE, Brazil.
   [van der Linden, Vanessa; de Valois, Luciana] Assoc Assistance Disabled Children, Recife, PE, Brazil.
   [Borges, Adriana C. G.] Prived Clin, Recife, PE, Brazil.
   [Moura, Catharina X.] Real Hosp Portugues, Recife, PE, Brazil.
   [Rodrigues, Laura C.] London Sch Hyg & Trop Med, London, England.
RP Leal, MC (corresponding author), Gen Abreu & Lima 65,Apto 901, BR-52041040 Recife, PE, Brazil.
EM marianacleal@hotmail.com
RI Antunes, Margarida/AAO-1732-2020
OI Antunes, Margarida/0000-0001-5785-9906
FU European Union's Horizon 2020 research and innovation program under
   Zika-PLAN [734584]
FX L.C.R. is partially funded by European Union's Horizon 2020 research and
   innovation program under Zika-PLAN grant agreement No. 734584.
CR Andrew MJ, 2012, ARCH DIS CHILDHOOD-E, V97, P222, DOI 10.1136/archdischild-2011-300914
   Arvedson JC, 2008, DEV DISABIL RES REV, V14, P118, DOI 10.1002/ddrr.17
   Aviv JE, 2000, DYSPHAGIA, V15, P39, DOI 10.1007/s004559910008
   Bastian Robert W., 1993, Dysphagia, V8, P359, DOI 10.1007/BF01321780
   Benfer KA, 2012, DEV MED CHILD NEUROL, V54, P784, DOI 10.1111/j.1469-8749.2012.04302.x
   Calis EAC, 2008, DEV MED CHILD NEUROL, V50, P625, DOI 10.1111/j.1469-8749.2008.03047.x
   Cameron NA, 2013, J PEDIATR REHAB MED, V6, P239, DOI 10.3233/PRM-140258
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Fung EB, 2002, J AM DIET ASSOC, V102, P361, DOI 10.1016/S0002-8223(02)90084-2
   GISEL EG, 1995, DEV MED CHILD NEUROL, V37, P528
   Kelly AM, 2007, LARYNGOSCOPE, V117, P1723, DOI 10.1097/MLG.0b013e318123ee6a
   Langmore S E, 1988, Dysphagia, V2, P216, DOI 10.1007/BF02414429
   Leopold NA, 2010, DYSPHAGIA, V25, P250, DOI 10.1007/s00455-009-9249-5
   Logeman JA, 1983, EVALUATION TREATMENT
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Miller AJ, 2008, DEV DISABIL RES REV, V14, P77, DOI 10.1002/ddrr.12
   Pan American Health Organization, 2016, EP UPD NEUR SYNDR CO
   Reilly S, 2000, SCHEDULE ORAL MOTOR
   Rosenbek JC, 1996, DYSPHAGIA, V11, P93, DOI 10.1007/BF00417897
   Santoro A, 2012, J CHILD NEUROL, V27, P708, DOI 10.1177/0883073811424083
   van den Engel-Hoek L, 2014, J CHILD NEUROL, V29, P646, DOI 10.1177/0883073813501871
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
NR 26
TC 24
Z9 24
U1 1
U2 15
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD AUG
PY 2017
VL 23
IS 8
BP 1253
EP 1259
DI 10.3201/eid2308.170354
PG 7
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA FA8CG
UT WOS:000405673200003
PM 28604336
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Haddow, AD
   Nalca, A
   Rossi, FD
   Miller, LJ
   Wiley, MR
   Perez-Sautu, U
   Washington, SC
   Norris, SL
   Wollen-Roberts, SE
   Shamblin, JD
   Kimmel, AE
   Bloomfield, HA
   Valdez, SM
   Sprague, TR
   Principe, LM
   Bellanca, SA
   Cinkovich, SS
   Lugo-Roman, L
   Cazares, LH
   Pratt, WD
   Palacios, GF
   Bavari, S
   Pitt, ML
   Nasar, F
AF Haddow, Andrew D.
   Nalca, Aysegul
   Rossi, Franco D.
   Miller, Lynn J.
   Wiley, Michael R.
   Perez-Sautu, Unai
   Washington, Samuel C.
   Norris, Sarah L.
   Wollen-Roberts, Suzanne E.
   Shamblin, Joshua D.
   Kimmel, Adrienne E.
   Bloomfield, Holly A.
   Valdez, Stephanie M.
   Sprague, Thomas R.
   Principe, Lucia M.
   Bellanca, Stephanie A.
   Cinkovich, Stephanie S.
   Lugo-Roman, Luis
   Cazares, Lisa H.
   Pratt, William D.
   Palacios, Gustavo F.
   Bavari, Sina
   Pitt, M. Louise
   Nasar, Farooq
TI High Infection Rates for Adult Macaques after Intravaginal or
   Intrarectal Inoculation with Zika Virus
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID VECTOR-BORNE TRANSMISSION; GROUP-B ARBOVIRUSES; SEXUAL TRANSMISSION;
   CROSS-NEUTRALIZATION; RHESUS; VACCINE; FLAVIVIRUSES; ISOLATIONS;
   MOSQUITOS; JANUARY
AB Unprotected sexual intercourse between persons residing in or traveling from regions with Zika virus transmission is a risk factor for infection. To model risk for infection after sexual intercourse, we inoculated rhesus and cynomolgus macaques with Zika virus by intravaginal or intrarectal routes. In macaques inoculated intravaginally, we detected viremia and virus RNA in 50% of macaques, followed by seroconversion. In macaques inoculated intrarectally, we detected viremia, virus RNA, or both, in 100% of both species, followed by seroconversion. The magnitude and duration of infectious virus in the blood of macaques suggest humans infected with Zika virus through sexual transmission will likely generate viremias sufficient to infect competent mosquito vectors. Our results indicate that transmission of Zika virus by sexual intercourse might serve as a virus maintenance mechanism in the absence of mosquitoto- human transmission and could increase the probability of establishment and spread of Zika virus in regions where this virus is not present.
C1 [Haddow, Andrew D.; Nalca, Aysegul; Rossi, Franco D.; Miller, Lynn J.; Wiley, Michael R.; Perez-Sautu, Unai; Washington, Samuel C.; Norris, Sarah L.; Wollen-Roberts, Suzanne E.; Shamblin, Joshua D.; Kimmel, Adrienne E.; Bloomfield, Holly A.; Valdez, Stephanie M.; Sprague, Thomas R.; Principe, Lucia M.; Bellanca, Stephanie A.; Cinkovich, Stephanie S.; Lugo-Roman, Luis; Cazares, Lisa H.; Pratt, William D.; Palacios, Gustavo F.; Bavari, Sina; Pitt, M. Louise; Nasar, Farooq] US Army, Med Res Inst Infect Dis, Frederick, MD USA.
RP Haddow, AD (corresponding author), US Army, Med Res Inst Infect Dis, Div Virol, 1425 Porter St, Ft Detrick, MD 21702 USA.
EM andrew.d.haddow.ctr@mail.mil
RI Nalca, Aysegul/L-8149-2019; Cazares, Lisa/H-1166-2019; Nasar,
   Farooq/C-7659-2019; Pitt, Margaret Louise/AAD-3437-2019; Haddow, Andrew
   D/C-5902-2008; Cazares, Lisa/M-6356-2019; Palacios, Gustavo/I-7773-2015;
   Bavari, Sina/L-3642-2019
OI Nalca, Aysegul/0000-0001-8581-7535; Cazares, Lisa/0000-0001-5754-6192;
   Nasar, Farooq/0000-0003-3658-9649; Pitt, Margaret
   Louise/0000-0003-0080-3260; Haddow, Andrew D/0000-0002-8957-2608;
   Cazares, Lisa/0000-0001-5754-6192; Palacios,
   Gustavo/0000-0001-5062-1938; Bavari, Sina/0000-0001-8424-5635;
   Perez-Sautu, Unai/0000-0001-8587-7001; Wollen-Roberts,
   Suzanne/0000-0002-9409-2756; , Stephanie/0000-0001-8385-0462; Kimmel,
   Adrienne/0000-0003-2977-1434; Wiley, Michael/0000-0001-6688-007X;
   Norris, Sarah/0000-0002-5393-6430
FU Defense Advanced Research Projects AgencyUnited States Department of
   DefenseDefense Advanced Research Projects Agency (DARPA)
FX This study was supported by a grant from the Defense Advanced Research
   Projects Agency.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Clements AN., 2012, MOSQUITO BIOL, V3
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   DEMADRID AT, 1974, J GEN VIROL, V23, P91, DOI 10.1099/0022-1317-23-1-91
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005083
   Haddow AD, 2016, B WORLD HEALTH ORGAN, V94, P711, DOI 10.2471/BLT.16.181503
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   HENDERSON BE, 1970, AM J TROP MED HYG, V19, P110, DOI 10.4269/ajtmh.1970.19.110
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   JUPP PG, 1974, J MED ENTOMOL, V11, P455, DOI 10.1093/jmedent/11.4.455
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Lugo-Roman LA, 2010, J MED PRIMATOL, V39, P41, DOI 10.1111/j.1600-0684.2009.00394.x
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Morris MR, 2015, J MED PRIMATOL, V44, P301, DOI 10.1111/jmp.12177
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V11, P21, DOI DOI 10.2807/1560-7917
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Smedley J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092830
   van den Hurk AF, 2009, AM J TROP MED HYG, V81, P457, DOI 10.4269/ajtmh.2009.81.457
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Ward H, 2010, CURR OPIN HIV AIDS, V5, P305, DOI 10.1097/COH.0b013e32833a8844
NR 50
TC 45
Z9 48
U1 0
U2 12
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD AUG
PY 2017
VL 23
IS 8
BP 1274
EP 1281
DI 10.3201/eid2308.170036
PG 8
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA FA8CG
UT WOS:000405673200006
PM 28548637
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ayllon, T
   Campos, RD
   Brasil, P
   Morone, FC
   Camara, DCP
   Meira, GLS
   Tannich, E
   Yamamoto, KA
   Carvalho, MS
   Pedro, RS
   Schmidt-Chanasit, J
   Cadar, D
   Ferreira, DF
   Honorio, NA
AF Ayllon, Tania
   Campos, Renata de Mendonca
   Brasil, Patricia
   Morone, Fernanda Cristina
   Portela Camara, Daniel Cardoso
   Silva Meira, Guilherme Louzada
   Tannich, Egbert
   Yamamoto, Kristie Aimi
   Carvalho, Marilia Sa
   Pedro, Renata Saraiva
   Schmidt-Chanasit, Jonas
   Cadar, Daniel
   Ferreira, Davis Fernandes
   Honorio, Nildimar Alves
TI Early Evidence for Zika Virus Circulation among Aedes aegypti
   Mosquitoes, Rio de Janeiro, Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID TRANSMISSION
AB During 2014-2016, we conducted mosquito-based Zika virus surveillance in Rio de Janeiro, Brazil. Results suggest that Zika virus was probably introduced into the area during May-November 2013 via multiple in-country sources. Furthermore, our results strengthen the hypothesis that Zika virus in the Americas originated in Brazil during October 2012-May 2013.
C1 [Ayllon, Tania; Brasil, Patricia; Pedro, Renata Saraiva] Fiocruz MS, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
   [Ayllon, Tania; Morone, Fernanda Cristina; Portela Camara, Daniel Cardoso; Honorio, Nildimar Alves] Fiocruz MS, Nucleo Operac Sentinela Mosquitos Vetores Nosmove, Rio De Janeiro, Brazil.
   [Campos, Renata de Mendonca; Silva Meira, Guilherme Louzada; Yamamoto, Kristie Aimi; Ferreira, Davis Fernandes] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
   [Portela Camara, Daniel Cardoso; Honorio, Nildimar Alves] Fiocruz MS, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Tannich, Egbert; Schmidt-Chanasit, Jonas; Cadar, Daniel] Bernhard Nocht Inst Trop Med, Hamburg, Germany.
   [Carvalho, Marilia Sa] Fiocruz MS, Programa Comp Cient, Rio De Janeiro, Brazil.
   [Schmidt-Chanasit, Jonas] German Ctr Infect Res Hamburg Luebeck Borstel, Hamburg, Germany.
RP Schmidt-Chanasit, J (corresponding author), Bernhard Nocht Inst Trop Med, WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.
EM jonassi@gmx.de
RI CARVALHO, MARILIA/AAD-8283-2020; Azevedo, Renata/V-3130-2019; Santiago,
   Tania Ayllon/B-2543-2019; Camara, Daniel C. P./S-3504-2018
OI CARVALHO, MARILIA/0000-0002-9566-0284; Santiago, Tania
   Ayllon/0000-0002-1195-5078; Camara, Daniel C. P./0000-0002-5439-4477;
   Cadar, Daniel/0000-0002-8063-2766
FU Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico-CNPqNational Council for Scientific and Technological
   Development (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de
   JaneiroFAPERJCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ) [401542/2015-7, E-26/102.241/2013,
   E-26/010.001610/2016]; Fundacao Oswaldo Cruz
FX This work was supported by grants from the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico-CNPq, Fundacao de Amparo a
   Pesquisa do Estado do Rio de JaneiroFAPERJ (grant nos. 401542/2015-7,
   E-26/102.241/2013, and E-26/010.001610/2016) and Fundacao Oswaldo Cruz.
CR Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   dos Reis IC, 2010, ACTA TROP, V114, P37, DOI 10.1016/j.actatropica.2010.01.001
   Jost H, 2011, AM J TROP MED HYG, V85, P551, DOI 10.4269/ajtmh.2011.11-0248
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Naccache SN, 2016, EMERG INFECT DIS, V22, P1788, DOI 10.3201/eid2210.160663
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 10
TC 23
Z9 23
U1 0
U2 8
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD AUG
PY 2017
VL 23
IS 8
BP 1411
EP 1412
DI 10.3201/eid2308.162007
PG 2
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA FA8CG
UT WOS:000405673200030
PM 28628464
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Besnard, M
   Dub, T
   Gerardin, P
AF Besnard, Marianne
   Dub, Timothee
   Gerardin, Patrick
TI Outcomes for 2 Children after Peripartum Acquisition of Zika Virus
   Infection, French Polynesia, 2013-2014
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID INFANTS
AB Congenital Zika virus infection is associated with severe brain anomalies and impaired function. To determine outcomes, we followed 2 affected children for approximate to 30 months. For 1 who was symptomatic at birth, transient hepatitis developed. However, neurodevelopment for both children was age appropriate.
C1 [Besnard, Marianne] Ctr Hosp Polynesie Francaise, Tahiti, French Polynesi, France.
   [Dub, Timothee] Inst Pasteur, Paris, France.
   [Gerardin, Patrick] Ctr Hosp Univ, St Pierre, Reunion, France.
RP Besnard, M (corresponding author), Ctr Hosp Polynesie Francaise, BP 1640 Papeete, F-98713 Tahiti Papeete, French Polynesi, France.
EM mbesnard@nohao.net
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   de Souza AS, 2016, CLIN INFECT DIS, V63, P1622, DOI 10.1093/cid/ciw613
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Paz-Bailey G, 2016, N ENGL J MED
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
NR 10
TC 13
Z9 13
U1 0
U2 3
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD AUG
PY 2017
VL 23
IS 8
BP 1421
EP 1423
DI 10.3201/eid2308.170198
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA FA8CG
UT WOS:000405673200035
PM 28514228
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rodriguez-Valero, N
   Borobia, AM
   Lago, M
   Sanchez-Seco, MP
   de Ory, F
   Vazquez, A
   Perez-Arellano, JL
   Rodriguez, CC
   Martinez, MJ
   Capon, A
   Canas, E
   Salas-Coronas, J
   Galparsoro, AA
   Munoz, J
AF Rodriguez-Valero, Natalia
   Borobia, Alberto M.
   Lago, Mar
   Paz Sanchez-Seco, Maria
   de Ory, Fernando
   Vazquez, Ana
   Luis Perez-Arellano, Jose
   Carranza Rodriguez, Cristina
   Martinez, Miguel J.
   Capon, Alicia
   Canas, Elias
   Salas-Coronas, Joaquin
   Azcune Galparsoro, Arkaitz
   Munoz, Jose
TI Zika Virus Screening among Spanish Team Members After 2016 Rio de
   Janeiro, Brazil, Olympic Games
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID PARALYMPIC GAMES
AB We evaluated the risk for the Spanish Olympic Team acquiring Zika virus in Rio de Janeiro, Brazil, during 2016. We recruited 117 team members, and all tested negative for Zika virus. Lack of cases in this cohort supports the minimum risk estimates made before the Games.
C1 [Rodriguez-Valero, Natalia; Munoz, Jose] IS Global Hosp Clin Barcelona, Barcelona, Spain.
   [Borobia, Alberto M.; Lago, Mar] Hosp La Paz Carlos III, Madrid, Spain.
   [Paz Sanchez-Seco, Maria; de Ory, Fernando; Vazquez, Ana] Inst Salud Carlos III, Madrid, Spain.
   [Luis Perez-Arellano, Jose; Carranza Rodriguez, Cristina] Complejo Hosp Univ Insular Materno Infantil, Las Palmas Gran Canaria, Spain.
   [Martinez, Miguel J.; Capon, Alicia] Hosp Clin Barcelona, Barcelona, Spain.
   [Canas, Elias] Hosp Univ Virgen del Rocio, Seville, Spain.
   [Salas-Coronas, Joaquin] Hosp Poniente, El Ejido, Spain.
   [Azcune Galparsoro, Arkaitz] Hosp Univ Donostia, Donostia San Sebastian, Spain.
RP Rodriguez-Valero, N (corresponding author), Hosp Clin Univ Barcelona, Hosp Clin Barcelona, Dept Trop Med & Int Hlth, ISGlobal,Barcelona Ctr Int Hlth Res CRESIB, C Rossello 132 2 2, Barcelona 08036, Spain.
EM natalia.rodriguez@isglobal.org; jose.munoz@isglobal.org
RI Rodriguez-Valero, Natalia/AAD-7083-2020; Gutierrez, Jose
   Munoz/X-5917-2018; Vazquez, Ana/H-4911-2013; Gutierrez, Jose
   Munoz/AAH-6954-2020; Borobia, Alberto M. M/H-6887-2013; PEREZ-ARELLANO,
   JOSE-LUIS/E-1565-2019
OI Gutierrez, Jose Munoz/0000-0002-0945-1735; Vazquez,
   Ana/0000-0002-9872-3316; Gutierrez, Jose Munoz/0000-0002-0945-1735;
   Borobia, Alberto M. M/0000-0002-8584-3263; Salas-Coronas,
   Joaquin/0000-0002-4302-7022; SANCHEZ-SECO, MARIA
   PAZ/0000-0001-9033-7704; PEREZ-ARELLANO, JOSE-LUIS/0000-0002-2936-8242;
   Fernandez, Ivette/0000-0001-5179-0477; Martinez, Miguel
   Julian/0000-0002-0682-1075
FU La Caixa FoundationLa Caixa Foundation; Spanish Olympic Committee; RICET
   (Network Biomedical Research on Tropical Diseases) [RD16CIII/003/003]
FX This work was supported by La Caixa Foundation and the Spanish Olympic
   Committee. The laboratory work was supported by RICET (Network
   Biomedical Research on Tropical Diseases), RD16CIII/003/003.
CR Attaran A, COMMUNICATION
   Brasil. Ministerio da Saude, 2016, B EPIDEMIOLOGICO
   Codeco C, 2016, MEM I OSWALDO CRUZ, V111, P414, DOI 10.1590/0074-02760160003
   Grills A, 2016, MMWR-MORBID MORTAL W, V65, P711, DOI 10.15585/mmwr.mm6528e1
   Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669
   World Health Organization, ZIK VIR OL PAR GAM 2
   Zumla A, 2016, INT J INFECT DIS, V47, P1, DOI 10.1016/j.ijid.2016.06.010
NR 7
TC 5
Z9 5
U1 0
U2 9
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD AUG
PY 2017
VL 23
IS 8
BP 1426
EP 1428
DI 10.3201/eid2308.170415
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA FA8CG
UT WOS:000405673200038
PM 28628450
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Massad, E
   Burattini, MN
   Khan, K
   Struchiner, CJ
   Coutinho, FAB
   Wilder-Smith, A
AF Massad, E.
   Nascimento Burattini, M.
   Khan, K.
   Struchiner, C. J.
   Coutinho, F. A. B.
   Wilder-Smith, A.
TI On the origin and timing of Zika virus introduction in Brazil
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Force of infection; French Polynesia; mathematical models; risk; Zika
   virus
ID RIO-DE-JANEIRO; OLYMPIC GAMES; FOREIGN VISITORS; WORLD CUP; DENGUE;
   RISK; INFECTION; TRAVELERS; AMERICA
AB The timing and origin of Zika virus (ZIKV) introduction in Brazil has been the subject of controversy. Initially, it was assumed that the virus was introduced during the FIFA World Cup in June-July 2014. Then, it was speculated that ZIKV may have been introduced by athletes from French Polynesia (FP) who competed in a canoe race in Rio de Janeiro in August 2014. We attempted to apply mathematical models to determine the most likely time window of ZIKV introduction in Brazil. Given that the timing and origin of ZIKV introduction in Brazil may be a politically sensitive issue, its determination (or the provision of a plausible hypothesis) may help to prevent undeserved blame. We used a simple mathematical model to estimate the force of infection and the corresponding individual probability of being infected with ZIKV in FP. Taking into account the air travel volume from FP to Brazil between October 2013 and March 2014, we estimated the expected number of infected travellers arriving at Brazilian airports during that period. During the period between December 2013 and February 2014, 51 individuals travelled from FP airports to 11 Brazilian cities. Basing on the calculated force of ZIKV infection (the per capita rate of new infections per time unit) and risk of infection (probability of at least one new infection), we estimated that 18 (95% CI 12-22) individuals who arrived in seven of the evaluated cities were infected. When basic ZIKV reproduction numbers greater than one were assumed in the seven evaluated cities, ZIKV could have been introduced in any one of the cities. Based on the force of infection in FP, basic reproduction ZIKV number in selected Brazilian cities, and estimated travel volume, we concluded that ZIKV was most likely introduced and established in Brazil by infected travellers arriving from FP in the period between October 2013 and March 2014, which was prior to the two aforementioned sporting events.
C1 [Massad, E.; Nascimento Burattini, M.; Coutinho, F. A. B.] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
   [Massad, E.] London Sch Hyg & Trop Med, London, England.
   [Nascimento Burattini, M.] Univ Fed Sao Paulo, Sao Paulo, Brazil.
   [Khan, K.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.
   [Struchiner, C. J.] Fundacao Oswaldo Cruz, Programme Sci Computat, Rio De Janeiro, Brazil.
   [Wilder-Smith, A.] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany.
   [Wilder-Smith, A.] Umea Univ, Dept Publ Hlth & Clin Med Epidemiol & Global Hlth, SE-90185 Umea, Sweden.
   [Wilder-Smith, A.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.; Massad, E (corresponding author), London Sch Hyg & Trop Med, London, England.
EM edmassad@usp.br
RI Massad, Eduardo/B-1169-2012; Coutinho, Francisco A B/H-5644-2011;
   Wilder-Smith, Annelies/F-8751-2015; Burattini, Marcelo N/J-9272-2014;
   Struchiner, Claudio J/M-9360-2013
OI Massad, Eduardo/0000-0002-7200-2916; Coutinho, Francisco A
   B/0000-0003-3127-3071; Burattini, Marcelo N/0000-0002-5407-6890;
   Struchiner, Claudio J/0000-0003-2114-847X
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); ZikaPLAN through the European Union's Horizon 2020 Research and
   Innovation Programme [734584]; Canadian Institutes of Health Research
   (CIHR)Canadian Institutes of Health Research (CIHR); consortium
   Canada-Latin/America-Caribbean Zika Virus Program [372512]; 
   [LIM01-HCFMUSP]
FX This work has been funded by LIM01-HCFMUSP; CNPq; ZikaPLAN through the
   European Union's Horizon 2020 Research and Innovation Programme under
   grant agreement No. 734584; and Canadian Institutes of Health Research
   (CIHR), consortium Canada-Latin/America-Caribbean Zika Virus Program
   (Grant 372512).
CR Amaku M, 2016, B MATH BIOL, V78, P970, DOI 10.1007/s11538-016-0170-4
   Brasil P., 2016, NEW ENGLAND J MED
   Burattini MN, 2016, EPIDEMIOL INFECT, V144, P1904, DOI 10.1017/S0950268816000649
   Enserink M., 2015, INFECT DIS OBSCURE M, P1012
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Funk S, 2016, BIORXIV, DOI [10.1101/043265, DOI 10.1101/043265]
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Lopez LF, 2016, B MATH BIOL, V78, P185, DOI 10.1007/s11538-015-0135-z
   Massad E, 2013, EPIDEMIOL INFECT, V141, P412, DOI 10.1017/S0950268812000507
   Massad E, 2010, TROP MED INT HEALTH, V15, P120, DOI 10.1111/j.1365-3156.2009.02413.x
   Massad E, 2016, LANCET, V388, P658, DOI 10.1016/S0140-6736(16)31228-4
   Massad E, 2016, LANCET, V388, P25, DOI 10.1016/S0140-6736(16)30842-X
   Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669
   Massad E, 2014, LANCET INFECT DIS, V14, P552, DOI 10.1016/S1473-3099(14)70807-2
   Massad E, 2014, MEM I OSWALDO CRUZ, V109, P394, DOI 10.1590/0074-0276140133
   Massad E, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-130
   Massad E, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-296
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Tabatabaei S, 2015, INT J INFECT, V2
   WHO, HIST ZIK VIR
   Ximenes R, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1517-z
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zinszer K, 2017, EMERG INFECT DIS, V23, P92, DOI 10.3201/eid2301.161274
NR 25
TC 17
Z9 18
U1 0
U2 19
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD AUG
PY 2017
VL 145
IS 11
BP 2303
EP 2312
DI 10.1017/S0950268817001200
PG 10
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA FF6MC
UT WOS:000409124100015
PM 28675351
OA Bronze
DA 2020-07-08
ER

PT J
AU Coelho, AVC
   Crovella, S
AF Campos Coelho, Antonio Victor
   Crovella, Sergio
TI Microcephaly Prevalence in Infants Born to Zika Virus-Infected Women: A
   Systematic Review and Meta-Analysis
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE flavivirus; arbovirus; congenital Zika virus syndrome; microcephaly;
   emergent diseases
ID ASSOCIATION; AMERICA; UPDATE; BRAZIL; RISK
AB Zika virus is an emergent flavivirus transmitted by Aedes genus mosquitoes that recently reached the Americas and was soon implicated in an increase of microcephaly incidence. The objective of the present study is to systematically review the published data and perform a meta-analysis to estimate the prevalence of microcephaly in babies born to Zika virus-infected women during pregnancy. We searched PubMed and Cochrane databases, included cohort studies, and excluded case reports and case series publications. We extracted sample sizes and the number of microcephaly cases from eight studies, which permitted a calculation of prevalence rates that are pooled in a random-effects model meta-analysis. We estimated the prevalence of microcephaly of 2.3% (95% CI = 1.0-5.3%) among all pregnancies. Limitations include mixed samples of women infected at different pregnancy times, since it is known that infection at the first trimester is associated with higher risk to congenital anomalies. The estimates are deceptively low, given the devastating impact the infection causes over children and their families. We hope our study contributes to public health knowledge to fight Zika virus epidemics to protect mothers and their newborns.
C1 [Campos Coelho, Antonio Victor] Univ Fed Pernambuco, Dept Genet, Ave Engn,Cidade Univ, BR-50740600 Recife, PE, Brazil.
   [Crovella, Sergio] Sci Inst Res Hospitalizat & Care IRCCS, Inst Maternal & Child Hlth, I-34137 Trieste, Italy.
   [Crovella, Sergio] Univ Trieste, Dept Dev & Reprod Sci, Genet Unit, I-34127 Trieste, Italy.
RP Crovella, S (corresponding author), Sci Inst Res Hospitalizat & Care IRCCS, Inst Maternal & Child Hlth, I-34137 Trieste, Italy.; Crovella, S (corresponding author), Univ Trieste, Dept Dev & Reprod Sci, Genet Unit, I-34127 Trieste, Italy.
EM avccbio@gmail.com; crovella@burlo.trieste.it
RI Coelho, Antonio Victor C/E-6795-2015
OI Coelho, Antonio Victor C/0000-0003-2143-9701
FU Comissao de Aperfeicoamento de Pessoal do Nivel Superior (CAPES,
   Brazil)CAPES [88881.130808/2016.1]; Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq. Brazil)National Council for Scientific
   and Technological Development (CNPq) [440371/2016-3]; Brazilian public
   notice Chamada [14/2016]; IRCCS Burlo Garofolo (Italy) [RC09/17];
   CAPESCAPES [88887.137992/2017-00]
FX This work was supported by grants 88881.130808/2016.1 from Comissao de
   Aperfeicoamento de Pessoal do Nivel Superior (CAPES, Brazil),
   440371/2016-3 from Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq. Brazil), from the Brazilian public notice Chamada
   14/2016-Prevencao e Combate ao virus Zika and RC09/17 from the IRCCS
   Burlo Garofolo (Italy), all granted to Sergio Crovella. Antonio Victor
   Campos Coelho was supported by a stipend by CAPES (88887.137992/2017-00)
   from the same public notice.
CR Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   Adhikari EH, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2017.01.018
   de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P553, DOI 10.1590/0037-8682-0245-2016
   Brasil Ministerio da Saude, MICR 1 638 CAS CONF
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   CASP, CASP COH STUD CHECKL
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chiodo F, 1993, Ann Ist Super Sanita, V29, P57
   Cragan JD, 2017, MMWR-MORBID MORTAL W, V66, P19, DOI 10.15585/mmwr.mm6608a4
   Cunha Antonio Jose Ledo Alves da, 2017, Pediatr Infect Dis J, V36, P528, DOI 10.1097/INF.0000000000001486
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eickmann S. H., 2016, SAUDE PUBLICA, V32, DOI 10.1590/0102-311X0004771627462846
   Ellington SR, 2016, JAMA PEDIATR, V170, P940, DOI 10.1001/jamapediatrics.2016.2974
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   MANTEL N, 1959, J NATL CANCER I, V22, P719
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Morris JK, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4721
   Pacheco O., 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa160403727305043, DOI 10.1056/NEJMOA160403727305043]
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Pomar L, 2017, ULTRASOUND OBST GYN, V49, P729, DOI 10.1002/uog.17404
   R Core Team, R LANG ENV STAT COMP
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 32
TC 17
Z9 18
U1 0
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD AUG
PY 2017
VL 18
IS 8
AR 1714
DI 10.3390/ijms18081714
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA FF4HB
UT WOS:000408897400115
PM 28783051
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zhao, ZY
   Yang, M
   Azar, SR
   Soong, L
   Weaver, SC
   Sun, JR
   Chen, Y
   Rossi, SL
   Cai, JY
AF Zhao, Zhenyang
   Yang, Matthew
   Azar, Sasha R.
   Soong, Lynn
   Weaver, Scott C.
   Sun, Jiaren
   Chen, Yan
   Rossi, Shannan L.
   Cai, Jiyang
TI Viral Retinopathy in Experimental Models of Zika Infection
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Article
DE Zika virus; Axl; Tyro 3; Muller cell; RPE
ID VIRUS-INFECTION; MULLER GLIA; INFANTS; BRAZIL
AB PURPOSE. Emerging evidence has shown that both congenital and adult Zika virus (ZIKV) infection can cause eye diseases. The goals of the current study were to explore mechanisms and pathophysiology of ZIKV-induced eye defects.
   METHODS. Wild-type or A129 interferon type I receptor-deficient mice were infected by either FSS13025 or Mex1-7 strain of ZIKV. Retinal histopathology was measured at different time points after infection. The presence of viral RNA and protein in the retina was determined by in situ hybridization and immunofluorescence staining, respectively. Growth curves of ZIKV in permissive retinal cells were assessed in cultured retinal pigment epithelial (RPE) and Muller glial cells.
   RESULTS. ZIKV-infected mice developed a spectrum of ocular pathologies that affected multiple layers of the retina. A primary target of ZIKV in the eye was Muller glial cells, which displayed decreased neurotrophic function and increased expression of proinflammatory cytokines after infection. ZIKV also infected RPE; and both the RPE and Muller cells expressed viral entry receptors TYRO3 and AXL. Retinitis, focal retinal degeneration, and ganglion cell loss were observed after the clearance of viral particles.
   CONCLUSIONS. Our data suggest that ZIKV can infect infant eyes with immature blood-retinal barrier and cause structural damages to the retina. The ocular findings in microcephalic infants may not be solely caused by ZIKV-induced impairment of neurodevelopment.
C1 [Zhao, Zhenyang; Yang, Matthew; Chen, Yan; Cai, Jiyang] Univ Texas Med Branch, Dept Ophthalmol & Visual Sci, 301 Univ Blvd, Galveston, TX 77555 USA.
   [Azar, Sasha R.] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA.
   [Soong, Lynn; Weaver, Scott C.; Sun, Jiaren; Rossi, Shannan L.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Weaver, Scott C.; Rossi, Shannan L.] Univ Texas Med Branch, Dept Pathol, 301 Univ Blvd, Galveston, TX 77555 USA.
   [Weaver, Scott C.; Rossi, Shannan L.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
RP Cai, JY (corresponding author), Univ Texas Med Branch, Dept Ophthalmol & Visual Sci, 301 Univ Blvd, Galveston, TX 77555 USA.; Rossi, SL (corresponding author), Univ Texas Med Branch, Dept Pathol, 301 Univ Blvd, Galveston, TX 77555 USA.
EM slrossi@utmb.edu; jicai@utmb.edu
RI Weaver, Scott C/D-6490-2011
OI Weaver, Scott C/0000-0001-8016-8556
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [EY 026999, EY 021937,
   AI 120942]; International Retina Research Foundation; Carl Marshall &
   Mildred Almen Reeves Foundation
FX Supported by National Institutes of Health Grants EY 026999 (YC), EY
   021937 (JC), and AI 120942 (SCW); the International Retina Research
   Foundation; and Carl Marshall & Mildred Almen Reeves Foundation.
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003
   Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001
   Chan CK, 2006, OPHTHALMOLOGY, V113, P1539, DOI 10.1016/j.ophtha.2006.04.021
   Cui LY, 2017, EBIOMEDICINE, V20, P193, DOI 10.1016/j.ebiom.2017.04.029
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   de Andrade Gabriel Costa, 2017, Int J Retina Vitreous, V3, P4, DOI 10.1186/s40942-016-0057-4
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Greenberg KP, 2007, INVEST OPHTH VIS SCI, V48, P1844, DOI 10.1167/iovs.05-1570
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Hamel R, 2015, J VIROL
   Ilasbun R, 2016, PLOS ONE, V11
   Jiang TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050661
   Khairallah Moncef, 2010, International Ophthalmology, V30, P465, DOI 10.1007/s10792-009-9319-6
   Kodati S, 2017, LANCET, V389, P125, DOI 10.1016/S0140-6736(16)32518-1
   Li L, 2015, BIOMED REP, V3, P25, DOI 10.3892/br.2014.370
   Mahendradas P, 2008, OPHTHALMOLOGY, V115, P287, DOI 10.1016/j.ophtha.2007.03.085
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Moshfeghi DM, 2016, JAMA OPHTHALMOL, V134, P945, DOI 10.1001/jamaophthalmol.2016.1303
   RIEPE RE, 1977, NATURE, V268, P654, DOI 10.1038/268654a0
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shen WY, 2012, J NEUROSCI, V32, P15715, DOI 10.1523/JNEUROSCI.2841-12.2012
   Shinoe T, 2010, J NEUROCHEM, V115, P1633, DOI 10.1111/j.1471-4159.2010.07072.x
   Sivakumar RR, 2013, OPHTHALMOLOGY, V120, P1820, DOI 10.1016/j.ophtha.2013.02.006
   Steptoe PJ, 2017, EMERG INFECT DIS, V23, P1102, DOI 10.3201/eid2307.161608
   Tabata T, 2016, CELL HOST MICROBE
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Varkey JB, 2015, NEW ENGL J MED, V372, P2423, DOI 10.1056/NEJMoa1500306
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Yanni SE, 2010, EXP EYE RES, V91, P34, DOI 10.1016/j.exer.2010.03.019
   Yao HL, 2014, NEURAL REGEN RES, V9, P1047, DOI 10.4103/1673-5374.133169
   Yip VCH, 2012, OPHTHALMOL THER, V1, DOI 10.1007/s40123-012-0002-z
   Yu B., 2014, INVEST OPHTH VIS SCI
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   ZHAO ZY, 2014, INVEST OPHTH VIS SCI, V55
NR 43
TC 29
Z9 29
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD AUG
PY 2017
VL 58
IS 10
BP 4355
EP 4365
DI 10.1167/iovs.17-22016
PG 11
WC Ophthalmology
SC Ophthalmology
GA FH2AG
UT WOS:000410940400065
PM 28810265
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ventura, LO
   Ventura, CV
   Lawrence, L
   van der Linden, V
   van der Linden, A
   Gois, AL
   Cavalcanti, MM
   Barros, EA
   Dias, NC
   Berrocal, AM
   Miller, MT
AF Ventura, Liana O.
   Ventura, Camila V.
   Lawrence, Linda
   van der Linden, Vanessa
   van der Linden, Ana
   Gois, Adriana L.
   Cavalcanti, Milena M.
   Barros, Eveline A.
   Dias, Natalia C.
   Berrocal, Audina M.
   Miller, Marilyn T.
TI Visual impairment in children with congenital Zika syndrome
SO JOURNAL OF AAPOS
LA English
DT Article
ID PREFERENTIAL LOOKING ACUITY; RETROSPECTIVE CASE SERIES; VIRUS-INFECTION;
   MENTAL-RETARDATION; INFANTS; BRAZIL; VISION; BIRTH; CARDS; MICE
AB PURPOSE To describe the visual impai ent associated with ocular and neurological abnormalities in a cohort of children with congenital Zika syndrome (CZS).
   METHODS This cross-sectional study included infants with micro cephaly born in Pernambuco, Brazil, from May to December 2015. Immunoglobulin M antibody capture enzyme-linked immunosorbent assay for the Zika virus on the cerebrospinal fluid samples was positive for all infants Clinical evaluation consisted of comprehensive ophthalmologic examination including visual acuity, visual function assessment, visual developmental milestone, neurologic examination, and neuroimaging.
   RESULTS A total of 32 infants (18 males [56%]) were included. Mean age at examination was 5.7 +/- 0.9 months (range, 4-7 months). Visual function and visual developmental milestone could not be tested in 1 child (3%). Visual impairment was detected in 32 infants (100%). Retinal and/or optic nerve findings were observed in 14 patients (44%). There was no statistical difference between the patients with ocular findings and those without (P = 0.180). All patients (100%) demonstrated neurological and neuroimaging abnormalities; 3 (9%) presented with late-onset of microcephaly.
   CONCLUSIONS Children with CZS demonstrated visual impairment regardless of retina and/or optic nerve abnormalities. This finding suggests that cortical/cerebral visual impairment may be the most common cause of blindness identified in children with CZS.
C1 [Ventura, Liana O.; Ventura, Camila V.; Gois, Adriana L.; Cavalcanti, Milena M.; Barros, Eveline A.; Dias, Natalia C.] Altino Ventura Fdn FAT, Recife, PE, Brazil.
   [Ventura, Liana O.; Ventura, Camila V.; Gois, Adriana L.; Barros, Eveline A.] HOPE Eye Hosp, Dept Ophthalmol, Recife, PE, Brazil.
   [Ventura, Camila V.; Berrocal, Audina M.] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Dept Ophthalmol, Miami, FL 33136 USA.
   [van der Linden, Vanessa; Cavalcanti, Milena M.] Disabled Childrens Assistance Assoc AACD, Dept Pediat Neurol, Recife, PE, Brazil.
   [van der Linden, Ana] IMIP Hosp, Materno Infantil Inst Pernambuco, Dept Pediat Neurol, Recife, PE, Brazil.
   [Miller, Marilyn T.] Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL USA.
RP Lawrence, L (corresponding author), 1410 East Iron 6, Salina, KS 67401 USA.
EM lmlawrencemd@gmail.com
RI Ventura, Camila V/N-2654-2018; Ventura, Liana Vieira O/N-6151-2018
OI Ventura, Camila V/0000-0002-2927-4684; Ventura, Liana Vieira
   O/0000-0001-6529-6883; Gois, Adriana/0000-0001-5542-1097
CR Alves Lucas Victor, 2016, Rev. Bras. Saude Mater. Infant., V16, pS27, DOI 10.1590/1806-9304201600s100003
   BIRCH EE, 1991, DEV MED CHILD NEUROL, V33, P722
   Chen D, 2015, PARENTS THEIR INFANT
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   DROSTE PJ, 1991, OPHTHALMOLOGY, V98, P1513
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   HERTZ BG, 1992, DEV MED CHILD NEUROL, V34, P115
   Hyvarinen L, 2016, DELAYED VISUAL DEV D
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   MAYER DL, 1983, BEHAV BRAIN RES, V10, P189, DOI 10.1016/0166-4328(83)90164-X
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   ODELL CD, 1993, MENT RETARD, V31, P154
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   SALOMAO SR, 1995, INVEST OPHTH VIS SCI, V36, P657
   Teller DY, 2005, REFERENCE INSTRUCTIO
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   World Health Organization, 2016, SCREEN ASS MAN NEON
   World Health Organization (WHO), ZIK SIT REP
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
NR 29
TC 25
Z9 25
U1 0
U2 3
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1091-8531
EI 1528-3933
J9 J AAPOS
JI J. AAPOS
PD AUG
PY 2017
VL 21
IS 4
BP 295
EP 299
DI 10.1016/j.jaapos.2017.04.003
PG 5
WC Ophthalmology; Pediatrics
SC Ophthalmology; Pediatrics
GA FG1OM
UT WOS:000409565500010
PM 28450178
DA 2020-07-08
ER

PT J
AU Vercosa, I
   Carneiro, P
   Vercosa, R
   Girao, R
   Ribeiro, EM
   Pessoa, A
   Almeida, NG
   Vercosa, P
   Tartarella, MB
AF Vercosa, Islane
   Carneiro, Paula
   Vercosa, Reno
   Girao, Renata
   Ribeiro, Erlane M.
   Pessoa, Andre
   Almeida, Nadia G.
   Vercosa, Paloma
   Tartarella, Marcia B.
TI The visual system in infants with microcephaly related to presumed
   congenital Zika syndrome
SO JOURNAL OF AAPOS
LA English
DT Article
ID VIRUS-INFECTION; BRAZIL; NORMS; AGE
AB PURPOSE To describe and analyze ocular features in infants with microcephaly due to presumed congenital Zika syndrome.
   METHODS Ophthalmologic evaluation, including indirect ophthalmoscopy and eye fundus imaging, visual acuity testing with Teller Acuity Cards, and strabismus assessment were performed in infants with microcephaly at a nongovernmental organization clinic for visually disabled children.
   RESULTS A total of 70 infants with microcephaly were referred to the clinic. Of these, 25 (mean age, 3 months; 14 males) had ophthalmologic changes: 18 (26%) had intraocular abnormalities, including macular chorioretinal atrophy, mottled retinal pigment epithelium and optic nerve pallor; 7 patients (10%) had strabismus or nystagmus without intraocular abnormalities. Visual acuity was below normal range in all 11 infants tested.
   CONCLUSIONS Ophthalmologic abnormalities occurred in 36% of the patients. Macular circumscribed chorioretinal atrophy, focal mottled retinal pigment epithelium, optic nerve pallor, early-onset strabismus, nystagmus and low visual acuity were common ophthalmological features in infants with microcephaly due to presumed congenital Zika syndrome. (J AAPOS 2017;21:300-304)
C1 [Vercosa, Islane; Carneiro, Paula; Vercosa, Reno; Girao, Renata; Vercosa, Paloma] CAVIVER NGO Clin, Fortaleza, Ceara, Brazil.
   [Ribeiro, Erlane M.; Pessoa, Andre] Albert Sabin Pediat Hosp, Fortaleza, Ceara, Brazil.
   [Almeida, Nadia G.] Univ State Ceara UECE, Fortaleza, Ceara, Brazil.
   [Tartarella, Marcia B.] Univ Fed Sao Paulo UNIFESP, Dept Ophthalmol & Visual Sci, Sao Paulo, SP, Brazil.
RP Tartarella, MB (corresponding author), Rua Passo Patria,1678,92V, BR-05085000 Sao Paulo, SP, Brazil.
EM tartarella@yahoo.com
OI Vercosa, Paloma/0000-0002-3590-3459; Almeida, Nadia/0000-0002-0159-0677
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   dePaula Freitas B, 2016, JAMA OPHTHALMOL, V9
   Fruhman G, 2012, J AAPOS, V16, P238, DOI 10.1016/j.jaapos.2012.01.008
   Ministerio da Sande Secretaria de Vigilancia Sanitaria Brazil, INF HEAD CURC MEAS B
   Ministerio da Sande Secretaria de Vigilancia Sanitaria Brazil, SURV PROT RESP OCC M
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Salomao SR, 2008, ARQ BRAS OFTALMOL, V71, P475, DOI 10.1590/S0004-27492008000400002
   SALOMAO SR, 1995, INVEST OPHTH VIS SCI, V36, P657
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sociedade Brasileira de Oftalmologia Pediatrica, 2016, REC SOC BRAS OFT PED
   Sun JF, 2016, JAMA OPHTHALMOL, V134, P1330, DOI 10.1001/jamaophthalmol.2016.3417
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1420, DOI 10.1001/jamaophthalmol.2016.4283
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 19
TC 15
Z9 15
U1 0
U2 1
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1091-8531
EI 1528-3933
J9 J AAPOS
JI J. AAPOS
PD AUG
PY 2017
VL 21
IS 4
BP 300
EP 304
DI 10.1016/j.jaapos.2017.05.024
PG 5
WC Ophthalmology; Pediatrics
SC Ophthalmology; Pediatrics
GA FG1OM
UT WOS:000409565500011
PM 28652051
DA 2020-07-08
ER

PT J
AU L'Huillier, AG
   Hamid-Allie, A
   Kristjanson, E
   Papageorgiou, L
   Hung, S
   Wong, CF
   Stein, DR
   Olsha, R
   Goneau, LW
   Dimitrova, K
   Drebot, M
   Safronetz, D
   Gubbay, JB
AF L'Huillier, Arnaud G.
   Hamid-Allie, Anne
   Kristjanson, Erik
   Papageorgiou, Louis
   Hung, Sam
   Wong, Chun Fai
   Stein, Derek R.
   Olsha, Romy
   Goneau, Lee W.
   Dimitrova, Kristina
   Drebot, Mike
   Safronetz, David
   Gubbay, Jonathan B.
TI Evaluation of Euroimmun Anti-Zika Virus IgM and IgG Enzyme-Linked
   Immunosorbent Assays for Zika Virus Serologic Testing
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
DE Zika virus; diagnostic testing; epidemic; flavivirus; serology
ID INTERIM GUIDANCE; OUTBREAK; STATES; ISLAND
AB With the emerging Zika virus (ZIKV) epidemic, serologic diagnosis relies on a labor-intensive IgM antibody capture enzyme-linked immunosorbent assay (MAC-ELISA) and confirmation by a plaque reduction neutralization test (PRNT). To streamline serologic testing, several commercial assays have been developed. Our aim was to compare the commercial Euroimmun anti-ZIKV IgM and IgG assays to the reference MAC-ELISA and PRNT currently in use. Serum specimens submitted to Public Health Ontario Laboratory, Canada, were tested for IgM and IgG using the Euroimmun assays and the results were compared with those from MAC-ELISA. The PRNT was performed on positive or equivocal specimens using either MAC-ELISA or Euroimmun assays, MAC-ELISA-inconclusive specimens, and a convenience sample of specimens negative by both assays (cohort 1). Another set of specimens selected on the basis of PRNT results was subsequently tested by the Euroimmun assays (cohort 2). MAC-ELISA was positive, equivocal, negative, and inconclusive in 57/223, 15/223, 147/223, and 4/223 specimens, respectively. Among the 76 specimens that were MAC-ELISA positive, equivocal, or inconclusive, 30 (39.5%) were Euroimmun IgM and/or IgG positive or equivocal. Among the 147 MAC-ELISA-negative specimens, 136 (92.5%) were Euroimmun IgM and IgG negative. The sensitivity of the combined Euroimmun IgM/IgG against the PRNT was 83% (cohort 1) and 92% (cohort 2), whereas the specificity was 81% (cohort 1) and 65% (cohort 2). The combined Euroimmun IgM/IgG showed good specificity (92.5%) but suboptimal sensitivity (39.5%) compared with that of the MAC-ELISA. However, the sensitivity of the combined Euroimmun IgM/IgG against the PRNT was significantly higher (83 to 92%). More studies are needed before commercial assays are implemented for routine ZIKV serologic diagnosis.
C1 [L'Huillier, Arnaud G.; Gubbay, Jonathan B.] Hosp Sick Children, Toronto, ON, Canada.
   [Hamid-Allie, Anne; Kristjanson, Erik; Papageorgiou, Louis; Hung, Sam; Wong, Chun Fai; Olsha, Romy; Goneau, Lee W.; Gubbay, Jonathan B.] Publ Hlth Ontario, Toronto, ON, Canada.
   [Stein, Derek R.; Dimitrova, Kristina; Drebot, Mike; Safronetz, David] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada.
   [Goneau, Lee W.; Gubbay, Jonathan B.] Univ Toronto, Toronto, ON, Canada.
RP Gubbay, JB (corresponding author), Hosp Sick Children, Toronto, ON, Canada.; Gubbay, JB (corresponding author), Publ Hlth Ontario, Toronto, ON, Canada.; Gubbay, JB (corresponding author), Univ Toronto, Toronto, ON, Canada.
EM jonathan.gubbay@oahpp.ca
RI L'Huillier, Arnaud/AAI-1872-2019; Gubbay, Jonathan/Q-8580-2019
OI L'Huillier, Arnaud/0000-0001-9230-7285; Gubbay,
   Jonathan/0000-0003-0026-3786
FU Public Health Ontario; GlaxoSmithKline, Inc.GlaxoSmithKline; Hoffman-La
   Roche, Ltd.; Pfizer, Inc.Pfizer
FX This study was supported by Public Health Ontario. Public Health Ontario
   had no role in study design, data collection and interpretation, or the
   decision to submit the work for publication.; J. B. Gubbay has received
   research grants from GlaxoSmithKline, Inc. and Hoffman-La Roche, Ltd. to
   study antiviral resistance in influenza, and from Pfizer, Inc. to
   conduct microbiologic surveillance of Streptococcus pneumoniae. The
   other authors have no conflict of interest to disclose.
CR CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Disease Control and Prevention, 2016, GUID US LAB TEST ZIK
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Euroimmun AG., 2016, EUR ANT VIR ELISA IG
   Food and Drug Administration, 2016, EM US AUTH ZIK MAC E
   Granger D, 2016, 32 CLIN VIR S DAYT B
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P1576, DOI 10.1128/JCM.02153-16
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   MACNAMARA F. N., 1959, TRANS ROY SOC TROP MED AND HYG, V53, P202, DOI 10.1016/0035-9203(59)90072-0
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Public Health Ontario Laboratories, 2017, PUBL HLTH ONT ZIK VI
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Steinhagen K., 2015, EUROSURVEILLANCE, V2016, P21, DOI DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
NR 20
TC 43
Z9 43
U1 0
U2 8
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD AUG
PY 2017
VL 55
IS 8
BP 2462
EP 2471
DI 10.1128/JCM.00442-17
PG 10
WC Microbiology
SC Microbiology
GA FE3IO
UT WOS:000408109800022
PM 28566316
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Cao, B
   Parnell, LA
   Diamond, MS
   Mysorekar, IU
AF Cao, Bin
   Parnell, Lindsay A.
   Diamond, Michael S.
   Mysorekar, Indira U.
TI Inhibition of autophagy limits vertical transmission of Zika virus in
   pregnant mice
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
ID HUMAN PLACENTAL TROPHOBLASTS; INFECTION; CELLS; REPLICATION;
   CHLOROQUINE; MOUSE; DRUG; IDENTIFICATION; DISEASES; OUTCOMES
AB Zika virus (ZIKV) infection during pregnancy leads to devastating fetal outcomes, including intrauterine growth restriction and microcephaly. Greater understanding of mechanisms underlying ZIKV maternal-fetal transmission is needed to develop new therapeutic interventions. Here, we define an important role for the autophagy pathway in ZIKV vertical transmission. ZIKV infection induced autophagic activity in human trophoblasts and pharmacological inhibition limited ZIKV infectivity. Furthermore, deficiency in an essential autophagy gene, Atg16l1, in mice limited ZIKV vertical transmission and placental and fetal damage and overall improved placental and fetal outcomes. This protection was due to a placental trophoblast cell-autonomous effect of autophagic activity, not to alterations in systemic maternal ZIKV infection. Finally, an autophagy inhibitor, hydroxychloroquine, approved for use in pregnant women, attenuated placental and fetal ZIKV infection and ameliorated adverse placental and fetal outcomes. Our study reveals new insights into the mechanism of ZIKV vertical transmission and suggests that an autophagy-based therapeutic warrants possible evaluation in humans to diminish the risks of ZIKV maternal-fetal transmission.
C1 [Cao, Bin; Parnell, Lindsay A.; Mysorekar, Indira U.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Diamond, Michael S.; Mysorekar, Indira U.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO USA.
RP Mysorekar, IU (corresponding author), Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA.; Mysorekar, IU (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.
EM indira@wustl.edu
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165
FU Preventing Prematurity Initiative grant from Burroughs Wellcome Fund;
   Prematurity Research Initiative Investigator award from March of Dimes
   [21-FY13-28]; National Institutes of Health/Eunice Kennedy Shriver
   National Institute of Child Health and Human DevelopmentUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Eunice Kennedy Shriver National Institute of Child Health &
   Human Development (NICHD) [R01HD091218, R01 AI073755, R01 AI104972]
FX This work was supported by a Preventing Prematurity Initiative grant
   from the Burroughs Wellcome Fund and a Prematurity Research Initiative
   Investigator award (21-FY13-28) from the March of Dimes (to I.U.
   Mysorekar), National Institutes of Health/Eunice Kennedy Shriver
   National Institute of Child Health and Human Development grants
   R01HD091218 (to I.U. Mysorekar and M.S. Diamond) and R01 AI073755 and
   R01 AI104972 (to M.S. Diamond).
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416
   Cao B., 2017, J INTERFERON CYTOKIN
   Cao B, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86654
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cemma M, 2012, CURR BIOL, V22, pR540, DOI 10.1016/j.cub.2012.06.001
   Chibueze EC, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0285-6
   Chiramel Abhilash I, 2013, Cells, V2, P83, DOI 10.3390/cells2010083
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Elfiky AA, 2016, J MED VIROL, V88, P2044, DOI 10.1002/jmv.24678
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Kaplan YC, 2016, BRIT J CLIN PHARMACO, V81, P835, DOI 10.1111/bcp.12872
   Khan MY, 2001, CLIN INFECT DIS, V32, P1172, DOI 10.1086/319758
   Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356
   Lamont RF, 2011, J PERINAT MED, V39, P227, DOI [10.1515/JPM.2011.035, 10.1515/jpm.2011.035]
   Lennemann NJ, 2017, AUTOPHAGY, V13, P322, DOI 10.1080/15548627.2016.1265192
   Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Martin-Acebes MA, 2015, AUTOPHAGY, V11, P861, DOI 10.1080/15548627.2015.1037062
   Mateo R, 2013, J VIROL, V87, P1312, DOI 10.1128/JVI.02177-12
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Pirooz S, 2014, AUTOPHAGY, V10, P1355, DOI 10.4161/auto.29075
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rosenfeldt MT, 2013, NATURE, V504, P296, DOI 10.1038/nature12865
   Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5
   Sharma M, 2014, AUTOPHAGY, V10, P1637, DOI 10.4161/auto.29455
   Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866
   Signorelli P, 2011, PLACENTA, V32, P482, DOI 10.1016/j.placenta.2011.03.005
   Farias KJS, 2014, MICROBIOL IMMUNOL, V58, P318, DOI 10.1111/1348-0421.12154
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tricou Vianney, 2010, PLoS Negl Trop Dis, V4, pe785, DOI 10.1371/journal.pntd.0000785
   Vandergaast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045800
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Wenzel PL, 2007, GENESIS, V45, P129, DOI 10.1002/dvg.20276
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 46
TC 78
Z9 80
U1 3
U2 10
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA
SN 0022-1007
EI 1540-9538
J9 J EXP MED
JI J. Exp. Med.
PD AUG
PY 2017
VL 214
IS 8
BP 2303
EP 2313
DI 10.1084/jem.20170957
PG 11
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA FC8FD
UT WOS:000407076300011
PM 28694387
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Wang, ZY
   Wang, Z
   Zhen, ZD
   Feng, KH
   Guo, J
   Gao, N
   Fan, DY
   Han, DS
   Wang, PG
   An, J
AF Wang, Zhao-Yang
   Wang, Zai
   Zhen, Zi-Da
   Feng, Kai-Hao
   Guo, Jing
   Gao, Na
   Fan, Dong-Ying
   Han, Dai-Shu
   Wang, Pei-Gang
   An, Jing
TI Axl is not an indispensable factor for Zika virus infection in mice
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Article
DE ZIKV; Axl; receptor; brain; in vivo role
ID ACIDIC PROTEIN GFAP; PRODUCTIVE INFECTION; CELLS; RECEPTORS; ENTRY
AB Recently, Zika virus (ZIKV) outbreak has been associated with a sharp increase in cases of Guillain-Barre syndrome and severe fetal abnormalities. However, the mechanism underlying the interaction of ZIKV with host cells is not yet clear. Axl, a receptor tyrosine kinase, is postulated as a receptor for ZIKV entry; however, its in vivo role during ZIKV infection and its impact on the outcome of the disease have not been fully characterized and evaluated. Moreover, there are contradictory results on its involvement in ZIKV infection. Here we utilized Axl-deficient mice (Axl(-/-)) and their littermates (Axl(+/-)) to study the in vivo role of Axl in ZIKV infection. Our results showed that both Axl(+/-) and Axl(-/-) suckling mice supported the replication of ZIKV and presented clinical manifestations. No significant difference has been found between Axl-deficient mice and their littermates in terms of the survival rate, clinical manifestations, viral load, ZIKV distribution and histopathological changes in major organs. These results therefore indicate that Axl is not an indispensable factor for ZIKV infection in mice.
C1 [Wang, Zhao-Yang; Zhen, Zi-Da; Feng, Kai-Hao; Gao, Na; Fan, Dong-Ying; Wang, Pei-Gang; An, Jing] Capital Med Univ, Sch Basic Med Sci, Dept Microbiol, Beijing 100069, Peoples R China.
   [Wang, Zai; Guo, Jing] China Japan Friendship Hosp, Inst Clin Med, Beijing 100029, Peoples R China.
   [Han, Dai-Shu] Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Beijing 100730, Peoples R China.
   [An, Jing] Beijing Inst Brain Disorders, Ctr Epilepsy, Beijing 100093, Peoples R China.
RP Wang, PG; An, J (corresponding author), Capital Med Univ, Sch Basic Med Sci, Dept Microbiol, Beijing 100069, Peoples R China.; An, J (corresponding author), Beijing Inst Brain Disorders, Ctr Epilepsy, Beijing 100093, Peoples R China.
EM pgwang@ccmu.edu.cn; anjing@ccmu.edu.cn
OI Wang, Peigang/0000-0001-6045-2007
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81471957, 81271839, 81671971, 81301435, 81372935,
   81401676, U1602223]
FX This work was supported by grants from the National Natural Science
   Foundation of China (No. 81471957, 81271839, 81671971, 81301435,
   81372935, 81401676 and U1602223).
CR Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Du Toit A, 2016, NAT REV MICROBIOL, V14, P268, DOI 10.1038/nrmicro.2016.47
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Graham DK, 2014, NAT REV CANCER, V14, P769, DOI 10.1038/nrc3847
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Herculano-Houzel S, 2005, J NEUROSCI, V25, P2518, DOI 10.1523/JNEUROSCI.4526-04.2005
   JACQUE CM, 1978, J NEUROL SCI, V35, P147, DOI 10.1016/0022-510X(78)90107-7
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li F, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.10
   Li MY, 2015, CELL REP, V10, P1496, DOI 10.1016/j.celrep.2015.02.021
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Ma WQ, 2017, CELL, V168, P542, DOI 10.1016/j.cell.2017.01.009
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   ROESSMANN U, 1980, BRAIN RES, V200, P13, DOI 10.1016/0006-8993(80)91090-2
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Wang ZY, 2016, VIROL SIN, V31, P103, DOI 10.1007/s12250-016-3780-y
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
   Zhang JL, 2007, BIOCHEM BIOPH RES CO, V356, P763, DOI 10.1016/j.bbrc.2007.03.051
NR 32
TC 30
Z9 30
U1 0
U2 7
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-1317
EI 1465-2099
J9 J GEN VIROL
JI J. Gen. Virol.
PD AUG
PY 2017
VL 98
IS 8
BP 2061
EP 2068
DI 10.1099/jgv.0.000886
PG 8
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA FG6IT
UT WOS:000410479400010
PM 28786784
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Silveira, ELV
   Rogers, KA
   Gumber, S
   Amancha, P
   Xiao, P
   Woollard, SM
   Byrareddy, SN
   Teixeira, MM
   Villinger, F
AF Silveira, Eduardo L. V.
   Rogers, Kenneth A.
   Gumber, Sanjeev
   Amancha, Praveen
   Xiao, Peng
   Woollard, Shawna M.
   Byrareddy, Siddappa N.
   Teixeira, Mauro Martins
   Villinger, Francois
TI Immune Cell Dynamics in Rhesus Macaques Infected with a Brazilian Strain
   of Zika Virus
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID T FOLLICULAR HELPER; DENGUE VIRUS; PLASMABLAST RESPONSES;
   INFLUENZA-VIRUS; MOUSE MODEL; B-CELLS; MICE; ANTIBODIES; TRANSMISSION;
   PROTECTION
AB Zika virus (ZIKV) is a mosquito-borne and sexually transmitted flavivirus that is associated with fetal CNS-damaging malformations during pregnancy in humans. This study documents the viral kinetics and immune responses in rhesus macaques infected with a clinical ZIKV Brazilian isolate. We evaluated the viral kinetics and immune responses induced after an i.v. infection with a Brazilian ZIKV clinical isolate (HS-2015-BA-01) in rhesus macaques for up to 142 d. ZIKV-specific Ab-secreting cells, germinal center reactions, and monocyte, dendritic cell, NK, and T cell frequencies were monitored. ZIKV loads were readily detected in plasma (until day 5 or 7), semen and urine (until days 7 and 14), and saliva (until day 42), but the viremia was rapidly controlled. No detectable clinical manifestations were observed. However, lymph node hyperplasia was clearly visible postviremia but was associated with low frequencies of ZIKV-specific Ab-secreting cells in lymph nodes and bone marrow, correlating with low Ab titers. CD14(+)/CD16(-) monocytes and myeloid CD11c(hi) dendritic cells decreased in blood, whereas NK and T cell numbers were only marginally altered during the course of the study. ZIKV infection caused a significant lymphoid tissue activation but limited induction of ZIKV-specific B cells, suggesting that these parameters need to be considered for ZIKV vaccine design.
C1 [Silveira, Eduardo L. V.] Univ Sao Paulo, Dept Clin & Toxicol Anal, Sch Pharmaceut Sci, BR-05508 Sao Paulo, Brazil.
   [Rogers, Kenneth A.; Amancha, Praveen; Xiao, Peng; Villinger, Francois] Univ Louisiana Lafayette, New Iberia Res Ctr, 4401 West Admiral Doyle Dr, New Iberia, LA 70560 USA.
   [Gumber, Sanjeev] Emory Univ, Div Pathol, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA.
   [Woollard, Shawna M.; Byrareddy, Siddappa N.] Univ Nebraska, Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.
   [Teixeira, Mauro Martins] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, BR-31270 Belo Horizonte, MG, Brazil.
RP Villinger, F (corresponding author), Univ Louisiana Lafayette, New Iberia Res Ctr, 4401 West Admiral Doyle Dr, New Iberia, LA 70560 USA.
EM fjv5939@louisiana.edu
RI Teixeira, Mauro M/A-4587-2008; Silveira, Eduardo L V/E-5733-2014;
   Amancha, Praveen Kumar/K-3445-2014
OI Teixeira, Mauro M/0000-0002-6944-3008; Silveira, Eduardo L
   V/0000-0001-8333-2884; Gumber, Sanjeev/0000-0001-9048-2717; Amancha,
   Praveen Kumar/0000-0001-6466-8112
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [8R24OD010947,
   R01AI113883]; Nebraska Neuroscience Alliance Endowed Fund Award;
   Conselho Nacional de Pesquisa (Brazil)National Council for Scientific
   and Technological Development (CNPq); Fundacao do Amparo a Pesquisas do
   Estado de Minas Gerais (Brazil); Conselho de Aperfeicoamento de Pessoal
   Nivel Superior
FX This work was supported in part by National Institutes of Health Grants
   8R24OD010947 (to F.V.) and R01AI113883 and by a Nebraska Neuroscience
   Alliance Endowed Fund Award (to S.N.B.). Research in M.M.T.'s laboratory
   received financial support from the Conselho Nacional de Pesquisa
   (Brazil), the Fundacao do Amparo a Pesquisas do Estado de Minas Gerais
   (Brazil), and the Conselho de Aperfeicoamento de Pessoal Nivel Superior.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Yam-Puc JC, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00188
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   El Ghouzzi V, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.266
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fossum E, 2015, EUR J IMMUNOL, V45, P624, DOI 10.1002/eji.201445080
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Garcia-Bates TM, 2013, J IMMUNOL, V190, P80, DOI 10.4049/jimmunol.1103350
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Gumber S, 2014, EXP TOXICOL PATHOL, V66, P437, DOI 10.1016/j.etp.2014.07.004
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Hong JJ, 2012, J IMMUNOL, V188, P3247, DOI 10.4049/jimmunol.1103138
   Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Kasturi SP, 2017, J VIROL, V91, DOI 10.1128/JVI.01844-16
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Kwissa M, 2014, CELL HOST MICROBE, V16, P115, DOI 10.1016/j.chom.2014.06.001
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Menon M, 2016, IMMUNITY, V44, P683, DOI 10.1016/j.immuni.2016.02.012
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330
   Onabajo OO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059758
   Onlamoon N, 2010, BLOOD, V115, P1823, DOI 10.1182/blood-2009-09-242990
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Petrovas C, 2012, J CLIN INVEST, V122, P3281, DOI 10.1172/JCI63039
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Silveira ELV, 2015, J IMMUNOL METHODS, V416, P69, DOI 10.1016/j.jim.2014.11.003
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Titanji K, 2010, J CLIN INVEST, V120, P3878, DOI 10.1172/JCI43271
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wolf AI, 2011, J CLIN INVEST, V121, P3954, DOI 10.1172/JCI57362
   Wong G, 2017, PROTEIN CELL, V8, P162, DOI 10.1007/s13238-016-0357-3
   Wrammert J, 2012, J VIROL, V86, P2911, DOI 10.1128/JVI.06075-11
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 53
TC 23
Z9 23
U1 0
U2 8
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD AUG 1
PY 2017
VL 199
IS 3
BP 1003
EP 1011
DI 10.4049/jimmunol.1700256
PG 9
WC Immunology
SC Immunology
GA FB5LF
UT WOS:000406182600020
PM 28667164
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Al-Saeed, MS
   El-Kafrawy, SA
   Farraj, SA
   Al-Subhi, TL
   Othman, NA
   Alsultan, A
   Ben Helaby, HG
   Alshawdari, MM
   Hassan, AM
   Charrel, RN
   Azhar, EI
   Hashem, AM
AF Al-Saeed, Moneerah S.
   El-Kafrawy, Sherif A.
   Farraj, Suha A.
   Al-Subhi, Tagreed L.
   Othman, Norah A.
   Alsultan, Arwa
   Ben Helaby, Huda G.
   Alshawdari, Mustafa M.
   Hassan, Ahmed M.
   Charrel, Remi N.
   Azhar, Esam I.
   Hashem, Anwar M.
TI Phylogenetic characterization of circulating Dengue and Alkhumra
   Hemorrhagic Fever viruses in western Saudi Arabia and lack of evidence
   of Zika virus in the region: A retrospective study, 2010-2015
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE Alkhumra hemorrhagic fever; dengue; flaviviruses; Saudi Arabia
ID POLYMERASE CHAIN-REACTION; MOSQUITO-BORNE FLAVIVIRUSES; REVERSE
   TRANSCRIPTION-PCR; RIFT-VALLEY FEVER; GENUS FLAVIVIRUS; RAPID
   IDENTIFICATION; SEQUENCE; INFECTION; ENCEPHALITIS; PRIMERS
AB Flaviviruses represent a global public health concern. They consist of similar to 70 viruses with almost half of them causing human diseases with unspecified febrile illnesses. Cities in western Saudi Arabia are endemic for viruses (DENV) with sporadic infections due to Alkhumra hemorrhagic fever virus (AHFV). They also represent a major destination for travelers coming for annual religious pilgrimages (Hajj and Umrah) from all over the world. However, whether other flaviviruses are circulating is not known because of the limited number of surveillance studies. Here, we retrospectively screened 690 samples for flaviviruses in samples from patients with unexplained febrile illnesses between 2010 and 2015 in western Saudi Arabia using a panflaviviruses RT-PCR assay. Despite Zika virus RNA was not detected, this study confirms circulation and/or sporadic spread of DENV-2, DENV-3, and AHFV, higher prevalence of DENV-2, and a role for visitors from DENV endemic countries in DENV importation into the Kingdom. Further analysis also showed very low genetic diversity of AHFV confirming its slow microevolution. Accordingly, continuous and prospective surveillance for flaviviruses using such assay are warranted in Saudi Arabia which receives millions of Muslims annually to implement effective control measures in light of the global widespread and outbreaks of several flaviviruses.
C1 [Al-Saeed, Moneerah S.; El-Kafrawy, Sherif A.; Farraj, Suha A.; Al-Subhi, Tagreed L.; Othman, Norah A.; Alsultan, Arwa; Ben Helaby, Huda G.; Alshawdari, Mustafa M.; Hassan, Ahmed M.; Charrel, Remi N.; Azhar, Esam I.; Hashem, Anwar M.] King Abdulaziz Univ, Special Infect Agents Unit, King Fahd Med Res Ctr, Jeddah, Saudi Arabia.
   [Charrel, Remi N.] Aix Marseille Univ, IRD 190, Inserm 1207, UMR Emergence Pathol Virales,EPV,EHESP, Marseille, France.
   [Charrel, Remi N.] Publ Hosp Marseille, AP HM, Inst Hosp Univ Mediterranee Infect, Marseille, France.
   [Azhar, Esam I.] King Abdulaziz Univ, Fac Appl Med Sci, Dept Med Lab Technol, Jeddah, Saudi Arabia.
   [Hashem, Anwar M.] King Abdulaziz Univ, Dept Med Microbiol & Parasitol, Fac Med, Jeddah, Saudi Arabia.
RP Azhar, EI; Hashem, AM (corresponding author), King Abdulaziz Univ, Special Infect Agents Unit, King Fahd Med Res Ctr, Jeddah, Saudi Arabia.
EM eazhar@kau.edu.sa; amhashem@kau.edu.sa
RI El-Kafrawy, Sherif A/C-8699-2012; Hassan, Ahmed/AAB-7241-2019
OI El-Kafrawy, Sherif A/0000-0002-3667-7529; Farraj,
   Suha/0000-0003-0383-9779; Azhar, Esam/0000-0002-1736-181X
FU Deanship of Scientific Research (DSR); King Abdulaziz University,
   Jeddah, Saudi Arabia [G-145-140-36]
FX Deanship of Scientific Research (DSR); King Abdulaziz University,
   Jeddah, Saudi Arabia, Grant number: G-145-140-36
CR Al-Azraqi TA, 2013, T ROY SOC TROP MED H, V107, P368, DOI 10.1093/trstmh/trt022
   Al-Azraqi TA, 2012, ACTA TROP, V123, P111, DOI 10.1016/j.actatropica.2012.04.007
   Alikhan M, 2014, J INSECT SCI, V14, DOI 10.1093/jis/14.1.69
   Aranda C, 2009, VECTOR-BORNE ZOONOT, V9, P171, DOI 10.1089/vbz.2008.0073
   Ayers M, 2006, J VIROL METHODS, V135, P235, DOI 10.1016/j.jviromet.2006.03.009
   Azhar EI, 2015, VIROL J, V11, DOI 10.1186/s12985-014-0235-7
   Azhar EI, 2014, NEW ENGL J MED, V370, P2499, DOI 10.1056/NEJMoa1401505
   Bakonyi T, 2005, EMERG INFECT DIS, V11, P225, DOI 10.3201/eid1102.041028
   Calisher CH, 2003, ADV VIRUS RES, V59, P1, DOI 10.1016/S0065-3527(03)59001-7
   CAMMISAPARKS H, 1992, VIROLOGY, V189, P511, DOI 10.1016/0042-6822(92)90575-A
   Carletti F, 2010, EMERG INFECT DIS, V16, P1979, DOI 10.3201/eid1612.101092
   Chao DY, 2007, J CLIN MICROBIOL, V45, P584, DOI 10.1128/JCM.00842-06
   Charrel RN, 2005, EMERG INFECT DIS, V11, P683, DOI 10.3201/eid1105.041298
   Charrel RN, 2001, BIOCHEM BIOPH RES CO, V287, P455, DOI 10.1006/bbrc.2001.5610
   CHOW VTK, 1993, ARCH VIROL, V133, P157, DOI 10.1007/BF01309751
   Crabtree MB, 2003, ARCH VIROL, V148, P1095, DOI 10.1007/s00705-003-0019-7
   de Lamballerie X, 2002, J GEN VIROL, V83, P2443, DOI 10.1099/0022-1317-83-10-2443
   Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002
   Dyer J, 2007, J VIROL METHODS, V135, P235
   El-Kafrawy SA, 2016, VECTOR-BORNE ZOONOT, V16, P391, DOI 10.1089/vbz.2015.1911
   ElAzazy OME, 1997, T ROY SOC TROP MED H, V91, P275, DOI 10.1016/S0035-9203(97)90072-9
   ELDADAH ZA, 1991, J MED VIROL, V33, P260, DOI 10.1002/jmv.1890330410
   Fakeeh M, 2001, AM J TROP MED HYG, V65, P764, DOI 10.4269/ajtmh.2001.65.764
   FAKEEH M., 2003, DENGUE B, V27, P13
   FAUQUET CM, 2005, VIRUS TAXONOMY 8 REP
   Figueiredo LTM, 1998, AM J TROP MED HYG, V59, P357, DOI 10.4269/ajtmh.1998.59.357
   FULOP L, 1993, J VIROL METHODS, V44, P179, DOI 10.1016/0166-0934(93)90053-T
   Grard G, 2006, J GEN VIROL, V87, P3273, DOI 10.1099/vir.0.82071-0
   Huhtamo E, 2009, J VIROL, V83, P9532, DOI 10.1128/JVI.00529-09
   Johnson N, 2010, VECTOR-BORNE ZOONOT, V10, P665, DOI 10.1089/vbz.2009.0210
   Junglen S, 2009, J VIROL, V83, P4462, DOI 10.1128/JVI.00014-09
   Karabatsos N., 1985, INT CATALOGUE ARBOVI
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kim DY, 2009, VIROLOGY, V386, P154, DOI 10.1016/j.virol.2008.12.034
   Kono Y, 2000, AM J TROP MED HYG, V63, P94, DOI 10.4269/ajtmh.2000.63.94
   Korhonen EM, 2016, EUROSURVEILLANCE, V14, P30107
   Madani TA, 2005, J INFECTION, V51, P91, DOI 10.1016/j.jinf.2004.11.012
   Madani TA, 2014, INTERVIROLOGY, V57, P300, DOI 10.1159/000362334
   Maher-Sturgess SL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-16
   Memish ZA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085564
   Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206
   Nisbet DJ, 2005, J GEN VIROL, V86, P121, DOI 10.1099/vir.0.80381-0
   Sang RC, 2003, ARCH VIROL, V148, P1085, DOI 10.1007/s00705-003-0018-8
   Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197
   TANAKA M, 1993, J VIROL METHODS, V41, P311, DOI 10.1016/0166-0934(93)90020-R
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Vazquez A, 2012, VECTOR-BORNE ZOONOT, V12, P223, DOI 10.1089/vbz.2011.0687
   Zaki A, 2008, TROP MED INT HEALTH, V13, P584, DOI 10.1111/j.1365-3156.2008.02037.x
   Zaki AM, 1997, T ROY SOC TROP MED H, V91, P179, DOI 10.1016/S0035-9203(97)90215-7
NR 50
TC 8
Z9 10
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD AUG
PY 2017
VL 89
IS 8
BP 1339
EP 1346
DI 10.1002/jmv.24785
PG 8
WC Virology
SC Virology
GA FA2UA
UT WOS:000405295100004
PM 28198548
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Felix, AC
   Souza, NCS
   Figueiredo, WM
   Costa, AA
   Inenami, M
   da Silva, RMG
   Levi, JE
   Pannuti, CS
   Romano, CM
AF Felix, Alvina Clara
   Santiago Souza, Nathalia C.
   Figueiredo, Walter M.
   Costa, Angela A.
   Inenami, Marta
   da Silva, Rosangela M. G.
   Levi, Jose Eduardo
   Pannuti, Claudio Sergio
   Romano, Camila Malta
TI Cross reactivity of commercial anti-dengue immunoassays in patients with
   acute Zika virus infection
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE cross reaction; dengue virus; serological tests; Zika virus
ID EPIDEMIOLOGY; BRAZIL
AB Several countries have local transmission of multiple arboviruses, in particular, dengue and Zika viruses, which have recently spread through many American countries. Cross reactivity among Flaviviruses is high and present a challenge for accurate identification of the infecting agent. Thus, we evaluated the level of cross reactivity of anti-dengue IgM/G Enzyme-Linked Immunosorbent Assays (ELISA) from three manufacturers against 122 serum samples obtained at two time-points from 61 patients with non-dengue confirmed Zika virus infection. All anti-dengue ELISAs cross reacted with serum from patients with acute Zika infection at some level and a worrisome number of seroconversion for dengue IgG and IgM was observed. These findings may impact the interpretation of currently standard criteria for dengue diagnosis in endemic regions.
C1 [Felix, Alvina Clara; Santiago Souza, Nathalia C.; Levi, Jose Eduardo; Pannuti, Claudio Sergio; Romano, Camila Malta] Univ Sao Paulo, Inst Med Trop Sao Paulo, Sao Paulo, Brazil.
   [Figueiredo, Walter M.; Costa, Angela A.; Inenami, Marta; da Silva, Rosangela M. G.] Univ Sao Paulo, Fac Saude Publ, SESA, Sao Paulo, Brazil.
RP Romano, CM (corresponding author), Inst Med Trop SP, Av Dr Eneas de Carvalho Aguiar 470, BR-05403000 Sao Paulo, SP, Brazil.
EM cmromano@usp.br
RI Romano, Camila M/C-8185-2013
CR Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Cabral-Castro MJ, 2016, J CLIN VIROL, V82, P108, DOI 10.1016/j.jcv.2016.07.017
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LANCIOTTI RS, 1994, J GEN VIROL, V75, P65, DOI 10.1099/0022-1317-75-1-65
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Figueiredo LTM, 2015, REV SOC BRAS MED TRO, V48, P233, DOI 10.1590/0037-8682-0179-2015
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Sabino EC, 2016, J INFECT DIS, V213, P694, DOI 10.1093/infdis/jiv326
   Vorou R, 2016, EUROSURVEILLANCE, V21, P27, DOI 10.2807/1560-7917.ES.2016.21.10.30161
NR 12
TC 41
Z9 42
U1 0
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD AUG
PY 2017
VL 89
IS 8
BP 1477
EP 1479
DI 10.1002/jmv.24789
PG 3
WC Virology
SC Virology
GA FA2UA
UT WOS:000405295100021
PM 28229481
DA 2020-07-08
ER

PT J
AU Suganya, P
   Vaseeharan, B
   Vijayakumar, S
   Balan, B
   Govindarajan, M
   Alharbi, NS
   Kadaikunnan, S
   Khaled, JM
   Benelli, G
AF Suganya, Periyakaruppan
   Vaseeharan, Baskaralingam
   Vijayakumar, Sekar
   Balan, Banumathi
   Govindarajan, Marimuthu
   Alharbi, Naiyf S.
   Kadaikunnan, Shine
   Khaled, Jamal M.
   Benelli, Giovanni
TI Biopolymer zein-coated gold nanoparticles: Synthesis, antibacterial
   potential, toxicity and histopathological effects against the Zika virus
   vector Aedes aegypti
SO JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
LA English
DT Article
DE Antimicrobial; Dengue; Mosquito control; Bionanotechnology;
   Polymer-mediated nanosynthesis
ID SILVER NANOPARTICLES; GREEN SYNTHESIS; LEAF EXTRACT; PROTEIN;
   BIOSYNTHESIS; ANTIBIOFILM; ANTIOXIDANT; FABRICATION; ANTICANCER;
   TRANSITION
AB The control of multidrug-resistant bacteria as well as insect pests and vectors is timely and important now a days. The present study was designed to evaluate the in vitro antibacterial, antibiofilm and mosquito larvicidal effects of gold nanoparticles synthesized using the zein biopolymer (Ze-AuNPs) against Gram positive (Bacillus pumilus and Bacillus subtilis), Gram negative (Shigella sonnei and Pseudomonas aeruginosa) bacteria and third instar larvae of the dengue and Zika virus vector Aedes aegypti. The synthesized Ze-AuNPs were characterized by UV-vis spectroscopy, X-ray diffraction (XRD), Fourier transform infrared (FTIR) spectroscopy, scanning electron microscopy (SEM), and transmission electron microscopy (TEM). The antibacterial assays testing Ze-AuNPs at 100 mu g/ml showed that the zones of inhibition against Gram positive species B. pumilus and B. subtilis were 13.9 and 14.2 mm, respectively, while for Gram negative S. sonnei and P. aeruginosa they were 18.1 and 18.4 mm, respectively. Light and confocal laser scanning microscopy (CLSM) confirmed the interruption and disintegration of bacterial biofilm post-treatment with Ze-AuNPs at 100 mu g/ml. In larvicidal assays on A. aegypti, HAuCl4 and Ze-AuNPs treated third instar larvae of A. aegypti showed LC50 of 26.6 and 6.81 mg/L, respectively, and LC90 of 81.1 and 13.6 mg/L respectively. The histopathological analysis of A. aegypti treated with Ze-AuNPs showed complete disintegration of abdominal region, particularly the midgut and caeca, with loss of lateral and caudal hairs. The stereomicroscopic visualization of A. aegypti treated with Ze-AuNPs showed the loss of upper head hair, lower head hair, antenna hair, lateral hair and caudal hair. Overall, the study concludes that Ze-AuNPs have excellent antibacterial, antibiofilm effects and has ability to control the larval populations of A. aegypti mosquitoes.
C1 [Suganya, Periyakaruppan; Vaseeharan, Baskaralingam; Vijayakumar, Sekar; Balan, Banumathi] Alagappa Univ, Nanobiosci & Nanopharmacol Div, Dept Anim Hlth & Management, Biomat & Biotechnol Anim Hlth Lab, Sci Campus,6th floor, Karaikkudi 630004, Tamil Nadu, India.
   [Govindarajan, Marimuthu] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [Alharbi, Naiyf S.; Kadaikunnan, Shine; Khaled, Jamal M.] King Saud Univ, Dept Bot & Microbiol, Coll Sci, Riyadh 11451, Saudi Arabia.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
RP Vaseeharan, B (corresponding author), Alagappa Univ, Nanobiosci & Nanopharmacol Div, Dept Anim Hlth & Management, Biomat & Biotechnol Anim Hlth Lab, Sci Campus,6th floor, Karaikkudi 630004, Tamil Nadu, India.
EM vaseeharanb@gmail.com
RI Benelli, Giovanni/A-9100-2013; Khaled, Jamal/D-8188-2017; /L-2836-2013;
   GOVINDARAJAN, MARIMUTHU/A-8070-2019; Sekar/A-8600-2018; Alharbi, Naiyf
   S/B-9402-2019
OI Benelli, Giovanni/0000-0001-8971-6010; /0000-0001-7018-5379;
   GOVINDARAJAN, MARIMUTHU/0000-0002-4662-8931; Sekar/0000-0001-8211-069X; 
FU Department of Biotechnology (DBT), New Delhi, IndiaDepartment of
   Biotechnology (DBT) India [BT/PR7903/AAquote/3/638/2013]; Department of
   Science and Technology (DST), New Delhi, IndiaDepartment of Science &
   Technology (India) [IF140145]; UGCUniversity Grants Commission, India
   [F1-17.1/RGNF-2012-13-SC-TAM-23853]; Deanship of Scientific Research at
   King Saud UniversityDeanship of Scientific Research at King Saud
   University [RG-1438-074]
FX This study was partially supported by Department of Biotechnology (DBT),
   New Delhi, India under the project grants code
   BT/PR7903/AAquote/3/638/2013. SV thank the Department of Science and
   Technology (DST) for grant of INSPIRE fellowship (Ref. No: IF140145),
   New Delhi, India. BB gratefully acknowledges the UGC for grant of Rajiv
   Gandhi National Fellowship (Ref. No: F1-17.1/RGNF-2012-13-SC-TAM-23853).
   The authors extend their appreciation to the Deanship of Scientific
   Research at King Saud University for funding this work through research
   group No. RG-1438-074.
CR Balasubramani G, 2015, J PHOTOCH PHOTOBIO B, V148, P1, DOI 10.1016/j.jphotobiol.2015.03.016
   Balasubramani G, 2015, J TRACE ELEM MED BIO, V30, P83, DOI 10.1016/j.jtemb.2014.11.001
   Banumathi B, 2016, VET PARASITOL, V216, P93, DOI 10.1016/j.vetpar.2015.12.003
   Benelli G, 2017, ENTOMOL GEN, V36, P309, DOI 10.1127/entomologia/2017/0496
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Bindhu MR, 2014, SPECTROCHIM ACTA A, V128, P37, DOI 10.1016/j.saa.2014.02.119
   CASELLA MLA, 1990, J FOOD BIOCHEM, V14, P453, DOI 10.1111/j.1745-4514.1990.tb00806.x
   Chen XD, 2015, APPL SURF SCI, V328, P444, DOI 10.1016/j.apsusc.2014.12.070
   Chwalibog A, 2010, INT J NANOMED, V5, P1085, DOI 10.2147/IJN.S13532
   Dadosh T, 2009, MATER LETT, V63, P2236, DOI 10.1016/j.matlet.2009.07.042
   Das S, 2015, J MOL LIQ, V212, P259, DOI 10.1016/j.molliq.2015.09.020
   Dinesh D, 2015, PARASITOL RES, V114, P1519, DOI 10.1007/s00436-015-4336-z
   Dong FY, 2013, SOFT MATTER, V9, P5933, DOI 10.1039/c3sm50667c
   Fallatah Sahar A. B., 2010, Journal of the Egyptian Society of Parasitology, V40, P1
   Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962
   Forato LA, 1998, ANAL BIOCHEM, V259, P136, DOI 10.1006/abio.1998.2599
   Geethalakshmi R, 2012, INT J NANOMED, V7, P5375, DOI 10.2147/IJN.S36516
   Gong SJ, 2006, BIOMATERIALS, V27, P3793, DOI 10.1016/j.biomaterials.2006.02.019
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Hu K, 2014, FOOD RES INT, V64, P329, DOI 10.1016/j.foodres.2014.07.004
   Huang JL, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/10/105104
   Huang QR, 2010, J FOOD SCI, V75, pR50, DOI 10.1111/j.1750-3841.2009.01457.x
   Ingle A, 2008, CURR NANOSCI, V4, P141, DOI 10.2174/157341308784340804
   Jayaseelan C, 2013, IND CROP PROD, V45, P423, DOI 10.1016/j.indcrop.2012.12.019
   Jiang QR, 2010, ACTA BIOMATER, V6, P4042, DOI 10.1016/j.actbio.2010.04.024
   Kalimuthu K, 2017, PROCESS SAF ENVIRON, V109, P82, DOI 10.1016/j.psep.2017.03.027
   Kalishwaralal K, 2010, COLLOID SURFACE B, V79, P340, DOI 10.1016/j.colsurfb.2010.04.014
   Kalyanasundaram M, 2013, J VECTOR DIS, V50, P225
   Kaviya S, 2011, SPECTROCHIM ACTA A, V79, P594, DOI 10.1016/j.saa.2011.03.040
   Kong BH, 2006, J AGR FOOD CHEM, V54, P6059, DOI 10.1021/jf060632q
   KUMAR CSS, 2007, NANOMATERIALS CANC D
   LAHKIMTSROR L, 1983, J INVERTEBR PATHOL, V41, P104, DOI 10.1016/0022-2011(83)90241-0
   LAWTON JW, 1992, CEREAL CHEM, V69, P351
   Liu XM, 2005, BIOMATERIALS, V26, P109, DOI 10.1016/j.biomaterials.2004.02.013
   MAGOSHI J, 1992, J APPL POLYM SCI, V45, P2043, DOI 10.1002/app.1992.070451119
   Mahal A, 2013, ACS SUSTAIN CHEM ENG, V1, P627, DOI 10.1021/sc300176r
   Manju S, 2016, MICROB PATHOGENESIS, V91, P129, DOI 10.1016/j.micpath.2015.11.021
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Muthuvel A, 2014, BIOMED PREV NUTR, V4, P325, DOI DOI 10.1016/J.BIONUT.2014.03.004
   Rai V. Ravishankar, 2011, SCI MICROBIAL PATHOG, P197
   Sathishkumar G, 2016, J MOL LIQ, V215, P229, DOI 10.1016/j.molliq.2015.12.043
   Sun RWY, 2007, DALTON T, P4884, DOI 10.1039/b705079h
   Svedman C, 2005, CONTACT DERMATITIS, V52, P192, DOI 10.1111/j.0105-1873.2005.00522.x
   Tavares LL, 2012, CIENCIA TECNOL ALIME, V32, P314, DOI 10.1590/S0101-20612012005000056
   Unnithan AR, 2014, CARBOHYD POLYM, V102, P884, DOI 10.1016/j.carbpol.2013.10.070
   Vaseeharan B., 2013, J COMPOS MATER, V1, P1
   Vinoj G, 2015, ANTIMICROB AGENTS CH, V59, P763, DOI 10.1128/AAC.03047-14
   Wen L, 2009, J NANOPART RES, V11, P279, DOI 10.1007/s11051-008-9378-z
   *WHO, 1996, CTDWHOPESIC961, P69
   Zhao YY, 2010, J AM CHEM SOC, V132, P12349, DOI 10.1021/ja1028843
NR 52
TC 23
Z9 24
U1 4
U2 30
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1011-1344
J9 J PHOTOCH PHOTOBIO B
JI J. Photochem. Photobiol. B-Biol.
PD AUG
PY 2017
VL 173
BP 404
EP 411
DI 10.1016/j.jphotobiol.2017.06.004
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA FE1NI
UT WOS:000407984500043
PM 28654862
DA 2020-07-08
ER

PT J
AU Fulton, BO
   Sachs, D
   Schwarz, MC
   Palese, P
   Evans, MJ
AF Fulton, Benjamin O.
   Sachs, David
   Schwarz, Megan C.
   Palese, Peter
   Evans, Matthew J.
TI Transposon Mutagenesis of the Zika Virus Genome Highlights Regions
   Essential for RNA Replication and Restricted for Immune Evasion
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE Zika virus; genetic mapping; mutagenesis; transposons
ID NS1 PROTEIN; ANTIBODIES; GLYCOSYLATION; DETERMINANTS; PATHOGENESIS;
   SURFACE
AB The molecular constraints affecting Zika virus (ZIKV) evolution are not well understood. To investigate ZIKV genetic flexibility, we used transposon mutagenesis to add 15-nucleotide insertions throughout the ZIKV MR766 genome and subsequently deep sequenced the viable mutants. Few ZIKV insertion mutants replicated, which likely reflects a high degree of functional constraints on the genome. The NS1 gene exhibited distinct mutational tolerances at different stages of the screen. This result may define regions of the NS1 protein that are required for the different stages of the viral life cycle. The ZIKV structural genes showed the highest degree of insertional tolerance. Although the envelope (E) protein exhibited particular flexibility, the highly conserved envelope domain II (EDII) fusion loop of the E protein was intolerant of transposon insertions. The fusion loop is also a target of pan-flavivirus antibodies that are generated against other flaviviruses and neutralize a broad range of dengue virus and ZIKV isolates. The genetic restrictions identified within the epitopes in the EDII fusion loop likely explain the sequence and antigenic conservation of these regions in ZIKV and among multiple flaviviruses. Thus, our results provide insights into the genetic restrictions on ZIKV that may affect the evolution of this virus.
   IMPORTANCE Zika virus recently emerged as a significant human pathogen. Determining the genetic constraints on Zika virus is important for understanding the factors affecting viral evolution. We used a genome-wide transposon mutagenesis screen to identify where mutations were tolerated in replicating viruses. We found that the genetic regions involved in RNA replication were mostly intolerant of mutations. The genes coding for structural proteins were more permissive to mutations. Despite the flexibility observed in these regions, we found that epitopes bound by broadly reactive antibodies were genetically constrained. This finding may explain the genetic conservation of these epitopes among flaviviruses.
C1 [Fulton, Benjamin O.; Schwarz, Megan C.; Palese, Peter; Evans, Matthew J.] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
   [Sachs, David] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.
   [Palese, Peter] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA.
RP Palese, P; Evans, MJ (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.; Palese, P (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA.
EM peter.palese@mssm.edu; matthew.evans@mssm.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01DK095125, 5U19AI109946-03]; CEIRS
   [HHSN272201400008C]; Burroughs Wellcome FundBurroughs Wellcome Fund
FX This work was supported by the following grants: NIH grant R01DK095125
   (M.J.E.), NIH grant 5U19AI109946-03 (P.P.), and CEIRS grant
   HHSN272201400008C (P.P.). M.J.E. holds an Investigators in Pathogenesis
   of Infectious Disease Award from the Burroughs Wellcome Fund.
CR Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Arumugaswami V, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000182
   Ashenberg O, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006288
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Beitzel BF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001146
   Belshaw R, 2007, GENOME RES, V17, P1496, DOI 10.1101/gr.6305707
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Crabtree MB, 2005, ARCH VIROL, V150, P771, DOI 10.1007/s00705-004-0430-8
   Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Doud MB, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060155
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fernandes JD, 2016, CELL, V167, P1762, DOI 10.1016/j.cell.2016.11.031
   Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999
   Forrester NL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002897
   Fulton BO, 2015, CELL REP, V11, P1331, DOI 10.1016/j.celrep.2015.04.054
   Haddox HK, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006114
   Heaton NS, 2013, P NATL ACAD SCI USA, V110, P20248, DOI 10.1073/pnas.1320524110
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Lange A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000536
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   PRYOR MJ, 1994, J GEN VIROL, V75, P1183, DOI 10.1099/0022-1317-75-5-1183
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Rernenyi R, 2014, MBIO, V5
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Scaturro P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005277
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Somnuke P, 2011, VIROLOGY, V413, P253, DOI 10.1016/j.virol.2011.02.022
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Thyagarajan B, 2014, ELIFE, V3, DOI 10.7554/eLife.03300
   Varble A, 2014, CELL HOST MICROBE, V16, P691, DOI 10.1016/j.chom.2014.09.020
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Wang TT, 2017, SCIENCE, V355, P395, DOI 10.1126/science.aai8128
   Wu Nicholas C, 2014, Sci Rep, V4, P4942, DOI 10.1038/srep04942
   Xu X, 2016, PLOS CURR, V8
   Youn S, 2012, J VIROL, V86, P7360, DOI 10.1128/JVI.00157-12
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 48
TC 16
Z9 16
U1 1
U2 15
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD AUG
PY 2017
VL 91
IS 15
AR UNSP e00698-17
DI 10.1128/JVI.00698-17
PG 16
WC Virology
SC Virology
GA FB0WV
UT WOS:000405866600034
PM 28515302
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Nalls, AV
   McNulty, E
   Hoover, CE
   Pulscher, LA
   Hoover, EA
   Mathiason, CK
AF Nalls, Amy V.
   McNulty, Erin
   Hoover, Clare E.
   Pulscher, Laura A.
   Hoover, Edward A.
   Mathiason, Candace K.
TI Infectious Prions in the Pregnancy Microenvironment of Chronic Wasting
   Disease-Infected Reeves' Muntjac Deer
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE CWD; maternal; pregnancy; prions
ID CREUTZFELDT-JAKOB-DISEASE; BOVINE SPONGIFORM ENCEPHALOPATHY;
   QUAKING-INDUCED CONVERSION; IN-UTERO TRANSMISSION; ROCKY-MOUNTAIN ELK;
   BLOOD-TRANSFUSION; PRPSC ACCUMULATION; CLASSICAL SCRAPIE; MULE DEER;
   VERTICAL TRANSMISSION
AB Ample evidence exists for the presence of infectious agents at the maternal-fetal interface, often with grave outcomes to the developing fetus (i.e., Zika virus, brucella, cytomegalovirus, and toxoplasma). While less studied, pregnancy-related transmissible spongiform encephalopathies (TSEs) have been implicated in several species, including humans. Our previous work has shown that prions can be transferred from mother to offspring, resulting in the development of clinical TSE disease in offspring born to muntjac dams infected with chronic wasting disease (CWD) (1). We further demonstrated protein misfolding cyclic amplification (PMCA)-competent prions within the female reproductive tract and in fetal tissues harvested from CWD experimentally and naturally exposed cervids (1, 2). To assess whether the PMCA-competent prions residing at the maternal-fetal interface were infectious and to determine if the real-time quaking-induced conversion (RT-QuIC) methodology may enhance our ability to detect amyloid fibrils within the pregnancy microenvironment, we employed a mouse bioassay and RT-QuIC. In this study, we have demonstrated RT-QuIC seeding activity in uterus, placentome, ovary, and amniotic fluid but not in allantoic fluids harvested from CWD-infected Reeves' muntjac dams showing clinical signs of infection (clinically CWD-infected) and in some placentomes from pre-clinically CWD-infected dams. Prion infectivity was confirmed within the uterus, amniotic fluid, and the placentome, the semipermeable interface that sustains the developing fetus, of CWD-infected dams. This is the first report of prion infectivity within the cervid pregnancy microenvironment, revealing a source of fetal CWD exposure prior to the birthing process, maternal grooming, or encounters with contaminated environments.
   IMPORTANCE The facile dissemination of chronic wasting disease within captive and free-range cervid populations has led to questions regarding the transmission dynamics of this disease. Direct contact with infected animals and indirect contact with infectious prions in bodily fluids and contaminated environments are suspected to explain the majority of this transmission. A third mode of transmission, from mother to offspring, may be underappreciated. The presence of pregnancy-related prion infectivity within the uterus, amniotic fluid, and the placental structure reveals that the developing fetus is exposed to a source of prions long before exposure to the infectious agent during and after the birthing process or via contact with contaminated environments. These findings have impact on our current concept of CWD disease transmission.
C1 [Nalls, Amy V.; McNulty, Erin; Hoover, Clare E.; Pulscher, Laura A.; Hoover, Edward A.; Mathiason, Candace K.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
RP Mathiason, CK (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
EM candace.mathiason@colostate.edu
FU NIH-NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01AI093634]; College of Veterinary
   Medicine and Biological Sciences College Research Council; Department of
   Microbiology, Immunology and Pathology
FX This work was supported by NIH-NIAID R01AI093634 and by the College of
   Veterinary Medicine and Biological Sciences College Research Council and
   the Department of Microbiology, Immunology and Pathology.
CR ABUYOUSEF MM, 1987, AM J ROENTGENOL, V149, P737, DOI 10.2214/ajr.149.4.737
   Aguilar-Calvo P, 2015, VIRUS RES, V207, P82, DOI 10.1016/j.virusres.2014.11.026
   Alverson J, 2006, J GEN VIROL, V87, P1035, DOI 10.1099/vir.0.81418-0
   Andreoletti O, 2002, J GEN VIROL, V83, P2607, DOI 10.1099/0022-1317-83-10-2607
   Andreoletti O, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002782
   Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066
   Beekes M, 2007, FEBS J, V274, P588, DOI 10.1111/j.1742-4658.2007.05631.x
   Belay ED, 2005, EMERG INFECT DIS, V11, P1351, DOI 10.3201/eid1109.050371
   Bencsik A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006929
   Benestad SL, 2016, VET RES, V47, DOI 10.1186/s13567-016-0375-4
   Benirschke K., 2012, COMP PLACENTATION
   Blanchong JA, 2012, J WILDLIFE DIS, V48, P361, DOI 10.7589/0090-3558-48.2.361
   Browning SR, 2004, J VIROL, V78, P13345, DOI 10.1128/JVI.78.23.13345-13350.2004
   BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0
   Garza MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027525
   Casalone C, 2005, J VIROL, V79, P5847, DOI 10.1128/JVI.79.9.5847-5849.2005
   Castilla J, 2005, J VIROL, V79, P8665, DOI 10.1128/JVI.79.13.8665-8668.2005
   Cho CKJ, 2007, MOL CELL PROTEOMICS, V6, P1406, DOI 10.1074/mcp.M700090-MCP200
   CLARKE MC, 1967, VET REC, V80, P504, DOI 10.1136/vr.80.16.504
   Cohen ML, 2014, PATHOBIOLOGY OF HUMAN DISEASE: A DYNAMIC ENCYCLOPEDIA OF DISEASE MECHANISMS, P2045, DOI 10.1016/B978-0-12-386456-7.04619-0
   DeJoia C, 2006, J VIROL, V80, P4546, DOI 10.1128/JVI.80.9.4546-4556.2006
   DICKINSO.AG, 1965, HEREDITY, V20, P485, DOI 10.1038/hdy.1965.64
   DICKINSON AG, 1975, NATURE, V256, P732, DOI 10.1038/256732a0
   DICKINSON AG, 1974, J COMP PATHOL, V84, P19, DOI 10.1016/0021-9975(74)90023-1
   DICKINSON AG, 1979, SLOW TRANSMISSIBLE D, V2, P13
   Donaldson DS, 2015, J VIROL, V89, P9532, DOI 10.1128/JVI.01544-15
   Donnelly CA, 1997, P ROY SOC B-BIOL SCI, V264, P1647, DOI 10.1098/rspb.1997.0229
   EKLUND CM, 1967, J INFECT DIS, V117, P15, DOI 10.1093/infdis/117.1.15
   Forde N, 2008, MOL REPROD DEV, V75, P243, DOI 10.1002/mrd.20807
   Foster JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079433
   Fox KA, 2006, J GEN VIROL, V87, P3451, DOI 10.1099/vir.0.81999-0
   Fujisawa M, 2004, J REPROD DEVELOP, V50, P565, DOI 10.1262/jrd.50.565
   Gill ON, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5675
   Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007
   Grassi R, 2005, AM J ROENTGENOL, V185, P1322, DOI 10.2214/AJR.04.1114
   HADLOW WJ, 1982, J INFECT DIS, V146, P657, DOI 10.1093/infdis/146.5.657
   Hafez S, 2017, PROG MOL BIOL TRANSL, V145, P1, DOI 10.1016/bs.pmbts.2016.12.001
   Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004848
   HARDING R, 1984, Q J EXP PHYSIOL CMS, V69, P487, DOI 10.1113/expphysiol.1984.sp002835
   Henderson DM, 2015, J VIROL, V89, P9338, DOI 10.1128/JVI.01118-15
   Henderson DM, 2015, J GEN VIROL, V96, P210, DOI 10.1099/vir.0.069906-0
   Hoover CE, 2016, SCI REP-UK, V6, DOI 10.1038/srep25098
   HORIUCHI M, 1995, J GEN VIROL, V76, P2583, DOI 10.1099/0022-1317-76-10-2583
   Houston F, 2000, LANCET, V356, P999, DOI 10.1016/S0140-6736(00)02719-7
   Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897
   Johnson ML, 2014, REPRODUCTION, V148, P1, DOI 10.1530/REP-13-0548
   KIMBERLIN RH, 1981, BRIT VET J, V137, P105
   KIMBERLIN RH, 1990, ARCH VIROL, V112, P103, DOI 10.1007/BF01348988
   Lacroux C, 2007, J GEN VIROL, V88, P1056, DOI 10.1099/vir.0.82218-0
   Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X
   Maltepe E, 2010, J CLIN INVEST, V120, P1016, DOI 10.1172/JCI41211
   Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661
   Mathiason CK, 2010, J VIROL, V84, P5097, DOI 10.1128/JVI.02169-09
   Mathiason CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005916
   Mathiason CK, 2004, 56 P AN PRION DIS AM
   McCutcheon S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023169
   Miller MW, 1998, J WILDLIFE DIS, V34, P532, DOI 10.7589/0090-3558-34.3.532
   Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010
   Miranda A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018422
   Mulcahy ER, 2004, J VIROL, V78, P6792, DOI 10.1128/JVI.78.13.6792-6798.2004
   Murray K, 2011, J NEUROL NEUROSUR PS, V82, P729, DOI 10.1136/jnnp.2009.172148
   Murugavel K., 2014, Indian Journal of Animal Reproduction, V35, P31
   MYAGKAYA G, 1981, CELL TISSUE RES, V214, P501, DOI 10.1007/BF00233491
   Nails AV, 2013, PLOS ONE, V8
   Notari S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008765
   O'Rourke KI, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-7
   ONODERA T, 1993, MICROBIOL IMMUNOL, V37, P311, DOI 10.1111/j.1348-0421.1993.tb03215.x
   Orru CD, 2015, MBIO, V6, DOI 10.1128/mBio.02451-14
   Orru CD, 2015, J CLIN MICROBIOL, V53, P1115, DOI 10.1128/JCM.02906-14
   Pattison I H, 1972, J Clin Pathol Suppl (R Coll Pathol), V6, P110
   PATTISON IH, 1972, VET REC, V90, P465, DOI 10.1136/vr.90.17.465
   PATTISON IH, 1962, J COMP PATHOL THERAP, V72, P233, DOI 10.1016/S0368-1742(62)80026-5
   Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6
   PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762
   Reynolds LP, 2001, BIOL REPROD, V64, P1033, DOI 10.1095/biolreprod64.4.1033
   Robbins JR, 2012, CURR OPIN MICROBIOL, V15, P36, DOI 10.1016/j.mib.2011.11.006
   Ross MG, 1998, AM J PHYSIOL-REG I, V274, pR879
   Safar JG, 2008, J INFECT DIS, V198, P81, DOI 10.1086/588193
   Schneider DA, 2015, J GEN VIROL, V96, P2464, DOI 10.1099/vir.0.000151
   Seelig DM, 2010, AM J PATHOL, V176, P2785, DOI 10.2353/ajpath.2010.090710
   Selariu A, 2015, J GEN VIROL, V96, P3444, DOI 10.1099/jgv.0.000281
   Sigurdson CJ, 2001, J GEN VIROL, V82, P2327, DOI 10.1099/0022-1317-82-10-2327
   Spiropoulos J, 2014, J VIROL, V88, P4591, DOI 10.1128/JVI.03264-13
   TAMAI Y, 1992, NEW ENGL J MED, V327, P649
   Tamguney G, 2009, NATURE, V461, P529, DOI 10.1038/nature08289
   Terry LA, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-65
   Thumdee P, 2007, GENE EXPRESSION, V13, P283
   Tuo WB, 2002, P NATL ACAD SCI USA, V99, P6310, DOI 10.1073/pnas.072071199
   Tuo WB, 2001, J BIOL CHEM, V276, P18229, DOI 10.1074/jbc.M008887200
   Underwood Mark A, 2005, J Perinatol, V25, P341, DOI 10.1038/sj.jp.7211290
   Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4
   Wilesmith JW, 2010, VET REC, V167, P279, DOI 10.1136/vr.c4552
   Wilesmith JW, 1997, VET REC, V141, P239, DOI 10.1136/vr.141.10.239
   Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217
   Williams E.S., 1992, Revue Scientifique et Technique Office International des Epizooties, V11, P551
   WINTOUR EM, 1986, AUST VET J, V63, P216, DOI 10.1111/j.1751-0813.1986.tb02999.x
   WINTOUR EM, 1993, SEMIN PERINATOL, V17, P158
   Wooding FB, 1994, MARSHALLS PHYSL REPR, V4, P235
   Wooding FBP, 1997, MICROSC RES TECHNIQ, V38, P88
   Wrathall AE, 2008, THERIOGENOLOGY, V70, P725, DOI 10.1016/j.theriogenology.2008.05.049
   Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8
   Xiao XZ, 2009, AM J PATHOL, V174, P1602, DOI 10.2353/ajpath.2009.081045
NR 102
TC 9
Z9 9
U1 0
U2 9
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD AUG
PY 2017
VL 91
IS 15
AR UNSP e00501
DI 10.1128/JVI.00501-17
PG 15
WC Virology
SC Virology
GA FB0WV
UT WOS:000405866600017
PM 28539446
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Suzuki, Y
   Frangeul, L
   Dickson, LB
   Blanc, H
   Verdier, Y
   Vinh, J
   Lambrechts, L
   Saleh, MC
AF Suzuki, Yasutsugu
   Frangeul, Lionel
   Dickson, Laura B.
   Blanc, Herve
   Verdier, Yann
   Vinh, Joelle
   Lambrechts, Louis
   Saleh, Maria-Carla
TI Uncovering the Repertoire of Endogenous Flaviviral Elements in Aedes
   Mosquito Genomes
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE ancient flaviviral infections; endogenous viral elements; mosquito-borne
   viruses; mosquito genome; viral infectious diseases
ID INSECT FLAVIVIRUS; RNA VIRUSES; AEGYPTI; EVOLUTION; SEQUENCE; INFECTION;
   PIRNAS; PIWI; DNA; INTERFERENCE
AB Endogenous viral elements derived from nonretroviral RNA viruses have been described in various animal genomes. Whether they have a biological function, such as host immune protection against related viruses, is a field of intense study. Here, we investigated the repertoire of endogenous flaviviral elements (EFVEs) in Aedes mosquitoes, the vectors of arboviruses such as dengue and chikungunya viruses. Previous studies identified three EFVEs from Aedes albopictus cell lines and one from Aedes aegypti cell lines. However, an in-depth characterization of EFVEs in wild-type mosquito populations and individual mosquitoes in vivo has not been performed. We detected the full-length DNA sequence of the previously described EFVEs and their respective transcripts in several A. albopictus and A. aegypti populations from geographically distinct areas. However, EFVE-derived proteins were not detected by mass spectrometry. Using deep sequencing, we detected the production of PIWI-interacting RNA-like small RNAs, in an antisense orientation, targeting the EFVEs and their flanking regions in vivo. The EFVEs were integrated in repetitive regions of the mosquito genomes, and their flanking sequences varied among mosquito populations. We bioinformatically predicted several new EFVEs from a Vietnamese A. albopictus population and observed variation in the occurrence of those elements among mosquitoes. Phylogenetic analysis of an A. aegypti EFVE suggested that it integrated prior to the global expansion of the species and subsequently diverged among and within populations. The findings of this study together reveal the substantial structural and nucleotide diversity of flaviviral integrations in Aedes genomes. Unraveling this diversity will help to elucidate the potential biological function of these EFVEs.
   IMPORTANCE Endogenous viral elements (EVEs) are whole or partial viral sequences integrated in host genomes. Interestingly, some EVEs have important functions for host fitness and antiviral defense. Because mosquitoes also have EVEs in their genomes, characterizing these EVEs is a prerequisite for their potential use to manipulate the mosquito antiviral response. In the study described here, we focused on EVEs related to the Flavivirus genus, to which dengue and Zika viruses belong, in individual Aedes mosquitoes from geographically distinct areas. We show the existence in vivo of flaviviral EVEs previously identified in mosquito cell lines, and we detected new ones. We show that EVEs have evolved differently in each mosquito population. They produce transcripts and small RNAs but not proteins, suggesting a function at the RNA level. Our study uncovers the diverse repertoire of flaviviral EVEs in Aedes mosquito populations and contributes to an understanding of their role in the host antiviral system.
C1 [Suzuki, Yasutsugu; Frangeul, Lionel; Blanc, Herve; Saleh, Maria-Carla] CNRS, Inst Pasteur, Viruses & RNA Interference Unit, Unite Mixte Rech 3569, Paris, France.
   [Dickson, Laura B.; Lambrechts, Louis] CNRS, Inst Pasteur, Dept Genom & Genet, Insect Virus Interact Grp,Unite Rech Associee 301, Paris, France.
   [Verdier, Yann; Vinh, Joelle] CNRS, Spectrometrie Masse Biol & Proteom, Unite Serv & Rech 3149, Ecole Super Phys & Chim Ind Paris, Paris, France.
RP Saleh, MC (corresponding author), CNRS, Inst Pasteur, Viruses & RNA Interference Unit, Unite Mixte Rech 3569, Paris, France.
EM carla.saleh@pasteur.fr
RI Vinh, Joelle/K-1347-2015; Suzuki, Yasutsugu/Z-2378-2019; Lambrechts,
   Louis/A-2057-2010
OI Vinh, Joelle/0000-0001-7184-2668; Suzuki, Yasutsugu/0000-0002-8202-3032;
   Saleh, Maria-Carla/0000-0001-8593-4117; Lambrechts,
   Louis/0000-0001-5958-2138; Verdier, Yann/0000-0002-3319-0053
FU European Research CouncilEuropean Research Council (ERC) [FP7/2013-2019
   ERC CoG 615220]; French Government's Investissement d'Avenir Program,
   Laboratoire d'Excellence Integrative Biology of Emerging Infectious
   DiseasesFrench National Research Agency (ANR) [ANR-10-LABX-62-IBEID];
   City of Paris Emergence(s) Program in Biomedical ResearchRegion
   Ile-de-France; European Union's Horizon Research and Innovation Program
   under ZikaPLAN grant [734584]; Conseil Regional Ile de France (Sesame
   grant) [10022268]; Roux-Cantarini postdoctoral fellowships; Japan
   Society for the Promotion of Science postdoctoral fellowships for
   research abroadMinistry of Education, Culture, Sports, Science and
   Technology, Japan (MEXT)Japan Society for the Promotion of Science
FX This work was supported by the European Research Council (FP7/2013-2019
   ERC CoG 615220 to M.-C.S.), the French Government's Investissement
   d'Avenir Program, Laboratoire d'Excellence Integrative Biology of
   Emerging Infectious Diseases (grant ANR-10-LABX-62-IBEID to L.L. and
   M.-C.S.), the City of Paris Emergence(s) Program in Biomedical Research
   (to L.L.), the European Union's Horizon 2020 Research and Innovation
   Program under ZikaPLAN grant agreement no. 734584 (to L.L.), and the
   Conseil Regional Ile de France (Sesame 2010 grant agreement 10022268 to
   J.V.). Y.S. is supported by Roux-Cantarini postdoctoral fellowships and
   Japan Society for the Promotion of Science postdoctoral fellowships for
   research abroad.
CR Anderson MM, 2000, SCIENCE, V287, P1828, DOI 10.1126/science.287.5459.1828
   Arensburger P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-606
   Bejarano ER, 1996, P NATL ACAD SCI USA, V93, P759, DOI 10.1073/pnas.93.2.759
   Belyi VA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001030
   Best S, 1996, NATURE, V382, P826, DOI 10.1038/382826a0
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Bryant B, 2010, P NATL ACAD SCI USA, V107, P22391, DOI 10.1073/pnas.1016230107
   Burt FJ, 2017, LANCET INFECT DIS, V17, pE107, DOI 10.1016/S1473-3099(16)30385-1
   CAMMISAPARKS H, 1992, VIROLOGY, V189, P511, DOI 10.1016/0042-6822(92)90575-A
   Caron MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066433
   Chen XG, 2015, P NATL ACAD SCI USA, V112, pE5907, DOI 10.1073/pnas.1516410112
   Chiba S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002146
   CONDREAY LD, 1986, J VIROL, V58, P81, DOI 10.1128/JVI.58.1.81-86.1986
   Crabtree MB, 2003, ARCH VIROL, V148, P1095, DOI 10.1007/s00705-003-0019-7
   Crochu S, 2004, J GEN VIROL, V85, P1971, DOI 10.1099/vir.0.79850-0
   Fansiri T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003621
   Fischer MG, 2016, NATURE, V540, P288, DOI 10.1038/nature20593
   Fontaine A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24885
   Fort P, 2012, MOL BIOL EVOL, V29, P381, DOI 10.1093/molbev/msr226
   Forum on Microbial Threats; Board on Global Health, 2016, GLOB HLTH IMP VECT B
   Fujino K, 2014, P NATL ACAD SCI USA, V111, P13175, DOI 10.1073/pnas.1407046111
   Girardi E, 2017, NUCLEIC ACIDS RES, V45, P4881, DOI 10.1093/nar/gkw1368
   Goh WSS, 2015, GENE DEV, V29, P1032, DOI 10.1101/gad.260455.115
   Goic B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12410
   Goic B, 2013, NAT IMMUNOL, V14, P396, DOI 10.1038/ni.2542
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Holmes EC, 2011, CELL HOST MICROBE, V10, P368, DOI 10.1016/j.chom.2011.09.002
   Horie M, 2010, NATURE, V463, P84, DOI 10.1038/nature08695
   Hoshino K, 2009, VIROLOGY, V391, P119, DOI 10.1016/j.virol.2009.06.025
   Katzourakis A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001191
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   LAN Q, 1990, AM J TROP MED HYG, V43, P669, DOI 10.4269/ajtmh.1990.43.669
   Leger P, 2013, J VIROL, V87, P1631, DOI 10.1128/JVI.02795-12
   Lequime S, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vew035
   Liu SP, 2014, P NATL ACAD SCI USA, V111, P14460, DOI 10.1073/pnas.1416278111
   Lucas KJ, 2015, P NATL ACAD SCI USA, V112, P1440, DOI 10.1073/pnas.1424408112
   Luteijn MJ, 2013, NAT REV GENET, V14, P523, DOI 10.1038/nrg3495
   Miesen P, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006017
   Miesen P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004452
   Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   Parrish NF, 2015, RNA, V21, P1691, DOI 10.1261/rna.052092.115
   Post C, 2014, RNA, V20, P1977, DOI 10.1261/rna.046300.114
   Powell JR, 2016, SCIENCE, V354, P971, DOI 10.1126/science.aal1717
   Roiz D, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-93
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Sim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010678
   Suzuki Y, 2017, BIORXIV
   Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333
   Waldock J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001565
   Walker T, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-382
   Zhang P, 2015, CELL RES, V25, P193, DOI [10.1038/cr.2015.4, 10.1038/cr.2015.14]
NR 53
TC 36
Z9 36
U1 0
U2 7
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD AUG
PY 2017
VL 91
IS 15
AR UNSP e00571-17
DI 10.1128/JVI.00571-17
PG 20
WC Virology
SC Virology
GA FB0WV
UT WOS:000405866600025
PM 28539440
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Moi, ML
   Nguyen, TTT
   Nguyen, CT
   Vu, TBH
   Tun, MMN
   Pham, TD
   Pham, NT
   Tran, T
   Morita, K
   Le, TQM
   Dang, DA
   Hasebe, F
AF Meng Ling Moi
   Thi Thu Thuy Nguyen
   Co Thach Nguyen
   Thi Bich Hau Vu
   Mya Myat Ngwe Tun
   Tho Duoc Pham
   Ngoc Thanh Pham
   Thuan Tran
   Morita, Kouichi
   Thi Quynh Mai Le
   Duc Anh Dang
   Hasebe, Futoshi
TI Zika virus infection and microcephaly in Vietnam
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
C1 [Meng Ling Moi; Mya Myat Ngwe Tun; Morita, Kouichi; Hasebe, Futoshi] Nagasaki Univ, Inst Trop Med, WHO Collaborating Ctr Reference & Res Trop & Emer, Nagasaki 8528523, Japan.
   [Thi Thu Thuy Nguyen; Co Thach Nguyen; Thi Bich Hau Vu; Thi Quynh Mai Le; Duc Anh Dang] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam.
   [Tho Duoc Pham; Ngoc Thanh Pham] Inst Hyg & Epidemiol Tay Nguyen, Dak Lak, Vietnam.
   [Thuan Tran] Prevent Med Ctr, Krong Buk Dist, Vietnam.
RP Moi, ML (corresponding author), Nagasaki Univ, Inst Trop Med, WHO Collaborating Ctr Reference & Res Trop & Emer, Nagasaki 8528523, Japan.
EM rainbow@nagasaki-u.ac.jp
FU Japan Initiative for Global Research Network on Infectious Diseases
   (JGRID)Ministry of Education, Culture, Sports, Science and Technology,
   Japan (MEXT); Research Program on Emerging and Re-emerging Infectious
   Diseases of the Japan Agency for Medical Research and Development
   (AMED)Japan Agency for Medical Research and Development (AMED); e-Asia
   Joint Research Program (e-Asia JRP) of the Japan Science and Technology
   Agency (JST); MSD Life Science Foundation International
FX We declare no competing interests. We thank the health-care
   practitioners of the clinics and hospitals in Vietnam who supported the
   study. We thank Phu Ly Minh Huong and Satoshi Shimada for helpful
   discussion. We also thank Shashika Lavangi Wijesooriya for technical
   assistance. This work was supported by grants from the Japan Initiative
   for Global Research Network on Infectious Diseases (JGRID) and the
   Research Program on Emerging and Re-emerging Infectious Diseases of the
   Japan Agency for Medical Research and Development (AMED); e-Asia Joint
   Research Program (e-Asia JRP) of the Japan Science and Technology Agency
   (JST); and MSD Life Science Foundation International. The ethics
   committee of the Institute of Tropical Medicine, Nagasaki University,
   Japan (08061924-7) and National Institute of Hygiene and Epidemiology,
   Hanoi, Vietnam (IRB-VN01057/2016) approved the study.
CR Cao-Lormeau V. M., 2016, LANCET
   Duong V, 2017, INT J INFECT DIS, V54, P121, DOI 10.1016/j.ijid.2016.11.420
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Oladapo OT, 2016, LANCET GLOB HEALTH, V4, pE510, DOI 10.1016/S2214-109X(16)30098-5
   The Singapore Zika Study Group, 2017, LANCET INFECT DIS
NR 5
TC 20
Z9 22
U1 1
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD AUG
PY 2017
VL 17
IS 8
BP 805
EP 806
DI 10.1016/S1473-3099(17)30412-7
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA FB0TC
UT WOS:000405856500020
PM 28741545
OA Bronze
DA 2020-07-08
ER

PT J
AU Ho, ZJM
   Hapuarachchi, HC
   Barkham, T
   Chow, LPA
   Ng, LC
   Lee, JMV
   Leo, YS
   Prem, K
   Lim, YHG
   de Sessions, PF
   Rabaa, MA
   Chong, CS
   Tan, CH
   Rajarethinam, J
   Tan, J
   Anderson, DE
   Ong, X
   Cook, AR
   Chong, CY
   Hsu, LY
   Yap, G
   Lai, YL
   Chawla, T
   Pan, L
   Sim, S
   Chen, ICM
   Thoon, KC
   Yung, CF
   Li, JH
   Ng, HLD
   Nandar, K
   Ooi, PL
   Lin, RTP
   Aw, P
   Uehara, A
   De, PP
   Soon, W
   Hibberd, ML
   Ng, HH
   Maurer-Stroh, S
   Sessions, OM
AF Ho, Zheng Jie Marc
   Hapuarachchi, Hapuarachchige Chanditha
   Barkham, Timothy
   Chow, Li Ping Angela
   Ng, Lee Ching
   Lee, Jian Ming Vernon
   Leo, Yee Sin
   Prem, Kiesha
   Lim, Yue Hui Georgina
   de Sessions, Paola F.
   Rabaa, Maia A.
   Chong, Chee Seng
   Tan, Cheong Huat
   Rajarethinam, Jayanthi
   Tan, Junhao
   Anderson, Danielle E.
   Ong, Xinmei
   Cook, Alex R.
   Chong, Chia Yin
   Hsu, Li Yang
   Yap, Grace
   Lai, Yee Ling
   Chawla, Tanu
   Pan, Louise
   Sim, Shuzhen
   Chen, I-Cheng Mark
   Thoon, Koh Cheng
   Yung, Chee Fu
   Li, Jia Hui
   Ng, Hee Ling Deborah
   Nandar, Khine
   Ooi, Peng Lim
   Lin, Raymond Tzer Pin
   Aw, Pauline
   Uehara, Anna
   De, Partha Pratim
   Soon, Wendy
   Hibberd, Martin Lloyd
   Ng, Huck Hui
   Maurer-Stroh, Sebastian
   Sessions, October M.
CA Singapore Zika Study Grp
TI Outbreak of Zika virus infection in Singapore: an epidemiological,
   entomological, virological, and clinical analysis
SO LANCET INFECTIOUS DISEASES
LA English
DT Article
ID DENGUE VIRUS; SURVEILLANCE; STATES
AB Background An outbreak of Zika virus infection was detected in Singapore in August, 2016. We report the first comprehensive analysis of a national response to an outbreak of Zika virus infection in Asia.
   Methods In the first phase of the outbreak, patients with suspected Zika virus infection were isolated in two national referral hospitals until their serum tested negative for the virus. Enhanced vector control and community engagement measures were deployed in disease clusters, including stepped-up mosquito larvicide and adulticide use, community participation in source reduction (destruction of mosquito breeding sites), and work with the local media to promote awareness of the outbreak. Clinical and epidemiological data were collected from patients with confirmed Zika virus infection during the first phase. In the second phase, admission into hospitals for isolation was stopped but vector control efforts continued. Mosquitoes were captured from areas with Zika disease clusters to assess which species were present, their breeding numbers, and to test for Zika virus. Mosquito virus strains were compared with human strains through phylogenetic analysis after full genome sequencing. Reproductive numbers and inferred dates of strain diversification were estimated through Bayesian analyses.
   Findings From Aug 27 to Nov 30, 2016, 455 cases of Zika virus infection were confirmed in Singapore. Of 163 patients with confirmed Zika virus infection who presented to national referral hospitals during the first phase of the outbreak, Zika virus was detected in the blood samples of 97 (60%) patients and the urine samples of 157 (96%) patients. There were 15 disease clusters, 12 of which had high Aedes aegypti breeding percentages. Captured mosquitoes were pooled into 517 pools for Zika virus screening; nine abdomen pools (2%) were positive for Zika virus, of which seven head and thorax pools were Zika-virus positive. In the phylogenetic analysis, all mosquito sequences clustered within the outbreak lineage. The lineage showed little diversity and was distinct from other Asian lineages. The estimated most recent common ancestor of the outbreak lineage was from May, 2016. With the deployment of vector control and community engagement measures, the estimated reproductive number fell from 3.62 (95% CI 3.48-3.77) for July 31 to Sept 1, 2016, to 1.22 (95% CI 1.19-1.24) 4 weeks later (Sept 1 to Nov 24, 2016).
   Interpretation The outbreak shows the ease with which Zika virus can be introduced and spread despite good baseline vector control. Disease surveillance, enhanced vector control, and community awareness and engagement helped to quickly curb further spread of the virus. These intensive measures might be useful for other countries facing the same threat.
C1 [Barkham, Timothy; Chow, Li Ping Angela; Leo, Yee Sin; Hsu, Li Yang; Ng, Hee Ling Deborah; De, Partha Pratim] Tan Tock Seng Hosp, Singapore, Singapore.
   [Hapuarachchi, Hapuarachchige Chanditha; Ng, Lee Ching; Chong, Chee Seng; Tan, Cheong Huat; Rajarethinam, Jayanthi; Yap, Grace; Lai, Yee Ling] Environm Hlth Inst Singapore, Singapore, Singapore.
   [Ho, Zheng Jie Marc; Lee, Jian Ming Vernon; Lim, Yue Hui Georgina; Nandar, Khine; Ooi, Peng Lim] Minist Hlth, Singapore, Singapore.
   [Ho, Zheng Jie Marc; Prem, Kiesha; Cook, Alex R.; Hsu, Li Yang; Chen, I-Cheng Mark] Natl Univ Hlth Syst, Singapore, Singapore.
   [Prem, Kiesha; Cook, Alex R.; Hsu, Li Yang; Chen, I-Cheng Mark] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.
   [de Sessions, Paola F.; Sim, Shuzhen; Aw, Pauline; Soon, Wendy; Hibberd, Martin Lloyd; Ng, Huck Hui] Genome Inst Singapore, Singapore, Singapore.
   [Rabaa, Maia A.] Oxford Clin Res Unit Vietnam, Ho Chi Minh City, Vietnam.
   [Rabaa, Maia A.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med, Oxford, England.
   [Tan, Junhao; Anderson, Danielle E.; Ong, Xinmei; Chawla, Tanu; Pan, Louise; Uehara, Anna; Sessions, October M.] Duke NUS Med Sch Singapore, Singapore, Singapore.
   [Chong, Chia Yin; Thoon, Koh Cheng; Yung, Chee Fu; Li, Jia Hui] KK Womens & Childrens Hosp, Singapore, Singapore.
   [Lin, Raymond Tzer Pin] Natl Publ Hlth Lab Singapore, Singapore, Singapore.
   [Maurer-Stroh, Sebastian] Bioinformat Inst Singapore, Singapore, Singapore.
RP Chow, LPA (corresponding author), Tan Tock Seng Hosp, Singapore, Singapore.; Ng, LC (corresponding author), Environm Hlth Inst Singapore, Singapore, Singapore.
EM angela_chow@ttsh.com.sg; ng_lee_ching@nea.gov.sg
RI Maurer-Stroh, Sebastian/Q-9476-2019; Cook, Alex/S-3576-2019; Rabaa,
   Maia/W-2223-2019; Chen, Mark/Q-5605-2019; Cook, Alex/B-5941-2011
OI Maurer-Stroh, Sebastian/0000-0003-0813-9640; Rabaa,
   Maia/0000-0003-0529-2228; Chen, Mark/0000-0001-9369-5830; Cook,
   Alex/0000-0002-6271-5832; Hapuarachchi, Hapuarachchige
   Chanditha/0000-0001-7079-8538; Prem, Kiesha/0000-0003-0528-798X;
   Hibberd, Martin/0000-0001-8587-1849; Uehara, Anna/0000-0001-9345-3575
FU National Medical Research Council SingaporeNational Medical Research
   Council, Singapore; Centre for Infectious Disease Epidemiology and
   Research; A<SUP>star</SUP>STAR Biomedical Research Council
FX National Medical Research Council Singapore, Centre for Infectious
   Disease Epidemiology and Research, and A<SUP>star</SUP>STAR Biomedical
   Research Council.
CR Ang LW, 2015, EPIDEMIOL INFECT, V143, P1585, DOI 10.1017/S0950268814002507
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Chow A, 2017, EMERG INFECT DIS, V23, P677, DOI 10.3201/eid2304.161716
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2017, INT J INFECT DIS, V54, P121, DOI 10.1016/j.ijid.2016.11.420
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Garnett GP, 1995, T R SOC TROP MED HYG, V89, P581
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hapuarachchi HC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1606-z
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee C, 2013, AM J TROP MED HYG, V88, P888, DOI 10.4269/ajtmh.12-0329
   Lee KS, 2012, INFECT GENET EVOL, V12, P77, DOI 10.1016/j.meegid.2011.10.012
   Lee KS, 2010, EMERG INFECT DIS, V16, P847, DOI 10.3201/eid1605.091006
   Leo YS, 2016, LANCET INFECT DIS, V16, P1317, DOI 10.1016/S1473-3099(16)30448-0
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Maurer-Stroh S, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.38.30347
   Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206
   Ng LC, 2016, EPIDEMIOL NEWS B, V42, P11
   Nishiura H, 2016, TRAVEL MED INFECT DI, V14, P274, DOI 10.1016/j.tmaid.2016.03.016
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Tan CH, 2011, VECTOR-BORNE ZOONOT, V11, P789, DOI 10.1089/vbz.2010.0028
NR 30
TC 60
Z9 61
U1 1
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD AUG
PY 2017
VL 17
IS 8
BP 813
EP 821
DI 10.1016/S1473-3099(17)30249-9
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA FB0TC
UT WOS:000405856500026
PM 28527892
OA Bronze
DA 2020-07-08
ER

PT J
AU White, SK
   Iovine, NM
   Nickels, LC
   Morris, JG
   Lednicky, JA
AF White, Sarah K.
   Iovine, Nicole M.
   Nickels, L. Connor
   Morris, J. Glenn, Jr.
   Lednicky, John A.
TI Complete Genome Sequence of Dengue virus Type 2 from a Resident of
   North-Central Florida with Locally Transmitted Dengue Fever
SO MICROBIOLOGY RESOURCE ANNOUNCEMENTS
LA English
DT Article
ID ZIKA
AB The majority of dengue fever cases reported in the United States recently have been imported. We isolated dengue virus type 2 (DENV-2) from a North-Central Florida resident with locally acquired dengue fever in May 2016. This is the first evidence of autochthonous transmission of the virus in north-central Florida.
C1 [White, Sarah K.; Lednicky, John A.] Univ Florida, Dept Environm & Global Hlth, Coll Publ Hlth & Hlth Profess, Gainesville, FL 32611 USA.
   [White, Sarah K.; Iovine, Nicole M.; Morris, J. Glenn, Jr.; Lednicky, John A.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.
   [Iovine, Nicole M.; Morris, J. Glenn, Jr.] Univ Florida Hlth, Shands Hosp, Div Infect Dis & Global Med, Dept Internal Med, Gainesville, FL USA.
   [Nickels, L. Connor] Univ Florida Hlth, Shands Hosp, Dept Emergency Med, Gainesville, FL USA.
RP Lednicky, JA (corresponding author), Univ Florida, Dept Environm & Global Hlth, Coll Publ Hlth & Hlth Profess, Gainesville, FL 32611 USA.; Lednicky, JA (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.
EM jlednicky@phhp.ufl.edu
RI Lednicky, John A/C-5678-2012
OI Lednicky, John/0000-0003-4069-0539
FU HHS/NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI126357-01S1]
FX Studies were funded in part by HHS/NIH grant R01 AI126357-01S1 to J.G.M.
CR Adalja AA, 2012, EMERG INFECT DIS, V18, P608, DOI 10.3201/eid1804.110968
   Arguello DF, 2015, AM J TROP MED HYG, V92, P486, DOI 10.4269/ajtmh.14-0231
   Christenbury JG, 2010, J VIROL METHODS, V169, P202, DOI 10.1016/j.jviromet.2010.06.013
   De Paula Sérgio Oliveira, 2004, Braz J Infect Dis, V8, P390, DOI 10.1590/S1413-86702004000600002
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Iovine NM, 2017, CLIN INFECT DIS, V64, P72, DOI 10.1093/cid/ciw667
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Muller DA, 2017, J INFECT DIS, V215, pS89, DOI 10.1093/infdis/jiw649
   Mustafa M S, 2015, Med J Armed Forces India, V71, P67, DOI 10.1016/j.mjafi.2014.09.011
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952
NR 12
TC 2
Z9 2
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2576-098X
J9 MICROBIOL RESOUR ANN
JI Microbiol. Resour. Ann.
PD AUG
PY 2017
VL 5
IS 31
AR e00782-17
DI 10.1128/genomeA.00782-17
PG 2
WC Microbiology
SC Microbiology
GA VI1EZ
UT WOS:000460708200028
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Goubert, C
   Henri, H
   Minard, G
   Moro, CV
   Mavingui, P
   Vieira, C
   Boulesteix, M
AF Goubert, Clement
   Henri, Helene
   Minard, Guillaume
   Moro, Claire Valiente
   Mavingui, Patrick
   Vieira, Cristina
   Boulesteix, Matthieu
TI High-throughput sequencing of transposable element insertions suggests
   adaptive evolution of the invasive Asian tiger mosquito towards
   temperate environments
SO MOLECULAR ECOLOGY
LA English
DT Article
DE Aedes albopictus; genome scan; invasive species; local adaptation;
   transposable elements
ID AEDES-ALBOPICTUS DIPTERA; SCANNING ME-SCAN; ANOPHELES-GAMBIAE;
   GENOME-SCAN; GENETIC DIFFERENTIATION; MOLECULAR PHYSIOLOGY;
   POPULATION-STRUCTURE; GEOGRAPHIC ORIGIN; NATURAL-SELECTION; RAPID
   ADAPTATION
AB Invasive species represent unique opportunities to evaluate the role of local adaptation during colonization of new environments. Among these species, the Asian tiger mosquito, Aedes albopictus, is a threatening vector of several human viral diseases, including dengue and chikungunya, and raises concerns about the Zika fever. Its broad presence in both temperate and tropical environments has been considered the reflection of great "ecological plasticity." However, no study has been conducted to assess the role of adaptive evolution in the ecological success of Ae. albopictus at the molecular level. In the present study, we performed a genomic scan to search for potential signatures of selection leading to local adaptation in one-hundred-forty field-collected mosquitoes from native populations of Vietnam and temperate invasive populations of Europe. High-throughput genotyping of transposable element insertions led to the discovery of more than 120,000 polymorphic loci, which, in their great majority, revealed a virtual absence of structure between the biogeographic areas. Nevertheless, 92 outlier loci showed a high level of differentiation between temperate and tropical populations. The majority of these loci segregate at high insertion frequencies among European populations, indicating that this pattern could have been caused by recent adaptive evolution events in temperate areas. An analysis of the overlapping and neighbouring genes highlighted several candidates, including diapause, lipid and juvenile hormone pathways.
C1 [Goubert, Clement; Henri, Helene; Minard, Guillaume; Moro, Claire Valiente; Mavingui, Patrick; Vieira, Cristina; Boulesteix, Matthieu] Univ Lyon, Lyon, France.
   [Goubert, Clement; Henri, Helene; Minard, Guillaume; Moro, Claire Valiente; Mavingui, Patrick; Vieira, Cristina; Boulesteix, Matthieu] Univ Lyon 1, Villeurbanne, France.
   [Goubert, Clement; Henri, Helene; Vieira, Cristina; Boulesteix, Matthieu] UMR CNRS 5558, Lab Biometrie & Biol Evolut, Villeurbanne, France.
   [Goubert, Clement] Univ Utah, Dept Human Genet, Salt Lake City, UT USA.
   [Minard, Guillaume; Moro, Claire Valiente; Mavingui, Patrick] UMR CNRS 5557, UMR INRA 1418, Ecol Microbienne, Villeurbanne, France.
   [Minard, Guillaume] Univ Helsinki, Metapopulat Res Ctr, Dept Biosci, Helsinki, Finland.
   [Mavingui, Patrick] Univ La Reunion, CNRS 9192, IRD 249, UMR PIMIT,INSERM 1187,Plateforme Technol CYROI, St Clothilde, Reunion, France.
RP Boulesteix, M (corresponding author), Univ Lyon 1, UMR CNRS 5558, Lab Biometrie & Biol Evolut, Villeurbanne, France.
EM matthieu.boulesteix@univ-lyon1.fr
RI Vieira, Cristina/Q-3137-2017; Goubert, Clement/AAG-6228-2019
OI Vieira, Cristina/0000-0003-3414-3993; Goubert,
   Clement/0000-0001-8034-5559; Minard, Guillaume/0000-0002-2079-8844;
   valiente moro, claire/0000-0002-7193-405X
FU French Ministry of Superior Education; Centre National de la Recherche
   ScientifiqueCentre National de la Recherche Scientifique (CNRS);
   Institut Universitaire de France; Federation de Recherche 41
   "Bio-Environnement et Sante"
FX French Ministry of Superior Education; Centre National de la Recherche
   Scientifique and the Institut Universitaire de France; Federation de
   Recherche 41 "Bio-Environnement et Sante."
CR Akkouche A, 2012, J VIROL, V86, P3675, DOI 10.1128/JVI.07146-11
   Becker N, 2013, PARASITOL RES, V112, P1787, DOI 10.1007/s00436-012-3230-1
   Biedler J, 2003, INSECT MOL BIOL, V12, P211, DOI 10.1046/j.1365-2583.2003.00403.x
   Birungi J, 2002, ANN ENTOMOL SOC AM, V95, P125, DOI 10.1603/0013-8746(2002)095[0125:GSOAAD]2.0.CO;2
   BLACK WC, 1988, HEREDITY, V60, P173, DOI 10.1038/hdy.1988.29
   Bonin A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-551
   Bonin A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-459
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Boulesteix M, 2007, MOL ECOL, V16, P441, DOI 10.1111/j.1365-294X.2006.03150.x
   BRAVERMAN JM, 1995, GENETICS, V140, P783
   Bridier-Nahmias A, 2015, SCIENCE, V348, P585, DOI 10.1126/science.1259114
   Carnelossi EAG, 2014, GENOME BIOL EVOL, V6, P1806, DOI 10.1093/gbe/evu141
   Casacuberta E, 2013, MOL ECOL, V22, P1503, DOI 10.1111/mec.12170
   CHARLESWORTH B, 1993, GENETICS, V134, P1289
   Chen XG, 2015, P NATL ACAD SCI USA, V112, pE5907, DOI 10.1073/pnas.1516410112
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Colautti RI, 2015, MOL ECOL, V24, P1999, DOI 10.1111/mec.13162
   Davey JW, 2013, MOL ECOL, V22, P3151, DOI 10.1111/mec.12084
   de Villemereuil P, 2014, MOL ECOL, V23, P2006, DOI 10.1111/mec.12705
   Denlinger DL, 2016, ADV INSECT PHYSIOL, V51, P329, DOI 10.1016/bs.aiip.2016.05.002
   Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04
   Dritsou V., 2015, PATHOGENS GLOBAL HLT, V109
   Esnault C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001968
   Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x
   Fay JC, 2000, GENETICS, V155, P1405
   Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221
   Goubert C, 2016, HEREDITY, V117, P125, DOI 10.1038/hdy.2016.35
   Goubert C, 2015, GENOME BIOL EVOL, V7, P1192, DOI 10.1093/gbe/evv050
   GOWER JC, 1986, J CLASSIF, V3, P5, DOI 10.1007/BF01896809
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gupta S, 2014, PARASITOL RES, V113, P2137, DOI 10.1007/s00436-014-3864-2
   HANSON SM, 1994, J MED ENTOMOL, V31, P192, DOI 10.1093/jmedent/31.2.192
   Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1
   HAWLEY WA, 1987, SCIENCE, V236, P1114, DOI 10.1126/science.3576225
   Huang X, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003724
   Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020
   KAMBHAMPATI S, 1991, HEREDITY, V67, P85, DOI 10.1038/hdy.1991.67
   Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202
   Lande R, 2015, MOL ECOL, V24, P2038, DOI 10.1111/mec.13037
   LEWONTIN RC, 1973, GENETICS, V74, P175
   Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158
   Louis C., 2015, PATHOGENS GLOBAL HLT, V109
   Manni M, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0794-5
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200
   Maynard-Smith J, 1974, GENET RES, V23, P23, DOI 10.1017/S0016672300014634
   Messer PW, 2013, TRENDS ECOL EVOL, V28, P659, DOI 10.1016/j.tree.2013.08.003
   Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207
   Minard G, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00970
   Modolo L, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0546-8
   Monden Y., 2015, HORTICULT J, V1, P40
   Monden Y., 2014, CURRENT PLANT BIOL, V21, P491
   MORI A, 1981, Tropical Medicine, V23, P79
   MUNROE DJ, 1994, GENOMICS, V19, P506, DOI 10.1006/geno.1994.1100
   Narum SR, 2011, MOL ECOL RESOUR, V11, P184, DOI 10.1111/j.1755-0998.2011.02987.x
   Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Peischl S, 2015, MOL ECOL, V24, P2084, DOI 10.1111/mec.13154
   Perez-Figueroa A, 2010, J EVOLUTION BIOL, V23, P2267, DOI 10.1111/j.1420-9101.2010.02093.x
   Poelchau MF, 2013, J EXP BIOL, V216, P4082, DOI 10.1242/jeb.089508
   Poelchau MF, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0143
   Porretta D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044515
   Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055
   Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033
   R Core Team, 2016, R LANG ENV STAT COMP
   Recknagel H, 2015, MOL ECOL RESOUR, V15, P1316, DOI 10.1111/1755-0998.12406
   Rishishwar L, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0052-6
   Roy AM, 1999, GENETICA, V107, P149, DOI 10.1023/A:1003941704138
   Sabot F, 2011, PLANT J, V66, P241, DOI 10.1111/j.1365-313X.2011.04492.x
   Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-163
   Schrader L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6495
   Stapley J, 2015, MOL ECOL, V24, P2241, DOI 10.1111/mec.13089
   Stephan W, 2010, PHILOS T R SOC B, V365, P1245, DOI 10.1098/rstb.2009.0278
   TAJIMA F, 1989, GENETICS, V123, P585
   Takumi K, 2009, VECTOR-BORNE ZOONOT, V9, P191, DOI 10.1089/vbz.2008.0038
   Urbanelli S, 2000, HEREDITY, V84, P331, DOI 10.1046/j.1365-2540.2000.00676.x
   Urbanski J, 2012, AM NAT, V179, P490, DOI 10.1086/664709
   Urbanski JM, 2010, P ROY SOC B-BIOL SCI, V277, P2683, DOI 10.1098/rspb.2010.0362
   Vitti JJ, 2013, ANNU REV GENET, V47, P97, DOI 10.1146/annurev-genet-111212-133526
   Watkins WS, 2003, GENOME RES, V13, P1607, DOI 10.1101/gr.894603
   Witherspoon DJ, 2013, GENOME RES, V23, P1170, DOI 10.1101/gr.148973.112
   Witherspoon DJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-410
   Zhong DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068586
NR 83
TC 15
Z9 16
U1 3
U2 46
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0962-1083
EI 1365-294X
J9 MOL ECOL
JI Mol. Ecol.
PD AUG
PY 2017
VL 26
IS 15
BP 3968
EP 3981
DI 10.1111/mec.14184
PG 14
WC Biochemistry & Molecular Biology; Ecology; Evolutionary Biology
SC Biochemistry & Molecular Biology; Environmental Sciences & Ecology;
   Evolutionary Biology
GA FB8AM
UT WOS:000406361200011
PM 28517033
OA Bronze
DA 2020-07-08
ER

PT J
AU Martinez, J
   Tolosana, I
   Ok, S
   Smith, S
   Snoeck, K
   Day, JP
   Jiggins, FM
AF Martinez, Julien
   Tolosana, Ignacio
   Ok, Suzan
   Smith, Sophie
   Snoeck, Kiana
   Day, Jonathan P.
   Jiggins, Francis M.
TI Symbiont strain is the main determinant of variation in
   Wolbachia-mediated protection against viruses across Drosophila species
SO MOLECULAR ECOLOGY
LA English
DT Article
DE Drosophila; symbiont-mediated protection; viruses; Wolbachia
ID AEDES-AEGYPTI MOSQUITOS; MALE-KILLING WOLBACHIA; CYTOPLASMIC
   INCOMPATIBILITY; DENGUE TRANSMISSION; BLOCKS DENGUE; HOST GENOTYPE; ZIKA
   VIRUS; INFECTION; SIMULANS; MELANOGASTER
AB Wolbachia is a common heritable bacterial symbiont in insects. Its evolutionary success lies in the diverse phenotypic effects it has on its hosts coupled to its propensity to move between host species over evolutionary timescales. In a survey of natural host-symbiont associations in a range of Drosophila species, we found that 10 of 16 Wolbachia strains protected their hosts against viral infection. By moving Wolbachia strains between host species, we found that the symbiont genome had a much greater influence on the level of antiviral protection than the host genome. The reason for this was that the level of protection depended on the density of the symbiont in host tissues, and Wolbachia rather than the host-controlled density. The finding that virus resistance and symbiont density are largely under the control of symbiont genes in this system has important implications both for the evolution of these traits and for public health programmes using Wolbachia to prevent mosquitoes from transmitting disease.
C1 [Martinez, Julien; Tolosana, Ignacio; Ok, Suzan; Smith, Sophie; Snoeck, Kiana; Day, Jonathan P.; Jiggins, Francis M.] Univ Cambridge, Dept Genet, Cambridge, England.
RP Martinez, J (corresponding author), Univ Cambridge, Dept Genet, Cambridge, England.
EM jtm35@cam.ac.uk
OI Bayley, Sophie/0000-0003-3928-4760; Martinez,
   Julien/0000-0001-8210-2921; Tolosana, Ignacio/0000-0002-3766-8296;
   Jiggins, Francis Michael/0000-0001-7470-8157
FU Wellcome TrustWellcome Trust [WT094664MA]; European Research Council
   (ERC)European Research Council (ERC) [281668 DrosophilaInfection]
FX We thank Kostas Bourtzis, Luis Teixeira, Wolfgang Miller and the East
   Malling Research Station for providing some of the fly lines used in our
   study. This study was funded by the Wellcome Trust grant WT094664MA
   (http://www.wellcome.ac.uk/) and the European Research Council (ERC)
   grant 281668 DrosophilaInfection.
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Bian GW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002250
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Bourtzis K, 2000, INSECT MOL BIOL, V9, P635, DOI 10.1046/j.1365-2583.2000.00224.x
   Caragata EP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003459
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Cattel J, 2016, INSECT MOL BIOL, V25, P595, DOI 10.1111/imb.12245
   Chrostek E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099025
   Chrostek E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003896
   COMENDADOR MA, 1986, GENET SEL EVOL, V18, P131, DOI 10.1186/1297-9686-18-2-131
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Fujii Y, 2001, P ROY SOC B-BIOL SCI, V268, P855, DOI 10.1098/rspb.2001.1593
   Glaser RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011977
   Haselkorn TS, 2013, EVOLUTION, V67, P934, DOI 10.1111/evo.12020
   Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoffmann AA, 2015, EVOL APPL, V8, P751, DOI 10.1111/eva.12286
   Hosokawa T, 2010, P NATL ACAD SCI USA, V107, P769, DOI 10.1073/pnas.0911476107
   Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425
   Hussain M, 2013, J VIROL, V87, P851, DOI 10.1128/JVI.01837-12
   Jaenike J, 2007, EVOLUTION, V61, P2244, DOI 10.1111/j.1558-5646.2007.00180.x
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Kondo N, 2005, BIOL LETTERS, V1, P488, DOI 10.1098/rsbl.2005.0340
   Longdon B, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004728
   Longdon B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073833
   Longdon B, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S8
   Longdon B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002260
   Magwire MM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003057
   Martinez J, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0778
   Martinez J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005021
   Martinez J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004369
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Mouton L, 2007, BIOL LETT-UK, V3, P210, DOI 10.1098/rsbl.2006.0590
   ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699
   Osborne SE, 2012, APPL ENVIRON MICROB, V78, P6922, DOI 10.1128/AEM.01727-12
   Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656
   PLUS N, 1975, ANN INST PASTEUR MIC, VA126, P107
   Poinsot D, 1998, GENETICS, V150, P227
   R Core Team, 2013, R LANG ENV STAT COMP
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Sakamoto H, 2005, GENET RES, V85, P205, DOI 10.1017/S0016672305007573
   SCOTTI PD, 1983, ARCH VIROL, V75, P181, DOI 10.1007/BF01315272
   Serbus LR, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004777
   Siozios S, 2008, INSECT SCI, V15, P89, DOI 10.1111/j.1744-7917.2008.00189.x
   Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002
   TURELLI M, 1994, EVOLUTION, V48, P1500, DOI 10.1111/j.1558-5646.1994.tb02192.x
   Ulrich JN, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004873
   Unckless RL, 2012, EVOLUTION, V66, P678, DOI 10.1111/j.1558-5646.2011.01485.x
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Vavre F, 1999, MOL BIOL EVOL, V16, P1711, DOI 10.1093/oxfordjournals.molbev.a026084
   Veneti Z, 2012, HEREDITY, V109, P306, DOI 10.1038/hdy.2012.43
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Webster CL, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002210
   WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   Yeap HL, 2011, GENETICS, V187, P583, DOI 10.1534/genetics.110.122390
   Zabalou S, 2008, GENETICS, V178, P2145, DOI 10.1534/genetics.107.086488
   Zhang KJ, 2013, INSECT SCI, V20, P329, DOI 10.1111/j.1744-7917.2012.01537.x
   Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324
NR 59
TC 19
Z9 19
U1 1
U2 22
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0962-1083
EI 1365-294X
J9 MOL ECOL
JI Mol. Ecol.
PD AUG
PY 2017
VL 26
IS 15
BP 4072
EP 4084
DI 10.1111/mec.14164
PG 13
WC Biochemistry & Molecular Biology; Ecology; Evolutionary Biology
SC Biochemistry & Molecular Biology; Environmental Sciences & Ecology;
   Evolutionary Biology
GA FB8AM
UT WOS:000406361200018
PM 28464440
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Xu, J
   Xu, Z
   Zheng, WM
AF Xu, Jun
   Xu, Zhao
   Zheng, Wenming
TI A Review of the Antiviral Role of Green Tea Catechins
SO MOLECULES
LA English
DT Review
DE green tea catechins; chronic infectious diseases; antiviral activity;
   mechanism
ID HEPATITIS-B-VIRUS; INFLUENZA-A VIRUS; EPIGALLOCATECHIN GALLATE;
   IN-VITRO; (-)-EPIGALLOCATECHIN GALLATE; NUTRIENT MIXTURE; TARGET GENES;
   ZIKA VIRUS; KAPPA-B; EGCG
AB Over the centuries, infectious diseases caused by viruses have seriously threatened human health globally. Viruses are responsible not only for acute infections but also many chronic infectious diseases. To prevent diseases caused by viruses, the discovery of effective antiviral drugs, in addition to vaccine development, is important. Green tea catechins (GTCs) are polyphenolic compounds from the leaves of Camellia sinensis. In recent decades, GTCs have been reported to provide various health benefits against numerous diseases. Studies have shown that GTCs, especially epigallocatechin-3-gallate (EGCG), have antiviral effects against diverse viruses. The aim of this review is to summarize the developments regarding the antiviral activities of GTCs, to discuss the mechanisms underlying these effects and to offer suggestions for future research directions and perspectives on the antiviral effects of EGCG.
C1 [Xu, Jun; Xu, Zhao; Zheng, Wenming] Henan Agr Univ, Coll Life Sci, 95 Wenhua Rd, Zhengzhou 450002, Henan, Peoples R China.
RP Xu, J (corresponding author), Henan Agr Univ, Coll Life Sci, 95 Wenhua Rd, Zhengzhou 450002, Henan, Peoples R China.
EM xujun0828@126.com; zhaoxufight@163.com; zhengwenmingw@hotmail.com
RI Zheng, Wenming/AAG-6507-2020
OI Zheng, Wenming/0000-0002-7709-2164
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31201332]
FX The authors would like to thank Zihan Li for his kind contribution in
   modifying Figure 2 and polishing the paper. This work was supported by
   grants from the National Natural Science Foundation of China (No.
   31201332).
CR Amin ARMR, 2007, P NATL ACAD SCI USA, V104, P5419, DOI 10.1073/pnas.0700642104
   Anderson KB, 2016, ANN INTERN MED, V165, P175, DOI 10.7326/M16-0617
   Bao GH, 2013, BIOMETALS, V26, P1041, DOI 10.1007/s10534-013-9681-8
   BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183
   Baselga-Escudero L, 2014, NUCLEIC ACIDS RES, V42, P882, DOI 10.1093/nar/gkt1011
   Beckham J David, 2015, Continuum (Minneap Minn), V21, P1599, DOI 10.1212/CON.0000000000000240
   Bhattacharjee R, 2015, J MOL MODEL, V21, DOI 10.1007/s00894-015-2801-3
   Calland N, 2015, J VIROL, V89, P10053, DOI 10.1128/JVI.01473-15
   Calland N, 2012, HEPATOLOGY, V55, P720, DOI 10.1002/hep.24803
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Chacko Sabu M, 2010, Chin Med, V5, P13, DOI 10.1186/1749-8546-5-13
   Chang C. W., 1994, Journal of Biomedical Science, V1, P163, DOI 10.1007/BF02253344
   Chen C, 2012, ARCH VIROL, V157, P1301, DOI 10.1007/s00705-012-1304-0
   Chen YL, 2012, BIOCHEM BIOPH RES CO, V417, P1093, DOI 10.1016/j.bbrc.2011.12.104
   Chiou YS, 2012, J AGR FOOD CHEM, V60, P3441, DOI 10.1021/jf300441p
   Churchill MJ, 2016, NAT REV MICROBIOL, V14, P55, DOI 10.1038/nrmicro.2015.5
   Ciesek S, 2011, HEPATOLOGY, V54, P1947, DOI 10.1002/hep.24610
   Coffin CS, 2015, BRIT MED BULL, V116, P79, DOI 10.1093/bmb/ldv039
   Colpitts CC, 2014, J VIROL, V88, P7806, DOI 10.1128/JVI.00896-14
   Cook LB, 2015, CURR OPIN INFECT DIS, V28, P583, DOI 10.1097/QCO.0000000000000207
   Daniel KG, 2006, INT J MOL MED, V18, P625
   de Oliveira A, 2013, FOOD CHEM TOXICOL, V52, P207, DOI 10.1016/j.fct.2012.11.006
   de Pace RCC, 2013, J LIPOSOME RES, V23, P187, DOI 10.3109/08982104.2013.788023
   Deryabin PG, 2008, BIOFACTORS, V33, P85, DOI 10.1002/biof.5520330201
   Dochez V, 2015, PRESSE MED, V44, P660, DOI 10.1016/j.lpm.2015.04.014
   Duan Jiang-man, 2012, Chinese Journal of Virology, V28, P84
   Estepa A, 2015, FISH SHELLFISH IMMUN, V47, P264, DOI 10.1016/j.fsi.2015.09.017
   Fassina G, 2002, AIDS, V16, P939, DOI 10.1097/00002030-200204120-00020
   Fukazawa H, 2012, BIOL PHARM BULL, V35, P1320, DOI 10.1248/bpb.b12-00251
   Furuta T, 2007, BIOORG MED CHEM LETT, V17, P3095, DOI 10.1016/j.bmcl.2007.03.041
   Ghosn J. P. R., 2017, P 9 IAS C HIV SCI PA
   Giunta B, 2006, BRAIN RES, V1123, P216, DOI 10.1016/j.brainres.2006.09.057
   Gomez-Mascaraque LG, 2016, CARBOHYD POLYM, V150, P121, DOI 10.1016/j.carbpol.2016.05.012
   GREEN ROBERT H., 1949, PROC SOC EXPTL BIOL AND MED, V71, P84, DOI 10.3181/00379727-71-17089P
   Halegoua-De Marzio D, 2012, CLIN THER, V34, P2279, DOI 10.1016/j.clinthera.2012.10.009
   Hamza A, 2006, J PHYS CHEM B, V110, P2910, DOI 10.1021/jp0550762
   Harakeh S, 2014, ASIAN PAC J CANCER P, V15, P1219, DOI 10.7314/APJCP.2014.15.3.1219
   Hartjen P, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-2
   Hashimoto O, 2014, NUTR CANCER, V66, P728, DOI 10.1080/01635581.2013.783601
   Hauber I, 2009, P NATL ACAD SCI USA, V106, P9033, DOI 10.1073/pnas.0811827106
   He W, 2011, WORLD J GASTROENTERO, V17, P1507, DOI 10.3748/wjg.v17.i11.1507
   Ho HY, 2009, J AGR FOOD CHEM, V57, P6140, DOI 10.1021/jf901128u
   Hsu Stephen, 2015, Inflammation & Allergy Drug Targets, V14, P13, DOI 10.2174/1871528114666151022150122
   Hu B, 2016, J AGR FOOD CHEM, V64, P3422, DOI 10.1021/acs.jafc.6b00931
   Hu B, 2012, CHEM COMMUN, V48, P2421, DOI 10.1039/c2cc17295j
   Huang HC, 2014, ANTIVIR RES, V111, P100, DOI 10.1016/j.antiviral.2014.09.009
   Huang R, 2012, J MOL BIOL, V416, P108, DOI 10.1016/j.jmb.2011.12.023
   Ide K, 2016, CURR MED CHEM, V23, P4773, DOI 10.2174/0929867324666161123091010
   Imanishi N, 2002, MICROBIOL IMMUNOL, V46, P491, DOI 10.1111/j.1348-0421.2002.tb02724.x
   Isaacs CE, 2008, ANTIMICROB AGENTS CH, V52, P962, DOI 10.1128/AAC.00825-07
   Isaacs CE, 2011, ANTIMICROB AGENTS CH, V55, P5646, DOI 10.1128/AAC.05531-11
   Ishii T, 2010, BIOORGAN MED CHEM, V18, P4892, DOI 10.1016/j.bmc.2010.06.021
   Ismail N.A., 2016, INTERDISCIP SCI, P1
   Jariwalla RJ, 2007, BIOFACTORS, V31, P1, DOI 10.1002/biof.5520310101
   Karamese Murat, 2015, Asian Pac J Cancer Prev, V16, P4199
   Kim HJ, 2015, PEDIATR INT, V57, P802, DOI 10.1111/ped.12735
   Li HC, 2000, JPN J CANCER RES, V91, P34, DOI 10.1111/j.1349-7006.2000.tb00857.x
   Li Shenwei, 2011, Antiviral Chemistry & Chemotherapy, V21, P239, DOI 10.3851/IMP1774
   Li Z, 2014, FOOD FUNCT, V5, P1278, DOI 10.1039/c3fo60500k
   Lin PY, 2015, APOPTOSIS, V20, P481, DOI 10.1007/s10495-015-1085-5
   Lin YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054466
   Liu D, 2016, J NUTR BIOCHEM, V28, P164, DOI 10.1016/j.jnutbio.2015.10.003
   Liu SF, 2013, CARCINOGENESIS, V34, P627, DOI 10.1093/carcin/bgs364
   Liu SW, 2005, BBA-GEN SUBJECTS, V1723, P270, DOI 10.1016/j.bbagen.2005.02.012
   Lyu S.Y., 2005, ARCH PHARM RES, V28, P1293
   Lyu SY, 2005, ARCH PHARM RES, V28, P1293, DOI 10.1007/BF02978215
   Matsumoto K, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-15
   Matsumoto Y, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00053
   Miyazato P, 2014, INT IMMUNOL, V26, P419, DOI 10.1093/intimm/dxu048
   Mizushina Yoshiyuki, 2011, Front Biosci (Elite Ed), V3, P1337
   Mori S., 2008, MED CHEM LETT, V18, P4249
   MUKOYAMA A, 1991, JPN J MED SCI BIOL, V44, P181, DOI 10.7883/yoken1952.44.181
   Munch M, 1997, ACTA NEUROL SCAND, V95, P59, DOI 10.1111/j.1600-0404.1997.tb08151.x
   Murata T, 2014, REV MED VIROL, V24, P242, DOI 10.1002/rmv.1786
   Nadim M, 2014, INT J COSMETIC SCI, V36, P579, DOI 10.1111/ics.12159
   NAKANE H, 1990, BIOCHEMISTRY-US, V29, P2841, DOI 10.1021/bi00463a029
   NAKAYAMA M, 1993, ANTIVIR RES, V21, P289, DOI 10.1016/0166-3542(93)90008-7
   Nance CL, 2009, J ALLERGY CLIN IMMUN, V123, P459, DOI 10.1016/j.jaci.2008.12.024
   Narotzki B, 2012, ARCH ORAL BIOL, V57, P429, DOI 10.1016/j.archoralbio.2011.11.017
   Nath S, 2012, J NEUROVIROL, V18, P445, DOI 10.1007/s13365-012-0122-1
   Oxford John S, 2007, Am J Ther, V14, P462, DOI 10.1097/MJT.0b013e3180a7206e
   Oxford John S, 2007, Am J Ther, V14, P455, DOI 10.1097/MJT.0b013e3180a6f9c2
   Pang JY, 2014, J ZHEJIANG UNIV-SC B, V15, P533, DOI 10.1631/jzus.B1300307
   Reid SP, 2014, ANTIVIR RES, V109, P171, DOI 10.1016/j.antiviral.2014.07.004
   Roomi MW, 2008, BIOFACTORS, V33, P61, DOI 10.1002/biof.5520330106
   Rrapo E, 2009, AM J TRANSL RES, V1, P72
   Sato M, 2010, CHEM PHARM BULL, V58, P98, DOI 10.1248/cpb.58.98
   Schinzari V, 2015, CLIN MICROBIOL INFEC, V21, P969, DOI 10.1016/j.cmi.2015.06.026
   Song JM, 2005, ANTIVIR RES, V68, P66, DOI 10.1016/j.antiviral.2005.06.010
   Tsatsos M, 2016, CLIN EXP OPHTHALMOL, V44, P824, DOI 10.1111/ceo.12785
   Vasilakis N, 2015, CURR OPIN VIROL, V15, P69, DOI 10.1016/j.coviro.2015.08.007
   Vyas S, 2007, J AGR FOOD CHEM, V55, P6319, DOI 10.1021/jf070519f
   Wang H, 2016, ARCH VIROL, V161, P1053, DOI 10.1007/s00705-016-2751-9
   Wang MF, 2016, FOOD CHEM, V190, P1022, DOI 10.1016/j.foodchem.2015.06.033
   Weber C, 2015, ANTIVIR RES, V113, P1, DOI 10.1016/j.antiviral.2014.11.001
   Weber JM, 2003, ANTIVIR RES, V58, P167, DOI 10.1016/S0166-3542(02)00212-7
   WHO (World Health Organization), EB VIR DIS
   Williamson MP, 2006, J ALLERGY CLIN IMMUN, V118, P1369, DOI 10.1016/j.jaci.2006.08.016
   Xu J, 2008, ANTIVIR RES, V78, P242, DOI 10.1016/j.antiviral.2007.11.011
   Xu J, 2016, J NAT MED-TOKYO, V70, P584, DOI 10.1007/s11418-016-0980-6
   Xue J, 2014, J AGR FOOD CHEM, V62, P4677, DOI 10.1021/jf405157x
   Yamada H, 2006, J ALTERN COMPLEM MED, V12, P669, DOI 10.1089/acm.2006.12.669
   Yamaguchi K, 2002, ANTIVIR RES, V53, P19, DOI 10.1016/S0166-3542(01)00189-9
   Yang CS, 2016, MOLECULES, V21, DOI 10.3390/molecules21121679
   Yang ZF, 2014, FITOTERAPIA, V93, P47, DOI 10.1016/j.fitote.2013.12.011
   Zhang X, 2016, MOLECULES, V21, DOI 10.3390/molecules21050620
   Zhao CJ, 2014, VIRUSES-BASEL, V6, P938, DOI 10.3390/v6020938
   Zhao Man, 2012, Inflammation & Allergy Drug Targets, V11, P364
   Zhao Y, 2004, INT J ELEC POWER, V26, P1, DOI 10.1016/S0142-0615(03)00065-6
   Zhong L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.136
   Zhong Y, 2011, J AGR FOOD CHEM, V59, P6526, DOI 10.1021/jf201050j
NR 111
TC 15
Z9 16
U1 7
U2 28
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1420-3049
J9 MOLECULES
JI Molecules
PD AUG
PY 2017
VL 22
IS 8
AR 1337
DI 10.3390/molecules22081337
PG 18
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA FF0PF
UT WOS:000408602900101
PM 28805687
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Newman, CM
   Dudley, DM
   Aliota, MT
   Weiler, AM
   Barry, GL
   Mohns, MS
   Breitbach, ME
   Stewart, LM
   Buechler, CR
   Graham, ME
   Post, J
   Schultz-Darken, N
   Peterson, E
   Newton, W
   Mohr, EL
   Capuanoiii, S
   O'Connor, DH
   Friedrich, TC
AF Newman, Christina M.
   Dudley, Dawn M.
   Aliota, Matthew T.
   Weiler, Andrea M.
   Barry, Gabrielle L.
   Mohns, Mariel S.
   Breitbach, Meghan E.
   Stewart, Laurel M.
   Buechler, Connor R.
   Graham, Michael E.
   Post, Jennifer
   Schultz-Darken, Nancy
   Peterson, Eric
   Newton, Wendy
   Mohr, Emma L.
   Capuanoiii, Saverio
   O'Connor, David H.
   Friedrich, Thomas C.
TI Oropharyngeal mucosal transmission of Zika virus in rhesus macaques
SO NATURE COMMUNICATIONS
LA English
DT Article
ID MALE SEXUAL TRANSMISSION; INFECTION; JANUARY; BRAZIL; SEMEN; MODEL
AB Zika virus is present in urine, saliva, tears, and breast milk, but the transmission risk associated with these body fluids is currently unknown. Here we evaluate the risk of Zika virus transmission through mucosal contact in rhesus macaques. Application of high-dose Zika virus directly to the tonsils of three rhesus macaques results in detectable plasma viremia in all animals by 2 days post-exposure; virus replication kinetics are similar to those observed in animals infected subcutaneously. Three additional macaques inoculated subcutaneously with Zika virus served as saliva donors to assess the transmission risk from contact with oral secretions from an infected individual. Seven naive animals repeatedly exposed to donor saliva via the conjunctivae, tonsils, or nostrils did not become infected. Our results suggest that there is a risk of Zika virus transmission via the mucosal route, but that the risk posed by oral secretions from individuals with a typical course of Zika virus infection is low.
C1 [Newman, Christina M.; Dudley, Dawn M.; Mohns, Mariel S.; Breitbach, Meghan E.; Stewart, Laurel M.; Buechler, Connor R.; Graham, Michael E.; O'Connor, David H.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pathol & Lab Med, 3170 UW Med Fdn Centennial Bldg,1685 Highland Ave, Madison, WI 53705 USA.
   [Weiler, Andrea M.; Friedrich, Thomas C.] Univ Wisconsin, Dept Pathobiol Sci, Sch Vet Med, 2015 Linden Dr, Madison, WI 53706 USA.
   [Weiler, Andrea M.; Barry, Gabrielle L.; Post, Jennifer; Schultz-Darken, Nancy; Peterson, Eric; Newton, Wendy; Capuanoiii, Saverio; O'Connor, David H.; Friedrich, Thomas C.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, 1220 Capitol Ct, Madison, WI 53715 USA.
   [Mohr, Emma L.] Univ Wisconsin, Ctr Clin Sci, Dept Pediat, 600 Highland Ave, Madison, WI 53792 USA.
RP Friedrich, TC (corresponding author), Univ Wisconsin, Dept Pathobiol Sci, Sch Vet Med, 2015 Linden Dr, Madison, WI 53706 USA.; Friedrich, TC (corresponding author), Univ Wisconsin, Wisconsin Natl Primate Res Ctr, 1220 Capitol Ct, Madison, WI 53715 USA.
EM thomasf@primate.wisc.edu
OI Aliota, Matthew/0000-0002-6902-9149
FU DHHS/PHS/NIH [R01AI116382]; Research Facilities Improvement
   ProgramUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Research
   Resources (NCRR) [RR15459-01, RR020141-01];  [P51OD011106]
FX We thank the Veterinary, Animal Care and Scientific Protocol
   Implementation staff at the Wisconsin National Primate Research Center
   (WNPRC) for their contribution to this study. We thank Emma Walker for
   assistance with the mouse studies. We acknowledge Jens Kuhn (NIAID/IRF,
   Frederick, MD) and Jiro Wada (US HHS/NIH, Washington, D. C., MD.) for
   preparing silhouettes of macaques used in figures. Funding for this
   project came from DHHS/PHS/NIH R01AI116382 to D.H.O. and from
   P51OD011106 awarded to the WNPRC, Madison-Wisconsin. This research was
   conducted in part at a facility constructed with support from Research
   Facilities Improvement Program grants RR15459-01 and RR020141-01. The
   publication's contents are solely the responsibility of the authors and
   do not necessarily represent the official views of NCRR or NIH.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Besnard M, 2014, EURO SURVEILL, V19
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Malamud D, 2011, Adv Dent Res, V23, P34, DOI 10.1177/0022034511399282
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ruprecht RM, 1999, J INFECT DIS, V179, pS408, DOI 10.1086/314794
   Shugars DC, 1999, J INFECT DIS, V179, pS431, DOI 10.1086/314799
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tauro LB, 2017, J MED VIROL, V89, P1, DOI 10.1002/jmv.24696
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   White MR, 2009, ORAL MICROBIOL IMMUN, V24, P18, DOI 10.1111/j.1399-302X.2008.00468.x
NR 35
TC 21
Z9 22
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD AUG 1
PY 2017
VL 8
AR 16
DI 10.1038/s41467-017-00246-8
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FC3KU
UT WOS:000406738500005
PM 28765581
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Boldescu, V
   Behnam, MAM
   Vasilakis, N
   Klein, CD
AF Boldescu, Veaceslav
   Behnam, Mira A. M.
   Vasilakis, Nikos
   Klein, Christian D.
TI Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond
SO NATURE REVIEWS DRUG DISCOVERY
LA English
DT Review
ID WEST-NILE-VIRUS; HEPATITIS-C VIRUS; JAPANESE ENCEPHALITIS-VIRUS;
   YELLOW-FEVER VIRUS; NS2B-NS3 PROTEASE INHIBITORS; TETRAPEPTIDE ALDEHYDE
   INHIBITORS; ADENOSINE NUCLEOSIDE INHIBITOR; HAMSTER
   MESOCRICETUS-AURATUS; PERIPHERAL CHALLENGE MODEL; ANTIVIRAL INNATE
   IMMUNITY
AB Infections with flaviviruses, such as dengue, West Nile virus and the recently re-emerging Zika virus, are an increasing and probably lasting global risk. This Review summarizes and comments on the opportunities for broad-spectrum agents that are active against multiple flaviviruses. Broad-spectrum activity is particularly desirable to prepare for the next flaviviral epidemic, which could emerge from as-yet unknown or neglected viruses. Potential molecular targets for broad-spectrum antiflaviviral compounds include viral proteins, such as the viral protease or polymerase, and host targets that are exploited by these viruses during entry and replication, including a-glucosidase and proteins involved in nucleoside biosynthesis. Numerous compounds with broad-spectrum antiviral activity have already been identified by target-specific or phenotypic assays. For other compounds, broad-spectrum activity can be anticipated because of their mode of action and molecular targets.
C1 [Boldescu, Veaceslav; Behnam, Mira A. M.; Klein, Christian D.] Heidelberg Univ, IPMB, Med Chem, Neuenheimer Feld 364, D-69120 Heidelberg, Germany.
   [Boldescu, Veaceslav] Moldavian Acad Sci, Inst Chem, Lab Organ Synth & Biopharmaceut, Acad 3, Kishinev 2028, Moldova.
   [Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, 2-138D Keiller Bldg,301 Univ Blvd, Galveston, TX 77555 USA.
   [Vasilakis, Nikos] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Ctr Trop Dis & Inst Human Infect & Immun, 2-138D Keiller Bldg,301 Univ Blvd, Galveston, TX 77555 USA.
RP Klein, CD (corresponding author), Heidelberg Univ, IPMB, Med Chem, Neuenheimer Feld 364, D-69120 Heidelberg, Germany.
EM c.klein@uni-heidelberg.de
RI Boldescu, Veaceslav/G-2106-2014
OI Boldescu, Veaceslav/0000-0003-0709-2086; Behnam,
   Mira/0000-0002-5839-7675; Klein, Christian/0000-0003-3522-9182
FU Alexander von Humboldt FoundationAlexander von Humboldt Foundation;
   German Academic Exchange Service (DAAD)Deutscher Akademischer Austausch
   Dienst (DAAD); National Institute of Allergy and Infectious Diseases, US
   National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R24AI120942, 1U01AI115577-01];
   Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [KL
   1356/3]
FX The authors are grateful for the highly valuable comments received from
   the reviewers of this work, who have chosen to remain anonymous. The
   authors also thank D. Graf and R. Bartenschlager for useful discussions
   on flaviviral biology and cell-based assays. V.B. appreciates funding by
   the Alexander von Humboldt Foundation. M.A.M.B. appreciates financial
   support from the German Academic Exchange Service (DAAD). N.V. receives
   funding from the National Institute of Allergy and Infectious Diseases,
   US National Institutes of Health (grants R24AI120942 and
   1U01AI115577-01). C.D.K. acknowledges support by the Deutsche
   Forschungsgemeinschaft (grant KL 1356/3).
CR Adamek RN, 2013, BIOORG MED CHEM LETT, V23, P4848, DOI 10.1016/j.bmcl.2013.06.081
   Aktepe TE, 2015, VIROLOGY, V484, P241, DOI 10.1016/j.virol.2015.06.015
   Al-Bari MAA, 2015, J ANTIMICROB CHEMOTH, V70, P1608, DOI 10.1093/jac/dkv018
   Ando T, 2015, INT J HEMATOL, V102, P379, DOI 10.1007/s12185-015-1788-y
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Barton C, 2014, ANTIMICROB AGENTS CH, V58, P120, DOI 10.1128/AAC.01407-13
   Basler M, 2009, J IMMUNOL, V183, P6145, DOI 10.4049/jimmunol.0901596
   BAZAN JF, 1989, VIROLOGY, V171, P637, DOI 10.1016/0042-6822(89)90639-9
   Beck A, 2014, J INFECT DIS, V209, P334, DOI 10.1093/infdis/jit546
   Behnam MAM, 2015, J MED CHEM, V58, P9354, DOI 10.1021/acs.jmedchem.5b01441
   Behnam MAM, 2014, ACS MED CHEM LETT, V5, P1037, DOI 10.1021/ml500245v
   Bentley R, 2000, CHEM REV, V100, P3801, DOI 10.1021/cr990097b
   Berke JM, 2011, ANTIMICROB AGENTS CH, V55, P3812, DOI 10.1128/AAC.00214-11
   Bernard KA, 2000, VIROLOGY, V276, P93, DOI 10.1006/viro.2000.0546
   Bhakat S, 2015, RSC ADV, V5, P85938, DOI 10.1039/c5ra14469h
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bhattacharya D, 2009, J VIROL, V83, P9195, DOI 10.1128/JVI.00271-09
   Boonyasuppayakorn S, 2014, ANTIVIR RES, V106, P125, DOI 10.1016/j.antiviral.2014.03.014
   Borel J F, 1996, Adv Pharmacol, V35, P115, DOI 10.1016/S1054-3589(08)60276-8
   Borges MC, 2013, MEM I OSWALDO CRUZ, V108, P596, DOI 10.1590/S0074-02762013000500010
   Brai A, 2016, P NATL ACAD SCI USA, V113, P5388, DOI 10.1073/pnas.1522987113
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brecher M, 2015, ACS INFECT DIS, V1, P340, DOI 10.1021/acsinfecdis.5b00070
   Bross PF, 2004, CLIN CANCER RES, V10, P3954, DOI 10.1158/1078-0432.CCR-03-0781
   Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P1902, DOI 10.1128/AAC.02251-12
   Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P15, DOI 10.1128/AAC.01429-12
   Calvert AE, 2014, VACCINE, V32, P258, DOI 10.1016/j.vaccine.2013.11.016
   Carocci M, 2016, ANTIVIR RES, V128, P57, DOI 10.1016/j.antiviral.2016.02.005
   Carocci M, 2015, ANTIMICROB AGENTS CH, V59, P85, DOI 10.1128/AAC.04177-14
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P877
   CHAMBERS TJ, 1991, J VIROL, V65, P6042, DOI 10.1128/JVI.65.11.6042-6050.1991
   CHAMBERS TJ, 1995, J VIROL, V69, P1600, DOI 10.1128/JVI.69.3.1600-1605.1995
   Chanan-Khan A, 2008, J CLIN ONCOL, V26, P4784, DOI 10.1200/JCO.2007.14.9641
   Chang JH, 2013, ANTIVIR RES, V98, P432, DOI 10.1016/j.antiviral.2013.03.023
   Chang JH, 2009, ANTIMICROB AGENTS CH, V53, P1501, DOI 10.1128/AAC.01457-08
   Chao CH, 2006, CANCER RES, V66, P6579, DOI 10.1158/0008-5472.CAN-05-2415
   Chappell KJ, 2006, J BIOL CHEM, V281, P38448, DOI 10.1074/jbc.M607641200
   Chen WN, 2014, FEBS LETT, V588, P2206, DOI 10.1016/j.febslet.2014.05.018
   Chen YL, 2015, ANTIVIR RES, V122, P12, DOI 10.1016/j.antiviral.2015.07.010
   Chen YL, 2014, J VIROL, V88, P1740, DOI 10.1128/JVI.02841-13
   Chen YL, 2010, ANTIMICROB AGENTS CH, V54, P2932, DOI 10.1128/AAC.00140-10
   Cheung YY, 2014, ANTIVIR RES, V111, P93, DOI 10.1016/j.antiviral.2014.09.007
   Chowers MY, 2001, EMERG INFECT DIS, V7, P675
   Choy MM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004058
   Chu JJH, 2015, ANTIVIR RES, V118, P68, DOI 10.1016/j.antiviral.2015.03.010
   Chung KY, 2010, VIROLOGY, V402, P52, DOI 10.1016/j.virol.2010.03.011
   Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3
   Coats SJ, 2014, ANTIVIR RES, V102, P119, DOI 10.1016/j.antiviral.2013.11.008
   Colombo G, 2011, ANTIVIR RES, V92, P408, DOI 10.1016/j.antiviral.2011.09.012
   Courageot MP, 2000, J VIROL, V74, P564, DOI 10.1128/JVI.74.1.564-572.2000
   Crance JM, 2003, ANTIVIR RES, V58, P73, DOI 10.1016/S0166-3542(02)00185-7
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DAVIDSON MM, 1991, J INFECTION, V23, P241, DOI 10.1016/0163-4453(91)92756-U
   De Burghgraeve T, 2013, ANTIVIR RES, V98, P242, DOI 10.1016/j.antiviral.2013.01.011
   De Clercq E, 2016, CLIN MICROBIOL REV, V29, P695, DOI 10.1128/CMR.00102-15
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   de Wispelaere M, 2013, J VIROL, V87, P7367, DOI 10.1128/JVI.00632-13
   Dean CH, 2005, HUM VACCINES, V1, P106, DOI 10.4161/hv.1.3.1797
   Deas TS, 2007, ANTIMICROB AGENTS CH, V51, P2470, DOI 10.1128/AAC.00069-07
   Deas TS, 2005, J VIROL, V79, P4599, DOI 10.1128/JVI.79.8.4599-4609.2005
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Dokland T, 2004, STRUCTURE, V12, P1157, DOI 10.1016/j.str.2004.04.024
   Dong HP, 2008, J VIROL, V82, P4295, DOI 10.1128/JVI.02202-07
   Dong HP, 2010, J BIOL CHEM, V285, P32586, DOI 10.1074/jbc.M110.129197
   Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Durantel D, 2009, CURR OPIN INVEST DR, V10, P860
   Egloff MP, 2007, J MOL BIOL, V372, P723, DOI 10.1016/j.jmb.2007.07.005
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Elazar M, 2009, GASTROENTEROLOGY, V137, P1827, DOI 10.1053/j.gastro.2009.07.056
   Eltahla AA, 2015, VIRUSES-BASEL, V7, P5206, DOI 10.3390/v7102868
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Eyer L, 2016, ANTIVIR RES, V133, P119, DOI 10.1016/j.antiviral.2016.07.018
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991
   Faustino A. F., 2012, NANOMEDICINE, V10, P247
   Ferguson NM, 2016, SCIENCE, V353, P1033, DOI 10.1126/science.aaf9590
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Firbas C, 2015, HUM VACC IMMUNOTHER, V11, P411, DOI 10.4161/21645515.2014.983412
   First MR, 1997, AM J KIDNEY DIS, V29, P303
   FISCHL MA, 1994, J ACQ IMMUN DEF SYND, V7, P139
   Flisiak R, 2009, HEPATOLOGY, V49, P1460, DOI 10.1002/hep.22835
   Forwood JK, 1999, BIOCHEM BIOPH RES CO, V257, P731, DOI 10.1006/bbrc.1999.0370
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Fraser JE, 2016, ANTIVIR RES, V130, P1, DOI 10.1016/j.antiviral.2016.03.006
   Fraser JE, 2014, J INFECT DIS, V210, P1780, DOI 10.1093/infdis/jiu319
   Frias-Staheli N, 2014, J VIROL, V88, P2205, DOI 10.1128/JVI.03085-13
   GAO WY, 1993, J CLIN INVEST, V91, P2326, DOI 10.1172/JCI116463
   Glass WG, 2005, J EXP MED, V202, P1087, DOI 10.1084/jem.20042530
   Godoy AS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14764
   Golitsina NL, 2010, ANTIVIR RES, V85, P470, DOI 10.1016/j.antiviral.2009.10.020
   Graci JD, 2006, REV MED VIROL, V16, P37, DOI 10.1002/rmv.483
   Green N, 2008, EXPERT OPIN DRUG DIS, V3, P671, DOI 10.1517/17460441.3.6.671
   Green RR, 2016, GENOM DATA, V7, P290, DOI 10.1016/j.gdata.2016.01.020
   Gu Baohua, 2007, Antiviral Chemistry & Chemotherapy, V18, P49
   Gupta G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134823
   Gustafsson D, 2001, THROMB RES, V101, P171, DOI 10.1016/S0049-3848(00)00399-6
   Habu A, 1977, Uirusu, V27, P21
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Haffizulla J, 2014, LANCET INFECT DIS, V14, P609, DOI 10.1016/S1473-3099(14)70717-0
   Haile WB, 2016, NEUROBIOL DIS, V92, P137, DOI 10.1016/j.nbd.2016.02.007
   Hansson MJ, 2004, J BIOENERG BIOMEMBR, V36, P407, DOI 10.1023/B:JOBB.0000041776.31885.45
   Heald AE, 2015, NEW ENGL J MED, V373, P339, DOI 10.1056/NEJMoa1410345
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Heil ML, 2001, J VIROL, V75, P6303, DOI 10.1128/JVI.75.14.6303-6309.2001
   Hidari KIPJ, 2008, BIOCHEM BIOPH RES CO, V376, P91, DOI 10.1016/j.bbrc.2008.08.100
   Hoffmann HH, 2011, P NATL ACAD SCI USA, V108, P5777, DOI 10.1073/pnas.1101143108
   Holbrook MR, 2012, ANTIVIR RES, V96, P353, DOI 10.1016/j.antiviral.2012.10.005
   Holbrook MR, 2005, J INFECT DIS, V191, P100, DOI 10.1086/426397
   Holmes E. C, 2009, EVOLUTION EMERGENCE
   Idris F, 2016, ARCH VIROL, V161, P1751, DOI 10.1007/s00705-016-2855-2
   Ishag HZA, 2013, ARCH VIROL, V158, P349, DOI 10.1007/s00705-012-1489-2
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709
   Ito M, 2010, ARCH VIROL, V155, P1617, DOI 10.1007/s00705-010-0741-x
   Jemielity S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003232
   Jia F, 2010, ARCH VIROL, V155, P1325, DOI 10.1007/s00705-010-0702-4
   Julander JG, 2014, ANTIMICROB AGENTS CH, V58, P6607, DOI 10.1128/AAC.03368-14
   Kampmann T, 2009, ANTIVIR RES, V84, P234, DOI 10.1016/j.antiviral.2009.09.007
   Kanai R, 2006, J VIROL, V80, P11000, DOI 10.1128/JVI.01735-06
   Kato F, 2016, ANTIVIR RES, V131, P141, DOI 10.1016/j.antiviral.2016.04.014
   Kim MY, 2013, J VIROL, V87, P998, DOI 10.1128/JVI.02710-12
   Klema VJ, 2015, VIRUSES-BASEL, V7, P4640, DOI 10.3390/v7082837
   Klimstra WB, 1998, J VIROL, V72, P7357, DOI 10.1128/JVI.72.9.7357-7366.1998
   Knox JE, 2006, J MED CHEM, V49, P6585, DOI 10.1021/jm0607606
   Kohler JJ, 2007, ENVIRON MOL MUTAGEN, V48, P166, DOI 10.1002/em.20223
   Korba BE, 2008, ANTIVIR RES, V77, P56, DOI 10.1016/j.antiviral.2007.08.005
   Kuhn S, 2011, CAN MED ASSOC J, V183, pE243, DOI 10.1503/cmaj.100619
   Kumar M, 2011, J MOL BIOL, V410, P944, DOI 10.1016/j.jmb.2011.04.005
   Kumar R, 2009, CLIN INFECT DIS, V48, P400, DOI 10.1086/596309
   Lai MC, 2016, FEBS J, V283, P88, DOI 10.1111/febs.13553
   Larena M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044834
   Larsen BJ, 2015, CHEM-EUR J, V21, P19159, DOI 10.1002/chem.201503527
   Latour DR, 2010, ANTIVIR RES, V87, P213, DOI 10.1016/j.antiviral.2010.05.003
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee E, 2006, ANTIVIR RES, V69, P31, DOI 10.1016/j.antiviral.2005.08.006
   Lee YR, 2005, INTERVIROLOGY, V48, P161, DOI 10.1159/000081744
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Lescar J, 2008, ANTIVIR RES, V80, P94, DOI 10.1016/j.antiviral.2008.07.001
   Leyssen P, 2001, VIROLOGY, V279, P27, DOI 10.1006/viro.2000.0723
   Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200
   Li XD, 2015, J GEN VIROL, V96, P1264, DOI 10.1099/vir.0.000044
   Lim SP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005737
   Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010
   Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184
   Lima AB, 2015, BIOORGAN MED CHEM, V23, P5748, DOI 10.1016/j.bmc.2015.07.012
   Lo MK, 2016, ANTIVIR RES, V130, P46, DOI 10.1016/j.antiviral.2016.03.013
   Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379
   Lopez-Gatell H, 2016, B WORLD HEALTH ORGAN, V94, P850, DOI 10.2471/BLT.15.168765
   Low JG, 2014, LANCET INFECT DIS, V14, P706, DOI 10.1016/S1473-3099(14)70730-3
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Malet H, 2008, ANTIVIR RES, V80, P23, DOI 10.1016/j.antiviral.2008.06.007
   Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Marques RE, 2015, IMMUNOLOGY, V145, P583, DOI 10.1111/imm.12476
   Martin-Acebes MA, 2016, J LIPID RES, V57, P422, DOI 10.1194/jlr.M064212
   Martin-Acebes MA, 2014, J VIROL, V88, P12041, DOI 10.1128/JVI.02061-14
   Martin-Acebes MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024970
   Martinez JP, 2015, NAT PROD REP, V32, P29, DOI 10.1039/c4np00085d
   Martinez-Gutierrez M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087412
   Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147
   Mastrangelo E, 2012, BIOCHEM BIOPH RES CO, V417, P84, DOI 10.1016/j.bbrc.2011.11.060
   McMahon AW, 2007, VACCINE, V25, P1727, DOI 10.1016/j.vaccine.2006.11.027
   McMinn PC, 1997, J GEN VIROL, V78, P2711, DOI 10.1099/0022-1317-78-11-2711
   Meanwell NA, 2016, J MED CHEM, V59, P7311, DOI 10.1021/acs.jmedchem.6b00915
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Meneses M. D. F., 2013, 26 INT C ANT RES ICA, V101
   Merino-Ramos T, 2016, ANTIMICROB AGENTS CH, V60, P307, DOI 10.1128/AAC.01578-15
   Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703
   Meuleman P, 2011, ANTIMICROB AGENTS CH, V55, P5159, DOI 10.1128/AAC.00633-11
   Meyskens FL, 1999, CLIN CANCER RES, V5, P945
   Miller S, 2006, J BIOL CHEM, V281, P8854, DOI 10.1074/jbc.M512697200
   Minakawa N, 1999, CURR MED CHEM, V6, P615
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Monath TP, 2013, AM J TROP MED HYG, V89, P1225, DOI 10.4269/ajtmh.13-0443a
   Mondelli MU, 2014, HEPATOLOGY, V60, P1126, DOI 10.1002/hep.27186
   Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200
   Mota J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020762
   Mota J, 2009, J VIROL, V83, P8638, DOI 10.1128/JVI.00581-09
   Moulton HM, 2004, BIOCONJUGATE CHEM, V15, P290, DOI 10.1021/bc034221g
   Mounce BC, 2016, J VIROL, V90, P9683, DOI 10.1128/JVI.01347-16
   Mounce BC, 2016, CELL HOST MICROBE, V20, P167, DOI 10.1016/j.chom.2016.06.011
   Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500
   Munier-Lehmann H, 2015, J MED CHEM, V58, P860, DOI 10.1021/jm501446r
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nall TA, 2004, J BIOL CHEM, V279, P48535, DOI 10.1074/jbc.M406810200
   Nelson J, 2015, ANTIVIR RES, V122, P39, DOI 10.1016/j.antiviral.2015.07.008
   Nguyen NM, 2013, J INFECT DIS, V207, P1442, DOI 10.1093/infdis/jis470
   Nitsche C., 2013, ANTIVIRAL METHODS PR, P221
   Nitsche C, 2017, J MED CHEM, V60, P511, DOI 10.1021/acs.jmedchem.6b01021
   Nitsche C, 2014, CHEM REV, V114, P11348, DOI 10.1021/cr500233q
   Nitsche C, 2013, J MED CHEM, V56, P8389, DOI 10.1021/jm400828u
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Nybakken GE, 2006, J VIROL, V80, P11467, DOI 10.1128/JVI.01125-06
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Olsen DB, 2004, ANTIMICROB AGENTS CH, V48, P3944, DOI 10.1128/AAC.48.10.3944-3953.2004
   Orlinger KK, 2011, J INFECT DIS, V203, P1556, DOI 10.1093/infdis/jir122
   Ortiz-Riano E, 2014, J VIROL, V88, P878, DOI 10.1128/JVI.02275-13
   Paessler S, 2013, ANNU REV PATHOL-MECH, V8, P411, DOI 10.1146/annurev-pathol-020712-164041
   Fontes CAP, 2016, NEURORADIOLOGY, V58, P837, DOI 10.1007/s00234-016-1687-9
   Pattabhi S, 2016, J VIROL, V90, P2372, DOI 10.1128/JVI.02202-15
   Payne AF, 2006, J VIROL METHODS, V134, P183, DOI 10.1016/j.jviromet.2006.01.003
   Penn RG, 2006, CLIN INFECT DIS, V42, P680, DOI 10.1086/500216
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   Perry ST, 2013, ANTIVIR RES, V98, P35, DOI 10.1016/j.antiviral.2013.01.004
   Perwitasari O, 2011, J BIOL CHEM, V286, P44412, DOI 10.1074/jbc.M111.285205
   Peterlin-Masic L, 2001, TETRAHEDRON, V57, P7073, DOI 10.1016/S0040-4020(01)00507-5
   Plentz A, 2009, VACCINE, V27, P853, DOI 10.1016/j.vaccine.2008.11.082
   Plummer E, 2015, J VIROL, V89, P5592, DOI 10.1128/JVI.00028-15
   Poh MK, 2012, ANTIVIR RES, V93, P191, DOI 10.1016/j.antiviral.2011.11.014
   Poh MK, 2009, ANTIVIR RES, V84, P260, DOI 10.1016/j.antiviral.2009.09.011
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Puccioni-Sohler M, 2009, NEUROLOGY, V73, P1413, DOI 10.1212/WNL.0b013e3181bd8258
   Qing M, 2010, ANTIMICROB AGENTS CH, V54, P3686, DOI 10.1128/AAC.00561-10
   Qing M, 2009, ANTIMICROB AGENTS CH, V53, P3226, DOI 10.1128/AAC.00189-09
   Raaben M, 2010, J VIROL, V84, P7880, DOI 10.1128/JVI.00486-10
   Raaben M, 2010, J VIROL, V84, P7869, DOI 10.1128/JVI.00485-10
   Rathore APS, 2011, ANTIVIR RES, V92, P453, DOI 10.1016/j.antiviral.2011.10.002
   Raung SL, 2007, NEUROSCI LETT, V419, P263, DOI 10.1016/j.neulet.2007.04.036
   RAVI V, 1993, J MED VIROL, V40, P326, DOI 10.1002/jmv.1890400412
   Rawlinson SM, 2009, J BIOL CHEM, V284, P15589, DOI 10.1074/jbc.M808271200
   REICHARD O, 1993, J MED VIROL, V41, P99, DOI 10.1002/jmv.1890410203
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707
   Richard AS, 2015, P NATL ACAD SCI USA, V112, P14682, DOI 10.1073/pnas.1508095112
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rossignol JF, 2006, ALIMENT PHARM THERAP, V24, P1423, DOI 10.1111/j.1365-2036.2006.03128.x
   Rossignol JF, 2009, J BIOL CHEM, V284, P29798, DOI 10.1074/jbc.M109.029470
   Rossignol JF, 2014, ANTIVIR RES, V110, P94, DOI 10.1016/j.antiviral.2014.07.014
   Rossignol JF, 2009, EXPERT OPIN DRUG MET, V5, P667, DOI 10.1517/17425250902988487
   Rossignol JF, 2009, GASTROENTEROLOGY, V136, P856, DOI 10.1053/j.gastro.2008.11.037
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Santoro MG, 2007, ANTIVIR RES, V74, pA31, DOI 10.1016/j.antiviral.2007.01.019
   Saudi M, 2016, EUR J MED CHEM, V121, P158, DOI 10.1016/j.ejmech.2016.05.043
   Saudi M, 2014, EUR J MED CHEM, V87, P529, DOI 10.1016/j.ejmech.2014.09.062
   Sbrana E, 2004, AM J TROP MED HYG, V71, P306, DOI 10.4269/ajtmh.2004.71.306
   Scaturro P, 2014, J VIROL, V88, P11540, DOI 10.1128/JVI.01745-14
   Schul W, 2007, J INFECT DIS, V195, P665, DOI 10.1086/511310
   Sebastian L, 2011, CHEMOTHERAPY, V57, P56, DOI 10.1159/000321483
   Selvey LA, 2016, INTERN MED J, V46, P193, DOI 10.1111/imj.12962
   Sharma N, 2016, INNATE IMMUN-LONDON, V22, P238, DOI 10.1177/1753425916632305
   Shi ZX, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-10
   Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06
   Shum D, 2010, ASSAY DRUG DEV TECHN, V8, P553, DOI 10.1089/adt.2010.0321
   Farias KJS, 2015, VIRAL IMMUNOL, V28, P161, DOI 10.1089/vim.2014.0090
   Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712
   Smit JM, 2002, J VIROL, V76, P10128, DOI 10.1128/JVI.76.20.10128-10137.2002
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Smith JL, 2014, J VIROL, V88, P5533, DOI 10.1128/JVI.00365-14
   Sofia MJ, 2013, ADV PHARMACOL, V67, P39, DOI 10.1016/B978-0-12-405880-4.00002-0
   Sofia MJ, 2010, J MED CHEM, V53, P7202, DOI 10.1021/jm100863x
   Stavale EJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121662
   Stein DA, 2008, J ANTIMICROB CHEMOTH, V62, P555, DOI 10.1093/jac/dkn221
   Steuer C, 2009, J BIOMOL SCREEN, V14, P1102, DOI 10.1177/1087057109344115
   Stoermer MJ, 2008, J MED CHEM, V51, P5714, DOI 10.1021/jm800503y
   Su XC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000561
   SUGAWARA K, 1992, J ANTIBIOT, V45, P1433, DOI 10.7164/antibiotics.45.1433
   Sugiyama R, 2013, ANTIVIR RES, V99, P307, DOI 10.1016/j.antiviral.2013.06.017
   Sweeney NL, 2015, ACS INFECT DIS, V1, P140, DOI 10.1021/id5000458
   Swenson DL, 2009, ANTIMICROB AGENTS CH, V53, P2089, DOI 10.1128/AAC.00936-08
   Taguwa S, 2015, CELL, V163, P1108, DOI 10.1016/j.cell.2015.10.046
   Tani H, 2010, J VIROL, V84, P2798, DOI 10.1128/JVI.02499-09
   Tay MYF, 2013, ANTIVIR RES, V99, P301, DOI 10.1016/j.antiviral.2013.06.002
   Taylor R, 2016, J INFECT PUBLIC HEAL, V9, P220, DOI 10.1016/j.jiph.2016.04.002
   Tesh RB, 2005, J INFECT DIS, V192, P287, DOI 10.1086/431153
   Tesh RB, 2001, J INFECT DIS, V183, P1431, DOI 10.1086/320199
   Theiler M, 1937, J EXP MED, V65, P787, DOI 10.1084/jem.65.6.787
   Thibodeaux BA, 2012, ANTIVIR RES, V94, P1, DOI 10.1016/j.antiviral.2012.02.001
   Thibodeaux BA, 2012, VACCINE, V30, P3180, DOI 10.1016/j.vaccine.2012.03.003
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Tigabu B, 2009, J MED VIROL, V81, P1261, DOI 10.1002/jmv.21524
   Tomlinson SM, 2012, ANTIVIR RES, V93, P245, DOI 10.1016/j.antiviral.2011.12.003
   Trabattoni D, 2016, SCI REP-UK, V6, DOI 10.1038/srep27148
   Tricou Vianney, 2010, PLoS Negl Trop Dis, V4, pe785, DOI 10.1371/journal.pntd.0000785
   Vasilakis N, 2003, NAT BIOTECHNOL, V21, P932, DOI 10.1038/nbt845
   Vernachio JH, 2011, ANTIMICROB AGENTS CH, V55, P1843, DOI 10.1128/AAC.01335-10
   Vernekar SKV, 2015, J MED CHEM, V58, P4016, DOI 10.1021/acs.jmedchem.5b00327
   Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268
   Wang BX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14763
   Wang LF, 2015, J INTERF CYTOK RES, V35, P143, DOI 10.1089/jir.2014.0038
   Wang P, 2014, CHEMMEDCHEM, V9, P1522, DOI 10.1002/cmdc.201300505
   Wang QY, 2015, J VIROL, V89, P8233, DOI 10.1128/JVI.00855-15
   Wang QY, 2009, ANTIMICROB AGENTS CH, V53, P1823, DOI 10.1128/AAC.01148-08
   Warren TK, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004456
   Warren TK, 2014, NATURE, V508, P402, DOI 10.1038/nature13027
   Watanabe S, 2016, ANTIVIR RES, V127, P10, DOI 10.1016/j.antiviral.2015.12.008
   Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weigel LF, 2015, J MED CHEM, V58, P7719, DOI 10.1021/acs.jmedchem.5b00612
   Weiskopf D, 2011, J IMMUNOL, V187, P4268, DOI 10.4049/jimmunol.1101970
   Whitby K, 2005, J VIROL, V79, P8698, DOI 10.1128/JVI.79.14.8698-8706.2005
   Widman DG, 2010, AM J TROP MED HYG, V82, P1160, DOI 10.4269/ajtmh.2010.09-0310
   Wu SF, 2002, J VIROL, V76, P3596, DOI 10.1128/JVI.76.8.3596-3604.2002
   Xiao SY, 2001, EMERG INFECT DIS, V7, P714
   Xie XP, 2015, ANTIVIR RES, V118, P39, DOI 10.1016/j.antiviral.2015.03.007
   Xie XP, 2011, J VIROL, V85, P11183, DOI 10.1128/JVI.05468-11
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yang CC, 2014, ANTIMICROB AGENTS CH, V58, P110, DOI 10.1128/AAC.01281-13
   Yang CC, 2011, ANTIMICROB AGENTS CH, V55, P229, DOI 10.1128/AAC.00855-10
   Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06
   Yeo KL, 2015, ANTIMICROB AGENTS CH, V59, P2086, DOI 10.1128/AAC.04779-14
   Yin Z, 2006, BIOORG MED CHEM LETT, V16, P36, DOI 10.1016/j.bmcl.2005.09.062
   Yin Z, 2006, BIOORG MED CHEM LETT, V16, P40, DOI 10.1016/j.bmcl.2005.09.049
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Youn S, 2012, J VIROL, V86, P7360, DOI 10.1128/JVI.00157-12
   Yu WQ, 2012, J MED CHEM, V55, P6061, DOI 10.1021/jm300171v
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zasloff M, 2011, P NATL ACAD SCI USA, V108, P15978, DOI 10.1073/pnas.1108558108
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zhao XS, 2015, ANTIMICROB AGENTS CH, V59, P206, DOI 10.1128/AAC.03999-14
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
   Zmurko J, 2015, REV MED VIROL, V25, P205, DOI 10.1002/rmv.1835
   Zou G, 2009, VIROLOGY, V384, P242, DOI 10.1016/j.virol.2008.11.003
NR 328
TC 82
Z9 86
U1 4
U2 48
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1474-1776
EI 1474-1784
J9 NAT REV DRUG DISCOV
JI Nat. Rev. Drug Discov.
PD AUG
PY 2017
VL 16
IS 8
BP 565
EP 586
DI 10.1038/nrd.2017.33
PG 22
WC Biotechnology & Applied Microbiology; Pharmacology & Pharmacy
SC Biotechnology & Applied Microbiology; Pharmacology & Pharmacy
GA FC0CC
UT WOS:000406504900016
PM 28473729
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Mor, G
   Aldo, P
   Alvero, AB
AF Mor, Gil
   Aldo, Paulomi
   Alvero, Ayesha B.
TI The unique immunological and microbial aspects of pregnancy
SO NATURE REVIEWS IMMUNOLOGY
LA English
DT Review
ID REGULATORY T-CELLS; MATERNAL IMMUNE ACTIVATION; TOLL-LIKE RECEPTORS;
   PLACENTAL INFLAMMATORY RESPONSE; FETAL-BRAIN DEVELOPMENT; INDUCED
   PRETERM LABOR; ZIKA VIRUS; VIRAL-INFECTION; I INTERFERON; NK CELLS
AB The comparison of the immunological state of pregnancy to an immunosuppressed host-graft model continues to lead research and clinical practice to ill-defined approaches. This Review discusses recent evidence that supports the idea that immunological responses at the receptive maternal-fetal interface are not simply suppressed but are instead highly dynamic. We discuss the crucial role of trophoblast cells in shaping not only the way in which immune cells respond to the invading blastocyst but also how they collectively react to external stimuli. We also discuss the role of the microbiota in promoting a tolerogenic maternal immune system and highlight how subclinical viral infections can disrupt this status quo, leading to pregnancy complications.
C1 [Mor, Gil; Aldo, Paulomi; Alvero, Ayesha B.] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, Div Reprod Sci, 333 Cedar St, New Haven, CT 06510 USA.
RP Mor, G (corresponding author), Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, Div Reprod Sci, 333 Cedar St, New Haven, CT 06510 USA.
EM gil.mor@yale.edu
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R56 AI124356]
CR Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599
   Abelius MS, 2015, AM J REPROD IMMUNOL, V73, P445, DOI 10.1111/aji.12350
   Aboagye-Mathiesen G, 1995, Early Pregnancy, V1, P41
   AboagyeMathiesen G, 1996, AM J REPROD IMMUNOL, V35, P309
   Abrahams VM, 2005, J IMMUNOL, V175, P8096, DOI 10.4049/jimmunol.175.12.8096
   Abrahams VM, 2005, PLACENTA, V26, P540, DOI 10.1016/j.placenta.2004.08.010
   Abrahams VM, 2004, AM J REPROD IMMUNOL, V51, P275, DOI 10.1111/j.1600-0897.2004.00156.x
   Abrahams VM, 2004, MOL HUM REPROD, V10, P55, DOI 10.1093/molehr/gah006
   Abrahams VM, 2005, AM J REPROD IMMUNOL, V53, P280
   Agrawal V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063990
   Aldo PB, 2014, AM J REPROD IMMUNOL, V72, P270, DOI 10.1111/aji.12288
   Allavena P, 2005, CANCER RES, V65, P2964, DOI 10.1158/0008-5472.CAN-04-4037
   Bai XX, 2015, J MED VIROL, V87, P375, DOI 10.1002/jmv.24072
   Balkundi DR, 2000, PEDIATR RES, V47, P301, DOI 10.1203/00006450-200003000-00004
   Bayraktar M, 2009, AM J REPROD IMMUNOL, V62, P390, DOI 10.1111/j.1600-0897.2009.00756.x
   Beaman KD, 2016, AM J REPROD IMMUNOL, V76, P3, DOI 10.1111/aji.12524
   Behnia F, 2016, AM J REPROD IMMUNOL, V75, P505, DOI 10.1111/aji.12496
   Bello O. O., 2016, CASE REP OBSTET GYNE, V2016
   BERRY SM, 1995, AM J OBSTET GYNECOL, V173, P1315, DOI 10.1016/0002-9378(95)91378-5
   Bidarimath M, 2014, CELL MOL IMMUNOL, V11, P538, DOI 10.1038/cmi.2014.45
   BIRNBERG T, 2007, AM J REPROD IMMUNOL, V57, P342
   Boasso A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002961
   Brown ZA, 1997, NEW ENGL J MED, V337, P509, DOI 10.1056/NEJM199708213370801
   BULMER JN, 1988, REPROD NUTR DEV, V28, P1599, DOI 10.1051/rnd:19881006
   Burd I, 2010, J NEUROSCI RES, V88, P1872, DOI 10.1002/jnr.22368
   Burke SD, 2010, AM J REPROD IMMUNOL, V63, P472, DOI 10.1111/j.1600-0897.2010.00818.x
   Burt TD, 2013, AM J REPROD IMMUNOL, V69, P346, DOI 10.1111/aji.12083
   Cao B, 2014, PLACENTA, V35, P139, DOI 10.1016/j.placenta.2013.12.007
   Cappelletti M, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91288
   Cappelletti M, 2016, J LEUKOCYTE BIOL, V99, P67, DOI 10.1189/jlb.3MR0615-272RR
   Cardenas I, 2011, J IMMUNOL, V187, P980, DOI 10.4049/jimmunol.1100578
   Cardenas I, 2011, AM J REPROD IMMUNOL, V65, P110, DOI 10.1111/j.1600-0897.2010.00908.x
   Cardenas I, 2010, J IMMUNOL, V185, P1248, DOI 10.4049/jimmunol.1000289
   Chaouat G, 1997, AM J REPROD IMMUNOL, V37, P427
   CHARD T, 1986, BRIT J OBSTET GYNAEC, V93, P1145, DOI 10.1111/j.1471-0528.1986.tb08635.x
   Chen R, 2007, AM J REPROD IMMUNOL, V57, P93, DOI 10.1111/j.1600-0897.2006.00441.x
   Ciaranello AL, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001156
   Collins MK, 2009, J CLIN INVEST, V119, P2062, DOI 10.1172/JCI38714
   Condon JC, 2004, P NATL ACAD SCI USA, V101, P4978, DOI 10.1073/pnas.0401124101
   Cordeiro CN, 2015, OBSTET GYNECOL SURV, V70, P644, DOI 10.1097/OGX.0000000000000236
   Costello MJ, 2007, AM J REPROD IMMUNOL, V57, P67, DOI 10.1111/j.1600-0897.2006.00447.x
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571
   De Carvalho NS, 2016, BRAZ J INFECT DIS, V20, P282, DOI 10.1016/j.bjid.2016.02.006
   Dekel N, 2010, AM J REPROD IMMUNOL, V63, P17, DOI 10.1111/j.1600-0897.2009.00792.x
   DiGiulio DB, 2010, J PERINAT MED, V38, P503, DOI [10.1515/JPM.2010.078, 10.1515/jpm.2010.078]
   Dontigny L, 2008, J OBSTET GYNAECOL CA, V30, P152, DOI 10.1016/S1701-2163(16)32740-2
   Dutia BM, 1999, VIROLOGY, V261, P173, DOI 10.1006/viro.1999.9834
   Dyer O, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2167
   Edey LF, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.143289
   Elovitz MA, 2006, PEDIATR RES, V59, P50, DOI 10.1203/01.pdr.0000191141.21932.b6
   Elovitz MA, 2004, TRENDS ENDOCRIN MET, V15, P479, DOI 10.1016/j.tem.2004.10.009
   ENDERS G, 1994, LANCET, V343, P1548, DOI 10.1016/S0140-6736(94)92943-2
   Erkan T, 1998, ACTA PAEDIATR, V87, P1008, DOI 10.1080/080352598750031725
   Erlebacher A, 2013, NAT REV IMMUNOL, V13, P23, DOI 10.1038/nri3361
   Espinoza J, 2006, AM J OBSTET GYNECOL, V194, P630, DOI 10.1016/j.ajog.2005.11.050
   Estes ML, 2016, SCIENCE, V353, P772, DOI 10.1126/science.aag3194
   Faas M. M., 2017, PLACENTA
   Faucher B, 2012, J INFECTION, V64, P104, DOI 10.1016/j.jinf.2011.10.008
   Fettke F, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00285
   Garbett KA, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.24
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676
   Gardner MB, 2008, ILAR J, V49, P220, DOI 10.1093/ilar.49.2.220
   Gervasi MT, 2012, J MATERN-FETAL NEO M, V25, P2002, DOI 10.3109/14767058.2012.683899
   Giugliano S, 2015, J IMMUNOL, V195, P3737, DOI 10.4049/jimmunol.1500409
   Gnainsky Y, 2015, REPRODUCTION, V149, P75, DOI 10.1530/REP-14-0395
   Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007
   Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4
   Gomez-Lopez N, 2016, AM J REPROD IMMUNOL, V75, P3, DOI 10.1111/aji.12443
   Guo Z, 2013, J VIRAL HEPATITIS, V20, P317, DOI 10.1111/jvh.12032
   Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452
   Holtan SG, 2009, MAYO CLIN PROC, V84, P985, DOI 10.1016/S0025-6196(11)60669-1
   Houser BL, 2011, J IMMUNOL, V186, P2633, DOI 10.4049/jimmunol.1003153
   HOWATSON AG, 1988, J ENDOCRINOL, V119, P531, DOI 10.1677/joe.0.1190531
   Hu YJ, 2016, J AUTOIMMUN, V72, P47, DOI 10.1016/j.jaut.2016.05.001
   Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581
   Iwasaki A, 2010, NAT REV IMMUNOL, V10, P699, DOI 10.1038/nri2836
   Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021
   Jamieson DJ, 2014, OBSTET GYNECOL, V124, P1005, DOI 10.1097/AOG.0000000000000533
   Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359
   Jasper MJ, 2006, MOL HUM REPROD, V12, P301, DOI 10.1093/molehr/gal032
   Jeyasuria P, 2011, BIOL REPROD, V85, P417, DOI 10.1095/biolreprod.111.091652
   Kiefer DG, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.08.002
   Kiefer DG, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.047
   Knuesel I, 2014, NAT REV NEUROL, V10, P643, DOI 10.1038/nrneurol.2014.187
   Koga K, 2010, AM J REPROD IMMUNOL, V63, P587, DOI 10.1111/j.1600-0897.2010.00848.x
   Koga K, 2009, AM J REPROD IMMUNOL, V61, P196, DOI 10.1111/j.1600-0897.2008.00682.x
   Korzeniewski SJ, 2014, J PERINAT MED, V42, P731, DOI 10.1515/jpm-2014-0250
   Kourtis AP, 2014, NEW ENGL J MED, V370, P2211, DOI 10.1056/NEJMra1213566
   Kwon JY, 2014, AM J REPROD IMMUNOL, V71, P387, DOI 10.1111/aji.12243
   Lamont RF, 2003, HOSP MED, V64, P644, DOI 10.12968/hosp.2003.64.11.2343
   Laskarin G, 2007, AM J REPROD IMMUNOL, V58, P255, DOI 10.1111/j.1600-0897.2007.00511.x
   Lee B N, 2001, Infect Dis Obstet Gynecol, V9, P95, DOI 10.1155/S1064744901000175
   Lee JY, 2000, CLIN MICROBIOL REV, V13, P571, DOI 10.1128/CMR.13.4.571-587.2000
   Leikin E, 1996, OBSTET GYNECOL, V88, P690, DOI 10.1016/0029-7844(96)00259-1
   LESSIN DL, 1988, AM J REPROD IMMUNOL, V16, P1
   Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537
   Lindstrom TM, 2005, REPRODUCTION, V130, P569, DOI 10.1530/rep.1.00197
   Lockwood CJ, 2013, AM J PATHOL, V183, P841, DOI 10.1016/j.ajpath.2013.05.029
   Mahic M, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00016-17, 10.1128/msphere.00016-17]
   Manaster I, 2008, J IMMUNOL, V181, P1869, DOI 10.4049/jimmunol.181.3.1869
   MEDAWAR PB, 1953, SYM SOC EXP BIOL, V7, P320
   Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506
   Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166
   Moffett-King A, 2002, NAT REV IMMUNOL, V2, P656, DOI 10.1038/nri886
   Mor G, 2005, CRIT REV IMMUNOL, V25, P375, DOI 10.1615/CritRevImmunol.v25.i5.30
   Mor G, 2007, NAT HIST, V116, P36
   Mor G, 2016, AM J REPROD IMMUNOL, V75, P421, DOI 10.1111/aji.12505
   Mor G, 2011, ANN NY ACAD SCI, V1221, P80, DOI 10.1111/j.1749-6632.2010.05938.x
   Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x
   Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132
   Muzzio DO, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.122366
   Nancy P, 2012, SCIENCE, V336, P1317, DOI 10.1126/science.1220030
   Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587
   Ng SC, 2002, AM J REPROD IMMUNOL, V48, P77, DOI 10.1034/j.1600-0897.2002.01105.x
   Norwitz ER, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a023143
   Obata Y, 2015, IMMUNOL CELL BIOL, V93, P226, DOI 10.1038/icb.2014.114
   Odorizzi PM, 2013, SCIENCE, V340, P155, DOI 10.1126/science.1237568
   Oettel A, 2016, SCI REP-UK, V6, DOI 10.1038/srep23278
   Olivadoti M, 2007, COMPARATIVE MED, V57, P44
   Parham P, 2013, NAT REV IMMUNOL, V13, P133, DOI 10.1038/nri3370
   PASTUSZAK AL, 1994, NEW ENGL J MED, V330, P901, DOI 10.1056/NEJM199403313301305
   Patra S, 2007, ANN INTERN MED, V147, P28, DOI 10.7326/0003-4819-147-1-200707030-00005
   Peltier MR, 2012, PLACENTA, V33, P745, DOI 10.1016/j.placenta.2012.06.005
   Pettker CM, 2007, OBSTET GYNECOL, V109, P739, DOI 10.1097/01.AOG.0000255663.47512.23
   Picone O, 2013, PRENATAL DIAG, V33, P751, DOI 10.1002/pd.4118
   Pirianov G, 2009, ENDOCRINOLOGY, V150, P699, DOI 10.1210/en.2008-1178
   Plaks V, 2008, J CLIN INVEST, V118, P3954, DOI 10.1172/JCI36682
   Plazyo O, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.144139
   Poloski E, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.135541
   PRICE ME, 1988, BRIT MED J, V297, P584, DOI 10.1136/bmj.297.6648.584
   Prince AL, 2014, J REPROD IMMUNOL, V104, P12, DOI 10.1016/j.jri.2014.03.006
   Prince AL, 2014, SEMIN REPROD MED, V32, P14, DOI 10.1055/s-0033-1361818
   Racicot K, 2017, J IMMUNOL, V198, P3029, DOI 10.4049/jimmunol.1601824
   Racicot K, 2016, AM J REPROD IMMUNOL, V75, P451, DOI 10.1111/aji.12501
   Racicot K, 2013, J IMMUNOL, V191, P934, DOI 10.4049/jimmunol.1300661
   Ramhorst R, 2012, AM J REPROD IMMUNOL, V67, P17, DOI 10.1111/j.1600-0897.2011.01056.x
   Ramos BD, 2015, AM J REPROD IMMUNOL, V73, P383, DOI 10.1111/aji.12326
   Repnik U, 2008, PLACENTA, V29, P405, DOI 10.1016/j.placenta.2008.02.004
   Reuben JM, 1996, J INTERF CYTOK RES, V16, P963, DOI 10.1089/jir.1996.16.963
   Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x
   Romero R, 2003, J NUTR, V133, p1668S, DOI 10.1093/jn/133.5.1668S
   Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773
   Romero R, 2017, AM J REPROD IMMUNOL, V78, DOI 10.1111/aji.12685
   Rose DR, 2017, BRAIN BEHAV IMMUN, V63, P60, DOI 10.1016/j.bbi.2016.11.020
   Rowe JH, 2012, NATURE, V490, P102, DOI 10.1038/nature11462
   Saito S, 2010, AM J REPROD IMMUNOL, V63, P601, DOI 10.1111/j.1600-0897.2010.00852.x
   Saito S, 2006, MED INTELL UNIT, P37
   Sasaki Y, 2004, MOL HUM REPROD, V10, P347, DOI 10.1093/molehr/gah044
   Schuler-Faccini L, 2016, CLIN PHARMACOL THER, V100, P28, DOI 10.1002/cpt.386
   Sharif MN, 2006, J EXP MED, V203, P1891, DOI 10.1084/jem.20051725
   Shi LM, 2009, BRAIN BEHAV IMMUN, V23, P116, DOI 10.1016/j.bbi.2008.07.012
   Shi LM, 2005, INT J DEV NEUROSCI, V23, P299, DOI 10.1016/j.ijdevneu.2004.05.005
   Shi LM, 2003, J NEUROSCI, V23, P297, DOI 10.1523/jneurosci.23-01-00297.2003
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479
   Slowik May K, 2005, Semin Pediatr Infect Dis, V16, P296, DOI 10.1053/j.spid.2005.06.009
   Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007
   Stout MJ, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.01.018
   Straszewski-Chavez SL, 2005, ENDOCR REV, V26, P877, DOI 10.1210/er.2005-0003
   Svensson-Arvelund J, 2015, J IMMUNOL, V194, P1534, DOI 10.4049/jimmunol.1401536
   Syggelou A, 2010, ANN NY ACAD SCI, V1205, P144, DOI 10.1111/j.1749-6632.2010.05649.x
   Tian M, 2016, SCI REP-UK, V6, DOI 10.1038/srep27683
   Tilburgs T, 2015, P NATL ACAD SCI USA, V112, P7219, DOI 10.1073/pnas.1507977112
   Vacca P, 2010, P NATL ACAD SCI USA, V107, P11918, DOI 10.1073/pnas.1001749107
   Waldorf KMA, 2011, BJOG-INT J OBSTET GY, V118, P136, DOI 10.1111/j.1471-0528.2010.02728.x
   Wang BX, 2011, SAMJ S AFR MED J, V101, P253, DOI 10.7196/SAMJ.4078
   Wang H, 2003, BIOL REPROD, V69, P1957, DOI 10.1095/biolreprod.103.019620
   WEGMANN TG, 1992, DEV COMP IMMUNOL, V16, P425, DOI 10.1016/0145-305X(92)90026-9
   Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336
   Wilson EB, 2013, TRENDS MICROBIOL, V21, P634, DOI 10.1016/j.tim.2013.10.003
   Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208
   Xu F., 2007, AM J OBSTET GYNECOL, V196
   Yeung LTF, 2001, HEPATOLOGY, V34, P223, DOI 10.1053/jhep.2001.25885
   Zenclussen AC, 2005, AM J PATHOL, V166, P811, DOI 10.1016/S0002-9440(10)62302-4
   Zenclussen AC, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00321
   Zhang JH, 2011, CELL MOL IMMUNOL, V8, P1, DOI 10.1038/cmi.2010.38
   Zuckerman L, 2003, NEUROPSYCHOPHARMACOL, V28, P1778, DOI 10.1038/sj.npp.1300248
NR 179
TC 129
Z9 129
U1 6
U2 43
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1474-1733
EI 1474-1741
J9 NAT REV IMMUNOL
JI Nat. Rev. Immunol.
PD AUG
PY 2017
VL 17
IS 8
BP 469
EP 482
DI 10.1038/nri.2017.64
PG 14
WC Immunology
SC Immunology
GA FB8YL
UT WOS:000406426200007
PM 28627518
DA 2020-07-08
ER

PT J
AU Hotez, PJ
   Murray, KO
AF Hotez, Peter J.
   Murray, Kristy O.
TI Dengue, West Nile virus, chikungunya, Zika - and now Mayaro?
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Editorial Material
ID HUMAN-DISEASE AGENT; TRANSMISSION; AMERICA; FLORIDA; FEVER
C1 [Hotez, Peter J.; Murray, Kristy O.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.
   [Hotez, Peter J.] Baylor Coll Med, Dept Mol Virol & Microbiol, Natl Sch Trop Med, Houston, TX 77030 USA.
   [Hotez, Peter J.] Texas Childrens Hosp, Baylor Coll Med, Ctr Vaccine Dev, Natl Sch Trop Med, Houston, TX 77030 USA.
   [Hotez, Peter J.] Baylor Univ, Dept Biol, Waco, TX 76798 USA.
   [Hotez, Peter J.] Rice Univ, James A Baker III Inst Publ Policy, Houston, TX 77005 USA.
   [Hotez, Peter J.] Texas A&M Univ, Scowcroft Inst Int Affairs, Bush Sch Govt & Publ Serv, College Stn, TX 77843 USA.
   [Murray, Kristy O.] Baylor Coll Med, Ctr Vector Borne & Zoonot Dis, Natl Sch Trop Med, Houston, TX 77030 USA.
RP Hotez, PJ; Murray, KO (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.; Hotez, PJ (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Natl Sch Trop Med, Houston, TX 77030 USA.; Hotez, PJ (corresponding author), Texas Childrens Hosp, Baylor Coll Med, Ctr Vaccine Dev, Natl Sch Trop Med, Houston, TX 77030 USA.; Hotez, PJ (corresponding author), Baylor Univ, Dept Biol, Waco, TX 76798 USA.; Hotez, PJ (corresponding author), Rice Univ, James A Baker III Inst Publ Policy, Houston, TX 77005 USA.; Hotez, PJ (corresponding author), Texas A&M Univ, Scowcroft Inst Int Affairs, Bush Sch Govt & Publ Serv, College Stn, TX 77843 USA.; Murray, KO (corresponding author), Baylor Coll Med, Ctr Vector Borne & Zoonot Dis, Natl Sch Trop Med, Houston, TX 77030 USA.
EM hotez@bcm.edu; kmurray@bcm.edu
CR ANDERSON CR, 1957, AM J TROP MED HYG, V6, P1012, DOI 10.4269/ajtmh.1957.6.1012
   [Anonymous], ZIK VIR
   Auguste AJ, 2015, EMERG INFECT DIS, V21, P1742, DOI 10.3201/eid2110.141660
   Calisher CH, 1974, B PAN AM HLTH ORG, V8, P243
   CASALS J, 1957, AM J TROP MED HYG, V6, P1004, DOI 10.4269/ajtmh.1957.6.1004
   *CDC, W NIL VIR
   Estofolete CF, 2016, REV SOC BRAS MED TRO, V49, P648, DOI 10.1590/0037-8682-0093-2016
   de Figueiredo MLG, 2014, REV SOC BRAS MED TRO, V47, P677, DOI 10.1590/0037-8682-0246-2014
   Hotez PJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004648
   Hotez PJ, VICE NEWS ZIKA VIRUS
   Kendrick K, 2014, MMWR-MORBID MORTAL W, V63, P1137
   Lednicky J, 2016, EMERG INFECT DIS, V22, P2000, DOI 10.3201/eid2211.161015
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359
   Mackay IM, 2016, MICROBES INFECT, V18, P724, DOI 10.1016/j.micinf.2016.10.007
   Murray KO, 2011, EPIDEMIOL INFECT, V139, P807, DOI 10.1017/S0950268811000185
   Murray KO, 2013, VECTOR-BORNE ZOONOT, V13, P835, DOI 10.1089/vbz.2013.1413
   Olivia Lwande Wesula, 2015, Infection Ecology & Epidemiology, V5, P29853, DOI 10.3402/iee.v5.29853
   Pinheiro FP, 1988, ARBOVIRUSES EPIDEMIO, P137
   Santiago FW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004104
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Terzian ACB, 2015, AM J TROP MED HYG, V92, P401, DOI 10.4269/ajtmh.14-0417
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952
   Vos T, 2016, LANCET, V388, P1545, DOI 10.1016/S0140-6736(16)31678-6
   Weise WJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002969
NR 25
TC 29
Z9 29
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD AUG
PY 2017
VL 11
IS 8
AR e0005462
DI 10.1371/journal.pntd.0005462
PG 5
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FH3SD
UT WOS:000411068800002
PM 28859086
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU McCracken, MK
   Gromowski, GD
   Friberg, HL
   Lin, XX
   Abbink, P
   De La Barrera, R
   Eckles, KH
   Garver, LS
   Boyd, M
   Jetton, D
   Barouch, DH
   Wise, MC
   Lewis, BS
   Currier, JR
   Modjarrad, K
   Milazzo, M
   Liu, M
   Mullins, AB
   Putnak, JR
   Michael, NL
   Jarman, RG
   Thomas, SJ
AF McCracken, Michael K.
   Gromowski, Gregory D.
   Friberg, Heather L.
   Lin, Xiaoxu
   Abbink, Peter
   De La Barrera, Rafael
   Eckles, Kenneth H.
   Garver, Lindsey S.
   Boyd, Michael
   Jetton, David
   Barouch, Dan H.
   Wise, Matthew C.
   Lewis, Bridget S.
   Currier, Jeffrey R.
   Modjarrad, Kayvon
   Milazzo, Mark
   Liu, Michelle
   Mullins, Anna B.
   Putnak, J. Robert
   Michael, Nelson L.
   Jarman, Richard G.
   Thomas, Stephen J.
TI Impact of prior flavivirus immunity on Zika virus infection in rhesus
   macaques
SO PLOS PATHOGENS
LA English
DT Article
ID DENGUE HEMORRHAGIC-FEVER; T-CELL RESPONSES; ORIGINAL ANTIGENIC SIN;
   CROSS-REACTIVITY; DISEASE SEVERITY; ANTIBODY; VACCINE; ENHANCEMENT;
   PATHOGENESIS; PROTECTION
AB Studies have demonstrated cross-reactivity of anti-dengue virus (DENV) antibodies in human sera against Zika virus (ZIKV), promoting increased ZIKV infection in vitro. However, the correlation between in vitro and in vivo findings is not well characterized. Thus, we evaluated the impact of heterotypic flavivirus immunity on ZIKV titers in biofluids of rhesus macaques. Animals previously infected (420 days) with DENV2, DENV4, or yellow fever virus were compared to flavivirus-naive animals following infection with a Brazilian ZIKV strain. Sera from DENV-immune macaques demonstrated cross-reactivity with ZIKV by antibody-binding and neutralization assays prior to ZIKV infection, and promoted increased ZIKV infection in cell culture assays. Despite these findings, no significant differences between flavivirus-naive and immune animals were observed in viral titers, neutralizing antibody levels, or immune cell kinetics following ZIKV infection. These results indicate that prior infection with heterologous flaviviruses neither conferred protection nor increased observed ZIKV titers in this non-human primate ZIKV infection model.
C1 [McCracken, Michael K.; Gromowski, Gregory D.; Friberg, Heather L.; Lin, Xiaoxu; Currier, Jeffrey R.; Putnak, J. Robert; Jarman, Richard G.] Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD USA.
   [Abbink, Peter; Boyd, Michael; Jetton, David; Barouch, Dan H.] Harvard Med Sch, Ctr Virol & Vaccine Res, Beth Israel Deaconess Med Ctr, Boston, MA USA.
   [De La Barrera, Rafael; Eckles, Kenneth H.] Walter Reed Army Inst Res, Pilot Bioprod Facil, Silver Spring, MD USA.
   [Garver, Lindsey S.] Walter Reed Army Inst Res, Entomol Branch, Silver Spring, MD USA.
   [Wise, Matthew C.; Lewis, Bridget S.; Mullins, Anna B.] Walter Reed Army Inst Res, Vet Serv Program, Silver Spring, MD USA.
   [Modjarrad, Kayvon; Milazzo, Mark; Liu, Michelle] Henry M Jackson Fdn, Bethesda, MD USA.
   [Modjarrad, Kayvon; Milazzo, Mark; Liu, Michelle; Michael, Nelson L.] Walter Reed Army Inst Res, Mil HIV Res Program, Silver Spring, MD USA.
   [Thomas, Stephen J.] Walter Reed Army Inst Res, Silver Spring, MD USA.
RP Jarman, RG (corresponding author), Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD USA.
EM richard.g.jarman.mil@mail.mil
RI Barouch, Dan/Y-3918-2019
OI McCracken, Michael/0000-0002-4035-5485; Jetton,
   David/0000-0002-1615-9986; Abbink, Peter/0000-0003-1978-088X
FU US Army Medical Research and Material CommandU.S. Army Medical Research
   & Materiel Command (USAMRMC)
FX This study was funded by the US Army Medical Research and Material
   Command. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Anderson KB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001311
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Austin SK, 2014, VIRUSES-BASEL, V6, P1015, DOI 10.3390/v6031015
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Centers for Disease Control and Prevention, 2016, ZIK VIR TRANSM RISK
   Centers for Disease Control and Prevention, 2016, GEOGR DISTR JAP ENC
   Centers for Disease Control and Prevention, 2016, AR RISK YELL FEV VIR
   Centers for Disease Control and Prevention (CDC), 2016, FLOR INV LINKS 4 REC
   Clapham HE, 2016, J INFECT DIS, V213, P1428, DOI 10.1093/infdis/jiv759
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Duangchinda T, 2010, P NATL ACAD SCI USA, V107, P16922, DOI 10.1073/pnas.1010867107
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   FAGBAMI AH, 1987, CYTOBIOS, V49, P49
   Friberg H, 2011, SCI REP-UK, V1, DOI 10.1038/srep00051
   Goncalvez AP, 2007, P NATL ACAD SCI USA, V104, P9422, DOI 10.1073/pnas.0703498104
   HALSTEAD SB, 1973, J INFECT DIS, V128, P15, DOI 10.1093/infdis/128.1.15
   HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527
   HOKE CH, 1988, NEW ENGL J MED, V319, P608, DOI 10.1056/NEJM198809083191004
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Johnson AJ, 2000, J CLIN MICROBIOL, V38, P1827, DOI 10.1128/JCM.38.5.1827-1831.2000
   Kraus AA, 2007, J CLIN MICROBIOL, V45, P3777, DOI 10.1128/JCM.00827-07
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Libraty DH, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000171
   Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365
   Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Mongkolsapaya J, 2006, J IMMUNOL, V176, P3821, DOI 10.4049/jimmunol.176.6.3821
   Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x
   Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Nguyen TPD, 2010, J IMMUNOL, V184, P7281, DOI 10.4049/jimmunol.0903262
   Pacheco O, 2016, ZIKA VIRUS DIS COLOM
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   Simmons CP, 2005, J VIROL, V79, P5665, DOI 10.1128/JVI.79.9.5665-5675.2005
   Simoni MK, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12613
   Snow GE, 2014, AM J TROP MED HYG, V91, P1203, DOI 10.4269/ajtmh.14-0132
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Thomas SJ, 2013, AM J TROP MED HYG, V88, P73, DOI 10.4269/ajtmh.2012.12-0361
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Wang WK, 2003, VIROLOGY, V305, P330, DOI 10.1006/viro.2002.1704
NR 49
TC 62
Z9 62
U1 2
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD AUG
PY 2017
VL 13
IS 8
AR e1006487
DI 10.1371/journal.ppat.1006487
PG 22
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA FF2WV
UT WOS:000408758400011
PM 28771605
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Balmaseda, A
   Stettler, K
   Medialdea-Carrera, R
   Collado, D
   Jin, X
   Zambrana, JV
   Jaconi, S
   Cameroni, E
   Saborio, S
   Rovida, F
   Percivalle, E
   Ijaz, S
   Dicks, S
   Ushiro-Lumb, I
   Barzon, L
   Siqueira, P
   Brown, DWG
   Baldanti, F
   Tedder, R
   Zambon, M
   de Filippis, AMB
   Harris, E
   Corti, D
AF Balmaseda, Angel
   Stettler, Karin
   Medialdea-Carrera, Raquel
   Collado, Damaris
   Jin, Xia
   Zambrana, Jose Victor
   Jaconi, Stefano
   Cameroni, Elisabetta
   Saborio, Saira
   Rovida, Francesca
   Percivalle, Elena
   Ijaz, Samreen
   Dicks, Steve
   Ushiro-Lumb, Ines
   Barzon, Luisa
   Siqueira, Patricia
   Brown, David W. G.
   Baldanti, Fausto
   Tedder, Richard
   Zambon, Maria
   de Filippis, A. M. Bispo
   Harris, Eva
   Corti, Davide
TI Antibody-based assay discriminates Zika virus infection from other
   flaviviruses
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE Zika; serology; flaviviruses; dengue; ELISA
ID REVERSE TRANSCRIPTION-PCR; PEDIATRIC DENGUE COHORT; TIME RT-PCR;
   CHIKUNGUNYA; SPECIMENS; DIAGNOSIS; TRAVELERS; DISEASE; RNA
AB Zika virus (ZIKV) is amosquito-borne flavivirus that emerged recently as a global health threat, causing a pandemic in the Americas. ZIKV infection mostly causes mild disease, but is linked to devastating congenital birth defects and Guillain-Barre syndrome in adults. The high level of cross-reactivity among flaviviruses and their cocirculation has complicated serological approaches to differentially detect ZIKV and dengue virus (DENV) infections, accentuating the urgent need for a specific and sensitive serological test. We previously generated a ZIKV nonstructural protein 1 (NS1)-specific human monoclonal antibody, which we used to develop an NS1-based competition ELISA. Well-characterized samples from RT-PCR-confirmed patients with Zika and individuals exposed to other flavivirus infections or vaccination were used in a comprehensive analysis to determine the sensitivity and specificity of the NS1 blockade-of-binding (BOB) assay, which was established in laboratories in five countries (Nicaragua, Brazil, Italy, United Kingdom, and Switzerland). Of 158 sera/plasma from RT-PCR-confirmed ZIKV infections, 145 (91.8%) yielded greater than 50% inhibition. Of 171 patients with primary or secondary DENV infections, 152 (88.9%) scored negative. When the control group was extended to patients infected by other flaviviruses, other viruses, or healthy donors (n = 540), the specificity was 95.9%. We also analyzed longitudinal samples from DENV-immune and DENV-naive ZIKV infections and found inhibition was achieved within 10 d postonset of illness and maintained over time. Thus, the Zika NS1 BOB assay is sensitive, specific, robust, simple, low-cost, and accessible, and can detect recent and past ZIKV infections for surveillance, seroprevalence studies, and intervention trials.
C1 [Balmaseda, Angel; Saborio, Saira] Minist Hlth, Lab Nacl Virol, Ctr Nacl Diag & Referencia, Managua 16064, Nicaragua.
   [Balmaseda, Angel; Collado, Damaris; Zambrana, Jose Victor; Saborio, Saira] Sustainable Sci Inst, Managua 14007, Nicaragua.
   [Stettler, Karin; Jin, Xia; Jaconi, Stefano; Cameroni, Elisabetta; Corti, Davide] Humabs BioMed SA, CH-6500 Bellinzona, Switzerland.
   [Medialdea-Carrera, Raquel] Univ Liverpool, Natl Inst Hlth Res Hlth Protect, Res Unit Emerging & Zoonot Infect, Liverpool L69 3BX, Merseyside, England.
   [Rovida, Francesca; Percivalle, Elena; Baldanti, Fausto] Fdn Ist Ricovero & Cura Carattere Sci Policlin Sa, Microbiol & Virol Dept, Mol Virol Unit, I-27100 Pavia, Italy.
   [Ijaz, Samreen; Dicks, Steve; Tedder, Richard; Zambon, Maria] Publ Hlth England, Microbiol Serv Colindale, London NW9 5EQ, England.
   [Ushiro-Lumb, Ines] Natl Hlth Serv Blood & Transplant, Microbiol Serv, London NW9 5BG, England.
   [Barzon, Luisa] Univ Padua, Dept Mol Med, I-35121 Padua, Italy.
   [Siqueira, Patricia; Brown, David W. G.; de Filippis, A. M. Bispo] Fundacao Oswaldo Cruz, BR-22061040 Rio De Janeiro, Brazil.
   [Baldanti, Fausto] Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, I-27100 Pavia, Italy.
   [Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
RP Corti, D (corresponding author), Humabs BioMed SA, CH-6500 Bellinzona, Switzerland.; Harris, E (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
EM eharris@berkeley.edu; davide.corti@humabs.ch
RI Rovida, Francesca/K-7984-2016; Barzon, Luisa/K-7961-2016; Zambrana, Jose
   Victor/Q-3214-2019; percivalle, elena/K-7994-2016; Zambrana, Jose
   Victor/D-1703-2018; Baldanti, Fausto/J-4924-2018
OI Rovida, Francesca/0000-0003-2345-2790; Barzon,
   Luisa/0000-0003-0720-8456; Zambrana, Jose Victor/0000-0003-0107-6173;
   percivalle, elena/0000-0002-3355-1410; Zambrana, Jose
   Victor/0000-0003-0107-6173; Baldanti, Fausto/0000-0002-3358-8969; Ijaz,
   Samreen/0000-0001-6658-3542; COLLADO GARCIA, DAMARIS
   LISANGELES/0000-0002-0878-3260; Medialdea-Carrera,
   Raquel/0000-0002-0371-5138; Tedder, Richard/0000-0002-9672-5721
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [P01AI106695,
   U19AI118610, R01AI099631]; National Institute for Health Research
   (Health Protection Research Unit) in Emerging and Zoonotic Infections at
   the University of Liverpool; PHE; Liverpool School of Tropical Medicine;
   Medical Research CouncilMedical Research Council UK (MRC) [MC_PC_15093]
FX We thank past and present members of the study team based at the Centro
   de Salud Socrates Flores Vivas, Hospital Infantil Manuel de Jesus
   Rivera, the National Virology Laboratory in the Centro Nacional de
   Diagnostico y Referencia, and the Sustainable Sciences Institute in
   Nicaragua for their dedication and high-quality work, as well as the
   children who participated in the studies and their families. We thank
   the Flavivirus Laboratory, the Influenza Laboratory, and the Viral
   Hepatitis Laboratory from Fiocruz and the Evandro Chagas National
   Institute of Infectious diseases for providing the samples from Brazil.
   We thank the staff of the Rare and Imported Disease Laboratory at Public
   Health England (PHE) in Porton Down, the staff of virus and bacterial
   reference divisions at PHE Colindale for technical assistance, and
   particularly Dr. Jennifer Tossiwil, Dr. Colin Brown, Dr. Tim Brooks, and
   Dr. Emma Aarons for their assistance. Partial funding support was
   provided by National Institutes of Health Grants P01AI106695 (to E.H.),
   U19AI118610 (to E.H.), and R01AI099631 (to A.B.). R.M.-C.'s work is
   supported by the National Institute for Health Research (Health
   Protection Research Unit) in Emerging and Zoonotic Infections at the
   University of Liverpool in partnership with PHE and Liverpool School of
   Tropical Medicine. This work was also supported by Medical Research
   Council "Rapid response to Zika virus" Grant MC_PC_15093.
CR Balmaseda A, 2006, TROP MED INT HEALTH, V11, P935, DOI 10.1111/j.1365-3156.2006.01641.x
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   FERNANDEZ RJ, 1990, MEM I OSWALDO CRUZ, V85, P347, DOI 10.1590/S0074-02761990000300012
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Gordon A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002462
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gutierrez G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002385
   Harris E, 1998, J CLIN MICROBIOL, V36, P2634, DOI 10.1128/JCM.36.9.2634-2639.1998
   Harrison SC, 2016, NAT IMMUNOL, V17, P1010, DOI 10.1038/ni.3539
   Huhtamo E, 2010, J CLIN VIROL, V47, P49, DOI 10.1016/j.jcv.2009.11.001
   Katzelnick Leah C, 2017, Lancet Infect Dis, V17, pe88, DOI 10.1016/S1473-3099(16)30473-X
   Kuan G, 2009, AM J EPIDEMIOL, V170, P120, DOI 10.1093/aje/kwp092
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Linke S, 2007, J VIROL METHODS, V146, P355, DOI 10.1016/j.jviromet.2007.05.021
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Midgley CM, 2011, J VIROL, V85, P410, DOI 10.1128/JVI.01826-10
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Narvaez F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001397
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001
   Steinhagen K., 2015, EUROSURVEILLANCE, V2016, P21, DOI DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017
   Timiryasova TM, 2013, AM J TROP MED HYG, V88, P962, DOI 10.4269/ajtmh.12-0461
   U.S. Food and Drug Administration, 2016, ZIK VIR EM US AUTH
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Waggoner JJ, 2016, J CLIN VIROL, V78, P57, DOI 10.1016/j.jcv.2016.01.007
NR 32
TC 80
Z9 83
U1 2
U2 22
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 1
PY 2017
VL 114
IS 31
BP 8384
EP 8389
DI 10.1073/pnas.1704984114
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FC2FR
UT WOS:000406653300072
PM 28716913
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Penot, P
   Balavoine, S
   Leplatois, A
   Brichler, S
   Leparc-Goffart, I
   Alloui, AC
   Flusin, O
   Guilleminot, J
   Amellou, M
   Molina, JM
AF Penot, P.
   Balavoine, S.
   Leplatois, A.
   Brichler, S.
   Leparc-Goffart, I.
   Alloui, A. -C.
   Flusin, O.
   Guilleminot, J.
   Amellou, M.
   Molina, J. -M.
TI Five cases of acute Zika virus infection in French women of reproductive
   age returning from Central and South America
SO REVUE DE MEDECINE INTERNE
LA English
DT Article
DE Zika virus; Imported viral disease; Vector-borne infections; Sexually
   transmitted infections; Mother to child transmission
AB Introduction. - The favorable season for Aedes albopictus circulation has started in Europe and may lead to autochthonous transmission of Zika virus. Health care providers should be familiar with evocative clinical presentations and able to give updated information to women of reproductive age infected by Zika virus.
   Observations. - We report five laboratory-confirmed Zika virus infections imported to metropolitan France from Central and South America between January and April, 2016. The five young women were not connected and not pregnant; common presentation combined a rash with persistent arthralgia. Zika virus was identified by RT-PCR from serum or urines, between two and eight days after the onset of the symptoms.
   Conclusion. - As the duration of potential materno-foetal infectivity is still unknown, we were unable to answer with certitude to the patients' questions about the time interval to respect before attempting a pregnancy: one of them became pregnant one month after the diagnosis. (C) 2016 Societe Nationale Francaise de Medecine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.
C1 [Penot, P.; Leplatois, A.; Molina, J. -M.] Hop St Louis, Serv Malad Infect & Trop, 1 Ave Claude Vellefaux, F-75010 Paris, France.
   [Balavoine, S.; Brichler, S.; Alloui, A. -C.] Hop Avicenne, Serv Bacteriol, Virol, Hyg, F-93000 Bobigny, France.
   [Leparc-Goffart, I.; Flusin, O.] Hop Instruct Armees Laveran, Ctr Natl Reference Arbovirus, F-13384 Marseille 13, France.
   [Guilleminot, J.; Amellou, M.] Hop St Louis, Ctr Planificat Familiale, F-75010 Paris, France.
RP Penot, P (corresponding author), Hop St Louis, Serv Malad Infect & Trop, 1 Ave Claude Vellefaux, F-75010 Paris, France.
EM pauline.penot@aphp.fr
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Besnard M, 2016, EURO SURVEILL, V21
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   O'Higgins T, 2014, ECOL SOC, V19, DOI 10.5751/ES-06507-190446
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Reusken C, 2016, EURO SURVEILL, V21
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 21
TC 3
Z9 3
U1 0
U2 0
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0248-8663
J9 REV MED INTERNE
JI Rev. Med. Interne
PD AUG
PY 2017
VL 38
IS 8
BP 547
EP 550
DI 10.1016/j.revmed.2016.12.011
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA VI3VZ
UT WOS:000479182300008
PM 28104381
DA 2020-07-08
ER

PT J
AU Li, Y
   Zhang, ZZ
   Phoo, WW
   Loh, YR
   Wang, WL
   Liu, S
   Chen, MW
   Hung, AW
   Keller, TH
   Luo, DH
   Kang, CB
AF Li, Yan
   Zhang, Zhenzhen
   Phoo, Wint Wint
   Loh, Ying Ru
   Wang, Weiling
   Liu, Shuang
   Chen, Ming Wei
   Hung, Alvin W.
   Keller, Thomas H.
   Luo, Dahai
   Kang, CongBao
TI Structural Dynamics of Zika Virus NS2B-NS3 Protease Binding to Dipeptide
   Inhibitors
SO STRUCTURE
LA English
DT Article
ID NS3 PROTEASE; CRYSTAL-STRUCTURE; PEPTIDE INHIBITORS; ANTIVIRAL ACTIVITY;
   DENGUE; HELICASE; CONFORMATIONS; REFINEMENT; ACTIVATION; INTERFACE
AB The NS2B-NS3 viral protease is an attractive drug target against Zika virus (ZIKV) due to its importance in viral replication and maturation. Here we report the crystal structure of protease in complex with a dipeptide inhibitor, Acyl-KR-aldehyde (compound 1). The aldehyde moiety forms a covalent bond with the catalytic Ser(135) of NS3. The Arg and Lys residues in the inhibitor occupy the S1 and S2 sites of the protease, respectively. Nuclear magnetic resonance studies demonstrate that the complex is in the closed conformation in solution. The chemical environment of residues surrounding the active site is sensitive to the bound inhibitor as demonstrated by the comparison with two other non-covalent dipeptides, Acyl-K-Agmatine (compound 2) and Acyl-KR-COOH (compound 3). Removing the aldehyde moiety in 1 converts the binding mode from a slow to a fast exchange regime. The structural dynamics information obtained in this study will guide future drug discovery against ZIKV and other flaviviruses.
C1 [Li, Yan; Loh, Ying Ru; Wang, Weiling; Liu, Shuang; Hung, Alvin W.; Keller, Thomas H.; Kang, CongBao] ASTAR, Expt Therapeut Ctr, 31 Biopolis Way,Nanos 03-01, Singapore 138669, Singapore.
   [Zhang, Zhenzhen; Phoo, Wint Wint; Chen, Ming Wei; Luo, Dahai] Nanyang Technol Univ, Lee Kong Chian Sch Med, EMB 03-07,59 Nanyang Dr, Singapore 636921, Singapore.
   [Zhang, Zhenzhen; Phoo, Wint Wint; Chen, Ming Wei; Luo, Dahai] Nanyang Technol Univ, NTU Inst Struct Biol, EMB 06-01,59 Nanyang Dr, Singapore 636921, Singapore.
   [Phoo, Wint Wint] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 636921, Singapore.
RP Kang, CB (corresponding author), ASTAR, Expt Therapeut Ctr, 31 Biopolis Way,Nanos 03-01, Singapore 138669, Singapore.; Luo, DH (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, EMB 03-07,59 Nanyang Dr, Singapore 636921, Singapore.; Luo, DH (corresponding author), Nanyang Technol Univ, NTU Inst Struct Biol, EMB 06-01,59 Nanyang Dr, Singapore 636921, Singapore.
EM luodahai@ntu.edu.sg; cbkang@etc.a-star.edu.sg
RI Li, Yan/G-4642-2013; Luo, Dahai/J-6022-2012; Kang, Congbao/AAP-7572-2020
OI Li, Yan/0000-0003-1963-839X; Luo, Dahai/0000-0001-7637-7275; Kang,
   Congbao/0000-0002-9886-9374; Keller, Thomas/0000-0002-7553-6235; Liu,
   Shuang/0000-0003-3287-2404
FU Lee Kong Chian School of Medicine, Nanyang Technological
   UniversityNanyang Technological University; National Medical Research
   CouncilMedical Research Council UK (MRC) [CBRG15May045]; National
   Research Foundation [NRF2016NRF-CRP001-063]; A*STAR JCOAgency for
   Science Technology & Research (ASTAR) [1431AFG102/1331A028]
FX We thank scientists from Australian Light Source MX beamline and Swiss
   Light Source PX beamline for their help with diffraction data
   collection. This work was supported by (1) a start-up grant from Lee
   Kong Chian School of Medicine, Nanyang Technological University, (2)
   National Medical Research Council grant CBRG15May045, (3) National
   Research Foundation grant NRF2016NRF-CRP001-063 to D.L., (4) A*STAR JCO
   grant (1431AFG102/1331A028) to C.K.
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308
   Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   Clark AM, 2007, J CHEM INF MODEL, V47, P1933, DOI 10.1021/ci7001473
   Darko R, 2016, PEDIATR EMERG CARE, V32, P705, DOI 10.1097/PEC.0000000000000932
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061
   Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X
   Evans PR, 2007, ACTA CRYSTALLOGR D, V63, P58, DOI 10.1107/S090744490604604X
   Gayen S, 2012, BIOCHEM BIOPH RES CO, V423, P799, DOI 10.1016/j.bbrc.2012.06.043
   Gayen S, 2011, PROTEINS, V79, P2557, DOI 10.1002/prot.23089
   Goddard T. D., 2008, SPARKY 3
   Hammamy MZ, 2013, CHEMMEDCHEM, V8, P231, DOI 10.1002/cmdc.201200497
   Headd JJ, 2012, ACTA CRYSTALLOGR D, V68, P381, DOI 10.1107/S0907444911047834
   Johnson Bruce A, 2004, Methods Mol Biol, V278, P313
   Kang CB, 2013, ANTIVIR RES, V97, P137, DOI 10.1016/j.antiviral.2012.11.008
   KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003
   Keller R, 2005, THESIS
   Knox JE, 2006, J MED CHEM, V49, P6585, DOI 10.1021/jm0607606
   Kuiper B. D., 2017, BIOCH BIOPHYS RES CO
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Luo DH, 2010, J BIOL CHEM, V285, P18817, DOI 10.1074/jbc.M109.090936
   Mahawaththa MC, 2017, ANTIVIR RES, V142, P141, DOI 10.1016/j.antiviral.2017.03.011
   Ndeffo-Mbah ML, 2016, ANN INTERN MED, V165, P551, DOI 10.7326/M16-0919
   Nitsche C, 2017, J MED CHEM, V60, P511, DOI 10.1021/acs.jmedchem.6b01021
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Pervushin K, 1998, P NATL ACAD SCI USA, V95, P14147, DOI 10.1073/pnas.95.24.14147
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126
   Poulsen A, 2014, CURR PHARM DESIGN, V20, P3422, DOI 10.2174/13816128113199990633
   Robin G, 2009, J MOL BIOL, V385, P1568, DOI 10.1016/j.jmb.2008.11.026
   Rut W, 2017, ANTIVIR RES, V139, P88, DOI 10.1016/j.antiviral.2016.12.018
   Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585
   Schrodinger, 2016, PYMOL MOL MOL GRAPH
   Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z
   Steuer C, 2011, BIOORGAN MED CHEM, V19, P4067, DOI 10.1016/j.bmc.2011.05.015
   Su XC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000561
   Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766
   Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589
   Venkatraman S, 2009, J MED CHEM, V52, P336, DOI 10.1021/jm800940u
   Yin Z, 2006, BIOORG MED CHEM LETT, V16, P36, DOI 10.1016/j.bmcl.2005.09.062
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
NR 54
TC 37
Z9 41
U1 1
U2 11
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0969-2126
EI 1878-4186
J9 STRUCTURE
JI Structure
PD AUG 1
PY 2017
VL 25
IS 8
BP 1242
EP +
DI 10.1016/j.str.2017.06.006
PG 12
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA FC3MY
UT WOS:000406744600008
PM 28689970
OA Bronze
DA 2020-07-08
ER

PT J
AU Pingen, M
   Schmid, MA
   Harris, E
   McKimmie, CS
AF Pingen, Marieke
   Schmid, Michael A.
   Harris, Eva
   McKimmie, Clive S.
TI Mosquito Biting Modulates Skin Response to Virus Infection
SO TRENDS IN PARASITOLOGY
LA English
DT Review
ID WEST NILE VIRUS; SEMLIKI-FOREST-VIRUS; EQUINE ENCEPHALITIS VIRUSES;
   DENGUE-VIRUS; DENDRITIC CELLS; CHIKUNGUNYA VIRUS; INFLAMMATORY RESPONSE;
   NONVASCULAR DELIVERY; LANGERHANS CELLS; MOUSE MODEL
AB Mosquito-borne infections are increasing in number and are spreading to new regions at an unprecedented rate. In particular, mosquito-transmitted viruses, such as those that cause Zika, dengue, West Nile encephalitis, and chikungunya, have become endemic or have caused dramatic epidemics in many parts of the world. Aedes and Culex mosquitoes are the main culprits, spreading infection when they bite. Importantly, mosquitoes do not act as simple conduits that passively transfer virus from one individual to another. Instead, host responses to mosquito-derived factors have an important influence on infection and disease, aiding replication and dissemination within the host. Here, we discuss the latest research developments regarding this fascinating interplay between mosquito, virus, and the mammalian host.
C1 [Pingen, Marieke; McKimmie, Clive S.] Univ Leeds, Leeds Inst Canc & Pathol, Sect Infect & Immun, Virus Host Interact Team, Leeds LS9 7TF, W Yorkshire, England.
   [Schmid, Michael A.] Univ Leuven, Dept Immunol & Microbiol, Rega Inst Med Res, Lab Virol & Chemotherapy, Leuven, Belgium.
   [Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
RP McKimmie, CS (corresponding author), Univ Leeds, Leeds Inst Canc & Pathol, Sect Infect & Immun, Virus Host Interact Team, Leeds LS9 7TF, W Yorkshire, England.
EM c.s.mckimmie@leeds.ac.uk
RI Pingen, Marieke/F-9990-2012; McKimmie, Clive/AAD-9509-2019
OI Pingen, Marieke/0000-0001-5689-9076; McKimmie,
   Clive/0000-0002-7694-9509; Schmid, Michael A./0000-0002-1137-9322
FU KU Leuven Rega FoundationKU Leuven; Wellcome TrustWellcome Trust; US
   National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 A1124493]
FX We would like to thank Johan Neyts for support and the KU Leuven Rega
   Foundation for a postdoctoral fellowship to Michael A. Schmid, the
   Wellcome Trust for funding Marieke Pingen and Clive McKimmie, and grant
   R01 A1124493 from the US National Institutes of Health to EH.
CR Ader DB, 2004, VIRAL IMMUNOL, V17, P252, DOI 10.1089/0882824041310496
   Agarwal A, 2016, INFECT GENET EVOL, V40, P126, DOI 10.1016/j.meegid.2016.02.033
   Bai FW, 2010, J INFECT DIS, V202, P1804, DOI 10.1086/657416
   Bardina S. V, 2017, SCIENCE, V38
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cerny D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004548
   Chen YL, 1998, INT ARCH ALLERGY IMM, V116, P269, DOI 10.1159/000023955
   Choumet V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050464
   Christofferson RC, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-127
   Colpitts TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002189
   Conway MJ, 2014, ANNU REV VIROL, V1, P71, DOI 10.1146/annurev-virology-031413-085513
   Conway MJ, 2014, J VIROL, V88, P164, DOI 10.1128/JVI.02235-13
   Cox J, 2012, J VIROL, V86, P7637, DOI 10.1128/JVI.00534-12
   Davison AM, 2011, J IMMUNOL, V186, P2382, DOI 10.4049/jimmunol.1002682
   Demeure CE, 2005, J IMMUNOL, V174, P3932, DOI 10.4049/jimmunol.174.7.3932
   Depinay N, 2006, J IMMUNOL, V176, P4141, DOI 10.4049/jimmunol.176.7.4141
   Deruaz M, 2008, J EXP MED, V205, P2019, DOI 10.1084/jem.20072689
   Donovan MJ, 2007, INFECT IMMUN, V75, P2523, DOI 10.1128/IAI.01928-06
   Edwards JF, 1998, J MED ENTOMOL, V35, P261, DOI 10.1093/jmedent/35.3.261
   FAZAKERLEY JK, 1993, VIROLOGY, V195, P627, DOI 10.1006/viro.1993.1414
   Ferguson MC, 2015, J VIROL, V89, P7536, DOI 10.1128/JVI.03645-14
   Fink K, 2009, EUR J IMMUNOL, V39, P2809, DOI 10.1002/eji.200939389
   Finney CAM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004646
   Fontaine A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-187
   Fox JM, 2015, CELL, V163, P1095, DOI 10.1016/j.cell.2015.10.050
   Fragkoudis R, 2007, J GEN VIROL, V88, P3373, DOI 10.1099/vir.0.83191-0
   Frauenschuh A, 2007, J BIOL CHEM, V282, P27250, DOI 10.1074/jbc.M704706200
   Furuya-Kanamori L., 2016, BMC INFECT DIS, V16
   Gabriel C, 2013, DNA CELL BIOL, V32, P665, DOI 10.1089/dna.2013.2211
   Gardner CL, 2008, J VIROL, V82, P10634, DOI 10.1128/JVI.01323-08
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gomes R, 2008, P NATL ACAD SCI USA, V105, P7845, DOI 10.1073/pnas.0712153105
   Gomes R, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00110
   Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025
   Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145
   Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Jenne CN, 2013, CELL HOST MICROBE, V13, P169, DOI 10.1016/j.chom.2013.01.005
   Johnston LJ, 2000, J INVEST DERMATOL, V114, P560, DOI 10.1046/j.1523-1747.2000.00904.x
   Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287
   Kebaier C, 2010, INFECT IMMUN, V78, P545, DOI 10.1128/IAI.00807-09
   Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004
   Klimstra WB, 2003, J VIROL, V77, P12022, DOI 10.1128/JVI.77.22.12022-12032.2003
   Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399
   Krishnamoorthy K, 2009, J VECTOR DIS, V46, P26
   Le Coupanec A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002237
   Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017
   Lim K, 2015, SCIENCE, V349, DOI 10.1126/science.aaa4352
   Limesand KH, 2000, PARASITE IMMUNOL, V22, P461, DOI 10.1046/j.1365-3024.2000.00326.x
   MacDonald GH, 2000, J VIROL, V74, P914, DOI 10.1128/JVI.74.2.914-922.2000
   Machain-Williams C, 2013, VIRAL IMMUNOL, V26, P84, DOI 10.1089/vim.2012.0051
   MacMicking JD, 2012, NAT REV IMMUNOL, V12, P367, DOI 10.1038/nri3210
   MARINOTTI O, 1990, J INSECT PHYSIOL, V36, P545, DOI 10.1016/0022-1910(90)90021-7
   McCracken MK, 2014, J VIROL, V88, P1881, DOI 10.1128/JVI.01218-13
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moser LA, 2016, J VIROL, V90, P292, DOI 10.1128/JVI.02280-15
   Oliveira F, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000226
   Peng ZK, 2002, J ALLERGY CLIN IMMUN, V110, P816, DOI 10.1067/mai.2002.128736
   Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194
   Peters NC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000484
   Pham AM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002465
   Pingen M, 2016, IMMUNITY, V44, P1455, DOI 10.1016/j.immuni.2016.06.002
   Reagan KL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001935
   REUNALA T, 1994, ANN MED, V26, P301, DOI 10.3109/07853899409147906
   Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812
   Ribeiro JMC, 2010, INSECT BIOCHEM MOLEC, V40, P767, DOI 10.1016/j.ibmb.2010.08.002
   Ribeiro-Gomes FL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002536
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Ryman KD, 2008, IMMUNOL REV, V225, P27, DOI 10.1111/j.1600-065X.2008.00670.x
   Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933
   Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005
   Schaeffer E, 2015, J INVEST DERMATOL, V135, P1743, DOI 10.1038/jid.2014.525
   Schilte C, 2010, J EXP MED, V207, P429, DOI 10.1084/jem.20090851
   Schmid MA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005676
   Schmid MA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00647
   Schmid MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004541
   Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024
   Schneider BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001171
   Schneider BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011704
   Schneider BS, 2006, VIRAL IMMUNOL, V19, P74, DOI 10.1089/vim.2006.19.74
   Schneider BS, 2004, VIRAL IMMUNOL, V17, P565, DOI 10.1089/vim.2004.17.565
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Shabman RS, 2008, J VIROL, V82, P12374, DOI 10.1128/JVI.00985-08
   Sharma P, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-235
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070
   Spence PJ, 2013, NATURE, V498, P228, DOI 10.1038/nature12231
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Styer LM, 2011, J VIROL, V85, P1517, DOI 10.1128/JVI.01112-10
   Suthar MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003541
   Syenina A, 2015, ELIFE, V4, DOI 10.7554/eLife.05291
   Thangamani S., 2010, PLOS ONE, V6
   Thiakaki M, 2005, MICROBES INFECT, V7, P760, DOI 10.1016/j.micinf.2005.01.013
   TURELL MJ, 1995, J MED ENTOMOL, V32, P563, DOI 10.1093/jmedent/32.4.563
   TURELL MJ, 1992, AM J TROP MED HYG, V47, P190, DOI 10.4269/ajtmh.1992.47.190
   Valenzuela JG, 2001, J EXP MED, V194, P331, DOI 10.1084/jem.194.3.331
   Vaughan JA, 1999, INFECT IMMUN, V67, P4285, DOI 10.1128/IAI.67.8.4285-4289.1999
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Zust R, 2014, J VIROL, V88, P7276, DOI 10.1128/JVI.03827-13
NR 105
TC 17
Z9 17
U1 0
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4922
EI 1471-5007
J9 TRENDS PARASITOL
JI Trends Parasitol.
PD AUG
PY 2017
VL 33
IS 8
BP 645
EP 657
DI 10.1016/j.pt.2017.04.003
PG 13
WC Parasitology
SC Parasitology
GA FD4UZ
UT WOS:000407529000011
PM 28495485
OA Green Published
DA 2020-07-08
ER

PT J
AU Han, GZ
AF Han, Guan-Zhu
TI A Single Substitution Changes Zika Virus Infectivity in Mosquitoes
SO TRENDS IN MICROBIOLOGY
LA English
DT Editorial Material
C1 [Han, Guan-Zhu] Nanjing Normal Univ, Jiangsu Key Lab Microbes & Funct Genom, Jiangsu Engn & Technol Res Ctr Microbiol, Coll Life Sci, Nanjing 210046, Jiangsu, Peoples R China.
RP Han, GZ (corresponding author), Nanjing Normal Univ, Jiangsu Key Lab Microbes & Funct Genom, Jiangsu Engn & Technol Res Ctr Microbiol, Coll Life Sci, Nanjing 210046, Jiangsu, Peoples R China.
EM guanzhu@njnu.edu.cn
RI Han, Guan-Zhu/A-6818-2011; Han, Guan-Zhu/P-4188-2019
OI Han, Guan-Zhu/0000-0002-8352-7726; Han, Guan-Zhu/0000-0002-8352-7726
FU Natural Science Foundation of Jiangsu ProvinceJiangsu Planned Projects
   for Postdoctoral Research FundsNatural Science Foundation of Jiangsu
   Province [BK20161016]; Priority Academic Program Development (PAPD) of
   Jiangsu Higher Education Institutions
FX G.-Z.H. was supported by the Natural Science Foundation of Jiangsu
   Province (BK20161016) and the Priority Academic Program Development
   (PAPD) of Jiangsu Higher Education Institutions.
CR Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Faria N. R., 2017, NATURE
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Gong Z, 2016, TRENDS MICROBIOL, V24, P521, DOI 10.1016/j.tim.2016.05.002
   Grard G, 2010, J GEN VIROL, V91, P87, DOI 10.1099/vir.0.014506-0
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Metsky HC, 2017, NATURE
   Singapore Zika Study Group, 2017, LANCET INFECT DIS
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
NR 9
TC 1
Z9 1
U1 0
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0966-842X
EI 1878-4380
J9 TRENDS MICROBIOL
JI Trends Microbiol.
PD AUG
PY 2017
VL 25
IS 8
BP 603
EP 605
DI 10.1016/j.tim.2017.05.014
PG 4
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA FA6NH
UT WOS:000405559700003
PM 28610876
DA 2020-07-08
ER

PT J
AU Kuntz, MT
   Tutiven, JL
   Read, SP
   Ventura, CV
   Berrocal, AM
AF Kuntz, Michael T.
   Tutiven, Jacqueline L.
   Read, Sarah Parker
   Ventura, Camilla V.
   Berrocal, Audina M.
TI Two infants with presumed Zika congenital syndrome presenting for exam
   under general anesthesia
SO PEDIATRIC ANESTHESIA
LA English
DT Letter
ID VIRUS
C1 [Kuntz, Michael T.] Jackson Mem Hosp, Dept Anesthesiol, Miami, FL 33136 USA.
   [Tutiven, Jacqueline L.] Univ Miami, Miller Sch Med, Dept Anesthesiol, Miami, FL 33136 USA.
   [Read, Sarah Parker; Ventura, Camilla V.; Berrocal, Audina M.] Univ Miami, Miller Sch Med, Dept Pediat Ophthalmol, Miami, FL 33136 USA.
RP Kuntz, MT (corresponding author), Jackson Mem Hosp, Dept Anesthesiol, Miami, FL 33136 USA.
EM Michael.Kuntz@jhsmiami.org
RI Ventura, Camila V/N-2654-2018
OI Ventura, Camila V/0000-0002-2927-4684
CR Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Spicer W., 2008, CLIN MICROBIOL INFEC, P144
   Tutiven JL, 2017, ANESTH ANALG, V124, P1918, DOI [10.1213/ANE.0000000000002047, 10.1213/ane.0000000000002047]
   Vigoda MM, 2011, CLIN OPHTHALMOL, V5, P503, DOI 10.2147/OPTH.S18605
NR 5
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1155-5645
EI 1460-9592
J9 PEDIATR ANESTH
JI Pediatr. Anesth.
PD AUG
PY 2017
VL 27
IS 8
BP 868
EP 869
DI 10.1111/pan.13186
PG 2
WC Anesthesiology; Pediatrics
SC Anesthesiology; Pediatrics
GA EZ9XG
UT WOS:000405082800019
PM 28685984
DA 2020-07-08
ER

PT J
AU Rossignol, ED
   Peters, KN
   Connor, JH
   Bullitt, E
AF Rossignol, Evan D.
   Peters, Kristen N.
   Connor, John H.
   Bullitt, Esther
TI Zika virus induced cellular remodelling
SO CELLULAR MICROBIOLOGY
LA English
DT Article
DE disease processes; infection; membrane; microbial-cell interaction;
   virulence; viruses (phages)
ID BORNE ENCEPHALITIS-VIRUS; DENGUE VIRUS; 3-DIMENSIONAL ARCHITECTURE;
   ULTRASTRUCTURAL CHARACTERIZATION; ENDOPLASMIC-RETICULUM; REPLICATION
   SITES; INFECTION; IMINOSUGAR; PARTICLES; TARGETS
AB Zika virus (ZIKV) has been associated with morbidities such as Guillain-Barre, infant microcephaly, and ocular disease. The spread of this positive-sense, single-stranded RNA virus and its growing public health threat underscore gaps in our understanding of basic ZIKV virology. To advance knowledge of the virus replication cycle within mammalian cells, we use serial section 3-dimensional electron tomography to demonstrate the widespread remodelling of intracellular membranes upon infection with ZIKV. We report extensive structural rearrangements of the endoplasmic reticulum and reveal stages of the ZIKV viral replication cycle. Structures associated with RNA genome replication and virus assembly are observed integrated within the endoplasmic reticulum, and we show viruses in transit through the Golgi apparatus for viral maturation, and subsequent cellular egress. This study characterises in detail the 3-dimensional ultrastructural organisation of the ZIKV replication cycle stages. Our results show close adherence of the ZIKV replication cycle to the existing flavivirus replication paradigm.
C1 [Rossignol, Evan D.; Bullitt, Esther] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA.
   [Peters, Kristen N.; Connor, John H.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA.
   [Peters, Kristen N.; Connor, John H.] Boston Univ, Sch Med, Natl Emerging Infect Dis Lab, Boston, MA 02118 USA.
RP Bullitt, E (corresponding author), Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA.
EM bullitt@bu.edu
OI Connor, John/0000-0002-8867-7256
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [GM102474, S10-RR025434]; BUBogazici
   University [CTSI UL1-TR001430]; NIAIDUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [UC6AI058618]
FX NIH, Grant/Award Number: GM102474, S10-RR025434; BU, Grant/Award Number:
   CTSI UL1-TR001430; NIAID, Grant/Award Number: UC6AI058618
CR Acosta EG, 2016, CURR OPIN VIROL, V20, P47, DOI 10.1016/j.coviro.2016.09.003
   Barreto-Vieira DF, 2016, MEM I OSWALDO CRUZ, V111, P532, DOI 10.1590/0074-02760160104
   Bily T, 2015, SCI REP-UK, V5, DOI 10.1038/srep10745
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Chatel-Chaix L, 2016, CELL HOST MICROBE, V20, P342, DOI 10.1016/j.chom.2016.07.008
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   dosRosario M. S., 2016, AM J
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Junjhon J, 2014, J VIROL, V88, P4687, DOI 10.1128/JVI.00118-14
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kovalev N, 2016, J VIROL, V90, P3611, DOI 10.1128/JVI.02775-15
   Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lessler J., 2016, SCIENCE, P353
   Lorenz IC, 2003, J VIROL, V77, P4370, DOI 10.1128/JVI.77.7.4370-4382.2003
   Mackenzie JM, 1999, J VIROL, V73, P9555, DOI 10.1128/JVI.73.11.9555-9567.1999
   MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001
   Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007
   Miorin L, 2013, J VIROL, V87, P6469, DOI 10.1128/JVI.03456-12
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Offerdahl DK, 2017, VIROLOGY, V501, P54, DOI 10.1016/j.virol.2016.11.002
   Offerdahl DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047912
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Perry ST, 2013, ANTIVIR RES, V98, P35, DOI 10.1016/j.antiviral.2013.01.004
   Pollock S, 2010, P NATL ACAD SCI USA, V107, P17176, DOI 10.1073/pnas.1009445107
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Romero-Brey I, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060160
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Slenczka W., 2016, MICROBIOL SPECTR, P4
   Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Warfield KL, 2015, VIRUSES-BASEL, V7, P2404, DOI 10.3390/v7052404
   WARFIELD KL, 2016, VIRUSES-BASEL, V8, DOI DOI 10.3390/V8030071
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Westaway EG, 1997, J VIROL, V71, P6650, DOI 10.1128/JVI.71.9.6650-6661.1997
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
NR 46
TC 11
Z9 11
U1 1
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1462-5814
EI 1462-5822
J9 CELL MICROBIOL
JI Cell Microbiol.
PD AUG
PY 2017
VL 19
IS 8
AR e12740
DI 10.1111/cmi.12740
PG 10
WC Cell Biology; Microbiology
SC Cell Biology; Microbiology
GA FA2AW
UT WOS:000405244000008
PM 28318141
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Levi, ME
AF Levi, Marilyn E.
TI Zika virus: a cause of concern in transplantation?
SO CURRENT OPINION IN INFECTIOUS DISEASES
LA English
DT Review
DE solid organ transplantation; stem cell transplantation; Zika virus
ID SEXUAL TRANSMISSION; INTERIM GUIDANCE; UNITED-STATES; DENGUE VIRUS;
   MENINGOENCEPHALITIS; INFECTION; TRANSFUSION; EPIDEMICS; URINE
AB Purpose of reviewWorldwide, the number of countries reporting Zika virus (ZKV) infection continues to increase. Although 80% of cases are asymptomatic, ZKV has been identified as a neurotropic virus associated with congenital microcephaly, Guillain-Barre' syndrome, and meningoencephalitis. Until recently, infection in transplant recipients has not been identified. This study will review the existing literature on ZKV infection, laboratory testing, and management in transplant recipients.Recent findingsDonor-derived transfusion of contaminated blood products and naturally occurring ZKV infections have been recently reported in solid organ and stem cell transplant recipients, ranging from asymptomatic infections to meningoencephalitis. Interpretation of diagnostic testing of ZKV is evolving, with prolonged viral shedding identified in blood, semen, and urine of unclear significance. Serologic testing may be associated with cross-reactivity with other flaviviridae, requiring plaque reduction neutralization testing for confirmation. Thus far, donor screening guidelines for transplantation have not been established.SummaryThe study reviews the limited existing literature in transplant recipients infected with ZKV, available laboratory testing and management. Ultimately, guidelines are needed for donor screening from high-risk areas, interpretation of studies and management of infected patients to ensure safe transplantation.
C1 [Levi, Marilyn E.] Univ Colorado Hosp, Div Infect Dis, Dept Internal Med, 12700 East 17th Ave,Mail Stop B-168, Aurora, CO 80045 USA.
RP Levi, ME (corresponding author), Univ Colorado Hosp, Div Infect Dis, Dept Internal Med, 12700 East 17th Ave,Mail Stop B-168, Aurora, CO 80045 USA.
EM Marilyn.Levi@ucdenver.edu
CR [Anonymous], 2016, GUIDANCE ORGAN DONAT
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Blumberg EA, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14083
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Frieden TR, 2016, JAMA-J AM MED ASSOC, V316, P1443, DOI 10.1001/jama.2016.11941
   Galel SA, 2017, TRANSFUSION, V57, P762, DOI 10.1111/trf.14029
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Haley M, 2003, CLIN INFECT DIS, V37, pE88, DOI 10.1086/377172
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kotton CN, 2016, TRANSPLANTATION, V100, P970, DOI 10.1097/TP.0000000000001179
   Levi ME, 2010, CLIN TRANSPLANT, V24, P223, DOI 10.1111/j.1399-0012.2009.01044.x
   Mawhorter SD, 2005, CLIN LYMPHOMA MYELOM, V6, P248, DOI 10.3816/CLM.2005.n.053
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Noruiera ML, 2017, AM J TRANSPLANT, V17, P791
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Pan American Health Organization, EP AL NEUR SYNDR CON
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Paz-Bailey G, 2017, N ENG J MED
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Raboni SM, 2017, TRANSPL INFECT DIS
   Schwartzmann PV, 2017, MAYO CLIN PROC, V92, P460, DOI 10.1016/j.mayocp.2016.12.019
   Silveira FP, 2016, J HEART LUNG TRANSPL, V35, P560, DOI 10.1016/j.healun.2016.03.010
   U.S. Food and Drug Administration, 2016, DON SCREEN REC RED R
   U. S. Food and Drug Administration, 2016, GUID IND REV REC RED
NR 32
TC 4
Z9 4
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0951-7375
EI 1473-6527
J9 CURR OPIN INFECT DIS
JI Curr. Opin. Infect. Dis.
PD AUG
PY 2017
VL 30
IS 4
BP 340
EP 345
DI 10.1097/QCO.0000000000000384
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA EZ8FQ
UT WOS:000404960500002
PM 28632511
DA 2020-07-08
ER

PT J
AU Niederberger, C
AF Niederberger, Craig
TI Re: Zika Virus Causes Testis Damage and Leads to Male Infertility in
   Mice Editorial Comment
SO JOURNAL OF UROLOGY
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-5347
EI 1527-3792
J9 J UROLOGY
JI J. Urol.
PD AUG
PY 2017
VL 198
IS 2
BP 242
EP 242
PG 1
WC Urology & Nephrology
SC Urology & Nephrology
GA FA0JU
UT WOS:000405120700037
DA 2020-07-08
ER

PT J
AU Murugan, K
   Anitha, J
   Suresh, U
   Rajaganesh, R
   Panneerselvam, C
   Aziz, A
   Tseng, LC
   Kalimuthu, K
   Alsalhi, MS
   Devanesan, S
   Nicoletti, M
   Sarkar, SK
   Benelli, G
   Hwang, JS
AF Murugan, Kadarkarai
   Anitha, Jaganathan
   Suresh, Udaiyan
   Rajaganesh, Rajapandian
   Panneerselvam, Chellasamy
   Aziz, Al Thabiani
   Tseng, Li-Chun
   Kalimuthu, Kandasamy
   Alsalhi, Mohamad Saleh
   Devanesan, Sandhanasamy
   Nicoletti, Marcello
   Sarkar, Santosh Kumar
   Benelli, Giovanni
   Hwang, Jiang-Shiou
TI Chitosan-fabricated Ag nanoparticles and larvivorous fishes: a novel
   route to control the coastal malaria vector Anopheles sundaicus?
SO HYDROBIOLOGIA
LA English
DT Article
DE Anopheline; Biocontrol agent; Indoor residual spraying; Mosquito borne
   diseases; Nanosynthesis
ID SYNTHESIZED SILVER NANOPARTICLES; ECO-FRIENDLY LARVICIDES;
   AEDES-AEGYPTI; MOSQUITO VECTORS; ANTIBACTERIAL PROPERTIES; ANTIMICROBIAL
   ACTIVITY; VETERINARY IMPORTANCE; MEDIATED SYNTHESIS; ESCHERICHIA-COLI;
   CONTROL TOOL
AB Mosquitoes represent a key threat for millions of humans worldwide, since they act as vectors for malaria, dengue fever, yellow fever, Zika virus, filariasis, and encephalitis. In this study, we tested chitosan-synthesized silver nanoparticles (Ch-AgNP) using male crab shells as a source of chitosan, which acted as a reducing and capping agent. Ch-AgNP were characterized by UV-Vis spectroscopy, FTIR, SEM, EDX, and XRD. Chitosan and Ch-AgNP were tested against larvae and pupae of the malaria vector Anopheles sundaicus under laboratory and field conditions. Antibacterial properties of Ch-AgNP were tested on Bacillus subtilis, Escherichia coli, Klebsiella pneumoniae, and Proteus vulgaris using the agar disk diffusion assay. The standard predation efficiency of the mosquito natural enemy Carassius auratus in laboratory conditions was 60.80 (on larva II) and 19.68 individuals (on larva III) per day, while post-treatment with sub-lethal doses of Ch-AgNP, the predation efficiency was boosted to 72.00 (on larva II) and 25.80 individuals (on larva III). Overall, Ch-AgNP fabricated using chitosan extracted from the male crab shells of the hydrothermal vent species Xenograpsus testudinatus may offer a novel and safer control strategy against A. sundaicus mosquito vectors, as well as against Gram-negative and Gram-positive pathogenic bacteria.
C1 [Murugan, Kadarkarai; Anitha, Jaganathan; Suresh, Udaiyan; Rajaganesh, Rajapandian] Bharathiar Univ, Sch Life Sci, Div Entomol, Dept Zool, Coimbatore 641046, Tamil Nadu, India.
   [Panneerselvam, Chellasamy; Aziz, Al Thabiani] Univ Tabuk, Dept Biol, Fac Sci, Tabuk 71491, Saudi Arabia.
   [Tseng, Li-Chun; Kalimuthu, Kandasamy; Hwang, Jiang-Shiou] Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung 20224, Taiwan.
   [Alsalhi, Mohamad Saleh; Devanesan, Sandhanasamy] King Saud Univ, Dept Phys & Astron, Laser Diag Canc, Riyadh, Saudi Arabia.
   [Nicoletti, Marcello] Sapienza Univ Rome, Dept Environm Biol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
   [Sarkar, Santosh Kumar] Univ Calcutta, Dept Marine Sci, 35 Ballygunge Circular Rd, Kolkata 700019, W Bengal, India.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
RP Hwang, JS (corresponding author), Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung 20224, Taiwan.; Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
EM benelli.giovanni@gmail.com; jshwang@mail.ntou.edu.tw
RI AlSalhi, Mohamad S/F-2217-2019; Benelli, Giovanni/A-9100-2013;
   Devanesan, S./AAH-9593-2020; alsalhi, mohamad/M-5013-2019; Murugan,
   Kadarkarai/AAP-3937-2020
OI AlSalhi, Mohamad S/0000-0002-4557-8821; Benelli,
   Giovanni/0000-0001-8971-6010; Devanesan, S./0000-0002-5897-9237;
   Panneerselvam, Chellasamy/0000-0003-3994-8141
FU University Grant Commission (New Delhi, India)University Grants
   Commission, India [PDFSS-2014-15-SC-TAM-10125]; King Saud University,
   through the Vice Deanship of Research Chairs; Ministry of Science and
   Technology (MOST) of TaiwanMinistry of Science and Technology, Taiwan
   [MOST 104-2611-M-019-004, MOST 105-2621-M-019-001, MOST
   105-2918-I-019-001, MOST 104-2811-M-019-005, MOST 105-2811-M-019-008]
FX We acknowledge the editor Veronica Ferreira and the two anonymous
   reviewers whose comments contributed to improve the manuscript. A.
   Jaganathan is grateful to the University Grant Commission (New Delhi,
   India), Project No. PDFSS-2014-15-SC-TAM-10125. The authors would like
   to thank the financial support rendered by King Saud University, through
   the Vice Deanship of Research Chairs. We are grateful for financial
   support from the Ministry of Science and Technology (MOST) of Taiwan
   through the Grant No. MOST 104-2611-M-019-004, MOST 105-2621-M-019-001
   and MOST 105-2918-I-019-001 to J.-S. Hwang as well as the Grant No. MOST
   104-2811-M-019-005 and MOST 105-2811-M-019-008 to L.-C. Tseng.
CR Ali SW, 2011, CARBOHYD POLYM, V83, P438, DOI 10.1016/j.carbpol.2010.08.004
   Amerasan D, 2016, J PEST SCI, V89, P249, DOI 10.1007/s10340-015-0675-x
   Arokiyaraj S, 2015, ENVIRON SCI POLLUT R, V22, P9759, DOI 10.1007/s11356-015-4148-9
   Azizi S, 2014, MATER LETT, V116, P275, DOI 10.1016/j.matlet.2013.11.038
   Badawy MEI, 2012, PLANT PROTECT SCI, V48, P131, DOI 10.17221/67/2010-PPS
   Badawy MEI, 2010, J APPL POLYM SCI, V117, P960, DOI 10.1002/app.31492
   Banerjee P., 2014, BIORESOURCES BIOPROC, V1, P3, DOI [DOI 10.1186/S40643-014-0003-Y, 10.1186/s40643-014-0003-y]
   Bartnicki-Garcia S., 1982, CRC HDB MICROBIOLOGY, P229
   BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
   Benelli G, 2017, J CLUST SCI, V28, P287, DOI 10.1007/s10876-016-1088-6
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Bowatte G, 2013, BIOL CONTROL, V67, P469, DOI 10.1016/j.biocontrol.2013.10.005
   Chandramohan B, 2016, PARASITOL RES, V115, P1015, DOI 10.1007/s00436-015-4829-9
   Chen P, 2007, RADIAT PHYS CHEM, V76, P1165, DOI 10.1016/j.radphyschem.2006.11.012
   Chen QC, 2014, J CARBOHYD CHEM, V33, P298, DOI 10.1080/07328303.2014.931962
   Chobu M, 2015, ACTA TROP, V142, P131, DOI 10.1016/j.actatropica.2014.11.012
   Cox FEG, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-5
   Dananjaya S. H. S., 2014, Journal of Veterinary Science and Technology, V5, P209
   Dinesh D, 2015, PARASITOL RES, V114, P1519, DOI 10.1007/s00436-015-4336-z
   El-Mohamedy R. S. R., 2014, Tunisian Journal of Plant Protection, V9, P31
   Fayaz AM, 2010, NANOMED-NANOTECHNOL, V6, P103, DOI 10.1016/j.nano.2009.04.006
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962
   Gaffigan T, 2015, SYSTEMATIC CATALOG C
   Gohel V, 2006, AFR J BIOTECHNOL, V5, P54
   GOODAY GW, 1990, ADV MICROB ECOL, V11, P387
   Govindan S, 2012, APPL NANOSCI, V2, P299, DOI 10.1007/s13204-012-0109-5
   Govindarajan M, 2016, ECOTOX ENVIRON SAFE, V133, P395, DOI 10.1016/j.ecoenv.2016.07.035
   Govindarajan M, 2016, RES VET SCI, V107, P95, DOI 10.1016/j.rvsc.2016.05.017
   Govindarajan M, 2016, J CLUST SCI, V27, P745, DOI 10.1007/s10876-016-0977-z
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   GOW NAR, 1983, PROTOPLASMA, V115, P52, DOI 10.1007/BF01293580
   Huang M, 2004, PHARM RES-DORDR, V21, P344, DOI 10.1023/B:PHAM.0000016249.52831.a5
   Jaganathan A, 2016, PARASITOL INT, V65, P276, DOI 10.1016/j.parint.2016.02.003
   Julkapli NM, 2009, AIP CONF PROC, V1202, P106
   Kalimuthu K, 2014, HYDROBIOLOGIA, V741, P113, DOI 10.1007/s10750-013-1745-9
   Kaur P, 2012, INT J SCI TECHNOL RE, V1, P83
   Kaviya S, 2011, SPECTROCHIM ACTA A, V79, P594, DOI 10.1016/j.saa.2011.03.040
   Kumar KP, 2012, SCIENCEASIA, V38, P141, DOI 10.2306/scienceasia1513-1874.2012.38.141
   Lamarque G, 2005, BIOMACROMOLECULES, V6, P131, DOI 10.1021/bm0496357
   Lee DS, 1980, ATLAS N AM FRESHWATE
   Lertsutthiwong P., 2002, J METALS MAT MINERAL, V12, P11
   Madhiyazhagan P, 2015, PARASITOL RES, V114, P4305, DOI 10.1007/s00436-015-4671-0
   Magudapathy P, 2001, PHYSICA B, V299, P142, DOI 10.1016/S0921-4526(00)00580-9
   Mehlhorn H., 2008, ENCY PARASITOLOGY
   Castro SPM, 2012, COMPLEX WORLD OF POLYSACCHARIDES, P3, DOI 10.5772/51200
   Murugadoss A, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/01/015603
   Murugan K., 2003, Annals of Medical Entomology, V12, P12
   Murugan K, 2016, ECOTOX ENVIRON SAFE, V132, P318, DOI 10.1016/j.ecoenv.2016.06.021
   Murugan K, 2015, ENVIRON SCI POLLUT R, V22, P17053, DOI 10.1007/s11356-015-4920-x
   Murugan K, 2015, RES VET SCI, V102, P127, DOI 10.1016/j.rvsc.2015.08.001
   Murugan K, 2015, PARASITOL RES, V114, P3601, DOI 10.1007/s00436-015-4582-0
   Murugan K, 2015, PARASITOL RES, V114, P2243, DOI 10.1007/s00436-015-4417-z
   Muthukumaran U, 2015, PARASITOL RES, V114, P989, DOI 10.1007/s00436-014-4265-2
   MUZZARELLI RAA, 1985, CARBOHYD POLYM, V5, P461, DOI 10.1016/0144-8617(85)90005-0
   PAGE LM, 1991, PETERSON FIELD GUIDE, V42
   Panneerselvam C, 2013, ASIAN PAC J TROP MED, V6, P102, DOI 10.1016/S1995-7645(13)60003-6
   Patil CD, 2012, PARASITOL RES, V111, P555, DOI 10.1007/s00436-012-2867-0
   Patil CD, 2012, PARASITOL RES, V110, P1815, DOI 10.1007/s00436-011-2704-x
   Patil SV, 2012, APPL BIOCHEM BIOTECH, V167, P776, DOI 10.1007/s12010-012-9710-z
   Rabea EI, 2005, PEST MANAG SCI, V61, P951, DOI 10.1002/ps.1085
   Rafeeq P. E. Muhammed, 2010, RES J PHARM BIOL CHE, V1, P383
   Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002
   Rao JV, 2010, Z NATURFORSCH C, V65, P303
   Rao KSVK, 2012, CARBOHYD POLYM, V87, P920, DOI 10.1016/j.carbpol.2011.07.028
   Roy K, 2015, APPL NANOSCI, V5, P945, DOI 10.1007/s13204-014-0393-3
   Ruparelia JP, 2008, ACTA BIOMATER, V4, P707, DOI 10.1016/j.actbio.2007.11.006
   Sabbour M., 2013, SPECIALTY J BIOL SCI, V1, P67
   Sahab A. F., 2015, International Journal of ChemTech Research, V8, P589
   Sanpui P, 2008, INT J FOOD MICROBIOL, V124, P142, DOI 10.1016/j.ijfoodmicro.2008.03.004
   Saraswathy G, 2001, B MATER SCI, V24, P415, DOI 10.1007/BF02708641
   Sorlier P, 2001, BIOMACROMOLECULES, V2, P765, DOI 10.1021/bm015531+
   Souza BWS, 2010, FOOD HYDROCOLLOID, V24, P330, DOI 10.1016/j.foodhyd.2009.10.011
   Stuart B., 2002, POLYM ANAL
   Subramaniam J, 2016, ENVIRON SCI POLLUT R, V23, P7543, DOI 10.1007/s11356-015-6007-0
   Subramaniam J, 2015, ENVIRON SCI POLLUT R, V22, P20067, DOI 10.1007/s11356-015-5253-5
   SUKUMAR K, 1991, J AM MOSQUITO CONTR, V7, P210
   Suman TY, 2013, COLLOID SURFACE B, V106, P74, DOI 10.1016/j.colsurfb.2013.01.037
   Suresh U, 2015, PARASITOL RES, V114, P1551, DOI 10.1007/s00436-015-4339-9
   Tan Xiao-Ling, 2010, Acta Entomologica Sinica, V53, P891
   Templeton AC, 2000, ACCOUNTS CHEM RES, V33, P27, DOI 10.1021/ar9602664
   Tiwari DK, 2009, ADV BIOL RES, V3, P89
   Trung TS, 2006, BIORESOURCE TECHNOL, V97, P659, DOI 10.1016/j.biortech.2005.03.023
   Twu YK, 2008, POWDER TECHNOL, V185, P251, DOI 10.1016/j.powtec.2007.10.025
   Usha M., 2014, INT J SCI RES, V3, P27
   Walker T., 2014, PARASITE VECTOR, V7, P1
   Ward M, 2017, PARASITOL RES, V116, P839, DOI 10.1007/s00436-016-5352-3
   Wazed Ali S., 2001, CARBOHYD POLYM, V83, P438
   Wei DW, 2009, CARBOHYD RES, V344, P2375, DOI 10.1016/j.carres.2009.09.001
   Yang K, 2010, J BIOTECHNOL, V148, P119, DOI 10.1016/j.jbiotec.2010.05.001
   Yoshizuka K, 2000, REACT FUNCT POLYM, V44, P47, DOI 10.1016/S1381-5148(99)00076-0
   Zhang M, 2003, J BIOACT COMPAT POL, V18, P391, DOI 10.1177/0883911503039019
   Zhao GJ, 1998, BIOMETALS, V11, P27, DOI 10.1023/A:1009253223055
NR 95
TC 10
Z9 12
U1 0
U2 15
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0018-8158
EI 1573-5117
J9 HYDROBIOLOGIA
JI Hydrobiologia
PD AUG
PY 2017
VL 797
IS 1
BP 335
EP 350
DI 10.1007/s10750-017-3196-1
PG 16
WC Marine & Freshwater Biology
SC Marine & Freshwater Biology
GA EY7MA
UT WOS:000404174200024
DA 2020-07-08
ER

PT J
AU Willis, E
   Hensley, SE
AF Willis, Elinor
   Hensley, Scott E.
TI Characterization of Zika virus binding and enhancement potential of a
   large panel of flavivirus murine monoclonal antibodies
SO VIROLOGY
LA English
DT Article
DE Zika virus; Antibody; Antibody mediated enhancement; Flavivirus
ID WEST-NILE-VIRUS; DENGUE VIRUS; DEPENDENT ENHANCEMENT; CROSS-REACTIVITY;
   STRUCTURAL BASIS; INFECTION; NEUTRALIZATION; DETERMINANTS; SPECIFICITY;
   PROTECTION
AB Zika viruses (ZIKVs) are circulating in parts of the world endemic for other flavivirus infections. Some cross reactive antibodies (Abs) elicited by prior flavivirus exposures can bind to ZIKV and enhance infection of Pc receptor-bearing cells. Here, we measured ZIKV binding of 54 murine monoclonal Abs (mAbs) elicited by exposure with Dengue virus and West Nile virus antigens. We found that 8 of 54 mAbs recognized the envelope protein of ZIKV in conventional binding assays. These 8 cross-reactive mAbs have different specificities; most recognize the DI/II region of the envelope protein but one mAbs recognized the DIII lateral ridge of the envelope protein. Interestingly, only 3 of these cross-reactive mAbs were able to enhance ZIKV infection in vitro, and enhancing potential was not strictly correlated with relative binding ability. These data suggest that the ability of flavivirus Abs to enhance ZIKV is dependent on multiple factors.
C1 [Willis, Elinor; Hensley, Scott E.] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.
   [Willis, Elinor] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA.
   [Hensley, Scott E.] 402 Johnson Pavil,3610 Hamilton Walk, Philadelphia, PA 19104 USA.
RP Hensley, SE (corresponding author), Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.; Hensley, SE (corresponding author), 402 Johnson Pavil,3610 Hamilton Walk, Philadelphia, PA 19104 USA.
EM hensley@mail.med.upenn.edu
FU National Institute of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [U19A1057229, T32A1055428]; University of Pennsylvania; Burroughs
   Wellcome FundBurroughs Wellcome Fund
FX This work was supported by the National Institute of Allergy and
   Infectious Diseases (U19A1057229, SEH; T32A1055428, EW) and
   institutional funds from the University of Pennsylvania (SEH). Scott E.
   Hensley, Ph.D. holds an Investigators in the Pathogenesis of Infectious
   Disease Award from the Burroughs Wellcome Fund.
CR Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina S.V., 2017, ENHANCEMENT ZIKA VIR
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brien JD, 2010, J VIROL, V84, P10630, DOI 10.1128/JVI.01190-10
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Charles A. S., 2016, PLOS CURR, V8
   Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Diamond MS, 2015, CELL, V162, P488, DOI 10.1016/j.cell.2015.07.005
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   GENTRY MK, 1982, AM J TROP MED HYG, V31, P548, DOI 10.4269/ajtmh.1982.31.548
   Goncalvez AP, 2007, P NATL ACAD SCI USA, V104, P9422, DOI 10.1073/pnas.0703498104
   Halstead S.B., 2015, PATHOGENESIS DENGUE, V4
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   LUBECK MD, 1985, J IMMUNOL, V135, P1299
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Schmid MA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00647
   Shrestha B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000823
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06
   Sukupolvi-Petty S, 2013, J VIROL, V87, P8826, DOI 10.1128/JVI.01314-13
   Vieira MACS, 2015, AM J TROP MED HYG, V93, P377, DOI 10.4269/ajtmh.15-0170
   Wang TT, 2017, SCIENCE, V355, P395, DOI 10.1126/science.aai8128
   Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690
   Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 43
TC 9
Z9 10
U1 0
U2 18
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD AUG
PY 2017
VL 508
BP 1
EP 6
DI 10.1016/j.virol.2017.04.031
PG 6
WC Virology
SC Virology
GA EY6FI
UT WOS:000404077500001
PM 28475924
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Suh, E
   Mercer, DR
   Dobson, SL
AF Suh, Eunho
   Mercer, David R.
   Dobson, Stephen L.
TI Life-shortening Wolbachia infection reduces population growth of Aedes
   aegypti
SO ACTA TROPICA
LA English
DT Article
DE Population replacement; Dengue; Larval competition; Fitness cost;
   Population biology; Population suppression
ID CYTOPLASMIC INCOMPATIBILITY; RESOURCE COMPETITION; DENGUE TRANSMISSION;
   LARVAL COMPETITION; ALBOPICTUS DIPTERA; WMELPOP-WOLBACHIA; FEVER
   MOSQUITO; BLOCKS DENGUE; ZIKA VIRUS; INVASION
AB Wolbachia bacteria are being introduced into natural populations of vector mosquitoes, with the goal of reducing the transmission of human diseases such as Zika and dengue fever. The successful establishment of Wolbachia infection is largely dependent on the effects of Wolbachia infection to host fitness, but the effects of Wolbachia infection on the individual life-history traits of immature mosquitoes can vary. Here, the effects of life-shortening Wolbachia (wMelPop) on population growth of infected individuals were evaluated by measuring larval survival, developmental time and adult size of Aedes aegypti in intra- (infected or uninfected only) and inter-group (mixed with infected and uninfected) larval competition assays. At low larval density conditions, the population growth of wMelPop infected and uninfected individuals was similar. At high larval densities, wMelPop infected individuals had a significantly reduced population growth rate relative to uninfected individuals, regardless of competition type. We discuss the results in relation to the invasion of the wMelPop Wolbachia infection into naturally uninfected populations.
C1 [Suh, Eunho; Mercer, David R.; Dobson, Stephen L.] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA.
   [Suh, Eunho] Penn State Univ, Dept Entomol, Ctr Infect Dis Dynam, 001 Merkle Lab, University Pk, PA 16802 USA.
RP Suh, E (corresponding author), Penn State Univ, Dept Entomol, Ctr Infect Dis Dynam, 001 Merkle Lab, University Pk, PA 16802 USA.
EM eus57@psu.edu
RI Dobson, Stephen L/E-5852-2010
OI Dobson, Stephen L/0000-0001-5486-8225
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI-067434]; Bill and
   Melinda Gates FoundationGates Foundation [44190]; Kentucky Agricultural
   Experiment Station [17-08-009]
FX We thank S. O'Neill for providing mosquito strains (PGYP1 and
   PGYP1.tet). We thank Adam F. Lindstrom for statistical advice. We thank
   Dr. Dong-Hwan Choe for helpful comments on the paper. This research was
   supported by grants from the National Institutes of Health [AI-067434]
   and the Bill and Melinda Gates Foundation [#44190]. The information
   reported in this paper (No. 17-08-009) is part of a project of the
   Kentucky Agricultural Experiment Station and is published with the
   approval of the Director.
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004
   Braks MAH, 2004, ANN ENTOMOL SOC AM, V97, P130, DOI 10.1603/0013-8746(2004)097[0130:ICBTIS]2.0.CO;2
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Chrostek E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003896
   Crain PR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-290
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Gavotte L, 2010, J INVERTEBR PATHOL, V105, P341, DOI 10.1016/j.jip.2010.08.005
   Gavotte L, 2009, J MED ENTOMOL, V46, P451, DOI 10.1603/033.046.0306
   Hancock PA, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0319-5
   Hancock PA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001024
   Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418
   Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x
   Hoffmann AA, 2014, MED VET ENTOMOL, V28, P90, DOI 10.1111/mve.12077
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   HOFFMANN AA, 1990, GENETICS, V126, P933
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Hoffmann AA, 2014, AUSTRAL ENTOMOL, V53, P125, DOI 10.1111/aen.12068
   Hoffmann AA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0371
   Iturbe-Ormaetxe I, 2011, EMBO REP, V12, P508, DOI 10.1038/embor.2011.84
   Jacups SP, 2013, J MED ENTOMOL, V50, P344, DOI 10.1603/ME12043
   Jeong Gilsang, 2008, Entomological Research, V38, P41, DOI 10.1111/j.1748-5967.2008.00135.x
   Juliano SA, 1998, ECOLOGY, V79, P255, DOI 10.1890/0012-9658(1998)079[0255:SIARAM]2.0.CO;2
   Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143
   Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531
   Kho EA, 2016, J MED ENTOMOL, V53, P894, DOI 10.1093/jme/tjw029
   Koenraadt CJM, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-92
   LIVDAHL TP, 1984, J ANIM ECOL, V53, P573, DOI 10.2307/4535
   LIVDAHL TP, 1991, SCIENCE, V253, P189, DOI 10.1126/science.1853204
   McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968
   McMeniman CJ, 2008, APPL ENVIRON MICROB, V74, P6963, DOI 10.1128/AEM.01038-08
   McMeniman CJ, 2011, J MED ENTOMOL, V48, P76, DOI 10.1603/ME09188
   McMeniman CJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000748
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Rasic G, 2014, ECOL APPL, V24, P1226, DOI 10.1890/13-1305.1
   Ritchie SA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003930
   Ross PA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004320
   Ross PA, 2014, AM J TROP MED HYG, V91, P198, DOI 10.4269/ajtmh.13-0576
   Suh E., 2016, J MED ENTOMOL
   Suh E, 2013, J INVERTEBR PATHOL, V114, P173, DOI 10.1016/j.jip.2013.08.001
   Suh E, 2009, APPL ENVIRON MICROB, V75, P7783, DOI 10.1128/AEM.01331-09
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   Turelli M, 2010, EVOLUTION, V64, P232, DOI 10.1111/j.1558-5646.2009.00822.x
   Turley AP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000516
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   Ye YXH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003894
   Ye YXH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002362
   Yeap HL, 2011, GENETICS, V187, P583, DOI 10.1534/genetics.110.122390
   Yeap HL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-58
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 58
TC 7
Z9 7
U1 1
U2 25
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD AUG
PY 2017
VL 172
BP 232
EP 239
DI 10.1016/j.actatropica.2017.05.015
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EY0GC
UT WOS:000403635200040
PM 28506794
OA Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Coelho, SVA
   Neris, RLS
   Papa, MP
   Schnellrath, LC
   Meuren, LM
   Tschoeke, DA
   Leomil, L
   Vercoza, BRF
   Miranda, M
   Thompson, FL
   Da Poian, AT
   Souza, TML
   Carneiro, FA
   Damaso, CR
   Assuncao-Miranda, I
   de Arruda, LB
AF Antunes Coelho, Sharton Vinicius
   Silva Neris, Romulo Leao
   Papa, Michelle Premazzi
   Schnellrath, Laila Castro
   Meuren, Lana Monteiro
   Tschoeke, Diogo A.
   Leomil, Luciana
   Farias Vercoza, Brunno Renato
   Miranda, Milene
   Thompson, Fabiano L.
   Da Poian, Andrea Thompson
   Souza, Thiago Moreno L.
   Carneiro, Fabiana Avila
   Damaso, Clarissa R.
   Assuncao-Miranda, Iranaia
   de Arruda, Luciana Barros
TI Development of standard methods for Zika virus propagation, titration,
   and purification
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE Zika virus; Virus propagation; Virus purification; Standard protocols
ID SEXUAL TRANSMISSION; BRAZIL
AB The emergence of Zika virus (ZIKV) infection has stimulated several research groups to study and collaborate to understand virus biology and pathogenesis. These efforts may assist with the development of antiviral drugs, vaccines and diagnostic tests, as well as to promote advancements in public health policies. Here, we aim to develop standard protocols for propagation, titration, and purification of ZIKV strains, by systematically testing different cell types, kinetics, multiplicity of infection and centrifugation protocols. ZIKV produces a productive infection in human, non-human primate, and rodents-derived cell lines, with different efficacies. The highest yield of ZIKV-AFR and ZIKV-BR infectious progeny was obtained at 7 days post infection in C6/36 cells (7 x 10(7) and 2 x 10(8) PFU/ml, respectively). However, high titers of ZIKV-AFR could be obtained at earlier time points in Vero cells (2.5 x 10(7) PFU/ml at 72 hpi), whereas ZIKV-BR titers reached 108 PFU/ml at 4dpi in C6/36 cells. High yield of purified virus was obtained by purification through a discontinuous sucrose gradient. This optimized procedure will certainly contribute to future studies of virus structure and vaccine development. Beyond the achievement of efficient virus propagation, the normalization of these protocols will also allow different laboratories around the world to better compare and discuss data regarding different features of ZIKV biology and disease, contributing to more efficient collaborations and progression in ZIKV research.
C1 [Antunes Coelho, Sharton Vinicius; Silva Neris, Romulo Leao; Papa, Michelle Premazzi; Meuren, Lana Monteiro; Assuncao-Miranda, Iranaia; de Arruda, Luciana Barros] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Virol, Rio de Janeiro, RJ, Brazil.
   [Schnellrath, Laila Castro; Damaso, Clarissa R.] Univ Fed Rio de Janeiro, IBCCF, Rio de Janeiro, RJ, Brazil.
   [Tschoeke, Diogo A.; Leomil, Luciana; Thompson, Fabiano L.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio de Janeiro, RJ, Brazil.
   [Farias Vercoza, Brunno Renato; Carneiro, Fabiana Avila] UFRJ, Polo Avancado Xerem, NUMPEX Nucleo Multidisciplinar Pesquisas, Duque De Caxias, RJ, Brazil.
   [Miranda, Milene; Souza, Thiago Moreno L.] Fundacao Oswaldo Cruz, FIOCRUZ, IOC, Lab Imunofarmacol, Rio De Janeiro, RJ, Brazil.
   [Da Poian, Andrea Thompson] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Rio de Janeiro, RJ, Brazil.
   [Souza, Thiago Moreno L.] Fiocruz MS, Ctr Technol Dev Hlth CDTS, Natl Inst Sci & Technol Innovat Neglected Dis INC, Rio De Janeiro, RJ, Brazil.
RP Assuncao-Miranda, I; de Arruda, LB (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, CCS, Bloco 1,Lab 1-SS-048,Lab 1-SS-055, Rio De Janeiro, RJ, Brazil.
EM iranaiamiranda@micro.ufrj.br; arruda@micro.ufrj.br
RI CARNEIRO, FABIANA A/S-4525-2018; Vercoza, Brunno Renato
   Farias/AAB-4725-2019; Tschoeke, Diogo A/F-9913-2019; Souza, Thiago
   Moreno L./G-2900-2012; Damaso, Clarissa/F-7737-2012; Da Poian, Andrea
   T./V-1699-2019; Arruda, Luciana B/N-9086-2013; Leomil,
   Luciana/O-4860-2019
OI Vercoza, Brunno Renato Farias/0000-0001-6117-7879; Tschoeke, Diogo
   A/0000-0001-8134-4259; Souza, Thiago Moreno L./0000-0003-2212-3899;
   Damaso, Clarissa/0000-0001-6299-2816; Da Poian,
   Andrea/0000-0002-3969-704X; Carneiro, Fabiana/0000-0002-6584-4875
FU CAPESCAPES; CAPES/PVE-Program; CNPqNational Council for Scientific and
   Technological Development (CNPq); FAPERJ-Rede ZIKA; FINEPCiencia
   Tecnologia e Inovacao (FINEP); FAPERJCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ)
FX This work was supported by CAPES, CAPES/PVE-Program, CNPq, FAPERJ-Rede
   ZIKA, and FINEP. SVAC was the recipient of a FAPERJ fellowship. RLSN and
   MPP were recipients of CNPq fellowships. LCS was the recipient of a
   CAPES fellowship. CD and ATP are recipients of CNPq research
   fellowships.
CR Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1960, DOI 10.3201/eid2011.141380
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chen SX, 2004, VIROLOGY, V318, P123, DOI 10.1016/j.virol.2003.09.013
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Freshney R. I., 2005, CULTURE ANIMAL CELLS, P315
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Maramorosch K., 1994, ARTHROPOD CELL CULTU
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nikolskaia OV, 2006, J CLIN INVEST, V116, P2739, DOI [10.1172/JC127798, 10.1172/JCI27798.]
   Nogueira ML, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14047
   Nurk S, 2013, J COMPUT BIOL, V20, P714, DOI 10.1089/cmb.2013.0084
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288
   Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 39
TC 20
Z9 20
U1 1
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD AUG
PY 2017
VL 246
BP 65
EP 74
DI 10.1016/j.jviromet.2017.04.011
PG 10
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA EY1PJ
UT WOS:000403737500011
PM 28445704
DA 2020-07-08
ER

PT J
AU Frankel, MB
   Pandya, K
   Gersch, J
   Siddiqui, S
   Schneider, GJ
AF Frankel, Matthew B.
   Pandya, Kinnari
   Gersch, Jeffrey
   Siddiqui, Sarah
   Schneider, George J.
TI Development of the Abbott RealTime ZIKA assay for the qualitative
   detection of Zika virus RNA from serum, plasma, urine, and whole blood
   specimens using the m2000 system
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE RT-PCR; Zika virus; Automated; RealTime; PCR
ID SEXUAL TRANSMISSION; INFECTION; OUTBREAK; BRAZIL; AMERICA; SALIVA;
   ISLAND
AB Zika virus is an arthropod-borne flavivirus that has rapidly developed into a world-wide concern. Discovered in 1947, the virus was relatively obscure until an outbreak occurred in 2007 in the Yap islands and spread eventually to the Americas in 2015. Only 20% of patients infected with Zika virus develop symptoms. However, there can be serious consequences of infection including birth defects in developing fetuses and links to Guillain-Barre syndrome. The swift rise in infections has necessitated the development of diagnostic tests for both the detection of viral RNA and the presence of virus-specific antibodies. Abbott has developed a dual target RT-PCR assay for the detection of Zika virus RNA within serum, plasma, whole blood, and urine using the automated m2000 system for sample extraction to result reporting. The Abbott RealTime ZIKA assay has a limit of detection of 30 copies per mL in serum, 40 copies per mL in plasma and urine, and 120 copies per mL in whole blood and demonstrates high specificity against challenges from closely related infectious agents.
C1 [Frankel, Matthew B.; Pandya, Kinnari; Gersch, Jeffrey; Siddiqui, Sarah; Schneider, George J.] Abbott Labs, Abbott Pk, IL 60064 USA.
RP Frankel, MB (corresponding author), Abbott Labs, Abbott Pk, IL 60064 USA.
EM matthew.frankel@abbott.com
CR Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fellner Chris, 2016, P T, V41, P242
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Klungthong C, 2007, J CLIN MICROBIOL, V45, P2480, DOI 10.1128/JCM.00305-07
   Lai L, 2012, TRANSFUSION, V52, P447, DOI 10.1111/j.1537-2995.2011.03289.x
   Lustig Y, 2016, EUROSURVEILLANCE, V30, P21
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D., 2014, EURO SURVEILL, V19
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Paz-Bailey G, 2017, N ENGL J MED
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
NR 36
TC 8
Z9 8
U1 3
U2 22
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD AUG
PY 2017
VL 246
BP 117
EP 124
DI 10.1016/j.jviromet.2017.05.002
PG 8
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA EY1PJ
UT WOS:000403737500019
PM 28479349
DA 2020-07-08
ER

PT J
AU Duan, XF
   Li, SH
   Wong, G
   Wang, DF
   Wang, HY
   Lu, J
   Bi, YH
   Lu, XC
   Shi, Y
   Yan, JH
   Fang, M
   Gao, GF
AF Duan, Xuefeng
   Li, Shihua
   Wong, Gary
   Wang, Dongfang
   Wang, Haoyu
   Lu, Jiao
   Bi, Yuhai
   Lu, Xuancheng
   Shi, Yi
   Yan, Jinghua
   Fang, Min
   Gao, George Fu
TI Natural killer cells are activated and play a protective role against
   ZIKA virus infection in mice
SO SCIENCE BULLETIN
LA English
DT Editorial Material
C1 [Duan, Xuefeng; Li, Shihua; Wong, Gary; Wang, Dongfang; Wang, Haoyu; Lu, Jiao; Bi, Yuhai; Shi, Yi; Yan, Jinghua; Fang, Min; Gao, George Fu] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.
   [Wang, Dongfang; Lu, Jiao] Univ Chinese Acad Sci, Beijing 100101, Peoples R China.
   [Wang, Haoyu] Anhui Univ, Inst Hlth Sci, Hefei 230601, Anhui, Peoples R China.
   [Lu, Xuancheng] Chinese Ctr Dis Control & Prevent China CDC, Lab Anim Ctr, Beijing 102206, Peoples R China.
   [Fang, Min] Univ Chinese Acad Sci, Int Coll, Beijing 100101, Peoples R China.
   [Gao, George Fu] Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China.
   [Gao, George Fu] Univ Chinese Acad Sci, Savaid Med Sch, Beijing 100049, Peoples R China.
   [Gao, George Fu] Chinese Acad Sci, Beijing Inst Life Sci, RNIH, Beijing 100101, Peoples R China.
RP Fang, M; Gao, GF (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.; Fang, M (corresponding author), Univ Chinese Acad Sci, Int Coll, Beijing 100101, Peoples R China.; Gao, GF (corresponding author), Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China.; Gao, GF (corresponding author), Univ Chinese Acad Sci, Savaid Med Sch, Beijing 100049, Peoples R China.; Gao, GF (corresponding author), Chinese Acad Sci, Beijing Inst Life Sci, RNIH, Beijing 100101, Peoples R China.
EM fangm@im.ac.cn; gaof@im.ac.cn
FU National Basic Research Program of ChinaNational Basic Research Program
   of China [2015CB910503, 2014CB542602]; National Natural Science
   Foundation of ChinaNational Natural Science Foundation of China
   [31370877, 31322020, 31400151]; National Key Plan for Scientific
   Research and Development of China [2016YFD0500300]; Task-Force of Zika
   Virus Research from the Chinese Academy of Sciences [KJZDEW-L15];
   MOSTMinistry of Science and Technology (MOST) Korea [CAIJIAO (2016)273];
   National Thousand Talent Plan of China; Banting Postdoctoral Fellowship
   from the Canadian Institutes of Health Research (CIHR)Canadian
   Institutes of Health Research (CIHR); President's International
   Fellowship Initiative from the Chinese Academy of Sciences
FX This work was supported by the National Basic Research Program of China
   (2015CB910503 and 2014CB542602), the National Natural Science Foundation
   of China (31370877, 31322020 and 31400151), the National Key Plan for
   Scientific Research and Development of China (2016YFD0500300), and the
   Task-Force of Zika Virus Research from the Chinese Academy of Sciences
   (KJZDEW-L15) and MOST (CAIJIAO (2016)273). M.F. is supported by an award
   from the National Thousand Talent Plan of China (2012). G.W. is the
   recipient of a Banting Postdoctoral Fellowship from the Canadian
   Institutes of Health Research (CIHR) and the President's International
   Fellowship Initiative from the Chinese Academy of Sciences.
CR Beltran D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00192
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Petitdemangew C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00209
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Zhang HM, 2016, SCI BULL, V61, P749, DOI 10.1007/s11434-016-1068-0
NR 10
TC 0
Z9 0
U1 0
U2 10
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 2095-9273
EI 2095-9281
J9 SCI BULL
JI Sci. Bull.
PD JUL 30
PY 2017
VL 62
IS 14
BP 982
EP 984
DI 10.1016/j.scib.2017.06.013
PG 3
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FF6BD
UT WOS:000409086700006
OA Bronze
DA 2020-07-08
ER

PT J
AU Oduyebo, T
   Polen, KD
   Walke, HT
   Reagan-Steiner, S
   Lathrop, E
   Rabe, IB
   Kuhnert-Tallman, WL
   Martin, SW
   Walker, AT
   Gregory, CJ
   Ades, EW
   Carroll, DS
   Rivera, M
   Perez-Padilla, J
   Gould, C
   Nemhauser, JB
   Ben Beard, C
   Harcourt, JL
   Viens, L
   Johansson, M
   Ellington, SR
   Petersen, E
   Smith, LA
   Reichard, J
   Munoz-Jordan, J
   Beach, MJ
   Rose, DA
   Barzilay, E
   Noonan-Smith, M
   Jamieson, DJ
   Zaki, SR
   Petersen, LR
   Honein, MA
   Meaney-Delman, D
AF Oduyebo, Titilope
   Polen, Kara D.
   Walke, Henry T.
   Reagan-Steiner, Sarah
   Lathrop, Eva
   Rabe, Ingrid B.
   Kuhnert-Tallman, Wendi L.
   Martin, Stacey W.
   Walker, Allison T.
   Gregory, Christopher J.
   Ades, Edwin W.
   Carroll, Darin S.
   Rivera, Maria
   Perez-Padilla, Janice
   Gould, Carolyn
   Nemhauser, Jeffrey B.
   Ben Beard, C.
   Harcourt, Jennifer L.
   Viens, Laura
   Johansson, Michael
   Ellington, Sascha R.
   Petersen, Emily
   Smith, Laura A.
   Reichard, Jessica
   Munoz-Jordan, Jorge
   Beach, Michael J.
   Rose, Dale A.
   Barzilay, Ezra
   Noonan-Smith, Michelle
   Jamieson, Denise J.
   Zaki, Sherif R.
   Petersen, Lyle R.
   Honein, Margaret A.
   Meaney-Delman, Dana
TI Update: Interim Guidance for Health Care Providers Caring for Pregnant
   Women with Possible Zika Virus Exposure - United States (Including US
   Territories), July 2017
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Editorial Material
ID INFECTION; PERSISTENCE; ANTIBODY; BRAIN; BLOOD; RNA; TRANSMISSION;
   SPECIMENS; INFANTS; FETUSES
C1 [Oduyebo, Titilope; Polen, Kara D.; Walke, Henry T.; Reagan-Steiner, Sarah; Lathrop, Eva; Rabe, Ingrid B.; Kuhnert-Tallman, Wendi L.; Martin, Stacey W.; Walker, Allison T.; Gregory, Christopher J.; Ades, Edwin W.; Carroll, Darin S.; Rivera, Maria; Perez-Padilla, Janice; Gould, Carolyn; Nemhauser, Jeffrey B.; Ben Beard, C.; Harcourt, Jennifer L.; Viens, Laura; Johansson, Michael; Ellington, Sascha R.; Petersen, Emily; Smith, Laura A.; Reichard, Jessica; Munoz-Jordan, Jorge; Beach, Michael J.; Rose, Dale A.; Barzilay, Ezra; Noonan-Smith, Michelle; Jamieson, Denise J.; Zaki, Sherif R.; Petersen, Lyle R.; Honein, Margaret A.; Meaney-Delman, Dana] CDC, Zika Virus Response Team, Atlanta, GA 30333 USA.
RP Oduyebo, T (corresponding author), CDC, Zika Virus Response Team, Atlanta, GA 30333 USA.
EM Zikamch@cdc.gov
RI Rose, Dale A/P-2721-2018
OI Rose, Dale A/0000-0002-0943-6121; Johansson,
   Michael/0000-0002-5090-7722; Jamieson, Denise/0000-0003-2597-1201
CR Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Bocanegra C, 2016, CLIN MICROBIOL INFEC, V22, P648, DOI 10.1016/j.cmi.2016.03.025
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   CDC, 2017, PROL IGM ANT RESP PE
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154
   Hancock WT, 2017, MMWR-MORBID MORTAL W, V66, P299, DOI 10.15585/mmwr.mm6611a5
   Ikejezie J, 2017, MMWR-MORBID MORTAL W, V66, P329, DOI 10.15585/mmwr.mm6612a4
   Johnson BW, 2005, VECTOR-BORNE ZOONOT, V5, P137, DOI 10.1089/vbz.2005.5.137
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Massad E, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-130
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   OKUNO Y, 1983, BIKEN J, V26, P161
   Pacheco O, 2016, N ENGL J MED
   Pan American Health Organization; World Health Organization, 2017, REG ZIK EP UPD
   Parra-Saavedra M, 2017, OBSTET GYNECOL, V130, P207, DOI 10.1097/AOG.0000000000002105
   Paz-Bailey G, 2017, N ENGL J MED
   Pinsent A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-298
   POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Reagan-Steiner S, 2017, MMWR-MORBID MORTAL W, V66, P636, DOI 10.15585/mmwr.mm6624a3
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Roehrig JT, 2003, EMERG INFECT DIS, V9, P376, DOI 10.3201/eid0903.020531
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   St George K, 2017, J CLIN MICROBIOL, V55, P535, DOI 10.1128/JCM.01232-16
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Williamson PC, 2017, TRANSFUSION, V57, P770, DOI 10.1111/trf.14041
   Woods CR, 2013, J PEDIATR INFECT DIS, V2, P87, DOI 10.1093/jpids/pis133
   World Health Organization, 2017, ZIKA VIRUS COUNTRY C
NR 34
TC 61
Z9 64
U1 1
U2 3
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD JUL 28
PY 2017
VL 66
IS 29
BP 781
EP 793
DI 10.15585/mmwr.mm6629e1
PG 13
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FB8SK
UT WOS:000406409100005
PM 28749921
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Overgaard, HJ
   Olano, VA
   Jaramillo, JF
   Matiz, MI
   Sarmiento, D
   Stenstrom, TA
   Alexander, N
AF Overgaard, Hans J.
   Olano, Victor Alberto
   Jaramillo, Juan Felipe
   Matiz, Maria Ines
   Sarmiento, Diana
   Stenstrom, Thor Axel
   Alexander, Neal
TI A cross-sectional survey of Aedes aegypti immature abundance in urban
   and rural household containers in central Colombia
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes aegypti; Immature stages; Household water container; Dengue;
   Mosquito
ID ALBOPICTUS DIPTERA; CULEX-QUINQUEFASCIATUS; STEGOMYIA AEGYPTI; CULICIDAE
   PRODUCTIVITY; LARVAE DIPTERA; LIFE-CYCLE; DENGUE; MOSQUITOS;
   TEMPERATURE; WATER
AB Background: Aedes aegypti, the major vector of dengue, breeds in domestic water containers. The development of immature mosquitoes in such containers is influenced by various environmental, ecological and socioeconomic factors. Urban and rural disparities in water storage practices and water source supply may affect mosquito immature abundance and, potentially, dengue risk. We evaluated the effect of water and container characteristics on A. aegypti immature abundance in urban and rural areas. Data were collected in the wet season of 2011 in central Colombia from 36 urban and 35 rural containers, which were either mosquito-positive or negative. Immature mosquitoes were identified to species. Data on water and container characteristics were collected from all containers.
   Results: A total of 1452 Aedes pupae and larvae were collected of which 81% were A. aegypti and 19% A. fluviatilis. Aedes aegypti immatures were found in both urban and rural sites. However, the mean number of A. aegypti pupae was five times higher in containers in the urban sites compared to those in the rural sites. One of the important factors associated with A. aegypti infestation was frequency of container washing. Monthly-washed or never-washed containers were both about four times more likely to be infested than those washed every week. There were no significant differences between urban and rural sites in frequency of washing containers. Aedes aegypti immature infestation was positively associated with total dissolved solids, but negatively associated with dissolved oxygen. Water temperature, total dissolved solids, ammonia, nitrate, and organic matter were significantly higher in urban than in rural containers, which might explain urban-rural differences in breeding of A. aegypti. However, many of these factors vary substantially between studies and in their degree of association with vector breeding, therefore they may not be reliable indices for vector control interventions.
   Conclusions: Although containers in urban areas were more likely to be infested with A. aegypti, rural containers still provide suitable habitats for A. aegypti. Containers that are washed more frequent are less likely to produce A. aegypti. These results highlight the importance of container washing as an effective vector control tool in both urban and rural areas. In addition, alternative designs of the highly productive washbasins should continue to be explored. To control diseases such as dengue, Zika and chikungunya, effective vector breeding site control must be implemented in addition to other interventions.
C1 [Overgaard, Hans J.] Norwegian Univ Life Sci, Fac Sci & Technol, As, Norway.
   [Olano, Victor Alberto; Jaramillo, Juan Felipe; Matiz, Maria Ines; Sarmiento, Diana] Univ El Bosque, Inst Salud & Ambiente, Bogota, Colombia.
   [Stenstrom, Thor Axel] Durban Univ Technol, Inst Water & Waste Water Technol, SARChI, Durban, South Africa.
   [Alexander, Neal] London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, London, England.
RP Overgaard, HJ (corresponding author), Norwegian Univ Life Sci, Fac Sci & Technol, As, Norway.
EM hans.overgaard@nmbu.no
RI Overgaard, Hans/AAE-9972-2020
OI Sarmiento, Diana/0000-0002-9959-3226; Jaramillo, Juan
   Felipe/0000-0001-6417-8578; Olano, Victor/0000-0003-4010-0973
FU Research Council of NorwayResearch Council of Norway [201349]; Fundacion
   Lazos de Calandaima, Colombia; Universidad El Bosque, Colombia
FX This work was funded by the Research Council of Norway (Project no.
   201349), the Fundacion Lazos de Calandaima, Colombia, and Universidad El
   Bosque, Colombia.
CR Olano VA, 2015, J AM MOSQUITO CONTR, V31, P212, DOI 10.2987/moco-31-03-212-222.1
   Alcala L, 2015, BIOMEDICA, V35, P258, DOI [10.7705/biomedica.v35i2.2567, 10.1590/S0120-41572015000200014]
   Allan SA, 1998, J MED ENTOMOL, V35, P943, DOI 10.1093/jmedent/35.6.943
   Alto BW, 2001, J MED ENTOMOL, V38, P646, DOI 10.1603/0022-2585-38.5.646
   Alto BW, 2001, J MED ENTOMOL, V38, P548, DOI 10.1603/0022-2585-38.4.548
   [Anonymous], 2012, GLOB STRAT DENG PREV
   APHA/AWWA/WPCF (American Public Health Association/American Water Works Association/Water Pollution Control Federation), 1998, STANDARD METHODS EXA
   Arunachalam N, 2010, B WORLD HEALTH ORGAN, V88, P173, DOI 10.2471/BLT.09.067892
   Barrera R, 2006, J MED ENTOMOL, V43, P484, DOI 10.1603/0022-2585(2006)43[484:EFIAAD]2.0.CO;2
   Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378
   BENTLEY MD, 1989, ANNU REV ENTOMOL, V34, P401, DOI 10.1146/annurev.en.34.010189.002153
   Beserra EB, 2010, NEOTROP ENTOMOL, V39, P1016, DOI 10.1590/S1519-566X2010000600026
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bhattacharya Sajal, 2016, Journal of Entomology and Zoology Studies, V4, P73
   BRIEGEL H, 1990, J INSECT PHYSIOL, V36, P165, DOI 10.1016/0022-1910(90)90118-Y
   Brooker S, 2005, EXPERT REV VACCINES, V4, P35, DOI 10.1586/14760584.4.1.35
   Burke R, 2010, MED VET ENTOMOL, V24, P117, DOI 10.1111/j.1365-2915.2010.00864.x
   CHADEE DD, 1990, ENTOMOL EXP APPL, V57, P295, DOI 10.1007/BF00355029
   Chatterjee S, 2015, INDIAN J MED RES, V142, P79, DOI 10.4103/0971-5916.176631
   Chitolina RF, 2016, ACTA TROP, V164, P290, DOI 10.1016/j.actatropica.2016.07.013
   DANE, 2010, PERF MUN AN CUND
   DANE, 2007, CART BCONC BAS IND D
   DANE. Departamento Administrativo Nacional de Estadistica (DANE), 2014, PROYECC POBL 2005 20
   Darriet F, 2008, CR BIOL, V331, P617, DOI 10.1016/j.crvi.2008.05.003
   Deborah C, 1996, WATER QUALITY ASSESS
   Diaz-Nieto LM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001963
   Eisen L, 2014, J MED ENTOMOL, V51, P496, DOI 10.1603/ME13214
   Espinoza GF, 2001, MEX PAN AM J PUBLIC, V10, P6, DOI DOI 10.1590/S1020-49892001000700002
   FAY R. W., 1965, MOSQUITO NEWS, V25, P276
   Ferdousi Farhana, 2015, Tropical Medicine and Health, V43, P253, DOI 10.2149/tmh.2015-16
   Fernandez EA, 1998, ACTA TROP, V70, P171, DOI 10.1016/S0001-706X(98)00033-3
   Focks D, 2006, WHOTDRIDEDEN20061, P48
   Forattini O. P., 1965, ENTOMOLOGIA MEDICA, V2
   Gonzalez PV, 2016, J MED ENTOMOL, V53, P268, DOI 10.1093/jme/tjv189
   Gonzalez Ranulfo, 1996, Boletin del Museo de Entomologia de la Universidad del Valle, V4, P21
   Gopalakrishnan R, 2013, J VECTOR DIS, V50, P215
   Guagliardo SA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003033
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Haramis L., 1984, ECOLOGY MOSQUITOES
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Ingram Deborah D., 2014, 2013 NCHS URBAN RURA
   Irving EC, 2004, ENVIRON TOXICOL CHEM, V23, P1561, DOI 10.1897/03-230
   Kent R, 2004, 034326 US GEOL SURV
   Kumar Avdhesh, 2001, Journal of Communicable Diseases, V33, P274
   Lane J, 1953, NEOTROPICAL CULICIDA, VI
   Lenhart AE, 2006, ANN TROP MED PARASIT, V100, pS53, DOI 10.1179/136485906X105516
   Ma MH, 2016, ACTA TROP, V163, P121, DOI 10.1016/j.actatropica.2016.08.010
   Maciel-De-Freitas R, 2007, MEM I OSWALDO CRUZ, V102, P489, DOI 10.1590/S0074-02762007005000056
   Marinho RA, 2016, J VECTOR ECOL, V41, P1, DOI 10.1111/jvec.12187
   MERRITT RW, 1992, ANNU REV ENTOMOL, V37, P349, DOI 10.1146/annurev.en.37.010192.002025
   Ministerio de la Proteccion Social, 2014, GEST VIG ENT CONTR T
   Muturi EJ, 2008, J VECTOR ECOL, V33, P56, DOI 10.3376/1081-1710(2008)33[56:EFAWTD]2.0.CO;2
   Padilla JC, 2012, DENGUE COLOMBIA EPID
   Pena O Sardinas, 2008, REV CUB HIG EPIDEMIO, V46, P1
   Perez-Castro R, 2016, MEM I OSWALDO CRUZ, V111, P233, DOI 10.1590/0074-02760150363
   Phuanukoonnon S, 2005, TROP MED INT HEALTH, V10, P755, DOI 10.1111/j.1365-3156.2005.01452.x
   Ponnusamy L, 2008, P NATL ACAD SCI USA, V105, P9262, DOI 10.1073/pnas.0802505105
   Quintero J, 2015, T ROY SOC TROP MED H, V109, P116, DOI 10.1093/trstmh/tru208
   Quintero J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-38
   Quintero J, 2009, CAD SAUDE PUBLICA, V25, pS93, DOI 10.1590/S0102-311X2009001300009
   RESTREPO JARAMILLO BERTA NELLY, 2014, CES Med., V28, P313
   Romero-Vivas CME, 2006, ANN TROP MED PARASIT, V100, pS87, DOI 10.1179/136485906X105543
   Ruiz-Lopez F, 2016, BIOMEDICA, V36, P303, DOI 10.7705/biomedica.v36i2.3301
   Schmidt WP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001082
   Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89
   Sommerfeld J, 2012, PATHOG GLOB HEALTH, V106, P428, DOI 10.1179/2047773212Y.0000000055
   Sumanochitrapon W, 1998, AM J TROP MED HYG, V58, P283, DOI 10.4269/ajtmh.1998.58.283
   Tinker M. E., 1993, Biomedica, V13, P5
   Troyes R Lucinda, 2006, Rev. perú. med. exp. salud publica, V23, P163
   Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x
   TunLin W, 1995, AM J TROP MED HYG, V53, P591, DOI 10.4269/ajtmh.1995.53.591
   UNICEF & WHO, 2015, PROGR SAN DRINK WAT
   Vezzani D, 2004, MEM I OSWALDO CRUZ, V99, P351, DOI 10.1590/S0074-02762004000400002
   Vong S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000903
   WALKER ED, 1991, ECOLOGY, V72, P1529, DOI 10.2307/1940953
   WALKER ED, 1988, J MED ENTOMOL, V25, P551, DOI 10.1093/jmedent/25.6.551
   Wetzel R. G., 2001, LIMNOLOGY LAKE RIVER
   WHO, 2017, ZIK SIT REP ZIK VIR
   WHO, 2016, WHOZIKVMOC161 REV3
   WHO/UNICEF, 2014, PROGR DRINK WAT SAN
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 81
TC 9
Z9 9
U1 0
U2 17
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD JUL 27
PY 2017
VL 10
AR 356
DI 10.1186/s13071-017-2295-1
PG 12
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FC7VW
UT WOS:000407051500001
PM 28750651
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Rather, IA
   Lone, JB
   Bajpai, VK
   Paek, WK
   Lim, J
AF Rather, Irfan A.
   Lone, Jameel B.
   Bajpai, Vivek K.
   Paek, Woon K.
   Lim, Jeongheui
TI Zika Virus: An Emerging Worldwide Threat
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Review
DE ZIKV; disease; infection; vaccines; diagnosis
ID AEDES-AEGYPTI; UNITED-STATES; INFECTION; TRANSMISSION; DENGUE;
   TRAVELERS; DISEASES; AREAS
AB ZIKA virus (ZIKV) poses a severe threat to the world. Recent outbreaks of ZIKV after 2007 along with its quick transmission have made this virus a matter of international concern. The virus shows symptoms that are similar to those caused in the wake of dengue virus (DENV) and other flaviviruses, which makes it difficult to discern the viral infection. Diagnosis is further complicated as the virus cross-reacts with antibodies of other viruses. Currently, molecular diagnosis of the virus is being performed by RT-PCR and IgM-captured enzyme-linked immunosorbent assay (MAC-ELISA). The real brunt of the virus is, however, borne by children and adults alike. Case studies of the ZIKV outbreaks in the French Polynesia and other places have suggested that there is a close link between the ZIKV and Gullian-Barre syndrome (GBS). The GBS has closely followed in areas facing ZIKV outbreaks. Although solid evidence is yet to emerge, clinical data integration has revealed a large number of ZIKV patients having GBS. Moreover, the amniotic fluids, blood cord, and miscarriage tissues of mothers have been detected with ZIKV, which indicates that the virus either gets transferred from mother to fetus or seeks direct entry in the fetus, causing microcephaly and other brain anomalies in the newborn babies. Studies on mice have confirmed the link between the ZIKV infection during pregnancy and microcephaly in babies. Reports have highlighted the sexual transmission of the ZIKV, as it has been detected in the semen and saliva of affected persons. The intensity with which the ZIKA is spreading can collapse the health sector of several countries, which are poor. A comprehensive strategy is a need of an hour to combat this virus so as to prevent its transmission and avert the looming threat. At the same time, more research on the cure of the ZIKV is imperative.
C1 [Rather, Irfan A.; Bajpai, Vivek K.] Daegu Univ, Dept Biotechnol, Gyongsan, South Korea.
   [Lone, Jameel B.] Yeungnam Univ, Sch Biotechnol, Dept Appl Microbiol & Biotechnol, Gyongsan, South Korea.
   [Paek, Woon K.; Lim, Jeongheui] Minist Sci ICT & Future Planning, Natl Sci Museum, Daejeon, South Korea.
RP Rather, IA; Bajpai, VK (corresponding author), Daegu Univ, Dept Biotechnol, Gyongsan, South Korea.; Paek, WK; Lim, J (corresponding author), Minist Sci ICT & Future Planning, Natl Sci Museum, Daejeon, South Korea.
EM rather@ynu.ac.kr; vkbajpai04@gmail.com; paekwk@naver.com;
   jeongheuilim@gmail.com
RI Rather, Irfan A./AAH-1425-2019
FU National Research Foundation of KoreaNational Research Foundation of
   Korea [2013M3A9A504705, 2017M3A9A5048999]
FX This work was supported by National Research Foundation of Korea
   (2013M3A9A504705 and 2017M3A9A5048999).
CR Alphey L, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003909
   Banks SD, 2014, MED VET ENTOMOL, V28, P14, DOI 10.1111/mve.12068
   Bierlaire D, 2017, TRANSFUSION, V57, P729, DOI 10.1111/trf.14028
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Capeding MR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002331
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2017, EMERG INFECT DIS, V23, P880, DOI 10.3201/eid2305.162041
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Darbellay J, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.133
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Dirlikov E, 2017, EMERG INFECT DIS, V23, P134, DOI 10.3201/eid2301.161290
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   ECDC, 2016, ZIK VIR EP AM POT AS
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Hall B., 2017, EMERGENCE ZIKA VIRUS, V7
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kalra S, 2014, J GLOB INFECT DIS, V6, P164, DOI 10.4103/0974-777X.145247
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mohammed H, 2012, TRANSFUSION, V52, P1652, DOI 10.1111/j.1537-2995.2011.03492.x
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P14, DOI DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Pagani I, 2017, SCI REP-UK, V7, DOI 10.1038/srep44286
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Santos J, 2017, ACTA TROP, V168, P80, DOI 10.1016/j.actatropica.2017.01.015
   Schuler-Faccini L, 2018, MOL NEUROBIOL, V55, P1551, DOI 10.1007/s12035-017-0429-2
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tauro LB, 2017, J MED VIROL, V89, P1, DOI 10.1002/jmv.24696
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   Uncini A, 2017, J NEUROL NEUROSUR PS, V88, P266, DOI 10.1136/jnnp-2016-314310
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Weaver S, 2017, JAIDS-J ACQ IMM DEF, V74, P42
   Weaver SC, 2017, MBIO, V8, DOI 10.1128/mBio.02063-16
   Weaver SC, 2013, TRENDS MICROBIOL, V21, P360, DOI 10.1016/j.tim.2013.03.003
   White MK, 2016, ANN NEUROL, V80, P479, DOI 10.1002/ana.24748
   WHO, 2016, ZIK VIR MICR GUILL B, V17, P1
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 51
TC 6
Z9 6
U1 0
U2 12
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JUL 26
PY 2017
VL 8
AR 1417
DI 10.3389/fmicb.2017.01417
PG 7
WC Microbiology
SC Microbiology
GA FB7VP
UT WOS:000406348400001
PM 28798738
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cheema, S
   Maisonneuve, P
   Weber, I
   Fernandez-Luque, L
   Abraham, A
   Alrouh, H
   Sheikh, J
   Lowenfels, AB
   Mamtani, R
AF Cheema, Sohaila
   Maisonneuve, Patrick
   Weber, Ingmar
   Fernandez-Luque, Luis
   Abraham, Amit
   Alrouh, Hekmat
   Sheikh, Javaid
   Lowenfels, Albert B.
   Mamtani, Ravinder
TI Knowledge and perceptions about Zika virus in a Middle East country
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; Infection; Flavivirus; Education; Survey; Epidemiology;
   Qatar; Middle East
ID INFECTION
AB Background: Zika virus, an emerging serious infectious disease, is a threat to persons living or travelling to regions where it is currently endemic, and also to contacts of infected individuals. The aim of this study was to assess knowledge about this new public health threat to persons residing in a Middle Eastern country.
   Methods: We conducted a survey at several international universities in Qatar to assess knowledge and awareness about this disease. An adapted version of the survey was also conducted using online channels from Qatar.
   Results: The median age of the 446 participants, was 25 years, 280 (63%) were females, and 32% were from Gulf Cooperation Council (GCC) or other Middle East countries. Based upon their knowledge about availability of a vaccine, role of mosquitoes and other modes of transmission, and disease complications, we classified respondent's knowledge as "poor" (66%), "basic" (27%) or "broad" (7%). Forty-five (16%) persons with poor knowledge considered themselves to be well-informed.
   Conclusions: This report from a sample of persons associated with Middle East educational complex, reveals inadequate knowledge about Zika virus, a serious emerging infectious disease. Although few cases have been reported from the region, future cases are possible, since this area is a transit hub connecting currently infected regions to North America, Europe and Asia. As a preventive measure, an educational program about Zika virus would be valuable, especially for individuals or family members travelling to afflicted regions.
C1 [Cheema, Sohaila; Abraham, Amit; Alrouh, Hekmat; Mamtani, Ravinder] Qatar Fdn, Weill Cornell Med Qatar, Inst Populat Hlth, POB 24144, Doha, Qatar.
   [Maisonneuve, Patrick] European Inst Oncol, Div Epidemiol & Biostat, Milan, Italy.
   [Weber, Ingmar; Fernandez-Luque, Luis] Qatar Comp Res Inst, Doha, Qatar.
   [Sheikh, Javaid] Qatar Fdn, Off Dean, Weill Cornell Med Qatar, POB 24144, Doha, Qatar.
   [Lowenfels, Albert B.] New York Med Coll, Dept Surg, Valhalla, NY 10595 USA.
   [Lowenfels, Albert B.] New York Med Coll, Dept Family Med, Valhalla, NY 10595 USA.
RP Cheema, S (corresponding author), Qatar Fdn, Weill Cornell Med Qatar, Inst Populat Hlth, POB 24144, Doha, Qatar.
EM soc2005@qatar-med.cornell.edu
RI Maisonneuve, Patrick/U-9789-2018; Weber, Ingmar/AAE-6909-2020
OI Maisonneuve, Patrick/0000-0002-5309-4704; Weber,
   Ingmar/0000-0003-4169-2579; Sheikh, Javaid/0000-0002-5762-4186
FU Institute for Population Health, Weill Cornell Medicine - Qatar and
   Qatar Foundation through the Weill Cornell Medicine-Qatar Biomedical
   Research Program
FX The work was funded by the Institute for Population Health, Weill
   Cornell Medicine - Qatar and Qatar Foundation through the Weill Cornell
   Medicine-Qatar Biomedical Research Program.
CR Binsaeed A A, 2016, J Egypt Soc Parasitol, V46, P571
   Chen HL, 2016, J CHIN MED ASSOC, V79, P174, DOI 10.1016/j.jcma.2016.03.001
   Dzau VJ, 2016, NEW ENGL J MED, V375, P203, DOI 10.1056/NEJMp1605847
   Frieden TR, 2016, JAMA-J AM MED ASSOC, V316, P1443, DOI 10.1001/jama.2016.11941
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1519-x
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Gratz NG, 2000, B WORLD HEALTH ORGAN, V78, P995
   Gupta Nidhi, 2016, Niger Postgrad Med J, V23, P33, DOI 10.4103/1117-1936.180179
   Harapan H, 2017, ASIAN PAC J TROP MED, V10, P182, DOI 10.1016/j.apjtm.2017.01.018
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Meltzer E, 2016, EMERG INFECT DIS, V22, P1521, DOI 10.3201/eid2208.160480
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   National Environment Agency Singapore Government, 2016, ZIK CAS CLUST
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Singh M, 2017, DENTISTRY, V7, P420, DOI [10.4172/2161-1122.1000420, DOI 10.4172/2161-1122.1000420]
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   World Health Organization, 2016, SIT REP ZIK VIR MICR
NR 17
TC 17
Z9 17
U1 0
U2 2
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD JUL 26
PY 2017
VL 17
AR 524
DI 10.1186/s12879-017-2603-6
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA FB7KE
UT WOS:000406318700006
PM 28747174
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Yu, YF
   Deng, YQ
   Zou, P
   Wang, Q
   Dai, YY
   Yu, F
   Du, LY
   Zhang, NN
   Tian, M
   Hao, JN
   Meng, Y
   Li, Y
   Zhou, XH
   Chan, JFW
   Yuen, KY
   Qin, CF
   Jiang, SB
   Lu, L
AF Yu, Yufeng
   Deng, Yong-Qiang
   Zou, Peng
   Wang, Qian
   Dai, Yanyan
   Yu, Fei
   Du, Lanying
   Zhang, Na-Na
   Tian, Min
   Hao, Jia-Nan
   Meng, Yu
   Li, Yuan
   Zhou, Xiaohui
   Chan, Jasper Fuk-Woo
   Yuen, Kwok-Yung
   Qin, Cheng-Feng
   Jiang, Shibo
   Lu, Lu
TI A peptide-based viral inactivator inhibits Zika virus infection in
   pregnant mice and fetuses
SO NATURE COMMUNICATIONS
LA English
DT Article
ID GUILLAIN-BARRE-SYNDROME; DENGUE VIRUS; CLINICAL PRESENTATION; ENVELOPE
   PROTEIN; FUSION; ENFUVIRTIDE; HIV-1; TRANSMISSION; ENTRY; IDENTIFICATION
AB Zika virus (ZIKV), a re-emerging flavivirus associated with neurological disorders, has spread rapidly to more than 70 countries and territories. However, no specific vaccines or antiviral drugs are currently available to prevent or treat ZIKV infection. Here we report that a synthetic peptide derived from the stem region of ZIKV envelope protein, designated Z2, potently inhibits infection of ZIKV and other flaviviruses in vitro. We show that Z2 interacts with ZIKV surface protein and disrupts the integrity of the viral membrane. Z2 can penetrate the placental barrier to enter fetal tissues and is safe for use in pregnant mice. Intraperitoneal administration of Z2 inhibits vertical transmission of ZIKV in pregnant C57BL/6 mice and protects type I or type I/II interferon receptor-deficient mice against lethal ZIKV challenge. Thus, Z2 has potential to be further developed as an antiviral treatment against ZIKV infection in high-risk populations, particularly pregnant women.
C1 [Yu, Yufeng; Zou, Peng; Wang, Qian; Dai, Yanyan; Yu, Fei; Meng, Yu; Li, Yuan; Zhou, Xiaohui; Jiang, Shibo; Lu, Lu] Fudan Univ, Sch Basic Med Sci, Key Lab Med Mol Virol MOE MOH, Shanghai 200032, Peoples R China.
   [Yu, Yufeng; Zou, Peng; Wang, Qian; Dai, Yanyan; Yu, Fei; Meng, Yu; Li, Yuan; Zhou, Xiaohui; Jiang, Shibo; Lu, Lu] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 200032, Peoples R China.
   [Deng, Yong-Qiang; Zhang, Na-Na; Hao, Jia-Nan; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100101, Peoples R China.
   [Du, Lanying; Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10065 USA.
   [Tian, Min] Capital Med Univ, Beijing Hosp Tradit Chinese Med, Beijing 100010, Peoples R China.
   [Chan, Jasper Fuk-Woo; Yuen, Kwok-Yung] Univ Hong Kong, Dept Microbiol, State Key Lab Emerging Infect Dis, Hong Kong 999077, Peoples R China.
RP Jiang, SB; Lu, L (corresponding author), Fudan Univ, Sch Basic Med Sci, Key Lab Med Mol Virol MOE MOH, Shanghai 200032, Peoples R China.; Jiang, SB; Lu, L (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 200032, Peoples R China.; Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100101, Peoples R China.; Jiang, SB (corresponding author), New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10065 USA.
EM qincf@bmi.ac.cn; shibojiang@fudan.edu.cn; lul@fudan.edu.cn
RI Chan, Jasper F. W./D-8007-2013; amsalu, ribka/G-8780-2019; Qin,
   Cheng-Feng/I-6839-2019; Jiang, Shibo/L-4500-2014; Lu, Lu/K-7070-2014;
   Yu, Fei/K-4953-2019
OI Chan, Jasper F. W./0000-0001-6336-6657; Qin,
   Cheng-Feng/0000-0002-0632-2807; Lu, Lu/0000-0002-2255-0391; Yu,
   Fei/0000-0001-6332-4326; Yuen, Kwok-yung/0000-0002-2083-1552
FU Hi-Tech Research and Development Program of China (863 Program)National
   High Technology Research and Development Program of China
   [2015AA020930]; National Key Research and Development Program of China
   [2016YFC1201000, 2016YFC1200405, 2016YFD0500304, 2016YFC1202901];
   National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81630090, 81522025, 81661130162, 81672019]; Food
   and Health Bureau; Government of the Hong Kong Special Administrative
   Region (ZIKA-HKU); Consultancy Service for Enhancing Laboratory
   Surveillance of Emerging Infectious Diseases of the Department of
   Health, Hong Kong Special Administrative Region
FX We thank Q. Wang at the sharing platform for large-scale instrument of
   Fudan University and all the staffs at the Animal Facility of Shanghai
   Public Health Clinical Center for their contribution to this study. This
   work was supported by grants from the Hi-Tech Research and Development
   Program of China (863 Program) (2015AA020930 to L.L.), the National Key
   Research and Development Program of China (2016YFC1201000 and
   2016YFC1200405 to S.J., 2016YFD0500304 to C.-F.Q. and 2016YFC1202901 to
   L.L.), the National Natural Science Foundation of China (81630090 to
   S.J., 81522025 and 81661130162 to C.-F.Q., and 81672019 to L.L.), the
   Food and Health Bureau, the Government of the Hong Kong Special
   Administrative Region (ZIKA-HKU to J.F.W.C.), and the Consultancy
   Service for Enhancing Laboratory Surveillance of Emerging Infectious
   Diseases of the Department of Health, Hong Kong Special Administrative
   Region (K.-Y.Y.).
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bothner B, 1998, J BIOL CHEM, V273, P673, DOI 10.1074/jbc.273.2.673
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059
   Di L, 2015, AAPS J, V17, P134, DOI 10.1208/s12248-014-9687-3
   Durbin AP, 2016, TRENDS IMMUNOL, V37, P635, DOI 10.1016/j.it.2016.08.006
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Fauci AS, 2003, NAT MED, V9, P839, DOI 10.1038/nm0703-839
   Furco A, 2009, AIDS, V23, P434, DOI 10.1097/QAD.0b013e32832027d6
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hrobowski YM, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-49
   Iovine NM, 2017, CLIN INFECT DIS, V64, P72, DOI 10.1093/cid/ciw667
   JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0
   JIANG SB, 1993, BIOCHEM BIOPH RES CO, V195, P533, DOI 10.1006/bbrc.1993.2078
   Jiang SB, 2004, ANTIMICROB AGENTS CH, V48, P4349, DOI 10.1128/AAC.48.11.4349-4359.2004
   Klein DE, 2013, J VIROL, V87, P2287, DOI 10.1128/JVI.02957-12
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lazzarin A, 2003, NEW ENGL J MED, V348, P2186, DOI 10.1056/NEJMoa035211
   Lewis JK, 1998, P NATL ACAD SCI USA, V95, P6774, DOI 10.1073/pnas.95.12.6774
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   Lok SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050995
   Lu L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4067
   Lu L, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-104
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Madeddu G, 2008, INT J STD AIDS, V19, P644, DOI 10.1258/ijsa.2008.008100
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Muller JA, 2017, MED MICROBIOL IMMUN, V206, P175, DOI 10.1007/s00430-017-0493-2
   Oller-Salvia B, 2016, CHEM SOC REV, V45, P4690, DOI 10.1039/c6cs00076b
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sato AK, 2006, CURR OPIN BIOTECH, V17, P638, DOI 10.1016/j.copbio.2006.10.002
   Schmidt AG, 2010, J VIROL, V84, P12549, DOI 10.1128/JVI.01440-10
   Schmidt AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000851
   Shust GF, 2014, J PEDIATR INFECT DIS, V3, P246, DOI 10.1093/jpids/pit019
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tan MQ, 2012, PHARM RES-DORDR, V29, P953, DOI 10.1007/s11095-011-0635-y
   Tong P, 2013, J ANTIMICROB CHEMOTH, V68, P2533, DOI 10.1093/jac/dkt230
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   WATANABE W, 1994, J VIROL METHODS, V48, P257, DOI 10.1016/0166-0934(94)90124-4
   Wimley WC, 2011, J MEMBRANE BIOL, V239, P27, DOI 10.1007/s00232-011-9343-0
   Wimley WC, 2010, ACS CHEM BIOL, V5, P905, DOI 10.1021/cb1001558
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
   Zhao GY, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-266
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 63
TC 49
Z9 51
U1 2
U2 15
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD JUL 25
PY 2017
VL 8
AR 15672
DI 10.1038/ncomms15672
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FZ3ME
UT WOS:000427491700001
PM 28742068
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Campos, JLS
   Poggianella, M
   Marchese, S
   Mossenta, M
   Rana, J
   Arnoldi, F
   Bestagno, M
   Burrone, OR
AF Campos, Jose L. Slon
   Poggianella, Monica
   Marchese, Sara
   Mossenta, Monica
   Rana, Jyoti
   Arnoldi, Francesca
   Bestagno, Marco
   Burrone, Oscar R.
TI DNA-immunisation with dengue virus E protein domains I/II, but not
   domain III, enhances Zika, West Nile and Yellow Fever virus infection
SO PLOS ONE
LA English
DT Article
ID ANTIBODY-DEPENDENT ENHANCEMENT; NEUTRALIZING ANTIBODIES;
   MONOCLONAL-ANTIBODIES; CROSS-REACTIVITY; STRUCTURAL BASIS;
   IMMUNE-RESPONSE; VACCINE; EPITOPES; DETERMINANTS; GLYCOPROTEIN
AB Dengue virus (DENV), the causative agent of dengue disease, is among the most important mosquito-borne pathogens worldwide. DENV is composed of four closely related serotypes and belongs to the Flaviviridae family alongside other important arthropod-borne viral pathogens such as Zika virus (ZIKV), West Nile virus (WNV) and Yellow Fever virus (YFV). After infection, the antibody response is mostly directed to the viral E glycoprotein which is composed of three structural domains named DI, DII and DIII that share variable degrees of homology among different viruses. Recent evidence supports a close serological interaction between ZIKV and DENV. The possibility of worse clinical outcomes as a consequence of antibody-dependent enhancement of infection (ADE) due to cross-reactive antibodies with poor neutralisation activity is a matter of concern. We tested polyclonal sera from groups of female Balb/C mice vaccinated with DNA constructs expressing DI/DII, DIII or the whole sE from different DENV serotypes and compared their activity in terms of cross-reactivity, neutralisation of virus infection and ADE. Our results indicate that the polyclonal antibody responses against the whole sE protein are highly cross-reactive with strong ADE and poor neutralisation activities due to DI/DII immunodominance. Conversely, anti-DIII polyclonal antibodies are type-specific, with no ADE towards ZIKV, WNV and YFV, and strong neutralisation activity restricted only to DENV.
C1 [Campos, Jose L. Slon; Poggianella, Monica; Marchese, Sara; Mossenta, Monica; Rana, Jyoti; Arnoldi, Francesca; Bestagno, Marco; Burrone, Oscar R.] Int Ctr Genet Engn & Biotechnol, Mol Immunol Grp, Trieste, Italy.
   [Arnoldi, Francesca] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy.
RP Burrone, OR (corresponding author), Int Ctr Genet Engn & Biotechnol, Mol Immunol Grp, Trieste, Italy.
EM burrone@icgeb.org
RI Rana, Jyoti/AAP-3614-2020; ARNOLDI, Francesca/K-5020-2016
OI Rana, Jyoti/0000-0001-9683-4592; ARNOLDI, Francesca/0000-0003-0651-5526;
   Slon Campos, Jose Luis/0000-0002-0012-5247
FU Arturo Falaschi ICGEB; FIRB-Futuro in Ricerca grant [RBFR13209E];
   Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR),
   ItalyMinistry of Education, Universities and Research (MIUR)
FX JLSC and JR were supported by Arturo Falaschi ICGEB pre-doctoral and
   postdoctoral fellowships, respectively. FA was supported by FIRB-Futuro
   in Ricerca grant (RBFR13209E), Ministero dell'Istruzione,
   dell'Universita e della Ricerca (MIUR), Italy. The funders played no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Block OKT, 2010, VACCINE, V28, P8085, DOI 10.1016/j.vaccine.2010.10.004
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Campos JLS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01097-5
   Campos JLS, 2015, J GEN VIROL, V96, P3265, DOI 10.1099/jgv.0.000278
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Cassetti MC, 2010, VACCINE, V28, P4229, DOI 10.1016/j.vaccine.2010.04.045
   Chan KR, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.164, 10.1038/nmicrobiol.2016.164]
   Chawla T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065231
   Chiang CY, 2016, SCI REP-UK, V6, DOI 10.1038/srep30648
   Costin JM, 2013, J VIROL, V87, P52, DOI 10.1128/JVI.02273-12
   Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001
   de Alwis R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004386
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   de Souza VAUF, 2004, J CLIN MICROBIOL, V42, P1782, DOI 10.1128/JCM.42.4.1782-1784.2004
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2011, VIROLOGY, V411, P306, DOI 10.1016/j.virol.2010.12.020
   FAGBAMI A, 1988, AM J TROP MED HYG, V38, P205, DOI 10.4269/ajtmh.1988.38.205
   Flipse J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003749
   Gromowski GD, 2008, J VIROL, V82, P8828, DOI 10.1128/JVI.00606-08
   Guzman MG, 2010, VIRUSES-BASEL, V2, P2649, DOI 10.3390/v2122649
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   HANKE T, 1992, J GEN VIROL, V73, P653, DOI 10.1099/0022-1317-73-3-653
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Li EQ, 1997, PROTEIN ENG, V10, P731, DOI 10.1093/protein/10.6.731
   LINDENBACH BD, 2007, FIELDS VIROLOGY
   Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002
   Poggianella M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003947
   Porter KR, 2015, VACCINE, V33, P7135, DOI 10.1016/j.vaccine.2015.09.102
   Predonzani A, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-41
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Puschnik A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002274
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Rouvinski A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15411
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Sambrook J., 1989, MOL CLONING LAB MANU
   Sanchez MD, 2005, VIROLOGY, V336, P70, DOI 10.1016/j.virol.2005.02.020
   SEIF SA, 1995, VACCINE, V13, P1515, DOI 10.1016/0264-410X(95)00097-K
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sukupolvi-Petty S, 2013, J VIROL, V87, P8826, DOI 10.1128/JVI.01314-13
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Vratskikh O, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003458
   Wahala WMPB, 2009, VIROLOGY, V392, P103, DOI 10.1016/j.virol.2009.06.037
   Wang TT, 2017, SCIENCE, V355, P395, DOI 10.1126/science.aai8128
   Zellweger RM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00151
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zompi S, 2012, VIRUSES-BASEL, V4, P62, DOI 10.3390/v4010062
NR 66
TC 12
Z9 12
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 25
PY 2017
VL 12
IS 7
AR e0181734
DI 10.1371/journal.pone.0181734
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FB8DV
UT WOS:000406370000051
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Oom, AL
   Smith, D
   Akrami, K
AF Oom, Aaron L.
   Smith, Davey
   Akrami, Kevan
TI Identification of putative unique immunogenic ZIKV and DENV1-4 peptides
   for diagnostic cellular based tests
SO SCIENTIFIC REPORTS
LA English
DT Article
ID DENGUE VIRUS; CROSS-REACTIVITY; PREDICTION; RESPONSES; EPITOPES;
   TUBERCULOSIS; ORGANIZATION; ENHANCEMENT; RECOGNITION; INFECTION
AB Since the re-emergence of Zika virus in 2014 and subsequent association with microcephaly, much work has focused on the development of a vaccine to halt its spread throughout the world. The mosquito vector that transmits this virus is widespread and responsible for the spread of other arboviridae including Dengue. Current diagnostic methods rely on serologic testing that are complicated by cross reactivity and therefore unable to distinguish Zika from Dengue infection in the absence of virus isolation. We performed an in silico analysis to identify potential epitopes that may stimulate a unique T-lymphocyte response to distinguish prior infection with Zika or Dengue. From this analysis, we not only identified epitopes unique to Zika and Dengue, but also identified epitopes unique to each Dengue serotype. These peptides contribute to a pool of peptides identified for vaccine development that can be tested in vitro to confirm immunogenicity, absence of homology and global population coverage. The current lack of accurate diagnostic testing hampers our ability to understand the scope of the epidemic, implications for vaccine implementation and complications related to monoinfection and co-infection with these two closely related viruses.
C1 [Oom, Aaron L.; Smith, Davey; Akrami, Kevan] Univ Calif San Diego, Dept Infect Dis, 9500 Gilman Dr 0711, La Jolla, CA 92093 USA.
RP Akrami, K (corresponding author), Univ Calif San Diego, Dept Infect Dis, 9500 Gilman Dr 0711, La Jolla, CA 92093 USA.
EM kakrami@ucsd.edu
OI Oom, Aaron/0000-0003-3300-0333; Smith, Davey/0000-0003-3603-1733
FU Genentech Inc.Roche HoldingGenentech
FX A.L.O. is funded through a fellowship established by Genentech Inc. for
   the UCSD Biomedical Sciences Ph.D. program. K.A. and D.S. have no
   conflicts of interest to declare.
CR Adiga R, 2016, J MED VIROL, V88, P1821, DOI 10.1002/jmv.24615
   Aguiar M, 2017, EXPERT REV VACCINES, V16, P301, DOI 10.1080/14760584.2017.1276831
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brinck-Jensen NS, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0127-7
   Brister JR, 2014, NUCLEIC ACIDS RES, V42, pD660, DOI 10.1093/nar/gkt1268
   Bui HH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-153
   Calis JJA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003266
   Dar H, 2016, ASIAN PAC J TROP MED, V9, P822, DOI 10.1016/j.apjtm.2016.07.004
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Devasundaram S, 2014, IMMUNOL INVEST, V43, P137, DOI 10.3109/08820139.2013.857353
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dikhit MR, 2016, INFECT GENET EVOL, V45, P187, DOI 10.1016/j.meegid.2016.08.037
   Duhovny D, 2002, LECT NOTES COMPUT SC, V2452, P185
   Eirin ME, 2015, TUBERCULOSIS, V95, P795, DOI 10.1016/j.tube.2015.07.009
   Giguere S, 2013, J IMMUNOL METHODS, V400, P30, DOI 10.1016/j.jim.2013.10.003
   Gras S, 2010, P NATL ACAD SCI USA, V107, P12599, DOI 10.1073/pnas.1007270107
   Greenbaum J, 2011, IMMUNOGENETICS, V63, P325, DOI 10.1007/s00251-011-0513-0
   Halstead SB, 2016, J INFECT DIS, V214, P1793, DOI 10.1093/infdis/jiw340
   Hillig RC, 2001, J MOL BIOL, V310, P1167, DOI 10.1006/jmbi.2001.4816
   Iovine NM, 2017, CLIN INFECT DIS, V64, P72, DOI 10.1093/cid/ciw667
   Kaur H, 2007, PROTEIN PEPTIDE LETT, V14, P626
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Liu Y, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.74
   Lohia N, 2015, VIRAL IMMUNOL, V28, P570, DOI 10.1089/vim.2015.0060
   Argolo AFLDE, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1867-6
   Mathew A, 1996, J CLIN INVEST, V98, P1684, DOI 10.1172/JCI118964
   McMahon RM, 2011, ACTA CRYSTALLOGR D, V67, P447, DOI 10.1107/S0907444911007888
   Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Oyarzn P, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-52
   Paul S, 2013, J IMMUNOL, V191, P5831, DOI 10.4049/jimmunol.1302101
   Pauvolid-Correa A, 2015, ARCH VIROL, V160, P21, DOI 10.1007/s00705-014-2219-8
   Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859
   Piedrahita LD, 2016, AM J TROP MED HYG, V95, P315, DOI 10.4269/ajtmh.15-0492
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Roder G, 2006, ACTA CRYSTALLOGR D, V62, P1300, DOI 10.1107/S0907444906027636
   Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334
   Sahadeo NSD, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex010
   Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481
   Singh S, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0103-4
   Soo KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154760
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938
   Wang P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-568
   Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Wong S. J., 2017, EBIOMED
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
NR 51
TC 3
Z9 3
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUL 24
PY 2017
VL 7
AR 6218
DI 10.1038/s41598-017-05980-z
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FB6NQ
UT WOS:000406260100022
PM 28740150
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Yang, M
   Dent, M
   Lai, HF
   Sun, HY
   Chen, Q
AF Yang, Ming
   Dent, Matthew
   Lai, Huafang
   Sun, Haiyan
   Chen, Qiang
TI Immunization of Zika virus envelope protein domain III induces specific
   and neutralizing immune responses against Zika virus
SO VACCINE
LA English
DT Article
DE Zika virus; Antigen; Vaccine; Envelope protein; Domain III (DIII);
   Neutralizing immunity; Antibody-dependent enhancement (ADE)
ID WEST-NILE-VIRUS; ANTIBODY-DEPENDENT ENHANCEMENT; TICK-BORNE
   ENCEPHALITIS; DENGUE VIRUS; MONOCLONAL-ANTIBODIES; STRUCTURAL BASIS;
   INFECTION; CHALLENGE; VACCINES; PROTECTION
AB In this study, we described the generation and immunogenicity of the Zika Virus (ZIKV) envelope protein (E) domain III (DIII) as a protein subunit vaccine candidate. ZIKV EDIII (zEDIII) was rapidly produced in E. coli in inclusion bodies. ZIKV EDIII was solubilized, refolded and purified to >95% homogeneity with a one-step Ni2+ affinity chromatography process. Further analysis revealed that zEDIII was refolded properly and demonstrated specific binding to an anti-zEDIII monoclonal antibody that recognizes a zEDIII conformational epitope. Subcutaneous immunization of mice with 25 and 50 mu g of zEDIII was performed over a period of 11 weeks. zEDIII evoked ZIKV-specific and neutralizing antibody response with titers that exceed the threshold that correlates with protective immunity against ZIKV. The antigen-specific IgG isotypes were predominantly IgG1 and splenocyte cultures from immunized mice secreted IFN-gamma, IL-4 and IL-6. Notably, zEDIII-elicited antibodies did not enhance the infection of dengue virus in Fc gamma receptor (Fc gamma R)-expressing cells. This study provided a proof of principle for the further development of recombinant protein-based subunit vaccines against ZIKV. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Yang, Ming; Dent, Matthew; Lai, Huafang; Sun, Haiyan; Chen, Qiang] Arizona State Univ, Biodesign Inst, 1001 S McAllister Ave, Tempe, AZ 85287 USA.
   [Chen, Qiang] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.
RP Chen, Q (corresponding author), Arizona State Univ, Biodesign Inst, 1001 S McAllister Ave, Tempe, AZ 85287 USA.
EM qiang.chen.4@asu.edu
RI Yang, Ming/J-9215-2019
OI chen, qiang/0000-0003-1498-7013; Dent, Matthew/0000-0002-0068-9325
FU National Institute of Allergy and Infectious Diseases (NIAID)United
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R33AI101329]
FX We thank Dr. F. Bai for the 4G2 mAb and J. Kilbourne for her technical
   assistance in animal studies. We also thank A. Esqueda and J. Hurtado
   for the critical reading of the manuscript. This work was supported in
   part by a grant from National Institute of Allergy and Infectious
   Diseases (NIAID) # R33AI101329 to QC.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Attar N., 2016, NAT REV MICROBIOL, V14, P62, DOI DOI 10.1038/NRMICR0.2015.28
   Ballou WR, 2004, AM J TROP MED HYG, V71, P239
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Belmusto-Worn VE, 2005, AM J TROP MED HYG, V72, P189, DOI 10.4269/ajtmh.2005.72.189
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2016, NAT IMMUNOL
   Demento SL, 2010, J IMMUNOL, V185, P2989, DOI 10.4049/jimmunol.1000768
   Dent M, 2016, J GEN VIROL, V97, P3280, DOI 10.1099/jgv.0.000635
   Foged C, 2011, THER DELIV, V2, P1057, DOI 10.4155/TDE.11.68
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   He JY, 2014, BIOMED RES INT, DOI 10.1155/2014/952865
   Heinz FX, 2007, VACCINE, V25, P7559, DOI 10.1016/j.vaccine.2007.08.024
   Hombach J, 2005, VACCINE, V23, P5205, DOI [10.1016/j.vaccine.2005.07.002, 10.1016/j.vaccine.2004.11.040]
   Jungblut M., 2008, PREPARATION SINGLE C, pe1029
   Kreil TR, 1997, CLIN EXP IMMUNOL, V110, P358, DOI 10.1046/j.1365-2249.1997.4311446.x
   Lai HF, 2014, PLANT BIOTECHNOL J, V12, P1098, DOI 10.1111/pbi.12217
   Lai HF, 2012, PLANT BIOTECHNOL J, V10, P95, DOI 10.1111/j.1467-7652.2011.00649.x
   Lai HF, 2010, P NATL ACAD SCI USA, V107, P2419, DOI 10.1073/pnas.0914503107
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lin HE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001447
   MASON RA, 1973, APPL MICROBIOL, V25, P539, DOI 10.1128/AEM.25.4.539-544.1973
   Mayer A, 2004, BRIT J CANCER, V90, P2402, DOI 10.1038/sj.bjc.6601888
   MORENS DM, 1994, CLIN INFECT DIS, V19, P500, DOI 10.1093/clinids/19.3.500
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Santi L, 2008, VACCINE, V26, P1846, DOI 10.1016/j.vaccine.2008.01.053
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sukupolvi-Petty S, 2010, J VIROL, V84, P9227, DOI 10.1128/JVI.01087-10
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 35
TC 31
Z9 32
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUL 24
PY 2017
VL 35
IS 33
BP 4287
EP 4294
DI 10.1016/j.vaccine.2017.04.052
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA FC3JS
UT WOS:000406735500032
PM 28669618
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Cimini, E
   Castilletti, C
   Sacchi, A
   Casetti, R
   Bordoni, V
   Romanelli, A
   Turchi, F
   Martini, F
   Tumino, N
   Nicastri, E
   Corpolongo, A
   Di Caro, A
   Kobinger, G
   Zumla, A
   Capobianchi, MR
   Ippolito, G
   Agrati, C
AF Cimini, Eleonora
   Castilletti, Concetta
   Sacchi, Alessandra
   Casetti, Rita
   Bordoni, Veronica
   Romanelli, Antonella
   Turchi, Federica
   Martini, Federico
   Tumino, Nicola
   Nicastri, Emanuele
   Corpolongo, Angela
   Di Caro, Antonino
   Kobinger, Gary
   Zumla, Alimuddin
   Capobianchi, Maria Rosaria
   Ippolito, Giuseppe
   Agrati, Chiara
TI Human Zika infection induces a reduction of IFN-gamma producing CD4
   T-cells and a parallel expansion of effector V delta 2 T-cells
SO SCIENTIFIC REPORTS
LA English
DT Article
ID VIRUS-INFECTION; DENGUE; PATHOGENESIS; ACTIVATION; IMMUNITY; MICE;
   MECHANISMS; RESPONSES; DISEASE
AB The definition of the immunological response to Zika (ZIKV) infection in humans represents a key issue to identify protective profile useful for vaccine development and for pathogenesis studies. No data are available on the cellular immune response in the acute phase of human ZIKV infection, and its role in the protection and/ or pathogenesis needs to be clarified. We studied and compared the phenotype and functionality of T-cells in patients with acute ZIKV and Dengue viral (DENV) infections. A significant activation of T-cells was observed during both ZIKV and DENV infections. ZIKV infection was characterized by a CD4 T cell differentiation toward effector cells and by a lower frequency of IFN-. producing CD4 T cells. Moreover, a substantial expansion of CD3+ CD4-CD8-T-cell subset expressing Vd2 TCR was specifically observed in ZIKV patients. Vd2 T cells presented a terminally differentiated profile, expressed granzyme B and maintained their ability to produce IFN-gamma. These findings provide new knowledge on the immune response profile during self-limited infection that may help in vaccine efficacy definition, and in identifying possible immuno-pathogenetic mechanisms of severe infection.
C1 [Cimini, Eleonora; Sacchi, Alessandra; Casetti, Rita; Bordoni, Veronica; Romanelli, Antonella; Turchi, Federica; Martini, Federico; Tumino, Nicola; Agrati, Chiara] IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Cellular Immunol Lab, Rome, Italy.
   [Castilletti, Concetta; Di Caro, Antonino; Capobianchi, Maria Rosaria] IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Virol Lab, Rome, Italy.
   [Nicastri, Emanuele; Corpolongo, Angela] IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Clin Dept, Rome, Italy.
   [Kobinger, Gary] Univ Laval, Fac Med, Dept Microbiol Immunol & Infect Dis, Quebec City, PQ, Canada.
   [Zumla, Alimuddin] UCL, Div Infect & Immun, London, England.
   [Zumla, Alimuddin] Univ Coll London Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, London, England.
   [Ippolito, Giuseppe] IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Sci Direct, Rome, Italy.
RP Agrati, C (corresponding author), IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Cellular Immunol Lab, Rome, Italy.
EM chiara.agrati@inmi.it
RI Cimini, Eleonora/K-8878-2016; bordoni, veronica/K-8614-2016; corpolongo,
   angela/AAC-5616-2020; Castilletti, Concetta/B-6545-2016; Castilletti,
   Concetta/AAA-8408-2019; Di Caro, Antonino/K-6854-2016; Sacchi,
   Alessandra/K-7782-2016; Tumino, Nicola/Y-4761-2019; nicastri,
   emanuele/K-7780-2016; Casetti, Rita/K-8631-2016; Agrati,
   Chiara/K-8806-2016
OI Cimini, Eleonora/0000-0002-2659-0868; bordoni,
   veronica/0000-0002-1747-2245; Castilletti, Concetta/0000-0001-9819-236X;
   Castilletti, Concetta/0000-0001-9819-236X; Di Caro,
   Antonino/0000-0001-6027-3009; Sacchi, Alessandra/0000-0003-4964-386X;
   Tumino, Nicola/0000-0003-3773-8829; nicastri,
   emanuele/0000-0002-5606-8712; Casetti, Rita/0000-0002-7574-8780; PERNO,
   CARLO FEDERICO/0000-0002-0825-5388; Zumla, Professor Sir
   Alimuddin/0000-0002-5111-5735; Agrati, Chiara/0000-0002-5252-0927;
   Ippolito, Giuseppe/0000-0002-1076-2979
FU Italian Ministry of HealthMinistry of Health, Italy [RC2015]; European
   Union Seventh Framework ProgrammeEuropean Union (EU) [278433-PREDEMICS];
   European Union Horizon Programme [653316]
FX We thank the clinical team and the patients who agreed to participate to
   the study. Professor Zumla acknowledges support from the NIHR Biomedical
   Research Centre, UCL Hospitals NHS Foundation Trust. This work was
   supported by funding from the Italian Ministry of Health (RC2015) and by
   European Union Seventh Framework Programme (Grant no 278433-PREDEMICS),
   and by European Union Horizon 2020 Programme (Grant no 653316 EVAg).
CR Agrati C, 2006, J INFECT DIS, V193, P1606, DOI 10.1086/503438
   Agrati C., 2016, LONGITUDINAL CHARACT, V7, DOI [10.1038/cddis.2016.55, DOI 10.1038/CDDIS.2016.55]
   Agrati C, 2009, J IMMUNOL, V182, P522, DOI 10.4049/jimmunol.182.1.522
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Borsellino G, 2000, J NEUROIMMUNOL, V107, P124, DOI 10.1016/S0165-5728(00)00220-4
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CDC, 2016, CDC DENV 1 4 REAL TI
   CDC, 2016, ZIK GUILL BARR SYNDR
   Conti L, 2005, J IMMUNOL, V174, P252, DOI 10.4049/jimmunol.174.1.252
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Falasca L, 2015, CELL DEATH DIFFER, V22, P1250, DOI 10.1038/cdd.2015.67
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Galliez RM, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw203
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Mathew A, 2008, IMMUNOL REV, V225, P300, DOI 10.1111/j.1600-065X.2008.00678.x
   McElroy AK, 2015, P NATL ACAD SCI USA, V112, P4719, DOI 10.1073/pnas.1502619112
   Mor G, 2016, AM J REPROD IMMUNOL, V75, P421, DOI 10.1111/aji.12505
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Paul S, 2015, J LEUKOCYTE BIOL, V97, P259, DOI 10.1189/jlb.3RU0914-443R
   Poccia F, 2006, J INFECT DIS, V193, P1244, DOI 10.1086/502975
   Poccia F, 2005, IMMUNOL LETT, V100, P14, DOI 10.1016/j.imlet.2005.06.025
   Poccia F, 2005, MICROBES INFECT, V7, P518, DOI 10.1016/j.micinf.2004.12.009
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Szekeres-Bartho J, 1999, AM J REPROD IMMUNOL, V42, P44
   Szekeres-Bartho J, 2001, SEMIN IMMUNOL, V13, P229, DOI 10.1006/smim.2000.0318
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Torrentes-Carvalho A, 2014, IMMUNOBIOLOGY, V219, P329, DOI 10.1016/j.imbio.2013.11.002
   Tu WW, 2011, J EXP MED, V208, P1511, DOI 10.1084/jem.20110226
   Van Rhijn I, 2003, NEUROLOGY, V61, P994, DOI 10.1212/01.WNL.0000083986.53792.90
   Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Wang T, 2006, J IMMUNOL, V177, P1825, DOI 10.4049/jimmunol.177.3.1825
   Wang T, 2011, J NEUROIMMUNOL, V240, P22, DOI 10.1016/j.jneuroim.2011.10.004
   Winer J, 2002, J NEUROL, V249, P616, DOI 10.1007/s004150200072
NR 41
TC 13
Z9 13
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUL 24
PY 2017
VL 7
AR 6313
DI 10.1038/s41598-017-06536-x
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FB6NX
UT WOS:000406260800026
PM 28740159
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cohen, J
AF Cohen, Jon
TI PUBLIC HEALTH Zika rewrites maternal immunization ethics
SO SCIENCE
LA English
DT News Item
NR 0
TC 5
Z9 5
U1 0
U2 4
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD JUL 21
PY 2017
VL 357
IS 6348
BP 241
EP 241
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FB1KF
UT WOS:000405901600017
PM 28729493
DA 2020-07-08
ER

PT J
AU Silva, JBL
   Alves, DM
   Bottino-Rojas, V
   Pereira, TN
   Sorgine, MHF
   Caragata, EP
   Moreira, LA
AF Lopes Silva, Jessica Barreto
   Alves, Debora Magalhaes
   Bottino-Rojas, Vanessa
   Pereira, Thiago Nunes
   Ferreira Sorgine, Marcos Henrique
   Caragata, Eric Pearce
   Moreira, Luciano Andrade
TI Wolbachia and dengue virus infection in the mosquito Aedes fluviatilis
   (Diptera: Culicidae)
SO PLOS ONE
LA English
DT Article
ID GLOBAL DISTRIBUTION; ZIKA VIRUS; TRANSMISSION; STRAIN; ESTABLISHMENT;
   POPULATIONS; ACTIVATION; ALBOPICTUS; BLOCKING; PATHWAY
AB Dengue represents a serious threat to human health, with billions of people living at risk of the disease. Wolbachia pipientis is a bacterial endosymbiont common to many insect species. Wolbachia transinfections in mosquito disease vectors have great value for disease control given the bacterium's ability to spread into wild mosquito populations, and to interfere with infections of pathogens, such as dengue virus. Aedes fluviatilis is a mosquito with a widespread distribution in Latin America, but its status as a dengue vector has not been clarified. Ae. fluviatilis is also naturally infected by the wFlu Wolbachia strain, which has been demonstrated to enhance infection with the avian malarial parasite Plasmodium gallinaceum. We performed experimental infections of Ae. fluviatilis with DENV-2 and DENV-3 isolates from Brazil via injection or oral feeding to provide insight into its competence for the virus. We also examined the effect of the native Wolbachia infection on the virus using a mosquito line where the wFlu infection had been cleared by antibiotic treatment. Through RT-qPCR, we observed that Ae. fluviatilis could become infected with both viruses via either method of infection, although at a lower rate than Aedes aegypti, the primary dengue vector. We then detected DENV-2 and DENV-3 in the saliva of injected mosquitoes, and observed that injection of DENV-3-infected saliva produced subsequent infections in naive Ae. aegypti. However, across our data we observed no difference in prevalence of infection and viral load between Wolbachia-infected and -uninfected mosquitoes, suggesting that there is no effect of wFlu on dengue virus. Our results highlight that Ae. fluviatilis could potentially serve as a dengue vector under the right circumstances, although further testing is required to determine if this occurs in the field.
C1 [Lopes Silva, Jessica Barreto; Alves, Debora Magalhaes; Pereira, Thiago Nunes; Caragata, Eric Pearce; Moreira, Luciano Andrade] Fiocruz MS, Ctr Pesquisas Rene Rachou, Grp Mosquitos Vetores Endossimbiontes & Interacao, Belo Horizonte, MG, Brazil.
   [Bottino-Rojas, Vanessa; Ferreira Sorgine, Marcos Henrique] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil.
RP Moreira, LA (corresponding author), Fiocruz MS, Ctr Pesquisas Rene Rachou, Grp Mosquitos Vetores Endossimbiontes & Interacao, Belo Horizonte, MG, Brazil.
EM luciano@cpqrr.fiocruz.br
OI Moreira, Luciano/0000-0002-9240-3506; Bottino-Rojas,
   Vanessa/0000-0001-8019-9942
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq); Fundacao de
   Amparo a Pesquisa do Estado de Minas GeraisMinas Gerais State Research
   Foundation (FAPEMIG); Institutos Nacionais de Ciencia e
   Tecnologia-Entomologia Molecular (ICNT-EM)
FX This work was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (EPC, LAM); Fundacao de Amparo a Pesquisa do
   Estado de Minas Gerais (EPC, LAM); Institutos Nacionais de Ciencia e
   Tecnologia-Entomologia Molecular (ICNT-EM) (LAM). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   Auguste AJ, 2010, AM J TROP MED HYG, V83, P1262, DOI 10.4269/ajtmh.2010.10-0280
   Augustinos AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028695
   Baton LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059619
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Bordenstein SR, 2009, MOL BIOL EVOL, V26, P231, DOI 10.1093/molbev/msn243
   Bouchon D, 1998, P ROY SOC B-BIOL SCI, V265, P1081, DOI 10.1098/rspb.1998.0402
   Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135
   Caragata EP, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3441-4
   Caragata EP, 2016, TRENDS PARASITOLOGY
   Caragata EP, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005158
   Dutra HL, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600175
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Dutra HLC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003689
   Consoli RA, 1983, MEM I O CRUZ, V78, P37
   Coon KL, 2016, MOL ECOL, V25, P5806, DOI 10.1111/mec.13877
   Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004
   DAVIS N. C., 1931, American Journal of Tropical Medicine, V11, P21
   de Figueiredo MLG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-152
   Dodson BL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002965
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Fialho RF, 2000, P ROY SOC B-BIOL SCI, V267, P1469, DOI 10.1098/rspb.2000.1166
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hughes GL, 2014, INSECT MOL BIOL, V23, P141, DOI 10.1111/imb.12066
   Hughes GL, 2012, APPL ENVIRON MICROB, V78, P1491, DOI 10.1128/AEM.06751-11
   Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Joubert DA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005275
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Mains JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep33846
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Molloy JC, 2015, VIRUSES-BASEL, V7, P4624, DOI 10.3390/v7082836
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Murdock CC, 2014, SCI REP-UK, V4, DOI 10.1038/srep03932
   Oliveira JHM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005525
   Olson KE, 2000, INSECT MOL BIOL, V9, P57, DOI 10.1046/j.1365-2583.2000.00162.x
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548
   Ranson H, 2016, TRENDS PARASITOL, V32, P187, DOI 10.1016/j.pt.2015.11.010
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   Tason de Camargo M.V., 1983, Memorias do Instituto Oswaldo Cruz, V78, P83
   TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002
   Wong ZS, 2015, APPL ENVIRON MICROB, V81, P3001, DOI 10.1128/AEM.03847-14
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   ZCHORIFEIN E, 1995, INSECT MOL BIOL, V4, P173, DOI 10.1111/j.1365-2583.1995.tb00023.x
   Zele F, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2837
   Zug R, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01201
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 56
TC 13
Z9 13
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 21
PY 2017
VL 12
IS 7
AR e0181678
DI 10.1371/journal.pone.0181678
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FC2BU
UT WOS:000406643100056
PM 28732048
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Teng, Y
   Liu, SF
   Guo, XC
   Liu, SX
   Jin, Y
   He, TT
   Bi, DH
   Zhang, P
   Lin, BH
   An, XP
   Feng, D
   Mi, ZQ
   Tong, YG
AF Teng, Yue
   Liu, Shufeng
   Guo, Xiaocan
   Liu, Shuxia
   Jin, Yuan
   He, Tongtong
   Bi, Dehua
   Zhang, Pei
   Lin, Baihan
   An, Xiaoping
   Feng, Dan
   Mi, Zhiqiang
   Tong, Yigang
TI An Integrative Analysis Reveals a Central Role of P53 Activation via
   MDM2 in Zika Virus Infection Induced Cell Death
SO FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
LA English
DT Article
DE Zika virus; microcephaly; capsid protein; P53; MDM2; cell death
ID FLAVIVIRUS INFECTIONS; HOST-CELL; PROTEIN; PATHOGENESIS; AMERICA;
   BIOLOGY; MODELS; HDM2; MICE
AB Zika virus (ZIKV) infection is an emerging global threat that is suspected to be associated with fetal microcephaly. However, the molecular mechanisms underlying ZIKV disease pathogenesis in humans remain elusive. Here, we investigated the human protein interaction network associated with ZIKV infection using a systemic virology approach, and reconstructed the transcriptional regulatory network to analyze the mechanisms underlying ZIKV-elicited microcephaly pathogenesis. The bioinformatics findings in this study show that P53 is the hub of the genetic regulatory network for ZIKV-related and microcephaly-associated proteins. Importantly, these results imply that the ZIKV capsid protein interacts with mouse double-minute-2 homolog (MDM2), which is involved in the P53-mediated apoptosis pathway, activating the death of infected neural cells. We also found that synthetic mimics of the ZIKV capsid protein induced cell death in vitro and in vivo. This study provides important insight into the relationship between ZIKV infection and brain diseases.
C1 [Teng, Yue; He, Tongtong; Bi, Dehua; An, Xiaoping; Mi, Zhiqiang; Tong, Yigang] State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.
   [Teng, Yue] Beijing Inst Microbiol & Epidemiol, Beijing, Peoples R China.
   [Liu, Shufeng] SRI Int, Ctr Infect Dis, Harrisonburg, VA USA.
   [Guo, Xiaocan] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Liu, Shuxia] Beijing Normal Univ, Coll Nucl Sci & Technol, Beijing, Peoples R China.
   [Jin, Yuan] Beijing Inst Biotechnol, Beijing, Peoples R China.
   [Zhang, Pei] Huazhong Univ Sci & Technol, Tongji Med Sch, Dept Neurobiol, Wuhan, Hubei, Peoples R China.
   [Lin, Baihan] Univ Washington, Dept Psychol Phys & Comp Sci & Engn, Computat Neurosci Program, Seattle, WA 98195 USA.
   [Lin, Baihan] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA.
   [Feng, Dan] Chinese Peoples Liberat Army Gen Hosp, Inst Hosp Management, Div Stand Operat Management, Beijing, Peoples R China.
RP Teng, Y; Tong, YG (corresponding author), State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.; Teng, Y (corresponding author), Beijing Inst Microbiol & Epidemiol, Beijing, Peoples R China.
EM yueteng@sklpb.org; tong.yigang@gmail.com
RI Zhang, Pei/AAC-7638-2019; Zhang, Pei/AAI-2262-2019
OI Zhang, Pei/0000-0003-0608-5677; Lin, Baihan/0000-0002-7979-5509
FU State Key Laboratory of Pathogen and BioSecurity Program [SKLPBS1408,
   SKLPBS1451]; National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [81572045]
FX We thank Dr. Wuchun Cao in State Key Laboratory of Pathogen and
   Biosecurity for discussions. This work was supported by the grants from
   the State Key Laboratory of Pathogen and BioSecurity Program (No.
   SKLPBS1408 and No. SKLPBS1451) and the National Natural Science
   Foundation of China (No. 81572045).
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Austin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036327
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bhuvanakantham R, 2010, MICROBES INFECT, V12, P615, DOI 10.1016/j.micinf.2010.04.005
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   Ekins Sean, 2016, F1000Res, V5, P275
   El Ghouzzi V, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.266
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Gabriel E, 2016, EMBO J, V35, P803, DOI 10.15252/embj.201593679
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Huang YJS, 2014, VIRUSES-BASEL, V6, P4703, DOI 10.3390/v6114703
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miyazaki M, 2013, BIOORGAN MED CHEM, V21, P4319, DOI 10.1016/j.bmc.2013.04.056
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Pastorino B, 2010, ANTIVIR RES, V87, P281, DOI 10.1016/j.antiviral.2010.04.014
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Shah PS, 2015, CURR OPIN MICROBIOL, V27, P62, DOI 10.1016/j.mib.2015.07.008
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Yang MR, 2008, CELL MICROBIOL, V10, P165, DOI 10.1111/j.1462-5822.2007.01027.x
NR 44
TC 7
Z9 7
U1 0
U2 9
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2235-2988
J9 FRONT CELL INFECT MI
JI Front. Cell. Infect. Microbiol.
PD JUL 20
PY 2017
VL 7
AR 327
DI 10.3389/fcimb.2017.00327
PG 12
WC Immunology; Microbiology
SC Immunology; Microbiology
GA FB5VB
UT WOS:000406209300001
PM 28775961
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Secundino, NFC
   Chaves, BA
   Orfano, AS
   Silveira, KRD
   Rodrigues, NB
   Campolina, TB
   Nacif-Pimenta, R
   Villegas, LEM
   Silva, BM
   Lacerda, MVG
   Norris, DE
   Pimenta, PFP
AF Costa Secundino, Nagila Francinete
   Chaves, Barbara Aparecida
   Orfano, Alessandra Silva
   Dias Silveira, Karine Renata
   Rodrigues, Nilton Barnabe
   Campolina, Thais Bonifacio
   Nacif-Pimenta, Rafael
   Martinez Villegas, Luiz Eduardo
   Silva, Breno Melo
   Guimaraes Lacerda, Marcus Vinicius
   Norris, Douglas Eric
   Paolucci Pimenta, Paulo Filemon
TI Zika virus transmission to mouse ear by mosquito bite: a laboratory
   model that replicates the natural transmission process
SO PARASITES & VECTORS
LA English
DT Article
DE Transmission; Laboratory model; Zika virus; Aedes aegypti
ID AEDES-AEGYPTI; INFECTION; SKIN
AB Background: Zika disease has transformed into a serious global health problem due to the rapid spread of the arbovirus and alarming severity including congenital complications, microcephaly and Guillain-Barre syndrome. Zika virus (ZIKV) is primarily transmitted to humans through the bite of an infective mosquito, with Aedes aegypti being the main vector.
   Methods: We successfully developed a ZIKV experimental transmission model by single infectious Ae. aegypti bite to a laboratory mouse using circulating Brazilian strains of both arbovirus and vector. Mosquitoes were orally infected and single Ae. aegypti were allowed to feed on mouse ears 14 days post-infection. Additionally, salivary gland (SG) homogenates from infected mosquitoes were intrathoracically inoculated into naive Ae. aegypti. Mosquito and mouse tissue samples were cultured in C6/36 cells and processed by quantitative real-time PCR.
   Results: A total of 26 Ae. aegypti were allowed to feed individually on mouse ears. Of these, 17 mosquitoes fed, all to full engorgement. The transmission rate of ZIKV by bite from these engorged mosquitoes to mouse ears was 100%. The amount of virus inoculated into the ears by bites ranged from 2 x 10(2)-2.1 x 10(10) ZIKV cDNA copies and was positively correlated with ZIKV cDNA quantified from SGs dissected from mosquitoes post-feeding. Replicating ZIKV was confirmed in macerated SGs (2.45 x 10(7) cDNA copies), mouse ear tissue (1.15 x 10(3) cDNA copies, and mosquitoes 14 days post-intrathoracic inoculation (1.49 x 10(7) cDNA copies) by cytopathic effect in C6/36 cell culture and qPCR.
   Conclusions: Our model illustrates successful transmission of ZIKV by an infectious mosquito bite to a live vertebrate host. This approach offers a comprehensive tool for evaluating the development of infection in and transmission from mosquitoes, and the vertebrate-ZIKV interaction and progression of infection following a natural transmission process.
C1 [Costa Secundino, Nagila Francinete; Orfano, Alessandra Silva; Dias Silveira, Karine Renata; Rodrigues, Nilton Barnabe; Campolina, Thais Bonifacio; Nacif-Pimenta, Rafael; Martinez Villegas, Luiz Eduardo; Paolucci Pimenta, Paulo Filemon] FIOCRUZ MG, Rene Rachou Res Ctr, Lab Med Entomol, Belo Horizonte, MG, Brazil.
   [Chaves, Barbara Aparecida; Guimaraes Lacerda, Marcus Vinicius] Trop Med Fdn Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil.
   [Silva, Breno Melo] Univ Fed Ouro Preto, Dept Biol Sci, Ouro Preto, MG, Brazil.
   [Guimaraes Lacerda, Marcus Vinicius] Fiocruz MS, Leonidas E Maria Deane Res Ctr, Manaus, Amazonas, Brazil.
   [Norris, Douglas Eric] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA.
RP Secundino, NFC (corresponding author), FIOCRUZ MG, Rene Rachou Res Ctr, Lab Med Entomol, Belo Horizonte, MG, Brazil.
EM nagila@cpqrr.fiocruz.br
RI silva, breno/W-5122-2018; Pimenta, Paulo/AAH-1502-2020; Secundino,
   Nagila/AAM-4553-2020
OI silva, breno/0000-0003-2472-8111; Martinez Villegas, Luis
   Eduardo/0000-0002-9628-4081; Norris, Douglas/0000-0002-4631-2777
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES
FX NS, ML and PP are research fellows, supported by CNPq. TC, BC and RNP
   are student fellows supported by CAPES and KS, NR, LV and AO are
   supported by CNPq.
CR Abdeladhim M, 2014, INFECT GENET EVOL, V28, P691, DOI 10.1016/j.meegid.2014.07.028
   Aman MJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004702
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Booth C, 2002, IMMUNOLOGY INFECT, V32
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Contreras D, 2016, JOVE-J VIS EXP, DOI 10.3791/54767
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Goncalves CM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-320
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Kamhawi S, 2000, SCIENCE, V290, P1351, DOI 10.1126/science.290.5495.1351
   Kimblin N, 2008, P NATL ACAD SCI USA, V105, P10125, DOI 10.1073/pnas.0802331105
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lourenco-De-Oliveira R, 2004, T ROY SOC TROP MED H, V98, P43, DOI 10.1016/S0035-9203(03)00006-3
   Ministerio da Saude, 2016, MON CAS DENG FEBR CH, V21
   OReilly DR, 1994, VIRUS METHODS, P124
   Pawitwar SS, 2017, J NEUROIMMUNE PHARM, V12, P371, DOI 10.1007/s11481-017-9743-8
   Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194
   Peters NC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000484
   Pingen M, 2016, IMMUNITY, V44, P1455, DOI 10.1016/j.immuni.2016.06.002
   Raquin V, 2017, VIROLOGY, V507, P75, DOI 10.1016/j.virol.2017.04.009
   ROSS R. W., 1956, JOUR HYG, V54, P192
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Secundino NFC, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-20
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
NR 29
TC 9
Z9 9
U1 0
U2 13
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD JUL 20
PY 2017
VL 10
AR 346
DI 10.1186/s13071-017-2286-2
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FB1LE
UT WOS:000405904200002
PM 28728607
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Schmid, MA
   Kauffman, E
   Payne, A
   Harris, E
   Kramer, LD
AF Schmid, Michael A.
   Kauffman, Elizabeth
   Payne, Anne
   Harris, Eva
   Kramer, Laura D.
TI Preparation of Mosquito Salivary Gland Extract and Intradermal
   Inoculation of Mice
SO BIO-PROTOCOL
LA English
DT Article
DE Mosquito; Saliva; Salivary gland; Extract; Virus transmission;
   Intradermal; Needle; Mouse
AB Mosquito-transmitted pathogens are among the leading causes of severe disease and death in humans. Components within the saliva of mosquito vectors facilitate blood feeding, modulate host responses, and allow efficient transmission of pathogens, such as Dengue, Zika, yellow fever, West Nile, Japanese encephalitis, and chikungunya viruses, as well as Plasmodium parasites, among others. Here, we describe standardized methods to assess the impact of mosquito-derived factors on immune responses and pathogenesis in mouse models of infection. This protocol includes the generation of mosquito salivary gland extracts and intradermal inoculation of mouse ears. Ultimately, the information obtained from using these techniques can help reveal fundamental mechanisms of interaction between pathogens, mosquito vectors, and the mammalian host. In addition, this protocol can help establish improved infection challenge models for pre-clinical testing of vaccines or therapeutics that take into account the natural route of transmission via mosquitoes.
C1 [Schmid, Michael A.] Univ Leuven, Dept Immunol & Microbiol, Rega Inst Med Res Virol & Chemotherapy, Leuven, Belgium.
   [Kauffman, Elizabeth; Payne, Anne; Kramer, Laura D.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12203 USA.
   [Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Kramer, Laura D.] SUNY Albany, Sch Publ Hlth, Albany, NY 12222 USA.
RP Schmid, MA (corresponding author), Univ Leuven, Dept Immunol & Microbiol, Rega Inst Med Res Virol & Chemotherapy, Leuven, Belgium.; Kramer, LD (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12203 USA.; Kramer, LD (corresponding author), SUNY Albany, Sch Publ Hlth, Albany, NY 12222 USA.
EM michael.alex.schmid@gmail.com; laura.kramer@health.ny.gov
OI Schmid, Michael A./0000-0002-1137-9322
FU US National Institute of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID);
   National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 AI085607]; German
   Research Foundation (Deutsche Forschungsgemeinschaft)German Research
   Foundation (DFG) [SCHM 3011/1-1]; KU Leuven Rega FoundationKU Leuven;
   IVAP-project of the Belgian Society of Virology (BELVIR) from the
   Belgian Federal Science Policy Office (Belspo)
FX All experiments using mice were performed with approval of and strictly
   followed the guidelines of the Animal Care and Use Committee of the
   University of California, Berkeley, USA (AUP-2014-08-6638) and the
   Ethical Committee of the University of Leuven, Belgium (P140-2016). The
   development and use of this protocol at University of California,
   Berkeley was supported by the US National Institute of Allergy and
   Infectious Diseases, National Institutes of Health grant R01 AI085607
   (EH) and the German Research Foundation (Deutsche
   Forschungsgemeinschaft), research fellowship SCHM 3011/1-1 (MAS). We
   would like to thank Johan Neyts and Kai Dallmeier for support, Ruben
   Pholien for technical assistance, and the KU Leuven Rega Foundation for
   a postdoctoral fellowship (MAS). The original work of the laboratory at
   KU Leuven was supported by the IVAP-project of the Belgian Society of
   Virology (BELVIR) from the Belgian Federal Science Policy Office
   (Belspo). This protocol was originally established to generate the
   primary data in Schmid et al., 2016 and was briefly described therein.
CR Agarwal A, 2016, INFECT GENET EVOL, V40, P126, DOI 10.1016/j.meegid.2016.02.033
   Conway MJ, 2014, J VIROL, V88, P164, DOI 10.1128/JVI.02235-13
   Cox J, 2012, J VIROL, V86, P7637, DOI 10.1128/JVI.00534-12
   Kauffman E, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2542
   Le Coupanec A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002237
   MARINOTTI O, 1990, J INSECT PHYSIOL, V36, P545, DOI 10.1016/0022-1910(90)90021-7
   McCracken MK, 2014, J VIROL, V88, P1881, DOI 10.1128/JVI.01218-13
   Moser LA, 2016, J VIROL, V90, P292, DOI 10.1128/JVI.02280-15
   Pingen M, 2016, IMMUNITY, V44, P1455, DOI 10.1016/j.immuni.2016.06.002
   Schmid MA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005676
   Schmid MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004541
   Schneider BS, 2011, VECTOR-BORNE ZOONOT, V11, P423, DOI 10.1089/vbz.2010.0120
   Schneider BS, 2006, VIRAL IMMUNOL, V19, P74, DOI 10.1089/vim.2006.19.74
   Schneider BS, 2004, VIRAL IMMUNOL, V17, P565, DOI 10.1089/vim.2004.17.565
   Styer LM, 2011, J VIROL, V85, P1517, DOI 10.1128/JVI.01112-10
NR 15
TC 2
Z9 2
U1 0
U2 0
PU BIO-PROTOCOL
PI SUNNYVALE
PA PO BOX 2073, SUNNYVALE, CA 94087 USA
EI 2331-8325
J9 BIO-PROTOCOL
JI Bio-protocol
PD JUL 20
PY 2017
VL 7
IS 14
AR e2407
DI 10.21769/BioProtoc.2407
PG 13
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA VH9EI
UT WOS:000457834500018
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Pashazanusi, L
   Lwoya, B
   Oak, S
   Khosla, T
   Albert, JNL
   Tian, Y
   Bansal, G
   Kumar, N
   Pesika, NS
AF Pashazanusi, Leila
   Lwoya, Baraka
   Oak, Shreyas
   Khosla, Tushar
   Albert, Julie N. L.
   Tian, Yu
   Bansal, Geetha
   Kumar, Nirbhay
   Pesika, Noshir S.
TI Enhanced Adhesion of Mosquitoes to Rough Surfaces
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE adhesion; hierarchical structure; mosquito; long lasting insecticidal
   nets; malaria
ID ELASTIC SOLIDS; FORCE; GECKO; ATTACHMENT; MECHANISM; HUMIDITY; SYSTEMS
AB Insects and small animals capable of adhering reversibly to a variety of surfaces employ the unique design of the distal part of their legs. In the case of mosquitoes, their feet are composed of thousands of micro- and nanoscale protruding structures, which impart superhydrophobic properties. Previous research has shown that the superhydrophobic nature of the feet allows mosquitoes to land on water, which is necessary for their reproduction cycle. Here, we show that van der Waals interactions are the main adhesion mechanism employed by mosquitoes to adhere to various surfaces. We further demonstrate that the judicious creation of surface roughness on an opposing surface can increase the adhesion strength because of the increased number of surface elements interacting with the setae through multiple contact points. Although van der Waals forces are shown to be the predominant mechanism by which mosquitoes adhere to surfaces, capillary forces can also contribute to the total adhesion force when the opposing surface is hydrophilic and under humid conditions. These fundamental properties can potentially be applied in the development of superior Long Lasting Insecticidal Nets (LLINs), which represent one of the most effective methods to mitigate mosquito-transmitted infectious diseases such as Malaria, Filaria, Zika, and Dengue.
C1 [Pashazanusi, Leila; Lwoya, Baraka; Oak, Shreyas; Khosla, Tushar; Albert, Julie N. L.; Pesika, Noshir S.] Tulane Univ, Dept Chem & Biomol Engn, New Orleans, LA 70118 USA.
   [Bansal, Geetha; Kumar, Nirbhay] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Trop Med, New Orleans, LA 70112 USA.
   [Tian, Yu] Tsinghua Univ, State Key Lab Tribol, Beijing 100084, Peoples R China.
   [Pashazanusi, Leila; Albert, Julie N. L.; Bansal, Geetha; Kumar, Nirbhay; Pesika, Noshir S.] Tulane Univ, Vector Borne Infect Dis Res Ctr, New Orleans, LA 70112 USA.
RP Pesika, NS (corresponding author), Tulane Univ, Dept Chem & Biomol Engn, New Orleans, LA 70118 USA.; Kumar, N (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Trop Med, New Orleans, LA 70112 USA.; Kumar, N; Pesika, NS (corresponding author), Tulane Univ, Vector Borne Infect Dis Res Ctr, New Orleans, LA 70112 USA.
EM nkumar@tulane.edu; npesika@tulane.edu
OI Pesika, Noshir/0000-0001-5017-4808; Albert, Julie/0000-0002-6000-9408
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [51425502]
FX We would like to thank Ray Dagastine (Chemical and Biomolecular
   Engineering, University of Melbourne) for valuable suggestions in
   regards to AFM force measurements. Y.T. is thankful for the support of
   the National Natural Science Foundation of China (Grant No. 51425502).
CR Asay DB, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2192510
   Autumn K, 2002, INTEGR COMP BIOL, V42, P1081, DOI 10.1093/icb/42.6.1081
   Autumn K, 2002, P NATL ACAD SCI USA, V99, P12252, DOI 10.1073/pnas.192252799
   Autumn K, 2007, MRS BULL, V32, P473, DOI 10.1557/mrs2007.80
   Brauer P, 2017, ARTHROPOD-PLANT INTE, V11, P171, DOI 10.1007/s11829-016-9478-0
   Buck ME, 2010, CHEM MATER, V22, P6319, DOI 10.1021/cm102115e
   Bush JWM, 2007, ADV INSECT PHYSIOL, V34, P117, DOI 10.1016/S0065-2806(07)34003-4
   Chen LJ, 2009, LANGMUIR, V25, P3494, DOI 10.1021/la8037928
   Dabire RK, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-12
   FULLER KNG, 1975, P ROY SOC LOND A MAT, V345, P327, DOI 10.1098/rspa.1975.0138
   Gao HJ, 2005, MECH MATER, V37, P275, DOI 10.1016/j.mechmat.2004.03.008
   Gorb SN, 2001, NATURWISSENSCHAFTEN, V88, P530, DOI 10.1007/s00114-001-0274-y
   Gorb Stanislav N., 2005, American Entomologist, V51, P31
   GUILLET P, 2001, B WHO, V79
   Heepe L, 2017, APPL PHYS A-MATER, V123, DOI 10.1007/s00339-016-0753-9
   Hu DL, 2003, NATURE, V424, P663, DOI 10.1038/nature01793
   Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1
   Jin KJ, 2014, ADV FUNCT MATER, V24, P574, DOI 10.1002/adfm.201301960
   Kappl M, 2016, BIOINSPIR BIOMIM, V11, DOI 10.1088/1748-3190/11/3/035003
   Kim S, 2008, IEEE T ROBOT, V24, P65, DOI 10.1109/TRO.2007.909786
   Klittich M. R., 2017, SCI REP, V7
   Kong XQ, 2015, AIP ADV, V5, DOI 10.1063/1.4908027
   Kong XQ, 2016, ACTA MECH SINICA-PRC, V32, P335, DOI 10.1007/s10409-015-0458-x
   Langer MG, 2004, P ROY SOC B-BIOL SCI, V271, P2209, DOI 10.1098/rspb.2004.2850
   Loudet JC, 2011, EUR PHYS J E, V34, DOI 10.1140/epje/i2011-11076-9
   NEUMANN AW, 1979, COLLOID POLYM SCI, V257, P413, DOI 10.1007/BF01521578
   Peattie AM, 2009, J COMP PHYSIOL B, V179, P231, DOI 10.1007/s00360-008-0310-8
   Persson BNJ, 2003, J CHEM PHYS, V118, P7614, DOI 10.1063/1.1562192
   Persson BNJ, 2001, J CHEM PHYS, V115, P5597, DOI 10.1063/1.1398300
   SADER JE, 1995, REV SCI INSTRUM, V66, P3789, DOI 10.1063/1.1145439
   SCHAEFER DM, 1995, J ADHES SCI TECHNOL, V9, P1049, DOI 10.1163/156856195X00897
   WALKER G, 1993, INT J ADHES ADHES, V13, P3, DOI 10.1016/0143-7496(93)90002-Q
   Wu CW, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.017301
   Xiao XD, 2000, LANGMUIR, V16, P8153, DOI 10.1021/la000770o
   Yang DD, 2016, SCI REP-UK, V6, DOI 10.1038/srep27297
   Zhou YM, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0499
NR 36
TC 7
Z9 7
U1 1
U2 57
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD JUL 19
PY 2017
VL 9
IS 28
BP 24373
EP 24380
DI 10.1021/acsami.7b06659
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA FB5HS
UT WOS:000406172700120
PM 28654231
DA 2020-07-08
ER

PT J
AU Moghadas, SM
   Shoukat, A
   Espindola, AL
   Pereira, RS
   Abdirizak, F
   Laskowski, M
   Viboud, C
   Chowell, G
AF Moghadas, Seyed M.
   Shoukat, Affan
   Espindola, Aquino L.
   Pereira, Rafael S.
   Abdirizak, Fatima
   Laskowski, Marek
   Viboud, Cecile
   Chowell, Gerardo
TI Asymptomatic Transmission and the Dynamics of Zika Infection
SO SCIENTIFIC REPORTS
LA English
DT Article
ID NATIONAL PROBABILITY SAMPLE; AEDES-AEGYPTI; VIRUS OUTBREAK; REPRODUCTION
   NUMBER; SEXUAL TRANSMISSION; PERCEIVED HEALTH; DENGUE; STATES;
   MOSQUITOS; EPIDEMIC
AB Following the 2013-14 outbreak in French Polynesia, the Zika virus (ZIKV) epidemic spread widely to many countries where Aedes Aegypti as the main transmitting vector is endemic. The lack of a second wave of ZIKV infection in most affected regions may suggest that a sufficiently high level of herd immunity was reached during the first wave. We developed an agent-based transmission model to investigate the role of asymptomatic infection on the likelihood of observing a second wave, while accounting for its relative transmissibility. We found that, as the relative transmissibility of asymptomatic infection increases, a second wave is more likely to occur, despite an increase in the attack rate during the first wave. When the reproduction number varies between 1.9 and 2.8 based on estimates for Antioquia, Colombia, the attack rate varies between 4% and 26% for a low (below 10%) effectiveness of interventions in blunting the ZIKV transmission from symptomatic cases to mosquitoes. Moreover, the fraction of cases due to sexual transmission is estimated below 4% of the cumulative incidence. Our analyses underscore the need to quantify the transmissibility of asymptomatic infections, without which the overall attack rates and the level of herd immunity cannot be accurately estimated.
C1 [Moghadas, Seyed M.; Shoukat, Affan; Laskowski, Marek] York Univ, Agent Based Modelling Lab, Toronto, ON, Canada.
   [Espindola, Aquino L.; Pereira, Rafael S.] Univ Fed Fluminense, Inst Ciencias Exatas ICEx, Dept Fis, Volta Redonda, RJ, Brazil.
   [Abdirizak, Fatima; Chowell, Gerardo] Georgia State Univ, Sch Publ Hlth, Div Epidemiol & Biostat, Atlanta, GA 30303 USA.
   [Viboud, Cecile; Chowell, Gerardo] NIH, Div Int Epidemiol & Populat Studies, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.
RP Moghadas, SM (corresponding author), York Univ, Agent Based Modelling Lab, Toronto, ON, Canada.
EM Moghadas@yorku.ca
OI Espindola, Aquino/0000-0002-4344-1899
FU Natural Sciences and Engineering Research Council of Canada
   (NSERC)Natural Sciences and Engineering Research Council of Canada;
   Mathematics of Information Technology and Complex Systems (Mitacs),
   Accelerate Internship Program; NSF as part of the joint NSF-NIH-USDA
   Ecology and Evolution of Infectious Diseases Program [1610429, 1414374];
   Division of International Epidemiology and Population Studies, Fogarty
   International Center, NIH
FX The authors would like to acknowledge Compute Canada (a not-for-profit
   organization) for providing computational resources. The authors also
   would like to thank the reviewers for their insightful comments that
   have greatly improved the paper. This study was in part supported by the
   Natural Sciences and Engineering Research Council of Canada (NSERC), and
   the Mathematics of Information Technology and Complex Systems (Mitacs),
   Accelerate Internship Program. GC acknowledges the support from NSF
   (Grant # 1610429, 1414374) as part of the joint NSF-NIH-USDA Ecology and
   Evolution of Infectious Diseases Program. CV and GC acknowledge the
   support from the Division of International Epidemiology and Population
   Studies, Fogarty International Center, NIH.
CR Althaus CL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002157
   [Anonymous], 2007, INFECT DIS, V195, P1007
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Carrington LB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00290
   Centre for Disease Control and Prevention, AR WITH ZIK
   Champredon D., 2017, EPIDEMIOL I IN PRESS
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Chowell G, 2016, PLOS CURR OUTBREAKS
   Coura JR, 2006, MEM I OSWALDO CRUZ, V101, P229, DOI 10.1590/S0074-02762006000300001
   Deckard D. T., 2016, MMWR, V65
   Dinh L, 2016, THEOR BIOL MED MODEL, V13, DOI 10.1186/s12976-016-0046-1
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Government of Canada, SURV ZIK VIR
   GUBLER DJ, 1981, AM J TROP MED HYG, V30, P1094, DOI 10.4269/ajtmh.1981.30.1094
   GUBLER DJ, 1978, AM J TROP MED HYG, V27, P581, DOI 10.4269/ajtmh.1978.27.581
   GUBLER DJ, 1981, B WORLD HEALTH ORGAN, V59, P623
   Herbenick D, 2010, J SEX MED, V7, P277, DOI 10.1111/j.1743-6109.2010.02010.x
   Kramer LD, 2003, ADV VIRUS RES, V60, P187, DOI 10.1016/S0065-3527(03)60006-0
   Ladhani S. N., 2016, ARCH DIS CHILDHOOD
   Laskowski M., 2015, BIOMAT P, P318
   Liebman KA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002702
   Majumder MS, 2016, B WHO, DOI 10.2471/BLT.16.171009
   Mostaco-Guidolin L. C., 2011, SOFTWARE DEV FRAMEWO
   Nguyen NM, 2013, P NATL ACAD SCI USA, V110, P9072, DOI 10.1073/pnas.1303395110
   Nishiura H, 2016, TRAVEL MED INFECT DI, V14, P274, DOI 10.1016/j.tmaid.2016.03.016
   Pan American Health Organization, ZIK VIR
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   PUTNAM JL, 1995, AM J TROP MED HYG, V52, P225, DOI 10.4269/ajtmh.1995.52.225
   R Editorial, 2016, BRAZ REP ZIK INF BLO
   Reece M, 2010, J SEX MED, V7, P291, DOI 10.1111/j.1743-6109.2010.02009.x
   Riley S, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.157, 10.1038/NMICROBIOL.2016.157]
   Styer LM, 2007, AM J TROP MED HYG, V76, P111, DOI 10.4269/ajtmh.2007.76.111
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   TRPIS M, 1986, AM J TROP MED HYG, V35, P1263, DOI 10.4269/ajtmh.1986.35.1263
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Walker WL, 2016, MMWR-MORBID MORTAL W, V65, P983, DOI 10.15585/mmwr.mm6536e5
   Wearing HJ, 2006, P NATL ACAD SCI USA, V103, P11802, DOI 10.1073/pnas.0602960103
   World Health Organization (WHO), ZIK SIT REP
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
   Zhang Q., 2017, P NATL ACAD SCI USA, P1
NR 46
TC 25
Z9 25
U1 0
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUL 19
PY 2017
VL 7
AR 5829
DI 10.1038/s41598-017-05013-9
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FB1HK
UT WOS:000405894200047
PM 28724972
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Millet, JP
   Montalvo, T
   Bueno-Mari, R
   Romero-Tamarit, A
   Prats-Uribe, A
   Fernandez, L
   Camprubi, E
   del Bano, L
   Peracho, V
   Figuerola, J
   Sulleiro, E
   Martinez, MJ
   Cayla, JA
AF Millet, Joan-Pau
   Montalvo, Tomas
   Bueno-Mari, Ruben
   Romero-Tamarit, Arancha
   Prats-Uribe, Albert
   Fernandez, Lidia
   Camprubi, Esteve
   del Bano, Lucia
   Peracho, Victor
   Figuerola, Jordi
   Sulleiro, Elena
   Martinez, Miguel J.
   Cayla, Joan A.
CA Zika Working Grp Barcelona
TI Imported Zika Virus in a European City: How to Prevent Local
   Transmission?
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE arbovirus; epidemiology; global health; Guillain-Barre syndrome;
   microcephaly; public health; mosquito; Zika virus
ID AEDES-ALBOPICTUS; SEXUAL TRANSMISSION; INFECTIONS; DENGUE
AB Background: On February 1st 2016 the WHO declared the Zika Virus (ZIKV) infection a worldwide public health emergency because of its rapid expansion and severe complications, such as Guillain-Barre Syndrome or microcephaly in newborn. The huge amount of people traveling to endemic areas and the presence of Aedes albopictus in Barcelona increase the risk of autochtonous transmission. The objective of this study was to describe the first ZIKV cases diagnosed in our city and to analyze the surveillance, prevention, and control measures implemented to avoid autochthonous transmission.
   Methods: An observational cross-sectional population-based study in Barcelona, Spain was performed. An analysis of the socio-demographic, epidemiological, clinical characteristics, and mosquito control activities of the ZIKV cases detected between January 1st and December 2016 was carried out using a specific ZIKV epidemiological survey of the Barcelona Public Health Agency.
   Results: A total of 118 notifications of possible ZIKV infections were received, and 44 corresponded to confirmed cases in Barcelona residents. Amongst these, the median age was 35 years and 57% were women. All cases were imported, 48% were Spanish-born and 52% foreign-born. Dominican Republic was the most visited country amongst foreign-born patients and Nicaragua amongst Spanish-born. The most frequent symptoms were exanthema, fever, and arthralgia. Among the 24 diagnosed women, 6 (25%) were pregnant. There was one case of microcephaly outside Barcelona city. Entomological inspections were done at the homes of 19 cases (43.2% of the total) and in 34 (77.3%) public spaces. Vector activity was found in one case of the 44 confirmed cases, and 134 surveillance and vector control were carried out associated to imported ZIKV cases. In all cases prevention measures were recommended to avoid mosquito bites on infected cases.
   Conclusion: Epidemiological and entomological surveillance are essential for the prevention of autochthonous transmission of arbovirosis that may have a great impact on Public Health. The good coordination between epidemiologists, entomologists, microbiologists, and clinicians is a priority in a touristic city with an intense relationship with endemic countries to minimize the risk of local transmission by competent vectors.
C1 [Millet, Joan-Pau; Romero-Tamarit, Arancha; Prats-Uribe, Albert; Camprubi, Esteve; del Bano, Lucia; Cayla, Joan A.] Agencia Salut Publ Barcelona, Serv Epidemiol, Barcelona, Spain.
   [Millet, Joan-Pau; Montalvo, Tomas; Figuerola, Jordi; Cayla, Joan A.] CIBER Epidemiol & Salud Publ, Barcelona, Spain.
   [Montalvo, Tomas; Fernandez, Lidia; Peracho, Victor] Agencia Salud Publ Barcelona, Serv Vigilancia & Control Plagas Urbanas, Barcelona, Spain.
   [Bueno-Mari, Ruben] Dept Invest & Desarrollo I D, Labs Lokim, Valencia, Spain.
   [Prats-Uribe, Albert] Univ Pompeu Fabra, Agencia Salut Publ Barcelona, Parc Salut Mar, Unitat Docent Med Prevent & Salut Publ, Barcelona, Spain.
   [Figuerola, Jordi] CSIC, Estn Biol Donana, Seville, Spain.
   [Sulleiro, Elena] Univ Autonoma Barcelona, PROSICS Barcelona, Hosp Vall dHebron, Microbiol Dept, Barcelona, Spain.
   [Martinez, Miguel J.] Univ Barcelona, Dept Microbiol, Hosp Clin Barcelona, Barcelona, Spain.
   [Martinez, Miguel J.] Univ Barcelona, ISGlobal, Hosp Clin Barcelona, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain.
RP Millet, JP (corresponding author), Agencia Salut Publ Barcelona, Serv Epidemiol, Barcelona, Spain.; Millet, JP (corresponding author), CIBER Epidemiol & Salud Publ, Barcelona, Spain.
EM jmillet@aspb.cat
RI Gutierrez, Jose Munoz/AAH-6954-2020; Pumarola, Tomas/AAB-5532-2019;
   amsalu, ribka/G-8780-2019; Pinazo, Maria Jesus M/X-6093-2018; Gascon,
   Joaquim/M-3598-2015; Gutierrez, Jose Munoz/X-5917-2018; Prats-Uribe,
   Albert/P-8940-2018; Soriano-Arandes, Antoni/G-6851-2013; Arandes,
   Antonio Soriano/Q-3348-2016; Figuerola, Jordi/B-7917-2008; Oliveira
   Souto, Ines/L-2947-2017
OI Gutierrez, Jose Munoz/0000-0002-0945-1735; Pumarola,
   Tomas/0000-0002-5171-7461; Pinazo, Maria Jesus M/0000-0002-4237-1075;
   Gascon, Joaquim/0000-0002-5045-1585; Gutierrez, Jose
   Munoz/0000-0002-0945-1735; Prats-Uribe, Albert/0000-0003-1202-9153;
   Arandes, Antonio Soriano/0000-0001-9613-7228; Figuerola,
   Jordi/0000-0002-4664-9011; Sulleiro, Elena/0000-0002-9783-6060;
   Martinez, Miguel Julian/0000-0002-0682-1075; Cayla, Joan
   A./0000-0003-3891-111X; Salvador, Fernando/0000-0002-0546-1354; Sentis,
   Alexis/0000-0002-8132-5645; Rando Segura, Ariadna/0000-0003-4555-7286;
   Espasa, Mateu/0000-0003-4822-1024; Fernandez,
   Ivette/0000-0001-5179-0477; Oliveira Souto, Ines/0000-0001-6018-5797;
   Molina Romero, Israel/0000-0001-6642-7515; Alamo-Junquera,
   Dolores/0000-0001-9252-647X
FU Department d'Universitats, Recerca i Societat de la Informacio de la
   Generalitat de Catalunya (AGAUR) [2014 SGR 26]; ISCIII RETIC (MICINN,
   Spain)Instituto de Salud Carlos IIISpanish Government [RD12/0018/0010];
   6th National Plan (PN) of Research + Development + Innovation (I + D +
   I); ISCIII-General Division Networks and Cooperative Research Centres +
   FEDER funds + Collaborative Research Network on Tropical Diseases
   (RICET) [RD12/0018/0020]
FX Our special gratitude to the Health Department in Catalonia, the Public
   Health Agency of Catalonia and all the doctors, nurses and admin
   personnel in different hospitals and at primary care for the good job
   performed together to fight against emerging arbovirosis. Special thanks
   to Silvia Brugueras for her great help with the translation. MJ, JG, NR,
   and JM receives funds from 2014 SGR 26 grant from the Department
   d'Universitats, Recerca i Societat de la Informacio de la Generalitat de
   Catalunya (AGAUR) and from RD12/0018/0010 grant, ISCIII RETIC (MICINN,
   Spain). PROSICS authors are supported by the 6th National Plan (PN) of
   Research + Development + Innovation (I + D + I) 2008-2011,
   ISCIII-General Division Networks and Cooperative Research Centres +
   FEDER funds + Collaborative Research Network on Tropical Diseases
   (RICET): RD12/0018/0020.
CR Agencia de Salut Publica de Catalunya, 2015, PROT VIG CONTR ARB T, P1
   Alejo-Cancho I, 2016, DIAGN MICR INFEC DIS, V86, P160, DOI 10.1016/j.diagmicrobio.2016.07.016
   Althaus CL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002157
   Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Bachiller-Luque P, 2016, ENFERM INFEC MICR CL, V34, P243, DOI 10.1016/j.eimc.2016.02.012
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Bocanegra C, 2016, CLIN MICROBIOL INFEC, V22, P648, DOI 10.1016/j.cmi.2016.03.025
   Boccolini D, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.35.30328
   Bonnefoy X, 2008, PUBLIC HLTH SIGNIFIC
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Bueno R., 2016, ENF EMERG, V15, P113
   Burattini MN, 2008, EPIDEMIOL INFECT, V136, P309, DOI 10.1017/S0950268807008667
   Camprubi E., 2016, ENF EMERG, V15, P111
   Caputo B, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004463
   Center for Ecological Research and Forestry Applications. Oltra, 2016, EUR HDB CROWDS GEOGR, P295, DOI [10.5334/bax, DOI 10.5334/BAX]
   Centers for Disease Control and Prevention (CDC), 2016, GUID US CIT RES LIV
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Diaz-Menendez M, 2018, ENFERM INFEC MICR CL, V36, P4, DOI 10.1016/j.eimc.2016.08.003
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Falcao MB, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0172-y
   Gonzalez R., 2017, REV ESP SALUD PUB
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Jupille H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004901
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kurolt IC, 2013, CLIN MICROBIOL INFEC, V19, pE163, DOI 10.1111/1469-0691.12104
   Leona S., 2016, EVALUACION RAPIDA RI, P1
   Lopez De Lera D., 1995, REV ESPANOLA INVESTI, V71-72, P225
   Lucientes-Curdi J, 2014, EUR J PUBLIC HEALTH, V24, P637, DOI 10.1093/eurpub/cku002
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Maria AT, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.6.30131
   Marrama-Rakotoarivony L., 2012, TECHNICAL REPORT
   Ministerio de Sanidad Servicios Sociales e Igualdad (MSSSI), 2016, MIN SAN SERV SOC I 1
   Montalvo T., 2016, VIURE SALUT, V105, P15
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Red Nacional de Vigilanca Epidemiologica, 2016, PROT VIG SAL PUBL EN
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Schuler-Faccini L., 2016, EM COM ZIK VIR OBS I, V44, P302
   Sochacki T, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.18.30221
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Tran A, 2013, INT J ENV RES PUB HE, V10, P1698, DOI 10.3390/ijerph10051698
   White MK, 2016, ANN NEUROL, V80, P479, DOI 10.1002/ana.24748
   WHO, 2016, PREV SEX TRANSM ZIK
   WHO, 2016, INT GUID PREV SEX TR
   WHO, 2016, ZIKA SIT REP ZIK VIR
   World Health Organization, 2016, ZIK VIR TECHN REP IN
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 53
TC 8
Z9 9
U1 1
U2 11
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JUL 18
PY 2017
VL 8
AR 1319
DI 10.3389/fmicb.2017.01319
PG 13
WC Microbiology
SC Microbiology
GA FB6EN
UT WOS:000406234200002
PM 28769893
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Halford, B
AF Halford, Bethany
TI Malaria drug prevents Zika-related birth defects in mice
SO CHEMICAL & ENGINEERING NEWS
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0009-2347
EI 1520-605X
J9 CHEM ENG NEWS
JI Chem. Eng. News
PD JUL 17
PY 2017
VL 95
IS 29
BP 11
EP 11
PG 1
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA FA9LS
UT WOS:000405767700015
DA 2020-07-08
ER

PT J
AU Alcendor, DJ
AF Alcendor, Donald J.
TI Zika Virus Infection of the Human Glomerular Cells: Implications for
   Viral Reservoirs and Renal Pathogenesis
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; kidney; renal; podocyte; transplantation; inflammation;
   cytokines
ID SEXUAL TRANSMISSION; RT-PCR; CYTOMEGALOVIRUS; PODOCYTE; URINE;
   PERICYTES; DISEASE; BIOLOGY; BRAIN; MODEL
AB Background. Zika virus (ZIKV) infection in the human renal compartment has not been reported. Several clinical reports have describe high-level persistent viral shedding in the urine of infected patients, but the associated mechanisms have not been explored until now. The current study examined cellular components of the glomerulus of the human kidney for ZIKV infectivity.
   Methods. I infected primary human podocytes, renal glomerular endothelial cells (GECs), and mesangial cells with ZIKV. Viral infectivity was analyzed by means of microscopy, immunofluorescence, real-time reverse-transcription polymerase chain reaction (RT-PCR), and quantitative RT-PCR (qRT-PCR), and the proinflammatory cytokines interleukin 1 beta, interferon beta, and RANTES (regulated on activation of normal T cells expressed and secreted) were assessed using qRT-PCR.
   Results. I show that glomerular podocytes, renal GECs, and mesangial cells are permissive for ZIKV infection. ZIKV infectivity was confirmed in all 3 cell types by means of immunofluorescence staining, RT-PCR, and qRT-PCR, and qRT-PCR analysis revealed increased transcriptional induction of interleukin 1 beta, interferon beta, and RANTES in ZIKV-infected podocytes at 72 hours, compared with renal GECs and mesangial cells.
   Conclusions. The findings of this study support the notion that the glomerulus may serve as an amplification reservoir for ZIKV in the renal compartment. The impact of ZIKV infection in the human renal compartment is unknown and will require further study.
C1 [Alcendor, Donald J.] Meharry Med Coll, Sch Med, Dept Microbiol & Immunol, Ctr AIDS Hlth Dispar Res, Nashville, TN 37208 USA.
RP Alcendor, DJ (corresponding author), Meharry Med Coll, Sch Med, Ctr AIDS Hlth Dispar Res, 1005 Dr DB Todd Jr Blvd, Nashville, TN 37208 USA.
EM dalcendor@mmc.edu
OI Alcendor, Donald/0000-0002-4568-8158
FU Zika virus research startup award; National Center For Advancing
   Translational Sciences of the National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Center for Advancing Translational Sciences (NCATS)
   [3UH2TR000491-02S1]
FX This work was supported by a Zika virus research startup award from
   James E. K. Hildreth, PhD, MD, president of Meharry Medical College (D.
   J. A.) and the National Center For Advancing Translational Sciences of
   the National Institutes of Health (grant 3UH2TR000491-02S1 to D. J. A.).
CR Alcendor DJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-95
   Aliota M. T., 2016, PLOS NEGLECT TROP D, V10, DOI DOI 10.1371/JOURNAL.PNTD.0004750
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barisoni L, 2003, AM J NEPHROL, V23, P353, DOI 10.1159/000072917
   Barzon L., 2016, EURO SURVEILL, V21
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Bryant P, 2002, ARCH DIS CHILD-FETAL, V87, pF75, DOI 10.1136/fn.87.2.F75
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Centers for Disease Control and Prevention, 1 CAS ZIK VIR REP PU
   Centers for Disease Control and Prevention, ZIK TRAV INF ZIK VIR
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Khatua AK, 2010, VIROLOGY, V408, P119, DOI 10.1016/j.virol.2010.09.005
   Lahon A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005019
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lizarraga Karlo J, 2014, J Nephropathol, V3, P57, DOI 10.12860/jnp.2014.13
   Maharajan MK, 2016, CLIN REV ALLERG IMMU, V51, P383, DOI 10.1007/s12016-016-8554-7
   Mallhi TH, 2015, JCPSP-J COLL PHYSICI, V25, P828, DOI 11.2015/JCPSP.828834
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Nagata M, 2016, KIDNEY INT, V89, P1221, DOI 10.1016/j.kint.2016.01.012
   Nogueira ML, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14047
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roze B, 2016, ZIKA VIRUS DETECTION, P21
   Saleem MA, 2002, J AM SOC NEPHROL, V13
   Sejvar JJ, 2014, VIRUSES-BASEL, V6, P606, DOI 10.3390/v6020606
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Wilkerson I, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-014-0219-y
   Xu MY, 2016, J VIROL METHODS, V236, P93, DOI 10.1016/j.jviromet.2016.07.014
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
   Zika virus microcephaly and Guillain-Barre syndrome, 2016, SIT REP
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 47
TC 21
Z9 21
U1 0
U2 6
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD JUL 15
PY 2017
VL 216
IS 2
BP 162
EP 171
DI 10.1093/infdis/jix171
PG 10
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FC4SX
UT WOS:000406832000004
PM 28398522
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Kam, YW
   Leite, JA
   Lum, FM
   Tan, JJL
   Lee, B
   Judice, CC
   Teixeira, DAD
   Andreata-Santos, R
   Vinolo, MA
   Angerami, R
   Resende, MR
   Freitas, ARR
   Amaral, E
   Passini, R
   Costa, ML
   Guida, JP
   Arns, CW
   Ferreira, LCS
   Nia, LR
   Proenca-Modena, JL
   Lisa, FPN
   Costa, FTM
AF Kam, Yiu-Wing
   Leite, Juliana Almeida
   Lum, Fok-Moon
   Tan, Jeslin J. L.
   Lee, Bernett
   Judice, Carla C.
   de Toledo Teixeira, Daniel Augusto
   Andreata-Santos, Robert
   Vinolo, Marco A.
   Angerami, Rodrigo
   Resende, Mariangela Ribeiro
   Ribas Freitas, Andre Ricardo
   Amaral, Eliana
   Passini Junior, Renato
   Costa, Maria Laura
   Guida, Jose Paulo
   Arns, Clarice Weis
   Ferreira, Luis Carlos S.
   Nia, Laurent R.
   Proenca-Modena, Jose Luiz
   Ng, Lisa F. P.
   Costa, Fabio T. M.
CA Zika-Unicamp Network
TI Specific Biomarkers Associated With Neurological Complications and
   Congenital Central Nervous System Abnormalities From Zika Virus-Infected
   Patients in Brazil
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; congenital CNS deformities; cytokines and biomarkers
ID HEPATOCYTE GROWTH-FACTOR; NK CELLS; KINETICS; AMERICA; DENGUE; BRAIN;
   MICRONESIA; EPIDEMIC; OUTBREAK; DISEASE
AB Background. Zika virus (ZIKV) infections have been linked to different levels of clinical outcomes, ranging from mild rash and fever to severe neurological complications and congenital malformations.
   Methods. We investigated the clinical and immunological response, focusing on the immune mediators profile in 95 acute ZIKV-infected adult patients from Campinas, Brazil. These patients included 6 pregnant women who later delivered during the course of this study. Clinical observations were recorded during hospitalization. Levels of 45 immune mediators were quantified using multiplex microbead-based immunoassays.
   Results. Whereas 11.6% of patients had neurological complications, 88.4% displayed mild disease of rash and fever. Several immune mediators were specifically higher in ZIKV-infected patients, and levels of interleukin 10, interferon gamma-induced protein 10 (IP-10), and hepatocyte growth factor differentiated between patients with or without neurological complications. Interestingly, higher levels of interleukin 22, monocyte chemoattractant protein 1, TNF-alpha, and IP-10 were observed in ZIKV-infected pregnant women carrying fetuses with fetal growth-associated malformations. Notably, infants with congenital central nervous system deformities had significantly higher levels of interleukin 18 and IP-10 but lower levels of hepatocyte growth factor than those without such abnormalities born to ZIKV-infected mothers.
   Conclusions. This study identified several key markers for the control of ZIKV pathogenesis. This will allow a better understanding of the molecular mechanisms of ZIKV infection in patients.
C1 [Kam, Yiu-Wing; Lum, Fok-Moon; Tan, Jeslin J. L.; Lee, Bernett; Nia, Laurent R.; Ng, Lisa F. P.] ASTAR, Singapore Immunol Network, Singapore, Singapore.
   [Leite, Juliana Almeida; Judice, Carla C.; de Toledo Teixeira, Daniel Augusto; Vinolo, Marco A.; Arns, Clarice Weis; Proenca-Modena, Jose Luiz; Costa, Fabio T. M.] Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Genet Evolut & Bioagents, Sao Paulo, Brazil.
   [Andreata-Santos, Robert; Ferreira, Luis Carlos S.] Univ Sao Paulo, Dept Microbiol, Biomed Sci Inst, Sao Paulo, Brazil.
   [Angerami, Rodrigo] Univ Estadual Campinas, Epidemiol Surveillance Sect, Hosp Clin, Campinas, SP, Brazil.
   [Resende, Mariangela Ribeiro] Univ Estadual Campinas, Fac Med Sci, Dept Internal Med, Campinas, SP, Brazil.
   [Ribas Freitas, Andre Ricardo] Univ Estadual Campinas, UNICAMP, Sch Med Sci, Obstet & Gynecol Dept, Sao Paulo, Brazil.
   [Amaral, Eliana; Passini Junior, Renato; Costa, Maria Laura; Guida, Jose Paulo] Campinas Dept Publ Hlth Surveillance, Campinas, SP, Brazil.
   [Ng, Lisa F. P.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.
RP Lisa, FPN (corresponding author), ASTAR, Singapore Immunol Network, Lab Microbial Immun, Biopolis, 8A Biomed Grove,04-06 Immunos, Singapore 138648, Singapore.
EM lisa_ng@immunol.a-star.edu.sg
RI Modena, Jose Luiz Proenca/C-8231-2014; Angerami, Rodrigo
   Nogueira/A-8926-2013; Costa, Maria Laura/I-4980-2019; amsalu,
   ribka/G-8780-2019; Freitas, Andre Ricardo Ribas/L-1969-2016; Amorim,
   Mariene/C-4102-2019; de Toledo Teixeira, Daniel Augusto/C-6940-2017;
   Costa, Fabio/E-1181-2012; Judice, Carla/P-4738-2014; Cavalheiro Martini,
   Matheus/E-9416-2015; Arns, Clarice/F-2762-2015
OI Modena, Jose Luiz Proenca/0000-0002-4996-3153; Angerami, Rodrigo
   Nogueira/0000-0002-4976-9238; Costa, Maria Laura/0000-0001-8280-3234;
   Freitas, Andre Ricardo Ribas/0000-0003-0291-7771; Costa,
   Fabio/0000-0001-9969-7300; Judice, Carla/0000-0003-1839-053X; Vinolo,
   Marco Aurelio/0000-0003-1335-760X; Cavalheiro Martini,
   Matheus/0000-0003-0135-4364; de Toledo Teixeira, Daniel
   Augusto/0000-0002-4055-058X; Arns, Clarice/0000-0002-7308-460X; Ng,
   Lisa/0000-0003-4071-5222
FU Biomedical Research Council (BMRC)Agency for Science Technology &
   Research (ASTAR); BMRC A*STAR-led Zika Virus Consortium Fund
   [15/1/82/27/001]; Agency for Science, Technology and Research (A*STAR),
   SingaporeAgency for Science Technology & Research (ASTAR); Fundacao de
   Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2016/00194-8]; Conselho Nacional de
   Desenvolvimento Cientifico e TecnologicoNational Council for Scientific
   and Technological Development (CNPq)
FX This work was supported by the Biomedical Research Council (BMRC; core
   research grants provided to the Singapore Immunology Network); the BMRC
   A*STAR-led Zika Virus Consortium Fund (project 15/1/82/27/001); the
   Agency for Science, Technology and Research (A*STAR), Singapore,
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (grant 2016/00194-8
   and fellowship to J.A.L.); and the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (including research fellowships to M.A.V.,
   E.A., L.C.F., and F.T.M.C.).
CR Baron R, 2008, FASEB J, V22, P2843, DOI 10.1096/fj.08-105866
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chaix J, 2008, J IMMUNOL, V181, P1627, DOI 10.4049/jimmunol.181.3.1627
   Cheng YL, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/274025
   Cloetta D, 2013, J NEUROSCI, V33, P7799, DOI 10.1523/JNEUROSCI.3294-12.2013
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Estes ML, 2015, NAT REV NEUROSCI, V16, P469, DOI 10.1038/nrn3978
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Funakoshi H, 2011, CURR SIGNAL TRANSD T, V6, P156, DOI 10.2174/157436211795659982
   Gaddi PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042850
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Her Z, 2017, J INFECT DIS, V215, P42, DOI 10.1093/infdis/jiw494
   Jeong YE, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0740-6
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li F, 2015, J VIROL, V89, P5602, DOI 10.1128/JVI.00143-15
   Liu Q, 2016, CELL MOL IMMUNOL, V13, P3, DOI 10.1038/cmi.2015.74
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Molnarfi N, 2015, AUTOIMMUN REV, V14, P293, DOI 10.1016/j.autrev.2014.11.013
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Pan-American Health Organization/World Health Organization, 2017, ZIK EP REP BRAZ
   Poli A, 2013, J IMMUNOL, V190, P5355, DOI 10.4049/jimmunol.1203401
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Steinhagen K., 2015, EUROSURVEILLANCE, V2016, P21, DOI DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Suwanmanee S, 2017, J MICROBIOL, V55, P81, DOI 10.1007/s12275-017-6494-4
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   World Health Organization, 2017, WORLD MALARIA REPORT, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
NR 38
TC 30
Z9 31
U1 0
U2 11
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD JUL 15
PY 2017
VL 216
IS 2
BP 172
EP 181
DI 10.1093/infdis/jix261
PG 10
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FC4SX
UT WOS:000406832000005
PM 28838147
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lum, FM
   Lin, C
   Susova, OY
   Teo, TH
   Fong, SW
   Mak, TM
   Lee, LK
   Chong, CY
   Lye, DCB
   Lin, RTP
   Merits, A
   Leo, YS
   Ng, LFP
AF Lum, Fok-Moon
   Lin, Cui
   Susova, Olga Y.
   Teo, Teck-Hui
   Fong, Siew-Wai
   Mak, Tze-Minn
   Lee, Linda Kay
   Chong, Chia-Yin
   Lye, David C. B.
   Lin, Raymond T. P.
   Merits, Andres
   Leo, Yee-Sin
   Ng, Lisa F. P.
TI A Sensitive Method for Detecting Zika Virus Antigen in Patients'
   Whole-Blood Specimens as an Alternative Diagnostic Approach
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; monocytes; detection; diagnosis
ID INFECTION; MICRONESIA; MONOCYTES; THREAT; TARGET; STATE; CELLS
AB Background. Epidemics caused by the reemergence of Zika virus (ZIKV) warrant the need to develop new diagnostic measures to complement currently used detection methods. In this study, we explored the detection of ZIKV antigen in a defined leukocyte subset from patients' whole-blood specimens.
   Methods. Whole-blood samples were obtained at the acute and early convalescent phases from ZIKV-infected patients during the Singapore outbreak in August-September 2016. Presence of ZIKV antigen was determined by flow cytometry staining for intracellular ZIKV NS3, using a ZIKV-specific polyclonal antibody. The presence of ZIKV antigen was determined in CD45(+)CD14(+) monocytes.
   Results. Data showed that ZIKV NS3 antigen could be detected in CD45(+)CD14(+) monocytes. The levels of detection were further categorized into 3 groups: high (positivity among >40% of monocytes), moderate (positivity among 10%-40%), and low (positivity among <10%). While a majority of patients showed a decrease in the amount of ZIKV antigen detected at later time points, some patients displayed higher levels as the disease progressed.
   Conclusions. Our data highlights an alternative approach in using flow cytometry as a sensitive method for detecting ZIKV antigen in whole blood. Importantly, it further confirms the role of CD14(+) monocytes as an important cellular target for ZIKV infection during the viremic phase.
C1 [Lum, Fok-Moon; Teo, Teck-Hui; Fong, Siew-Wai; Ng, Lisa F. P.] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore.
   [Lin, Cui; Mak, Tze-Minn; Lin, Raymond T. P.] Minist Hlth, Natl Publ Hlth Lab, Singapore, Singapore.
   [Fong, Siew-Wai] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore.
   [Leo, Yee-Sin] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.
   [Lee, Linda Kay; Lye, David C. B.; Leo, Yee-Sin] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Singapore, Singapore.
   [Chong, Chia-Yin] KK Womens & Childrens Hosp, Singapore, Singapore.
   [Leo, Yee-Sin] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
   [Susova, Olga Y.] Minist Hlth Russian Federat, Blokhin Russian Canc Res Ctr, Moscow, Russia.
   [Merits, Andres] Univ Tartu, Inst Technol, Tartu, Estonia.
   [Ng, Lisa F. P.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.
RP Lisa, FPN (corresponding author), Agcy Sci Technol & Res, Singapore Immunol Network, Biopolis, 8A Biomed Grove,04-06 Immunos, Singapore 138648, Singapore.
EM lisa_ng@immunol.a-star.edu.sg
RI Merits, Andres/H-3125-2015; Susova, Olga/R-9570-2019
OI Merits, Andres/0000-0001-8193-0071; Susova, Olga/0000-0001-8192-7913;
   Lye, David/0000-0003-0324-0205; Mak, Tze Minn/0000-0002-8249-8353; Ng,
   Lisa/0000-0003-4071-5222
FU Biomedical Research Council (BMRC)Agency for Science Technology &
   Research (ASTAR); National Public Health Laboratory of Singapore;
   University of Tartu in Estonia; BMRC Agency for Science, Technology, and
   Research, Singapore (A*STAR) [15/1/82/27/001]; A*STARAgency for Science
   Technology & Research (ASTAR)
FX This work was supported by the Biomedical Research Council (BMRC; core
   research grants to the Singapore Immunology Network), the National
   Public Health Laboratory of Singapore, the University of Tartu in
   Estonia, the BMRC Agency for Science, Technology, and Research,
   Singapore (A*STAR)-led Zika Virus Consortium Fund (project
   15/1/82/27/001), and A*STAR.
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Das PK, 2014, J BIOL CHEM, V289, P5635, DOI 10.1074/jbc.M113.503433
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2017, INT J INFECT DIS, V54, P121, DOI 10.1016/j.ijid.2016.11.420
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Goldszmid RS, 2014, CELL HOST MICROBE, V15, P295, DOI 10.1016/j.chom.2014.02.003
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Gyawali N, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0132-y
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Handel A, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1083
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   Kassim FM, 2011, SE ASIAN J TROP MED, V42, P562
   Keasey SL, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00036-17
   Korzeniewski K, 2016, INT MARIT HEALTH, V67, P31, DOI 10.5603/IMH.2016.0007
   Kou Z, 2008, J MED VIROL, V80, P134, DOI 10.1002/jmv.21051
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ludlow M, 2016, ACTA NEUROPATHOL, V131, P159, DOI 10.1007/s00401-015-1511-3
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   National Environment Agency Singapore, ZIK CAS CLUST
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Prisant N, 2017, CLIN INFECT DIS, V64, P107, DOI 10.1093/cid/ciw669
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rios M, 2006, TRANSFUSION, V46, P659, DOI 10.1111/j.1537-2995.2006.00769.x
   Shukla S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01685
NR 32
TC 16
Z9 17
U1 0
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD JUL 15
PY 2017
VL 216
IS 2
BP 182
EP 190
DI 10.1093/infdis/jix276
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FC4SX
UT WOS:000406832000006
PM 28586426
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Song, BH
   Yun, SI
   Woolley, M
   Lee, YM
AF Song, Byung-Hak
   Yun, Sang-Im
   Woolley, Michael
   Lee, Young-Min
TI Zika virus: History, epidemiology, transmission, and clinical
   presentation
SO JOURNAL OF NEUROIMMUNOLOGY
LA English
DT Review
DE Zika virus; Flavivirus; Arbovirus; Mosquito-borne pathogen; Zika
   outbreak; Zika pandemic; Microcephaly; Guillain-Barre syndrome
ID GUILLAIN-BARRE-SYNDROME; BORNE ENCEPHALITIS-VIRUS; DENGUE VIRUS; SEXUAL
   TRANSMISSION; WEST-NILE; YELLOW-FEVER; FRENCH-POLYNESIA; JAPANESE
   ENCEPHALITIS; ENDOPLASMIC-RETICULUM; HEAD CIRCUMFERENCE
AB Zika virus (ZIKV), a mosquito-borne positive-stranded RNA virus of the family Flaviviridae (genus Flavivirus), is now causing an unprecedented large-scale outbreak in the Americas. Historically, ZIKV spread eastward from equatorial Africa and Asia to the Pacific Islands during the late 2000s to early 2010s, invaded the Caribbean and Central and South America in 2015, and reached North America in 2016. Although ZIKV infection generally causes no symptoms or only a mild self-limiting illness, it has recently been linked to a rising number of severe neurological diseases, including microcephaly and Guillain-Barre syndrome. Because of the continuous geographic expansion of both the virus and its mosquito vectors, ZIKV poses a serious threat to public health around the globe. However, there are no vaccines or antiviral therapies available against this pathogen. This review summarizes a fast-growing body of literature on the history, epidemiology, transmission, and clinical presentation of ZIKV and highlights the urgent need for the development of efficient control strategies for this emerging pathogen. (C) 2017 The Authors. Published by Elsevier B.V.
C1 [Song, Byung-Hak; Yun, Sang-Im; Woolley, Michael; Lee, Young-Min] Utah State Univ, Dept Anim Dairy & Vet Sci, Coll Agr & Appl Sci, 9830 Old Main Hill, Logan, UT 84322 USA.
RP Lee, YM (corresponding author), Utah State Univ, Dept Anim Dairy & Vet Sci, Coll Agr & Appl Sci, 9830 Old Main Hill, Logan, UT 84322 USA.
EM youngmin.lee@usu.edu
FU Utah Science Technology and Research Initiative (USTAR) [A34637,
   A36815]; American Board of Obstetrics and Gynecology [200784-00001];
   American College of Obstetricians and Gynecologists; American Society
   for Reproductive Medicine; Society for Reproductive Endocrinology and
   Infertility
FX This work was supported by the Utah Science Technology and Research
   Initiative (USTAR A34637 and A36815) and by a grant (200784-00001) from
   the American Board of Obstetrics and Gynecology, the American College of
   Obstetricians and Gynecologists, the American Society for Reproductive
   Medicine, and the Society for Reproductive Endocrinology and
   Infertility. We thank Dr. Deborah McClellan for her careful and critical
   reading of our paper. There is no conflict of interest in this paper.
CR ADEKOLUJOHN EO, 1983, T ROY SOC TROP MED H, V77, P149, DOI 10.1016/0035-9203(83)90053-6
   Adiga R, 2016, J MED VIROL, V88, P1821, DOI 10.1002/jmv.24615
   AGDH, 2016, ZIK VIR NOT ZIK VIR
   Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Alcantara D, 2014, AM J MED GENET C, V166, P124, DOI 10.1002/ajmg.c.31397
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Barbier A, 2013, PEDIATRICS, V131, pE1158, DOI 10.1542/peds.2011-3846
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bolduc FV, 2005, DEV MED CHILD NEUROL, V47, P766, DOI 10.1017/S001216220500160X
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brinton MA, 2014, VIRUSES-BASEL, V6, P13, DOI 10.3390/v6010013
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Butler Declan, 2016, Nature, V531, P153, DOI 10.1038/nature.2016.19502
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CDC, 2016, CAS COUNTS US
   CDC, 2016, CONG MICR CAS DEF
   CDC, 2016, ALL COUNTR TERR ACT
   CDC, 2016, POT RANG US
   CDC, 2016, OUTC PREGN LAB EV PO
   CDC, 2016, ZIK CAS REP US
   CDC, 2016, ZIK VIR
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Chen JC, 2016, INT J INFECT DIS, V51, P139, DOI 10.1016/j.ijid.2016.07.015
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Chraibi S, 2016, J CLIN VIROL, V83, P61, DOI 10.1016/j.jcv.2016.08.299
   Clyde K, 2006, J VIROL, V80, P11418, DOI 10.1128/JVI.01257-06
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P47
   Cornet M., 1979, ORSTOM ENTOMOL MED P, V17, P149
   Cox Bryan D., 2015, Antiviral Chemistry & Chemotherapy, V24, P118, DOI 10.1177/2040206616653873
   Creange A, 2016, REV NEUROL-FRANCE, V172, P770, DOI 10.1016/j.neurol.2016.10.011
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Magalhaes-Barbosa MC, 2016, TRAVEL MED INFECT DI, V14, P458, DOI 10.1016/j.tmaid.2016.09.006
   De Santis M, 2006, REPROD TOXICOL, V21, P390, DOI 10.1016/j.reprotox.2005.01.014
   De Smet B, 2016, J CLIN VIROL, V80, P8, DOI 10.1016/j.jcv.2016.04.009
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Diaz-Menendez M., 2016, ENFERM INFECC MICROB
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Douglas L, 2001, FETAL DIAGN THER, V16, P323, DOI 10.1159/000053935
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duijster JW, 2016, INFECTION, V44, P797, DOI 10.1007/s15010-016-0906-y
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   ECDC, 2016, MAIN DIAGN MORPH CHA
   ECDC, 2016, CURR ZIK TRANSM
   Ellison DW, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00359-16
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   European Centre for Disease Prevention and Control (ECDC), 2014, RAP RISK ASS ZIK VIR
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gaunt MW, 2001, J GEN VIROL, V82, P1867, DOI 10.1099/0022-1317-82-8-1867
   GC, 2016, SURV ZIK VIR
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Giovanetti M, 2016, INFECT GENET EVOL, V41, P142, DOI 10.1016/j.meegid.2016.03.030
   Goodfellow JA, 2016, NAT REV NEUROL, V12, P723, DOI 10.1038/nrneurol.2016.172
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gubler D., 2007, FIELDS VIROLOGY, V1, P1153
   GUBLER DJ, 1979, AM J TROP MED HYG, V28, P1045, DOI 10.4269/ajtmh.1979.28.1045
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   ICutsuna S., 2014, EUROSURVEILLANCE, V19, P20683
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Kaufmann B, 2011, MICROBES INFECT, V13, P1, DOI 10.1016/j.micinf.2010.09.005
   Kim JK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124318
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kramer LD, 2003, ADV VIRUS RES, V60, P187, DOI 10.1016/S0065-3527(03)60006-0
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Ladner JT, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00377-16
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Leal MC., 2016, BRAZ J OTOR IN PRESS
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   Liu L, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00291-16
   Lorenz IC, 2002, J VIROL, V76, P5480, DOI 10.1128/JVI.76.11.5480-5491.2002
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mallet H. P., 2015, B INFORM SANITAIRES
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Maria AT, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.6.30131
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   MILLER BR, 1989, TROP MED PARASITOL, V40, P396
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monaghan Ai., 2016, PLOS CURR, V8
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2016, LANCET INFECT DIS, V16, P620, DOI 10.1016/S1473-3099(16)00096-7
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nicastri E, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1973-5
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   PAHO/WHO, 2016, ZIK EP UPD
   PAHO/WHO, 2016, ZIK SUSP CONF CAS RE
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Passemard S, 2013, HAND CLINIC, V111, P129, DOI 10.1016/B978-0-444-52891-9.00013-0
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Plosa EJ, 2012, PEDIATR REV, V33, P156, DOI 10.1542/pir.33-4-156
   Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Pyke A. T., 2016, PLOS CURR, V8
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Ralapanawa Dissanayake Mudiyanselage Priyantha Udaya Kumara, 2015, BMC Res Notes, V8, P729, DOI 10.1186/s13104-015-1672-0
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   SALUZZO JF, 1982, B SOC PATHOL EXOT, V75, P262
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Scott TW, 2012, TRENDS PARASITOL, V28, P114, DOI 10.1016/j.pt.2012.01.001
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Sharp TM, 2016, CLIN INFECT DIS, V63, P1198, DOI 10.1093/cid/ciw476
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Simmonds P., 2012, VIRUS TAXONOMY, P1003
   Simon O, 2016, J CLIN VIROL, V77, P29, DOI 10.1016/j.jcv.2016.01.016
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9, DOI 10.4269/ajtmh.1954.3.9
   Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997
   Stiasny K, 2011, AMINO ACIDS, V41, P1159, DOI 10.1007/s00726-009-0370-4
   Sullivan JC, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-2
   Sun JF, 2016, JAMA OPHTHALMOL, V134, P1330, DOI 10.1001/jamaophthalmol.2016.3417
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Swanson EC, 2013, PEDIATR CLIN N AM, V60, P335, DOI 10.1016/j.pcl.2012.12.008
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang BL, 2016, ARCH MICROBIOL, V198, P595, DOI 10.1007/s00203-016-1268-7
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Thomas SM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-100
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Verma R, 2014, J NEUROL SCI, V346, P26, DOI 10.1016/j.jns.2014.08.044
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Villamil-Gomez WE, 2016, TRAVEL MED INFECT DI, V14, P155, DOI 10.1016/j.tmaid.2016.02.004
   Villordo SM, 2009, VIRUS RES, V139, P230, DOI 10.1016/j.virusres.2008.07.016
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Watemberg N, 2002, J CHILD NEUROL, V17, P117, DOI 10.1177/088307380201700205
   Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Webster WS, 1998, TERATOLOGY, V58, P13
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Westaway EG, 2002, CURR TOP MICROBIOL, V267, P323
   WHO, 2016, WHO CONF ZIK VIR STR
   WHO, 2016, WHO STAT 5 M EM COMM
   Wielanek AC, 2007, NEUROLOGY, V69, P2105, DOI 10.1212/01.wnl.0000277267.07220.88
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003
   World Health Organization, 2016, WHO STAT 1 M INT HLT
   World Health Organization, 2016, SIT REP ZIK VIR MICR
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yin YX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.100
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Yun SI, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00800-16
   Yun SI, 2014, HUM VACC IMMUNOTHER, V10, P263, DOI 10.4161/hv.26902
   Yun SI, 2006, MOL BIOL FLAVIVIRUS, P225
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Ze-Ze L, 2016, IDCases, V4, P46, DOI 10.1016/j.idcr.2016.03.004
   Zhang C, 2016, BIOCH BIOPHYS RES CO
   Zhang J., 2016, J TRAVEL MED, V23
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
   Zhang Y, 2007, J VIROL, V81, P6141, DOI 10.1128/JVI.00037-07
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 292
TC 82
Z9 85
U1 6
U2 38
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0165-5728
EI 1872-8421
J9 J NEUROIMMUNOL
JI J. Neuroimmunol.
PD JUL 15
PY 2017
VL 308
SI SI
BP 50
EP 64
DI 10.1016/j.jneuroim.2017.03.001
PG 15
WC Immunology; Neurosciences
SC Immunology; Neurosciences & Neurology
GA EZ4US
UT WOS:000404708600009
PM 28285789
OA Other Gold
DA 2020-07-08
ER

PT J
AU Miller, KD
   Rall, GF
AF Miller, Katelyn D.
   Rall, Glenn F.
TI What Kaplan-Meier survival curves don't tell us about CNS disease
SO JOURNAL OF NEUROIMMUNOLOGY
LA English
DT Article
ID MEASLES-VIRUS INFECTION; CD8(+) T-CELLS; MEDIATED PROTECTION;
   GAMMA-INTERFERON; VIRAL-INFECTION; MESSENGER-RNA; I INTERFERON; B-CELLS;
   NEURONS; MICE
AB Central nervous system consequences of viral infections are rare, but when they do occur, they are often serious and clinically challenging to manage. Our awareness of the perils of neuroinvasion by viruses is growing: the recently appreciated impact of Ebola and Zika virus infections on CNS integrity, decreases in vaccination coverage for potentially neurotropic viruses such as measles, and increased neurovirulence of some influenza strains collectively highlight the need for a better understanding of the viral-neural interaction. Defining these interactions and how they result in neuropathogenesis is paramount for the development of better clinical strategies, especially given the limited treatment options that are available due to the unique physiology of the brain that limits migration of blood-borne molecules into the CNS parenchyma. In this perspective, we discuss some unique aspects of neuronal viral infections and immune-mediated control that impact the pathogenic outcomes of these infections. Further, we draw attention to an often overlooked aspect of neuropathogenesis research: that lack of overt disease, which is often equated with survival post-infection, likely only scratches the surface of the myriad ways by which neurotropic infections can impair CNS function. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Rall, Glenn F.] Univ Penn, Program Cell & Mol Biol, Philadelphia, PA 19104 USA.
   Fox Chase Canc Ctr, Program Blood Cell Dev & Funct, 7701 Burholme Ave, Philadelphia, PA 19111 USA.
RP Rall, GF (corresponding author), Univ Penn, Program Cell & Mol Biol, Philadelphia, PA 19104 USA.
EM glenn.rall@fccc.edu
FU National Cancer InstituteUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) [P30CA006927];  [R01 NS40500];  [F31 NS092307];  [T32
   NS007180-32]
FX This work was supported by the following sources: R01 NS40500 (GFR), F31
   NS092307 (KDM), T32 NS007180-32 (KDM), a gift from the F. M. Kirby
   Foundation (GFR), and by P30CA006927 from the National Cancer Institute.
   The content is solely the responsibility of the authors and does not
   necessarily represent the official views of the National Institute of
   Neurological Disorders And Stroke or the National Institutes of Health.
CR Amaral DCG, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-23
   Brooks SP, 2009, NAT REV NEUROSCI, V10, P519, DOI 10.1038/nrn2652
   Brot MD, 1997, J NEUROVIROL, V3, P265, DOI 10.3109/13550289709029467
   Burdeinick-Kerr R, 2009, J VIROL, V83, P3429, DOI 10.1128/JVI.02381-08
   Cavanaugh SE, 2015, J NEUROIMMUNOL, V279, P11, DOI 10.1016/j.jneuroim.2014.12.012
   Cebrian C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4633
   Cohen S., 1986, EPIDERMAL GROWTH FAC, P1
   DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300
   Delhaye S, 2006, P NATL ACAD SCI USA, V103, P7835, DOI 10.1073/pnas.0602460103
   Detje CN, 2009, J IMMUNOL, V182, P2297, DOI 10.4049/jimmunol.0800596
   DORIG RE, 1993, CELL, V75, P295, DOI 10.1016/0092-8674(93)80071-L
   Gomme EA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002971
   GRAHAM JB, 2016, PLOS PATHOG, V12, DOI DOI 10.1371/J0URNAL.PPAT
   Griffin DE, 2010, IMMUNOL RES, V47, P123, DOI 10.1007/s12026-009-8143-4
   Gutierrez J, 2010, DEV MED CHILD NEUROL, V52, P901, DOI 10.1111/j.1469-8749.2010.03717.x
   Harty RN, 2009, J INNATE IMMUN, V1, P397, DOI 10.1159/000226245
   Holmgren AM, 2015, J VIROL, V89, P11011, DOI 10.1128/JVI.01745-15
   Horwitz MS, 1999, LAB INVEST, V79, P235
   Ireland DDC, 2008, J VIROL, V82, P300, DOI 10.1128/JVI.01794-07
   JOLY E, 1992, NEURON, V8, P1185, DOI 10.1016/0896-6273(92)90138-4
   JOLY E, 1991, SCIENCE, V253, P1283, DOI 10.1126/science.1891717
   Jurgens HA, 2012, J NEUROSCI, V32, P3958, DOI 10.1523/JNEUROSCI.6389-11.2012
   KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0
   Katayama Y, 1998, J CLIN MICROBIOL, V36, P299, DOI 10.1128/JCM.36.1.299-301.1998
   Kinchington P. R., 2012, HERPESVIRIDAE, V3, P1
   Knickelbein JE, 2008, SCIENCE, V322, P268, DOI 10.1126/science.1164164
   KOCH EM, 1984, VIROLOGY, V136, P78, DOI 10.1016/0042-6822(84)90249-6
   LAVI E, 1984, J VIROL, V51, P563, DOI 10.1128/JVI.51.2.563-566.1984
   Lawrence DMP, 1999, J VIROL, V73, P1795, DOI 10.1128/JVI.73.3.1795-1801.1999
   LEVINE B, 1992, J VIROL, V66, P6429, DOI 10.1128/JVI.66.11.6429-6435.1992
   LIPKIN WI, 1988, BRAIN RES, V451, P333
   Mani S, 2013, BRAIN, V136, P1288, DOI 10.1093/brain/aws283
   Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X
   MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221
   NANICHE D, 1993, J VIROL, V67, P6025, DOI 10.1128/JVI.67.10.6025-6032.1993
   Neumann H, 1997, J EXP MED, V185, P305, DOI 10.1084/jem.185.2.305
   NEUMANN H, 1995, SCIENCE, V269, P549, DOI 10.1126/science.7624779
   O'Donnell LA, 2015, J NEUROCHEM, V135, P309, DOI 10.1111/jnc.13250
   O'Donnell LA, 2012, J IMMUNOL, V188, P1915, DOI 10.4049/jimmunol.1101356
   Patterson CE, 2002, J VIROL, V76, P4497, DOI 10.1128/JVI.76.9.4497-4506.2002
   Rall GF, 1997, P NATL ACAD SCI USA, V94, P4659, DOI 10.1073/pnas.94.9.4659
   Rosato PC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005028
   Rose RW, 2007, J NEUROIMMUNOL, V192, P145, DOI 10.1016/j.jneuroim.2007.10.007
   Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005
   Schubert S, 2006, J GEN VIROL, V87, P2011, DOI 10.1099/vir.0.81838-0
   SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C
   Solomos AC, 2016, VIROLOGY, V499, P196, DOI 10.1016/j.virol.2016.09.013
   St Leger AJ, 2011, J NEUROVIROL, V17, P528, DOI 10.1007/s13365-011-0062-1
   Sun XN, 2016, CURR MICROBIOL, V73, P301, DOI 10.1007/s00284-016-1061-5
   Tishon A, 2006, VIROLOGY, V347, P234, DOI 10.1016/j.virol.2006.01.050
   Tsai PT, 2012, NATURE, V488, P647, DOI 10.1038/nature11310
NR 51
TC 1
Z9 1
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-5728
EI 1872-8421
J9 J NEUROIMMUNOL
JI J. Neuroimmunol.
PD JUL 15
PY 2017
VL 308
SI SI
BP 25
EP 29
DI 10.1016/j.jneuroim.2017.01.020
PG 5
WC Immunology; Neurosciences
SC Immunology; Neurosciences & Neurology
GA EZ4US
UT WOS:000404708600006
PM 28187911
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Guedes, DRD
   Gomes, ETB
   Paiva, MHS
   de Melo-Santos, MAV
   Alves, J
   Gomez, LF
   Ayres, CFJ
AF Guedes, Duschinka R. D.
   Gomes, Elisete T. B.
   Paiva, Marcelo H. S.
   de Melo-Santos, Maria A. V.
   Alves, Joana
   Gomez, Lara F.
   Ayres, Constancia F. J.
TI Circulation of DENV2 and DENV4 in Aedes aegypti (Diptera: Culicidae)
   mosquitoes from Praia, Santiago Island, Cabo Verde
SO JOURNAL OF INSECT SCIENCE
LA English
DT Article
DE Aedes aegypti; dengue; diagnostics; arboviral transmission
ID DENGUE VIRUS; CHIKUNGUNYA-VIRUS; ZIKA; INFECTION; SURVEILLANCE;
   POPULATIONS; COINFECTION; SENEGAL
AB Arthropod-borne viruses, such as Dengue (DENV), Chikungunya (CHIKV), and Zika (ZIKV), pose a challenge to public health, due to their worldwide distribution and large-scale outbreaks. Dengue fever is currently one of the most important diseases and it is caused by four serotypes of DENV and is mainly transmitted by the mosquito Aedes aegypti. It is estimated that 50-100 million cases are reported every year worldwide. More recently, CHIKV and ZIKV, which are also transmitted by Ae. aegypti, have caused epidemics in countries in the Caribbean region, the Pacific region, and Americas. Cabo Verde faced its first dengue outbreak in 2009, with more than 21,000 reported cases and four registered deaths. The epidemic was caused by DENV-3 transmitted by Ae. aegypti mosquitoes. In addition, the country faced a Zika outbreak with more than 7,500 notified cases from October 2015 to May 2016. In the present study, we conducted a survey in mosquito samples to detect arboviruses circulating in the local vector population. Collections were performed from November 2014 to January 2015, in the City of Praia, the capital of Cabo Verde, using aspirators and BG-sentinel traps. Samples were examined by multiplex Reverse Transcription-polymerase chain reaction. A total of 161 Ae. aegypti adult females were analyzed (34 pools) and from these samples, eight pools were found positive for DENV-2 and DENV-4. Our results revealed a very high natural infection rate in the vector population and showed two different serotypes co-circulating in the island that differ from the one detected in the 2009 outbreak in Cabo Verde.
C1 [Guedes, Duschinka R. D.; Paiva, Marcelo H. S.; de Melo-Santos, Maria A. V.; Ayres, Constancia F. J.] Fundacao Oswaldo Cruz IAM FIOCRUZ PE, Inst Aggeu Magalhaes, Dept Entomol, Ave Prof Moraes Rego S-N, BR-50670420 Recife, PE, Brazil.
   [Gomes, Elisete T. B.; Gomez, Lara F.] Univ Jean Piaget UniPiaget, Caixa Postal 775, Praia, Cape Verde.
   [Paiva, Marcelo H. S.] Univ Fed Pernambuco, Ctr Acad Agreste, Rodovia BR 104,Km 59, BR-55002970 Caruaru, PE, Brazil.
   [Alves, Joana] Minist Saude Cabo Verde, Inst Nacl Saude Publ, CP 719, Praia, Cape Verde.
RP Guedes, DRD (corresponding author), Fundacao Oswaldo Cruz IAM FIOCRUZ PE, Inst Aggeu Magalhaes, Dept Entomol, Ave Prof Moraes Rego S-N, BR-50670420 Recife, PE, Brazil.
EM dguedes@cpqam.fiocruz.br; elisetegomes92@gmail.com;
   marceloh@cpqam.fioc-ruz.br; mavarjal@cpqam.fiocruz.br;
   alveslima@hotmail.com; lara.ferrero.gomez@gmail.com;
   tans@cpqam.fiocruz.br
RI Ayres, Constancia/AAQ-3448-2020
FU Fundacao de Amparoa Pesquisa do Estado de Pernambuco (FACEPE)
   [APQ-1608-2.13/15, APQ-0085-2.13/16, APQ-345-2.13/13]; Brazilian
   National Council for Research and Development (CNPq)National Council for
   Scientific and Technological Development (CNPq) [441100/2016-3];
   CNPqNational Council for Scientific and Technological Development (CNPq)
FX We thank the staff of the insectary at Aggeu Magalhaes Institute for
   technical assistance, the Program for Technological Development in Tools
   for Health (PDTIS-FIOCRUZ) for allowing us to use their facilities to
   sequence our data. This work was supported by the Fundacao de Amparoa
   Pesquisa do Estado de Pernambuco (FACEPE; APQ-1608-2.13/15,
   APQ-0085-2.13/16 to C.F.J.A.; APQ-345-2.13/13 to M.A.V.M.S) and the
   Brazilian National Council for Research and Development (CNPq)
   (441100/2016-3 to C.F.J.A). C.F.J.A. is supported by productivity
   fellowship from the CNPq. We also thank the staff of Grupo de
   Investigacao de Doenc, as Tropicais da UniPiaget (GIDTPiaget) for
   collecting mosquitoes and shipment.
CR Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Barbosa PP, 2016, J MED ENTOMOL, V53, P613, DOI 10.1093/jme/tjw034
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carvalho-Leandro D, 2012, ACTA TROP, V124, P113, DOI 10.1016/j.actatropica.2012.07.006
   Chahar HS, 2009, EMERG INFECT DIS, V15, P1077, DOI 10.3201/eid1507.080638
   Chow VTK, 1998, AM J TROP MED HYG, V58, P578, DOI 10.4269/ajtmh.1998.58.578
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Diagne CT, 2014, AM J TROP MED HYG, V91, P635, DOI 10.4269/ajtmh.13-0627
   Diallo D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001649
   Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281
   dos Santos CND, 2016, TRENDS PARASITOL, V32, P508, DOI 10.1016/j.pt.2016.03.008
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Dzul-Manzanilla F, 2015, J AM MOSQUITO CONTR, V31, P275, DOI 10.2987/moco-31-03-275-277.1
   Faye O, 2014, EMERG INFECT DIS, V20, P456, DOI 10.3201/eid2003.121885
   da Moura AJF, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0706-8
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Guedes DRD, 2010, J VECTOR DIS, V47, P67
   Hasebe F, 2002, J MED VIROL, V67, P370, DOI 10.1002/jmv.10085
   Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Moron AF, 2016, BJOG-INT J OBSTET GY, V123, P1265, DOI 10.1111/1471-0528.14072
   (MS- BRASIL) Ministerio da Saude-Brasil, 2016, INF EP NO 44 SEM EP
   (MS- CV) Ministerio da Saude de Cabo Verde, 2011, REL EST 2010
   (MS- CV) Ministerio da Saude de Cabo Verde, 2016, INF VIR ZIK SEM 1 21
   Nasci R. S., 1981, MOSQ NEWS, V41, P4
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Patel P, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-58
   Precioso AR, 2015, VACCINE, V33, P7121, DOI 10.1016/j.vaccine.2015.09.105
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Ribeiro H., 1980, MOSQUITOS CABO VERDE
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwartz LM, 2015, VACCINE, V33, P3293, DOI 10.1016/j.vaccine.2015.05.010
   Urdaneta Ludmel, 2005, Infection Genetics and Evolution, V5, P177, DOI 10.1016/j.meegid.2004.09.004
   (WHO) World Health Organization, 2016, WHO SUPP CAB VERD MA
   (WHO) World Health Organization, 2016, YELL FEV URB OUTBR A
NR 39
TC 2
Z9 2
U1 0
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1536-2442
EI 2250-2645
J9 J INSECT SCI
JI J Insect Sci.
PD JUL 14
PY 2017
VL 17
AR 86
DI 10.1093/jisesa/iex057
PG 6
WC Entomology
SC Entomology
GA FJ0XI
UT WOS:000412433900001
PM 28973490
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Metcalf, CJE
   Lessler, J
AF Metcalf, C. Jessica E.
   Lessler, Justin
TI Opportunities and challenges in modeling emerging infectious diseases
SO SCIENCE
LA English
DT Review
ID EBOLA-VIRUS DISEASE; PANDEMIC INFLUENZA; WEST-AFRICA; ZIKA VIRUS;
   TRANSMISSION; EPIDEMIC; SURVEILLANCE; PROJECTIONS; STRATEGIES; OUTBREAK
AB The term "pathogen emergence" encompasses everything from previously unidentified viruses entering the human population to established pathogens invading new populations and the evolution of drug resistance. Mathematical models of emergent pathogens allow forecasts of case numbers, investigation of transmission mechanisms, and evaluation of control options. Yet, there are numerous limitations and pitfalls to their use, often driven by data scarcity. Growing availability of data on pathogen genetics and human ecology, coupled with computational and methodological innovations, is amplifying the power of models to inform the public health response to emergence events. Tighter integration of infectious disease models with public health practice and development of resources at the ready has the potential to increase the timeliness and quality of responses.
C1 [Metcalf, C. Jessica E.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.
   [Metcalf, C. Jessica E.] Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA.
   [Lessler, Justin] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.
RP Metcalf, CJE (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.; Metcalf, CJE (corresponding author), Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA.
EM cmetcalf@princeton.edu
OI Lessler, Justin/0000-0002-9741-8109
FU NICHD NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [P2C HD047879]
CR A gluten-free-for-all L. L., 2009, WASHINGTON POST
   Agua-Agum J, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002170
   Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104
   Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Breban R, 2013, LANCET, V382, P694, DOI 10.1016/S0140-6736(13)61492-0
   Camacho A, 2017, VACCINE, V35, P544, DOI 10.1016/j.vaccine.2016.12.019
   Camacho A, 2014, EPIDEMICS-NETH, V9, P70, DOI 10.1016/j.epidem.2014.09.003
   Cauchemez S, 2016, P NATL ACAD SCI USA, V113, P9081, DOI 10.1073/pnas.1519235113
   Cauchemez S, 2014, LANCET INFECT DIS, V14, P50, DOI 10.1016/S1473-3099(13)70304-9
   Cauchemez S, 2011, P NATL ACAD SCI USA, V108, P2825, DOI 10.1073/pnas.1008895108
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017
   Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101
   Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062
   Funk S, 2014, NATURE, V515, P493, DOI 10.1038/515492b
   Ghani AC, 2005, AM J EPIDEMIOL, V162, P479, DOI 10.1093/aje/kwi230
   Gostic KM, 2016, SCIENCE, V354, P722, DOI 10.1126/science.aag1322
   Kucharski AJ, 2014, LANCET, V384, P1260, DOI 10.1016/S0140-6736(14)61706-2
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lessler J, 2016, AM J EPIDEMIOL, V183, P657, DOI 10.1093/aje/kwv452
   Longdon B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004395
   Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717
   Manore CA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005255
   Mao L, 2015, J TRANSP GEOGR, V48, P52, DOI 10.1016/j.jtrangeo.2015.08.017
   MAY RM, 1987, NATURE, V326, P137, DOI 10.1038/326137a0
   Meltzer Martin I, 2014, MMWR Suppl, V63, P1
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Metcalf CJE, 2016, LANCET, V388, P728, DOI 10.1016/S0140-6736(16)30164-7
   Pandey A, 2014, SCIENCE, V346, P991, DOI 10.1126/science.1260612
   Peak CM, 2017, P NATL ACAD SCI USA, V114, P4023, DOI 10.1073/pnas.1616438114
   Pepin KM, 2010, NAT REV MICROBIOL, V8, P802, DOI 10.1038/nrmicro2440
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Read JM, 2015, LANCET, V385, P23, DOI 10.1016/S0140-6736(14)61894-8
   Shacham E, 2017, AM J PUBLIC HEALTH, V107, P724, DOI 10.2105/AJPH.2017.303670
   Stobbe M., 2015, SEATTLE TIMES
   Tatem AJ, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.4
   Wesolowski A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05678
   Yang W, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003583
   Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373
NR 44
TC 20
Z9 21
U1 8
U2 70
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD JUL 14
PY 2017
VL 357
IS 6347
SI SI
BP 149
EP 152
DI 10.1126/science.aam8335
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FA4CP
UT WOS:000405391700034
PM 28706037
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Lipsitch, M
   Eyal, N
AF Lipsitch, Marc
   Eyal, Nir
TI Improving vaccine trials in infectious disease emergencies
SO SCIENCE
LA English
DT Review
ID EBOLA-VIRUS DISEASE; RING VACCINATION; SIERRA-LEONE; DESIGN; EFFICACY;
   ZIKA; GUINEA; PREVENTION; EPIDEMIC; RISK
AB Unprecedented global effort is under way to facilitate the testing of countermeasures in infectious disease emergencies. Better understanding of the various options for trial design is needed in advance of outbreaks, as is preliminary global agreement on the most suitable designs for the various scenarios. What would enhance the speed, validity, and ethics of clinical studies of such countermeasures? Focusing on studies of vaccine efficacy and effectiveness in emergencies, we highlight three needs: for formal randomized trialseven in most emergencies; for individually randomized trials-even in many emergencies; and for six areas of innovation in trial methodology. These needs should inform current updates of protocols and roadmaps.
C1 [Lipsitch, Marc] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Ctr Communicable Dis Dynam, Boston, MA 02115 USA.
   [Lipsitch, Marc] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.
   [Eyal, Nir] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA.
RP Lipsitch, M (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Ctr Communicable Dis Dynam, Boston, MA 02115 USA.; Lipsitch, M (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.
EM mlipsitc@hsph.harvard.edu
OI Lipsitch, Marc/0000-0003-1504-9213; Eyal, Nir/0000-0003-1056-6609
FU National Institute of General Medical SciencesUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [U54GM088558];
   MerckMerck & Company; PfizerPfizer; Antigen Discovery; Affinivax; PATH
   Vaccine Solutions
FX Supported by National Institute of General Medical Sciences grant
   U54GM088558 (M.L.). We thank R. Kahn, S. Bellan, and A. Rid for helpful
   conversations as we were writing this article, R. Kahn for research
   assistance, and anonymous reviewers for written comments. The content is
   solely the responsibility of the authors and does not necessarily
   represent the official views of the National Institute of General
   Medical Sciences or the National Institutes of Health. M.L. served on
   the Scientific Advisory Group for the Ebola ca Suffit vaccine efficacy
   trial (unpaid position) and has received consulting fees or honoraria
   from Merck, Pfizer, Antigen Discovery, and Affinivax. His research has
   received funding (through his employer) from Pfizer and PATH Vaccine
   Solutions. Discussions leading to the Oxford University Ethox workshop
   on Ethical Design of Vaccine Trials in Emerging Infections helped
   stimulate this paper.
CR Ajelli M, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0678-3
   [Anonymous], 1987, CANCER RES, V47, P5782
   Bellan SE, 2015, LANCET INFECT DIS, V15, P703, DOI 10.1016/S1473-3099(15)70139-8
   Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151
   Bhatt DL, 2016, NEW ENGL J MED, V375, P65, DOI 10.1056/NEJMra1510061
   Brende B, 2017, LANCET, V389, P233, DOI 10.1016/S0140-6736(17)30131-9
   Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3
   Butler D, 2017, NATURE, V545, P396, DOI 10.1038/545396a
   Camacho A, 2017, VACCINE, V35, P544, DOI 10.1016/j.vaccine.2016.12.019
   Campbell MS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016986, 10.1371/journal.pone.0018283]
   Chan KP, 2002, EPIDEMIOL INFECT, V128, P93, DOI 10.1017/S0950268801006422
   Cohen J, 2020, SCIENCE
   Cooper B, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001815
   Eyal N., 2016, DISASTER MED, P67
   Eyal N., 2017, J MED ETHICS
   Ferguson NM, 2016, SCIENCE, V353, P1033, DOI 10.1126/science.aaf9590
   Fowler VG, 2013, JAMA-J AM MED ASSOC, V309, P1368, DOI 10.1001/jama.2013.3010
   Gertler PJ, 2011, IMPACT EVALUATION IN PRACTICE, P1, DOI 10.1596/978-0-8213-8541-8
   Griffiths C, 2017, CLIN MICROBIOL REV, V30, P277, DOI 10.1128/CMR.00010-16
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Harling G, 2017, CLIN TRIALS, V14, P37, DOI 10.1177/1740774516673355
   Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786
   Henao-Restrepo AM, 2017, LANCET, V389, P505, DOI 10.1016/S0140-6736(16)32621-6
   Henao-Restrepo AM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3740
   Hersey S, 2015, MMWR-MORBID MORTAL W, V64, P981, DOI 10.15585/mmwr.mm6435a6
   Hitchings MDT, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005470
   Ikejezie J, 2017, MMWR-MORBID MORTAL W, V66, P329, DOI 10.15585/mmwr.mm6612a4
   Joffe S, 2014, JAMA-J AM MED ASSOC, V312, P1299, DOI 10.1001/jama.2014.12867
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Keusch G, 2017, INTEGRATING CLIN RES
   Koff WC, 2016, EXPERT REV VACCINES, V15, P1235, DOI 10.1586/14760584.2016.1170600
   Kupferschmidt K., 2016, SCIENCE, DOI [10.1126/science.aag0746, DOI 10.1126/SCIENCE.AAG0746]
   Kupferschmidt K, 2015, SCIENCE, V348, P20, DOI 10.1126/science.348.6230.20
   Lang T, 2011, AM J TROP MED HYG, V85, P967, DOI 10.4269/ajtmh.2011.11-0151
   Lipsitch M, 2016, INT J EPIDEMIOL, V45, P2060, DOI 10.1093/ije/dyw124
   Lipsitch M, 2015, SCIENCE, V348, P46, DOI 10.1126/science.aaa3178
   Nakaya HI, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0146
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Pronker ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057755
   Rid A, 2016, AM J PUBLIC HEALTH, V106, P432, DOI 10.2105/AJPH.2015.302996
   Rid A, 2014, LANCET, V384, P1896, DOI 10.1016/S0140-6736(14)61315-5
   Riley S, 2007, PLOS MED, V4, P1032, DOI 10.1371/journal.pmed.0040218
   World Health Organization, 2017, R D BLUEPR UPD
   World Medical Association, 1994, Bull Med Ethics, VNo. 102, P9
NR 45
TC 8
Z9 9
U1 3
U2 21
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD JUL 14
PY 2017
VL 357
IS 6347
SI SI
BP 153
EP +
DI 10.1126/science.aam8334
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FA4CP
UT WOS:000405391700035
PM 28706038
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Fagerlin, A
   Valley, TS
   Scherer, AM
   Knaus, M
   Das, E
   Zikmund-Fisher, BJ
AF Fagerlin, Angela
   Valley, Thomas S.
   Scherer, Aaron M.
   Knaus, Megan
   Das, Enny
   Zikmund-Fisher, Brian J.
TI Communicating infectious disease prevalence through graphics: Results
   from an international survey
SO VACCINE
LA English
DT Article
DE Influenza; Communication; Graphics; Vaccination; Infectious disease
ID SOCIAL MEDIA; EPIDEMIOLOGIC TOOL; DOT MAPS; VACCINATION; OUTBREAK;
   FORMAT; RISKS; KNOWLEDGE; WARNINGS; FACEBOOK
AB Background: Graphics are increasingly used to represent the spread of infectious diseases (e.g., influenza, Zika, Ebola); however, the impact of using graphics to adequately inform the general population is unknown. Objective: To examine whether three ways of visually presenting data (heat map, dot map, or pictotrendline) all depicting the same information regarding the spread of a hypothetical outbreak of influenza influence intent to vaccinate, risk perception, and knowledge.
   Design: Survey with participants randomized to receive a simulated news article accompanied by one of the three graphics that communicated prevalence of influenza and number of influenza-related deaths. Setting: International online survey.
   Participants: 16,510 adults living in 11 countries selected using stratified random sampling based on age and gender.
   Measurements: After reading the article and viewing the presented graphic, participants completed a survey that measured interest in vaccination, perceived risk of contracting disease, knowledge gained, interest in additional information about the disease, and perception of the graphic.
   Results: Heat maps and picto-trendlines were evaluated more positively than dot maps. Heat maps were more effective than picto-trendlines and no different from dot maps at increasing interest in vaccination, perceived risk of contracting disease, and interest in additional information about the disease. Heat maps and picto-trendlines were more successful at conveying knowledge than dot maps. Overall, heat maps were the only graphic to be superior in every outcome.
   Limitations: Results are based on a hypothetical scenario.
   Conclusion: Heat maps are a viable option to promote interest in and concern about infectious diseases. Published by Elsevier Ltd.
C1 [Fagerlin, Angela] Univ Utah, Sch Med, Dept Populat Hlth Sci, Salt Lake City, UT 84112 USA.
   [Fagerlin, Angela] Vet Affairs Salt Lake City Ctr Informat Decis Enh, Salt Lake City, UT USA.
   [Valley, Thomas S.] Univ Michigan, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA.
   [Valley, Thomas S.] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA.
   [Valley, Thomas S.; Knaus, Megan; Zikmund-Fisher, Brian J.] Univ Michigan, Ctr Bioeth & Social Sci Med, Ann Arbor, MI 48109 USA.
   [Scherer, Aaron M.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.
   [Das, Enny] Radboud Univ Nijmegen, Ctr Language Studies, Nijmegen, Netherlands.
   [Zikmund-Fisher, Brian J.] Univ Michigan, Dept Hlth Behav & Hlth Educ, Ann Arbor, MI 48109 USA.
   [Zikmund-Fisher, Brian J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.
RP Fagerlin, A (corresponding author), Univ Utah, Sch Med, Dept Populat Hlth Sci, Salt Lake City, UT 84112 USA.
EM angie.fagerlin@hsc.utah.edu
RI Zikmund-Fisher, Brian J./A-7677-2009
OI Scherer, Aaron M/0000-0002-4134-9300; Valley,
   Thomas/0000-0002-5766-4970; Zikmund-Fisher, Brian/0000-0002-1637-4176
FU European Union's Seventh Framework Programme for research, technological
   development and demonstrationEuropean Union (EU) [278763]; NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [T32HL007749]
FX This work was supported by the European Union's Seventh Framework
   Programme for research, technological development and demonstration
   under grant agreement #278763 and NIH T32HL007749 (TSV).
CR Ahmed OH, 2016, PHYS THER SPORT, V21, P82, DOI 10.1016/j.ptsp.2016.03.001
   BARRETO ML, 1993, INT J EPIDEMIOL, V22, P731, DOI 10.1093/ije/22.4.731
   Bish A, 2011, VACCINE, V29, P6472, DOI 10.1016/j.vaccine.2011.06.107
   Centers for disease control and prevention, 2016, EB VIR DIS DISTR MAP
   Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118
   Duke CH, 2016, AM J INFECT CONTROL
   Duncan B, 2009, EUROSURVEILLANCE, V14, P15
   Eden KB, 2009, J CLIN EPIDEMIOL, V62, P415, DOI 10.1016/j.jclinepi.2008.05.012
   Eng SB, 1999, EMERG INFECT DIS, V5, P815, DOI 10.3201/eid0506.990613
   European Centre for Disease Prevention and Control, 2015, SEAS INFL VACC EUR O
   Fagerlin A, 2005, MED DECIS MAKING, V25, P398, DOI 10.1177/0272989X05278931
   Field RI, 2013, HUM VACC IMMUNOTHER, V9, P2670, DOI 10.4161/hv.26653
   Fu K-W, 2016, AM J INFECT CONTROL
   Gesualdo F, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-561
   Grijalva CG, 2015, JAMA-J AM MED ASSOC, V314, P1488, DOI 10.1001/jama.2015.12160
   Hale TM, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3275
   Hammond D, 2007, AM J PREV MED, V32, P202, DOI 10.1016/j.amepre.2006.11.011
   Hawker MD, 2010, STUD HEALTH TECHNOL, V160, P356, DOI 10.3233/978-1-60750-588-4-356
   Hawley ST, 2008, PATIENT EDUC COUNS, V73, P448, DOI 10.1016/j.pec.2008.07.023
   Hawn C, 2009, HEALTH AFFAIR, V28, P361, DOI 10.1377/hlthaff.28.2.361
   Househ M, 2016, HEALTH INFORM J, V22, P470, DOI 10.1177/1460458214568037
   Huesch MD, 2016, HEALTH SERV RES, V51, P1273, DOI 10.1111/1475-6773.12496
   Karlsson D, 2013, STUD HEALTH TECHNOL, V192, P697, DOI 10.3233/978-1-61499-289-9-697
   Keller B, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.2982
   Lehmann BA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-547
   Leitner M, 2000, CARTOGR GEOGR INF SC, V27, P3, DOI DOI 10.1559/152304000783548037
   Magnan RE, 2015, ANN BEHAV MED, V49, P594, DOI 10.1007/s12160-015-9691-6
   MARTINEZ BF, 1989, JAMA-J AM MED ASSOC, V262, P2246, DOI 10.1001/jama.262.16.2246
   Mollema L, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3863
   Mowbray F, 2016, VACCINE, V34, P3268, DOI 10.1016/j.vaccine.2016.05.006
   Norman G, 2010, ADV HEALTH SCI EDUC, V15, P625, DOI 10.1007/s10459-010-9222-y
   Odlum M, 2015, AM J INFECT CONTROL, V43, P563, DOI 10.1016/j.ajic.2015.02.023
   Poland GA, 2010, VACCINE, V28, pD3, DOI 10.1016/j.vaccine.2010.08.024
   Rosling H, 2011, J EPIDEMIOL GLOB HEA, V1, P11, DOI 10.1016/j.jegh.2011.07.001
   Seltzer EK, 2015, PUBLIC HEALTH, V129, P1273, DOI 10.1016/j.puhe.2015.07.025
   Severtson DJ, 2012, RISK ANAL, V32, P259, DOI 10.1111/j.1539-6924.2011.01700.x
   Smith CM, 2015, EUROSURVEILLANCE, V20, P6, DOI 10.2807/1560-7917.ES.2015.20.39.30026
   Spiegelhalter D, 2011, SCIENCE, V333, P1393, DOI 10.1126/science.1191181
   Strekalova YA, 2016, HLTH ED BEHAV
   Survey Sampling International, 2017, DAT QUAL MARK RES SU
   Tait AR, 2010, ANESTH ANALG, V111, P718, DOI 10.1213/ANE.0b013e3181e8570a
   Tait AR, 2010, J HEALTH COMMUN, V15, P487, DOI 10.1080/10810730.2010.492560
   Taylor AL, 2015, PHILOS T R SOC A, V373, P2055
   Thackeray R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-242
   Towers S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129179
   Turner AM, 2013, J BIOMED INFORM, V46, P575, DOI 10.1016/j.jbi.2013.04.006
   WHO, 2016, EB MAPS
   Witteman HO, 2015, RISK ANAL, V35, P1801, DOI 10.1111/risa.12418
   Witteman HO, 2014, J MED INTERNET RES, V16, P294, DOI 10.2196/jmir.2895
   Zikmund-Fisher BJ, 2005, RISK ANAL, V25, P589, DOI 10.1111/j.1539-6924.2005.00626.x
   Zikmund-Fisher BJ, 2012, J MED INTERNET RES, V14, P148, DOI 10.2196/jmir.2030
   Zikmund-Fisher BJ, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1665
NR 52
TC 1
Z9 1
U1 2
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUL 13
PY 2017
VL 35
IS 32
BP 4041
EP 4047
DI 10.1016/j.vaccine.2017.05.048
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA FC1BI
UT WOS:000406572000022
PM 28647168
OA Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Richner, JM
   Jagger, BW
   Shan, C
   Fontes, CR
   Dowd, KA
   Cao, B
   Himansu, S
   Caine, EA
   Nunes, BTD
   Medeiros, DBA
   Muruato, AE
   Foreman, BM
   Luo, HL
   Wang, T
   Barrett, AD
   Weaver, SC
   Vasconcelos, PFC
   Rossi, SL
   Ciaramella, G
   Mysorekar, IU
   Pierson, TC
   Shi, PY
   Diamond, MS
AF Richner, Justin M.
   Jagger, Brett W.
   Shan, Chao
   Fontes, Camila R.
   Dowd, Kimberly A.
   Cao, Bin
   Himansu, Sunny
   Caine, Elizabeth A.
   Nunes, Bruno T. D.
   Medeiros, Daniele B. A.
   Muruato, Antonio E.
   Foreman, Bryant M.
   Luo, Huanle
   Wang, Tian
   Barrett, Alan D.
   Weaver, Scott C.
   Vasconcelos, Pedro F. C.
   Rossi, Shannan L.
   Ciaramella, Giuseppe
   Mysorekar, Indira U.
   Pierson, Theodore C.
   Shi, Pei-Yong
   Diamond, Michael S.
TI Vaccine Mediated Protection Against Zika Virus-Induced Congenital
   Disease
SO CELL
LA English
DT Article
ID MESSENGER-RNA VACCINES; N-LINKED GLYCOSYLATION; WEST NILE VIRUS; NS1
   PROTEIN; DENGUE VIRUS; CDNA CLONE; MOUSE; ANTIBODIES; ORGANIZATION;
   REPLICATION
AB The emergence of Zika virus (ZIKV) and its association with congenital malformations has prompted the rapid development of vaccines. Although efficacy with multiple viral vaccine platforms has been established in animals, no study has addressed protection during pregnancy. We tested in mice two vaccine platforms, a lipid nanoparticle-encapsulated modified mRNA vaccine encoding ZIKV prM and E genes and a live-attenuated ZIKV strain encoding an NS1 protein without glycosylation, for their ability to protect against transmission to the fetus. Vaccinated dams challenged with a heterologous ZIKV strain at embryo day 6 (E6) and evaluated at E13 showed markedly diminished levels of viral RNA in maternal, placental, and fetal tissues, which resulted in protection against placental damage and fetal demise. As modified mRNA and live-attenuated vaccine platforms can restrict in utero transmission of ZIKV in mice, their further development in humans to prevent congenital ZIKV syndrome is warranted.
C1 [Richner, Justin M.; Jagger, Brett W.; Caine, Elizabeth A.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO USA.
   [Shan, Chao; Fontes, Camila R.; Nunes, Bruno T. D.; Medeiros, Daniele B. A.; Muruato, Antonio E.; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem Mol Biol, Galveston, TX USA.
   [Dowd, Kimberly A.; Foreman, Bryant M.; Pierson, Theodore C.] Natl Inst Hlth, Viral Pathogenesis Sect, Lab Viral Dis, Bethesda, MD USA.
   [Cao, Bin; Mysorekar, Indira U.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO USA.
   [Himansu, Sunny; Ciaramella, Giuseppe] Valera LLC, Moderna Venture, 500 Technol Sq, Cambridge, MA USA.
   [Nunes, Bruno T. D.; Medeiros, Daniele B. A.; Vasconcelos, Pedro F. C.] Evandro Chagas Inst, Dept Arbovirol & Hemorrhag Fevers, Minist Hlth, Ananindeua, Para, Brazil.
   [Muruato, Antonio E.; Luo, Huanle; Rossi, Shannan L.] Univ Texas Med Branch, Dept Pathol, Galveston, TX USA.
   [Wang, Tian; Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX USA.
   [Weaver, Scott C.; Rossi, Shannan L.; Shi, Pei-Yong] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX USA.
   [Wang, Tian; Barrett, Alan D.; Weaver, Scott C.] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX USA.
   [Mysorekar, Indira U.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO USA.
   [Vasconcelos, Pedro F. C.] Para State Univ, Dept Pathol, Belem, Para, Brazil.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Pharmacol Toxicol, Galveston, TX USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol Mol Biophys, Galveston, TX USA.
   [Richner, Justin M.; Jagger, Brett W.; Shan, Chao; Fontes, Camila R.; Dowd, Kimberly A.] IIT Res Inst, Chicago, IL USA.
RP Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Dept Biochem Mol Biol, Galveston, TX USA.; Pierson, TC (corresponding author), Natl Inst Hlth, Viral Pathogenesis Sect, Lab Viral Dis, Bethesda, MD USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Inst Translat Sci, Galveston, TX USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Dept Pharmacol Toxicol, Galveston, TX USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Sealy Ctr Struct Biol Mol Biophys, Galveston, TX USA.
EM piersontc@niaid.nih.gov; peshi@utmb.edu; diamond@wusm.wustl.edu
RI Vasconcelos, Pedro/AAH-3142-2019; Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165; Richner,
   Justin/0000-0002-5344-118X; Shan, Chao/0000-0002-3953-3782
FU NIH-NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI073755, R01 AI104972, P01 AI106695,
   R24AI120942, T32 AI007172]; NIH/NICHDUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice
   Kennedy Shriver National Institute of Child Health & Human Development
   (NICHD) [R01 HD091218]; intramural program of NIH-NIAID; DARPAUnited
   States Department of DefenseDefense Advanced Research Projects Agency
   (DARPA) [W911NF-13-1-0417]; Preventing Prematurity Initiative grant from
   the Burroughs Wellcome Fund; Prematurity Research Initiative
   Investigator award from the March of Dimes [(21-FY13-28) 8]; Moderna
   [OTM10991]; University of Texas Medical Branch (UTMB) startup award;
   UTMB Innovation and Commercialization award; University of Texas STARs
   Award; Pan American Health Organization [SCON2016-01353]; Ministry of
   Health of Brazil; CNPqNational Council for Scientific and Technological
   Development (CNPq) [303999/2016-0, 440405/2016-5]; CAPES (Zika fast
   track project)
FX This work was supported by grants from the NIH-NIAID (R01 AI073755, R01
   AI104972, and P01 AI106695 to M.S.D., R24AI120942 to S.C.W., and T32
   AI007172 to B.W.J.), the NIH/NICHD (R01 HD091218 to I.U.M. and M.S.D.),
   the intramural program of NIH-NIAID (T.C.P), a research grant by DARPA
   (agreement # W911NF-13-1-0417), a Preventing Prematurity Initiative
   grant from the Burroughs Wellcome Fund (to I.U.M.), a Prematurity
   Research Initiative Investigator award (21-FY13-28) 8 from the March of
   Dimes (to I.U.M.), and a research grant from Moderna (OTM10991). P.-Y.S.
   was supported by University of Texas Medical Branch (UTMB) startup
   award, UTMB Innovation and Commercialization award, University of Texas
   STARs Award, and a grant from Pan American Health Organization
   SCON2016-01353. P.F.C.V. was supported by the Ministry of Health of
   Brazil and by the grants from CNPq (process 303999/2016-0 and
   440405/2016-5) and CAPES (Zika fast track project). We thank the Animal
   Resource Center and Sasha Azar at UTMB for their assistance in
   maintaining the A129 mouse breeding colony. M.S.D. is a consultant for
   Inbios, Visterra, and Takeda Pharmaceuticals and on the Scientific
   Advisory Boards of Moderna and OvaGene. S.C.W. is a consultant for
   Valera LLC, GeoVax, Inc. and Sanofi-Pasteur. S.H. and G.C. are employees
   of Valera LLC, a Moderna Venture focusing on the development of
   therapeutic approaches for Infectious Diseases, including ZIKV mRNA
   vaccines.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brien J.D., 2013, CURR PROTOC MICROBIO, V31, P18
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Dowd KA, 2015, MBIO, V6, DOI 10.1128/mBio.01559-15
   Durbin AP, 2016, SEMIN REPROD MED, V34, P299, DOI 10.1055/s-0036-1592070
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferlenghi I, 2001, MOL CELL, V7, P593, DOI 10.1016/S1097-2765(01)00206-4
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Guy B, 2016, NAT REV MICROBIOL, V14, P45, DOI 10.1038/nrmicro.2015.2
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Khan S, 2016, J EXP MED, V213, P2913, DOI 10.1084/jem.20161289
   Kim J, 2009, J IMMUNOL, V182, P2583, DOI 10.4049/jimmunol.0803247
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Muylaert IR, 1996, VIROLOGY, V222, P159, DOI 10.1006/viro.1996.0406
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pardi N, 2017, METHODS MOL BIOL, V1499, P109, DOI 10.1007/978-1-4939-6481-9_6
   Pentsuk N, 2009, BIRTH DEFECTS RES B, V86, P328, DOI 10.1002/bdrb.20201
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Pryor MJ, 1998, J GEN VIROL, V79, P2631, DOI 10.1099/0022-1317-79-11-2631
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schlake T, 2012, RNA BIOL, V9, P1319, DOI 10.4161/rna.22269
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shan C, 2017, EBIOMEDICINE, V17, P157, DOI 10.1016/j.ebiom.2017.03.006
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804
   Shi PY, 2002, J VIROL, V76, P5847, DOI 10.1128/JVI.76.12.5847-5856.2002
   Shin HN, 2013, TRENDS IMMUNOL, V34, P487, DOI 10.1016/j.it.2013.08.001
   Somnuke P, 2011, VIROLOGY, V413, P253, DOI 10.1016/j.virol.2011.02.022
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Whiteman MC, 2011, VACCINE, V29, P9702, DOI 10.1016/j.vaccine.2011.09.036
   Whiteman MC, 2010, VACCINE, V28, P1075, DOI 10.1016/j.vaccine.2009.10.112
   Yang YJ, 2017, EBIOMEDICINE, V17, P145, DOI 10.1016/j.ebiom.2017.02.003
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 51
TC 110
Z9 112
U1 0
U2 42
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD JUL 13
PY 2017
VL 170
IS 2
BP 273
EP +
DI 10.1016/j.cell.2017.06.040
PG 23
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA FA5OU
UT WOS:000405493900008
PM 28708997
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Munoz, AG
   Thomson, MC
   Stewart-Ibarra, AM
   Vecchi, GA
   Chourio, X
   Najera, P
   Moran, Z
   Yang, XS
AF Munoz, Angel G.
   Thomson, Madeleine C.
   Stewart-Ibarra, Anna M.
   Vecchi, Gabriel A.
   Chourio, Xandre
   Najera, Patricia
   Moran, Zelda
   Yang, Xiaosong
TI Could the Recent Zika Epidemic Have Been Predicted?
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Aedes-borne diseases; zika; dengue; chikungunya; predictability; R-0
   model; climate
ID AEDES-ALBOPICTUS; GLOBAL RISK; VIRUS; CLIMATE; TRANSMISSION; AMERICA
AB Given knowledge at the time, the recent 2015-2016 zika virus (ZIKV) epidemic probably could not have been predicted. Without the prior knowledge of ZIKV being already present in South America, and given the lack of understanding of key epidemiologic processes and long-term records of ZIKV cases in the continent, the best related prediction could be carried out for the potential risk of a generic Aedes-borne disease epidemic. Here we use a recently published two-vector basic reproduction number model to assess the predictability of the conditions conducive to epidemics of diseases like zika, chikungunya, or dengue, transmitted by the independent or concurrent presence of Aedes aegypti and Aedes albopictus. We compare the potential risk of transmission forcing the model with the observed climate and with state-of-the-art operational forecasts from the North American Multi Model Ensemble (NMME), finding that the predictive skill of this new seasonal forecast system is highest for multiple countries in Latin America and the Caribbean during the December-February and March-May seasons, and slightly lower-but still of potential use to decision-makers-for the rest of the year. In particular, we find that above-normal suitable conditions for the occurrence of the zika epidemic at the beginning of 2015 could have been successfully predicted at least 1 month in advance for several zika hotspots, and in particular for Northeast Brazil: the heart of the epidemic. Nonetheless, the initiation and spread of an epidemic depends on the effect of multiple factors beyond climate conditions, and thus this type of approach must be considered as a guide and not as a formal predictive tool of vector-borne epidemics.
C1 [Munoz, Angel G.; Vecchi, Gabriel A.] Princeton Univ, Atmospher & Ocean Sci, Princeton, NJ 08544 USA.
   [Munoz, Angel G.; Yang, Xiaosong] Princeton Univ, Geophys Fluid Dynam Lab, Princeton, NJ 08544 USA.
   [Munoz, Angel G.; Thomson, Madeleine C.] Columbia Univ, Earth Inst, Int Res Inst Climate & Soc, New York, NY 10027 USA.
   [Thomson, Madeleine C.; Moran, Zelda] Columbia Univ, Dept Environm Hlth Sci, Mailman Sch Publ Hlth, New York, NY USA.
   [Thomson, Madeleine C.] Columbia Univ, Collaborating Ctr Early Warning Syst Malaria & Ot, WHO, New York, NY USA.
   [Stewart-Ibarra, Anna M.] SUNY Upstate Med Univ, Ctr Global Hlth & Translat Sci, Syracuse, NY 13210 USA.
   [Stewart-Ibarra, Anna M.] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA.
   [Vecchi, Gabriel A.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA.
   [Vecchi, Gabriel A.] Princeton Univ, Princeton Environm Inst, Princeton, NJ 08544 USA.
   [Chourio, Xandre] Univ Zulia, Ctr Modelado Cient, Latin Amer Observ Climate Events, Maracaibo, Venezuela.
   [Najera, Patricia] Pan Amer Hlth Org, Communicable Dis & Hlth Anal Dept, Int Hlth Regulat Epidem Alert & Response & Water, Washington, DC USA.
RP Munoz, AG (corresponding author), Princeton Univ, Atmospher & Ocean Sci, Princeton, NJ 08544 USA.; Munoz, AG (corresponding author), Princeton Univ, Geophys Fluid Dynam Lab, Princeton, NJ 08544 USA.; Munoz, AG (corresponding author), Columbia Univ, Earth Inst, Int Res Inst Climate & Soc, New York, NY 10027 USA.
EM agms@princeton.edu
RI Vecchi, Gabriel/A-2413-2008
OI Vecchi, Gabriel/0000-0002-5085-224X; Moran, Zelda/0000-0002-1493-5734;
   Stewart-Ibarra, Anna/0000-0002-3383-4672
FU National Oceanic and Atmospheric Administration Oceanic; Atmospheric
   Research; auspices of the National Earth System Prediction Capability;
   Centro de Modelado Cientifico's project CMC-CC-Dat-2016; IRIWHO
   Collaborating Center (430) Malaria Early Warning and Other Climate
   Sensitive Diseases
FX AM was supported by National Oceanic and Atmospheric Administration
   Oceanic and Atmospheric Research, under the auspices of the National
   Earth System Prediction Capability. XC was supported by the Centro de
   Modelado Cientifico's project CMC-CC-Dat-2016. This work was supported
   by the IRIWHO Collaborating Center ( 430) Malaria Early Warning and
   Other Climate Sensitive Diseases
   (http://apps.who.int/whocc/Detail.aspx?cc_ref=USA-430&cc_region=amro&cc_
   subject= malaria&).
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   ANDERSON R M, 1991
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carlson CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004968
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Chourio X., 2016, CLIMATE SERVICE PART
   Chretien JP, 2007, AM J TROP MED HYG, V76, P405, DOI 10.4269/ajtmh.2007.76.405
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fan Y, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008470
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Gardner LM, 2016, LANCET INFECT DIS, V16, P522, DOI 10.1016/S1473-3099(16)00176-6
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711
   Ibarra AMS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078263
   Jolliffe I. T., 2012, FORECAST VERIFICATIO
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kirtman BP, 2014, B AM METEOROL SOC, V95, P585, DOI 10.1175/BAMS-D-12-00050.1
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Li YJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003301
   Lourenco J., 2017, EPIDEMIOLOGICAL ECOL, DOI [10.1101/101972, DOI 10.1101/101972]
   Magori K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000508
   Mason SJ, 2008, NATO SCI S SS IV EAR, V82, P163
   Mason SJ, 2009, MON WEATHER REV, V137, P331, DOI 10.1175/2008MWR2553.1
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Monaghan Andrew J, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.50dfc7f46798675fc63e7d7da563da76
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Moreno Y, 2002, EUR PHYS J B, V26, P521, DOI 10.1140/epjb/e20020122
   Morin CW, 2010, INT J BIOMETEOROL, V54, P517, DOI 10.1007/s00484-010-0349-6
   Munoz A. G., 2012, RISK MANAGEMENT CURR, DOI [10.5772/50788, DOI 10.5772/50788]
   Munoz AG, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0146-1
   Munoz AG, 2010, B AM METEOROL SOC, V91, P1645, DOI 10.1175/2010BAMS2958.1
   Murray J D, 2002, MATH BIOL, V17
   PAHO, 2016, WHO ZIK SIT REP
   PAHO, 2017, PAHO WHO ZIK CUM CAS
   PAHO, 2016, PAHO WHO DENG ANN CA
   Perkins TA, 2017, P NATL ACAD SCI USA, V114, P5558, DOI 10.1073/pnas.1705969114
   Samy AM, 2016, MEM I OSWALDO CRUZ, V111, P559, DOI 10.1590/0074-02760160149
   Santos LBL, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016102
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588
   Stewart-Ibarra AM, 2013, AM J TROP MED HYG, V88, P971, DOI 10.4269/ajtmh.12-0478
   Thomson MC, 2006, NATURE, V439, P576, DOI 10.1038/nature04503
   Turner J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053128
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   WHO, 2016, DENG FEV UR
NR 52
TC 12
Z9 12
U1 0
U2 12
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JUL 12
PY 2017
VL 8
AR 1291
DI 10.3389/fmicb.2017.01291
PG 10
WC Microbiology
SC Microbiology
GA FB5AB
UT WOS:000406152500001
PM 28747901
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Klein, RS
AF Klein, Robyn S.
TI Dual Blades: The Role of Musashi 1 in Zika Replication and Microcephaly
SO CELL HOST & MICROBE
LA English
DT Editorial Material
ID VIRUS
AB Infection with Zika virus (ZIKV) during pregnancy may cause severe developmental defects in the human brain via unknown mechanisms. In a recent issue of Science, Chavali et al. (2017) identified a neural progenitor cell (NPC)-specific RNA binding protein that may underlie the high levels of ZIKV replication and apoptosis observed in these cells during congenital infections.
C1 [Klein, Robyn S.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA.
   [Klein, Robyn S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Klein, Robyn S.] Washington Univ, Sch Med, Dept Neurosci, St Louis, MO 63110 USA.
RP Klein, RS (corresponding author), Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA.; Klein, RS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Klein, RS (corresponding author), Washington Univ, Sch Med, Dept Neurosci, St Louis, MO 63110 USA.
EM rklein@wustl.edu
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U19 AI083019, R01 AI101400]; NINDS NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [R01 NS052632]
CR Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Barbelanne M, 2014, BIOMED RES INT, DOI 10.1155/2014/547986
   Cernescu C, 1981, Virologie, V32, P199
   Chavali P. L., 2017, SCIENCE
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Glazer RI, 2012, FRONT BIOSCI-LANDMRK, V17, P54, DOI 10.2741/3915
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   O'Driscoll M, 2006, CELL CYCLE, V5, P2339, DOI 10.4161/cc.5.20.3358
   Shibata S, 2012, BRAIN RES, V1462, P162, DOI 10.1016/j.brainres.2012.01.068
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 11
TC 2
Z9 2
U1 0
U2 5
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD JUL 12
PY 2017
VL 22
IS 1
BP 9
EP 11
DI 10.1016/j.chom.2017.06.015
PG 4
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA FA2ZA
UT WOS:000405309400005
PM 28704657
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Abdelhameed, RM
   Kamel, OMHM
   Amr, A
   Rocha, J
   Silva, AMS
AF Abdelhameed, Reda M.
   Kamel, Omnia M. H. M.
   Amr, A.
   Rocha, Joao
   Silva, Artur M. S.
TI Antimosquito Activity of a Titanium-Organic Framework Supported on
   Fabrics
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE antimosquito; NH2-MIL-125; metal organic frameworks; cotton; viscose;
   linen
ID COTTON FABRICS; NANOPARTICLES; INSECTICIDE; COMPOSITES; CULICIDAE;
   DIPTERA; FIBERS; GROWTH; CUBTC; WATER
AB Waste swamps, stagnant water, and poor hygiene practices result in the proliferation of mosquitoes that may cause transmissible and infectious diseases such as malaria, typhoid, cholera, and Zika virus sickness. It has been shown that composites of the traditional natural fibers cotton, viscose, and linen and a Ti-bearing metal-organic framework, NH2-MIL-125, are very effective against mosquitoes in the absence of any conventional insecticides. In our study, prior to coating with NH2-MIL-125 crystals, the fabrics were modified with 3-glycidyloxypropyltrimethoxysilane. The composite materials were characterized by powder X-ray diffraction, UV-vis spectroscopy, Fourier transform infrared spectroscopy, and scanning electron microscopy with energy-dispersive X-ray spectroscopy analysis. The latter, in particular, has shown the uniform coating of the fabrics with NH2-MIL-125 crystals. The modified fabrics have excellent antimosquito properties, attracting and killing them.
C1 [Abdelhameed, Reda M.; Kamel, Omnia M. H. M.] Natl Res Ctr, Appl Organ Chem Dept, 33 EL Bohouthst, Giza 12622, Egypt.
   [Amr, A.] Natl Res Ctr, Pretreatment & Finishing Cellulos Fibers Dept, Text Ind Res Div, 33 EL Bohouthst, Giza 12622, Egypt.
   [Rocha, Joao] Univ Aveiro, CICECO, Dept Chem, P-3810193 Aveiro, Portugal.
   [Silva, Artur M. S.] Univ Aveiro, QOPNA, Dept Chem, P-3810193 Aveiro, Portugal.
RP Abdelhameed, RM (corresponding author), Natl Res Ctr, Appl Organ Chem Dept, 33 EL Bohouthst, Giza 12622, Egypt.; Silva, AMS (corresponding author), Univ Aveiro, QOPNA, Dept Chem, P-3810193 Aveiro, Portugal.
EM reda_nrc@yahoo.com; artur.silva@ua.pt
RI Silva, Artur/L-9222-2014; Abdelhameed, Reda M./R-3286-2019; Rocha,
   Joao/A-2486-2010
OI Silva, Artur/0000-0003-2861-8286; Rocha, Joao/0000-0002-0417-9402;
   Abdelhameed, Reda/0000-0003-1700-5361; Kamel, Dr
   Omnia/0000-0003-0344-2472
FU FCT/MEC [FCT UID/QUI/00062/2013]; FEDER, within the PT Partnership
   Agreement; CICECO Aveiro Institute of Materials
   [POCI-01-0145-FEDER-007679 - FCT UID/CTM/50011/2013]
FX Thanks are due to FCT/MEC for the financial support to the QOPNA
   Research Unit (FCT UID/QUI/00062/2013) and CICECO Aveiro Institute of
   Materials (POCI-01-0145-FEDER-007679 - FCT UID/CTM/50011/2013) through
   national funds and, where applicable, cofinanced by the FEDER, within
   the PT2020 Partnership Agreement, and to the Portuguese NMR Network.
CR Abdel-Mohdy FA, 2008, CARBOHYD POLYM, V73, P92, DOI 10.1016/j.carbpol.2007.11.006
   Abdelhameed RM, 2017, FUEL PROCESS TECHNOL, V159, P306, DOI 10.1016/j.fuproc.2017.02.001
   Abdelhameed RM, 2016, RSC ADV, V6, P42324, DOI 10.1039/c6ra04719j
   Abdelhameed RM, 2015, CHEM-EUR J, V21, P11072, DOI 10.1002/chem.201500808
   Abdelhameed RM, 2015, NEW J CHEM, V39, P4249, DOI 10.1039/c4nj02382j
   Abdelhameed RM, 2014, EUR J INORG CHEM, P5285, DOI 10.1002/ejic.201402789
   Abdelhameed RM, 2013, CHEM COMMUN, V49, P5019, DOI 10.1039/c3cc41446a
   Ahmed HB, 2016, FIBER POLYM, V17, P418, DOI 10.1007/s12221-016-5814-3
   Conn R. C., 1958, U.S. Patent No. US, Patent No. [2846337 A, 2846337]
   Darwish M., 1981, JOURNAL OF THE EGYPTIAN PUBLIC HEALTH ASSOCIATION, V56, P1
   DEBACH P, 1991, BIOL CONTROL NATURAL
   El Hag EA, 1999, PHYTOTHER RES, V13, P388, DOI 10.1002/(SICI)1099-1573(199908/09)13:5&lt;388::AID-PTR455&gt;3.0.CO;2-U
   El-Bahnasawy Mamdouh M, 2013, J Egypt Soc Parasitol, V43, P87
   El-Bahnasawy Mamdouh M. M., 2012, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V42, P373
   Emam H. E., 2017, J POROUS MAT, P1
   Emam HE, 2015, APPL SURF SCI, V357, P1878, DOI 10.1016/j.apsusc.2015.09.095
   Farha OK, 2010, NAT CHEM, V2, P944, DOI [10.1038/nchem.834, 10.1038/NCHEM.834]
   Gad AM, 1999, J MED ENTOMOL, V36, P709, DOI 10.1093/jmedent/36.6.709
   Gascon J, 2008, CHEMSUSCHEM, V1, P981, DOI 10.1002/cssc.200800203
   Geethadevi R, 2015, INDIAN J FIBRE TEXT, V40, P175
   Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326
   Hebeish A, 2008, CARBOHYD POLYM, V74, P268, DOI 10.1016/j.carbpol.2008.02.013
   Hendon CH, 2013, J AM CHEM SOC, V135, P10942, DOI 10.1021/ja405350u
   Horcajada P, 2012, CHEM REV, V112, P1232, DOI 10.1021/cr200256v
   Horcajada P, 2010, NAT MATER, V9, P172, DOI [10.1038/NMAT2608, 10.1038/nmat2608, 10.1038/NMAT260B]
   James SL, 2003, CHEM SOC REV, V32, P276, DOI 10.1039/b200393g
   JOSEPH ML, 1986, INTRO TEXTILE SCI
   Kamel O. M., 2005, EGYPT ACAD SOC ENV D, V6, P277
   Lange LE, 2014, FIBER POLYM, V15, P200, DOI 10.1007/s12221-014-0200-5
   Lee K., 2005, Patent No. US, Patent No. [2005/0060926 Al, 20050060926]
   Lopez-Maya E, 2015, ANGEW CHEM INT EDIT, V54, P6790, DOI 10.1002/anie.201502094
   Moreira MA, 2012, MICROPOR MESOPOR MAT, V158, P229, DOI 10.1016/j.micromeso.2012.03.039
   Nasalevich MA, 2013, CHEM COMMUN, V49, P10575, DOI 10.1039/c3cc46398b
   Neufeld MJ, 2015, ACS APPL MATER INTER, V7, P26742, DOI 10.1021/acsami.5b08773
   Omar MS, 1996, TROP MED INT HEALTH, V1, P155
   Ozer RR, 2015, RSC ADV, V5, P15198, DOI 10.1039/c4ra15161e
   Park OH, 1999, J SOL-GEL SCI TECHN, V16, P235, DOI 10.1023/A:1008717219952
   RAJA ASM, 2015, INT J MOSQ RES A, V2, P49
   Rodriguez HS, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40815
   Rowe MD, 2009, BIOMACROMOLECULES, V10, P983, DOI 10.1021/bm900043e
   Schramm C, 2005, J MATER SCI, V40, P1883, DOI 10.1007/s10853-005-1207-5
   Schramm C, 2004, J SOL-GEL SCI TECHN, V29, P155, DOI 10.1023/B:JSST.0000023850.97771.7d
   Schramm C, 2017, COLOR TECHNOL, V133, P234, DOI 10.1111/cote.12274
   Shang SM, 2010, APPL SURF SCI, V257, P1495, DOI 10.1016/j.apsusc.2010.08.081
   Song JL, 2013, NORD PULP PAP RES J, V28, P216, DOI 10.3183/npprj-2013-28-02-p216-238
   Wang C, 2015, CELLULOSE, V22, P3789, DOI 10.1007/s10570-015-0754-4
   Yu M., 2016, SCI REP, V6, P1
   Zhang XM, 2010, SCI CHINA CHEM, V53, P626, DOI 10.1007/s11426-010-0050-y
   Zhou HC, 2012, CHEM REV, V112, P673, DOI 10.1021/cr300014x
NR 49
TC 23
Z9 23
U1 8
U2 51
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD JUL 12
PY 2017
VL 9
IS 27
BP 22112
EP 22120
DI 10.1021/acsami.7b03164
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA FA9KO
UT WOS:000405764700006
PM 28618230
DA 2020-07-08
ER

PT J
AU Vazquez-Calvo, A
   de Oya, NJ
   Martin-Acebes, MA
   Garcia-Moruno, E
   Saiz, JC
AF Vazquez-Calvo, Angela
   Jimenez de Oya, Nereida
   Martin-Acebes, Miguel A.
   Garcia-Moruno, Emilia
   Saiz, Juan-Carlos
TI Antiviral Properties of the Natural Polyphenols Delphinidin and
   Epigallocatechin Gallate against the Flaviviruses West Nile Virus, Zika
   Virus, and Dengue Virus
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Flavivirus; polyphenol; delphinidin; epigallocatechin gallate;
   virucidal; West Nile virus; Dengue virus; Zika virus
ID ENTRY; INFECTION; (-)-EPIGALLOCATECHIN-3-GALLATE; BAICALEIN; HONOKIOL;
   TYPE-2; DRUGS
AB The Flavivirus genus contains important pathogens, such as West Nile virus (WNV), Zika virus (ZIKV), and Dengue virus (DENV), which are enveloped plus-strand RNA viruses transmitted by mosquitoes and constitute a worrisome threat to global human and animal health. Currently no licensed drugs against them are available, being, thus, still necessary the search for effective antiviral molecules. In this line, a novel antiviral approach (economical, simple to use, and environmental friendly) is the use of natural compounds. Consequently, we have tested the antiviral potential of different polyphenols present in plants and natural products, such as wine and tea, against WNV, ZIKV, and DENV. So that, we assayed the effect of a panel of structurally related polyphenols [delphinidin (D), cyanidin (Cy), catechin (C), epicatechin (EC), epigallocatechin (EGC), and epigallocatechin gallate (EGCG)] on WNV infection, and found that D and EGCG inhibited more effectively the virus production. Further analysis with both compounds indicated that they mainly affected the attachment and entry steps of the virus life cycle. Moreover, D and EGCG showed a direct effect on WNV particles exerting a virucidal effect. We showed a similar inhibition of viral production of these compounds on WNV variants that differed on acidic pH requirements for viral fusion, indicating that their antiviral activity against WNV is produced by a virucidal effect rather than by an inhibition of pH-dependent viral fusion. Both polyphenols also reduced the infectivity of ZIKV and DENV. Therefore, D and EGCG impair the infectivity in cell culture of these three medically relevant flaviviruses.
C1 [Vazquez-Calvo, Angela; Jimenez de Oya, Nereida; Martin-Acebes, Miguel A.; Saiz, Juan-Carlos] Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Biotecnol, Madrid, Spain.
   [Garcia-Moruno, Emilia] Consiglio Ric Agri & Anal Econ Agr, Ctr Ric Viticoltura Enol CREA VE, Asti, Italy.
RP Saiz, JC (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Biotecnol, Madrid, Spain.
EM jcsaiz@inia.es
RI Martin-Acebes, Miguel A./L-2258-2014; Jimenez de Oya,
   Nereida/K-8470-2016; de Oya, Nereida Jimenez/T-6449-2019; Vazquez-Calvo,
   Angela/G-8795-2015
OI Martin-Acebes, Miguel A./0000-0001-6015-3613; Jimenez de Oya,
   Nereida/0000-0003-3129-813X; de Oya, Nereida
   Jimenez/0000-0003-3129-813X; Saiz, Juan-Carlos/0000-0001-8269-5544;
   Vazquez-Calvo, Angela/0000-0003-3172-2762
FU Comunidad Autonoma de MadridComunidad de Madrid [E_RTA2013-00013-C04,
   ZIKA-BIO-2016-01]; Instituto Nacional de Investigacion y Tecnologia
   Agraria y Alimentaria (INIA)Instituto de Investigacion Agropecuaria
   (INIA) [RTA201500009]; Spanish Ministry of Economy and Competitiveness
   (MINECO) [AGL2014-56518]; MINECO
FX The work was supported in part by grants PLATESA (P2013/ABI2906) from
   the Comunidad Autonoma de Madrid, and E_RTA2013-00013-C04,
   ZIKA-BIO-2016-01, and RTA201500009 from the Instituto Nacional de
   Investigacion y Tecnologia Agraria y Alimentaria (INIA) to J-CS and
   AGL2014-56518-JIN from the Spanish Ministry of Economy and
   Competitiveness (MINECO) to MM-A. AV-C is a recipient of a "Contrato de
   formacion postdoctoral" from MINECO.
CR Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Blazquez AB, 2016, FRONT MICROBIOL, V7, DOI [10.3389/fmicb.2016.00296, 10.3389/fmicb.2010.00296]
   Blazquez Ana-Belen, 2016, World J Virol, V5, P135
   Blazquez AB, 2010, VIRUS RES, V151, P240, DOI 10.1016/j.virusres.2010.04.009
   Calland N, 2015, J VIROL, V89, P10053, DOI 10.1128/JVI.01473-15
   Calland N, 2012, HEPATOLOGY, V55, P720, DOI 10.1002/hep.24803
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Ciesek S, 2011, HEPATOLOGY, V54, P1947, DOI 10.1002/hep.24610
   Colpitts CC, 2014, J VIROL, V88, P7806, DOI 10.1128/JVI.00896-14
   David S, 2016, INFECT DIS-NOR, V48, P571, DOI 10.3109/23744235.2016.1164890
   Fang CY, 2015, VIRUSES-BASEL, V7, P4894, DOI 10.3390/v7092852
   Hsu Stephen, 2015, Inflammation & Allergy Drug Targets, V14, P13, DOI 10.2174/1871528114666151022150122
   Huang HC, 2014, ANTIVIR RES, V111, P100, DOI 10.1016/j.antiviral.2014.09.009
   Imanishi N, 2002, MICROBIOL IMMUNOL, V46, P491, DOI 10.1111/j.1348-0421.2002.tb02724.x
   Ismail NA, 2017, INTERDISCIP SCI, V9, P499, DOI 10.1007/s12539-016-0157-8
   Johari J, 2012, INT J MOL SCI, V13, P16785, DOI 10.3390/ijms131216785
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Li AN, 2014, NUTRIENTS, V6, P6020, DOI 10.3390/nu6126020
   Martin-Acebes Miguel A, 2012, World J Virol, V1, P51, DOI 10.5501/wjv.v1.i2.51
   Martin-Acebes MA, 2014, J VIROL, V88, P12041, DOI 10.1128/JVI.02061-14
   Martin-Acebes MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069479
   Martin-Acebes MA, 2011, J GEN VIROL, V92, P831, DOI 10.1099/vir.0.027185-0
   Martinez JP, 2015, NAT PROD REP, V32, P29, DOI 10.1039/c4np00085d
   Merino-Ramos T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108056
   Pandey KB, 2009, OXID MED CELL LONGEV, V2, P270, DOI 10.4161/oxim.2.5.9498
   Pang Tikki, 2017, Lancet Infect Dis, V17, pe79, DOI 10.1016/S1473-3099(16)30471-6
   Parker S, 2016, PHYTOTHER RES, V30, P1445, DOI 10.1002/ptr.5653
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00411-17, 10.1128/aac.00411-17]
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Sejvar JJ, 2014, VIRUSES-BASEL, V6, P606, DOI 10.3390/v6020606
   Weber C, 2015, ANTIVIR RES, V113, P1, DOI 10.1016/j.antiviral.2014.11.001
   Yang C, 2016, MINI-REV MED CHEM, V16, P404, DOI 10.2174/1389557516666151120115558
   Zandi K, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-214
   Zandi K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-560
   Zhang XZ, 2015, CURR OPIN VIROL, V12, P109, DOI 10.1016/j.coviro.2015.04.006
   Zhong L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.136
NR 37
TC 34
Z9 35
U1 9
U2 30
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JUL 11
PY 2017
VL 8
AR 1314
DI 10.3389/fmicb.2017.01314
PG 8
WC Microbiology
SC Microbiology
GA FA1YX
UT WOS:000405238700001
PM 28744282
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Souza, RL
   Mugabe, VA
   Paploski, IAD
   Rodrigues, MS
   Moreira, PSD
   Nascimento, LCJ
   Roundy, CM
   Weaver, SC
   Reis, MG
   Kitron, U
   Ribeiro, GS
AF Souza, Raquel Lima
   Mugabe, Vanio Andre
   Dexheimer Paploski, Igor Adolfo
   Rodrigues, Moreno S.
   dos Santos Moreira, Patricia Sousa
   Jacob Nascimento, Leile Camila
   Roundy, Christopher Michael
   Weaver, Scott C.
   Reis, Mitermayer Galvao
   Kitron, Uriel
   Ribeiro, Guilherme Sousa
TI Effect of an intervention in storm drains to prevent Aedes aegypti
   reproduction in Salvador, Brazil
SO PARASITES & VECTORS
LA English
DT Article
DE Epidemiology; Entomology; Arboviruses; Insect vectors; Disease vectors;
   Mosquitoes; Aedes aegypti; Storm drain; Catch basin
ID CATCH BASINS; DRY SEASON; VIRUS; SITES
AB Background: Aedes aegypti, the principal vector for dengue, chikungunya and Zika viruses, is a synanthropic species that uses stagnant water to complete its reproductive cycle. In urban settings, rainfall water draining structures, such as storm drains, may retain water and serve as a larval development site for Aedes spp. reproduction. Herein, we describe the effect of a community-based intervention on preventing standing water accumulation in storm drains and their consequent infestation by adult and immature Ae. aegypti and other mosquitoes.
   Methods: Between April and May of 2016, local residents association of Salvador, Brazil, after being informed of water accumulation and Ae. aegypti infestation in the storm drains in their area, performed an intervention on 52 storm drains. The intervention consisted of placing concrete at the bottom of the storm drains to elevate their base to the level of the outflow tube, avoiding water accumulation, and placement of a metal mesh covering the outflow tube to avoid its clogging with debris. To determine the impact of the intervention, we compared the frequency at which the 52 storm drains contained water, as well as adult and immature mosquitoes using data from two surveys performed before and two surveys performed after the intervention.
   Results: During the pre-intervention period, water accumulated in 48 (92.3%) of the storm drains, and immature Ae. aegypti were found in 11 (21.2%) and adults in 10 (19.2%). After the intervention, water accumulated in 5 (9.6%) of the storm drains (P < 0.001), none (0.0%) had immatures (P < 0.001), and 3 (5.8%) contained adults (P = 0.039). The total number of Ae. aegypti immatures collected decreased from 109 to 0 (P < 0.001) and adults decreased from 37 to 8 (P = 0.011) after the intervention. Collection of immature and adult non-Aedes mosquitoes (mainly Culex spp.) in the storm drains also decreased after the intervention.
   Conclusion: This study exemplifies how a simple intervention targeting storm drains can result in a major reduction of water retention, and, consequently, impact Ae. aegypti larval populations. Larger and multi-center evaluations are needed to confirm the potential of citywide structural modifications of storm drains to reduce Aedes spp. infestation level.
C1 [Souza, Raquel Lima; Mugabe, Vanio Andre; Dexheimer Paploski, Igor Adolfo; Rodrigues, Moreno S.; dos Santos Moreira, Patricia Sousa; Jacob Nascimento, Leile Camila; Reis, Mitermayer Galvao; Kitron, Uriel; Ribeiro, Guilherme Sousa] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Mugabe, Vanio Andre; Dexheimer Paploski, Igor Adolfo; Ribeiro, Guilherme Sousa] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Mugabe, Vanio Andre] Univ Pedag Mocambique, Quelimane, Zambezia, Mozambique.
   [Roundy, Christopher Michael; Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Reis, Mitermayer Galvao] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.
   [Kitron, Uriel] Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA.
RP Ribeiro, GS (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.; Ribeiro, GS (corresponding author), Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
EM guilherme.ribeiro@bahia.fiocruz.br
RI Paploski, Igor AD/D-7015-2014; Reis, Mitermayer/AAO-9742-2020; Ribeiro,
   Guilherme/B-6624-2008
OI Paploski, Igor AD/0000-0002-3689-2042; Reis,
   Mitermayer/0000-0002-3051-9060; Ribeiro, Guilherme/0000-0002-6798-2059;
   Rodrigues, Moreno/0000-0002-1594-2311; Mugabe, Vanio/0000-0001-6676-4378
FU Brazilian National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq) [400830/2013-2, 440891/2016-7]; Brazilian Coordination for the
   Improvement of Higher Education [440891/2016-7]; UTMB's Institute for
   Human Infections and Immunity (pilot grant)
FX This study was supported by the Brazilian National Council for
   Scientific and Technological Development (grants 400830/2013-2 and
   440891/2016-7 to GSR, and scholarships to IADP, MSR, VAM, UK, MGR and
   GSR), the Brazilian Coordination for the Improvement of Higher Education
   (grant 440891/2016-7 to GSR), and the UTMB's Institute for Human
   Infections and Immunity (pilot grant to CR and SW). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript. The authors have no conflicting
   financial interests.
CR [Anonymous], 2012, GLOB STRAT DENG PREV
   Paploski IAD, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1705-0
   Manrique-Saide P, 2013, J AM MOSQUITO CONTR, V29, P164, DOI 10.2987/12-6320R.1
   Montgomery BL, 2004, J AM MOSQUITO CONTR, V20, P365
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Ocampo CB, 2014, ACTA TROP, V132, P15, DOI 10.1016/j.actatropica.2013.12.019
   PAHO, NUMB REP CAS CHIK FE
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Russell BM, 2001, J MED ENTOMOL, V38, P441, DOI 10.1603/0022-2585-38.3.441
   Seidahmed OME, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004842
   Vazquez-Prokopec GM, 2009, J MED ENTOMOL, V46, P1256, DOI 10.1603/033.046.0602
   Wong J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001015
NR 12
TC 2
Z9 2
U1 0
U2 8
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD JUL 11
PY 2017
VL 10
AR 328
DI 10.1186/s13071-017-2266-6
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FB1KN
UT WOS:000405902400001
PM 28697811
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Roy, A
   Lim, LZ
   Srivastava, S
   Lu, YM
   Song, JX
AF Roy, Amrita
   Lim, Liangzhong
   Srivastava, Shagun
   Lu, Yimei
   Song, Jianxing
TI Solution conformations of Zika NS2B-NS3pro and its inhibition by natural
   products from edible plants
SO PLOS ONE
LA English
DT Article
ID NONCOMPETITIVE INHIBITORS; STRUCTURAL BIOLOGY; NS3 PROTEASES; VIRUS;
   DENGUE; PROTEIN; COMPLEX; DESIGN; TRANSMISSION; ACTIVATION
AB The recent Zika viral (ZIKV) epidemic has been associated with severe neurological pathologies such as neonatal microcephaly and Guillain-Barre syndrome but unfortunately no vaccine or medication is effectively available yet. Zika NS2B-NS3pro is essential for the proteolysis of the viral polyprotein and thereby viral replication. Thus NS2B-NS3pro represents an attractive target for anti-Zika drug discovery/design. Here, we have characterized the solution conformations and catalytic parameters of both linked and unlinked Zika NS2BNS3pro complexes and found that the unlinked complex manifested well-dispersed NMR spectra. Subsequently with selective isotope-labeling using NMR spectroscopy, we demonstrated that C-terminal residues (R73-K100) of NS2B is highly disordered without any stable tertiary and secondary structures in the Zika NS2B-NS3pro complex in the free state. Upon binding to the well-characterized serine protease inhibitor, bovine pancreatic trypsin inhibitor (BPTI), only the extreme C-terminal residues (L86-K100) remain disordered. Additionally, we have identified five flavonoids and one natural phenol rich in edible plants including fruits and vegetables, which inhibit Zika NS2B-NS3pro in a non-competitive mode, with Ki ranging from 770 nM for Myricetin to 34.02 ae M for Apigenin. Molecular docking showed that they all bind to a pocket on the back of the active site and their structure-activity relationship was elucidated. Our study provides valuable insights into the solution conformation of Zika NS2B-NS3pro and further deciphers its susceptibility towards allosteric inhibition by natural products. As these natural product inhibitors fundamentally differ from the currently-known active site inhibitors in terms of both inhibitory mode and chemical scaffold, our finding might open a new avenue for development of better allosteric inhibitors to fight ZIKV infection.
C1 [Roy, Amrita; Lim, Liangzhong; Srivastava, Shagun; Lu, Yimei; Song, Jianxing] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore, Singapore.
RP Song, JX (corresponding author), Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore, Singapore.
EM dbssjx@nus.edu.sg
OI Song, Jianxing/0000-0003-0224-6322
FU Ministry of Education of Singapore (MOE) Tier 3 [R-154002-580-112];
   Ministry of Education of Singapore (MOE) Tier 2 [MOE2015-T2-1-111]
FX This study is supported by Ministry of Education of Singapore (MOE) Tier
   3 Grant R-154002-580-112; Tier 2 Grant MOE2015-T2-1-111 to Jianxing
   Song. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Chen WN, 2014, FEBS LETT, V588, P2206, DOI 10.1016/j.febslet.2014.05.018
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   Cox Bryan D., 2015, Antiviral Chemistry & Chemotherapy, V24, P118, DOI 10.1177/2040206616653873
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   da Silva SR, 2016, J MED VIROL, V88, P1291, DOI 10.1002/jmv.24563
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2016, NAT IMMUNOL
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dyson HJ, 2004, CHEM REV, V104, P3607, DOI 10.1021/cr030403s
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Fan X, 2014, MOL BIOSYST, V10, P1345, DOI 10.1039/c4mb00027g
   de Sousa LRF, 2015, BIOORGAN MED CHEM, V23, P466, DOI 10.1016/j.bmc.2014.12.015
   Gupta G, 2015, PLOS ONE, V10
   Gupta G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039261
   Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Hollman PCH, 1999, FREE RADICAL RES, V31, pS75, DOI 10.1080/10715769900301351
   Iempridee T, 2008, BBA-GEN SUBJECTS, V1780, P989, DOI 10.1016/j.bbagen.2008.03.018
   Jordan J, 2016, CLIN DIS
   Kim YM, 2013, J BIOL CHEM, V288, P12891, DOI 10.1074/jbc.M112.442723
   Lee H, 2016, ANTIVIR RES
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200
   Lim HJ, 2017, BIOTECHNOL LETT, V39, P415, DOI 10.1007/s10529-016-2261-6
   Lim LZ, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002338
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Ma BY, 2016, NAT CHEM BIOL, V12, P890, DOI 10.1038/nchembio.2212
   Ma BY, 2013, TOP CURR CHEM, V337, P123, DOI 10.1007/128_2012_316
   Mahawaththa MC, 2017, ANTIVIR RES, V142, P141, DOI 10.1016/j.antiviral.2017.03.011
   Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   MOTULSKY H, 2004, FITTING MODELS BIOL
   Noble CG, 2012, ANTIVIR RES, V96, P115, DOI 10.1016/j.antiviral.2012.09.007
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Organization WH. WHO statement on the first meeting of the International Health Regulations (2005) (IHR 2005), 2016, EM COMM ZIKV OBS INC
   Othman R, 2008, J CHEM INF MODEL, V48, P1582, DOI 10.1021/ci700388k
   Papaleo E, 2016, CHEM REV, V116, P6391, DOI 10.1021/acs.chemrev.5b00623
   Qin HN, 2015, ACS CHEM BIOL, V10, P372, DOI 10.1021/cb500413n
   Qin HN, 2010, J BIOL CHEM, V285, P644, DOI 10.1074/jbc.M109.064824
   Ran XY, 2005, J BIOL CHEM, V280, P19205, DOI 10.1074/jbc.M500330200
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Shi JH, 2004, J BIOL CHEM, V279, P24765, DOI 10.1074/jbc.M311744200
   Shi JH, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001084
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Song JX, 1999, NAT STRUCT BIOL, V6, P129, DOI 10.1038/5815
   Song JX, 1998, BIOCHEM CELL BIOL, V76, P177
   van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m
   Vogel G, 2016, SCIENCE, V352, P1375, DOI 10.1126/science.352.6292.1375
   Vogiatzoglou A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128132
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wilken R, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-12
   Yildiz M, 2013, ACS CHEM BIOL, V8, P2744, DOI 10.1021/cb400612h
NR 62
TC 21
Z9 23
U1 2
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 10
PY 2017
VL 12
IS 7
AR e0180632
DI 10.1371/journal.pone.0180632
PG 22
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FA6HV
UT WOS:000405544800059
PM 28700665
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Reveiz, L
   Haby, MM
   Martinez-Vega, R
   Pinzon-Flores, CE
   Elias, V
   Smith, E
   Pinart, M
   Broutet, N
   Becerra-Posada, F
   Aldighieri, S
   Van Kerkhove, MD
AF Reveiz, Ludovic
   Haby, Michelle M.
   Martinez-Vega, Ruth
   Pinzon-Flores, Carlos E.
   Elias, Vanessa
   Smith, Emma
   Pinart, Mariona
   Broutet, Nathalie
   Becerra-Posada, Francisco
   Aldighieri, Sylvain
   Van Kerkhove, Maria D.
TI Risk of bias and confounding of observational studies of Zika virus
   infection: A scoping review of research protocols
SO PLOS ONE
LA English
DT Review
ID GUILLAIN-BARRE-SYNDROME; UNITED-STATES; COHORT; SELECTION; DESIGN;
   ASSAY; EPIDEMIOLOGY; ASSOCIATION; JANUARY; TRIALS
AB Introduction Given the severity and impact of the current Zika virus (ZIKV) outbreak in the Americas, numerous countries have rushed to develop research studies to assess ZIKV and its potential health consequences. In an effort to ensure that studies are comprehensive, both internally and externally valid, and with reliable results, the World Health Organization, the Pan American Health Organization, Institut Pasteur, the networks of Fiocruz, the Consortia for the Standardization of Influenza Seroepidemiology (CONSISE) and the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) have generated six standardized clinical and epidemiological research protocols and questionnaires to address key public health questions on ZIKV.
   Methods We conducted a systematic search of ongoing study protocols related to ZIKV research. We analyzed the content of protocols of 32 cohort studies and 13 case control studies for systematic bias that could produce erroneous results. Additionally we aimed to characterize the risks of bias and confounding in observational studies related to ZIKV and to propose ways to minimize them, including the use of six newly standardized research protocols.
   Results Observational studies of ZIKV face an array of challenges, including measurement of exposure and outcomes (microcephaly and Guillain-Barre A Syndrome). Potential confounders need to be measured where known and controlled for in the analysis. Selection bias due to non-random selection is a significant issue, particularly in the case-control design, and losses to follow-up is equally important for the cohort design.
   Conclusion Observational research seeking to answer key questions on the ZIKV should consider these restrictions and take precautions to minimize bias in an effort to provide reliable and valid results. Utilization of the standardized research protocols developed by the WHO, PAHO, Institut Pasteur, and CONSISE will harmonize the key methodological aspects of each study design to minimize bias at different stages of the study. Biases need to be considered by researchers implementing the standardized protocols as well as by users of observational epidemiological studies of ZIKV.
C1 [Reveiz, Ludovic; Elias, Vanessa; Smith, Emma; Becerra-Posada, Francisco; Aldighieri, Sylvain] Pan Amer Hlth Org, Washington, DC 20037 USA.
   [Haby, Michelle M.] Univ Sonora, Dept Chem & Biol Sci, Hermosillo, Sonora, Mexico.
   [Martinez-Vega, Ruth] Univ Santander, Escuela Med, Bucaramanga, Colombia.
   [Pinzon-Flores, Carlos E.] Univ La Sabana, Grp Invest Salud, Bogota, Colombia.
   [Pinzon-Flores, Carlos E.] IETS, Subdirecc Prod Guias Pract Clin, Bogota, Colombia.
   [Smith, Emma] Yale Sch Publ Hlth, New Haven, CT USA.
   [Pinart, Mariona] Univ Nottingham, Cochrane Skin Grp, Nottingham, England.
   [Broutet, Nathalie; Van Kerkhove, Maria D.] WHO, Geneva, Switzerland.
   [Van Kerkhove, Maria D.] Inst Pasteur, Ctr Global Hlth, Paris, France.
RP Reveiz, L (corresponding author), Pan Amer Hlth Org, Washington, DC 20037 USA.
EM reveizl@paho.org
RI Martinez-Vega, Ruth/AAD-3601-2019; Pinart, Mariona/L-1931-2015
OI Martinez-Vega, Ruth/0000-0002-6477-334X; Van Kerkhove,
   Maria/0000-0002-6135-0018; Pinart, Mariona/0000-0002-8223-1325; Haby,
   Michelle/0000-0001-6203-9195
FU World Health OrganizationWorld Health Organization [001]
CR Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   [Anonymous], 2016, WHOZIKVMOC164
   Benchimol EI, 2016, Z EVIDENZ FORTBILD Q, V115, P33, DOI 10.1016/j.zefq.2016.07.010
   Bonita R, 2006, BASIC EPIDEMIOLOGY
   Bossuyt PM, 2015, CLIN CHEM, V61, P1446, DOI 10.1373/clinchem.2015.246280
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CDC, 2016, REV DIAGN TEST ZIK C
   Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Cragan JD, 2016, BIRTH DEFECTS RES A, V106, P972, DOI 10.1002/bdra.23587
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Diniz D, 2017, INT J GYNECOL OBSTET, V136, P105, DOI 10.1002/ijgo.12018
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fitchett EJA, 2016, LANCET INFECT DIS, V16, pE202, DOI 10.1016/S1473-3099(16)30082-2
   Goebel S, 2016, J VIROL METHODS, V238, P13, DOI 10.1016/j.jviromet.2016.09.015
   Gonzalez U, 2010, CLIN INFECT DIS, V51, P409, DOI 10.1086/655134
   Grimes DA, 2002, LANCET, V359, P248, DOI 10.1016/S0140-6736(02)07451-2
   Grimes DA, 2002, LANCET, V359, P341, DOI 10.1016/S0140-6736(02)07500-1
   Harville EW, 2016, PAEDIATR PERINAT EP, V30, P531, DOI 10.1111/ppe.12312
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Krauss MJ, 2003, AM J OBSTET GYNECOL, V188, P1484, DOI 10.1067/mob.2003.452
   Kristman V, 2004, EUR J EPIDEMIOL, V19, P751, DOI 10.1023/B:EJEP.0000036568.02655.f8
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   MAGIC, 2017, TOOL ASS RISK BIAS C
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Mann CJ, 2003, EMERG MED J, V20, P54, DOI 10.1136/emj.20.1.54
   Mayeux Richard, 2004, NeuroRx, V1, P182, DOI 10.1007/BF03206601
   PAHO, 2016, CAS DEF PAN AM HLTH
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Porta M, 2014, DICT EPIDEMIOLOGY
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6726
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Stegmann Barbara J, 2002, Curr Womens Health Rep, V2, P253
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   URY HK, 1975, BIOMETRICS, V31, P643, DOI 10.2307/2529548
   Van Kerkhove MD, 2016, LANCET GLOB HLTH
   Viswanathan M., 2013, AHRQ PUBLICATION, V13-EHC106-EF
   von Elm E, 2007, PLOS MED, V4, P1623, DOI 10.1371/journal.pmed.0040296
   WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1019, DOI 10.1093/oxfordjournals.aje.a116396
   WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1029, DOI 10.1093/oxfordjournals.aje.a116397
   WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1042, DOI 10.1093/oxfordjournals.aje.a116398
   White E, 1998, EPIDEMIOL REV, V20, P43, DOI 10.1093/oxfordjournals.epirev.a017971
   WHO, 2016, SCREEN ASS MAN NEON
   WHO, 2016, CAS DEF PAN AM HLTH
   WHO Institut Pasteur, 2016, STAND PROT CROSS SEC
   WHO Institut Pasteur, 2016, STAND PROT CAS CONTR
   WHO Institut Pasteur, 2016, STAND PROT PROSP LON
   WOODWARD M, 2005, EPIDEMIOLOGY STUDY D
   World Health O, 2016, ZIK VIR RES AG
   World Health Organisation, 2016, HARM ZIKV RES PROT A
   World Health Organization, 2016, ZIK SIT REP ZIK VIR
   World Health Organization, 2016, WHOZIKVLAB161
   World Health Organization, 2016, DIR GEN SUMM OUTC EM
NR 62
TC 5
Z9 5
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 7
PY 2017
VL 12
IS 7
AR e0180220
DI 10.1371/journal.pone.0180220
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FA5DZ
UT WOS:000405464100041
PM 28686621
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hunter, FF
AF Hunter, Fiona F.
TI Linking Only Aedes aegypti with Zika Virus Has World-Wide Public Health
   Implications
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Editorial Material
ID POTENTIAL VECTOR; CULEX-PIPIENS; MOSQUITOS; SUSCEPTIBILITY
C1 [Hunter, Fiona F.] Brock Univ, Dept Biol Sci, Ctr Vector Borne Dis, St Catharines, ON, Canada.
RP Hunter, FF (corresponding author), Brock Univ, Dept Biol Sci, Ctr Vector Borne Dis, St Catharines, ON, Canada.
EM fhunter@brocku.ca
CR Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P47
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Evans MV, 2017, ELIFE, V6, DOI 10.7554/eLife.22053
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Grard G, 2010, J GEN VIROL, V91, P87, DOI 10.1099/vir.0.014506-0
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Jupille H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004901
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Moureau G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117849
   Okai N. O., 1971, E AFR MED J, V48, P725
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
NR 28
TC 4
Z9 4
U1 0
U2 8
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JUL 7
PY 2017
VL 8
AR 1248
DI 10.3389/fmicb.2017.01248
PG 5
WC Microbiology
SC Microbiology
GA FA1VU
UT WOS:000405229800001
PM 28736548
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Griffin, DE
AF Griffin, Diane E.
TI Why are neurons susceptible to Zika virus?
SO SCIENCE
LA English
DT Editorial Material
ID HEPATITIS-C VIRUS; PROGENITOR CELLS; TRANSMISSION; REPLICATION; CNS
C1 [Griffin, Diane E.] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.
RP Griffin, DE (corresponding author), Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.
EM dgriffi6@jhmi.edu
CR Arora N, 2017, CELL HOST MICROBE, V21, P561, DOI 10.1016/j.chom.2017.04.007
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Colomer-Lluch M, 2016, CURR HIV RES, V14, P175, DOI 10.2174/1570162X14999160224094621
   Feuer R, 2005, J NEUROSCI, V25, P2434, DOI 10.1523/JNEUROSCI.4517-04.2005
   Gritsun TS, 2007, ADV VIRUS RES, V69, P203, DOI 10.1016/S0065-3527(06)69005-2
   Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435
   Schultz KLW, 2015, J VIROL, V89, P48, DOI 10.1128/JVI.02394-14
   Song YT, 2006, J VIROL, V80, P11579, DOI 10.1128/JVI.00675-06
   Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Yano M, 2016, INT J DEV NEUROSCI, V55, P124, DOI 10.1016/j.ijdevneu.2016.01.002
   Zhou LY, 2016, WORLD J GASTROENTERO, V22, P1477, DOI 10.3748/wjg.v22.i4.1477
NR 12
TC 2
Z9 2
U1 0
U2 15
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD JUL 7
PY 2017
VL 357
IS 6346
SI SI
BP 33
EP 34
DI 10.1126/science.aan8626
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EZ6UL
UT WOS:000404854100036
PM 28684491
OA Bronze
DA 2020-07-08
ER

PT J
AU Chavali, PL
   Stojic, L
   Meredith, LW
   Joseph, N
   Nahorski, MS
   Sanford, TJ
   Sweeney, TR
   Krishna, BA
   Hosmillo, M
   Firth, AE
   Bayliss, R
   Marcelis, CL
   Lindsay, S
   Goodfellow, I
   Woods, CG
   Gergely, F
AF Chavali, Pavithra L.
   Stojic, Lovorka
   Meredith, Luke W.
   Joseph, Nimesh
   Nahorski, Michael S.
   Sanford, Thomas J.
   Sweeney, Trevor R.
   Krishna, Ben A.
   Hosmillo, Myra
   Firth, Andrew E.
   Bayliss, Richard
   Marcelis, Carlo L.
   Lindsay, Susan
   Goodfellow, Ian
   Woods, C. Geoffrey
   Gergely, Fanni
TI Neurodevelopmental protein Musashi-1 interacts with the Zika genome and
   promotes viral replication
SO SCIENCE
LA English
DT Article
ID RNA-BINDING PROTEIN; STEM-CELLS; NEURAL PROGENITORS; VIRUS-INFECTION;
   MAMMALIAN CNS; MOUSE; IDENTIFICATION; MICROCEPHALIN; FLAVIVIRUSES;
   GLIOBLASTOMA
AB A recent outbreak of Zika virus in Brazil has led to a simultaneous increase in reports of neonatal microcephaly. Zika targets cerebral neural precursors, a cell population essential for cortical development, but the cause of this neurotropism remains obscure. Here we report that the neural RNA-binding protein Musashi-1 (MSI1) interacts with the Zika genome and enables viral replication. Zika infection disrupts the binding of MSI1 to its endogenous targets, thereby deregulating expression of factors implicated in neural stem cell function. We further show that MSI1 is highly expressed in neural progenitors of the human embryonic brain and is mutated in individuals with autosomal recessive primary microcephaly. Selective MSI1 expression in neural precursors could therefore explain the exceptional vulnerability of these cells to Zika infection.
C1 [Chavali, Pavithra L.; Stojic, Lovorka; Joseph, Nimesh; Gergely, Fanni] Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Robinson Way, Cambridge CB3 0RE, England.
   [Meredith, Luke W.; Sanford, Thomas J.; Sweeney, Trevor R.; Hosmillo, Myra; Firth, Andrew E.; Goodfellow, Ian] Univ Cambridge, Addenbrookes Hosp, Div Virol, Dept Pathol, Cambridge CB2 2QQ, England.
   [Nahorski, Michael S.; Woods, C. Geoffrey] Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Hills Rd, Cambridge CB2 0XY, England.
   [Krishna, Ben A.] Univ Cambridge, Dept Med, Hills Rd, Cambridge CB2 2QQ, England.
   [Bayliss, Richard] Univ Leeds, Fac Biol Sci, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.
   [Marcelis, Carlo L.] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, Nijmegen, Netherlands.
   [Lindsay, Susan] Newcastle Univ, Inst Med Genet, Int Ctr Life, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
   [Chavali, Pavithra L.] MRC, Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England.
RP Gergely, F (corresponding author), Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Robinson Way, Cambridge CB3 0RE, England.
EM fanni.gergely@cruk.cam.ac.uk
RI Stojic, Lovorka/C-8598-2016
OI Stojic, Lovorka/0000-0001-6691-3396; Goodfellow,
   Ian/0000-0002-9483-510X; Hosmillo, Myra/0000-0002-3514-7681; Meredith,
   Luke/0000-0002-3802-8290; Bayliss, Richard/0000-0003-0604-2773; Krishna,
   Benjamin/0000-0003-0919-2961; Nahorski, Mike/0000-0003-2681-9041;
   Lindsay, Susan/0000-0003-2980-4582; Firth, Andrew/0000-0002-7986-9520;
   Sweeney, Trevor/0000-0003-4016-7326; Sanford,
   Thomas/0000-0002-5091-1457; Gergely, Fanni/0000-0002-2441-8095;
   Lakshminarasimhan Chavali, Pavithra/0000-0002-7525-5230; Joseph,
   Nimesh/0000-0002-9204-9164
FU UK Medical Research Council (MRC)/Wellcome Trust grant [0991/5/Z/12/Z];
   Wellcome TrustWellcome Trust [200183/Z/15/Z]; CRUKCancer Research UK
   [C14303/A17197, C24461/A12772]; National Institute for Health Research
   (NIHR) Cambridge Biomedical Research CentreNational Institute for Health
   Research (NIHR); University of CambridgeUniversity of Cambridge;
   Hutchison Whampoa Ltd.;  [097997/Z/11/A];  [097997/Z/11/Z];  [106207]
FX The authors are indebted to A. Kohl (Centre for Virus Research,
   University of Glasgow) and L. J. Pena and R. Oliveira de Freitas Franca,
   Fiocruz Recife, Pernambuco, Brazil, for the provision of PE243 ZIKV RNA
   used to generate the virus stock. We thank and acknowledge S. Lisgo for
   the provision of human embryonic histology sections through the Human
   Developmental Biology Resource (HDBR) at the University of Newcastle
   funded by a joint UK Medical Research Council (MRC)/Wellcome Trust grant
   (0991/5/Z/12/Z). We thank L. Smith for her assistance with homology
   modeling, G. van Zande for his help, and the patients' families for
   their participation. The National Research Ethics Service Committee,
   East of England-Cambridge Central, UK (C.G.W., REC 05/Q0108/402)
   approved the informed consent to enter the study. We further thank T.
   Hussain for help with polysome fractionations and J. Sinclair and A. Git
   for technical advice. We thank K. J. Patel and members of the Gergely
   lab for useful discussions and comments. We are grateful for help from
   the Cancer Research UK Cambridge Institute (CRUK CI) Core Facilities.
   I.G. and A.E.F. are Wellcome Trust Senior Fellows. I.G. was supported by
   research grants 097997/Z/11/A and 097997/Z/11/Z, and A.E.F. was
   supported by grant 106207. M.S.N. was funded by the Wellcome Trust
   (200183/Z/15/Z), and T. R. S. is a Wellcome Trust Henry Dale Fellow
   (202471/Z/16/Z). This work was made possible by funding from CRUK
   C14303/A17197 to F.G. and C24461/A12772 to R.B. F.G. and C.G.W.
   acknowledge support from the National Institute for Health Research
   (NIHR) Cambridge Biomedical Research Centre, the University of
   Cambridge, and Hutchison Whampoa Ltd. All data to understand and assess
   the conclusions of this research are available in the main paper and
   supplementary materials.
CR Battelli C, 2006, MOL CELL NEUROSCI, V31, P85, DOI 10.1016/j.mcn.2005.09.003
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Cambuli FM, 2015, STEM CELLS, V33, P3621, DOI 10.1002/stem.2202
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chavali PL, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0468
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Araujo PR, 2016, AM J PATHOL, V186, P2271, DOI 10.1016/j.ajpath.2016.05.020
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Eppig JT, 2015, NUCLEIC ACIDS RES, V43, pD726, DOI 10.1093/nar/gku967
   Fox RG, 2015, ANNU REV CELL DEV BI, V31, P249, DOI 10.1146/annurev-cellbio-100814-125446
   Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hussain MS, 2013, HUM MOL GENET, V22, P5199, DOI 10.1093/hmg/ddt374
   Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001
   Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283
   Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435
   Kawahara H, 2008, J CELL BIOL, V181, P639, DOI 10.1083/jcb.200708004
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Li ZH, 2011, RNA BIOL, V8, P305, DOI 10.4161/rna.8.2.15391
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Martin CA, 2016, GENE DEV, V30, P2158, DOI 10.1101/gad.286351.116
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL STEM CELL, V18, P559, DOI 10.1016/j.stem.2016.04.009
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nagata T, 1999, J MOL BIOL, V287, P315, DOI 10.1006/jmbi.1999.2596
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499
   Sakakibara S, 2001, J NEUROSCI, V21, P8091
   Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130
   Salinas S, 2017, J VIROL, V91, DOI [10.1128/JVI.02144-16, 10.1128/jvi.02144-16]
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   Susaki K, 2009, EXP EYE RES, V88, P347, DOI 10.1016/j.exer.2008.06.019
   Trimborn M, 2004, AM J HUM GENET, V75, P261, DOI 10.1086/422855
   Uren PJ, 2015, MOL CELL BIOL, V35, P2965, DOI 10.1128/MCB.00410-15
   Villordo SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004604
   Waldorf KMA, 2013, REPRODUCTION, V146, pR151, DOI 10.1530/REP-13-0232
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
NR 41
TC 64
Z9 66
U1 2
U2 13
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD JUL 7
PY 2017
VL 357
IS 6346
BP 83
EP 88
DI 10.1126/science.aam9243
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FO5OK
UT WOS:000416909500007
PM 28572454
OA Green Accepted, Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Lebani, K
   Jones, ML
   Watterson, D
   Ranzoni, A
   Traves, RJ
   Young, PR
   Mahler, SM
AF Lebani, Kebaneilwe
   Jones, Martina L.
   Watterson, Daniel
   Ranzoni, Andrea
   Traves, Renee J.
   Young, Paul R.
   Mahler, Stephen M.
TI Isolation of serotype-specific antibodies against dengue virus
   non-structural protein 1 using phage display and application in a
   multiplexed serotyping assay
SO PLOS ONE
LA English
DT Article
ID ANTIGEN CAPTURE IMMUNOASSAY; MONOCLONAL-ANTIBODIES; NS1; DIAGNOSIS;
   SENSITIVITY; LIBRARY; TESTS; BLOOD; SERUM
AB The multidimensional nature of dengue virus (DENV) infections, which can be caused by four distinct serotypes of the virus, complicates the sensitivity of assays designed for the diagnosis of infection. Different viral markers can be optimally detected at different stages of infection. Of particular clinical importance is the early identification of infection, which is pivotal for disease management and the development of blood screening assays. Nonstructural protein 1 ( NS1) is an early surrogate marker of infection and its detection in serum coincides with detectable viraemia. The aim of this work was to isolate and characterise serotype-specific monoclonal antibodies that bind to NS1 for each of the four DENV serotypes. This was achieved using phage display and a subtractive biopanning strategy to direct the antibody selection towards serotype-specific epitopes. This antibody isolation strategy has advantages over immunisation techniques where it is difficult to avoid antibody responses to cross-reactive, immunodominant epitopes. Serotype specificity to recombinant antigen for each of the antibodies was confirmed by Enzyme Linked Immunosorbent Assay ( ELISA) and Surface Plasmon Resonance. Confirmation of binding to native DENV NS1 was achieved using ELISA and immunofluorescence assay on DENV infected Vero cells. No cross-reactivity with Zika or Kunjin viruses was observed. A previously isolated pan-reactive antibody that binds to an immunodominant epitope was able to pair with each of the serotype-specific antibodies in a sandwich ELISA, indicating that the serotype specific antibodies bind to epitopes which are all spatially distinct from the immunodominant epitope. These antibodies were suitable for use in a multiplexed assay for simultaneous detection and serotyping of DENV NS1 in human serum. This work demonstrates that phage display coupled with novel biopanning strategies is a valuable in vitro methodology for isolation of binders that can discern amongst antigens with high homology for diagnostic applicability.
C1 [Lebani, Kebaneilwe; Jones, Martina L.; Mahler, Stephen M.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia.
   [Jones, Martina L.; Young, Paul R.; Mahler, Stephen M.] Univ Queensland, ARC Training Ctr Biopharmaceut Innovat, Brisbane, Qld, Australia.
   [Watterson, Daniel; Traves, Renee J.; Young, Paul R.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia.
   [Watterson, Daniel; Young, Paul R.] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia.
   [Ranzoni, Andrea] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.
   [Lebani, Kebaneilwe] Botswana Int Univ Sci & Technol, Dept Biol & Biotechnol Sci, Palapye, Botswana.
RP Jones, ML (corresponding author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia.; Jones, ML (corresponding author), Univ Queensland, ARC Training Ctr Biopharmaceut Innovat, Brisbane, Qld, Australia.
EM martina.jones@uq.edu.au
RI Young, Paul R/A-6176-2010
OI Young, Paul R/0000-0002-2040-5190; mahler, stephen/0000-0003-2403-1437;
   Watterson, Daniel/0000-0001-5957-2853; Traves, Renee
   Joycelyn/0000-0003-4291-8699; Jones, Martina/0000-0002-5154-6017
FU Australian Research Council Linkage GrantAustralian Research Council;
   Australian Red Cross Blood Service
FX This work was supported by an Australian Research Council Linkage Grant
   with project partner Australian Red Cross Blood Service. The Blood
   Service. The funders had no role in study design, data colloction and
   analysis,decision to publish, or preparation of the manuscript.
CR Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Andries AC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001993
   Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183
   Bessoff K, 2010, CLIN VACCINE IMMUNOL, V17, P949, DOI 10.1128/CVI.00041-10
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blacksell SD, 2011, CLIN VACCINE IMMUNOL, V18, P2095, DOI 10.1128/CVI.05285-11
   Bock G., 2006, NEW TREATMENT STRATE
   Cabezas S, 2008, J VIROL METHODS, V147, P235, DOI 10.1016/j.jviromet.2007.09.001
   Callahan JD, 2001, J CLIN MICROBIOL, V39, P4119, DOI 10.1128/JCM.39.11.4119-4124.2001
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Codamo J, 2011, J CHEM TECHNOL BIOT, V86, P923, DOI 10.1002/jctb.2572
   Das S, 2008, J CLIN MICROBIOL, V46, P3276, DOI 10.1128/JCM.00163-08
   de Haard HJ, 1999, J BIOL CHEM, V274, P18218, DOI 10.1074/jbc.274.26.18218
   Ding XX, 2011, CLIN VACCINE IMMUNOL, V18, P430, DOI 10.1128/CVI.00462-10
   FALCONAR AKI, 1991, J GEN VIROL, V72, P961, DOI 10.1099/0022-1317-72-4-961
   Guzman MG, 2004, INT J INFECT DIS, V8, P69, DOI 10.1016/j.ijid.2003.03.003
   Halstead SB, 2008, DENGUE
   Hang VT, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000360
   Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126
   Jones ML, 2017, MOLECULES, V22, DOI 10.3390/molecules22040607
   Jones ML, 2010, J IMMUNOL METHODS, V354, P85, DOI 10.1016/j.jim.2010.02.001
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Poulsen TR, 2011, J IMMUNOL, V187, P4229, DOI 10.4049/jimmunol.1000928
   PRYOR MJ, 1994, J GEN VIROL, V75, P1183, DOI 10.1099/0022-1317-75-5-1183
   Qiu LW, 2009, CLIN VACCINE IMMUNOL, V16, P88, DOI 10.1128/CVI.00212-08
   Lima MDQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000738
   Ranzoni A, 2015, ANAL CHEM, V87, P6150, DOI 10.1021/acs.analchem.5b00762
   Rathakrishnan Anusyah, 2013, Expert Opin Med Diagn, V7, P99, DOI 10.1517/17530059.2012.718759
   Sanjaya KC, 2015, BIOSENS BIOELECTRON, V67, P769, DOI 10.1016/j.bios.2014.09.048
   Sheets MD, 1998, P NATL ACAD SCI USA, V95, P6157, DOI 10.1073/pnas.95.11.6157
   Teles FRR, 2005, REV MED VIROL, V15, P287, DOI 10.1002/rmv.461
   Tezuka K, 2016, TRANSFUSION, V56, P3094, DOI 10.1111/trf.13875
   Xu H, 2006, J CLIN MICROBIOL, V44, P2872, DOI 10.1128/JCM.00777-06
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000
NR 37
TC 9
Z9 9
U1 1
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 6
PY 2017
VL 12
IS 7
AR e0180669
DI 10.1371/journal.pone.0180669
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FA3HX
UT WOS:000405335200059
PM 28683141
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Palatini, U
   Miesen, P
   Carballar-Lejarazu, R
   Ometto, L
   Rizzo, E
   Tu, ZJ
   van Rij, RP
   Bonizzoni, M
AF Palatini, Umberto
   Miesen, Pascal
   Carballar-Lejarazu, Rebeca
   Ometto, Lino
   Rizzo, Ettore
   Tu, Zhijian
   van Rij, Ronald P.
   Bonizzoni, Mariangela
TI Comparative genomics shows that viral integrations are abundant and
   express piRNAs in the arboviral vectors Aedes aegypti and Aedes
   albopictus
SO BMC GENOMICS
LA English
DT Article
DE Mosquitoes; Arboviruses; Non-retroviral integrated RNA viruses;
   Endogenous viral elements; piRNA
ID RNA VIRUS; MOSQUITO; EVOLUTION; TRANSMISSION; INFECTION; DROSOPHILA;
   DISCOVERY; SEQUENCES; ELEMENTS; DISEASE
AB Background: Arthropod-borne viruses (arboviruses) transmitted by mosquito vectors cause many important emerging or resurging infectious diseases in humans including dengue, chikungunya and Zika. Understanding the co-evolutionary processes among viruses and vectors is essential for the development of novel transmission-blocking strategies. Episomal viral DNA fragments are produced from arboviral RNA upon infection of mosquito cells and adults. Additionally, sequences from insect-specific viruses and arboviruses have been found integrated into mosquito genomes.
   Results: We used a bioinformatic approach to analyse the presence, abundance, distribution, and transcriptional activity of integrations from 425 non-retroviral viruses, including 133 arboviruses, across the presently available 22 mosquito genome sequences. Large differences in abundance and types of viral integrations were observed in mosquito species from the same region. Viral integrations are unexpectedly abundant in the arboviral vector species Aedes aegypti and Ae. albopictus, in which they are approximately similar to 10-fold more abundant than in other mosquito species analysed. Additionally, viral integrations are enriched in piRNA clusters of both the Ae. aegypti and Ae. albopictus genomes and, accordingly, they express piRNAs, but not siRNAs.
   Conclusions: Differences in the number of viral integrations in the genomes of mosquito species from the same geographic area support the conclusion that integrations of viral sequences is not dependent on viral exposure, but that lineage-specific interactions exist. Viral integrations are abundant in Ae. aegypti and Ae. albopictus, and represent a thus far underappreciated component of their genomes. Additionally, the genome locations of viral integrations and their production of piRNAs indicate a functional link between viral integrations and the piRNA pathway. These results greatly expand the breadth and complexity of small RNA-mediated regulation and suggest a role for viral integrations in antiviral defense in these two mosquito species.
C1 [Palatini, Umberto; Carballar-Lejarazu, Rebeca; Bonizzoni, Mariangela] Univ Pavia, Dept Biol & Biotechnol, Via Ferrata 9, I-27100 Pavia, Italy.
   [Miesen, Pascal; van Rij, Ronald P.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Med Microbiol, POB 9101, NL-6500 HB Nijmegen, Netherlands.
   [Rizzo, Ettore] Engenome Srl, Via Ferrata 5, Pavia, Italy.
   [Tu, Zhijian] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA.
   [Tu, Zhijian] Virginia Tech, Fralin Life Sci Inst, Blacksburg, VA 24061 USA.
RP Bonizzoni, M (corresponding author), Univ Pavia, Dept Biol & Biotechnol, Via Ferrata 9, I-27100 Pavia, Italy.
EM m.bonizzoni@unipv.it
RI Ometto, Lino/C-3609-2008; Van Rij, Ronald/I-7073-2012
OI Ometto, Lino/0000-0002-2679-625X; Van Rij, Ronald/0000-0003-0221-4689;
   Carballar Lejarazu, Rebeca/0000-0002-9338-8774; PALATINI,
   UMBERTO/0000-0002-2435-2655; Bonizzoni, Mariangela/0000-0003-0568-8564;
   Miesen, Pascal/0000-0002-6378-0871
FU European Research Council Consolidator Grant (ERC-CoG) under the
   European Union's Seventh Framework Programme [ERC CoG 615,680]; ERC-CoG
   under the European Union's Horizon Programme [ERC CoG 682,394]
FX The project was supported by a European Research Council Consolidator
   Grant (ERC-CoG) under the European Union's Seventh Framework Programme
   (grant number ERC CoG 615,680) to R.P.v.R and an ERC-CoG under the
   European Union's Horizon 2020 Programme (Grant Number ERC CoG 682,394)
   to M.B. The funders had no role in study design, data collection and
   interpretation, or the decision to submit the work for publication.
CR Aiewsakun P, 2015, VIROLOGY, V479, P26, DOI 10.1016/j.virol.2015.02.011
   Arensburger P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-606
   Assis R, 2009, P NATL ACAD SCI USA, V106, P7079, DOI 10.1073/pnas.0900523106
   Aswad A, 2012, TRENDS ECOL EVOL, V27, P627, DOI 10.1016/j.tree.2012.07.007
   Attoui H, 2006, J GEN VIROL, V87, P199, DOI 10.1099/vir.0.81294-0
   Ballinger MJ, 2012, MOL PHYLOGENET EVOL, V65, P251, DOI 10.1016/j.ympev.2012.06.008
   Ballinger MJ, 2014, J VIROL, V88, P8783, DOI 10.1128/JVI.00531-14
   Bartholomay LC, 2010, SCIENCE, V330, P88, DOI 10.1126/science.1193162
   Belyi VA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001030
   Bhattacharya Sajal, 2016, Journal of Entomology and Zoology Studies, V4, P73
   Blair CD, ARTHROPOD VECTOR CON, V1, P201
   Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281
   Bolling BG, 2015, VIRUSES-BASEL, V7, P4911, DOI 10.3390/v7092851
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Bronkhorst AW, 2014, CURR OPIN VIROL, V7, P19, DOI 10.1016/j.coviro.2014.03.010
   Carissimo G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153881
   Chen XG, 2015, P NATL ACAD SCI USA, V112, pE5907, DOI 10.1073/pnas.1516410112
   Cheng G, 2016, TRENDS PARASITOL, V32, P177, DOI 10.1016/j.pt.2015.09.009
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Crochu S, 2004, J GEN VIROL, V85, P1971, DOI 10.1099/vir.0.79850-0
   Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004
   Dennison NJ, 2014, CURR OPIN INSECT SCI, V3, P6, DOI 10.1016/j.cois.2014.07.004
   Falda M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S14
   Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013
   Fauver JR, 2016, VIROLOGY, V498, P288, DOI 10.1016/j.virol.2016.07.031
   Fort P, 2012, MOL BIOL EVOL, V29, P381, DOI 10.1093/molbev/msr226
   Fujino K, 2014, P NATL ACAD SCI USA, V111, P13175, DOI 10.1073/pnas.1407046111
   Geisler C, 2016, BIOLOGICALS, V44, P219, DOI 10.1016/j.biologicals.2016.04.004
   Girardi E, 2017, NUCLEIC ACIDS RES, V45, P4881, DOI 10.1093/nar/gkw1368
   Goic B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12410
   Goic B, 2013, NAT IMMUNOL, V14, P396, DOI 10.1038/ni.2542
   Grunnill M, 2016, J MED ENTOMOL, V53, P1, DOI 10.1093/jme/tjv168
   Gu J., 2013, EVID-BASED COMPL ALT, V8, DOI DOI 10.1371/J0URNAL.P0NE.0062839
   Handler D, 2013, MOL CELL, V50, P762, DOI 10.1016/j.molcel.2013.04.031
   Hermanns K, 2017, J GEN VIROL, V98, P43, DOI 10.1099/jgv.0.000694
   Homolka D, 2015, CELL REP, V12, P418, DOI 10.1016/j.celrep.2015.06.030
   Honda Tomoyuki, 2016, Mob Genet Elements, V6, pe1165785, DOI 10.1080/2159256X.2016.1165785
   Horie M, 2010, NATURE, V463, P84, DOI 10.1038/nature08695
   Hu W, 2015, INSECT MOL BIOL, V24, P240, DOI 10.1111/imb.12152
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Katzourakis A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001191
   Koonin EV, 2015, VIROLOGY, V479, P2, DOI 10.1016/j.virol.2015.02.039
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Lequime S, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vew035
   Lewis SH, 2016, GENOME BIOL EVOL, V8, P507, DOI 10.1093/gbe/evw018
   Li C, 2015, ELIFE, V4, DOI 10.7554/eLife.06587
   Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698
   Linthicum KJ, 2016, ANNU REV ENTOMOL, V61, P395, DOI 10.1146/annurev-ento-010715-023819
   Liu PW, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1815-8
   Maori E, 2007, VIROLOGY, V362, P342, DOI 10.1016/j.virol.2006.11.038
   Marklewitz M, 2015, P NATL ACAD SCI USA, V112, P7536, DOI 10.1073/pnas.1502036112
   Miesen P, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006017
   Miesen P, 2015, NUCLEIC ACIDS RES, V43, P6545, DOI 10.1093/nar/gkv590
   Nag DK, 2016, VIROLOGY, V498, P164, DOI 10.1016/j.virol.2016.08.022
   Neafsey DE, 2015, SCIENCE, V347, DOI 10.1126/science.1258522
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   Olson KE, 2015, CURR OPIN VIROL, V15, P119, DOI 10.1016/j.coviro.2015.10.001
   Parrish NF, 2015, RNA, V21, P1691, DOI 10.1261/rna.052092.115
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Powell JR, 2010, MEM I O CRUZ, V108, P11
   Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033
   Reynolds JA, 2012, J INSECT PHYSIOL, V58, P966, DOI 10.1016/j.jinsphys.2012.04.013
   Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754
   Song JW, 2009, J VIROL, V83, P6184, DOI 10.1128/JVI.00371-09
   Stapleford KA, 2014, CELL HOST MICROBE, V15, P706, DOI 10.1016/j.chom.2014.05.008
   Tabachnick WJ, 2013, INT J ENV RES PUB HE, V10, P249, DOI 10.3390/ijerph10010249
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Tromas N, 2014, GENOME BIOL EVOL, V6, P538, DOI 10.1093/gbe/evu036
   Vasilakis N, 2015, CURR OPIN VIROL, V15, P69, DOI 10.1016/j.coviro.2015.08.007
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
NR 71
TC 41
Z9 41
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2164
J9 BMC GENOMICS
JI BMC Genomics
PD JUL 5
PY 2017
VL 18
AR 512
DI 10.1186/s12864-017-3903-3
PG 15
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA FB0YJ
UT WOS:000405870600001
PM 28676109
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Metz, SW
   Gallichotte, EN
   Brackbill, A
   Premkumar, L
   Miley, MJ
   Baric, R
   de Silva, AM
AF Metz, Stefan W.
   Gallichotte, Emily N.
   Brackbill, Alex
   Premkumar, Lakshmanane
   Miley, Michael J.
   Baric, Ralph
   de Silva, Aravinda M.
TI In Vitro Assembly and Stabilization of Dengue and Zika Virus Envelope
   Protein Homo-Dimers
SO SCIENTIFIC REPORTS
LA English
DT Article
ID NEUTRALIZING ANTIBODIES; HIGHLY POTENT; DOMAIN III; VACCINE; PROTECTION;
   DETERMINANTS; ENHANCEMENT; TEMPERATURE; CHALLENGE; INFECTION
AB Zika virus (ZIKV) and the 4 dengue virus (DENV) serotypes are mosquito-borne Flaviviruses that are associated with severe neuronal and hemorrhagic syndromes. The mature flavivirus infectious virion has 90 envelope (E) protein homo-dimers that pack tightly to form a smooth protein coat with icosahedral symmetry. Human antibodies that strongly neutralize ZIKV and DENVs recognize complex quaternary structure epitopes displayed on E-homo-dimers and higher order structures. The ZIKV and DENV E protein expressed as a soluble protein is mainly a monomer that does not display quaternary epitopes, which may explain the modest success with soluble recombinant E (sRecE) as a vaccine and diagnostic antigen. New strategies are needed to design recombinant immunogens that display these critical immune targets. Here we present two novel methods for building or stabilizing in vitro E-protein homo-dimers that display quaternary epitopes. In the first approach we immobilize sRecE to enable subsequent dimer generation. As an alternate method, we describe the use of human mAbs to stabilize homo-dimers in solution. The ability to produce recombinant E protein dimers displaying quaternary structure epitopes is an important advance with applications in flavivirus diagnostics and vaccine development.
C1 [Metz, Stefan W.; Gallichotte, Emily N.; Premkumar, Lakshmanane; Baric, Ralph; de Silva, Aravinda M.] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.
   [Brackbill, Alex; Miley, Michael J.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC USA.
   [Gallichotte, Emily N.; Baric, Ralph] Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA.
RP Metz, SW; de Silva, AM (corresponding author), Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.
EM swmetz@med.unc.edu; aravinda_desilva@med.unc.edu
RI Metz, Stefan/J-1974-2019
OI Metz, Stefan/0000-0002-9249-2844
FU NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [1-R01-AI107731-01, U19 AI109784-01];
   NCI-NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)
   [P30CA016086]; European Union Zika Plan Research Consortium
FX We would like to thank Prof. Ashutosh Tripathy from the UNC for his help
   in protein characterization. These studies were supported by NIAID
   grants 1-R01-AI107731-01 (PI A. de Silva, UNC), U19 AI109784-01 (PI J.
   Ting, UNC), NCI-NIH P30CA016086 and the European Union Zika Plan
   Research Consortium. The content is solely the responsibility of the
   authors and does not necessarily represent the official views of the
   National Institutes of Health.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Abbink P, 2015, J VIROL, V89, P1512, DOI 10.1128/JVI.02950-14
   ALLISON SL, 1995, J VIROL, V69, P5816, DOI 10.1128/JVI.69.9.5816-5820.1995
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Block OKT, 2010, VACCINE, V28, P8085, DOI 10.1016/j.vaccine.2010.10.004
   Campos JLS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01097-5
   Chahal JS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00193-w
   Coller BAG, 2011, VACCINE, V29, P7267, DOI 10.1016/j.vaccine.2011.07.021
   Correia BE, 2014, NATURE, V507, P201, DOI 10.1038/nature12966
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Durbin AP, 2016, SEMIN REPROD MED, V34, P299, DOI 10.1055/s-0036-1592070
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651
   Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13
   Gallichotte EN, 2015, MBIO, V6, DOI 10.1128/mBio.01461-15
   Guzman MG, 2003, AM J TROP MED HYG, V69, P129, DOI 10.4269/ajtmh.2003.69.129
   HENCHAL EA, 1985, AM J TROP MED HYG, V34, P162, DOI 10.4269/ajtmh.1985.34.162
   Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150
   Kelly EP, 2000, VACCINE, V18, P2549, DOI 10.1016/S0264-410X(00)00032-3
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Kirkpatrick BD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1517
   Kirkpatrick BD, 2015, J INFECT DIS, V212, P702, DOI 10.1093/infdis/jiv082
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Liu Y, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.74
   Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382
   Mamo T, 2012, VACCINE, V30, P6609, DOI 10.1016/j.vaccine.2012.08.023
   Metz SW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005071
   Midgley CM, 2011, J VIROL, V85, P410, DOI 10.1128/JVI.01826-10
   Peterson A. T., 2016, PLOS CURRENTS, V8
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Smith SA, 2014, J VIROL, V88, P12233, DOI 10.1128/JVI.00247-14
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Williams KL, 2012, VIROLOGY, V429, P12, DOI 10.1016/j.virol.2012.03.003
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang XZ, 2015, CURR OPIN VIROL, V12, P109, DOI 10.1016/j.coviro.2015.04.006
   Zhang XZ, 2015, J VIROL, V89, P743, DOI 10.1128/JVI.02411-14
   Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110
NR 41
TC 22
Z9 22
U1 0
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUL 3
PY 2017
VL 7
AR 4524
DI 10.1038/s41598-017-04767-6
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EZ3NT
UT WOS:000404618400038
PM 28674411
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Karimi, N
   Razavi, AS
AF Karimi, Narges
   Razavi, Athena Sharifi
TI Zika Virus, Congenital Infection, and Neurologic Manifestations in
   Children: A Narrative Review
SO JOURNAL OF PEDIATRICS REVIEW
LA English
DT Review
DE Zika Virus; Clinical; Neurologic Manifestation; Congenital Infection
ID UPDATE INTERIM GUIDELINES; UNITED-STATES; PREGNANT-WOMEN; INFANTS;
   OUTBREAK; BRAZIL; TRANSMISSION; VECTORS; DENGUE; FEVER
AB Context: Zika virus (ZIKV) is an arbovirus of the family Flaviviridae. This virus, which is transmitted by mosquitoes, usually affects children and causes self-limited diseases, associated with fever, maculopapular rash, conjunctivitis, arthralgia, and myalgia. There is a significant relationship between ZIKV infection and central nervous system disorders in infants. In this study, we aimed to review neurologic manifestations of ZIKV infection in infants.
   Evidence Acquisition: We searched the following Mesh terms in scientific databases: "Zika virus", "infants", "children", "neurologic manifestations", and "congenital infection". Electronic databases including Google Scholar, Science Direct, PubMed, Web of Science, Scientific Information Database, and Scopus were searched from 2000 to 2016.
   Results: The literature review showed a probable relationship between ZIKV infection and prevalence of microcephaly in new-borns. Besides microcephaly, other central nervous system abnormalities included abnormal gyral arrangement, decreased brain parenchymal volume, cortical atrophy and malformation, cerebellar hypoplasia, and delayed myelination of the brain stem.
   Conclusions: Vertical transmission of ZIKV in pregnant women is associated with intrauterine infection and brain malformations in the developing fetus, including microcephaly, calcification, cortical displacement, ventriculomegaly, and white-matter abnormalities.
C1 [Karimi, Narges] Mazandaran Univ Med Sci, Bou Ali Sina Hosp, Dept Neurol,Fac Med, Immunogenet Res Ctr,Clin Res Dev Unit, Sari, Iran.
   [Razavi, Athena Sharifi] Mazandaran Univ Med Sci, Dept Neurol, Fac Med, Sari, Iran.
RP Karimi, N (corresponding author), Mazandaran Univ Med Sci, Bou Ali Sina Hosp, Clin Res Dev Unit, Dept Neurol, Sari, Iran.
EM drkarimi_236@yahoo.com
RI amsalu, ribka/G-8780-2019
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Besnard M, 2014, EURO SURVEILL, V19
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for disease control and prevention, CDC ISS ADV TRAV 201
   Centers for disease control and prevention, QUEST ANSW ZIK VIR I
   Centers for Disease Control and Prevention, CDC NEWSR CDC ADDS C
   Cetron M., REVISION CDCS ZIKA T
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Derraik JG, 2015, AUST NZ J PUBL HEAL, V39, P5, DOI 10.1111/1753-6405.12302
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   European centre for disease prevention and control, MICR BRAZ POT LINK Z
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, 2014, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control (ECDC), RAP RISK ASS ZIK VIR
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Kline MW, 2016, JAMA PEDIATR, V170, P309, DOI 10.1001/jamapediatrics.2016.0429
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Linden V, 2016, BMJ-BRIT MED J, P353
   Martines RB, NOTES FIELD EVIDENCE
   Masuzaki H, 2004, CLIN CHEM, V50, P1709, DOI 10.1373/clinchem.2004.036517
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Ministerio da Saude, MICR MIN SAUD
   Minsterio S., 2015, PROT VIG RESP OC MIC
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oehler E, 2014, EURO SURVEILL, V19
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pan American Health Organization, EP UPD NEUR SYNDR CO
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Prazeres J, 2016, JAMA OPHTALMOL, DOI [10.1001/jamaophthal-mol.2016.0267, DOI 10.1001/JAMAOPHTHAL-MOL.2016.0267]
   ProMED-mail, ZIK VIR BRAZ 16 PERN
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1271, DOI 10.1016/S1473-3099(14)70834-5
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tappe D, 2013, EURO SURVEILL, V19
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
   World Health Organization, CONS CAUS LINK ZIK N
   World Health Organization, WHO DIR GEN BRIEFS E
   World Health Organization, ZIK SIT REP EM
   World Health Organization, PREGN MAN CONT ZIK V
   World Health Organization (WHO), ZIK SIT REP
   World Health Organization (WHO), EP AL NEUR SYNDR CON
   Zammarchi L, 2015, EURO SURVEILL, V20
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 77
TC 0
Z9 0
U1 0
U2 0
PU MAZANDARAN UNIV MED SCI
PI SARI
PA BOU ALI SINA HOSP, PASDARAN BLVD, SARI, 48158-38477, IRAN
SN 2322-4398
EI 2322-4401
J9 J PEDIAT REV
JI J. Pediat. Rev.
PD JUL
PY 2017
VL 5
IS 2
AR UNSP e9813
DI 10.5812/jpr.9813
PG 6
WC Pediatrics
SC Pediatrics
GA FU6BG
UT WOS:000423936100006
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Lagunas-Rangel, FA
   Viveros-Sandoval, ME
   Reyes-Sandoval, A
AF Lagunas-Rangel, Francisco A.
   Viveros-Sandoval, Martha E.
   Reyes-Sandoval, Arturo
TI Current trends in Zika vaccine development
SO JOURNAL OF VIRUS ERADICATION
LA English
DT Review
DE Zika virus; flavivirus; vaccine
ID PROTECTIVE EFFICACY; CLINICAL-TRIALS; VIRUS OUTBREAK; CHALLENGES;
   FLAVIVIRUS; SUCCESSES; INFECTION; VECTORS; BIOLOGY
AB The Zika virus (ZIKV) was first isolated in 1947 in Uganda. While it took 60 years for this virus to cause major outbreaks, an important shift in its ability to cause epidemics took place in the first and second decades of the this century: in 2007 in Yap Island, Micronesia, followed by French Polynesia in 2013 and, finally in 2015 and 2016, when ZIKV infections occurred throughout South America, Central America and the Caribbean, spreading rapidly to reach North America in just a single year. No licensed prophylactic vaccine is yet available but recent efforts towards the development of a vaccine have been remarkable from both the private and public sectors and include new candidate vaccines ranging from the classical live-attenuated or inactivated vaccines to more sophisticated approaches such as mRNA or genetically engineered viral platforms. Previous successes with licensed flavivirus vaccines indicate that a protective ZIKV vaccine should be an achievable goal. Nevertheless, numerous pre- and post-licensure challenges need to be taken into account, such as the interaction of vaccine-induced immune responses with other flaviviruses, in particular with dengue, where antibody-dependent enhancement could become an issue, and the importance of a rapid induction of protective responses during pregnancy.
C1 [Lagunas-Rangel, Francisco A.; Viveros-Sandoval, Martha E.; Reyes-Sandoval, Arturo] Univ Michoacana, Fac Biol & Med Sci Dr Ignacio Chavez, UMSNH Oxford Univ Clin Res Lab UMOCRL, Morelia, Michoacan, Mexico.
   [Viveros-Sandoval, Martha E.] Univ Michoacana, Fac Biol & Med Sci Dr Ignacio Chavez, Div Posgrado & Invest, Lab Hemostasia & Biol Vasc, Morelia, Michoacan, Mexico.
   [Reyes-Sandoval, Arturo] Univ Oxford, Nuffield Dept Med, Jenner Inst, Oxford, England.
RP Reyes-Sandoval, A (corresponding author), Univ Oxford, Nuffield Dept Med, Jenner Inst, Ctr Cellular & Mol Physiol CCMP, Oxford OX3 7BN, England.
EM arturo.reyes@ndm.ox.ac.uk
OI Lagunas-Rangel, Francisco Alejandro/0000-0001-7730-6452
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Abbink P, 2015, J VIROL, V89, P1512, DOI 10.1128/JVI.02950-14
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Brinton MA, 2015, VIRUS RES, V206, P108, DOI 10.1016/j.virusres.2015.02.006
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1960, DOI 10.3201/eid2011.141380
   Capone S, 2013, EXPERT REV VACCINES, V12, P379, DOI [10.1586/erv.13.15, 10.1586/ERV.13.15]
   Chahal JS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00193-w
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Kramps T, 2013, WIRES RNA, V4, P737, DOI 10.1002/wrna.1189
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Minor PD, 2015, VIROLOGY, V479, P379, DOI 10.1016/j.virol.2015.03.032
   Mirza MU, 2016, SCI REP-UK, V6, DOI 10.1038/srep37313
   Morrison C, 2016, NAT REV DRUG DISCOV, V15, P521, DOI 10.1038/nrd.2016.159
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016
   Sebastian M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-748
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shirbaghaee Z, 2016, BIOPOLYMERS, V105, P113, DOI 10.1002/bip.22759
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   World Health Organization, 2016, 1 M INT HLTH REG 200
NR 29
TC 12
Z9 12
U1 0
U2 4
PU MEDISCRIPT LTD
PI LONDON
PA 1 MOUNTVIEW CT, 310 FRIERN BARNET LN, LONDON, N20 0LD, ENGLAND
SN 2055-6640
EI 2055-6659
J9 J VIRUS ERAD
JI J. Virus Erad.
PD JUL
PY 2017
VL 3
IS 3
BP 124
EP 127
PG 4
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA FR6XU
UT WOS:000419211600003
PM 28758019
DA 2020-07-08
ER

PT J
AU Broughton, D
   Caine, E
   Salazar, V
   Scheaffer, S
   Govero, J
   Owuor, T
   Diamond, M
   Moley, K
AF Broughton, D.
   Caine, E.
   Salazar, V.
   Scheaffer, S.
   Govero, J.
   Owuor, T.
   Diamond, M.
   Moley, K.
TI Zika virus infects the female reproductive tract of mice via
   subcutaneous route
SO HUMAN REPRODUCTION
LA English
DT Meeting Abstract
CT 33rd Annual Meeting of the
   European-Society-of-Human-Reproduction-and-Embryology (ESHRE)
CY JUL 02-05, 2017
CL Geneva, SWITZERLAND
SP European Soc Human Reprod & Embryol
C1 [Caine, E.; Salazar, V.; Govero, J.; Diamond, M.] Washington Univ St Louis, Med, St Louis, MO USA.
   [Scheaffer, S.; Owuor, T.; Moley, K.] Washington Univ St Louis, Obstet & Gynecol, St Louis, MO USA.
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0268-1161
EI 1460-2350
J9 HUM REPROD
JI Hum. Reprod.
PD JUL
PY 2017
VL 32
SU 1
MA O-297
BP 137
EP 137
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA FN9VH
UT WOS:000416390501089
DA 2020-07-08
ER

PT J
AU Ono, E
   Braga, DPAF
   Setti, AS
   Iaconelli, A
   Borges, E
AF Ono, E.
   Braga, D. P. A. F.
   Setti, A. S.
   Iaconelli, A., Jr.
   Borges, E., Jr.
TI Zika Virus Outbreak - Assisted reproduction patients should avoid
   pregnancy?
SO HUMAN REPRODUCTION
LA English
DT Meeting Abstract
CT 33rd Annual Meeting of the
   European-Society-of-Human-Reproduction-and-Embryology (ESHRE)
CY JUL 02-05, 2017
CL Geneva, SWITZERLAND
SP European Soc Human Reprod & Embryol
C1 [Ono, E.; Setti, A. S.] Inst Sapientiae, Ctr Estudos & Pesquisa Reprod Assistida, Sci Res, Sao Paulo, SP, Brazil.
   [Braga, D. P. A. F.; Iaconelli, A., Jr.] Fertil Med Grp, Sci Res, Sao Paulo, Brazil.
   [Borges, E., Jr.] Fertil Med Grp, Clin Dept, Sao Paulo, Brazil.
RI Jr., Borges/AAJ-1232-2020
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0268-1161
EI 1460-2350
J9 HUM REPROD
JI Hum. Reprod.
PD JUL
PY 2017
VL 32
SU 1
MA P-307
BP 277
EP 277
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA FN9VH
UT WOS:000416390502182
DA 2020-07-08
ER

PT J
AU Huerta, H
   Gonzalez-Roldan, JF
   Sanchez-Tejeda, G
   Correa-Morales, F
   Romero-Contreras, FE
   Cardenas-Flores, R
   Rangel-Martinez, ML
   Mata-Rivera, JM
   Siller-Martinez, JD
   Vazquez-Prokopec, GM
   Manrique-Saide, P
   Dzul-Manzanilla, F
   Vazquez-Pichardo, M
   Rosales-Jimenez, C
   Torres-Rodriguez, MD
   Nunez-Leon, A
   Torres-Longoria, B
   Lopez-Martinez, I
   Ruiz-Matus, C
   Kuri-Morales, PA
   Diaz-Quinoneza, JA
AF Huerta, Heron
   Felipe Gonzalez-Roldan, Jesus
   Sanchez-Tejeda, Gustavo
   Correa-Morales, Fabian
   Eduardo Romero-Contreras, Francisco
   Cardenas-Flores, Raul
   Liliana Rangel-Martinez, Monica
   Manuel Mata-Rivera, Juan
   de Jesus Siller-Martinez, Jose
   Vazquez-Prokopec, Gonzalo M.
   Manrique-Saide, Pablo
   Dzul-Manzanilla, Felipe
   Vazquez-Pichardo, Mauricio
   Rosales-Jimenez, Claudia
   de la Luz Torres-Rodriguez, Maria
   Nunez-Leon, Alma
   Torres-Longoria, Belem
   Lopez-Martinez, Irma
   Ruiz-Matus, Cuitlahuac
   Antonio Kuri-Morales, Pablo
   Alberto Diaz-Quinoneza, Jose
TI Detection of Zika virus in Aedes mosquitoes from Mexico
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE Aedes aegypti; Aedes albopictus; Dengue; Mexico; Surveillance; ZIKV
AB Background: We report on the results of an entomovirological surveillance system of Aedes populations performed by the Ministry of Health of the central state of San Luis Potosi, Mexico.
   Methods: Indoor adult Aedes aegypti and Aedes albopictus pools collected at San Martin, Tamazunchale, Ciudad Valles, Metlapa, Ebano, Tamuin and Axtla during the dry season of 2016 were examined for the presence of dengue (DENV), chikungunya (CHIKV) and Zika (ZIKV) viruses using real-time PCR.
   Results: Both Ae. aegypti and Ae. albopictus were found to be infected with ZIKV in the absence of confirmed symptomatic human cases.
   Conclusions: The entomovirological surveillance system analysed here identified both Ae. aegypti and Ae. albopictus infected with ZIKV which triggered an immediate aggressive vector control campaign.
C1 [Huerta, Heron; Vazquez-Pichardo, Mauricio; Rosales-Jimenez, Claudia; de la Luz Torres-Rodriguez, Maria; Nunez-Leon, Alma; Torres-Longoria, Belem; Lopez-Martinez, Irma; Alberto Diaz-Quinoneza, Jose] Inst Diagn & Referencia Epidemiol Dr Manuel Marti, Secretaria Salud, Francisco P Miranda 177,Col Unidad Lomas Plateros, Ciudad De Mexico 01480, Mexico.
   [Felipe Gonzalez-Roldan, Jesus; Sanchez-Tejeda, Gustavo; Correa-Morales, Fabian; Eduardo Romero-Contreras, Francisco; Dzul-Manzanilla, Felipe] CENAPRECE, Secretaria Salud, Benjamin Franklin 132,Col Escandon, Ciudad De Mexico 11800, Mexico.
   [Cardenas-Flores, Raul; Liliana Rangel-Martinez, Monica; Manuel Mata-Rivera, Juan; de Jesus Siller-Martinez, Jose] Serv Salud San Luis Potosi, 5850 Col Lomas Virgen, San Luis Potosi 78380, Mexico.
   [Vazquez-Prokopec, Gonzalo M.] Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA.
   [Manrique-Saide, Pablo] Univ Autonoma Yucatan, Dept Zool, Unidad Colaborat Bioensayos Entomol, Campus Ciencias Biol Agropecuarias, Merida 97315, Yucatan, Mexico.
   [Ruiz-Matus, Cuitlahuac] Secretaria Salud, DGE, Francisco P Miranda 177,Col Unidad Lomas Plateros, Ciudad De Mexico 01480, Mexico.
   [Antonio Kuri-Morales, Pablo] Secretaria Salud Mexico, Subsecretaria Prevenc Promoc Salud, Lieja 7,Col Juarez,Delegacion Cuauhtemoc, Mexico City 06600, DF, Mexico.
   [Antonio Kuri-Morales, Pablo; Alberto Diaz-Quinoneza, Jose] Univ Nacl Autonoma Mexico, Fac Med, Div Estudios Posgrado, Ave Univ 3000, Mexico City 04510, DF, Mexico.
RP Diaz-Quinoneza, JA (corresponding author), Inst Diagn & Referencia Epidemiol Dr Manuel Marti, Secretaria Salud, Francisco P Miranda 177,Col Unidad Lomas Plateros, Ciudad De Mexico 01480, Mexico.; Diaz-Quinoneza, JA (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Div Estudios Posgrado, Ave Univ 3000, Mexico City 04510, DF, Mexico.
EM alberto.diaz@salud.gob.mx
OI Diaz-Quinonez, Jose Alberto/0000-0002-3503-7079; Correa Morales,
   Fabian/0000-0002-6193-1242
FU Servicios de Salud del Estado de San Luis Potosi; CENAPRECE
FX This study received financial support from the Servicios de Salud del
   Estado de San Luis Potosi and CENAPRECE.
CR Diaz-Quinonez JA, 2016, EMERG INFECT DIS, V22, P937, DOI 10.3201/eid2205.160190
   Diaz-Quionez JA, 2016, VIRUS GENES, V52, P855, DOI 10.1007/s11262-016-1384-0
   Kuri-Morales P, 2017, MED VET ENTOMOL, V31, P240, DOI 10.1111/mve.12225
   Ortega-Morales AI, 2016, J VECTOR ECOL, V41, P314, DOI 10.1111/jvec.12229
   Vazquez-Prokopec GM, 2009, J MED ENTOMOL, V46, P1256, DOI 10.1603/033.046.0602
NR 5
TC 6
Z9 6
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD JUL
PY 2017
VL 111
IS 7
BP 328
EP 331
DI 10.1093/trstmh/trx056
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FQ3DU
UT WOS:000418237900007
PM 29232453
DA 2020-07-08
ER

PT J
AU Mirsane, SA
   Oraei, N
AF Mirsane, Sayed Alireza
   Oraei, Nasrin
TI Zika Virus Infection and Sexual Transmission: A Serious Challenge in the
   Public Health of the Societies
SO ARCHIVES OF PEDIATRIC INFECTIOUS DISEASES
LA English
DT Letter
DE Zika Virus; Infection; Sexual Transmission
C1 [Mirsane, Sayed Alireza] Kashan Univ Med Sci, Kashan, Iran.
   [Oraei, Nasrin] Educ Off, Esfahan, Iran.
RP Mirsane, SA (corresponding author), Kashan Univ Med Sci, Kashan, Iran.
EM alireza.seyed70@gmail.com
CR Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Falcao MB, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0172-y
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01398
   World Health Organization, ZIK SIT REP 2016
NR 10
TC 0
Z9 0
U1 0
U2 1
PU KOWSAR CORP
PI TEHRAN
PA PO BOX 14155-3651, TEHRAN, 14155, IRAN
SN 2322-1828
EI 2322-1836
J9 ARCH PEDIATR INFECT
JI Arch. Pediatr. Infect. Dis.
PD JUL
PY 2017
VL 5
IS 3
AR e58308
DI 10.5812/pedinfect.58308
PG 1
WC Pediatrics
SC Pediatrics
GA FP1SX
UT WOS:000417396100016
OA Other Gold
DA 2020-07-08
ER

PT J
AU Roth, W
   Tyshkov, C
   Thakur, K
   Vargas, W
AF Roth, William
   Tyshkov, Charles
   Thakur, Kiran
   Vargas, Wendy
TI ENCEPHALOMYELITIS FOLLOWING DEFINITIVE ZIKA VIRUS INFECTION
SO NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION
LA English
DT Editorial Material
ID MULTIPLE-SCLEROSIS
C1 [Roth, William; Thakur, Kiran; Vargas, Wendy] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10027 USA.
   [Tyshkov, Charles; Vargas, Wendy] Columbia Univ, Med Ctr, Dept Pediat Neurol, New York, NY 10027 USA.
RP Roth, W (corresponding author), Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10027 USA.
EM wmhroth@gmail.com
CR Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117
   Brito Ferreira ML, 2016, C AM AC NEUR APR 15
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cusick MF, 2013, CURR OPIN RHEUMATOL, V25, P496, DOI 10.1097/BOR.0b013e328362004d
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
NR 7
TC 6
Z9 7
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 2332-7812
J9 NEUROL-NEUROIMMUNOL
JI Neurol.-Neuroimmunol. Neuroinflammation
PD JUL
PY 2017
VL 4
IS 4
AR e349
DI 10.1212/NXI.0000000000000349
PG 3
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FM2FB
UT WOS:000414799200003
PM 28508009
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Predicted seasonal reproduction number of Zika virus infection: A
   mathematical model simulation analysis for cases in Thailand
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Wiwanitkit, Viroj] Surindra Rajabhat Univ, Inst Nat Med Sci Dev & Estab Project, Res & Dev Ctr, Suvannhabhumi Clin Training, Surin, Surin Province, Thailand.
RP Wiwanitkit, V (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM wviroj@yahoo.com
CR Polwiang S, 2015, PEERJ, V3, DOI 10.7717/peerj.1069
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P698, DOI 10.1016/j.apjtm.2016.05.014
NR 3
TC 0
Z9 0
U1 0
U2 2
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD JUL-AUG
PY 2017
VL 10
IS 4
BP 1069
EP 1069
DI 10.4103/1755-6783.196662
PG 1
WC Tropical Medicine
SC Tropical Medicine
GA FK4GM
UT WOS:000413449300069
DA 2020-07-08
ER

PT J
AU Wiwanitkit, S
   Wiwanitkit, V
AF Wiwanitkit, Somsri
   Wiwanitkit, Viroj
TI Nuclear-expressed sequence Tag (NEST) analysis of Zika virus
   nonstructural protein 1: Transciptomics approach
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Wiwanitkit, Somsri] Wiwanitkit House, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Wiwanitkit, S (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM somsriwiwan@hotmail.com
CR Kiechle FL, 2003, ARCH PATHOL LAB MED, V127, P1089
   Macas J, 1998, CYTOMETRY, V33, P460, DOI 10.1002/(SICI)1097-0320(19981201)33:4<460::AID-CYTO10>3.3.CO;2-R
NR 2
TC 0
Z9 0
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD JUL-AUG
PY 2017
VL 10
IS 4
BP 1081
EP +
DI 10.4103/1755-6783.196696
PG 2
WC Tropical Medicine
SC Tropical Medicine
GA FK4GM
UT WOS:000413449300082
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Structure of nonstructural protein 1 of dengue and Zika virus:
   Difference and implication for pathogenesis and vaccine development
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
EM wviroj@yahoo.com
CR Choumet V, 2015, REV SCI TECH OIE, V34, P473
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
NR 2
TC 0
Z9 0
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD JUL-AUG
PY 2017
VL 10
IS 4
DI 10.4103/1755-6783.196675
PG 1
WC Tropical Medicine
SC Tropical Medicine
GA FK4GM
UT WOS:000413449300075
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Estimated imported Zika virus infection from Thailand: A mathematical
   model simulation analysis
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Wiwanitkit, Viroj] Surindra Rajabhat Univ, Inst Nat Med Sci Dev & Estab Project, Suvannhabhumi Clin Training Res & Dev Ctr, Surin, Surin Province, Thailand.
RP Wiwanitkit, V (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM wviroj@yahoo.com
CR Polwiang S, 2015, J TRAVEL MED, V22, P194, DOI 10.1111/jtm.12193
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 3
TC 0
Z9 0
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD JUL-AUG
PY 2017
VL 10
IS 4
DI 10.4103/1755-6783.196671
PG 1
WC Tropical Medicine
SC Tropical Medicine
GA FK4GM
UT WOS:000413449300071
DA 2020-07-08
ER

PT J
AU Cole, P
   Bofill, X
   Torramade, E
AF Cole, P.
   Bofill, X.
   Torramade, E.
TI Experimental models snapshot
SO DRUGS OF THE FUTURE
LA English
DT Article
DE Experimental models; Animal models
AB The development of new therapies can be greatly facilitated by the use of experimental models of disease, and the development of these models represents an active and exciting field of investigation. This article highlights a selection of newly created models described in the literature and at conferences for a variety of diseases and conditions, such as moyamoya disease, fatty liver, Zika virus infection, arrhythmogenic right ventricular cardiomyopathy type 8, idiopathic pulmonary fibrosis, depression and neonatal encephalopathy.
C1 [Cole, P.; Bofill, X.; Torramade, E.] Clarivate Analyt, Barcelona, Spain.
RP Torramade, E (corresponding author), Clarivate Analyt, Barcelona, Spain.
EM eva.torramade@clarivate.com
NR 0
TC 0
Z9 0
U1 0
U2 2
PU PROUS SCIENCE, SAU-THOMSON REUTERS
PI BARCELONA
PA 398 PROVENCA, 08025 BARCELONA, SPAIN
SN 0377-8282
EI 2013-0368
J9 DRUG FUTURE
JI Drug Future
PD JUL
PY 2017
VL 42
IS 7
BP 401
EP 406
DI 10.1358/dof.2017.042.07.2669150
PG 6
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA FL2FZ
UT WOS:000414032100003
DA 2020-07-08
ER

PT J
AU Cavalcanti, AL
AF Cavalcanti, Alessandro Leite
TI Challenges of Dental Care for Children with Microcephaly Carrying Zika
   Congenital Syndrome
SO CONTEMPORARY CLINICAL DENTISTRY
LA English
DT Editorial Material
C1 [Cavalcanti, Alessandro Leite] State Univ Paraiba, Campina Grande, Brazil.
RP Cavalcanti, AL (corresponding author), State Univ Paraiba, Campina Grande, Brazil.
EM dralessandro@ibest.com.br
RI Cavalcanti, Alessandro/A-2828-2010; Cavalcanti, Alessandro
   Leite/I-4286-2019
OI Cavalcanti, Alessandro/0000-0003-3572-3332; Cavalcanti, Alessandro
   Leite/0000-0003-3572-3332
CR [Anonymous], 2017, INT MON CHANG GROWTH
   Xavier AFC, 2015, PESQUI BRAS ODONTOPE, V15, P279, DOI 10.4034/PBOCI.2015.151.30
   Hartwig AD, 2016, PESQUI BRAS ODONTOPE, V16, P59, DOI 10.4034/PBOCI.2016.161.07
NR 3
TC 8
Z9 9
U1 0
U2 3
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 0976-237X
EI 0976-2361
J9 CONTEMP CLIN DENT
JI Contemp. Clin. Dent.
PD JUL-SEP
PY 2017
VL 8
IS 3
BP 345
EP 346
DI 10.4103/0976-237X.214553
PG 2
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA FH7RX
UT WOS:000411390200002
PM 29042714
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Borges, E
   Braga, DPDF
   Zanetti, BF
   Setti, AS
   Provenza, RR
   Iaconelli, A
AF Borges, Edson, Jr.
   de Almeida Ferreira Braga, Daniela Paes
   Zanetti, Bianca Ferrarini
   Setti, Amanda Souza
   Provenza, Rodrigo Rosa
   Iaconelli, Assumpto, Jr.
TI Zika Virus Outbreak - Should assisted reproduction patients avoid
   pregnancy?
SO JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA
LA English
DT Article
DE Zika virus; pregnancy; miscarriage; microcephaly; birth defects
ID TRANSMISSION; PREVALENCE; INFECTION; AMERICA; STATES; BRAZIL; RISK
AB Objective: To discuss the requirement from the National Health Surveillance Agency(ANVISA), for assisted reproduction treatment patients to undergo laboratory tests for ZIKV detection, and if the public health authorities and government leaders' recommendations to women simply avoid pregnancy is prudent.
   Methods: This study was performed in a universityaffiliated in vitro fertilization center in Brazil. We present a critical discussion on the risk of microcephaly due to ZIKV infection and the prevalence of other harmful pathogens to vulnerable pregnant women and infants. We assessed, 954 patients undergoing intracytoplasmic sperm injection cycles(ICSI), between April and November of 2016, concerning the results of ZIKV test, according to different regions in Brazil.
   Results: Patients undergoing ICSI cycles were split into groups, according to their region of origin: 28(3.0%) were from the North, 27(2.8%) were from the Northeast, 40(4.2%) were from the Midwest, 830(87.2%) were from the Southeast, and 29(3.0%) were from the South. Concerning the diagnosis, 112 samples had a positive or inconclusive result for ZIKV, by chromatography immunoassay. These samples were re-analyzed by ELISA and no result was positive. All positive results were from the Southeast region and none from the Northeast or Midwest regions, which are considered endemic regions.
   Conclusion: ZIKV test before the onset of assisted reproduction treatments does not rule out the risk of the infection during pregnancy. In addition, although ZIKV infection risk is extremely high, the microcephaly risk due to ZIKV is not higher than the risk of miscarriage and birth defects due to other recognized pathogens.
C1 [Borges, Edson, Jr.; de Almeida Ferreira Braga, Daniela Paes; Zanetti, Bianca Ferrarini; Provenza, Rodrigo Rosa; Iaconelli, Assumpto, Jr.] Fertil Med Grp, Sao Paulo, SP, Brazil.
   [Borges, Edson, Jr.; Setti, Amanda Souza] Ctr Estudos & Pesquisa Reprod Humana Assistida, Inst Sapientiae, Sao Paulo, SP, Brazil.
   [de Almeida Ferreira Braga, Daniela Paes] Univ Fed Sao Paulo UNIFESP, Dept Cirurgia, Area Reprod Humana, Disciplina Urol, Sao Paulo, Brazil.
RP Borges, E (corresponding author), Fertil Med Grp, Sao Paulo, SP, Brazil.
EM edson@fertility.com.br
RI Jr., Borges/AAJ-1232-2020
CR [Anonymous], 2015, MONITORING CASES DEN
   Benzaken AS, 2006, SEX TRANSM INFECT, V82, pV26, DOI 10.1136/sti.2006.022566
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brazil, 2016, EPID WEEK, V5
   Brazil, 2015, MIN SAUD DIV B EPID
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gottlieb SL, 2008, SEX TRANSM DIS, V35, P507, DOI 10.1097/OLQ.0b013e3181644bae
   Helmuth IG, 2015, VACCINE, V33, P2406, DOI 10.1016/j.vaccine.2015.03.055
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kourtis AP, 2014, NEW ENGL J MED, V370, P2211, DOI 10.1056/NEJMra1213566
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Martins-Melo FR, 2014, TROP MED INT HEALTH, V19, P943, DOI 10.1111/tmi.12328
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Mylonas I, 2012, ARCH GYNECOL OBSTET, V285, P1271, DOI 10.1007/s00404-012-2240-7
   PREECE PM, 1986, J EPIDEMIOL COMMUN H, V40, P205, DOI 10.1136/jech.40.3.205
   Rao GG, 2008, SEX TRANSM INFECT, V84, P117, DOI 10.1136/sti.2007.026914
   Valeur-Jensen AK, 1999, JAMA-J AM MED ASSOC, V281, P1099, DOI 10.1001/jama.281.12.1099
   Vargas JE, 2001, J PEDIATR-US, V139, P210, DOI 10.1067/mpd.2001.115314
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 31
TC 1
Z9 1
U1 0
U2 1
PU SOC BRASILEIRA REPRODUCAO ASSISTIDA-SBRA
PI RIBEIRAO
PA SOC BRASILEIRA REPRODUCAO ASSISTIDA-SBRA, RIBEIRAO, 00000, BRAZIL
SN 1517-5693
EI 1518-0557
J9 J BRAS REPROD ASSIST
JI J. Bras. Reprod. Assist.
PD JUL-SEP
PY 2017
VL 21
IS 3
BP 208
EP 211
DI 10.5935/1518-0557.20170040
PG 4
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FH6CH
UT WOS:000411259400007
PM 28837029
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU da Silva, MVG
   Esposito, DLA
   da Fonseca, BAL
AF Gomes da Silva, Marcus Vinicius
   Alves Esposito, Danillo Lucas
   Lopes da Fonseca, Benedito Antonio
TI Digital disease data: what is the impact on the Zika virus epidemic?
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Editorial Material
C1 [Gomes da Silva, Marcus Vinicius; Alves Esposito, Danillo Lucas; Lopes da Fonseca, Benedito Antonio] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Ribeirao Preto, SP, Brazil.
RP da Fonseca, BAL (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Ribeirao Preto, SP, Brazil.
EM baldfons@fmrp.usp.br
RI Esposito, Danillo L.A./N-9261-2017; Fonseca, Benedito/F-3252-2012
OI Esposito, Danillo L.A./0000-0002-2755-4471; Fonseca,
   Benedito/0000-0003-3159-5687
CR Bittencourt Sonia Azevedo, 2006, Cad. Saúde Pública, V22, P19, DOI 10.1590/S0102-311X2006000100003
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Falcao MB, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0172-y
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Ministerio da Saude Secretaria de Vigilancia em Saude, 2017, B EPIDEMIOL, V48, P1, DOI DOI 10.5588/IJTLD.11.0170
   Santos SR, 2014, COGITARE ENFERM, V19, P772
NR 6
TC 0
Z9 0
U1 0
U2 2
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD JUL-AUG
PY 2017
VL 50
IS 4
BP 437
EP 438
DI 10.1590/0037-8682-0312-2017
PG 2
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FH9ZK
UT WOS:000411577300001
PM 28954062
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Pavao, ALB
   Barcellos, C
   Pedroso, M
   Boccolini, C
   Romero, D
AF Braz Pavao, Ana Luiza
   Barcellos, Christovam
   Pedroso, Marcel
   Boccolini, Cristiano
   Romero, Dalia
TI The role of Brazilian National Health Information Systems in assessing
   the impact of Zika virus outbreak
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Review
DE Zika virus; Infection; Outbreak; Brazil; Health information systems
ID DATA SCIENCE; INFECTION; EPIDEMIOLOGY; TRANSMISSION; HOSPITALIZATION;
   EMERGENCE; HISTORY; BRAIN
AB The Zika virus (ZIKV) epidemic has become a public health emergency following its association with severe neurological complications. We aim to discuss how the Brazilian National Health Information Systems can help to assess the impact of the ZIKV epidemic on health outcomes potentially related to ZIKV. Health outcomes potentially related to ZIKV infection were described based on a literature review of published studies on ZIKV infection outcomes and on recent protocols developed and published by the Brazilian Ministry of Health for different stages of the life cycle. These outcomes were correlated with the International Classification of Diseases 10th Revision (ICD-10) classification system, as this is the diagnostic classification registered in the Health Information System. A suggested list of 50 clinical manifestations, dispersed into 4 ICD chapters, and their information sources was created to help monitor the ZIKV epidemics and trends. Correlation of these selected ICD-10 codes and the HIS, as well as, a review of the potentialities and limitations of health information systems were performed. The potential of the Health Information System and its underutilization by stakeholders and researchers have been a barrier in diagnosing and reporting ZIKV infection and its complications. The ZIKV outbreak is still a challenge for health practice and the Brazilian Health Information System.
C1 [Braz Pavao, Ana Luiza; Barcellos, Christovam; Pedroso, Marcel; Boccolini, Cristiano; Romero, Dalia] Fundacao Oswaldo Cruz, Inst Informacao & Comunicacao Cient & Tecnol Saud, Lab Informacao Saude, Rio De Janeiro, RJ, Brazil.
RP Pavao, ALB (corresponding author), Fundacao Oswaldo Cruz, Inst Informacao & Comunicacao Cient & Tecnol Saud, Lab Informacao Saude, Rio De Janeiro, RJ, Brazil.
EM ana.pavao@icict.fiocruz.br
RI Barcellos, Christovam/G-6856-2012; Pedroso, Marcel/AAG-2318-2020
OI Barcellos, Christovam/0000-0002-1161-2753; Pedroso,
   Marcel/0000-0002-7323-2107; Romero M., Dalia E./0000-0002-2643-9797
CR Agarwal R, 2014, INFORM SYST RES, V25, P443, DOI 10.1287/isre.2014.0546
   Barcellos C, 2016, EMERG INFECT DIS, V22, P1894, DOI 10.3201/eid2211.160901
   Bhavnani SP, 2016, CIRC-CARDIOVASC QUAL, V9, P683, DOI 10.1161/CIRCOUTCOMES.116.003081
   Boccolini CS, 2012, CIENC SAUDE COLETIVA, V17, P1857, DOI 10.1590/S1413-81232012000700025
   Boccolini CS, 2011, J PEDIAT-BRAZIL, V87, P399, DOI 10.2223/JPED.2136
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carod-Artal FJ, 2016, REV NEUROLOGIA, V62, P317, DOI 10.33588/rn.6207.2016152
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   de Frias PG, 2014, CAD SAUDE PUBLICA, V30, P2068, DOI 10.1590/0102-311X00196113
   de Oliveira CS, 2016, J PEDIAT-BRAZIL, V92, P103, DOI 10.1016/j.jped.2016.02.003
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jorge Maria Helena Prado de Mello, 2007, Ciênc. saúde coletiva, V12, P643
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Lopes MH, 2016, REV ASSOC MED BRAS, V62, P4, DOI 10.1590/1806-9282.62.01.4
   Luquetti DV, 2010, CAD SAUDE PUBLICA, V26, P1756, DOI 10.1590/S0102-311X2010000900009
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mattmann CA, 2013, NATURE, V493, P473, DOI 10.1038/493473a
   Ministerio da Saude, 2015, PROT VIG CAS MAN NEU
   Ministerio da Saude. Agencia Nacional de Saude Suplementar (ANS), 2017, DAD GER BEN PLAN PRI
   Ministerio da Saude (Brazil), 2016, PROT VIG RESP OC MIC
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Organizacao Mundicial de Saude, 2015, NOV COD ZIK VIR
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Freitas ARR, 2016, REV INST MED TROP SP, V58, DOI 10.1590/S1678-9946201658024
   Salvador FS, 2016, TRAVEL MED INFECT DI, V14, P49, DOI 10.1016/j.tmaid.2015.10.004
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   WHO, 2006, INT STAT CLASS DIS R
   Wong SSY, 2016, J FORMOS MED ASSOC, V115, P226, DOI 10.1016/j.jfma.2016.02.002
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 45
TC 1
Z9 1
U1 0
U2 1
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD JUL-AUG
PY 2017
VL 50
IS 4
BP 450
EP 457
DI 10.1590/0037-8682-0506-2016
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FH9ZK
UT WOS:000411577300003
PM 28954064
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Percivalle, E
   Zavattoni, M
   Baldanti, F
   Rovida, F
AF Percivalle, Elena
   Zavattoni, Maurizio
   Baldanti, Fausto
   Rovida, Francesca
TI Zika virus isolation in semen
SO NEW MICROBIOLOGICA
LA English
DT Article
DE Zika virus; Semen; Viral isolation
ID SEXUAL CONTACT; UNITED-STATES; VIRAL LOAD; TRANSMISSION
AB Zika virus (ZIKV) can be sexually transmitted and replicative particles were first detected in a semen sample from a patient during the 2013-14 French Polynesia outbreak. Here we describe the virus isolation from semen of a patient returning to Italy from Brazil.
C1 [Percivalle, Elena; Zavattoni, Maurizio; Baldanti, Fausto; Rovida, Francesca] Fdn IRCCS Policlin San Matteo, Microbiol & Virol Dept, Pavia, Italy.
   [Baldanti, Fausto] Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, Sect Microbiol, Pavia, Italy.
RP Baldanti, F (corresponding author), Fdn IRCCS Policlin San Matteo, Microbiol & Virol Dept, Pavia, Italy.; Baldanti, F (corresponding author), Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, Sect Microbiol, Pavia, Italy.
EM f.baldanti@smatteo.pv.it
RI percivalle, elena/K-7994-2016; Rovida, Francesca/K-7984-2016; Baldanti,
   Fausto/J-4924-2018
OI percivalle, elena/0000-0002-3355-1410; Rovida,
   Francesca/0000-0003-2345-2790; Baldanti, Fausto/0000-0002-3358-8969
FU Ministero della Salute, Fondazione IRCCS Policlinico San Matteo, Ricerca
   CorrenteMinistry of Health, Italy [80206]
FX We thank Daniela Sartori for manuscript editing and Laurene Kelly for
   revision of the English. This work was supported by the Ministero della
   Salute, Fondazione IRCCS Policlinico San Matteo, Ricerca Corrente (grant
   no. 80206).
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Fourcade C, 2016, J CLIN VIROL, V82, P1, DOI 10.1016/j.jcv.2016.06.011
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Jang HC, 2016, J KOREAN MED SCI, V31, P1173, DOI 10.3346/jkms.2016.31.7.1173
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Reusken C, 2016, EURO SURVEILL, V21
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Wolfisberg R, 2013, J VIROL METHODS, V193, P215, DOI 10.1016/j.jviromet.2013.06.003
NR 15
TC 8
Z9 8
U1 0
U2 4
PU EDIZIONI INT SRL
PI PAVIA
PA DIV EDIMES, EDIZIONI MEDICO SCIENTIFICHE PAVIA, VIA RIVIERA, PAVIA,
   39-27100, ITALY
SN 1121-7138
J9 NEW MICROBIOL
JI New Microbiol.
PD JUL
PY 2017
VL 40
IS 3
BP 197
EP 198
PG 2
WC Microbiology
SC Microbiology
GA FI4KB
UT WOS:000411938900008
PM 28513814
DA 2020-07-08
ER

PT J
AU Rodriguez-Morales, AJ
   Ruiz, P
   Tabares, J
   Ossa, CA
   Yepes-Echeverry, MC
   Ramirez-Jaramillo, V
   Galindo-Marquez, ML
   Garcia-Loaiza, CJ
   Sabogal-Roman, JA
   Parra-Valencia, E
   Lagos-Grisales, GJ
   Lozada-Riascos, CO
   de Pijper, CA
   Grobusch, MP
AF Rodriguez-Morales, Alfonso J.
   Ruiz, Pablo
   Tabares, Javier
   Augusto Ossa, Carlos
   Camila Yepes-Echeverry, Maria
   Ramirez-Jaramillo, Valeria
   Leonor Galindo-Marquez, Maria
   Julian Garcia-Loaiza, Carlos
   Alejandro Sabogal-Roman, Juan
   Parra-Valencia, Esteban
   Lagos-Grisales, Guillermo J.
   Lozada-Riascos, Carlos O.
   de Pijper, Cornelis A.
   Grobusch, Martin P.
TI Mapping the ecoepidemiology of Zika virus infection in urban and rural
   areas of Pereira, Risaralda, Colombia, 2015-2016: Implications for
   public health and travel medicine
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Article
DE Zika virus (ZIKV); Geographical information systems (GIS); Public
   health; Travelers; Colombia; Latin America
ID GEOGRAPHIC INFORMATION-SYSTEMS; COFFEE-TRIANGLE REGION; OUTBREAK
   IMPLICATIONS; DENGUE INCIDENCE; CHIKUNGUNYA; DISEASE; TRANSMISSION;
   COINFECTION; GIS; MUNICIPALITIES
AB Objective: Geographical information systems (GIS) have been demonstrated earlier to be of great use to inform public health action against vector-borne infectious diseases.
   Methods: Using surveillance data on the ongoing ZIKV outbreak from Pereira, Colombia (2015-2016), we estimated incidence rates (cases/ 100,000 population), and developed maps correlating with the ecoepidemiology of the area.
   Results: Up to October 8, 2016, 439 cases of ZIKV were reported in Pereira (93 cases/ 100,000 pop.), with highest rates in the South-West area. At the corregiments (sub-municipalities) of Pereira, Caimalito presented the highest rate. An urban area, Cuba, has 169 cases/ 100,000 pop., with a low economical level and the highest Aedic index (9.1%). Entomological indexes were associated with ZIKV incidence at simple and multiple non-linear regressions (r(2) > 0.25; p < 0.05).
   Conclusions: Combining entomological, environmental, human population density, travel patterns and case data of vector-borne infections, such as ZIKV, leads to a valuable tool that can be used to pinpoint hotspots also for infections such as dengue, chikungunya and malaria. Such a tool is key to planning mosquito control and the prevention of mosquito-borne diseases in local populations. Such data also enable microepidemiology and the prediction of risk for travelers who visit specific areas in a destination country. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Rodriguez-Morales, Alfonso J.; Camila Yepes-Echeverry, Maria; Ramirez-Jaramillo, Valeria; Leonor Galindo-Marquez, Maria; Julian Garcia-Loaiza, Carlos; Alejandro Sabogal-Roman, Juan; Lagos-Grisales, Guillermo J.; Lozada-Riascos, Carlos O.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.] Asociac Panamer Infectol, Comm Travel Med, Quito, Ecuador.
   [Rodriguez-Morales, Alfonso J.; Ruiz, Pablo; Tabares, Javier; Parra-Valencia, Esteban; Lagos-Grisales, Guillermo J.; Lozada-Riascos, Carlos O.; Grobusch, Martin P.] Colombian Collaborat Network Zika RECOLZIKA, Pereira, Risaralda, Colombia.
   [Ruiz, Pablo; Tabares, Javier; Augusto Ossa, Carlos] Secretary Hlth & Social Secur Pereira, Pereira, Risaralda, Colombia.
   [Parra-Valencia, Esteban] Univ Catolica Santisima Concepcion, Fac Med, Concepcion, Chile.
   [Lozada-Riascos, Carlos O.] Univ Tecnol Pereira, Reg Informat Syst, Pereira, Risaralda, Colombia.
   [de Pijper, Cornelis A.; Grobusch, Martin P.] Univ Amsterdam, Acad Med Ctr, Div Internal Med, Ctr Trop Med & Travel Med,Dept Infect Dis, Amsterdam, Netherlands.
RP Rodriguez-Morales, AJ (corresponding author), Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
EM arodriguezm@utp.edu.co
RI AJ, Rodriguez-Morales/R-9765-2016
OI AJ, Rodriguez-Morales/0000-0001-9773-2192; Galindo Marquez, Maria
   Leonor/0000-0003-2498-0878; Parra-Valencia, Esteban/0000-0002-7071-9374
FU Universidad Tecnologica de Pereira, Pereira, Risaralda, Colombia;
   Universidad Tecnologica de Pereira, Pereira, Risaralda, Colombia
   [5-15-5]
FX Universidad Tecnologica de Pereira, Pereira, Risaralda, Colombia. This
   study is part of the project "Desarrollo de Mapas Epidemiologicos a
   traves de Sistemas de Informacion Geografica para la Caracterizacion
   Geografica de Enfermedades Infecciosas y Tropicales en el Eje Cafetero
   de Colombia" (Code 5-15-5 [2015-2017]), Universidad Tecnologica de
   Pereira, Pereira, Risaralda, Colombia.
CR Alfaro-Murillo JA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004743
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Butler Declan, 2016, Nature, V531, P153, DOI 10.1038/nature.2016.19502
   Cardona-Cardona AF, 2016, J INFECT PUBLIC HEAL, V9, P372, DOI 10.1016/j.jiph.2016.03.001
   Castaneda-Hernandez DM, 2013, TUBERCULOSIS, V93, P275, DOI 10.1016/j.tube.2013.02.001
   Chowell G, 2016, PLOS CURR, V8, DOI [10.1371/currents.outbreaks.f14b2217c902f453d9320a43a35b9583, DOI 10.1371/CURRENTS.OUTBREAKS.F14B2217C902F453D9320A43A35B9583]
   Coura JR, 2015, ACTA TROP, V151, P51, DOI 10.1016/j.actatropica.2015.04.029
   Salomon OD, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/601242
   Gallego V, 2014, TRAVEL MED INFECT DI, V12, P208, DOI 10.1016/j.tmaid.2014.04.004
   Herrera-Martinez AD, 2010, TROP BIOMED, V27, P280
   INS, 2016, B EP SEM, V2016, P103
   Iovine NM, 2017, CLIN INFECT DIS, V64, P72, DOI 10.1093/cid/ciw667
   Lednicky J, 2016, EMERG INFECT DIS, V22, P2000, DOI 10.3201/eid2211.161015
   Lysaght T, 2016, SINGAP MED J, V57, P528, DOI 10.11622/smedj.2016161
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P55, DOI 10.1016/j.tmaid.2015.07.005
   Mattar S, 2013, INT J INFECT DIS, V17, pE358, DOI 10.1016/j.ijid.2012.11.021
   Norman FF, 2016, AM J TROP MED HYG, V95, P1166, DOI 10.4269/ajtmh.16-0426
   Pacheco O, 2016, N ENGL J MED
   Paniz-Mondolfi AE, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0157-x
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Patino-Barbosa AM, 2016, J INFECT PUBLIC HEAL, V9, P532, DOI 10.1016/j.jiph.2015.10.001
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Pena-Garcia VH, 2016, INT J ENV RES PUB HE, P13
   Quintero-Herrera LL, 2015, J INFECT PUBLIC HEAL, V8, P291, DOI 10.1016/j.jiph.2014.11.005
   Rodriguez-Morales AJ, 2017, INFECTION, V45, P93, DOI 10.1007/s15010-016-0948-1
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P286, DOI 10.1016/j.tmaid.2016.03.018
   Rodriguez-Morales AJ, 2016, INT J INFECT DIS, V48, P70, DOI 10.1016/j.ijid.2016.05.012
   Rodriguez-Morales Alfonso J, 2016, F1000Res, V5, P568, DOI 10.12688/f1000research.8436.1
   Rodriguez-Morales Alfonso J, 2016, F1000Res, V5, P360, DOI 10.12688/f1000research.8235.1
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P62, DOI 10.1016/j.tmaid.2015.06.009
   Rodriguez-Morales AJ, 2015, J INFECT PUBLIC HEAL, V8, P603, DOI 10.1016/j.jiph.2015.05.011
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Saldarriaga-Arenas PA, 2013, J INFECT PUBLIC HEAL, V6, P496, DOI 10.1016/j.jiph.2013.07.003
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Singer M, 2016, GLOB PUBLIC HEALTH, P1
   Tami A, 2016, TRAVEL MED INFECT DI, V14, P9, DOI 10.1016/j.tmaid.2016.01.002
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Villamil-Gomez WE, 2016, TRAVEL MED INFECT DI, V14, P155, DOI 10.1016/j.tmaid.2016.02.004
   Woodall JP, 2016, INT J INFECT DIS, V48, P96, DOI 10.1016/j.ijid.2016.05.001
   Zambrano H, 2016, AM J TROP MED HYG, V95, P894, DOI 10.4269/ajtmh.16-0323
   Zambrano LI, 2016, J INFECT PUBLIC HLTH
   Zambrano LI, 2010, TROP BIOMED, V2012, P499
NR 46
TC 11
Z9 11
U1 3
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD JUL-AUG
PY 2017
VL 18
BP 57
EP 66
DI 10.1016/j.tmaid.2017.05.004
PG 10
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA FH3DT
UT WOS:000411025800010
PM 28487212
DA 2020-07-08
ER

PT J
AU Mallhi, TH
   Khan, YH
   Tanveer, N
   Khan, AH
   Bukhsh, A
AF Mallhi, Tauqeer Hussain
   Khan, Yusra Habib
   Tanveer, Nida
   Khan, Amer Hayat
   Bukhsh, Allah
TI Zika in India and the need for transparent reporting
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Letter
ID CHIKUNGUNYA
C1 [Mallhi, Tauqeer Hussain; Khan, Yusra Habib; Khan, Amer Hayat] Univ Sains Malaysia, Discipline Clin Pharm, Sch Pharmaceut Sci, George Town 11800, Malaysia.
   [Tanveer, Nida] Punjab Med Coll, Faisalabad, Pakistan.
   [Bukhsh, Allah] Univ Vet & Anim Sci, Inst Pharmaceut Sci, Lahore, Pakistan.
RP Mallhi, TH (corresponding author), Univ Sains Malaysia, Discipline Clin Pharm, Sch Pharmaceut Sci, George Town 11800, Malaysia.
EM tauqeer.hussain.mallhi@hotmail.com
RI Khan, Amer Hayat/O-5310-2018; Mallhi, Tauqeer Hussain/W-5155-2017;
   Bukhsh, Allah/G-3110-2018
OI Mallhi, Tauqeer Hussain/0000-0001-9957-5362; Bukhsh,
   Allah/0000-0003-4285-0102
CR Mallhi T H, 2017, New Microbes New Infect, V19, P13, DOI 10.1016/j.nmni.2017.05.008
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Selvaretnam AAP, 2016, ASIAN PAC J TROP BIO, V6, P633, DOI 10.1016/j.apjtb.2016.05.008
   World Health Organization, 2017, DIS OUTBREAK NE 0208
   World Health Organization (WHO), 2016, INT HLTH REG 2005
   Zhao Jinqiu, 2016, MEDIA ASIA, V30, P191
NR 6
TC 3
Z9 3
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD JUL-AUG
PY 2017
VL 18
BP 75
EP 76
DI 10.1016/j.tmaid.2017.07.005
PG 2
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA FH3DT
UT WOS:000411025800014
PM 28709958
OA Green Published
DA 2020-07-08
ER

PT J
AU Paiva, MHS
   Guedes, DRD
   Leal, WS
   Ayres, CFJ
AF Santos Paiva, Marcelo Henrique
   Duarte Guedes, Duschinka Ribeiro
   Leal, Walter Soares
   Junqueira Ayres, Constancia Flavia
TI Sensitivity of RT-PCR method in samples shown to be positive for Zika
   virus by RT-qPCR in vector competence studies
SO GENETICS AND MOLECULAR BIOLOGY
LA English
DT Article
DE ZIKV; RT-PCR; Aedes aegypti; vector competence
ID MOSQUITOS; BRAZIL
AB Tissue samples from mosquitoes artificially infected with Zika virus and shown to be positive by RT-qPCR were reex-amined by RT-PCR. Using these samples we compared the two methods employed in virus RNA detection for vector competence studies. Results demonstrated that, albeit useful, RT-PCR gave false negatives with low viral loads (<10(6) RNA copies/ml).
C1 [Santos Paiva, Marcelo Henrique; Duarte Guedes, Duschinka Ribeiro; Junqueira Ayres, Constancia Flavia] Univ Fed Pernambuco, Ctr Acad Agreste, Caruaru, PE, Brazil.
   [Santos Paiva, Marcelo Henrique] Fundacao Oswaldo Cruz Pernambuco, Inst Aggeu Magalhaes, Dept Entomol, Recife, PE, Brazil.
   [Leal, Walter Soares] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.
RP Paiva, MHS (corresponding author), Fundacao Oswaldo Cruz Pernambuco, Ctr Pesquisas Aggeu Magalhaes, Dept Entomol, Av Moraes Rego,S-N Campus UFPE,Cidade Univ, BR-50670420 Recife, PE, Brazil.
EM marceloh@cpqam.fiocruz.br
RI Ayres, Constancia/AAQ-3448-2020
FU Fundacao de Amparo a Pesquisa do Estado de Pernambuco (FACEPE); Oswaldo
   Cruz Foundation (PROEP); Conselho Nacional de Desenvolvimento Cientifico
   e TecnologicoNational Council for Scientific and Technological
   Development (CNPq) [CNPq - 441100/2016-3]; National Institute of Allergy
   and Infectious Diseases of the National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R01AI095514, 1R21AI128931]
FX We are thankful to Fundacao de Amparo a Pesquisa do Estado de Pernambuco
   (FACEPE), Oswaldo Cruz Foundation (PROEP) and Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq - 441100/2016-3) for
   financially supporting this work, as well as the National Institute of
   Allergy and Infectious Diseases of the National Institutes of Health
   (grants R01AI095514 and 1R21AI128931 to W.S.L.) for partial support. We
   also thank QIAGEN-Brasil, for providing technical support and the Nucleo
   de Estatistica e Georreferenciamento (NEG-IAM), for statistical support.
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Corman VM, 2016, B WHO
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guedes D. R. D., 2016, ZIKA VIRUS REPLICATI, DOI 10.1101/073197
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   R Core Team, 2008, R FDN STAT COMP
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   WHO, 2016, ZIK VIR MICR PHAL GU
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 16
TC 5
Z9 5
U1 1
U2 10
PU SOC BRASIL GENETICA
PI RIBEIRAO PRET
PA RUA CAP ADELMIO NORBET DA SILVA, 736, ALTO DA BOA VISTA, 14025-670
   RIBEIRAO PRET, BRAZIL
SN 1415-4757
EI 1678-4685
J9 GENET MOL BIOL
JI Genet. Mol. Biol.
PD JUL-SEP
PY 2017
VL 40
IS 3
BP 597
EP 599
DI 10.1590/1678-4685-GMB-2016-0312
PG 3
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA FF9XL
UT WOS:000409372000005
PM 28534930
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Londono-Renteria, B
   Troupin, A
   Cardenas, JC
   Hall, A
   Perez, OG
   Cardenas, L
   Hartstone-Rose, A
   Halstead, SB
   Colpitts, TM
AF Londono-Renteria, Berlin
   Troupin, Andrea
   Cardenas, Jenny C.
   Hall, Alex
   Perez, Omar G.
   Cardenas, Lucio
   Hartstone-Rose, Adam
   Halstead, Scott B.
   Colpitts, Tonya M.
TI A relevant in vitro human model for the study of Zika virus
   antibody-dependent enhancement
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Article
DE Dengue immunity; Zika virus; antibody-dependent enhancement;
   macrophages; primary cell model
ID DENGUE-VIRUS; CROSS-REACTIVITY; WEST-NILE; INFECTION; MACROPHAGES;
   DISEASE; FLAVIVIRUSES; SUBVERSION; COMPLEXES; RESPONSES
AB Zika virus (ZIKV) is a mosquito-borne flavivirus that has recently been responsible for a serious outbreak of disease in South and Central America. Infection with ZIKV has been associated with severe neurological symptoms and the development of microcephaly in unborn fetuses. Many of the regions involved in the current outbreak are known to be endemic for another flavivirus, dengue virus (DENV), which indicates that a large percentage of the population may have pre-existing DENV immunity. Thus, it is vital to investigate what impact pre-existing DENV immunity has on ZIKV infection. Here, we use primary human myeloid cells as a model for ZIKV enhancement in the presence of DENV antibodies. We show that sera containing DENV antibodies from individuals living in a DENV-endemic area are able to enhance ZIKV infection in a human macrophage-derived cell line and primary human macrophages. We also demonstrate altered pro-inflammatory cytokine production in macrophages with enhanced ZIKV infection. Our study indicates an important role for pre-existing DENV immunity on ZIKV infection in primary human immune cells and establishes a relevant in vitro model to study ZIKV antibody-dependent enhancement.
C1 [Londono-Renteria, Berlin; Troupin, Andrea; Hall, Alex; Colpitts, Tonya M.] Univ South Carolina, Dept Pathol Microbiol & Immunol, Sch Med, Columbia, SC 29208 USA.
   [Cardenas, Jenny C.] Hosp Los Patios, Clin Lab, Los Patios, Colombia.
   [Perez, Omar G.; Cardenas, Lucio] Univ Pamplona, Grp Invest Enfermedades Parasitarias GIEPATI, Pamplona, Colombia.
   [Hartstone-Rose, Adam] Univ South Carolina, Dept Cell Biol & Anat, Sch Med, Columbia, SC USA.
   [Halstead, Scott B.] Uniformed Serv Univ Hlth Sci, Dept Preventat Med & Biometr, Bethesda, MD 20814 USA.
   [Colpitts, Tonya M.] Tulane Sch Publ Hlth & Trop Med, Trop Med, New Orleans, LA USA.
   [Londono-Renteria, Berlin] Kansas State Univ, Entomol, Manhattan, KS 66506 USA.
   [Colpitts, Tonya M.] Boston Univ, Sch Med, Microbiol, Boston, MA 02118 USA.
RP Colpitts, TM (corresponding author), Univ South Carolina, Dept Pathol Microbiol & Immunol, Sch Med, Columbia, SC 29208 USA.; Colpitts, TM (corresponding author), Tulane Sch Publ Hlth & Trop Med, Trop Med, New Orleans, LA USA.; Colpitts, TM (corresponding author), Boston Univ, Sch Med, Microbiol, Boston, MA 02118 USA.
EM tonya.colpitts@uscmed.sc.edu
RI Londono, Berlin/I-8830-2019; Hartstone-Rose, Adam/I-3503-2016
OI Londono, Berlin/0000-0001-5956-5274; Colpitts,
   Tonya/0000-0003-3915-1554; Hartstone-Rose, Adam/0000-0001-5307-5573
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [1 K22 AI103067];
   University of South Carolina School of Medicine, Department of
   Pathology, Microbiology and Immunology
FX The work in this study was supported by the National Institutes of
   Health (1 K22 AI103067) and funding from the University of South
   Carolina School of Medicine, Department of Pathology, Microbiology and
   Immunology.
CR Arauz D, 2016, EMERG INFECT DIS, V22, P1515, DOI 10.3201/eid2208.160292
   Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bhoopat L, 1996, ASIAN PAC J ALLERGY, V14, P107
   Burke DS, 2006, J INFECT DIS, V193, P601, DOI 10.1086/499282
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen RF, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-340
   Colpitts TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024365
   Colpitts TM, 2011, VIROLOGY, V417, P179, DOI 10.1016/j.virol.2011.06.002
   Costa VV, 2014, MED MICROBIOL IMMUN, V203, P231, DOI 10.1007/s00430-014-0334-5
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dong T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001192
   FAGBAMI AH, 1987, CYTOBIOS, V49, P49
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Govindarajan D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152209
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   HALL WC, 1991, AM J TROP MED HYG, V45, P408, DOI 10.4269/ajtmh.1991.45.408
   HALSTEAD SB, 1980, AM J TROP MED HYG, V29, P638, DOI 10.4269/ajtmh.1980.29.638
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3
   Harrison SC, 2016, NAT IMMUNOL, V17, P1010, DOI 10.1038/ni.3539
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Huang XW, 2016, SCI REP-UK, V6, DOI 10.1038/srep22303
   Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Krishnamurthy Pavan K, 2011, Front Psychiatry, V2, P59, DOI 10.3389/fpsyt.2011.00059
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Londono-Renteria B, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1160-3
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   MORENS DM, 1987, MICROB PATHOGENESIS, V3, P231, DOI 10.1016/0882-4010(87)90056-8
   Munoz-Jordan JL, 2013, EMERG INFECT DIS, V19, P652, DOI 10.3201/eid1904.121295
   Murray KO, 2013, VECTOR-BORNE ZOONOT, V13, P835, DOI 10.1089/vbz.2013.1413
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Puerta-Guardo H, 2013, J VIROL, V87, P7486, DOI 10.1128/JVI.00085-13
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rolph MS, 2011, J INFECT DIS, V204, P489, DOI 10.1093/infdis/jir271
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tampellini D, 2007, J BIOL CHEM, V282, P18895, DOI 10.1074/jbc.M700373200
   Tsai TT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003320
   Wise J, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1242
NR 51
TC 14
Z9 14
U1 0
U2 1
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-1317
EI 1465-2099
J9 J GEN VIROL
JI J. Gen. Virol.
PD JUL
PY 2017
VL 98
IS 7
BP 1702
EP 1712
DI 10.1099/jgv.0.000833
PG 11
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA FG4SX
UT WOS:000410256900014
PM 28691657
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Deng, CL
   Zhang, QY
   Chen, DD
   Liu, SQ
   Qin, CF
   Zhang, B
   Ye, HQ
AF Deng, Cheng-Lin
   Zhang, Qiu-Yan
   Chen, Dong-Dong
   Liu, Si-Qing
   Qin, Cheng-Feng
   Zhang, Bo
   Ye, Han-Qing
TI Recovery of the Zika virus through an in vitro ligation approach
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Article
DE Flavivirus: Zika virus; infectious clone; in vitro ligation
ID RNA
AB In this study, an in vitro Ligation method was developed to assemble a full-length infectious cDNA clone of the Zika virus (ZIKV). Four contiguous cDNA subclones covering the complete ZIKV genome were constructed with unique Bgll restriction sites at the ends of each fragment. The Bgll restriction sites only allow in vitro ligation to happen between interconnecting restriction sites from adjacent cDNA fragments, resulting in an intact full-length cDNA of ZIKV. RNA transcripts derived from the full-length cDNA were infectious. The recombinant virus replicated as efficiently as the wild-type virus with similar growth kinetics and plaque morphologies in Vero and C6/36 cells. Both viruses were inhibited by NITD008 treatment. This in vitro ligation method will facilitate manipulation of the viral genome through genetic modifications of four separated subclones of ZIKV for the rapid and rational development of candidate vaccines and viral replication study.
C1 [Deng, Cheng-Lin; Zhang, Qiu-Yan; Chen, Dong-Dong; Liu, Si-Qing; Zhang, Bo; Ye, Han-Qing] Chinese Acad Sci, CAS Key Lab Special Pathogens & Biosafety, Ctr Emerging Infect Dis, Wuhan Inst Virol, Wuhan 430071, Hubei, Peoples R China.
   [Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
RP Ye, HQ (corresponding author), Chinese Acad Sci, CAS Key Lab Special Pathogens & Biosafety, Ctr Emerging Infect Dis, Wuhan Inst Virol, Wuhan 430071, Hubei, Peoples R China.
EM yehq@wh.iov.cn
RI Qin, Cheng-Feng/I-6839-2019
OI Qin, Cheng-Feng/0000-0002-0632-2807; Zhang, Bo/0000-0002-8895-3679
FU National Key Research and Development Program of China [2016YFD0500400,
   2016YFC1200400]; National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [81572003]
FX This work was funded by the National Key Research and Development
   Program of China (2016YFD0500400 to B. Z. and 2016YFC1200400 to H.
   Q.Y.), the National Natural Science Foundation of China (81572003 to B.
   Z.).
CR Atieh T, 2016, SCI REP-UK, V6, DOI 10.1038/srep39384
   BURGER KJ, 1983, MOL GEN GENET, V189, P269, DOI 10.1007/BF00337816
   Curtis KM, 2001, ADV EXP MED BIOL, V494, P475
   Deng CL, 2014, J VIROL, V88, P11915, DOI 10.1128/JVI.01207-14
   Deng CL, 2016, VIROL SIN, V31, P176, DOI 10.1007/s12250-016-3778-5
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   KAPOOR M, 1995, GENE, V162, P175, DOI 10.1016/0378-1119(95)00332-Z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   MILLIGAN JF, 1989, METHOD ENZYMOL, V180, P51, DOI DOI 10.1016/0076-6879(89)80091-6
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   SUMIYOSHI H, 1992, J VIROL, V66, P5425, DOI 10.1128/JVI.66.9.5425-5431.1992
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Widman DG, 2017, MBIO, V8, DOI [10.1128/mBio.02014-16, 10.1128/mbio.02014-16]
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
NR 20
TC 7
Z9 7
U1 0
U2 5
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-1317
EI 1465-2099
J9 J GEN VIROL
JI J. Gen. Virol.
PD JUL
PY 2017
VL 98
IS 7
BP 1739
EP 1743
DI 10.1099/jgv.0.000862
PG 5
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA FG4SX
UT WOS:000410256900018
PM 28703698
OA Bronze
DA 2020-07-08
ER

PT J
AU Krisberg, K
AF Krisberg, Kim
TI Zika: Public Health on High Alert as Mosquito Season Begins
SO AMERICAN JOURNAL OF PUBLIC HEALTH
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER PUBLIC HEALTH ASSOC INC
PI WASHINGTON
PA 800 I STREET, NW, WASHINGTON, DC 20001-3710 USA
SN 0090-0036
EI 1541-0048
J9 AM J PUBLIC HEALTH
JI Am. J. Public Health
PD JUL
PY 2017
VL 107
IS 7
BP 1015
EP 1015
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FF8NF
UT WOS:000409274400012
DA 2020-07-08
ER

PT J
AU Vasquez, D
   Palacio, A
   Nunez, J
   Briones, W
   Beier, JC
   Pareja, DC
   Tamariz, L
AF Vasquez, Diego
   Palacio, Ana
   Nunez, Jose
   Briones, Wladimir
   Beier, John C.
   Pareja, Denisse C.
   Tamariz, Leonardo
TI Impact of the 2016 Ecuador Earthquake on Zika Virus Cases
SO AMERICAN JOURNAL OF PUBLIC HEALTH
LA English
DT Article
AB Objectives. To evaluate the impact of the April 2016 7.8-magnitude earthquake in Ecuador on the incidence of Zika virus (ZIKV) cases.
   Methods. We used the national public health surveillance system for reportable transmissible conditions and included suspected and laboratory-confirmed ZIKV cases. Wecompared the number of cases before and after the earthquake in areas closer to and farther from the epicenter.
   Results. From January to July 2016, 2234 patients suspected of having ZIKV infection were reported in both affected and control areas. A total of 1110 patients had a reverse transcription-polymerase chain reaction assay, and 159 were positive for ZIKV. The cumulative incidence of ZIKV in the affected area was 11.1 per 100 000 after the earthquake. The odds ratio of having ZIKV infection in those living in the affected area was 8.0 (95% CI = 4.4, 14.6; P < .01) compared with the control area and adjusted for age, gender, province population, and number of government health care facilities.
   Conclusions. A spike in ZIKV cases occurred after the earthquake. Patients in the area closest to the epicenter had a delay in seeking care.
C1 [Vasquez, Diego; Nunez, Jose] Univ Catolica Santiago Guayaquil, Guayaquil, Ecuador.
   [Palacio, Ana; Tamariz, Leonardo] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA.
   [Briones, Wladimir] Minist Salud Publ Ecuador, Quito, Ecuador.
   [Beier, John C.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.
   [Pareja, Denisse C.] Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Miami, FL 33125 USA.
RP Pareja, DC (corresponding author), Bruce W Carter VA Med Ctr, Dept Vet Affairs, 1201 NW 16th St,207G, Miami, FL 33125 USA.
EM denpareja@gmail.com
CR Alimi TO, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1052-1
   [Anonymous], 2016, DIS DECL 2016
   [Anonymous], 2016, DESASTRES PREPARATIV
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Daniels A, 2009, DISASTER MED PUBLIC, V3, P97, DOI 10.1097/DMP.0b013e3181a20328
   Department of Health Emergencies, DIS ARCH
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Feng J, 2016, AM J TROP MED HYG, V94, P674, DOI 10.4269/ajtmh.15-0624
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Instituto Nacional de Estadistica y Censos, 2010, FASC PROV GUAYAS RES
   Instituto Nacional de Estadistica y Censos, 2010, FASC PROV RIOS RES C
   Instituto Nacional de Estadistica y Censos, 2010, FASC PROV MAN
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Norris DE, 2004, ECOHEALTH, V1, P19, DOI DOI 10.1007/s10393-004-0008-7
   Organizacion Panamericana de la Salud, 2016, TERR EC REP SIT
   Pacheco O, N ENGL J MED
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Pan American Health Organization World Health Organization, CAS DEF
   Salazar MA, 2016, GLOB HLTH ACTION, V9
   Samson DM, 2015, J VECTOR ECOL, V40, P46, DOI 10.1111/jvec.12131
   Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601
   Watson JT, 2007, EMERG INFECT DIS, V13, P1, DOI 10.3201/eid1301.060779
NR 24
TC 7
Z9 7
U1 0
U2 4
PU AMER PUBLIC HEALTH ASSOC INC
PI WASHINGTON
PA 800 I STREET, NW, WASHINGTON, DC 20001-3710 USA
SN 0090-0036
EI 1541-0048
J9 AM J PUBLIC HEALTH
JI Am. J. Public Health
PD JUL
PY 2017
VL 107
IS 7
BP 1137
EP 1142
DI 10.2105/AJPH.2017.303769
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FF8NF
UT WOS:000409274400044
PM 28520489
OA Green Published
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Outbreak of Zika virus disease
SO JOURNAL OF RESEARCH IN MEDICAL SCIENCES
LA English
DT Letter
ID INFECTION
C1 [Wiwanitkit, Viroj] Hainan Med Univ, Dept Trop Med, Haikou, Hainan, Peoples R China.
   [Wiwanitkit, Viroj] Dr DY Patil Univ, Dept Community Med, Pune, Maharashtra, India.
RP Wiwanitkit, V (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM wviroj@yahoo.com
CR Armstrong Najealicka, 2017, World J Virol, V6, P1, DOI 10.5501/wjv.v6.i1.1
   Jia PF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2071-2
   Kim S, 2016, ADV LAB MED INT, V6, P37
   Shrivastava Saurabh RamBihariLal, 2016, J Res Med Sci, V21, P55
   Wiwanitkit S., 2016, Asian Pacific Journal of Tropical Disease, V6, P757, DOI 10.1016/S2222-1808(16)61124-6
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 6
TC 0
Z9 0
U1 0
U2 0
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1735-1995
EI 1735-7136
J9 J RES MED SCI
JI J. Res. Med. Sci.
PD JUL
PY 2017
VL 22
AR 89
DI 10.4103/jrms.JRMS_982_16
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA FF8OL
UT WOS:000409277600008
PM 28919916
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Arbuckle, JH
   Gardina, PJ
   Gordon, DN
   Hickman, HD
   Yewdell, JW
   Pierson, TC
   Myers, TG
   Kristie, TM
AF Arbuckle, Jesse H.
   Gardina, Paul J.
   Gordon, David N.
   Hickman, Heather D.
   Yewdell, Jonathan W.
   Pierson, Theodore C.
   Myers, Timothy G.
   Kristie, Thomas M.
TI Inhibitors of the Histone Methyltransferases EZH2/1 Induce a Potent
   Antiviral State and Suppress Infection by Diverse Viral Pathogens
SO MBIO
LA English
DT Article
DE antiviral; chromatin; epigenetics; herpesvirus; immune mechanisms;
   innate immunity; Zika virus
ID HERPES-SIMPLEX-VIRUS; CHROMATIN CONTROL; LATENT INFECTION; TARGETING
   EZH2; REACTIVATION; CELLS; PROMOTERS; CANCER; HIV; TRANSCRIPTION
AB Epigenetic regulation is based on a network of complexes that modulate the chromatin character and structure of the genome to impact gene expression, cell fate, and development. Thus, epigenetic modulators represent novel therapeutic targets used to treat a range of diseases, including malignancies. Infectious pathogens such as herpesviruses are also regulated by cellular epigenetic machinery, and epigenetic therapeutics represent a novel approach used to control infection, persistence, and the resulting recurrent disease. The histone H3K27 methyltransferases EZH2 and EZH1 (EZH2/1) are epigenetic repressors that suppress gene transcription via propagation of repressive H3K27me3-enriched chromatin domains. However, while EZH2/1 are implicated in the repression of herpesviral gene expression, inhibitors of these enzymes suppressed primary herpes simplex virus (HSV) infection in vitro and in vivo. Furthermore, these compounds blocked lytic viral replication following induction of HSV reactivation in latently infected sensory ganglia. Suppression correlated with the induction of multiple inflammatory, stress, and antipathogen pathways, as well as enhanced recruitment of immune cells to in vivo infection sites. Importantly, EZH2/1 inhibitors induced a cellular antiviral state that also suppressed infection with DNA (human cytomegalovirus, adenovirus) and RNA (Zika virus) viruses. Thus, EZH2/1 inhibitors have considerable potential as general antivirals through the activation of cellular antiviral and immune responses.
   IMPORTANCE A significant proportion of the world's population is infected with herpes simplex virus. Primary infection and subsequent recurrent reactivation can result in diseases ranging from mild lesions to severe ocular or neurological damage. Herpesviruses are subject to epigenetic regulation that modulates viral gene expression, lytic replication, and latency-reactivation cycles. Thus, epigenetic pharmaceuticals have the potential to alter the course of infection and disease. Here, while the histone methyltransferases EZH2/1 are implicated in the suppression of herpesviruses, inhibitors of these repressors unexpectedly suppress viral infection in vitro and in vivo by induction of key components of cellular innate defense pathways. These inhibitors suppress infection by multiple viral pathogens, indicating their potential as broad-spectrum antivirals.
C1 [Arbuckle, Jesse H.; Gordon, David N.; Hickman, Heather D.; Yewdell, Jonathan W.; Pierson, Theodore C.; Kristie, Thomas M.] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA.
   [Gardina, Paul J.; Myers, Timothy G.] NIAID, Genom Technol Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
RP Kristie, TM (corresponding author), NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA.
EM tkristie@niaid.nih.gov
RI Arbuckle, Jesse H/H-7513-2019
OI Hickman, Heather/0000-0003-4168-4894
FU Intramural Research Program of the NIH, NIAIDUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
FX This study was supported by the Intramural Research Program of the NIH,
   NIAID (T.M.K., T.C.P., J.W.Y.).
CR Abou El Hassan M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126466
   Abraham CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029410
   Arbuckle JH, 2014, CURR PROTOC MICROBIO, V35
   Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041
   Bloom DC, 2010, BBA-GENE REGUL MECH, V1799, P246, DOI 10.1016/j.bbagrm.2009.12.001
   Choudhary SK, 2011, ANNU REV PHARMACOL, V51, P397, DOI 10.1146/annurev-pharmtox-010510-100237
   Cliffe AR, 2015, CELL HOST MICROBE, V18, P649, DOI 10.1016/j.chom.2015.11.007
   Cliffe AR, 2013, MBIO, V4, DOI 10.1128/mBio.00590-12
   Cliffe AR, 2009, J VIROL, V83, P8182, DOI 10.1128/JVI.00712-09
   Comet I, 2016, NAT REV CANCER, V16, P803, DOI 10.1038/nrc.2016.83
   Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669
   Enquist LW, 2017, J VIROL, V91, DOI 10.1128/JVI.01200-16
   Farooq AV, 2012, SURV OPHTHALMOL, V57, P448, DOI 10.1016/j.survophthal.2012.01.005
   Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7
   Gunther T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000935
   Helin K, 2013, NATURE, V502, P480, DOI 10.1038/nature12751
   Hill J.M., 2014, FRONT AGING NEUROSCI, V6, P1, DOI DOI 10.1126/SCITRANSLMED.3010643
   Johnston C, 2016, CLIN MICROBIOL REV, V29, P149, DOI 10.1128/CMR.00043-15
   Kim JM, 2015, SCI REP-UK, V5, DOI 10.1038/srep16714
   Kim KH, 2016, NAT MED, V22, P128, DOI 10.1038/nm.4036
   Knickelbein JE, 2008, SCIENCE, V322, P268, DOI 10.1126/science.1164164
   Knipe DM, 2008, NAT REV MICROBIOL, V6, P211, DOI 10.1038/nrmicro1794
   Knipe DM, 2013, VIROLOGY, V435, P141, DOI 10.1016/j.virol.2012.09.023
   Kong XQ, 2014, J MED CHEM, V57, P9512, DOI 10.1021/jm501230c
   Konze KD, 2013, ACS CHEM BIOL, V8, P1324, DOI [10.1021/cb400133j, 10.1021/cb400133J]
   Kristie TM, 2015, VIROLOGY, V479, P555, DOI 10.1016/j.virol.2015.01.026
   Kwiatkowski DL, 2009, J VIROL, V83, P8173, DOI 10.1128/JVI.00686-09
   Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661
   Levin MJ, 2004, CLIN INFECT DIS, V39, pS248, DOI 10.1086/422364
   Liang Y, 2013, MBIO, V4, DOI 10.1128/mBio.00558-12
   Liang Y, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005145
   Liang Y, 2009, NAT MED, V15, P1312, DOI 10.1038/nm.2051
   Lieberman PM, 2016, CELL HOST MICROBE, V19, P619, DOI 10.1016/j.chom.2016.04.008
   Lieberman PM, 2013, NAT REV MICROBIOL, V11, P863, DOI 10.1038/nrmicro3135
   Majer CR, 2012, FEBS LETT, V586, P3448, DOI 10.1016/j.febslet.2012.07.066
   Margolis DM, 2016, SCIENCE, V353, P362, DOI 10.1126/science.aaf6517
   Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784
   McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606
   McCabe MT, 2012, P NATL ACAD SCI USA, V109, P2989, DOI 10.1073/pnas.1116418109
   Messer HGP, 2015, J VIROL, V89, P3417, DOI 10.1128/JVI.03052-14
   Morera L, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0223-4
   Murata T, 2012, J VIROL, V86, P4752, DOI 10.1128/JVI.06768-11
   Narayanan A, 2007, P NATL ACAD SCI USA, V104, P10835, DOI 10.1073/pnas.0704351104
   Piret J, 2011, ANTIMICROB AGENTS CH, V55, P459, DOI 10.1128/AAC.00615-10
   Qi W, 2017, NAT CHEM BIOL, V13, P381, DOI 10.1038/nchembio.2304
   Raja P, 2016, MBIO, V7, DOI [10.1128/mBio.00633-16, 10.1128/mBio.02007-15]
   Reeves M, 2013, VIRUSES-BASEL, V5, P1395, DOI 10.3390/v5061395
   Rosato PC, 2015, FUTURE VIROL, V10, P699, DOI 10.2217/fvl.15.45
   Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215
   Shirakawa K, 2013, TRENDS MICROBIOL, V21, P277, DOI 10.1016/j.tim.2013.02.005
   Silva Lindsey, 2008, PLoS Pathog, V4, pe1000071, DOI 10.1371/journal.ppat.1000071
   St Leger AJ, 2011, J NEUROVIROL, V17, P528, DOI 10.1007/s13365-011-0062-1
   Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003
   Toth Z, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005878
   Toth Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001013
   van Velzen M, 2013, J INFECT DIS, V208, P1359, DOI 10.1093/infdis/jit350
   van Velzen M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003547
   Verma SK, 2012, ACS MED CHEM LETT, V3, P1091, DOI 10.1021/ml3003346
   Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113
   Wang QY, 2005, P NATL ACAD SCI USA, V102, P16055, DOI 10.1073/pnas.0505850102
   Whitley R, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P589
   Xu BW, 2015, EXP HEMATOL, V43, P698, DOI 10.1016/j.exphem.2015.05.001
   Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208
   Zhu J, 2009, NAT MED, V15, P886, DOI 10.1038/nm.2006
NR 64
TC 17
Z9 17
U1 1
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD JUL-AUG
PY 2017
VL 8
IS 4
AR e01141-17
DI 10.1128/mBio.01141-17
PG 14
WC Microbiology
SC Microbiology
GA FG0BP
UT WOS:000409384300004
PM 28811345
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hadi, T
   MacGregor, J
   Mann, L
AF Hadi, Tamer
   MacGregor, Jennifer
   Mann, Lauren
TI SOCIAL MEDIA MONITORING: 2016 ZIKA RESPONSE IN NYC
SO HEALTH SECURITY
LA English
DT Article
C1 [Hadi, Tamer] New York City Dept Hlth & Mental Hyg, Off Emergency Preparedness & Response, Strateg Technol, Long Isl City, NY 11101 USA.
   [MacGregor, Jennifer] New York City Dept Hlth & Mental Hyg, Bur Commun, Social Media, Long Isl City, NY USA.
   [Mann, Lauren] New York City Dept Hlth & Mental Hyg, Div Family & Child Hlth, Long Isl City, NY USA.
RP Hadi, T (corresponding author), New York City Dept Hlth & Mental Hyg, Off Emergency Preparedness & Response, Strateg Technol, Long Isl City, NY 11101 USA.
FU Centers for Disease Control and Prevention Public Health Emergency
   Preparedness
FX Initial development of the NYC DOHMH social media monitoring team was
   possible because of funding from the Centers for Disease Control and
   Prevention Public Health Emergency Preparedness. The authors would like
   to acknowledge Estella Yu, who assisted with social media monitoring
   during the Zika response.
CR Department of Homeland Security Science and Technology Directorate Virtual Social Media Working Group and DHS First Responders Group, 2012, COMM ENG SOC MED BES
   Department of Homeland Security Science and Technology Directorate Virtual Social Media Working Group and DHS First Responders Group, 2014, US SOC MED ENH SIT A
   Florida Department of Health, ZIK VIR TIM
   Hadi TA, 2016, DISASTER MED PUBLIC, V10, P775, DOI 10.1017/dmp.2016.39
   New York City Department of Health and Mental Hygiene, 2016, ZIK VIR
   New York City Department of Health and Mental Hygiene (@nycHealthy), 2016, WER ANN 1 EV REP CAS
NR 6
TC 1
Z9 1
U1 0
U2 4
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2326-5094
EI 2326-5108
J9 HEALTH SECUR
JI Health Secur.
PD JUL-AUG
PY 2017
VL 15
IS 4
BP 440
EP 444
DI 10.1089/hs.2017.0031
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FE6JY
UT WOS:000408317000020
PM 28806098
DA 2020-07-08
ER

PT J
AU Tin, SS
   Wiwanitkit, V
AF Tin, Sim Sai
   Wiwanitkit, Viroj
TI ZIKA VIRUS IN ONTARIO: EVALUATING A RAPID RISK ASSESSMENT TOOL
SO HEALTH SECURITY
LA English
DT Letter
C1 [Tin, Sim Sai] Shantou Med Ctr, Shantou, Peoples R China.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Tin, SS (corresponding author), Shantou Med Ctr, Shantou, Peoples R China.
EM simsaitin@gmail.com
CR Koenig KL, 2016, WEST J EMERG MED, V17, P238, DOI 10.5811/westjem.2016.3.30188
   Van Meer R, 2017, HEALTH SECUR, V15, P230, DOI 10.1089/hs.2016.0127
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 3
TC 0
Z9 0
U1 0
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2326-5094
EI 2326-5108
J9 HEALTH SECUR
JI Health Secur.
PD JUL-AUG
PY 2017
VL 15
IS 4
BP 452
EP 452
DI 10.1089/hs.2017.0053
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FE6JY
UT WOS:000408317000023
PM 28806105
DA 2020-07-08
ER

PT J
AU Radha, B
   Muniraj, G
AF Radha, Baburajan
   Muniraj, Gnanaraj
TI Alternate paradigms on Zika virus-related complications: An analytical
   review
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
DE Zika Virus; Microcephaly; Neurotropism; Koch's postulates; Placenta;
   Vaccines
ID GROUP-B STREPTOCOCCUS; PLACENTAL-TRANSFER; CELLS; PROGENITORS; GROWTH;
   TERM
AB The proportion of the reported cases of Zika virus (ZIKV) infection reached the status of a pandemic. Numerous studies are being conducted on the isolation of ZIKV strains from various epidemics, diagnosis of the infections, various animal models and cell culture designs to study the pathogenesis of ZIKV in the attempts to find an effective ZIKV vaccine. This review focuses upon the 'Off-Spectrum' body of studies which analyses the epidemiology, pathogenesis and other attributes of ZIKV in the light of various dissident hypotheses.
C1 [Radha, Baburajan] MVK Hosp, Hitech Diagnost Lab, Tanjavur 02, Tamil Nadu, India.
   [Muniraj, Gnanaraj] Madurai Kamaraj Univ, Sch Biol Sci, Dept Plant Morphol & Algol, Madurai 21, Tamil Nadu, India.
RP Radha, B (corresponding author), MVK Hosp, Hitech Diagnost Lab, Tanjavur 02, Tamil Nadu, India.
EM babumkubct@gmail.com
CR Abu-Raya B, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00338
   Barr KL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004931
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Book JA, 1953, AM J MENT DEF, V57, P637
   BRANDON MGW, 1959, ARCH DIS CHILD, V34, P56, DOI 10.1136/adc.34.173.56
   Burton GJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0066
   Collado MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23129
   Cleal JK, 2015, BRIT J NUTR, V113, P1903, DOI 10.1017/S0007114515001178
   Culina S, 2015, DIABETES, V64, P3532, DOI 10.2337/db15-0024
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Ewing G, 2015, CLIN PHARMACOKINET, V54, P359, DOI 10.1007/s40262-014-0233-3
   Geyer H, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0475-9
   Goo L, 2016, MBIO, V7, DOI [10.1128/mBio.01396-16, 10.1128/mbio.01396-16]
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hayward CE, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00028
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Holder B, 2016, TRAFFIC, V17, P168, DOI 10.1111/tra.12352
   Idris FM, 2016, MALAYS J MED SCI, V23, P70
   Ishida Y, 2015, INT J MOL MED, V35, P1511, DOI 10.3892/ijmm.2015.2157
   Jamil Z, 2016, ASIAN PAC J TROP MED, V9, P606, DOI 10.1016/j.apjtm.2016.05.020
   Jelgersma HC, 1928, Z GESAMTE NEUROL PSY, V112, P88, DOI 10.1007/BF02863887
   Katz BZ, 2016, JAMA PEDIATR, V170, P1115, DOI 10.1001/jamapediatrics.2016.2750
   Komai T, 1954, J HUM GENET, V7, P51
   Le Doare K, 2016, AIDS, V30, P471, DOI 10.1097/QAD.0000000000000923
   Li J, 2015, PROTEIN CELL, V6, P391, DOI 10.1007/s13238-015-0156-2
   Macchiaverni P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139064
   Torres-Mendoza BM, 2014, BIOMED RES INT, DOI 10.1155/2014/851820
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Muller JA, 2016, EMERG INFECT DIS, V22, P1685, DOI 10.3201/eid2209.160664
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nguyen T. V., 2014, EBIOMEDICINE, V2, P59
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   PLUMMER G, 1952, PEDIATRICS, V10, P687
   Prasad K M, 1995, Indian J Psychiatry, V37, P70
   Radha B, 2016, INT J PHARM BIOL SIC, V6, P166
   Roche AF, 1997, ARCH PEDIAT ADOL MED, V151, P50, DOI 10.1001/archpedi.1997.02170380054009
   Sferruzzi-Perri AN, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00033
   Shafiee A, 2015, STEM CELL TRANSL MED, V4, P419, DOI 10.5966/sctm.2014-0224
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Stach SCL, 2015, SCAND J IMMUNOL, V81, P135, DOI 10.1111/sji.12258
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   WESTROPP CK, 1956, J NEUROL NEUROSUR PS, V19, P52, DOI 10.1136/jnnp.19.1.52
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Zhang S, 2015, NUTRIENTS, V7, P360, DOI 10.3390/nu7010360
NR 45
TC 0
Z9 0
U1 0
U2 0
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1995-7645
EI 2352-4146
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD JUL
PY 2017
VL 10
IS 7
BP 701
EP 704
DI 10.1016/j.apjtm.2017.07.003
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FE1PB
UT WOS:000407989000002
PM 28870338
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Amorim, R
   Temzi, A
   Griffin, BD
   Mouland, AJ
AF Amorim, Raquel
   Temzi, Abdelkrim
   Griffin, Bryan D.
   Mouland, Andrew J.
TI Zika virus inhibits eIF2 alpha-dependent stress granule assembly
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID INITIATION-FACTOR 2; TRANSLATION INITIATION; PROTEIN-SYNTHESIS;
   ALPHA-SUBUNIT; WEST-NILE; RNA; PHOSPHORYLATION; CELLS; TIA-1;
   REPLICATION
AB Zika virus (ZIKV), a member of the Flaviviridae family, is the most recent emerging arbovirus with pandemic potential. During infection, viruses trigger the host cell stress response, leading to changes in RNA translation and the assembly of large aggregates of stalled translation preinitiation complexes, termed stress granules (SGs). Several reports demonstrate that flaviviruses modulate the assembly of stress granules (SG). As an emerging pathogen, little is known however about how ZIKV modulates the host cell stress response. In this work, we investigate how ZIKV modulates SG assembly. We demonstrate that ZIKV negatively impacts SG assembly under oxidative stress conditions induced by sodium arsenite (Ars), a treatment that leads to the phosphorylation of eIF2 alpha. By contrast, no measurable difference in SG assembly was observed between mock and ZIKV-infected cells treated with sodium selenite (Se) or Pateamine A (PatA), compounds that trigger eIF2 alpha-independent SG assembly. Interestingly, ZIKV infection markedly impaired the phosphorylation of eIF2 alpha triggered in Ars-treated infected cells, and the abrogation of SG assembly in ZIKV-infected cells is, at least in part, dependent on eIF2 alpha dephosphorylation. These data demonstrate that ZIKV elicits mechanisms to counteract host anti-viral stress responses to promote a cellular environment propitious for viral replication.
C1 [Amorim, Raquel; Temzi, Abdelkrim; Mouland, Andrew J.] Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ, Canada.
   [Amorim, Raquel; Mouland, Andrew J.] McGill Univ, Div Expt Med, Dept Med, Montreal, PQ, Canada.
   [Griffin, Bryan D.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Special Pathogens Program, Winnipeg, MB, Canada.
   [Griffin, Bryan D.] Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada.
   [Mouland, Andrew J.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada.
RP Amorim, R; Mouland, AJ (corresponding author), Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ, Canada.; Amorim, R; Mouland, AJ (corresponding author), McGill Univ, Div Expt Med, Dept Med, Montreal, PQ, Canada.; Mouland, AJ (corresponding author), McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada.
EM raquel.amorim@mail.mcgill.ca; andrew.mouland@mcgill.ca
RI Amorim, Raquel/M-8161-2013
OI Amorim, Raquel/0000-0002-1605-0702; Mouland, Andrew/0000-0002-1828-0296;
   Temzi, Abdelkrim/0000-0002-6356-2364
FU Canadian Institutes of Health Research (CIHR)Canadian Institutes of
   Health Research (CIHR) [MOP 38111, MOP-56974]; Canadian HIV Cure
   Enterprise Team Grant from the CIHRCanadian Institutes of Health
   Research (CIHR) [HIG-133050]; Canadian Foundation for HIV-1/AIDS
   Research; International AIDS Society; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico Fellowship (Brazil)
FX This work was supported by grants MOP 38111 and MOP-56974 from the
   Canadian Institutes of Health Research (CIHR) to AJM and by The Canadian
   HIV Cure Enterprise Team Grant HIG-133050 (to AJM) from the CIHR in
   partnership with Canadian Foundation for HIV-1/AIDS Research and The
   International AIDS Society. RA was funded by a Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico Fellowship (Brazil). The
   funders had no role in study design, data collection and interpretation,
   or the decision to submit the work for publication.
CR Albornoz A, 2014, J VIROL, V88, P6611, DOI 10.1128/JVI.03736-13
   Anderson P, 2002, CELL STRESS CHAPERON, V7, P213, DOI 10.1379/1466-1268(2002)007<0213:VSTROE>2.0.CO;2
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Baer A, 2014, JOVE-J VIS EXP, DOI 10.3791/52065
   Basu M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006240
   Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902
   Bryant KF, 2008, VIROLOGY, V379, P197, DOI 10.1016/j.virol.2008.06.028
   Buchman PD, 2017, SCI REPORTS
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Dang YJ, 2006, J BIOL CHEM, V281, P32870, DOI 10.1074/jbc.M606149200
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Emara MM, 2007, P NATL ACAD SCI USA, V104, P9041, DOI 10.1073/pnas.0703348104
   Fujimura K, 2012, NUCLEIC ACIDS RES, V40, P8099, DOI 10.1093/nar/gks566
   Garaigorta U, 2012, J VIROL, V86, P11043, DOI 10.1128/JVI.07101-11
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Hakki M, 2008, VIROLOGY, V380, P255, DOI 10.1016/j.virol.2008.07.028
   He B, 1997, P NATL ACAD SCI USA, V94, P843, DOI 10.1073/pnas.94.3.843
   Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618
   Janes KA, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005966
   Jefferson M, PLOS ONE
   Katoh H, 2013, J VIROL, V87, P489, DOI 10.1128/JVI.02186-12
   Kazemi S, 2004, MOL CELL BIOL, V24, P3415, DOI 10.1128/MCB.24.8.3415-3429.2004
   Kedersha N, 2008, METHOD ENZYMOL, V448, P521, DOI 10.1016/S0076-6879(08)02626-8
   Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431
   Kimball SR, 2003, AM J PHYSIOL-CELL PH, V284, pC273, DOI 10.1152/ajpcell.00314.2002
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Le Sage V, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060152
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li W, 2002, J VIROL, V76, P11989, DOI 10.1128/JVI.76.23.11989-12000.2002
   Liao Y, 2016, J GEN VIROL, V97, P867, DOI 10.1099/jgv.0.000426
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Linero FN, 2011, J GEN VIROL, V92, P2889, DOI 10.1099/vir.0.033407-0
   McEwen E, 2005, J BIOL CHEM, V280, P16925, DOI 10.1074/jbc.M412882200
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Onomoto K, 2014, TRENDS IMMUNOL, V35, P420, DOI 10.1016/j.it.2014.07.006
   Panas MD, 2015, METHODS, V90, P57, DOI 10.1016/j.ymeth.2015.04.009
   Poblete-Duran N, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8070180
   Roth H, 2017, MBIO, V8
   Ruggieri A, 2012, CELL HOST MICROBE, V12, P71, DOI 10.1016/j.chom.2012.05.013
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042
   Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111
   Valiente-Echeverria F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5819
   Vyboh K, 2012, JOVE-J VIS EXP, DOI 10.3791/4002
   Wang XX, 2009, J VIROL, V83, P12462, DOI 10.1128/JVI.01546-09
   White JP, 2007, CELL HOST MICROBE, V2, P295, DOI 10.1016/j.chom.2007.08.006
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang FQ, 2010, J VIROL, V84, P10681, DOI 10.1128/JVI.01027-10
   Zismanov V, 2016, CELL STEM CELL, V18, P79, DOI 10.1016/j.stem.2015.09.020
NR 51
TC 18
Z9 19
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUL
PY 2017
VL 11
IS 7
AR e0005775
DI 10.1371/journal.pntd.0005775
PG 20
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FE2PD
UT WOS:000408057300074
PM 28715409
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kotsakiozi, P
   Gloria-Soria, A
   Caccone, A
   Evans, B
   Schama, R
   Martins, AJ
   Powell, JR
AF Kotsakiozi, Panayiota
   Gloria-Soria, Andrea
   Caccone, Adalgisa
   Evans, Benjamin
   Schama, Renata
   Martins, Ademir Jesus
   Powell, Jeffrey R.
TI Tracking the return of Aedes aegypti to Brazil, the major vector of the
   dengue, chikungunya and Zika viruses
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID GENETIC-VARIABILITY; POPULATION-GENETICS; DIPTERA-CULICIDAE;
   COMPUTER-PROGRAM; SOFTWARE; POLYMORPHISM; RAREFACTION; RESISTANCE;
   PATTERNS; ALLELES
AB Background
   Aedes aegypti, commonly known as "the yellow fever mosquito", is of great medical concern today primarily as the major vector of dengue, chikungunya and Zika viruses, although yellow fever remains a serious health concern in some regions. The history of Ae. aegypti in Brazil is of particular interest because the country was subjected to a well-documented eradication program during 1940s-1950s. After cessation of the campaign, the mosquito quickly re-established in the early 1970s with several dengue outbreaks reported during the last 30 years. Brazil can be considered the country suffering the most from the yellow fever mosquito, given the high number of dengue, chikungunya and Zika cases reported in the country, after having once been declared "free of Ae. aegypti".
   Methodology/Principal findings
   We used 12 microsatellite markers to infer the genetic structure of Brazilian Ae. aegypti populations, genetic variability, genetic affinities with neighboring geographic areas, and the timing of their arrival and spread. This enabled us to reconstruct their recent history and evaluate whether the reappearance in Brazil was the result of re-invasion from neighboring non-eradicated areas or re-emergence from local refugia surviving the eradication program. Our results indicate a genetic break separating the northern and southern Brazilian Ae. aegypti populations, with further genetic differentiation within each cluster, especially in southern Brazil.
   Conclusions/Significance
   Based on our results, re-invasions from non-eradicated regions are the most likely scenario for the reappearance of Ae. aegypti in Brazil. While populations in the northern cluster are likely to have descended from Venezuela populations as early as the 1970s, southern populations seem to have derived more recently from northern Brazilian areas. Possible entry points are also revealed within both southern and northern clusters that could inform strategies to control and monitor this important arbovirus vector.
C1 [Kotsakiozi, Panayiota; Gloria-Soria, Andrea; Caccone, Adalgisa; Evans, Benjamin; Powell, Jeffrey R.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.
   [Schama, Renata] IOC Fiocruz, Lab Biol Computac & Sistemas, Rio De Janeiro, Brazil.
   [Martins, Ademir Jesus] IOC FIOCRUZ, Lab Fisiol & Controle Artro podes Vetores, Rio De Janeiro, Brazil.
RP Kotsakiozi, P (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.
EM panagiota.kotsakiozi@yale.edu
RI Martins, Ademir J./B-4117-2009; Schama, Renata/E-1855-2013; Martins,
   Ademir/W-3251-2019; Gloria-Soria, Andrea/AAJ-3304-2020
OI Schama, Renata/0000-0003-1978-3757; Martins, Ademir/0000-0001-5739-1215;
   Gloria-Soria, Andrea/0000-0002-5401-3988; Evans,
   Benjamin/0000-0003-2069-4938
FU Bodossaki Foundation in Greece; Brazilian Health ministry (CNPq);
   Brazilian Health ministry (Fiocruz); Rio de Janeiro state research
   foundation (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   -FAPERJ); National Institute of Science and Technology - Molecular
   Entomology (INCT-EM); NIAIDUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [RO1 AI101112, UO1 AI115595]
FX PK was supported by the Bodossaki Foundation in Greece. RS and AJM were
   supported by grants from the Brazilian Health ministry (CNPq and
   Fiocruz) and the Rio de Janeiro state research foundation (Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro -FAPERJ) and the National
   Institute of Science and Technology - Molecular Entomology (INCT-EM).
   Financial support was provided by NIAID RO1 AI101112 and U01 AI115595
   awarded to JRP. The funders had no role in the study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR [Anonymous], 1997, Rev Panam Salud Publica, V1, P68
   Bass C, 2011, PEST MANAG SCI, V67, P886, DOI 10.1002/ps.2189
   Beaumont MA, 2002, GENETICS, V162, P2025
   Beserra EB, 2006, NEOTROP ENTOMOL, V35, P853, DOI 10.1590/S1519-566X2006000600021
   Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25
   Bracco JE, 2007, MEM I OSWALDO CRUZ, V102, P573, DOI 10.1590/S0074-02762007005000062
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469
   CHAKRABORTY R, 1992, HUM GENET, V88, P267, DOI 10.1007/BF00197257
   Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191
   Cornuet JM, 2014, BIOINFORMATICS
   da Costa-Ribeiro MCV, 2006, TROP MED INT HEALTH, V11, P1276, DOI 10.1111/j.1365-3156.2006.01667.x
   da Silva AG, 2012, EVOL APPL, V5, P664, DOI 10.1111/j.1752-4571.2012.00244.x
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166
   Paduan KD, 2006, GENET MOL BIOL, V29, P391, DOI 10.1590/S1415-47572006000200030
   Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7
   Endersby NM, 2011, J MED ENTOMOL, V48, P999, DOI 10.1603/ME10264
   Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x
   Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003
   Gaubert P, 2015, BIOL INVASIONS, V17, P1897, DOI 10.1007/s10530-015-0846-y
   Gloria-Soria A, 2016, MOL ECOL, V25, P5377, DOI 10.1111/mec.13866
   Guagliardo SA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003648
   Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233
   Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13
   Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94
   Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a
   Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x
   Kalinowski ST, 2008, ONCOR
   Lourenco-De-Oliveira R, 2004, T ROY SOC TROP MED H, V98, P43, DOI 10.1016/S0035-9203(03)00006-3
   Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238
   Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x
   Marinho RA, 2016, J VECTOR ECOL, V41, P1, DOI 10.1111/jvec.12187
   Martins AJ, 2009, TROP MED INT HEALTH, V14, P1351, DOI 10.1111/j.1365-3156.2009.02378.x
   Martins AJ, 2009, AM J TROP MED HYG, V81, P108, DOI 10.4269/ajtmh.2009.81.108
   Monteiro FA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003167
   Montella IR, 2007, AM J TROP MED HYG, V77, P467, DOI 10.4269/ajtmh.2007.77.467
   Morrison AC, 2006, ANN TROP MED PARASIT, V100, pS73, DOI 10.1179/136485906X105534
   Nei M., 1987, MOL EVOLUTIONARY GEN
   Olanratmanee P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001913
   Paduan KD, 2008, J MED ENTOMOL, V45, P59, DOI 10.1603/0022-2585(2008)45[59:MDPAHI]2.0.CO;2
   Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x
   Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460
   Pfeiler E, 2013, SCI WORLD J, DOI 10.1155/2013/724609
   Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074
   Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502
   Pollegioni P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172541
   Pritchard JK, 2000, GENETICS, V155, P945
   Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197
   Rasic G, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1230-6
   RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573
   Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x
   Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x
   Scarpassa VM, 2008, AM J TROP MED HYG, V78, P895, DOI 10.4269/ajtmh.2008.78.895
   Schug MD, 1997, NAT GENET, V15, P99, DOI 10.1038/ng0197-99
   SLATKIN M, 1995, GENETICS, V139, P457
   Slotman MA, 2007, MOL ECOL NOTES, V7, P168, DOI 10.1111/j.1471-8286.2006.01533.x
   Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x
   Vasconcelos P, 1999, DENGUE B, V23
   WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x
   Yang JQ, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0645-9
NR 61
TC 20
Z9 21
U1 0
U2 17
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUL
PY 2017
VL 11
IS 7
AR e0005653
DI 10.1371/journal.pntd.0005653
PG 20
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FE2PD
UT WOS:000408057300013
PM 28742801
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Seixas, G
   Grigoraki, L
   Weetman, D
   Vicente, JL
   Silva, AC
   Pinto, J
   Vontas, J
   Sousa, CA
AF Seixas, Goncalo
   Grigoraki, Linda
   Weetman, David
   Vicente, Jose Luis
   Silva, Ana Clara
   Pinto, Joao
   Vontas, John
   Sousa, Carla Alexandra
TI Insecticide resistance is mediated by multiple mechanisms in recently
   introduced Aedes aegypti from Madeira Island (Portugal)
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID PYRETHROID RESISTANCE; GENETIC-VARIATION; DELTAMETHRIN; PENETRATION;
   METABOLISM; PROTEINS
AB Background
   Aedes aegypti is a major mosquito vector of arboviruses, including dengue, chikungunya and Zika. In 2005, Ae. aegypti was identified for the first time in Madeira Island. Despite an initial insecticide-based vector control program, the species expanded throughout the Southern coast of the island, suggesting the presence of insecticide resistance. Here, we characterized the insecticide resistance status and the underlying mechanisms of two populations of Ae. aegypti from Madeira Island, Funchal and Paul do Mar.
   Methodology/Principal findings
   WHO susceptibility bioassays indicated resistance to cyfluthrin, permethrin, fenitrothion and bendiocarb. Use of synergists significantly increased mortality rates, and biochemical assays indicated elevated activities of detoxification enzymes, suggesting the importance of metabolic resistance. Microarray-based transcriptome analysis detected significant upregulation in both populations of nine cytochrome P450 oxidase genes (including four known pyrethroid metabolizing enzymes), the organophosphate metabolizer CCEae3a, Glutathione- S-transferases, and multiple putative cuticle proteins. Genotyping of knockdown resistance loci linked to pyrethroid resistance revealed fixation of the 1534C mutation, and presence with moderate frequencies of the V1016I mutation in each population.
   Conclusions/Significance
   Significant resistance to three major insecticide classes (pyrethroid, carbamate and organophosphate) is present in Ae. aegypti from Madeira Island, and appears to be mediated by multiple mechanisms. Implementation of appropriate resistance management strategies including rotation of insecticides with alternative modes of action, and methods other than chemical-based vector control are strongly advised to delay or reverse the spread of resistance and achieve efficient control.
C1 [Seixas, Goncalo; Vicente, Jose Luis; Pinto, Joao; Sousa, Carla Alexandra] Univ Nova Lisboa, Inst Higiene & Med Trop, Global Hlth & Trop Med, Lisbon, Portugal.
   [Grigoraki, Linda; Vontas, John] Fdn Res & Technol, Inst Mol Biol & Biotechnol, Iraklion, Greece.
   [Weetman, David] Univ Liverpool Liverpool Sch Trop Med, Dept Vector Biol, Liverpool, Merseyside, England.
   [Silva, Ana Clara] IP RAM, Inst Adm Saude & Assuntos Sociais, Dept Planeamento Saude & Adm Geral, Funchal, Madeira, Portugal.
   [Vontas, John] Agr Univ Athens, Dept Crop Sci, Athens, Greece.
RP Sousa, CA (corresponding author), Univ Nova Lisboa, Inst Higiene & Med Trop, Global Hlth & Trop Med, Lisbon, Portugal.
EM casousa@ihmt.unl.pt
RI Pinto, Joao/C-2208-2012; J., Pinto/H-6177-2019; Seixas,
   Goncalo/L-7932-2019; Sousa, Carla/G-6531-2012; Seixas,
   Goncalo/F-9282-2014; Weetman, David/M-1261-2014
OI Pinto, Joao/0000-0001-8572-7708; J., Pinto/0000-0001-8572-7708; Sousa,
   Carla/0000-0002-2386-7577; Seixas, Goncalo/0000-0001-5745-2153; Weetman,
   David/0000-0002-5820-1388; Vontas, John/0000-0002-8704-2574; Grigoraki,
   Linda/0000-0001-8997-0406
FU FEDER - COMPETE Program and Fundacao para a Ciencia e TecnologiaEuropean
   Union (EU) [PTDC/SAU-EPI/115853/2009]; European Union's Horizon Research
   and Innovation Programme under ZIKAlliance Grant [734548]; FCT PhD
   grantPortuguese Foundation for Science and Technology
   [SFRH/BD/98873/2013];  [GHTM-UID/Multi/04413/2013]
FX This study was supported by the following projects:
   PTDC/SAU-EPI/115853/2009 (FEDER - COMPETE Program and Fundacao para a
   Ciencia e Tecnologia); GHTM-UID/Multi/04413/2013; and by the European
   Union's Horizon 2020 Research and Innovation Programme under ZIKAlliance
   Grant Agreement no. 734548. GS was funded by a FCT PhD grant
   (SFRH/BD/98873/2013). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Ahmad M, 2006, PEST MANAG SCI, V62, P805, DOI 10.1002/ps.1225
   Almeida AP, 2007, EUROSURVEILLANCE, V12, P3311
   Arcaz AC, 2016, J EXP BIOL, V219, P1675, DOI 10.1242/jeb.135665
   Balabanidou V, 2016, P NATL ACAD SCI USA, V113, P9268, DOI 10.1073/pnas.1608295113
   Beebe NW, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000429
   Bingham G, 2011, TROP MED INT HEALTH, V16, P492, DOI 10.1111/j.1365-3156.2010.02717.x
   Brown JE, 2013, J MED ENTOMOL, V50, P294, DOI 10.1603/ME12173
   Burmester T, 1999, EUR J ENTOMOL, V96, P213
   CHRYSANTHIS G, 1994, INSECT BIOCHEM MOLEC, V24, P811, DOI 10.1016/0965-1748(94)90109-0
   Coleman M, 2007, J PESTIC SCI, V32, P69, DOI 10.1584/jpestics.R07-01
   COLLINS FH, 1987, AM J TROP MED HYG, V37, P37, DOI 10.4269/ajtmh.1987.37.37
   David JP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-174
   David JP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-216
   European Centre for Disease Prevention and Control, 2014, DENG OUTBR MAD PORT
   Fang FJ, 2015, PARASITOL RES, V114, P4421, DOI 10.1007/s00436-015-4683-9
   Fedorka KM, 2013, J EXP BIOL, V216, P4005, DOI 10.1242/jeb.091538
   Gefen E, 2015, COMP BIOCHEM PHYS A, V182, P58, DOI 10.1016/j.cbpa.2014.12.004
   Gjenero-Margan I, 2011, EURO SURVEILL, V16
   Goncalves Ysabel, 2008, Boletim do Museu Municipal do Funchal, P53
   Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x
   Grigoraki L, 2016, INSECT BIOCHEM MOLEC, V74, P61, DOI 10.1016/j.ibmb.2016.05.007
   Grigoraki L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003771
   Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623
   Hu ZN, 2011, INSECT BIOCHEM MOLEC, V41, P9, DOI 10.1016/j.ibmb.2010.09.005
   Ishak IH, 2016, SCI REP-UK, V6, DOI 10.1038/srep24707
   Kasai S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002948
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Margarita Y, 2006, ACTA PARASITOL, V1, P59
   Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x
   Morou Evangelia, 2010, PLoS Neglected Tropical Diseases, V4, P1
   Nazareth T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-39
   Nkya TE, 2013, INSECT BIOCHEM MOLEC, V43, P407, DOI 10.1016/j.ibmb.2012.10.006
   Oliveira P, 2008, TOURISM ECON, V14, P155, DOI 10.5367/000000008783554758
   Pavlidi N, 2012, PESTIC BIOCHEM PHYS, V104, P132, DOI 10.1016/j.pestbp.2012.07.003
   Pedrini N, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000434
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Poupardin R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002743
   Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x
   Seixas G, 2013, MEM I OSWALDO CRUZ, V108, P3, DOI 10.1590/0074-0276130386
   Smith LB, 2016, PESTIC BIOCH PHYSL
   Stevenson BJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001595
   Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007
   Strycharz JP, 2013, PESTIC BIOCHEM PHYS, V107, P207, DOI 10.1016/j.pestbp.2013.06.010
   Succo T, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.21.30240
   Vera-Maloof FZ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004263
   Vontas J, 2007, INSECT MOL BIOL, V16, P315, DOI 10.1111/j.1365-2583.2007.00728.x
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   WHO, 2013, TEST PROC INREMO
   WHO, 2016, MON MAN INS RES AED
   Wood OR, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-67
   World Health Organization, 1998, TEACHN DET INS RES M
NR 51
TC 14
Z9 15
U1 2
U2 22
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUL
PY 2017
VL 11
IS 7
AR e0005799
DI 10.1371/journal.pntd.0005799
PG 16
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FE2PD
UT WOS:000408057300090
PM 28742096
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Dehlendorf, C
   Gavin, L
   Witt, J
   Moskosky, S
AF Dehlendorf, Christine
   Gavin, Loretta
   Witt, Jacki
   Moskosky, Susan
TI Facilitating State-Wide Collaboration around Family Planning Care in the
   Context of Zika
SO WOMENS HEALTH ISSUES
LA English
DT Article
ID VIRUS
AB Introduction: Family planning providers have an important role to play in the response to the public health challenge posed by Zika. In the United States, there are high rates of unintended pregnancy, especially in states most at risk for mosquito-borne transmission of the Zika virus. This paper describes efforts by eight of these states ( Arizona, California, Florida, Georgia, Louisiana, Mississippi, South Carolina, and Texas) to build capacity for quality family planning care in the context of Zika.
   Methods: Drawing on resources developed by the Office of Population Affairs, including a toolkit for family planning care in the context of Zika, agencies and stakeholders involved in the family planning delivery system in Southern states at risk for mosquito-borne transmission met over several months in the summer of 2016 to coordinate efforts to respond to the risk of Zika in their jurisdictions.
   Results: Through proactive communication and collaboration, states took steps to integrate Zika-related family planning care, including screening for Zika risk and providing appropriate, client-centered counseling. Challenges faced by the states included not having family planning included as a component of their state's Zika response effort, limited funding for family planning activities, and the need for robust communication networks between multiple state and federal agencies.
   Conclusions: The efforts described in this paper can help other states to integrate family planning into their Zika response. This is relevant to all states; even when mosquito-borne transmission is not occurring or expected, all states experience travel-related and sexually transmitted Zika infections. (C) 2017 Jacobs Institute of Women's Health. Published by Elsevier Inc.
C1 [Dehlendorf, Christine] UCSF, Dept Family & Community Med, San Francisco, CA USA.
   [Gavin, Loretta; Moskosky, Susan] OPA, Dept Hlth & Human Serv, Rockville, MD USA.
   [Witt, Jacki] Univ Missouri Kansas City, Sch Nursing & Hlth Studies, Kansas City, MO USA.
RP Dehlendorf, C (corresponding author), 1001 Potrero Ave,Bldg 20,Room 2205, San Francisco, CA 94110 USA.
EM Christine.Dehlendorf@ucsf.edu
FU OPA
FX The work described here and the preparation of the manuscript was funded
   by OPA; the authors report no conflicts of interest.
CR Center for Medicaid and CHIP Services, 2016, STAT MED PAYM APPR I
   Centers for Disease Control and Prevention, 2016, 6 18 IN PREV UN PREG
   Dehlendorf C, 2017, CONTRACEPTION, V95, P1, DOI 10.1016/j.contraception.2016.08.013
   Dreweke J, 2016, GUTTMACHER POLICY RE, V19
   Gavin L, 2014, MMWR RECOMM REP, V63, P1
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Louisiana Department of Health, 2016, PREV UN PREGN RISKS
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rankin KM, 2016, MATERN CHILD HLTH J, V20, pS173, DOI 10.1007/s10995-016-2002-4
NR 9
TC 0
Z9 0
U1 0
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1049-3867
EI 1878-4321
J9 WOMEN HEALTH ISS
JI Womens Health Iss.
PD JUL-AUG
PY 2017
VL 27
IS 4
BP 392
EP 399
DI 10.1016/j.whi.2017.03.011
PG 8
WC Public, Environmental & Occupational Health; Women's Studies
SC Public, Environmental & Occupational Health; Women's Studies
GA FD9EO
UT WOS:000407825800001
PM 28495527
OA Bronze
DA 2020-07-08
ER

PT J
AU Kalimuthu, K
   Panneerselvam, C
   Chou, C
   Tseng, LC
   Murugan, K
   Tsai, KH
   Alarfaj, AA
   Higuchi, A
   Canale, A
   Hwang, JS
   Benelli, G
AF Kalimuthu, Kandasamy
   Panneerselvam, Chellasamy
   Chou, Chi
   Tseng, Li-Chun
   Murugan, Kadarkarai
   Tsai, Kun-Hsien
   Alarfaj, Abdullah A.
   Higuchi, Akon
   Canale, Angelo
   Hwang, Jiang-Shiou
   Benelli, Giovanni
TI Control of dengue and Zika virus vector Aedes aegypti using the
   predatory copepod Megacyclops formosanus: Synergy with Hedychium
   coronarium-synthesized silver nanoparticles and related histological
   changes in targeted mosquitoes
SO PROCESS SAFETY AND ENVIRONMENTAL PROTECTION
LA English
DT Article
DE Biological control; Biosafety; Dengue; Nanosynthesis; Biosynthesis; Zika
   virus
ID ECO-FRIENDLY LARVICIDES; CULEX-QUINQUEFASCIATUS; ESSENTIAL OILS;
   ANOPHELES-STEPHENSI; MESOCYCLOPS-THERMOCYCLOPOIDES; LEAF EXTRACT;
   OVIPOSITION ATTRACTANTS; ANTIBACTERIAL ACTIVITY; MEDIATED BIOSYNTHESIS;
   VETERINARY IMPORTANCE
AB The employ of nano-formulated biopesticides for mosquito control represents a promising strategy. Recently, it has been outlined that differences in the green reducing extracts used in nanosynthesis led to the production of nanoparticles with distinct bio-physical properities. In the present investigation, Hedychium coronarium-synthesized silver nanoparticles (AgNPs) were characterized by UV vis spectroscopy, Fourier transform infrared spectroscopy (FTIR), energy-dispersive X-ray diffraction (EDX), and transmission electron microscopy (TEM). The toxicity of H. coronarium rhizome extract and H. coronarium-synthesized AgNPs was assessed against larvae and pupae of the dengue vector Aedes aegypti, as well as against adults of the non-target copepod Mesocyclopsformosanus. Then, the control of A. aegypti larval population was attempted using the predatory copepod M. formosanus in synergy with H. coronarium-synthesized silver nanoparticles, evaluating predation efficiency pre- and post-nanoparticle treatment. In presence of both predaceous copepods and nano-larvicides high control of the larval populations was obtained. Furthermore, histological changes in mosquitoes targeted with nanopesticides were studied by light microscopy, evaluating the impact on mid-gut epithelial cells following treatment with LC50 of AgNP. Overall, this study highlighted the concrete potential of synergizing copepod-based control programs with highly effective green nano-larvicides in the fight against dengue and Zika virus vectors. (C) 2017 Institution of Chemical Engineers. Published by Elsevier B.V. All rights reserved.
C1 [Kalimuthu, Kandasamy; Tseng, Li-Chun; Hwang, Jiang-Shiou] Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung 20224, Taiwan.
   [Panneerselvam, Chellasamy] Univ Tabuk, Dept Biol, Fac Sci, Tabuk 71491, Saudi Arabia.
   [Chou, Chi] Mackay Mem Hosp, Dept Pathol, New Taipei, Taiwan.
   [Kalimuthu, Kandasamy; Murugan, Kadarkarai] Bharathiar Univ, Sch Life Sci, Dept Zool, Div Entomol, Coimbatore 641046, Tamil Nadu, India.
   [Tsai, Kun-Hsien] Natl Taiwan Univ, Coll Publ Hlth, Inst Environm Hlth, Taipei 100, Taiwan.
   [Alarfaj, Abdullah A.] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh 11451, Saudi Arabia.
   [Higuchi, Akon] Natl Cent Univ, Dept Chem & Mat Engn, 300 Jhongda RD, Taoyuan 32001, Taiwan.
   [Canale, Angelo; Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Pisa, Italy.
RP Hwang, JS (corresponding author), Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung 20224, Taiwan.; Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Pisa, Italy.
EM jshwang@mail.ntou.edu.tw; benelli.giovanni@gmail.com
RI Alarfaj, Abdullah/AAA-2018-2019; Murugan, Kadarkarai/AAP-3937-2020;
   Higuchi, Akon/AAA-9711-2019; Benelli, Giovanni/A-9100-2013
OI Benelli, Giovanni/0000-0001-8971-6010; TSAI,
   KUN-HSIEN/0000-0002-6154-113X; Panneerselvam,
   Chellasamy/0000-0003-3994-8141
FU Ministry of Science and Technology of TaiwanMinistry of Science and
   Technology, Taiwan [NSC98-2621-B-019-001-MY3, NSC101-2621-B-019-002,
   NSC102-2923-B-019-001-MY3]; International Scientific Partnership Program
   ISPP at King Saud University through ISPP [0062]
FX The authors thank the Ministry of Science and Technology of Taiwan
   (grant nos. NSC98-2621-B-019-001-MY3, NSC101-2621-B-019-002, and
   NSC102-2923-B-019-001-MY3) for supporting our research. Furthermore, we
   extend our appreciation to the International Scientific Partnership
   Program ISPP at King Saud University for funding through ISPP# 0062.
CR Ahmad N, 2010, COLLOID SURFACE B, V81, P81, DOI 10.1016/j.colsurfb.2010.06.029
   Al-Mehmadi R. M., 2010, Journal of King Saud University Science, V22, P77, DOI 10.1016/j.jksus.2010.02.004
   Ali DM, 2011, DIG J NANOMATER BIOS, V6, P385
   Amer A, 2006, PARASITOL RES, V99, P466, DOI [10.1007/s00436-006-0182-3, 10.1007/s00436-006-0184-1]
   Anbu P, 2016, NAT PROD RES, V30, P2077, DOI 10.1080/14786419.2015.1114935
   Awasthi AK, 2015, HYDROBIOLOGIA, V749, P113, DOI 10.1007/s10750-014-2154-4
   Awasthi AK, 2012, ZOOL STUD, V51, P927
   Benelli G., 2017, ENV SCI POLLUT RES
   Benelli G, 2017, IND CROP PROD, V96, P186, DOI 10.1016/j.indcrop.2016.11.059
   Benelli G, 2017, J CLUST SCI, V28, P287, DOI 10.1007/s10876-016-1088-6
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Benelli G, 2015, PARASITOL RES, V114, P391, DOI 10.1007/s00436-014-4286-x
   BHANDARY MJ, 1995, J ETHNOPHARMACOL, V47, P149, DOI 10.1016/0378-8741(95)01274-H
   Biswas P, 2005, J AIR WASTE MANAGE, V55, P708, DOI 10.1080/10473289.2005.10464656
   Chandramohan B, 2016, PARASITOL RES, V115, P1015, DOI 10.1007/s00436-015-4829-9
   Chansang UR, 2004, J VECTOR ECOL, V29, P218
   Choochote W, 2005, J VECTOR ECOL, V30, P302
   Dhanker R, 2012, J EXP MAR BIOL ECOL, V414, P44, DOI 10.1016/j.jembe.2012.01.011
   Dinesh D, 2015, PARASITOL RES, V114, P1519, DOI 10.1007/s00436-015-4336-z
   Duran Nelson, 2005, J Nanobiotechnology, V3, P8, DOI 10.1186/1477-3155-3-8
   Dussart B. H., 2001, GUIDES IDENTIFICATIO, V16
   Elechiguerra Jose Luis, 2005, J Nanobiotechnology, V3, P6
   Fabrega J, 2011, ENVIRON INT, V37, P517, DOI 10.1016/j.envint.2010.10.012
   Fabrega J, 2009, ENVIRON SCI TECHNOL, V43, P7285, DOI 10.1021/es803259g
   Fayaz AM, 2010, NANOMED-NANOTECHNOL, V6, P103, DOI 10.1016/j.nano.2009.04.006
   Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962
   Geetha I, 2003, MEM I OSWALDO CRUZ, V98, P223, DOI 10.1590/S0074-02762003000200010
   Govindarajan M, 2016, ECOTOX ENVIRON SAFE, V133, P395, DOI 10.1016/j.ecoenv.2016.07.035
   Govindarajan M, 2016, RES VET SCI, V107, P95, DOI 10.1016/j.rvsc.2016.05.017
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Hamouda LS, 1996, J EGYPT GER SOC ZOOL, V20, P43
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Huang JL, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/10/105104
   Hwang JS, 2011, HYDROBIOLOGIA, V666, P179, DOI 10.1007/s10750-011-0630-7
   Hwang JS, 2009, ZOOL STUD, V48, P738
   Hwang JS, 2001, ZOOL STUD, V40, P1
   Kalimuthu K., 2013, Journal of Entomological and Acarological Research, V45, P57, DOI 10.4081/jear.2013.e11
   Kalimuthu K, 2014, HYDROBIOLOGIA, V741, P113, DOI 10.1007/s10750-013-1745-9
   Kalimuthu K, 2013, J MAR SCI TECH-TAIW, V21, P308, DOI 10.6119/JMST-013-1223-8
   Kalimuthu K, 2013, J MAR SCI TECH-TAIW, V21, P258, DOI 10.6119/JMST-013-1223-4
   Kaviya S, 2011, SPECTROCHIM ACTA A, V79, P594, DOI 10.1016/j.saa.2011.03.040
   KAY BH, 1992, J MED ENTOMOL, V29, P599, DOI 10.1093/jmedent/29.4.599
   Kong H, 2006, CHEM COMMUN, P3010, DOI 10.1039/b605286j
   Kumar PM, 2012, PARASITOL RES, V111, P609, DOI 10.1007/s00436-012-2876-z
   Kumar R, 2006, ZOOL STUD, V45, P447
   Kumar R, 2012, AQUACULTURE, V338, P274, DOI 10.1016/j.aquaculture.2012.01.001
   Kumar RM, 2003, INT REV HYDROBIOL, V88, P570, DOI 10.1002/iroh.200310631
   Kumar V, 2010, J CHEM TECHNOL BIOT, V85, P1301, DOI 10.1002/jctb.2427
   Kundu S, 2004, J PHOTOCH PHOTOBIO A, V162, P625, DOI 10.1016/S1010-6030(03)00398-8
   LARDEUX FJR, 1992, MED VET ENTOMOL, V6, P9, DOI 10.1111/j.1365-2915.1992.tb00028.x
   Liu JY, 2010, ACS NANO, V4, P6903, DOI 10.1021/nn102272n
   Madhiyazhagan P, 2015, PARASITOL RES, V114, P4305, DOI 10.1007/s00436-015-4671-0
   Magudapathy P, 2001, PHYSICA B, V299, P142, DOI 10.1016/S0921-4526(00)00580-9
   Mahitha B, 2011, DIG J NANOMATER BIOS, V6, P135
   Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y
   Marten GG, 2007, J AM MOSQUITO CONTR, V23, P65, DOI 10.2987/8756-971X(2007)23[65:CC]2.0.CO;2
   MARTEN GG, 1994, J MED ENTOMOL, V31, P36, DOI 10.1093/jmedent/31.1.36
   MARTEN GG, 1994, HYDROBIOLOGIA, V293, P491
   MILLAR JG, 1992, J AM MOSQUITO CONTR, V8, P11
   Murrell S, 2011, BIOTECHNOL ADV, V29, P239, DOI 10.1016/j.biotechadv.2010.11.008
   Murugan K, 2011, HYDROBIOLOGIA, V666, P331, DOI 10.1007/s10750-011-0629-0
   Murugan K., 2016, ENVIRON SCI POLLUT R, V23, P16617
   Murugan K, 2016, RES VET SCI, V106, P14, DOI 10.1016/j.rvsc.2016.03.001
   Murugan K, 2016, PARASITOL RES, V115, P651, DOI 10.1007/s00436-015-4783-6
   Murugan K, 2015, PARASITOL RES, V114, P3601, DOI 10.1007/s00436-015-4582-0
   Murugan K, 2015, PARASITOL RES, V114, P2243, DOI 10.1007/s00436-015-4417-z
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Murugan K, 2013, PHYTOPARASITICA, V41, P307, DOI 10.1007/s12600-013-0291-3
   Muthukumaran U, 2015, PARASITOL RES, V114, P989, DOI 10.1007/s00436-014-4265-2
   NAKATANI N, 1994, PHYTOCHEMISTRY, V37, P1383, DOI 10.1016/S0031-9422(00)90417-5
   Navarro E, 2008, ENVIRON SCI TECHNOL, V42, P8959, DOI 10.1021/es801785m
   Olagbemiro TO, 1999, J AGR FOOD CHEM, V47, P3411, DOI 10.1021/jf990294b
   Panneerselvam C, 2013, ASIAN PAC J TROP MED, V6, P102, DOI 10.1016/S1995-7645(13)60003-6
   Panneerselvam C, 2016, PARASITOL RES, V115, P997, DOI 10.1007/s00436-015-4828-x
   Panneerselvam C, 2013, ASIAN PAC J TROP MED, V6, P847, DOI 10.1016/S1995-7645(13)60151-0
   Pavela R, 2016, TRENDS PLANT SCI, V21, P1000, DOI 10.1016/j.tplants.2016.10.005
   Pavela R, 2016, EXP PARASITOL, V167, P103, DOI 10.1016/j.exppara.2016.05.010
   Pavela R, 2015, PARASITOL RES, V114, P3835, DOI 10.1007/s00436-015-4614-9
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Pavela R, 2009, IND CROP PROD, V30, P311, DOI 10.1016/j.indcrop.2009.06.005
   PETIT C, 1993, J PHYS CHEM-US, V97, P12974, DOI 10.1021/j100151a054
   Kiem PV, 2012, CHEM PHARM BULL, V60, P246, DOI 10.1248/cpb.60.246
   Pitasawat B, 2003, J VECTOR ECOL, V28, P234
   Prajapati V, 2005, BIORESOURCE TECHNOL, V96, P1749, DOI 10.1016/j.biortech.2005.01.007
   Priya MM, 2011, DIG J NANOMATER BIOS, V6, P869
   Rajkumar G, 2011, ACTA TROP, V118, P196
   Rawlins SC, 1997, J AM MOSQUITO CONTR, V13, P18
   Ray S, 2011, INDIAN J TRADIT KNOW, V10, P367
   Rey D, 1999, J INVERTEBR PATHOL, V73, P173, DOI 10.1006/jipa.1998.4810
   Roco MC, 2003, J NANOPART RES, V5, P181, DOI 10.1023/A:1025548512438
   Roni M, 2015, ECOTOX ENVIRON SAFE, V121, P31, DOI 10.1016/j.ecoenv.2015.07.005
   Roni M, 2013, PARASITOL RES, V112, P981, DOI 10.1007/s00436-012-3220-3
   Sathyavathi R, 2010, ADV SCI LETT, V3, P138, DOI 10.1166/asl.2010.1099
   Schreiber ET, 1993, J FLA MOSQ CONTROL A, V64, P7317
   Shankar SS, 2004, J COLLOID INTERF SCI, V275, P496, DOI 10.1016/j.jcis.2004.03.003
   Shrivastava S, 2010, NANO-MICRO LETT, V2, P164, DOI 10.1007/BF03353636
   Song JY, 2009, PROCESS BIOCHEM, V44, P1133, DOI 10.1016/j.procbio.2009.06.005
   Sotiriou GA, 2010, ENVIRON SCI TECHNOL, V44, P5649, DOI 10.1021/es101072s
   Subramaniam J, 2016, ENVIRON SCI POLLUT R, V23, P7543, DOI 10.1007/s11356-015-6007-0
   Subramaniam J, 2015, ENVIRON SCI POLLUT R, V22, P20067, DOI 10.1007/s11356-015-5253-5
   Suganya A, 2013, PARASITOL RES, V112, P1385, DOI 10.1007/s00436-012-3269-z
   Sujitha V, 2015, PARASITOL RES, V114, P3315, DOI 10.1007/s00436-015-4556-2
   Suresh U, 2015, PARASITOL RES, V114, P1551, DOI 10.1007/s00436-015-4339-9
   Turney K, 2004, RAPID COMMUN MASS SP, V18, P2367, DOI 10.1002/rcm.1634
   Veerakumar K, 2013, PARASITOL RES, V112, P4073, DOI 10.1007/s00436-013-3598-6
   Wei H, 2008, ANAL CHEM, V80, P7051, DOI 10.1021/ac801144t
   WHO, 2015, DENG SEV DENG
   Williamson Craig E., 2001, P915, DOI 10.1016/B978-012690647-9/50023-5
   World Health Organization, 2012, HDB INT VECT MAN
   Wu CH, 2010, ZOOL STUD, V49, P157
NR 112
TC 16
Z9 16
U1 2
U2 23
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0957-5820
EI 1744-3598
J9 PROCESS SAF ENVIRON
JI Process Saf. Environ. Protect.
PD JUL
PY 2017
VL 109
BP 82
EP 96
DI 10.1016/j.psep.2017.03.027
PG 15
WC Engineering, Environmental; Engineering, Chemical
SC Engineering
GA FC3IN
UT WOS:000406732400009
DA 2020-07-08
ER

PT J
AU Reis, NN
   da Silva, AL
   Reis, EPG
   Silva, FCE
   Reis, IGN
AF Reis, Nelson Nogueira
   da Silva, Alcino Lazaro
   Guedes Reis, Elma Pereira
   Chaves e Silva, Flavia
   Nogueira Reis, Igor Guedes
TI Viruses vector control proposal: genus Aedes emphasis
SO BRAZILIAN JOURNAL OF INFECTIOUS DISEASES
LA English
DT Review
DE Dengue; Vector control; Aedes; Arbovirus; Sterile insect technique
ID ZIKA VIRUS; DENGUE
AB The dengue fever is a major public health problem in the world. In Brazil, in 2015, there were 1,534,932 cases, being 20,320 cases of severe form, and 811 deaths related to this disease. The distribution of Aedes aegypti, the vector, is extensive. Recently, Zika and Chikungunya viruses had arisen, sharing the same vector as dengue and became a huge public health issue. Without specific treatment, it is urgently required as an effective vector control. This article is focused on reviewing vector control strategies, their effectiveness, viability and economical impact. Among all, the Sterile Insect Technique is highlighted as the best option to be adopted in Brazil, once it is largely effectively used in the USA and Mexico for plagues related to agribusiness. (C) 2017 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda.
C1 [da Silva, Alcino Lazaro; Nogueira Reis, Igor Guedes] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   [Guedes Reis, Elma Pereira] Ctr Especialidades Med, Belo Horizonte, MG, Brazil.
   [Chaves e Silva, Flavia] Fac Ciencias Med Minas Gerais, Belo Horizonte, MG, Brazil.
RP Reis, IGN (corresponding author), Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
EM igorgnreis@gmail.com
CR Atyame CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146834
   Baldacchino F, 2015, PEST MANAG SCI, V71, P1471, DOI 10.1002/ps.4044
   Bellini R, 2013, J MED ENTOMOL, V50, P317, DOI 10.1603/ME12048
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Cambricoli F., 2015, 5 AN DENG CUST R 4 2
   Carod-Artal FJ, 2016, REV NEUROLOGIA, V62, P317, DOI 10.33588/rn.6207.2016152
   COSEMS/SP, 2012, AT IMP DENG INT COSE
   Degallier N, 1996, B SOC PATHOL EXOT, V89, P128
   Feldmann U, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P701, DOI 10.1007/1-4020-4051-2_27
   Ferreira BJ, 2009, CIENC SAUDE COLETIVA, V14, P961, DOI 10.1590/S1413-81232009000300032
   G1, 2016, PIR TEM 142 CAS DENG
   lioang KP, 2016, PARASITE VECTOR, V9, P49
   Malavasi A, 2003, S CONTR BIOL AG DE S
   Md Saude, 2016, B EPIDEMIOLOGICO MON, V27
   Meadows M. E., 1985, Miscellaneous Publications of the Entomological Society of America, P8
   Novy JE, 1991, SCREWWORM CONTROL ER
   Pinheiro Fransisco P., 1997, World Health Statistics Quarterly, V50, P161
   Regina T, 2016, J MED VIROL, V88, P1711, DOI 10.1002/jmv.24533
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Suaya JA, 2009, AM J TROP MED HYG, V80, P846, DOI 10.4269/ajtmh.2009.80.846
   SUS PdS, 2016, INTERNET2016
   Martelli CMT, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004042
   UOL, 2015, CAS DENG CHEG 1 5 MI
   Wentzel M., 2015, BRASIL TESTA DUAS AR
NR 25
TC 0
Z9 0
U1 1
U2 15
PU ELSEVIER BRAZIL
PI RIO DE JANEIRO
PA R SETE SETEMBRO, 111-16, RIO DE JANEIRO, RJ 20050-006, BRAZIL
SN 1413-8670
EI 1678-4391
J9 BRAZ J INFECT DIS
JI Braz. J. Infect. Dis.
PD JUL-AUG
PY 2017
VL 21
IS 4
BP 457
EP 463
DI 10.1016/j.bjid.2017.03.020
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA FB2TG
UT WOS:000405995500013
PM 28577370
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gake, B
   Vernet, MA
   Leparc-Goffart, I
   Drexler, JF
   Gould, EA
   Gallian, P
   de Lamballerie, X
AF Gake, Bouba
   Vernet, Marie A.
   Leparc-Goffart, Isabelle
   Drexler, Jan Felix
   Gould, Ernest A.
   Gallian, Pierre
   de lamballerie, Xavier
TI Low seroprevalence of Zika virus in Cameroonian blood donors
SO BRAZILIAN JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; Seroprevalence; Africa
ID TRANSMISSION
AB A Zika virus seroepidemiology study was performed in 1084 blood donors collected from August to October 2015 in six sites of Cameroon representing a large panel of ecoenvironments. Samples were tested using an anti-NS1 IgG ELISA detection kit and positives were further confirmed by seroneutralization. The observed global seroprevalence was low (around 5%, peaking at 10% and 7.7% in Douala and Bertoua, respectively) with risk factors associated with seropositivity pointing to the existence of a local (peri-)sylvatic cycle of transmission. These results call attention to the potential introduction and subsequent spread in African urban areas of Asian genotype Zika virus currently circulating in the Americas and adapted to transmission by pen-domestic mosquitoes. They should leverage reinforced surveillance efforts in Africa. (C) 2017 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda.
C1 [Gake, Bouba; Leparc-Goffart, Isabelle; Gould, Ernest A.; Gallian, Pierre; de lamballerie, Xavier] Aix Marseille Univ, UMR Emergence Pathol Virales, IRD 190, EHESP,INSERM 1207, Marseille, France.
   [Gake, Bouba; Vernet, Marie A.] Ctr Pasteur Cameroun, Yaounde, Cameroon.
   [Leparc-Goffart, Isabelle] Inst Rech Biomed Armees, Natl Reference Lab Arboviruses, Marseille, France.
   [Drexler, Jan Felix] Univ Bonn, Med Ctr, Inst Virol, Bonn, Germany.
   [Gallian, Pierre] Etab Francais Sang, La Plaine St Denis, France.
RP de Lamballerie, X (corresponding author), Aix Marseille Univ, UMR Emergence Pathol Virales, IRD 190, EHESP,INSERM 1207, Marseille, France.
EM xavier.de-lamballerie@univ-amu.fr
OI Drexler, Jan Felix/0000-0002-3509-0232
FU European Union's Horizon Research and Innovation Program under
   ZIKAlliance Grant [734548]
FX This work was partially supported by the European Union's Horizon 2020
   Research and Innovation Program under ZIKAlliance Grant Agreement no.
   734548.
CR Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Gallian P, 2016, BLOOD
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
NR 8
TC 22
Z9 22
U1 0
U2 3
PU ELSEVIER BRAZIL
PI RIO DE JANEIRO
PA R SETE SETEMBRO, 111-16, RIO DE JANEIRO, RJ 20050-006, BRAZIL
SN 1413-8670
EI 1678-4391
J9 BRAZ J INFECT DIS
JI Braz. J. Infect. Dis.
PD JUL-AUG
PY 2017
VL 21
IS 4
BP 481
EP 483
DI 10.1016/j.bjid.2017.03.018
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA FB2TG
UT WOS:000405995500018
PM 28549857
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Islam, J
   Dhiman, S
   Tyagi, V
   Duarah, S
   Zaman, K
   Chattopadhyay, P
AF Islam, Johirul
   Dhiman, Sunil
   Tyagi, Varun
   Duarah, Sanjukta
   Zaman, Kamaruz
   Chattopadhyay, Pronobesh
TI Behavioural and Electrophysiological Responses of Mosquito Vectors Aedes
   aegypti, Anopheles stephensi and Culex quinquefasciatus to an Ethyl
   Ester: Ethyl 2-aminobenzoate
SO JOURNAL OF INSECT BEHAVIOR
LA English
DT Article
DE Electroantennogram; ethyl 2-aminobenzoate; flight orientation; mosquito;
   odorant receptor neurons
ID INSECT REPELLENT DEET; HUMAN SKIN EMANATIONS; FLIGHT ORIENTATION; ZIKA
   VIRUS; OVIPOSITION RESPONSES; PLANT VOLATILES; ESSENTIAL OILS; ODORANT
   RECEPTOR; ELECTROANTENNOGRAM; GAMBIAE
AB Mosquito control using different methods remains an integral component of intervention programmes which aim to protect humans from various mosquito-borne diseases. The host seeking behaviour of mosquitoes is essentially guided by odorant receptor neurons housed in the antenna, maxillary palps and proboscis. The odorant receptor neurons are responsible for detecting chemical cues from hosts and also useful for developing sustainable mosquito-control strategies that exploit host-seeking behaviours. The present investigation evaluates host seeking behavioural responses of a novel, non-toxic and environment friendly repellent, ethyl 2-aminobenzoate against three known vector species of mosquitoes viz. Aedes aegypti, Anopheles stephensi and Culex quinquefasciatus maintained in laboratory. The flight orientation of the test mosquitoes was studied using Y-tube olfactometer, whereas the antennae of adult female mosquitoes were used to investigate the effect of ethyl 2-aminobenzoate on the peripheral olfactory system using electroantennogram (EAG). The findings demonstrate that ethyl 2-aminobenzoate exhibited significant response in Y-tube olfactometer against all the three known vector species of mosquitoes. However, only Anopheles stephensi significantly elicited responses in EAG experiments, while the responses obtained for Aedes aegypti and Culex quinquefasciatus were not statistically significant. The results conclude that currently evaluated chemical ethyl 2-aminobenzoate has potential against some well established mosquito vector species and could be exploited to develop new and comparatively more effective anti-mosquito formulations.
C1 [Islam, Johirul; Duarah, Sanjukta; Chattopadhyay, Pronobesh] Def Res Lab, Div Pharmaceut Technol, Tezpur 784001, Assam, India.
   [Islam, Johirul; Zaman, Kamaruz] Dibrugarh Univ, Dept Pharmaceut Sci, Dibrugarh 786004, Assam, India.
   [Dhiman, Sunil; Tyagi, Varun] Def Res Lab, Div Med Entomol, Tezpur 784001, Assam, India.
RP Islam, J (corresponding author), Def Res Lab, Div Pharmaceut Technol, Tezpur 784001, Assam, India.; Islam, J (corresponding author), Dibrugarh Univ, Dept Pharmaceut Sci, Dibrugarh 786004, Assam, India.
EM johirulmon@gmail.com
RI Duarah, Sanjukta/P-8927-2019; Zaman, Kamaruz/AAR-6444-2020
OI Duarah, Sanjukta/0000-0003-4762-3443; Zaman, Kamaruz/0000-0002-1688-4117
CR Afify A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103765
   Allan SA, 2006, J MED ENTOMOL, V43, P225, DOI 10.1603/0022-2585(2006)043[0225:LEOAOF]2.0.CO;2
   Alpern JD, 2016, MED CLIN N AM, V100, P303, DOI 10.1016/j.mcna.2015.08.019
   [Anonymous], 2007, FLAVORS FRAGRANCES 2
   Api A M, 2015, Food Chem Toxicol, V82 Suppl, pS97, DOI 10.1016/j.fct.2015.03.017
   Auysawasdi N, 2016, PARASITOL RES, V115, P99, DOI 10.1007/s00436-015-4725-3
   Bernier UR, 2015, J AM MOSQUITO CONTR, V31, P63, DOI 10.2987/14-6452R.1
   Bezerra-Silva PC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150008
   Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834
   Chattopadhyay P, 2015, ACTA TROP, V147, P45, DOI 10.1016/j.actatropica.2015.03.027
   Chen L, 2007, J INSECT BEHAV, V20, P267, DOI 10.1007/s10905-007-9079-y
   Costantini C, 2001, MED VET ENTOMOL, V15, P259, DOI 10.1046/j.0269-283x.2001.00297.x
   Das NG, 2015, J INFECT PUBLIC HEAL, V8, P323, DOI 10.1016/j.jiph.2015.02.005
   Dasti JI, 2016, ASIAN PAC J TROP MED, V9, P601, DOI 10.1016/j.apjtm.2016.05.010
   Deletre E, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0934-y
   Dhiman S, 2013, INDIAN J MED RES, V138, P988
   Diaz JH, 2016, WILD ENVIRON MED, V27, P153, DOI 10.1016/j.wem.2015.11.007
   Dickens JC, 2013, PESTIC BIOCHEM PHYS, V106, P149, DOI 10.1016/j.pestbp.2013.02.006
   Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121
   Dube FF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-375
   Dusfour I, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004226
   Fang J, 2010, NATURE, V466, P432, DOI 10.1038/466432a
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Ghaninia M, 2008, J EXP BIOL, V211, P3020, DOI 10.1242/jeb.016360
   Ghosh A, 2012, INDIAN J MED RES, V135, P581
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Guda T, 2015, BIORXIV, DOI [10.1101/017145, DOI 10.1101/017145]
   Guha L, 2014, PARASITOL RES, V113, P3781, DOI 10.1007/s00436-014-4044-0
   Hansson BS, 2011, NEURON, V72, P698, DOI 10.1016/j.neuron.2011.11.003
   Islam J, 2017, ACTA TROP, V167, P216, DOI 10.1016/j.actatropica.2016.12.031
   Jamil Z, 2016, ASIAN PAC J TROP MED, V9, P606, DOI 10.1016/j.apjtm.2016.05.020
   Kain P, 2013, NATURE, V502, P507, DOI 10.1038/nature12594
   Klun JA, 2004, J MED ENTOMOL, V41, P418, DOI 10.1603/0022-2585-41.3.418
   Lavialle-Defaix C, 2011, J NEUROSCI METH, V200, P68, DOI 10.1016/j.jneumeth.2011.06.003
   Leal WS, 2014, CURR OPIN INSECT SCI, V6, P93, DOI 10.1016/j.cois.2014.10.007
   Lupi E, 2013, TRAVEL MED INFECT DI, V11, P374, DOI 10.1016/j.tmaid.2013.10.005
   Meepagala KM, 2016, J AGR FOOD CHEM, V64, P4914, DOI 10.1021/acs.jafc.6b01299
   Menger DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123415
   Opdyke D. L. J., 1979, MONOGRAPHS FRAGRANCE
   Pickett JA, 2008, P NATL ACAD SCI USA, V105, P13195, DOI 10.1073/pnas.0807167105
   Ray A, 2015, CURR OPIN NEUROBIOL, V34, P158, DOI 10.1016/j.conb.2015.06.014
   Rytz R, 2013, INSECT BIOCHEM MOLEC, V43, P888, DOI 10.1016/j.ibmb.2013.02.007
   Sathantriphop S, 2014, J VECTOR ECOL, V39, P328, DOI 10.1111/jvec.12108
   Seenivasagan T, 2014, PARASITOL RES, V113, P1927, DOI 10.1007/s00436-014-3840-x
   Seenivasagan T, 2010, J MED ENTOMOL, V47, P329, DOI 10.1603/ME09130
   Seenivasagan T, 2009, PARASITOL RES, V104, P827, DOI 10.1007/s00436-008-1263-2
   Seenivasagan T, 2012, ACTA TROP, V124, P54, DOI 10.1016/j.actatropica.2012.06.009
   Song E, 2012, DEV CELL, V22, P363, DOI 10.1016/j.devcel.2011.12.015
   Stanczyk NM, 2010, P NATL ACAD SCI USA, V107, P8575, DOI 10.1073/pnas.1001313107
   Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105
   Tisgratog R, 2011, J VECTOR ECOL, V36, P321, DOI 10.1111/j.1948-7134.2011.00172.x
   Wang YC, 2016, J ASIA-PAC ENTOMOL, V19, P261, DOI 10.1016/j.aspen.2016.03.002
   Webster B, 2017, BIOL REV, V92, P1241, DOI 10.1111/brv.12281
   Wee SL, 2008, AUST J ENTOMOL, V47, P24, DOI 10.1111/j.1440-6055.2007.00624.x
   Wibe A, 2004, J INSECT PHYSIOL, V50, P497, DOI 10.1016/j.jinsphys.2004.03.006
   Wibe A, 1997, J COMP PHYSIOL A, V180, P585, DOI 10.1007/s003590050075
   Williams L, 2010, J CHEM ECOL, V36, P467, DOI 10.1007/s10886-010-9778-2
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P698, DOI 10.1016/j.apjtm.2016.05.014
   Xu PX, 2014, P NATL ACAD SCI USA, V111, P16592, DOI 10.1073/pnas.1417244111
   Yang MW, 2009, J INSECT BEHAV, V22, P153, DOI 10.1007/s10905-008-9162-z
   Ye Z, 2016, CHEM SENSES, V41, P441, DOI 10.1093/chemse/bjv089
NR 61
TC 3
Z9 3
U1 2
U2 17
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0892-7553
EI 1572-8889
J9 J INSECT BEHAV
JI J. Insect Behav.
PD JUL
PY 2017
VL 30
IS 4
BP 343
EP 358
DI 10.1007/s10905-017-9614-4
PG 16
WC Entomology
SC Entomology
GA FC5KJ
UT WOS:000406880400001
DA 2020-07-08
ER

PT J
AU Bandzuh, JT
   Juran, L
   Kolivras, KN
   Wallis, AB
AF Bandzuh, John T.
   Juran, Luke
   Kolivras, Korine N.
   Wallis, Anne B.
TI Local perceptions of measures to control Aedes mosquitoes and
   mosquito-borne diseases in Puntarenas and San Jose, Costa Rica
SO JOURNAL OF LATIN AMERICAN GEOGRAPHY
LA English
DT Article
DE Costa Rica; mosquito control; mosquito-borne diseases; public health
ID DENGUE PREVENTION; PUERTO-RICO; AEGYPTI; KNOWLEDGE; HISTORY; MEXICO;
   HEALTH
AB Dengue has become an increasingly significant risk to global health. With up to 400 million cases annually, dengue constitutes the fastest growing vector-borne disease globally. In the western hemisphere, dengue, and more recently chikungunya and Zika, exist throughout much of Latin America. These diseases are spread by Aedes mosquitoes, which have been present in the region for centuries. While perceptions of mosquito-borne disease have been studied in Latin America, such qualitative literature on Costa Rica is relatively scarce. Therefore, this study uses qualitative methods to critically investigate the prevention of Aedes mosquito-borne diseases in Puntarenas and San Jose, Costa Rica. Specifically, this study examines local perceptions of policies and programs to combat Aedes mosquitoes and their associated diseases. Data were collected via household interviews (n=80); semi-structured interviews with public health officials, researchers, nonprofit organizations, and community leaders (n=22); and a focus group discussion in each of two study areas (Puntarenas and San Jose). Results are presented as place-specific narratives on mosquito and disease control among at-risk communities. Varying degrees of local knowledge on mosquitoes and mosquito-borne diseases exist both within and across the study areas. These differences include conflicting perceptions of mosquito control techniques (e.g., fumigation, education campaigns) as well as disease source, habitat, and risk. Local narratives may inform public health actors on the perspectives of communities who confront, cope with, and manage issues of mosquito-borne disease.
C1 [Bandzuh, John T.; Juran, Luke; Kolivras, Korine N.] Virginia Tech Univ, Blacksburg, VA 24061 USA.
   [Wallis, Anne B.] Univ Louisville, Louisville, KY 40292 USA.
RP Bandzuh, JT (corresponding author), Virginia Tech Univ, Blacksburg, VA 24061 USA.
FU Sidman P. Poole Endowment in the Department of Geography at Virginia
   Tech
FX This research was partially supported by the Sidman P. Poole Endowment
   in the Department of Geography at Virginia Tech. We also extend
   gratitude to Gail Nystrom and the Costa Rica Humanitarian Foundation for
   use of their facilities. Lastly, special acknowledgment is reserved for
   the two research assistants: Carlos Bogarin (Puntarenas) and Sophia
   Freer (San Jose).
CR [Anonymous], 2016, COSTA RICAN TIM 0707
   Babbie E., 2010, PRACTICE SOCIAL RES
   Bernard HR, 1988, RES METHODS CULTURAL
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bisset J. A., 2008, J MED ENTOMOL, V50, P352
   Calderon-Arguedas O, 2009, REV BIOL TROP, V57, P1223
   CARTER ED, 2016, J LATIN AM GEOGRAPHY, V15, P157
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Egedus VL, 2014, REV BIOL TROP, V62, P859
   Epstein PR, 2000, SCI AM, V283, P50, DOI 10.1038/scientificamerican0800-50
   Espinoza-Gomez F, 2002, J EPIDEMIOL COMMUN H, V56, P148, DOI 10.1136/jech.56.2.148
   Farmer P, 2006, AIDS ACCUSATION HAIT
   Gaba E., 2008, COSTA RICA RELIEF MA
   Geertz C., 1973, INTERPRETATION CULTU, P3
   GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55
   Hairi Farizah, 2003, Asia Pac J Public Health, V15, P37
   LONGHURST R, 2010, KEY METHODS GEOGRAPH, P103
   Lozano-Fuentes S, 2012, AM J TROP MED HYG, V87, P902, DOI 10.4269/ajtmh.2012.12-0244
   Nading A.M., 2014, MOSQUITO TRAILS ECOL
   Parks W., 2004, PLANNING SOCIAL MOBI
   Perez-Guerra CL, 2009, REV PANAM SALUD PUBL, V25, P218, DOI 10.1590/S1020-49892009000300005
   Perich MJ, 2003, J AM MOSQUITO CONTR, V19, P58
   Philander SG, 2012, ENCY GLOBAL WARMING
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Rodriguez MM, 2007, J AM MOSQUITO CONTR, V23, P420, DOI 10.2987/5588.1
   ROSENBAUM J, 1995, AM J TROP MED HYG, V53, P111, DOI 10.4269/ajtmh.1995.53.111
   San Martin JL, 2004, REV PANAM SALUD PUBL, V15, P135, DOI 10.1590/S1020-49892004000200014
   Sanofi Pasteur, 2016, DENG VACC AV COST RI
   SMITH SJ, 1981, AREA, V13, P293
   Solís Ramírez María Isabel, 2010, Rev. costarric. salud pública, V19, P88
   Swaddiwudhipong Witaya, 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P207
   Troyo A, 2006, REV PANAM SALUD PUBL, V20, P350, DOI 10.1590/S1020-49892006001000012
   Troyo A, 2009, SINGAPORE J TROP GEO, V30, P265, DOI 10.1111/j.1467-9493.2009.00367.x
   Winch PJ, 2002, AM J TROP MED HYG, V67, P363, DOI 10.4269/ajtmh.2002.67.363
   World Health Organization (WHO), 2016, QUEST ANSW DENG VACC
NR 35
TC 1
Z9 1
U1 0
U2 6
PU CONFERENCE LATIN AMER GEOGRAPHERS
PI TUCSON
PA CONFERENCE LATIN AMER GEOGRAPHERS, TUCSON, AZ 00000 USA
SN 1545-2476
EI 1548-5811
J9 J LAT AM GEOGR
JI J. Lat. Am. Geogr.
PD JUL
PY 2017
VL 16
IS 2
BP 139
EP 162
DI 10.1353/lag.2017.0025
PG 24
WC Geography
SC Geography
GA FB1YW
UT WOS:000405941100008
DA 2020-07-08
ER

PT J
AU Yasri, S
   Wiwanitkit, V
AF Yasri, Sora
   Wiwanitkit, Viroj
TI Solid Organ Transplantation and Zika Virus Infection
SO SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION
LA English
DT Letter
C1 [Yasri, Sora] KMT Primary Care Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Yasri, S (corresponding author), KMT Primary Care Ctr, Bangkok, Thailand.
EM sorayasri@outlook.co.th
CR Blumberg EA, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14083
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Gupta RK, 2016, J CLIN EXP HEPATOL, V6, P59, DOI 10.1016/j.jceh.2016.01.005
   Joob B, 2014, SAUDI J KIDNEY DIS T, V25, P152, DOI 10.4103/1319-2442.124546
   Nogueira ML, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14047
   Wiwanitkit V, 2016, INFECT CONT HOSP EP, V37, P1519, DOI 10.1017/ice.2016.212
NR 6
TC 0
Z9 0
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1319-2442
EI 2320-3838
J9 SAUDI J KIDNEY DIS T
JI Saudi J. Kidney Dis. Transplant.
PD JUL-AUG
PY 2017
VL 28
IS 4
BP 947
EP 947
PG 1
WC Urology & Nephrology
SC Urology & Nephrology
GA FC3PM
UT WOS:000406751300036
PM 28748906
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Kuno, G
   Mackenzie, JS
   Junglen, S
   Hubalek, Z
   Plyusnin, A
   Gubler, DJ
AF Kuno, Goro
   Mackenzie, John S.
   Junglen, Sandra
   Hubalek, Zdenek
   Plyusnin, Alexander
   Gubler, Duane J.
TI Vertebrate Reservoirs of Arboviruses: Myth, Synonym of Amplifier, or
   Reality?
SO VIRUSES-BASEL
LA English
DT Review
DE insect-specific virus; arbovirus; transmission mechanism; vertebrate
   reservoir; origin of arbovirus; virus maintenance; zoonosis; host range
ID WEST-NILE-VIRUS; MURRAY VALLEY ENCEPHALITIS; YELLOW-FEVER VIRUS; LOUPING
   ILL VIRUS; ROSS-RIVER-VIRUS; DENGUE VIRUS; JAPANESE ENCEPHALITIS;
   BLUETONGUE VIRUS; HOUSE SPARROWS; EXPERIMENTAL INOCULATION
AB The rapid succession of the pandemic of arbovirus diseases, such as dengue, West Nile fever, chikungunya, and Zika fever, has intensified research on these and other arbovirus diseases worldwide. Investigating the unique mode of vector-borne transmission requires a clear understanding of the roles of vertebrates. One major obstacle to this understanding is the ambiguity of the arbovirus definition originally established by the World Health Organization. The paucity of pertinent information on arbovirus transmission at the time contributed to the notion that vertebrates played the role of reservoir in the arbovirus transmission cycle. Because this notion is a salient feature of the arbovirus definition, it is important to reexamine its validity. This review addresses controversial issues concerning vertebrate reservoirs and their role in arbovirus persistence in nature, examines the genesis of the problem from a historical perspective, discusses various unresolved issues from multiple points of view, assesses the present status of the notion in light of current knowledge, and provides options for a solution to resolve the issue.
C1 [Kuno, Goro] Ctr Control & Prevent, Div Vector Borne Infect Dis, Ft Collins, CO 80521 USA.
   [Mackenzie, John S.] Curtin Univ, Fac Med Sci, GPO Box U1987, Perth, WA 6845, Australia.
   [Mackenzie, John S.] Div Microbiol & Infect Dis, Nedlands, WA 6009, Australia.
   [Junglen, Sandra] Charite Univ Med Berlin, Inst Virol, Helmut Ruska Haus, Helmut Ruska Haus,Charitepl 1, D-10117 Berlin, Germany.
   [Hubalek, Zdenek] Acad Sci Czech Republ, Inst Vertebrate Biol, CS-60365 Brno, Czech Republic.
   [Plyusnin, Alexander] Univ Helsinki, Dept Virol, Haartmaninkatu 3, Helsinki 00014, Finland.
   [Gubler, Duane J.] Duke NUS Med Sch, Program Emerging Infect Dis, 8 Coll Rd, Singapore 169857, Singapore.
EM gykuno@gmail.com; j.mackenzie@curtin.edu.au; sandra.junglen@charite.de;
   zhubalek@brno.cas.cz; Alexander.Plyusnin@helsinki.fi;
   duane.gubler@duke-nus.edu.sg
RI Hubalek, Zdenek/AAF-8071-2019; /S-4986-2019; Hubalek, Zdenek/G-1111-2014
OI /0000-0002-5918-2190; Hubalek, Zdenek/0000-0003-4732-0987; Junglen,
   Sandra/0000-0002-3799-6011
CR ABDUSSALAM M, 1959, Bull World Health Organ, V21, P179
   Diaz LA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001177
   Ahmed Rafi, 1997, P181
   AITKEN THG, 1984, AM J TROP MED HYG, V33, P945, DOI 10.4269/ajtmh.1984.33.945
   Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   Althouse BM, 2016, BIORXIV
   ANDREWES C H, 1957, Adv Virus Res, V4, P1, DOI 10.1016/S0065-3527(08)60594-1
   Auguste AJ, 2010, J VIROL, V84, P9967, DOI 10.1128/JVI.00588-10
   Baker Arthur C., 1943, AMER JOUR TROP MED, V23, P559
   Bakhvalova VN, 2009, VIRUS RES, V140, P172, DOI 10.1016/j.virusres.2008.12.001
   Bakonyi T, 2016, VET MICROBIOL, V183, P135, DOI 10.1016/j.vetmic.2015.12.012
   Balfour A, 1914, LANCET, V1, P1176
   Ballinger MJ, 2014, J VIROL, V88, P8783, DOI 10.1128/JVI.00531-14
   Beaty B. J., 1988, ARBOVIRUSES EPIDEMIO, V1, P59
   Belaganahalli MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023605
   Benda R., 1958, HYG EPIDEMIOL MICROB, V2, P331
   Bewick S, 2016, EMERG INFECT DIS, V22, P1921, DOI 10.3201/eid2211.160308
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Bichaud L, 2014, MICROB PATHOGENESIS, V77, P136, DOI 10.1016/j.micpath.2014.09.002
   Bolling BG, 2015, VIRUSES-BASEL, V7, P4911, DOI 10.3390/v7092851
   BOWEN GS, 1977, AM J TROP MED HYG, V26, P171, DOI 10.4269/ajtmh.1977.26.171
   Boyce R. W., 1909, MOSQUITO MAN CONCEPT, P41
   Brault AC, 2002, J VIROL, V76, P6387, DOI 10.1128/JVI.76.12.6387-6392.2002
   BROOM AK, 1995, AM J TROP MED HYG, V53, P95, DOI 10.4269/ajtmh.1995.53.95
   Brown CR, 2010, J MED ENTOMOL, V47, P436, DOI 10.1603/ME09288
   Brown CR, 2010, ARCH VIROL, V155, P745, DOI 10.1007/s00705-010-0638-8
   Bueno MG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005073
   Bugher J. C., 1951, YELLOW FEVER, P299
   BURTON AN, 1966, SCIENCE, V154, P1029, DOI 10.1126/science.154.3752.1029
   CALISHER CH, 1988, AM J TROP MED HYG, V38, P447, DOI 10.4269/ajtmh.1988.38.447
   Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06
   Maya WDC, 2016, J ASSIST REPROD GEN, V33, P1255, DOI 10.1007/s10815-016-0747-8
   CAREY D E, 1971, Journal of the History of Medicine and Allied Sciences, V26, P243
   Carver S, 2009, VECTOR-BORNE ZOONOT, V9, P51, DOI 10.1089/vbz.2008.0040
   Casadevall A, 2000, INFECT IMMUN, V68, P6511, DOI 10.1128/IAI.68.12.6511-6518.2000
   Castel G, 2017, VIRUS RES, V233, P60, DOI 10.1016/j.virusres.2017.03.011
   CHAMBERLAIN RW, 1982, AM J TROP MED HYG, V31, P430, DOI 10.4269/ajtmh.1982.31.430
   CHAMBERLAIN RW, 1980, TOGAVIRUSES, P175
   Chung HC, 2014, EMERG INFECT DIS, V20, P2072, DOI 10.3201/eid2012.131742
   Clements A. N., 2012, BIOL MOSQUITOES, V3, P105
   COGGINS L, 1974, PROG MED VIROL, V18, P48
   Collins D. L., 1963, DIS TRANSMITTED ANIM, P731
   Cowled C, 2012, ARCH VIROL, V157, P1161, DOI 10.1007/s00705-012-1277-z
   Dawson JR, 2007, EMERG INFECT DIS, V13, P1912, DOI 10.3201/eid1312.070413
   DEFOLIART GR, 1987, ANNU REV ENTOMOL, V32, P479, DOI 10.1146/annurev.en.32.010187.002403
   DOHERTY R. L., 1964, Queensland Health., V1, P1
   Downs W. G., 1970, INFECT AGENTS HOST R, P538
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudas G, 2015, ELIFE, V4, DOI 10.7554/eLife.06837
   DUDLEY SHELDON F., 1934, JOUR TROP MED AND HYG, V37, P273
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Duggal NK, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003262
   DUMINA A. L., 1958, VOPROSY VIRUSOL [TRANSL], V3, P166
   EKLUND CM, 1953, ANNU REV MICROBIOL, V7, P339, DOI 10.1146/annurev.mi.07.100153.002011
   ENDRIS RG, 1992, J MED ENTOMOL, V29, P652, DOI 10.1093/jmedent/29.4.652
   Endy TP, 2004, J INFECT DIS, V189, P990, DOI 10.1086/382280
   Favoretto S, 2016, BIORXIV
   Fontenille D, 1997, T ROY SOC TROP MED H, V91, P533, DOI 10.1016/S0035-9203(97)90013-4
   Forrester NL, 2012, J VIROL, V86, P2729, DOI 10.1128/JVI.05591-11
   Garcia MN, 2015, MICROBES INFECT, V17, P163, DOI 10.1016/j.micinf.2014.12.003
   Gaudreault NN, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00664
   Gaunt MW, 2001, J GEN VIROL, V82, P1867, DOI 10.1099/0022-1317-82-8-1867
   GEBHARDT LP, 1967, JPN J MED SCI BIOL, VS 20, P30
   GEEVARGHESE G, 1990, CURR SCI INDIA, V59, P26
   Geoghegan JL, 2016, P NATL ACAD SCI USA, V113, P4170, DOI 10.1073/pnas.1521582113
   GERLOFF RK, 1959, AM J PATHOL, V35, P1043
   Gibney KB, 2011, J INFECT DIS, V203, P344, DOI 10.1093/infdis/jiq057
   Gilbert L, 2004, P ROY SOC B-BIOL SCI, V271, pS202, DOI 10.1098/rsbl.2003.0147
   Gilbert L, 2016, EXP APPL ACAROL, V68, P363, DOI 10.1007/s10493-015-9952-x
   Go YY, 2014, CLIN EXP VACCINE RES, V3, P58, DOI 10.7774/cevr.2014.3.1.58
   Goic B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12410
   Gonzalez-Salazar C, 2017, ECOHEALTH
   Goupil Brad A, 2016, Open Rheumatol J, V10, P129, DOI 10.2174/1874312901610010129
   Gritsun TS, 2003, J VIROL, V77, P25, DOI 10.1128/JVI.77.1.25-36.2003
   Gubala A, 2011, J GEN VIROL, V92, P2160, DOI 10.1099/vir.0.026120-0
   Gubler D.J., 1982, P343
   Gubler DJ, 2001, AM J TROP MED HYG, V65, pV
   Gubler DJ, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P1, DOI 10.1079/9781845939649.0001
   HAMMON WM, 1945, AM J PUBLIC HEALTH, V35, P994
   HANSON RP, 1952, BACTERIOL REV, V16, P179, DOI 10.1128/MMBR.16.3.179-204.1952
   Hardy A, 2003, PERSPECT BIOL MED, V46, P200, DOI 10.1353/pbm.2003.0021
   Hardy J. L., 1990, Epidemiology and control of mosquito-borne arboviruses in California, 1943-1987., P66
   Harrison A, 2010, J APPL ECOL, V47, P926, DOI 10.1111/j.1365-2664.2010.01834.x
   Harrison JJ, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8050141
   Haydon DT, 2002, EMERG INFECT DIS, V8, P1468
   Hernandez R, 2014, ADV VIROL, V2014, DOI 10.1155/2014/259382
   Hindle E., 1929, T ROY SOC TROP MED H, V12, P405
   Holmes EC, 2004, MOL ECOL, V13, P745, DOI 10.1046/j.1365-294X.2003.02051.x
   Holmes EC, 2003, INFECT GENET EVOL, V3, P19, DOI 10.1016/S1567-1348(03)00004-2
   Honda Tomoyuki, 2016, Mob Genet Elements, V6, pe1165785, DOI 10.1080/2159256X.2016.1165785
   Honig JE, 2004, VIROLOGY, V318, P10, DOI 10.1016/j.virol.2003.09.021
   Honigsbaum M, 2016, J HIST BIOL, V49, P261, DOI 10.1007/s10739-015-9430-7
   Huang ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060827
   Hubalek Z, 2003, EMERG INFECT DIS, V9, P403, DOI 10.3201/eid0903.020208
   Huff CG, 1931, SCIENCE, V74, P456, DOI 10.1126/science.74.1923.456-a
   Huff CG, 1938, Q REV BIOL, V13, P196, DOI 10.1086/394557
   Huhtamo E, 2014, VIROLOGY, V464, P320, DOI 10.1016/j.virol.2014.07.015
   Huyvaert KP, 2008, J WILDLIFE DIS, V44, P331, DOI 10.7589/0090-3558-44.2.331
   Jaafar FM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086392
   Jenny B. W., 1984, P AN M US AN HLTH AS, V88, P337
   JIANG WR, 1993, J GEN VIROL, V74, P931, DOI 10.1099/0022-1317-74-5-931
   JOHNSON BK, 1976, T ROY SOC TROP MED H, V70, P230, DOI 10.1016/0035-9203(76)90045-6
   Johnson CK, 2015, SCI REP-UK, V5, DOI 10.1038/srep14830
   Johnson H. N., 1981, CRC HDB SERIES ZOONO, V1
   JOHNSON KM, 1987, AM J TROP MED HYG, V37, pS3, DOI 10.4269/ajtmh.1987.37.3S
   JOURNEAUX SF, 1987, J GEN VIROL, V68, P3165, DOI 10.1099/0022-1317-68-12-3165
   Junglen S, 2016, CURR OPIN INSECT SCI, V16, P81, DOI 10.1016/j.cois.2016.05.017
   Junglen S, 2015, EMERG INFECT DIS, V21, P2190, DOI 10.3201/eid2112.141840
   Junglen S, 2013, CURR OPIN MICROBIOL, V16, P507, DOI 10.1016/j.mib.2013.06.005
   Katzourakis A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001191
   Kitchen A, 2011, P NATL ACAD SCI USA, V108, P238, DOI 10.1073/pnas.1011090108
   KOBLET H, 1993, IN VITRO CELL DEV-AN, V29A, P274, DOI 10.1007/BF02633955
   Kock RA, 2015, REV SCI TECH OIE, V34, P151, DOI 10.20506/rst.34.1.2351
   Komar Nicholas, 2003, Adv Virus Res, V61, P185
   Koolhof IS, 2017, EPIDEMIOL INFECT, V145, P656, DOI 10.1017/S0950268816002739
   KUMM HENRY W., 1932, ANN TROP MED AND PARASITOL [LIVERPOOL], V26, P207
   Kuno G, 2007, J MED ENTOMOL, V44, P93, DOI 10.1603/0022-2585(2007)44[93:HRSOFC]2.0.CO;2
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   Kuno G, 2001, REV MED VIROL, V11, P165, DOI 10.1002/rmv.314
   Kuno G, 2001, ACTA VIROL, V45, P139
   Kuno G, 2016, ARBOVIRUSES: MOLECULAR BIOLOGY, EVOLUTION AND CONTROL, P219
   L'vov D. K., 2015, ZOONOTIC VIRUSES NO, P274
   Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Lancaster MU, 1998, J VIROL, V72, P2474, DOI 10.1128/JVI.72.3.2474-2482.1998
   le Lay-Rogues G., 1986, Medecine Tropicale, V46, P389
   Leendertz SAJ, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8020030
   Leonova GN, 2015, ARCH VIROL, V160, P663, DOI 10.1007/s00705-014-2310-1
   Li CX, 2015, ELIFE, V4, DOI 10.7554/eLife.05378
   Lobo FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006282
   Lok SM, 2001, J MED VIROL, V65, P315, DOI 10.1002/jmv.2036
   Lord CC, 2006, J MED ENTOMOL, V43, P623, DOI 10.1603/0022-2585(2006)43[623:RBHVAV]2.0.CO;2
   Lord JS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004074
   LUEDKE AJ, 1977, AM J TROP MED HYG, V26, P313, DOI 10.4269/ajtmh.1977.26.313
   Mackenzie J. S., 2014, CONFRONTING EMERGING, P163
   Mackenzie JS, 2014, GLOB PUBLIC HEALTH, V9, P1023, DOI 10.1080/17441692.2014.951870
   Mackenzie JS, 2013, CURR OPIN VIROL, V3, P170, DOI 10.1016/j.coviro.2013.02.002
   Maramorosch K., 1954, T N Y ACAD SCI, V83, P234
   Marklewitz M, 2015, P NATL ACAD SCI USA, V112, P7536, DOI 10.1073/pnas.1502036112
   Masembe C, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-218
   McCarthy MK, 2017, CURR OPIN VIROL, V23, P8, DOI 10.1016/j.coviro.2017.01.003
   Melville L F, 2004, Vet Ital, V40, P502
   Melzi E, 2016, P NATL ACAD SCI USA, V113, pE6238, DOI 10.1073/pnas.1610012113
   Meyer K. F., 1956, ZOONOSES THEIR RELAT, P49
   Meyer KF, 1934, ANN INTERN MED, V8, P552, DOI 10.7326/0003-4819-8-5-552
   MEYER KF, 1948, ANN INTERN MED, V29, P326, DOI 10.7326/0003-4819-29-2-326
   MIMS CA, 1975, B WORLD HEALTH ORGAN, V52, P747
   Monath T. P., 1988, ARBOVIRUSES EPIDEMIO, P257
   Mondet B, 2002, VECTOR-BORNE ZOONOT, V2, P47, DOI 10.1089/153036602760260779
   Moreira-Soto A, 2017, COMP IMMUNOL MICROB, V50, P101, DOI 10.1016/j.cimid.2016.12.004
   Murray K, 2010, J INFECT DIS, V201, P2, DOI 10.1086/648731
   MUUL I, 1970, SCIENCE, V170, P1275, DOI 10.1126/science.170.3964.1275
   Nag DK, 2016, VIROLOGY, V498, P164, DOI 10.1016/j.virol.2016.08.022
   Nelms BM, 2013, J MED ENTOMOL, V50, P773, DOI 10.1603/ME12280
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nuttall PA, 2003, ADV VIRUS RES, V60, P233, DOI 10.1016/S0065-3527(03)60007-2
   Nuttall Patricia A., 1994, P351
   OSHIRO LS, 1978, J GEN VIROL, V39, P73, DOI 10.1099/0022-1317-39-1-73
   Owen JC, 2010, J MED ENTOMOL, V47, P451, DOI 10.1603/ME09035
   Pal P, 2014, J VIROL, V88, P8213, DOI 10.1128/JVI.01032-14
   Palacios G, 2013, J VIROL, V87, P3187, DOI 10.1128/JVI.02719-12
   Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001
   Parrish CR, 2008, MICROBIOL MOL BIOL R, V72, P457, DOI 10.1128/MMBR.00004-08
   PHILIP CB, 1961, ANNU REV ENTOMOL, V6, P391, DOI 10.1146/annurev.en.06.010161.002135
   Plowright RK, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004796
   Plyusnin A, 2014, VIRUS RES, V187, P22, DOI 10.1016/j.virusres.2014.01.008
   Porterfield J.H., 1980, TOGAVIRUSES BIOL STR, P13
   PRICE WH, 1966, VIROLOGY, V29, P679, DOI 10.1016/0042-6822(66)90294-7
   Querido JFB, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0632-9
   RAVI V, 1993, J MED VIROL, V40, P326, DOI 10.1002/jmv.1890400412
   Reeves W. C., 1990, Epidemiology and control of mosquito-borne arboviruses in California, 1943-1987., P357
   Reeves W.C., 1983, Progress in Clinical and Biological Research, V123, P19
   Reeves W. C., 1962, P75
   Reeves W. C., 1986, Proceedings and Papers of the Annual Conference of the California Mosquito and Vector Control Association, V53, P30
   Reeves W. C., 1993, ARBOVIROLOGIST PROFE, P193
   REEVES WC, 1958, P SOC EXP BIOL MED, V97, P733, DOI 10.3181/00379727-97-23862
   REEVES WC, 1974, PROG MED VIROL, V17, P193
   Reeves WC, 1958, HDB VIRUSFORSCHUNG, P177
   REISEN W K, 1990, Bulletin of the Society for Vector Ecology, V15, P11
   Reisen WK, 2006, J MED ENTOMOL, V43, P344, DOI 10.1603/0022-2585(2006)043[0344:OOWNVI]2.0.CO;2
   Ricklin ME, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10832
   RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W
   Rodhain F, 1998, B SOC PATHOL EXOT, V91, P279
   Rupprecht Charles, 2017, F1000Res, V6, P184, DOI 10.12688/f1000research.10416.1
   RUSSELL PK, 1972, AM J TROP MED HYG, V21, P97, DOI 10.4269/ajtmh.1972.21.97
   Russell RC, 2002, ANNU REV ENTOMOL, V47, P1, DOI 10.1146/annurev.ento.47.091201.145100
   Ryazantseva NV, 2002, B EXP BIOL MED+, V134, P471, DOI 10.1023/A:1022698532379
   Sanchez-Vizcaino JM, 2015, REV SCI TECH OIE, V34, P503, DOI 10.20506/rst.34.2.2375
   Sasaki T, 2015, JPN J INFECT DIS, V68, P425, DOI 10.7883/yoken.JJID.2014.511
   Schlesinger R W, 1971, Curr Top Microbiol Immunol, V55, P241
   SCOTTI PD, 1980, INTERVIROLOGY, V13, P186, DOI 10.1159/000149124
   SEMENOV B F, 1973, Vestnik Akademii Meditsinskikh Nauk SSSR, V28, P79
   Shi M, 2016, NATURE, V540, P539, DOI 10.1038/nature20167
   Shi M, 2016, J VIROL, V90, P659, DOI 10.1128/JVI.02036-15
   Simon-Loriere E, 2017, NEW ENGL J MED, V376, P1483, DOI 10.1056/NEJMc1701600
   Sirivichayakul C, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-48
   Smith W., 1963, MECH VIRUS INFECT, P1
   Soden M, 2000, ARTHRITIS RHEUM, V43, P365, DOI 10.1002/1529-0131(200002)43:2<365::AID-ANR16>3.0.CO;2-E
   Spielman A, 2003, J EXP BIOL, V206, P3727, DOI 10.1242/jeb.00677
   Spielman A, 2001, VECTOR-BORNE ZOONOT, V1, P3, DOI 10.1089/153036601750137606
   Stallknecht D. E., 2009, ANN NY ACAD SCI, V916, P431
   Steele J. H., 1981, CRC HDB SERIES ZOO B, V2
   Suhrbier A, 2012, NAT REV RHEUMATOL, V8, P420, DOI 10.1038/nrrheum.2012.64
   SULKIN SE, 1962, PROG MED VIROL, V4, P157
   Suss J, 2003, VACCINE, V21, pS19, DOI 10.1016/S0264-410X(02)00812-5
   Swanepoel R, 1996, EMERG INFECT DIS, V2, P321, DOI 10.3201/eid0204.960407
   Takamatsu H, 2003, J GEN VIROL, V84, P227, DOI 10.1099/vir.0.18705-0
   TAYLOR RM, 1951, YELLOW FEVER, P427
   Tesh RB, 2016, ARBOVIRUSES: MOLECULAR BIOLOGY, EVOLUTION AND CONTROL, P385
   Theiler M., 1973, The arthropod-borne viruses of vertebrates. An account of the Rockefeller Foundation virus program, 1951-1970.
   Thomas H. W., 1909, T R SOC TROP MED HYG, V3, P59
   Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412
   Turell MJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004012
   Valencia A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151001
   van Vuuren M, 2015, REV SCI TECH OIE, V34, P139, DOI 10.20506/rst.34.1.2350
   VARELASWESLEY I, 1982, AM J TROP MED HYG, V31, P1273, DOI 10.4269/ajtmh.1982.31.1273
   Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007
   Vasilakis N, 2010, J VIROL, V84, P3726, DOI 10.1128/JVI.02640-09
   Vazeille M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29564
   Venter GJ, 2014, J S AFR VET ASSOC, V85, DOI 10.4102/jsava.v85i1.1102
   Viana M, 2014, TRENDS ECOL EVOL, V29, P270, DOI 10.1016/j.tree.2014.03.002
   Villarreal LP, 2000, VIROLOGY, V272, P1, DOI 10.1006/viro.2000.0381
   VINUELA E, 1985, CURR TOP MICROBIOL, V116, P151
   Vogtlin A, 2013, VET MICROBIOL, V166, P165, DOI 10.1016/j.vetmic.2013.06.001
   Walker PJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004664
   Walton TE, 2004, VETER ITAL SER, V40, P31
   Wang XX, 2015, NATURE, V517, P85, DOI 10.1038/nature13806
   Wasserman S, 2016, INT J INFECT DIS, V48, P98, DOI 10.1016/j.ijid.2016.04.025
   Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003
   Weissenbock H, 2010, VET MICROBIOL, V140, P271, DOI 10.1016/j.vetmic.2009.08.025
   WESTAWAY EG, 1965, VIROLOGY, V26, P528, DOI 10.1016/0042-6822(65)90314-4
   Wheeler SS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001860
   Wheeler SS, 2012, AM J TROP MED HYG, V87, P559, DOI 10.4269/ajtmh.2012.11-0654
   Wheeler SS, 2012, J MED ENTOMOL, V49, P895, DOI 10.1603/ME11286
   Wilson AJ, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0085
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   World Health Organization, 1967, JOINT FAO WHO EXP CO, P68
   World Health Organization, 1967, ARB HUM DIS, P5
   World Health Organization, 1985, ARTHR BORN ROD BORN, P1
   Yamanishi S., 1997, Journal of the Japan Veterinary Medical Association, V50, P731
   ZHDANOV VM, 1975, NATURE, V256, P471, DOI 10.1038/256471a0
NR 241
TC 16
Z9 16
U1 1
U2 17
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JUL
PY 2017
VL 9
IS 7
AR 185
DI 10.3390/v9070185
PG 28
WC Virology
SC Virology
GA FC2QZ
UT WOS:000406684400027
PM 28703771
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Yu, JH
   Liu, XL
   Ke, CW
   Wu, QH
   Lu, WZ
   Qin, ZR
   He, XE
   Liu, YJ
   Deng, JL
   Xu, SQ
   Li, Y
   Zhu, L
   Wan, CS
   Zhang, QW
   Xiao, WW
   Xie, Q
   Zhang, B
   Zhao, W
AF Yu, Jianhai
   Liu, Xuling
   Ke, Changwen
   Wu, Qinghua
   Lu, Weizhi
   Qin, Zhiran
   He, Xiaoen
   Liu, Yujing
   Deng, Jieli
   Xu, Suiqi
   Li, Ying
   Zhu, Li
   Wan, Chengsong
   Zhang, Qiwei
   Xiao, Weiwei
   Xie, Qian
   Zhang, Bao
   Zhao, Wei
TI Effective Suckling C57BL/6, Kunming, and BALB/c Mouse Models with
   Remarkable Neurological Manifestation for Zika Virus Infection
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; Guillain-Barre syndrome (GBS); suckling mouse model; C57BL/6
   mice; Kunming mice; BALB/c mice; neurologic manifestation
ID SWISS MICE; VACCINE; BRAIN; MICRONESIA; DISEASE
AB Since 2015, 84 countries and territories reported evidence of vector-borne Zika Virus (ZIKV) transmission. The World Health Organization (WHO) declared that ZIKV and associated consequences especially the neurological autoimmune disorder Guillain-Barre syndrome (GBS) and microcephaly will remain a significant enduring public health challenge requiring intense action. We apply a standardization of the multi-subcutaneous dorsal inoculation method to systematically summarize clinical neurological manifestation, viral distribution, and tissue damage during the progress of viremia and systemic spread in suckling mouse models. We found that C57BL/6 and Kunming mice (KM) both showed remarkable and uniform neurologic manifestations. C57BL/6 owned the highest susceptibility and pathogenicity to the nervous system, referred to as movement disorders, with 100% incidence, while KM was an economic model for a Chinese study characterized by lower limb weakness with 62% morbidity. Slight yellow extraocular exudates were observed in BALB/c, suggesting the association with similar ocular findings to those of clinical cases. The virus distribution and pathological changes in the sera, brains, livers, kidneys, spleens, and testes during disease progression had strong regularity and uniformity, demonstrating the effectiveness and plasticity of the animal models. The successful establishment of these animal models will be conducive to expound the pathogenic mechanism of GBS.
C1 [Yu, Jianhai; Liu, Xuling; Wu, Qinghua; Lu, Weizhi; Qin, Zhiran; He, Xiaoen; Liu, Yujing; Deng, Jieli; Xu, Suiqi; Li, Ying; Zhu, Li; Wan, Chengsong; Zhang, Qiwei; Xiao, Weiwei; Xie, Qian; Zhang, Bao; Zhao, Wei] Southern Med Univ, Sch Publ Hlth, Guangdong Prov Key Lab Trop Dis Res, Guangzhou 510515, Guangdong, Peoples R China.
   [Ke, Changwen] Ctr Dis Control & Prevent Guangdong Prov, Inst Microbiol, 176 Xin Gang West Rd, Guangzhou 510300, Guangdong, Peoples R China.
   [Zhao, Wei] Southern Med Univ, Sch Pharm, Guangzhou Key Lab Drug Res Emerging Virus Prevent, Guangzhou 510515, Guangdong, Peoples R China.
RP Zhang, B; Zhao, W (corresponding author), Southern Med Univ, Sch Publ Hlth, Guangdong Prov Key Lab Trop Dis Res, Guangzhou 510515, Guangdong, Peoples R China.; Zhao, W (corresponding author), Southern Med Univ, Sch Pharm, Guangzhou Key Lab Drug Res Emerging Virus Prevent, Guangzhou 510515, Guangdong, Peoples R China.
EM chienhai@163.com; maiblume@163.com; Kecw1965@aliyun.com;
   wuqh@smu.edu.cn; pigiraffe@126.com; baobaofei666666@outlook.com;
   hexiaoen24@163.com; liuyujing0729@outlook.com; 15626436064@163.com;
   ikius33@163.com; ly3130090083@sina.com; zhuli89@126.com;
   gzwcs@smu.edu.cn; zhangqw@smu.edu.cn; xweiwei74@126.com;
   xiyuxie89@126.com; zhangb@smu.edu.cn; zhaowei@smu.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31270974, 31470271]; Guangdong Science and
   Technology Department [2013A020229004]; Guangzhou Science and Technology
   Program key projects [2013A020229004]
FX This study was funded by the National Natural Science Foundation of
   China (No. 31270974, No. 31470271),
   https://isisn.nsfc.gov.cn/egrantweb/, Guangdong Science and Technology
   Department (No. 2013A020229004),
   http://pro.gdstc.gov.cn/egrantweb/index?username=hexy, and Guangzhou
   Science and Technology Program key projects (No. 2013A020229004),
   http://apply.gzsi.gov.cn.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Alam A, 2016, IMMUNOLOGY, V149, P386, DOI 10.1111/imm.12656
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Arashkia A, 2010, VIRUS GENES, V40, P44, DOI 10.1007/s11262-009-0417-3
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferreira J., 2005, J. Venom. Anim. Toxins incl. Trop. Dis, V11, P336, DOI 10.1590/S1678-91992005000300010
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hickman HD, 2016, TRENDS MOL MED, V22, P639, DOI 10.1016/j.molmed.2016.06.004
   Huang LH, 2013, NEPHRON EXTRA, V3, P12, DOI 10.1159/000346180
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   Kim E, 2014, VACCINE, V32, P5975, DOI 10.1016/j.vaccine.2014.08.058
   Kong XY, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-3
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li T, 1996, Wei Sheng Wu Xue Bao, V36, P292
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Pedras-Vasconcelos JA, 2008, J IMMUNOL, V180, P8231, DOI 10.4049/jimmunol.180.12.8231
   Pereira NB, 2012, TOXICON, V59, P672, DOI 10.1016/j.toxicon.2012.02.005
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Pletnikov MV, 2003, CEREBELLUM, V2, P62
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Rabaan AA, 2017, J INFECT PUBLIC HEAL, V10, P141, DOI 10.1016/j.jiph.2016.05.007
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Saxena V, 2008, MICROBES INFECT, V10, P1210, DOI 10.1016/j.micinf.2008.06.015
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Solomon IH, 2016, J NEUROINFECT DIS, V7, P220
   Sun Shi-guang, 2012, Chinese Pharmacological Bulletin, V28, P289, DOI 10.3969/j.issn.1001-1978.2012.02.032
   Tang L, 2004, DNA CELL BIOL, V23, P391, DOI 10.1089/104454904323145272
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   White MK, 2016, ANN NEUROL, V80, P479, DOI 10.1002/ana.24748
   Winkelmann E. R., 2016, F1000RESEARCH, V5, P341
   World Health Organization, 2016, ZIK VIR COMPL
   World Health Organization. Fifth meeting of the Emergency Committee under the International Health Regulations, 2005, 5 M EM COMM INT HLTH
   [吴德 Wu De], 2016, [中华微生物学和免疫学杂志, Chinese Journal of Microbiology and Immunology], V36, P721
   [吴德 Wu De], 2016, [中华微生物学和免疫学杂志, Chinese Journal of Microbiology and Immunology], V36, P247
   Yamamoto Y, 2009, PHYSIOL GENOMICS, V39, P227, DOI 10.1152/physiolgenomics.00082.2009
   [杨红旗 Yang Hongqi], 2012, [中华物理医学与康复杂志, Chinese Journal of Physical Medicine and Rehabilitation], V34, P17
   Yang PH, 2010, CELL MOL IMMUNOL, V7, P116, DOI 10.1038/cmi.2009.116
NR 62
TC 9
Z9 10
U1 1
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JUL
PY 2017
VL 9
IS 7
AR 165
DI 10.3390/v9070165
PG 18
WC Virology
SC Virology
GA FC2QZ
UT WOS:000406684400007
PM 28661429
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Alam, A
   Imam, N
   Farooqui, A
   Ali, S
   Malik, MZ
   Ishrat, R
AF Alam, Aftab
   Imam, Nikhat
   Farooqui, Anam
   Ali, Shahnawaz
   Malik, Md. Zubbair
   Ishrat, Romana
TI Recent trends in ZikV research: A step away from cure
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Review
DE ZikV; GBS; Microcephaly; DNA vaccination; FDA; MPA DNA; ZPIV; LAIV;
   AGS-v
ID WEST-NILE VIRUS; DNA VACCINES; HEAD CIRCUMFERENCE; INFECTION;
   IDENTIFICATION; PROTEINS
AB Zika virus (ZikV) is a member of the Flaviviridae virus family, genus Flavivirus has emerged as a potential threat to human health worldwide. Consequences of vertical infections includes microcephaly with brain and eye anomalies, and adult infections includes Guillain-Barre'syndrome (GBS), brain ischemia, myelitis and meningoencephalitis. To develop a better treatment, many efforts are being made, like drug-repurposing concept for FDA-approved drugs for antiviral activity are screened against ZikV infection and emerging as a promising alternative to expedite drug development and various vaccines like DNA, ZPIV, LAIV, mRNA and AGS - v vaccines have been designed and in under clinical trial phases. Moreover, few pharmacological agents like My cophenolicacid, Niclosamide, PHA-690509, Emricasan and Bortezomib are most potent anti-ZikV candidates and highly effective single or combining treatment with these drugs. This article reviews the ZikV illness, transmission patterns, pathophysiology of disease, global efforts, challenges and the prospects for the development of vaccines and antiviral agents. (C) 2017 Elsevier Masson SAS. All rights reserved.
C1 [Alam, Aftab; Farooqui, Anam; Ali, Shahnawaz; Malik, Md. Zubbair; Ishrat, Romana] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India.
   [Imam, Nikhat] Magadh Univ, Inst Comp Sci & Informat Technol, Bodhgaya, Bihar, India.
RP Ishrat, R (corresponding author), Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India.
EM rishrat@jmi.ac.in
RI ali, shahnawaz/K-5884-2015
OI ali, shahnawaz/0000-0002-7601-4762; ALAM, AFTAB/0000-0002-6989-9398
FU University Grants Commission, Government of IndiaUniversity Grants
   Commission, India; Indian Council of Medical ResearchIndian Council of
   Medical Research (ICMR)
FX Aftab Alam is supported by a research fellowship of the University
   Grants Commission, Government of India., SA and MZM are supported by the
   Indian Council of Medical Research under SRF (Senior Research
   Fellowship).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Alam A, 2016, IMMUNOLOGY, V149, P386, DOI 10.1111/imm.12656
   Alarcon JB, 1999, ADV PARASIT, V42, P343, DOI 10.1016/S0065-308X(08)60152-9
   Alexandra K. R., 2016, UPDATE INTERIM GUIDA
   Alvino Ana Catarina Matos Ishigami, 2016, Rev. Bras. Saude Mater. Infant., V16, pS83, DOI 10.1590/1806-9304201600s100007
   Angeliki M., 2011, PAEDIAT NEUROL, V11, P18
   Araujo HRC, 2015, INSECTS, V6, P576, DOI 10.3390/insects6020576
   Bailey CC, 2014, ANNU REV VIROL, V1, P261, DOI 10.1146/annurev-virology-031413-085537
   Barbier A, 2013, PEDIATRICS, V131, pE1158, DOI 10.1542/peds.2011-3846
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Castanha PMS, 2016, J INFECT DIS, V214, P265, DOI 10.1093/infdis/jiw143
   Cheng FX, 2016, TRENDS MOL MED, V22, P919, DOI 10.1016/j.molmed.2016.09.006
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Costello A., 2016, B WORLD HEALTH ORGAN, V94, p406A
   Delvecchio R., 2016, BIORXIV 051268V1
   Dichtelmueller HO, 2011, TRANSFUSION, V51, P1412, DOI 10.1111/j.1537-2995.2010.03003.x
   Dirlikov C. G. M. Emilio, GUILLAIN BARRE SYNDR
   Dobyns WB, 2002, AM J MED GENET, V112, P315, DOI 10.1002/ajmg.10580
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Ernst KC, 2015, EMERG INFECT DIS, V21, P320, DOI 10.3201/eid2102.141035
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Harris SR, 2015, CAN FAM PHYSICIAN, V61, P680
   Harris SR, 2013, DEV NEUROREHABIL, V16, P129, DOI 10.3109/17518423.2012.737040
   He S., 2015, SCI TRANSL MED, V9, p282ra
   Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114
   Jamil Z, 2016, ASIAN PAC J TROP MED, V9, P606, DOI 10.1016/j.apjtm.2016.05.020
   Kalampokas Emmanouil, 2012, ISRN Obstet Gynecol, V2012, P264918, DOI 10.5402/2012/264918
   Kennedy RB, 2016, EBIOMEDICINE, V13, P29, DOI 10.1016/j.ebiom.2016.10.016
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kreil TR, 2003, TRANSFUSION, V43, P1023, DOI 10.1046/j.1537-2995.2003.00496.x
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kwak-Kim J., 2016, AM J REPROD IMMUNOL
   Leonardi W, 2016, SCI REP-UK, V6, DOI 10.1038/srep34475
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Michelle A. G. P., 2006, MALAR J, V5
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mocarski ES, 2012, NAT REV IMMUNOL, V12, P79, DOI 10.1038/nri3131
   Moller-Madsen B, 2015, J CHILD ORTHOP, V9, P425, DOI 10.1007/s11832-015-0688-2
   Morrison C, 2016, NAT REV DRUG DISCOV, V15, P521, DOI 10.1038/nrd.2016.159
   Motta Iara, 2016, ZIKA VIRUS TRANSMITT
   Mumtaz N, 2016, CURR TREAT OPTIONS I, V8, P208, DOI [10.1007/s40506-016-0083-7, DOI 10.1007/S40506-016-0083-7]
   Nosengo N, 2016, NATURE, V534, P314, DOI 10.1038/534314a
   OUP accepted manuscript, 2016, J TROP PEDIAT
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Phongsamart W, 2008, PEDIATR INFECT DIS J, V27, P500, DOI 10.1097/INF.0b013e318167917a
   QAZI QH, 1973, CLIN GENET, V4, P46
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Robinson HL, 2000, ADV VIRUS RES, V55, P1, DOI 10.1016/S0065-3527(00)55001-5
   RUSSELL LJ, 1984, AM J MED GENET, V17, P509, DOI 10.1002/ajmg.1320170213
   Science D., 2017, SCIENCEDAILY
   Shan C, 2017, NAT MED
   Unwin V., 2017, BIOMED CENT
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
   Vouga M, 2016, LANCET INFECT DIS, V16, P773, DOI 10.1016/S1473-3099(16)30083-4
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   WRAIR, 2016, VACC CAND PROT ZIK V
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
NR 69
TC 14
Z9 15
U1 1
U2 16
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0753-3322
EI 1950-6007
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD JUL
PY 2017
VL 91
BP 1152
EP 1159
DI 10.1016/j.biopha.2017.05.045
PG 8
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA FB8PB
UT WOS:000406399900123
PM 28531943
DA 2020-07-08
ER

PT J
AU Forman, RN
   Mehta, PK
   Louis, KR
   Finneseth, MK
   Yarrington, CD
AF Forman, Rosha N.
   Mehta, Pooja K.
   Louis, Kettie R.
   Finneseth, Molly K.
   Yarrington, Christina D.
TI Addressing the Global Zika Epidemic Locally An Interprofessional Model
   of Universal Screening at One Center
SO JOURNAL OF PERINATAL & NEONATAL NURSING
LA English
DT Article
DE community health centers; delivery of healthcare; emigrants and
   immigrants; prenatal diagnosis; Zika virus infection
ID PREGNANT-WOMEN; UNITED-STATES; VULNERABILITY
AB Escalating evidence for the fetal impact of Zika virus infection required a change in care by all prenatal providers. This article describes an effective model of rapid implementation of universal prenatal screening at one hospital and its network of community health centers for a large and diverse immigrant population exploring the challenges, experiences, and lessons learned. Implementation of national recommendations required a workflow change, challenging a system with a heterogeneity of settings and providers. Using a physician clinical champion and advanced practice nurses in the roles of logistical coordinator and liaison to the network, Zika screening was embedded into prenatal intake visits at both the hospital and community health centers. Challenges addressed include varied medical record systems, acceptance by patients, providers, and community health center leadership, as well as culturally appropriate outreach to diverse ethnic and linguistic communities. In 6 months, the prenatal screening rates increased from 20% to 88%, which resulted in the identification of more than 300 pregnant patients at risk of exposure to Zika virus. This model offers key lessons for emergency preparedness in heterogeneous, safety net hospital settings.
C1 [Forman, Rosha N.; Mehta, Pooja K.; Louis, Kettie R.; Finneseth, Molly K.; Yarrington, Christina D.] Boston Univ, Sch Med, Dept OBGYN, Boston, MA 02118 USA.
RP Forman, RN (corresponding author), Dept OBGYN, 85 E Concord St,6th Floor, Boston, MA 02118 USA.
EM rosha.forman@bmc.org
CR Ajzen I., THEORY PLANNED BEHAV
   Annenberg Public Policy Center of the University of Pennsylvania, ZIK SURV SOM INC LIN
   Bengiamin MI, 2010, MATERN CHILD HLTH J, V14, P618, DOI 10.1007/s10995-009-0485-y
   Centers for Disease Control, 2020, PROT YOURS
   Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50
   de Haes H, 2006, PATIENT EDUC COUNS, V62, P291, DOI 10.1016/j.pec.2006.06.012
   Garg T, 2015, JT COMM J QUAL PATIE, V41, P126, DOI 10.1016/S1553-7250(15)41017-7
   Greenhalgh T., 2004, SPREAD GOOD IDEAS SY
   Johnson EJ, 2003, SCIENCE, V302, P1338, DOI 10.1126/science.1091721
   Langley GJ, 2009, IMPROVEMENT GUIDE PR
   Levine C, 2004, AM J BIOETHICS, V4, P44, DOI 10.1080/15265160490497083
   Metz JP, 2011, J AM BOARD FAM MED, V24, P344, DOI 10.3122/jabfm.2011.04.100296
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Pew Research Center, SOC MED UPD 2016
   Romero Simon, NY TIMES
   Rozansky M., ONE 5 AM SAY VACC PE
   Shivayogi Preethi, 2013, Perspect Clin Res, V4, P53, DOI 10.4103/2229-3485.106389
   The American College of Obstetricians and Gynecologists, 2011, ACOG COMM OP
   Travelers' Health &VERBAR; CDC, WORLD MAP AR RISK ZI
   Triunfol M, 2016, LANCET INFECT DIS, V16, P156, DOI 10.1016/S1473-3099(15)00548-4
   U.S. Census Bureau, AM FACTFINDER RES
   US Department of Health & Human Services, HIV SCREEN PREGN WOM
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
NR 24
TC 1
Z9 1
U1 1
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0893-2190
EI 1550-5073
J9 J PERINAT NEONAT NUR
JI J. Perinat. Neonatal Nurs.
PD JUL-SEP
PY 2017
VL 31
IS 3
BP 216
EP 224
DI 10.1097/JPN.0000000000000266
PG 9
WC Nursing; Obstetrics & Gynecology; Pediatrics
SC Nursing; Obstetrics & Gynecology; Pediatrics
GA FC1MD
UT WOS:000406600500009
PM 28590945
DA 2020-07-08
ER

PT J
AU Passi, GR
AF Passi, Gouri Rao
TI FIRST CASES OF ZIKA VIRUS IN INDIA
SO INDIAN PEDIATRICS
LA English
DT News Item
EM gouripassi@hotmail.com
RI Passi, Gouri/AAE-5210-2019
OI Passi, Gouri/0000-0003-0327-9644
NR 0
TC 0
Z9 0
U1 0
U2 2
PU SPRINGER INDIA
PI NEW DELHI
PA 7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001,
   INDIA
SN 0019-6061
EI 0974-7559
J9 INDIAN PEDIATR
JI Indian Pediatrics
PD JUL
PY 2017
VL 54
IS 7
BP 605
EP 605
PG 1
WC Pediatrics
SC Pediatrics
GA FB3ZB
UT WOS:000406080200024
DA 2020-07-08
ER

PT J
AU Bueno, FTC
AF Costa Bueno, Flavia Thedim
TI Health surveillance and response on a regional scale: a preliminary
   study of the Zika virus fever case
SO CIENCIA & SAUDE COLETIVA
LA English
DT Article
DE Zika virus; International cooperation; Global health; Regional
   Integration
ID GLOBAL HEALTH; BRAZIL; DIPLOMACY
AB Although awareness of the Zika virus has existed since the 1950s, only recently has it attracted the interest of the international community. In 2015 and 2016, the virus spread throughout Brazil and suspicions on the possible relation between parallel increases in neurological disorders and the infection arose. By November 2015, this concern had developed into a National Public Health Emergency. On February 1, 2016, WHO formally declared its suspicion that this was a Public Health Emergency of International Concern (PHEIC), and sent a response in accordance with International Health Regulations (2005). Zika is present in almost all South American countries, and PAHO/WHO, Unasur, and Mercosur are developing responsive actions to the epidemic. The aim of this article is to present a critical analysis of the regional South American and Brazilian responses of February through September 2016, in respect of this PHEIC announcement, utilizing qualitative methodologies via bibliographical examination and document analysis. In this context, the PAHO/WHO played a prominent role as compared with the other organizations. Moreover, the political environment of the region also played a major role in the instability of both Mercosur and Unasur, which could impact the capacity and effectiveness of the response.
C1 [Costa Bueno, Flavia Thedim] Univ Sao Paulo, Fac Saude Publ, Ave Dr Arnaldo 715, BR-01246904 Sao Paulo, SP, Brazil.
RP Bueno, FTC (corresponding author), Univ Sao Paulo, Fac Saude Publ, Ave Dr Arnaldo 715, BR-01246904 Sao Paulo, SP, Brazil.
EM flaviatcbueno@gmail.com
CR Alcazar SLBF, 2005, THESIS
   ALMEIDA Celia, 2010, REV ELECT COMMURANTE, V4, P25, DOI DOI 10.3395/RECIIS.V4I1.343PT
   [Anonymous], 2016, INT HLTH REG
   Barreto ML, 2016, LANCET, V387, P919, DOI 10.1016/S0140-6736(16)00545-6
   Brasil. Ministerio da Saude (MS), 2016, MS B EP
   Brasil. Ministerio da Saude (MS), 2016, INF EP NO 40 SEM EP
   Brasil. Ministerio da Saude (MS), 2016, AC REAL ENFR EM SAUD
   Brown Theodore M., 2006, Hist. cienc. saude-Manguinhos, V13, P623, DOI 10.1590/S0104-59702006000300005
   Buss PM, GOVERNANCA SAUDE GLO
   Carmo EH, 2013, VIGILANCIA SALUD SUR, P115
   Cervo AL, 2010, HIST POLITICA EXTERI, P491
   Cervo AL, 2014, REV BRAS POLIT INT, V57, P133, DOI 10.1590/0034-7329201400308
   De Oliveira MF, 2011, REV BRAS POLIT INT, V54, P5, DOI 10.1590/S0034-73292011000200001
   DINIZ Debora, 2016, ZIKA SERTAO NORDESTI
   Faria Mariana, 2015, Saúde debate, V39, P920, DOI 10.1590/0103-110420151070230
   Feldbaum H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000226
   Ferreira JR, 2016, HIST CIENC SAUDE-MAN, V23, DOI 10.1590/S0104-59702016000200002
   Gomez E, 2016, LUA NOVA, V98, P171
   Queiroz LG, 2011, REV PANAM SALUD PUBL, V30, P182
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hirst M., 2010, NUEVA SOCIEDAD, P22
   Horton R, 2016, LANCET, V387, P633, DOI 10.1016/S0140-6736(16)00268-3
   Instituto Sul Americano de Governo em Saude (ISA-GS), 2016, INF UN SE MOB ENFR V
   Instituto Sul Americano de Governo em Saude (ISA- GS), 2011, EST I SUL AM GOV SAU
   Instituto Sul Americano de Governo em Saude (ISA-GS), 2016, OL RIO VIG SAUD
   Instituto Sul Americano de Governo em Saude (ISAGS), 2012, INF 65A AMS DISC REF
   Instituto Sul Americano de Governo em Saude (ISAGS), 2016, INF ENTR JG TEMP
   Instituto Sul- Americano de Governo em Saude (ISA- GS), 2016, 69 SESS ASS MUND SAU
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Kastler F., 2013, TRIBUNES SANTE, V39, P13
   Kickbusch I, 2007, B WORLD HEALTH ORGAN, V85, P971, DOI 10.2471/BLT.07.045856
   Kickbusch I, 2007, B WORLD HEALTH ORGAN, V85, P230, DOI 10.2471/BLT.06.039222
   Kickbush I., 2010, REVISTA ELETRONICA D, V4, P19
   Leite I., 2012, OBSERVADOR ON LINE, V7, P41
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Marks-Sultan G, 2016, B WORLD HEALTH ORGAN, V94, P534, DOI 10.2471/BLT.15.164749
   Mercado Comon del Sur (Mercosur), 2012, TEXT FUND
   Mercado Comun del Sur (Mercosur), 2016, MERC
   Nunes João, 2016, Lua Nova, V0, P21, DOI 10.1590/0102-6445021-046/98
   Organizacion Panamericana de Salud (OPS), 2016, ZIK MISS SUPP COUNTR
   Organizacion Panamericana de Salud (OPS), 2016, CD55INF4 OPS
   Organizacion Panamericana de Salud (OPS), 2007, AG SAL AM 2008 2015
   Organizacion Panamericana de Salud (OPS), 1999, CONST ORG PAN SAL
   Organizacion Panamericana de Salud (OPS), 2016, ZIK CAS CONG SYNDR A
   PINHEIRO L, 2004, POLITICA EXTERNA BRA
   Pinheiro L., 2000, CONTEXTO INT, V22, P305
   Sato E., 2010, REV ELETRONICA COMUN, V4, P46
   Simoes AJF, 2011, INTEGRACAO SONHO REA, P55
   Telam D., 2016, GOVERNO VENEZUELA SE
   Union de Naciones Suramericanas (Unasur), 2008, CONS SAL SUR PLAN QU
   Union de Naciones Suramericanas (Unasur), 2016, ERN SAMP ASP REEL SE
   Ventura D., 2016, BLOG SAUDE GLOBAL
   Ventura D., 2013, REV INT DIREITOS HUM, V10, P99
   VENTURA D., 2013, DIREITO SAUDE GLOBAL
   Ventura Deisy, 2014, Lua Nova, V0, P45, DOI 10.1590/S0102-64452014000200003
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Vigevani Tullo, 2007, Contexto int., V29, P273, DOI 10.1590/S0102-85292007000200002
   WHO, 2016, WHO STAT 2 M IHR EM
   WHO, 2016, 1 M INT HLTH REG IHR
   World Health Organization, 2016, ZIK SIT REP ZIK VIR
   World Health Organization (WHO), 2016, 3 M INT HLTH REG 200
   World Health Organization (WHO), 2011, FIN OMS FUT RES OBS
   World Health Organization (WHO), 2014, DOC BAS
NR 63
TC 1
Z9 2
U1 0
U2 8
PU ABRASCO
PI RIO DE JANEIRO
PA RUA HESPERIA, 16-PARTE MANGUINHOS, RIO DE JANEIRO, 21050-040, BRAZIL
SN 1413-8123
EI 1678-4561
J9 CIENC SAUDE COLETIVA
JI Cienc. Saude Coletiva
PD JUL
PY 2017
VL 22
IS 7
BP 2305
EP 2314
DI 10.1590/1413-81232017227.07012017
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FB1ZN
UT WOS:000405942900023
PM 28724012
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Infant outcomes among women with Zika virus infection during pregnancy:
   observation on microcephaly
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Letter
C1 [Joob, Beuy; Wiwanitkit, Viroj] Surindra Rajabhat Univ, Surin 10330, Thailand.
RP Joob, B (corresponding author), Surindra Rajabhat Univ, Surin 10330, Thailand.
EM beuyjoob@hotmail.com
CR Adhikari EH, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2017.01.018
   Ronchetti R, 2016, EPIDEMIOL PREV, V40, P466, DOI 10.19191/EP16.6.P466.128
   Wiwanitkit V, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016026
NR 3
TC 1
Z9 1
U1 0
U2 3
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JUL
PY 2017
VL 217
IS 1
BP 91
EP 92
DI 10.1016/j.ajog.2017.02.045
PG 3
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FA2MZ
UT WOS:000405276800033
PM 28274708
OA Bronze
DA 2020-07-08
ER

PT J
AU Adhikari, EH
   Nelson, DB
AF Adhikari, Emily H.
   Nelson, David B.
TI Infant outcomes among women with Zika virus infection during pregnancy:
   observation on microcephaly REPLY
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Letter
ID REPLICATION
C1 [Adhikari, Emily H.; Nelson, David B.] Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, Div Maternal Fetal Med, Dallas, TX 75390 USA.
RP Adhikari, EH (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, Div Maternal Fetal Med, Dallas, TX 75390 USA.
EM emily.adhikari@utsouthwestern.edu
OI Adhikari, Emily/0000-0002-4060-2685
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Centers for Disease Control and Prevention, ZIK VIR SE AS
NR 3
TC 0
Z9 0
U1 0
U2 2
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JUL
PY 2017
VL 217
IS 1
BP 92
EP 92
DI 10.1016/j.ajog.2017.02.047
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FA2MZ
UT WOS:000405276800034
PM 28268198
OA Bronze
DA 2020-07-08
ER

PT J
AU Granger, D
   Hilgart, H
   Misner, L
   Christensen, J
   Bistodeau, S
   Palm, J
   Strain, AK
   Konstantinovski, M
   Liu, DK
   Tran, A
   Theel, ES
AF Granger, Dane
   Hilgart, Heather
   Misner, Lori
   Christensen, Jaime
   Bistodeau, Sarah
   Palm, Jennifer
   Strain, Anna K.
   Konstantinovski, Marja
   Liu, Dakai
   Tran, Anthony
   Theel, Elitza S.
TI Serologic Testing for Zika Virus: Comparison of Three Zika Virus
   IgM-Screening Enzyme-Linked Immunosorbent Assays and Initial Laboratory
   Experiences
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
DE Zika virus; serology
ID TRANSMISSION; SPECIFICITY; DIAGNOSTICS; INFECTION; EXPOSURE; OUTBREAK
AB Serologic evaluation for Zika virus (ZIKV) infection currently includes an initial screen using an anti-ZIKV IgM antibody capture enzyme-linked immunosorbent assay (MAC-ELISA) followed by supplemental testing of specimens with non-negative results by a plaque reduction neutralization test (PRNT). We compared the performance characteristics of three ELISAs for the detection of IgM class antibodies to ZIKV, including the Centers for Disease Control and Prevention (CDC) Zika MAC-ELISA, the InBios ZIKV Detect MAC-ELISA, and the Euroimmun anti-Zika Virus IgM ELISA. Additionally, we present our initial experiences with ZIKV serologic testing from a national reference laboratory perspective. Using both retrospectively and prospectively collected specimens from patients with possible ZIKV infection, we show that the CDC and InBios MAC-ELISAs perform comparably to each other, with positive agreement, negative agreement, and interrater kappa values ranging from 87.5% to 93.1%, 95.7% to 98.5%, and 0.52 to 0.83, respectively. In contrast, comparison of the Euroimmun ZIKV ELISA to either the CDC or InBios MAC-ELISAs resulted in positive agreement, negative agreement, and interrater kappa values ranging from 17.9% to 42.9%, 91.7% to 98.6%, and 0.10 to 0.39, respectively. Among the 19 prospective samples submitted for PRNT, nine were negative, eight specimens had neutralizing antibodies to a flavivirus (unable to be identified), and one sample each was confirmed for ZIKV or dengue virus infection. This study highlights the ongoing challenges associated with serologic diagnosis of ZIKV infection. Although the availability of a commercial serologic test for ZIKV has greatly expanded the national capacity for such testing, the need to further characterize and improve these assays, particularly with regard to specificity, remains.
C1 [Granger, Dane; Hilgart, Heather; Misner, Lori; Theel, Elitza S.] Mayo Clin, Div Clin Microbiol, Dept Lab Med & Pathol, Rochester, MN 55902 USA.
   [Christensen, Jaime; Bistodeau, Sarah; Palm, Jennifer; Strain, Anna K.] Minnesota Dept Hlth, St Paul, MN USA.
   [Konstantinovski, Marja; Liu, Dakai; Tran, Anthony] New York City Dept Hlth & Mental Hyg, Bur Publ Hlth Lab, New York, NY USA.
RP Theel, ES (corresponding author), Mayo Clin, Div Clin Microbiol, Dept Lab Med & Pathol, Rochester, MN 55902 USA.
EM theel.elitza@mayo.edu
CR [Anonymous], 2016, MMWR Morb Mortal Wkly Rep, V65, P1304, DOI 10.15585/mmwr.mm6546a7
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CDC, 2016, ZIK MAC ELISA INSTR
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   FDA, 2017, FDA WARNS HLTH C AR
   FLEISS JL, 2003, STAT METHODS RATES P
   Food and Drug Administration, 2016, ZIK VIR EM US AUTH
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   InBios, 2017, ZIKV DET IGM CAPT EL
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   PAHO, 2016, ZIK SUSP CONF CAS RE
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Silveira FP, 2016, J HEART LUNG TRANSPL, V35, P560, DOI 10.1016/j.healun.2016.03.010
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Speer SD, 2016, SCIENCE, V353, P750, DOI 10.1126/science.aah6187
   Steinhagen K, 2016, EURO SURVEILL, V21
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   World Health Organization, 2016, LAB TEST ZIK VIR INF
   World Health Organization. Fifth meeting of the Emergency Committee under the International Health Regulations, 2005, 5 M EM COMM INT HLTH
NR 28
TC 42
Z9 44
U1 1
U2 17
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD JUL
PY 2017
VL 55
IS 7
BP 2127
EP 2136
DI 10.1128/JCM.00580-17
PG 10
WC Microbiology
SC Microbiology
GA FA3IX
UT WOS:000405338100019
PM 28446573
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Ren, P
   Ortiz, DA
   Terzian, ACB
   Colombo, TE
   Nogueira, ML
   Vasilakis, N
   Loeffelholz, MJ
AF Ren, Ping
   Ortiz, Daniel A.
   Terzian, Ana C. B.
   Colombo, Tatiana E.
   Nogueira, Mauricio L.
   Vasilakis, Nikos
   Loeffelholz, Michael J.
TI Evaluation of Aptima Zika Virus Assay
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
DE Aptima Zika virus assay; sensitivity; specificity
AB The Zika virus (ZIKV) epidemic in the Americas poses a public health emergency that requires a swift response. Accurate and reliable ZIKV diagnostic tests serve as an important tool for limiting the spread of ZIKV infections. The Aptima Zika virus assay (Hologic, Marlborough, MA) performed on the automated Panther system is a rapid and high-throughput method for detecting ZIKV RNA using transcriptionmediated amplification (TMA) technology. We evaluated the performance characteristics of the Aptima Zika virus assay on clinical serum and urine specimens (n = 124) from two different patient populations and samples spiked with ZIKV from three different lineages (n = 10). Compared to the real-time reverse transcription-PCR (rRTPCR) reference method, the Aptima ZIKV assay detected ZIKV RNA with a diagnostic accuracy of 94.8% (95% confidence interval [CI], 89.4 to 97.6), a sensitivity of 94.7% (95% CI, 73.5 to 99.9), and a specificity of 94.8% (95% CI, 88.9 to 97.8). Similar results were obtained regardless of whether a serum or urine source was used. The limits of detection of the assay at a 95% detection probability were 11.5 genome copy equivalents (GCE)/ml (95% fiducial limits, 7.9 to 20.2) in serum and 17.9 GCE/ml (95% fiducial limits, 13.1 to 27.5) in urine. The Aptima Zika virus assay results were highly reproducible (99%), and no cross-reactivity was seen during the testing of a panel of 95 specimens with potentially interfering substances, such as clinically relevant bacteria, fungi, and viruses, including other flaviviruses. The excellent performance characteristics and the convenience of a fully automated testing system make the Aptima ZIKV assay an attractive choice for clinical laboratories detecting ZIKV RNA from serum and urine.
C1 [Ren, Ping; Ortiz, Daniel A.; Vasilakis, Nikos; Loeffelholz, Michael J.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Terzian, Ana C. B.; Colombo, Tatiana E.; Nogueira, Mauricio L.] Fac Med Sao Jose do Rio Preto FAMERP, Sao Jose Do Rio Preto, SP, Brazil.
   [Vasilakis, Nikos] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Ctr Trop Dis, Galveston, TX 77555 USA.
   [Vasilakis, Nikos] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
RP Ren, P; Loeffelholz, MJ (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
EM piren@utmb.edu; mjloeffe@utmb.edu
RI Nogueira, Mauricio L/B-7599-2012
OI Nogueira, Mauricio L/0000-0003-1102-2419; Ortiz,
   Daniel/0000-0001-6100-1822; Ren, Ping/0000-0002-4022-6667
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [13/21719-3, 15/12295-0]; CNPq- FAPESP PPSUS [16/15021-1]
FX M.L.N. is supported by FAPESP (grant 13/21719-3) and CNPq- FAPESP PPSUS
   (grant 16/15021-1). M.L.N. is a CNPq Research Fellow. A.C.B.T. is a
   FAPESP Fellow and is supported by FAPESP (grant 15/12295-0). Hologic
   provided Aptima ZIKV assay reagents. Hologic also provided travel
   support for P.R.,D.A.O., and M.J.L.
CR Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Food and Drug Administration, 2016, EM US AUTH TRIOPL RE
   Food and Drug Administration, 2016, EM US AUTH APT ZIK V
   Hologic, 2016, APT ZIK VIR ASS PACK
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Lustig Y, 2016, EURO SURVEILL, V21
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Stone M, 2017, TRANSFUSION, V57, P734, DOI 10.1111/trf.14031
   WHO, 2017, ZIK SIT REP
NR 14
TC 12
Z9 12
U1 1
U2 9
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD JUL
PY 2017
VL 55
IS 7
BP 2198
EP 2203
DI 10.1128/JCM.00603-17
PG 6
WC Microbiology
SC Microbiology
GA FA3IX
UT WOS:000405338100027
PM 28468854
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Santibanez, S
   Lynch, J
   Paye, YP
   McCalla, H
   Gaines, J
   Konkel, K
   Torres, LJO
   North, WA
   Likos, A
   Daniel, KL
AF Santibanez, Scott
   Lynch, Jonathan
   Paye, Y. Peter
   McCalla, Haley
   Gaines, Joanna
   Konkel, Kimberly
   Torres, Luis J. Ocasio
   North, Wayne A.
   Likos, Anna
   Daniel, Katherine Lyon
TI Engaging Community and Faith-Based Organizations in the Zika Response,
   United States, 2016
SO PUBLIC HEALTH REPORTS
LA English
DT Editorial Material
DE Zika; faith based; health communications
C1 [Santibanez, Scott; Lynch, Jonathan; Paye, Y. Peter; McCalla, Haley] Ctr Dis Control & Prevent, CDC Zika Response, Joint Informat Ctr Outreach Team, Atlanta, GA 30333 USA.
   [Gaines, Joanna] Ctr Dis Control & Prevent, Div Global Migrat, Natl Ctr Emerging & Zoonot Dis, Atlanta, GA 30333 USA.
   [Gaines, Joanna] Ctr Dis Control & Prevent, Quarantines Travelers Hlth Branch, Natl Ctr Emerging & Zoonot Dis, Atlanta, GA 30333 USA.
   [Konkel, Kimberly] US Dept Hlth & Human Serv, Ctr Faith Based & Neighborhood Partnerships, Washington, DC USA.
   [Torres, Luis J. Ocasio] Faith Based & Neighborhood Commun Off, Off Governor, San Juan, PR USA.
   [North, Wayne A.; Likos, Anna] Florida Dept Hlth, Tallahassee, FL USA.
   [Daniel, Katherine Lyon] Ctr Dis Control & Prevent, Off Associate Director Commun, Off Director, Atlanta, GA 30333 USA.
RP Santibanez, S (corresponding author), Ctr Dis Control & Prevent, Div Preparedness & Emerging Infect, Natl Ctr Emerging & Zoonot Dis, 1600 Clifton Rd NE,MS-C18, Atlanta, GA 30333 USA.
EM zqg5@cdc.gov
CR Association of State and Territorial Health Officials, 2014, PUBL HLTH FAITH COMM
   Basch Corey H, 2017, J Prev Med Public Health, V50, P133, DOI 10.3961/jpmph.16.107
   Centers for Disease Control and Prevention, 2016, ZIK VIR SEX TRANSM P
   Centers for Disease Control and Prevention, 1999, FRAM PROGR EV
   Centers for Disease Control and Prevention, 2014, CRIS EM RISK COMM
   Centers for Disease Control and Prevention (CDC), 2016, ZIK COMM EFF
   Fowler S., 2014, WHY MOTIVATING PEOPL
   Fu KW, 2016, AM J INFECT CONTROL, V44, P1700, DOI 10.1016/j.ajic.2016.04.253
   Gottfried J., 2016, NEWS USE SOCIAL MEDI
   Neitzel D., 2010, Morbidity and Mortality Weekly Report, V59, P654
   North Carolina Stop Torture Now, 2014, WHO WE AR
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Pink D. H., 2011, DRIVE SURPRISING TRU
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Santibanez S, 2011, HLTH COMMUNICATION F, P29
   Santibanez S, 2015, PUBLIC HEALTH REP, V130, P128, DOI 10.1177/003335491513000205
   Sharp TM, 2012, AM J TROP MED HYG, V86, P16, DOI 10.4269/ajtmh.2012.11-0427
   US Department of Health and Human Services Center for Faith-Based and Neighborhood Partnerships, 2016, HLTH MIN GUID ZIK
   US Department of Health and Human Services Center for Faith-Based and Neighborhood Partnerships, 2016, ZIK ACT GUID HLTH MI
   US Department of Health and Human Services Center for Faith-Based and Neighborhood Partnerships, 2016, HLTH MIN GUID
NR 20
TC 6
Z9 6
U1 0
U2 3
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0033-3549
EI 1468-2877
J9 PUBLIC HEALTH REP
JI Public Health Rep.
PD JUL-AUG
PY 2017
VL 132
IS 4
BP 436
EP 442
DI 10.1177/0033354917710212
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EZ8TO
UT WOS:000405001100004
PM 28586630
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Zika Virus: The Topic That Should Not Be Forgotten in Sport Medicine
SO CURRENT SPORTS MEDICINE REPORTS
LA English
DT Letter
C1 [Wiwanitkit, Viroj] Surindra Rajabhat Univ, Nok Mueang, Surin Province, Thailand.
RP Wiwanitkit, V (corresponding author), Surindra Rajabhat Univ, Nok Mueang, Surin Province, Thailand.
EM wviroj@yahoo.com
CR Pyzocha NJ, 2017, CURR SPORT MED REP, V16, P109, DOI 10.1249/JSR.0000000000000346
   Shadgan B, 2016, CLIN J SPORT MED, V26, P345, DOI 10.1097/JSM.0000000000000365
   Toresdahl BG, 2016, SPORTS HEALTH, V8, P438, DOI 10.1177/1941738116659060
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 4
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1537-890X
EI 1537-8918
J9 CURR SPORT MED REP
JI Curr. Sport. Med. Rep.
PD JUL-AUG
PY 2017
VL 16
IS 4
BP 294
EP 294
DI 10.1249/JSR.0000000000000376
PG 1
WC Sport Sciences
SC Sport Sciences
GA FA2QR
UT WOS:000405286400018
PM 28696994
DA 2020-07-08
ER

PT J
AU Pyzocha, NJ
   Chinchen, SE
   Maurer, DM
AF Pyzocha, Natasha J.
   Chinchen, Stephanie E.
   Maurer, Douglas M.
TI Zika Virus: The Topic That Should Not Be Forgotten in Sport Medicine
   Response
SO CURRENT SPORTS MEDICINE REPORTS
LA English
DT Letter
C1 [Pyzocha, Natasha J.] DiRaimondo Aviat Clin, Dept Family Med, Ft Carson, CO 80906 USA.
   [Chinchen, Stephanie E.; Maurer, Douglas M.] Madigan Army Med Ctr, Dept Family Med, Tacoma, WA 98431 USA.
RP Pyzocha, NJ (corresponding author), DiRaimondo Aviat Clin, Dept Family Med, Ft Carson, CO 80906 USA.
EM Natasha.j.Pyzocha.mil@mail.mil
CR Centers for Disease Control and Prevention, TEST ZIK VIR
   Pyzocha NJ, 2017, CURR SPORT MED REP, V16, P109, DOI 10.1249/JSR.0000000000000346
   Shadgan B, 2016, CLIN J SPORT MED, V26, P345, DOI 10.1097/JSM.0000000000000365
NR 3
TC 0
Z9 0
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1537-890X
EI 1537-8918
J9 CURR SPORT MED REP
JI Curr. Sport. Med. Rep.
PD JUL-AUG
PY 2017
VL 16
IS 4
BP 295
EP 295
DI 10.1249/JSR.0000000000000375
PG 1
WC Sport Sciences
SC Sport Sciences
GA FA2QR
UT WOS:000405286400019
PM 28696995
DA 2020-07-08
ER

PT J
AU Zhao, LM
   Alto, BW
   Duguma, D
AF Zhao, Liming
   Alto, Barry W.
   Duguma, Dagne
TI Transcriptional Profile for Detoxification Enzymes AeaGGT1 and AaeGGT2
   From Aedes aegypti (Diptera: Culicidae) in Response to Larvicides
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Aedes aegypti; metabolic detoxification; larvicide; VectoBac 12AS;
   Natular 2EC
ID BACILLUS-THURINGIENSIS-ISRAELENSIS; NATURALLY DERIVED INSECTICIDE;
   DRUG-METABOLIZING-ENZYMES; UDP-GLUCURONOSYLTRANSFERASES; CYTOCHROME-P450
   ENZYMES; SOUTHERN MEXICO; MOSQUITO LARVAE; MALARIA VECTOR; DENGUE
   VECTOR; SPINOSAD
AB Aedes aegypti (L.) is the vector responsible for transmitting dengue, chikungunya, yellow fever, and Zika viruses, as well as other pathogens. Microbial larvicides based on Bacillus thuringiensis Berliner israelensis (Bti) and Saccharopolyspora spinosa Mertz and Yao, such as VectoBac 12AS and Natular 2EC, have been shown to be effective in reducing larval populations of Ae. aegypti. We examined the gene expression of two detoxification enzymes, glucosyl and glucuronosyl transferases (AaeGGT1 and AaeGGT2), through developmental stages and a time course study in response to larvicide exposure using qualitative real-time polymerase chain reaction (qPCR). AaeGGT1 and AaeGGT2 gene expressions were differentially regulated during development of the immature stages. We also found that male adults had higher expression than female adults after controlling for age effects. AaeGGT1 and AaeGGT2 gene expression were both upregulated in response to VectoBac 12AS and Natular 2EC treatments with the maximum level of expression occurring 24h after treatment applications. This information sheds light on larvicide-induced changes in the physiology of Ae. aegypti with implications for development of mosquito control strategies.
C1 [Zhao, Liming; Alto, Barry W.; Duguma, Dagne] Univ Florida, Florida Med Entomol Lab, 200 9th St South East, Vero Beach, FL 32962 USA.
RP Zhao, LM (corresponding author), Univ Florida, Florida Med Entomol Lab, 200 9th St South East, Vero Beach, FL 32962 USA.
EM lmzhao@ufl.edu; bwalto@ufl.edu; duguma@ufl.edu
FU Florida Department of Agriculture and Consumer Services [020190, 020180]
FX We thank Melissa Williams, Tanise Stenn, Anna Gioseffi, Daniel Velez,
   and Bradley Eastmond of the Florida Medical Entomology Laboratory,
   University of Florida, Vero Beach, for their excellent technical
   support. We thank Michael Hudon of Indian River Mosquito Control
   District who provided the larvicides VectoBac 12AS and Natular 2EC for
   the experiments. We would also like to thank Drs. Walter Tabachnick and
   Jorge Rey for their support. Funding for this work was provided by
   Florida Department of Agriculture and Consumer Services: Contract Number
   020190 to Jorge Rey and Contract Number 020180 to Walter Tabachnick.
CR Aldemir A, 2009, J AM MOSQUITO CONTR, V25, P113, DOI 10.2987/08-5836.1
   Anderson JF, 2011, J AM MOSQUITO CONTR, V27, P45, DOI 10.2987/10-6079.1
   Basu NK, 2004, J BIOL CHEM, V279, P1429, DOI 10.1074/jbc.M306439200
   BATT AM, 1980, ANN BIOL CLIN-PARIS, V38, P35
   BEACH RF, 1989, PARASITOL TODAY, V5, P326, DOI 10.1016/0169-4758(89)90126-9
   Ben-Dov E, 2014, TOXINS, V6, P1222, DOI 10.3390/toxins6041222
   Bock KW, 2009, BIOCHEM PHARMACOL, V77, P1458, DOI 10.1016/j.bcp.2008.12.004
   Bock KW, 2005, METHOD ENZYMOL, V400, P57, DOI 10.1016/S0076-6879(05)00004-2
   Bond JG, 2004, MED VET ENTOMOL, V18, P50, DOI 10.1111/j.0269-283X.2004.0480.x
   BOYLAND E, 1969, ADV ENZYMOL RAMB, V32, P173
   Brand W, 2010, DRUG METAB DISPOS, V38, P617, DOI 10.1124/dmd.109.031047
   Canton PE, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2240-7
   Cheng ZQ, 1998, TOXICOL SCI, V45, P52, DOI 10.1006/toxs.1998.2494
   Darriet F, 2005, J AM MOSQUITO CONTR, V21, P495, DOI 10.2987/8756-971X(2006)21[495:SANLAI]2.0.CO;2
   Despres L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-926
   Esquivel CJ, 2016, PEERJ, V4, DOI 10.7717/peerj.1784
   GILL SS, 1992, ANNU REV ENTOMOL, V37, P615, DOI 10.1146/annurev.en.37.010192.003151
   Goindin D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135489
   Han Guang-jie, 2015, Zhongguo Xuexichongbing Fangzhi Zazhi, V27, P385
   Harker BW, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-29
   Harwood JF, 2015, J MED ENTOMOL, V52, P663, DOI 10.1093/jme/tjv043
   Hertlein MB, 2010, J AM MOSQUITO CONTR, V26, P67, DOI 10.2987/09-5936.1
   Ismail HM, 2013, P NATL ACAD SCI USA, V110, P19766, DOI 10.1073/pnas.1320185110
   Iyanagi T, 2007, INT REV CYTOL, V260, P35, DOI 10.1016/S0074-7696(06)60002-8
   King CD, 2000, CURR DRUG METAB, V1, P143, DOI 10.2174/1389200003339171
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lumjuan N, 2005, INSECT BIOCHEM MOLEC, V35, P861, DOI 10.1016/j.ibmb.2005.03.008
   Lumjuan N, 2007, INSECT BIOCHEM MOLEC, V37, P1026, DOI 10.1016/j.ibmb.2007.05.018
   Mahmood F, 1997, J VECTOR ECOL, V22, P90
   Maletz S, 2015, SCI TOTAL ENVIRON, V536, P729, DOI 10.1016/j.scitotenv.2015.07.053
   Marina CF, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-55
   Marina CF, 2011, PEST MANAG SCI, V67, P114, DOI [10.1002/ps.2043, 10.1002/pros.21278]
   Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627
   NARANG S, 1975, BIOCHEM GENET, V13, P73, DOI 10.1007/BF00486008
   Oesch F, 2000, TOXICOL PATHOL, V28, P382, DOI 10.1177/019262330002800305
   Paris BL, 2009, DRUG METAB DISPOS, V37, P2045, DOI 10.1124/dmd.109.028274
   Parkinson A, 2011, DRUG METAB DISPOS, V39, P1370, DOI 10.1124/dmd.111.038596
   Perez CM, 2007, J MED ENTOMOL, V44, P631, DOI 10.1603/0022-2585(2007)44[631:SANDIF]2.0.CO;2
   Portereiko MF, 2006, PLANT CELL, V18, P1862, DOI 10.1105/tpc.106.040824
   Pridgeon JW, 2008, J MED ENTOMOL, V45, P1071, DOI 10.1603/0022-2585(2008)45[1071:DAEROA]2.0.CO;2
   Rendic S, 1997, DRUG METAB REV, V29, P413, DOI 10.3109/03602539709037591
   Riaz MA, 2013, AQUAT TOXICOL, V126, P326, DOI 10.1016/j.aquatox.2012.09.010
   Ritchie SA, 2010, AM J TROP MED HYG, V82, P1053, DOI 10.4269/ajtmh.2010.09-0603
   Sanil D, 2014, J VECTOR DIS, V51, P97
   Sheweita SA, 2000, CURR DRUG METAB, V1, P107, DOI 10.2174/1389200003339117
   Sparks TC, 2001, PEST MANAG SCI, V57, P896, DOI 10.1002/ps.358
   Vasiliou Vasilis, 2009, Human Genomics, V3, P281
   Wiwatanaratanabutr S, 2006, MED VET ENTOMOL, V20, P300, DOI 10.1111/j.1365-2915.2006.00640.x
   Zamek-Gliszczynski MJ, 2006, EUR J PHARM SCI, V27, P447, DOI 10.1016/j.ejps.2005.12.007
   Zhang N, 2015, SCI REP-UK, V5, DOI 10.1038/srep17778
   Zhao LM, 2008, J MED ENTOMOL, V45, P401, DOI 10.1603/0022-2585(2008)45[401:CCGAPE]2.0.CO;2
   Zhao LM, 2009, J MED ENTOMOL, V46, P1361, DOI 10.1603/033.046.0615
NR 52
TC 4
Z9 4
U1 0
U2 15
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD JUL
PY 2017
VL 54
IS 4
BP 878
EP 887
DI 10.1093/jme/tjw244
PG 10
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA FA3MW
UT WOS:000405349000010
PM 28399278
DA 2020-07-08
ER

PT J
AU Sparks, JT
   Bohbot, JD
   Ristic, M
   Misic, D
   Skoric, M
   Mattoo, A
   Dickens, JC
AF Sparks, Jackson T.
   Bohbot, Jonathan D.
   Ristic, Mihailo
   Misic, Danijela
   Skoric, Marijana
   Mattoo, Autar
   Dickens, Joseph C.
TI Chemosensory Responses to the Repellent Nepeta Essential Oil and Its
   Major Component Nepetalactone by Aedes aegypti (Diptera: Culicidae), a
   Vector of Zika Virus
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Nepeta; catnip; taste; olfaction; mosquito
ID YELLOW-FEVER; CATNIP OIL; MOSQUITOS; DENGUE; DEET
AB Nepeta essential oil (Neo; catnip) and its major component, nepetalactone, have long been known to repel insects including mosquitoes. However, the neural mechanisms through which these repellents are detected by mosquitoes, including the yellow fever mosquito Aedes aegypti (L.), an important vector of Zika virus, were poorly understood. Here we show that Neo volatiles activate olfactory receptor neurons within the basiconic sensilla on the maxillary palps of female Ae. aegypti. A gustatory receptor neuron sensitive to the feeding deterrent quinine and housed within sensilla on the labella of females was activated by both Neo and nepetalactone. Activity of a second gustatory receptor neuron sensitive to the feeding stimulant sucrose was suppressed by both repellents. Our results provide neural pathways for the reported spatial repellency and feeding deterrence of these repellents. A better understanding of the neural input through which female mosquitoes make decisions to feed will facilitate design of new repellents and management strategies involving their use.
C1 [Sparks, Jackson T.; Bohbot, Jonathan D.; Dickens, Joseph C.] ARS, USDA, Henry A Wallace Beltsville Agr Res Ctr, Invas Insect Biocontrol & Behav Lab, Beltsville, MD 20705 USA.
   [Sparks, Jackson T.] High Point Univ, Dept Biol, High Point, NC USA.
   [Bohbot, Jonathan D.] Hebrew Univ Jerusalem, Dept Entomol, Rehovot, Israel.
   [Ristic, Mihailo] Univ Belgrade, Inst Med Plants Res Dr Josif Pancic, Tadeusa Koscuska 1, Belgrade 11000, Serbia.
   [Misic, Danijela; Skoric, Marijana] Univ Belgrade, Inst Biol Res Sinisa Stankovic, Bulevar Despota Stefana 142, Belgrade 11060, Serbia.
   [Mattoo, Autar] ARS, USDA, Henry A Wallace Beltsville Agr Res Ctr, Sustainable Agr Syst Lab, Beltsville, MD USA.
RP Dickens, JC (corresponding author), ARS, USDA, Henry A Wallace Beltsville Agr Res Ctr, Invas Insect Biocontrol & Behav Lab, Beltsville, MD 20705 USA.
EM jsparks@highpoint.edu; jonathan.bohbot@mail.huji.ac.il;
   mristic@mocbilja.rs; dmisic@ibiss.bg.ac.rs; mdevic@ibiss.bg.ac.rs;
   autar.mattoo@ars.usda.gov; joseph.dickens@ars.usda.gov
RI Mattoo, Autar/U-9751-2019
OI Mattoo, Autar/0000-0001-9226-7164; Skoric, Marijana/0000-0002-3727-4692;
   Misic, Danijela/0000-0002-5419-0773
FU Deployed War Fighter Protection (DWFP) Research Program, - U.S.
   Department of Defense through the Armed Forces Pest Management Board
   (AFPMB)
FX We are grateful for the gift of nepetalactone from Dr. Kamal Chauhan of
   the USDA, ARS, NEA, BARC, Invasive Insects Biocontrol and Behavior
   Laboratory, Beltsville, MD. This work was supported in part by a grant
   to J.C.D. from the Deployed War Fighter Protection (DWFP) Research
   Program, funded by the U.S. Department of Defense through the Armed
   Forces Pest Management Board (AFPMB).
CR Adams R.P., 2007, IDENTIFICATION ESSEN
   Barton V. M., 2003, THESIS
   Bernier UR, 2005, J MED ENTOMOL, V42, P306, DOI 10.1603/0022-2585(2005)042[0306:COCASR]2.0.CO;2
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Chauhan KR, 2005, J MED ENTOMOL, V42, P643, DOI 10.1603/0022-2585(2005)042[0643:FDEOCO]2.0.CO;2
   Debboun M, 2015, INSECT REPELLENTS HANDBOOK, 2ND EDITION, P1
   Dickens JC, 2013, PESTIC BIOCHEM PHYS, V106, P149, DOI 10.1016/j.pestbp.2013.02.006
   EISNER T, 1964, SCIENCE, V146, P1318, DOI 10.1126/science.146.3649.1318
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Ghaninia M, 2008, J EXP BIOL, V211, P3020, DOI 10.1242/jeb.016360
   Grant AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021785
   Gribic ML, 2008, J SERB CHEM SOC, V73, P961, DOI 10.2298/JSC0810961L
   HODGSON ES, 1955, SCIENCE, V122, P417, DOI 10.1126/science.122.3166.417-a
   Misic D, 2015, PHYTOCHEM ANALYSIS, V26, P72, DOI 10.1002/pca.2538
   MONATH TP, 1994, SEMIN VIROL, V5, P133, DOI 10.1006/smvy.1994.1014
   Reidenbach KR, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-298
   ROE RM, 2004, Patent No. 20040242703
   Sanford JL, 2013, NATURWISSENSCHAFTEN, V100, P269, DOI 10.1007/s00114-013-1021-x
   Sparks JT, 2016, J MED ENTOMOL, V53, P1148, DOI 10.1093/jme/tjw073
   Sparks JT, 2016, SCI NAT-HEIDELBERG, V103, DOI 10.1007/s00114-016-1367-y
   Sparks JT, 2014, JOVE-J VIS EXP, DOI 10.3791/52088
   Nerio LS, 2010, BIORESOURCE TECHNOL, V101, P372, DOI 10.1016/j.biortech.2009.07.048
   Trigg JK, 1996, J AM MOSQUITO CONTR, V12, P243
   Weldon PJ, 2011, J CHEM ECOL, V37, P348, DOI 10.1007/s10886-011-9922-7
NR 25
TC 3
Z9 3
U1 2
U2 24
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD JUL
PY 2017
VL 54
IS 4
BP 957
EP 963
DI 10.1093/jme/tjx059
PG 7
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA FA3MW
UT WOS:000405349000020
PM 28407077
DA 2020-07-08
ER

PT J
AU Smartt, CT
   Stenn, TMS
   Chen, TY
   Teixeira, MG
   Queiroz, EP
   Dos Santos, LS
   Queiroz, GAN
   Souza, KR
   Silva, LK
   Shin, DY
   Tabachnick, WJ
AF Smartt, Chelsea T.
   Stenn, Tanise M. S.
   Chen, Tse-Yu
   Teixeira, Maria Gloria
   Queiroz, Erivaldo P.
   Dos Santos, Luciano Souza
   Queiroz, Gabriel A. N.
   Souza, Kathleen Ribeiro
   Silva, Luciano Kalabric
   Shin, Dongyoung
   Tabachnick, Walter J.
TI Evidence of Zika Virus RNA Fragments in Aedes albopictus (Diptera:
   Culicidae) Field-Collected Eggs From Camacari, Bahia, Brazil
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Zika virus; Aedes albopictus; vertical transmission
ID CULEX-PIPIENS-QUINQUEFASCIATUS; POTENTIAL VECTOR; AEGYPTI; INFECTION;
   OUTBREAK
AB A major mosquito-borne viral disease outbreak caused by Zika virus (ZIKV) occurred in Bahia, Brazil, in 2015, largely due to transmission by the mosquito, Aedes aegypti (L.). Detecting ZIKV in field samples of Ae. aegypti has proven problematic in some locations, suggesting other mosquito species might be contributing to the spread of ZIKV. In this study, several (five) adult Aedes albopictus (Skuse) mosquitoes that emerged from a 2015 field collection of eggs from Camac, ari, Bahia, Brazil, were positive for ZIKV RNA; however, attempts to isolate live virus were not successful. Results from this study suggest that field-collected Ae. albopictus eggs may contain ZIKV RNA that require further tests for infectious ZIKV. There is a need to investigate the role of Ae. albopictus in the ZIKV infection process in Brazil and to study the potential presence of vertical and sexual transmission of ZIKV in this species.
C1 [Smartt, Chelsea T.; Stenn, Tanise M. S.; Chen, Tse-Yu; Shin, Dongyoung; Tabachnick, Walter J.] Univ Florida, IFAS, Dept Entomol & Nematol, Florida Med Entomol Lab, Gainesville, FL 32611 USA.
   [Teixeira, Maria Gloria] Univ Fed Bahia, Inst Hlth Collect, Salvador, BA, Brazil.
   [Queiroz, Erivaldo P.] Hlth Municipal Secretary, Salvador, BA, Brazil.
   [Dos Santos, Luciano Souza] Bot Gardens Salvador, Salvador, BA, Brazil.
   [Queiroz, Gabriel A. N.; Souza, Kathleen Ribeiro; Silva, Luciano Kalabric] Fundacao Oswaldo Cruz, Adv Lab Publ Hlth, Salvador, BA, Brazil.
RP Smartt, CT (corresponding author), Univ Florida, IFAS, Dept Entomol & Nematol, Florida Med Entomol Lab, Gainesville, FL 32611 USA.
EM ctsmart@ufl.edu; tanise@ufl.edu; papilioninae@ufl.edu; magloria@ufba.br;
   eripqueiroz@yahoo.com.br; luciano.jbssa@salvador.ba.gov.br;
   ganqueiroz@yahoo.com.br; kathleen_ribeiro@yahoo.com.br;
   kalabric@bahia.fiocruz.br; dshin@ufl.edu; wjt@ufl.edu
RI Silva, Luciano K/L-9041-2013
OI Silva, Luciano K/0000-0002-7739-4082
FU Florida Department of Agriculture and Consumer Services [00119227]
FX We thank J. Day and B. Alto for critical review of earlier drafts of
   this manuscript. This research was supported in part by the Florida
   Department of Agriculture and Consumer Services Grant 00119227 to
   Chelsea T. Smartt.
CR Alto BW, 2014, J VECTOR ECOL, V39, P406, DOI 10.1111/jvec.12116
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   (CDC) Centers for Disease Control and Prevention, 2016, ZIK VIR NAT CTR EM Z
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Goindin M. Dupont-Rouzeyrol, 2016, PLOS NEGLECT TROP D, V10
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lequime S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005548
   (PAHO/ WHO) Pan American Health Organization/ World Health Organization, 2016, ZIK EP UPD 21 APR 20
   Secretaria de Saude do Estado da Bahia SUVISA-DIVEP, 2016, SIT EP ARB
   Shin D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-513
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 20
TC 21
Z9 22
U1 1
U2 6
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD JUL
PY 2017
VL 54
IS 4
BP 1085
EP 1087
DI 10.1093/jme/tjx058
PG 3
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA FA3MW
UT WOS:000405349000041
PM 28419254
DA 2020-07-08
ER

PT J
AU Teruya, J
   Versalovic, J
AF Teruya, Jun
   Versalovic, James
TI From Z to A: Putting Zika virus in perspective
SO JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
LA English
DT Editorial Material
C1 [Teruya, Jun; Versalovic, James] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.
   [Teruya, Jun; Versalovic, James] Texas Childrens Hosp, Dept Pathol, 1102 Bates Ave,Suite 830-19, Houston, TX 77030 USA.
RP Versalovic, J (corresponding author), Texas Childrens Hosp, Dept Pathol, 1102 Bates Ave,Suite 830-19, Houston, TX 77030 USA.
EM jxversal@texaschildrens.org
CR AABB, ZIK VIR OV
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   U.S. Food & Drug Administration, REV REC RED RISK ZIK
   Yacoub S, 2014, NAT REV CARDIOL, V11, P335, DOI 10.1038/nrcardio.2014.40
NR 8
TC 3
Z9 3
U1 0
U2 2
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-5223
EI 1097-685X
J9 J THORAC CARDIOV SUR
JI J. Thorac. Cardiovasc. Surg.
PD JUL
PY 2017
VL 154
IS 1
BP 303
EP 304
DI 10.1016/j.jtcvs.2016.11.074
PG 2
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA FA3WA
UT WOS:000405374100080
PM 28274564
OA Bronze
DA 2020-07-08
ER

PT J
AU Backer, CL
AF Backer, Carl L.
TI Blood and the Zika virus
SO JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
LA English
DT Editorial Material
C1 [Backer, Carl L.] Ann & Robert H Lurie Childrens Hosp Chicago, Div Cardiovasc Thorac Surg, Chicago, IL 60611 USA.
   [Backer, Carl L.] Northwestern Univ, Dept Surg, Feinberg Sch Med, Chicago, IL 60611 USA.
RP Backer, CL (corresponding author), Div Cardiovasc Thorac Surg, 225 E Chicago Ave,Mc 22, Chicago, IL 60611 USA.
EM cbacker@luriechildrens.org
CR Teruya J, 2017, J THORAC CARDIOV SUR, V154, P303, DOI 10.1016/j.jtcvs.2016.11.074
NR 1
TC 0
Z9 1
U1 0
U2 1
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-5223
EI 1097-685X
J9 J THORAC CARDIOV SUR
JI J. Thorac. Cardiovasc. Surg.
PD JUL
PY 2017
VL 154
IS 1
BP 305
EP 305
DI 10.1016/j.jtcvs.2017.03.028
PG 1
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA FA3WA
UT WOS:000405374100081
PM 28433358
OA Bronze
DA 2020-07-08
ER

PT J
AU Schultz, MJ
   Isern, S
   Michael, SF
   Corley, RB
   Connor, JH
   Frydman, HM
AF Schultz, Michaela J.
   Isern, Sharon
   Michael, Scott F.
   Corley, Ronald B.
   Connor, John H.
   Frydman, Horacio M.
TI Variable Inhibition of Zika Virus Replication by Different Wolbachia
   Strains in Mosquito Cell Cultures
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE Wolbachia; Zika virus; arthropod vectors; vector biology
ID AEDES-AEGYPTI MOSQUITOS; WEST NILE VIRUS; DENGUE VIRUS; CYTOPLASMIC
   INCOMPATIBILITY; NATIVE WOLBACHIA; BLOCKS DENGUE; ALBOPICTUS; INFECTION;
   TRANSMISSION; CHIKUNGUNYA
AB Mosquito-borne arboviruses are a major source of human disease. One strategy to reduce arbovirus disease is to reduce the mosquito's ability to transmit virus. Mosquito infection with the bacterial endosymbiont Wolbachia pipientis wMel is a novel strategy to reduce Aedes mosquito competency for flavivirus infection. However, experiments investigating cyclic environmental temperatures have shown a reduction in maternal transmission of wMel, potentially weakening the integration of this strain into a mosquito population relative to that of other Wolbachia strains. Consequently, it is important to investigate additional Wolbachia strains. All Zika virus (ZIKV) suppression studies are limited to the wMel Wolbachia strain. Here we show ZIKV inhibition by two different Wolbachia strains: wAlbB (isolated from Aedes albopictus mosquitoes) and wStri (isolated from the planthopper Laodelphax striatellus) in mosquito cells. Wolbachia strain wStri inhibited ZIKV most effectively. Singlecycle infection experiments showed that ZIKV RNA replication and nonstructural protein 5 translation were reduced below the limits of detection in wStri-containing cells, demonstrating early inhibition of virus replication. ZIKV replication was rescued when Wolbachia was inhibited with a bacteriostatic antibiotic. We observed a partial rescue of ZIKV growth when Wolbachia-infected cells were supplemented with cholesterol-lipid concentrate, suggesting competition for nutrients as one of the possible mechanisms of Wolbachia inhibition of ZIKV. Our data show that wAlbB and wStri infection causes inhibition of ZIKV, making them attractive candidates for further in vitro mechanistic and in vivo studies and future vector-centered approaches to limit ZIKV infection and spread.
   IMPORTANCE Zika virus (ZIKV) has swiftly spread throughout most of the Western Hemisphere. This is due in large part to its replication in and spread by a mosquito vector host. There is an urgent need for approaches that limit ZIKV replication in mosquitoes. One exciting approach for this is to use a bacterial endosymbiont called Wolbachia that can populate mosquito cells and inhibit ZIKV replication. Here we show that two different strains of Wolbachia, wAlbB and wStri, are effective at repressing ZIKV in mosquito cell lines. Repression of virus growth is through the inhibition of an early stage of infection and requires actively replicating Wolbachia. Our findings further the understanding of Wolbachia viral inhibition and provide novel tools that can be used in an effort to limit ZIKV replication in the mosquito vector, thereby interrupting the transmission and spread of the virus.
C1 [Schultz, Michaela J.; Frydman, Horacio M.] Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.
   [Schultz, Michaela J.; Corley, Ronald B.; Connor, John H.; Frydman, Horacio M.] Boston Univ, Natl Emerging Infect Dis Labs, Boston, MA 02215 USA.
   [Isern, Sharon; Michael, Scott F.] Florida Gulf Coast Univ, Dept Biol Sci, Ft Myers, FL USA.
   [Corley, Ronald B.; Connor, John H.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA.
RP Frydman, HM (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.; Connor, JH; Frydman, HM (corresponding author), Boston Univ, Natl Emerging Infect Dis Labs, Boston, MA 02215 USA.; Connor, JH (corresponding author), Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA.
EM jhconnor@bu.edu; hfrydman@bu.edu
RI Schultz, Michaela/AAP-1140-2020
OI Connor, John/0000-0002-8867-7256; Frydman, Horacio/0000-0003-0191-7948;
   Schultz, Michaela/0000-0002-5054-8029
FU National Institute of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R21 NS101151, 1R56AI097589, 1R56AI097589-01A1]
FX Funding was provided by the following: The Directors Fund (BU NEIDL) and
   the National Institute of Allergy and Infectious Diseases (R21 NS101151,
   1R56AI097589, and 1R56AI097589- 01A1).
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06
   Bian GW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002250
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Blagrove MSC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002152
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004
   Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856
   Caragata EP, 2016, TRENDS PARASITOL, V32, P207, DOI 10.1016/j.pt.2015.10.011
   Caragata EP, 2014, MICROB ECOL, V67, P205, DOI 10.1007/s00248-013-0339-4
   Caragata EP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003459
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Chrostek E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003896
   Costin JM, 2013, J VIROL, V87, P52, DOI 10.1128/JVI.02273-12
   Dobson SL, 2004, HEREDITY, V93, P135, DOI 10.1038/sj.hdy.6800458
   Dodson BL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002965
   Fallon AM, 2013, IN VITRO CELL DEV-AN, V49, P66, DOI 10.1007/s11626-012-9571-3
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hussain M, 2013, J VIROL, V87, P851, DOI 10.1128/JVI.01837-12
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Joubert DA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005275
   Kittayapong P, 2000, J MED ENTOMOL, V37, P340, DOI 10.1603/0022-2585(2000)037[0340:DADOWI]2.0.CO;2
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754
   McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968
   Molloy JC, 2016, APPL ENVIRON MICROB, V82, P3109, DOI 10.1128/AEM.00275-16
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Mousson L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001989
   Offerdahl DK, 2017, VIROLOGY, V501, P54, DOI 10.1016/j.virol.2016.11.002
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Rainey SM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005536
   Rances E, 2013, J VIROL, V87, P11945, DOI 10.1128/JVI.01522-13
   Raquin V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125066
   Ross PA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006006
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Stiasny K, 2003, J VIROL, V77, P7856, DOI 10.1128/JVI.77.14.7856-7862.2003
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197
   Toomey ME, 2013, P NATL ACAD SCI USA, V110, P10788, DOI 10.1073/pnas.1301524110
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   van Meer MMM, 1999, INSECT MOL BIOL, V8, P399, DOI 10.1046/j.1365-2583.1999.83129.x
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Ye YXH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003894
   Zug R, 2015, BIOL REV, V90, P89, DOI 10.1111/brv.12098
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 52
TC 21
Z9 21
U1 1
U2 15
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JUL
PY 2017
VL 91
IS 14
AR UNSP e00339-17
DI 10.1128/JVI.00339-17
PG 13
WC Virology
SC Virology
GA FA5EP
UT WOS:000405465700019
PM 28446677
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Cao, B
   Diamond, MS
   Mysorekar, IU
AF Cao, Bin
   Diamond, Michael S.
   Mysorekar, Indira U.
TI Maternal-Fetal Transmission of Zika Virus: Routes and Signals for
   Infection
SO JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
LA English
DT Review
DE trophoblast; placenta; Hofbauer; interferon
ID HUMAN PLACENTAL TROPHOBLASTS; SEXUAL TRANSMISSION; BIRTH-DEFECTS; CELL
   TROPISM; GLIAL-CELLS; BRAIN; MECHANISMS; PREGNANCY; AXL; PERSPECTIVES
AB The emerging mosquito-borne virus, Zika virus (ZIKV), has been causally associated with adverse pregnancy and neonatal outcomes, including miscarriage, microcephaly, serious brain abnormalities, and other birth defects indicative of a congenital ZIKV syndrome. In this review, we highlight work from human and animal studies on routes of infection in pregnancy that lead to adverse fetal and neonatal outcomes. A number of innate and adaptive immune mechanisms and signaling molecules that may have key roles in ZIKV infection pathogenesis are discussed along with putative viral entry pathways. A more granular understanding of pathogenesis of ZIKV infection during pregnancy is critical for developing therapeutics and vaccines and mounting a global public health response to limit ZIKV infections. We also report on new therapeutic interventions that have shown success in preclinical studies.
C1 [Cao, Bin; Mysorekar, Indira U.] Washington Univ, Sch Med, Dept Obstet & Gynecol, 660 South Euclid Ave, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Diamond, Michael S.; Mysorekar, Indira U.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
RP Mysorekar, IU (corresponding author), Washington Univ, Sch Med, Dept Obstet & Gynecol, 660 South Euclid Ave, St Louis, MO 63110 USA.
EM indira@wustl.edu
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165
FU Burroughs Wellcome FundBurroughs Wellcome Fund; March of DimesMarch of
   Dimes; NIH/NICHDUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy
   Shriver National Institute of Child Health & Human Development (NICHD)
   [R01HD091218, R01 AI073755, R01 AI104972, P01 AI106695]
FX This work was supported by a Preventing Prematurity Initiative grant
   from the Burroughs Wellcome Fund and a Prematurity Research Initiative
   Investigator award from the March of Dimes (to I.U.M.), NIH/NICHD grant
   R01HD091218 (to I.UM. and M.S.D.), and R01 AI073755, R01 AI104972, and
   P01 AI106695 to M.S.D.
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Bhattacharyya S, 2013, CELL HOST MICROBE, V14, P136, DOI 10.1016/j.chom.2013.07.005
   Bierne H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039080
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao B, 2014, PLACENTA, V35, P139, DOI 10.1016/j.placenta.2013.12.007
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Khan S, 2016, J EXP MED, V213, P2913, DOI 10.1084/jem.20161289
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2015, IMMUNITY, V43, P15, DOI 10.1016/j.immuni.2015.07.001
   Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   MacMicking JD, 2012, NAT REV IMMUNOL, V12, P367, DOI 10.1038/nri3210
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Nicastri E., 2016, EURO SURVEILL, V21
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Parameswaran P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000764
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   PrabhuDas M, 2015, NAT IMMUNOL, V16, P328, DOI 10.1038/ni.3131
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Robbins JR, 2012, INFECT IMMUN, V80, P418, DOI 10.1128/IAI.05899-11
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804
   Simoni MK, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12613
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Versteeg GA, 2010, CURR OPIN MICROBIOL, V13, P508, DOI 10.1016/j.mib.2010.05.009
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wang S, 2017, CELL RES, V27, P158, DOI 10.1038/cr.2016.144
   Weisblum Y, 2017, J VIROL, V91, DOI [10.1128/jvi.01905-16, 10.1128/JVI.01905-16]
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zeldovich VB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003821
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 69
TC 21
Z9 22
U1 2
U2 13
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1079-9907
EI 1557-7465
J9 J INTERF CYTOK RES
JI J. Interferon Cytokine Res.
PD JUL
PY 2017
VL 37
IS 7
BP 287
EP 294
DI 10.1089/jir.2017.0011
PG 8
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA FA0CS
UT WOS:000405099200001
PM 28402153
OA Green Published
DA 2020-07-08
ER

PT J
AU Mehrjardi, MZ
   Carteaux, G
   Poretti, A
   Taheri, MS
   Bermudez, S
   Werner, H
   da Cruz, LCH
AF Mehrjardi, Mohammad Zare
   Carteaux, Guillaume
   Poretti, Andrea
   Taheri, Morteza Sanei
   Bermudez, Sonia
   Werner, Heron
   Hygino da Cruz, Luiz Celso, Jr.
TI Neuroimaging findings of postnatally acquired Zika virus infection: a
   pictorial essay
SO JAPANESE JOURNAL OF RADIOLOGY
LA English
DT Article
DE Zika virus (ZIKV); Postnatally acquired; Radiology; Neuroimaging;
   Guillain-Barre syndrome (GBS)
ID GUILLAIN-BARRE-SYNDROME; IMAGING FINDINGS; MENINGOENCEPHALITIS;
   ENCEPHALITIS; EMPHASIS
AB Zika virus (ZIKV) is a mosquito-borne arbovirus from the Flaviviridae family, first discovered in 1947. There has been no report of severe complications caused by this virus in humans until recently. However, it is confirmed now that prenatally acquired ZIKV infection may cause severe congenital brain abnormalities in the infected fetuses. In addition, there has been an increasing number of reports during recent years about the causal relationship between postnatally acquired ZIKV infection and severe neurologic complications (mostly immune-mediated ones). Hence, ZIKV should not be considered as benign as it was initially thought, but it might be seen as a serious global threat to human health that may severely affect not only fetuses. In this pictorial essay, we aim to describe and illustrate the currently recognized spectrum of neuroimaging findings in postnatally acquired ZIKV infection. Although neurologic complications do not frequently occur in postnatal ZIKV infection, it is important to be aware of them because they may cause high morbidity and mortality in the affected patients. In addition to clinical and laboratory findings, neuroimaging may help in the diagnostic work-up to make the correct diagnosis, determine the extent of the disease, and follow the clinical course.
C1 [Mehrjardi, Mohammad Zare; Taheri, Morteza Sanei] Shahid Beheshti Univ Med Sci, Sch Med, Shohada Tajrish Hosp, Dept Radiol, Tehran, Iran.
   [Mehrjardi, Mohammad Zare] Climax Radiol Educ Fdn, Div Clin Res, Sect Neuroimaging, Tehran, Iran.
   [Carteaux, Guillaume] CHU Henri Mondor, AP HP, DHU A TVB, Serv Reanimat Med, Creteil, France.
   [Carteaux, Guillaume] Univ Paris Est Creteil, Fac Med Creteil, Grp Rech Clin CARMAS, Creteil, France.
   [Poretti, Andrea] Johns Hopkins Univ, Russell H Morgan Dept Radiol & Radiol Sci, Div Pediat Radiol, Sect Pediat Neuroradiol,Sch Med, Baltimore, MD USA.
   [Bermudez, Sonia] Bogota Univ Hosp, Fdn Santa Fe, Dept Diagnost Imaging, Neuroradiol Sect, Bogota, Colombia.
   [Werner, Heron] Clin Diagnost Imagem CDPI, Dept Radiol, Rio De Janeiro, RJ, Brazil.
   [Hygino da Cruz, Luiz Celso, Jr.] CDPI DASA, Dept Radiol, Amer Med City, Rio De Janeiro, RJ, Brazil.
RP Mehrjardi, MZ (corresponding author), Shahid Beheshti Univ Med Sci, Sch Med, Shohada Tajrish Hosp, Dept Radiol, Tehran, Iran.; Mehrjardi, MZ (corresponding author), Climax Radiol Educ Fdn, Div Clin Res, Sect Neuroimaging, Tehran, Iran.
EM zare@sbmu.ac.ir; guillaume.carteaux@yahoo.fr; aporett1@jhmi.edu;
   saneim@gmail.com; sonia.bermudez@radiologiafsfb.org;
   heronwerner@hotmail.com; celsohygino@hotmail.com
RI Bermudez, Sonia/I-9324-2019; Mehrjardi, Mohammad Zare/G-8980-2017;
   Taheri, Morteza Sanei/I-8789-2017; Werner, Heron/W-1578-2019
OI Mehrjardi, Mohammad Zare/0000-0001-5793-5323; Taheri, Morteza
   Sanei/0000-0002-8881-9058; Bermudez, Sonia/0000-0003-4027-4391;
   carteaux, guillaume/0000-0003-1175-8821
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Kumar S, 1997, NEURORADIOLOGY, V39, P180, DOI 10.1007/s002340050388
   Mahecha MP, 2017, IMMUNOL RES, V65, P72, DOI 10.1007/s12026-016-8816-8
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P89, DOI 10.1007/s11604-016-0609-4
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P87, DOI 10.1007/s11604-016-0605-8
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P41, DOI 10.1007/s11604-016-0599-2
   Mehrjardi MZ, 2016, JPN J RADIOL, V34, P765, DOI 10.1007/s11604-016-0588-5
   Niemeyer B, 2017, EUR NEUROL, V77, P45, DOI 10.1159/000453396
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Palacios E, 2019, NEUROLOGIA, V34, P204, DOI 10.1016/j.nrl.2016.08.006
   Fontes CAP, 2016, NEURORADIOLOGY, V58, P837, DOI 10.1007/s00234-016-1687-9
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pascuzzi RM, 1997, NEUROL CLIN, V15, P529, DOI 10.1016/S0733-8619(05)70332-7
   Petropoulou KA, 2005, AM J NEURORADIOL, V26, P1986
   Schwartzmann PV, 2017, MAYO CLIN PROC, V92, P460, DOI 10.1016/j.mayocp.2016.12.019
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
NR 18
TC 11
Z9 12
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1867-1071
EI 1867-108X
J9 JPN J RADIOL
JI Jpn. J. Radiol.
PD JUL
PY 2017
VL 35
IS 7
BP 341
EP 349
DI 10.1007/s11604-017-0641-z
PG 9
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA EZ9EA
UT WOS:000405030800001
PM 28447317
OA Bronze
DA 2020-07-08
ER

PT J
AU Li, ST
   Fu, BS
   Wang, LY
   Dorf, ME
AF Li, Shitao
   Fu, Bishi
   Wang, Lingyan
   Dorf, Martin E.
TI ZMPSTE24 Is Downstream Effector of Interferon-Induced Transmembrane
   Antiviral Activity
SO DNA AND CELL BIOLOGY
LA English
DT Article
DE enveloped viruses; endosome; viral entry; influenza; interferon; IFITM3
   proteome
ID WEST NILE VIRUS; IFITM3 RESTRICTS; PRELAMIN-A; PATHOGENIC VIRUSES;
   MEMBRANE-FUSION; MICE; INFLUENZA; PROTEINS; PROTEASE; DEFICIENCY
AB The zinc metalloprotease ZMPSTE24 is a constitutively and ubiquitously expressed host restriction factor that is responsible for limiting infection by a broad spectrum of enveloped viruses, including influenza A, vesicular stomatitis, zika, ebola, Sindbis, cowpox, and vaccinia viruses, but not murine leukemia or adenovirus. Antiviral function is independent of ZMPSTE24 enzymatic activity. Protein interaction and genetic complementation studies indicate that ZMPSTE24 is a component of a common antiviral pathway that is associated with interferon-induced transmembrane proteins. In vivo studies with zmpste24-deficient mice demonstrate the importance of ZMPSTE24 for antiviral defense.
C1 [Li, Shitao; Wang, Lingyan] Oklahoma State Univ, Dept Physiol Sci, Stillwater, OK 74078 USA.
   [Fu, Bishi; Dorf, Martin E.] Harvard Med Sch, Dept Microbiol & Immunobiol, 77 Ave Louis Pasteur,NRB830, Boston, MA 02115 USA.
   [Fu, Bishi] Yangtze Univ, Coll Life Sci, Jingzhou, Hunan, Peoples R China.
RP Dorf, ME (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, 77 Ave Louis Pasteur,NRB830, Boston, MA 02115 USA.
EM dorf@hms.harvard.edu
OI Li, Shitao/0000-0002-1398-8519
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI121288]
FX This project is supported by NIH grant AI121288.
CR Ast T, 2016, CELL, V164, P103, DOI 10.1016/j.cell.2015.11.053
   Bailey CC, 2014, ANNU REV VIROL, V1, P261, DOI 10.1146/annurev-virology-031413-085537
   Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909
   Barrowman J, 2012, HUM MOL GENET, V21, P4084, DOI 10.1093/hmg/dds233
   Bergo MO, 2002, P NATL ACAD SCI USA, V99, P13049, DOI 10.1073/pnas.192460799
   Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017
   Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541
   Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344
   Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921
   Fong LG, 2004, P NATL ACAD SCI USA, V101, P18111, DOI 10.1073/pnas.0408558102
   Fong LG, 2006, J CLIN INVEST, V116, P743, DOI 10.1172/JCI27125
   Fu BS, 2017, J EXP MED, V214, P919, DOI 10.1084/jem.20161270
   Fu BS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004960
   Gorman MJ, 2016, J VIROL, V90, P8212, DOI 10.1128/JVI.00581-16
   Harrison SC, 2015, VIROLOGY, V479, P498, DOI 10.1016/j.virol.2015.03.043
   Hildebrandt ER, 2016, J BIOL CHEM, V291, P14185, DOI 10.1074/jbc.M116.718197
   Kim IS, 2017, P NATL ACAD SCI USA, V114, pE28, DOI 10.1073/pnas.1618883114
   Marino G, 2008, HUM MOL GENET, V17, P2196, DOI 10.1093/hmg/ddn120
   Pendas AM, 2002, NAT GENET, V31, P94, DOI 10.1038/ng871
   Perreira JM, 2013, J MOL BIOL, V425, P4937, DOI 10.1016/j.jmb.2013.09.024
   Poddar S, 2016, J VIROL, V90, P8780, DOI 10.1128/JVI.00655-16
   Pryor EE, 2013, SCIENCE, V339, P1600, DOI 10.1126/science.1232048
   Quigley A, 2013, SCIENCE, V339, P1604, DOI 10.1126/science.1231513
   Rasmussen I, 2015, J VIROL, V89, P1851, DOI 10.1128/JVI.02343-14
   Schmidt FI, 2012, CURR OPIN VIROL, V2, P20, DOI 10.1016/j.coviro.2011.11.007
   Varela I, 2005, NATURE, V437, P564, DOI 10.1038/nature04019
   Wang LY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13876
   Warren CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096579
   White JM, 2016, TRAFFIC, V17, P593, DOI 10.1111/tra.12389
   Yang XX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124985
NR 30
TC 4
Z9 4
U1 0
U2 8
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1044-5498
EI 1557-7430
J9 DNA CELL BIOL
JI DNA Cell Biol.
PD JUL
PY 2017
VL 36
IS 7
BP 513
EP 517
DI 10.1089/dna.2017.3791
PG 5
WC Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity
GA EZ9TH
UT WOS:000405072300001
PM 28594571
OA Green Published
DA 2020-07-08
ER

PT J
AU Merfeld, E
   Ben-Avi, L
   Kennon, M
   Cerveny, KL
AF Merfeld, Emily
   Ben-Avi, Lily
   Kennon, Mason
   Cerveny, Kara L.
TI Potential mechanisms of Zika-linked microcephaly
SO WILEY INTERDISCIPLINARY REVIEWS-DEVELOPMENTAL BIOLOGY
LA English
DT Article
ID INTERKINETIC NUCLEAR MIGRATION; RADIAL GLIAL-CELLS; NEURAL PROGENITOR
   CELLS; VIRUS-INFECTION; DENGUE VIRUS; CEREBRAL ORGANOIDS; HUMAN BRAIN;
   MITOTIC ENTRY; STEM-CELLS; NEUROGENESIS
AB A recent outbreak of Zika virus (ZIKV) in Brazil is associated with microcephaly in infants born of infected mothers. As this pandemic spreads, rapid scientific investigation is shedding new light on how prenatal infection with ZIKV causes microcephaly. In this analysis we provide an overview of both microcephaly and ZIKV, explore the connection between prenatal ZIKV infection and microcephaly, and highlight recent insights into how prenatal ZIKV infection depletes the pool of neural progenitors in the developing brain. (C) 2017 The Authors. WIREs Developmental Biology published by Wiley Periodicals, Inc.
C1 [Merfeld, Emily; Ben-Avi, Lily; Kennon, Mason; Cerveny, Kara L.] Reed Coll, Dept Biol, Portland, OR 97202 USA.
RP Cerveny, KL (corresponding author), Reed Coll, Dept Biol, Portland, OR 97202 USA.
EM cervenyk@reed.edu
OI Cerveny, Kara/0000-0003-0667-827X
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Adachi Y, 2014, NEUROPEDIATRICS, V45, P93, DOI 10.1055/s-0033-1360483
   Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431
   Aldo P, 2016, AM J REPROD IMMUNOL, V76, P348, DOI 10.1111/aji.12578
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Awad S, 2013, HUM MOL GENET, V22, P2200, DOI 10.1093/hmg/ddt072
   Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974
   Barbelanne M, 2014, BIOMED RES INT, DOI 10.1155/2014/547986
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Baye LM, 2007, J NEUROSCI, V27, P10143, DOI 10.1523/JNEUROSCI.2754-07.2007
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   Cottee MA, 2013, ELIFE, V2, DOI 10.7554/eLife.01071
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   Cunha MS, 2016, GENOME ANNOUNC, V4, P2015
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Deng TT, 2016, FRONT BIOSCI-LANDMRK, V21, P316, DOI 10.2741/4390
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ekins Sean, 2016, F1000Res, V5, P275
   Faheem M, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S1-S4
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fijak M, 2006, IMMUNOL REV, V213, P66, DOI 10.1111/j.1600-065X.2006.00438.x
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Garcez PP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7474
   Geschwind DH, 2013, NEURON, V80, P633, DOI 10.1016/j.neuron.2013.10.045
   Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gruber R, 2011, NAT CELL BIOL, V13, P1325, DOI 10.1038/ncb2342
   Guernsey DL, 2010, AM J HUM GENET, V87, P40, DOI 10.1016/j.ajhg.2010.06.003
   Haddow AD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005083
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845
   Harrison SC, 2016, NAT IMMUNOL, V17, P1010, DOI 10.1038/ni.3539
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Homem CCF, 2015, NAT REV NEUROSCI, V16, P647, DOI 10.1038/nrn4021
   Hori J, 2003, STEM CELLS, V21, P405, DOI 10.1634/stemcells.21-4-405
   Hussain MS, 2013, HUM MOL GENET, V22, P5199, DOI 10.1093/hmg/ddt374
   Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027
   Ji R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115140
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kouprina N, 2005, HUM MOL GENET, V14, P2155, DOI 10.1093/hmg/ddi220
   Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600
   LaMonica BE, 2012, CURR OPIN NEUROBIOL, V22, P747, DOI 10.1016/j.conb.2012.03.006
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lange C, 2009, CELL STEM CELL, V5, P320, DOI 10.1016/j.stem.2009.05.026
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lathia JD, 2008, J NEUROSCI, V28, P13978, DOI 10.1523/JNEUROSCI.2140-08.2008
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076
   Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Liu Y, 2014, VIROLOGY, V448, P15, DOI 10.1016/j.virol.2013.09.016
   Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410
   MacLean B, 2012, SAMJ S AFR MED J, V102, P47
   Malatesta P, 2000, DEVELOPMENT, V127, P5253
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Melian EB, 2013, J GEN VIROL, V94, P308, DOI 10.1099/vir.0.047076-0
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miner JJ, 2016, CELL STEM CELL, V18, P559, DOI 10.1016/j.stem.2016.04.009
   Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nicholas AK, 2010, NAT GENET, V42, P1010, DOI 10.1038/ng.682
   Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Ohta T, 2002, J CELL BIOL, V156, P87, DOI 10.1083/jcb.200108088
   Ostrem B, 2017, CURR OPIN NEUROBIOL, V42, P61, DOI 10.1016/j.conb.2016.11.007
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pfaff KL, 2007, MOL CELL BIOL, V27, P5887, DOI 10.1128/MCB.00175-07
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shrinet J, 2016, ANAL GENETIC DIVERGE
   Silbereis JC, 2016, NEURON, V89, P248, DOI 10.1016/j.neuron.2015.12.008
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Strzyz PJ, 2015, DEV CELL, V32, P203, DOI 10.1016/j.devcel.2014.12.001
   Sun T, 2014, NAT REV NEUROSCI, V15, P217, DOI 10.1038/nrn3707
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Taverna E, 2014, ANNU REV CELL DEV BI, V30, P465, DOI 10.1146/annurev-cellbio-101011-155801
   Valencia A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151001
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Vulprecht J, 2012, J CELL SCI, V125, P1353, DOI 10.1242/jcs.104109
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wang X, 2016, J VIROL METHODS, V238, P86, DOI 10.1016/j.jviromet.2016.10.010
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yang YWJ, 2012, CELL, V151, P1097, DOI 10.1016/j.cell.2012.10.043
   Yang YT, 2012, NAT NEUROSCI, V15, P1201, DOI 10.1038/nn.3171
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhang C, 2016, BIOCH BIOPHYS RES CO
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zhou Ru, 2010, F1000 Biol Rep, V2, DOI 10.3410/B2-3
NR 138
TC 13
Z9 13
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1759-7684
EI 1759-7692
J9 WIRES DEV BIOL
JI Wiley Interdiscip. Rev.-Dev. Biol.
PD JUL-AUG
PY 2017
VL 6
IS 4
AR UNSP e273
DI 10.1002/wdev.273
PG 14
WC Developmental Biology
SC Developmental Biology
GA EZ3MF
UT WOS:000404614400003
PM 28383800
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Dobson, J
   Levell, N
AF Dobson, J.
   Levell, N.
TI Spotting Zika spots: descriptive features of the rash used in 79
   published cases
SO BRITISH JOURNAL OF DERMATOLOGY
LA English
DT Meeting Abstract
CT 97th Annual Meeting of the British-Association-of-Dermatologists
CY JUL 04-06, 2017
CL Liverpool, ENGLAND
SP British Assoc Dermatologists
C1 [Dobson, J.; Levell, N.] Norfolk & Norwich Univ Hosp NHS Fdn Trust, Norwich, Norfolk, England.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0007-0963
EI 1365-2133
J9 BRIT J DERMATOL
JI Br. J. Dermatol.
PD JUL
PY 2017
VL 177
SU 1
SI SI
MA P56
BP 50
EP 51
PG 2
WC Dermatology
SC Dermatology
GA EZ2QI
UT WOS:000404554000084
DA 2020-07-08
ER

PT J
AU Folkers, KM
   Caplan, AL
   Igel, LH
AF Folkers, K. M.
   Caplan, A. L.
   Igel, L. H.
TI Zika, sexual transmission and prudent public health policy
SO PUBLIC HEALTH
LA English
DT Article
ID VIRUS OUTBREAK
C1 [Folkers, K. M.; Caplan, A. L.; Igel, L. H.] NYU, Sch Med, Div Med Eth, 227 E 30th St, New York, NY 10016 USA.
RP Folkers, KM (corresponding author), NYU, Sch Med, Div Med Eth, 227 E 30th St, New York, NY 10016 USA.
EM kelly.folkers@nyu.edu
OI Caplan, Art/0000-0002-4061-8011
CR Abramson D., 2016, US PUBLICS PERCEPTIO
   Althaus CL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002157
   Belluz J., 2016, ZIKA CAN SPREAD SEX
   Branswell H., 2016, ZIKA VIRUS SPREADING
   Carlson CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004968
   Carrasco-Baca D, 2016, B MATH BIOL, V78, P2228
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Folkers KM, 2016, NY TIMES
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Frieden TR, 2016, JAMA-J AM MED ASSOC, V316, P1443, DOI 10.1001/jama.2016.11941
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   McKenna M., 2016, OFFICIAL ZIKA IS SEX
   Mo Y, 2016, BRIT MED BULL, V119, P25, DOI 10.1093/bmb/ldw023
   Moreira J., 2017, CLIN MICROBIOL INFEC
   O'Dwyer G, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-70
   Tepper NK, 2016, MMWR-MORBID MORTAL W, V65, P311, DOI 10.15585/mmwr.mm6512e1
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Victora CG, 2011, LANCET, V377, P2042, DOI 10.1016/S0140-6736(11)60055-X
   WHO, 2016, 5 M EM COMM UND INT
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
NR 24
TC 6
Z9 6
U1 0
U2 8
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0033-3506
EI 1476-5616
J9 PUBLIC HEALTH
JI Public Health
PD JUL
PY 2017
VL 148
BP 66
EP 68
DI 10.1016/j.puhe.2017.02.018
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EY7XN
UT WOS:000404205600012
PM 28419888
DA 2020-07-08
ER

PT J
AU Parra-Saavedra, M
   Reefhuis, J
   Piraquive, JP
   Gilboa, SM
   Badell, ML
   Moore, CA
   Mercado, M
   Valencia, D
   Jamieson, DJ
   Beltran, M
   Sanz-Cortes, M
   Rivera-Casas, AM
   Yepez, M
   Parra, G
   Martinez, MO
   Honein, MA
AF Parra-Saavedra, Miguel
   Reefhuis, Jennita
   Piraquive, Juan Pablo
   Gilboa, Suzanne M.
   Badell, Martina L.
   Moore, Cynthia A.
   Mercado, Marcela
   Valencia, Diana
   Jamieson, Denise J.
   Beltran, Mauricio
   Sanz-Cortes, Magda
   Rivera-Casas, Ana Maria
   Yepez, Mayel
   Parra, Guido
   Martinez, Martha Ospina
   Honein, Margaret A.
TI Serial Head and Brain Imaging of 17 Fetuses With Confirmed Zika Virus
   Infection in Colombia, South America
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Article
ID UNITED-STATES; INTERIM GUIDANCE; TRANSMISSION; BRAZIL
AB OBJECTIVE: To evaluate fetal ultrasound and magnetic resonance imaging findings among a series of pregnant women with confirmed Zika virus infection to evaluate the signs of congenital Zika syndrome with respect to timing of infection.
   METHODS: We conducted a retrospective case series of pregnant women referred to two perinatal clinics in Barranquilla and Ibague ', Colombia, who had findings consistent with congenital Zika syndrome and Zika virus infection confirmed in maternal, fetal, or neonatal samples. Serial ultrasound measurements, fetal magnetic resonance imaging results, laboratory results, and perinatal outcomes were evaluated.
   RESULTS: We describe 17 cases of confirmed prenatal maternal Zika virus infection with adverse fetal outcomes. Among the 14 symptomatic women, the median gestational age for maternal Zika virus symptoms was 10 weeks (range 7-14 weeks of gestation). The median time between Zika virus symptom onset and microcephaly (head circumference less than 3 standard deviations below the mean) was 18 weeks (range 15-24 weeks). The earliest fetal head circumference measurement consistent with microcephaly diagnosis was at 24 weeks of gestation. The earliest sign of congenital Zika syndrome was talipes equinovarus, which in two patients was noted first at 19 weeks of gestation. Common findings on fetal magnetic resonance imaging were microcephaly, ventriculomegaly, polymicrogyria, and calcifications.
   CONCLUSION: Our analysis suggests a period of at least 15 weeks between maternal Zika virus infection in pregnancy and development of microcephaly and highlights the importance of serial and detailed neuroimaging.
C1 CEDIUL, Ctr Diagnost Ultrasonido & Imagenes, CEDIFETAL, Maternal Fetal Unit, Barranquilla, Colombia.
   [Reefhuis, Jennita] Ctr Dis Control & Prevent, 1600 Clifton Rd NE,MS E-86, Atlanta, GA 30333 USA.
   IPS SOMEFA Ibague, Serv Med Materno Fetal, Ibague, Colombia.
   Emory Univ, Dept Gynecol & Obstet, Atlanta, GA 30322 USA.
   Inst Nacl Salud, Bogota, Colombia.
   Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA.
RP Reefhuis, J (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,MS E-86, Atlanta, GA 30333 USA.
EM nzr5@cdc.gov
OI Jamieson, Denise/0000-0003-2597-1201
FU Colombian Instituto Nacional de Salud; Centers for Disease Control and
   PreventionUnited States Department of Health & Human ServicesCenters for
   Disease Control & Prevention - USA
FX Supported by the Colombian Instituto Nacional de Salud and the Centers
   for Disease Control and Prevention.
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Centers for Disease Control and Prevention, PREGN WOM AN LAB EV
   Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Pacheco O, 2016, N ENGL J MED
   Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V47, P530, DOI 10.1002/uog.15896
   Pomar L, 2017, ULTRASOUND OBSTET GY
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   The Global Health Network, INTERGROWTH 21 FET G
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Vorona GA, 2016, PEDIATR NEUROL, V65, P98, DOI 10.1016/j.pediatrneurol.2016.07.014
   Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
   Werner H, 2016, ULTRASOUND OBST GYN, V47, P657, DOI 10.1002/uog.15901
NR 24
TC 15
Z9 16
U1 0
U2 13
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD JUL
PY 2017
VL 130
IS 1
BP 207
EP 212
DI 10.1097/AOG.0000000000002105
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EY5UT
UT WOS:000404046700035
PM 28594771
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Ramsey, PS
AF Ramsey, Patrick S.
TI What Is New in Zika Virus in Pregnancy? Best Articles From the Past Year
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Editorial Material
C1 [Ramsey, Patrick S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, Ctr Pregnancy & Newborn Res, San Antonio, TX 78229 USA.
RP Ramsey, PS (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, Ctr Pregnancy & Newborn Res, San Antonio, TX 78229 USA.
EM ramseyp@uthscsa.edu
OI Ramsey, Patrick/0000-0002-2613-9364
CR Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
NR 2
TC 0
Z9 0
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD JUL
PY 2017
VL 130
IS 1
BP 213
EP 214
DI 10.1097/AOG.0000000000002119
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EY5UT
UT WOS:000404046700036
PM 28594778
DA 2020-07-08
ER

PT J
AU Mahalingam, S
   Teixeira, MM
   Halstead, SB
AF Mahalingam, Suresh
   Teixeira, Mauro M.
   Halstead, Scott B.
TI Zika enhancement: a reality check
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
ID ANTIBODY-DEPENDENT ENHANCEMENT; DENGUE VIRUS; SHOCK SYNDROME; INFECTION;
   THAILAND
C1 [Mahalingam, Suresh] Griffith Univ, Inst Glyc, Southport, Qld 4222, Australia.
   [Teixeira, Mauro M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Sao Paulo, Brazil.
   [Halstead, Scott B.] Pediat Dengue Vaccinat Initiat, Rockville, MD USA.
RP Mahalingam, S (corresponding author), Griffith Univ, Inst Glyc, Southport, Qld 4222, Australia.
EM s.mahalingam@griffith.edu.au
RI Teixeira, Mauro M/A-4587-2008
OI Teixeira, Mauro M/0000-0002-6944-3008
CR Anderson KB, 2014, J INFECT DIS, V209, P360, DOI 10.1093/infdis/jit436
   Anderson KB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001311
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cavalcanti LPD, 2016, J INFECT DEV COUNTR, V10, P563, DOI 10.3855/jidc.8575
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Guzman Maria G., 2002, International Journal of Infectious Diseases, V6, P118, DOI 10.1016/S1201-9712(02)90072-X
   GUZMAN MG, 2002, PAN AM HLTH ORG J EP, V81, P223
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   Halstead SB, 2002, EMERG INFECT DIS, V8, P1474, DOI 10.3201/eid0812.020170
   Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932
NR 15
TC 8
Z9 8
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JUL
PY 2017
VL 17
IS 7
BP 686
EP 688
DI 10.1016/S1473-3099(17)30340-7
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA EY2TW
UT WOS:000403825500014
PM 28653626
OA Bronze
DA 2020-07-08
ER

PT J
AU Freire, MCLC
   Pol-Fachin, L
   Coelho, DF
   Viana, IFT
   Magalhaes, T
   Cordeiro, MT
   Fischer, N
   Loeffler, FF
   Jaenisch, T
   Franca, RF
   Marques, ETA
   Lins, RD
AF Freire, Marjorie C. L. C.
   Pol-Fachin, Laercio
   Coelho, Danilo F.
   Viana, Isabelle F. T.
   Magalhaes, Tereza
   Cordeiro, Marli T.
   Fischer, Nico
   Loeffler, Felix F.
   Jaenisch, Thomas
   Franca, Rafael F.
   Marques, Ernesto T. A.
   Lins, Roberto D.
TI Mapping Putative B-Cell Zika Virus NS1 Epitopes Provides Molecular Basis
   for Anti-NS1 Antibody Discrimination between Zika and Dengue Viruses
SO ACS OMEGA
LA English
DT Article
ID GROMOS FORCE-FIELD; PRINTED ELECTRODE; PROTEIN NS1; DYNAMICS;
   ASSOCIATION; LOOPS; ASSAY
AB B-cell epitope sequences from Zika virus (ZIKV) NS1 protein have been identified using epitope prediction tools. Mapping these sequences onto the NS1 surface reveals two major conformational epitopes and a single linear one. Despite an overall average sequence identity of ca. 55% between the NS1 from ZIKV and the four dengue virus (DENV) serotypes, epitope sequences were found to be highly conserved. Nevertheless, nonconserved epitope-flanking residues are responsible for a dramatically divergent electrostatic surface potential on the epitope regions of ZIKV and DENV2 serotypes. These findings suggest that strategies for differential diagnostics on the basis of short linear NS1 sequences are likely to fail due to immunological cross-reactions. Overall, results provide the molecular basis of differential discrimination between Zika and DENVs by NS1 monoclonal antibodies.
C1 [Freire, Marjorie C. L. C.; Pol-Fachin, Laercio; Coelho, Danilo F.; Viana, Isabelle F. T.; Magalhaes, Tereza; Cordeiro, Marli T.; Franca, Rafael F.; Marques, Ernesto T. A.; Lins, Roberto D.] Fundacao Oswaldo Cruz, Aggeu Magalhaes Inst, BR-50740465 Recife, PE, Brazil.
   [Pol-Fachin, Laercio; Coelho, Danilo F.; Lins, Roberto D.] Univ Fed Pernambuco, Dept Fundamental Chem, BR-50740670 Recife, PE, Brazil.
   [Fischer, Nico; Jaenisch, Thomas] Heidelberg Univ Hosp, Dept Infect Dis, Sect Clin Trop Med, INF 324, D-69120 Heidelberg, Germany.
   [Loeffler, Felix F.] Max Planck Inst Colloids & Interfaces, Dept Biomol Syst, Muhlenberg 1, D-14476 Potsdam, Germany.
   [Fischer, Nico; Loeffler, Felix F.; Jaenisch, Thomas] Heidelberg Univ, Karlsruhe Inst Technol KIT, HEiKA Heidelberg Karlsruhe Res Partnership, D-76131 Karlsruhe, Germany.
   [Marques, Ernesto T. A.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15261 USA.
RP Marques, ETA; Lins, RD (corresponding author), Fundacao Oswaldo Cruz, Aggeu Magalhaes Inst, BR-50740465 Recife, PE, Brazil.; Lins, RD (corresponding author), Univ Fed Pernambuco, Dept Fundamental Chem, BR-50740670 Recife, PE, Brazil.; Marques, ETA (corresponding author), Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15261 USA.
EM marques@pitt.edu; roberto.lins@cpqam.fiocruz.br
RI Marques, Ernesto T. A/L-4967-2013; Loeffler, Felix F/C-7920-2017;
   Magalhaes, Tereza/V-6632-2019; Coelho, Danilo Fernandes/AAC-9206-2020;
   Lins, Roberto D/J-7511-2012; Viana, Isabelle/M-4435-2017
OI Marques, Ernesto T. A/0000-0003-3826-9358; Loeffler, Felix
   F/0000-0002-8227-2522; Coelho, Danilo Fernandes/0000-0002-1111-0825;
   Lins, Roberto D/0000-0002-3983-8025; Freitas de Oliveira Franca,
   Rafael/0000-0002-1846-6007; Viana, Isabelle/0000-0003-4648-6635
FU FACEPE; CAPESCAPES; CNPqNational Council for Scientific and
   Technological Development (CNPq); CuraZika Foundation
FX This work was supported by grants from FACEPE, CAPES, CNPq and CuraZika
   Foundation. Computational resources were provided by the Brazilian
   National Supercomputing Center (LNCC).
CR Abraham M. J., 2015, SOFTWAREX, V1-2, P19
   Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906
   Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398
   BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038
   Borley DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061122
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420
   Cavalcanti IT, 2012, BIOCHEM ENG J, V67, P225, DOI 10.1016/j.bej.2012.06.016
   Cecchetto J, 2017, BIOSENS BIOELECTRON, V87, P949, DOI 10.1016/j.bios.2016.08.097
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   Dawes BE, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.7
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Dias ACMS, 2013, BIOSENS BIOELECTRON, V44, P216, DOI 10.1016/j.bios.2012.12.033
   Edeling MA, 2014, P NATL ACAD SCI USA, V111, P4285, DOI 10.1073/pnas.1322036111
   Figueiredo A, 2015, SCI REP-UK, V5, DOI 10.1038/srep07865
   Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753
   Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362
   Flower DR, 2013, NAT CHEM BIOL, V9, P748, DOI 10.1038/nchembio.1383
   Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108
   Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.3.CO;2-L
   Jaenisch T, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1440-3
   Johnson AJ, 2000, J CLIN MICROBIOL, V38, P1827, DOI 10.1128/JCM.38.5.1827-1831.2000
   Johnson BW, 2009, CLIN VACCINE IMMUNOL, V16, P1052, DOI 10.1128/CVI.00095-09
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kuno Goro, 2003, Adv Virus Res, V61, P3, DOI 10.1016/S0065-3527(03)61001-8
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lover AA, 2016, LANCET INFECT DIS, V16, P1331, DOI 10.1016/S1473-3099(16)30462-5
   Lutteke T, 2006, GLYCOBIOLOGY, V16, p71R, DOI 10.1093/glycob/cwj049
   Maeda A, 2013, VET J, V195, P33, DOI 10.1016/j.tvjl.2012.08.019
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851
   PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693
   Pol-Fachin L, 2012, J CHEM THEORY COMPUT, V8, P4681, DOI 10.1021/ct300479h
   Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514
   PRYOR MJ, 1994, J GEN VIROL, V75, P1183, DOI 10.1099/0022-1317-75-5-1183
   Rubinstein ND, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-287
   Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9
   Silva MMS, 2014, TALANTA, V128, P505, DOI 10.1016/j.talanta.2014.06.009
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Stadler V, 2008, ANGEW CHEM INT EDIT, V47, P7132, DOI 10.1002/anie.200801616
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sumita LM, 2016, REV INST MED TROP SP, V58, DOI [10.1590/s1678-9946201658089, 10.1590/S1678-9946201658089]
   TIRONI IG, 1995, J CHEM PHYS, V102, P5451, DOI 10.1063/1.469273
   Viana IFT, 2013, RSC ADV, V3, P11790, DOI 10.1039/c3ra41562g
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000
NR 55
TC 14
Z9 14
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2470-1343
J9 ACS OMEGA
JI ACS Omega
PD JUL
PY 2017
VL 2
IS 7
BP 3913
EP 3920
DI 10.1021/acsomega.7b00608
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA FG2GV
UT WOS:000409909900090
PM 30023708
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Aragao, MFVV
   Holanda, AC
   Brainer-Lima, AM
   Petribu, NCL
   Castillo, M
   van der Linden, V
   Serpa, SC
   Tenorio, AG
   Travassos, PTC
   Cordeiro, MT
   Sarteschi, C
   Valenca, MM
   Costello, A
AF Aragao, M. F. V. V.
   Holanda, A. C.
   Brainer-Lima, A. M.
   Petribu, N. C. L.
   Castillo, M.
   van der Linden, V.
   Serpa, S. C.
   Tenorio, A. G.
   Travassos, P. T. C.
   Cordeiro, M. T.
   Sarteschi, C.
   Valenca, M. M.
   Costello, A.
TI Nonmicrocephalic Infants with Congenital Zika Syndrome Suspected Only
   after Neuroimaging Evaluation Compared with Those with Microcephaly at
   Birth and Postnatally: How Large Is the Zika Virus "Iceberg"?
SO AMERICAN JOURNAL OF NEURORADIOLOGY
LA English
DT Article
ID INFECTION; ASSOCIATION; OUTBREAK; BRAZIL
AB BACKGROUND AND PURPOSE: Although microcephaly is the most prominent feature of congenital Zika syndrome, a spectrum with less severe cases is starting to be recognized. Our aim was to review neuroimaging of infants to detect cases without microcephaly and compare them with those with microcephaly.
   MATERIALS AND METHODS: We retrospectively evaluated all neuroimaging (MR imaging/CT) of infants 1 year of age or younger. Patients with congenital Zika syndrome were divided into those with microcephaly at birth, postnatal microcephaly, and without microcephaly. Neuroimaging was compared among groups.
   RESULTS: Among 77 infants, 24.6% had congenital Zika syndrome (11.7% microcephaly at birth, 9.1% postnatal microcephaly, 3.9% without microcephaly). The postnatal microcephaly and without microcephaly groups showed statistically similar imaging findings. The microcephaly at birth compared with the group without microcephaly showed statistically significant differences for the following: reduced brain volume, calcifications outside the cortico-subcortical junctions, corpus callosum abnormalities, moderate-to-severe ventriculomegaly, an enlarged extra-axial space, an enlarged cisterna magna (all absent in those without microcephaly), and polymicrogyria (the only malformation present without microcephaly). There was a trend toward pachygyria (absent in groups without microcephaly). The group with microcephaly at birth compared with the group with postnatal microcephaly showed significant differences for simplified gyral pattern, calcifications outside the cortico-subcortical junctions, corpus callosum abnormalities, moderate-to-severe ventriculomegaly, and an enlarged extra-axial space.
   CONCLUSIONS: In microcephaly at birth, except for polymicrogyria, all patients showed abnormalities described in the literature. In postnatal microcephaly, the only abnormalities not seen were a simplified gyral pattern and calcifications outside the cortico-subcortical junction. Infants with normocephaly presented with asymmetric frontal polymicrogyria, calcifications in the cortico-subcortical junction, mild ventriculomegaly, and delayed myelination.
C1 [Aragao, M. F. V. V.] Ctr Diagnost Multimagem, Recife, PE, Brazil.
   [Holanda, A. C.] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Brainer-Lima, A. M.; Valenca, M. M.] Univ Pernambuco, Pronto Socorro Cardiol Pernambuco Procape, Recife, PE, Brazil.
   [Petribu, N. C. L.] Barao Lucena Hosp, Recife, PE, Brazil.
   [Castillo, M.] Univ N Carolina, Dept Radiol, Chapel Hill, NC USA.
   [van der Linden, V.] Assoc Assistance Disabled Children, Recife, PE, Brazil.
   [Serpa, S. C.] Clin Apoio Ocupac, Jaboatao, Brazil.
   [Tenorio, A. G.] Dom Malan Hosp, Petrolina, Brazil.
   [Travassos, P. T. C.] Lab Fernando Travassos, Recife, PE, Brazil.
   [Cordeiro, M. T.; Sarteschi, C.] Fiocruz MS, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
   [Costello, A.] WHO, Dept Maternal Child & Adolescent Hlth, Geneva, Switzerland.
RP Aragao, MFVV (corresponding author), Rua Frei Matias Teves,194 Ilha Leite, BR-50070450 Recife, PE, Brazil.
EM fatima.vascoaragao@gmail.com
RI Valenca, Marcelo/A-4302-2013
OI Valenca, Marcelo/0000-0003-0678-3782; Cordeiro,
   Marli/0000-0001-8196-807X; Cintia Brainer de Queiroz Lima,
   Alessandra/0000-0003-0096-4101; Castillo, Mauricio/0000-0003-2960-1064
FU World Health OrganizationWorld Health Organization [001]
CR Adachi Y, 2011, AM J NEURORADIOL, V32, P1123, DOI 10.3174/ajnr.A2440
   [Anonymous], 2015, NAT AN EST PERN
   AragAo MF, 2017, ZIKA IN FOCUS, P63
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DIEBLER C, 1981, NEURORADIOLOGY, V21, P185, DOI 10.1007/BF00367340
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Leal MC, 2016, BRAZ J OTORHINOLAR, DOI [10.1016/j.bjorl.2016.06.00127444419, DOI 10.1016/J.BJORL.2016.06.00127444419]
   Livingston JH, 2014, DEV MED CHILD NEUROL, V56, P612, DOI 10.1111/dmcn.12359
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Ministerio da Saude (Brazil), 2016, OR INT VIG AT SAUD A
   Ministerio da Saude (Brazil), 2016, PROT VIG RESP OC MIC
   Petribu NC, 2017, ZIKA IN FOCUS, P107
   Poretti A, 2016, AM J NEURORADIOL, V37, P1764, DOI 10.3174/ajnr.A4924
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   van der Linden V, 2017, ZIKA IN FOCUS
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
NR 28
TC 44
Z9 45
U1 0
U2 5
PU AMER SOC NEURORADIOLOGY
PI DENVILLE
PA PO BOX 3000, DENVILLE, NJ 07834-9349 USA
SN 0195-6108
EI 1936-959X
J9 AM J NEURORADIOL
JI Am. J. Neuroradiol.
PD JUL
PY 2017
VL 38
IS 7
BP 1427
EP 1434
DI 10.3174/ajnr.A5216
PG 8
WC Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical
   Imaging
SC Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA FA6PB
UT WOS:000405565100028
PM 28522665
OA Other Gold
DA 2020-07-08
ER

PT J
AU Rodriguez-Morales, AJ
   Culquichicon, C
AF Rodriguez-Morales, Alfonso J.
   Culquichicon, Carlos
TI The need for enhancing the message: Screening for Zika, STORCH, and
   other agents and co-infections should be considered and assessed
SO AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
LA English
DT Letter
ID CHIKUNGUNYA; DENGUE
C1 [Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Publ Hlth & Infect Res Grp, Fac Hlth Sci, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.] Colombian Collaborat Network Zika RECOLZIKA, Pereira, Risaralda, Colombia.
   [Culquichicon, Carlos] Univ Peruana Cayetano Heredia, Emerge Emerging Dis & Climate Change Res Unit, Sch Publ Hlth & Adm Univ, Lima, Peru.
   [Culquichicon, Carlos] Scientia Clin & Epidemiol Res Inst, Trujillo, Peru.
RP Rodriguez-Morales, AJ (corresponding author), Univ Tecnol Pereira, Publ Hlth & Infect Res Grp, Fac Hlth Sci, Pereira, Risaralda, Colombia.
EM arodriguezm@utp.edu.co
RI AJ, Rodriguez-Morales/R-9765-2016
OI AJ, Rodriguez-Morales/0000-0001-9773-2192; Culquichicon,
   Carlos/0000-0001-5349-3521
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [D43 TW007393]
CR de Carvalho NS, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12616
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Zambrano H, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12630
NR 5
TC 2
Z9 2
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1046-7408
EI 1600-0897
J9 AM J REPROD IMMUNOL
JI Am. J. Reprod. Immunol.
PD JUL
PY 2017
VL 78
IS 1
AR e12688
DI 10.1111/aji.12688
PG 1
WC Immunology; Reproductive Biology
SC Immunology; Reproductive Biology
GA EX6QO
UT WOS:000403367400009
PM 28397374
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Ho, CY
   Ames, HM
   Tipton, A
   Vezina, G
   Liu, JS
   Scafidi, J
   Torii, M
   Rodriguez, FJ
   du Plessis, A
   DeBiasi, RL
AF Ho, Cheng-Ying
   Ames, Heather M.
   Tipton, Ashley
   Vezina, Gilbert
   Liu, Judy S.
   Scafidi, Joseph
   Torii, Masaaki
   Rodriguez, Fausto J.
   du Plessis, Adre
   DeBiasi, Roberta L.
TI Differential Neuronal Susceptibility and Apoptosis in Congenital Zika
   Virus Infection
SO ANNALS OF NEUROLOGY
LA English
DT Article
ID ASTROCYTES; PATHOLOGY
AB To characterize the mechanism of Zika virus (ZIKV)-associated microcephaly, we performed immunolabeling on brain tissue from a 20-week fetus with intrauterine ZIKV infection. Although ZIKV demonstrated a wide range of neuronal and non-neuronal tropism, the infection rate was highest in intermediate progenitor cells and immature neurons. Apoptosis was observed in both infected and uninfected bystander cortical neurons, suggesting a role for paracrine factors in induction of neuronal apoptosis. Our results highlight differential neuronal susceptibility and neuronal apoptosis as potential mechanisms in the development of ZIKV-associated microcephaly, and may provide insights into the design and best timing of future therapy.
C1 [Ho, Cheng-Ying] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA.
   [Ho, Cheng-Ying; Tipton, Ashley] Childrens Natl Hlth Syst, Div Pathol, Washington, DC USA.
   [Ames, Heather M.; Rodriguez, Fausto J.] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA.
   [Vezina, Gilbert] Childrens Natl Hlth Syst, Dept Diagnost Radiol & Imaging, Washington, DC USA.
   [Liu, Judy S.; Scafidi, Joseph; Torii, Masaaki] Childrens Natl Hlth Syst, Ctr Neurosci Res, Washington, DC USA.
   [Torii, Masaaki; DeBiasi, Roberta L.] George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA.
   [Torii, Masaaki] George Washington Univ, Sch Med & Hlth Sci, Pharmacol & Physiol, Washington, DC 20052 USA.
   [du Plessis, Adre; DeBiasi, Roberta L.] Childrens Natl Hlth Syst, Fetal Med Inst, Washington, DC USA.
   [DeBiasi, Roberta L.] Childrens Natl Hlth Syst, Div Pediat Infect Dis, Washington, DC USA.
   [DeBiasi, Roberta L.] George Washington Univ, Sch Med & Hlth Sci, Microbiol Immunol & Trop Med, Washington, DC 20052 USA.
RP Ho, CY (corresponding author), Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA.
EM CHo@som.umaryland.edu
RI Ho, Cheng-Ying/AAA-5098-2019
OI Ames, Heather/0000-0002-5868-7672; Scafidi, Joseph/0000-0003-2379-1370
CR Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   DeBiasi RL, 2002, J INFECT DIS, V186, P1547, DOI 10.1086/345375
   Del Bigio MR, 2011, BRAIN, V134, P1344, DOI 10.1093/brain/awr052
   Donadieu E, 2013, VIRUSES-BASEL, V5, P2856, DOI 10.3390/v5112856
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Garg H, 2012, VIRUSES-BASEL, V4, P3020, DOI 10.3390/v4113020
   GIULIAN D, 1994, NEUROCHEM INT, V25, P227, DOI 10.1016/0197-0186(94)90066-3
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Palmer DR, 2005, J VIROL, V79, P2432, DOI 10.1128/JVI.79.4.2432-2439.2005
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
NR 24
TC 12
Z9 13
U1 1
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD JUL
PY 2017
VL 82
IS 1
BP 121
EP 127
DI 10.1002/ana.24968
PG 7
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FB5VT
UT WOS:000406211100012
PM 28556287
OA Green Published
DA 2020-07-08
ER

PT J
AU Shragai, T
   Tesla, B
   Murdock, C
   Harrington, LC
AF Shragai, Talya
   Tesla, Blanka
   Murdock, Courtney
   Harrington, Laura C.
TI Zika and chikungunya: mosquito-borne viruses in a changing world
SO ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
LA English
DT Review
DE mosquito; climate change; Aedes aegypti; Aedes albopictus; chikungunya;
   Zika
ID AEDES-ALBOPICTUS DIPTERA; HOST-FEEDING PATTERNS; CLIMATE-CHANGE;
   ANOPHELES-GAMBIAE; DENGUE VIRUS; MALARIA TRANSMISSION;
   GEOGRAPHIC-VARIATION; INTERSPECIFIC COMPETITION; SPATIAL-DISTRIBUTION;
   INVASIVE MOSQUITOS
AB The reemergence and growing burden of mosquito-borne virus infections have incited public fear and growing research efforts to understand the mechanisms of infection-associated health outcomes and to provide better approaches for mosquito vector control. While efforts to develop therapeutics, vaccines, and novel genetic mosquito-control technologies are underway, many important underlying ecological questions remain that could significantly enhance our understanding and ability to predict and prevent transmission. Here, we review the current knowledge about the transmission ecology of two recent arbovirus invaders, the chikungunya and Zika viruses. We introduce the viruses and mosquito vectors, highlighting viral biology, historical routes of transmission, and viral mechanisms facilitating rapid global invasion. In addition, we review factors contributing to vector global invasiveness and transmission efficiency. We conclude with a discussion of how human-induced biotic and abiotic environmental changes facilitate mosquito-borne virus transmission, emphasizing critical gaps in understanding. These knowledge gaps are tremendous; much of our data on basic mosquito ecology in the field predate 1960, and the mosquitoes themselves, as well as the world they live in, have substantially changed. A concerted investment in understanding the basic ecology of these vectors, which serve as the main drivers of pathogen transmission in both wildlife and human populations, is now more important than ever.
C1 [Shragai, Talya; Harrington, Laura C.] Cornell Univ, Dept Entomol, 3138 Comstock Hall, Ithaca, NY 14850 USA.
   [Tesla, Blanka; Murdock, Courtney] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA.
   [Tesla, Blanka; Murdock, Courtney] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.
RP Harrington, LC (corresponding author), Cornell Univ, Dept Entomol, 3138 Comstock Hall, Ithaca, NY 14850 USA.
EM lch27@cornell.edu
FU USDA National Institute of Food and Agriculture multistate Project
   [NYC-139835/NE-1443]; National Science Foundation (NSF)-EEID RAPID
   [1640780]
FX This research was funded in part by USDA National Institute of Food and
   Agriculture multistate Project NYC-139835/NE-1443. Any opinions,
   findings, conclusions, or recommendations expressed in this publication
   are those of the author(s) and do not necessarily reflect the view of
   the National Institute of Food and Agriculture (NIFA) or the United
   States Department of Agriculture (USDA). Support was also made possible
   in part by a National Science Foundation (NSF)-EEID RAPID grant
   (1640780). The content of this paper is solely the responsibility of the
   authors and does not necessarily represent the official views of the
   NSF. T.S., L.C.H., and C.C.M. conceptualized the ideas; T.S., B.T.,
   C.C.M., and L.C.H. wrote the manuscript. T.S. created the artwork for
   Figure 1.
CR Afrane YA, 2005, J MED ENTOMOL, V42, P974, DOI 10.1603/0022-2585(2005)042[0974:EOMCCB]2.0.CO;2
   Afrane YA, 2008, EMERG INFECT DIS, V14, P1533, DOI 10.3201/eid1410.070781
   Afrane YA, 2007, AM J TROP MED HYG, V77, P660, DOI 10.4269/ajtmh.2007.77.660
   Afrane YA, 2006, AM J TROP MED HYG, V74, P772, DOI 10.4269/ajtmh.2006.74.772
   Alout H, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0389
   Alout H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063849
   Alto BW, 2015, J MED ENTOMOL, V52, P163, DOI 10.1093/jme/tju062
   Alto BW, 2013, ECOL CONT VECTOR-BOR, V3, P81
   Alto BW, 2013, AM J TROP MED HYG, V88, P497, DOI 10.4269/ajtmh.12-0421
   Alto BW, 2001, J MED ENTOMOL, V38, P646, DOI 10.1603/0022-2585-38.5.646
   Angelini R, 2007, Euro Surveill, V12
   Ansell J, 2002, T ROY SOC TROP MED H, V96, P113, DOI 10.1016/S0035-9203(02)90271-3
   Armbruster P, 2006, ANN ENTOMOL SOC AM, V99, P1234, DOI 10.1603/0013-8746(2006)99[1234:GVOLGI]2.0.CO;2
   Bagny L, 2009, J MED ENTOMOL, V46, P198, DOI 10.1603/033.046.0204
   Bara J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126703
   Bargielowski IE, 2015, INFECT GENET EVOL, V36, P456, DOI 10.1016/j.meegid.2015.08.016
   Barker CM, 2003, J MED ENTOMOL, V40, P403, DOI 10.1603/0022-2585-40.4.403
   Beck-Johnson LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079276
   Beguin A, 2011, GLOBAL ENVIRON CHANG, V21, P1209, DOI 10.1016/j.gloenvcha.2011.06.001
   Beilhe LB, 2012, BIOL INVASIONS, V14, P1623, DOI 10.1007/s10530-012-0177-1
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bonds MH, 2010, P ROY SOC B-BIOL SCI, V277, P1185, DOI 10.1098/rspb.2009.1778
   Borgherini G, 2008, CLIN INFECT DIS, V47, P469, DOI 10.1086/590003
   Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785
   Brown L, 2014, PUBLIC HEALTH, V128, P29, DOI 10.1016/j.puhe.2013.09.006
   Carrasquilla MC, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0527
   Carvalho RG, 2014, MEM I OSWALDO CRUZ, V109, P787, DOI 10.1590/0074-0276140304
   CDC, 2016, ZIK VIR
   Centers for Disease Control, 2016, CHIK VIR US
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Charrel RN, 2014, CLIN MICROBIOL INFEC, V20, P662, DOI 10.1111/1469-0691.12694
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Christophers S., 1960, AEDES AEGYPTI L YELL
   Ciota AT, 2014, J MED ENTOMOL, V51, P55, DOI 10.1603/ME13003
   Colless D. H., 2016, NOTES CULICINE MOSQU
   Cristophers S. R., 1960, AEDES AEGYPTI L YELL
   David JP, 2003, MOL ECOL, V12, P1951, DOI 10.1046/j.1365-294X.2003.01870.x
   Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Eteng M., 2014, MALARIA J, V13, P1475
   Fader JE, 2016, J MED ENTOMOL, V53, P992, DOI 10.1093/jme/tjw095
   Faraji A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003037
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   FOCKS DA, 1994, J MED ENTOMOL, V31, P278, DOI 10.1093/jmedent/31.2.278
   Gething PW, 2010, NATURE, V465, P342, DOI 10.1038/nature09098
   Getis A, 2003, AM J TROP MED HYG, V69, P494, DOI 10.4269/ajtmh.2003.69.494
   Gomes AC, 2003, J VECTOR ECOL, V28, P74
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hanley KA, 2013, INFECT GENET EVOL, V19, P292, DOI 10.1016/j.meegid.2013.03.008
   Harrington LC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003048
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Harrington LC, 2001, J MED ENTOMOL, V38, P411, DOI 10.1603/0022-2585-38.3.411
   HAWLEY WA, 1989, J MED ENTOMOL, V26, P122, DOI 10.1093/jmedent/26.2.122
   Higa Y, 2010, J AM MOSQUITO CONTR, V26, P1, DOI 10.2987/09-5945.1
   Honorio NA, 2009, CAD SAUDE PUBLICA, V25, P1203, DOI 10.1590/S0102-311X2009000600003
   HORNBY JA, 1994, J AM MOSQUITO CONTR, V10, P397
   Hoshen MB, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-32
   Houngbedji CA, 2015, MALARIA J, V14, DOI 10.1186/1475-2875-14-7
   Johansson MA, 2010, AM J TROP MED HYG, V83, P183, DOI 10.4269/ajtmh.2010.09-0782
   Johnson LR, 2015, ECOLOGY, V96, P203, DOI 10.1890/13-1964.1
   Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x
   Juliano SA, 2004, OECOLOGIA, V139, P583, DOI 10.1007/s00442-004-1532-4
   Kamgang B, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-57
   Kek R, 2014, J MED ENTOMOL, V51, P880, DOI 10.1603/ME13213
   Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575
   Kilpatrick AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000092
   KNUDSEN AB, 1992, B WORLD HEALTH ORGAN, V70, P1
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kuo SC, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-44
   La Ruche G., 2010, B EPIDEMIOL HEBDO, V31-32, P325
   LaDeau SL, 2015, FUNCT ECOL, V29, P889, DOI 10.1111/1365-2435.12487
   LaDeau SL, 2013, INT J ENV RES PUB HE, V10, P1505, DOI 10.3390/ijerph10041505
   Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1
   Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lazzaro BP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000025
   Leahy Sister M. G., 1965, Mosquito News Albany NY, V25, P448
   Leisnham PT, 2008, J MED ENTOMOL, V45, P210, DOI 10.1603/0022-2585(2008)45[210:GVIASA]2.0.CO;2
   Leisnham PT, 2011, ANN ENTOMOL SOC AM, V104, P1309, DOI 10.1603/AN11032
   Lima A, 2016, AM J TROP MED HYG, V94, P231, DOI 10.4269/ajtmh.15-0351
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Lounibos LP, 2007, J AM MOSQUITO CONTR, V23, P276, DOI 10.2987/8756-971X(2007)23[276:CDAR]2.0.CO;2
   Lounibos LP, 2011, J AM MOSQUITO CONTR, V27, P433, DOI 10.2987/11-6164.1
   Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206
   LYIMO EO, 1992, ENTOMOL EXP APPL, V63, P265, DOI 10.1007/BF00192775
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Manda H, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-113
   Martens WJM, 1998, ENVIRON HEALTH PERSP, V106, P241, DOI 10.2307/3433924
   MCLEAN DM, 1974, CAN J MICROBIOL, V20, P255, DOI 10.1139/m74-040
   Medley KA, 2015, MOL ECOL, V24, P284, DOI 10.1111/mec.12925
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Mogi M, 1996, J MED ENTOMOL, V33, P53, DOI 10.1093/jmedent/33.1.53
   Mordecai EA, 2013, ECOL LETT, V16, P22, DOI 10.1111/ele.12015
   Munoz J, 2011, J MED ENTOMOL, V48, P956, DOI 10.1603/ME11016
   Murdock CC, 2012, P ROY SOC B-BIOL SCI, V279, P3357, DOI 10.1098/rspb.2012.0638
   Murdock CC, 2014, J INSECT PHYSIOL, V67, P37, DOI 10.1016/j.jinsphys.2014.05.020
   Murdock CC, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2030
   Murrell EG, 2008, J MED ENTOMOL, V45, P375, DOI 10.1603/0022-2585(2008)45[375:DTATOO]2.0.CO;2
   Musso D., 2014, EURO SURVEILL, V19
   NASCI RS, 1989, J AM MOSQUITO CONTR, V5, P416
   NIEBYLSKI ML, 1994, J AM MOSQUITO CONTR, V10, P447
   Nsoesie EO, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.20.30234
   O'Donnell D, 2009, ANN ENTOMOL SOC AM, V102, P1135, DOI 10.1603/008.102.0623
   Paaijmans KP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055777
   Paaijmans KP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-196
   Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106
   Padmanabha H, 2010, ECOHEALTH, V7, P78, DOI 10.1007/s10393-010-0301-6
   Padmanabha H, 2012, J INSECT PHYSIOL, V58, P1597, DOI 10.1016/j.jinsphys.2012.09.015
   Pan American Health Organization, 2016, TIM EM ZIK VIR AM
   Pan American Health Organization, 2016, CHIK STAT DAT
   Parham PE, 2010, ADV EXP MED BIOL, V673, P184
   Parham PE, 2010, ENVIRON HEALTH PERSP, V118, P620, DOI 10.1289/ehp.0901256
   Parham PE, 2015, PHILOS T R SOC LON B, V370
   Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103
   Paty MC, 2014, EUROSURVEILLANCE, V19, P10, DOI 10.2807/1560-7917.ES2014.19.28.20856
   Pincebourde S, 2016, INTEGR COMP BIOL, V56, P45, DOI 10.1093/icb/icw016
   Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0
   Pumpuni C. B., 1989, FACTORS INFLUENCING
   Ravi V, 2006, Indian J Med Microbiol, V24, P83
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Richards SL, 2006, J MED ENTOMOL, V43, P543, DOI 10.1603/0022-2585(2006)43[543:HPOAAD]2.0.CO;2
   Richter-Boix A, 2013, MOL ECOL, V22, P1322, DOI 10.1111/mec.12181
   Rivero A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001000
   Robin S, 2008, J CHILD NEUROL, V23, P1028, DOI 10.1177/0883073808314151
   Rodo X, 2013, CLIMATIC CHANGE, V118, P625, DOI 10.1007/s10584-013-0744-1
   Rohr JR, 2011, TRENDS ECOL EVOL, V26, P270, DOI 10.1016/j.tree.2011.03.002
   ROSS R. W., 1956, JOUR HYG, V54, P177
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   SAVAGE HM, 1993, J MED ENTOMOL, V30, P27, DOI 10.1093/jmedent/30.1.27
   Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368
   SCOTT TW, 1993, J MED ENTOMOL, V30, P94, DOI 10.1093/jmedent/30.1.94
   Siraj AS, 2014, SCIENCE, V343, P1154, DOI 10.1126/science.1244325
   Sivan A, 2015, PARASITOL RES, V114, P3539, DOI 10.1007/s00436-015-4634-5
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   SOTA T, 1992, OECOLOGIA, V90, P353, DOI 10.1007/BF00317691
   Sourisseau M, 2007, PLOS PATHOG, V3, P804, DOI 10.1371/journal.ppat.0030089
   Stacey DA, 2003, PHYSIOL ENTOMOL, V28, P75, DOI 10.1046/j.1365-3032.2003.00309.x
   Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481
   SULLIVAN MF, 1971, J MED ENTOMOL, V8, P713, DOI 10.1093/jmedent/8.6.713
   Tabachnick WJ, 2010, J EXP BIOL, V213, P946, DOI 10.1242/jeb.037564
   TABACHNICK WJ, 1991, J MED ENTOMOL, V28, P287, DOI 10.1093/jmedent/28.3.297
   Traore L, 2006, ANN ENTOMOL SOC AM, V99, P1121, DOI 10.1603/0013-8746(2006)99[1121:AOTDPO]2.0.CO;2
   Tripet F, 2011, AM J TROP MED HYG, V85, P265, DOI 10.4269/ajtmh.2011.10-0677
   Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412
   Tsuda Y, 2006, J AM MOSQUITO CONTR, V22, P222, DOI 10.2987/8756-971X(2006)22[222:DSDOAA]2.0.CO;2
   Urbanski J, 2012, AM NAT, V179, P490, DOI 10.1086/664709
   Vale PF, 2008, J EVOLUTION BIOL, V21, P1418, DOI 10.1111/j.1420-9101.2008.01555.x
   Valerio L, 2010, VECTOR-BORNE ZOONOT, V10, P291, DOI 10.1089/vbz.2009.0007
   Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595
   Vega-Rua A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003780
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   Weaver SC, 2012, EXPERT REV VACCINES, V11, P1087, DOI [10.1586/erv.12.84, 10.1586/ERV.12.84]
   Wong ML, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004135
   World Health Organization, 2016, WHO STAT 1 M INT HLT
   World Health Organization Global Health Observatory, 2014, URB POP GROWTH 2014
   Yang HM, 2009, EPIDEMIOL INFECT, V137, P1179, DOI 10.1017/S0950268809002052
   Yoon IK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001730
   Zouache K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1078
NR 166
TC 33
Z9 34
U1 4
U2 60
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0077-8923
EI 1749-6632
J9 ANN NY ACAD SCI
JI Ann. N.Y. Acad. Sci.
PD JUL
PY 2017
VL 1399
IS 1
SI SI
BP 61
EP 77
DI 10.1111/nyas.13306
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FC4TA
UT WOS:000406832400004
PM 28187236
OA Other Gold
DA 2020-07-08
ER

PT J
AU Tan, CW
   Sam, IC
   Chong, WL
   Lee, VS
   Chan, YF
AF Tan, Chee Wah
   Sam, I-Ching
   Chong, Wei Lim
   Lee, Vannajan Sanghiran
   Chan, Yoke Fun
TI Polysulfonate suramin inhibits Zika virus infection
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Zika virus; Suramin; Heparan sulfate; Heparin; Antiviral
ID SURFACE HEPARAN-SULFATE; JAPANESE ENCEPHALITIS-VIRUS;
   AMINO-ACID-RESIDUES; ENVELOPE PROTEIN; DENGUE VIRUS; SINDBIS VIRUS; NS3
   HELICASE; BINDING; IDENTIFICATION; ATTACHMENT
AB Zika virus (ZIKV) is an arthropod-borne flavivirus that causes newborn microcephaly and Guillian-Barre syndrome in adults. No therapeutics are available to treat ZIKV infection or other flaviviruses. In this study, we explored the inhibitory effect of glycosaminoglycans and analogues against ZIKV infection. Highly sulfated heparin, dextran sulfate and suramin significantly inhibited ZIKV infection in Vero cells. De-sulfated heparin analogues lose inhibitory effect, implying that sulfonate groups are critical for viral inhibition. Suramin, an FDA-approved anti-parasitic drug, inhibits ZIKV infection with 3-5 log(10) PFU viral reduction with IC50 value of similar to 2.5-5 mu/ml (1.93 mu M-3.85 mu M). A time-of-drug-addition study revealed that suramin remains potent even when administrated at 1-24 hpi. Suramin inhibits ZIKV infection by preventing viral adsorption, entry and replication. Molecular dynamics simulation revealed stronger interaction of suramin with ZIKV NS3 helicase than with the envelope protein. Suramin warrants further investigation as a potential antiviral candidate for ZIKV infection. Heparan sulfate (HS) is a cellular attachment receptor for multiple flaviviruses. However, no direct ZIKV-heparin interaction was observed in heparin-binding analysis, and downregulate or removal of cellular HS with sodium chlorate or heparinase did not inhibit ZIKV infection. This indicates that cell surface HS is not utilized by ZIKV as an attachment receptor. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Tan, Chee Wah; Sam, I-Ching; Chan, Yoke Fun] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur 50603, Malaysia.
   [Chong, Wei Lim; Lee, Vannajan Sanghiran] Univ Malaya, Fac Sci, Dept Chem, Ctr Theoret & Computat Phys, Kuala Lumpur 50603, Malaysia.
RP Tan, CW (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur 50603, Malaysia.
EM tancw86@gmail.com
RI Sam, Jamal I-Ching/B-8688-2010; Chan, Yoke Fun/B-5351-2010; Lahuddin,
   Haslinda/S-1588-2017; Lee, Vannajan Sanghiran/E-9869-2011
OI Sam, Jamal I-Ching/0000-0002-1296-7898; Chan, Yoke
   Fun/0000-0001-7089-0510; Lee, Vannajan Sanghiran/0000-0002-2911-7726
FU University of MalayaUniversiti Malaya [BK046-2015, RP020C-14AFR];
   European Union's Horizon research and innovation program [653316]
FX This work was supported by University of Malaya Research Fund Assistance
   (BK046-2015) and University of Malaya Research Grant (RP020C-14AFR). The
   ZIKV strain MRS_OPY_Martinique_PaRi_2015 was provided by the European
   Virus Archive goes Global (EVAg) project that has received funding from
   the European Union's Horizon 2020 research and innovation program under
   grant agreement No 653316.
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Balasubramanian A, 2017, ANTIVIR RES, V137, P141, DOI 10.1016/j.antiviral.2016.11.015
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Basavannacharya C, 2014, BIOCHEM BIOPH RES CO, V453, P539, DOI 10.1016/j.bbrc.2014.09.113
   BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004
   Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287
   Brynes AP, 1998, J VIROL, V72, P7349, DOI 10.1128/JVI.72.9.7349-7356.1998
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Case D.A., 2010, AMBER 11
   Chen HL, 2010, BIOPOLYMERS, V94, P331, DOI 10.1002/bip.21371
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Chien YJ, 2008, VIROLOGY, V379, P143, DOI 10.1016/j.virol.2008.06.017
   Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004
   Croci R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091765
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Daelemans D, 2011, NAT PROTOC, V6, P925, DOI 10.1038/nprot.2011.330
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Ellenbecker M, 2014, ANTIMICROB AGENTS CH, V58, P7405, DOI 10.1128/AAC.03595-14
   Fang JE, 2016, SCI REP-UK, V6, DOI 10.1038/srep34550
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Ferguson MC, 2015, J VIROL, V89, P7536, DOI 10.1128/JVI.03645-14
   Germi R, 2002, VIROLOGY, V292, P162, DOI 10.1006/viro.2001.1232
   Ghezzi S, 2017, ANTIVIR RES, V140, P13, DOI 10.1016/j.antiviral.2016.12.023
   Giroglou T, 2001, J VIROL, V75, P1565, DOI 10.1128/JVI.75.3.1565-1570.2001
   Grossman, 1998, Cancer Control, V5, P107
   Guibinga GH, 2002, MOL THER, V5, P538, DOI 10.1006/mthe.2002.0578
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hilgard P, 2000, HEPATOLOGY, V32, P1069, DOI 10.1053/jhep.2000.18713
   Hu QY, 2011, J VIROL, V85, P7108, DOI 10.1128/JVI.00573-11
   KHAW M, 1995, CLIN MICROBIOL REV, V8, P427, DOI 10.1128/CMR.8.3.427
   Kim SY, 2017, BIOCHEMISTRY-US, V56, P1151, DOI 10.1021/acs.biochem.6b01056
   Klimstra WB, 1998, J VIROL, V72, P7357, DOI 10.1128/JVI.72.9.7357-7366.1998
   Knappe M, 2007, J BIOL CHEM, V282, P27913, DOI 10.1074/jbc.M705127200
   Kozakov D, 2015, NAT PROTOC, V10, P733, DOI 10.1038/nprot.2015.043
   Kozlovskaya LI, 2010, VIROLOGY, V398, P262, DOI 10.1016/j.virol.2009.12.012
   Lam ET, 2010, CANCER CHEMOTH PHARM, V66, P1019, DOI 10.1007/s00280-010-1252-x
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Leal MC, 2016, BRAZ J OTORHINOLARYN
   Lee E, 2006, ANTIVIR RES, V69, P31, DOI 10.1016/j.antiviral.2005.08.006
   Lee E, 2008, J VIROL, V82, P6024, DOI 10.1128/JVI.02509-07
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Lortat-Jacob H, 2002, P NATL ACAD SCI USA, V99, P1229, DOI 10.1073/pnas.032497699
   Mandl CW, 2001, J VIROL, V75, P5627, DOI 10.1128/JVI.75.12.5627-5637.2001
   Mastrangelo E, 2014, CHEMMEDCHEM, V9, P933, DOI 10.1002/cmdc.201300563
   Mastrangelo E, 2012, J MOL BIOL, V419, P198, DOI 10.1016/j.jmb.2012.03.008
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   MOMANY FA, 1992, J COMPUT CHEM, V13, P888, DOI 10.1002/jcc.540130714
   Mukherjee S, 2012, NUCLEIC ACIDS RES, V40, P8607, DOI 10.1093/nar/gks623
   Nishimura Y, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005184
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Raman K, 2013, MOL PHARMACEUT, V10, P1442, DOI 10.1021/mp300679a
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ren PJ, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.60
   RODERIQUEZ G, 1995, J VIROL, V69, P2233, DOI 10.1128/JVI.69.4.2233-2239.1995
   Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p
   Ryman KD, 2004, VIROLOGY, V322, P1, DOI 10.1016/j.virol.2004.01.003
   Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952
   SCHER HI, 1992, CANCER RES, V52, P64
   Silva LA, 2014, J VIROL, V88, P2385, DOI 10.1128/JVI.03116-13
   Sweeney NL, 2015, ACS INFECT DIS, V1, P140, DOI 10.1021/id5000458
   Tan CW, 2017, VIROLOGY, V501, P79, DOI 10.1016/j.virol.2016.11.009
   Tan CW, 2013, J VIROL, V87, P611, DOI 10.1128/JVI.02226-12
   Wang Y, 2016, MBIO, V7, DOI 10.1128/mBio.00119-16
   YURA Y, 1992, J INVEST DERMATOL, V98, P494, DOI 10.1111/1523-1747.ep12499867
NR 72
TC 32
Z9 32
U1 1
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD JUL
PY 2017
VL 143
BP 186
EP 194
DI 10.1016/j.antiviral.2017.04.017
PG 9
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA EX0YQ
UT WOS:000402947100020
PM 28457855
DA 2020-07-08
ER

PT J
AU Shiryaev, SA
   Farhy, C
   Pinto, A
   Huang, CT
   Simonetti, N
   Ngono, AE
   Dewing, A
   Shresta, S
   Pinkerton, AB
   Cieplak, P
   Strongin, AY
   Terskikh, AV
AF Shiryaev, Sergey A.
   Farhy, Chen
   Pinto, Antonella
   Huang, Chun-Teng
   Simonetti, Nicole
   Ngono, Annie Elong
   Dewing, Antimone
   Shresta, Sujan
   Pinkerton, Anthony B.
   Cieplak, Piotr
   Strongin, Alex Y.
   Terskikh, Alexey V.
TI Characterization of the Zika virus two-component NS2B-NS3 protease and
   structure-assisted identification of allosteric small-molecule
   antagonists
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Zika virus; Protease; NS3; NS2B; Inhibitors; Flavivirus
ID WEST-NILE-VIRUS; NS2B/NS3 SERINE-PROTEASE; ADULT-MOUSE BRAIN; NS3
   PROTEASES; SOX2; PROTEINASE; ACTIVATION; INHIBITORS; CLEAVAGE; DENGUE
AB The recent re-emergence of Zilca virus (ZIKV)(1), a member of the Flaviviridae family, has become a global emergency. Currently, there are no effective methods of preventing or treating ZIKV infection, which causes severe neuroimmunopathology and is particularly harmful to the developing fetuses of infected pregnant women. However, the pathology induced by ZIKV is unique among flaviviruses, and knowledge of the biology of other family members cannot easily be extrapolated to ZIKV. Thus, structure-function studies of ZIKV proteins are urgently needed to facilitate the development of effective preventative and therapeutic agents. Like other flaviviruses, ZIKV expresses an NS2B-NS3 protease, which consists of the NS2B cofactor and the NS3 protease domain and is essential for cleavage of the ZIKV polyprotein precursor and generation of fully functional viral proteins. Here, we report the enzymatic characterization of ZIKV protease, and we identify structural scaffolds for allosteric small-molecule inhibitors of this protease. Molecular modeling of the protease-inhibitor complexes suggests that these compounds bind to the druggable cavity in the NS2B-NS3 protease interface and affect productive interactions of the protease domain with its cofactor. The most potent compound demonstrated efficient inhibition of ZIKV propagation in vitro in human fetal neural progenitor cells and in vivo in SJL mice. The inhibitory scaffolds could be further developed into valuable research reagents and, ultimately, provide a roadmap for the selection of efficient inhibitors of ZIKV infection. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Shiryaev, Sergey A.; Farhy, Chen; Pinto, Antonella; Huang, Chun-Teng; Simonetti, Nicole; Dewing, Antimone; Pinkerton, Anthony B.; Cieplak, Piotr; Strongin, Alex Y.; Terskikh, Alexey V.] Sanford Burnham Prebys Med Discovery Inst, Ctr Neurosci Aging & Stem Cell Res, La Jolla, CA 92037 USA.
   [Ngono, Annie Elong; Shresta, Sujan] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA.
RP Strongin, AY; Terskikh, AV (corresponding author), 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.
EM strongin@sbpdiscovery.org; terskikh@sbpdiscovery.org
RI Terskikh, Alexey/U-8407-2019; Strongin, Alex/R-6609-2019; amsalu,
   ribka/G-8780-2019
OI Strongin, Alex/0000-0003-3765-3016; Huang, Chun-Teng/0000-0003-3737-7875
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R21NS100477,
   R01GM107523]
FX The work was supported, in whole or in part, by National Institutes of
   Health Grants R21NS100477 (to A.Y.S. and A.V.T.) and R01GM107523 (to
   P.C.).
CR Aleshin AE, 2007, PROTEIN SCI, V16, P795, DOI 10.1110/ps.072753207
   Amador-Arjona A, 2015, P NATL ACAD SCI USA, V112, pE1936, DOI 10.1073/pnas.1421480112
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cavallaro M, 2008, DEVELOPMENT, V135, P541, DOI 10.1242/dev.010801
   Chambers TJ, 2005, J GEN VIROL, V86, P1403, DOI 10.1099/vir.0.80427-0
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   Cimadamore F, 2011, CELL STEM CELL, V8, P538, DOI 10.1016/j.stem.2011.03.011
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   FALGOUT B, 1993, J VIROL, V67, P2034, DOI 10.1128/JVI.67.4.2034-2042.1993
   Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204
   Gawlik K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005031
   Grosdidier A, 2011, J COMPUT CHEM, V32, P2149, DOI 10.1002/jcc.21797
   Hagstrom SA, 2005, AM J MED GENET A, V138A, P95, DOI 10.1002/ajmg.a.30803
   Johnston PA, 2007, ASSAY DRUG DEV TECHN, V5, P737, DOI 10.1089/adt.2007.101
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Shiryaev SA, 2006, BIOCHEM J, V393, P503, DOI 10.1042/BJ20051374
   Shiryaev SA, 2007, PROTEIN EXPRES PURIF, V52, P334, DOI 10.1016/j.pep.2006.11.009
   Shiryaev SA, 2011, ASSAY DRUG DEV TECHN, V9, P69, DOI 10.1089/adt.2010.0309
   Shiryaev SA, 2010, FUTURE VIROL, V5, P593, DOI 10.2217/FVL.10.39
   Sidique S, 2009, BIOORG MED CHEM LETT, V19, P5773, DOI 10.1016/j.bmcl.2009.07.150
   Sironi M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004978
   Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934
   Yusof R, 2000, J BIOL CHEM, V275, P9963, DOI 10.1074/jbc.275.14.9963
NR 34
TC 47
Z9 48
U1 2
U2 33
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD JUL
PY 2017
VL 143
BP 218
EP 229
DI 10.1016/j.antiviral.2017.04.015
PG 12
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA EX0YQ
UT WOS:000402947100023
PM 28461069
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Albulescu, IC
   Kovacikova, K
   Tas, A
   Snijder, EJ
   van Hemert, MJ
AF Albulescu, Irina C.
   Kovacikova, Kristina
   Tas, Ali
   Snijder, Eric J.
   van Hemert, Martijn J.
TI Suramin inhibits Zika virus replication by interfering with virus
   attachment and release of infectious particles
SO ANTIVIRAL RESEARCH
LA English
DT Article
ID POTENT INHIBITOR; ENVELOPE PROTEIN; ENDOTHELIAL-CELLS; DENGUE VIRUS;
   CHIKUNGUNYA; DRUG; BINDING; SCREEN; ENTRY; IDENTIFICATION
AB Zika virus (ZIKV) is a mosquito-borne flavivirus that mostly causes asymptomatic infections or mild disease characterized by low-grade fever, rash, conjunctivitis, and malaise. However, the recent massive ZIKV epidemics in the Americas have also linked ZIKV infection to fetal malformations like microcephaly and Guillain-Barre syndrome in adults, and have uncovered previously unrecognized routes of vertical and sexual transmission. Here we describe inhibition of ZIKV replication by suramin, originally an anti parasitic drug, which was more recently shown to inhibit multiple viruses. In cell culture-based assays, using reduction of cytopathic effect as read-out, suramin had an EC50 of similar to 40 mu M and a selectivity index of 48. In single replication cycle experiments, suramin treatment also caused a strong dose-dependent decrease in intracellular ZIKV RNA levels and a >3-log reduction in infectious progeny titers. Time-of addition experiments revealed that suramin inhibits a very early step of the replication cycle as well as the release of infectious progeny. Only during the first 2 h of infection suramin treatment strongly reduced the fraction of cells that became infected with ZIKV, suggesting the drug affects virus binding/entry. Binding experiments at 4 degrees C using S-35-labeled ZIKV demonstrated that suramin interferes with attachment to host cells. When suramin treatment was initiated post-entry, viral RNA synthesis was unaffected, while both the release of genomes and the infectivity of ZIKV were reduced. This suggests the compound also affects virion biogenesis, possibly by interfering with glycosylation and the maturation of ZIKV during its traffic through the secretory pathway. The inhibitory effect of suramin on ZIKV attachment and virion biogenesis and its broad-spectrum activity warrant further evaluation of this compound as a potential therapeutic. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Albulescu, Irina C.; Kovacikova, Kristina; Tas, Ali; Snijder, Eric J.; van Hemert, Martijn J.] Leiden Univ, Med Ctr, Dept Med Microbiol, Mol Virol Lab, Leiden, Netherlands.
RP van Hemert, MJ (corresponding author), Leiden Univ, Med Ctr, Dept Med Microbiol, POB 9600, NL-2300 RC Leiden, Netherlands.
EM M.J.van_Hemert@lumc.nl
RI Snijder, Eric J./E-6073-2018
OI Snijder, Eric J./0000-0003-3297-2309; van Hemert,
   Martijn/0000-0002-2617-9243
FU European Union's Horizon Research and Innovation Programme under
   ZIKAlliance Grant [734548]; European Union's Horizon Research and
   Innovation Programme under the Marie Skio-dowska-Curie ETN 'ANTIVIRALS'
   Grant [642434]
FX This work was supported by the European Union's Horizon 2020 Research
   and Innovation Programme under ZIKAlliance Grant Agreement no. 734548
   (MJvH, AT, ICA) and under the Marie Skio-dowska-Curie ETN 'ANTIVIRALS'
   Grant Agreement no. 642434 (KK). Funding sources were not involved in
   study design, data collection, analysis and interpretation, writing of
   the report and the decision to submit the manuscript for publication.
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Albulescu IC, 2015, ANTIVIR RES, V121, P39, DOI 10.1016/j.antiviral.2015.06.013
   Baghdiguian S, 1996, EUR J CANCER, V32A, P525, DOI 10.1016/0959-8049(95)00588-9
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Basavannacharya C, 2014, BIOCHEM BIOPH RES CO, V453, P539, DOI 10.1016/j.bbrc.2014.09.113
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   CHANDRA P, 1985, CANCER RES, V45, P4677
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Cheng FX, 2016, TRENDS MOL MED, V22, P919, DOI 10.1016/j.molmed.2016.09.006
   COFFEY RJ, 1987, J CELL PHYSIOL, V132, P143, DOI 10.1002/jcp.1041320120
   Dallmeier K, 2016, CELL HOST MICROBE, V20, P420, DOI 10.1016/j.chom.2016.09.011
   DECLERCQ E, 1979, CANCER LETT, V8, P9, DOI 10.1016/0304-3835(79)90017-X
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Garcia-Blanco MA, 2016, ANTIVIR RES, V134, P244, DOI 10.1016/j.antiviral.2016.09.010
   Henss L, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0607-2
   Ho YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133511
   Kim SY, 2017, BIOCHEMISTRY-US, V56, P1151, DOI 10.1021/acs.biochem.6b01056
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kuo SC, 2016, ANTIVIR RES, V134, P89, DOI 10.1016/j.antiviral.2016.07.025
   Li J, 2006, J GEN VIROL, V87, P613, DOI 10.1099/vir.0.81320-0
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Mastrangelo E, 2012, J MOL BIOL, V419, P198, DOI 10.1016/j.jmb.2012.03.008
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mossenta M, 2017, BIOCH BIOPHYS RES CO
   Mukherjee S, 2012, NUCLEIC ACIDS RES, V40, P8607, DOI 10.1093/nar/gks623
   Nishimura Y, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005184
   Ren PJ, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.60
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Scholte FEM, 2015, J VIROL, V89, P4457, DOI 10.1128/JVI.03612-14
   Scholte FEM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071047
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tarantino D, 2014, ANTIVIR RES, V102, P23, DOI 10.1016/j.antiviral.2013.11.016
   Van Boheemen S, 2017, SCI REP IN PRESS
   Waltenberger J, 1996, J MOL CELL CARDIOL, V28, P1523, DOI 10.1006/jmcc.1996.0142
   Wu ZSA, 2016, BIOCHEM BIOPH RES CO, V477, P861, DOI 10.1016/j.bbrc.2016.06.149
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
NR 37
TC 36
Z9 37
U1 1
U2 22
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD JUL
PY 2017
VL 143
BP 230
EP 236
DI 10.1016/j.antiviral.2017.04.016
PG 7
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA EX0YQ
UT WOS:000402947100024
PM 28461070
DA 2020-07-08
ER

PT J
AU Langsjoen, RM
   Auguste, AJ
   Rossi, SL
   Roundy, CM
   Penate, HN
   Kastis, M
   Schnizlein, MK
   Le, KC
   Haller, SL
   Chen, RB
   Watowich, SJ
   Weaver, SC
AF Langsjoen, Rose M.
   Auguste, Albert J.
   Rossi, Shannan L.
   Roundy, Christopher M.
   Penate, Heidy N.
   Kastis, Maria
   Schnizlein, Matthew K.
   Le, Kevin C.
   Haller, Sherry L.
   Chen, Rubing
   Watowich, Stanley J.
   Weaver, Scott C.
TI Host oxidative folding pathways offer novel anti-chikungunya virus drug
   targets with broad spectrum potential
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Alphavirus; Chikungunya virus; Protein folding; Protein disulfide
   isomerase; Thioredoxin reductase; Auranofin
ID PROTEIN DISULFIDE-ISOMERASE; CONSERVED CYSTEINES; GLYCOPROTEIN;
   AURANOFIN; ARTHRITIS; BONDS; GOLD; MATURATION; SUSPENSION; INHIBITOR
AB Alphaviruses require conserved cysteine residues for proper folding and assembly of the El and E2 envelope glycoproteins, and likely depend on host protein disulfide isomerase-family enzymes (PDI) to aid in facilitating disulfide bond formation and isomerization in these proteins. Here, we show that in human HEK293 cells, commercially available inhibitors of PDI or modulators thereof (thioredoxin reductase, TRX-R; endoplasmic reticulum oxidoreductin-1, ERO-1) inhibit the replication of CHIKV chikungunya virus (CHIKV) in vitro in a dose-dependent manner. Further, the TRX-R inhibitor auranofin inhibited Venezuelan equine encephalitis virus and the flavivirus Zika virus replication in vitro, while PDI inhibitor 16F16 reduced replication but demonstrated notable toxicity. 16F16 significantly altered the viral genome: plaque-forming unit (PFU) ratio of CHIKV in vitro without affecting relative intracellular viral RNA quantities and inhibited CHIKV El-induced cell-cell fusion, suggesting that PDI inhibitors alter progeny virion infectivity through altered envelope function. Auranofin also increased the extracellular genome:PFU ratio but decreased the amount of intracellular CHIKV RNA, suggesting an alternative mechanism of action. Finally, auranofin reduced footpad swelling and viremia in the C57BL/6 murine model of CHIKV infection. Our results suggest that targeting oxidative folding pathways represents a potential new anti-alphavirus therapeutic strategy. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Langsjoen, Rose M.; Roundy, Christopher M.; Weaver, Scott C.] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA.
   [Langsjoen, Rose M.; Auguste, Albert J.; Rossi, Shannan L.; Roundy, Christopher M.; Haller, Sherry L.; Chen, Rubing; Watowich, Stanley J.; Weaver, Scott C.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Auguste, Albert J.; Rossi, Shannan L.; Penate, Heidy N.; Schnizlein, Matthew K.; Le, Kevin C.; Haller, Sherry L.; Chen, Rubing; Weaver, Scott C.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Penate, Heidy N.; Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Kastis, Maria; Watowich, Stanley J.] Univ Texas Med Branch, Ctr Environm Toxicol, Galveston, TX 77555 USA.
RP Weaver, SC (corresponding author), Univ Texas Med Branch, Galveston Natl Lab, 6 200D 301 Univ Blvd, Galveston, TX 77555 USA.
EM sweaver@utmb.edu
RI Weaver, Scott C/D-6490-2011
OI Weaver, Scott C/0000-0001-8016-8556; Langsjoen,
   Rose/0000-0001-9008-425X; Le, Kevin-Phu/0000-0001-5098-7737; Auguste,
   Albert/0000-0001-9048-0041; Haller, Sherry L./0000-0002-4340-721X
FU Institute for Human Infections and Immunity, University of Texas Medical
   Branch, Galveston, TX; Graduate School of Biomedical Sciences,
   University of Texas Medical Branch, Galveston, TX; McLaughlin Endowment,
   University of Texas Medical Branch, Galveston, TX; National Institutes
   of HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI120942, TR001439, ES0066761]
FX this work was funded by the Institute for Human Infections and Immunity,
   University of Texas Medical Branch, Galveston, TX; the Graduate School
   of Biomedical Sciences, University of Texas Medical Branch, Galveston,
   TX; the McLaughlin Endowment, University of Texas Medical Branch,
   Galveston, TX; and the National Institutes of Health [grant numbers
   AI120942, TR001439, ES0066761.
CR Anishchenko M, 2004, J VIROL, V78, P1, DOI 10.1128/JVI.78.1.1-8.2004
   ANTHONY RP, 1992, VIROLOGY, V190, P330, DOI 10.1016/0042-6822(92)91219-K
   Benham AM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0403
   Blais JD, 2010, J BIOL CHEM, V285, P20993, DOI 10.1074/jbc.M110.126599
   Carleton M, 1997, J VIROL, V71, P1558, DOI 10.1128/JVI.71.2.1558-1566.1997
   Chirullo B, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.473
   Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311
   Erasmus JH, 2017, NAT MED, V23, P192, DOI 10.1038/nm.4253
   FURST DE, 1983, PHARMACOTHERAPY, V3, P284
   Gardner J, 2010, J VIROL, V84, P8021, DOI 10.1128/JVI.02603-09
   Geller R, 2007, GENE DEV, V21, P195, DOI 10.1101/gad.1505307
   Hoffstrom BG, 2010, NAT CHEM BIOL, V6, P900, DOI 10.1038/NCHEMBIO.467
   KALUZA G, 1980, VIROLOGY, V102, P300, DOI 10.1016/0042-6822(80)90097-5
   Lewis MG, 2011, AIDS, V25, P1347, DOI 10.1097/QAD.0b013e328347bd77
   Liao MF, 2006, J VIROL, V80, P11362, DOI 10.1128/JVI.01679-06
   LUNDSTROM J, 1990, J BIOL CHEM, V265, P9114
   MULVEY M, 1994, J VIROL, V68, P805, DOI 10.1128/JVI.68.2.805-812.1994
   Parrott MM, 2009, J VIROL, V83, P2584, DOI 10.1128/JVI.02158-08
   Phinney BS, 2000, J VIROL, V74, P9313, DOI 10.1128/JVI.74.19.9313-9316.2000
   Seymour RL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003800
   Shapiro DL, 1996, J RHEUMATOL, V23, P1818
   Shytaj IL, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-71
   Snyder AJ, 2012, J VIROL, V86, P3100, DOI 10.1128/JVI.06615-11
   Tejman-Yarden N, 2013, ANTIMICROB AGENTS CH, V57, P2029, DOI 10.1128/AAC.01675-12
   Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412
   Tsetsarkin KA, 2011, P NATL ACAD SCI USA, V108, P7872, DOI 10.1073/pnas.1018344108
   Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555
   Xu SL, 2012, P NATL ACAD SCI USA, V109, P16348, DOI 10.1073/pnas.1205226109
NR 28
TC 8
Z9 8
U1 1
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD JUL
PY 2017
VL 143
BP 246
EP 251
DI 10.1016/j.antiviral.2017.04.014
PG 6
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA EX0YQ
UT WOS:000402947100026
PM 28461071
DA 2020-07-08
ER

PT J
AU Singh, NK
   Tyagi, A
AF Singh, Niraj K.
   Tyagi, Anuj
TI A detailed analysis of codon usage patterns and influencing factors in
   Zika virus
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID NUCLEOTIDE COMPOSITION; BIAS; ADAPTATION; EVOLUTION; GENOMES; GENES
AB Recent outbreaks of Zika virus (ZIKV) in Africa, Latin America, Europe, and Southeast Asia have resulted in serious health concerns. To understand more about evolution and transmission of ZIKV, detailed codon usage analysis was performed for all available strains. A high effective number of codons (ENC) value indicated the presence of low codon usage bias in ZIKV. The effect of mutational pressure on codon usage bias was confirmed by significant correlations between nucleotide compositions at third codon positions and ENCs. Correlation analysis between Gravy values, Aroma values and nucleotide compositions at third codon positions also indicated some influence of natural selection. However, the low codon adaptation index (CAI) value of ZIKV with reference to human and mosquito indicated poor adaptation of ZIKV codon usage towards its hosts, signifying that natural selection has a weaker influence than mutational pressure. Additionally, relative dinucleotide frequencies, geographical distribution, and evolutionary processes also influenced the codon usage pattern to some extent.
C1 [Singh, Niraj K.] Guru Angad Dev Vet & Anim Sci Univ, Sch Anim Biotechnol, Ludhiana 141004, Punjab, India.
   [Tyagi, Anuj] Guru Angad Dev Vet & Anim Sci Univ, Coll Fisheries, Ludhiana 141004, Punjab, India.
RP Singh, NK (corresponding author), Guru Angad Dev Vet & Anim Sci Univ, Sch Anim Biotechnol, Ludhiana 141004, Punjab, India.
EM nirajvet57@gmail.com
OI Tyagi, Anuj/0000-0002-4818-0827
CR Ahn I, 2012, VIRUS GENES, V44, P198, DOI 10.1007/s11262-011-0687-4
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Belalov IS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056642
   Butt AM, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.106
   Butt AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090905
   Chen Y, 2014, INFECT GENET EVOL, V28, P95, DOI 10.1016/j.meegid.2014.09.004
   Cristina J, 2016, VIRUS RES, V223, P147, DOI 10.1016/j.virusres.2016.06.022
   Cristina J, 2015, VIRUS RES, V196, P87, DOI 10.1016/j.virusres.2014.11.005
   Dorn A, 2008, CURR OPIN MOL THER, V10, P10
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Freire C. C. d, 2015, BIORXIV, DOI [10.1101/032839, DOI 10.1101/032839]
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Greenacre M.J., 1984, THEORY APPL CORRES A
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hu JS, 2011, INFECT GENET EVOL, V11, P2098, DOI 10.1016/j.meegid.2011.08.025
   Jenkins GM, 2003, VIRUS RES, V92, P1, DOI 10.1016/S0168-1702(02)00309-X
   Lara-Ramirez EE, 2014, BIOMED RES INT, DOI 10.1155/2014/851425
   Levin DB, 2000, J GEN VIROL, V81, P2313, DOI 10.1099/0022-1317-81-9-2313
   LOBRY JR, 1994, NUCLEIC ACIDS RES, V22, P3174, DOI 10.1093/nar/22.15.3174
   Lucey DR, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i781
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   MARIN A, 1989, NUCLEIC ACIDS RES, V17, P6181
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   PEDEN JF, 1999, ANAL CODON USAGE
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Puigbo P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-65
   Puigbo P, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-38
   Qin H, 2004, GENETICS, V168, P2245, DOI 10.1534/genetics.104.030866
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   SHARP PM, 1986, J MOL EVOL, V24, P28, DOI 10.1007/BF02099948
   Singh NK, 2016, VIRUS RES, V221, P58, DOI 10.1016/j.virusres.2016.05.008
   Tulloch F, 2014, ELIFE, V3, DOI 10.7554/eLife.04531
   van Hemert F, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0551-1
   WRESCHNER DH, 1981, NATURE, V289, P414, DOI 10.1038/289414a0
   WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9
   Xu Y, 2015, GENE, V557, P138, DOI 10.1016/j.gene.2014.12.019
   Zhang J, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-146
   Zhang Shuo, 2016, Bing Du Xue Bao, V32, P121
NR 38
TC 5
Z9 5
U1 0
U2 6
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD JUL
PY 2017
VL 162
IS 7
BP 1963
EP 1973
DI 10.1007/s00705-017-3324-2
PG 11
WC Virology
SC Virology
GA EX7UO
UT WOS:000403454900013
PM 28324177
DA 2020-07-08
ER

PT J
AU Hercik, K
   Brynda, J
   Nencka, R
   Boura, E
AF Hercik, Kamil
   Brynda, Jiri
   Nencka, Radim
   Boura, Evzen
TI Structural basis of Zika virus methyltransferase inhibition by
   sinefungin
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID CRYSTAL-STRUCTURE; FLAVIVIRUS; RNA; NS5; TRANSMISSION; DISCOVERY;
   INSIGHT; BRAZIL
AB Zika virus is considered a major global threat to human kind. Here, we present a crystal structure of one of its essential enzymes, the methyltransferase, with the inhibitor sinefungin. This structure, together with previously solved structures with bound substrates, will provide the information needed for rational inhibitor design. Based on the structural data we suggest the modification of the adenine moiety of sinefungin to increase selectivity and to covalently link it to a GTP analogue, to increase the affinity of the synthesized compounds.
C1 [Hercik, Kamil; Brynda, Jiri; Nencka, Radim; Boura, Evzen] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Vvi, Flemingovo Nam 2, CR-16610 Prague 6, Czech Republic.
RP Nencka, R; Boura, E (corresponding author), Acad Sci Czech Republ, Inst Organ Chem & Biochem, Vvi, Flemingovo Nam 2, CR-16610 Prague 6, Czech Republic.
EM nencka@uochb.cas.cz; boura@uochb.cas.cz
RI Boura, Evzen/G-5275-2014; Nencka, Radim/G-5296-2014; Brynda,
   Jiri/G-2760-2014
OI Brynda, Jiri/0000-0003-3675-6769; Boura, Evzen/0000-0002-9652-4065
FU Ministry of Education of the Czech RepublicMinistry of Education, Youth
   & Sports - Czech Republic [LO1302]; Academy of Sciences of the Czech
   RepublicCzech Academy of Sciences [RVO: 61388963]
FX The Project was also supported by Project InterBioMed LO1302 from
   Ministry of Education of the Czech Republic, the support of the Academy
   of Sciences of the Czech Republic (RVO: 61388963) is also acknowledged.
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   BARTON DHR, 1991, J CHEM SOC PERK T 1, P981, DOI 10.1039/p19910000981
   Barzon L, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw202
   Baumlova A, 2014, EMBO REP, V15, P1085, DOI 10.15252/embr.201438841
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Brecher M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130062
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Dong HP, 2008, ANTIVIR RES, V80, P1, DOI 10.1016/j.antiviral.2008.05.003
   Dong HP, 2014, J GEN VIROL, V95, P763, DOI 10.1099/vir.0.062208-0
   Dong HP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002642
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Fiorentino DG, 2016, CURR OBSTET GYNECOL, V5, P234, DOI 10.1007/s13669-016-0171-1
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10
   HAMILL RL, 1973, J ANTIBIOT, V26, P463, DOI 10.7164/antibiotics.26.463
   Hercik K, 2017, ANTIVIR RES, V137, P131, DOI 10.1016/j.antiviral.2016.11.020
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Jansson AM, 2009, ACTA CRYSTALLOGR D, V65, P796, DOI 10.1107/S0907444909017260
   Klima M, 2016, SCI REP-UK, V6, DOI 10.1038/srep23641
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   LANGBERG SR, 1981, J BIOL CHEM, V256, P54
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Mejdrova I, 2015, J MED CHEM, V58, P3767, DOI 10.1021/acs.jmedchem.5b00499
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rajah MM, 2016, ACS INFECT DIS, V2, P763, DOI 10.1021/acsinfecdis.6b00161
   Rezabkova L, 2010, J STRUCT BIOL, V170, P451, DOI 10.1016/j.jsb.2010.03.009
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sironi M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004978
   Stephen P, 2016, J AM CHEM SOC, V138, P16212, DOI 10.1021/jacs.6b10399
   Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Zhang CY, 2017, BIOCHEM BIOPH RES CO, V492, P624, DOI 10.1016/j.bbrc.2016.11.098
   Zhang J, 2016, ACS CHEM BIOL, V11, P583, DOI 10.1021/acschembio.5b00812
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 45
TC 29
Z9 33
U1 0
U2 17
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD JUL
PY 2017
VL 162
IS 7
BP 2091
EP 2096
DI 10.1007/s00705-017-3345-x
PG 6
WC Virology
SC Virology
GA EX7UO
UT WOS:000403454900031
PM 28357511
DA 2020-07-08
ER

PT J
AU Chang, HH
   Huber, RG
   Bond, PJ
   Grad, YH
   Camerini, D
   Maurer-Stroh, S
   Lipsitch, M
AF Chang, Hsiao-Han
   Huber, Roland G.
   Bond, Peter J.
   Grad, Yonatan H.
   Camerini, David
   Maurer-Stroh, Sebastian
   Lipsitch, Marc
TI Systematic analysis of protein identity between Zika virus and other
   arthropod-borne viruses
SO BULLETIN OF THE WORLD HEALTH ORGANIZATION
LA English
DT Article
ID REACTIVITY; INFECTION; RESOURCE
AB Objective To analyse the proportions of protein identity between Zika virus and dengue, Japanese encephalitis, yellow fever, West Nile and chikungunya viruses as well as polymorphism between different Zika virus strains.
   Methods We used published protein sequences for the Zika virus and obtained protein sequences for the other viruses from the National Center for Biotechnology Information (NCBI) protein database or the NCBI virus variation resource. We used BLASTP to find regions of identity between viruses. We quantified the identity between the Zika virus and each of the other viruses, as well as within-Zika virus polymorphism for all amino acid k-mers across the proteome, with k ranging from 6 to 100. We assessed accessibility of protein fragments by calculating the solvent accessible surface area for the envelope and nonstructural-1 (NS1) proteins.
   Findings In total, we identified 294 Zika virus protein fragments with both low proportion of identity with other viruses and low levels of polymorphisms among Zika virus strains. The list includes protein fragments from all Zika virus proteins, except NS3. NS4A has the highest number (190 k-mers) of protein fragments on the list.
   Conclusion We provide a candidate list of protein fragments that could be used when developing a sensitive and specific serological test to detect previous Zika virus infections.
C1 [Chang, Hsiao-Han; Lipsitch, Marc] Harvard TH Chan, Sch Publ Hlth, Ctr Communicable Dis Dynam, Dept Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA.
   [Huber, Roland G.; Bond, Peter J.; Maurer-Stroh, Sebastian] ASTAR, Bioinformat Inst BII, Singapore, Singapore.
   [Grad, Yonatan H.] Harvard TH Chan, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA.
   [Camerini, David] Antigen Discovery Inc, Irvine, CA USA.
RP Chang, HH (corresponding author), Harvard TH Chan, Sch Publ Hlth, Ctr Communicable Dis Dynam, Dept Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA.
EM hhchang@hsph.harvard.edu
RI Maurer-Stroh, Sebastian/Q-9476-2019; Huber, Roland/AAG-6353-2019
OI Maurer-Stroh, Sebastian/0000-0003-0813-9640; Huber,
   Roland/0000-0001-5093-5988; Bond, Peter/0000-0003-2900-098X
FU National Institute of General Medical Sciences of the National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [U54GM088558];  [MOE2012-T3-1-008]; 
   [15/1/82/27/001];  [H16/99/b0/013]
FX This study was supported by the National Institute of General Medical
   Sciences of the National Institutes of Health under award number
   U54GM088558 and MOE2012-T3-1-008, 15/1/82/27/001, H16/99/b0/013 for the
   Singapore side.
CR Allwinn R, 2002, MED MICROBIOL IMMUN, V190, P199, DOI 10.1007/s00430-001-0107-9
   [Anonymous], 2016, TARG PROD PROF BETT
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Brister JR, 2014, NUCLEIC ACIDS RES, V42, pD660, DOI 10.1093/nar/gkt1268
   Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421
   Centers for Disease Control and Prevention, 2016, REV DIAGN TEST ZIK C
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Felgner PL, 2009, P NATL ACAD SCI USA, V106, P13499, DOI 10.1073/pnas.0812080106
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Koraka P, 2002, MICROBES INFECT, V4, P1209, DOI 10.1016/S1286-4579(02)01647-7
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Liu JF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r69
   Marzinek JK, 2016, STRUCTURE, V24, P1410, DOI 10.1016/j.str.2016.05.014
   MEGRET F, 1992, VIROLOGY, V187, P480, DOI 10.1016/0042-6822(92)90450-4
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Strauss JH, 2001, CELL, V105, P5, DOI 10.1016/S0092-8674(01)00291-4
   Tappe D, 2014, EUROSURVEILLANCE, V19, P1
   VANREGENMORTEL MHV, 1994, PEPTIDE RES, V7, P224
   Vorou R, 2016, EUROSURVEILLANCE, V21, P27, DOI 10.2807/1560-7917.ES.2016.21.10.30161
   Weiser J, 1999, J COMPUT CHEM, V20, P217, DOI 10.1002/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A
   Xu GJ, 2015, SCIENCE, V348, DOI 10.1126/science.aaa0698
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 28
TC 19
Z9 19
U1 2
U2 7
PU WORLD HEALTH ORGANIZATION
PI GENEVA 27
PA MARKETING AND DISSEMINATION, CH-1211 GENEVA 27, SWITZERLAND
SN 0042-9686
EI 1564-0604
J9 B WORLD HEALTH ORGAN
JI Bull. World Health Organ.
PD JUL
PY 2017
VL 95
IS 7
BP 517
EP 525
DI 10.2471/BLT.16.182105
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FC9VW
UT WOS:000407190200014
PM 28670016
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Chandrasekaran, N
   Marotta, M
   Taldone, S
   Curry, C
AF Chandrasekaran, Neeraja .
   Marotta, Mabel
   Taldone, Sabrina
   Curry, Christine
TI Perceptions of Community Risk and Travel During Pregnancy in an Area of
   Zika Transmission
SO CUREUS
LA English
DT Article
DE zika virus; pregnancy; public health; patient education; zika;
   prevention
AB Introduction
   Between June 2016 and August 2016, the first cases of the Zika transmission were reported in Miami, FL, US. Since then, travel advisories have been issued by the Centers for Disease Control and Prevention (CDC) to avoid travel to Florida. Women that are of childbearing age or pregnant are the populations most vulnerable to Zika infection because birth defects can occur in infants born to infected mothers. Till date, there are no studies assessing the perception of the community risk of Zika in pregnant women residing in an affected region such as Miami.
   Methods
   A cross-sectional design was utilized for this study. The survey included questions assessing community risk and travel perceptions. Surveys were distributed in the antenatal clinics at the University of Miami Hospital and the Jackson Memorial Hospital.
   Results
   A total of 85 women were surveyed between January 27, 2016 and March 3, 2017. Of the surveyed women, 92.6 percent believed Zika is an important issue in their community, 85.9 percent reported a change in behavior because of Zika, 26.9 percent believed they can get Zika at their location, and 13.9 percent considered moving away from Florida because of Zika.
   Conclusion
   Despite the majority of women believing Zika is an important issue in their community, only one-fourth believed they could get Zika in Miami. Efforts to educate pregnant women in affected areas about preventive measures against the Zika infection should be undertaken. Further studies comparing the perceptions of community risks and travel behaviors in other affected areas are warranted.
C1 [Chandrasekaran, Neeraja .] Univ Miami, Miller Sch Med, Publ Hlth Sci, Coral Gables, FL 33124 USA.
   [Marotta, Mabel; Curry, Christine] Univ Miami, Miller Sch Med, Dept Obstet & Gynecol, Coral Gables, FL 33124 USA.
   [Marotta, Mabel; Taldone, Sabrina; Curry, Christine] Jackson Mem Hosp, Miami, FL 33136 USA.
   [Taldone, Sabrina] Univ Miami, Miller Sch Med, Dept Internal Med, Coral Gables, FL 33124 USA.
RP Chandrasekaran, N (corresponding author), Univ Miami, Miller Sch Med, Publ Hlth Sci, Coral Gables, FL 33124 USA.
EM mdneeruthimma@gmail.com
CR [Anonymous], 2016, ZIKA VIRUS AM AWARNE
   [Anonymous], 2017, ADVICE PEOPLE LIVING
   [Anonymous], 2016, LOCAL MOSQUITO BORNE
   [Anonymous], 2017, MICROCEPHALY OTHER B
   Mouchtouri VA, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040367
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rather IA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00305
   Whittemore K, 2017, EMERG INFECT DIS, V23, P164, DOI 10.3201/eid2301.161614
NR 8
TC 3
Z9 3
U1 0
U2 2
PU CUREUS INC
PI PALO ALTO
PA PO BOX 61002, PALO ALTO, CA 94306 USA
SN 2168-8184
J9 CUREUS
JI Cureus
PD JUL
PY 2017
VL 9
IS 7
AR UNSP e1516
DI 10.7759/cureus.1516
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA HE7MX
UT WOS:000453623000101
PM 28959511
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kadkhoda, K
   Gretchen, A
   Racano, A
AF Kadkhoda, Kamran
   Gretchen, Ainsley
   Racano, Adrianna
TI Evaluation of a commercially available Zika virus IgM ELISA: specificity
   in focus
SO DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
LA English
DT Article
DE Zika; IgM; Elisa; Specificity
ID INFECTION; DISEASE
AB Zika virus (ZIKV), an emerging arbovirus, has become the center of attention since it was linked to congenital abnormalities. Given the overlapping clinical picture of ZIKV disease with other infectious diseases and as an exigent public health matter, timely and reliable diagnosis of ZIKV infection is crucial. We evaluated the performance of a commercially available NS1-based ZIKV IgM ELISA. Our results showed suboptimal sensitivity within the first 5 days after onset while specificity remained robust. Crown Copyright (C) 2017 Published by Elsevier Inc. All rights reserved.
C1 [Kadkhoda, Kamran; Gretchen, Ainsley; Racano, Adrianna] Cadham Prov Publ Hlth Lab, Winnipeg, MB, Canada.
   [Kadkhoda, Kamran] Univ Manitoba, Rady Fac Hlth Sci, Max Rady Coll Med, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada.
   [Kadkhoda, Kamran] Univ Manitoba, Rady Fac Hlth Sci, Max Rady Coll Med, Dept Immunol, Winnipeg, MB, Canada.
RP Kadkhoda, K (corresponding author), Cadham Prov Publ Hlth Lab, Winnipeg, MB, Canada.; Kadkhoda, K (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Max Rady Coll Med, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada.; Kadkhoda, K (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Max Rady Coll Med, Dept Immunol, Winnipeg, MB, Canada.
EM kamran.kadkhoda@gov.mb.ca
FU Cadham Provincial Laboratory internal research funds
FX This study was supported by Cadham Provincial Laboratory internal
   research funds.
CR ABRAMO C, 1995, AM J TROP MED HYG, V53, P202, DOI 10.4269/ajtmh.1995.53.202
   [Anonymous], 2016, MMWR-MORBID MORTAL W, V65, P474, DOI 10.15585/mmwr.mm6518e1
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cunha Antonio Jose Ledo Alves da, 2017, Pediatr Infect Dis J, V36, P528, DOI 10.1097/INF.0000000000001486
   de Laval F, 2016, LANCET, V388, P868, DOI 10.1016/S0140-6736(16)31429-5
   Donati D, 2006, J IMMUNOL, V177, P3035, DOI 10.4049/jimmunol.177.5.3035
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Huzly D, 2016, EURO SURVEILL, V21
   Meersman K, 2016, EURO SURVEILL, V21
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   ORTIZORTIZ L, 1980, J IMMUNOL, V124, P121
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Saba ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074493
   Steinhagen K, 2016, EURO SURVEILL, V21
NR 21
TC 15
Z9 15
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0732-8893
EI 1879-0070
J9 DIAGN MICR INFEC DIS
JI Diagn. Microbiol. Infect. Dis.
PD JUL
PY 2017
VL 88
IS 3
BP 233
EP 235
DI 10.1016/j.diagmicrobio.2017.04.002
PG 3
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA EZ4OQ
UT WOS:000404692800006
PM 28478111
DA 2020-07-08
ER

PT J
AU Liu, ZZ
   Zhou, TF
   Lai, ZT
   Zhang, ZH
   Jia, ZR
   Zhou, GF
   Williams, T
   Xu, JB
   Gu, JB
   Zhou, XH
   Lin, LF
   Yan, GY
   Chen, XG
AF Liu, Zhuanzhuan
   Zhou, Tengfei
   Lai, Zetian
   Zhang, Zhenhong
   Jia, Zhirong
   Zhou, Guofa
   Williams, Tricia
   Xu, Jiabao
   Gu, Jinbao
   Zhou, Xiaohong
   Lin, Lifeng
   Yan, Guiyun
   Chen, Xiao-Guang
TI Competence of Aedes aegypti, Ae. albopictus, and Culex quinquefasciatus
   Mosquitoes as Zika Virus Vectors, China
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID DIPTERA-CULICIDAE; PIPIENS-QUINQUEFASCIATUS; POTENTIAL VECTOR;
   INFECTION; DENGUE; SUSCEPTIBILITY; IDENTIFICATION; RESISTANCE;
   MUTATIONS; SINGAPORE
AB In China, the prevention and control of Zika virus disease has been a public health threat since the first imported case was reported in February 2016. To determine the vector competence of potential vector mosquito species, we experimentally infected Aedes aegypti, Ae. albopictus, and Culex quinquefasciatus mosquitoes and determined infection rates, dissemination rates, and transmission rates. We found the highest vector competence for the imported Zika virus in Ae. aegypti mosquitoes, some susceptibility of Ae. albopictus mosquitoes, but no transmission ability for Cx. quinquefasciatus mosquitoes. Considering that, in China, Ae. albopictus mosquitoes are widely distributed but Ae. aegypti mosquito distribution is limited, Ae. albopictus mosquitoes are a potential primary vector for Zika virus and should be targeted in vector control strategies.
C1 [Liu, Zhuanzhuan; Zhou, Tengfei; Lai, Zetian; Zhang, Zhenhong; Jia, Zhirong; Williams, Tricia; Xu, Jiabao; Gu, Jinbao; Zhou, Xiaohong; Chen, Xiao-Guang] Southern Med Univ, Guangzhou, Guangdong, Peoples R China.
   [Zhou, Guofa; Yan, Guiyun] Univ Calif Irvine, Irvine, CA USA.
   [Lin, Lifeng] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China.
RP Chen, XG (corresponding author), Southern Med Univ, Sch Publ Hlth, Dept Pathogen Biol, 1038 Sha Tai North Rd, Guangzhou, Guangdong, Peoples R China.
EM xgchen2001@hotmail.com
FU National Key Research and Development Program of China [2016YFC1200500];
   National Nature Science Foundation of ChinaNational Natural Science
   Foundation of China [81371845, 81420108024]; Natural Science Foundation
   of Guangdong ProvinceNational Natural Science Foundation of Guangdong
   Province [2013B051000052, 2014A030312016]; US National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01AI083202, D43 TW009527]
FX This study was supported by grants from the National Key Research and
   Development Program of China (2016YFC1200500), the National Nature
   Science Foundation of China (81371845, 81420108024), the Natural Science
   Foundation of Guangdong Province (2013B051000052, 2014A030312016), and
   the US National Institutes of Health (R01AI083202, D43 TW009527).
CR Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Centers for Disease Control and Prevention, COUNTR TERR ACT LOC
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   De Smet B, 2016, J CLIN VIROL, V80, P8, DOI 10.1016/j.jcv.2016.04.009
   Deng CL, 2016, VIROL SIN, V31, P176, DOI 10.1007/s12250-016-3778-5
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dong X J, 2016, Zhonghua Liu Xing Bing Xue Za Zhi, V37, P597, DOI 10.3760/cma.j.issn.0254-6450.2016.05.002
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Fortuna C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1067-z
   Franca RFO, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004760
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Howard CR, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.37
   Jang HC, 2016, J KOREAN MED SCI, V31, P1173, DOI 10.3346/jkms.2016.31.7.1173
   Li CX, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0933-z
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Li YJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003301
   Liu L, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00291-16
   Luo L, 2015, J VECTOR ECOL, V40, P240, DOI 10.1111/jvec.12160
   Manica M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004758
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Possas C, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016023
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Samy AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163863
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Wang G, 2014, SE ASIAN J TROP MED, V45, P290
   Wang ZM, 2012, VECTOR-BORNE ZOONOT, V12, P605, DOI 10.1089/vbz.2011.0660
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization, EM COMM ZIK VIR OBS
   Wu F, 2011, VECTOR-BORNE ZOONOT, V11, P1181, DOI 10.1089/vbz.2010.0032
   Zhang MC, 2010, AM J TROP MED HYG, V83, P700, DOI 10.4269/ajtmh.2010.10-0193
   Zhang YJ, 2016, PROTEIN CELL, V7, P461, DOI 10.1007/s13238-016-0274-5
   Zhao H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156548
   Zhao MH, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-369
NR 41
TC 47
Z9 54
U1 1
U2 23
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JUL
PY 2017
VL 23
IS 7
BP 1085
EP 1091
DI 10.3201/eid2307.161528
PG 7
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA EX9FS
UT WOS:000403563100005
PM 28430562
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ciota, AT
   Bialosuknia, SM
   Zink, SD
   Brecher, M
   Ehrbar, DJ
   Morrissette, MN
   Kramer, LD
AF Ciota, Alexander T.
   Bialosuknia, Sean M.
   Zink, Steven D.
   Brecher, Matthew
   Ehrbar, Dylan J.
   Morrissette, Madeline N.
   Kramer, Laura D.
TI Effects of Zika Virus Strain and Aedes Mosquito Species on Vector
   Competence
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID DENGUE VIRUSES; SEXUAL TRANSMISSION; CHIKUNGUNYA VIRUS; INFECTION;
   AEGYPTI; SUSCEPTIBILITY; ALBOPICTUS; CULICIDAE; DIPTERA; FROZEN
AB In the Western Hemisphere, Zika virus is thought to be transmitted primarily by Aedes aegypti mosquitoes. To determine the extent to which Ae. albopictus mosquitoes from the United States are capable of transmitting Zika virus and the influence of virus dose, virus strain, and mosquito species on vector competence, we evaluated multiple doses of representative Zika virus strains in Ae. aegypti and Ae. albopictus mosquitoes. Virus preparation (fresh vs. frozen) significantly affected virus infectivity in mosquitoes. We calculated 50% infectious doses to be 6.1-7.5 log(10) PFU/mL; minimum infective dose was 4.2 log(10) PFU/mL. Ae. albopictus mosquitoes were more susceptible to infection than Ae. aegypti mosquitoes, but transmission efficiency was higher for Ae. aegypti mosquitoes, indicating a transmission barrier in Ae. albopictus mosquitoes. Results suggest that, although Zika virus transmission is relatively inefficient overall and dependent on virus strain and mosquito species, Ae. albopictus mosquitoes could become major vectors in the Americas.
C1 [Ciota, Alexander T.; Bialosuknia, Sean M.; Zink, Steven D.; Brecher, Matthew; Ehrbar, Dylan J.; Morrissette, Madeline N.; Kramer, Laura D.] New York State Dept Hlth, Slingerlands, NY USA.
   [Ciota, Alexander T.; Kramer, Laura D.] SUNY Albany, Sch Publ Hlth, Albany, NY USA.
RP Ciota, AT (corresponding author), NYS Dept Hlth, Arbovirus Lab, Wadsworth Ctr, 5668 State Farm Rd, Slingerlands, NY 12159 USA.
EM alexander.ciota@health.ny.gov
RI Ciota, Alexander/E-1634-2017
OI Ciota, Alexander/0000-0001-6589-4728; Ehrbar, Dylan/0000-0001-7872-3338
FU National Institutes of Health grantUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [C06-RR-17715];
   Centers for Disease Control and Prevention Vector-borne Disease Regional
   Center of Excellence, CDC [CK17-005]
FX Construction of the Arbovirus Laboratory insectary facilities was
   partially funded by National Institutes of Health grant C06-RR-17715.
   These studies were partially funded by the Centers for Disease Control
   and Prevention Vector-borne Disease Regional Center of Excellence, CDC #
   CK17-005.
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Armstrong PM, 2001, VECTOR-BORNE ZOONOT, V1, P159, DOI 10.1089/153036601316977769
   Brent C, 2016, MMWR-MORBID MORTAL W, V65, P981, DOI 10.15585/mmwr.mm6536e4
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2017, EMERG INFECT DIS, V23, P880, DOI 10.3201/eid2305.162041
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ebel GD, 2005, J MED ENTOMOL, V42, P838, DOI 10.1603/0022-2585(2005)042[0838:CRDCRA]2.0.CO;2
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   GUBLER DJ, 1979, AM J TROP MED HYG, V28, P1045, DOI 10.4269/ajtmh.1979.28.1045
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Hansen RK, 2005, BIOTECHNOL PROGR, V21, P911, DOI 10.1021/bp049601a
   Hardy J. L., 1990, Epidemiology and control of mosquito-borne arboviruses in California, 1943-1987., P145
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kilpatrick AM, 2010, AM J TROP MED HYG, V83, P607, DOI 10.4269/ajtmh.2010.10-0005
   Kramer LD, 2003, ADV VIRUS RES, V60, P187, DOI 10.1016/S0065-3527(03)60006-0
   Lambrechts L, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2437
   Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   McCarthy M, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4235
   MILLER BR, 1989, TROP MED PARASITOL, V40, P396
   MILLER BR, 1987, T ROY SOC TROP MED H, V81, P1011, DOI 10.1016/0035-9203(87)90381-6
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nguyen NM, 2013, P NATL ACAD SCI USA, V110, P9072, DOI 10.1073/pnas.1303395110
   OLSEN MA, 1993, J CLIN MICROBIOL, V31, P422, DOI 10.1128/JCM.31.2.422-425.1993
   Payne AF, 2006, J VIROL METHODS, V134, P183, DOI 10.1016/j.jviromet.2006.01.003
   Pongsiri A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092971
   Richards SL, 2007, VIRUS RES, V129, P224, DOI 10.1016/j.virusres.2007.06.019
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   ROSEN L, 1983, AM J TROP MED HYG, V32, P1108, DOI 10.4269/ajtmh.1983.32.1108
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Tsetsarkin KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006835
   TURELL MJ, 1988, AM J TROP MED HYG, V39, P597, DOI 10.4269/ajtmh.1988.39.597
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zouache K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1078
NR 50
TC 57
Z9 58
U1 1
U2 15
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JUL
PY 2017
VL 23
IS 7
BP 1110
EP 1117
DI 10.3201/eid2307.161633
PG 8
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA EX9FS
UT WOS:000403563100008
PM 28430564
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sousa, AQ
   Cavalcante, DIM
   Franco, LM
   Araujo, FMC
   Sousa, ET
   Valenca, JT
   Rolim, DB
   Melo, MEL
   Sindeaux, PDT
   Araujo, MTF
   Pearson, RD
   Wilson, ME
   Pompeu, MML
AF Sousa, Anastacio Q.
   Cavalcante, Diane I. M.
   Franco, Luciano M.
   Araujo, Fernanda M. C.
   Sousa, Emlia T.
   Valenca-Junior, Jose Telmo
   Rolim, Dionne B.
   Melo, Maria E. L.
   Sindeaux, Pedro D. T.
   Araujo, Marialva T. F.
   Pearson, Richard D.
   Wilson, Mary E.
   Pompeu, Margarida M. L.
TI Postmortem Findings for 7 Neonates with Congenital Zika Virus Infection
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID DENGUE; ANTIGEN
AB Postmortem examination of 7 neonates with congenital Zika virus infection in Brazil revealed microcephaly, ventriculomegaly, dystrophic calcifications, and severe cortical neuronal depletion in all and arthrogryposis in 6. Other findings were leptomeningeal and brain parenchymal inflammation and pulmonary hypoplasia and lymphocytic infiltration in liver and lungs. Findings confirmed virus neurotropism and multiple organ infection.
C1 [Sousa, Anastacio Q.; Cavalcante, Diane I. M.; Franco, Luciano M.; Sousa, Emlia T.; Valenca-Junior, Jose Telmo; Sindeaux, Pedro D. T.; Pompeu, Margarida M. L.] Univ Fed Ceara, Fortaleza, Ceara, Brazil.
   [Franco, Luciano M.; Sousa, Emlia T.; Valenca-Junior, Jose Telmo] Serv Verificacao Obitos SVO, Fortaleza, Ceara, Brazil.
   [Araujo, Fernanda M. C.; Melo, Maria E. L.] Ceara State Cent Publ Hlth Lab, Fortaleza, Ceara, Brazil.
   [Rolim, Dionne B.] Univ Fortaleza, Fortaleza, Ceara, Brazil.
   [Rolim, Dionne B.] Ceara State Secretariat Hlth, Fortaleza, Ceara, Brazil.
   [Araujo, Marialva T. F.] Evandro Chagas Inst, Belem, Para, Brazil.
   [Pearson, Richard D.] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA.
   [Wilson, Mary E.] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Wilson, Mary E.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA.
RP Sousa, AQ (corresponding author), Univ Fed Ceara, Sch Med, Dept Clin Med, Rua Prof Costa Mendes,1608 4 Andar, BR-60430140 Fortaleza, Ceara, Brazil.
EM aqsousa@gmail.com
CR Araujo FMC, 2011, J VIROL METHODS, V177, P128, DOI 10.1016/j.jviromet.2011.07.003
   Aye KS, 2014, HUM PATHOL, V45, P1221, DOI 10.1016/j.humpath.2014.01.022
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Folkerth R, 2008, GREENFIELDS NEUROPAT, P241
   Kowalczyk B, 2016, ARCH MED SCI, V12, P10, DOI 10.5114/aoms.2016.57578
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Perez S, 2016, EUROSURVEILLANCE, V21, P1, DOI 10.2807/1560-7917.ES.2016.21.24.30261
   Lima MDQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000738
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   WIGGLESWORTH JS, 1981, ARCH DIS CHILD, V56, P601, DOI 10.1136/adc.56.8.601
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 15
TC 24
Z9 24
U1 0
U2 6
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JUL
PY 2017
VL 23
IS 7
BP 1164
EP 1167
DI 10.3201/eid2307.162019
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA EX9FS
UT WOS:000403563100016
PM 28459414
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Dar, HA
   Zaheer, T
   Paracha, RZ
   Ali, A
AF Dar, Hamza Arshad
   Zaheer, Tahreem
   Paracha, Rehan Zafar
   Ali, Amjad
TI Structural analysis and insight into Zika virus NS5 mediated interferon
   inhibition
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE Zika virus; NS5 docking; Interferon antagonism; STAT2 degradation;
   Phylogenetic analysis
ID MULTIPLE SEQUENCE ALIGNMENT; SCORING FUNCTION; HIGH-THROUGHPUT; PROTEIN;
   PREDICTION; BINDING; DENGUE; FLAVIVIRUS; NETWORK
AB The Zika virus outbreak in 2015-2016 is the largest of its kind for which WHO declared a Public Health Emergency of International Concerns. No FDA approved drug is available for the treatment of the viral infection. The interaction of flavivirus NS5 protein with SIAH2 ubiquitin ligase has been previously known. NS5 of Zika virus has been implicated in the degradation of STAT2 protein, which activates interferon-stimulated antiviral activity. Based on our proposition that NS5 utilizes SIAH2-mediated proteasomal degradation of STAT2, an in-silico study was carded out to characterize the protein-protein interactions between NS5, SIAH2 and STAT2 proteins. The aim of our study was to identify the amino acid residues of NS5 involved in IFN antagonism as well as to find the association between NS5, SIAH2 and STAT2 to predict the interaction pattern of these proteins. Analysis proposed that NS5 recruits SIAH2 for the ubiquitination-dependent degradation of STAT2. NS5 residues involved in interaction with SIAH2 and/or STAT2 were found to be mostly conserved across related flaviviruses. These are novel findings regarding the Zika virus and require confirmation through experimental approaches. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Dar, Hamza Arshad; Zaheer, Tahreem; Ali, Amjad] NUST, Atta Ur Rahman Sch Appl Biosci ASAB, Islamabad 44000, Pakistan.
   [Paracha, Rehan Zafar] NUST, RCMS, Islamabad 44000, Pakistan.
RP Ali, A (corresponding author), NUST, Atta Ur Rahman Sch Appl Biosci ASAB, Islamabad 44000, Pakistan.
EM amjad.ali@asab.nust.edu.pk
RI Ali, Amjad/I-9764-2019
OI Ali, Amjad/0000-0002-0486-4661; Dar, Hamza Arshad/0000-0002-0667-5653
CR Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001
   Altschul SF, 1998, TRENDS BIOCHEM SCI, V23, P444, DOI 10.1016/S0968-0004(98)01298-5
   [Anonymous], 2016, ZIKA VIRUS RESPONSE
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Aslam B, 2015, GENET MOL RES, V14, P4215, DOI 10.4238/2015.April.28.4
   Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715
   Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen HL, 2005, PROTEINS, V61, P21, DOI 10.1002/prot.20514
   COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916
   de Vries SJ, 2006, PROTEINS, V63, P479, DOI 10.1002/prot.20842
   de Vries SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017695
   Delano W.L., 2002, PYMOL MOL GRAPHICS S
   Diamond MS, 2009, J INTERF CYTOK RES, V29, P521, DOI 10.1089/jir.2009.0069
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   European Centre for Disease Prevention and Control, 2016, ZIK VIR INF
   Grant A., 2016, CELL HOST MICROBE
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Horner SM, 2009, J INTERF CYTOK RES, V29, P489, DOI 10.1089/jir.2009.0063
   Hu XY, 2008, IMMUNOL REV, V226, P41, DOI 10.1111/j.1600-065X.2008.00707.x
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Kaminski G.A., 2001, EVALUATION REPARAMET
   Kufareva I, 2007, PROTEINS, V67, P400, DOI 10.1002/prot.21233
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221
   Le Breton M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-234
   Liang SD, 2006, NUCLEIC ACIDS RES, V34, P3698, DOI 10.1093/nar/gkl454
   Longenecker K., 2016, CRYSTAL STR IN PRESS
   Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286
   Mairiang D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053535
   Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Neuvirth H, 2004, J MOL BIOL, V338, P181, DOI 10.1016/j.jmb.2004.02.040
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Porollo A, 2007, PROTEINS, V66, P630, DOI 10.1002/prot.21248
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005
   Turner P., 2005, CENT COAST LAND MARG
   van Zundert G. C., 2016, J MOL BIOL, V428, P720
   Wassenaar TA, 2012, J GRID COMPUT, V10, P743, DOI 10.1007/s10723-012-9246-z
   Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033
   World Health Organization, 2016, ZIK VIR
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
   Zuckerkandl E., 1965, EVOLVING GENES PROTE, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6
NR 49
TC 7
Z9 7
U1 1
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD JUL
PY 2017
VL 51
BP 143
EP 152
DI 10.1016/j.meegid.2017.03.027
PG 10
WC Infectious Diseases
SC Infectious Diseases
GA EW4AJ
UT WOS:000402444100024
PM 28365387
DA 2020-07-08
ER

PT J
AU van Meer, MPA
   Mogling, R
   Klaasse, J
   Chandler, FD
   Pas, SD
   van der Eijk, AA
   Koopmans, MPG
   Reusken, CBEM
   GeurtsvanKessel, CH
AF van Meer, Maurits P. A.
   Mogling, Ramona
   Klaasse, Janienne
   Chandler, Felicity D.
   Pas, Suzan D.
   van der Eijk, Annemiek A.
   Koopmans, Marion P. G.
   Reusken, Chantal B. E. M.
   GeurtsvanKessel, Corine H.
TI Re-evaluation of routine dengue virus serology in travelers in the era
   of Zika virus emergence
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
ID REVERSE-TRANSCRIPTASE PCR; ORIGINAL ANTIGENIC SIN; CO-CIRCULATION;
   INFECTION; SPECIFICITY; COINFECTION; URINE
AB Background: Diagnostic requests for both Zika virus (ZIKV) and dengue virus (DENV) infections in returning travelers have significantly increased during the recent ZIKV outbreak in the Americas. These flaviviruses have overlapping clinical syndromes and geographical distribution, but diagnostic differentiation is important because of different clinical consequences. As flaviviruses are known to have a short viremic period, diagnostics often rely on serological methods, which are challenging due to extensive cross-reactive antibodies.
   Objective: To re-evaluate the performance of DENV serological assays in laboratory confirmed ZIKV-infected travelers.
   Study design: The extent of cross-reactivity of the DENV NS1 antigen, IgM and IgG ELISA was analyzed in 152 clinical blood samples collected from 69 qRT-PCR and 24 virus neutralization titer (VNT) confirmed ZIKV-infected travelers.
   Results: The majority of travelers in the presented cohort returned to the Netherlands from Suriname and presented with symptoms of fever and rash. Twenty-three percent of the female travelers were pregnant. None of the 39 ZIKV RNA positive blood samples were cross-reactive in the DENV NS1 antigen ELISA. The rates of cross-reactivity of the DENV IgM and IgG ELISAs were 31% and 54%, respectively, after excluding travelers with (potential) previous DENV exposure.
   Conclusions: Although the DENV NS1 antigen assay was highly specific in this cohort of laboratory confirmed ZIKV-infected travelers, we demonstrate high percentages of cross-reactivity of DENV IgM and IgG ELISAs of which diagnostic laboratories should be aware. In addition, the high rate of DENV IgG background of > 25% complicates a proper serological diagnosis in this group.
C1 [van Meer, Maurits P. A.] Erasmus Univ, Med Ctr, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.
   [van Meer, Maurits P. A.; Mogling, Ramona; Klaasse, Janienne; Chandler, Felicity D.; Pas, Suzan D.; van der Eijk, Annemiek A.; Koopmans, Marion P. G.; Reusken, Chantal B. E. M.; GeurtsvanKessel, Corine H.] Erasmus Univ, Med Ctr, Dept Virosci, Rotterdam, Netherlands.
RP GeurtsvanKessel, CH (corresponding author), Erasmus Univ, Med Ctr, Dept Virosci, Rotterdam, Netherlands.
EM m.p.a.vanmeer@erasmusmc.nl; c.geurtsvankessel@erasmusmc.nl
RI amsalu, ribka/G-8780-2019; Koopmans, Marion/Y-9170-2019
OI Koopmans, Marion/0000-0002-5204-2312
FU European Union Seventh Framework Programme (FP7) under the project
   PREPARE [602525]; European Union's Horizon 2020 research and innovation
   programme under project ZIKALLIANCE [734548]
FX The work presented here was partially funded by the European Union
   Seventh Framework Programme (FP7) under the project PREPARE (grant
   agreement No 602525) and the European Union's Horizon 2020 research and
   innovation programme under project ZIKALLIANCE (grant agreement No
   734548).
CR [Anonymous], 2016, ZIK VIR ZIKV SURV AM
   Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467
   Cabral-Castro MJ, 2016, J CLIN VIROL, V82, P108, DOI 10.1016/j.jcv.2016.07.017
   Callahan JD, 2001, J CLIN MICROBIOL, V39, P4119, DOI 10.1128/JCM.39.11.4119-4124.2001
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   deO A.S., 2016, JAMA NEUROL, P1
   Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Erra EO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065900
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154
   Hirayama T, 2012, J CLIN MICROBIOL, V50, P2047, DOI 10.1128/JCM.06557-11
   Hu DM, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-47
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Iovine N. M., 2016, CLIN INFECT DIS, V64
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lustig Y, 2016, J CLIN MICROBIOL, V54, P2294, DOI 10.1128/JCM.01283-16
   Matheus S, 2016, EMERG INFECT DIS, V22, P1691, DOI 10.3201/eid2209.160725
   Midgley CM, 2011, J VIROL, V85, P410, DOI 10.1128/JVI.01826-10
   Murray K. O., 2016, EID, V23, P99
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Van Esbroeck M, 2016, EUROSURVEILLANCE, V21, P32, DOI 10.2807/1560-7917.ES.2016.21.21.30237
   Vorou R, 2016, EUROSURVEILLANCE, V21, P27, DOI 10.2807/1560-7917.ES.2016.21.10.30161
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
NR 32
TC 25
Z9 25
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD JUL
PY 2017
VL 92
BP 25
EP 31
DI 10.1016/j.jcv.2017.05.001
PG 7
WC Virology
SC Virology
GA FA0FW
UT WOS:000405107800006
PM 28505571
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Kuivanen, S
   Korhonen, EM
   Helisten, AA
   Huhtamo, E
   Smura, T
   Vapalahti, O
AF Kuivanen, Suvi
   Korhonen, Essi M.
   Helisten, Alma-Aurora
   Huhtamo, Eili
   Smura, Teemu
   Vapalahti, Olli
TI Differences in the growth properties of Zika virus foetal brain isolate
   and related epidemic strains in vitro
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Article
DE flavivirus; zika virus; cell line; cell tropism
ID INFECTION; TISSUE
AB Zika virus (ZIKV) has recently emerged into new areas in the Americas and Asia, causing an epidemic characterized by severe congenital infections. While ZIKV infection is usually asymptomatic or causes mild symptoms, it has now caused a high rate of foetal brain and ocular abnormalities. The underlying reasons for the varying severity of disease outcomes is poorly understood. In this study, we compared the infectivity and replication of three disease-associated Zika viruses of Asian lineage, as well as the prototypic ZIKV strain from Africa. The recent foetal brain isolate FB-GWUH-2016 demonstrated enhanced infectivity and replication over the serum-origin isolates from French Polynesia and Martinique, suggesting differences in the pathogenic properties.
C1 [Kuivanen, Suvi; Korhonen, Essi M.; Helisten, Alma-Aurora; Huhtamo, Eili; Smura, Teemu; Vapalahti, Olli] Univ Helsinki, Dept Virol, Helsinki, Finland.
   [Korhonen, Essi M.; Vapalahti, Olli] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland.
   [Smura, Teemu; Vapalahti, Olli] Univ Helsinki, Virol & Immunol, Helsinki, Finland.
   [Smura, Teemu; Vapalahti, Olli] Helsinki Univ Hosp, Helsinki, Finland.
RP Kuivanen, S (corresponding author), Univ Helsinki, Dept Virol, Helsinki, Finland.
EM suvi.kuivanen@helsinki.fi
RI Smura, Teemu P/C-4063-2016
OI Vapalahti, Olli/0000-0003-2270-6824; Huhtamo, Eili/0000-0001-9640-6547;
   Korhonen, Essi/0000-0003-4730-7715
FU Academy of FinlandAcademy of Finland [277590]; Helsinki University
   Hospital Funds [TYH2016258]; Sigrid Juselius FoundationSigrid Juselius
   Foundation; Eemil Aattonen Foundation
FX This work was supported by grants from the Academy of Finland (no.
   277590), Helsinki University Hospital Funds (no. TYH2016258), the Sigrid
   Juselius Foundation (to O.V.) and the Eemil Aattonen Foundation (to E.
   M. K.).
CR Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Chan JF, 2016, EMERG MICROBES INFEC, V5
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   JAASKELAINEN J, 1989, J IMMUNOL, V142, P1036
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Piorkowski G., 2016, New Microbes and New Infections, V11, P52, DOI 10.1016/j.nmni.2016.02.013
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
NR 16
TC 6
Z9 6
U1 1
U2 3
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-1317
EI 1465-2099
J9 J GEN VIROL
JI J. Gen. Virol.
PD JUL
PY 2017
VL 98
IS 7
BP 1744
EP 1748
DI 10.1099/jgv.0.000857
PG 5
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA FG4SX
UT WOS:000410256900019
PM 28699857
OA Bronze
DA 2020-07-08
ER

PT J
AU Carvalho, CAM
   Casseb, SMM
   Goncalves, RB
   Silva, EVP
   Gomes, AMO
   Vasconcelos, PFC
AF Carvalho, Carlos A. M.
   Casseb, Samir M. M.
   Goncalves, Rafael B.
   Silva, Eliana V. P.
   Gomes, Andre M. O.
   Vasconcelos, Pedro F. C.
TI Bovine lactoferrin activity against Chikungunya and Zika viruses
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Article
DE antiviral; arbovirus; bovine lactoferrin; Chikungunya virus; Zika virus
ID IRON-BINDING PROTEIN; RED PROTEIN; RECEPTOR; AMERICA; COMMON
AB Chikungunya (CHIKV) and Zika (ZIKV) viruses are arboviruses which have recently broken their sylvatic isolation and gone on to spread rampantly among humans in some urban areas of the world, especially in Latin America. Given the lack of effective interventions against such viruses, the aim of this work was to evaluate the antiviral potential of bovine lactoferrin (bLf) in their infections. Through viability, plaque, immunofluorescence and nucleic acid quantification assays, our data show that bLf exerts a dose-dependent strong inhibitory effect on the infection of Vero cells by the aforementioned arboviruses, reducing their infection efficiency by up to nearly 80 %, with no expressive cytotoxicity, and that such antiviral activity occurs at the levels of input and output of virus particles. These findings reveal that bLf antimicrobial properties are extendable to CHIKV and ZIKV, underlining a generic inhibition mechanism that can be explored to develop a potential strategy against their infections.
C1 [Carvalho, Carlos A. M.; Casseb, Samir M. M.; Silva, Eliana V. P.; Vasconcelos, Pedro F. C.] Minist Saude, Secao Arbovirol & Febres Hemorrag, Inst Evandro Chagas, Ananindeua, Brazil.
   [Goncalves, Rafael B.] Univ Fed Rio de Janeiro, Dept Bioquim, Inst Biomed, Rio De Janeiro, Brazil.
   [Gomes, Andre M. O.] Univ Fed Rio de Janeiro, Programa Biol Estrutural, Inst Bioquim Med Leopoldo Meis, Rio De Janeiro, Brazil.
RP Carvalho, CAM (corresponding author), Minist Saude, Secao Arbovirol & Febres Hemorrag, Inst Evandro Chagas, Ananindeua, Brazil.
EM c_marques@live.com
RI Vasconcelos, Pedro/AAH-3142-2019
OI Carvalho, Carlos/0000-0001-6615-1387
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [380477/2016-5, 457664/2013-4]; Fundacao Carlos Chagas Filho de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ) [E-26/010.001102/2016]
FX This work was supported by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) (grant numbers 380477/2016-5,
   457664/2013-4) and the Fundacao Carlos Chagas Filho de Amparo a Pesquisa
   do Estado do Rio de Janeiro (FAPERJ) (grant number
   E-26/010.001102/2016). These funding sources had no role in study
   design; in the collection, analysis and interpretation of data; in the
   writing of the report; and in the decision to submit the article for
   publication.
CR Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Baker EN, 2005, CELL MOL LIFE SCI, V62, P2531, DOI 10.1007/s00018-005-5368-9
   Balcao VM, 2013, FOOD HYDROCOLLOID, V32, P425, DOI 10.1016/j.foodhyd.2013.02.004
   Berlutti F, 2011, MOLECULES, V16, P6992, DOI 10.3390/molecules16086992
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carvalho CAM, 2014, VIROLOGY, V452, P297, DOI 10.1016/j.virol.2014.01.022
   Chien YJ, 2008, VIROLOGY, V379, P143, DOI 10.1016/j.virol.2008.06.017
   Debing Y, 2015, CURR OPIN INFECT DIS, V28, P596, DOI 10.1097/QCO.0000000000000212
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DULBECCO R, 1953, COLD SPRING HARB SYM, V18, P273, DOI 10.1101/SQB.1953.018.01.039
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Favoretto S, 2016, BIORXIV, DOI [10.1101/049395, DOI 10.1101/049395]
   GROVES ML, 1960, J AM CHEM SOC, V82, P3345, DOI 10.1021/ja01498a029
   Harada E, 1999, COMP BIOCHEM PHYS A, V124, P321, DOI 10.1016/S1095-6433(99)00122-1
   Jenssen H, 2009, BIOCHIMIE, V91, P19, DOI 10.1016/j.biochi.2008.05.015
   Ji B, 2006, LIFE SCI, V78, P851, DOI 10.1016/j.lfs.2005.05.085
   JOHANSON B, 1960, ACTA CHEM SCAND, V14, P510, DOI 10.3891/acta.chem.scand.14-0510
   Kanyshkova TG, 2003, EUR J BIOCHEM, V270, P3353, DOI 10.1046/j.1432-1033.2003.03715.x
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   LUMSDEN W. H. R., 1955, TANGANYIKA TERRITORY IN 1952 53 II TRANS ROY SOC TROP MED AND HYG, V49, P33, DOI 10.1016/0035-9203(55)90081-X
   MANN DM, 1994, J BIOL CHEM, V269, P23661
   Martinez JP, 2015, NAT PROD REP, V32, P29, DOI 10.1039/c4np00085d
   MASSON PL, 1966, CLIN CHIM ACTA, V14, P735, DOI 10.1016/0009-8981(66)90004-0
   MASSON PL, 1969, J EXP MED, V130, P643, DOI 10.1084/jem.130.3.643
   MATTHEWS DM, 1972, P NUTR SOC, V31, P171, DOI 10.1079/PNS19720033
   PAULSSON MA, 1993, J DAIRY SCI, V76, P3711, DOI 10.3168/jds.S0022-0302(93)77713-9
   PIERCE A, 1991, EUR J BIOCHEM, V196, P177, DOI 10.1111/j.1432-1033.1991.tb15801.x
   ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(55)90080-8, 10.1016/0035-9203(57)90022-6]
   Russell-Jones G, 2011, THER DELIV, V2, P1575, DOI 10.4155/TDE.11.129
   Schwarcz WD, 2008, BIOL CHEM, V389, P1137, DOI 10.1515/BC.2008.116
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Sinha Mau, 2013, Int J Pept, V2013, P390230, DOI 10.1155/2013/390230
   TIKASINGH E. S., 1966, AMER J TROP MED HYG, V15, P219
   Tomita M, 2009, BIOCHIMIE, V91, P52, DOI 10.1016/j.biochi.2008.05.021
   van der Strate BWA, 2001, ANTIVIR RES, V52, P225, DOI 10.1016/S0166-3542(01)00195-4
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952
   Wakabayashi H, 2014, J INFECT CHEMOTHER, V20, P666, DOI 10.1016/j.jiac.2014.08.003
   Weinberg ED, 2007, CURR PHARM DESIGN, V13, P801, DOI 10.2174/138161207780363095
NR 40
TC 8
Z9 8
U1 0
U2 6
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-1317
EI 1465-2099
J9 J GEN VIROL
JI J. Gen. Virol.
PD JUL
PY 2017
VL 98
IS 7
BP 1749
EP 1754
DI 10.1099/jgv.0.000849
PG 6
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA FG4SX
UT WOS:000410256900020
PM 28699858
OA Bronze
DA 2020-07-08
ER

PT J
AU Lee, M
   Etebari, K
   Hall-Mendelin, S
   van den Hurk, AF
   Hobson-Peters, J
   Vatipally, S
   Schnettler, E
   Hall, R
   Asgari, S
AF Lee, Morris
   Etebari, Kayvan
   Hall-Mendelin, Sonja
   van den Hurk, Andrew F.
   Hobson-Peters, Jody
   Vatipally, Sreenu
   Schnettler, Esther
   Hall, Roy
   Asgari, Sassan
TI Understanding the role of microRNAs in the interaction of Aedes aegypti
   mosquitoes with an insect-specific flavivirus
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Article
DE insect-specific flavivirus; Palm Creek virus; mosquito; microRNA; piRNA
ID NILE VIRUS-INFECTION; RNA INTERFERENCE; GENE-EXPRESSION; WOLBACHIA USES;
   TRANSMISSION; METHYLTRANSFERASE; ARBOVIRUS; MIRNAS
AB The Flavivirus genus contains some of the most prevalent vector-borne viruses, such as the dengue, Zika and yellow fever viruses that cause devastating diseases in humans. However, the insect-specific Glade of flaviviruses is restricted to mosquito hosts, albeit they have retained the general features of the genus, such as genome structure and replication. The interactions between insect-specific flaviviruses (ISFs) and their mosquito hosts are largely unknown. Pathogenic flaviviruses are known to modulate host-derived microRNAs (miRNAs), a class of non-coding RNAs that are important in controlling gene expression. Alterations in miRNAs may represent changes in host gene expression and promote understanding of virus-host interactions. The role of miRNAs in ISF-mosquito interactions is largely unknown. A recently discovered Australian ISF, Palm Creek virus (PCV), has the ability to suppress medically relevant flaviviruses. Here, we investigated the potential involvement of miRNAs in PCV infection using the model mosquito Aedes aegypti. By combining small-RNA sequencing and bioinformatics analysis, differentially expressed miRNAs were determined. Our results indicated that PCV infection hardly affects host miRNAs. Out of 101 reported miRNAs of Ae. aegypti, only aae-miR-2940-5p had a significantly altered expression over the course of infection. However, further analysis of aae-miR-2940-5p revealed that this miRNA does not have any direct impact on PCV replication in vitro. Thus, overall the results suggest that PCV infection has a limited effect on the mosquito miRNA profile and therefore miRNAs may not play a significant role in the PCV-Ae. aegypti interaction.
C1 [Lee, Morris; Etebari, Kayvan; Asgari, Sassan] Univ Queensland, Australian Infect Dis Res Ctr, Sch Biol Sci, Brisbane, Qld 4072, Australia.
   [Hall-Mendelin, Sonja; van den Hurk, Andrew F.] Queensland Govt, Dept Hlth, Publ Hlth Virol Forens & Sci Serv, POB 594, Archerfield, Qld 4108, Australia.
   [Hobson-Peters, Jody; Hall, Roy] Univ Queensland, Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia.
   [Vatipally, Sreenu; Schnettler, Esther] Univ Glasgow, MRC, Ctr Virus Res, Glasgow G61 1QH, Lanark, Scotland.
   [Schnettler, Esther] Bernhard Nocht Inst Trop Med, Hamburg, Germany.
RP Asgari, S (corresponding author), Univ Queensland, Australian Infect Dis Res Ctr, Sch Biol Sci, Brisbane, Qld 4072, Australia.
EM s.asgari@uq.edu.au
RI van den Hurk, Andrew/X-9831-2019; Etebari, Kayvan/C-6436-2008; Asgari,
   Sassan/G-2678-2011
OI van den Hurk, Andrew/0000-0001-6262-831X; Etebari,
   Kayvan/0000-0001-5213-6362; Asgari, Sassan/0000-0001-7885-6544
FU Australian National Health and Medical Research CouncilNational Health
   and Medical Research Council of Australia [APP1062983]; Medical Research
   Council UKMedical Research Council UK (MRC) [MC_UU_120141/1]; German
   Center for Infection Research grant
FX This project was supported by an Australian National Health and Medical
   Research Council grant (APP1062983) to S. A., a Medical Research Council
   UK grant (MC_UU_120141/1) to S. V. and E. S., and a German Center for
   Infection Research grant to E. S.
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Antoniewski C, 2014, METHODS MOL BIOL, V1173, P135, DOI 10.1007/978-1-4939-0931-5_12
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856
   Calzolari M, 2016, INFECT GENET EVOL, V40, P381, DOI 10.1016/j.meegid.2015.07.032
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Clark DC, 2007, J GEN VIROL, V88, P1175, DOI 10.1099/vir.0.82609-0
   Dennison NJ, 2015, DEV COMP IMMUNOL, V49, P170, DOI 10.1016/j.dci.2014.10.016
   Dietrich I, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005272
   Donald Claire L, 2012, Insects, V3, P511, DOI 10.3390/insects3020511
   Dusi E, 2015, EVOLUTION, V69, P1069, DOI 10.1111/evo.12638
   Goertz GP, 2016, J VIROL, V90, P10145, DOI 10.1128/JVI.00930-16
   Goic B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12410
   Aguiar ERGR, 2016, WIRES RNA, V7, P824, DOI 10.1002/wrna.1361
   Hall-Mendelin S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1683-2
   Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504
   Hess AM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-45
   Hobson-Peters J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056534
   Hussain M, 2011, P NATL ACAD SCI USA, V108, P9250, DOI 10.1073/pnas.1105469108
   Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101
   Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181
   Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2
   Leger P, 2013, J VIROL, V87, P1631, DOI 10.1128/JVI.02795-12
   Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3
   Linsen SEV, 2009, NAT METHODS, V6, P474, DOI 10.1038/nmeth0709-474
   Liu YX, 2016, INSECT SCI, V23, P377, DOI 10.1111/1744-7917.12339
   Liu YX, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0009-y
   Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104
   Maharaj PD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003386
   McFarlane M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002994
   McLean BJ, 2015, VIROLOGY, V486, P272, DOI 10.1016/j.virol.2015.07.021
   Mead EA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-244
   Miesen P, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006017
   Miesen P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004452
   Miesen P, 2015, NUCLEIC ACIDS RES, V43, P6545, DOI 10.1093/nar/gkv590
   Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470
   O'Brien CA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003629
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Schnettler E, 2013, J GEN VIROL, V94, P1680, DOI 10.1099/vir.0.053850-0
   Schnettler E, 2013, J VIROL, V87, P2441, DOI 10.1128/JVI.02848-12
   Scott JC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000848
   Siu RWC, 2011, J VIROL, V85, P2907, DOI 10.1128/JVI.02052-10
   Skalsky RL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-119
   Slonchak A, 2014, J VIROL, V88, P8457, DOI 10.1128/JVI.00317-14
   Stiburek L, 2012, MOL BIOL CELL, V23, P1010, DOI 10.1091/mbc.E11-08-0674
   Tavanez JP, 2014, FUTURE VIROL, V9, P1077, DOI 10.2217/FVL.14.84
   Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299
   Tree MO, 2016, VIROLOGY, V497, P81, DOI 10.1016/j.virol.2016.07.005
   Vodovar N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030861
   Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803
   Zhang GM, 2016, J GEN VIROL, V97, P3427, DOI 10.1099/jgv.0.000653
   Zhang GM, 2014, INSECT BIOCHEM MOLEC, V53, P81, DOI 10.1016/j.ibmb.2014.08.003
   Zhang GM, 2013, P NATL ACAD SCI USA, V110, P10276, DOI 10.1073/pnas.1303603110
NR 54
TC 12
Z9 12
U1 3
U2 15
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-1317
EI 1465-2099
J9 J GEN VIROL
JI J. Gen. Virol.
PD JUL
PY 2017
VL 98
IS 7
BP 1892
EP 1903
DI 10.1099/jgv.0.000832
PG 12
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA FG4SX
UT WOS:000410256900034
PM 28699859
OA Bronze
DA 2020-07-08
ER

PT J
AU Zambrano, LI
   Sierra, M
   Lara, B
   Rodriguez-Nunez, I
   Medina, MT
   Lozada-Riascos, CO
   Rodriguez-Morales, AJ
AF Zambrano, Lysien I.
   Sierra, Manuel
   Lara, Bredy
   Rodriguez-Nunez, Ivan
   Medina, Marco T.
   Lozada-Riascos, Carlos O.
   Rodriguez-Morales, Alfonso J.
TI Estimating and mapping the incidence of dengue and chikungunya in
   Honduras during 2015 using Geographic Information Systems (GIS)
SO JOURNAL OF INFECTION AND PUBLIC HEALTH
LA English
DT Article
DE Dengue; Chikungunya; Arboviruses; Infectious diseases epidemiology;
   Honduras
ID HEALTH-CARE STUDENTS; OUTBREAK IMPLICATIONS; ONE COASTAL; CLIMATE
   VARIABILITY; CHRONIC ARTHRALGIA; WORKERS KNOWLEDGE; PUBLIC-HEALTH; DALY
   LOST; ZIKA; COLOMBIA
AB Geographical information systems (GIS) use for development of epidemiological maps in dengue has been extensively used, however not in other emerging arboviral diseases, nor in Central America. Surveillance cases data (2015) were used to estimate annual incidence rates of dengue and chikungunya (cases/100,000 pop) to develop the first maps in the departments and municipalities of Honduras. The GIS software used was Kosmo Desktop 3.0RC1 (R). Four thematic maps were developed according departments, municipalities, diseases incidence rates. A total of 19,289 cases of dengue and 85,386 of chikungunya were reported (median, 726 cases/week for dengue and 1460 for chikungunya). Highest peaks were observed at weeks 25th and 27th, respectively. There was association between progression by weeks (p < 0.0001). The cumulated crude national rate was estimated in 224.9 cases/100,000 pop for dengue and 995.6 for chikungunya. The incidence rates ratio between chikungunya and dengue is 4.42 (ranging in municipalities from 0.0 up to 893.0 [San Vicente Centenario]). Burden of both arboviral diseases is concentrated in capital Central District(>37%, both). Use of GIS-based epidemiological maps allow to guide decisions-takingfor prevention and control of diseases that still represents significant issues in the region and the country, but also in emerging conditions. (C) 2016 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier Limited. All rights reserved.
C1 [Zambrano, Lysien I.] Univ Nacl Autonoma Honduras, Dept Morphol Sci, Sch Med, Sci, Tegucigalpa, Honduras.
   [Zambrano, Lysien I.] Univ Fed Sao Paulo, Cardiovasc Div, Dept Physiol, Escola Paulista Med UNIFESP EPM, Sao Paulo, Brazil.
   [Sierra, Manuel] HEU, Informat Management Unit, Tegucigalpa, Honduras.
   [Sierra, Manuel] Univ Nacl Autonoma Honduras, Sch Med Sci, Dept Publ Hlth, Tegucigalpa, Honduras.
   [Lara, Bredy] Minist Publ Hlth Honduras SESAL, Hlth Surveillance Unit, Tegucigalpa, Honduras.
   [Rodriguez-Nunez, Ivan] Univ San Sebastian, Fac Ciencias Salud, Escuela Kinesiol, Concepcion, Chile.
   [Medina, Marco T.] Univ Nacl Autonoma Honduras, Sch Med Sci, Tegucigalpa, Honduras.
   [Lozada-Riascos, Carlos O.] UTP, Reg Informat Syst, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.] UTP, Fac Hlth Sci, Res Grp Publ Hlth & Infect, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.] Colombian Assoc Infect Dis, Comm Zoonoses & Hemorrhag Fevers, Asociaci Colombiana Infectol, ACIN, Bogota, Colombia.
   [Rodriguez-Morales, Alfonso J.] Working Grp Zoonoses, Int Soc Chemotherapy, Aberdeen, Scotland.
   [Rodriguez-Morales, Alfonso J.] OLFIS, Santander, Spain.
RP Rodriguez-Morales, AJ (corresponding author), Univ Tecnol Pereira, Fac Ciencias Salud, Dept Med Comunitaria, Piso 3, Pereira, Risaralda, Colombia.
EM arodriguezm@utp.edu.co
RI Zambrano, Lysien/R-5628-2019; Zambrano, Lysien/N-8843-2015; AJ,
   Rodriguez-Morales/R-9765-2016
OI Zambrano, Lysien/0000-0001-9002-5807; Zambrano,
   Lysien/0000-0001-9002-5807; AJ, Rodriguez-Morales/0000-0001-9773-2192;
   Medina, Marco Tulio/0000-0003-0469-054X
FU Universidad Tecnologica de Pereira, Pereira, Risaralda, Colombia
   [5-15-5]; Universidad Tecnologica de Pereira, Pereira, Risaralda,
   Colombia
FX Training on GIS for Alfonso J. Rodriguez-Morales was funded by
   Universidad Tecnologica de Pereira, Pereira, Risaralda, Colombia. This
   study is linked to the project "Desarrollo de Mapas Epidemiologicos a
   traves de Sistemas de Informacion Geografica para la Caracterizacion
   Geografica de Enfermedades Infecciosas y Tropicales en el Eje Cafetero
   de Colombia'' (Code 5-15-5 [2015-2017]), Universidad Tecnologica de
   Pereira, Pereira, Risaralda, Colombia. This study was partially
   presented as an oral dissertation at the 10th Congress of Scientific
   Research of the Universidad Nacional Autonoma de Honduras, Tegucigalpa,
   Honduras, August 2, 2016, being granted with the Shared Award for the
   was evidenced at a linear regression model between dengue and
   chikungunya (r<SUP>2</SUP>= 0.6130; F = 79.21; p < 0.0001).
CR Alfaro-Toloza P, 2015, LANCET INFECT DIS, V15, P510, DOI 10.1016/S1473-3099(15)70160-X
   Cardona-Ospina JA, 2015, INT J INFECT DIS, V38, P60, DOI 10.1016/j.ijid.2015.07.015
   Buekens P, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0200-6
   Cardona-Ospina JA, 2015, T ROY SOC TROP MED H, V109, P793, DOI 10.1093/trstmh/trv094
   Cardona-Ospina JA, 2015, J INFECT PUBLIC HEAL, V8, P644, DOI 10.1016/j.jiph.2015.06.001
   Christofferson RC, 2016, AM J TROP MED HYG, V95, P15, DOI 10.4269/ajtmh.15-0866
   Chu HJ, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-42
   Clouet-Huerta D, 2014, REV CHIL INFECTOL, V31, P761, DOI 10.4067/S0716-10182014000600022
   Deeba F, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftv119
   Diaz Y, 2015, AM J TROP MED HYG, V92, P482, DOI 10.4269/ajtmh.14-0404
   Dyer O, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i630
   Bedoya-Arias JE, 2015, J INFECT DEV COUNTR, V9, P330, DOI 10.3855/jidc.6445
   Figueroa M, 1982, Bull Pan Am Health Organ, V16, P130
   Franco-Paredes C, 2007, AM J TROP MED HYG, V77, P633, DOI 10.4269/ajtmh.2007.77.633
   Hamer D, 2015, W INDIAN MED J, V64, P344, DOI 10.7727/wimj.2014.118
   Herrera-Martinez AD, 2010, TROP BIOMED, V27, P280
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P55, DOI 10.1016/j.tmaid.2015.07.005
   Miller MJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003383
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Murugan K, 2016, ECOTOX ENVIRON SAFE, V132, P283
   Nicoletti L, 2008, EMERG INFECT DIS, V14, P177, DOI 10.3201/eid1401.070618
   Perich MJ, 2001, J AM MOSQUITO CONTR, V17, P221
   Quintero-Herrera LL, 2015, J INFECT PUBLIC HEAL, V8, P291, DOI 10.1016/j.jiph.2014.11.005
   Raut CG, 2015, EMERG INFECT DIS, V21, P908, DOI 10.3201/eid2105.141804
   Rodriguez-Morales AJ, 2015, RHEUMATOL INT, V35, P2091, DOI 10.1007/s00296-015-3302-5
   Rodriguez-Morales AJ, 2016, INT J INFECT DIS, P2009
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P286, DOI 10.1016/j.tmaid.2016.03.018
   Rodriguez-Morales AJ, 2016, INT J INFECT DIS, V48, P70, DOI 10.1016/j.ijid.2016.05.012
   Rodriguez-Morales Alfonso J, 2016, F1000Res, V5, P568, DOI 10.12688/f1000research.8436.1
   Rodriguez-Morales AJ, 2016, CLIN RHEUMATOL, V35, P831, DOI 10.1007/s10067-015-3041-8
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P58, DOI 10.1016/j.tmaid.2015.09.001
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P62, DOI 10.1016/j.tmaid.2015.06.009
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Rodriguez-Morales AJ, 2015, TRAVEL MED INFECT DI, V13, P256, DOI 10.1016/j.tmaid.2015.05.007
   Rodriguez-Morales AJ, 2015, J CLIN VIROL, V66, P60, DOI 10.1016/j.jcv.2015.02.020
   Sabogal-Roman JA, 2016, TRAVEL MED INFECT DI, V14, P52, DOI 10.1016/j.tmaid.2015.12.003
   Sanchez-Duque JA, 2015, P R HEALTH SCI J, V34, P231
   Sardi S, 2016, J CLIN MICROBIOL
   Sarti E, 2016, INT J INFECT DIS, V44, P44, DOI 10.1016/j.ijid.2016.01.015
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Telle O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146539
   Vera-Polania F, 2015, J INFECT PUBLIC HEAL, V8, P386, DOI 10.1016/j.jiph.2015.03.006
   Vera-Polania Felipe, 2014, Recent Pat Antiinfect Drug Discov, V9, P195
   Villamil-Gomez WE, 2016, TRAVEL MED INFECT DI
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Villar LA, 2013, PEDIATR INFECT DIS J, V32, P1102, DOI 10.1097/INF.0b013e31829b8022
   Zambrano H, 2016, AM J TROP MED HYG
   Zambrano LI, 2012, TROP BIOMED, V29, P499
   Zamora Antón, 2015, Rev. perú. med. exp. salud publica, V32, P397
NR 51
TC 7
Z9 7
U1 1
U2 10
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1876-0341
EI 1876-035X
J9 J INFECT PUBLIC HEAL
JI J. Infect. Public Health
PD JUL-AUG
PY 2017
VL 10
IS 4
BP 446
EP 456
DI 10.1016/j.jiph.2016.08.003
PG 11
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA FD7PA
UT WOS:000407716800011
PM 27562685
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Sadarangani, SP
   Lim, PL
   Vasoo, S
AF Sadarangani, Sapna P.
   Lim, Poh Lian
   Vasoo, Shawn
TI Infectious diseases and migrant worker health in Singapore: a receiving
   country's perspective
SO JOURNAL OF TRAVEL MEDICINE
LA English
DT Review
DE Migrant worker; infectious diseases; Singapore; foreign worker; domestic
   worker; health
ID HEPATITIS-A; EPIDEMIOLOGIC CHARACTERISTICS; ENTERTAINMENT WORKERS;
   ERYTHEMATOUS PLAQUES; VIRUS-INFECTION; DEATH-SYNDROME; SEX WORKERS;
   CHIKUNGUNYA; OUTBREAK; DENGUE
AB Background. Approximately 1.4 million migrant workers reside in Singapore, presenting unique infectious disease challenges to both migrants and Singapore.
   Methods. A Pubmed, MEDLINE (Ovid), EBSCO Host (Global Health) and Google Scholar search was performed for both peer, non-peer reviewed articles and reports relevant to migrant health in Singapore, published between 1 January 1989 and 1 September 2016. Additional studies were identified from citations within searched articles. We also reviewed published data and policy documents from the Ministries of Health and Manpower, Singapore.
   Results. A significant proportion of malaria, enteric fevers, hepatitis A and E and tuberculosis diagnosed in Singapore involve migrant workers. From the 1990-2000 through 2009-11, while malaria and hepatitis A cases have decreased and remain sporadic, enteric fevers and tuberculosis cases have increased, possibly due to greater influx of migrant workers. Hepatitis E numbers remain low but migrant workers account for half of diagnosed cases. In an interplay of immune naivete, work and living conditions, migrants in the construction industry are at higher risk of arboviral infections such as dengue, Zika and chikungunya. Infections such as chikungunya were likely introduced into Singapore by travellers including migrant workers from the Indian subcontinent but autochthonous transmission continued due to the presence of competent mosquito vectors. There is less data regarding sexual health, networks and infections amongst migrant workers, an area which merits further attention.
   Conclusions. Migrant workers appear to be at higher risk than Singaporeans for specific infectious diseases, probably due to a complex interplay of several factors, including higher disease prevalence in their countries of origin, socio-economic factors, their living conditions in Singapore and financial, language and cultural barriers to healthcare access. Receiving countries need improved surveillance, expansion of preventive measures and decreased barriers to healthcare access for migrant workers.
C1 [Sadarangani, Sapna P.; Lim, Poh Lian; Vasoo, Shawn] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
   [Sadarangani, Sapna P.; Lim, Poh Lian; Vasoo, Shawn] Tan Tock Seng Hosp, Communicable Dis Ctr, Inst Infect Dis & Epidemiol, Dept Infect Dis, Moulmein Rd, Singapore 308433, Singapore.
RP Vasoo, S (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.; Vasoo, S (corresponding author), Tan Tock Seng Hosp, Communicable Dis Ctr, Inst Infect Dis & Epidemiol, Dept Infect Dis, Moulmein Rd, Singapore 308433, Singapore.
EM shawn_vasoo@ttsh.com.sg
OI Sadarangani, Sapna/0000-0002-8781-0713
CR Abraham G., 1997, Annals Academy of Medicine Singapore, V26, P713
   [Anonymous], REUTERS
   Chai LY, 2007, ANN ACAD MED SINGAP, V36, P847
   Chan Kwai Peng, 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P408
   Chan M, 2013, ANN ACAD MED SINGAP, V42, P257
   Chan O Y, 1987, Ann Acad Med Singapore, V16, P586
   CHEE CBE, 2007, MINISTRY HLTH EPIDEM, V33, P50
   Chee CBE, 2015, EMERG INFECT DIS, V21, P179, DOI 10.3201/eid2101.141159
   Chee CBE, 2013, EMERG INFECT DIS, V19, P1151, DOI 10.3201/eid1907.120372
   Chen K., 1999, Annals Academy of Medicine Singapore, V28, P199
   Chen MIC, 2001, CHARACTERISTICS 19 S, V42, P553
   Chew LL, 2013, J CLIN ULTRASOUND, V41, P377, DOI 10.1002/jcu.21966
   Chua Angeline Poh-Gek, 2015, BMJ Case Rep, V2015, DOI 10.1136/bcr-2015-210961
   Chuah SY, 2013, ANN ACAD MED SINGAP, V42, P419
   Foo SS, 2008, SINGAP MED J, V49, pE147
   GOH KT, 1984, INT J EPIDEMIOL, V13, P210, DOI 10.1093/ije/13.2.210
   GOH KT, 1993, J MED VIROL, V41, P146, DOI 10.1002/jmv.1890410210
   GOH KT, 1993, INT J EPIDEMIOL, V22, P88, DOI 10.1093/ije/22.1.88
   HENG BH, 1994, EPIDEMIOL INFECT, V113, P121, DOI 10.1017/S0950268800051530
   Himmunngan Pensiri, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P357
   Ho KW, 2011, J INFECTION, V62, P263, DOI 10.1016/j.jinf.2011.02.001
   Hsu P, 2009, TRADING OFF HEALTH F
   Johansson P, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-15
   Lee CH, 2013, INT J CARDIOL, V166, P696, DOI 10.1016/j.ijcard.2011.11.103
   Lee GKM, 2010, ANN ACAD MED SINGAP, V39, P764
   Lee HC, 2011, ANN ACAD MED SINGAP, V40, P439
   Lee L. S. U., 2004, SMJ Singapore Medical Journal, V45, P227
   Lee WX, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-300
   Lee Y, 2009, ANN ACAD MED SINGAP, V38, P840
   Leo YS, 2016, LANCET INFECT DIS, V16, P1317, DOI 10.1016/S1473-3099(16)30448-0
   Lew JWS, 2007, SINGAP MED J, V48, P111
   Lim PL, 2009, J TRAVEL MED, V16, P289, DOI 10.1111/j.1708-8305.2009.00313.x
   Lim RBT, 2017, SEX TRANSM INFECT, V93, P118, DOI 10.1136/sextrans-2015-052530
   Lin Yj, 2016, EPIDEMIOL NEWS B, V42, P49
   Lingegowda BP, 2011, SINGAP MED J, V52, pE160
   Loh K, 1996, SINGAP MED J, V37, P38
   Maurer-Stroh S, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.38.30347
   Ministry of Health, 2014, EPIDEMIOL NEWS B, V40, P68
   Ministry of Health, 2015, COMM DIS SURV SING 2
   Ministry of Health, 2004, EPIDEMIOL NEWS B, V30, P32
   Ministry of Health Singapore, 2006, EPIDEMIOL NEWS B, V32, P33
   Ministry of Health Singapore, 2011, EPIDEMIOL NEWS B, V37, P18
   Ministry of Health Singapore, PREV DIAGN TREATM TU
   Ministry of Health Singapore, 2007, EPIDEMIOL NEWS B, V33, P63
   Ministry of Health Singapore, COMM DIS SURV SING 2
   Ministry of Health Singapore, EPIDEMIOLOGICAL NEWS
   Ministry of Manpower Singapore, WORK PASS PERM
   Ministry of Manpower Singapore, FOR WORKF NUMB
   Ministry of Manpower Singapore, 6 MONTHL MED EX 6ME
   Ministry of Manpower Singapore, SING INT TASKF TRAFF
   National Environment Agency, DENG UPD STOP WORK O
   Ng LC, 2013, ANN ACAD MED SINGAP, V42, P696
   Ng LC, 2009, EMERG INFECT DIS, V15, P1243, DOI 10.3201/eid1508.081486
   Ngeow Y, 2002, JUNMEC, V1, P67
   Ong A. K. Y., 2001, SMJ Singapore Medical Journal, V42, P549
   Oon LLE, 2014, ANN ACAD MED SINGAP, V43, P325
   Parliament of Singapore-Offical reports, PARL DEB POL PROST
   Phua CK, 2011, ANN ACAD MED SINGAP, V40, P132
   Phua KH, SOCIAL EC COSTS MIGR
   Project X, SIT SING
   Sadarangani SP, 2016, ANN ACAD MED SINGAP, V45, P381
   Sangwatanaroj Somkiat, 2006, J Med Assoc Thai, V89 Suppl 3, pS213
   Seet RCS, 2005, J CLIN VIROL, V33, P336, DOI 10.1016/j.jcv.2005.03.002
   Tam CC, 2016, LANCET, V388, P1374, DOI 10.1016/S0140-6736(16)31645-2
   Tan CH, 2011, VECTOR-BORNE ZOONOT, V11, P383, DOI 10.1089/vbz.2010.0022
   Tan H. H., 2000, SMJ, V41, P179
   Tan LTC, 2013, J INFECTION, V66, P453, DOI 10.1016/j.jinf.2012.11.015
   Tan SK, 2010, ANN ACAD MED SINGAP, V39, P503
   The Straits Times, STRAITS TIMES
   Theng TSC, 2006, INT J STD AIDS, V17, P395, DOI 10.1258/095646206777323364
   TODAY, TODAY
   Tow C, 2016, EPIDEMIOL NEWS B, V42, P116
   Transient Workers Count Too, CHICK POX TWC2 STOPP
   Ty AU, 2010, ANN ACAD MED SINGAP, V39, P889
   United Nations Department of Economic and Social Affairs, 2015, INT MIGR REP 2015 HI
   United Nations Development Programme (UNDP), 2008, HIV AIDS MOB S E AS, V66
   Wasserman S, 2016, INT J INFECT DIS, V48, P98, DOI 10.1016/j.ijid.2016.04.025
   Win KMK, 2011, EMERG INFECT DIS, V17, P517, DOI 10.3201/eid1703.101615
   Wong A. S. C., 1997, SMJ, V38, P297
   Wong CS, 2010, ANN ACAD MED SINGAP, V39, P507
   Wong ML, 2012, J URBAN HEALTH, V89, P1031, DOI 10.1007/s11524-012-9723-5
   Wong ML, 2004, AIDS, V18, P1195, DOI 10.1097/00002030-200405210-00013
   WONG T-W, 1985, Southeast Asian Journal of Tropical Medicine and Public Health, V16, P525
   WONG TW, 1989, T ROY SOC TROP MED H, V83, P248, DOI 10.1016/0035-9203(89)90666-4
   Yoshikawa Minako Jen, 2013, Trop Med Health, V41, P61, DOI 10.2149/tmh.2011-04
   Yung CF, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1662-4
   Zowawi HM, 2013, CLIN MICROBIOL REV, V26, P361, DOI 10.1128/CMR.00096-12
NR 87
TC 22
Z9 23
U1 1
U2 29
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1195-1982
EI 1708-8305
J9 J TRAVEL MED
JI J. Travel Med.
PD JUL-AUG
PY 2017
VL 24
IS 4
AR UNSP tax014
DI 10.1093/jtm/tax014
PG 9
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Medicine, General & Internal
SC Public, Environmental & Occupational Health; Infectious Diseases;
   General & Internal Medicine
GA EU3BQ
UT WOS:000400904000007
PM 28426114
OA Bronze
DA 2020-07-08
ER

PT J
AU Wilder-Smith, A
   Leong, WY
AF Wilder-Smith, Annelies
   Leong, W. Y.
TI Importation of yellow fever into China: assessing travel patterns
SO JOURNAL OF TRAVEL MEDICINE
LA English
DT Article
DE Yellow fever; international health regulations; air travel; importation;
   proof of yellow fever vaccination
ID DENGUE OUTBREAK; ZIKA VIRUS; AIR-TRAVEL; SPREAD; ORIGIN
AB Rapid increase in trade and a growing air passenger market encourages high travel volume between the regions associated with increasing risks of such importations including China. Eleven Chinese workers infected during the 2016 yellow fever (YF) outbreak in Angola imported YF into China highlighting the potential for spread into Asia. Using outbound and inbound travel data, we assessed travel patterns from and to YF endemic countries in relation to China. Among YF endemic countries, Angola has the second highest number of travellers into China and also receives the second highest number of Chinese visitors. We estimated that China needs around half a million YF vaccine doses to cover their population travelling to YF endemic countries. The recent importation cases into China also unmasked the low YF vaccination coverage among Chinese travellers and workers to Angola, indicating the need to ensure better adherence to the International Health Regulations.
C1 [Wilder-Smith, Annelies; Leong, W. Y.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
   [Wilder-Smith, Annelies] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany.
   [Wilder-Smith, Annelies] London Sch Hyg & Trop Med, Infect & Trop Dis, London, England.
RP Wilder-Smith, A (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.; Wilder-Smith, A (corresponding author), Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany.; Wilder-Smith, A (corresponding author), London Sch Hyg & Trop Med, Infect & Trop Dis, London, England.
EM anneliesws@gmail.com
RI Wilder-Smith, Annelies/F-8751-2015
CR [Anonymous], 2016, EM PREP RESP
   Glaesser D, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax007
   Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Khan K, 2009, NEW ENGL J MED, V361, P212, DOI 10.1056/NEJMc0904559
   Lopez LF, 2016, B MATH BIOL, V78, P185, DOI 10.1007/s11538-015-0135-z
   Mackenzie J S, 1998, Commun Dis Intell, V22, P93
   Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669
   Massad E, 2009, J TRAVEL MED, V16, P191, DOI 10.1111/j.1708-8305.2009.00310.x
   Monath TP, 2016, LANCET, V387, P1599, DOI 10.1016/S0140-6736(16)30195-7
   Quam MB, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw059
   Quam MB, 2016, AM J TROP MED HYG, V94, P409, DOI 10.4269/ajtmh.15-0468
   Quam MB, 2015, J TRAVEL MED, V22, P186, DOI 10.1111/jtm.12192
   Quam MB, 2015, J TRAVEL MED, V22, P72, DOI 10.1111/jtm.12177
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Sessions OM, 2013, GLOBAL HEALTH ACTION, V6, DOI 10.3402/gha.v6i0.21822
   Tatem AJ, 2012, PARASITOLOGY, V139, P1816, DOI 10.1017/S0031182012000352
   UNWTO, TOURISM STAT
   Wilder-Smith A, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.8.20718
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P1109, DOI 10.1016/S1473-3099(17)30494-2
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P248, DOI 10.1016/S1473-3099(16)30588-6
   Wilder-Smith A, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0363-y
   World Bank, 2015, WORLD DEV IND
   World Health Organization (WHO), 2016, EM PREP RESP YELL FE
   Zhang J., 2016, J TRAVEL MED, V23
NR 25
TC 34
Z9 34
U1 1
U2 8
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1195-1982
EI 1708-8305
J9 J TRAVEL MED
JI J. Travel Med.
PD JUL-AUG
PY 2017
VL 24
IS 4
AR tax008
DI 10.1093/jtm/tax008
PG 4
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Medicine, General & Internal
SC Public, Environmental & Occupational Health; Infectious Diseases;
   General & Internal Medicine
GA EU3BQ
UT WOS:000400904000004
PM 28426111
OA Bronze
DA 2020-07-08
ER

PT J
AU Chaudhary, V
   Yuen, KS
   Chan, JFW
   Chan, CP
   Wang, PH
   Cai, JP
   Zhang, S
   Liang, MF
   Kok, KH
   Chan, CP
   Yuen, KY
   Jin, DY
AF Chaudhary, Vidyanath
   Yuen, Kit-San
   Chan, Jasper Fuk-Woo
   Chan, Ching-Ping
   Wang, Pei-Hui
   Cai, Jian-Piao
   Zhang, Shuo
   Liang, Mifang
   Kok, Kin-Hang
   Chan, Chi-Ping
   Yuen, Kwok-Yung
   Jin, Dong-Yan
TI Selective Activation of Type II Interferon Signaling by Zika Virus NS5
   Protein
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE Zika virus; NS5 protein; type II interferon; STAT1; STAT2
ID ANTIVIRAL RESPONSES; GAMMA RECEPTOR; IFN-GAMMA; INFECTION;
   TRANSCRIPTION; CELLS; STAT2; GENE; IDENTIFICATION; INHIBITION
AB Severe complications of Zika virus (ZIKV) infection might be caused by inflammation, but how ZIKV induces proinflammatory cytokines is not understood. In this study, we show opposite regulatory effects of the ZIKV NS5 protein on interferon (IFN) signaling. Whereas ZIKV and its NS5 protein were potent suppressors of type I and type III IFN signaling, they were found to activate type II IFN signaling. Inversely, IFN-gamma augmented ZIKV replication. NS5 interacted with STAT2 and targeted it for ubiquitination and degradation, but it had no influence on STAT1 stability or nuclear translocation. The recruitment of STAT1-STAT2-IRF9 to IFN-beta-stimulated genes was compromised when NS5 was expressed. Concurrently, the formation of STAT1-STAT1 homodimers and their recruitment to IFN-gamma-stimulated genes, such as the gene encoding the proinflammatory cytokine CXCL10, were augmented. Silencing the expression of an IFN-gamma receptor subunit or treatment of ZIKV-infected cells with a JAK2 inhibitor suppressed viral replication and viral induction of IFN-gamma-stimulated genes. Taken together, our findings provide a new mechanism by which the ZIKV NS5 protein differentially regulates IFN signaling to facilitate viral replication and cause diseases. This activity might be shared by a group of viral IFN modulators.
   IMPORTANCE Mammalian cells produce three types of interferons to combat viral infection and to control host immune responses. To replicate and cause diseases, pathogenic viruses have developed different strategies to defeat the action of host interferons. Many viral proteins, including the Zika virus (ZIKV) NS5 protein, are known to be able to suppress the antiviral property of type I and type III interferons. Here we further show that the ZIKV NS5 protein can also boost the activity of type II interferon to induce cellular proteins that promote inflammation. This is mediated by the differential effect of the ZIKV NS5 protein on a pair of cellular transcription factors, STAT1 and STAT2. NS5 induces the degradation of STAT2 but promotes the formation of STAT1-STAT1 protein complexes, which activate genes controlled by type II interferon. A drug that specifically inhibits the IFN-gamma receptor or STAT1 shows an anti-ZIKV effect and might also have anti-inflammatory activity.
C1 [Chaudhary, Vidyanath; Yuen, Kit-San; Chan, Ching-Ping; Wang, Pei-Hui; Chan, Chi-Ping; Jin, Dong-Yan] Univ Hong Kong, Sch Biomed Sci, Pokfulam, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; Cai, Jian-Piao; Kok, Kin-Hang; Yuen, Kwok-Yung] Univ Hong Kong, State Key Lab Emerging Infect Dis, Pokfulam, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; Cai, Jian-Piao; Kok, Kin-Hang; Yuen, Kwok-Yung] Univ Hong Kong, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China.
   [Zhang, Shuo; Liang, Mifang] Chinese Ctr Dis Control & Prevent, Key Lab Med Virol, Beijing, Peoples R China.
   [Zhang, Shuo; Liang, Mifang] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.
RP Jin, DY (corresponding author), Univ Hong Kong, Sch Biomed Sci, Pokfulam, Hong Kong, Peoples R China.
EM dyjin@hku.hk
RI Wang, Pei-Hui/F-7682-2014; Chan, Chi Ping/AAB-9463-2020; Chan, Jasper F.
   W./D-8007-2013; Kok, Kin-Hang/C-4184-2009; Jin, Dong-Yan/C-4287-2009
OI Wang, Pei-Hui/0000-0001-6853-2423; Chan, Jasper F.
   W./0000-0001-6336-6657; Yuen, Kwok-yung/0000-0002-2083-1552;
   /0000-0003-3426-332X; Jin, Dong-Yan/0000-0002-2778-3530; Chan, Chi
   Ping/0000-0001-6876-0864
FU Hong Kong Health and Medical Research Fund [HKM-15-M01]; Hong Kong
   Research Grants CouncilHong Kong Research Grants Council [N-HKU 714/12,
   C7011-15R, T11-707/15-R]; Government of Hong Kong [ZIKA-HKU];
   Collaborative Innovation Center for Diagnosis and Treatment of
   Infectious Diseases, Ministry of Education of China
FX This work was supported by the Hong Kong Health and Medical Research
   Fund (grant HKM-15-M01), the Hong Kong Research Grants Council (grants
   N-HKU 714/12, C7011-15R, and T11-707/15-R), the Government of Hong Kong
   (grant ZIKA-HKU), and the Collaborative Innovation Center for Diagnosis
   and Treatment of Infectious Diseases, Ministry of Education of China.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Beachboard DC, 2016, CURR OPIN MICROBIOL, V32, P113, DOI 10.1016/j.mib.2016.05.015
   Begitt A, 2014, NAT IMMUNOL, V15, P168, DOI 10.1038/ni.2794
   Best SM, 2017, J VIROL, V91, DOI [10.1128/JVI.01970-16, 10.1128/jvi.01970-16]
   Blaszczyk K, 2016, CYTOKINE GROWTH F R, V29, P71, DOI 10.1016/j.cytogfr.2016.02.010
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Chaudhary V, 2015, J GEN VIROL, V96, P3204, DOI 10.1099/jgv.0.000280
   Cheng Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep23938
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Danthi P, 2016, ANNU REV VIROL, V3, P533, DOI 10.1146/annurev-virology-110615-042435
   Deng JJ, 2017, BBA-GENE REGUL MECH, V1860, P491, DOI 10.1016/j.bbagrm.2017.02.007
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   FU XY, 1992, P NATL ACAD SCI USA, V89, P7840, DOI 10.1073/pnas.89.16.7840
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Ho J, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000117
   Ho TH, 2016, J VIROL, V90, P1557, DOI 10.1128/JVI.02161-15
   Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002
   Jordan TX, 2017, J VIROL, V91, DOI 10.1128/JVI.02020-16
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lazear HM, 2015, IMMUNITY, V43, P15, DOI 10.1016/j.immuni.2015.07.001
   LEUNG S, 1995, MOL CELL BIOL, V15, P1312
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lui PY, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.33
   Maurer-Stroh S, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.38.30347
   Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Morrison Juliet, 2014, JAKSTAT, V3, pe27715, DOI 10.4161/jkst.27715
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Ng SL, 2011, P NATL ACAD SCI USA, V108, P21170, DOI 10.1073/pnas.1119137109
   Oda K, 2015, J VIROL, V89, P11487, DOI 10.1128/JVI.01887-15
   OHMORI Y, 1995, J IMMUNOL, V154, P5235
   Olagnier D, 2016, DNA CELL BIOL, V35, P367, DOI 10.1089/dna.2016.3404
   Park C, 2000, IMMUNITY, V13, P795, DOI 10.1016/S1074-7613(00)00077-7
   Pingen M, 2016, IMMUNITY, V44, P1455, DOI 10.1016/j.immuni.2016.06.002
   Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604
   Plazolles N, 2011, J LEUKOCYTE BIOL, V89, P329, DOI 10.1189/jlb.0710386
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reich NC, 2007, CYTOKINE GROWTH F R, V18, P511, DOI 10.1016/j.cytogfr.2007.06.021
   Saha B, 2010, CYTOKINE, V50, P1, DOI 10.1016/j.cyto.2009.11.021
   Shih SR, 2004, J NEUROVIROL, V10, P293, DOI 10.1080/13550280490499551
   SHUAI K, 1992, SCIENCE, V258, P1808, DOI 10.1126/science.1281555
   Siddharthan V, 2017, VIROLOGY, V507, P89, DOI 10.1016/j.virol.2017.04.013
   Siu KL, 2009, J BIOL CHEM, V284, P16202, DOI 10.1074/jbc.M109.008227
   SOH J, 1994, CELL, V76, P793, DOI 10.1016/0092-8674(94)90354-9
   Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013
   Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400
   Tang HMV, 2015, J VIROL, V89, P8623, DOI 10.1128/JVI.01229-15
   Tang HMV, 2014, NUCLEIC ACIDS RES, V42, P12455, DOI 10.1093/nar/gku925
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   VALENTE G, 1992, EUR J IMMUNOL, V22, P2403, DOI 10.1002/eji.1830220933
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weisblum Y, 2011, J VIROL, V85, P13204, DOI 10.1128/JVI.05749-11
   Xie XP, 2016, CELL HOST MICROBE, V19, P566, DOI 10.1016/j.chom.2016.04.019
   Yamaguchi H, 1999, BIOCHEM J, V340, P767, DOI 10.1042/0264-6021:3400767
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yun SI, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00800-16
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 78
TC 44
Z9 46
U1 4
U2 20
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JUL
PY 2017
VL 91
IS 14
AR UNSP e00163
DI 10.1128/JVI.00163-17
PG 17
WC Virology
SC Virology
GA FA5EP
UT WOS:000405465700005
PM 28468880
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Lowe, R
   Stewart-Ibarra, AM
   Petrova, D
   Garcia-Diez, M
   Borbor-Cordova, MJ
   Mejia, R
   Regato, M
   Rodo, X
AF Lowe, Rachel
   Stewart-Ibarra, Anna M.
   Petrova, Desislava
   Garcia-Diez, Markel
   Borbor-Cordova, Mercy J.
   Mejia, Raul
   Regato, Mary
   Rodo, Xavier
TI Climate services for health: predicting the evolution of the 2016 dengue
   season in Machala, Ecuador
SO LANCET PLANETARY HEALTH
LA English
DT Article
AB Background El Nino and its effect on local meteorological conditions potentially influences interannual variability in dengue transmission in southern coastal Ecuador. El Oro province is a key dengue surveillance site, due to the high burden of dengue, seasonal transmission, co-circulation of all four dengue serotypes, and the recent introduction of chikungunya and Zika. In this study, we used climate forecasts to predict the evolution of the 2016 dengue season in the city of Machala, following one of the strongest El Nino events on record.
   Methods We incorporated precipitation, minimum temperature, and Nino3.4 index forecasts in a Bayesian hierarchical mixed model to predict dengue incidence. The model was initiated on Jan 1, 2016, producing monthly dengue forecasts until November, 2016. We accounted for misreporting of dengue due to the introduction of chikungunya in 2015, by using active surveillance data to correct reported dengue case data from passive surveillance records. We then evaluated the forecast retrospectively with available epidemiological information.
   Findings The predictions correctly forecast an early peak in dengue incidence in March, 2016, with a 90% chance of exceeding the mean dengue incidence for the previous 5 years. Accounting for the proportion of chikungunya cases that had been incorrectly recorded as dengue in 2015 improved the prediction of the magnitude of dengue incidence in 2016.
   Interpretation This dengue prediction framework, which uses seasonal climate and El Nino forecasts, allows a prediction to be made at the start of the year for the entire dengue season. Combining active surveillance data with routine dengue reports improved not only model fit and performance, but also the accuracy of benchmark estimates based on historical seasonal averages. This study advances the state-of-the-art of climate services for the health sector, by showing the potential value of incorporating climate information in the public health decision-making process in Ecuador. Copyright (C) The Author(s). Published by Elsevier Ltd.
C1 [Lowe, Rachel] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England.
   [Lowe, Rachel] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Keppel St, London WC1E 7HT, England.
   [Lowe, Rachel; Petrova, Desislava; Rodo, Xavier] Barcelona Inst Global Hlth ISGLOBAL, CLIMA Climate & Hlth Programme, Barcelona, Spain.
   [Stewart-Ibarra, Anna M.] SUNY Upstate Med Univ, Ctr Global Hlth & Translat Sci, Syracuse, NY 13210 USA.
   [Stewart-Ibarra, Anna M.] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA.
   [Garcia-Diez, Markel] Predictia Intelligent Data Solut, Santander, Spain.
   [Borbor-Cordova, Mercy J.] Escuela Super Politecn Litoral ESPOL, Sch Maritime Engn Biol Sci Ocean & Nat Resources, Guayaquil, Ecuador.
   [Mejia, Raul] Natl Inst Meteorol & Hydrol INAMHI, Guayaquil, Ecuador.
   [Regato, Mary] Natl Inst Publ Hlth Res INSPI, Minist Hlth, Guayaquil, Ecuador.
   [Rodo, Xavier] ICREA, Barcelona, Spain.
RP Lowe, R (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Keppel St, London WC1E 7HT, England.
EM rachel.lowe@lshtm.ac.uk
RI Rodo, Xavier/F-7663-2017
OI Rodo, Xavier/0000-0003-4843-6180; Borbor, Mercy/0000-0002-7418-141X;
   Stewart-Ibarra, Anna/0000-0002-3383-4672; Lowe,
   Rachel/0000-0003-3939-7343; REGATO, MARY/0000-0001-9541-5329
FU DENFREE project (FP7-HEALTH.2011.2.3.3-2) - European Commission's
   Seventh Framework Research ProgrammeEuropean Union (EU) [282378];
   EUPORIAS project (FP7-ENV.2012.6.1-1) - European Commission's Seventh
   Framework Research ProgrammeEuropean Union (EU) [308291]; PICAT project
   - PERIS call from the Ministry of Health, Government of Catalonia; Royal
   Society Dorothy Hodgkin FellowshipRoyal Society of London; NSFNational
   Science Foundation (NSF) [DEB EEID 1518681, DEB RAPID 1641145]
FX The research leading to these results was supported by the DENFREE
   project (FP7-HEALTH.2011.2.3.3-2; 282378) and EUPORIAS project
   (FP7-ENV.2012.6.1-1; 308291), funded by the European Commission's
   Seventh Framework Research Programme, and the PICAT project funded by
   the PERIS call from the Ministry of Health, Government of Catalonia. RL
   acknowledges funding from a Royal Society Dorothy Hodgkin Fellowship.
   AMS-I was supported by NSF DEB EEID 1518681 and NSF DEB RAPID 1641145.
   We thank Jefferson Adrian, Naveed Heydari, Elizabeth McMahon, and
   Eduardo Jurado who helped compile the data. We thank Trevor C Bailey for
   fruitful discussions about quantifying forecast uncertainty. We also
   thank the four anonymous reviewers who helped strengthen the arguments
   of this Article.
CR Ballester J, 2016, ANN NY ACAD SCI, V1382, P8, DOI 10.1111/nyas.13129
   Barnston AG, 2012, B AM METEOROL SOC, V93, P631, DOI 10.1175/BAMS-D-11-00111.1
   Borbor-Cordova M, 2016, CLIMATE SERVICES HLT
   Carrington LB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002190
   Climate Prediction Center, COLD WARM EP SEAS
   Couret J, 2014, BMC ECOL, V14, DOI 10.1186/1472-6785-14-3
   Recalde-Coronel GC, 2014, J APPL METEOROL CLIM, V53, P1471, DOI 10.1175/JAMC-D-13-0133.1
   de Guenni LB, 2017, THEOR APPL CLIMATOL, V129, P1059, DOI 10.1007/s00704-016-1828-4
   Doblas-Reyes FJ, 2013, WIRES CLIM CHANGE, V4, P245, DOI 10.1002/wcc.217
   Eastin MD, 2014, AM J TROP MED HYG, V91, P598, DOI 10.4269/ajtmh.13-0303
   Guemas V, 2015, Q J ROY METEOR SOC, V141, P580, DOI 10.1002/qj.2379
   Ibarra AMS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078263
   Kovats RS, 2003, LANCET, V362, P1481, DOI 10.1016/S0140-6736(03)14695-8
   KUHN K, 2005, USING CLIMATE PREDIC
   Lowe R, 2016, ELIFE, V5, DOI 10.7554/eLife.11285
   Lowe R, 2016, STOCH ENV RES RISK A, V30, P2067, DOI 10.1007/s00477-015-1053-1
   Lowe R, 2014, LANCET INFECT DIS, V14, P619, DOI 10.1016/S1473-3099(14)70781-9
   Lowe R, 2013, STAT MED, V32, P864, DOI 10.1002/sim.5549
   Mitchell C., 2016, ZIKA CUMULATIVE CASE
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Munoz AG, 2010, B AM METEOROL SOC, V91, P1645, DOI 10.1175/2010BAMS2958.1
   PAHO, NUMB REP CAS CHIK FE
   Petrova D, 2017, CLIM DYNAM, V48, P1249, DOI 10.1007/s00382-016-3139-y
   Pontes RJS, 2000, AM J TROP MED HYG, V62, P378, DOI 10.4269/ajtmh.2000.62.378
   Quintero J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-38
   Rossel F, 2009, HYDROL PROCESS, V23, P3253, DOI 10.1002/hyp.7401
   Saha S, 2014, J CLIMATE, V27, P2185, DOI 10.1175/JCLI-D-12-00823.1
   Sarachik E. S., 2010, NINO SO OSCILLATION
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Ibarra AMS, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1135
   Stewart-Ibarra AM, 2017, BIORXIV
   Stewart-Ibarra AM, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0610-4
   Stewart-Ibarra AM, 2013, AM J TROP MED HYG, V88, P971, DOI 10.4269/ajtmh.12-0478
   WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143
   Watts N, 2017, LANCET, V389, P1151, DOI 10.1016/S0140-6736(16)32124-9
   Wetterhall F, 2012, NONLINEAR PROC GEOPH, V19, P623, DOI 10.5194/npg-19-623-2012
   World Meteorological Organisation, 2016, CLIM SERV HLTH CAS S
   YASUNO M, 1970, B WORLD HEALTH ORGAN, V43, P319
NR 38
TC 27
Z9 27
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
EI 2542-5196
J9 LANCET PLANET HEALTH
JI Lancet Planet. Health
PD JUL
PY 2017
VL 1
IS 4
BP E142
EP E151
DI 10.1016/S2542-5196(17)30064-5
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA VJ0OA
UT WOS:000525849200008
PM 29851600
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Zea-Vera, AF
   Parra, B
AF Zea-Vera, A. F.
   Parra, B.
TI Zika virus (ZIKV) infection related with immune thrombocytopenic purpura
   (ITP) exacerbation and antinuclear antibody positivity
SO LUPUS
LA English
DT Article
DE Immune thrombocytopenic purpura; Zika virus; severe thrombocytopenia
ID DENGUE
AB A 30-year-old Colombian woman with past history of immune thrombocytopenia (ITP) presented to the emergency room with two days of global headache, arthralgia, myalgia, and low level fever and generalized erythematous rash. Platelets dropped to 9x10(9)/L (fourth day of symptoms) without hemorrhagic manifestations but recovered to 30x10(9)/L in 24 hours (fifth day). Dengue virus infection, as well as other viral infections, was ruled out. Zika virus (ZIKV) was evaluated in serum and urine samples by real-time reverse-transcriptase polymerase chain reaction (genomic regions within E protein and NS2b protein). Urine sample was positive and serum sample negative for ZIKV, confirming a recent ZIKV infection with urinary tract virus excretion at 7(th) day after disease onset. To our knowledge this is the first description of a case of severe immune thrombocytopenia exacerbation and antinuclear antibody positivity induced by ZIKV infection.
C1 [Zea-Vera, A. F.; Parra, B.] Univ Valle, Hlth Fac, Dept Microbiol, Cali, Colombia.
RP Zea-Vera, AF (corresponding author), Univ Valle, Hlth Fac, Dept Microbiol, Cali, Colombia.
EM andres.zea@correounivalle.edu.co
OI Zea-Vera, Andres Felipe/0000-0001-9127-3677
FU VIREM research group at Universidad del Valle, Cali, Colombia
FX The authors disclosed receipt of the following financial support for the
   research, authorship, and/or publication of this article: the VIREM
   research group at Universidad del Valle, Cali, Colombia, funded this
   research.
CR Amancio FF, 2014, REV INST MED TROP SP, V56, P267, DOI 10.1590/S0036-46652014000300014
   Cooper N, 2006, BRIT J HAEMATOL, V133, P364, DOI 10.1111/j.1365-2141.2006.06024.x
   DiMaggio D, 2009, BRIT J HAEMATOL, V146, P104, DOI 10.1111/j.1365-2141.2009.07714.x
   Jin CQ, 2012, INT J LAB HEMATOL, V34, P164, DOI 10.1111/j.1751-553X.2011.01375.x
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Musso D, 2016, LANCET, V387, P1812, DOI 10.1016/S0140-6736(16)30317-8
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Ramirez-Fonseca Tania, 2015, Bol Asoc Med P R, V107, P51
   Rinaldi M, 2014, LUPUS, V23, P554, DOI 10.1177/0961203313499959
   RodriguezAngulo EM, 1997, REV INVEST CLIN, V49, P47
   Shimanovsky A, 2016, MEDITERR J HEMATOL I, V8, DOI 10.4084/MJHID.2016.010
NR 13
TC 8
Z9 9
U1 0
U2 4
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0961-2033
EI 1477-0962
J9 LUPUS
JI Lupus
PD JUL
PY 2017
VL 26
IS 8
BP 890
EP 892
DI 10.1177/0961203316671816
PG 3
WC Rheumatology
SC Rheumatology
GA EW4FO
UT WOS:000402457600013
PM 27694629
DA 2020-07-08
ER

PT J
AU Jiang, Y
   Patel, CD
   Manivanh, R
   North, B
   Backes, IM
   Posner, DA
   Gilli, F
   Pachner, AR
   Nguyen, LN
   Leib, DA
AF Jiang, Yike
   Patel, Chaya D.
   Manivanh, Richard
   North, Brian
   Backes, Iara M.
   Posner, David A.
   Gilli, Francesca
   Pachner, Andrew R.
   Nguyen, Lananh N.
   Leib, David A.
TI Maternal Antiviral Immunoglobulin Accumulates in Neural Tissue of
   Neonates To Prevent HSV Neurological Disease
SO MBIO
LA English
DT Article
DE herpes simplex virus; maternal antibody; neonatal infection;
   neuroimmunology; trigeminal ganglion
ID HERPES-SIMPLEX-VIRUS; HUMAN TRIGEMINAL GANGLIA;
   POLYMERASE-CHAIN-REACTION; VARICELLA-ZOSTER-VIRUS; TYPE-1 CORNEAL
   INFECTION; PRIMARY SENSORY NEURONS; GAMMA RECEPTOR-I; G FC-RECEPTOR;
   NERVOUS-SYSTEM; ZIKA VIRUS
AB While antibody responses to neurovirulent pathogens are critical for clearance, the extent to which antibodies access the nervous system to ameliorate infection is poorly understood. In this study on herpes simplex virus 1 (HSV-1), we demonstrate that HSV-specific antibodies are present during HSV-1 latency in the nervous systems of both mice and humans. We show that antibody-secreting cells entered the trigeminal ganglion (TG), a key site of HSV infection, and persisted long after the establishment of latent infection. We also demonstrate the ability of passively administered IgG to enter the TG independently of infection, showing that the naive TG is accessible to antibodies. The translational implication of this finding is that human fetal neural tissue could contain HSV-specific maternally derived antibodies. Exploring this possibility, we observed HSV-specific IgG in HSV DNA-negative human fetal TG, suggesting passive transfer of maternal immunity into the prenatal nervous system. To further investigate the role of maternal antibodies in the neonatal nervous system, we established a murine model to demonstrate that maternal IgG can access and persist in neonatal TG. This maternal antibody not only prevented disseminated infection but also completely protected the neonate from neurological disease and death following HSV challenge. Maternal antibodies therefore have a potent protective role in the neonatal nervous system against HSV infection. These findings strongly support the concept that prevention of prenatal and neonatal neurotropic infections can be achieved through maternal immunization.
   IMPORTANCE Herpes simplex virus 1 is a common infection of the nervous system that causes devastating neonatal disease. Using mouse and human tissue, we discovered that antiviral antibodies accumulate in neural tissue after HSV-1 infection in adults. Similarly, these antibodies pass to the offspring during pregnancy. We found that antiviral maternal antibodies can readily access neural tissue of the fetus and neonate. These maternal antibodies then protect neonatal mice against HSV-1 neurological infection and death. These results underscore the previously unappreciated role of maternal antibodies in protecting fetal and newborn nervous systems against infection. These data suggest that maternal immunization would be efficacious at preventing fetal/neonatal neurological infections.
C1 [Jiang, Yike; Patel, Chaya D.; Manivanh, Richard; North, Brian; Backes, Iara M.; Posner, David A.; Leib, David A.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Lebanon, NH 03756 USA.
   [Gilli, Francesca; Pachner, Andrew R.] Geisel Sch Med Dartmouth, Dept Neurol, Lebanon, NH USA.
   [Nguyen, Lananh N.] Geisel Sch Med Dartmouth, Dept Pathol, Lebanon, NH USA.
RP Leib, DA (corresponding author), Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Lebanon, NH 03756 USA.
EM david.a.leib@dartmouth.edu
RI Gilli, Francesca/H-4428-2019
OI Jiang, Yike/0000-0003-1921-2874; Patel, Chaya/0000-0002-9055-5696;
   Nguyen, Lananh/0000-0003-4276-8934; Gilli, Francesca/0000-0002-2306-458X
FU Munck-Pfefferkorn Education and Research Fund [RO1 EY09083, PO1
   AI098681]; Geisel School of Medicine Molecular and Cellular Biology
   Program Training Grant [T32GM8704]; NRSA Individual Predoctoral
   Fellowship from the National Institutes of Health [F30EY026487]
FX This study was supported by the Munck-Pfefferkorn Education and Research
   Fund to D.A.L. and A.R.P. and RO1 EY09083 and PO1 AI098681 to D.A.L.
   Y.J. received support from Geisel School of Medicine Molecular and
   Cellular Biology Program Training Grant T32GM8704 and NRSA Individual
   Predoctoral Fellowship F30EY026487 from the National Institutes of
   Health.
CR Andoh T, 2004, FASEB J, V18, P182, DOI 10.1096/fj.02-1169fje
   Andoh T, 2004, NEUROREPORT, V15, P2029, DOI 10.1097/00001756-200409150-00007
   ASHLEY RL, 1992, J CLIN INVEST, V90, P511, DOI 10.1172/JCI115888
   Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290
   Awasthi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006141
   Bale JF, 2009, CLIN PERINATOL, V36, P639, DOI 10.1016/j.clp.2009.06.005
   BARINGER JR, 1994, ANN NEUROL, V36, P823, DOI 10.1002/ana.410360605
   Beland JL, 1999, J NEUROIMMUNOL, V94, P122, DOI 10.1016/S0165-5728(98)00238-0
   Bernstein DI, 2013, CLIN INFECT DIS, V56, P344, DOI 10.1093/cid/cis891
   BROWN SM, 1973, J GEN VIROL, V18, P329, DOI 10.1099/0022-1317-18-3-329
   Brown ZA, 2003, JAMA-J AM MED ASSOC, V289, P203, DOI 10.1001/jama.289.2.203
   Brown ZA, 1997, NEW ENGL J MED, V337, P509, DOI 10.1056/NEJM199708213370801
   Cairns TM, 2014, J VIROL, V88, P12612, DOI 10.1128/JVI.01930-14
   Chan PKS, 2001, J MED VIROL, V64, P42, DOI 10.1002/jmv.1015
   Chen CY, 2008, SEX TRANSM INFECT, V84, P273, DOI 10.1136/sti.2007.029058
   COREY L, 1988, LANCET, V1, P1
   Corey L, 2009, NEW ENGL J MED, V361, P1376, DOI 10.1056/NEJMra0807633
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Da Costa X, 2000, J VIROL, V74, P7963, DOI 10.1128/JVI.74.17.7963-7971.2000
   Da Costa XJ, 1999, P NATL ACAD SCI USA, V96, P6994, DOI 10.1073/pnas.96.12.6994
   DAVIS WB, 1979, J INFECT DIS, V140, P534, DOI 10.1093/infdis/140.4.534
   Deahpande SP, 2000, CELL IMMUNOL, V202, P79, DOI 10.1006/cimm.2000.1666
   Dosa S, 2011, BRAIN PATHOL, V21, P583, DOI 10.1111/j.1750-3639.2011.00485.x
   Dropulic LK, 2012, EXPERT REV VACCINES, V11, P1429, DOI [10.1586/ERV.12.129, 10.1586/erv.12.129]
   Engelhardt B, 2017, NAT IMMUNOL, V18, P123, DOI 10.1038/ni.3666
   Everly DN, 1999, J VIROL, V73, P9117, DOI 10.1128/JVI.73.11.9117-9129.1999
   Flagg EW, 2011, PEDIATRICS, V127, pE1, DOI 10.1542/peds.2010-0134
   Geltz JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116091
   Ghosh S, 2012, J IMMUNOL, V189, P1322, DOI 10.4049/jimmunol.1200138
   Gnann JW, 2015, CLIN INFECT DIS, V61, P683, DOI 10.1093/cid/civ369
   Gordon L, 1996, CLIN DIAGN VIROL, V6, P33, DOI 10.1016/0928-0197(95)00203-0
   Halford WP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017748
   Halford WP, 1996, J IMMUNOL, V157, P3542
   HAYASHI Y, 1983, J GEN VIROL, V64, P1007, DOI 10.1099/0022-1317-64-5-1007
   Hill JM, 2008, J VIROL, V82, P8230, DOI 10.1128/JVI.00686-08
   Hoshino Y, 2005, J VIROL, V79, P410, DOI 10.1128/JVI.79.1.410-418.2005
   Iijima N, 2016, NATURE, V533, P552, DOI 10.1038/nature17979
   Inoue H, 2010, J MED VIROL, V82, P345, DOI 10.1002/jmv.21687
   JOHANSSON PJH, 1985, J VIROL, V56, P489, DOI 10.1128/JVI.56.2.489-494.1985
   JOHNSON DC, 1987, J VIROL, V61, P2208, DOI 10.1128/JVI.61.7.2208-2216.1987
   JOHNSON DC, 1988, J VIROL, V62, P1347, DOI 10.1128/JVI.62.4.1347-1354.1988
   Kimberlin DW, 2017, LANCET GLOB HEALTH, V5, pE234, DOI 10.1016/S2214-109X(17)30047-5
   Kimberlin DW, 2004, CLIN MICROBIOL REV, V17, P1, DOI 10.1128/CMR.17.1.1-13.2004
   Kimberlin DW, 2001, PEDIATRICS, V108, P230, DOI 10.1542/peds.108.2.230
   Knickelbein JE, 2009, SURV OPHTHALMOL, V54, P226, DOI 10.1016/j.survophthal.2008.12.004
   KOHL S, 1982, J IMMUNOL, V129, P370
   KOHL S, 1984, J INFECT DIS, V149, P38, DOI 10.1093/infdis/149.1.38
   Kopp SJ, 2013, J VIROL, V87, P474, DOI 10.1128/JVI.01849-12
   Kowal C, 2015, IMMUNOL RES, V63, P18, DOI 10.1007/s12026-015-8714-5
   KRAUSE PR, 1991, J VIROL, V65, P5619, DOI 10.1128/JVI.65.10.5619-5623.1991
   LEIB DA, 1989, J VIROL, V63, P759, DOI 10.1128/JVI.63.2.759-768.1989
   Li LB, 2006, J NEUROIMMUNOL, V173, P56, DOI 10.1016/j.jneuroim.2005.11.019
   Liu T, 1996, J VIROL, V70, P264, DOI 10.1128/JVI.70.1.264-271.1996
   Looker KJ, 2017, LANCET GLOB HEALTH, V5, pE300, DOI [10.1016/S2214-109X(16)30362-X, 10.1016/s2214-109x(16)30362-x]
   Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432
   Louyeau A, 2015, TRENDS IMMUNOL, V36, P569, DOI 10.1016/j.it.2015.08.006
   Lubinski JM, 2011, J VIROL, V85, P3239, DOI 10.1128/JVI.02509-10
   Mayo Clinic, CER FLUID CSF IGG IN
   McAllister SC, 2014, EXPERT REV VACCINES, V13, P1349, DOI 10.1586/14760584.2014.932694
   MCGEOCH DJ, 1990, J GEN VIROL, V71, P2361, DOI 10.1099/0022-1317-71-10-2361
   MCLEAN CS, 1994, J INFECT DIS, V170, P1100, DOI 10.1093/infdis/170.5.1100
   Meckel JF, 1748, TRACTATUS ANATOMICO
   Nagashunmugam T, 1998, J VIROL, V72, P5351, DOI 10.1128/JVI.72.7.5351-5359.1998
   Ndjamen B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003961
   OAKES JE, 1980, INFECT IMMUN, V29, P642
   Orinska Z, 2002, EUR J IMMUNOL, V32, P3472, DOI 10.1002/1521-4141(200212)32:12<3472::AID-IMMU3472>3.0.CO;2-F
   Pappas G, 2009, INT J PARASITOL, V39, P1385, DOI 10.1016/j.ijpara.2009.04.003
   Park D, 2015, J VIROL, V89, P2892, DOI 10.1128/JVI.02994-14
   Pevenstein SR, 1999, J VIROL, V73, P10514, DOI 10.1128/JVI.73.12.10514-10518.1999
   PROBER CG, 1987, NEW ENGL J MED, V316, P240, DOI 10.1056/NEJM198701293160503
   Qu LT, 2011, BRAIN BEHAV IMMUN, V25, P1399, DOI 10.1016/j.bbi.2011.04.008
   RADER KA, 1993, J GEN VIROL, V74, P1859, DOI 10.1099/0022-1317-74-9-1859
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   RICHARDS JT, 1981, J INFECT DIS, V144, P464, DOI 10.1093/infdis/144.5.464
   Roberts S, 2009, CURR OPIN OBSTET GYN, V21, P124, DOI 10.1097/GCO.0b013e3283294840
   ROSS JDC, 1993, GENITOURIN MED, V69, P381
   Russo MV, 2015, TRENDS IMMUNOL, V36, P637, DOI 10.1016/j.it.2015.08.002
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schmutzhard J, 2004, J CLIN VIROL, V29, P120, DOI 10.1016/S1386-6532(03)00113-6
   SHIMELD C, 1995, J NEUROIMMUNOL, V61, P7, DOI 10.1016/0165-5728(95)00068-D
   Summers BC, 2001, J VIROL, V75, P5069, DOI 10.1128/JVI.75.11.5069-5075.2001
   Theil D, 2003, AM J PATHOL, V163, P2179, DOI 10.1016/S0002-9440(10)63575-4
   Valyi-Nagy T, 2000, VIROLOGY, V278, P309, DOI 10.1006/viro.2000.0678
   Van de Perre P, 2003, VACCINE, V21, P3374, DOI 10.1016/S0264-410X(03)00336-0
   White MK, 2016, ANN NEUROL, V80, P479, DOI 10.1002/ana.24748
   WHITLEY RJ, 1994, PEDIATR INFECT DIS J, V13, P432, DOI 10.1097/00006454-199405000-00035
   WILLIAMS LE, 1965, ARCH OPHTHALMOL-CHIC, V73, P112
   Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964
NR 88
TC 8
Z9 8
U1 0
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD JUL-AUG
PY 2017
VL 8
IS 4
AR e00678-17
DI 10.1128/mBio.00678-17
PG 14
WC Microbiology
SC Microbiology
GA FG0BP
UT WOS:000409384300042
PM 28679745
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lin, DL
   Cherepanova, NA
   Bozzacco, L
   MacDonald, MR
   Gilmore, R
   Tai, AW
AF Lin, David L.
   Cherepanova, Natalia A.
   Bozzacco, Leonia
   MacDonald, Margaret R.
   Gilmore, Reid
   Tai, Andrew W.
TI Dengue Virus Hijacks a Noncanonical Oxidoreductase Function of a
   Cellular Oligosaccharyltransferase Complex
SO MBIO
LA English
DT Article
DE dengue fever; endoplasmic reticulum; glycosylation; host-pathogen
   interactions; oxidoreductases
ID PROTEIN-DISULFIDE-ISOMERASE; N-GLYCOSYLATION; LINKED GLYCOSYLATION;
   VIRAL REPLICATION; CELLS LACKING; HOST FACTORS; ZIKA VIRUS; SITES;
   INFECTION; CYSTEINE
AB Dengue virus (DENV) is the most common arboviral infection globally, infecting an estimated 390 million people each year. We employed a genome-wide clustered regularly interspaced short palindromic repeat (CRISPR) screen to identify host dependency factors required for DENV propagation and identified the oligosaccharyltransferase (OST) complex as an essential host factor for DENV infection. Mammalian cells express two OSTs containing either STT3A or STT3B. We found that the canonical catalytic function of the OSTs as oligosaccharyltransferases is not necessary for DENV infection, as cells expressing catalytically inactive STT3A or STT3B are able to support DENV propagation. However, the OST subunit MAGT1, which associates with STT3B, is also required for DENV propagation. MAGT1 expression requires STT3B, and a catalytically inactive STT3B also rescues MAGT1 expression, supporting the hypothesis that STT3B serves to stabilize MAGT1 in the context of DENV infection. We found that the oxidoreductase CXXC active site motif of MAGT1 was necessary for DENV propagation, as cells expressing an AXXA MAGT1 mutant were unable to support DENV infection. Interestingly, cells expressing single-cysteine CXXA or AXXC mutants of MAGT1 were able to support DENV propagation. Utilizing the engineered peroxidase APEX2, we demonstrate the close proximity between MAGT1 and NS1 or NS4B during DENV infection. These results reveal that the oxidoreductase activity of the STT3B-containing OST is necessary for DENV infection, which may guide the development of antiviral agents targeting DENV.
   IMPORTANCE The host oligosaccharyltransferase (OST) complexes have been identified as essential host factors for dengue virus (DENV) replication; however, their functions during DENV infection are unclear. A previous study showed that the canonical OST activity was dispensable for DENV replication, suggesting that the OST complexes serve as scaffolds for DENV replication. However, our work demonstrates that one function of the OST complex during DENV infection is to provide oxidoreductase activity via the OST subunit MAGT1. We also show that MAGT1 associates with DENV NS1 and NS4B during viral infection, suggesting that these nonstructural proteins may be targets of MAGT1 oxidoreductase activity. These results provide insight into the cell biology of DENV infection, which may guide the development of antivirals against DENV.
C1 [Lin, David L.; Tai, Andrew W.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.
   [Cherepanova, Natalia A.; Gilmore, Reid] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA USA.
   [Bozzacco, Leonia; MacDonald, Margaret R.] Rockefeller Univ, Lab Virol & Infect Dis, 1230 York Ave, New York, NY 10021 USA.
   [Tai, Andrew W.] Univ Michigan, Sch Med, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI USA.
   [Tai, Andrew W.] Ann Arbor Vet Adm Hlth Syst, Med Serv, Ann Arbor, MI 48105 USA.
RP Tai, AW (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.; Tai, AW (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI USA.; Tai, AW (corresponding author), Ann Arbor Vet Adm Hlth Syst, Med Serv, Ann Arbor, MI 48105 USA.
EM andrewwt@umich.edu
RI Tai, Andrew W./M-8380-2017
OI Tai, Andrew W./0000-0002-6877-450X
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01DK097374];
   Molecular Mechanisms of Microbial Pathogenesis Training Program
   [5T32AI007528, R01AI124690, R01GM043768]; University of Michigan Center
   for Gastrointestinal Research (National Institutes of Health)
   [P30DK034933]
FX This work was supported by National Institutes of Health grants
   R01DK097374 (A.W.T.), the Molecular Mechanisms of Microbial Pathogenesis
   Training Program 5T32AI007528 (D.L.L.), R01AI124690 (M.R.M.) and
   R01GM043768 (R.G.). Microscopy was performed at the University of
   Michigan Microscopy & Image Analysis Laboratory with support from the
   University of Michigan Center for Gastrointestinal Research (National
   Institutes of Health P30DK034933).
CR Atasheva S, 2010, J VIROL, V84, P10004, DOI 10.1128/JVI.01151-10
   Bagchi P, 2016, ELIFE, V5, DOI 10.7554/eLife.21470
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   BOCCHINFUSO WP, 1992, ENDOCRINOLOGY, V131, P2331, DOI 10.1210/en.131.5.2331
   Cherepanova N, 2016, CURR OPIN CELL BIOL, V41, P57, DOI 10.1016/j.ceb.2016.03.021
   Cherepanova NA, 2016, SCI REP-UK, V6, DOI 10.1038/srep20946
   Cherepanova NA, 2014, J CELL BIOL, V206, P525, DOI 10.1083/jcb.201404083
   Frolova EI, 2002, J VIROL, V76, P11254, DOI 10.1128/JVI.76.22.11254-11264.2002
   Hatahet F, 2007, FEBS J, V274, P5223, DOI 10.1111/j.1742-4658.2007.06058.x
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Houzet L, 2011, EXP BIOL MED, V236, P962, DOI 10.1258/ebm.2010.010272
   Huang CYH, 2010, VIROLOGY, V396, P305, DOI 10.1016/j.virol.2009.10.027
   Hung V, 2016, NAT PROTOC, V11, P456, DOI 10.1038/nprot.2016.018
   LABOISSIERE MCA, 1995, J BIOL CHEM, V270, P28006
   Lam SS, 2015, NAT METHODS, V12, P51, DOI 10.1038/nmeth.3179
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   McGee CE, 2010, VECTOR-BORNE ZOONOT, V10, P267, DOI 10.1089/vbz.2009.0067
   Mohorko E, 2014, STRUCTURE, V22, P590, DOI 10.1016/j.str.2014.02.013
   Naik NG, 2015, J VIROL, V89, P6746, DOI 10.1128/JVI.00423-15
   Roboti P, 2012, J CELL SCI, V125, P3474, DOI 10.1242/jcs.103952
   Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047
   Salloum S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003513
   Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047
   Satoh T, 2015, ELIFE, V4, DOI 10.7554/eLife.06306
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Schoggins JW, 2012, P NATL ACAD SCI USA, V109, P14610, DOI 10.1073/pnas.1212379109
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Shrimal S, 2015, GLYCOBIOLOGY, V25, P774, DOI 10.1093/glycob/cwv018
   Tsetsarkin K, 2006, VECTOR-BORNE ZOONOT, V6, P325, DOI 10.1089/vbz.2006.6.325
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Walker KW, 1996, BIOCHEMISTRY-US, V35, P1972, DOI 10.1021/bi952157n
   Wang HL, 2014, GASTROENTEROLOGY, V146, P1373, DOI 10.1053/j.gastro.2014.02.002
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   Yan G, 2002, J BIOL CHEM, V277, P47692, DOI 10.1074/jbc.M208136200
   Yi ZG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001255
   Zhou H, 2009, P NATL ACAD SCI USA, V106, P15750, DOI 10.1073/pnas.0908332106
NR 38
TC 18
Z9 19
U1 0
U2 6
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD JUL-AUG
PY 2017
VL 8
IS 4
AR e00939-17
DI 10.1128/mBio.00939-17
PG 16
WC Microbiology
SC Microbiology
GA FG0BP
UT WOS:000409384300052
PM 28720733
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mladinich, MC
   Schwedes, J
   Mackow, ER
AF Mladinich, Megan C.
   Schwedes, John
   Mackow, Erich R.
TI Zika Virus Persistently Infects and Is Basolaterally Released from
   Primary Human Brain Microvascular Endothelial Cells
SO MBIO
LA English
DT Article
DE basolateral release; chemokine CCL5; IFN-beta regulation; ISG15
   induction; persistent infection; Zika virus; cell survival; human brain
   endothelial cells; innate immune regulation; transcriptome analysis
ID HEPATITIS-C VIRUS; VIRAL-INFECTION; MEASLES-VIRUS; DENGUE VIRUS;
   IN-VITRO; BARRIER; PATHOGENESIS; BRAZIL; MODEL; RESISTANCE
AB Zika virus (ZIKV) is a mosquito-borne Flavivirus that has emerged as the cause of encephalitis and fetal microencephaly in the Americas. ZIKV uniquely persists in human bodily fluids for up to 6 months, is sexually transmitted, and traverses the placenta and the blood-brain barrier (BBB) to damage neurons. Cells that support persistent ZIKV replication and mechanisms by which ZIKV establishes persistence remain enigmatic but central to ZIKV entry into protected neuronal compartments. The endothelial cell (EC) lining of capillaries normally constrains transplacental transmission and forms the BBB, which selectively restricts access of blood constituents to neurons. We found that ZIKV (strain PRVABC59) persistently infects and continuously replicates in primary human brain microvascular ECs (hBMECs), without cytopathology, for >9 days and following hBMEC passage. ZIKV did not permeabilize hBMECs but was released basolaterally from polarized hBMECs, suggesting a direct mechanism for ZIKV to cross the BBB. ZIKV-infected hBMECs were rapidly resistant to alpha interferon (IFN-lambda) and transiently induced, but failed to secrete, IFN-beta and IFN-lambda. Global transcriptome analysis determined that ZIKV constitutively induced IFN regulatory factor 7 (IRF7), IRF9, and IFN-stimulated genes (ISGs) 1 to 9 days postinfection, despite persistently replicating in hBMECs. ZIKV constitutively induced ISG15, HERC5, and USP18, which are linked to hepatitis C virus (HCV) persistence and IFN regulation, chemokine CCL5, which is associated with immunopathogenesis, as well as cell survival factors. Our results reveal that hBMECs act as a reservoir of persistent ZIKV replication, suggest routes for ZIKV to cross hBMECs into neuronal compartments, and define novel mechanisms of ZIKV persistence that can be targeted to restrict ZIKV spread.
   IMPORTANCE ZIKV persists in patients, crossing placental and neuronal barriers, damaging neurons, and causing fetal microencephaly. We found that ZIKV persistently infects brain endothelial cells that normally protect neurons from viral exposure. hBMECs are not damaged by ZIKV infection and, analogous to persistent HCV infection, ZIKV constitutively induces and evades antiviral ISG and IFN responses to continuously replicate in hBMECs. As a result, hBMECs provide a protective niche for systemic ZIKV spread and a viral reservoir localized in the normally protective blood-brain barrier. Consistent with the spread of ZIKV into neuronal compartments, ZIKV was released basolaterally from hBMECs. Our findings define hBMEC responses that contribute to persistent ZIKV infection and potential targets for clearing ZIKV infections from hBMECs. These results further suggest roles for additional ZIKV-infected ECs to facilitate viral spread and persistence in the protected placental, retinal, and testicular compartments.
C1 [Mladinich, Megan C.; Mackow, Erich R.] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.
   [Schwedes, John] SUNY Stony Brook, Genom Core Facil, Stony Brook, NY 11794 USA.
   [Mladinich, Megan C.; Mackow, Erich R.] SUNY Stony Brook, Mol & Cell Biol Program, Stony Brook, NY 11794 USA.
RP Mackow, ER (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.; Mackow, ER (corresponding author), SUNY Stony Brook, Mol & Cell Biol Program, Stony Brook, NY 11794 USA.
EM Erich.Mackow@stonybrook.edu
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01AI093792,
   1R01AI129010, R21AI131729]
FX This work was supported by National Institutes of Health grants
   R01AI093792, 1R01AI129010, and R21AI131729. We declare no conflicts of
   interest for studies performed.
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Arora V, 2007, J BIOL CHEM, V282, P26202, DOI 10.1074/jbc.M700776200
   Axelrod H, 2014, ONCOTARGET, V5, P1
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Baron V, 2006, CANCER GENE THER, V13, P115, DOI 10.1038/sj.cgt.7700896
   Bauhofer O, 2012, GASTROENTEROLOGY, V143, P429, DOI 10.1053/j.gastro.2012.04.018
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bergelson JM, 2009, CELL HOST MICROBE, V5, P517, DOI 10.1016/j.chom.2009.05.009
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Broering R, 2010, GUT, V59, P1111, DOI 10.1136/gut.2009.195545
   Brooks DG, 2008, P NATL ACAD SCI USA, V105, P20428, DOI 10.1073/pnas.0811139106
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Chan O, 2012, J BIOL CHEM, V287, P29406, DOI 10.1074/jbc.M112.348946
   Chen LM, 2011, INT J BIOCHEM CELL B, V43, P1427, DOI 10.1016/j.biocel.2011.06.006
   Cheng CY, 2012, PHARMACOL REV, V64, P16, DOI 10.1124/pr.110.002790
   Chua PK, 2009, J GEN VIROL, V90, P2929, DOI 10.1099/vir.0.013128-0
   Crane IJ, 2008, SEMIN IMMUNOPATHOL, V30, P165, DOI 10.1007/s00281-008-0106-7
   Dalrymple NA, 2015, MBIO, V6, DOI 10.1128/mBio.00553-15
   Dalrymple NA, 2012, J VIROL, V86, P6408, DOI 10.1128/JVI.00213-12
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Dittmar S, 2008, J VIROL, V82, P11273, DOI 10.1128/JVI.00775-08
   Doss S, 2014, J NEUROIMMUNOL, V267, P102, DOI 10.1016/j.jneuroim.2013.10.010
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Edagawa M, 2014, J BIOL CHEM, V289, P21544, DOI 10.1074/jbc.M114.558890
   Eigenmann DE, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-33
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gavrilovskaya IN, 2008, J VIROL, V82, P5797, DOI 10.1128/JVI.02397-07
   Goasdoue K, 2017, PLACENTA, V54, P111, DOI 10.1016/j.placenta.2016.12.005
   Gorbunova E, 2010, J VIROL, V84, P7405, DOI 10.1128/JVI.00576-10
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Greenwood J, 2011, NEUROPATH APPL NEURO, V37, P24, DOI 10.1111/j.1365-2990.2010.01140.x
   Griffin DE, 2012, FEMS MICROBIOL REV, V36, P649, DOI 10.1111/j.1574-6976.2012.00330.x
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Hussmann KL, 2014, J GEN VIROL, V95, P862, DOI 10.1099/vir.0.060558-0
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Kumar SS, 2017, CLIN TRANSL ONCOL, V19, P718, DOI 10.1007/s12094-016-1596-8
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Man S, 2008, CLIN DEV IMMUNOL, P1, DOI 10.1155/2008/384982
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Martina Byron E. E., 2014, Science Progress, V97, P197, DOI 10.3184/003685014X14049173153889
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miner JJ, 2016, CELL STEM CELL, V18, P559, DOI 10.1016/j.stem.2016.04.009
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrison J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003265
   Morrison J, 2012, VIRUSES-BASEL, V4, P397, DOI 10.3390/v4030397
   Murooka TT, 2008, BLOOD, V111, P4892, DOI 10.1182/blood-2007-11-125039
   Olagnier D, 2016, J MOL BIOL, V428, P3429, DOI 10.1016/j.jmb.2016.04.024
   Oynebraten I, 2015, SCI REP-UK, V5, DOI 10.1038/srep09261
   Perelygina L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073014
   Quandt J, 2004, J NEUROPATH EXP NEUR, V63, P350, DOI 10.1093/jnen/63.4.350
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Reynaud JM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004863
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   de Souza LER, 2014, EXP CELL RES, V324, P84, DOI 10.1016/j.yexcr.2014.03.017
   Roe K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102598
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Shi HX, 2010, MOL CELL BIOL, V30, P2424, DOI 10.1128/MCB.01466-09
   Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Speer SD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11496
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tan GK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000672
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Thimme R, 2002, P NATL ACAD SCI USA, V99, P15661, DOI 10.1073/pnas.202608299
   Tyner JW, 2005, NAT MED, V11, P1180, DOI 10.1038/nm1303
   Wang W, 2017, SCI SIGNAL, V10
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Ye J, 2013, VACCINE, V31, P461, DOI 10.1016/j.vaccine.2012.11.015
   Zhang DX, 2011, J INTERF CYTOK RES, V31, P119, DOI 10.1089/jir.2010.0110
   Zhang XQ, 2015, NATURE, V517, P89, DOI 10.1038/nature13801
   Zhang XW, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0665-9
   Zhu LM, 2014, ONCOTARGET, V5, P5403, DOI 10.18632/oncotarget.2114
NR 86
TC 38
Z9 38
U1 0
U2 17
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD JUL-AUG
PY 2017
VL 8
IS 4
AR e00952-17
DI 10.1128/mBio.00952-17
PG 17
WC Microbiology
SC Microbiology
GA FG0BP
UT WOS:000409384300063
PM 28698279
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Shrivastava, S
   Puri, V
   Fedorova, N
   Amedeo, P
   Stockwell, TB
   Shabman, RS
   Rashid, S
   Pickett, BE
AF Shrivastava, Susmita
   Puri, Vinita
   Fedorova, Nadia
   Amedeo, Paolo
   Stockwell, Timothy B.
   Shabman, Reed S.
   Rashid, Sujatha
   Pickett, Brett E.
TI Identification of Dezidougou Virus in a DAK AR 41524 Zika Virus Stock
SO MICROBIOLOGY RESOURCE ANNOUNCEMENTS
LA English
DT Article
AB We report here the complete genome of a Dezidougou virus (DEZV) isolated from a passaged culture of the Zika virus strain DAK AR 41524. The consensus DEZV sequence we recovered shows 99% nucleotide similarity using BLASTN to a previously reported DEZV (accession no. JQ675604.1). The current sequence has additional repeat regions as well as a deleted repeat region, which we confirmed by Sanger sequencing, that were not present in the originally published sequence, JQ675604.1.
C1 [Shrivastava, Susmita; Puri, Vinita; Fedorova, Nadia; Amedeo, Paolo; Stockwell, Timothy B.; Shabman, Reed S.] J Craig Venter Inst, Rockville, MD USA.
   [Rashid, Sujatha] BEI Resources, Manassas, VA USA.
   [Pickett, Brett E.] J Craig Venter Inst, La Jolla, CA 92037 USA.
   [Stockwell, Timothy B.; Shabman, Reed S.] Natl Biodef Anal & Countermeasures Ctr, Ft Detrick, MD USA.
   [Shabman, Reed S.] Amer Type Culture Collect, Manassas, VA USA.
RP Pickett, BE (corresponding author), J Craig Venter Inst, La Jolla, CA 92037 USA.
EM bpickett@jcvi.org
RI Pickett, Brett/AAE-3582-2020
OI Pickett, Brett/0000-0001-7930-8160
FU National Institute of Allergy and Infectious Diseases, National
   Institutes of Health, Department of Health and Human ServicesUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [U19AI110819]
FX This project has been funded in whole or part with federal funds from
   the National Institute of Allergy and Infectious Diseases, National
   Institutes of Health, Department of Health and Human Services, under
   award number U19AI110819.
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5
   Vasilakis N, 2013, J VIROL, V87, P2475, DOI 10.1128/JVI.00776-12
NR 3
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2576-098X
J9 MICROBIOL RESOUR ANN
JI Microbiol. Resour. Ann.
PD JUL
PY 2017
VL 5
IS 30
AR e00605-17
DI 10.1128/genomeA.00605-17
PG 2
WC Microbiology
SC Microbiology
GA VI1EY
UT WOS:000460706000006
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Anfasa, F
   Siegers, JY
   van der Kroeg, M
   Mumtaz, N
   Raj, VS
   de Vrij, FMS
   Widagdo, W
   Gabriel, G
   Salinas, S
   Simonin, Y
   Reusken, C
   Kushner, SA
   Koopmans, MPG
   Haagmans, B
   Martina, BEE
   van Riel, D
AF Anfasa, Fatih
   Siegers, Jurre Y.
   van der Kroeg, Mark
   Mumtaz, Noreen
   Raj, V. Stalin
   de Vrij, Femke M. S.
   Widagdo, W.
   Gabriel, Glsah
   Salinas, Sara
   Simonin, Yannick
   Reusken, Chantal
   Kushner, Steven A.
   Koopmans, Marion P. G.
   Haagmans, Bart
   Martina, Byron E. E.
   van Riel, Debby
TI Phenotypic Differences between Asian and African Lineage Zika Viruses in
   Human Neural Progenitor Cells
SO MSPHERE
LA English
DT Article
DE African strains; Asian strains; growth kinetics; human neural progenitor
   cells; neuronal cells; one-step growth curve; pathogenesis; phenotype;
   Zika virus; cell death
ID IN-VIVO; BRAIN; ORGANOIDS
AB Recent Zika virus (ZIKV) infections have been associated with a range of neurological complications, in particular congenital microcephaly. Human neural progenitor cells (hNPCs) are thought to play an important role in the pathogenesis of microcephaly, and experimental ZIKV infection of hNPCs has been shown to induce cell death. However, the infection efficiency and rate of cell death have varied between studies, which might be related to intrinsic differences between African and Asian lineage ZIKV strains. Therefore, we determined the replication kinetics, including infection efficiency, burst size, and ability to induce cell death, of two Asian and two African ZIKV strains. African ZIKV strains replicated to higher titers in Vero cells, human glioblastoma (U87MG) cells, human neuroblastoma (SK-N-SH) cells, and hNPCs than Asian ZIKV strains. Furthermore, infection with Asian ZIKV strains did not result in significant cell death early after infection, whereas infection with African ZIKV strains resulted in high percentages of cell death in hNPCs. The differences between African and Asian lineage ZIKV strains highlight the importance of including relevant ZIKV strains to study the pathogenesis of congenital microcephaly and caution against extrapolation of experimental data obtained using historical African ZIKV strains to the current outbreak. Finally, the fact that Asian ZIKV strains infect only a minority of cells with a relatively low burst size together with the lack of early cell death induction might contribute to its ability to cause chronic infections within the central nervous system (CNS).
   IMPORTANCE The mechanism by which ZIKV causes a range of neurological complications, especially congenital microcephaly, is not well understood. The fact that congenital microcephaly is associated with Asian lineage ZIKV strains raises the question of why this was not discovered earlier. One possible explanation is that Asian and African ZIKV strains differ in their abilities to infect cells of the CNS and to cause neurodevelopmental problems. Here, we show that Asian ZIKV strains infect and induce cell death in human neural progenitor cells-which are important target cells in the development of congenital microcephaly-less efficiently than African ZIKV strains. These features of Asian ZIKV strains likely contribute to their ability to cause chronic infections, often observed in congenital microcephaly cases. It is therefore likely that phenotypic differences between ZIKV strains could be, at least in part, responsible for the ability of Asian ZIKV strains to cause congenital microcephaly.
C1 [Anfasa, Fatih; Siegers, Jurre Y.; Mumtaz, Noreen; Raj, V. Stalin; Widagdo, W.; Reusken, Chantal; Koopmans, Marion P. G.; Haagmans, Bart; Martina, Byron E. E.; van Riel, Debby] Erasmus MC, Dept Virosci, Rotterdam, Netherlands.
   [Anfasa, Fatih] Univ Indonesia, Fac Med, Jakarta, Indonesia.
   [van der Kroeg, Mark; de Vrij, Femke M. S.; Kushner, Steven A.] Erasmus MC, Dept Psychiat, Rotterdam, Netherlands.
   [Gabriel, Glsah] Heinrich Pette Inst Expt Virol, Hamburg, Germany.
   [Salinas, Sara; Simonin, Yannick] Univ Montpellier, INSERM, Pathogenesis & Control Chron Infect, Etab Francais Sang,UMR1058, Montpellier, France.
   [Martina, Byron E. E.] Artemis One Hlth Res Fdn, Utrecht, Netherlands.
RP van Riel, D (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.
EM d.vanriel@erasmusmc.nl
RI Koopmans, Marion/Y-9170-2019; Salinas, Sara/O-1856-2013; de Vrij, Femke
   M.S./O-9706-2019; Salinas, Sara/O-1150-2019; Siegers, Jurre
   Y/U-9730-2018; Raj, Victor Stalin/E-9670-2016
OI Koopmans, Marion/0000-0002-5204-2312; Salinas, Sara/0000-0003-4492-2093;
   de Vrij, Femke M.S./0000-0003-0825-3806; Salinas,
   Sara/0000-0003-4492-2093; Raj, Victor Stalin/0000-0003-2250-8481;
   simonin, yannick/0000-0002-3475-1369; Haagmans,
   Bart/0000-0001-6221-2015; van Riel, Debby/0000-0001-9753-3564
FU Erasmus MC Foundation; Ministry of Research, Technology and Higher
   Education of the Republic of Indonesia; European Union program
   ZIKAlliance [734548]; Reacting [UMR1058]; La Region
   Languedoc-RoussillonRegion Occitanie [UMR1058]
FX D.V.R. and this study were supported by a fellowship from the Erasmus MC
   Foundation. F.A. was supported by a Directorate of Higher Education
   (DIKTI) PhD grant from the Ministry of Research, Technology and Higher
   Education of the Republic of Indonesia. Part of this work was further
   supported by the European Union program ZIKAlliance (contract no.
   734548). Work at UMR1058 was supported by Reacting and La Region
   Languedoc-Roussillon.
CR Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Chen HY, 2007, P NATL ACAD SCI USA, V104, P19079, DOI 10.1073/pnas.0707449104
   Chen LK, 1996, VIROLOGY, V223, P79, DOI 10.1006/viro.1996.0457
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   KARBER G, 1931, ARCH EXP PATHOL PH, V162, P480, DOI DOI 10.1007/BF01863914
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Meda N, 2016, LANCET, V388, P337, DOI 10.1016/S0140-6736(16)31103-5
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Smits SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071595
   Stray SJ, 2001, VIRUS RES, V77, P3, DOI 10.1016/S0168-1702(01)00260-X
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Weaver SC, 2017, MBIO, V8, DOI 10.1128/mBio.02063-16
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
NR 28
TC 35
Z9 35
U1 1
U2 10
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5042
J9 MSPHERE
JI mSphere
PD JUL-AUG
PY 2017
VL 2
IS 4
AR e00292-17
DI 10.1128/mSphere.00292-17
PG 10
WC Microbiology
SC Microbiology
GA FF0VF
UT WOS:000408618500028
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Colmant, AMG
   Hobson-Peters, J
   Bielefeldt-Ohmann, H
   van den Hurk, AF
   Hall-Mendelin, S
   Chow, WK
   Johansen, CA
   Fros, J
   Simmonds, P
   Watterson, D
   Cazier, C
   Etebari, K
   Asgari, S
   Schulz, BL
   Beebe, N
   Vet, LJ
   Piyasena, TBH
   Nguyen, HD
   Barnard, RT
   Hall, RA
AF Colmant, Agathe M. G.
   Hobson-Peters, Jody
   Bielefeldt-Ohmann, Helle
   van den Hurk, Andrew F.
   Hall-Mendelin, Sonja
   Chow, Weng Kong
   Johansen, Cheryl A.
   Fros, Jelke
   Simmonds, Peter
   Watterson, Daniel
   Cazier, Chris
   Etebari, Kayvan
   Asgari, Sassan
   Schulz, Benjamin L.
   Beebe, Nigel
   Vet, Laura J.
   Piyasena, Thisun B. H.
   Nguyen, Hong-Duyen
   Barnard, Ross T.
   Hall, Roy A.
TI A New Clade of Insect-Specific Flaviviruses from Australian Anopheles
   Mosquitoes Displays Species-Specific Host Restriction
SO MSPHERE
LA English
DT Article
DE Anopheles; insect-specific flavivirus; coevolution; dinucleotide
   analysis; host restriction; immunohistochemistry; monoclonal antibodies;
   mosquito midgut; recombinant NS1; siRNA
ID POLYMERASE-CHAIN-REACTION; WEST NILE VIRUS; ENCEPHALITIS-VIRUS;
   TRANSMISSION; IDENTIFICATION; ARBOVIRUSES; SEQUENCES; RNAI;
   EVOLUTIONARY; ORGANIZATION
AB Flaviviruses are arthropod-borne viruses found worldwide and are responsible for significant human and veterinary diseases, including dengue, Zika, and West Nile fever. Some flaviviruses are insect specific and replicate only in mosquitoes. We report a genetically divergent group of insect-specific flaviviruses from Anopheles mosquitoes that do not replicate in arthropod cell lines or heterologous Anopheles species, exhibiting unprecedented specialization for their host species. Determination of the complete sequences of the RNA genomes of three of these viruses, Karumba virus (KRBV), Haslams Creek virus, and Mac Peak virus (McPV), that are found in high prevalence in some Anopheles mosquito populations and detection of virus-specific proteins, replicative double-stranded RNA, and small interfering RNA responses in the host mosquito species provided strong evidence of a functional replicating virus in the mosquito midgut. Analysis of nucleotide composition in the KRBV and McPV sequences also revealed a pattern consistent with the virus evolving to replicate only in insects. These findings represent a significant advance in our knowledge of mosquito-borne flavivirus ecology, host restriction, and evolution.
   IMPORTANCE Flaviviruses like dengue, Zika, or West Nile virus infect millions of people each year and are transmitted to humans via infected-mosquito bites. A subset of flaviviruses can only replicate in the mosquito host, and recent studies have shown that some can interfere with pathogenic flaviviruses in mosquitoes and limit the replication and transmission of the latter. The insect-specific flaviviruses (ISFs) reported here form a new Anopheles mosquito-associated clade separate from the Aedes-and Culex-associated ISF clades. The identification of distinct clades for each mosquito genus provides new insights into the evolution and ecology of flaviviruses. One of these viruses was shown to replicate in the midgut of the mosquito host and exhibit the most specialized host restriction reported to date for ISFs. Understanding this unprecedented host restriction in ISFs could help identify the mechanisms involved in the evolution of flaviviruses and their emergence as mosquitoborne pathogens.
C1 [Colmant, Agathe M. G.; Hobson-Peters, Jody; Bielefeldt-Ohmann, Helle; Watterson, Daniel; Schulz, Benjamin L.; Vet, Laura J.; Piyasena, Thisun B. H.; Nguyen, Hong-Duyen; Barnard, Ross T.; Hall, Roy A.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia.
   [Colmant, Agathe M. G.; Hobson-Peters, Jody; Bielefeldt-Ohmann, Helle; Watterson, Daniel; Etebari, Kayvan; Asgari, Sassan; Schulz, Benjamin L.; Vet, Laura J.; Piyasena, Thisun B. H.; Nguyen, Hong-Duyen; Barnard, Ross T.; Hall, Roy A.] Univ Queensland, AIDRC, St Lucia, Qld, Australia.
   [van den Hurk, Andrew F.; Hall-Mendelin, Sonja] Dept Hlth, Publ Hlth Virol Serv, Coopers Plains, Qld, Australia.
   [van den Hurk, Andrew F.; Hall-Mendelin, Sonja] Dept Hlth, Forens Serv, Coopers Plains, Qld, Australia.
   [van den Hurk, Andrew F.; Hall-Mendelin, Sonja] Dept Hlth, Sci Serv, Coopers Plains, Qld, Australia.
   [Chow, Weng Kong] Gallipoli Barracks, Australian Army Malaria Inst, Enoggera, Qld, Australia.
   [Johansen, Cheryl A.] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA, Australia.
   [Johansen, Cheryl A.] PathWest Lab Med WA, Nedlands, WA, Australia.
   [Fros, Jelke; Simmonds, Peter] Univ Oxford, Nuffield Dept Med, Oxford, England.
   [Cazier, Chris] Queensland Univ Technol, Fac Hlth, Biosciences Div, Tech Serv, Gardens Point Campus, Brisbane, Qld, Australia.
   [Etebari, Kayvan; Asgari, Sassan; Beebe, Nigel] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia.
   [Beebe, Nigel] CSIRO, Dutton Pk, Qld, Australia.
RP Hall, RA (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia.; Hall, RA (corresponding author), Univ Queensland, AIDRC, St Lucia, Qld, Australia.
EM roy.hall@uq.edu.au
RI van den Hurk, Andrew/X-9831-2019; Etebari, Kayvan/C-6436-2008; Beebe,
   Nigel W/C-5610-2008; Barnard, Ross/AAR-9852-2020; Piyasena,
   Thisun/I-3247-2016; Johansen, Cheryl A/A-2208-2009; Fros,
   Jelke/AAN-5110-2020; Asgari, Sassan/G-2678-2011; Schulz,
   Benjamin/B-3911-2009
OI van den Hurk, Andrew/0000-0001-6262-831X; Etebari,
   Kayvan/0000-0001-5213-6362; Beebe, Nigel W/0000-0003-2877-0691; Barnard,
   Ross/0000-0002-5685-4828; Piyasena, Thisun/0000-0002-1657-8558; Asgari,
   Sassan/0000-0001-7885-6544; Watterson, Daniel/0000-0001-5957-2853;
   Colmant, Agathe/0000-0002-2004-4073; Simmonds,
   Peter/0000-0002-7964-4700; Schulz, Benjamin/0000-0002-4823-7758; Vet,
   Laura/0000-0001-7587-2936
FU Western Australia Department of Health; Australian Government Research
   Training ProgramAustralian Government; Australian Research
   CouncilAustralian Research Council [DP120103994]; AIDRC
FX The Western Australia Department of Health funded the Western Australia
   arbovirus surveillance program. The Australian Government Research
   Training Program Scholarship funded Ph.D. students A.M.G.C. and T.B.H.P.
   This study was supported by the Australian Research Council
   (DP120103994) and the AIDRC.
CR Beebe NW, 1999, INSECT MOL BIOL, V8, P381, DOI 10.1046/j.1365-2583.1999.83127.x
   BEEBE NW, 1995, AM J TROP MED HYG, V53, P478, DOI 10.4269/ajtmh.1995.53.478
   Blair CD, 2015, VIRUSES-BASEL, V7, P820, DOI 10.3390/v7020820
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Bolling BG, 2012, VIROLOGY, V427, P90, DOI 10.1016/j.virol.2012.02.016
   Bolling BG, 2011, AM J TROP MED HYG, V85, P169, DOI 10.4269/ajtmh.2011.10-0474
   Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856
   Brackney DE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000502
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Colmant AMG, 2016, J GEN VIROL, V97, P1087, DOI 10.1099/jgv.0.000430
   Cook S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080720
   Crochu S, 2004, J GEN VIROL, V85, P1971, DOI 10.1099/vir.0.79850-0
   Fauver JR, 2016, VIROLOGY, V498, P288, DOI 10.1016/j.virol.2016.07.031
   Firth AE, 2010, VIROLOGY, V399, P153, DOI 10.1016/j.virol.2009.12.033
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   HALL RA, 1988, IMMUNOL CELL BIOL, V66, P51, DOI 10.1038/icb.1988.6
   Hall RA, 2016, EVOL BIOINFORM, V12, P35, DOI 10.4137/EBO.S40740
   Hall-Mendelin S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1683-2
   Harbach RE, 2007, ZOOTAXA, P591
   Hobson-Peters J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056534
   Jansen CC, 2009, J AM MOSQUITO CONTR, V25, P272, DOI 10.2987/09-5908.1
   Jia DS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.25
   Kapoor A, 2010, J VIROL, V84, P10322, DOI 10.1128/JVI.00601-10
   Kent RJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000671
   Kramer LD, 2003, ADV VIRUS RES, V60, P187, DOI 10.1016/S0065-3527(03)60006-0
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Larena M, 2013, J VIROL, V87, P4395, DOI 10.1128/JVI.03144-12
   Lequime S, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vew035
   Lobo FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006282
   LUDWIG GV, 1993, IN VITRO CELL DEV-AN, V29A, P296, DOI 10.1007/BF02633958
   Lutomiah JJL, 2007, J INSECT SCI, V7
   Maher-Sturgess SL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-16
   MARHOUL Z, 1972, T ROY SOC TROP MED H, V66, P183, DOI 10.1016/0035-9203(72)90068-5
   Marklewitz M, 2015, P NATL ACAD SCI USA, V112, P7536, DOI 10.1073/pnas.1502036112
   McLean BJ, 2017, NGUYEN, V2
   McLean BJ, 2015, VIROLOGY, V486, P272, DOI 10.1016/j.virol.2015.07.021
   Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206
   MUNDERLOH UG, 1989, EXP APPL ACAROL, V7, P219, DOI 10.1007/BF01194061
   O'Brien CA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003629
   Obbard DJ, 2009, PHILOS T R SOC B, V364, P99, DOI 10.1098/rstb.2008.0168
   Perng G-C, 2013, ENCEPHALITIS, P73
   PIERRE V, 1994, RES VIROLOGY, V145, P93, DOI 10.1016/S0923-2516(07)80011-2
   Reidenbach KR, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-298
   Roiz D, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-93
   Shi M, 2016, NATURE, V540, P539, DOI 10.1038/nature20167
   Shi M, 2016, J VIROL, V90, P659, DOI 10.1128/JVI.02036-15
   Simmonds Peter, 2012, BMC Res Notes, V5, P50, DOI 10.1186/1756-0500-5-50
   Van Den Hurk AF, 2002, J MED ENTOMOL, V39, P786, DOI 10.1603/0022-2585-39.5.786
   van Mierlo JT, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004256
   van Mierlo JT, 2011, METHODS MOL BIOL, V721, P3, DOI 10.1007/978-1-61779-037-9_1
   Ventoso I, 2012, J VIROL, V86, P9484, DOI 10.1128/JVI.01114-12
   Villinger J, 2017, MOL ECOL RESOUR, V17, P466, DOI 10.1111/1755-0998.12584
   VONHEIJNE G, 1984, J MOL BIOL, V173, P243, DOI 10.1016/0022-2836(84)90192-X
   WESTAWAY EG, 1985, INTERVIROLOGY, V24, P183, DOI 10.1159/000149642
   Xu Y, 2014, RAPID COMMUN MASS SP, V28, P471, DOI 10.1002/rcm.6806
NR 56
TC 20
Z9 20
U1 0
U2 9
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5042
J9 MSPHERE
JI mSphere
PD JUL-AUG
PY 2017
VL 2
IS 4
AR e00262-17
DI 10.1128/mSphere.00262-17
PG 19
WC Microbiology
SC Microbiology
GA FF0VF
UT WOS:000408618500018
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Brito, CAA
   Azevedo, F
   Cordeiro, MT
   Marques, ETA
   Franca, RFO
AF Brito, Carlos A. A.
   Azevedo, Fernanda
   Cordeiro, Marli T.
   Marques, Ernesto T. A., Jr.
   Franca, Rafael F. O.
TI Central and peripheral nervous system involvement caused by Zika and
   chikungunya coinfection
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID VIRUS; INFECTION; HISTORY
C1 [Brito, Carlos A. A.] Fed Univ Pernambuco UFPE, Dept Clin Med, Recife, PE, Brazil.
   [Azevedo, Fernanda] Santa Joana Hosp, Dept Neurol, Recife, PE, Brazil.
   [Cordeiro, Marli T.; Marques, Ernesto T. A., Jr.; Franca, Rafael F. O.] Fiocruz MS, Aggeu Magalhaes Inst, Oswaldo Cruz Fdn, Dept Virol & Expt Therapy, Recife, PE, Brazil.
   [Marques, Ernesto T. A., Jr.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Ctr Vaccine Res Pittsburgh, Pittsburgh, PA USA.
RP Franca, RFO (corresponding author), Fiocruz MS, Aggeu Magalhaes Inst, Oswaldo Cruz Fdn, Dept Virol & Expt Therapy, Recife, PE, Brazil.
EM rafael.franca@cpqam.fiocruz.br
RI Marques, Ernesto T. A/L-4967-2013
OI Marques, Ernesto T. A/0000-0003-3826-9358; Freitas de Oliveira Franca,
   Rafael/0000-0002-1846-6007
FU FACEPE - Fundacao de Amparo a Ciencia e Tecnologia de Pernambuco under
   RFOF [APQ-0055.2.11/16, APQ-0044.2.11/16]
FX The research leading to these results received funding from the FACEPE -
   Fundacao de Amparo a Ciencia e Tecnologia de Pernambuco, grant agreement
   nos. APQ-0055.2.11/16 and APQ-0044.2.11/16 under RFOF coordination and
   responsibility. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   Brooks JB, 2016, J INFECT PUBLIC HLTH
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chandak NH, 2009, NEUROL INDIA, V57, P177, DOI 10.4103/0028-3886.51289
   Chusri S, 2011, AM J TROP MED HYG, V85, P386, DOI 10.4269/ajtmh.2011.10-0725
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Franca RFO, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004760
   MATHIAS CJ, 1989, J NEUROL SCI, V94, P255, DOI 10.1016/0022-510X(89)90235-9
   Mercado M, 2016, EURO SURVEILL, P21
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Omarjee R., 2014, EURO SURVEILL, V19
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Roth A, 2014, EURO SURVEILL, V19
   Solet J. L., 2007, PLOS BIOL, V77, P727
   Tandale BV, 2009, J CLIN VIROL, V46, P145, DOI 10.1016/j.jcv.2009.06.027
   Taraphdar D, 2012, AM J TROP MED HYG, V86, P720, DOI 10.4269/ajtmh.2012.11-0704
   Villamil-Gomez WE, 2016, INT J INFECT DIS
   Waggoner JJ, 2016, CLIN INFECT DIS
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Zambrano H, 2016, AM J TROP MED HYG
   Zinszer K, 2017, EMERG INFECT DIS, V23, P92, DOI 10.3201/eid2301.161274
NR 24
TC 8
Z9 8
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUL
PY 2017
VL 11
IS 7
AR e0005583
DI 10.1371/journal.pntd.0005583
PG 6
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FE2PD
UT WOS:000408057300004
PM 28704365
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Carvalho, MS
   Honorio, NA
   Garcia, LMT
   Carvalho, LCD
AF Carvalho, Marilia Sa
   Honorio, Nildimar Alves
   Totaro Garcia, Leandro Martin
   de Sa Carvalho, Luiz Carlos
TI Aedes aegypti control in urban areas: A systemic approach to a complex
   dynamic
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID RIO-DE-JANEIRO; OVIPOSITION; DISPERSAL; IMMATURE; BRAZIL; VIRUS
AB The available strategy for controlling the diseases transmitted by Aedes aegypti (dengue fever, Zika, and chikungunya) relies on continued community participation. Despite slogans emphasizing how easy it should be, no country has achieved it since the seventies. To better investigate potentially sustainable interventions, we developed a systemic model based on a multidisciplinary approach, integrating as deeply as possible specialized knowledge and field experience. The resulting model is composed of 4 external and 8 internal subsystems and 31 relationships, consistent with the literature and checked over multiple iterations with specialists of the many areas. We analyzed the model and the main feedback loops responsible for the system's stability, searching for possible interventions that could shift the existing balance. We suggest the introduction of 1 more player, the local primary health care structure, with the potential to change the undesired equilibrium. The health agents in the areas are the first to detect disease cases, and they could stimulate individuals to inform about potential mosquitoes' breeding sites and bring timely information to the vector-control program. Triggering such an action could introduce changes in people's attitude through a positive feedback loop in the desired direction.
C1 [Carvalho, Marilia Sa; Totaro Garcia, Leandro Martin] Fundacao Oswaldo Cruz, Programa Computacao Cient, Rio De Janeiro, Brazil.
   [Honorio, Nildimar Alves] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios LATHEMA, Rio De Janeiro, Brazil.
   [Honorio, Nildimar Alves] Fiocruz MS, Nucleo Operac Sentinela Mosquitos Vetores Nosmove, Rio De Janeiro, Brazil.
   [de Sa Carvalho, Luiz Carlos] Pontificia Univ Catolica Rio de Janeiro, Rio De Janeiro, Brazil.
RP Carvalho, MS (corresponding author), Fundacao Oswaldo Cruz, Programa Computacao Cient, Rio De Janeiro, Brazil.
EM marilia.carvalho@fiocruz.br
RI CARVALHO, MARILIA/AAD-8283-2020; Garcia, Leandro MT/I-7520-2013
OI CARVALHO, MARILIA/0000-0002-9566-0284; Garcia, Leandro
   MT/0000-0001-5947-2617
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [200716/2015-8, 206402/2014-7, 150213/2016-6]; Fundacao Carlos Chagas
   Filho de Amparo a Pesquisa do Estado do Rio de JaneiroCarlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ) [E-26/2014-203577, E-26/102.241/2013, E-26/010.001610/2016]
FX MSC is funded by the Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (http://www.cnpq.br/ grant # 200716/2015-8) and Fundacao
   Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro
   (http ://www.faperj.br/, grant # E-26/2014-203577). NAH is funded by the
   Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro (http://www.faperj.br/, grant # E-26/102.241/2013 and
   E-26/010.001610/2016) and received a scholarship from the Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico
   (http://www.cnpq.br/, grant # 206402/2014-7). LMTG receives a
   postdoctoral scholarship from the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (http://www.cnpq.br/, grant # 150213/2016-6).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR [Anonymous], 1997, Rev Panam Salud Publica, V1, P68
   Becker B, 2014, INT J ENV RES PUB HE, V11, P3256, DOI 10.3390/ijerph110303256
   Bertollini R, 2016, EUR RESPIR REV, V25, P151, DOI 10.1183/16000617.0021-2016
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   Carabali M, 2013, BIOMEDICA, V33, P130, DOI 10.7705/biomedica.v33i0.724
   Carvalho MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132216
   Chang FS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004043
   Cilliers P., 2013, HDB SYSTEMS COMPLEXI, P27, DOI DOI 10.1007/978-1-4614-4998-0_3
   de Pinho H., 2017, SYSTEMS SCI POPULATI, P240
   Paploski IAD, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1705-0
   Diez Roux AV, 2015, CAD SAUDE PUBLICA, V31, pS9, DOI 10.1590/0102-311XDE01S115
   dos Reis IC, 2010, ACTA TROP, V114, P37, DOI 10.1016/j.actatropica.2010.01.001
   El-Sayed A.M.G. S., 2017, SYSTEMS SCI POPULATI
   Engstrom EM, 2016, CIENC SAUDE COLETIVA, V21, P1839, DOI 10.1590/1413-81232015216.0782016
   Fernandez-Salas I, 2015, ANTIVIR RES, V124, P30, DOI 10.1016/j.antiviral.2015.10.015
   Fine P, 2011, CLIN INFECT DIS, V52, P911, DOI 10.1093/cid/cir007
   Garcia-Betancourt T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129054
   Gurtler RE, 2009, PLOS NEGL TROP DIS, V3
   Gurugama Padmalal, 2010, Indian J Dermatol, V55, P68, DOI 10.4103/0019-5154.60357
   Harrington LC, 2008, VECTOR-BORNE ZOONOT, V8, P415, DOI 10.1089/vbz.2007.0203
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Honorio NA, 2009, J MED ENTOMOL, V46, P1001, DOI 10.1603/033.046.0505
   Instituto Brasileiro de Geografia e Estatistica, 2015, PESQ NAC SAUD 2013 A
   Kuno G, 1995, EPIDEMIOL REV, V17, P321, DOI 10.1093/oxfordjournals.epirev.a036196
   Lima EP, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2199-y
   McCarthy M, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4235
   Medronho RA, 2009, AM J TROP MED HYG, V80, P401, DOI 10.4269/ajtmh.2009.80.401
   Ministe A rio da Saude-Brasil, XZ3 MIN SAUD
   Ministerio da Saude-Brasil, 2009, AG COM SAUD CONTR DE
   Nazareth T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-39
   Nowell B, 2014, AM J COMMUN PSYCHOL, V54, P229, DOI 10.1007/s10464-014-9667-x
   Pappas G, 2009, CLIN MICROBIOL INFEC, V15, P743, DOI 10.1111/j.1469-0691.2009.02947.x
   Paz-Soldan VA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004409
   Regis LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067682
   Reiter P, 2007, VECTOR-BORNE ZOONOT, V7, P261, DOI 10.1089/vbz.2006.0630
   Saied KG, 2015, INT HEALTH, V7, P420, DOI 10.1093/inthealth/ihv021
   Southwell BG, 2016, EMERG INFECT DIS, V22, P1320, DOI 10.3201/eid2207.160415
   Sturmberg JP, 2013, HDB SYSTEMS COMPLEXI
   TABACHNICK WJ, 1991, J MED ENTOMOL, V28, P287, DOI 10.1093/jmedent/28.3.297
   Tauil P L, 2001, Cad Saude Publica, V17 Suppl, P99, DOI 10.1590/S0102-311X2001000700018
   Tauil Pedro Luiz, 2002, Cad. Saúde Pública, V18, P867, DOI 10.1590/S0102-311X2002000300030
   Thai KTD, 2011, EXP BIOL MED, V236, P944, DOI 10.1258/ebm.2011.010402
   Venturi G, 2013, MULHERES BRASILEIRAS
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   Yuhas Alan, 2016, GUARDIAN
   Zaff JF, 2011, ADV CHILD DEV BEHAV, V41, P273
NR 47
TC 13
Z9 13
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUL
PY 2017
VL 11
IS 7
AR e0005632
DI 10.1371/journal.pntd.0005632
PG 15
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FE2PD
UT WOS:000408057300008
PM 28749942
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Dowall, SD
   Graham, VA
   Rayner, E
   Hunter, L
   Atkinson, B
   Pearson, G
   Dennis, M
   Hewson, R
AF Dowall, Stuart D.
   Graham, Victoria A.
   Rayner, Emma
   Hunter, Laura
   Atkinson, Barry
   Pearson, Geoff
   Dennis, Mike
   Hewson, Roger
TI Lineage-dependent differences in the disease progression of Zika virus
   infection in type-I interferon receptor knockout (A129) mice
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID MOUSE MODEL; VACCINE; BRAZIL; TRANSMISSION; MICRONESIA; ISOLATIONS;
   PROTECTION; MOSQUITOS; OUTBREAK; EFFICACY
AB Zika virus (ZIKV) falls into two lineages: African (ZIKV(AF)) and Asian (ZIKV(AS)). These lineages have not been tested comprehensively in parallel for disease progression using an animal model system. Here, using the established type-I interferon receptor knockout (A129) mouse model, it is first demonstrated that ZIKV(AF) causes lethal infection, with different kinetics of disease manifestations according to the challenge dose. Animals challenged with a low dose of 10 plaque-forming units (pfu) developed more neurological symptoms than those challenged with 5-log higher doses. By contrast, animals challenged with ZIKV(AS) displayed no clinical signs or mortality, even at doses of 10(6) pfu. However, viral RNA was detected in the tissues of animals infected with ZIKV strains from both lineages and similar histological changes were observed. The present study highlights strain specific virulence differences between the African and Asian lineages in a ZIKV mouse model.
C1 [Dowall, Stuart D.; Graham, Victoria A.; Rayner, Emma; Hunter, Laura; Atkinson, Barry; Pearson, Geoff; Dennis, Mike; Hewson, Roger] Publ Hlth England, Natl Infect Serv, Salisbury, Wilts, England.
RP Dowall, SD (corresponding author), Publ Hlth England, Natl Infect Serv, Salisbury, Wilts, England.
EM stuart.dowall@phe.gov.uk
OI Dowall, Stuart/0000-0001-7378-8167; Atkinson, Barry/0000-0002-1348-7204
FU Public Health England
FX This work was funded by Grant-In-Aid funding from Public Health England.
   The funders has no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Althaus CL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002157
   [Anonymous], 2016, EURO SURVEILLANCE B, V21, P32
   Atkinson B, 2016, GENOME ANNOUNCEMENTS, V4
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brault AC, 2016, AM J TROP MED HYG, V94, P1187, DOI 10.4269/ajtmh.16-0277
   Buttigieg KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091516
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Guenet Jean-Louis, 2005, Briefings in Functional Genomics & Proteomics, V4, P225, DOI 10.1093/bfgp/4.3.225
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Holzer GW, 2011, VACCINE, V29, P4132, DOI 10.1016/j.vaccine.2011.03.089
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Lim PY, 2011, J VIROL, V85, P5197, DOI 10.1128/JVI.02692-10
   Limon-Flores AY, 2005, INT J EXP PATHOL, V86, P323, DOI 10.1111/j.0959-9673.2005.00445.x
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Osuna CE, 2016, NATURE MED
   Plante KS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004007
   PONNUDURAI T, 1991, T ROY SOC TROP MED H, V85, P175, DOI 10.1016/0035-9203(91)90012-N
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Surasombatpattana P, 2011, INFECT GENET EVOL, V11, P1664, DOI 10.1016/j.meegid.2011.06.009
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   VANDENBROEK MF, 1995, J VIROL, V69, P4792, DOI 10.1128/JVI.69.8.4792-4796.1995
   Watanabe H, 2004, SHOCK, V22, P460, DOI 10.1097/01.shk.0000142249.08135.e9
   Weger-Lucarelli J, 2016, J VIROLOGY
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yun SI, 2016, GENOME ANNOUNCEMENTS, V4
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 61
TC 28
Z9 29
U1 1
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUL
PY 2017
VL 11
IS 7
AR e0005704
DI 10.1371/journal.pntd.0005704
PG 22
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FE2PD
UT WOS:000408057300027
PM 28672028
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Moyes, CL
   Vontas, J
   Martins, AJ
   Ng, LC
   Koou, SY
   Dusfour, I
   Raghavendra, K
   Pinto, J
   Corbel, V
   David, JP
   Weetman, D
AF Moyes, Catherine L.
   Vontas, John
   Martins, Ademir J.
   Ng, Lee Ching
   Koou, Sin Ying
   Dusfour, Isabelle
   Raghavendra, Kamaraju
   Pinto, Joao
   Corbel, Vincent
   David, Jean-Philippe
   Weetman, David
TI Contemporary status of insecticide resistance in the major Aedes vectors
   of arboviruses infecting humans
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Review
ID BACILLUS-THURINGIENSIS-ISRAELENSIS; L. DIPTERA-CULICIDAE; PYRETHROID
   RESISTANCE; TEMEPHOS RESISTANCE; AEGYPTI; ALBOPICTUS; MUTATION; GENE;
   ACETYLCHOLINESTERASE; SUSCEPTIBILITY
AB Both Aedes aegytpi and Ae. albopictus are major vectors of 5 important arboviruses (namely chikungunya virus, dengue virus, Rift Valley fever virus, yellow fever virus, and Zika virus), making these mosquitoes an important factor in the worldwide burden of infectious disease. Vector control using insecticides coupled with larval source reduction is critical to control the transmission of these viruses to humans but is threatened by the emergence of insecticide resistance. Here, we review the available evidence for the geographical distribution of insecticide resistance in these 2 major vectors worldwide and map the data collated for the 4 main classes of neurotoxic insecticide (carbamates, organochlorines, organophosphates, and pyrethroids). Emerging resistance to all 4 of these insecticide classes has been detected in the Americas, Africa, and Asia. Target-site mutations and increased insecticide detoxification have both been linked to resistance in Ae. aegypti and Ae. albopictus but more work is required to further elucidate metabolic mechanisms and develop robust diagnostic assays. Geographical distributions are provided for the mechanisms that have been shown to be important to date. Estimating insecticide resistance in unsampled locations is hampered by a lack of standardisation in the diagnostic tools used and by a lack of data in a number of regions for both resistance phenotypes and genotypes. The need for increased sampling using standard methods is critical to tackle the issue of emerging insecticide resistance threatening human health. Specifically, diagnostic doses and well-characterised susceptible strains are needed for the full range of insecticides used to control Ae. aegypti and Ae. albopictus to standardise measurement of the resistant phenotype, and calibrated diagnostic assays are needed for the major mechanisms of resistance.
C1 [Moyes, Catherine L.] Univ Oxford, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford Big Data Inst, Oxford, England.
   [Vontas, John] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Greece.
   [Vontas, John] Agr Univ Athens, Pesticide Sci Lab, Dept Crop Sci, Athens, Greece.
   [Martins, Ademir J.] Fiocruz MS, Fdn Oswaldo Cruz, Inst Oswaldo Cruz, Lab Fisiol & Controle Artropodes Vetores, Rio De Janeiro, RJ, Brazil.
   [Ng, Lee Ching; Koou, Sin Ying] Natl Environm Agcy, Environm Hlth Inst, Helios Block, Singapore, Singapore.
   [Dusfour, Isabelle] Inst Pasteur, Unite Entomol Med, Cayenne, French Guiana.
   [Raghavendra, Kamaraju] Natl Inst Malaria Res ICMR, Insecticides & Insecticide Resistance Lab, Delhi, India.
   [Pinto, Joao] Univ Nova Lisboa, IHMT, GHTM, Lisbon, Portugal.
   [Corbel, Vincent] MIVEGEC, IRD, Montpellier, France.
   [David, Jean-Philippe] UGA, CNRS, Lab Ecol Alpine LECA, Grenoble, France.
   [Weetman, David] Univ Liverpool Liverpool Sch Trop Med, Dept Vector Biol, Liverpool, Merseyside, England.
RP Moyes, CL (corresponding author), Univ Oxford, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford Big Data Inst, Oxford, England.
EM catherinemoyes@gmail.com
RI Martins, Ademir J./B-4117-2009; DAVID, jean-philippe/F-3077-2012; Pinto,
   Joao/C-2208-2012; Martins, Ademir/W-3251-2019; J., Pinto/H-6177-2019;
   Weetman, David/M-1261-2014
OI DAVID, jean-philippe/0000-0002-3950-5909; Pinto,
   Joao/0000-0001-8572-7708; Martins, Ademir/0000-0001-5739-1215; J.,
   Pinto/0000-0001-8572-7708; Moyes, Catherine/0000-0002-8028-4079; Vontas,
   John/0000-0002-8704-2574; Weetman, David/0000-0002-5820-1388; Kamaraju,
   Raghavendra/0000-0002-4098-7095
FU World Health Organization's Special Programme for Research and Training
   in Tropical Diseases; Wellcome TrustWellcome Trust [108440/Z/15/Z]
FX The preparation of this review was funded by an award from the World
   Health Organization's Special Programme for Research and Training in
   Tropical Diseases (http://www.who.int/tdr/) to VC, JPD, and the WIN
   network. The bioassay data extraction was funded by Wellcome Trust
   (https://wellcome.ac.uk/) grant 108440/Z/15/Z awarded to CLM. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Araujo AP, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-297
   Balabanidou V, 2016, P NATL ACAD SCI USA, V113, P9268, DOI 10.1073/pnas.1608295113
   Bellinato DF, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8603263
   Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25
   Bisset J, 2006, J MED ENTOMOL, V43, P1185, DOI 10.1603/0022-2585(2006)43[1185:SOIAAA]2.0.CO;2
   Chandor-Proust A, 2013, BIOCHEM J, V455, P75, DOI 10.1042/BJ20130577
   Chen CD, 2013, TROP BIOMED, V30, P220
   Chen HY, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0125-x
   Coleman M, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1733-z
   Corbel V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005054
   David JP, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0429
   Davies TGE, 2007, INSECT MOL BIOL, V16, P361, DOI 10.1111/j.1365-2583.2007.00733.x
   Melo ALD, 2016, CRIT REV BIOTECHNOL, V36, P317, DOI 10.3109/07388551.2014.960793
   Djogbenou LS, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1026-3
   Du YZ, 2013, P NATL ACAD SCI USA, V110, P11785, DOI 10.1073/pnas.1305118110
   Dusfour I, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004226
   Esu E, 2010, TROP MED INT HEALTH, V15, P619, DOI 10.1111/j.1365-3156.2010.02489.x
   Faucon F, 2015, GENOME RES, V25, P1347, DOI 10.1101/gr.189225.115
   Feyereisen R, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P236, DOI 10.1016/B978-0-12-384747-8.10008-X
   Ffrench-Constant RH, 2000, ANNU REV ENTOMOL, V45, P449, DOI 10.1146/annurev.ento.45.1.449
   George L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004006
   Giraldo-Calderon GI, 2015, NUCLEIC ACIDS RES, V43, pD707, DOI 10.1093/nar/gku1117
   Grigoraki L, 2016, INSECT BIOCHEM MOLEC, V74, P61, DOI 10.1016/j.ibmb.2016.05.007
   Grigoraki L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003771
   Grisales N, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002438
   Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623
   Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Hirata K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003085
   Horstick O, 2010, T ROY SOC TROP MED H, V104, P379, DOI 10.1016/j.trstmh.2009.07.027
   Ishak IH, 2016, SCI REP-UK, V6, DOI 10.1038/srep24707
   Ismail HM, 2013, P NATL ACAD SCI USA, V110, P19766, DOI 10.1073/pnas.1320185110
   Kamgang B, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-79
   Kasai S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002948
   Kawada H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004780
   Knox TB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-76
   Kushwah RBS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003332
   Labbe P, 2007, MOL BIOL EVOL, V24, P1056, DOI 10.1093/molbev/msm025
   Lau KW, 2015, J MED ENTOMOL, V52, P199, DOI 10.1093/jme/tju019
   Lee RML, 2014, TROP BIOMED, V31, P670
   Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   Loke SR, 2010, TROP BIOMED, V27, P493
   Low VL, 2015, TROP BIOMED, V32, P554
   Lumjuan N, 2011, INSECT BIOCHEM MOLEC, V41, P203, DOI 10.1016/j.ibmb.2010.12.005
   Marcombe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101992
   Marcombe S, 2011, AM J TROP MED HYG, V84, P118, DOI 10.4269/ajtmh.2011.10-0335
   Marcombe S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-494
   Martins AJ, 2009, TROP MED INT HEALTH, V14, P1351, DOI 10.1111/j.1365-3156.2009.02378.x
   Moyes CL, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-161
   Muthusamy R, 2015, J VECTOR DIS, V52, P159
   Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2
   Noort D, 2008, CHEM RES TOXICOL, V21, P1396, DOI 10.1021/tx8000362
   Paris M, 2011, PEST MANAG SCI, V67, P122, DOI 10.1002/ps.2046
   Pavlidi N, 2012, PESTIC BIOCHEM PHYS, V104, P132, DOI 10.1016/j.pestbp.2012.07.003
   Plernsub S, 2016, PARASITE VECTOR, P9
   Plernsub S, 2016, ACTA TROP, V162, P125, DOI 10.1016/j.actatropica.2016.06.019
   Pocquet N, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-299
   Polson KA, 2011, ACTA TROP, V117, P31, DOI 10.1016/j.actatropica.2010.09.005
   Garcia GP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000531
   Poupardin R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002743
   Ranson H, 2005, METHOD ENZYMOL, V401, P226, DOI 10.1016/S0076-6879(05)01014-1
   Ranson H, 2010, TROPIKA NET J, V1, P1
   Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x
   Saavedra-Rodriguez K, 2014, INSECT MOL BIOL, V23, P199, DOI 10.1111/imb.12073
   Stevenson BJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001595
   Tantely ML, 2010, INSECT BIOCHEM MOLEC, V40, P317, DOI 10.1016/j.ibmb.2010.02.005
   THOMPSON M, 1993, FEBS LETT, V325, P187, DOI 10.1016/0014-5793(93)81070-G
   Vera-Maloof FZ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004263
   Vos T, 2016, LANCET, V388, P1545, DOI 10.1016/S0140-6736(16)31678-6
   Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4
   Weill M, 2004, INSECT MOL BIOL, V13, P1, DOI 10.1111/j.1365-2583.2004.00452.x
   Wiebe A, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1734-y
   Wood OR, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-67
   Xu JB, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004696
   Yanola J, 2010, PESTIC BIOCHEM PHYS, V96, P127, DOI 10.1016/j.pestbp.2009.10.005
   Yen C, 2015, LANCET INFECT DIS, V15, P340, DOI 10.1016/S1473-3099(14)70999-5
NR 77
TC 137
Z9 139
U1 3
U2 32
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUL
PY 2017
VL 11
IS 7
AR e0005625
DI 10.1371/journal.pntd.0005625
PG 20
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FE2PD
UT WOS:000408057300007
PM 28727779
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Saldana, MA
   Etebari, K
   Hart, CE
   Widen, SG
   Wood, TG
   Thangamani, S
   Asgari, S
   Hughes, GL
AF Saldana, Miguel A.
   Etebari, Kayvan
   Hart, Charles E.
   Widen, Steven G.
   Wood, Thomas G.
   Thangamani, Saravanan
   Asgari, Sassan
   Hughes, Grant L.
TI Zika virus alters the microRNA expression profile and elicits an RNAi
   response in Aedes aegypti mosquitoes
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID ARBOVIRUS; VECTOR; PROTEINS; PATHWAY; REPLICATION; TARGETS; GENES
AB Zika virus (ZIKV), a flavivirus transmitted primarily by Aedes aegypti, has recently spread globally in an unprecedented fashion, yet we have a poor understanding of host-microbe interactions in this system. To gain insights into the interplay between ZIKV and the mosquito, we sequenced the small RNA profiles in ZIKV-infected and non-infected Ae. aegypti mosquitoes at 2, 7 and 14 days post-infection. ZIKA induced an RNAi response in the mosquito with virus-derived short interfering RNAs and PIWI-interacting RNAs dramatically increased in abundance post-infection. Further, we found 17 host microRNAs (miRNAs) that were modulated by ZIKV infection at all time points. Strikingly, many of these regulated miRNAs have been reported to have their expression altered by dengue and West Nile viruses, while the response was divergent from that induced by the alphavirus Chikungunya virus in mosquitoes. This suggests that conserved miRNA responses occur within mosquitoes in response to flavivirus infection. This study expands our understanding of ZIKV-vector interactions and provides potential avenues to be further investigated to target ZIKV in the mosquito host.
C1 [Saldana, Miguel A.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Etebari, Kayvan; Asgari, Sassan] Univ Queensland, Australian Infect Dis Res Ctr, Sch Biol Sci, Brisbane, Qld, Australia.
   [Hart, Charles E.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Widen, Steven G.; Wood, Thomas G.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Thangamani, Saravanan; Hughes, Grant L.] Univ Texas Med Branch, Dept Pathol, Ctr Biodef & Emerging Infect Dis, Inst Human Infect & Immun,Ctr Trop Dis, Galveston, TX 77555 USA.
RP Asgari, S (corresponding author), Univ Queensland, Australian Infect Dis Res Ctr, Sch Biol Sci, Brisbane, Qld, Australia.; Hughes, GL (corresponding author), Univ Texas Med Branch, Dept Pathol, Ctr Biodef & Emerging Infect Dis, Inst Human Infect & Immun,Ctr Trop Dis, Galveston, TX 77555 USA.
EM s.asgari@uq.edu.edu; glhughes@utmb.edu
RI Thangamani, Saravanan/E-7371-2010; Etebari, Kayvan/C-6436-2008; Asgari,
   Sassan/G-2678-2011
OI Thangamani, Saravanan/0000-0002-4269-5993; Etebari,
   Kayvan/0000-0001-5213-6362; Asgari, Sassan/0000-0001-7885-6544; Saldana,
   Miguel/0000-0003-0470-1667; Hughes, Grant/0000-0002-7567-7185
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R21AI124452]; University of Texas
   Rising Star award; Australian National Health and Medical Research
   Council grantNational Health and Medical Research Council of Australia
   [APP1062983]; Western Gulf Center of Excellence for Vector-borne
   Diseases (CDC grant)United States Department of Health & Human
   ServicesCenters for Disease Control & Prevention - USA [CK17-005]; NIH
   T32 fellowshipUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [2T32AI007526]
FX This project was supported by a NIH grant (R21AI124452) and a University
   of Texas Rising Star award to GLH, an Australian National Health and
   Medical Research Council grant (APP1062983) to SA. GLH and ST are
   additionally supported by the Western Gulf Center of Excellence for
   Vector-borne Diseases (CDC grant CK17-005). MAS was supported by a NIH
   T32 fellowship (2T32AI007526). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Ahluwalia JK, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-117
   Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106
   Castillo JA, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1364-y
   Asgari S, 2014, VIRUSES-BASEL, V6, P3514, DOI 10.3390/v6093514
   Asgari S, 2013, INSECT BIOCHEM MOLEC, V43, P388, DOI 10.1016/j.ibmb.2012.10.005
   Asgari S, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00048
   Blair CD, 2015, VIRUSES-BASEL, V7, P820, DOI 10.3390/v7020820
   Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856
   Brackney DE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000502
   Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043
   Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558
   Busto GU, 2015, GENETICS, V200, P569, DOI 10.1534/genetics.114.169623
   Campbell CL, 2014, INSECT MOL BIOL, V23, P132, DOI 10.1111/imb.12070
   Daneshvar K, 2013, BIOL OPEN, V2, P1, DOI 10.1242/bio.20122725
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dietrich I, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00090-17
   Enright AJ, 2004, GENOME BIOL, V5
   Foronda D, 2014, GENE DEV, V28, P2421, DOI 10.1101/gad.241588.114
   Goertz GP, 2016, J VIROL, V90, P10145, DOI 10.1128/JVI.00930-16
   Aguiar ERGR, 2016, WIRES RNA, V7, P824, DOI 10.1002/wrna.1361
   Hess AM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-45
   Hussain M, 2016, ADV INSECT PHYSIOL, V51, P189, DOI 10.1016/bs.aiip.2016.04.001
   Hussain M, 2013, INSECT BIOCHEM MOLEC, V43, P146, DOI 10.1016/j.ibmb.2012.11.005
   Jupatanakul N, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005187
   Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181
   Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243
   Lee M, J GEN VIROL IN PRESS
   Li X, 2016, SCI REP
   Liu YX, 2016, INSECT SCI, V23, P377, DOI 10.1111/1744-7917.12339
   Liu YX, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0009-y
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lucas KJ, 2013, TRENDS PARASITOL, V29, P295, DOI 10.1016/j.pt.2013.04.003
   McFarlane M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002994
   Miesen P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004452
   Miesen P, 2015, NUCLEIC ACIDS RES, V43, P6545, DOI 10.1093/nar/gkv590
   Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031
   Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470
   Olson KE, 2015, CURR OPIN VIROL, V15, P119, DOI 10.1016/j.coviro.2015.10.001
   Pijlman GP, 2014, CURR OPIN VIROL, V7, P55, DOI 10.1016/j.coviro.2014.04.002
   Ramirez JL, 2010, DEV COMP IMMUNOL, V34, P625, DOI 10.1016/j.dci.2010.01.006
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roby JA, 2014, VIRUSES-BASEL, V6, P404, DOI 10.3390/v6020404
   Rueda A, 2015, NUCLEIC ACIDS RES, V43, pW467, DOI 10.1093/nar/gkv555
   Schnettler E, 2013, J GEN VIROL, V94, P1680, DOI 10.1099/vir.0.053850-0
   Schnettler E, 2013, J VIROL, V87, P2441, DOI 10.1128/JVI.02848-12
   Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12
   Scott JC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000848
   Shrinet J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002616
   Skalsky RL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-119
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Trobaugh DW, 2014, NATURE, V506, P245, DOI 10.1038/nature12869
   Vodovar N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030861
   Wen WT, 2015, J INFECTION, V70, P631, DOI 10.1016/j.jinf.2014.12.001
   Yan H, 2014, J MED VIROL, V86, P1428, DOI 10.1002/jmv.23815
   Zhang Y, 2016, P NATL ACAD SCI USA, V113, pE4828, DOI 10.1073/pnas.1609792113
   Zhou YH, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0488-4
NR 58
TC 37
Z9 38
U1 4
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUL
PY 2017
VL 11
IS 7
AR e0005760
DI 10.1371/journal.pntd.0005760
PG 18
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FE2PD
UT WOS:000408057300061
PM 28715413
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Carroll, T
   Lo, M
   Lanteri, M
   Dutra, J
   Zarbock, K
   Silveira, P
   Rourke, T
   Ma, ZM
   Fritts, L
   O'Connor, S
   Busch, M
   Miller, CJ
AF Carroll, Timothy
   Lo, Ming
   Lanteri, Marion
   Dutra, Joseph
   Zarbock, Katie
   Silveira, Paola
   Rourke, Tracy
   Ma, Zhong-min
   Fritts, Linda
   O'Connor, Shelby
   Busch, Michael
   Miller, Christopher J.
TI Zika virus preferentially replicates in the female reproductive tract
   after vaginal inoculation of rhesus macaques
SO PLOS PATHOGENS
LA English
DT Article
ID SEXUALLY-TRANSMITTED-DISEASE; IMMUNODEFICIENCY-VIRUS; MENSTRUAL-CYCLE;
   UNITED-STATES; HORMONAL CONTRACEPTION; RECEPTOR ANTAGONIST;
   IMMUNE-RESPONSES; HIV-INFECTION; MOUSE MODEL; TRANSMISSION
AB Zika virus (ZIKV) is a mosquito-transmitted virus that can cause severe defects in an infected fetus. ZIKV is also transmitted by sexual contact, although the relative importance of sexual transmission is unclear. To better understand the role of sexual transmission in ZIKV pathogenesis, a nonhuman primate (NHP) model of vaginal transmission was developed. ZIKV was readily transmitted to mature cycling female rhesus macaque (RM) by vaginal inoculation with 10(4)-10(6) plaque-forming units (PFU). However, there was variability in susceptibility between the individual RM with 1-5 vaginal inoculations required to establish infection. After treatment with Depoprovera, a widely used contraceptive progestin, two RM that initially resisted 8 vaginal ZIKV inoculations became infected after one ZIKV inoculation. Thus, Depoprovera seemed to enhance susceptibility to vaginal ZIKV transmission. Unexpectedly, the kinetics of virus replication and dissemination after intravaginal ZIKV inoculation were markedly different from RM infected with ZIKV by subcutaneous (SQ) virus inoculation. Several groups have reported that after SQ ZIKV inoculation vRNA is rapidly detected in blood plasma with vRNA less common in urine and saliva and only rarely detected in female reproductive tract (FRT) secretions. In contrast, in vaginally inoculated RM, plasma vRNA is delayed for several days and ZIKV replication in, and vRNA shedding from, the FRT was found in all 6 animals. Further, after intravaginal transmission ZIKV RNA shedding from FRT secretions was detected before or simultaneously with plasma vRNA, and persisted for at least as long. Thus, ZIKV replication in the FRT was independent of, and often preceded virus replication in the tissues contributing to plasma vRNA. These results support the conclusion that ZIKV preferentially replicates in the FRT after vaginal transmission, but not after SQ transmission, and raise the possibility that there is enhanced fetal infection and pathology after vaginal ZIKV transmission compared to a mosquito transmitted ZIKV.
C1 [Carroll, Timothy; Lo, Ming; Dutra, Joseph; Rourke, Tracy; Ma, Zhong-min; Fritts, Linda; Miller, Christopher J.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA.
   [Carroll, Timothy; Lo, Ming; Dutra, Joseph; Rourke, Tracy; Ma, Zhong-min; Fritts, Linda; Miller, Christopher J.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.
   [Lanteri, Marion; Busch, Michael] Blood Syst Res Inst, San Francisco, CA USA.
   [Zarbock, Katie; O'Connor, Shelby] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI USA.
   [Silveira, Paola] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
RP Miller, CJ (corresponding author), Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA.; Miller, CJ (corresponding author), Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.
EM cjmiller@ucdavis.edu
FU Public Health ServiceUnited States Public Health Service [P51RR00169];
   Office of Research Infrastructure Programs [P51RR000167, P510D011106];
   National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R210D023818]
FX This work was supported by Public Health Service grants P51RR00169 that
   supports the CNPRC and P51RR000167 and P510D011106 that support the
   WNPRC from the Office of Research Infrastructure Programs and
   R210D023818 to CJM from National Institutes of Health. The funders had
   no role in study design data collection and analysis decision
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Abel K, 2004, J INFECT DIS, V190, P1697, DOI 10.1086/424600
   Arndt U, 2002, J VIROL, V76, P9298, DOI 10.1128/JVI.76.18.9298-9306.2002
   Arnold F, 2012, J VIROL, V86, P1244, DOI 10.1128/JVI.06121-11
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Baeten JM, 2001, AM J OBSTET GYNECOL, V185, P380, DOI 10.1067/mob.2001.115862
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Barzon L, 2016, EUROSURVEILL
   BELEC L, 1989, J INFECT DIS, V160, P385, DOI 10.1093/infdis/160.3.385
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Birse KD, 2017, J INFECT DIS, V215, P590, DOI 10.1093/infdis/jiw590
   Bouhlal H, 2002, J IMMUNOL, V169, P3301, DOI 10.4049/jimmunol.169.6.3301
   BOZIC CR, 1994, J BIOL CHEM, V269, P29355
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Calla NEQ, 2016, MUCOSAL IMMUNOL, V9, P1571, DOI 10.1038/mi.2016.22
   Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CDC, 2017, CAS COUNTS US
   Chen HR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004828
   Chuang YC, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/547094
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Cox J, 2012, J VIROL, V86, P7637, DOI 10.1128/JVI.00534-12
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dienz O, 2012, MUCOSAL IMMUNOL, V5, P258, DOI 10.1038/mi.2012.2
   Dienz O, 2009, CLIN IMMUNOL, V130, P27, DOI 10.1016/j.clim.2008.08.018
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Faria NR, 2016, SCIENCE
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EUROSURVEILLANCE, P21
   Freour T, 2016, EUROSURVEILL
   Gabay C, 1997, J CLIN INVEST, V99, P2930, DOI 10.1172/JCI119488
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Gillgrass AE, 2005, J VIROL, V79, P3117, DOI 10.1128/JVI.79.5.3117-3126.2005
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Heffron R, 2011, LANCET INFECT DIS
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Kaushic C, 2003, J VIROL, V77, P4558, DOI 10.1128/JVI.77.8.4558-4565.2003
   Kersh EN, 2014, J MED PRIMATOL, V43, P310, DOI 10.1111/jmp.12124
   Kim KA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-55
   Kishimoto T, 2010, INT IMMUNOL, V22, P347, DOI 10.1093/intimm/dxq030
   Kreuzer KA, 1997, CLIN EXP IMMUNOL, V109, P54, DOI 10.1046/j.1365-2249.1997.4181315.x
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   LEE J, 1995, J IMMUNOL, V155, P2158
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024
   MARX PA, 1985, J VIROL, V56, P571, DOI 10.1128/JVI.56.2.571-578.1985
   MCDERMOTT MR, 1989, J INFECT DIS, V159, P460, DOI 10.1093/infdis/159.3.460
   McNicholl JM, 2014, AM J REPROD IMMUNOL, V71, P513, DOI 10.1111/aji.12246
   Mestecky J, 2014, AM J REPROD IMMUNOL, V71, P600, DOI 10.1111/aji.12203
   MILLER CJ, 1994, J VIROL, V68, P6391, DOI 10.1128/JVI.68.10.6391-6400.1994
   MILLER CJ, 1992, CLIN EXP IMMUNOL, V88, P520, DOI 10.1111/j.1365-2249.1992.tb06481.x
   Miller CJ, 2003, INT REV IMMUNOL, V22, P65, DOI 10.1080/08830180305230
   Miller LS, 2007, J IMMUNOL, V179, P6933, DOI 10.4049/jimmunol.179.10.6933
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miotla JM, 2001, BRIT J PHARMACOL, V133, P550, DOI 10.1038/sj.bjp.0704118
   Morris MR, 2015, J MED PRIMATOL, V44, P301, DOI 10.1111/jmp.12177
   Morrison CS, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001778
   Morrison CS, 2004, SEX TRANSM DIS, V31, P561, DOI 10.1097/01.olq.0000137904.56037.70
   Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014
   Munch J, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-148
   Murphy K, 2014, AM J REPROD IMMUNOL, V72, P228, DOI 10.1111/aji.12209
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Neildez O, 1998, RES VIROLOGY, V149, P53, DOI 10.1016/S0923-2516(97)86900-2
   Nicastri E, 2016, EUROSURVEILL
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Parr EL, 1998, J REPROD IMMUNOL, V38, P15, DOI 10.1016/S0165-0378(97)00081-8
   Paz-Bailey G, 2017, N ENGL J MED
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Quick J, 2017, MULTIPLEX PCR METHOD
   Randolph SE, 2010, NAT REV MICROBIOL, V8, P361, DOI 10.1038/nrmicro2336
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rider P, 2011, J IMMUNOL, V187, P4835, DOI 10.4049/jimmunol.1102048
   Roan NR, 2011, CELL HOST MICROBE, V10, P541, DOI 10.1016/j.chom.2011.10.010
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roth A, 2014, EUROSURVEILLANCE, P19
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Thea DM, 1996, ANN INTERN MED, V124, P757, DOI 10.7326/0003-4819-124-8-199604150-00009
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Vishwanathan SA, 2011, JAIDS-J ACQ IMM DEF, V57, P261, DOI 10.1097/QAI.0b013e318220ebd3
   Visseaux B, 2016, LANCET INFECT DIS, V16, P1220, DOI 10.1016/S1473-3099(16)30387-5
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 98
TC 42
Z9 42
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD JUL
PY 2017
VL 13
IS 7
AR e1006537
DI 10.1371/journal.ppat.1006537
PG 23
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA FC1UR
UT WOS:000406623700058
PM 28746373
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rosenthal, SL
   Fraiz, LD
   De Roche, LM
   Catallozzi, M
   Shapiro, GK
   Zimet, GD
AF Rosenthal, Susan L.
   Fraiz, Lauren Dapena
   De Roche, Lariel M.
   Catallozzi, Marina
   Shapiro, Gilla K.
   Zimet, Greg D.
TI A PSYCHOSOCIAL EVALUATION OF THE ZIKA VIRUS: US PREGNANT WOMEN'S
   KNOWLEDGE AND ATTITUDES ABOUT PREVENTION
SO SEXUALLY TRANSMITTED INFECTIONS
LA English
DT Meeting Abstract
C1 [Rosenthal, Susan L.; Fraiz, Lauren Dapena; De Roche, Lariel M.; Catallozzi, Marina] Columbia Univ, New York, NY USA.
   [Shapiro, Gilla K.] McGill Univ, Montreal, PQ, Canada.
   [Zimet, Greg D.] Indiana Univ, Bloomington, IN 47405 USA.
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R33AI098654]
FX National Institutes of Health (R33AI098654)
NR 0
TC 0
Z9 0
U1 0
U2 1
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1368-4973
EI 1472-3263
J9 SEX TRANSM INFECT
JI Sex. Transm. Infect.
PD JUL
PY 2017
VL 93
SU 2
MA O04.5
BP A9
EP A9
DI 10.1136/sextrans-2017-053264.22
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA GR3LP
UT WOS:000442492000023
OA Bronze
DA 2020-07-08
ER

PT J
AU Zambrano, H
   Waggoner, J
   Leon, K
   Pinsky, B
   Schettino, M
   Vera, K
   Rivera, L
   Landivar, J
   Mor, G
AF Zambrano, Hector
   Waggoner, Jesse
   Leon, Karina
   Pinsky, Benjamin
   Schettino, Marissa
   Vera, Ketty
   Rivera, Lissette
   Landivar, Jose
   Mor, Gil
TI DETECTION OF ZIKA VIRUS AND CYTOMEGALOVIRUS IN CERVICAL CYTOLOGY SAMPLES
   OF PREGNANT WOMEN FROM GUAYAQUIL, ECUADOR, USING TWO REAL-TIME
   POLYMERASE CHAIN REACTION (RT-PCR) MOLECULAR ASSAYS
SO SEXUALLY TRANSMITTED INFECTIONS
LA English
DT Meeting Abstract
C1 [Zambrano, Hector] Univ Ghent, Gent, Ecuador.
   [Waggoner, Jesse] Emory Univ, Atlanta, GA 30322 USA.
   [Leon, Karina] Hosp Alfredo Paulson, Guayaquil, Ecuador.
   [Pinsky, Benjamin] Stanford, Stanford, CA USA.
   [Schettino, Marissa] Minist Salud Publ, Canton Bolivar, Ecuador.
   [Vera, Ketty] Minist Salud Publ, Gen Villamil, Ecuador.
   [Rivera, Lissette; Landivar, Jose] Hosp Lius Vernaza, Guayaquil, Ecuador.
   [Mor, Gil] Yale Univ, New Haven, CT USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1368-4973
EI 1472-3263
J9 SEX TRANSM INFECT
JI Sex. Transm. Infect.
PD JUL
PY 2017
VL 93
SU 2
MA LB1.66
BP A68
EP A68
DI 10.1136/sextrans-2017-053264.171
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA GR3LP
UT WOS:000442492000172
OA Bronze
DA 2020-07-08
ER

PT J
AU Moreira, A
   Alonso-Calvo, R
   Munoz, A
   Crespo, J
AF Moreira, Albert
   Alonso-Calvo, Raul
   Munoz, Alberto
   Crespo, Jose
TI Enhancing Collaborative Case Diagnoses Through Unified Medical Language
   System-Based Disambiguation: A Case Study of the Zika Virus
SO TELEMEDICINE AND E-HEALTH
LA English
DT Article
DE medical informatics; collaboration; UMLS; Zika virus
ID INFORMATICS
AB Background:During clinical case diagnoses, especially in low-resourced areas, the use of vocabularies within Unified Medical Language System (UMLS) can strengthen discussions between health professionals and, in certain cases, eliminate the need, enabling faster treatment.Introduction:This article presents the benefits of using UMLS as a collaborative discussion tool and verifies its impact.Materials and Methods:The Sanar system has been improved by UMLS when using text retrieval to extract relevant medical concepts from cases investigated by the user and to provide contextualized searches of related articles. An experiment was conducted, focused on team engagement and discussion of a Zika virus case using Sanar, both with and without UMLS contextualization.Results:The use of the tool was measured, and it was determined that the discussion in the group with UMLS support was more complete based on better information and inclusion of more variables. Clinicians involved responded to a questionnaire evaluating the relevance of functions.Discussion:From the questionnaire showed that most of the group supported UMLS as important in complex diagnostics; the use of knowledge extraction before discussion is relevant to align knowledge of participants with more variables, such as the Zika virus, and to minimize the need for interaction in widely discussed cases.Conclusions:Based on the results obtained with the questionnaire, the use of UMLS provides acceleration in the diagnostic process that precedes interaction with other health professionals through clinical discussion tools. For future work, a mobile version will support offline navigation for locations with limited Internet access.
C1 [Moreira, Albert; Alonso-Calvo, Raul; Crespo, Jose] Univ Politecn Madrid, Biomed Informat Grp, DLSIIS, Madrid, Spain.
   [Moreira, Albert; Alonso-Calvo, Raul; Crespo, Jose] Univ Politecn Madrid, DIA, ETSIINF, Madrid, Spain.
   [Munoz, Alberto] Univ Complutense Madrid, Fac Med, Madrid, Spain.
RP Alonso-Calvo, R (corresponding author), Univ Politecn Madrid, Fac Informat, Dept Lenguajes & Sistemas Informat & Ingn Softwar, Campus Montegancedo S-N, E-28660 Madrid, Spain.
EM ralonso@infomed.dia.fi.upm.es
RI CALVO, RAUL ALONSO/AAE-5436-2019
OI CALVO, RAUL ALONSO/0000-0002-2803-0215
CR Alexander M, 1995, J Telemed Telecare, V1, P187
   Bajaj Y, 2013, J LARYNGOL OTOL, V127, P295, DOI 10.1017/S0022215112003192
   Balka E, 2008, CSCW: 2008 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK, CONFERENCE PROCEEDINGS, P515
   Bardram J. E., 2010, P CSCW 2010 WORKSH C
   Bates David W, 2002, BMC Med Inform Decis Mak, V2, P7, DOI 10.1186/1472-6947-2-7
   Bjorn P, 2007, ECSCW 2007: PROCEEDINGS OF THE 10TH EUROPEAN CONFERENCE ON COMPUTER-SUPPORTED COOPERATIVE WORK, P371, DOI 10.1007/978-1-84800-031-5_20
   Butte AJ, 2008, J AM MED INFORM ASSN, V15, P709, DOI 10.1197/jamia.M2824
   Button Graham, 2009, STUDIES WORK WORKPLA
   Crabtree A, 2003, DESIGNING COLLABORAT
   Fox G, 2005, INT S COLLAB TECHNOL, P11
   Fraser HSF, 2001, ST HEAL T, V84, P815
   Gomes H, 2007, LECT NOTES COMPUT SC, V4804, P1583
   Grigsby WJ, 2002, J RURAL HEALTH, V18, P348, DOI 10.1111/j.1748-0361.2002.tb00896.x
   Gross T, 2003, ECSCW 2003: PROCEEDINGS OF THE EIGHTH EUROPEAN CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK, P295
   Hailey D, 2005, J Postgrad Med, V51, P275
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Humphreys BL, 1998, J AM MED INFORM ASSN, V5, P1
   Kusunoki DS, 2015, PROCEEDINGS OF THE 2015 ACM INTERNATIONAL CONFERENCE ON COMPUTER-SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING (CSCW'15), P1465, DOI 10.1145/2675133.2675279
   LYNCH KJ, 1990, MULTI-USER INTERFACES AND APPLICATIONS, P159
   Moreira A., 2012, 2012 Brazilian Symposium on Collaborative Systems (SBSC 2012), P35, DOI 10.1109/SBSC.2012.14
   *NLM, 2000, UMLS KNOWL SOURC
   Oberholzer Martin, 2003, Curr Probl Dermatol, V32, P102
   Payne PRO, 2005, J INVEST MED, V53, P192, DOI 10.2310/6650.2005.00402
   Reddy M., 2002, P 2002 ACM C COMP SU, P344, DOI DOI 10.1145/587078.587126
   Rodden T, 1996, P 1996 ACM C COMP SU, P87, DOI DOI 10.1145/240080.240200
   Schmidt K., 2002, Computer Supported Cooperative Work: The Journal of Collaborative Computing, V11, P285, DOI 10.1023/A:1021272909573
   Sung NS, 2003, JAMA-J AM MED ASSOC, V289, P1278, DOI 10.1001/jama.289.10.1278
   TRIPATHI A., 2005, PERVASIVE MOB COMPUT, V1, P21
NR 29
TC 1
Z9 1
U1 0
U2 3
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1530-5627
EI 1556-3669
J9 TELEMED E-HEALTH
JI Telemed. e-Health
PD JUL
PY 2017
VL 23
IS 7
BP 608
EP 614
DI 10.1089/tmj.2016.0203
PG 7
WC Health Care Sciences & Services
SC Health Care Sciences & Services
GA FA5SA
UT WOS:000405502700010
PM 28092493
DA 2020-07-08
ER

PT J
AU Kiely, P
   Gambhir, M
   Cheng, AC
   McQuilten, ZK
   Seed, CR
   Wood, EM
AF Kiely, Philip
   Gambhir, Manoj
   Cheng, Allen C.
   McQuilten, Zoe K.
   Seed, Clive R.
   Wood, Erica M.
TI Emerging Infectious Diseases and Blood Safety: Modeling the
   Transfusion-Transmission Risk
SO TRANSFUSION MEDICINE REVIEWS
LA English
DT Review
DE Emerging infectious diseases; Blood safety; Risk modeling; Zika virus
ID WEST-NILE-VIRUS; HEPATITIS-C VIRUS; GUILLAIN-BARRE-SYNDROME;
   HUMAN-IMMUNODEFICIENCY-VIRUS; VECTOR-BORNE TRANSMISSION; MALE SEXUAL
   TRANSMISSION; T-LYMPHOTROPIC VIRUS; ZIKA VIRUS; UNITED-STATES; RESIDUAL
   RISK
AB While the transfusion-transmission (11) risk associated with the major transfusion-relevant viruses such as HIV is now very low, during the last 20 years there has been a growing awareness of the threat to blood safety from emerging infectious diseases, a number of which are known to be, or are potentially, transfusion transmissible. Two published models for estimating the transfusion-transmission risk from EID5, referred to as the Biggerstaff-Petersen model and the European Upfront Risk Assessment Tool (EUFRAT), respectively, have been applied to several EIDs in outbreak situations. We describe and compare the methodological principles of both models, highlighting their similarities and differences. We also discuss the appropriateness of comparing results from the two models. Quantitating the TT risk of EIDs can inform decisions about risk mitigation strategies and their cost-effectiveness. Finally, we present a qualitative risk assessment for Zika virus (ZIKV), an EID agent that has caused several outbreaks since 2007. In the latest and largest ever outbreak, several probable cases of transfusion-transmission ZIKV have been reported, indicating that it is transfusion-transmissible and therefore a risk to blood safety. We discuss why quantitative modeling the TT risk of ZIKV is currently problematic. Crown Copyright (C) 2017 Published by Elsevier Inc. All rights reserved.
C1 [Kiely, Philip; Seed, Clive R.] Australian Red Cross Blood Serv, Melbourne, Vic, Australia.
   [Kiely, Philip; Gambhir, Manoj; Cheng, Allen C.; McQuilten, Zoe K.; Wood, Erica M.] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia.
   [Cheng, Allen C.] Alfred Hlth, Dept Infect Dis, Melbourne, Vic, Australia.
RP Kiely, P (corresponding author), Australian Red Cross Blood Serv, POB 354, S Melbourne, Vic 3205, Australia.
EM pkiely@redcrossblood.org.au
RI Wood, Erica/I-1956-2014
OI Wood, Erica/0000-0001-7527-2340; Gambhir, Manoj/0000-0002-4831-6261
FU Australian governmentsAustralian Government
FX Australian governments fund the Australian Red Cross Blood Service for
   the provision of blood, blood products and services to the Australian
   community.
CR Al-Tawfiq JA, 2016, FRONT MED-PRC, V10, P111, DOI 10.1007/s11684-016-0446-y
   Allain JP, 2009, BIOLOGICALS, V37, P71, DOI 10.1016/j.biologicals.2009.01.002
   Alter HJ, 2004, VOX SANG, V87, P56, DOI 10.1111/j.1741-6892.2004.00496.x
   an der Heiden M, 2015, VOX SANG, V108, P123, DOI 10.1111/vox.12204
   [Anonymous], 2015, OUTBREAK NEWS T 1218
   [Anonymous], 2016, STAT CHIEF PUBL HLTH
   Appassakij H, 2014, TRANSFUSION, V54, P1945, DOI 10.1111/trf.12575
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Atreya Chintamani, 2011, Transfusion, V51, P1855, DOI 10.1111/j.1537-2995.2011.03084.x
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Besnard M, 2014, EURO SURVEILL, V19
   Bierlaire D, 2017, TRANSFUSION
   Biggerstaff BJ, 2003, TRANSFUSION, V43, P1007, DOI 10.1046/j.1537-2995.2003.00480.x
   Biggerstaff BJ, 2002, TRANSFUSION, V42, P1019, DOI 10.1046/j.1537-2995.2002.00167.x
   Bish EK, 2014, BIOSTATISTICS, V15, P620, DOI 10.1093/biostatistics/kxu017
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Brouard C, 2008, TRANSFUSION, V48, P1333, DOI 10.1111/j.1537-2995.2008.01646.x
   Bruhn R, 2015, TRANSFUSION, V55, P1195, DOI 10.1111/trf.13024
   Busch MP, 2014, ISBT SCI SER, V9, P276, DOI 10.1111/voxs.12082
   Busch MP, 2005, TRANSFUSION, V45, P254, DOI 10.1111/j.1537-2995.2004.04215.x
   Calleri G, 2016, TRAVEL MED INFECT DI, V14, P506, DOI 10.1016/j.tmaid.2016.07.001
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P842
   Chamberland ME, 2001, EMERG INFECT DIS, V7, P552, DOI 10.3201/eid0703.010331
   Chamberland ME, 2002, CLIN INFECT DIS, V34, P797, DOI 10.1086/338787
   Chamberland ME, 1998, EMERG INFECT DIS, V4, P410, DOI 10.3201/eid0403.980317
   Chancey C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/376230
   Cheng VCC, 2007, CLIN MICROBIOL REV, V20, P660, DOI 10.1128/CMR.00023-07
   Chuang Vivien W. M., 2008, Hong Kong Medical Journal, V14, P170
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Custer B, 2010, ISBT SCI SER, V5, P294, DOI 10.1111/j.1751-2824.2010.01384.x
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   David S, 2016, INFECT DIS-NOR, V48, P571, DOI 10.3109/23744235.2016.1164890
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Magalhaes-Barbosa MC, 2016, TRAVEL MED INFECT DI, V14, P458, DOI 10.1016/j.tmaid.2016.09.006
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Derraik JG, 2015, AUST NZ J PUBL HEAL, V39, P5, DOI 10.1111/1753-6405.12302
   Di Minno G, 2016, BLOOD REV, V30, P35, DOI 10.1016/j.blre.2015.07.004
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   Dodd RY, 2014, ISBT SCI SER, V9, P1
   Dodd RY, 2015, TRANSFUS MED REV, V29, P153, DOI 10.1016/j.tmrv.2015.03.001
   Dodd RY, 2004, INT J HEMATOL, V80, P301, DOI 10.1532/IJH97.04123
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   European Centre for Disease Control and Prevention, 2014, RAP RISK ASS ZIK INF
   Faddy HM, 2013, EMERG INFECT DIS, V19, P787, DOI 10.3201/eid1905.121664
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fourcade C, 2016, J CLIN VIROL, V82, P1, DOI 10.1016/j.jcv.2016.06.011
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franchini M, 2016, BLOOD TRANSFUS-ITALY, V14, P93, DOI 10.2450/2015.0187-15
   Frank C, 2016, EURO SURVEILL, V21
   Frank C, 2016, EMBO MOL MED, V8, P305, DOI 10.15252/emmm.201506058
   Freour T., 2016, EURO SURVEILL, V21
   Galel SA, 2017, TRANSFUSION
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Goldman M, 2013, ISBT SCI SER, V8, P54
   Gray TJ, 2014, INT J GEN MED, V7, P193, DOI 10.2147/IJGM.S59902
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141253, 10.3201/eid2011.141380]
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heymann DL, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1499
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Howard CR, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.47
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Karim F, 2016, TRANSFUS APHER SCI
   Kashima Simone, 2016, Rev. Bras. Hematol. Hemoter., V38, P90, DOI 10.1016/j.bjhh.2016.01.002
   Katz LM, 2017, ARCH PATHOL LAB MED, V141, P85, DOI 10.5858/arpa.2016-0430-RA
   Kaur G, 2015, BLOOD TRANSFUS-ITALY, V13, P197, DOI 10.2450/2014.0146-14
   Kelly S, 2013, MMWR-MORBID MORTAL W, V62, P622
   Kightlinger L., 2007, Morbidity and Mortality Weekly Report, V56, P76
   Kleinman S, 1997, TRANSFUS MED REV, V11, P155, DOI 10.1053/tmrv.1997.0110155
   Kleinman SH, 2009, TRANSFUSION, V49, P2454, DOI 10.1111/j.1537-2995.2009.02322.x
   Koepsell SA, 2010, TRANSPL INFECT DIS, V12, P459, DOI 10.1111/j.1399-3062.2010.00530.x
   Koppelman MHGM, 2012, TRANSFUSION, V52, P1498, DOI 10.1111/j.1537-2995.2012.03705.x
   Krauer F, 2016, BIORXIV
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Kwon SY, 2016, ISBT SCI SERIES, V11, P117
   Ladhani SN, 2016, ARCH DIS CHILD, V101, P600, DOI 10.1136/archdischild-2016-310590
   Lai SJ, 2016, LANCET INFECT DIS, V16, pE108, DOI 10.1016/S1473-3099(16)00153-5
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Laperche S, 2011, ISBT Sci Ser, V6, P112, DOI 10.1111/j.1751-2824.2011.01452.x
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Levi JE, 2015, TRANSFUSION, V55, P961, DOI 10.1111/trf.12944
   Lin CK, 2014, ISBT SCI SER, V9, P26, DOI 10.1111/voxs.12056
   Linnen JM, 2008, TRANSFUSION, V48, P1355, DOI 10.1111/j.1537-2995.2008.01772.x
   Liumbruno GM, 2008, BLOOD TRANSFUS-ITALY, V6, P199, DOI 10.2450/2008.0016-08
   Lo Presti A, 2016, INFECT GENET EVOL, V41, P270, DOI 10.1016/j.meegid.2016.04.006
   Lo Presti A, 2014, ASIAN PAC J TROP MED, V7, P925, DOI 10.1016/S1995-7645(14)60164-4
   Mackey TK, 2014, CLIN MICROBIOL REV, V27, P949, DOI 10.1128/CMR.00045-14
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mapako T, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1452-z
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Marano G, 2016, TRANSFUSION, V56, P249, DOI 10.1111/trf.13329
   Maria AT, 2016, EURO SURVEILL, V21
   Marka A, 2013, INT J ENV RES PUB HE, V10, P6534, DOI 10.3390/ijerph10126534
   Marks PW, 2016, J INFECT DIS, V213, P1676, DOI 10.1093/infdis/jiw089
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Meltzer E, 2016, EMERG INFECT DIS, V22, P1521, DOI 10.3201/eid2208.160480
   Meny GM, 2011, BLOOD, V117, P5778, DOI 10.1182/blood-2011-02-335901
   Mohammed H, 2008, TRANSFUSION, V48, P1348, DOI 10.1111/j.1537-2995.2008.01771.x
   Montgomery SP, 2006, TRANSFUSION, V46, P2038, DOI 10.1111/j.1537-2995.2006.01030.x
   Morens DM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003467
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Muller MM, 2013, VOX SANG, V104, P19, DOI 10.1111/j.1423-0410.2012.01635.x
   Munoz LS, 2016, SEMIN REPROD MED, V34, P273, DOI 10.1055/s-0036-1592066
   Murphy EL, 2016, TRANSFUS CLIN BIOL, V23, P13, DOI 10.1016/j.tracli.2015.12.001
   Murray KO, 2011, EPIDEMIOL INFECT, V139, P807, DOI 10.1017/S0950268811000185
   Murray KO, 2010, VET RES, V41, DOI 10.1051/vetres/2010039
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, BLOOD TRANSFUS
   Musso D, 2014, EUROSURVEILLANCE, P19
   Musso D, 2016, J MED VIROL
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nayak S, 2016, SEMIN REPROD MED, V34, P266, DOI 10.1055/s-0036-1592071
   Neumann G, 2011, INFLUENZA OTHER RESP, V5, P157, DOI 10.1111/j.1750-2659.2011.00231.x
   Oei W, 2016, VOX SANG, V110, P301, DOI 10.1111/vox.12370
   Oei W, 2014, TRANSFUSION, V54, P1705, DOI 10.1111/trf.12539
   Oei W, 2013, TRANSFUSION, V53, P1421, DOI 10.1111/j.1537-2995.2012.03941.x
   Oh HB, 2015, TRANSFUSION, V55, P1655, DOI 10.1111/trf.13054
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pacheco O, 2016, N ENGL J MED
   Pan American Health Organisation, 2016, REG ZIK EP UPD AM
   Pan American Health Organization/World Health Organization, 2017, ZIK SUSP CONF CAS RE
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Perevoscikovs J, 2010, EUROSURVEILLANCE, V15
   Perkins HA, 2010, TRANSFUSION, V50, P2080, DOI 10.1111/j.1537-2995.2010.02851.x
   Pietersz RNI, 2014, VOX SANG, V106, P256, DOI 10.1111/vox.12098
   ProMED-mail, 2015, ZIK VIR AM ATL OC
   Reesink HW, 2010, VOX SANG, V98, P468, DOI 10.1111/j.1423-0410.2009.01301.x
   Reusken C, 2016, EURO SURVEILL, V21
   Reuters, 2016, REUTERS
   Rodrigues LC, 2016, LANCET INFECT DIS
   Roth A, 2014, EURO SURVEIL, V19
   Rougeron V, 2015, J CLIN VIROL, V64, P144, DOI 10.1016/j.jcv.2014.08.032
   Sabino EC, 2016, J INFECT DIS, V213, P694, DOI 10.1093/infdis/jiv326
   Sakkas H, 2016, J VECTOR DIS, V53, P305
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Seed CR, 2016, VOX SANG, V110, P317, DOI 10.1111/vox.12372
   Seed CR, 2014, ISBT SCI SER, V9, P6, DOI 10.1111/voxs.12060
   Seed CR, 2009, TRANSFUSION, V49, P1482, DOI 10.1111/j.1537-2995.2009.02159.x
   Seed CR, 2005, INTERN MED J, V35, P592, DOI 10.1111/j.1445-5994.2005.00926.x
   Shander A, 2016, EXPERT REV HEMATOL, V9, P597, DOI 10.1586/17474086.2016.1164593
   Shang G, 2012, VOX SANG, V102, P185, DOI 10.1111/j.1423-0410.2011.01536.x
   Shang GF, 2016, TRANSFUS APHER SCI, V55, P233, DOI 10.1016/j.transci.2016.07.018
   Stanley E., 2009, Morbidity and Mortality Weekly Report, V58, P1263
   Stramer SL, 2014, ISBT SCI SER, V9, P30, DOI 10.1111/voxs.12070
   Stramer SL, 2013, TRANSFUSION, V53, P2375, DOI 10.1111/trf.12371
   Stramer SL, 2012, TRANSFUSION, V52, P1657, DOI 10.1111/j.1537-2995.2012.03566.x
   Stramer SL, 2009, TRANSFUSION, V49, p1S, DOI 10.1111/j.1537-2995.2009.02279.x
   Tambyah PA, 2008, NEW ENGL J MED, V359, P1526, DOI 10.1056/NEJMc0708673
   Teo D, 2009, TRANSFUSION MED, V19, P66, DOI 10.1111/j.1365-3148.2009.00916.x
   Ticconi C, 2016, PATHOG GLOB HEALTH, V110, P262, DOI 10.1080/20477724.2016.1234804
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   U.S.Food and Drug Administration (FDA), 2016, REV REC RED RIDK ZIK
   Ulbert S, 2011, INTERVIROLOGY, V54, P171, DOI 10.1159/000328320
   Uncini A, 2017, J NEUROL NEUROSUR PS, V88, P266, DOI 10.1136/jnnp-2016-314310
   US Centers for Disease Control and Prevention, 2015, ZIK VIR HOM CAS COUN
   US Food and Drug Administration, 2009, GUID IND NUCL AC TES
   van Doorn H Rogier, 2014, Medicine (Abingdon), V42, P60
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Walsh GM, 2016, TRANSFUS MED REV, V30, P53, DOI 10.1016/j.tmrv.2016.02.003
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Weusten JJAM, 2002, TRANSFUSION, V42, P537, DOI 10.1046/j.1537-2995.2002.00099.x
   Weusten J, 2011, TRANSFUSION, V51, P203, DOI 10.1111/j.1537-2995.2010.02804.x
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Winston DJ, 2014, TRANSPLANTATION, V97, P881, DOI 10.1097/TP.0000000000000024
   World Health Organisation, 2005, IHR 2005 EM COMM ZIK
   World Health Organization, 2014, EB OUTBR
   Wu D, 2016, J INFECTION, V73, P300, DOI 10.1016/j.jinf.2016.06.008
   Xiang NJ, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2049-2
   Yasui Y, 2002, BIOSTATISTICS, V3, P133, DOI 10.1093/biostatistics/3.1.133
   Yip CW, 2009, INFECT GENET EVOL, V9, P1185, DOI 10.1016/j.meegid.2009.09.015
   Zhang W, 2009, TRANSFUS MED REV, V23, P146, DOI 10.1016/j.tmrv.2008.12.008
   Ziermann R, 2008, EXPERT REV MOL DIAGN, V8, P239, DOI 10.1586/14737159.8.3.239
NR 185
TC 5
Z9 5
U1 1
U2 9
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0887-7963
EI 1532-9496
J9 TRANSFUS MED REV
JI Transf. Med. Rev.
PD JUL
PY 2017
VL 31
IS 3
BP 154
EP 164
DI 10.1016/j.tmrv.2017.05.002
PG 11
WC Hematology
SC Hematology
GA EZ0VX
UT WOS:000404425400003
PM 28545882
OA Green Published
DA 2020-07-08
ER

EF